>KECLDBNJ_00005 hypothetical protein
MKLTEKQTHIYEGLKGIGEEISSFYLDAIKIIHQNNIASQSYLLAHFAREIDGGLRDILS
PLKVKEELQKDPALKDRGLVASILVALDLKLDDPFAIKYASVASKFNKYAHRRGATKKPR
KLLEVIVLWEEYEDILLKLIGSFINQLRRIERITRFQKPTKQILEALKNMFDNKQIERHF
YINLKSEYWLEPMFNKGFFSPESIKDEELWNQAEYLIFIAKNIKTKVFKETNAIFLVKII
EKINFHSENIQKLKNYRIWYFIFDILTELPKKYINNKIINSIPNYLNTEHENTLESLGIF
KLIYSYSVEEKNSSSFKDQITKLVELVFEISNDKKFKDSSAYENDNYYPIIRAYQLKQEC
KKPEFYKLVAINCSNQTIYRIADYLNTFLETNNISNFLIKTIFDLNITRKHSHSIETIYS
LFLQNVCVEIAQLEKNRIIEIIESFLSERYKHKHFIKLSLFLFAKTWNKTKELFFGFISK
QKKDLFSEPFWRDDFYFMLDHISIHLNNLESLVIENLIEKFSENCGSYKSPEHFRLYWFS
SLNDNENFEKKYSDLSLKLGANKQEIKPKLESNVTFGSTSPLSKNEILTIPILELTSFLK
KFDPERGFREPCVEGLSRVLHEVIKENPSLFTDNWEMFLEVPYRHIAEIFSSLSDVWKNK
QQIDWDSCIKFIYKYTSQNKFGTNDLTLPNSTYNADHYWPLREFCRLLSAGMRDDTKAFD
ALLLPKVEKIIFFVIEKYLKNEIPDSQKEKLGSATSVINSDTGIFIGTLFDYSLRKARLS
NIAGKKRSRWSSAERNLFENLLTNRVQEIFTYLGWHRNQFYFLDFKWTQKQLITIPKLDN
QTIKSYFGGHLLNNPYSKFDYRTFKNLYISAIKENWQLVDSHMIDNPIELHAAVFYIFDY
EDLNEGDIITEIFKNDKIEQIRNLIHSLSFKFDEYIKELDASGKIEFRKKIYKIWQYTLT
TLDKYKTLKTKEIPTIFYLIKYIDELDEESFQLIKQSSRFARNRRDLDKLIENLNRLKTK
GNIIQSSIYACEIFIDSVFTDVYYASVMQKEIIEFTEYMFTLNDDRLTEYSNKICNEFAK
KGEYFLLEIYENFNN
>KECLDBNJ_00006 hypothetical protein
MKKKKIYKHLKQVGEDHLRKLKPHPHFKNNQQVCFPAQSHLHLMFLIEDLIKVSVMALNG
IERGGDRPLKEPERSISEVLKHTLDLLPLEEAEFIDKTMALLSEESSNTEQ
>KECLDBNJ_00007 hypothetical protein
MKRNKINKRKIKSLQTIAQRTYGLQKERIGKHTYRTAKVHFEDFEDHMMRTTALLDVCIL
ALESEGKFYSKILSHKSGDIAIQQALELVIQLLPHEDISKYQQLIHILEEDVEALGLPKK
LKKLIKMNADEKEKNI
>KECLDBNJ_00008 hypothetical protein
MLIISHDQVADPKIFMNEVFNKTQEQVSLYAIHYTLNEANNKINYGCNFLNRVLREDTLL
YSEDNRLKQLGSYLYHPEVFLRIQKHWNKRFEHARYFEEKSTICEDNPSNQGRYLILQQA
IQQACLGLIYVFWEYQSSYYSLPYLLHLCEQFSDVPKIIYPKRSFQSQQMYSRLCHAQYN
LNEKIQENPSESDSLKAEHLTYKFIQAARKEADKKLEELKKLHLKN
>KECLDBNJ_00009 hypothetical protein
MTTTKPNHIGRKIARIRELRGMKQETLAEELGISQQSVSTLEKSETVEDEKLERVAQVLG
VTKEAIENFSEERVINFFNNFNDNSFSNSQGTFAAYNCTFNPIDKLVESYEENKKLYERL
VQAEKDKVAYLEKLLNK
>KECLDBNJ_00010 hypothetical protein
MELIVNRIKYQLPVKEKLNIIVSDKIDLPFRMRLDFFKKRFQSPEIGLINEWEREKKINN
DTFISYTFSVNGSANYLALDYNQIFEYKYTIWLLCNHFKSLGFAVNFNPRVIDVSCYEFV
RVYNESWDIFRRWDFKFNTKFKELTFNIGSSETFISKNAIELNDNLGNLSCILPNGEIEK
SKYFEIKKSKVIANRELRNTSNLGYNKNPINYFARYEELRQFFNQNLKPSKELIFPSIGF
DSIRAEKVNFSKNKMLFRNGETDINPVSGMRSHGVYQDVPDSLEKQFIFIYQNNDDANTL
YKYLKNGYKGFPGLQPYVNIPLTLANSVEKGKNKRLEYENIQSLMDAYQDFENRELPNNY
YLNLFAIVIGPFDKNDPCTEYYELKLSLIKKGIPTQFVNYENIRKSGVFNYHLPNIAIGI
HAKMGGIPWRLATPKKQDLVIGFNQIKSGNKKFIGSTVFFDNQGKLKRTQAFGEQDSSNE
ILYLLKKAIENYLELESDIQRLVIHYYKTLSKKDQGNIERILREEFNLSIPYAVVEVNDT
KSRLDLGFDPDSNFRMPVSGSYLRLYPKEYLLFNNNRFKTIAPVVIKDELPLKLKIHFAD
EAGFSHRELIEQVYEFSRLIWKGLKQRSQPATCYYAKEIARFKSEIGEPIPDNKLTQTTP
WVI
>KECLDBNJ_00011 hypothetical protein
MTKLNLNSTLNKCLFLFGAGASYGTGCLTSNGMLKALEKKLTTPNLSEMSEPQAEAFRFV
ISSLEYHSKWRSLDGNSQFRFEPNIEELALVIRKIKNRENFLPYPITGNWADKLINLEKQ
HELNNNYEEGLFESIERKLKSEFVPSWLNHDPDKLDYLDPLIKLLASENLKHPLECFSLN
YDNTIEDALGNHEIKPYTGFISGEWAGMDVSEVVDEFDKIKYYKLHGSLNWIRLLQDGSV
KERNRLTQEQQEDIDNEHSPYIVFGHGSKTFSFDPFFNLISNFKKKLLERDYIFAIGYSF
FDPYINNLIIEALNASPYKKLIIINPSWKPGDLQENEKNEKFDLYTINNGKSVSPQLSEY
IRQIQLNSFYSELPEFNLSRISGENTIHLMPIGFDKFLEKYFLNEGEDLIKLVEYYESKR
VLEENPF
>KECLDBNJ_00012 hypothetical protein
MNIFKKKLEDAKPKEVNFEPTELFQTLFHKEGYAYLRGIQEEVLNSWHKIRSQRDVLCKM
NTGSGKTLVSLLMLYSKMVEGVGPSLYMCPDRQLLEQAKIQADLYGIPVCEVEYYGQRSV
FPNEFLNSRAILLCTFQKMFNSRSIFERDNIDVGSIVLDDAHVCLDIARETTTLFIPFGH
SLGERLLKLFEADLKYQAPGTYHRLIQGDPYAKILKVPYWSWLSRNSELIDLIGGFSEDD
ELRFKWGLMADDLKSYDCYVGPRGLEIAPSYVPFHNVRAFNEAKHRYILSATFEDQIDLI
KDLGISIDSIKNALIPRDRKDVGQRLILAPQRFDSRITDEQIMAMVKEYSVSGINVMVLT
PSSDRAKKWEDIGAQILENNNINKDISKLKSNRGLFYVLVNRYDGVDLNGDMCRVLVLDG
YPSFSSYEQLYAEMRLESVKASLKAQIIEQGLGRAVRSGSDYCTVFLMGKDLLQFVGKKS
NLQYFTPVTRRQLKLGLSLLDDESKEDSLTKIKETANLCLVQDMSWREYHSEILSDVETD
KTGERILTNLKIADIESKAVDKFRRRDYEGASNMILNELVDTIDLSQKQKGWYFELAANY
LFLDNAPKSNDLQLKAAQTASHMLQSKNGHSYTKIMASEEQSIQVLHFVKRFETSQDFKI
YIEKLFEDLNFSQDISHTKFENALAETGRLIGFYTQEPEAEFGNGPDVLWVMTDNHYLVL
EAKSRAIHDEITRDNINQLLGSGEWFKKLYGSAAKHYLVTLQPPNIKGWNVNTSPNTRVI
DENSLILLKDNLRRFVDGIISYGFSAAKPKEIANLLGMHNLTPVGFRNTYLKEVNLKKK
>KECLDBNJ_00013 Adenosine monophosphate-protein transferase SoFic
MYNWQHEDWPNFKYTTTEIEEKLFDFSQRAGRVNGLLEGLSGKMQMEAILSLMVAEAVKT
SEIEGEYLSREDVMSSIRNNMGYGTPKTVKDPMAQGVGDLMVRVRQNFAKPLTDQVLFQW
HETLLEGAVRINTGQWRKHSEPMQIVSGSWGKEKIHFEAPPSHLLPNEMRAFITWFNESH
PAGASPIKKPLIRAAIAHLYFESIHPFEDGNGRIGRALSEKALSQDLNRPVLLSLSKAIE
HDKQAYYKALKNAQQSNEITDWIIYFVNTVLEAQSQAEDLVSFTLKKARFFDRHRNSLNE
RQLKVINRMLDEEPEGFKGGMTAKKYIALTKTSKATATRDLQDLAAKKLFISIGEGRSTR
YEINFED
>KECLDBNJ_00014 Tyrosine recombinase XerD
MPVHSTLGVNFFTRPKRNNPNKLDIYLRITVNKKRSEMSIKRDVDVKDWDILRVKAKETS
DQLITLNSYMDDVKAEVLNAHKELHAERKVITAKAIKLRYIGEDEERMTLLELVKYHNDN
MGLSLKPGTMKNYYSTEKYIKAYLLDHYKSDDLFLVELNYRFITEFEHYIRTYKPKKKRK
TCSINGTRKHLERLRKMVNLAVRMEWLPKDPFVNYKLKLERKERCYLTQRELNRIEETHF
QSKGYERVRDCFLFACYTGLSYVDLKALRKDQLIPASNGRLWIYTKREKTNESVRVPLLP
QALELVKKYTKDKELEVSGKLMPLYSNQKVNKYLKEITTVCQIHKNVTFHVARHTFATTV
TLSNGVPIETVSKLLGHTQLQTTQIYARVLQKKVGDDMDALMRKMEARNTKESFGS
>KECLDBNJ_00016 hypothetical protein
MPPNTVAGDYTFTYSVCENLNPGNCQTASVTISVAAGTLVAEDDDFSLTPVNGVDGGIAG
DVTLNDTLDGAPVDDADIYIVNNGGLNGVAINANGNLIVPPNTPQGTYTVAYSICETLNP
GNCDSAQITIVVQESGLALIKDAVFVDTDANASVNIGDIITYTFSITNTGSYVIDDLRLT
DSELGIADLAITPSSLAPGESASLTIDYSITQSDIDFGRVINTASISGIDENDNTISDVS
DSGNAADDTGRDDDATVTLLNGNSNLELLKVVRYEDTNSDGLVNSGDNLIYNFTVNNNGS
VTINDITIVDDLVTVTGGPIDLAPGESDASSFSAEYTITPADVEAGEVINIALATGVDTN
GVLIDDFSDDPTDALNVDEDNDGDFEDPTVFVINEDASIELLKMAEYVDANSSNIPDLGD
IIRYTFVVTNTGNTTINNITITDELVTVIGGPISLAPGESDATTFYAEYAITRSDVMTGY
VDNTASVYGTTQRSTIVTDISDDPTNSTNEDANGDGNPDDPTRLVLSIEDVFIYNVITPN
GDGLNDQLVIGAIERFPDNTLRIFNRWGVEVFKEENYGQPGSEPFRGYSNGRVVIDSGEL
LPTGTYFYVLEYVTQRGNTRQKAGYIYIN
>KECLDBNJ_00017 hypothetical protein
MVFLLSYSLGIAQQDPQYTQYMYNPLVINPAYAGNRGVTSILLLHRSQWVGLDGAPSTQN
LSVHSPIGLGKVGLGFSLVNDVLGPARETYFNTDFSYTIDTGAEGKFSFGLKGSLNLLDV
DFSRTNPFNQNDPFLVSIDNKLSPNVGVGIFYHDAKFYGGLSAPQLLRTDHFDRSGSQGA
QTFVSEEEIHYYGLAGYVFDLNRNLKFKPSTLVKMVAGAPLSVDVNANFLLYDKLTLGAS
YRWSAALSALAAFQVNDGLLIGFAYDRESTDLGNATYNNGTYEVFLRFELFKEYNRMLTP
RFF
>KECLDBNJ_00018 hypothetical protein
MVLRPAFPFLEYALDYEYISTVLCENKDKPQLNCNGKCYLMQALADASEKESTQKKKSTM
SSIELLPFIIEVNELSIPIVFAEETQVTFSFYPNLSARETATGLFRPPIV
>KECLDBNJ_00019 hypothetical protein
MYIFNKCRVVLLCILMATSLISCDENAVLRDQYNALFTEVIDLHDELMPKMSELTNLEEQ
LEAKDSLGQADQQILENLKKADSRMMDWMHDFTDTYVKDRTPVAKMTAQELEQGIEGLQG
ELQEVKDLRDFTHKSLDEATTTLK
>KECLDBNJ_00020 hypothetical protein
MVFRPVAPLLDYMVNYDYIADELCVNRDRPELNCNGRCYLMNALAEEASKKKDAQQREGK
LNFQLSITYFVSETDWSFELPQAATKTQPTDHYLFKKIEGFTAALLKPPIS
>KECLDBNJ_00021 hypothetical protein
MKTIIKLQLLILTLALSVISCSSDDDATQELSGENNLTIEFDNSVNGDDLLLGTSSYTNS
NGETLTINRFNYIVSNFVLIDAEGNEYVYPKDDSYFVVSEEEAMNEVVLENIPAGDYVAM
RFGVGVDQEKYLQGAEGQGDFLQIAEETEMMWSWQAGYKFLNFEGIFTSATVTEATNFQI
HMGSHGSSLDNYKEVTVELPTTALVSESLSPIVHFAVDANEILDGNTKILLSEKAVVMID
EVKSPQIAVNATGMFRVDHVHNGENIEH
>KECLDBNJ_00022 Cytochrome c551 peroxidase
MKSLLISCCALLCIFASCSSNDDAEYTAIDEALVLELPDNFPEINYDLSANPPTKNGVEL
GKKLFYDGKLSANGFISCGFCHEQRFAFTHHGHQFSHGIDDLEGTRNAPAIQNMAFQTEF
AWDGATSHLDLFPIIPITNEVEMGETMTNVLSKLQADSEYQRLFASAFEDAEVSNENFLK
ALAQFMVTMISSNSKYDKYVRNEEGGEFSDLEKEGLAVFESKCATCHATDLFTDNSFRNN
GLPPYPGIDDIGRAEVSGSAADNYKFKVPSLRNVAITAPYMHDGRFGSLQSVLNFYNSGV
QESETLDPILKQNERLGIALTTDEQEALIAFLNTLTDNEFLEDERFAEY
>KECLDBNJ_00023 hypothetical protein
MLKYISSCFILLATLMVNANTPIEDPIASAVNPFYKYDYEECDFCGCGSTGGGMGYGTIG
NENFIGIRYIYQRYQSRDGIFNNSPWVEENFNTLQLWGKIPVTEKLSVTAILPYHFHNRN
FVDGSSQSINGIGDLSVLAFYSLITPKVDGLYANQQTSIKHMLEIGGGVKMPTGAYDRAN
NEGSVNPSFQVGTGSWDYILAANYSVGYETWGLGVLANYTFKTENNVDYHFGNQFTYGVN
VSKVYNTLSIDKIIPYAGLAGEVYAENESYGLPVADTKGNVMFARLGAEISFGKLGTGVN
VMLPVYQSLNAGNVEAKYRLGLHLNYML
>KECLDBNJ_00024 hypothetical protein
MPKKTVKRTFRISKYIIYRETFVDYKEYFWSFLGAFMGIGIIAYIQSRYLLEVENIFLIG
SFGASSVLVYGAINSPMAQPRNLLGGHLISALIGVSVAKWIPDIVWIEAPLAVALSILAM
QFTKTLHPPGGATALIAIIGTSKIQELGYYYALSPVLSGALILYLTALVFNNLTKHRSYP
LKKR
>KECLDBNJ_00025 hypothetical protein
MRTLFLIAALALGTVSVQAQETCETPKVKAGDVLKIAEPAHSSYDHFNFPKSNFIIKRGG
IANYRALINQEVEVTDVTMKNGCIAKVDVKLANGKKFFNTVNTVSVDFKEALAAGELRLK
>KECLDBNJ_00026 Transcriptional regulatory protein ZraR
MRLRKENILIVDDDLHILELLQRHLHSWNYHTYRAVSVKEAVAILKDTHVDLLITDLKMP
QIDGFELIKFVTEHYPDLPKLVVTGFPSVQDSLKAIKSGVVEYLTKPFTKGELQAAVAKA
LPKSVKEVVKNDTAKPKQHGEIIGASEKIEEVLQIIDRVKDNKATIFINGESGTGKELVA
RAIHYEGKFSKAPFIPVNCGGIPENLLEAELFGYTKGAFTGADKDRKGAFQAAQGGTIFL
DEIGNASLAVQARLLRVLQEKEVVRVGAQKPEKIDVRVIAATNNNLREMIKKQTFREDLY
YRLSVVEIPLPALRERMSDIPLLVDKFLFKYGVEYKDRFIRIDPEALEILKRYTWPGNIR
ELENIIQRAVIMCDKAVGVKDLPDHLKYNLEMPENKLVSLAEMERDYIKKVLRSTGNNKT
KAAEILQITRKTLRHKLDN
>KECLDBNJ_00027 Sensor protein ZraS
MSTIEAALKERIKELTCLYEVSSILVDADPKEHIKTFTAIAQSIKVGFQYPEDTEVVIEQ
GSIHVATGTILTDKFLSTKIKVFDAVEGFIKVYLNKESLDFLPEEQPLIDNIGIKIGDYL
DRVASKQNAARLRQQMEHADRLAIIGELTAGIAHELNTPLANILGFAELLKEDLEENFSV
AADLDKIIKNAIFSREVVKKLMFFSRAMPQEKTLVNIVPQVREAMNLLDATFRKENVRYT
VTIADEEMLLEVDTVQLTQILFNLTINAIYFSPPDGLVQIKVNQDAETIYLEIIDEGPGL
SDEGFEKVFQPFFTTKPTGSGAGLGLSVVHGIVTSHNGSISAKNNEDKGATFKVSLPK
>KECLDBNJ_00028 hypothetical protein
MARRIHTFLALLVVFLMVLATNRIDQHHFEKAQETVNEVFKDRVLVQGYIFSIAQALHEK
ELMLVQQTYNQSKTTNAAIEDLIADFETTKLTRSEAELLSQFKSDFVALQKLETRSEQPE
MVAQQQRQIADLKEYLSKLSEIQITESRNLTTSAQKSLDMSNMIANFEIFFLICIGIALQ
IIVFYKAKKSVKA
>KECLDBNJ_00029 hypothetical protein
MPIIMKFSRIFYVFLLSVLSLNSTTLVAQNGDQMLDGIGETALIARYIFDGNAKDWSRNN
LHATLSENAEFTTDSTFNKVLSLTDAAFVQLPKTTLNSMESLSISTWIQLDQNTENQTLF
DFGKDSARHFYVNPVSGNVVLKSNANAVTGTFSKLNSGTWAHLALIVDVTAQRLEIYLNG
ALASQKTLSAFDLNTIINTENNTLYLGKSLAASEANLQAKLHDFRIYRIPLSQNQVKNIY
AIATGKEESVVNERHEPEDNLPQFADDVPQLYNHYLTGVSDLTVETVVGQLPRLPRFVDA
TYKIPVNTTKVRVIWPAPTDNSSVLQPGTYEITGQVLGTSFQPKATVVVKKGNAQETPQR
TLEAFALNEVSLDANRLGQKSKFIENRDKFITTLAGTNPDSFLYMFRNAFGQPQPEGAMP
LGVWDTQETKLRGHATGHYLTAIAQAYASTGYDSALQQNFEAKMKYMVNTLYDLSQRSGK
PATASANFVSDPTAVPTGPNKEIYSSDLSEAGIRTDYWNWGEGYISAYPPDQFIMLEHGA
KYGGQETQVWAPYYTLHKILAGLLDVYEVSGNEKALHTAEGMASWVYARLSQLPTETLIT
MWNTYIAGEFGGINESLAQLYRITENENYLKAAQLFDNIKVFYGDAEHNHGLAKNVDTYR
GLHANQHIPQIMGALELYRNSKNAAYYHIADNFWYKTKNDYMYSIGGVAGARNPANAECF
VAQPATLYENGLSAGGQNETCGTYNMLKLSRGLFLYNQQPELMDYYEQALYNQILASVAE
HTPANTYHIPLRPGSKKQFSNADMSGFTCCNGTAIESSTKLQNSIYFKSKDNKALYVNLF
VPSTLQWSEQQISIQQVTAYPQEDQTKLIINGKAKFDLHLRIPGWATNGIEVKINGKIQK
TNAIPGSYLKLSRSWKNGDTVALKIPFGFRLDPIMDQENIASLFYGPVLLAAQEEAPRTD
FRTITLNAEDLGKTISGDPKALEFTIDDTTFKPFFETYDRHSVYLDVQLQQ
>KECLDBNJ_00030 hypothetical protein
MNARIKQYISLLFLAFFLTTKMAGLHVLTHEDTDVKDDCAICHVLVTEHKTAVILQEPEA
FVPDSFYPEYQEKQPITTAVFYQGTSYSYHLFSRPPPAA
>KECLDBNJ_00031 putative TonB-dependent receptor
MLFRLLVVCLSLVLSTYSFAQQTSIVKGSVVDSVSLKPLSGVTILGENTYAVTDDSGAFQ
LKSPKNSTVFEVSHLGYASAKFTLNANQSTPLVIKLKPSSTSLDEVSVQGKTSSRIEKES
ATVSVSVDEEFLHANRENSLMQTLRKIPGVSTMTIGSGQSKPTIRGLGFNRVSVVQNGIK
HEAQQWGSDHGLEIDQYGIQDIRIIKGPASLMYGSDAIAGVVDIQPSKAPAINSFGGEVN
VLGETNNDLLAVSAGVQGRKEKWYYRARLTYRDYADFKVPTDRINYENYVFELYDNDLRN
TAGREANGSFSFGYVSDNFRSETFVSNVNAKNGFFANAHGLEVRSSTIDYDASNRDIDLP
FHKVNHVKVTNNTTINLNEHTLHFDLGYQNNQREEHSEPVPHGYMPTPPNSRERVFTKNT
YSLNAKDIFKVENHTLSAGINTELQNNNIGGWGFLIPAYDRYTAGAYLFDHFELTEDIHL
QGGLRFDAGRVATQAHYDWYRSPRDNPDGSTSNVYLQRAENRTLDFGSFSGSVGVSYIRG
NTTYKLNAGKSFRMPLAHELASDGVNYHMYRYERGNLDLDPEASYQLDAEVTHTAGRFNF
GVSPFLNYFENYIYLNPTSSYVETLQVYEYTQAEVFRTGGEVTAGMQVSQDFRLDASAEY
VYSRQTSGPKEGFTIPFSPPLIGMLSANYNLGNWSLFKDVNLNADLRVAAAQTDIVPPEE
ITAGYQMLNLAVMSKLNLFNNQNPTLLRVKLNNVFNTEYYDHTSFYRLIDVPEAGRNLSV
SLTLPF
>KECLDBNJ_00032 hypothetical protein
MKLNMKHLALFVLAGITLSSCSDDDTDVIVEEAPLISNFEFGEGSTHGDEQVAYKGSDIH
LEAEIVAEATVSSITLDIHAHDLEVGEGEEEWHFEQEFTDESYLVINPTFHEHVDVPATA
PAGEYHITLTVTDTNGNSTEVEGHIQVLDPVTTSNLSIDESVARGSDFHAEFLIEAVHGV
HNITVDIHAHGLTVGEGEAEWDFEQIFEEGYHGETSVEFHEHIDVPATAPVGEYHMVITI
EDEEGNISEIDTHLDVTA
>KECLDBNJ_00033 hypothetical protein
MKRIALITLVFGSLFIASCSSDSDSVRDEERPTITVDYSAGFPQGCETLQRGETYTFTAR
VTDNLALASYSLDLHHNFDHHTHDDQAATCDLEPVKTAVNPLIYMENFSLDNRPTEYEIQ
IEVSIPEDIDTGDYHCAYSVTDETGWQSRTSIDIKITD
>KECLDBNJ_00034 hypothetical protein
MKIINQHFITRITLFLFSAFFSLMITSCSEDETNIEGPKPEPTISDIEVGLHNNEIGVVG
GDFHFNAEVLAGDLL
>KECLDBNJ_00035 hypothetical protein
MIFTERIAGLKNATLHRHFDIPEEAPKGLYDFKITVEDMNGTSLEETRKISLIDIEDYLD
VFPHVSAFGVDKIDIDGKGGFNNFYNNGEFRNTENPSFRKDESIWASVQIGNIKGDGIMY
GLLIKKSFDHKPETVEDIDFSKAIVTDLKQHSDYDEIRAFQSSYNTNFNNHYMYGAAYKI
GADADNNLPNSNLVTGNKAWENGTYYYGYVYTNTTYNLSTFKYIEFEITGF
>KECLDBNJ_00036 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MRENTTDFQNTTETQVQPSKESDLLKARRDALHDATEKTEETEGSFKWLTEHSRSFLAAG
YLSEGVSAEERIREIADRAEEILEMPGFSDKFYKYMGEGYFSLASPVWSNFGKKRGLPIS
CFGSHIDDDMGNILYTQSEVGMMSKLGGGTSGYFGKIRHRGAAVKNNGYASGAVHIMQLF
DKMVDVVSQGSVRRGRFSPYLPISHPDIKEFLEIGTEGNSIQQLTHGVTVDSTWMQEMID
GDTDKREVWAKVLQRRGEMGYPYIFYTDNANNGKPDVYKDKGHDIYASNLCTEIMLPSSD
EWSFVCVLSSINVLHYDKWKNTDAVETMVCFLDAVLTEFIDKLEEYRDSDNRDHRQTFMF
MERAYNFAKSNRALGLGVLGWHSLLQSKRHAFDSQEAYDLNSEIFREIKQRSYKASEELA
EKFGEPEVLKGYGRRNATLNAIAPTTSSAFILGQVSQGIEPIWSNVYVKDIAKIKTTIKN
PFLEELFEEKGMNTPEVWRSVRDNDGSVQHLEFLTEQEKDVFKTYAEIDQMAIIYQAANR
QNHIDQGQSINLLVHPDMPIKEINKIHITAWKLGLKSLYYQHSMNAAQKFKQKKECVSCE
A
>KECLDBNJ_00037 Ribonucleoside-diphosphate reductase subunit beta
MSSQEIKKIIKRDYSTAPFVLEKITNAISNAMAALGHGSEQDAKLISMQVYEALLINKDS
EADYIPTVEQVQDMVEEKLMSSEFHDVAKAYIIYRNKRAIERKTNIFEKRINLKPYEYPE
LNEYVAAIRHSYWIHTEFNFTSDIQDFKTGLSEVERNAIKNTMLAISQIEVAVKTFWGDV
HHRLPKPEIAAVGATFAESEVRHHDAYSHLLEILGLNEEFKELKKKPVIMKRVHYLETSL
KHAKSDDDREYTESILLFALFIEHVSLFSQFLIIMAFNKHKNMLKGISNAVEATSKEEQI
HGDFGVDIINIIKKENPEWFDEDHNNLIKDMCLRSFEAESKVVDWIFEKGELDFLPKAVI
NEFVKNRFNKSLEAIGLDKLFDIDEALLQETEWFDDEIIGTKHGDFFVKRSINYSKRTQS
ITSDDLF
>KECLDBNJ_00038 Oligosaccharide 4-alpha-D-glucosyltransferase
MLFLALLFVSFQLSVAQTSSLVQPDVAIFYPKDFKAYKTLPSLAVTQDVSQEKPLPANWA
VKPQFLQIEGKNAVQFMFPEHVDLYGTGEVLGDLRRNGTDVTLWNTDNYEYGKFEGKQLY
QAHPWVLGVRKDGTSFGILADHSWRQQIVLDDKVTFISEGPTFRVLVIEKDSPQEVMKAL
GELTGTIAMPPLWALGYQQSRYSYYPDTSVKELADEFRARKIPADVIWMDIDYMDGFRVF
TFDKEGFPDPKGLNDYLHDKDFKSVYMIDPGVKQDSLYTIYQQGTAGDHWVQTAGGKEFN
GEVWPGQVAFPDYTQPRTQKWWASLYTDFMNLGIDGVWNDMNEPAVFDGPGGSMPDSNLH
RGGGALPMDKHLRYHNVYGLLMVRSSREGIMAVNPEKRPFVLSRANFLGGQRYAATWTGD
NSSTWENLKMSIPMSINLSLSGQPFNGPDIGGFTKSPTPEVFANWIALGAYYPFSRNHTS
NETEAQEPWAFGEEIEQVSRTAINRRYRLLPYLYTLFHEASQTGMPIMRPAFFADITDTS
LRGEQQSFLLGEDLMVIPQWAEDLKMPQGDWQDLTLEENTDKYQATVKLRDGAILPVGPV
IQSTVDYSTSEITLFINLNAEGKASGSLYDDAGEGYGYQSGDYSILDFEATTVDGQVEVH
IEQTEGSRKLDRKFKIALVQDGAVKYSEWQSGDTIRLN
>KECLDBNJ_00039 Cyclomaltodextrinase
MKLFFNSMLFLFLFSAPLCAQIDRVEPPYWWADMETSEVQILFYGENIAAYDVSTEDEVL
ITGVTKTENPNYLFVTIETDGLQAGTFQFNFSKKGKKSFTRTYELKKREAGSAQRQGYDS
SDAMYLLMPDRFANGNPDNDSVEGLTDTYDREASGGRHGGDLQGITDHLDYLEDLGVTTI
WSTPLLEDNDPGYSYHTYAQSDVYKIDPRYGTNADYRNLADELHKREMKLVMDYVTNHWG
AEHWMIKDLPTYDWINQFPGYAQSNYRMETQYDMHAAERDQHYCVDGWFVKTMPDLNQKN
PLVLQYLIQNAIWWIEYANLDGFRVDTYSYNDKEGISKWTKAIMDEYPNFNIVGEVWLHD
QAQIAYWQKDSKIGAIQNYNTHLPSVMDFTLHDGLTSMFSEGAGWDTGMMKAYNNFVNDF
LYPDINNLLVFLENHDTGRFNEIYDQNLDNYKLGLALIATTRGIPQLYYGSEIGMRGDKG
KGDGDIRRDFPGGWKDDAQNAFEAASRTQQQEAFFSFTKKLMNWRKTAKAVHQGSLTQFI
PENDVYVYFRILGDEKIMVVLNNSSSDQTLDLGRFREVLPDAGNGFEILSGRSIKLEETL
EVSAKTPLIIQLN
>KECLDBNJ_00040 Glucan 1,4-alpha-maltohexaosidase
MKQYFFKYPFLLLLLLAISISCSSDDDAAVEAEEGQETPDPVAYQALNLAEYDNGSRVMM
QAFYWDVEPRFEWWNTISSQLEDWSAAGVNRIWLPPATKGQSGGYSMGYDVSDYFDFGDY
EQHGTVATRFGTRTDLENLIATAHDNNIEVIADIVLNHNSGGGLEYNPYRGYDTYSLFDE
THGNASGMFNRNYEDFYPNSVSNYDPGSLFYAETNLDHHRERVQNWLWKDENSVAKYYKN
VMGFDGWRFDYVLGFESFVIKDFLAEVGGFSVSELWDGDPDLIREHIEATGSGAFDFAAF
YRMEQAFDRYSDLTYLTRDQVWQTHPDKAVTFTANHDTEKDGNIDNYIERENKLKAYAFI
MTHPGYPTLFYSDYQNEAFKAQLDKLVSIHNSLAVGDLEVLYTDEDEYIAKRKGTDANPG
LIIYITTNTSTKRRTINTGWSSRQLMDYTENSTYYPATAEDGSTQLEAPANGYAIWSVME
E
>KECLDBNJ_00041 hypothetical protein
MKNLTLVFIALIAALNFTACTDDDGFTFTAKPDPEGVVFTNSTLETYNLMASSSDNLAER
FVWNEVDFGVQTPVNYEIQGATTESFETFSVIGVGTQTNLPVTVGNMLSLAREAGLDNDP
LTPEPNTGMIYFRVRAYVGADAGNVVEQFSDALAISVTLPEAEEEEEIQLPQIFVVGNFL
TGGGYGSDWTPADAVPLAASAEGNTDYEGFVFVNSDTPELKFLPTNESFDGDYGDTGENN
GDFSGTIEQEGEVNAGTPDGTGGYYLINVDTEALTYAMTKTSWGIIGNATPTGWDSDTDM
VYDPATKIWSLTLDLTEQEAPDNGIKFRANDAWDLNIGDNDADGTMEFGGQNIGIPEDGN
YTITLDLSNPRQYKYSITKN
>KECLDBNJ_00042 Starch-binding protein SusD
MNYIKKIALLIPTLLLIACHDDLDQTPIDPDSFTETNVFANADEAKGALAKLYASLALTG
QQGPAGQADITGIDEGTSQYSRLLFSLNELTTDNAVVGWGDPGLPNLHAMNWGAGNDFTT
GMYYRLAQEVSFTNSFIENAQLLNDNAEVEAYIAEARFLRAFAYFNLMDLFGDVPLVTVV
STDLPEQSTRSEIFNFVEGELLEIQDLLKESGANEYGRVDRVAAWALLSKLYLNAQVWTG
TERYTDAITYAEMAINSSYSINTTDANGNGSAYDELFLADNNSNGAQNEFIFALNFDGNN
SRTYGGTTFLVHAAIGGSMDAFNFGVNGGWSGLRTTKALVNKFDASVTESDADGNPTAWA
DSRAMFYTDGQSFEINTIANQFTDGYAVTKFTNIDSNGAAGSDTGGDFVDTDLPIIRLAE
IYLTYAEAVLRGGAGGDVNTAAGYINELRARAYGNTSGNITSAALTLDFILDERARELYW
EGQRRTDLIRFNDFTTGNYLWPFKGGSRSGTAVDEFRNLFPLPSNIILINTNLTQNPGY
>KECLDBNJ_00043 TonB-dependent receptor SusC
MGLKTETSISNYLMNVNFMRELFKSLRFLLFMVPVALFAQNSVTGVVTEKATGMSIPGAN
IIVQGTSNGTTTDFDGNYTINNVNEGDVLLFSFLGFTEQQITYTGQATVNVALEENQTSL
DEVVVIGYGSVTKKDATGAVNQVSTEDFNKGQVNTAGQLITGKIAGVTVTSGGGAPGEGQ
NINIRGIGSISLNSSPLYVVDGIPLDNSNVGGSRNPLDFINPADIESMTVLKDASSTAIY
GSRAANGVILITTKKGKGTEFKFNYSGATTVYRPTNYVDVMNGDEFRTLVNRVGNDAARA
RLGNASINWQEEIYTEAMGAEHNISTTGNVGNFMPVRASLGYTNQDGVLRGDNFTRTTGS
VSLRPSVLDGYLKAEINARGMYTENEFANRDAIGASVDYDPTKPIYSADSPFSNYNGWYI
YNAEADRFIQNSLSPTNPIALINEKDDSAEIRRFIGNAKIDYKLHFFSDITATVNIGLDK
TNSHGRTIVSENMPSSQLDWNGSYSNYINRATNQLFDAYLTYDKDFGKSSLNAVAGYSYQ
SFEYDNYSFDSEAQEEGNDAEFIDKWRSTLLSYFGRANYNYDDRYLLTATMRADASSKLN
PDDRWGYFPSFAVAWNINNEDFFNSETINQLKLRVGYGEIANVNGLGDYLFLTNYTGSRS
NANYQFGDTYYQTYRPDAYNEDLRWEVGKTFNAGIDYALFNNRVTGSLNAYLKKTEDLIS
FVTVDPFTNFSNKINKNIGDMENKGIEFELNVTPVQTEDFTWRIGYNVAYNDNEITNLPD
QVEVGGISGGTGNTVQLHKEGYTPFSYWVYKQVYDDNGRPIEGAFVDRNGDSQINDEDRY
LYKDPFADVTMGLNTNLNYKSWDLAIVTRASLGNYAYNNMASSRSYEVRATENSILTNLH
RDYFNTGFQTITESSLQSDYYVQNASFFKLDNITLGYTFPQLFDDASLRLYGSAQNVLII
TEYDGLDPEISGGIDNNFYPRPRIFTFGVNLNF
>KECLDBNJ_00044 hypothetical protein
MNFTTKHTALIFSFCLVLFCGEIFAQKNDVLDELLQTIEQSEAYDRIKVERINDLSKQLY
ALDGASVQQQFDLNRALFFEYRIFKQDSAFKYAIQSKLLAEQLGDERLIAETTLDLANVC
VSAGMFSEALAYLNDADLEDIPKDIRFSLNGLLGRCYSDMADYSTISYYSDLYRKRAKDY
HQKSLELAVPDTWDFIMLRGYLNFKYGNLEEALKDLKPSLAMRDDLRSQAVVNSVLGDIY
VQMGAEELAIKHLAQSSIADIKSSAKENLSMIQLAEFLFKKGDVKLASVFIKKANADAEA
YGAQQRKIRVGAILPNIEEQIINQVETQRARLSKQNIMLSILLVVLLALAIITYVQLRRL
KRARKALLVAHNDLQVKNDRIVEVNETVHSQNEELNRVNDLLLEANTIKEEYIGFFFTQD
ADIFEKFKEFKTGIERNLKSNNLERIKYLTTVYDLKKEKKKLLESFDEAFIKLFPNFIAE
FNALLKPEEQIKLKKDQLLNKELRIFALIRLGIKHNEIIAQILGYSVNSIYAYKTKIRNK
SFLDKKDFDQMLLEKTRIKQ
>KECLDBNJ_00046 Ribose-phosphate pyrophosphokinase
MSLSAPDAKIFPCTQSRDLAEKIAKAYGQPLGKIITSTYSDGEFQPSFEESIRGSRVFII
GSTMPSSENLMEMLLMLDAAKRASARHITAVLPYFGWARQDRKDKPRVPIAAKLVANLLE
TAGATRIITMDLHADQIQGFFERPVDHLFASTVFLPYLESLNLPNLTIASPDMGGSKRAY
AYSKALDCDVVICYKQREKANVISHMELIGDVKGRNVILADDMVDTAGTLTKAADLMMER
GALSVRAICTHALLSGNAYERLENSKLQELIVTDSIPPKQESSKVRILSCAELFADVMHR
VHSNTSIASKFLM
>KECLDBNJ_00047 General stress protein CTC
MKSITITGSKRESVGKKATKALRNAGEVPCVLYGGDEPVHFSAPELAFKGLVYTPDAHTA
TLELDGTTYMAILQDIQFHPVTDRILHIDFYQIFEGKEVTMTIPVHYEGNSRGVRNGGVL
RKTYRTLRVKALPKNLPDYVVADITKLKIGDKLYITGIEQGEWKYLHPDNTVVCQVRTSR
NMVEDLDDEDEDEEGATAEGTEATEQAADAAE
>KECLDBNJ_00048 Peptidyl-tRNA hydrolase
MTSGFFSKLFGSKKESIDPMNKYLIIGLGNIGPKYDNTRHNIGFKIIDAYASEKETSWST
EKLGDIAYTKVRGRTVVLLKPNTYMNLSGKAVKYWMQKENISIENILVITDDLNLEFGTI
RVKSKGSDGGHNGLKDIQNQLSTTKYPRFRFGIGDRFSRGKQIDYVLGEWDKDEELDMPE
RLDISCKVIESFIASGIANTMNAYNGK
>KECLDBNJ_00049 Riboflavin biosynthesis protein RibF
MKQHTSADTFDGLKGTVVTIGTFDGVHLGHRKIIDRLLASAQSNDLESVVLTFFPHPRMV
LQKDTGIKLINSIDERIALLEASGLDHLIIHPFTKAFSRLTAEEFVKDILVDQLKARKVI
IGYDHRFGRNRNANIEDLKAFGTQYDFEVEEISKQDVDDVAVSSTKIRKALNEGDLTKAN
EYLGYPFMLNGIVSRGKGLGKKFNYPTANLKIEETYKLIPAKGVYVARASINGKEVYGMM
SIGTNPTVGGSDLTIETFFFDFEADLYDQHLQIELLTRIRDEKKFNSVDELIAAMQADER
FSRDFIQKLDA
>KECLDBNJ_00050 hypothetical protein
MLERWLYKRVDNSALIVFRAIFGFLITAEAWGAIATGWIKHTLLEGEFTFNFIGFDFLQP
LPGDGMYYYYGLMGLFGVFVMLGFKYRFSVIAYGLMWTCVYLMQKSSYNNHYYLLMLLLG
IMACLPAHRYLSLDVKFNPKLKKISMPRWVYIIIIAQLWIVYTYASIAKIYPDWLDASMA
AQLMAARKDYWLVGDFLQQNWVHWSIAYVGILFDGLIIPALLFKPTRKMAFFISIFFHLF
NSFIFHIGIFPYMSLAFTLFFFPAETVRNIFLKGKELYSGNEIIKPKTYKPIVALFGLYF
VIQIALPLRHWIIKDDVLWTEEGHRLSWRMMLRSKGGRISFKVIDKKTGLEQSFNYRKML
SRKQQRVVATKPDVIWQFCQRIKEDFAKKGKEVAIYVNCRIKVNDSDFHTLIDPKVDMAS
ASWDYFWHNEWILPSPLHNEKRKPPYAPEGLQ
>KECLDBNJ_00051 Serine--tRNA ligase
MLHVTDIRDHKEDYINALTKRNFDATEMFEQVLSLDEKRRSTQASLDNTLAESNKLSKEI
GMLFKNGEAQKANLLKERTGKLKEDSKNLQEVLNATVEELDQLLYTIPNIPQASVPAGKS
DEDNEEVFRKGDVPVLAEGSLPHWELAKKYDIIDFELGTKVTGAGFPIYKGKGARLQRAL
INYFLDKNTAAGYNEVQVPHLVNEASGFGTGQLPDKEGQMYHVGVDDLYLIPTAEVPVTN
MFRDSLLEEKDLPITCTGYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRIEKAEDSDAA
LDGMVEHVKMILDELKLPYRILRLCGGDLGFTSSLTYDFEVFSTAQDRWLEISSVSNFKT
FQANRLKLRYRDAEGNKQLAHTLNGSSLALPRVLAGILENYQTEDGITIPEVLVPYCGFD
KI
>KECLDBNJ_00052 hypothetical protein
MLRIFFLALSLLGFLPLQAQEDLLARNYMQQGAYEKAALLYEGLVAKTPGNTNLVTSLVE
AYQQLEQYDKAEKVLLETLELSKNLVYIKVDLAYNYQLQGLDAKAQQLYTEVIEQVRANP
PLASMVGRTFKKYNLLDEAATTYTLAKDAGLNSVYINVELARIYGEQGNIEQMFDAYINL
ILESDRYQSLAQRAFNDFITDDPQNEANGIFRTLLLKRLQDDPNLLYNRLLSWLFIQQKE
YSKAFIQEKAIARRTNDLNGIFTLASVAKENEAFELASTIYQYLVEQAPSDEMRLFAHQE
LLDLRVQKNDQADFASIEATYKSLLNQFGTAAETLDLQTKYAHFLAFNQNKKEEASAFLK
ETLNLKLNRFQEARVKMELADILVLEERFNAALIYYSQIQKNLKDNILAQEARFKVAKTS
YYKGDFEWAKTQLKVLKSSAEQLIANDAQDLYLLITDNTVGDSTQTALKTFAKADLLLFQ
NKQDAALEVYNTLLAEHKDKAIEDETLLEQAKIFENKGLYDRAAQNYLLILERHGDDILA
DDAHYRLGNLYANQLDQPEKAKEQYEKIIFNFADSIFYVDAQQKYRKLRGDAIN
>KECLDBNJ_00053 hypothetical protein
MIIYNVTVNVDDSVHSDWLYWIRNEHIPDMLATGKFVKALMTKVLVKEEMGGQSYSIQYT
AKSKDSLARYYKEDAPKLREEAGRFGDKVLSFRTELEIITEQTEFKPQ
>KECLDBNJ_00054 Ribosomal RNA small subunit methyltransferase A
MKKKFTRTHKKAASEDPVKAKKHLGQHFLKDETIAKKIAETLSYDGYSEVLEIGPGTGVL
TKYLLRKDSNVTAIDLDSESIVYLNHSFPLEHPQLMEGCTLNVVEADFLKFDLSKLYGDQ
AFAITGNFPYNISTQIVFKMLEWRDQVPEFSGMFQKEVAQRICEPEGSKAYGILSVLAQA
FYDAEYLFTVPPGVFNPPPKVDSGVLKLTRKANYKDLACDPDQLFKVVKMAFQQRRKTLR
NSLKQLELSDSFRESEIFNKRPEQLSVDAFIKLTQDIAEDLEK
>KECLDBNJ_00055 Magnesium transporter MgtE
MAFELTEDLIEQIENFIEVGDDTSILALLEEVHHADIAEILDEISTEEATYLIKLLDSEK
TSEALMELDEGYREEILDNLSPQEIADELNELDTDDAVDFLSELDEDIQRQVIDAIEDEE
HARDIIEMLRYDEDSAGGLMAKELVRVRETWTVAGCVRKMRAQAQNVTRVHSVYVVDKND
HLIGRLSLKDLLTAEAKSKISDIYIPNVDSVNVHDTGEDVARIMQKYDLEAVPVVNDAGV
LLGRITVDDILDFIRDEADEDYRMAAGISQTVEADDNLFKLTRARLPWLMIGMFGGLGAA
SIITGFNSIFETFPKLLVFVPLIQATAGNVGVQSSAIVVQGLANDSLKGNIAGRLLKECA
LAIINGLAIATVVLVISHFFFETTYLESVSIGVAIIAVIILAALIGTFIPIVLDKRGIDP
AVATGPFITTSNDVFGILTYFLIAKLILGF
>KECLDBNJ_00056 hypothetical protein
MMNAKTFKLNITVPAEAIDGLGHVNNVIYLQWVQDVAEAHWQHNSTEEMLEKYAWVALEH
TIKYHAPAFEGEQITIETWVEKFEGVRSIRRTKIFRPSDNKILATSITNWCLLNMQTRKP
MRVPETFTAYYEEVNQ
>KECLDBNJ_00057 Hydroxypyruvate reductase
MRILHIDSNHDLMIEQLQAAGHINEEDYTSSKEEIEAKIEQYEGVVIRSRFKIDKQFLDA
ATNLKFIARVGAGLESIDIPYAESKGIALIAAPEGNRNAVGEHALGMLLMLFNKLKQADA
EVRAGQWNREKNRGLELEGKTVGLIGYGNMGNAFSKKLKGFDCEVLCYDIRPNLGNENAT
QVSLEELQQRADVLSLHTPWTPLTDKMVDTEFINGFKKPFWLINTARGKSVVTEALTNAL
KSGKILGAGLDVLEYEKLSFENLFTDTEQMPEPLQYLIQAENVVLTPHIAGWTVESKIKL
AQTIVDKILALAIK
>KECLDBNJ_00058 Organic hydroperoxide resistance transcriptional regulator
MQHIYDPDFQNKDLAAKTTAALDKLADAFKTLQWASQKENGFSPLQQKLVFFIAYHGPTE
NTVSQLVKEFQVTKATISDCIKTLEQRKLLTKVLNHKDNRRFHITLTEKGKEVVAQLNEP
ATPVYNALETESSEDLKQLYTSLFSILSKLKKENTVALSRSCHDCKAYRSDGINHAFCME
LRTQLHPENRRIDCPKHQPK
>KECLDBNJ_00059 hypothetical protein
MKNRVTGLGGFFFKTQNPDAIKAWYKTHLGIPTDQYGWTFWWRDEHGNKCSTQWSPFQQD
TSYFSPSEKQFMMNFRVENLVELLEVLKQEGVEIVGEMEEYDYGKFGWILDPEGNKIELW
EPVDSVFLDESEK
>KECLDBNJ_00060 Phosphinothricin N-acetyltransferase
MDLLIRPFKPKDYPEVAKIYQAGIDTQIATFETEAPAFAAWDLRFCKACRLVAEVDHKVA
GWAALSLVSKREVYRGVAEVTVYVAPQHQNKRIGFQLLDALIQASEQAGFWTLTAHIFPQ
NKASIHVHQKLGFKLLGVHDKIAQRNGKWQDNALLERRSTKIL
>KECLDBNJ_00061 hypothetical protein
MGLVTAKEVAKAINVDKFGFAGTFMGWTLMKVLKISKANEIYDRNKHLSDLEFLNAILNE
FEIDFEIPEEDLKRLPKAGSYITISNHPLGGIDGILLLKLLIEQRPDFKIIANFLLHRIK
PLKPYVMPVNPFEDHKDAQSSIAGFKQAIRHLRDGHPLGIFPAGEVSTYKDDKLIIDKPW
EEAAMKLIKRAEVPVVPIYFHAKNSRLFYQLSRISDTLRTAKLPSELLTQKKRTIHVRIG
NPISVKAQKEHESLEDFTEFLRRKTYILAKTFEKKSSLLSTIPQSLKTPKEPKKIANEVK
AELIEQEVNKLRENEKRLLQSKNYEVFLASAEIIPNILNEIGRLREITFREVGEGTNEPT
DLDRYDHHYHHLFLWDEDSKKIAGAYRMGLGAHIMPEHGINGFYLQSLFRFEPELHKMMG
ESIEMGRAFVIKEYQQKPMPLFLLWRGIVHTTLRFPEHKYLIGGVSISNQFSNFSKSLMI
EFMRSHYYDPYIAQYIRPKKEFKVKLKDADKEFVFDETEADLNKFDKIIEEMETGNLRLP
VLIKKYIKQNAKVIAFNVDPLFNDAIDGLMYIKIEDLPESTVKPVLEEFQAELEQKLEQA
RNEDESAKES
>KECLDBNJ_00062 Lysine-sensitive aspartokinase 3
MGFQVYKFGGASVQNAEGVKNLVKVLEQTQVEDLVIVVSAMGKMTNALEDFVASYFDANA
KTDTIETVEAFHHNIALELFENPSAPVFKQIQALLEELKGFLQRNKSPDYNFVYDQVVIY
GELLSTTIVNAFLEKEGYRTTWHDVRDYLKTDTNYREGKVDWELTMRNLSRKLPKKGIQL
TQGFIASDPNGFSTTLGREGSDYTAAIIAYCLNAERVTIWKDVPGVLSADPRYFEQATLL
NFISYQEAIELAFYGASVIHPKTLQPLQRKEIPLFVKSFLNPEQPGTQVSVGTLIEPLIP
CYIRKTDQVLIALSSLDFSFMAEENIGEIFKLLGMFKMKVDLIQNSAISFSVCVDNKYKN
LDALVAKLRADFKVTVHENVSLYTLRHATDEALAKLEKDKEILLKQVMQNTVQLVSL
>KECLDBNJ_00063 hypothetical protein
MQATIRKAEADDMAQVLRLIKELAVYEKEPYAVEVTVDDLIAYGTGNNADFTCFVAERDT
EILGIALVYYRFSTWKGRTVHLEDLIVREQYRGEGLGMALYTEVIKYTYELGLKRVEWVV
LDWNTSAVDFYEASGANVMKEWNTVQMDTEAMKTFLSKKGLA
>KECLDBNJ_00064 hypothetical protein
MSFTDLFDSGEHRRNLGHFAAIANMATVDGELNAEEIKLLKRFAVKLDIDETEYVDIVEN
ARRYPINPPNNSEKRLERLHDLFRMIFVDHTIDDHERFLIEKYAIGLGFSAERAKQLIER
SIQIFQGGIDFDDYLYLLDKK
>KECLDBNJ_00065 hypothetical protein
MYLDPWKPVDKAIISHGHADHSRWGHKAYITHHINVPIIKHRLGEINVTGKEWGETFTIK
NVKFSLHPAGHIIGSSQIRVEHKGEVWVFTGDYKTEDDGVATPYEPIKCHTFITECTFGL
PAFKWRPQSEVFNDINTWWSDNKAEGKTSVIFGYSLGKAQRLLRYLDTDIGKIYTHGAIE
NMTEVIRPLSPMPETTRVTRETKKEELLGNIVVAPPSAHGSTWIRKMVPYVTASASGWMA
FRGARRRRAIDKGFILSDHCDWQGLLESVEATGAEKIISTHGYTDIFTRYLLEQGYDART
EATQYEGELGEETEKEQE
>KECLDBNJ_00066 DNA ligase B
MRAFAQLIKKIDSTNKTNIKVDALTEYFKVAPPQDKVWTIAILSHRRPPRPVNTTLLRTW
ASELANIPLWLFEESYHIVGDLAETIALVIPASEESTDKSLTQFLEEIIALKKKPEEEKR
AYLRSNWTDLNYYERFVFSKLITGSFRIGVSQKLMTRALAKATGIDVDILAYKLMGNWDP
KTISFQELILEENKADYLSKPYPFYLAYAIEDEPEDLGNVSEWFAEHKWDGIRSQVIIRD
NELFVWSRGEELVTDKYPEFEALVEALPNGTVLDGEILPFKNGVIGTFNDLQTRIGRKNV
SKALLKKTPVILKAYDILEWKDKDIRDLAFAERRKILEKLYTEVTTESLPLHLSETMEFD
SWDAAAQERERSREVMSEGLMLKRKDSPYLVGRKKGDWWKWKVDPLTIDAVLTYAMRGHG
RRSNLFTDYTFGLWDDNKEELVTFAKAYSGLTDKEFRSLDAWIKKNTLERFGPVRSVTPH
HVFEIAFEGIAPSKRHKSGVATRFPRMLRWRKDKKIEDANTLEDLKQLIPKPEKA
>KECLDBNJ_00067 DEAD-box ATP-dependent RNA helicase CshC
MTHKQLHKLATSWFKDQGWKPFAFQEETWNAFLEGKNGLLNAPTGSGKTYALWVAFVLDY
IKNNPDYKTKHKPGLKAIWITPLRALSIEIAQAAQRFADGLETQLTVGIRTGDTPQAERA
KQKKKMPDLLVTTPESLQLLLTSKGYDKVFKNTSAIVIDEWHELLGSKRGVQVELGLSRL
KTIAPQLRTWGVSATIGNLNQAREVLLGPESEAFKNSALIKANLGKTYKVESIIPETMEK
FPWRGHMGLHLLEEVVPIINNSKTTLLFTNTRAQCELWFQKLMHKHPEFAGEMAMHHGSI
NKETRLWVEEAIRNESLKAVICTSSLDLGVDFAPVESIIQIGGPKGVARFLQRAGRSGHQ
PGKESVIYFLPTHAIELIEASALGKAAINQVVEDRIPYLLSFDVLIQYLTTLAVSDGFYP
SEIYQEVKQTFCFQAMSDEQWRWILNFITKGSQSLQAYDEYKKIEIEEDGKFKVNSRSVA
MRHRLQIGTIVGDAALQVKYLKGGYIGTVEEWFISKLKPGDVFTFAGRNLELYRIKGMQV
LVKKAKTKKQARVVSWMGGRLTLSAQMSELLREELYSANLPFEQQTRELQALKDIFARQR
VESIVPTDDQFLIETFKSREGYHHIFYPFEGRFVHEALGSLLAYRISLLSPITFSIAFND
YGFEILSDQQIDMQQVLDNDLFTSAYLFEDLQKSLNSTEMARRKFRDIAVISGMVFTGFP
GKIIKNKHLQSNSQLLFEVFRDYEPENLLFQQAYRETFEHQLEEGRLRIALERIEQQEIV
VKNCKKATPFSFPIITDRLREKLSSEKLEDRIKNMLKYLDKY
>KECLDBNJ_00068 hypothetical protein
MKSVQPYLTFRGNCQEALNFYQNCFGGQIKNKDTYEGKEIDIPGDYRNKLQHAELEGKGI
HIMAYDAAPDTPLTEGNQVQLSVDLESKEETDELFEKLSAGGQVVTQLQETSWNAYYGRL
RDQFGVTWMLNYQMN
>KECLDBNJ_00069 hypothetical protein
MTQEISIQNNTFTMHPSGGMLWHEKRMLLIADVHLGKVSHFRKHGSAVPLRAVAANFDQL
TRVADYYQAQSICFLGDLFHSSLNTEWKLFEKWVRSRDETLILIAGNHDIISPVKYENLD
IDIYSEFQSNGFLLTHHPEEREGFFNFCGHIHPGIRLGGIGRQVLKLSCFFKTENQLILP
AFGTFTGNYYLEPQPGNQVFAITKNEVIPIQ
>KECLDBNJ_00070 hypothetical protein
MKKKLALINLVSVITAVVVNYLSQTQRWNNTTIGEMSAKYDNLFTPAGYAFAIWGVIFLG
LIAYALFGIKRAFFSKKETPHIEQTGYWFALTNFLNTAWVVAFTYDYVWLSVLIIIGMLI
SLLKIVFKTNMERWDAPIEIIALVWWPVCIYSGWIAVATIANISAFLVKLGFAGSQLTQI
IFTMLLITIAVYINLLITNLRNMREFAMVGAWALFAIFIRHKDSLESVAFFALAGCVLLV
VTAGLHGYRNRATNPFNKLGERLNS
>KECLDBNJ_00071 Mercuric reductase
MAIAHYDLFVIGTGNAGKHVAYDAVEAGLNVAIADNREFGGTCANRGCDPKKVLVGLTEI
IERSQNLKGKGIKELPEVSWSDLMEFKKTFTGAVPFTTEEKLKDQGITLYHQSPKFLDEN
TLSVEGKTVTADKIVIATGNTALNLNIPGDELAQISDDFLKLEALPESIIFIGAGYIGME
FAHIAARCGVDVTVVDVNARILSNFDEDLTLQLQKKSEEIGIKFLFNAEAKAIEKLRKNY
RLTVDHNGKSEGLKAELIFNTAGRVPAVDELDLDKGNVAFSKKGVAVNSFMQSTTNPIVY
ACGDVSDTSNLPLTPVAHQEAYYVSKNILNGNTAEVNVPATPSAVFTIPQLASVGLTEQE
AQEQGYDFMVKTASVEDWYNAQRLNEKFYAYKTLIDKKTGQVLGAHLLGSEAAETINLFM
MAMHSKLEVNTIKGMVFSYPSWANDVKSMI
>KECLDBNJ_00072 Transcription-repair-coupling factor
MGKTTITKPFLESAQLQELGNAIAVSQNRINLDGLIGSSLSITIAESFKTADKPFLVILN
DKEEAAYILNDLEQLVKEDHVLFYPGSYRRPYQIEETDNANVLLRAEVLNRINSRKKPAL
IVTYPDALFEKVVTRKELDKSTLKVKVNDNLSLDFVNEMLFEYKFKRVDFVTEPGEFSVR
GGIIDVFSFSHDQPYRIEFFGDEVDSIRTFDVESQLSVDKINKISLMPNVENKALQETRE
SFLKYIAADTVIFTQDIEQLATRIDTNFSKAEEAFQKLDSEIKRHKPSELFCDATSIKKQ
LLDFTLVRVSEGLSLPSDKASASIDFNQQPQPAFNKQFNLLIENLNENHEAGYTNYICCA
SEQQAKRFQDIFNDAELNVKQYETIIVSLYRGFIDDDLKMVCYTDHQIFERYHKFKLKDG
YAKKQAITLKELTSLQVGDYITHIDHGIGKFGGLQKIEVEGKRQEAIKLIYGERDVLYLS
IHSLHKVTKYNGKDGKPPQIYKLGSAAWKKLKQKTKTKVKEIAFNLIKLYAKRRLEKGFA
FGPDTYLQNELEASFIYEDTPDQSSATEAVKADMESPRPMDRLVCGDVGFGKTEVAIRAA
FKAVDNGKQVAVLVPTTILAFQHHKTFSERLKDLPVTVDYLNRFRTAKEKRETLERLENG
RLDIIIGTHQLTNKNVKFKDLGLLIVDEEQKFGVAVKDKLKTIKENVDTLTLTATPIPRT
LQFSLMAARDLSTITTPPPNRYPIETHIIRLSEETIRDAISYEIQRGGQVFFIHNRLQNI
KEVAGMIQRLVPDAKVAIGHGQMDGKKLEELMLQFMDGAFDVLVSTTIIESGLDVPNANT
IFINNANNFGLSDLHQMRGRVGRSNKKAFCYFITPPLSAMTDDARKRITALEQFSSLGSG
FNIAMKDLEIRGAGDLLGGEQSGFINEIGFDTYQKILNEAIEELKENEFAELYAHENVDD
ENKEYVKDTVIDSDFSLLFPDDYINNITERLNLYTELNNLKTEEELADFEARLIDRFGEL
PKQAEDLLNSVRIKWIATHYGLEKVVMKNKKLIGFFIADQQSKFYQSPAFSRVLQFVQTH
SNKVTLKEKKTSKGLRLLLTASGVSSVEKALDILRPLMPKMVEQVSE
>KECLDBNJ_00073 hypothetical protein
MKQPQLGLKILELRQQKGFTQEELVEQCNISVRTIQRIEAGEVMPRVYTVKTILAALDRD
LDDLQESVFEKKVKKAFLIEIDKNKKVSFLFYQLHLGWIAGILSMILLVFQLIEETTFLA
TGGYYFGEVFYVTITILAAIAFALHMRAFVLIGELFKAGFLKTSALIAIAINTLIAIYSI
IDLHFQYIKLEAFALIYSVLFGIVFICMGIGLYKTNHLGQLPKVTGIITLVLGFMFLTII
MVAIAGPASILVQGFYVAIILRAIATIKQQITAKA
>KECLDBNJ_00074 hypothetical protein
MANQWGIPEDVEKFVLIRDKTCVYCGVDFSITHVSRKTKPSWEHIINDIHLSSVDNIALC
CTSCNASKGAKKLQEWLKSNYCLSKNINENTVAEVVQNVIRKSISKT
>KECLDBNJ_00075 hypothetical protein
MNHNELGKWGEEYAANYLEKKGYELLERNWFFNKAELDIIALKDDQLVVVEVKTRNSDFF
GDPQDFVTPAKIKLLVKAANEYIISNDLDLEVRFDVIAILKNKTQEQLEHFEDAFYYF
>KECLDBNJ_00076 putative murein peptide carboxypeptidase
MLTPPYLKEGDKVGIVCTARKADREDLENGIALLKSCRLEPVLGKTIGASDNQYGGTDAL
RAADLQAMLDDEDINAIWCAKGGYGTVRIIDEINFYKFIKYPKWIIGYSDVTVLHSQIHK
LGFETIHGVMPVGIARNTAVAKQTLENAWSGKPVHYHIESAPLNRLGTAKGELVGGNISI
LYSLCGSHSAIDTTNKILFLEDLDEYLYHVDRMMVNLKRNGLLRNIRGLVVGGLTSMHDN
STPFGKTAKEIVMDAVAEYDYPVCFDFPAGHLKDNRALILGRSASLEVNERGAKLYFDQL
E
>KECLDBNJ_00077 Methionine--tRNA ligase
MSPKRYTITAALPYTNGPIHIGHLAGVYVPADIYARYLRGMGKDVAYICGSDEHGVAISI
KAKKEGITPQEVVDKYHKIIKDSFEDFGISFDNYSRTSAQVHHDTASEFFKTLYEKGDFI
EEVTEQLFDAEANQYLADRFVTGTCPKCGHEEAYGDQCENCGSSLNATDLINPKSTISGS
KPILKETRHWFLPLDRYEDFLKKWILDGHKSDWKPNVYGQCKSWIDEGLRPRAVTRDLDW
GIPVPVDGAEGKVLYVWFDAPIGYISSTKEWASREGKNWEDYWKADDTKLVHFIGKDNIV
FHCIIFPSMLEAEGSYILPDNVPANEFLNLEGNKLSTSKNWAVWLHEYLEEFPGQQDVLR
YTLTANAPETKDNDFTWADFQARNNNELVAIFGNFINRVVVLTNKYYEGAIPQPSEFNAE
DERVLAEMKAYPAVIASSIERYRFREAQNELMNVARLGNKYLADAEPWKSVKTDPERTKT
VMYIALQIAGTLAVLSEPFLPHTAKTLKHMLNIESEDPLMQLPEPLSWELLGEKIDLLPV
GHSINKAALLFRKIEDEQIQKQLDKLEATKMSNQAENTPVTPQKDTIEFDDFTKLDLRVG
TILEAEKMAKTKKLLILKVDTGLDVRTIVSGIAESFKPEDIIGKQVTVVANLAPRKLRGV
ESQGMILMTEDKQGKLVFMNPDTAGVKNGEAVS
>KECLDBNJ_00078 hypothetical protein
MKTYFVYILQCADGSYYTGLTNNLELRLEQHNSGTNPASYTYRRRPVFLAFNQDFSDVNQ
AILFEKKIKKWSAKKKKALIDGDFDLLQILAECRNETHHKFKPD
>KECLDBNJ_00079 General stress protein 13
MLALLSYLKSSTNLPEKGIKNVLQLLDEDATIPFIARYRKERTGNLDEVQLGEIVKFKEQ
FEALEKRKATILKALEEQEVLTAELQKQIENTTDTTALEDLYLPYKKTRKTKADTAREQG
LEPLAKIIMAQNTRDLEQAAGRFLNNEVASIEEALEGARHIIAEWVNERSDVRNYLRNQI
ERYAQIASKVVKSKKDDEKALKYKDYFDWEEALNRIPSHRFLALSRAADEGFVRLKLDID
TDRALAHIANRMVKSRGDCAEHIELAVADAYKRLLFPALSNEALSTAKEKADAEAISVFA
KNLRQLLLGSPLGEKRILAIDPGFRTGCKVVCLDENGGLQHNETIYPHPPKNDTKGAMRK
ISFLVDAHKIEAIAIGNGTASRETEQFIKRMQFNRDLEVFVVSEAGASIYSASKIARDEF
PNYDVTVRGAVSIGRRLADPLAELVKIDAKSIGVGQYQHDVDQTKLKNELDRVVESCVNT
VGVNINTASIPLLSYVSGIGPKLAENIVTFRDENGAFASRKEILNVPRLGAKAYEQAAGF
LRIKNAENPLDDSAVHPERYALVEQMAKNLKLSVAELVGNKTVIKELSLEDYVSDEVGEL
TLKDILDELEKPGLDPREPAKAFTFNQNIHKIEDLEPGQLLPGIVNNITNFGAFVDIGIK
ESGLIHISNLADGFVSDVNAHVSLQEQVVVKVLEVDIKRKRIQLKLHRLNA
>KECLDBNJ_00080 Acetoin utilization protein AcuC
MLKIAYHPIYKHPLPEGHRFPMEKYDLLPKQLLYEGTCTEANFFEPGFPEEKYLTAVHTQ
EYVSNLKALDLDRRAIRKTGFPLSQELVDREQIIAQGTMMGCELALKHGIAFNIAGGTHH
AYSDHGEAFCLLNDQAIAARFLQSKELAKQILVVDLDVHQGNGTAEIFEDDPSVFTFSMH
GAGNYPFKKETSDLDIAVPDKSGDAVYLAKLKETLPKLIKQVKPDFIFYLSGVDILETDK
LGRLSCTVEGCKERDRFALSCFRESGIPVQVSMGGGYSPDIKIIIEAHANTYRLAQELYF
>KECLDBNJ_00081 hypothetical protein
MKKFTTFFALSLFVFAFNSCDAVDELTEIRVSPDLKAEVDVSIPEGSSSVNSAISLDATS
NSDVRDNLDKIESVDISGFTYVFKDVEAAAGTTLSGTLSSGGQSVTLSNIAVANGTTGTV
SSSEAAFLNSLGSSLKSNGKVTIDIDGSLSNDEGANFTLEITPTWTFLIDVL
>KECLDBNJ_00082 hypothetical protein
MTKPDKSEAYWRENKKYLAILLSIWFVVSFGCGILFKDLLNRYSLGGFKLGFWFAQQGSI
YVFVVLIFVYVWLMNRLDKKYGYNE
>KECLDBNJ_00083 Cation/acetate symporter ActP
MSVQLWTWILVGITFALYFGIAIWARAGSTKEFYVAGGGVSPLANGMATAADWMSAASFI
SMAGIISFAGYDGSVYLMGWTGGYVLLALLLAPYLRKFGKFTVPDFIGDRYYSNTARTVA
VICALIVSFTYVAGQMRGVGIVFSQFLQVEITTGVIIGMAVVLVFAFLGGMKGITYTQVA
QYCVLIFAFMVPAIFISIQMTGNIIPQIGMGSRVEDGTFLLEKLDNLHTQLGFKEYTEGT
KSTWDVFAITLALMAGTAGLPHVIVRFFTVPNVKDARKSAGLALLLIAILYTTAPAVSVF
ARTNLIETVSDQEYTSLPEWFKNWENMGLIAWSDKNEDGKIQYVNGDATTGKPEFTEARG
ASGERLIANASTETNELYVDRDIMVLANPEIAQLPSWVIALVAAGGLAAALSTAAGLLLV
ISTSVSHDLIKKQLKPNISEKGELLAARLSILVAIIVAGLFGIYPPGFVAAVVALAFGLA
AASFFPAIVLGIFDKRMNKQGAISGMIVGTVLMLFYMIRFKTGLIGVLEPLPASEWWFGT
SPEGFGTFAMLINVVISITISRLTPAPPKDVQEIVERIRIPSGAGEAQHH
>KECLDBNJ_00084 Acetyl-coenzyme A synthetase
MSNYHIKHLEEYFQVYRKSVRNPESYWEEIAEEHFMWHKRWDNVLSYDFDKPEFKWFEGA
QLNITENCIDRHLRTRGDKTAILFEPNDPKEKAQHITYNELHKRVAKMANVLKAKGIKKG
DRVCIYLPMIPELAISLLACARIGAIHSVVFAGFSSKALATRINDASCKMVITSDGSYRG
SKTIDLKGIVDEGLKSCESVENVLVVKRINAEIPMEEGRDHWLQPLLDAAEETCAPEIMN
AEDPLFILYTSGSTGTPKGMVHTTAGYMVYTAFTFKNVFQYREDDIYWCTADIGWITGHS
YIVYGPLANGATTVMFEGVPSYPDHARFWEIVEKHKVTQFYTAPTAIRALGKENLDFVEK
HDLSSLKVLGTVGEPINEEAWHWYDENIGKRNCPIVDTWWQTETGGIMISPIPYSTPAIP
TFATLPLPGIQPALMDEEGKEIKGNQVDGRLCIKFPWPSMARTIWGNHQRYKDTYFSAFK
NMYFTGDGALRDSVGYYRITGRVDDVVIVSGHNLGTAPIEDAINEHPAVAESAIVGYPHE
VKGNALYGYVILKETGETRNQDNLRKEINQMISDRIGPIAKLNKVQFTSGLPKTRSGKIM
RRILRKIASNDTSNLGDTSTLLNPEIVQEIMDNVIK
>KECLDBNJ_00085 Single-stranded DNA-binding protein
MSTLRNKVQLIGNLGNDPEIVNLDSGKKLAKFSIATNETYKNNKGERVTDTQWHNVVAWG
KTAEVIENYVTKGKEVAIEGKLTSRSYETKHGEKRYLTEIVCNELLLLGK
>KECLDBNJ_00086 Apolipoprotein N-acyltransferase
MKICLAQIAPHRGNVQKNMEIHKKWIERAIHEQADLIAFPELSLTGYEPQKSKALAFSEH
DERLDLFKQLSDTYKITIAIGVPTTSKTGLHISMFIFQPQQERKMYSKQHLHVDELPFFT
PGTEQLIFKVNQTPIAPAICFESLQNEHAENAFDLGAAIYLASVAKSETGMKKAYAHYPK
IAKKHAFPVACVNNIGFCDNFYGTGQSAIWNEKGDLIAALSKDQEGLLFYDFENHSIRII
EV
>KECLDBNJ_00087 Putative metal-dependent hydrolase YfiT
MNLEQLKYPIGHFQKLEAITANHITSWIATIAEFPQKIAALTKNLEEDALSKTYRPNGWT
IRQLVHHCADSHMNAFIRFKLALTEEAPKIKPYFEDKWSELPDTRSAAITSSLKLIEGLH
ARWTTLLQSLHSEDLIREYIHPEHGKRFSLSETIGMYAWHCEHHLAHVQIALKN
>KECLDBNJ_00088 hypothetical protein
MQKTCPECGDKIIGRADKKYCSDACRNAANNKLNSDTKNLIRNTNNHLRKNYRILESLNP
EDKTKTTRDKLTSLGFDFNLFTSIYTTKAGTVYYFVYDQGYLPLEGDYYALVKRN
>KECLDBNJ_00089 Inosine-5'-monophosphate dehydrogenase
MGIKSFMGKRSKVVAEEVNIKVSDYMTTKLITFTPDQSVMDVMQKLIKHRISGAPVVNEN
NELLGVISEGDCIKHISDSRYHNLPMDNATVGQNMAIDVETIDGNMNVFDAARFFIERKH
RRFPIVENGKLVGQISQMDVIKAALKLRGNTWK
>KECLDBNJ_00090 Aminopeptidase S
MKTTYAAVLSFLLLLGLTYFSFYTHKPQQVSGLDTPETKFSTARAFQLLDSIAQKPHAVG
MPAHQEVQDFIVTTLEGYGLEVELQSDFAYKPGWGALSRAENIITRIPGTGEGETLLAMT
HYDSAPHTASKGASDAGSGVVTILESIRAFLAKGEKQKNDIILLFTDAEELGLNGASVFV
NKHPWAKEVALALNFEARGSGGPSNMIVETNGGNGALIKAFAEANPSHPYANSLMYSVYK
LLPNDTDSTVLRENGDIDGFFFAFIGDHFDYHTANDIPSRLDPQSLEHQGSYLTALLDHF
SNADLNLKADQDYIYLNMPLIKMLYYPFSWIFPMLILGWILFFAVLIYGLRNKSFKLIEV
LRGFLPLLIALVLAYVISLGWKLILALDPKQADILQGFPYNGYELLAGFVALTLAVDFFI
YKLFYRPNSAASLSFAPLFFWLLIATGVAVYLPGASFFIIPVYFGLLAVFLLIEFSKPKF
FILTLLCAPALFIITHYIKEFPVGLGLKMLAAATILTVLLFGLLLPVIGFYKMNAKIAGL
FTLVSIGAFIAAYGKADFTEERPFPTSLNYVYDVDQEQAFYATYNTQLDPWLHEILVQNA
TDDTPLEINPPSGKYGSQYNYITAAPKNFVAPSQVYTEKDTVISGERRLDFVIFPQRNVG
DMILMCPQGTLFNRLSFNGQEVFPRSGETHPLENRNSDYLLSYRLVDREPLEVHLSIAED
AALSFTLFDYSYDLLENSSFDLPSRPKNSMPMPFVNTDALVTKQHIQF
>KECLDBNJ_00091 hypothetical protein
MSNIAIAGLGWLGLPLAAQLQELGHRVKGSVTSKNKQAELRNHGLDVYQVEIAEDEIRGE
IQSFLADTEILIILIPPGLRRNTGHNHALRMAQLLDATEKASVKKVILISSTGVYDDAQG
AVTEKDLPQPQDNKGKQLLEVEQIFFKSPTLETTVIRFGGLFGGSRNPVKYLAGRTGLSN
GNAPVNLIHRQDCMGIILGVIYKNAFGHIINAVHPEHPKKAEYYTKQAIALGLEPPQYDT
EEAEETYKKVDSVTLKPLLGYTFQKSL
>KECLDBNJ_00092 Lysine-sensitive aspartokinase 3
MMNVLKFGGTSVGSAQNIRKVVEILAVTEKPKIVVLSAMSGVTNLLVSLNQASIDKDLAQ
ITNVLEQLQAKHFEAIEDLFTAENQPETKAQIETFVAALQEIATGGRTLTTYAELVTYGE
TMLTWMFSRFLDQENVSNVLLNASTFMNVGSVENPNIDAVAEALAPQLAENPSELYITQG
FVCRDERGALATLKRGGSDFSATIIAAAVDAAGVQIWTDIDGLHNNDPRYVQETQPIEHL
TYNEAAELAYFGAKILHPQTVAPVIDRDIPVWLKNTFEPSAPGTKISNEYHNRGLKAISA
KDGITAIKIKSNRMLGAHGFLRTIFEVFDRHETSIDMITTSEVAISLTIDDTRNLKAIIT
ELSVIAEVTVEEDHSIICIVGENLIADHESYKAFGILNSIPVRMIAYGGSNNNISLLVPT
REKINTLQYLNAQLFQLEGAIA
>KECLDBNJ_00093 hypothetical protein
MKTITSVVEQLIKHQPYTEDALMRKIINYSALAEDFQPRIEKELGKPVNVGSIVMALRRY
YPQKRVDERMMRDLGDIVVRSGITDFTFLNSNTILESQSKLLEETKTIPKAYLTYSSTFH
ESNILVSNDLTDLVERCFQDETCVMVKHDLSSLSIALPANNSKTVGLYFYIFKLLAYEGI
PIFEAISTSNYFTLFLEKEYVNQAFALVNEIKG
>KECLDBNJ_00094 Neutral endopeptidase
MIVPVSLGILSLTACKQESKTDAVAEAKIPALDMANMDTLVKPQDDFYNFVNGNWMKATE
IPEEESVWGGFSVLRKTTREDVLTIINDARKSNTYAADSDQAKALALYESELDTVARNEA
GLQPLQPALDSIASIASVADIQRVGQLRNGTGTPFFNFRVFSDFSNSKMNAGYIAPGRLG
LPDRDYYIEQDEKSKEIREQYKEYISWVLEYAGDDAATAKEEAERILALETKLAEPKLDK
VEQRDARNLNNPKSVAELQKITPAVNWEVFFENQGLAKEVDTVIVLQPKYMSALQNVLTK
TSLEDLKLLMRWATLNSWSDKLTTDLEYANWEFYSKTLNGTPKQKPADERALATVDGTLG
EAVGKLYVDKVFPPEAKEKAEAMIANIKEAFRDRINALEWMTDSTKVQAIEKLNKFTVKI
GYPDKWEDYSTLEIDAEQGYFENMLAYGSWSLDKNNADYKEPVDKTRWGMSPQTVNAYFN
PSFNEIVFPAAILQPPFYNYQADEAVNYGGIGAVIGHEISHAFDDSGARFDGDGNLKNWW
SDADLEAFTARSGALAEQYSNIEVADSLYINGKFTLGENIGDLGGLLAAYTGLQKFYEKN
GRPENIDGFTPEQRFFISWATIWRTKMRDDALRTRIKTDPHSPGMYRAYVPLQNIDAFYE
AFNIKEGDPMFVPEEDRVRIW
>KECLDBNJ_00095 hypothetical protein
MKHLFLGLLLLSTISLTAQKQDKIEMAINTQLEAWHKAAADADFDAYFDLMTEDAVFIGT
DAEENWQLDQFKAFSKPYFDRGKAWSFSTLERTIYHPKKAKMAWFDELLDTQMGICRGSG
VMLLDGKEWKVQHYVLSIAVPNENVDELTQLKKTHDDALIKVFRAN
>KECLDBNJ_00096 hypothetical protein
MCVPLCTFETMKFYATALLLVLMLFSCKEETKVTVNPRNATDTLQVNFDENKKGNIALTP
AAVTAIEGWESFPELQAHIAALDTVRIQYLRVNGEDWISTASLAQSKVNDSLVNNAMRSR
LTVLFTKMNTTIQEASKLEVDTVSYYKEATELYNAFQNLKLQINLKFQKSIEELLEQYEV
EADSLSAVRDSTQVRKDSLLRANRVPVN
>KECLDBNJ_00097 hypothetical protein
MLIPNAMKYYLLQILLCVVLCVSCKKGASSTTQDFAIKAHVEELEPNVKEMIKDWDGYWA
LKRNIAMIENTNALNAIDFMDKMANNCNAMILQIPDAIETPEIKNRVEKVDTRINQFYTE
VNRNEMRERIVQNHIETIVQAFDTLNKELNRTL
>KECLDBNJ_00098 hypothetical protein
MKTIKIAVSALLIASLASCKTDKDKEAQVEENQEVQVVDSTAPEKARYADAVVTPKKPTM
PENYEIDWEGVEADADKKLDFDGWLEYQTFSGSLGKLELKEVPEEEITDYITQLENETTA
LESTIPASLLTEEVQEDIKDIREEVADLRRVVEQPGVETSKIDNQVEELVEAYQDLNEEL
KETMTKKAS
>KECLDBNJ_00099 hypothetical protein
MSTENLSDRELDRIIEMAWEDRTTFDAIEFQFGLKEQEVIELMRREMKPSSFRMWRARVQ
GRATKHAAKRTFEKGTFKSSRQKQITHNKISKR
>KECLDBNJ_00100 TonB-dependent receptor SusC
MLFFALVVQMALAQTQTITGTVVDDTGLPLPGASVVIKGTSTGTSTDFDGNFSLNASTGD
ILVVSFMGFNDQEIPVTEETTYSISLKSGESLDEVVVTANGIKREKKSLGYSQQSIDGSS
VVQAKDTDINSALAGKIAGVQLIGSPSSTFDNALIRLRGETGVLYVVDGVKIYSVSDINM
EDVADISVLKGVAGTALYGTEARNGAVIITTKSAKNGETRISIDEAVSMSSLYLLPEYQN
QYGGGYSQEFSTFEGQLTPNYSADESWGPELDGTLVRHWDSWIPNSDTYGELRPWSANPD
NVRDFYETATTNNLTFSLLKGGDDYNIKTTINNLKTSLITPNTNREQTTVSFKGSYNVAP
KLKFNGNFNYQYRLTDNFPVQGYGSIGSNFNQWWQRQLDINRLKNYRQNGQVYSWNMKSA
SDPTPLYWNSPYFDVYENTNSQIKNAVYGSIGLEYEYDEHLSGLVDLRRTFNSYEYESKT
GWYGLSQPGYSENTTTNEFNELYTQINYENKFGAFDVVANVGAQWNQRKYSYIGANTTGG
LQIPDYYSIRTSVGNINYSRDHSSEKNYSMFATASIGYENYLYLDGSYRKEWSSTADVND
NSVDTYGVSGSFIFTNVLENNDVLSFGKLRAGLAQAPSFPGVYALNNTYSIQNSYEDKLS
ISTPNTLANLTLKGGIREEKELGTELRFFGNRIGLDFTYFARKDSELPSSLTINGATGYT
ATTGNESITKTNGWELGITATPFDGPDFRWNMAFNIANYNKKVVKINDLTDQTLLASVWR
GYLYADEGDDWGNIYGYKWQRDEDGNILLNEAGTPQYTNAIEKIANIQPDFTGGFNNQMS
YKNFDLNFSFDFQKGGKFYSVTKMFNASSGVGIQTVGTNDLGNPIRDVVIDASGNEVTSV
NVNNAQSSSGGIRVDGADATTGELVSYYVNPRTYFGNLYGVVEEWLYDASYIKLRQASLG
YNFPKSMIENLPFENVKVSVYANNLWLIYSSVKGIDPSEIEDYYSSGNARWVEAGQNPSQ
RTFGMDIKLTF
>KECLDBNJ_00101 hypothetical protein
MKNYILKLTLLSILLFEVSSCDTVDFNDTNIDPDATTAAISSGLLTYAESQIGSAVTAET
GNLYVQYISNITYTEGSRYGTRNWDIDYLYYGPLINLQTIIDLNSDEETALTQVAYGFND
NQIAVAKLLKAYFYQFATDRWGMLPYSEALQGLDNTTPVFDSQEEIYLSLFDEIDDALAL
INTSEAGPTGDLIFDGDMTRWIQFANTLKLSMALRLSNVYPGASGVAATKFQEAMSGAIS
SNAENLLYPFIADQSYDNPWEDRFETREDYAVSDVFVNRLLADDDSRIDVYAEYTRSSVV
AGDPQYIGMPYGLTTSSYAASDVSFITSDIIYDQTAPGVIYSYAQVLFSYAEAVKLGWIS
GSASDYYEAAITASYEQWGAADADAYIATVPLSTNDATAMQQIAEEKWKALFLQGYEAWA
EWRRLGYPKLTPAAEPLNGSDIPVRHGYDLDWSQSNSANYEAAVSTQGEDNLGTNLWWDA
PHPITNQ
>KECLDBNJ_00102 hypothetical protein
MTENNQKIVVLSIIGLIILLLFLFQENKESSLSENQLTTIGKVVDIKMCGKPASGCITFA
YLIDGKWIDGTDPESAAYPEFVREGKPEIGKYYKVVYDKTDINNSKILITKKPLTEKQTE
KYLN
>KECLDBNJ_00103 hypothetical protein
MKKLLVAVAFLGAVSFASAQEKKNIYVKEGNLIKATLFHDNGQVSQKGYYTADGKLQGEW
ISYDKSGIKTAVANYENGAKTGKWFFWNDDTLREVDYSQSQITSVNTWKIEGERVVSNE
>KECLDBNJ_00104 hypothetical protein
MDNIYLIMLIALAILAIADLVVGVSNDAVNFLNSAIGSKAVSFKTIMIVASIGIAFGALS
SSGMMEVARKGIFVPEKFYFDEIMVIFMAVMITDILLLDFFNTLGLPTSTTVSIVFELLG
AAFCMTFIKLSGNSDTLLHLGEYINSDKAIEIIVGILLSVAIAFTVGALVQFITRLLLTF
NFAKRPTWNAAAFSGIATAAISYFIIIKGLKSADFVQGAFLDWANANVWPFIGLSFIVWF
LISYILIKAFKLNVYVMVIIFGTFALAMAFAGNDLVNFIGVPMAAYNSYEIWLASGEPAT
SFTMESLAEKVPTQPLLLLGAGLVMILTLWFSKKARRVVKTSVDLSRQDEGQERFKANAG
SRALVRGAMKLNAGIMSILPDSAKQMMEKRFAKPKVTSRVATIDMPAFDLVRASVNLMIA
SVLISVATSLKLPLSTTYVTFMVAMGSSLADRAWGSESAVYRVAGVLNVIGGWFMTALSA
FTAAAIMAFLLYKGGSIALFLLFAAAIAILVRNYMNHKKRSEAEAEEGRLMRAVSNSIQG
IINESTTNVASAFRRGSKVYVGTIEGLAKVDLGKLKKSKKGIAKLNNEVEELRNSLYYFI
KNLDETHVQASRFYIDVLGYLQDVTQSIDFVTTSSYNHLNNNHKGLKFTQLKDLKEIEDK
LDKLFSKIEDTFNAKNFDDLVAILEEKQNLLDSVSQKIEKQVERTRSADSSPKNTMLYFS
ILQETEDLIKATMNLLEHYYIEHKKHM
>KECLDBNJ_00105 hypothetical protein
MKPSILFAFLLFICFGCSDNEPGFIEEEETDQETPIENPENPETPEEPEETYEVAGEIEF
YDENLISEGYVLVNDVGFNRVYMINKDKAEIRYEWELEQGIGNDAELLENSDLLVSLIAE
DVAFSFGGFGGLVQLVAPDNTVKWEYEINTTFELGHHDVEELPNGNILILVWEGKLNDEA
RENFGYAYDDEVIYAEKLIEVNPATNEIVWQWSSWDHTIQEDDVTKSNYGLISENPQRID
LNYRDALRDGSYNGDIMHANGIEYDAQNDLIYISVNFYSEVWVLDHSTTTEEAALNTGGN
RNKGGDLVYRFGNPEAYNNSQGTRTFFYNHGINKIANTEHILIYANGGLGGVTQSVVYEL
ALPDAFVMQADTDNELEEVWSFTDPDLFAPRVSGAYRLSNGNTLITEGDYGCWEVTENQE
IAWKYKGTGFTWRAYAYDNDDTVLDPFDLQ
>KECLDBNJ_00106 hypothetical protein
MTESLKLHKSDIALIEKTSDYVKKTLLEAEGGHDWFHTLRVYKNALNIAKGEDQADVVIV
ALGALLHDIADSKFNKGDERIGPKLATAFLQSQNVTFSRVEAVVKIVENVSYRGGNPKSD
YSSIELQIVQDADRLDAIGAIGIARTFNYGGFKNRKLYDPAIAPKLDMTAEQYKKSEAPT
INHFYEKLLLLKDKMHTKTAQAIAQERHTFMETFLEQFYAEWEGKK
>KECLDBNJ_00107 hypothetical protein
MRKFFAYPLSVIFYLAFGLTICIFHPVQWVCYNWFGYQAHKKSVDYLNFCILKCLNLLGT
RFTFENPYTITRNQPIIIVANHQGQWDISPIIWYLRRLHPKFISKIELGKGIPSISYNLR
KGGSALIDRKDKRQSIMAIRDLTKTLNKTNRSVVIFPEGTRSKDGIPKQFATGGLVTLFK
FMPDAIVVPVTINNSWKLMRWGGFPQDIGVHVKHTVHKPIPVAGTAPEELVKQVQDIVLA
DFPKIKEHTRKSKLI
>KECLDBNJ_00108 hypothetical protein
MKQSLIIRLTIALIGFNCIAFGVNYFGISPKIQAVSERETFEIFLFTDREPGTKSSLSQV
GGFLQDQDGFWPFESFYTKTSIGIDQYTGRFRGFFTGFLLSEFVFYNLIILALLLFLKLW
>KECLDBNJ_00109 TVP38/TMEM64 family inner membrane protein YdjZ
MRNFLVKNLPKILTVFVVLCGVAAYFTLPEVQHFLDEAWRVLTGGDEQEIKNWVDSFGWA
GPVVLILAMVIQMFLIVIPSIALMVVCILAYGPIWGSLLVGIAISCASTVGYFLGRKLGD
GVVKNLVGASTEDKLEDFLNDYGFWAIAITRLNPFLSNDAISFVAGILKMNYFKFLGATL
AGIAPLTLFIAIMGESTDGLKNGLLWGSIVSLVIFLGYVFWSKKHKKKKQKA
>KECLDBNJ_00110 hypothetical protein
MKNNIKTLRAAFQLTQSDLAEKIEVSRQTVNAIEKGKFDPSLPTAFRLAAVFNCSIEELF
IYESEE
>KECLDBNJ_00111 hypothetical protein
MSSELYINQKSNSMNSKFIASRNRLAKWSLAWVFTTALVTFGSQFLWDSQIITVLSISIS
LAVGVGMVLANRKFVNDGDELQRKIQLESMALTLGLAVVVGIAYSQLDTTNLIKADAEIS
VLILFMGITYIFCVFFNSRRYS
>KECLDBNJ_00112 Glycerate 3-kinase
MSRILIAPDSFKESLSATQVCKAIAEGLQSIDPNVHLDQLPFSDGGEGAFELFEALQLGN
TIECQVCDPLGRPLTAAYYGFKDGKTAWIELSQASGIALLKDEEKNPMRTSTFGTGLQLK
HALENGYQNIILGIGGSATNDVATGIFIALGGKLLDHNQNSVQACGAHLKAITDLDFDSL
VPQIASAQITVACDVSNLLLGATGAATIYAPQKGATPAQVTALEQGAEHLAQIIQQKTGR
TITSITGGGAAGGTSAGMFGFFNSKLEPGFELLSKLANLEERVKQADLIITGEGKTDNQS
QYGKVPFKLAELARKHYKPLYLFAGSVQADLEVLTAAGITKAIAIKTETMSLEYAKSNAF
ALLKTAVAQYLNTEL
>KECLDBNJ_00113 High-affinity gluconate transporter
MGLDLLYIVLVVVWIIAGTSYLRWHPFFVLLISALGLAFLLQIPLEEIPETISTGFGAMF
KNIGLLILFGAWIGVALETTNATTAIAKGIIKKLTILPLPFVISALGYLVSIPVFCDAAF
VILAPLTKKLALNNTARRNALTVALSTGLFSAHVLVPPTPGPLAAAGNLQLENLYLLLLA
GGIFGLVLMLIGACFSYYFFRKSNQQDAFDRNNLENFFDQYTDLPSFSAAIWPLALPILL
MAAASIIPLLFEVSNLFIDILLFLGDPAIALLAGVLVAFSICKKQQQDISEIIKKGMTQA
APILLITAMGGALGTVIQTANLTDGINLESFSNGLGLAIPFLLAALLKSAQGSSTVAIIT
ISSIMLPLLPALGFDSELGKVWVIMAIGAGSLTVSHANDSYFWIVSQLGEMPVKEAYRKH
TLGTLLQGVVGFVILFCAYSVYSAF
>KECLDBNJ_00115 Putative zinc metalloprotease
MDPFFVKGAQLFLSLSLLIVLHEFGHFIPARLFKIRVEKFFLFFDVKFSLFKKKIGETVY
GIGWLPLGGYVKIAGMIDESMDKEAMAQEPKEWEFRSKPAWQRLIVMIGGVTVNIILGFF
IYIMIIAYYGNPVVGPEQMPDGIEVSEGFKEYGFRDGDQILAVNGAPYENNLAINRDMML
RDVSSITVAHTDGSEETITIPEDIGTTMFQSGESDALAPLIKPVLDSVVPESAAAKAGLK
KGDVLTQINDEPINTWTDFKGSKKEGVNEYAVTYSRDGQLANTTVTLDDNGNFGVYPKAN
YKSKVIKYSFGESIAKGINHGYWKLHDYVAQFKYVFTKKGASQVGGFGAIAGLFPDTWNW
LSFWETTAFISIILAFMNILPIPALDGGHVMFLLYEIITGRKPSDKFLEYAQMIGFFLLI
ALVLYANGNDIYRWITGS
>KECLDBNJ_00116 SCO1 protein 
MLQFFAKYKKFAIVMVILSAVILYTFYTLMKPAPSLPVYQPTMVDNSLVDSTVQFVKKYH
KIADFELVNQNGDTITQKDYPGIYVADFFFTTCQTICPIMTEHMVQIQEKLKDDPSVKLL
SHTVIPATDTVAQLKRYALEKGVNDSKWNLVTGPKKQIYELARKSYLAVKTQGDGGKYDM
IHTENFMLIDSKKRIRGFYDGTDPEAIEKLLEDIAILKAIEGDENS
>KECLDBNJ_00117 hypothetical protein
MTTSLNLLKRGEKAIIVSFELDNVPLKLLEMGCLPGNEVELVQIAPFKDPMYLNINGSHL
AIRRETASFITVEKLSHE
>KECLDBNJ_00118 Fe(2+) transporter FeoB
MSKQLNVALIGNPNTGKTSVFNQLTGLKQQVGNYPGITVEKKEGVCKLPRGVKAHILDLP
GTYSLNASSLDENVVIELLLNKNDKDYPDVAVVVADVENLKRNLLLFTQIKDLNIPTILA
INMADRMDRKAISLDIEKLEERLNTKIALVSSRKNTGFDKLKELIANYKNITTEPCVNAS
VIAPEYFERLRNAFPKQDLYKLWLVITQDVNFGKLDRNEMQSISTFKTESKSNLKRLQQK
ETIVRYQFINGVLKETLSIDHLAAKDLRSRLDRILTHKVWGYVIFFAILLLIFQAIYDWS
SYPMDLIDESFAAMGEWVRNTMPPGAFTNLIAEGIIPGLGGIVIFIPQIAFLFLFISLLE
ESGYMSRVVFLMDRIMRRFGLSGKSVVPLVSGTACAIPAIMATRNIENWKERLITILVTP
FTTCSARLPVYLIIISLVIPDERVLYIFNLQSLVLMLLYLIGFGTAVLSAWILDRILKIK
SRSFFVIEMPNYKLPLFKNVAYNVIEKTKSFVVGAGKIILAISIVLWVLASNGPGDQFDN
AEENSIARMEAGEFPESELDKHIASQKLEYSYIGYMGKAIEPVVQPLGYDWKIGIAIVSS
FAAREVFVGTLATIYSVGSEEEETIKNRMAGEVNPILGGPLFNLASGISLLLFYAFAMQC
MSTLAIVKRETNTWKWPILQLVVMSGFAYVVALVAYQLII
>KECLDBNJ_00119 hypothetical protein
MLQNILVVLIFLIAVGYLVTKYIWKPAFLNGKSNDKSCGSDNCGCH
>KECLDBNJ_00120 hypothetical protein
MRVLPPNGRYYYIFCFLLILVFCQPVLSQVAIGTTNPDDGSAFQIDSKVGALVPPRMTNS
EMLAIPSPLDGSIVYNNTFSSLFLYSSGTWNDLTRPDLPSAVLRREYPSESTNGIVATGN
NTYYNFPLNTADVTSIDNSYFQITGNGTLRILEGGNYMVSSGFAVSNLPSGNRKYIIGVY
RNNSLIGYLVRGNVNFPSGTNEWGTSGVLVFSFNANDVVSLRYVLNNSGTSLNARYFNIG
IVKL
>KECLDBNJ_00121 hypothetical protein
MLCRIFTVFLIPFFLNPLFSQETEENQVGVGIGTSTLAPGSAFQIESTTGAMVQPRMTSS
EMNAIPTPLDGAFIFNTTENAWYIHKEGSWQTFVRVQTPSIILNRGQTNNAIIITDTTNI
TPFPLNQDNTLVSDIDFYEATENNGEIRILRSGTYLISAGFSTTNLPPGSLTYRLEVSLN
NTTSSIITNGEVNLPGSDYWGTSGNILLILQTNDLINIGYILKGASASTRTAAFFNIGVS
KL
>KECLDBNJ_00122 hypothetical protein
MMRFLVVLFLLVFNCRLSAQAQQGQIVIGEAVHEPQLVVQVPFGERVAFGDVEIELTRVI
DSRCPQNTTCVWAGIVEIEALVFKNGKPIESRKINLNSPAKTLFNSSAQELMGQSVLPYP
DASQPKIKQEDYVLNVVWSQF
>KECLDBNJ_00123 Zinc transporter ZupT
MNEIINYFETLSPVTGAFYATLFTWGVTALGAALVFFFKGMNRALFDAMLGFAGGVMVAA
SFWSLLAPGIEMSPGEGFVKVIPAAVGFALGAAFLFGLDKVLPHLHVNFKEEDKEGIRSP
WHKSVLLTLAITLHNIPEGLAVGVLFGGVAAGFDGATIGGAVALAIGIGLQNFPEGFAVA
MPLRRQGFSRWKSFNYGQLSAIVEPIAAVVGAYAVMTFQPILPYALGFAAGAMIFVVVEE
VVPETQQGNHTDIATMGFIGGFILMMTLDVGLG
>KECLDBNJ_00124 Iron-dependent repressor IdeR
MTFSEENYLKSIYALQKEHPKGVSTNVLSKYLDTKPASATEMIKKLDEKGLVHYQPYQGV
ILKDSGAVSALKIIRKHRLWETFLANKLDFSWDEIHDVAEQLEHIKSDKLIRELDKFLGY
PKHDPHGDPIPDEEGNVVKMEKKRVSQLNPGDIGTCIGVNDTSSSFLQFLDQQNIRLGSV
IHILSVQEFDKSMTVRIDDRELLLSQIATEHIYVRV
>KECLDBNJ_00125 Colicin I receptor
MSLNNYLKIAFLFITQLVLAQEQTTITGVITDGTTPVPFANIIVEGSTNGVAADENGSFE
ITLSLEEATLVFKAVGFKTQRKAIQPENFRNKPLAIELQEDLLGLEEVVVSATRNRISKK
EAPVIVKVLSPKLFKATQSISLADGLNYQPGVRVETNCQNCGFTQVRLNGLEGQYTQILV
NSRPVFSALNGVYGLEQIPVSIIDRVEVVRSGGSALFGSNAIAGTVNVITKEPVNNSWEV
NSNLGLIDGKTADRTLNMNTSIVSEDLSTGVTLYGMYRDRDAFDANGDGFSEITKLTNHS
FGSKAFYRPNDNSRIGLDFTAIKEYRRGGDRIELAPQFTDITEELDHNTIFTGADYELYN
DERTNNLSVYASLQHTDRKSYYGGLGGGRTAADSIAANNAFGNTKDLGLVSGAKFSHTFK
NKDVLTSGVEYQLNDTEDAILGYNRVVDQQVNSFGLYSQYEWKPLKDFTTLLGARLDHIS
VDGYYTIQNIERTSEVSETVLSPRITLLYDITHELQFRGGYARGFRAPQAFNEDLHISSV
GGEQRFAILSDDLESEFSNAYTASLNLTKNFNKTQTSLLVEGFYTTLQNPFTLVSTGASL
PNGAILEESRNGSGAYVAGTNVELTVSPSQDLYFQAGITYQKSIYKEDQVLFESDGTVPG
ENNVVISEFTRAPNLYGFFNVNWVISEAFKMDLAASYTGSMIAPHVVSDSGFIALEETPQ
FIDVTPKVTYHFDLKDTFHIELSTGIQNVFNSYQDDFDRGPLRDSDYIYGPNRPRTFFFG
IRFGDF
>KECLDBNJ_00126 Thiol:disulfide interchange protein DsbD
MKQLIFFLFLSCGSLIAQKSDQQINWLSWEELEEALTENPKKTLVFFHADWCAYCKKIDR
VVFTKPEVIAKVNRDFYAVRMNAETTDTITFDGKVFTNPLAKTQRNAVHQLAALLGSRED
QDFSLPVTLIFDKQFKVKRRIFEYYTSKELLKYLNQ
>KECLDBNJ_00127 hypothetical protein
MQDATNHFDYIILGAGLSGLMLAYRMSQDAFFKDKSVLILDKSDKKINDRTWCFWSQHTA
EWDTVISKKWNTIRFKSAGFDAEIPLKKYTYSKIEGLDFYNQIFEQLQASKNFQFRTETY
LSHREHNVSVEVQTKNNTYSAAKLFTSILPPERLEKQTQFPVLQQHFIGWEVKTPSSVFE
PEIATFMDFDIPQRRNTRFMYVLPTEKNKALVEYTLFSEKLLPKAEYEVAIKEYLEELGV
PEYTIHATEQGSIPMTAFPFEQFNSKNILHIGTAGGWTRGSTGYTFTYTTKRTKQLIAFL
RTESDLSKFSIKDRYRWYDAIFLDVLYRKNQMGAQLFTRMFKKNNVDAIFRFLDGESSLK
DDLSIILSMPKKEFIKSFFGLK
>KECLDBNJ_00128 HTH-type transcriptional activator RhaS
MQHTSLEAFYKEAAIFTGKEIETLLPPGINKEIGHFNVFDISETIRAVKEKNEMPYNRRA
YYKISLIRGENRAEYADKVIEIKSNALLFATPNVPYHWVPLDEDQNGSFCVFTDAFLMQS
KSGIDLEKLPIFQPGSLPVFEISDEQAEAIAPIFSKMKTEIASDYEFKYDLLRTYLLELI
HYGQKLRPAHQVSNNQNAAKRIISLFIELLERQFPIESPQQRLQLRSAKDYADRLAIHVN
HLNKVLKESLGSTTTDIIKKRIIQESKILLKQTDWTVSEIAFSLGFEEVAHFSNFFKKQT
QLSPLNFRT
>KECLDBNJ_00129 3-oxoacyl-[acyl-carrier-protein] reductase FabG
METKNKIALITGGSRGLGKDMALSLAKTGVDVLITYHSNADKAQEVVTAIEALGQKAAAF
QLDTANVKSFDDFIAQITNHLKEQESHPNIDFLINNAGTALYAPIMQTTEEQFDEMVNIH
HKGVFFLTQKALPYMNDGGRIINISSGLARFSLPGSSTYASMKGAIEVLTRYLAKELGDR
KITANVVAPGAIETDFGNGHVRDDAKTNEMVAQMTALGRAGLPEDIGGVVAFLCSPEARW
VNGQRIEVSGGMNL
>KECLDBNJ_00130 hypothetical protein
MRRVVVILFLLVQTISQAQDYKSNIKASFSDYLDAIVNLEFERSMDYMLPEFFEIVPREQ
LVGLMEQTFNNPDIHFKIKNPEILKVEDAQKIDGKYYALLTYANDMEIQLQAAADETSEE
KGMRVSLTQAAFEQSFGKDNVVYNDSLDQYLIHSETDVYSISENGVTDWKFLVLEEKQKA
ILEKLLPAQLIED
>KECLDBNJ_00131 hypothetical protein
MKNTILALLLLVVVNAFAQNAEERKIIKVLEKESATWRAGDVEGHASCWAVKPYSRILIS
TGDGEVIDLDPQLMINPPKGMMGNGGTSVNSNYKFHINGNEAWVSHDEQSTSADGSVSKT
IEIRMLEKINGSWKLTGQSIHVKKDRTNLTAIDAIRLSDPYILADEATQTYYLTGTGGKM
WKSKDLAYWEGPFDVVETDPNSWMGPKPIIWAAELHQYKDRYYDFATFTNRAVKIDTVDG
NIIERRASHILVSDTPDGPYKPMEDDIYLPADMPTLDGTFWVDEDGKPYMVYCYEWLQNG
NGTIEKIELKPDLSGSVGEAELLFKASDSPWSREKDKDGNDKPNKVTDGPFLFKTETGKL
GMLWTSWIYDEYVQGVAYSESGTLNGPWIQEEKPITPRNYGHGMLFKTFDGKILMAAHSH
AVVNGNYHRVPHLFEVDLSGDKLKVVAPYTP
>KECLDBNJ_00132 hypothetical protein
MNKYYLLVLVFLFTYLDGYTQQVSVDSPRPAQDLVNTLVGDACAEISNIAISSTQAAGLF
SNNGGPFPLANGVVLRTGNAQLSGGAYTGNEAQLSSELNTNGDAYLQSINDATGTSAPIE
ETAFLEFDFVPLSSDFSFDFIFASNEYGEWQCSSQDVVAFILTDLSTGTSQNLALTPSGE
EVSVRNIRDDQNNASCNSVNPGLFDSYEVTNAQSTINMRGYTQVLTASSTLTPGTSYNIR
IVIGDSNDTNFDSAIFLAGGSFNTSVDLGPDLVLCSGDSTTLSTGLDATVYTHQWFLSGS
AIPGETGSTLTVSNNGMYRVEVSNNGCVIADEVVVSPLSITAPEDLIACYNNGNPSSFNL
TQNDASALGLSNAQFEVVYYASTTALSTNQPIPDSELNAFQSAGQRIFIRLRNLNTGNFC
GGSYSFMLEQRPEIRVTTPNPLQACARPGNDVAVDLTQLNNEILNGQNPALFNITYYENQ
ADADAMSNEVFSPYVISEGTTTQNFVARISFADEDACYETVEVTVEVNDLPPVDQLADVI
TCNAYELEPLTNGNYFSGSNGRGTPYNAGDIITEDMVLFIYTGPDANGCSNETSFSITFV
SEYDLSDRESCGAFIIPSTLAGGFYTAAGGPDGGGTRLNPGDALTTSQTIYFYFEENGAV
CRDEAFNITVYPLPPVDEPADVVACNDYTLPALTNGSYNTEPDGTGTTLNVGEVITTTQT
IYIFNDDTRCTNSHEWRVFIVPEFDNLDACGSYTVPEVEEGAFYTAAAGGGSVIPEGTVF
TTSQRIYYYVNTTTGSNCTTNAFFDVNVIAIPPVDTLPDQLLCEGETYTLPTLTDGEYFT
ETERGGTQLFAGDVIDESQIIYINNEVSGCQNQTQFEVEIRPLLPVDNLTFVYSCEPYVL
PELENGQYFTQPMGVGDQLFAGEVITATRTIYVYNAYDDFTSCYSENTFTINILGVEVEE
FNDTAQCDSYTLPALAVGDYFTESGGQGTQLNPGDVLTTTQEVFVYARNGTRFFCEDESS
FTVTISQTPVLVPEPDVEQCGSYMLPALSQATFTQGYYLGPNKQAPIDPADYELMPGTYT
IYKYAEATDNTNCFAEDVFEVTVYPLLNFSVEGGTLCRNATTGAVENPVLLDSGLDASEF
LVSWFLDGQLAGQGSTYTAVEAGVYSVSTQKLNPEVGAACNYNPTTVEVFESAEPVFDVE
VSQPFENVSEIAVTVTAGFGEYEYRLDDQAFQNTPRFINVSPGTHLITVRGVNGTCGAAS
VEVQVIDFPKYFTPNNDGYHDTWNITSLEDFPEAQIFIFDRFGKLLKSLSPQGPGWDGTY
RNQNMPSDDYWFRVEYTFEDTPAVFKSHFTLKR
>KECLDBNJ_00133 Chaperone protein DnaJ
MIRWIGAIIGFAYRGFLGAVAGYVIGMLIDNLFFNKSDSQASGRSRSPFSGGQQTVTPGD
FELNLLSLCSIVIKADGQVSQREMDYVRQYFVQAYGKERANATFRTFNEVVKKREVNAQR
ICAYLVQRTRREVRLQIVHFLFGIAQADGNVSTAEVNKISSIAGYLGLSRNEFEGLKAMF
FKNSDSAYKILEIDKSATDAEVKKAYRDMAKKYHPDKLQHMDEAYRAGAEEKFRNVQDAY
ETIQKERGM
>KECLDBNJ_00134 hypothetical protein
MYPAELVKPMREDLTSVGFTELHTTDDVQAAMKKEGTTLVVVNSVCGCAAANARPGARMA
LQNAKTPDNLYTVFAGVDREATELARNFMVPFPPSSPSMALFKDGELVHMLERHHIEGRP
AELIADNLVDAFNEYCQ
>KECLDBNJ_00135 H(+)/Cl(-) exchange transporter ClcA
MPGKKPLLHRFHAWRYKHISKTTFIYFLSVITGLLAGLGAVLIKNFTHVIQNLLEGKLVE
NYRYGFYFLFPIIGLALTVLIVKFIIRNPLSHGVPMTLRAIAKRKGLLRNYQVYASLITA
PITVGFGGSVGLESPTVVTGAGISSYLSRIFHMDQAHRNLLLGCAAAGAMSCIFKAPIAA
IIFAVEVFSLDLTLLSLMPLLLASLSAILTSYFFFGSDTILPFELKDAFTIADFPYYMVL
GVVAGLTSVYFSKAYFATQKFYSRWTSATTRLIIAGASLGVLLFFIPPLYGEGFDIINQL
LEGNTISALGETFFSDYLENIWVVIALLAGLVLFKVIASAITFAGGGIGGIFAPVLFMGS
VMGNCIAKVINNLGINGVHISESNFTLVGMTGLLAGVLHAPLTAIFLIAEITGGYGLFIP
LMITAAIAYGINKYFLPHSVYGMELAVKGELITHDKDQAVLTLLNVDQIIESNFIRVKPN
MTLGEMVKCAVAKSTRNLFPVVNEEDELVGVITLDDIREIMFDASLYDTTKVGSLMHAAP
EYIYLESDPAKEVMRKFQDSGAWNLPVIKDGKYHGFISKSKLLTAYRRMLVSFSRK
>KECLDBNJ_00136 hypothetical protein
MFKQKYVIIICCVFCFSAYAQDISPSVFAKLNGFRNKSFKENGFYDIQLGFVLFSDFWIA
PKLAFKHNIGALNDASVFTETTEEQLRTNYTGNLVSVGTKIRLSKPEDVWLFFWPEYSFG
NFKYTSSYFKTENNPARLQLQESVNYKNQQDYFDFALGLEGYLDFDQRFLISAYLVYTTL
DLRQDFDQLSFTQTGRRPIPEKNSSLGIGVSLEYHFSKK
>KECLDBNJ_00137 hypothetical protein
MRNAIIILFCILCLTLGYGFYLRYFTEDTLTGDRFLGLTILAVAFILMPMFLYHRWKDRN
VKDYMLDEDNIRKMRDFNESKESRKNSENQ
>KECLDBNJ_00138 Cold shock protein CspV
MKGTVKFFNESKGYGFITNDDTGKDIFVHATGLNGEVLEEGDQVEYIEEEGRKGMVAAQV
RVL
>KECLDBNJ_00139 2-oxoglutaramate amidase
MQDTLKIAAIQADLAWEDPETNRAYFDQKISEIDGVDLIVLPEMFATGFSMNPEGIADTG
AMVAWMKATAKAKQAALAGSLMIQEHDNYYNRFYFITPDGTSTTYDKRHTFTLAGEHKVY
KRGEKPVIATYKGFKFLLQVCYDLRFPVFARNTSNYDVMLYVANWPKKRVFAWDTLLKAR
AIENMSYCIGVNRVGVDGGNYEYNGYSGIYDSLGATLAFAEAEEKTIYATLSKAHLEETR
NQLNFLADQDAFILK
>KECLDBNJ_00140 hypothetical protein
MSKKVLQLVSVSILLLFVVQCAKRGTPTGGPKDETPPVLVRADPPNYTTNFDRKEIRIYF
DEYIKLKDISKNLIVSPPMDPKAQVSPQGSASRYIDIQITDTLTPNTTYQFNFGESVTDN
NEGNAFPFFKYVFSTGDYIDSLNVTGVIRDALLQKPDEYVTVMLYEADSTYSDSIVYKDV
PRYITNTLDSTVVFELTNVKEGRYKLVAMKDDANNYTFQPDKDKIAFYDGFIEVPTDSVY
VLRLFNEQLKSETGRPKQASAQRIAFPFTGNPDSIDIKLISAKPEGFERLVTLKKGQDSL
QYWYKPQVETDSLIFETYGNKQLLDTMYIRKRGLKPDSLQIQSVSSSLILEEPYLFNTTI
PVVAVDTSKIRISRKDSTLVEAFQVKLFPEKLQMSLKFETEENESYSIQMLPEALTDFYE
SKNDTLNFSASTKAYGDYGEYDLTLQGAADVQHIVQLVTEKGDVKREIIGVPGTTVFQFN
RIEPGKYYARVIVDLNENGKYDTGNYLEQKQPEEVLYYPDLLDLRSGWYPKNTFILTQE
>KECLDBNJ_00141 hypothetical protein
MKSLLKLFFPDQCSACDELLSEGEAFVCTSCRHTLPVTHLHTTTLNPIQKLLYGRTTIHL
EAALFYFDKKTRVQQLIHNLKYRRQEQLSPFMGNWLGSQLAEAPAFTAIDCIIPVPLHKS
RLRERGYNQVAGFGKAIAHCLNKPYLDAILYRTKATRTQVFLNRVFRGTEVLDSFAVTET
ASLQGKHILLVDDLITTGGTIEGCALALQQIPDIKLSVAVMAIAQ
>KECLDBNJ_00142 hypothetical protein
MSATRNNNALKILIGILFLLLLGMGGYTYKFYHELSASKVALSEEKELLKEELSDLLTNY
NSEIETNKLLTSELKEARSRIQNLLYRLEQSNSTQSTLQNYRRELAILRDERDALRKKAD
SLLLENALLVTQKTNAEAAFDESIVERDSLKQQNEALQENLTKGAQLTVSKFRTSGVILR
RSGKTVPNDRAGRIDKIEICYTINENVLAAPGIHDFYIQVINPKNNVMGEHVSLAFGENI
LIYSAYQQINYQNEELQSCVWINPMAEEFDPGIYRINLFENDRLLSNSVVELE
>KECLDBNJ_00143 Glycine--tRNA ligase
MAQQEDHFKKVISHAKEYGYIFGSSEIYDGLSAVYDYGQNGAELKKNIRDYWWKSMVQMH
DNIVGIDASIFMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLIEDYAEKLNQKALKE
IAKAKKRFGDKFDEQEFVTTNPRVLRYRKEQETVLQRMARSLEAEDLADVKALIEELGIA
DPDTGSKNWTDVRQFNLMFGTKLGASAETATDLYLRPETAQGIFVNFLNVQKTGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVRPGDELKWYEHWKETRLKWHLSLGLG
EENYRFHDHEKLAHYANAAADIEFDFPFGFKELEGIHSRTDFDLKAHEEFSGKKLQFFDP
ELNENYVPYVVETSIGLDRMFLAVFSKSLEEEELENGSTRTVLKLPAILAPVKAAILPLV
KKDGLPEVAQKIIDDLKYDFNVTYDEKDAVGRRYRRQDAAGTPFCITVDHDTLEDESVTI
RDRDTMEQKRVKISELATILHEKIDFKHWAQ
>KECLDBNJ_00144 hypothetical protein
MKQRYTLKFHHTTLLAFFIVFIISSLDTTAFGQEKEKPTLYGKMRFVREVPSLASQLKNG
TFKAADRSHNPEEINPKRRRANQVVPGKGFPKDGDPLIKKRDHKNKSDSKSYMLEPINVF
EANVSNFTPSDPTGAAGPNHYVAAWNVGFAIFDKDGNALTEAASLGTLFEGNEAGDPIVL
YDAPADRFIITQFENEDESDADNDFDNGLNIAICQGSDPVNDGWYVYTAGFETGAFPDYP
KYSVWHDGYYITSNIAISGGDATGDAVFVMEREKMLQGLSDAGFLGFPLPTLQRTGFYSP
QFFNVSTANAPTTGGATVLYFQDDGWSGVDDDHLKLWTVDVDWDTPENSSISQPEILTVS
DFDGVFDGGSFSNLPQPAGAEIDAMQGTVMNQAQFRKFDDHNSAIFNFVVNVAPLGEEQA
GIRWYELRQTGDGQPWTIYQEGTYVSPTGNNAFGASMAMDGAGSIAMGYTTVSADLPVTL
NFTGRYTNDPLGEMSVPEAFLASSTGVSTSERYADYTHLTIDPADDETFWFISEYFNPQR
TDIVSVFKLAPDNANDVQVIAIDSPQDGALSATESISITIRNAGNTTQTSIPVSYTVDGV
TVEETYTGSLAFNETASYTFTQTADLSTIGADYTIEASTNLENDEDTSNDTMSITVKNLW
QNDVGVASIDTPESDSGLGAAIAISVTVTNYGQDAQSNFPVYYQLNDGEQVTETFDRSIA
AQTSETFTFSTTEDFSAIGTYEITAGTALETDSDTSNDIASVTVTNDYCQPVSNCSGFGD
GVTLFTLEGTLVTPPCSSTGYSANLETTFNLNVQKDSHMGTLQMGYQNSGYVIFIDFNNN
GGFEASELVSSGTVETADTDAVFTIDLPEGVELGTYRMRIRGKDNNEEGDLNDPCGELAY
GRTNDYSVRIFNSLSVEENIFPESELVILEPEQNHFQISLSTEETTEKMAVSVYSILGQK
LAENWIENEYGSYVYDLDMSYASSGVYIVRIGNRTGGQSKKIIVK
>KECLDBNJ_00145 hypothetical protein
MRHLVLILCFGIAATGFAQDFQFSDSRVKHLAVRDTMLIDSVSINPVEFAVYTLSGMQLD
STAYAIDYGRALFSLNAQAPKVDSLKFKYRVFPDFLTKTYFEYDPDRVVNSSGNLNKVYA
LKEEKNTAVFTPFDGLTTSGSLVRGVTAGNNQNSTLTSELDLQITGKLSEKVSLRASLQD
ANLPQQNGGYSQRLDEFDQIFIELFSDDWNIRAGDINLENNTSYFGRFTKKVQGLSLYGR
INHESSQTEAFATGALVRGVFTQSRFTGQEGNQGPYKLTGPNGELYVLIVSGSERVFVNG
VLLERGETADYVIDYNAGELRFNPTFPITSEMRISVEYQYSEQNFTRIIAYAGGGHRSDD
GKLELNAHVYSENDAKNQPLLQNLNQEQVAVLQEAGDNKELMIAPSANLDSYNENKILYR
KFFQDGRAVYEFSNNPEEELYNVRFTEVGANQGNYVLTNASAINRIYEYVAPINGVAQGN
YAPVSRLFAPTQLQMAVVQGAYNPSDKTSVSFEGAASKEDLNLFSDLDDGDNKGFAGRLN
LAQTLYEQNQSKQLTAFGTLDYIQNTFQNVERTYAIEFSRDWNLPLLPQGDQTLITSGIQ
YQDTAVGVVNYSFEHLQYRQNYSGNRNMLSGALRFKKLRTQFNASYLKSEADTANTRFFR
LNAATIYGFKKAWVGAKVQAEDNVSRNPVSGIYDPLSQGFKAHQGFVGNGDSTAVFVELG
YRYRVNDSLRGNSLQEVNHSNTYYLKSQLIQNENTSLGVYANYRKLRYTDQSYEDEQSLN
SRILYDQKLFKNLIRLNTVFETSSGTLPQQEFTYVKVDEGLGTYTWIDYNADGVQQLEEF
EVAQFQDQADFVRVLLPNQVFVKTHQNKLSQIITFNLQQWSGKNGFKKFASHFYNQTSYL
IDRRVLREGDTFNLNPFKEIDNTLGLNLNFRNTFFFNRGKQKYTSSYTYLANSTRNLISL
GLQTNELRSHQFTFLHKIKSSYLFNFNADLGTNSSTSENFEQRNYSLETMALNPKLSYLF
NDNTRLEAFYTLNRKENTLGELEQLNQQNFGMAFAYSNAEKVSFNIEANYIKNSFRGSAF
SPVAYQMLEGLQPGSNFTWNVLAQKRLTKFLDLNLAYFGRNSEDSRTIHTGTVQLRAIF
>KECLDBNJ_00146 Exodeoxyribonuclease
MKIITYNVNGIRAAIRKGLLDWLKAANPDVLLLQETKAHKEQLDIDLFKETGYHDYWFSA
QKKGYSGVAILSKKEPDNIVHGTGIDYMDHEGRNIRADFGDLSIMSMYLPSGTNIDRLEH
KLRYMADFQEYAEELRKTRPNLIVSGDYNICHEPIDIHDPVRLKNVSGFLPVEREWLSGF
INSGFTDSFRHLNPDVEQYSWWSYRANARANNKGWRLDYNMVSEPLKDKIKRAVILPEAK
HSDHCPALLELDHQS
>KECLDBNJ_00147 putative lipoprotein YiaD
MFRKFCIIAGAAATLSSCVSAKVYKDLESRFAGLKAENQELQQELSQEERLRKQFEDQAA
QLERDLAQATSERDDLQRKYTAAQTNLKNLQESYDALEANSSKALAENSKQNRELLAQLD
EKQADLAAEQTRLEKMQRDLTERSRRVEELEAMIAAKDAKMRALKDAISKALVDFEGNGL
TVEQRDGKVYVSLENKLLFESGSWNVGAKGKQAVNQLGSVLAQNPEIAVLIEGHTDDVPY
GGNGPLKDNWDLSTKRATAIVEILRQNAQIDPKNLTAAGRGEFAPVATNSTAEGKAKNRR
IEVILTPKLDEVTKLLNDI
>KECLDBNJ_00148 General stress protein 69
MRYTKLPGTSIEVSKICLGTMTWGEQNTEAEGHAQLDYAIDQGINFIDTAELYSVPSRAE
THGSTERIIGSWLKNRGKRDDLIIASKIVGPAAMSKHIRTGGYTKEEFKDAIHKSLKRLQ
TDYLDLYQLHWPERNTNYFGKLGYTHNPDEKWKDNFAEVLGYLQDFVSEGLIRHVGVSNE
TAYGLSRYMEESRKGLPKMITVQNPYNLLNRKDEIGLTEVMQREDVGYLAYSPLGFGTLS
GKYIEQKDTEASRINKFPQYSRYSNEQAVEATKRYLDLAKKHDLSLTQMALAFVTDRPFM
TANIIGATNLEQLKENIDSVNIQLSPELLEEIETIHNAVPNPAP
>KECLDBNJ_00149 Peptidyl-prolyl cis-trans isomerase Mip
MKKLVLAGAAAIVLASCGGTKKLPETPEPPLLQSFQDSVAYYMGVSIAENIKKDKATYEN
YFDKKVFLTGFQEALKDSAQISEKEGRQVMGRYSRELLELQEKLKEERIAAQKAFLEENA
AKEGIITTESGLQYEIITAGSGASPEASDRVEVHYEGTLTDGTVFDSSYERGESITFGVG
QVIAGWTEVLQLMKEGAKYRAYIPADLAYGDRDIGEIPPGSTLIFDIELIKVK
>KECLDBNJ_00150 hypothetical protein
MTYLVIAVVSGALILGAIWGIYGNLQKKTEGFLVALAGGALIVSTVLELINPAVEKANVL
IALGIVLLGAGVFTGLDYLVKQKWGSDSGGGLLAAITLDGIPENLALGVALIGADALTVA
ALSGSIFLSNLPEAAGGAKEMTENGVSKKKILLLWAATALILSLAALIGNWALADVSEEL
LAYIRCFAGGAVVASLAIEVFPKAYKQDSYWAGIANAIGLVLAFYLNSLG
>KECLDBNJ_00151 Peptidyl-prolyl cis-trans isomerase Mip
MPLFASEIFKNYKMKFNRLFLALPVALTLVNCNDSKMGSGSDVELKTFKDSVSYIIGANT
GAQFKQALGDNAEEFFDADVYYSGVQKALTDSVEIPQADMRRIMNQFQTQLRERQQEEQA
AVAAEKKEAEQAYLAENAKKEGVQTTESGLQYKVIEEGSGESPAETDQVQVNYEGKLLDG
TVFDSSYERQQPATFGVNQVISGWTEGLQLMKEGAKYEFYIPADLAYGQRGSGPKIGPGE
TLIFTVELLDVIKQ
>KECLDBNJ_00152 Acyl-CoA dehydrogenase
MSLFGKVKNTIGLLKSVDLEALNKLSQKVDLSQVMAAVGNLDDRQLKGLMKMLNSQAKKG
QHKLPPIDGDFYNLAQKLTPEEREIQMKMRNFMEDEVKPIANQYWNRAEFPHEIIPKFAE
LNLAGIAYKGYGCPGQSFLLEGILAMELARVDVSISTFFGVHSGLAMGSIYLCGSEEQKQ
EWLPKMQKFEKIGAFGLTEPEVGSGAAGGLGTSCKKVGDEWVLNGEKKWIGNATFSDITI
IWARDEDSGRVKGFIVRKENPGFHAEKMKDKMALRTVQNALITLTNCRVPESDRLQNANS
FKDTAKVLQMTRASVAWQAVGCARGAYEAALKYTKKREQFGRPIASFQLIQNHLVEMVSN
LTAMQTLCFRLSEMQDGGQLTDEHASLAKVFCSMRTRDVVSRAREVMGGNGILLEYDVAR
FVADAEAIYSYEGTKEINSLIVGRAITGYSAFVS
>KECLDBNJ_00153 putative HTH-type transcriptional regulator
MGLAKTEIFSDNQNAIAKFAKAFAHPARVSILQHLFKIDSCVCGDLVNEIGLAQPTISQH
LKELKHLGLIKGSVEGTSVCYCIDKENWTEMKKLMTHFLDQDLSNSADCC
>KECLDBNJ_00154 hypothetical protein
MKLSQVKTVLKNLEQIGFQLPDGSLVPNHFHVTEVGKVSKHFIDCGGTLRQEEVVNFQLW
NADDYDHRLHPEKLLSIIELSEKVLKIEDHEVEVEYQGETIRKFGIDFDGTNFLLTTKQT
DCLAKDACGIPAEKPKVKLSDLNQEPCCGPDGNCC
>KECLDBNJ_00155 Protein ArsC
MATVVNPFNHVMMNTVLFPEIDQFITTLKPETISEERKETLEPLIAFIQEKVSANAAVRI
NFICTHNSRRSHLSQVWAQTLAAHFNIDNVVCFSGGTEATALFPMVAETLSNTGFQIAKL
SQENNPVYSIKYAENAHPVIGFSKRLDDAFNPTSAFAAIMTCSQADAGCPFVPGAEKRIP
ITFDDPKAFDNTPQQAEKYQERSEQIATELFYVFSKIS
>KECLDBNJ_00156 Arsenical-resistance protein Acr3
MSTKKLSFLDRNLTLWIFVAMALGVAIGYFVPSFPEVVNTMSSGATNIPLAIGLILMMYP
PLAKVNYALLPKVFKNVKILSISLILNWIIGPVLMFILAITFLQDYPEYMVGLILIGLAR
CIAMVLVWNDLADGSSEYGAGLVALNSIFQVFAYSFYAWIFITVLPPYFGFEGAIVDISI
ATIAESVAIYLGIPFVLGILSRSILVRLKSETWYNEKFIPTISPITLIALLFTIVVMFSL
KGELIVEIPQDVLIVAIPLLIYFALMFIIGFFFTKAMGATYDKTASVAFTAAGNNFELAI
AVAIAVFGLNSGQAFAGVIGPLVEVPALIFLVRVSFWFRKKYFPKATA
>KECLDBNJ_00157 L-Ala--D-Glu endopeptidase
MKNHFLKFIGIALVFLCFSCGKLTKVTDVITQPTAREVYARNFDADSVPYRLWMNAFQNA
LNDSLQVASPYQETGIFNPEIEPVYGYDLDLERGRRYTFSIQTDTLQPKVFIDLYEKTSD
SIRPYKLVQQADDKATTLDFSPKNSGTYKVLYQPELNTSSSFAIRIQSKPSYYFPVSGAS
AKSIQSFWGAARDGGKRSHEGIDIFAKRGTPVVASVDGYISRTGNRGLGGKQVWLREGLF
GNSLYYAHLDSIIATSGQRVKVGDTLGLVGNTGNARTTPPHLHFGVYSRGAINPLPFVKE
EPELPALNASTEFYKTYAIKTAQANLRSSASAKSQKVGTLSRKDTVHLLGKSADWLHIET
STAQRAFVHQSLVKAL
>KECLDBNJ_00158 hypothetical protein
MQAEGEHLKGRGAQRHIANRFDVNSHELRDDFLNYCAQEGDEPQNLKTLFIDTFPKTIVN
KVESPDVGMGYSLNPYQGCEHGCVYCYARNSHEYWGYDAGLDFESRILVKRNAVRLLEKH
LAKKSWRASPIVLSGNTDCYQPAEKQFKITRKLLETFLNYRHPVAIITKNALIQRDLDII
KELASYNLIQVNMSITTLEEKTRRLLEPRTASIKKRLETVKKLAEVGVPVNVMTAPIIPG
INSHEVLPLIKAAADHSAKSVGYTVVRLNGAIGKIFEQWLKTAMPDRADKVLNQIAACHE
GNLNDSQFGRRMRGSGEFAKQIAAQMELGRKKYLKGRSIAPLNCELFEQYRPGQLSLF
>KECLDBNJ_00159 hypothetical protein
MKKITLFILLFVNLCTAQSKDNLEFGIITALSISNVSDSYNQRTKSLVEFSGGAFGNYYL
SDQWSLKLKAIYERKGYAEGLYENRETDVAFNMISVPVTANFYFGNNNNWYINLGPYIGF
MIAAKATSFNVDVTRLFNSTDFGIAGGIGYKLPIGENLDVFAEIDNQTGLSDILIDNPGS
AVRNNRLSFNLGIIF
>KECLDBNJ_00160 hypothetical protein
MKSITCILFLFSLISYSQNEDQLIEDNCNCVKTIEKNISLEQKRKLIMDCSLNAFKENRL
YTEKVVKEFTGKNSVNGYDVFNYLQEVFDYTMTNNCSEYKDLMAEILGATSINPTVKEIG
LKVCSELSQDFSEEEANTIIEKLTKEKGQKLIKLYGPNFKENYKNELNLFLFYNCEVYRL
NTNK
>KECLDBNJ_00161 Short-chain-enoyl-CoA hydratase
MNFENLIYEVDDHLAIITINRPKKLNALNKETIQELHDAFAEADADEDIGVIILTGSGEK
AFVAGADISEFADFEEEEGALLARKGQKILFDFIENLSTPVIAAINGFALGGGLELAMAA
HIRIASHNARMGLPETSLGLIPGYGGTQRLPQLVGKGRAFEMIMTAGMIDADQAFQSGLV
NHVTSQEELMALAEKIAGKILNNSGVAIATAIQAVNAGFKPGVNGYDAEIEGFGASFATE
DFKEGTTAFLEKRKPEFPGK
>KECLDBNJ_00162 Sensor protein ZraS
MKFNKLSLRLRIFFGMVLLILGASILIGIISVVQYKEEAKEYHRDRLLRKEDQIRAEIDY
VLDQTTYEVISKNIPFILKYNNDIYRIADVHELPINIYDLNGKLLVKSKETFTEDTLETS
LNPSVLEGLANTPTKRWIVQSEIDGVKYQSSYTYINDNKFKPLAIMNLPYIQDDDFITRE
LDEFLRRLAEGYLFMLLIATVLSYFLSRYITSSLKTISDKMIQTRLDKRNQRIEIDDASE
EISNLVRSYNGMIDELENSAAKLAQSEREAAWREMAKQVAHEIKNPLTPMRLTVQSFQMR
FDPNDPDIHKKLDEYSKTLIQQIDTMSSIAEAFSNFAKMPAQQNETLNVVFVTKLALDIF
TEHYLTFGTDADEITVKLDRTQLIRVITNLVKNAIQATEGVEDPKIRVEIKSDEDQVCIL
VCDNGHGIPEENIEKVFEPKFTTKSSGMGLGLAMVKNIVETYNGTITFTSKEDRGTVFKV
TFPKAEA
>KECLDBNJ_00163 hypothetical protein
MEYYNYFKSLHLIFIVTWFAGLFYAPRLFMYQIEASQKPEPDRSILGDQLALMTKRLWKI
ITWPSMILASLFAFVMLHFNPGLLYAPWMQIKLAFVVLLYAYHFKSHQIFKQLQRGEINY
TTRYMRIWNEGPTLILFAVIFLVITKSATNWIWGLAGLICLAVLLMLGIKLYKSIREKNP
NA
>KECLDBNJ_00164 Xyloglucanase
MHKLLLVNRGSNAASGYTPTTRSAHNAFRSVSCLLGLFCSLFFLSSTNIQAQEVDEALYE
ALEYRLIGPFRGGRSAAVTGVPGKPNLFYFGATGGGVWRTKDGGRSWDNISDGYFGGSIG
AVEIAPSDHNIIYVGGGENTLRGNVSSGYGMWKSTDAGKTWEKAGLPKSRHVSKIRVHPT
NPDIVYAAVLGDIYKPTQERGVYKSTDGGANWERVLFATEDAGAVDLTFDPNNPRVLYAS
TWHSRRTPYSFISGGEGSALWKSTDSGKTWKEISKNDGFPTDTLGIIGVAVSPVNSERVF
AMVENKDKGGLYRSEDGGTSWKLINDDRNLRQRAWYYTKVYADTQDEDVVYVLNVSYHKS
TDGGKTFESNNAPHGDHHDLWIAPENPMRMVMGDDGGAQITYDGGETWSTYGNQPTAQFY
RLATDNQFPYRIYAAQQDNSTVRIPHRTDGYSISEEDWESTAGGESAHIAVDPENPNIVY
GGSYDGFLTRVNHENNTVRSVSVWPDNPMGHGVEDMKYRFQWNFPIMFSRHNPDVLYTFS
NHVHKTTNEGQSWEVISPDLTTDDKSKQGSSGGPITQDNTSVEYYCTIFAANESPLKEGL
LWTGSDDGLVYVSRDGGENWENVTPKGMPQWMMINSIEPSYFDEGTCYIAGTKYKTGDFA
PYLYKTTDYGKSWEKITDGIEAEHFTRVVREDPEKEGLLYAGTETGMYISFDAGENWKPF
QLNLPIVPITDLVLKENNLIVATQGRSLYIIDDLSMLHQAIEAEDTDAVHLYKPKDTYRM
DGGSRKSNSAGTNHPSGVMTYFYLPEYDAEKDSIALTYFDAKNDTIKSYSSKGSDDKLKV
KEGANQFNWDMTYDGAERLPGMILWWASTQGPQQIPGEYTVKLNVNGTNYAQPYTVLADP
RSEATVADMQAQFDFISDVNETVDHAHQSIKKIRNINTQLSAFEKQYKDNPDTEELREKS
KTLREDLEEIEKALYQTKNRSGQDPLNFPIKLTNKLAHLNSLVSMGDFAPTDQDVAVKNE
LTAKIDAELDKFDTLINDEVAAFNKEFNAMQLNYLFVAEE
>KECLDBNJ_00165 Multidrug export protein MepA
MLKTERSEALGNEPISTLLIKQAVPASIGILVMSLNILVDTIFVGNWIGSIAIAAINVVL
PVSFFIAALGMAIGIGGSSIISRALGANDKSKALKTFGNQITITLLLTISMVILGLVFIN
QLIPAFGGKGDIFEPAKIYYRIVLYGVPVLALCMMGNNVIRAEGKPKFAMIAMIIPSLGN
LILDYLLINILDMGMEGAAWATTASYICCFFYVLWYFLSDNSELKIDVSHFGLDWPILKE
MSALGFVTLARQAVVSLTYLLMNNILFELGGEASVTVYAIIGRMLMFALFPVLGVTQGFL
PIAGYNYGAQNYDRVRQSIKLAIYYACGVAVLIFIAIMAFPEAIVSVFTQDEAVLRDTPW
AMRWVFAAIPIIGIQLIGSAYYQAIGKATPALLLTLTRQGFFFIPLVLILPNYFGELGVW
ISFPIADTLSTVVTAYFLWRETRLKLD
>KECLDBNJ_00166 Ferrochelatase
MKKGVLLVNLGSPKSTDPKDVKEYLGEFLMDERVIDVPLWARTLLVKGIILNTRPKKSAE
AYSKIWWDEGSPLIVLSERLQVKVSEKVDVPVALAMRYGTPSLKEGLEELNAKGVDEVLI
LPLYPQFAMATTETILVLAEELRKAHFPHMRFSDIPAFYNKPEYIEVLSKSIHEKIENLD
YEMLVFSYHGVPERHIRKSDVTKSHCNIDGSCCQTPSQAHQFCYRHQCYETTRQVAEKLN
LKEGTYFTSFQSRLGFDPWLQPYTDRTIERFGKEGIKKMAIVTPAFVSDCLETLEEIAME
GEEIFHEMGGKEFTTIPCLNDRDDWAHVVATWINDWALVEASKTIA
>KECLDBNJ_00167 hypothetical protein
MRKLIPVLGLLLILSSCNSTRTTNQPVTKQVLVFTKTMGWRHGSIEKGVATLKEIGAQEG
WQITQSEDSLAINTENLAKTDLVIFLSTTGDILGPDQEAAFKKYIQNGGAFMGIHAATDT
EFDWPWYGKLVGGYFKDHPNDPNVRKASLKKAAPHVTTSMYSKTFERTDEWYNYYNLSDA
VTPTLYLDESSYEGGTNGDYHPIAWYQDFDGGGMYYTGGGHTDEAYDEVAFKAHLESVMR
WLME
>KECLDBNJ_00168 Regulatory protein PchR
MEGVKNIATGLYSETTIEEGFFILKFNNETTEAQQIAREVDSSFIQFHFCAKGNSVFQFN
EGNYKLPLAEEHSLLLYNPQRDLPINLEIAPESWVISVFISIKKFHSLFSREADFITFLS
DENRDRKYYKDGLISPSMAIVLNQLMNYNLHPSVKALYFKGKVYELISLYFNRPSEADVE
QCPFLVDEDNVAKIKRAKDIVIARMAEPPSLQELADEINLSLNKLKEGFKQIYGDSVYSF
LFDYKMEVARQLLASGSHNVNEVGLRIGYSTASHFIAAFKKQYGTTPKKYIQSLS
>KECLDBNJ_00169 Glutamyl-tRNA reductase
MNTNGKRHFYPAYPGDFFAIGLSYLKADAETRGHFSVDSTIQEAILSRAHEEGIEGLSII
STCNRTELYGFAQEPLDLIKLLCEHTRGTIEEFKAVSYEYKNEQAVEHLFKVGTGLDSQI
LGDFEIISQLKSGFKRAKKLNLVNPFMERLINAVIQASKRIKNETNISSGATSVSFASVQ
YMLSRVPFISEKNILLFGTGKIGRNTCENLVKHTKNDHITLINRTKDKAERIAGKFNLIV
KDYADIQSEIAQADVLIVATGAQKPTISKELLYLKKPLLILDLSIPKNVNENVEEVNGVS
LVHLDQLSKITNDTLNRRKKQLPQAEAIIEEIQEEFYEWLTARQFAPTIRALKMKLADFK
DGEIDNQRKKIDGFNEEQAEIISERIIQKITTQFAKHLKTEDFSNTESLELIQKVFKLQN
N
>KECLDBNJ_00170 Porphobilinogen deaminase
MAKTIRIGTRDSELALWQAHTVQNQLESLGYKTELISVKSTGDLILDKPLYELGITGIFT
KTLDVAMINGDVDIAVHSMKDVPTQLPKGIVQGAVLPRAATEDIFVFKGDKNTTYFSDSV
TIATGSLRRKAQWLNKYPKHQVVDLRGNVNTRLQKVADNDWAGAVFAKAGLERINLKPEN
HEVLDWMIPAPAQGAMVIAVMDNDAFCKEACAKLNDADAALTTKVEREFLRKLEGGCTAP
IGAIAKIEDDHIHFHGALFSLDGSQKLEIKERIPVSECQDFGALCALKILEEGGRELMEA
IKKEI
>KECLDBNJ_00171 hypothetical protein
MKRSNHIKLARLLRQDSTEVEKVLWELLRDRKINGLKFRRQHPLKGYIVDFFCYELKLVI
ELDGGYHNHPEQKEKDELRDLHLKALGYKVLRFSNTTVLKESKVITDTIAEYKNSKVNRS
PPLSVGRGAGGEGKSILSTKKLTSAQKNLILGAGFSVVEYDAIQIEFLDVDFPKNLENLI
FTSKNGVQAFLKMQPDLNTESFSCFCVGSKTESSLIKKGLNVVKTAQNAADLADFIVKNY
KNAHFSFFCSVIRRDELPDYLTKNQVSFEEIVCYKTKSNPQEFKQEFDAVLFFSPSGVQS
FSAVNHFKNMLSVCIGNTTAAEVQKHTQNVTVANTTTIESVIARAVKALN
>KECLDBNJ_00172 Uroporphyrinogen decarboxylase
MIKNDLFLRALKGETVERPPVWMMRQAGRYLPEFQEIKAKYDFFTRCQTPELASEITVQP
IRRYGMDAAILFSDILVIPQAMNIHVEMKPGIGPWLPDPIRSHKDLDRVIVPDINDTLGY
VMDAIKMTKEKLNDEIPLIGFAGSPWTILCYCVQGQGSKNFDIAKEFCFTQPEAAHALLQ
KITDTTILYLKEKVKAGVNAVQVFDSWGGMLSPVDYQEFSWQYIQQIIDALKEEIPVIAF
GKGCWFALGEMAKSGASALGVDWTCSPRNARYLTGGNITLQGNFDPTRLFSPPAEIKRMV
TEMIDAFGKDKYIVNLGHGILPNIPLENAGAFIEAVKEYKAER
>KECLDBNJ_00173 hypothetical protein
MSILARLKGLSFSQLFKLAGLFVQNPGYVFLTAKASKKALSIATKYYGNTHHKSNKANAF
RHAVWNVLLGQAVYKKTQSLRQAQDWAQRFTDLHEELFVNRKMDRVMDLHNNAFGIQALR
MFANRPEAEAIHFLREAAENAIAIASPAEAENHQNKLVYIPKS
>KECLDBNJ_00174 Sulfate transporter CysZ
MIKALLNGLLAYKDALPLISKLNLWKYFAVPMLISLITALSIGFSAYGFSDDLGGLISSL
WIWEWGASTVRTISDIAGALLIIALGLIAYKHIVMALSAPFMSPVSEKIEAHLYANVHQH
RNTSNASQLLRGLKINLRNLAWELLLSIPFLLLSLIPVVGVLATASLFLIQAYYAGFGNM
DYTLERHFSYRESINFVKAHRGFATGNGIVFMLFLLIPFVGIILVLPISVTAASTTTLQL
LKKQSL
>KECLDBNJ_00175 hypothetical protein
MMRILEKYDTSLVYTGVAMNLLLAFQYFKFWCWPQYGDIDTITTLTLFITFEFILVHSGV
FMALAPRKMSLFLFFPFYGVFAYGFFKAGNNPFIIVSYLLIMLNRMRFAFSDVSEAIRSR
AILTSILAAGIYFVLIFVVLFSQSILPDLGLNEPFLKQSGYFEQNSSGGLFNEDPKTALC
LGCVYYLILALIEVKLINRAQKSSIATR
>KECLDBNJ_00176 Oxygen-dependent coproporphyrinogen-III oxidase
MREQFVSYIKNLQDQITAKLEAIDGKATFKEDLWQREEGGGGRTRVIENGNVIEKGGVNI
SEVHGPLAPAMQQYFKVGDVDFFACGLSLVIHPKNPYAPTVHANWRYFEMLDKAGNLVDS
WFGGGQDLTPYYLFEEDAQHFHQTCKTACDAHDAAFYPQYKKRCDEYFYNSHRGEARGLG
GLFFDYLKATDERSMQDWYNFVTEVGDSFLTAYAPILEKRKDLAYGEKERDWQEVRRGRY
VEFNLVHDKGTLFGLKTNGRIESILMSLPPAVQWRYDHHPEPGSPEAQLVDVLENPKDWV
>KECLDBNJ_00177 Delta-aminolevulinic acid dehydratase
MFPLRRNRRLRTSEALRAMVRETIVTPSDFIVPLFVVEGRGVKDEIASMPGYYRLSLDNL
QKEIKELWKLGLKSVLLFVKVDDKLKDNAGTEALNPDGLMQRAIKTVKETEPQMVVMTDV
ALDPFSSFGHDGIVGGGKIINDDSSAVLAEMGLSHANAGADFIAPSDMMDGRIFEMRTLL
EDEGHHDVGIMSYSAKYASAFYGPFRDALDSAPVDLKDVPKDKKTYQMDYANREEAIKET
LMDVDEGADIVMVKPGLCYLDIVRDIKNAVNIPVSVYQVSGEYAMIKAASEKGWLDHDAV
VLEQTYAIKRAGADLIASYFAKDVVKLIS
>KECLDBNJ_00178 Magnesium and cobalt efflux protein CorC
MLLLIAFAFISIFFSFLCSILEAVLLSITPSFIRIKTKEGKKYAETLANFKKDIDKPLIA
ILTLNTIAHTVGAILVGDQAGKMAAESGYDVNILGINFVGLVSTVMTLAILVLSEIIPKT
IGATYWKSLGNFTAKSLKIILLLLKYTGVLWLLMQVTKLVGKSAHVGTMSREEFMALTDA
AEKEGVFEDNETTVIKNLLVFKSVMAKDVMTPFPVVISEDETITLKEFQKQHPHLKFSRI
PVFKDKSHNITGFILKDDVLEEIVEERGEKTLADIRRDILIVDADQPIPQLFDTFVSSRG
HLALVTDEFGNTIGIVTMEDIIETLLGLEIMDESDDIEDMQVQARKNWERRAKRMGIVLD
RAPEPVKEVKLSPQHDTDVKHEDRPDTDKPSE
>KECLDBNJ_00179 Methylated-DNA--protein-cysteine methyltransferase
MNQVLVASPLGTLEISGDLNGISAVTFLEEEFPQSEKIPDVLKTAVIQLQEYFDGNRTDF
ELKLNPQGTDFQKRVWQELSQIPFGKTTSYLQMAKNLGDPKVIRAAASANGKNPIAIIIP
CHRVIGSDQSMTGYAGGIWRKKWLLAHESPVTQQSLF
>KECLDBNJ_00180 6-aminohexanoate-dimer hydrolase
MKILKRIFLSLISLILILIIALYVFDYDYLIKAVHTIYFTGHTTAYLEDYKKFDNTTIKA
GTAQPWPHAKNYNNYTLSDELMQIHKEFGSIAYMVIKNDSIVFEDYYDGFGQDSNSNSFS
MAKSYVSALLGKAIKDGYIKSLDQTVGDFISEYSEGTAAQMTVGDLASMASGLNWDESYY
SPFSVTTRAYFDDHLEPVMLGLGMKEKPGTGYQYLSGNTQLLAMVLERATGKKLADYLSE
SLWKPLGANQNALWQLDSEEGGLVKAYCCIASNARDFARLGKLYKDYGEWNGQQILDSAF
VAKSITPRFEGEPYGYGFWLKDFKDKKVFMMRGHLGQYVVVIPEDDLIVVRLGHSRGETN
ATGYPDEMDAYLEEAYKMN
>KECLDBNJ_00181 hypothetical protein
MISRLQLENILFLDIETVPQQEHFSDLDPELQQLYADKTEYQRKDEFTAEAFYDRAGIWA
EFGKIVCISVGYFHNTEQGRSFRTTSFHGDEKQQLLAFKKLLTEHYNKPQHVLCAHNGKE
FDFPFIARRMIINGIKLPFKLDLFGKKPWEVPHLDTLEQWKFGDYKHYTSLKLLTKILNI
PSPKTDIDGSQVCEVFYKDKDIQRIVEYCERDVVAVAQIVLRLRNEQLLQENEVTSV
>KECLDBNJ_00182 Glutathione import ATP-binding protein GsiA
MNKTPLLSVKNLSLGFKSRNTTNAVLHDISFDVLANEIVGIVGESGSGKSVTNLAVLGLL
PQKSVNISSGEILFEGADLLNYSTKKLQEIRGNAISMIFQEPMSSLNPSMRCGKQVTEIL
QRHKKLSAQEAKTETLKLFEQVKLPRPASVFKAYPHEISGGQKQRVMIAMAIACKPKLLI
ADEPTTALDVTVQKEIILLLKELQKETGMSILFISHDLSLVSEIADRVIVMYKGKIVERG
SSASIFKNPQEEYTKALIYARPSTKERLERLPTVADFLNQKPMAPAVSEAVRTAKHQKLY
SKTPLLEIKNAQKEYYSNVSFFGKKETIKAVNDVSFKIYEGETLGLVGESGCGKSTLGNL
ILQLDQVTSGHIFYQGTDLTRLKTRELRKLRRDIQIIFQDPYSSLNPRLTVGQAITEAME
VHKLYASKKERRAEALKLLEQVGLLPEHYDRYPHEFSGGQRQRIGIARTIAVKPKFIVCD
ESVSALDISVQAQVLNLLNTLKEEYNFTYLFISHDLAVVKYISDRLLVMRNGQFEEMGEA
DAVYAAPQSDYTQALINAIPKGI
>KECLDBNJ_00183 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MLDKNGIARRIAREVQDGFYVNLGIGIPTLVANYVRDDIEVEFQSENGVLGMGPFPFEGE
EDADIINAGKQTITTLPGASFFDSALSFSMIRGQHVDLTILGAMEVAENGDIANWKIPGK
MVKGMGGAMDLVASAENIIVAMMHTNRAGQSKLLKRCTLPLTGVGCVTKIVTNLAVLEVT
AKGFKLLERAPGVSVEEIKKATEGTLEIPDEVPEMILA
>KECLDBNJ_00184 Selenocysteine-containing peroxiredoxin PrxU
MAHLRLGDVAPDFTTDTTEGTINFHEWLGDSWGILFSHPADYTPVCTTELGTVANYHNEF
KKRNVKPIALSVDGVASHREWIKDINETQNTTVDYPIIGDEDRKVAELYDMIHPNASEKA
TVRSVFVIGPDKKIKLTLTYPPSTGRNFDEIVRVIDSLQLTAYHKVATPANWKDGEDCVI
SPSVSNEQIPEFFPKGHTEIKPYLRMTPQPNK
>KECLDBNJ_00185 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MITKTVNSVTEALTGIEDNMTLMLGGFGLSGIPEKAIEQLVKLNVKNLTCISNNAGVDDF
GLGLLLQKKQIKKMISSYVGENAEFERQMLSGELEVELIPQGTLAERCRAAQAGFPAIYT
PAGYGTEVAEGKETREFDGKMYVLEHAFKADFSFIKAWKGDTAGNLIFKGTARNFNPPMC
GAAKITVAEVEELVPAGELDPNQIHIPGIFVQRIFEGKNYEKRIEQRTVRKHND
>KECLDBNJ_00186 Penicillin-binding protein 1A
MAQSKKKPAKQAKTSNHKPYIKGFWILFLSGLAAVILVFLLASWGAFGKLPTFEELENPE
SNLATEILSSDGKTLGKFYNENRTPVKYEDLPQNLVDAVVATEDRRFYEHSGIDMRGTAR
AVAFLGSKGGASTITQQLAKLLFSDTPSSKFERVLQKVKEWIIAARLESQYTKEEIITMY
LNKQDFLFQAVGIRSASKIYFDKEPRELHPEESAIIAGMLKNPRQFNPYREISRDKSLER
RNTVLALMAETGKITETERDSLIAMPMEIKFSPEGHADGIATYFREYLRAFMSEWIEENP
KGVDADGNEEYYNIYRDGLVITTTLDSRMQRYAEEAVTAHMENLQREFDRQNEKNSTAPF
RDISKEEEEVIINRAMRNSDRWRKMAAQDISVKDIKASFDKKTDMRVFVWKDGAKEVDTV
MTPRDSILYYKRFLRAGLLSMTPQTGEVKAWVGGINYKHFQYDHVKTGRRQVGSTFKPFL
YATAIDQLHLSPCDTVPDIPYCIPAGEMGAQKAWCPENSSSGFKGMVTLKSALANSINTV
SARLMHRVGPKPVINLIEKLGVDTENIPEVPSIALGTADLSLFEMVSAYSAFANKGVHVE
PQIVSTIVDKNGTVLYQSVPKAKDIISQESAYVTVNLMEGVTQYGSGARLRSGAINNYVY
NNVVTGHPYAFKNPIAGKTGTTQNQSDGWFMGMVPNLVSGVWVGGDDRSVHFPSITYGQG
ATMALPIWAVFMKKCYEDEELKISKGDFERPENLSIRVDCSAPAEGAAQEVDLPDELDF
>KECLDBNJ_00187 Gliding motility lipoprotein GldH
MHKFLCALLVLSCFWSCDKTAAFHEYKSLPKHWKSDSAVTLKVDNLDTLSTYNAFITLRN
DNSYAFSNVFLIASMQFPNGKTITDTLEYKMANPDGSWLGTGFGDIKENKLWYKEHIQFS
EAGSYTFKLKQAMRRNGDVNPIADLEGIRDVGLRIEKTNE
>KECLDBNJ_00188 hypothetical protein
MACGNCGTTKNGQPRGCQNNGTCGTDGCNKLTVFDWLSNMSLPDGQEPFDFVEVRFKNGR
KEYVKNVDKLQINVGEVLAVQAASGHDVGIVSLTGELVRIQMKKKKISYTSDDFLKIYRK
ANQKDIEVWESVKEREEGIKVRSRQIAIRLGLQMKISDIEFQGDGSKATFFYTAEERVDF
RQLIKEFAQEFRTRIEMRQIGFRQEAARLGGIGSCGRELCCSTWLTDFRSVTTSAARYQQ
LSLNPQKLAGQCGKLKCCLNYELDAYLDALKDFPKTEQKLYTDKGTAVCQKIDIFQGHLW
YAYEGEWMNWHKLTTTQANEIIEANKNKNKVASLEEYAAELITDAKVDFGNVVGQDSLTR
FDKPKNSRKRSKNRRKKGNFRKKGPKKNA
>KECLDBNJ_00189 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNKLSAKERAALIDEAGEDRLTLSFYQYAKIGNPQLFRDHLFLAWNQMDVLGRIYVA
QEGINAQLSVPAKRFEEFKTFLDGINFLENVRLNIAIEQDAKSFLKLKVKVRPKIVADGL
DDETFDVTNKGVHVDAATFNELIEADDVVLVDMRNHYESEIGHFKNAVTPDVDTFRDSLD
LIEEDLRDHKEDKKLVMYCTGGIRCEKASAYYKHKGFKQVYQLEGGIIEYARQVEQLKLE
NKFKGKNFVFDHRRGERISEDIISNCHQCGKPCDTHVNCANQACHLLFIQCDECAEAMNH
TCSDECKEVIALPYEVQKELRKGIPNSNKIFKKGRSEKLKFQKKV
>KECLDBNJ_00190 Protein RecA
MSKEQEAKLKALKLTLDKMDKTYGKGTVMKMGDNAIVEVESISTGSLGLDMALGVGGLPK
GRIIEIYGPESSGKTTLTLHAIAEAQKKGGIAAFIDAEHAFDRFYAEKLGVDIENLIISQ
PDNGEQALEITDNLIRSGAIDIIVVDSVAALTPKSEIEGEMGDSKMGLHARLMSQALRKL
TGSISKTNCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRSTQIKDSNGEV
QGNKTRVKVVKNKVAPPFRQAEFDIMYGEGVSKVGEILDIGVDYEIIKKSGSWFSYQDTK
LGQGRDAVKAILKDNPDLLEELEVKIKEAIKIAKEA
>KECLDBNJ_00191 hypothetical protein
MKKVFLLIGLLGLITSCSLDDEGQVVSYEALPIADYELPESFVYGERYQLPVSFVLPTTC
HEFYNFEAAREDSTRFVYAISQVLESDMCTDTPNDTISTFLNFDVIYRYTYVFKMYKGDD
ENGEPIYETQEVPVEQP
>KECLDBNJ_00192 ECF RNA polymerase sigma factor SigR
MSLEKLLKGLTKEKPKAQAELYTLYARTLFGVSLKYSRNYEEAEDNLQDAFLTIFKKVHQ
YKGKGSFEGWLKRIVINTALQRYRKQSLFELVNEEQIEQEEVLVDTNEIPLQFLLKIIQE
LPDRYRLVFNLYVLDGYPHKEIAQMLSISEGTSKSNLARARMILKEKVENYQQSETLQSS
TR
>KECLDBNJ_00193 hypothetical protein
MKEQKNIDRLFQEKFKDFEAMPDDKVWAGIVDKQQKKRAIIPLWLQLSGAAAVLALILLA
GNFIFSTSDAQDVEVVLEETETPEQEQRAPKTIEQTANNAVVSSEEKSTEDSNSLKKAES
NSSTKATTVASTSATEANQEKHKALNTTQNRNTSESKKSGSTAASTGIATADQGNDANAT
QDDKTSNTEQNTTAIAATENESQENAAADELPSLEEIANAQNEEEALADTETSNTASQDA
SRWGITPMVAPVYYNSFGGSGIAAEFADNKKSGDVNFSYGVQVSYAINDRLTVRSGVNKV
DLGYRTEQVNFAPSIQGQSISSIDYNQNSQLIQVADANKSLASSAAEFASNASVAGTSIN
NALRQELGYIEVPFEAEYALLNRKFGIQVIGGFSTLFLNDNSISLEENNNLVSRIGSSNS
LNNTSFSTNVGLGLDYKFTPHIQFNLEPMFKYQLNAYTKSVSDFRPYYLGLYTGLSIRF
>KECLDBNJ_00194 1-acyl-sn-glycerol-3-phosphate acyltransferase
MLRLLQKLLILLWRIWFYVLIIVPIIILLPFLLISVAKDSWYPYFFKMARLWARIILYGM
GFWPEVKGLEKTEQGKSYMYIANHTSMTDIMLMLSSVRNPFVFVGKQELAKFPLFGYFYK
QTCILVDRGDPKSRRAVFESAQNRLNQGLSICIFPEGGVPDDTSIVLDTFKDGAFRLAID
HQVPIVPMVFYDNKKRFSYEFFTGTPGLMRVKVLPFIQTKGLKAIDRKTVKEQAFKAIHA
ELLKDQAYAET
>KECLDBNJ_00195 Tryptophan--tRNA ligase
MSRILTGVQSTGTPHLGNLLGAIIPAINMANQPENESFLFIADMHSLTQIKNGETLRHNT
YSTAATWLACGLDIEKTVFYRQSDIPQTTELTWYLSCFFPYQRLTLAHSFKDKADRLEDV
NAGLFTYPMLMAADILLYDAEIVPVGKDQSQHLEMTRDVASRFHAQMGETFVIPELKLHE
ETMYIPGTDGAKMSKSKGNTIIIFQSDKALKKQIMSIETDSTPLEDPKDPDTCNVFGIYK
LLASKDEVAQMRKNYEAGGYGYGHAKKALYELVLNKFEKERALYNHYMDNLDELDAALRV
GAEKARVIANEVLDRVRKKVGY
>KECLDBNJ_00196 DNA processing protein DprA
MKEDELHAFLTLQRIPNLGDTSIKRLIARFETAQQVLDQKKESLLKLDGIGAFKLKAFFE
KEHRLAAEEELKFIQEHNIDYCSYKDQNYPERLKHCIDGPILLFKRGSKDFSQQRMISIV
GTRKVTNHGVDFIKQFVEDLAPLNPLVVSGFAYGVDITAHRAALDQGLDTIAVLAHGLNQ
IYPKVHAKYVKPVEAQGAFITDFWSSDAFDRTNFLRRNRIIAGMSEATVVIESAEKGGSL
VTADIANSYNRDVFAVPGRPGDAQSLGCNNLIKTQKAQLITSAADLIYLLNWQIEEELKP
VQKQLFVELNAEEKVICNFLSDVGKEQLDLIALHCKMPTFKVASILLNMELKGVVRPLPG
KQFELT
>KECLDBNJ_00197 hypothetical protein
MHFSNYISDLLYRYECVIVPGFGAFLAHRVSAYHDESAQAFFPPKKRISFNAQLKENDGL
LANYVASAEHLSYESALLKVQEFAVNIQQKLNAEETLVFDKIGTLSQNEAGNLSFEPEQS
TNYLTEAFGLASYTAQPVTREVLAQEAEALEEKAPIHLTPARRSNGWMKYAAVGLLTIGL
SGALGFLYFKDIADHNFAEKQKAESQIENTIQHATFTIDNPLPAVTLNAFKPKGNFHIVA
GAFRIPENAETRVNQLREAGYKARTLGENKYGLHQVVYGSYTDRTEALKELRNIRNTDNP
NAWMLIQELN
>KECLDBNJ_00198 putative acyl-CoA thioester hydrolase
MKAKTPSESRTTQTDLVLPNETNPLNNMFGGELLARMDRVASITARRHSRRIVVTASVNH
VAFNKAIPLGSVVTVEASISRAFKTSMEVVIDVWVEDRENGLKSKANDAIYTFVAVDETG
MPVPIPQIKPETEKEIQRYDAALRRKQLSLVLAGKMEAKEATELKALFE
>KECLDBNJ_00199 p-aminobenzoyl-glutamate hydrolase subunit B
MKKTTFLFTCLLSTILFAQNKQEQVLEQLDQNTQAYGEIAHKIWSFAEMGYQEEQSVALL
QKTLKEEDFTIEAGVAGMPTAFVASYGSGKPVIAVLGEYDALPGLSQKAVAHKESNGGVA
GHACGHHLFGTASAAAAISIKHYLENTGTSGTIRFYGCPAEEGGSGKVYLTRAGLFDDVD
AVINWHPGNSNGADPGAALANKSAKFRFHGIAAHAAGAPEKGRSALDGVEAMNYMVNMMR
EHVPEDTRIHYVITEGGKAPNVVPDFAEVYYYARHTTRDVVIDVFDRMVKAAEGAALGTG
TTMDYEMIGGTHELLPNLTLQKLMYDNLKEVGGYTYTPEEREFAEEIATSLNTDLDVKNV
EGISEYNPIPEAGGSTDVGDVSFTVPTVGLYTATWVPGTPAHSWQAVAAGGTSIGTKGMM
VAAKTMAKTGMDLFDQPEILKAAWTEFEEKRGEDFEYIPLLGDREPALDYRN
>KECLDBNJ_00200 Murein hydrolase activator EnvC
MQLKLKLKYTLFFGLLLSSLLAVAQNDKQAELERQRRALMSQIEELSKLRQSNKKKEINV
LSQVEDLASKIKTRENLIRVTNSQANLLTQKINQNINKISELRAELSKLKEDYAAMVQKS
YKSKSSQSRIMFLLSSESFLQAYKRVQYMKQYSNYRKKQGDQIKERTTLLQETNTKLIDQ
KEEKQQLIAQNKREQEKLEDEKKQQDALIATIREKESSYAAQINKKQAEANRIDREIDRL
IREAIAASKKESGATTTSETEIKKGAMPTFALTPAAKALANDFASNKGRMDWPVERGRVY
KKFGTSKHPTLPNITTYNSGVEIETAPGSVARAAFKGTVQQVQLIRGGGYTILIRHGNYL
TVYQNLKNLKVKVNDQVSTKQALGEIAENSFNGKTILKFLVYKDSERLNPEDWIYNM
>KECLDBNJ_00201 hypothetical protein
MQLIYRGILVLTLIGLVGCKATKNAASTEDLASAKIIKAHYDTHPEFQTLAARLKIRYSD
PETTQNVTVSLRMKQGETIWMSASVLGISLAKAMITKDRVQFYEKIDGTYFDGDFELLSD
LLGTELDYDQVEALLLGQPIYDLRSGGFSAGATSSRYLVAPRKQSALFDLFFYLNSGAFT
LQEQRLAQREAQRDLTISYGDYIEEQQGFFPSEIHVKAQEAEKTTTIDITYRGLDFNSEV
SFPFNIPGGLKEIEL
>KECLDBNJ_00202 Beta-barrel assembly-enhancing protease
MKRFAFLGMLLLFSPLAEAQEPTPLQDVNVDQLEDVTDAFQESFFEALKQKGIENYDRAI
AALDKCIALRPQESILYFEKGKNEAALGNTQEAENNYLKALQLKANQRDIMEALYEVYYA
RQDFDKAIDLVQDLAKFDIKYKEDLARIYVRKGAFKEALDVLDELDEALGKDAYRNQIRK
QAMALSGGDYKEKMLLDAIAQNPQNEKNYLNLIYIYSEQGKTQQAYATAQKLLKVNPKAD
EVHLALYKFHLEQNDVARAFQSLERVMKSSKVEAKAKHSVLNDFLIFVDRNPEFEPELEQ
AIALFSEEEATDVNEELGAYYLKNNDKTKALSYYEAAYKKNPDDVNVLRNLVLLQLQAQQ
FENAAALSEEALALYPAQAVFYLVYGVAQNALGKAQNAVDYLEMGIDYVIENPQMQADFY
SELARAYETLGNAEKAAVYRKRLTNLTQ
>KECLDBNJ_00203 Bifunctional protein GlmU
MAGRGSRLRPHTLTIPKPLIPIAGKPIVQRLVEDIASVLDEKIEEVAYVIAEDFGKETED
NLKQIAQNLGAKGSIYYQDKPLGTGHAIMCAQQSLSGPCVIAYADTLFRADFTLDKEADS
VIWVKQVKNPEAYGVVSLNENNEIEGLVEKPKDFVSDLAVIGIYYFKDGAVLKSELQAVL
DAKLMHGGEYQINDGIKQMQAKGYTFKPGKIDEWMDCGNKNVTVETNGRMLQFLHKEGAH
LVASSAQLENASVIPPCYIGENAVIKDATIGPNVSIGEGTVIENSTIEESLIQNYSQVTN
AQLKNAMIGNYAKFDGNFTAISIGDYSELV
>KECLDBNJ_00204 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MQINIINTSNHALPHYETEASAGMDLRAALDAPVTLKPLERAIIKTGLFIELPVGIEAQV
RPRSGLAAKKGITVLNAPGTIDADYRGEIGVILVNLSNEDFTIENGERIAQLVIAKHERA
DWNEVEVLSETARGAGGFGSTGTK
>KECLDBNJ_00205 hypothetical protein
MSVLKGFVKDTAVYGLATILPRLMNLFLISLHTDSLETSGYADNTAFYVGAAFLNVLLAY
GMETAFFRFFSKAEDENKVYSTVLIALTVTSLIAFTLLYALRVPICEALELPVEYFGYLL
GVTILDALVVAPFAYLRAKGKALRFTGIKLTNLAIYVVLNIFFLWAIPEFNMQFSWYDPT
ALLTYIFAANLAASAVTFLLIAPDFFRIKLVFDKQLFGQLWQYGWPVLVAGLAFVVNENL
DKLLIGNMLDKDIMGAYSGCYKLAVFMTIFIQAFRLGAEPFFFSHAKNKNAPTTYATILK
YFVVVGAAGLLFIVCFIDFFKALLISDSSYFKAIEIVPYILLANLFLGIYHNLSVWYKLT
DKTRYGMYFSILGAALTIALNWYFIPLIGFMASAYTTVVAYGTMMLISYFYGQKYYQIPY
NVSRISMYLLLATSGALVSFYFFRSNYGVNGVIFLAFMGLTLLLEHKELNAILGRNKK
>KECLDBNJ_00206 hypothetical protein
MKKMLSALFLFTLFSCGGSNQLVKNPPFEIEKTTRKSGVKGLENIRFVAKNIPQEVSFES
LYFQQKKSKVLWEDTNLYYATFSTVPANSKDRVLSVNREDEAKNPLPQIPVEVPFKIKAN
EALLEYKVGDKTFYTVLEVK
>KECLDBNJ_00207 ATP synthase gamma chain
MANLKEIRNRISSVSSTMQITSAMKMVSAAKLKKAQDAITAMRPYSDKLTELLQNLSASM
EGDSGSRFAEERPVEKVLVIAISSNRGLAGAFNSNIVKEAKNIADTVYAGKEVHFLTIGK
KANDILKKSHTVIFNDSEIFDDLTFENVEAIAERAMNLFTEGTYDKVELLYNSFKNAATQ
IVTREQFLPIVPLKEQFEEVAPANTTDYIFEPSKEEIVKQLIPKALKTQFFKGIRDSVAS
EHGARMTAMHKATDNATELRDQLKLTYNKARQAAITNEILEIVGGAEALNN
>KECLDBNJ_00208 hypothetical protein
MAYVPRNNAIVDKSFHFACEIVVYTQQLKAQGFYEIGSQLLKSGTSIGANVRESQRAVST
KDFKNKLSIALKEAEETQYWLQIIEHTEIAEVSKALSENCEELIRLLVSIIKNS
>KECLDBNJ_00209 ATP synthase subunit alpha
MAEVKPAEVSTILKKQLSGFEASASLDEVGTVLTVGDGIARVYGLSNAQYGELVEFDGGL
EGIVLNLEEDNVGVVLLGPSKEVKEGATVKRTQRIASINVGEGIVGRVVNTLGQPIDGKG
AIEGETYEMPLERKAPGVIYRQPVNEPLQTGIKSIDAMIPVGRGQRELVIGDRQTGKTTV
CIDTILNQKEFYDAGEPVYCIYVAVGQKASTVAGIASVLEEKGAMAYTTIVAANASDPAP
MQVYAPFAGAAIGEYFRDTGRPALIIYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFFL
HSRLLERAAKVIADDDIAKNMNDLPDSLKPIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLDGDLFNSGVRPAINVGISVSRVGGSAQIKSMKKVSGTLKLDQAAFRELEAF
AKFGSDLDAATLSVIEKGKRNVEILKQAENTPYTVEDQIAIIYAGSKNLLRNVPIDKVKE
FETDYLELLNAKHRATLDTLKAGKLTDEVIDTLTTVANDLAARYKK
>KECLDBNJ_00210 ATP synthase subunit delta
MSSRAAIRYAKAILDQAKEKGTEEVVFGNMKSIDATLNASKELRSVLKSPVIKPEDKRAS
LKAVFADYDPSTLSLIDLLVDKKRSALLGQVAQSYVSLYNESKGIVVAQVTTAVELDASL
EAKILAKVKELTNSSEVTLEQHIDPSLIGGFILRVGDVQYDASVANQLVSVQKEFSKRL
>KECLDBNJ_00211 ATP synthase subunit b
MDQLLNDFSPGLFVMQAVILIILILLMKKFAWKPILSSLDEREQGIQGALEAAEKARLEM
KNLQADNEKALQEARAERDAMLKEAREIRTKMIAEAEGDAKAQADKIITQAQEAIAAEKR
AAVAELKGQVAELSLEIAEKVVKQELSDKEKQQQYVDKMLQDATLN
>KECLDBNJ_00212 ATP synthase subunit c
MYNLIGAGLIVIGGGIGLGQIGGKAMEGIARQPEAAGKIQTAMIIIGALLEGLAFGALIL
GK
>KECLDBNJ_00213 ATP synthase subunit a
MKITSLPIHFLAVISFLLCGTLLNAQEHSVAEANDEGPVNTQQEITDYTNHHLKDSHDFH
LFSYQGSDGERHSFGFSLPVILWASNGPVAFMSSEFHHDIDGGVVVEKGGSRFVNLHDKI
YELEDGAEEIVMGEDHHPVNAHKPFDLSITKSVFGILLVGLLLLFWFGSLGKQYKKKNIP
TGFGRALEPLVIYVRDEIARPNIGEHKYRKYMSFLLTVFFFIWVSNLLGMTPFGFNITGQ
IAVTVCLALFTFFIVQFSGNKDYWKHIFWMPDVPVIMKIILIPIEVLGMLTKPFSLLIRL
FANITAGHVVVMGLIALMITLKAQFGAVGSTGLSLVLTLFISVIEILVAFLQAFIFTMLS
ALFIGMAVAEHDHHHEHDEEGHEVDDVEDVRESFV
>KECLDBNJ_00214 hypothetical protein
MNLTKPLLTTAGTIIGLAVVFYGLHLGILHLLDVELPYNLLNFYLFGGVSSLIICLTFIT
LPALLPELHDKVGYMFLFTIFGKLFLWALVFKNLLFSETVFTRMERLSMLIPIFIFLIYE
VLVIVKILKKES
>KECLDBNJ_00215 hypothetical protein
MSEKKPESPLKSWAKFSTVAIQMGVTIYLGNLLGSWLDGKFNTTFLEPAVTLLAVFLSMY
VIIKAVKDLNS
>KECLDBNJ_00216 hypothetical protein
MRKDRSVKAPETGNKQNRISDGTSITGEIKSEGDFRIDGKLEGKIESTGKVVIGKSGVLI
GTLECKEADIEGKVDGTVAISGLLNLRASAVIKGEVATEKLAIEPGADFNASCVMGSGVK
NLSKDVRKETGKSA
>KECLDBNJ_00217 hypothetical protein
MQTQVQKLLAILVLLTVLVGCSRKKDKFLSRNFHAITAEYNTLFNGRQAFEQGRDALIEG
YQDNFWAILPIERLDSPDFVPLPGEAIDPSFKIAEEKAVKAIQKHSMEINGTERNPQIDE
AFMLLGKARYYDLRFLRALEAFNYILSYYPASDNIAQAKIWKAKTQIRLDNTKLAIASLH
KLLEEEDALDRQDFADASAMLAQGYIFENRLDSALVYIEKAAYLTRKNEEKGRYYFIKGQ
LYDNIGQNQLANANYDKVIDLNRRSPRRYMINAYINKIRNFDYETGDQERLFKLLTDLEE
NRENRPYLDIIQYQFAEFYRNVGREDSAVAYYNKSIASQGEDKYLTSRDYLSLGDLNFNN
SEYLIAGAYYDSTLAFIPENTREYRNISKKRENLSDVILYEGIATRNDSILNLVYMNDAD
RQAYFESYITALKEQKAKDSIAEANAEAAIANNEFFVANNPNSGPNPPGGSSGFYFYNPV
QVAQGKLDFKQRWGSRENADNWRVSSSVGSALASNEIAGEKDLLEEVDNGIYNADNYISK
IPSEQPIIDSISTARNFAYYQLGLIYKEKLKEPQLAIQRLEALLAANPEERLVLPAKYNL
YQLYEASGDTFNSDKYKFDILQNYGDTRYASIINNPDKALEQDQNSPEVLYNNLYRDFEN
QEYARVITQANRYIDEYAGDAFVPKFELLKATAIGRSKGYDAYEQALNYVALNYPNQEEG
KKAKELLEKALPQLKNNTFVADAEAKKYNLLYTFKTSEKNTLLQKQDSISNYLKQNNFTQ
LSVSRDVYDEATQFLALHGFKSKVEALYFGERLKEAKLVVIEEDQEPVVISSANYRIIQL
HKNLEAYKNLDSQ
>KECLDBNJ_00218 hypothetical protein
MKKIILLISLFSLVGSNLLFAAHRQGDSKNPLINLISTLEHNYFDITENLLNEELEANFE
LSRLKFLLNDFHQVTEVILQSISTADQTRVLKENSSFNQIRQLTLLNLKEIESKLIQLEA
RSTSYNLINLLKLVELANTYCEEIVRYREHINNPYFAKASLIKKVRKSKMLEERLGADGI
TNNQWQKIMTSGVGSQAPDLIRQINRQNQDLLIQFRKEEKAIVKTGTLEEVVTNTNVVDG
LIYTYSDFPPDKLSYIYSSDSFLIQGLISWLVYINSGTKVLLSELFHSRLDEQRLLKELN
LKSATTNTIHRSIKNENQDEIWLELNSSILKNKYFSEIRIDRVSIEKENIIFYSQENAIL
SLNNRSGDLLEQIKAQINNQRQLEYQMNSFNIQLSTY
>KECLDBNJ_00219 Methionine import ATP-binding protein MetN
MIHIHDLSKTYNGVTVLKIDELQIPKGESFGLVGNNGAGKTTLFSALLDLIQPTTGYIQN
GEVKVHESEAWKSHTASFIDESFLIGYLTAEEYFYFIGELRGQNKADVDKLLAGFEDFFN
DEILNKRKYLRDLSKGNMKKVGIVATLIGNPEVVILDEPFANLDPTTQIRLKGIIKKLAA
ETGVTVLVSSHDLMHVTEVCERIVVLEKGSVVKDIKTSEATLKELEAYFSKEEPLVE
>KECLDBNJ_00220 hypothetical protein
MIKYFLTLEWKSFFRSAAFQTNLILKIFMALGALYFIGLFTLAGVGAYFGLEKAGLEPLE
TVNRFMIYYVVLDLVIKYMLQKMPVVNIKPLLLMPFKKSKIVNFALGKTIFSFFNIVHAF
FFIPFSVVLLTQGYDPLHVITWHLGMMAMIYINNFINVFLNDAMPLVVGVASVLIGLGAL
QYYGIFDVTPYTGVYFQGLFEQLWMFAIPVLVSIALYKVAHSYFLNRLYLDAGLSAKTKE
ASTENLDWLDRFGKTAIFLKNDIKLIKRNKRSKTTVIMSVLFLFYGLLFFSGGIDSYDNP
FMKIFAGIFVTGGFLFSFGQFVPSWDSSYYPLMMTQNISYEEYLRSKWMLVVLASGISTI
LALGYLYFGWEAYAAVFVGGIYNMGVNGHVVLWGGAYIKTPIDLTSNKKAFGDSSSFNVK
TLLITMPKLLLPIVLYTIGHFTLGPVFGYALVALAGIAGFAFRDFMFKKIIGIYKTEKYK
TIAAYKQKN
>KECLDBNJ_00221 1,2-phenylacetyl-CoA epoxidase, subunit E
MSDFHALTIQDITRETQQAVSITFGVPNALKEAFTFKAGQYITLKTKIDGKEVRRAYSLC
STPKSGNLKVAVKEVQGGTFSVLANNKLTVGESLEVHPPEGKFIVEPNGENQKDYVAFAA
GSGITPVLSIVKTVLEEEPKSRFVLAYGNRTVEETIFHKELLELQLKYPDRLFIEFIYSR
KQETDAHFGRIEKATVNFVLKNKFKAHDFDQYFLCGPEEMINGVRGVLEENGVAKEQVKF
ELFTSSDDGEEIAEALDGQTTLKIVCDDEEFELVIPQDKIILDAALDNDIDAPHSCQGGI
CSSCIARVTEGTAVMRKNQILTDDEVEEGLILTCQALATSANLVVDYDDI
>KECLDBNJ_00222 Putative monooxygenase
MKTPLTQLLNIKHPIIMAPMFLVSNVAMVKAAMQAGIAGCIPALNYRTLPELREALTELK
TAKTEGGAFGFNLIVNKSNLKFPEQLKVCCELGCDFIITSLGNPKQVIEEAHKKGILVFC
DIVNLEQAKKVEALGCDAVIAVNNEAGGHRGNIAPKQLIEELNAALKIPVISAGGVGTKT
QLEEKLSFGAVGVSVGSPFIASEEAGVSKEYKEACVNYGAEDIVLTQKISGTPCTVINTP
YVQEIGTEQTWLEKILNKNKWLKKYVKMLRFLKGTNMVTKAATEATYKTIWVAGPTIEHS
KAIEPVEKIIRRFI
>KECLDBNJ_00223 ADP-heptose--LPS heptosyltransferase 2
MPSPKAAHILCIRFSAMGDVAMTVPVLIALTRAYPKLEITVVSKPFFEPFFLGIERVHFF
GAEVKTKFKGVAGLYKLYKALKPEQFTAIADLHNVIRSKVLLSFFRLRGSQTAQIDKGRA
EKKALTRETDKVFKPLKTTHQRYADVFGALGFPVQLKGDELLPKRKLNDTIQKAIGQEPY
KWLGFAPFAAHEGKKYPLHLIDQVLSSLNKNPLKIILFGGGKEEEQLLNSFAAKYENCIN
VAGKFSFKEELALISHLDAMLAMDSGNGHMAALFGVPVVTLWGVTHPYLGFAPYGQPEEN
QITADRKKFPAIPTSAYGNKVPEGYERAMHSIQPETVLQRLSEILD
>KECLDBNJ_00224 hypothetical protein
MITHTAKRIFQSAVDDYHIKDRVDQPFSNPYDTDVDFLEHLLYRKAWIDTVQWHYEDIIR
DPQIDPEAALKLKRQIDASNQERTDMVEYIDSYFLNEYKDIEPKESAIINTESPAWALDR
LAILTLKIYHMEEEATREDASQEHKLACQQKLDVLLEQRTDLCTAIDQLIKDIRNGDKYM
KVYKQMKMYNDDELNPVLRGQAKK
>KECLDBNJ_00225 Modification methylase FokI
MNYIGSKHKLSDWLLENIKVVCGDDLSQLVFCDLFAGTGAVGRTFKPYLKSVIANDLEFY
SYVLNRNYIGNNSAIDASALIEELNEIPSRKGFIFHQYSETGSENRLYFSAENGQKIDAI
RAKIEEWLEQSRIDEDTYFFLLASLLESADKVANTASVYGAYLKKLKKSAQKTLELAPAN
FEITAGSHSVYNTNSNALINDIEGDILYLDPPYNARQYGANYHVLNTIAKKDTFVPKGKT
GLRAYTKSAFCSKLEVENSFEELIAKARFKTLFLSYNNEGLMPAATVKEIMQRYGKYDLV
TKEYQRFKADKTENRNHKANATTEYLHILEKHQK
>KECLDBNJ_00226 hypothetical protein
MARVVLEHIENELKKRWPYRDVWFRRQNNIWDNQSNFIYNIQDFDELIERIKSQLQHNQF
NKKEFFYYSLNRWYNYWSARAVEQLFIDQPNVNAVLNEKDRLKDFSIQGISFDLKTTKFP
KGFQKDFADAQKYPEMLIKWLYKNQSKGRRFHLENRLFLVVFAANGEHYKLKAEISWLRA
LIENYVSTFEPEKLISVTTATNKTALSDIIWATR
>KECLDBNJ_00227 hypothetical protein
MLTSFFGGSKPINFAMIVLAVIVYFTGFYLVSDVYEFTSLEALGQFFVLLAYLFSLGVLN
FVVKRNTLSKRTTYILYFFVCFTFAVPVSFFNYDIVFSGLFVLLALRRIISMKTEKDFKK
KVFDAAFWITIASLFFFWSILFLVVLYFSILFYGRSEYRNWLMPLGGIFVVLLLTFTFSL
YYEGAKEFALSYFELPTLDFRAYSSLKLLLPTSFFLALYIWCGLRYIKQVSDAPQKLKAS
FILIIISSLVALFIAIFVAPLRDGSELYFLFGPLAIITATYIETSKSFWFKEMMMWLALL
IPILLIFWRV
>KECLDBNJ_00228 hypothetical protein
MELKDLFYGIQDFFVNVAFAPLDAIRELQDSSWVAANLLNFVFIIIVSVAFTYWCVQLNK
FDKDEHHNIHG
>KECLDBNJ_00229 Phosphoribosylamine--glycine ligase
MNILILGSGGREHTFAYKIAQSSKCERLFVAPGNAGTAGIATNVAIGVTDFEAIKKLVLD
EQITMVVVGPEDPLVQGVYDFFQNDKELSEIAVIGPSKRGALLEGSKERAKEFMAMYDIP
TAAYESFKAESLEAGKAFLEKLNAPYVLKADGLAAGKGVVILNDLEEAKAELTDMLTNQK
FGTASETVVIEEFLDGIELSVFVLTDGKNYITLPTAKDYKRIGEGDKGLNTGGMGAISPV
PFADDAFMEKIENRIIKPTVDGLKAEDIDYKGFIFIGLIKVGDEPKVIEYNVRMGDPETE
VVLPRIKNDLVEVFEKVAAQKLDEVTLDLDARAATTVMLVSGGYPEAYEKGKMITGTEEV
EDVLVFHAGTTLKDGEVVTAGGRVMAVTSLDADFRAALKNSYKNIEKIKFDKMNYRKDIG
FDL
>KECLDBNJ_00230 hypothetical protein
MNLINLSLHLNGYAIATAQKQLQELKQQVEHNYAAYIETKKTEILKHHLKNTPFYKNLVG
DQYQTWEDLPVLTKQNLQQALKSRLSKEFSTKNVHVHKTSGSSGTPFIFAKDKFCHALTW
ASITQLYSTSGIDLHNSYEARFYGIPKHGAARLKERLKDRLSNRYRFSIFDTSDANFESF
ISRFKKEPFGHLNGYTSALVLFARYLAGKKLVLKDLCPSLTHCIATAEMLFKEDIELLQK
QFGVPVINEYGASETGIIALGKAGDILHIDSSLLYVEILDEVNRPVDPGTSGKIVVTSLF
NKAHPFIRYEIGDLGVLSYQNGLSVLTKLEGRVGDFALLPDGKKIPALAFYYVTKEIMND
TASVKEFKIIQNKPNHFSINYVADAEFSTQDVEKIKRAMLNYLGTEIQLSFNKKPILDRS
KRGKLKQFTRTF
>KECLDBNJ_00231 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MAIKKPIDARPLVSIVTPCYNSEKFISETIASVQKQTVTDWELLIIDDASSDETVACVQK
LQEKDFRIDCIALSENKGPAHARNLGIQKARGKYLTFLDADDLWFPKFLERSIIEAKKHP
FVFASYKRLDENLEPYLSDFIVPRKVSYTDILKSNAISCLTAFLDIEVLGKKYMPLIKKR
QDMGLWLQYLKKIDYAYGIQEPLAIYRIRRNSLSRNKTGLIKHQWKFYREVEQLSVFASA
NYLMCWAYKGFVKYRN
>KECLDBNJ_00232 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MNENGTKHSFVLQPLVGFCDLLILMLCALLFEFSKAEYTYFIPFLIFSWLITSVGIGFYK
VYRFTPLVNILGLVLKQAFLLLVCCFSFFGIFNEIDVVASAVLEYVCLSIGFIALLKLVV
FNLRKKFRKQLGRDTIRVIIVGRNAKTEQLKNFFNFNPAYGFQFIANFDLRLDTIELEEV
TRFAIGQRIHQIYCSVAELKNKEIQELIQFADNNLIALKFLPDNKDIFTKKMDFQYYGIT
PILALRTLPIDTPINLFLKRLLDIVFSLVVILGILSWLTPILALIIPLTSKGPLFFKQKR
NGIDGKEFYCYKFRSMTINKDANDKQASKNDMRTTELGKFLRRTSIDELPQFYNVLLGDM
SVVGPRPHMVSHTHSFKQQIDKFMVRHLVKPGITGLAQVSGYRGGIETEHDIKSRVRFDI
FYVENWSILMDLRIIAKTFFQVIYGDKKAY
>KECLDBNJ_00233 Putative glycosyltransferase EpsD
MALDNGLIEFMMLSCYPSKALKHPKLLLMSTLKIVHIVEALGGGVYTYFKNLTQVLCEAP
DLEVTVIYSGNRDEINNDQVAADFHPKTRLICISMHREIRFKEDFKAFKALKTTLKQIEP
DVLHLHSSKSGILGRFAYLFSPRLKAKLFYTPHGFSFLRKDISSIKRHLFFSIEFLSQKL
TGGTLIACGDTELRYAKKIGPALLVRNGIQQLGLTNFEKQHRPQIKCIGTLGRITYARNP
AYFNQLALNHPELEFLWIGDGELRHQLTAPNIFITGWFNNYEQGLQKLEALDLYLQTSLW
EGLPIAILEASAREIPIVATNIIGNKDIVADGKTGFLFDAEHEFDQILQKSKNQSTRIVL
GNAAKKRTAILFNSEVNFEKLIRLYRA
>KECLDBNJ_00234 hypothetical protein
MIVSERTYRFSYNAWLTILAVSIPFRIPATVLLILFAVYNLVFFNQLKFTRRRVFFMFLI
AAPFILDLLFLWNNTSIAEGIKHGEKRLSLLLLPFFILSQNHRFNTVLILRYYALATTAI
LSLCLMRFAIIEPELFSKYLNGVDLWEMGYAFARSIKMHAPALNMHVAFVVVINFYFFKE
ALGQIRKTHVIWRLVFFLISVILLQYINTRLAIVNAFFGIILISLADVRKLKTKGLLKRL
VIGVFGFALLSYGFVKIFPYSVEKFSEVTFAHLDKVGKLDSLENPEASAYNGLVTRLSIW
KTSLDVALEHPVIGVGAADGKQAVINKFEATNQQFLAKYKFPVHNQFLDFWIKFGILGLL
VVAVYIGLFAYIGFSSRQILCVFFFVLFLTANLVDDFLIRFDGIVFSALWLSIFTKNALD
IKLDKA
>KECLDBNJ_00235 hypothetical protein
MRLLIPRSTLLYLLLGLVVVVLGVLAPSYLPERFFFDAIVIAEDFYNEKGFWRSYPVTML
IYDKTGLGSLPFELVAIIQLPILLWVIYKIGIPEQFAKLTVRNILAYSLVLMLAFFISMP
SKEFITFLFIAWMPWLLIKRRWSLRTTLTLIVLGLFFFGIWYRPYYVLIPIVAGVIYLIT
LISFKRKALTGICSGLLMVIFISLSYGMVKGEYLSQSTREALNEERLGEEATNSVIISPI
DPETWYGEAYGILYGFASVNVPVNGLKHLFRPQIVLFVFWQLILSLYLLYLFKNCLSNKN
AYRYELWAFYFVFAYFIIQGVFEPDLGSAVKHKIGILPFIYVALYYDSFRKNIPV
>KECLDBNJ_00236 hypothetical protein
MVKKLQEYFNRFNLHNVLGGALRVLILRVLGVIFLFGITLYLTNFYSAEVVGAYEFTRSS
LFLIGGVTLLGTDQSILFFSGRFSKPEQAGTLFQVYLKMLALLLGVSIVLLGIILVIPKE
YYNLFFNDQRSGTLLIKMGFCLFFYAVTLFNTEFFRAFDLHEKSELYRGILKQLPFGFGL
LILFLFNKHDYVVEVFLLSFLFCALLSGLEVYIKYKRLNPVVSRQTSIRFKTVLKATIPI
TISAFGFYLLISIDVFFLKRYTNFETLAYYGTSIKIIFLISTLINVMGSYLSVRIADLFV
TDQVALQAVLKKGVRVIVGLALGLSVILFVFAAEILGVFGAAYQEAVPALRILIAGHFMS
TLFGVTQVYLNMTKKQVVLQYILIIAVVINAIINAILIPKYGMLGAAVASAFSVIFWNGC
AVIWVYKKDRIKLFLH
>KECLDBNJ_00237 hypothetical protein
MPQNNNQDIDVFDLFRGLKSQMKKLLIFGYRFVKFLLRNSLILVALIVLGAALGYGLSKL
FNPLKTAEILVAPNVQSTSYLYGKIETLDRSISENEADFTGYFSAEKLKKIEIEPVEDIT
SVLKNLQAFPVDIVPRISESYDDESSFFEKPLYAPAYDLHKIVVVATDTIRAQGILDYLE
ANTFLQNKRKAAYKSIETEIQANRFSINQLDSILTVVPSAVAQDHRNLALLNSAENNEVS
AIINSKTKLLERNAELVQQLESLDAVFKVYGVSNWVDKTSLRSFLMYIIPLILVLIFIFY
HLALRIHNRLKDQH
>KECLDBNJ_00238 hypothetical protein
MSLIKQQDRTRSQESSAAIERMYITMRHLFNRGFYKPMGVSGETLREALLILRPEIYGTI
AEEKVELNGLLYVIDRLPEGIEECRYINLTSDEGYKNSHFKPIVPPKRRRNCYRIDDEQM
NIEITRGRSEIYDILTHLTFLFVESHKIMKRVVINEEGHTTRDWQKLEKAVLTEEPLSQA
EREIALTHTANILGRTFHEVTSIYSKFSAPNNEKRFLKLVYWLGKRAIEEIVESDKRLVT
FSPVLRERLGHHIHGEVWADSIKKELDAKDLLRRPIHIISANMHSVMNTLFAPVALEKEM
AKKSNLEIYETLSNASSGKLRARVEKTAQQHGMLFIPDQSGTNIDVQIFDTAKLDLKQNN
FCSKTSYPEGKEPVIIVMDYAFGEQAYETMEELLKPYEDKRETVHLDVKSVSIMGKAGIL
EGGKGDIMIPTAHLFEGTADNYPFENQLKKEDLEGHGISVYDGAMITVLGTSLQNRDILR
FFYESTWNVIGLEMEGAHYQKAIQAAAKLRGSISDSVKVRYAYYASDNPLETGSTLASGG
LGTTGVKPTYLITEQILEQIFKD
>KECLDBNJ_00239 hypothetical protein
MSIKSFSAKIFAKYIVSKTWKWSANPVTTQKAVFQHLIKNGAQTRFGQDHDFQHIDSFEA
FAKKVPVRDYEALKSYVEEAVAGKPDILWPGKPEYFAKTSGTTSGAKYIPITKASMPMHV
NAARDAILHYIAESGNSDFVDGKMIFLQGSPELQIKNGIKTGRLSGIVAHYVPGYLQRNR
MPSWSTNCIDDWEAKVDAIVEETLPENMTVISGIPPWVQMYFEKLQEKTGKNIGDIFPEF
NLFIYGGVNYEPYRKKFENLIGRRVDSIELYPASEGFFAFQDSQKEKGMLLLLNSGIFYE
FIKADEFFTEKPQRLTIGEVEVGVNYVMLISTTAGLWAYNVGDTVMFTSTKPHRVVVTGR
IKHFISAFGEHVIGKEVEEALTSTASQFKAQVSEFTVAPQINPDQGLPYHEWFIEFDAPP
ENLETFAQAIDLALQEQNSYYKDLITGNILKRLEIRVIPQGGFTAYMKSKGKLGGQNKLP
RLANDRSIADALNQLDF
>KECLDBNJ_00240 Glycyl-glycine endopeptidase LytM
MAKSKEKKKLKKRLLHKYRLLILNEDTFEERVSFKLTRLNVFIVVGFSVIILIALTTLLI
AYTPLREYIPGYSSVKLKRQATELMFETDSLKRQLDINQQYFASIKKVLTGDVEEVNFNR
DSILLLEPRDTSGLNMRISREDSLLREQVANEDRYNLFEPASSTVSFSLFPPVKGSITEG
FDAEEKHYGTDVVVPKNEAIKAVADGTVIFSEWTAETGYVIILDHGNDLLSVYKHNASLT
KDQGDLVKAGEVIATAGSTGKFSTGPHLHFELWNSGYPVDPTNYISFE
>KECLDBNJ_00241 Sec-independent protein translocase protein TatA
MNALAIFLGMVGPWQIGLIVVVILLLFGGKKIPEMMRGLGSGIKEFKDASKDEEASHKSD
ETLEEKKS
>KECLDBNJ_00242 hypothetical protein
MQKLILAFLIFALVACNDKPSSKILSASSGALNNLTVVMPNTMWEGPVGESIREKLAGPI
NGLPQVEPMFAINQMPDEAFSGFMRKQRTFLKIEQADTAALEIIKDEYARPQTGILVKGP
TEEAIINLIKQDSAQIVNTIKETEFTEKVRRISLSLKEDKPLTEAFGITMKFPTAYRYAK
EDEDFFWIRKDIPNGDMNITVYEVPYNLIDRDSNTIGSLIKMRDSIGGDNITVSEGMRFI
TEAAFAPYLSETTIAGRPAYQMNGIWEVKGRYMAGPFVNFTVDDKENDRYLVLEGFVFKP
SANKRDNLFELESILRSVKFVDKK
>KECLDBNJ_00243 Membrane-bound lytic murein transglycosylase D
MKKRYCLGYAFAIMTSLASYAQKKNPNAATLQISQSLPIVDTVELKNLMRELNSANAHVV
QKVPEPFLFKEVKWDSTSKKLNDRKFPAKVDKLWLEELTTNTLYDDMAALVEDTNYEEVD
YPELTTETLKKRLADLNARTPFNVEYNPSLENVIKGYLKRHKPTLERLMGLSQFYFPGFE
QTFDKYDMPLELKYLAIVESALRPRAKSRVGATGMWQFMFNTGKLYGLDISSYVDERMDP
ILSTEAAAQYLSKLYEIFGDWDLALASYNSGPGNVSKAIRRSGGRTNYWNIRHHLPRETA
GYIPAFLATMYIFEYAEEHGYHPAQPDVNYFETDTIKVKETITLQQVSSYTGVSLEEIQF
LNPAYKLDVIPFVADENYYLRLPITAIGPFVANENNIYQTAKKELERDEKTLPEYLEVPS
SISYRVRSGDYLGKIAERYGVGVSQIKRWNNLRSNNLRIGQRLTLYPSKPSASVASSQSS
SGSSQKKYVVRKGDSLWKIARKFPGVSAENLKVWNDISGTKLKPGMTLVIAN
>KECLDBNJ_00244 Phosphoglycerate kinase
MKTIDDFNFENKKALIRVDFNVPLDDNHQVTDTTRIEAAKPTILKVLEDGGSAILMSHLG
RPKNNEPEFSLKHIVAKVSEIIGVQVKFVENCVGAAAEKAASELEPGEILLLENLRYHDE
ETAGDKGFAEQLAQLGDIYVNDAFGTAHRAHASTTIVAQFFPENKCFGYLLAKEIESIDK
VLHDSESPVLAILGGAKVSSKITVIENVLDKVDDLILGGGMAYTFIKAQGGQIGSSICED
DKQELALDILKKAKEKNVNVHLPVDVLAADSFSEFANTKVEPIDKIPDGWQGLDAGPKSL
ENFAQVVKNSKTILWNGPLGVFEMEPFAKGTIALGDAIAEATSNGTFSLVGGGDSVAAVK
QFGFENKVSYVSTGGGAMLEMLEGKELPGIAAIKE
>KECLDBNJ_00245 DNA polymerase III subunit gamma/tau
MQFQSILGQNFIKKHLTTSVDRGRVAHAQLFVGPSGSGVLPCALAYAQYLICNNVDGENS
GGSSACNLKFDHLAHPDLHFAYPVAPNENVKSHPVSDNFAKEWRAFIQENPYGSLYDWHR
HIGIEKKQGKIGVDEAQDIVKKLSLKSYEGGFKVMIIWMADKLNNAASNKLLKLIEEPPK
KTVFILIAENEDQILDTIKSRCQVLRFPPLAAEALEEALINTHHCNPSEAKKLAIKAHGD
YNLALHLLDHSSDEEEFETWFVSWVRTAFKARGNKKAIIDLIAWSENIASKGRETQKSFL
GYCEDFFRQAMFLNYKADQLVYLQPVTQFELAKFAPFIHGNNIIAIIEELQTAAYHIERN
GNAKIVLTDLSIKLTRLLHTKA
>KECLDBNJ_00246 hypothetical protein
MKTKLSLFVIAVAFTLASCTKSKSAFVDTQKLFEEYSEMTEVQDKYTKLTDEVREELQPK
IQAFQIKVDLYQKNASTMSPAERQSKEQELGVLQQEIQQMQQARGGQIQQESQAAIDSVI
SKVRKFIDTYGEENGYDFIYGKNESGNVLYGNKELDITDDILKALNTSYSSGETTSTSEA
QEEESDTVSAE
>KECLDBNJ_00247 Ubiquinone biosynthesis O-methyltransferase
MTKKANLKIKDYSISQEEFTLVYDEVLDMFSTDPVPDNLGKYYLSENYISHTDSNDGLFE
KVYQWVKNYMLKKKVKLISSYVEKGTLLDIGAGTGDFLNQAKKSGWKVTGIEPSPAARKR
AFEKGINLFEEEAEVGDRKFDVITMWHVLEHVPDVEKQIEWIKNHLSTDGVLIVAVPNFN
SYDAKYYKSFWAAWDVPRHLHHFSSKSIKTLFETNGFNLIEQKPLIFDSFYVSLLSEKYK
STSLIKPVSAFMIGLRSNWRAQQNKEYSSIIYIIKSRNTQNKTF
>KECLDBNJ_00248 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MSFFEDIYDVIVVGGGHAGCEAAAAAANTGSKTLLVTMNLQTIAQMSCNPAMGGIAKGQI
VREIDALGGYSGIVSDKTAIQFKMLNKSKGPAMWSPRVQSDRMRFAEEWRLMLENTPNLD
FYQEMVNGLLIEGDRVAGVRTSLGIEIKGKSVVLTNGTFLNGLIHIGEKQFGGGRAGERK
ATGITEQLVDLGFDSGRMKTGTPPRVDGRSLDFSKMIEQPGDDDPQKFSYSDVTKPLTKQ
RSCQMSYTSPEVHNLLREGFDRSPMFNGRIKSTGPRYCPSIEDKINRFADKDRHQLFVEP
EGWNTIEYYVNGFSTSLPEEVQFKALRQVAGFENVKFFRPGYAIEYDYFPPTQLKHTLET
KLVAGLYFAGQINGTTGYEEAASQGLVAGVNASLKVQEKDPFILKRDEAYIGVLVDDLIT
KGTKEPYRMFTSRAEYRTLLRQDNADARLTPRSFEVGLASEERMRALEKKEAQAVNLVEF
FNTTSIQPEEANPVLAEKGTTPMKQSDKMVKIFSRPQIALDDMLSFKDVKEYVAEHDLDT
EVLEQAEIRIKYSGYIEKEKANADKLQRLENIKIPDNFDYSKLKSLSYEAREKLSKIQPT
TISQASRVSGVSPSDISVMLVYMGR
>KECLDBNJ_00249 Endoribonuclease YbeY
MIEFSSQNDFNLEDEERVEHWLKAAAVKESFGIESLGYVFCSDDFLLEINKQFLDHDTLT
DIVTFDYTEGKILNGEIYISTDRVADNAKDFNVGFDVELRRVIIHGLLHMCGYGDKTYEE
KEMMRAKEDEYLVLWNA
>KECLDBNJ_00250 hypothetical protein
MQELEAKLERFIRKYYKDELLRGLLFFVAIGLAYVLLVLVIEYFFWLSTWGRAFLFWSFV
GLAGLLLFRFVLIPIARLFKLSKGIDYTQASRLIGNHFPEVQDKLLNTLQLQTSASNSDL
VQASILQKSKELEPIPFSLAIDYRKNLKYLKYALIPVCIFLGISLSKGTTFFKESATRVM
DYKRVYAPPAPFSFELQNENTSIVEGQTLEISAKVNGQELPEEVEVSLNEVSYFMKNRGG
GNFSYTVEQPTEDLNVYFEGNGFVSDQYQFELINTPRISEFKIELNYPKYLNRTDEIIEN
TGNITIPEGTQVRWLLATEQTNLVEWISDTVFQFEKENQQFSFSERFFNPTAYSIATSNA
HLKRFERLNYELAVIKDAYPEMNLEVRKDSLDDAETYFQGNLADDYGLYDLNLIYYTENQ
IDNSKKVSIPVNSSTVDQFYYAFPGNLDLSAGVSYSYYFEVRDNDVLHGHKATRSETFSF
QSLTTEEAVDKQLEIQENSLQGLDRSVKQMQEQERDLKELQNLQKEKNALDFNDKRRIQS
FLERQKAQEQMMQNYSEKLKKSINALDELSESKSEKNELLKNRLEKNEEQLKEQEKLVEE
LNKLQGLMDDEELKEKLDELSKKSKNSSRSMQQLLELTKRFFVQTKGERIGRALDKLGQD
QEEESKKQNPELNRQKELSESFENLKEELENLKDENKQLNKPIDIPEDSKTEEEISQEQK
SAEENLQKQEDSKAQENAKSNQQKAGKKMQQMGQKMMQQMSSGGGGDVEQLQEDVEMLRQ
ILDNLVIFSFDQEALKDKFSSIDNGNPSFSKYLVKQNELRDNFEHIDDSLFVLSLRNPML
QEDINEQLTEITYNLDQSLERLADNDIIKGVASEQYVFAGANTLADMLSDILDNMQAQLS
FAMGSGSSGMPMPMPSGGQGSGKQLSDIIMSQKELQEQLGEGKKDGKSGQEGENGKEGNS
GSQGDSGKPFGEGDGNGDSGEGTSESELARQYEIYKQQEAIRNQLENLLQGSGSTEETER
LLRSIEAVENDLLNGNAETARRRMNNVIQQFLKLEEAEQEKDKNTQREANANRKEFNNNT
SNSIPDAKRYFNAKEILNRDKLPLQEQYKIKVKQYFQRQDD
>KECLDBNJ_00251 Glutamate--tRNA ligase
MHQNVRVRFAPSPTGPLHIGGVRTALYNYLFAKKHGGTFVLRIEDTDQNRYVEGAEDYIV
EALNWCGIPYDEGPGKEGGFGPYRQSERKDKYFAFAEKLIASGDAYYAFDTAEALDAHRK
SHEDEGKTFIYNWHNREKLDNSLNLSAEETQKRIDAGEDYVIRFKSPQSEILELDDIIRG
AVEVDTSLLDDKVLFKADGMPTYHLANIVDDHLMEITHVIRGEEWLPSLALHVMLYRAFG
WEAPQFAHLPLIMKPVGKGKLSKRDGDKMGFPVFPLEWKDPKSGDIASGYREDGYLPEAV
INMLAFLGWNPGTEKEIYTLEELVQDFELTRVHKSGAKFDPEKTKWFQQQHLQLASDASL
VSGLQGILKEKHLDYDDAYVKQIIHLVKERAVFVSDLFDQGSFFFERPTSYDEKAAKKAW
KDDTGEIMINLSKIISETEDFSAENLSANVKGWIQNEGLGFGKVMQPLRLSLVGSMSGPD
VFDIASTIGKAKTLERIRFAIETL
>KECLDBNJ_00252 hypothetical protein
MSPILKIRNTLKHFLLFLLISTTFAANAQRNSKYASNRIGVQGQYALLDLNTSNFHTNQE
AGFLAGLSKRSAFYNNFDLIFGVDFMQTSLSLNASGAASEIEKVKYTWSGAQVKMLLSYL
IAGDHFSVEFGPIFQVNGKMELNDENQRALVLDGYTSLRAEDIQEWSRVNGLVTLGLSAG
FTRVRFTANYQYGFTNALKRLNDEGLTLKDPAATNFKGNLGLITAGIVLYL
>KECLDBNJ_00253 Modulator of FtsH protease HflK
MTYFLPILLFFGIIILISAVFIVKQQTAAIIERFGKFTSVRNSGIQIKIPLIDKVAGRVN
LRIQQLDVIVETKTKDDVFVRLKISVQFQVVKSNVYDAFYKLEDPQNQITSYVFDVVRSE
VPKMKLDDVFERKDDIAIAVKSELNQSMTDYGYDIIKTLVTDIDPDQQVKIAMNRINASE
REKVAAEYEAEAERIKIVAKARAEAESKRLQGQGIADQRREIARGLEESVEVLNNVGINS
QEASALIVVTQHYDTLQSIGEETNSNLILLPNSPQAGSDMLNNMIASFVASNQIGEEMKK
RNEQLGLKTPKKKDKPKQESGYDDDFDADDDLSTL
>KECLDBNJ_00254 hypothetical protein
MKVYKSFDQIEQDLRILKLQQQIDEEQLKLSINDTKAAFSPVSLVAGSVGAIVQKTIVLK
AVNKILGIKKVKVKNIDDNK
>KECLDBNJ_00255 hypothetical protein
MSIFNLSEHISKVSDDAKKYLNSSLEYYKLDSFKKMMDGAVSLVNLMVSGSIFLIFILFI
SVGVAIVIGESLGSLSYGYFIVAGIYLVIYVLYKLFGKPFITEIVLRKYSKVFFNESSQE
DVLDEEFKHLQE
>KECLDBNJ_00256 hypothetical protein
MSKTSNTILALVTGAAIGAGLGLLYAPESGDKTRKKISKNAKEAKKKLEKQIQETSDHLS
ASAKEAKKSFDAKLEDTLKTASSKADNILVSMEKKLEELRKKNAKATTEVVEEVKDIDVP
TAKA
>KECLDBNJ_00257 Glutamine--tRNA ligase
MAEDYVALNFLEQIVEEDITNGFPQEDLRFRFPPEPNGYLHIGHCKAICISFGLGEKYNA
PVNLRFDDTNPSKEEQEYVDAIQEDIKWLGFKWDKVCYSSDYFQQLYDWAIQLIKDGKAY
IDSQSSEAMAEQKGTPTEPGTNSPYRERSVEENLELFEKMAKGEFAEGVHVLRAKIDMQS
PNMLLRDPIMYRVINKAHHRTGNTWNIYPMYDWAHGESDYVEQVSHSLCSLEFKPHRPLY
EWFVDNVYTNGIKPKQREFARLNLSYTIMSKRKLLKLVQEGIVSGWDDPRMPTISGIRRR
GYTPAAIRNFIDAVGVAKRDNVIDVSLLEFNVREDLNKTAPRVMAVLDPVKLVITNYPED
QEEWLEAENNQEDENAGYRKVPFSKELYIEKDDFKENANSKYFRLTLGKEVRLKNAYIIK
GESVVKDANGNITEIHCTYDADSRSGSGTEASLRKVKGTLHWVSIKHAIKAEVRLYDRLF
NHESPDGDKEVDFMEHLNPNSLETITGYLEPSLSEVEPMDIFQFQRLGYFNVDKDSTPEH
LVFNKTVGLRDTWAKVESKSTKKEQPKAAPKKQIPQIPALNEIKKVGKKLAQIPDEKRVK
AIARIRELAKDVHYEELKELFNTSAKKIGTRLAVLETLIVLIQLNKVDQKNEEVAAYLEE
MKTSGNELLENSVNNL
>KECLDBNJ_00258 Dihydroneopterin aldolase
MGVIKLNRVKVYAYHGCLVEEGQIGSDYLVDLKINTDLSIPAQSDNLSDTVDYVHLNKII
KEEMAHRSKLLEHVCDRILNRSLSEISTITKAKVTVRKINPPIGGDVASVGVSMTKKR
>KECLDBNJ_00260 hypothetical protein
MLQDISTAIPLGFLLAFLVGPVFFVLLETAALKGFRAAVLFDIGVVTADTLFIFIAYFST
NQLLDKLKDDPALYIFGGMLLAVYGIMSFLRVKKNKLDDDEHPTVVMSKRNYFGLFVKGF
LLNFINIGVLGFWLVILISAGPQLDMNSERLTVFFGTILLTYLIIDIIKILLAKKLRSKL
TPTRIAIIKQIISVLMFLFGLLLISKGLFPSKIHQIEKRIEEIAPENEFIEGDTIPF
>KECLDBNJ_00261 hypothetical protein
MAVLFVAAGATYAQDDTKDVGDFTEVKVFDRMRVNLIKDSENKVYLKGKDTDYIELVNKD
GVLKIRMDLDKIFDGNETFVEVHYNNLRVIDGNEGAEIVVNELLKQPKIEIRVQEGAQVT
AGLKVENAEMRAVTGGIITASGSAVNQNVEVNTGGVFEGKSLETTDTTIRIQAGGEADIF
ARRTAEVKIRAGGDVDVYGNPTELIKDKFIGGRVRVMK
>KECLDBNJ_00262 Ribonuclease R
MPNKKRRRRSNTQIGDLTQKILKILKREPGKLFNHKQIAAKLQVDDPNSRNEIVKKLSQL
TAKKHIEEKERGKYSFNATSHYHTGTLDATSRGDGYVVVEGMEQDIYIPKNNMNKALHGD
TVKVYVYKQRRSKKHEGEIVEILERKTDEFVGVVQMQKNFAFVNTSAEGKMRTDIFVPKN
KLNGAQDGEKVLVKIEDWPEKADSPFGKVIKVLGLPGEHNTEIHSILAQYGLPHDFPEEV
EAYANNIDTSIKAEEIAKRRDMREVLTFTIDPKDAKDFDDALSFQVLENGNYEVGIHIAD
VSHYVIPGTILDEEAYERATSVYLVDRVVPMLPEILSNNACSLRPNEEKYTFSAVFELDK
SSGKVKKQWFGRTVTYSDARFAYEEAQQIIETREGLIPEDISLTGKSYNVDPAIVKATLE
LDRIAKIMRRQRMKDGAISFDKVEVKFELDQENDPVGVFFKTSKDANKLIEEFMLLANRK
VAEFIGKQSPKKTFVYRIHDEPNDEKLAALQTIAGRFGYKMNLKDRKSTTASLNNLLTDV
VGKKEQNLIDTLAIRTMSKAVYSTDNIGHYGLAFEYYTHFTSPIRRYPDLMVHRLLQHYL
DQGKSASEEEYESKCKHSSDMEYLATSAERDSIKYMQVKFMQDHKDETFLGVISGVTEWG
IYVEIIDNKCEGMIRLRDIKGDHFDFDQEKYAIVGRKTGATITLGDEVYVKVKEADLVKK
HLDFTLVDVKEAIQ
>KECLDBNJ_00263 Acetyltransferase
MMTIEIKAFNELTLNSLYEVLQLRTEVFVVEQNCPYQDVDGKDQKAMHILGYHKEQLVAY
TRVFKPGYYFDNASIGRVVVKENARQYGFGKDIMKASIAFIEDTLDLSTIELSAQTYLKK
FYNDLGFQEIGEGYLEDDIPHIRMIKK
>KECLDBNJ_00264 hypothetical protein
MITIDKDTDKNTEILGTAISYLEDRGYENIKADTDGFESPKSYIRRGSEVSITPDIVAER
DGEKHIFELSLKSKKPRLLKSKWLFLDTLSSMKNFKFKIFTTRGHYKFTDDTLNSINLDM
TPVKI
>KECLDBNJ_00265 putative CtpA-like serine protease
MKKRILISVTAVLILFTTVSFKSDFFEIAKQIEIFTTLFKELNMNYVDEVNPAELMDSAI
EGMLADLDPYTKYWTEQEVEDARISNSGEYTGIGASVLTRNKTITILEAYKDYPADKAGL
QAGDELIKIGDINIADFEEDAGDLLQGAPGTSIPITYKRQGKLQTTSLTREEIDINAVPY
YTLIDGKIGYVVLSKFNKKASSETAAAIKDLKEQGATSLILDLRGNPGGLLTEAINVSNL
FLPKGKLITNTKSVIEKYNQEYYTPKEPLDTEIPVAVLINGRSASASEIVSGSLQDYDRA
VVVGARSFGKGLVQRPKELTYGTQLKITISRYYTPSGRCIQALDYWNRDDNGNAIRTNAE
DYNEFKTSTGRKVYDGGGILPDIQIESARMSAITEALLRDQAIFDFATDYFYKHKYNDIS
DFKFTNADYTAFKTYLDKQGFEYQTQTEKDLEEVYLDASKDNLQDDISSEYANLMRTIDV
AKKEQLNRKEREISKLIIDELVKRYFYREGLYEYQLSHNEEIEEAKKVLQDPQRYAKILN
R
>KECLDBNJ_00266 Ribonuclease P protein component
MDQTFPKKEHLKRKKLLDKLFSEGQKINSYPLLLFYVPTALPEEQVPIQAGVSVAKRNHK
KAVTRNRLKRLMREVYRKNKTQFQTNDKTFAFMFIYTGKEIASYTELEKAMLKLIAKFNA
KTAATDQEAGF
>KECLDBNJ_00267 Aminopeptidase N
MTTRVFVSILVLSLFSCKPSTEDYNLLSTGISRELADFRKQQLSDIVYDLNFSIPEKLED
SIPASLDLTLTIHDSSQPLYLDFNVEKGHVSNVIANTEAIDIIHEQEHVIIPSEYLKEGK
NHIEIAFTAGEQSLNRNEDFLYTLLVPDRASTLFPCFDQPNVKATYNLSITAPQDWEVLA
GAPEQEQSKNGNFITHTFATSDLMSTYLFSFVAGKFKTATKDLSGFDMKLLYRETDSTKV
QSSLDPIFELHKGAVDYLEDYTAYSFPFQKLDFATIPIFQYGGMEHVGAIQYRESTLFLD
QTATESQLLSRAKLIAHETSHMWFGDLVTMNWFNDVWMKEVFANFMADKIVNPEFPEVNH
DLLFVLSHYPSAYGEDRTKGANPIRQELDNLKNAGSLYGGIIYHKAPIMMRQLELATGKK
AFQEGIQEYIKTYAYDNAVWDDLVSILDTKTNLDLKKWSEVWVNQSSRPVFSEEITYDAQ
NTIEKLQLIQSAEDGSAKIWPQTFKIGLVYADSTHILTAAFKEKRLLLEGAQGLPKPQQI
IYNYDGMGYGIFPQKDDLLQSLPQVQDEVARGYSYINVHENLLNAGLNPISVFELYKKGL
VNEKNALILNRISSQMQNLYWTYLTDIQRESHQKELEDLVYNQLQQALPANIKKTFFGLF
ESIAYSPSGKDRLYAIWNKETQINNLKLNEDDYTGIAMQLALFGHEHTDIILKEAAAAIT
NPDKKRRFEFLQPTLSSDESTRANFVNSLQDAKNREKESWVLSALGYINHPLRQESGLKH
LKTSLELLEEIQLTGDIFFPKNWLNATIGRYSSAEAYTIRENYLKAHPDLNKVLKNKLLQ
ATDDLERVHVMQASLEN
>KECLDBNJ_00268 Aminopeptidase N
MNLKTLVGLSILGFFSFAQAQNNTSYWQQHVDYTMEVDMNVEDYNYTGKQELVYTNNSPD
TLDQVFYHLYFNAFQPGSEMDVRSLTIQDPDRRVVDRISKLEPDEIGFLKVSTLTQDGTA
LTYNVAGTVLEVSLAEPIAPGESTTFNMDFNGQVPVQIRRSGRNNAEGVALSMTQWYPKL
AEYDFQGWHADPYIAREFHGVWGDFDVKISIDADYTIGGTGYLQNPEIGHGYGAPDQKPV
KPTKGKYTWHFVAPNVHDFTWAADPDYIHDKITAEDGTILHFFYKDNKEIIENWKNLQPK
TAELLAFYNKHVGQYPYDQYSVIQGGDGGMEYAMCTLITGERSFGSLVGVTAHEFAHSWF
QFLMATNEQKYEWMDEGFTTYISTEAENVVMGEKKENPQAGNYSSYFRLATSGIEQPQTT
YADRYALNAAYGASAYSKGAVFLAQLGYVIGQENLAKTLTRYFDEWHFKHPTPNDFKRVA
EKVSGMQLDWYLVDWTETTNTIDYAIKNVEEVDGKTQVTLERKGLMPMPVDFYINTTDDA
TEAYYIPLRMMRASKVNPFPTMPRTQLEDWPWAYPTYTFTIDKPLSEIKAMTIDAQQLMA
DIDRSNNSWSKDAE
>KECLDBNJ_00269 Thermophilic serine proteinase
MKKIVLAAFGAALLLSSCDSTAPLISIPAENVDQLPLKVSELNETQEKAWPTKDITADTI
PGMSVAKTYDEIIKGTGSSVIVAVIDSGVDIEHEDLDGVIWTNEDEIPNNGIDDDKNGYI
DDVHGWNFLGDVVNEQLEKSRIVQKYDAQFKGKTLDQIPAAQKELFKTYTEAKKQVETEK
DELIQQKMQYDQIVAAVKSAHTAVSQKLGKEDYTAEELQALETTTEMDQRNKAILTQMLN
YEDSIPEFLVMINEQLESMTNQINHNYNLEGNYRAVVGDDPDDIKDTDYGNNNVIGPDPD
AARHGTHVAGIIAAERNNGIGMDGVANNVKIMVVRAVPDGDERDKDIALAIRYAVDNGAK
VINTSFGKYFATNPEWVYDAIKYAAKKDVLIVNAAGNEGIDLDTGDTVYPNDQLDNETEF
ADNLISVGALNETYGGKLVASFSNYGKSNVDVFAPGVQIYSTVPGNEYEFLQGTSMASPE
VAGVAAMLRSYFPQFSAAQIKQIILQTGVSTNIQVSAGGDPENVKSFSQLSKSGKMVNMY
NAFKMAELSSK
>KECLDBNJ_00270 putative quorum-quenching lactonase YtnP
MTIHAIDAGSFKLDGGAMFGVVPKSLWTRTNPADANNMIDIGARCMLIEEGDRLILIDTG
MGDKQSEKFFSHYHPWGGATLENSLLEKGFHPDDVTDVFLTHLHFDHSGGCIKWAKDGKT
LVPVFKNATYWSNKDHWEWATKPNAREKASFLKENILPIEESGLLRFVDRPDTAFTATSA
LDFGILFVDGHTDKQMIPHIEYQGKTIVFAADLLPTAGHLPLPYVMGFDTRPLLTLGEKE
NFLKDAADKNYYLWLQHDAHNPIITVKHTEKGVRLNEKFNIADIL
>KECLDBNJ_00271 K(+)/H(+) antiporter NhaP2
MLELGGIIILGILAQWVAWKFKIPAILPLILIGLFVGPISTLFTYDGSKWIEPIWDGEVG
IFPGERLFNFVSLAIGIILFEGGLTLRFSEIKNVGPVITKLIIIGSLVTFFGAGAAAYYI
FDLSLRISFLFAALIIVTGPTVITPILRNIPLKKDISAILKWEGILIDPIGALVAVLVFE
FISVGAGSEFTLTALEEFGKIVLFGFTFGFTFAHALAICIKRNIIPHYLLNVFTLACVLG
VFVLSDLFAHESGLLSVVVMGMVMGNMKLPNIKELLYFKESLSVLLISLLFILLSANIEM
QDLYLVYTWKAALLFAVVVFVLRPIGVFLSAKGSGLKFNEKLFVSWVGPRGIVAAGIASL
FGLQLVSEGVEGAEYITPLVFMIVLGTVLLNATTARLFAKIVGVFLKESKGIVIIGASKA
SRIIGEYLMQNGRHVVLVDSNSYNIEKAKDRGLEAIEESIYSDSLMNNIELNDVGYLMAL
TGNGDINEYAINRFKNIFGENGSFRLITPDEMRSPQASPHEGLFSPTDDFIRLTEVARAH
PTIQEIDIESKEAFVKLVKSTRADENIVPIFLKKESGELEILKSNLDEVDVESFANTKLV
YLGKPFDPEEVAVAKKEAEETETED
>KECLDBNJ_00272 Glucose--fructose oxidoreductase
MKNRRSFLKTTGLALAASTLPLPHFAYGNPQMKLGVALLGLGGYATNNLAPALMQTKHIE
LRGIVTGSPEKIPVWQEKYGIKDQNIYSYETLPEIANNEDIDVVYIVTPTFLHKKYAVMA
ANAGKHVFCEKPMAMTVSECQEIIDACKKNNVRLAIGYRMQHEQNTQTIINWAEINPYGA
LQNVHTEAGFRIGSSGGWRLDGAKGGGAIYDMGVYPINAMRYATGLEPISLTASHETQRP
NLFLNGAPEITYFDLEFPNGITAKGRVTYADNVNFLKVNCADGNYELAPFQSYNGVSGST
SDGKYLAPCECNQQAIQMDDDALAIMNDKPMIAPGIEGLRDIQIVEAALASGRNNGERIA
LKQY
>KECLDBNJ_00273 hypothetical protein
MKRIQFIGLALIIICGMISQYTNATQNQFLVWLLAIGAVAGILMVISDYFTSKEKK
>KECLDBNJ_00274 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLDFTGSVTEREKQEQLLDNMDLERERGITIKSHAIQ
MNYIHNGEPFILNLIDTPGHVDFSYEVSRSIAACEGALLVVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEEVTDDIVDLLGCDAADVIPASAKTGIGIQEILDAIITRIP
APKGNPDEPLQALIFDSVYNPFRGVETYFRVINGEITKGQHIKFMATGKDYHADEVGTLN
LKQSPKKVIKTGDVGYLITGIKEAKEVKVGDTITDAKSPTTNMISGFEDVKPMVFAGIYP
VDTEDYEDLRSSMEKLQLNDASLVFQPESSAALGFGFRCGFLGMLHLEIIQERLEREFDM
TVITTVPNVSYQAYTIKDKQTPILVNNPSDLPDPAGMDRVEEPFIKASIITKADFVGPVM
SLCIEKRGQITNQTYLTPERVELSFDMPLAEIVFDFYDRLKTVSKGYASFDYAPIGMRAS
HLVKVDVLLNGNTVDALSALLHKDNAYDIGKKMCEKLKELIPRQQFDIPIQAAIGAKIIA
RETVKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQVGNVEIPQEAFMAVLKLND
>KECLDBNJ_00275 hypothetical protein
MKHPILLSVLLFSFVSVAQTGSITGKIVDTNKQEVSYANVLLLKAADSTFVKGAVSEENG
AILFAEIPSGRYLIKASFVGFKDGYSSSFELKDEIRISDLILQENSEALEAVTVNYRKPT
IVRGIDRMVFNVENTAISSGTTYDILQRTPGVVVNQGQLLVKNRPAQVYINDRKVYLTNE
ELQQLLEGFAGVNIKSVEVITNPPARYDAEGGAILNIVTSKNLSIGYKGSINASNTVGIK
PKYNAGTSQYYKTDWLNAFASYNFNSRFDVKTDEGFVQFYNPNGSEKATWEDLFQRETRT
ISHSLNTILDFTLSETELLSFTANILHTPKANSDISGRTETYNPQGQLDSLYTTQSRLEN
QRDNLLFNLNYEKQLGENGATLSANANYIDYTDDQMQAVATRYVSAQGNLSNSNAFNTIP
TQKSQIYTGQLDYLGNLGSWAFEAGAKYSGINSESRQEFFNTAGNVSDADAILNDHFDYT
EAIYASYFSVAKDWEKWSFKAGLRGEYTDANGNSRTLGVVNTQEYLELFPTVYLMHNPFD
NHSFGIDYSRRIDRPRFQSLNPFRYFLNENNFQEGNPNIQPAIANRVNFNYTYKNKLSFD
LYWDRIDNAMSRLPFQDNENLTLRSVNTNLNYEQQYSLDVSYSEFVNNWMWMSIYASFFN
MQNEFTSLDGNQSKIENEINGFFFQSVNYLIINSTLNVTISNNFTTNYLVGSYEYDRPQY
RLNVDIQKRFLDGRLILNLSSEDVFNTMKTPLKSRYLNQNNTFFAMPEFQKIRVGLRYNF
GNFKLSDNNRETSVDEESRLQELGAN
>KECLDBNJ_00276 putative tRNA-dihydrouridine synthase
MAKIGDIDVGDFPLLLAPMEDVSDPPFRALCKEQGADVVYTEFISSEGLIRDAAKSVMKL
DIYEKERPVGIQIFGANLESMLQSVEIVEASKPDIIDINFGCPVKKVVSKGAGAGILKDI
DLMVSLTKAMVKHTNLPITVKTRLGWDHDSIKIVEVAERLQDVGCKAIAIHGRTRAQMYK
GNADWKPIAEVKNNQRMHIPVFGNGDVDTPERAVEMRDHYGLDGAMIGRASIGYPWFFRE
VKHFFNTGEHMAPPTMQERVDAARRHLQMSIDWKGEKLGVFETRRHYTNYFKGIPGFKPY
RMKMVTSDAPEDVFAAFDEVEELFADYDFAQQTY
>KECLDBNJ_00277 Lipoprotein-releasing system transmembrane protein LolE
MKFPVFIAKRYLFTKSSNNAINIITLISAISIIAGSAALFVVLSGFSGLKDFSLSFASIF
DPDLKVLPASGKTIKFTSEQATELEDNPDIASYTQVIEERAFLEFRGKNHIAYIKGVDEN
YRSVNSIDSTLLYGNWITPEEPVAAIGFGISRILSLGVNNYTDLLRVMVPRPGTGQITDP
TQAFNSSQLVVSDIFQVNEELDQKYIFTNINYARKLLNYKDTTLSAIEIKINPNADPLKV
QREVQQIFGPTTQVKTRFQLNDKLYKMLNAENLAVYLIFTLVLIIALFNLVGSIIMIIID
KKANIKTLHSLGASLKDIKKIYFLQGAMMSVFGGIIGLVLGSLIVGAQLQFQLKMITPTL
PYPMEFTLVNFLAVFLTISVLGILASYLAASTIRPKLLDD
>KECLDBNJ_00278 Ribosome-binding factor A
METNRQKKVAGVLQRDLVDIIQKALMQAGVKNIIVSVSKVNVTTDLSQAKVYLSIFPHDK
ASEILKEVSAVKPFIKHEIANRTRHQLRRMPELQFYVDDSLEYIDGIDKSLKGSEDPIQN
PDLLPRRKKS
>KECLDBNJ_00279 hypothetical protein
MKKIEHIGIAVKSLQDSNEMYTKLFGKQPYKTEAVASEAVNTSFFEMGDSKIELLEATKE
DSPIAKFLEKRGEGIHHIAYAVDDIKAEINRLKSEGFTILNETPKKGADNKWVVFLHPKT
TGGVLIELCQDID
>KECLDBNJ_00281 hypothetical protein
MRSKLYTYVVTLILIAGAAHIGYGQGAKEPPEPQVRTGDAPPFGLPTPIDDYIPHLLIFG
VFMGGYFFYKAERQKVTNS
>KECLDBNJ_00282 Riboflavin synthase
MFTGIIEDLGKVEKLEREGDNLHITVSSRLTAELKIDQSVAHNGVCLTVVSLNDNSYTVT
AIEETLNKTNLNELKEQDLVNLERAMILGSRLDGHIVQGHVDQTATCINKENKDGSWIFT
FSYNPDLNNVTIEKGSITINGVSLTVVNSKINEFSVAIIPYTYEHTTFKFIQKNTEVNLE
FDVIGKYVKRLMNL
>KECLDBNJ_00283 4-hydroxythreonine-4-phosphate dehydrogenase 1
MKEQSIKLGISIGDLNGIGGEVVLKTFEDARMLDFCTPVIFASAKTVSFLLKHFELDINF
QGVKEASNVIEGKINVVNVWKDNPRINFGSETPEAGSYAIKSLKAAVTALKSGEIDALVT
APINKANIQGEEFNFPGHTDYLNQELEGHSLMFMVSQKLKVGLLTDHVPVKDVTTKITAN
LIKQKFKTIHHSLVQDFGVSKPKIAFLGINPHVGDNGVIGKEDDEVLIPTLEELRDQGNL
TYGPYAADSFFGSGNYKNFDAIIAAYHDQGLIPFKTLAFGKGVNYTAGLNKVRTSPDHGT
AFEIAGKGTADINSFKEAVYMALDIYKKREEYAVLTENILQKQPRKKQYSGRSRGK
>KECLDBNJ_00284 hypothetical protein
MHPPFAEVEILGKRKVMKHLKTYTIQFVGLKQGEHDFQYDIDNTFFEHFDYDDFNSIAVD
LKVTLIKKSTLMEFYFDAEGTVNVNCDLTNEPYDNPLETSYKLVVKFGQEYNDEIDDILI
LPHGEYEVNIAQYIYETLVLAMPAKRVHPGVEDGTLKSDILDKLEELSIKDNQEEEEQEP
QPKEIDPRWDKLKDFLTDN
>KECLDBNJ_00285 50S ribosomal protein L32
MAHPKRKISKTRRDKRRTHYKAAMPKIGVDATTGEAHLYHRAHWHEGKLYYRGQVVIDAT
AGEEVA
>KECLDBNJ_00286 3-oxoacyl-[acyl-carrier-protein] synthase 3
MSKITAAITAVGAYVPEYVLTNEILETMVETNDEWITTRTGIKERRILKDPDKGTSFLGI
KAAEDLINKSGIEPSEIDMVIMATATPDLPVASTAAYVATQIGATNAFSYDLQAACSSFL
YGMSTASAYVASGKYKKVLLIGADKMSSIIDYTDRTTCIIFGDGGGAVLFEPNEEGLGLQ
DEFLRSDGIGRDFLRIEAGGSLMPASEETVANKKHYVFQDGKTVFKFAVSNMADVSERIM
QRNNLSHDDVSWLVAHQANKRIIDATARRMGLDDSKVLMNIARYGNTTSATLPLLLSDFE
KQFKKGDNLIFAAFGGGFTWGSIYLKWAYNA
>KECLDBNJ_00287 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLKEIQNLIKFVAKSGASEVKLEMDDVKITIRTGEDSKGETTILQQVPMMGSAMPQQAA
PAAQPAAPAPAPVAPEAEKPKADDSDKYITVKSPIIGTFYRKPAPDKPTFVEVGASIKEG
DVLCVIEAMKLFNEIESEVSGKIVKVLVDDSSPVEFDQPLFLVDPA
>KECLDBNJ_00288 Biotin carboxylase
MFKKILIANRGEIALRVIRTCKEMGIKTVAVYSTADAESLHVRFADEAVCIGPAPSSESY
LKIANIMAAAEITNADAIHPGYGFLSENARFSKICQEHDVKFIGASPDMISKMGDKATAK
ATMKAAGVPCVPGSDGIIEDFESCERIAEETGYPVMLKATAGGGGKGMRAVWKKEDLRKA
WDSARQEASASFGNDGMYMEKLIEEPRHIEIQVVGDSNGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELREKMGAAAVRAAEFIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVVDYDLIREQILVAAGVAISGKNYYPQLHSIECRINAEDPYNNFRPSPGKITNLHAPG
GHGVRIDTHVYSGYSIVPNYDSMIAKLITTAQTREEAINKMKRALDEFVIEGIKTTIPFH
RQLMDDPAYISGNYTTAFMDDFKMNPPVEE
>KECLDBNJ_00289 hypothetical protein
MQEPYSNLSYWEYKSWLADVDFTIVGSGITGLNCALQLRKRFPEAKILILERGSLPQGAS
TKNAGFACFGSVSELLSDLERHSEDEVLKLVKMRVEGLKVLRETLGDRAIDFQKCGGYEL
FLNTNLELFENCLSQIEYLNELLAPVFEKPVFSSVANRFHFKNVQDRLLFNAEEGAIDTG
KMMQGLLQKALRQNILILNNWTVTGFETLSNSVEVRANSISFKTKKLFIATNGFAAHLGI
TQVQPARNQVLVTKPIPDLKIKGTFHLDKGYTYFRNIDNRILLGGGRNLDLTGEQTDALG
TSAIIQAHLEKKLSQIILPQTQVEIDYRWSGILGVGAQKKPILKPLSEHVFCGVRLGGMG
VAIGSQIGKELADLLDPPKNMKV
>KECLDBNJ_00290 Fe(3+) ions import ATP-binding protein FbpC 2
MLKVDITDFGYTEKTVLKNLDFTVEKGKHISILGESGCGKSTLLKIIYGLLHVENGTVFW
NDIELLGPNFNLVPGEPFIKYLAQDFDLMPYISVADNIGKHLSRRFMRQREERINELLEV
VDMTAFADVHVKLLSGGQKQRVALARAIAKEPELLLLDEPFSHIDNFRRNALRRNLYAYL
KKENITCITATHDSEEALSFSDEIKMMREGQFIQTATPEALFENPKNAYVASFFGDVNTL
ELDGEKHLIMPHQLEVSESETGLKATVIKSYFKGSYYLVEAEAQGQKIYFNTVDDLDKDT
FVYLKLKL
>KECLDBNJ_00291 Prolyl endopeptidase
MKKIAYVGALTILFSACETNEKKSPEMAVTYPETKKVDTVDTYFGTEVPDPYRWLEDDRS
AETEAWVKAENKATFGYLDKIPFKDEIKQKLEKIWNYEKIGAPFKEGDYTYFYKNDGLQN
QYVIYRYKTGEDPSTAEVFLDPNTFAEDGTVSLGGLSFSDNGKLAAYSISEGGSDWRKVL
VMDAETKEITEDTLVDIKFSGISWRENDGFYYSSYDKPDGSELSAKTDQHKVYYHKLNTA
QKEDKLIFGGTPEQKHRYIGAGTTEDNKYLILSASNATSGNKLYIKDLSKPNADFVAIVD
TEETNTSVIENVGSKLYIVTDKDAPNRKIVTVDAANPTPENWEDFIPETENVLSPSTGGG
YFFAEYMVDAVSQVKQYDYEGKLVREVELPGIGSAGGFGAKKEDKELYYSFTNYTTPGSI
YKYDIKSGASELFRKPAINFDPENYESKQVFYTSKDGTKVPMIITFKKGLELNGKNPTIL
YGYGGFNISLTPSFSITNAIWMEMGGVYAVPNLRGGGEYGKEWHDAGTKMQKQNVFDDFI
AAAEYLISENYTSSDYLAVRGGSNGGLLVGATMTQRPDLMKVALPAVGVMDMLRYHTFTA
GAGWAYDYGTSEDSKEMFEYIKGYSPVHNVKAGTEYPATLVTTGDHDDRVVPAHSFKFAA
ELQEKQAGDAPVLIRIETDAGHGAGTPVSKQIEQTADIFAFTLYNMGFDVLPEKTKSEIK
G
>KECLDBNJ_00292 Aspartate-semialdehyde dehydrogenase
MKVAVVGATGMVGHVMLQVLAERNFPITELIPVASARSVGKTVTYKDKEYTISSMEDAIA
ARPDIAIFSAGGGTSLEFAPKFAEVGTTVVDNSSAWRMDPDKKLIVPEINASELEDSDKI
IANPNCSTIQMVLALAPLHKKYKIKRLVISTYQSITGTGVKAVQQLENEYKGEQGDMAYA
YPIHRNAIPACDVFTENGYTKEEMKLVNETQKILGDNTIAVTATAVRIPVVGGHSEAINV
QFENDFDLAEVRQLLQAQDGVTVQDNPDTNTYPMPIYAEGKNDVFVGRIRRDFSQENTLN
MWVVADNLRKGAATNAVQIAEYLAAKELV
>KECLDBNJ_00293 Large-conductance mechanosensitive channel
MAFFKDFKAFLMKGDIVALATAVIIGGAFNKIVGSLVKDVIMPVIGVIMGGKNVNNLFFS
LDGGEYETVDAAIEAGGAIMTYGNFLQAVIDFIIIGFVIFWLLKGYEKTKKKEEPKPAAP
KGPTQEELLIEIRDELRKK
>KECLDBNJ_00294 Alanine racemase 1
MPHTVLEIDLNALSHNYDYLRSKLEPDVKMLAVVKAYAYGSESVAVARKLEEKGIDYFAV
AYTPEGVALRDAGIKTPILVLHPQIENFDQVIEHKLEPSIYSFRVLKAFTEIAESKGLKD
YPIHIKFNTGLNRLGFKDVNEKDILEQLHATEALKVKSLFSHLVASEDLNERTFTQQQID
AFESNAKHMIAGLGYTPMLHQSNTSAIINYPQAQFDMVRTGIGLYGYGNIQAEDLKLKPV
ATLKTVISQIHDIAIGETVGYNRAHTAAKLGRSATLPIGHADGISRAYGKGRGYVMIKGK
KAPIIGNVCMDMIMVDVTKIDCEEGDEVIIFGKDASAVALTARIKSIPYELITAISQRVQ
RKIIE
>KECLDBNJ_00295 Thymidine kinase
MFLENTVNHKEQFGWIEVICGSMFSGKTEELIRRLKRAKFAKQKVEIFKPAIDTRYDDEL
VISHDANEIRSTPVPAAANIPILADGCDVIGIDEAQFFDEEIVKVCNDLANRGIRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTRTGNLAQFSYRKATSDDLVLLGETEEYEP
LSRSAYYKAMLRERLKTIEVKDPEELKNPKTKD
>KECLDBNJ_00296 hypothetical protein
MKKKLKSDLVSLAHKILKLDSESDYETLKIEAQKIYEALSILAYVEAHFDTAKPTIGKAE
IIKALEEEDSEVIAESIQEIQQEQVEETPAEAPQKEETELERIARIAAANEELFERLRTP
QETQPKAEDPEPKKQKEPKINQASLHEPVIEKIKDIVAQMPPEADAIEAMFQQITQKPDV
VKNDKDEIGEYGRIAEFEDDAKPQESKPRKLNDRISRGLSFGLNDRIAFIKHLFNGSDTD
YNRVLSQLNTANSEEEAFTLIDQMVKPDYNNWDGKEMYETRFKELVARKFDS
>KECLDBNJ_00297 Ribosomal RNA small subunit methyltransferase I
MGKLFLVPTPIGNLEDMTFRAVKVLQEADLILAEDTRTSGKLLKHFEITTQMHSHHMHNE
HKTVEGLVDRIKNGQTLALISDAGTPAISDPGFLLTRACVEAGMEVDCLPGATAFVPALV
NSGLPNDKFVFEGFLPVKKGRQTRFLLLAEEERTMIFYESPHKLVKTLKNMVEFFGEDRS
ISVSREISKLHEETVRGTAAEVLKHFEAKAPKGEIVIIVGGKPKG
>KECLDBNJ_00298 hypothetical protein
MSAKKITFINQNEPWRLAVPAVGFVLFLVGMLALKETALGMVIQPLGMLLMFVPHFIPFK
LKNYVRFTRRMISFKLEKGGSYHYRFSQIKYVEAYEDRLVIYTSRKKSEKVRIKGYAKAD
LNRLLDLLQPETEHTAETV
>KECLDBNJ_00299 hypothetical protein
MQRIKFYKTLSTSNLLILGVVLLAMGFSSYKILFSETEDVSTYVIINSLVSVLPVIIYSY
RKQKAHWVQYDQKRINLQLAGVQQIIKRKAISKIKVNGKSIEILFKASPGLVLDLESYAT
EDVLFFEKILKNNYS
>KECLDBNJ_00300 hypothetical protein
MHIKLLVSFLFFSVLSFAQGVAFKKVNEFYLKGDTRVIGNTILGDHPTRAYVRPKGLNDR
TEMVYVDVDKNAATFSSSSATLTMPKDATIKYAGLYWVATYPGERGKQRVRNDRVEYKLN
KKRSKPFDLVKLQLPNSKTYHSIQGEVLYDGMRDEVIELQNAAPYVCYSEITSLLKSQKA
SSGTYTLANVTALEGYMYGGSSAGWMLYIIYEDAQAPLQYFTGYHGFSFINPNNSQEIDF
NNFRVVESGAVKTSIMLAALEGDLVLPGDAVSIFSEQENEYVALQSRVRYANNFFNSSIT
VKDKKYVNRTPKSSNTLGFDLAKVDIPNENNALIANDATQVKLQFKTESDRLFVFFNAFQ
TEISPAYYQRVVVEGKADSIPSKMPVEIPQTKQDIVEEPLPQTESPSETEDDVQQYGKDG
EPIPSKSLSTIKNSTRSQVLQDMLASKPLTVPGMDQGYYIVNHVFAQGDNALRWQDKMKL
RGLTPVRFVNPANNYHYIYIDYSTDPDALYERLVDFRKLNDFEDAWIIKVNL
>KECLDBNJ_00301 Single-stranded-DNA-specific exonuclease RecJ
MRWTLKPIPETEKINAFAKQLSIPEKIAQLLIQRGIDTYDKAKAFFRPSLDDLHDPFLMK
DMDKAVARLNLAIAQNENILVYGDYDVDGTTSVALMSSYLQTLHPQVATYIPDRYAEGYG
VSYTGIDYAHDNDITLIVALDCGVKAIEKIAYAKKLGIDFIICDHHRPGAEIPEAVAVLD
PKREDCDYPYKELCGCGVGFKLIQAMEQEKGLPVKTLVPYLDLVATAIGADIVPITGENR
VLAFYGLDVINTLPRTGIQALIENVNKDELTITDVVFIIAPRINAAGRIKHGLHAVELLT
EQDYERAQEMASGIEGFNAERKDLDKVITQEALLQIETNKEENRKTTVVFQENWHKGVIG
IVASRLTETYYRPTLVFTKSGEKLAASARSVKGFDVYDALEQCSEHIEQFGGHKYAAGLT
LAEHQYEGFKNKFEEVVGSSIDERLLIPEITIDAELELDDITLKFYRILRQFAPYGPGNM
TPVFMSKNLTDTGFGKCVGADETHLKCSVKQNDSQTIGAIGFGLGSKCDLIQHRKPFKAA
YSLDINEWNGTKSIQLKLRDLQE
>KECLDBNJ_00302 hypothetical protein
MKHIDIIYRNDSGISFYWKTSKYSSIKAQVVFRDMGFYFSLDQLKEFAHLTQDTLAQYTC
KDCPAPRECRSLLLKTPSPDVDLAVSRDEVYEIQDLLDQTILRMEMHFFMQTALN
>KECLDBNJ_00303 UDP-2,3-diacylglucosamine hydrolase
MSQPIVQINIPEGKKVYFSSDNHLGAPTAEASKPREKKFIAWLSAIETDAAAIFLLGDLF
DFWFEYKTVVPKGFVRVLGKLAQLRDKGIPIYFFVGNHDLWMKDYFKTELDIPVFHEPRI
FNLNNKRFFIGHGDGLGPGDKGYKRMKKVFTSPFFQWLFRWVHPDIGVRVAQHLSVKNKL
ISGEDDQNFLGEENEWLAAYAKRKLESAHYDYFIFGHRHLPMEIQVGPQSTYYNLGDWIS
HYTYGVFDGSSFQLKEYSI
>KECLDBNJ_00304 hypothetical protein
MSNIRITKQFSFETGHALYGYDGKCRNVHGHSYKLSVTVIGTPISDNNNVKFGMVIDFGD
LKKIVKSEIVDVFDHATVFNKNTPHVELAKELSDRGHNVLLVDYQPTSEMMVIDFAEKIK
KHLPENITLFSLKLQETDTSFAEWYAADNA
>KECLDBNJ_00305 PKHD-type hydroxylase YbiX
MNTQLFEQVDFIENPAYEQVITDLLECNYAIVDDFFSSEEIDELRQSLKEVYEADSFKKA
AIGNKFNEETDKTIRGDFIKWINEAEARPKERLFFEKINDLVAYLNRTCFLGILQTEFHY
AIYPKGTFYKRHLDTFQNDDRRKLSMVCYLNDDSWVASNGGELTIYLPEGNGERALDIIP
KPGRVVIFESQILEHEVKPVLASERLSITGWLKTR
>KECLDBNJ_00306 DNA damage-inducible protein F
MTATNPLSFKNINRLAVPALLAGIAEPILSATDAAVVGNVPDNATEVLAAVGIVGSFLSA
LIWILGQTRSALQAIIAQYYGADKIDEISTLPAQAIYFNILLSIVILVTTLPFIEAIFSL
YNASGLILDYCVQYYSIRVWGFPLTLFTFAVFGIFRGLQNTFWPMVVALIGAGVNILLDF
ILVYGIEGYIPTMQIEGAAYASLGAQALMAVLSLILVLIKTDVSLKLRFPIHSELWRLVG
MALNLFVRTIALNLALYLANSFATDYGASYIAAQTILINIWLFSAFFIDGYAAAGNILAG
RFLGAKDYTSLWEMSKKLSKYSLIIAGGLMLISAFLYEPIGLIFSKEPEVIARFTALFFV
VILMQPLNALAFIFDGIFKGMGEMKYLRNVLMAATFLGFVPAIFIGDYFGLKLYAVWIAF
SVWMMVRSGALILKFRKRFKPKVA
>KECLDBNJ_00307 dTDP-fucosamine acetyltransferase
MIRPATSADVDEILQVTAACAKAMIANGIYQWNEHYPSRAAFEEDIKRNELYIYTQQERI
LGTVVVSTLKDEIYEEITWLTPADARCIYIHRLAVHPEAQGQGIAQQMMQFAEDYAREHG
FASVRLDTFSKNERNNIFYTKRGYQKLDPVYFPKQSEFPFYCYELVL
>KECLDBNJ_00309 hypothetical protein
MNPKPVLISILIYLPSVLLAVFYVPTALDKLLDPNQTGKIVQSSAVMLTAGVFILTGLTL
FYYHKTMLWGVTMLSLYMLPVIGIHLYKGKPAEVLMLILMSTLFAAYLRKPEVFAKN
>KECLDBNJ_00310 Chloride/fluoride channel protein
MNLDKFKRSLTSIEQIPSLVYLFKWIIICTLIGAIAGSISAFFLLSLEWATNYREAHLWI
IALLPIGGFLVGLSYHLYGNSVVKGNNLLLEEFHTPKKVIPFKMAPLVLFGTIATHLFGG
SAGREGTAVQIGGAVADQFTKIFKLNNQDRKILLIAGISAGFASVFGTPLAGGIFALEVL
ILGRIRLDAIVPSFLAAVLSDYFCQAWNVGHTHYHINSIAEMNPANLLWALLAGIIFGLV
SMLFSKSTHFWSSQFKKYIKYPPLRPFIGGVVIVIAVYLIGTTKYIGLGVPTIVDSFSEA
MNKYDFLVKVLFTSFTLGAGFKGGEVTPLFYIGATLGNALIWFIPLPMDLLAGMGFVAVF
AGATNTPIACTIMGIELFGIESGVFIAIACSTAYLFSGHSGVYAAQIIGSPKNKNYDSEK
GSLLSEISEKRANKEL
>KECLDBNJ_00311 hypothetical protein
METQTNNLNTYRILYIIKGIFNLLGAVFFIGYGFFMNFIFTEVNQNAETPFDMSTFFGII
CGIGFVVSLIFGIVTLMGAKYIGEARNYTFVLIVAILNCLTGILGILLGIFSIIEINKPH
VKALFDQNK
>KECLDBNJ_00312 Aminopeptidase N
MNKMKNKIAAALLIIGGYAGINAQEVQSNQSLFDEFLDHNGNEFRTATGKPGEDYWQNET
DYKIEATLDDQAHTITGKLTLEYTNNSPQELDFIWMHLEQNRFTADSRGTLTTPINGNRY
NGDVDGGYTITNLEAKVKRSSSSKHIITDTRMQVFFDEPIPADGGKATVSMNFTYKIPVK
GMDRMGRLETENGTIYALAQWFPRAAVLDDIEGWNIEPYLGAGEFYLDYGDYDFKITAPY
NHIVVASGALQNERDVLSATLRDRMEKAKNSDETVMLVKADELDDMSLRAKQSGTLTWHF
KMENTRDVAFASSKAFIWDAAKINLPSGKKALAQSVYPIESDGQGAWARSTEYTKHSIEN
NSEMWFEYPYPVAVNVAADIGGMEYPGLSFCSWKSTGAGLWGVTDHEFGHNWFPMIVGTN
ERRYAWMDEGFNTFINHYSSNKFNNGEYPSNLNQTRNALGWYTNPNREGIDTYPDVTNLR
NLGMIAYAKPAQGLFMLREYILGPERFDNAFKSYIKTWAYKHPQPRDFFNHMENVAGENL
AWFFKGWFYGTGNIDLAVNSVRQYQGNYVISLSNNGDIPMPVKMQVTFADDTTQMVELPV
EIWQRGNDWNYLLETNKEVSKVVIDPSKMLPDVNFSNDSWPVAQYQN
>KECLDBNJ_00313 hypothetical protein
MTTFIDEVISNLLEASPSLTQTVVVLPSRRAGNFFLQSLQQQLGDTVCFLPQVISIEELV
EEISGLTSASQTQLQIELYHIYQTVYEGETPDPFLNFLGWGQTLLGDFNEIDRHLIDTKP
FFNYLSAVKELNHWSTDQDSQLISSYLTFWKSINKYYDRFQEHLLRLGLGYQGMLYRKAV
ENLEPFLNANQSQNYLFCGFNALNAAEQKIITRFLEIPSTKIYWDIDPYFLDDDNHVASK
FIKSYMKRWATNAKQNLFFPKSESNFNTTKTITATGVAQNIGQVKYVGQLLNSLDATALN
NTAVILGDEALLLPLLNSLPESVTHLNVTMGLPLEQVAQAAFFESWFQMHINRQNNGYYY
KDILAVLDQQYAILLLDKERELLKKSITEKNLIYLDPLQLLGDQASAHCELLFKDWVNDS
SIAIQQILSSIQELKELLYPKKNWLQLEFLYAFLEVFTRLKNLNETYAYLGDLKTLKQFY
KEILSQETLDFKGDPYKGLQIMGVLESRVLDFEHIIITSLNEGTFPSGKSQNSFIPFDLK
IESKLPTYREKDAIYAYHFFRILQRAASVNLIYNNEAGGLNSGEKSRFLLQLATDTSANY
NFVDQSAAASVAVEPVALKQIKKTAEIIEALKKHAASGFSPSALSTYIRNPIDFYYNYVL
GIEELDAVEDVIAHNTLGTVVHETLDQLYQPYLNTQLSKPILQAIRAKVDAEVSRQFEKN
YNAVNIKTGKNLIIFNVAKQFVHNFLNQELQRIEAGDEIIIKALEAKHVAQLTPEIKLKG
TVDRIDAVNGITRILDYKTGKVEKGQLVIKDWDELITDYKKQSKAFQVLCYGLMIAKNEG
LPANCEAGIISFKNLKSGFLKLTEDRNTILSQELLQTFEKYLLQLIDELLNIDMPFMEKE
V
>KECLDBNJ_00314 Outer membrane porin F
MLLDFNKLHLLQLTLKFYLLNMKNLTKLFLFAVLTFVGLNTANAQDKNNPWAVSIGVNAV
DTYPVYPPDNRPLTGGFPDEFYNVEDHWNILPSVSTLYVGRYIGAGFALGVRGSINKIDK
MGDLPVDDLAYYSVDGMFSYSFRDALFGEGGWFDPYLGGGGGYVFIGDMPSHGTLNGTVG
LKIWLSDNINLDLSSTYKHAMMPGTYYTRHMQHIVGVGFAFGGTDTDGDGIYDDEDECPE
TPGLEEFNGCPDTDGDGIKDSEDACPEVAGLPEFNGCPDSDGDGIPDNEDNCPDVAGPAA
TNGCPDADGDGVIDSEDECPNEAGPASNNGCPFADRDGDGVADKDDKCPDVAGPASNDGC
PEVDAAVLETLNGEAGRILFDTDKATIRKSSYETLTRIANIVKEYPTASFEVEGHADSRA
SNAYNMDLSERRAQSVVDYLTSKEGVNGSQLSIKAYGEEKPIAPNTTAAGMQLNRRVKLT
LK
>KECLDBNJ_00315 Outer membrane porin F
MIRNTSLLLILVALFVGSQNATAQDENNPWYLSVGVNAVDTYPVWPGERPTTGGFPNEFY
NVDDHWNILPSISTIYVGRYIGSGFTFGVRGSLNKIEKLGDAPANDLAYYAVDGMFSYSF
KDLLFGEDSWFDPYLGGGGGYVFIGDMPSHGTLNGTAGLKLWLSDNFNINLSSTYKHAME
GYYTRHMQHTAGIGFSFGGTDTDGDGIYDDVDECPDTPGLEEFNGCPDTDGDGIKDSEDE
CPEVAGLPEFNGCPDSDGDGIADPEDECPDVAGIAALNGCPDADGDGVKDSEDECPNEAG
PAENNGCPYEDQDNDGVLDKDDECPTVPGTVANNGCPEVTVEVLEEINVQVRTVLFDLNK
ATIRAESYETLNAVAETMKEYPNTRFLIEGHTDSQGSDAYNLKLSDERAASVKDYLIKQG
LPASRLSSEGFGESKPVATNATAAGRQQNRRVELSLIE
>KECLDBNJ_00316 ATP-dependent helicase/nuclease subunit A
MQDHHSISVYNASAGAGKTFALVKNYLTILFSSKNDFKYRRILAITFTNKAVAEMKLRII
ENLEAFAQSDEQIEEDAMFNAIVEATGLAPGEIQLKAKRILKHIVQDYASFDVVTIDNFT
HRIIRTFAYDLKIPQNFEVELNTQDILEQAVDNLIDKAGRDQLITNVLLDFAFEKIDNDK
SWDISRDFYEISKLLLSENDREYLKKIQSRSLEDFAALKKHFNTSRNEKSKVIVDKAQRL
LQFIAENQLEHAHFTRKYLPNALSKIAEADFNVNFDTKWVQNLGQEPLYTKTQKEGIKAI
LDQIAPEITLQFNAIKALILQLKLEDELYKKITPLSVLQSIQQEVEKIKSENNLVLISDF
NELIHKNIANQPTPFIYERLGERYENYFIDEFQDTSVLQWSNIVPLIDNAVSTAQTETLA
NSLMIVGDPKQAIYRWRGGEAEQFISLSKNENNPFQNQDKKTITLPHNYRSYDQVIDFNN
SFFTQVANNFAYPEYKELYLSGNSQKHNHRKGGYVSINFIEADKAEEAKPLYLDEVVKTV
NSCVENGFQLHELCILVRRNAEGIEIAQRLQEETIPVISSESLLLKQSPQVQFIVDVLHY
TVEPNSRAISIKILTYLAENYFDLADSHTFYKNHLESNGPTLFNQIFPDTSRFDFEQCAL
LPIYESAEYIIRAFDLHQKGGAYLQFFLDAVYDFSQKHSGGIPEFITWWDRKQDKLSIST
PPASQAVQIMTIHKSKGLEFPVVIYPFAHTELYDNRSDSYNWYLPEPEEFLGFEALLIGQ
KAELTSYNEQTAMLYEYKRMQQQLDTINVLYVALTRSVEQLHIITKTSKTKGEPKNFSDL
FIQFLEQQQLFDSNQNVYTFGSASRVSQPKRLKQDAAFLDLISTAKEDHNLAIVTQAEAL
WDFERKEAITFGNIIHELMADIKSEADIEIAIKRALTRGMIENDQKETLQAQLHRLISDL
KAHGFFDNRHTVLNERAIHLEGQMIRPDRVEIDKDNNVWLLDYKTGSPNVSHKDQLELYV
KSLQKMGLHIKKKAIIYLNAPESVVLI
>KECLDBNJ_00317 Superoxide dismutase [Mn]
MSFQLPELKYAKDALEPHIDSKTMEIHHDKHHAGYTSKLNAAIEGTDLEGKTIENILINL
DMTNSAVRNNGGGFYNHSLFWEVMSPDGGGEPTGELAEAIDAAFGSFEAFKDKFSSAAGT
QFGSGWAWLCVHEGGKVEVCSTPNQDNPLMPEVGCGGTPILGIDVWEHAYYLKYQNQRPA
YIDAFFNVINWKEVSSRYAQNK
>KECLDBNJ_00318 hypothetical protein
MVDLVQIKKVDFFHLFYLHQIGVASINLNNRIPKLAENNSYSSSTKPTLRAVFTPCDFPP
F
>KECLDBNJ_00319 Amidophosphoribosyltransferase
MSDAIKHECGISVIRLLKPLEYYKEKYGTAFYGVNKMYLMMEKQHNRGQDGAGFASIKLD
MEPGERYISRQRSIAQQPIQDIFAQINSRINQVLLENPEYADDVALQKRHVPYVGELLLG
HVRYGTFGKNSVESVHPFLRQNNWMHRNLIVAGNFNMTNVFKLFNKLVELGQHPKEKADT
ITVMEKIGHFLDDAVAKIYKKLKKEGFSKFEASPQIAERLNIAKILKKASKEWDGGYAMA
GLLGHGDAFVLRDPSGIRPAYYYKDDEVVVVASERPVIQTVFNAKFEDVKELDPGHAMII
KKSGKTSIEKIQEPHERKACSFERIYFSRGSDAEIYQERKELGRLLMPEVLKHIDHDTQN
SVFSYIPNTAETSFYGMVEAAQAELDKQKAAEILERRNELDKQGLEAILSKKLRTEKIAI
KDVKLRTFITEDSSRDDLVAHVYDVTYGVVKESDNLVIIDDSIVRGTTLKKSIIKMLSRL
NPKKIVVVSSAPQIRYPDCYGIDMAKLQDFIAFRAAIDLLKENGKEEIINQVYEKCVSQV
DFEDVDVINYVKEIYEPFTDEEISNKIAELLKDETIAPEVSVIYQKVSDLHKACPKNLGD
WYFTGDYPTVGGNRVVNRAFINYVEGNLKRAY
>KECLDBNJ_00320 putative sugar kinase YdjH
MHKLVIVGTCAFDEIESPFGKTGKILGGAGTFIGLAASNFEVDQAIVSVVGSDFPQEYID
LLKNRGINMEGLEVVKDGKTFFWKGRYHNDLNSRDTLITELNTLADFNPVVPEAYKNAEI
VMLGNLHPLVQLSVLDQMNKKPKLAILDTMNFWMDSALEDLKKVIARVDVITINDEEARQ
LSGEYSLVTAAQKISAMGPRFVVIKKGEHGALLFEKDKIFFAPALPLEEVFDPTGAGDTF
AGGFAGYLTSTGDLSFENMKRAIIHGSNLASFCVEKFGTERMQNLKPEEIEKRLLKFKAL
TQFNLDL
>KECLDBNJ_00321 Ribonuclease H
MAKKEKFYVVWQGKKPGIYTSWKDCKAMIDGFAGAQYKSFPTFPEAKAAYNKDYKDVKGS
AKKKKTLTAEEKAKYGEPNLYSIAVDAASSGNPGIMEYRGVDTQTGKQLFHQGPFKQGTN
NIGEFLALVHGLALLKQKNSDRIIYSDSRIAIGWVKKKKCNTKLSENSKNKDVYDLVRRA
ENWLQNNTYKTVIVKWETKAWGEIPADFGRK
>KECLDBNJ_00322 Phosphoribosylglycinamide formyltransferase
MKRIIIFASGSGSNAQRITEFFQDRKDAQVVQILSNKSTAKVLERANNLKISAFSFNRSA
FYETDQVLNLIKATQPDLIVLAGFLWLFPKNIIAAYPGKIINIHPALLPAYGGKGMYGAN
VHQAVVAAGEKESGITIHEVTAEYDKGAVIFQAKTQLEPEETAASLAAKIHELEYEHFPR
VIAEILENQ
>KECLDBNJ_00323 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVAEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEEAK
>KECLDBNJ_00324 3-oxoacyl-[acyl-carrier-protein] synthase 2
MELKRVVVTGLGALTPIGNNIEEYWEGLSTGKSGCAPITYFDTEKFKTKFACELKNFNAQ
DYFDRKEARKLDRFAQYALVSSDQAIKDAGIDLDVVDKFRVGVIWGAGIGGLETFQDEVI
NFAEGDGTPRFNPFFIPKMIADIAPGNISIKHGFMGPNYTTVSACASSANALIDALNYIR
LGHCDIIVTGGSEAAVTKAGMGGFNAMHALSTRNEDPATASRPFDATRDGFVLGEGAGAL
ILEEYEHAKARGAKIYAEVVGGGMSSDAHHMTAPHPDGIGVERVMLNCLRDANIKPEEVD
AINTHGTSTPLGDVAELKAITKVFGEHAKDININSTKSMTGHLLGAAGAIEAIASILAME
HGLVPPTINHTTVDENIDSSLNLTLNKAQKREVNVAMSNTFGFGGHNACVLFKKYSE
>KECLDBNJ_00325 Ribonuclease 3
MSVIRNIFTSRPEKGGNFFVTVKKIIGFKPNTLRHYEEAFTHRSMALQDDKGNAFNYERL
EFLGDAMLGAVIAAYLFDEVGKGDEGYLTKMRSKVVSREHLNELGRDLGLLGLVKSAIPK
ENFGANIHGNLFEALVGAIYQDKGYNYAKKFINKRVIDPYVDIEKLEGRVISYKSLLIEW
CQKEKHSFDFDTYEDTGQDVVRHFSVRLSIDEKQVAKARATSKKKAEEKAAKRAYYVFQN
KIDVHRFN
>KECLDBNJ_00326 hypothetical protein
MAALKLLLDDAFDFDFSLIAIHCSLEDYRLAFMANKYAGLRLKSSKDVDFYIKKLKYSFA
SFKYDDQKNYQTFTLIANKYKLKQAQRLVTSDLFADSESEHYKTVNLIPEVKNADYLLKI
ESDNGKSPRLKLLAHLNQIPQIITAYEVEVSALKSKQNLIFE
>KECLDBNJ_00327 Pyruvate kinase
MSNTKKTKIVATLGPATSKKEVLHNMIKAGVDVFRINFSHADYDAVKERIDMIRSLSEEF
GYNTAILADLQGPKLRVGIMKDEVVVNPGDKIIFSTKEEFEGTKERVYMNYQHFPRDVNK
GERILLDDGKLIFEVLKTDNENEVETVVIQGGPLKSRKGVNLPNTNISLPALTEKDVEDA
IFAINQKVDWIALSFVRHEGDLIQLQDLIKEHSEHKIPIISKIEKPEAVKNIDKIVAYSD
GLMVARGDLGVEVPAEEVPLIQKQLVLAAKKARIPVIIATQMMETMIDSLTPTRAEVNDV
ANSVMDGADAVMLSGETSVGKYPVQVIERMASILAKVEDSPLIKVPQNPPHIRTKRYITK
SICYHAALMANDIDAKAITTLTNSGYTAFQISAWRPNAHILVFTSNRNILSQLNLLWGVK
AFYYDKFVSTDETVRDVNRIARDSGYLNVGDMVISLAAMPISEKGMVNTLRVREIQGN
>KECLDBNJ_00328 DNA polymerase IV
MEEPPKSRKIIHVDMDAFYASVEQLDNPDLRGKPVAVGGGSERGVVSAASYEARIFGVRS
AMAGALARKLCPDLIFVKTRFDRYREISGQIREVFHEYTDLVEPLSLDEAYLDVTENKKG
NPSATLIAKEIRAKIKEKTGLNASAGISINKFIAKVASDVNKPNGQKTVNPEEVLPFLEA
LDIRKFYGVGKVTAEKMYQLGIFTGNDLKSKSLEFLQEKFGKSGNHYYNVVRGIHLSEVK
PHRIRKSLGAERTFSENISSEIFMLERLENIAEEIERRLKKSNVAGKTVTLKIKYSDFTL
KTRSKTLQYYIRSKEVIYETAKELLYQEKMENSVRLLGITLANLNTEDKREKPAEKKEIA
VQLKFEF
>KECLDBNJ_00329 hypothetical protein
MKKTALILGITGVTGTLLARHLFDDDRFEKVISFHRRKSGLQHPKLEEHIVDMFELDKHQ
DRFKADVVFCCVGTTQSKTSDKETYKKIDYGIPLAAAKLCVANGIERLVVISALGADPES
RVFYNKTKGEMERDVLAEKPNNTYLLEPALLAAEREEKRTSEKIGIMVFKVLNPFLIGPL
KKFRSIKPEALVKTMLYLSFNSYENARITSDEIQKIADNA
>KECLDBNJ_00330 Inorganic triphosphatase
MLEIERKFLVKTDAFKAEAFREHVIKQGYLNSNPERAVRVRIKDDSGFLTIKGKSDDTGT
TRFEWEKEISREEAEALLKLCEPGVISKVRFLVKARQHTFEVDEFFEENQGLYLAEIELQ
SATEDFNKPDWLGEEVTGDPRYYNSQLSKNPFVLWK
>KECLDBNJ_00331 hypothetical protein
MEVKIMVKIGLLSLLLWACKEKEAEKEVPVLKKENSKTVYELQAELKEAGYLTMNYVDEK
TRDTVIMQQYFIAFLKSGPNRDQPKDVADSLQNLHLEHLGRMYELGYADISGPFGDDGEI
RGITIYNTPTQQMADSLANLDPMVQAGRLQIEIHPWWAAKGFPLR
>KECLDBNJ_00332 Outer membrane protein OprM
MKKQLIYRLLLIASVPMLLASCFAAKEYERPQELIDETYYRTDAIKQDSTNMAVVSWKEL
FSDPTLQSYIETGLENNIDIRVAVQQILAAEAYFKQGKAGYFPTLDATAQLTHQELSSNS
QFGGLFSSLDQYELSGSLSWEADIWGKIRSNKRAYGAQYLQTVEAHKAVKTQLVAMIASS
YYQLLALDEQLRVTEETIETRSSSLETTKALKEAGNVTEVGVKQTEAQLYTAQALRIDLL
NQIRLLENSFSILLAQQPGAITRGSLREQRIETPLKTGVPSQLLSNRPDVRASEFALINA
FELTNVARSSFYPSLTLSATGGLQALQLDQLFDTNSLFATLIGGLTQPIFNRRAIKTQYE
VAQAQQEQARLQFKQALLTASQEVSDALYTYQASTEKLEVKRNEFESYNTATEYSEELLN
NGLANYLEVLTARENALNSSLDLIDTRLTQLQSVVDLYEALGGGWQ
>KECLDBNJ_00333 Efflux pump membrane transporter BepE
MLKTFIERPVLSTVISIIIVILGVLGLTSLPVEQYPDIAPPTVQVTATYTGASAETILES
VIIPIEEQINGVEGMDYITSTATNNGTAEITVYFDQDTDPDIDAVNVQNRVALASPLLPQ
EVTQAGVVTQKRQTGSLMFMSMYSTNPEYDATFINNYLNINVVPAFKRINGVGDVNVFSQ
QDYAMRIWLKPDRLKAYNLVPADVTAALNEQSLEAAAGTLGQNNGETFSYTIKYPGRYKE
EGQYQDIIIKALDNGQFLRLKDVADIQLDAQTYSASSQTKGYPSVSFAIYQTKGSNAQEI
IETVMGELETIEANLPEGLEVFIPYNTNEFLEASVEKVAHTLIEAFILVFIVVFIFLQDF
RSTLIPAIAVPVSIVGTFFFLNLFGYSINLLTLFALVLAIGIVVDDAIVVVEAVHAKIDE
GAKSAKSATTTAMHEISGAIISITLVMAAVFIPVTFITGPTGVFYEQFGITLIVAIIISA
INALTLSPALCALFLKAHDEEEEHKKKSFLQRFYDKFNKGFDATIKRYGSSLQFLYKRKW
ITFAMLILAGVGIYWSATTTRTGFVPNEDRGVLFIDLSLAPGSSLDRTNEAVTDLYNKIK
DVPGIEGVSTVAGRGLISGQGSNNALGFIKLNDFSERGEDSLSVDAITAKLFGIAAGYPD
ANIIFFAPPSIPGFSISSGVEVNLLDRASGSITDLDQANQEFMGNIMAHPEVQYAQSSFN
TRYPQYQMDINVPLAKQTGVAISDIFSSLQGYIGGIYAADFSRFGKQYRVYIQAYPDYRA
DTDDLNSMYIRTSAGDMTPLSEYVSFERVYGPQAVTRFNLFNSTKVNVSMNPGYSSGDGI
SIVEAEAAKLANNYDIAYSGLTREEVSAGSQTIVVFLLCVVFVYFLLSAQYESYLLPLAV
ILSLPLGIFGAFFSTKVMGLENNIYFQIALIMLVGLLAKNAILIVEFAIQRRKNGESIVD
SAIDGAKARLRPILMTSFAFILGLMPLVLATGVGAEGNRSIGTGAVGGLLIGTLLGVFVI
PILYIMFQWLQEKISGTPTQTEETH
>KECLDBNJ_00334 Multidrug/solvent efflux pump periplasmic linker protein MepA
MKKRIFNYLIPALLGVLVTTSCGEDKSSGEGQAQAQQAQKLPVISIPQQTLTGYSSYPAS
IEGIVNSGVRAKIQGYISNVLVDEGAKVRKGQALFKLETQSLSQDANAARANVNAAQVEV
DKLKPLVDKGIISNVQLETAKAQLEQAKSNYESIAANISYATVKSPVDGYVGAIPYREGA
LVGPTDTTPLTTVADIEQVYAFFSMNESEYLNFIQKTEGATLQEKIENFPEVTLVLANGK
EYEQKGKIQTVTAQVDRTTGTVSFRAIFDNPNQLITNGNSGTLKIPIEYRDVPVVPLNST
FEQQGKIIAYKVSDDNKAQTAEIITRATIGNLYVVESGVQAGDKIIAKGANKVRPGTALE
PQEVPFDSIAKPVEKLFQ
>KECLDBNJ_00335 HTH-type transcriptional regulator MmpR5
MELEALNEEKQLLIERLGVHIEKKDNIPPLAARIVSTLILTGKKGCTFEELVTNLQASKS
TVSTHLNNLQHLKTITYYTVCGDRKKYFIMNPNSMIIHMGEMLDTWEKEKHLHIAIMNYK
EKINQVDPENIDLHFDLEFHLDYLNYLEQASESLKRIRERLLEKNKQ
>KECLDBNJ_00336 Penicillin-binding protein 1C
MLLVVFTLWLFALPKPLFNTPTATVVTSAEGQLMGARIAQDGQWRFPPIDEVPPRFETCI
LNFEDAYFYKHPGFNAVSMAKAFWQNLTTSKRRGGSTITQQVIRLSRNNPDRTYFEKLLE
TFLATRLEAGYSKKEILNFYASQAPFGGNVVGLQSASWRYFGIEPSELSWGQAAALAVLP
NAPALVFPGKNELIFEAKRNRLLKKLNKEGIIDATTYELAIAESLPGKPLELPDIASHFT
ERLAREHQGERINSTLQFNLQKRVNQITEEAHYRLNQNQIHNLAVLILDVNTREVLSYVG
NAPTTKEHANYVDIISSNRSTGSTLKPFLYAALMGEGQLLPHSLVADVPTSINGYNPQNF
DQSYQGAVPASQALARSLNVPAVTLLQEYGLQKFYNKLHQLHFKTIKRPADYYGLSLILG
GAESNLWDLTNAYAGLAATLNHFNNTSSEYPQQAFQEPVYIQDSNYDYGEKMPNPEVLDA
GAIYKTLEALKEVNRPQGSKNWEFFTDAQPLAWKTGTSYGFKDAWAVGVTPKYAIGVWVG
NADGEGRPGITGVEAAAPILFDVLNLLPNASWFETPYDELVEASVCTQSGNLAGLYCPET
TTEWIPKNGTRTMACSYHKQVILNEARSLQVNANCYPIGKLIAEPWFDLPTVWEYYYAPL
HPEYKTLPPFAPGCSPEEQAVMAFIFPKKGEQILLPKDFSGTQEVVFKLAHRDPDITVYW
YLDGIYVGSTTTFHELSMALKPGKYTISATDAQGNTQAQTLEIRPA
>KECLDBNJ_00337 putative lipoprotein YfhM
MKTTKFLYIALVFISVLSCTKTKPEPDNIFRFKEYIAFNTFGEVSIASPIRVVLAQPTDQ
YQNNQEIPSEYLIINPKTEGSFYIENGSTLLFKPEEPLRPDTEYSVTLKLSRFFEDIDPE
YKNYTFGFKTITPNFKLNLGNLQSYSKEWQYLTGSVETSDQVDATLASQLVRASQEGKNL
HIDWPNEQQNGTFFNFTIDSIHRKKENSQIRIAWDGEPIESTTQGQSTLNIPGQAQFTVV
DVVSALSPESAITVNFSDPLMMEQNFEGLVQLDSLTNLRYEVQGNVLNIYPKQPVSGTLD
LTLNRGIKNAEGAALQATYAQKISFQQLKPQVRLLSKGSILPASMKTPLYFEAVNLSAVD
VRVIKVFEDNMLQYLQESNLNSTSTYDLQRVGRRVAKKTIPLINNSIGQTGLWKAYAVDL
SELFKADPGAMYRVEFSFDQKYSLYPCSDDAEEITRSKEDIYLEESYEDYYKTNLDNEEE
EREERYWDNELYSWRNRVYNWEEEDNPCHPAYYNEERFAQTNIIGSDLGLIVKESDNGSY
DFVTSNLLTAAPEIGVDIRIYNYQQQLIKNLKTDLKGFASFKSDKNAAFVVAQQRNNFAY
AKLDDGNALSLSNFNIAGTQLQKGLRGFIYTERGVHRPGDSIHLSFVLNDIANPLPKEHP
VKLEVTDARGKLVQRTLLSSTLTNKNVSGGSSHGFYYFPIPTQSTDPTGNWHATISVGGV
QFSKTLRIATVKPNRLKIALDFNSEILSTKEPLTGSISAQWLHGAAARNLKAELTTTLTA
TEASFKNYEQYRFIDPVRKFSEVELPLLKDKTLDANGKLNFNQKIELSNKAPGMLKANFL
TKVFEGGGDFSVDVFSKTIAPYTHFVGLKAPEPQKYDAYFTDEDIQFDLVNLTETGKPSP
NRSLQVQLFKMEWRWWYSRGYDNLSRYDNTSVYKPVQDFEVTTNAKGKATAKINVPEKDG
GRYLLRVIDKESGHATGLITYFYRNWSNAPSANAESAKMLIFNADKEQYTVGEEAVIKFP
SAEAGNALVSLENGTEVLSKQWVKTTKEETVVRIPITKAMAPNVYVHISLLQPHAQTLND
RPIRLYGVIPLLVEDPQTVLRPQLSMPQELKPETDYTIKVSEASNKEMTYTLAVVDEGLL
DLTRFATPDIHKAFYARQALGVKTFDIYDYVIGAYSGSVDNIYAIGGGDMAAGAKNRKAQ
RFKPVVQFLGPFHLEAGKTASHKLHMPNYVGSVRTMLIAGDNTTGAYGTTEKTTPVRKPL
MVLASIPRRLAPGEQLTLPVTVFAMDDKVKQATITVKSSSALKAIGSKSKTITFSQPGET
MVNFEFEVLEAQAPQRFEIVAKGGGEQASYEVTLDVENPNPISQKATYYTLEPDAKLSVD
FTPFGVAGSNGATLEFSTLPQIDFTKRLQYLIDYPYGCAEQTTSSGFPQLYLASIFDLET
SQNQETVKNIKATLDRLGMLQNPSGGVSYWPGERESDAWATSYAGHFILEAQKQGYAPPI
TFLSNWLNYQKNAAKQWRNVATAYNSSLTQAYRLYTLALAGQPELAAMNRLRESGELNND
SRWRLAAAYALAGKKQVAQELVNNASLDFATKRELQYTYGSVLRNKAMALETMVLLNDTR
QNELANSIAKELNAATWHSTQTTAFALLSLSKMLIANGGKTINVTAADQTLSSAKGFARK
ALKVTEGKNTLTIKNKESNRVYVSLIQQGQLPLGKELASQNNLILNTQFLDGNGKKIDVS
NLRQATGITAKITVTNPTLNAVDNVALSQIFPSGWEIVNTSFTSLNGGASGQARYKDIRD
DRVNFYFDLKPNATRTFTVDLNASFLGTYYLPGTQVEAMYDRDYFARSKGQWVEVKQ
>KECLDBNJ_00338 hypothetical protein
MRLNLSYKIRVDKTNNEEIHLIIDEMHSFALVIDKVHF
>KECLDBNJ_00339 hypothetical protein
MRTFTTNLLAITFAIFLTSCSQDEELMTTNDEATLEVSADLTVEDAFAQEILVEVNKHRS
SIGLSELAFNNDSKVKAIEHSKYMATKNEISHDNFFQRSDYLKAKGAARVSENVAYGYRS
AQEVVAAWLKSESHKEAIEGNFTHSGLSVVKNEKGIAFFTQIFITK
>KECLDBNJ_00340 hypothetical protein
MELTEDQSYYAVIFTSIQTENTSGYAEMASKMETLAQEQPGYLGMEHARSELGITISYWK
TEAAIAGWKNQVDHLVAQQTGKDKWYSKYSVRVCKVEREYHFNTEN
>KECLDBNJ_00341 Isoaspartyl peptidase
MKSLLTVLLLSFLCFACKQENAPQTTVKPTPQQQEFAIIIHGGAGTILKKNMTDSMEQAY
KAKLTEAIKTGYEILKNGGNSLEAVQRTINVMEDSPLFNSAKGAVFTHDGKNELDASIMD
GATLNAGAVAGVTTVRNPINLAYEVMTNSEHVMLSGKGAETFAKEKGIELVDPSYFFTQN
RYDALQRALDREKQDSLSKATAFYDPYIKDEKFGTVGCVALDKNGNIAAGTSTGGMSNKR
YNRIGDSPIIGSGTYANNATCGVSSTGWGEYFIRGQVAYDISAQMEYAEKSLSEATANVI
QEKLTKLGGTGGIVALDHYGNPSMEFNTEGMYRAYMNDQGELTLGIYKENEN
>KECLDBNJ_00342 3-hydroxyanthranilate 3,4-dioxygenase
MAIAKPFNLIQWVEENRDLLKPPVGNKNLYKDADDYIVMVVAGPNARKDYHYNETEELFY
QLEGEIEVHVQDEGEKRKMKLGPGDMYLHPAKVPHSPVRKAGSIGLVVERKRADLYGKDG
LLWFCDNCNHKLYEVYFPLNDIEKDFLKHFKVFYGSEELRTCDNCGTMMEADARFVE
>KECLDBNJ_00343 3,6-anhydro-alpha-L-galactose dehydrogenase
MAHITDNAAIAETLKALEITSENAGTSTGLQTSNSGKLITSVSPVDGKNIASVTQTTPEE
YEQVVQTAAEAFKVWRVIPAPQRGEVVRQFNEELRRLKEPLGKLVSYEMGKSYQEGLGEV
QEMIDICDFAVGLSRQLHGLTMHSERPGHRMYEQYHPLGIVGIISAFNFPVAVWSWNTAL
AWVCGDVCIWKPSEKTPLTGIACQKIAARVFAKNNLPEGISCLINGDYTVGELMTKDERV
PLVSATGSTRMGKQVAQTVGARLGKSLLELGGNNAIIVTPDSDLKMTVIGAVFGAVGTAG
QRCTSTRRLIIHESIYDKVKNAIVDAYGQLRIGNPLDENNHVGPVIDKDAVKNYQNALTK
VVEEGGKILVEGGVLEGEGYESGCYVKPAIAEAENHYEIVQHETFAPVLYLMKYSGEVEN
AIELQNGVRQGLSSAIMTNNLREAERFLSVAGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKVYMRRQTNTINYTTELPLAQGIKFDL
>KECLDBNJ_00344 hypothetical protein
MTEPSIQKSELKKACKNCGAELKYKPGTTTITCEYCGNQEQIALETDPIKELPLRQFLQE
KGAQANSEEISILHCKNCGANQHVEENYKSLHCVYCGTPLIREDAKTEQWILPGAVLPFQ
LTQQEAILRFKKWVNGLWWAPNDLKKATLDPQFTKGLYLPYWTFDAQLYGQYSGARGDYY
YETQSYKDSKGRRQTRRVRKTRWIPISGNISGFVDDTLINASKQHTGKVPRGVALWNLKK
LQSFESSFLAGFVTEKYTIPLKDGHLEAQEEMRRIADTWARRDIGGDEQRVNTLNINLEE
ETFKHILLPVYISAYRYKGNEYSFFVNGENGSISGKRPYSFWKIFFAVLAGILLFGLVYL
FSK
>KECLDBNJ_00345 hypothetical protein
MGIFDKIKEKLSHEFIDIIEWLDYTPDTIAHRFERYQNEIKNNAKLIVREGQTAVFVNEG
QLADVFTPGTYTLNTQNLPILTTLKGWKYGFDSPFKAEVYFVNTHLFTDEKWGTKNPITL
SDDRFGLVEIRAFGTYAFKISDAGTFIKDIVGTDNNFTNFEINEHLKSLIATRFTDTVGE
ANLPIELYAANTTELSETCKEVMQPEFTSVGISLEKFYIENVSMPEELKKEIFEYSRIDK
LDLDKLTKFKTAKAIEAAANNEGGTAGAGMGMGMGFALAQQMGNAMSKPQAQQPQAAATP
PPMPVATQYYYAQNNAQQGPVSFDQLQALFASRAINRNSLIWKQGMSEWKALQEIEELKP
FLGGNTPPPLPGQ
>KECLDBNJ_00346 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MTRTLAIGDIHGGLRALKQILERAKTTQDDLLIFLGDYVDGWSESAQTVSFLIELSKTHN
CIFMRGNHDDLTYQWLRDNTKNDTWLNHGGRSTLKSYEDLSRETKEKHIEFYKNLKDYHI
DKQNRMFVHAGFQNRNGPEFEHYSTAFYWDRTFWEMAVSLDKRINKEDPEYPMRLQYHKE
IFIGHTPVTRIARDEPTQMANVWNVDTGAAFKGKLSIIDADTKEFWQSDPVYTLYPNEEG
RNG
>KECLDBNJ_00347 hypothetical protein
MINKRLLIKNLLAHNDENSFYDKKRKVDISTKEGKAKFLKHVCALSNSNPKNNSYIVIGV
EDETNEILGVPFFDDSKIQNLVNAYLTNPPLISYENIPFPHLPSDQVIGLVTIRPINKLT
ALKKNIWKYWGGTAFFRDGSISMPKIFQSEILDVNSEIVATIEKHAHNSIELTLDGVIDF
INVRHADLFTQYKVFKEQFVVCWAGNKKEVKGNTYFSRVDIELINEQVRLFYSALDEVSI
TMTSDHFTILEYVLLGLQNEYKYYPLEELTINFNENGSYTIDSNLVFEPPQFDRKLLYHI
YNNNNTILKKVLANKELNKGELEDLYNLPATYLICYLNGFEPALDKLESIRPYLRKYGTK
LYNAYKENIRILRKVKYNS
>KECLDBNJ_00348 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MTTKTAFITGATSGIGAATATYFAKNGINLILCGRRQERLDALKAELQNQVNVHTLTFDV
RNKKDVANAINGLPEAFQHIDILINNAGNAHGLDPIQEGNTEDWDAMLDINVKGLLYVSD
MIIPKMIAQNSGHIINIGSTAGKEVYPKGNVYCASKHAVDAINQGMRIDLNGHNIRVGAV
NPGMVETEFSEVRFKGDSEKADKVYQGFKPLQAEDIADIIHFVVTRPYHVNIADLVVMSV
DQASSTVVNKQ
>KECLDBNJ_00349 hypothetical protein
MEDTSASVDIGAINEKIEKESAFVKILTMEMNKVIVGQKHMVERLLIGLLGRGHILLEGV
PGLAKTLAINTLSQAVHGSFSRIQFTPDLLPADVVGTLIYNMKLNDFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQEKQVTIGDETFKLDRPFLVMATQNPVEQEGTYPLPEAQVD
RFMLKTVIDYPKHAEEQLIIRANLKGSFEKVNPVVSIEQILRAQEAVKEVYMDEKIEKYI
LDIIFATRYPENYKLADLKPLISFGSSPRGSINLATASKCYAFIKGRGYVIPEDVRAVVH
DVLRHRIGITYEAEAENVTTVEIINKIVNEIEVP
>KECLDBNJ_00350 hypothetical protein
MDTKELLKKVRKIEIKTRRLSDHIFGGEYHSTFKGRGMTFSEVRQYQFGDDVRNIDWNVT
ARYNEPFVKVFEEERELTMMLVADVSGSEFFGTDQQLKSEVVTEIAATLAFSALQNNDKI
GLILFSDGIELYIPPKKGKSHVLRIIRELLEFKPKSKKTDVAQALKFLSGVMKKKAIVFV
LSDFIADDYQDTMKIAAKRHDITGIRIYDQREEEIPSLGIVQMEDEETGELLLVNTTSRK
VRNSYAKYYRDRVAYYKDSFTRSGAGVIDVRTDESYVKKLLGYFKRRG
>KECLDBNJ_00351 hypothetical protein
MNSNLNNHIPKSSFYNIRAFAFAMIIAFLTTLNVQAQQVKGAVDTTSIRIGEQITYEFQV
EADSTDLVLFPEGQTFQPLEMIEAYQVDTSYAGAKMNLIKRYGLTQFDSGSYTIPRQLVS
INQQPFYTDSVAIEVNNVVIDTTKQGLYDIKDIVAVERATSKFWEYLLYFLLLAAVIGGF
LFFIIRRSRKKAAAEQKLPPFEQALFSLKQLDEEYKEPARGIDERDATKAYYSKLTDIVR
RYLDEEVYDRSMESTSSELIERLMLEKEEGKIDLSKETILKLDQILKRADLTKFARTSPG
AGQAEADRIVAEEIVKETKEAIPPPTEEELMRDAAYREALAKRRKRKLILTSIIGVFGIL
VIATGILIATKGFDFVKDNFIGHPSKDLLESDWVRSEYGYPPVIISTPRVLERNEIALPD
SLKQQMDMSTFTYGSLIDDFYVVVNNTRFGGKNEANLEASAQGFISTIEANGAKNLIVKT
EKYTTPEGTEGLRVYGTGDFPETLNKDEFSKGEYEMLLFTAPGVLQQILVAHREDDTYAK
EMSARIINSVELQKTVPTDVK
>KECLDBNJ_00352 hypothetical protein
MLSNFEFQSPEFFWLFLLLPVVAVWYFFKRNKITAQVKLSSLKGFKAGSGLLAKFRPVLF
VLRLLALACLITALARPRNVDVSTRTNTTRGIDIVIAIDVSASMLARDLKPNRLEALKEV
ASQFIADRPSDRIGLVEYAGESYTRTPITSDKSIVLSSLNDIEYNSIIEGGTAIGMGLAT
SVNRLKDSKAKSKVIILMTDGVNNAGFIEPTTASELAQEFGIKVYTIGLGTNGTALSPVA
LRPDGSFQYGSIPVEIDETLLQEIADKTGGLYFRATDNESLEEIYAEINKLEKTDVEEFK
YTNYEEKFRPLVILAGLLLLFELLLRYTVFRSFV
>KECLDBNJ_00353 hypothetical protein
MYLLEEKIWFWALLAIPVVVLLYFAVTLWKRSAQKRFVTNRELLEKLTPQRSVFKPVLKL
IVLCLALACMAVALVNPKIGTKLETVKREGVDVVFAVDVSKSMDAEDIAPSRIDKAKQLV
TQIINNLGSDRVGIIAYAGSAYPQLPITTDYSSAKMFLNSMNTDMLSSQGTAIRDAIELA
KTYYNDEEQTNRVLVIISDGEDHAGEVASIAESATEQGIRIFTIGVGSETGDRIPIKRNG
VVQSYKKDQNGETVITKLDPATLQEIAAEADGEYINGNSTQEVVDKMASALNQMDKKEFE
AKQFADFKDQFQWFVAAALFLLIIDVFLLERKTAWVRKLNLFNENKSKS
>KECLDBNJ_00354 hypothetical protein
MMKNFINNLLSLTFILVTGVVFAQSEKPDPAILEAQDFVAEANDEFASNEFAAAESAYRK
AVAKDPANTAAKYNMGNNYYRNKKYGEGMNRYIQAAEVAQTKAEKHKAFHNLGNAFYQQK
DFKKAVEAYKNALRNDPTDEETRYNLALAKKEEEKNGGGGGDDENQDQNQDQNEDQKDQD
GEGDDKESDDGKPKDQDDQGDEKKDQGDQNKDDKGKPEDKDGDQKDQGKDGDKEKQQQQP
QPGQGQLSPQQVKSLLEAMKNEENKVQDKINAQKVKGAKVKTDKDW
>KECLDBNJ_00355 hypothetical protein
MKMKLKFLLIVLFAGFSAWSQVEFDAVVSKQRLGVNERLRVDFEMNQDGDNFRPPSFQGF
TVVGGPNQSISKQWINGKASFSKTFSYFLQPNATGTLKIGQAEIEIDGTVYKTIPIEITV
TGAVEKPKDPNDPVAAAEDNVHLVAEVSKNDPYLNEAFTVVYKLYVSRETAVNGWNELDA
PKFADFWSQSIDEKQFKVYDGSYDGKPYRYVILRRTLLYPQKTGELTIEPLALNINVEAP
TNRRDIFGMRITRPAKITVTAPTRKVNVKALPEDGKPESFTGAVGNFDFEVTASKTTLDA
QEALDLTLTAKGNGNLKLFTLPKPKLPSALEVYEPENEQDVRVSLNGMAGSNNARYTIVP
QQKGSYPIPPIRFSYFDPATEQYKTLSSDEIVIDVENGPATLATSDKADKIPVEETKQFA
YIKSDAKLKSMNQDRFFGSTTFWSLLATPVVLIPLAILFGRKRRAYQNDVKGNRLRKADK
LARKYLGDAKKSLGDQTAFYLALEKCLHNYLKARLNIQTSEMSKERISQLLQDRGVTVET
TAAFLKLLESCEFARYTPSSSDAMQHDYEQASRVISEIDKQL
>KECLDBNJ_00356 hypothetical protein
MKTMIRSSYRFVVLVLFMAALSLNAQTPQQLFETGNSQYAQNNFEEAIKNYEKVLDAGYE
SAAVYYNLANANYKLNRIAPSVYNYEKALELKPNDKEIKNNLEFAQNMTIDAITPLPENT
FKRWWNQLLNMFSLDGWAIVTVVCLLLFAVSLIIYYFGKTTTLKRGFFTMAFVALGFGLL
SLTLAFQAQSNENNKQFAIVFSAEAEIKSEPSMASEEAFVLHEGTKVRVLETEGDWQMIR
LADGKEGWIPTTDIKIL
>KECLDBNJ_00357 Carbonic anhydrase 2
MDIKKIFENNKEWVQERLSAEPEYFKKLSQGQSPKILYIGCSDSRVSSEELMGVGPGDVF
VHRNIANMVPNTDLNSMSVINYAVEHLEVEHVVVCGHYYCGGVKAAMQSSDLGLLNPWLR
NIRDVYRIHKEELSLIEDEDERYKKFVELNVQEQCVNVIKTADVQKAIRKRNLSVHGWVF
DIHSGKLIDLKIDFDAILENIMEIYRLDD
>KECLDBNJ_00358 hypothetical protein
MNYLDIIIGILLLLGLFKGLKNGLLIEVASLIALILGIYGAIHFSYYAVDFLTEKVDWSI
QAINLAAFAVTFIIIVLVITLAGRILTKAASLAMLGIVNRILGAAFGLLKSAFILSVILM
FLAAMTSSLNLIDEETRESSILYSLIKPIAPAVLPSILEEVKEFRENEDTDKSKIELQSV
>KECLDBNJ_00359 hypothetical protein
MLVQVLFDLDYICAMARDEQLKERWEQVVSKLSARFADGEVLDLDAIIYLIGVQELGKPD
KRFKKDDKINLMHIAICRLLEPFGYYRFDYQDEDGWPHYEIIEPLPALKAGEQSLLMKEA
IVQYFLEKELVQ
>KECLDBNJ_00360 hypothetical protein
MLLSILQELFPNDTGPIYKETIAGRFPVEPFNTYSNLIFLFIVVYFGIKIYRKPKKQWFL
MIALPFIFIGYVGGTLYHGLRNEEAWLLLDWVPIRGLSFAALLYFIFKWQDTWGKRLIFV
LSIGLAFIGLRYLPLPKQLEHSIGYLISALSILIPILGYLIKTKWRYAKSALTAFVIFGF
AVLFRVLDNRLDFEFFWMGTHWLWHIFGGTAVFFILQYIYRDNKAQAADIS
>KECLDBNJ_00361 Phenylalanine--tRNA ligase alpha subunit
MLDKIKELISEAEAFTASSLDEVEAFRIKFLGKKGLFNQYFSEFKNIPNEQKKAFGQTMN
QLKTTVQDKIDTLKSGLESAEEQSVYGDLTRPGDAITLGSRHPISIVKNQIIDIFSRIGF
DVSEGPEIEDDWHNFTALNLPEHHPARDMQDTFFIQTNPDVLLRTHTSSVQVRYMEANKP
PIRTISPGRVFRNEAISARSHCFFHQVEGLYIDKDVSFADLKQTLQHFTTEMFGKSKIRL
RPSYFPFTEPSAEVDVYWGLETETDYRMTKGTGWLEIMGCGMVDPNVLENCGIDSKEYSG
FAFGMGIDRIALLLHQISDIRLLSENDLRFLNQFKSAL
>KECLDBNJ_00362 hypothetical protein
MKKYVVIAVLLIALALVAYLTFVIAAIKIIIGSIFLGIMAIAILALWIMWKVNDD
>KECLDBNJ_00363 hypothetical protein
MKKDIIIPEVEGVYVAAVKEFNETHRTNDWNAYLINDTGEPLEMVLIVSKGYSAKQTTSQ
MRHKLQTLPAKAFAKIEFIEDSVLKLTNEFAVTFFKNGKLFDKKFIFPANSIQDSKAGPL
PSMLKEGVLAE
>KECLDBNJ_00364 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MSLKFGVIGGGSWATAIVKMLTENLEEVGWYMRSVYALEHLKKEKHNPNYLSAVEFDTAH
LKLSNDINEIIAYADYLIFAVPSAFVGKELEKVTASFKGKIIFSAIKGIVPETGQIVGAH
FHHKYDIPFENIGVITGPCHAEEVALERLSYLTIACADEQHAQVVADHLKSWYINTTISD
DTIGTEYAAMLKNIYAIAAGIAHGLGYGDNFQSVLMSNAIREMKKFIKKVHKMKRNINDS
AYLGDLLVTGYSVFSRNRMFGNMIGKGYTVKSAQMEMSMVAEGYYAAESAFKINQELGAK
TPIINAVYNVLYKGKDPKSTFKKLTEKLT
>KECLDBNJ_00365 hypothetical protein
MRTIKLLSAYFLMLAVFTSCYTDVFIEDDLATPVAPLSSVLADYELWYVDIDQTQGNGSI
PFMDKAFTFSFLNGTVMANNNLAGIGDQGSGFGIEVGYYDVFDYDLDISHDIDGFYSFEV
SLLSNNAIELYNRYTNTSYVLIGYQRSNFDYDRLFYDNIHFFLQEYAVWEKVHTSLSGTS
NAFDAENYLQFLPANSGLYFRSSQDPRGSSTTNLYWDYSGIYEVNNVVNNAYLKTLTLDY
DYFANEYFELSILDDATIALYHPASGSEYRFRGRGYIQYKTPSEGKSRLKQSEIEQNIKA
IKALAL
>KECLDBNJ_00366 hypothetical protein
MGLFSFIKNAGAKIGIGKSTAEEAAEKKAEAAAAAAAATKKAEASLKETVADLGLEVEGL
DIKIDGETATVTGKAKDQATKEKVVLVVGNVDGIAQVDDQMSVEHKEPEAQFHTVVSGDT
LSKIAKKFYGNAMKYPVIFEANKPMLKDPDKIYPGQMLRIPNLD
>KECLDBNJ_00367 Nicotinate-nucleotide adenylyltransferase
MKIGLYFGTFNPVHIGHLIIANHFAEYSDLDKIWMVITPHNPFKKKKTLLDNNHRYQLVL
EAVEEYPKIEASTIEFNLPQPNYTSNTLAHLQEKYPQHEFCLIMGEDNLRTLHKWKNYEV
ILERHEIYVYPRIGEQETKPELLAHPNVHVVDAPVVEISSTAIRKAIKAGKNCRPLLPHS
VWIYIDQMNFYR
>KECLDBNJ_00368 Guanylate kinase
MADTGKLIVFSAPSGSGKTTIVRWLLEKKELNLEFSISAASREPRPTEKDGVDYYFLSLK
EFKRRIKEDEFLEWEEVYRDNFYGTLKSEVERIWKEGKHVIFDIDVVGGLDIKKLYPERT
LAVFVKPPSIEELKIRLKKRKTESEDRINMRVAKASIELATAPQFDYIIENNDLDTALAE
AYELVTKHINA
>KECLDBNJ_00369 hypothetical protein
MIKSMTGFGKSVTQLPTKKITIEIKSLNSKNQDLNARIPSFYREKELELRNLVAQRLERG
KIDFSLYVELNGEETSSSINADVVKQYMKQLREVTPDAADIELLKIATRLPDALKTERDE
IDDEEYKSILAGVEEALNAIDTYRVDEGKALKKDFELRIKNIATNLDEVITLDPERMTGV
RQRLTKAVSDLKTEVDENRFEQELTYYLEKYDITEEKVRLSNHLKYFQKSLDSADSNGKK
LAFISQEMGREINTIGSKSNYAPMQQVVVRMKDELEKIKEQLLNVL
>KECLDBNJ_00370 hypothetical protein
MNKKFIVPFVAAGLLFSCDTSEKKSEETTAPVEDTTAVEEEAPITDPEATEVWEPEPEVV
SFDENNVPSDAVVLFNGENLDAWESTKDSVVNAPWQINKDGSMTVVGGTGDIQTKESFGD
MQLHVEWQAPQVVEGEGQGRGNSGIFLQGLYEVQVLNSFENRTYSNGQATAIYKQSIPLV
NATKPTEQWQAYDIIYHQPEFDADGNKTKAATVTVLHNGVLVQDNTEIQGTTEYIGKPKN
PAHGEGPIKLQDHGNPVSFRNIWVRKL
>KECLDBNJ_00371 hypothetical protein
MKQLILSVALAMAFFTSCKEKAQEAKTEEVAVATTETTQPEDGEWEVLFDGTNLDKWHAY
NGEAPTQWEIVDDALVFTPAENRDGSENLVTNEAYTSFVLKMDWMISEGGNSGIMWAVEE
DPKYHEPYATGPEIQILDDERHPDTKAGPSHRSGALYDMIGAPEGIVNPAGEWNSYEITI
DYNTNQGIIVLNGEEVVTFPVKGEGWEDLVSNSKFASWEAFAKTDTGLIALQDHGHQVSF
KNIKIKKL
>KECLDBNJ_00372 Inosose dehydratase
MKTIKGPAVFLAQFMDDKEPFNSLDGLCKWASDLGYKGIQIPTWEGRLIDLKKAAESKTY
CDELKGKVQSYGLEITELSTHLQGQLVAVHPAYDEMFDNFAPDDYKNNPKKRQAWAVDQL
MSAAKASRNLGIDVHGTFSGSLLWHTFHPWPQRPPGLVEMGFKELANRWTPILNTFDEQG
VDVCYEVHPGEDIHDGVTFERFLEATGNHKRVNILYDPSHFVLQQLDYIEYIDNYHEFIK
MFHVKDSEFNPTGKKGAFGGYGDWRDRAGRYRSLGDGQIDFKTIFTKLTEYSCDVWAVME
WECCIKSPEQGAREGAPFIASHIIEATEKAFDDFAGAKTDEAKLKRILGL
>KECLDBNJ_00373 Glucose--fructose oxidoreductase
MGMVGGGQGSFIGDVHRRASRIDGMVDLVCGAFSSNAERSLKSAEALGVAPERAYKSFEE
MIEKEAELPEDERMDFVSIVTPNHMHFPPAKMALEHGFHVICDKPVTLSLEEAFDLQKVV
KQSGKVFALTHNYTGYPMVKQARLMIQNGELGDIRKVVVQYLQGWMSTAVEETEHKGASW
RVDPSKSGIGGALGDIGTHAENLTEYITGKKIVELAADLTSFGAGRVLDDDGNILLRLED
NAKGTLSISQIATGEENNLAIRVYGTKGSIAWGQENPNELTAYWLDKPKQIYTPGGNGTY
EASTEYTRVPPGHPEGYLEGFATIYRSFAKEVLSVKDGAAISERPDFPTIDDGLRGMQFI
YAAVASNDNNSAWVSLKE
>KECLDBNJ_00374 Putative nucleoside transporter YegT
MKPLVRFQLSLMMFLEFFIWGGWFVTLGTFLGNNLEASGAQSAMAFSTQSWGAIIAPFII
GLIADKFFNAERILGVLHLVGAFLMYQMSQTTDFAVFYPYVLGYMIAYMPTLALVNSVAF
RQMNNPSKDFGWIRVFGTIGWIVAGFIISLLGWDSQSGIQEGLLSNTFTMTAIASAFLGV
FSFLLPKTPPIKSDENQSILEKTGLSSVTMLKNKNFLIFFISSILICIPLAFYYQNTNPF
LTELQMENPTLKQSIGQISEVLFMLLIPVFLLRFGIKKTLLFGMLAWVIRYVLFAFGNAD
ELSFMLLIGIALHGVCYDFFFVSGQIYTDSKAGSSNKSAAQGLITLATYGVGMLIGFWVA
GQITDNYLVGETHDWKTIWLYPAAFAAAVFVFFLIAFKNEKIEYKGEKV
>KECLDBNJ_00375 hypothetical protein
MNVKLALTALFAVAVFSCKSEKKTEKNSNESVVVAQKQPFFKISLAQWSLNEAIRNGEMN
PLDFAEKAHEMGFEGIEYVSQLYTPMMETYDNDQVALDSILPKLKAKSAEFEVENVLIMV
DGEGNLAAESESERDQAVEDHKKWVDAAKYLGCHAIRVNLIGSPDREIWKNSAIDGLKKL
AEYGASQNIEVTVENHGGYSSDAALLMEVINAIDMDNCGTLPDFGNFCLERENGEMWGAP
CVKEYDKYKGIAELMPKALAVSAKTYDFNEAGEETSMDFTKILQTVKDAGYTDFIGVEYE
GENHTPEEGIMLTKELLINTAQNLK
>KECLDBNJ_00376 Fructose dehydrogenase large subunit
MSSIKPEEMYDAIVVGTGISGGWAAKELCENGLKTLVLERGRMVKHIEDYPTMNMDPWDF
KFKGQPTKEEEAKQFKQARTGYTTNKAHSHFFVNDLEHPYNETKRFDWMRGYHVGGRSIM
WGRQSYRLSDIDFEANKKEGIAVDWPVRYKDISPWYDKVEEYIGVSGENLGLPQLPDGNF
GPPMELNCVEEHLKKNMAQNYKDRLLTIGRTAHITYTDKTFEGRSACQYRNRCMRGCPFG
AYFSSNSSTLPAAERTGNMTLRPFSIVSEVIYDDNTKLATGVKVIDAETKEEMIFNSKVV
FLCASAIASASILMQSKSDRFPNGLGNDSGELGHNIMDHHFNVGASAKFDGFEDQYYKGR
RANGLYIPRFRNVGGDSDQKNFKRGYGYQGGASRGDWTEAISEMKYGEDLKKAISEPGGW
TIGINAFGECLPYHENKMTLDYDKLDKWGLPTITFDAEWKENEWEMRKDMKQQAAEMLTN
AGFKDVQTYDNPGAPGLGIHEMGTARMGRDPKTSVLNGNNQVHTVPNVYVTDGSFMTSAS
CVNPSLTYMAFTARAANHAAEQFKNGKFA
>KECLDBNJ_00377 hypothetical protein
MKRRQVLKNLGLGAGYVIAAPAVFNILQSCKSEPKSDWEPVFMNAANGYALTQVLDVILP
KTDTPGASELNIAQFIDSYMDEVAGDKQREEFKAGANAFALSFKENFDKELEDGDAEDFE
QAVAKYLGADEETRNGYLKRISETQDPEAPEADFDAHAGSYAYLNAVRDLGIWAWKNSEA
VGENVLWYDPIPGAYLGCISTEEAGGGKTMSL
>KECLDBNJ_00378 Hydroxypyruvate isomerase
MKRRSFIQKGALSGSFLALGGPELFAMQHRLAAMPKHHFNLNYAPHLGMFKNLAGDDPIA
QINFMADQGFTAFEDNEMRNRPVDMQNKIGAALQKHSMQMGVFVAHKIYWTAPNLTSGKQ
DLRAEFLADIEASIEVAKRVNAKWMTVVPGYVDMTQDINYQTAHVVESLRQASALLEPHG
LTMVLEPLNFFNHPGLFLKESPQAYQICKAVDSPACKILFDVYHQQIQEGNLIPNIDACW
EEIGYFQMGDNPGRKEPTTGEINYKNIFKHIHKKGFKGVLGMEHGNSMPGPKGEQAVIDA
YVSCDDFL
>KECLDBNJ_00379 hypothetical protein
MGKIQSSIKKLWDAFTNEHPEYRDNNIPPSFYFCDNEKDANTCAHLVLKRIKQATATSLW
WFETHKESLPEINDLNIVTDWDGNAVAVIKTTQIDLVPFNQVTSEFSKIEGEGDGSLAY
>KECLDBNJ_00380 Cytoplasmic trehalase
MVKSYSKIFVLLAMIFVSSCKNEQQDTAVSTTQFPDKDLNPIDRYGELLVAVQTNHVFAD
GKTFVDCEPKIPSEKILEKYQEQKEQPDFDLEAFVLEHFTLPVTPTSGFEADTTRTTEEH
INALWSYLKRDADSVENGSRIALPNAYIVPGGRFQEVYYWDSYFILLGLKEAGEIDLIEN
ILDNFAYQINTIGFIPNGNRTYYLGRSQPPFFAEMVNLLAEIKEEKSVYLKYHDVLEKEY
AFWMKGAQSINPSETEARVVKMPDGHVLNRYFSNTQTPRAESYFEDITTAQEADRDAHEV
YLNIAAACESGWDFSSRWFADPNKISTIQTTQIVPVDLNALMYNLEQTLAKVRRYADDVE
GAEQMVKAAASRKDAIDKWLWDATQQTYTDYDLKAEALSPILSLAMVYPLYFKVASPQQA
EHVATTLESQFLKPGGLVTSLINNKQQWDSPNGWPPHQWLAIRGLQTYGLNDLANEITSR
WLHLNDRVYKRTGKMLEKYNVIDTTLVAGGGEYPTQDGFGWTNGVYLDLKK
>KECLDBNJ_00381 Azurin
MKTLKITLLFALSLILVNCGDDKKKEEKETVKIGSNSSSTSKKSDENVTEVVLLATDMMQ
FDKNEIRVPAGKKVKLTLRHTGKQAVEVMGHNFVLLTQGTEIPAFGAKASAARDNAYIPQ
DTDAVIVHTKMLGGGQSDTIEFDPPAPGTYDFICSFPGHYSVMKGKFIVE
>KECLDBNJ_00382 hypothetical protein
MPIIASSYKPRVPFTNGHFNTIYAAKIRKIRGLTYERERIALSDGDFLDIDFSFAPERST
QKIAIIVHGLEGHAKRPYMQGTARILNSNGFDCASINLRGCSGEDNSKIRSYHSGASEDL
SDVVNYILTKQKYHQLFLCGFSLGGNLILKYLGENRNRPGCITAAVAVSTPVDLYDSLGA
LEQRKNWVYRWSFLKDLRKKYQAKLKVFPNELSKENHRKIKSLMLFDELYTAPANGFTDA
LDYYTKSSSRQFLPQIEVPTLLINALDDSFLNEKCYPTEEASQSELLFLETPAFGGHVGF
IENQEHTYCEHRTLQFFQKYLD
>KECLDBNJ_00383 hypothetical protein
MLIKRNISWKLIIRLTWRNLIFFLIYSLVIFYAYHDLGFEDIDIPFEPLTVIGIAVSFYL
GFKNSQSYDRFWEGRKIWGMIVNWSRTWGIRTLSLIKLDDAEAEKEIKRDLIYRHIAWLN
ALRVQLRQPRSWTLQEGRYVERLFDRHNERNIESNQAYQFVGHEEYDEIKKRVNPATHLI
KNQGLIVQRLRKDGVIDGFQEMQLQEALAKFYDFQGMCERIKNTPFPRQYGYFSKVFTWI
FVLLLPLGLLNIFENHVTDTVHPSQQISIMFLQMIPFTILIMWIFTTMEYVGDASEDPFE
GKANDVPMTALCRTIEIDLRDMLDEEDLPAGIEPKDDILY
>KECLDBNJ_00384 hypothetical protein
MYTKEFEIRWSDIDANRHLANSAYINFMSHTRMAFLMENGFGQREMAKHNIGPVVFYEHM
YYFKEVFAGNPVKVTLQLKGLSEDGMYFEFIHNFYDHKGRNFASCEMMGAWIDLKERKLI
GLPEALFVNLSSLSKTENFKVLTKEDTRKFGKKPKDLA
>KECLDBNJ_00385 hypothetical protein
MNQRVLALAAATGASTIYGINHTLAKGVMPVYIGAFGFILLRVLGASALFWLLSIFSKSE
KIDRADYWRFLGCAVFGMFVNMLAFFKGLSLSTPINSSVIITLSPVILLILSALFLKERI
GLTKIIGILIGMFGALVLVLFGAAEQPNAPNIPLGNLLFFVNGATYAVYLILVKPISNKY
STITLMKWLFLIGVLLNLPFTLTEFTAVDWLNLPAKAIWVMVFVVVGTTFSTYLLNLYAL
KTLKASTIGAFIYLQPVIAILFAVLVGADHLSWVRAGAAAFIFLGVYLSTRTKKTA
>KECLDBNJ_00386 Regulatory protein Spx
MKKIYYLSTCDTCTRIMNEIELPSAFIKQDIKTDPITEEQLDELYNLSESYEALFNKRAR
LYRERGLNNEKLEEGNYAELILEHYTFLKRPVIVNNDQIFIGNSKKTVAAAKEAIHP
>KECLDBNJ_00387 hypothetical protein
MEASIAYTLKITYKTRVILKNYLETIALEDLNKIPKGYNNNIFWNIAHLVATQQILVYKF
SEVPALVSDEIINKYRKGTKPEADATQAEVDEIKTLLFSTLEQTEEDYKAGKFKTYNTIT
TSMDSTLSNVDEAIAYNNFHEGIHLGSVLALRHAIGLV
>KECLDBNJ_00388 hypothetical protein
MLLLTIISISSCQKRTTPLTFKTETLKAETLDHCADGICPIIEIEKIKVFGREHFADTIN
NAVDQVLLNNLVIAPEEEPDIKTLDQALEHFISSYRVYKSDFPEAGTEYEINSTSQVSYN
GAQLLSIKFENYTYWGGAHGYGSTTYLNFDKDAETSLNNEALFKDYTGFLKLAETQFRNQ
KKLSAEENINSTGFYFENDVFALPNTIGFTENEMVLVYNPYEIASYADGQTILRFKFSEV
QEFLKLDL
>KECLDBNJ_00389 Cystathionine beta-lyase
MKFNTKTIHGGQHNTDPAYGSVMPPIYQTSTYAQSTPGGHKGFEYSRSGNPTRKALEDAL
ASLENGKFGLAFGSGLAAIDAVLKLFKPGDEIISTNDLYGGSYRLFTKIFEDFGLKFHFV
SMQDTSAIEAVISEKTKMIWVETPTNPMMNIINIEAVAQVAKKHKILLAVDNTFATPYLQ
QPLDLGADLVMHSVTKYLGGHSDLVMGGLVVNDKELADKLYFIQNASGAVCGPQDSFLAL
RGIKTLHVRMQRHCENGKAVAHYLKEHPKVDQVYWPGFENHPNHEIAKKQMKDFGGMVSF
TTKKDSLDGAVEVVEKLKVFTLAESLGGVESLAGHPASMTHASIPKEERQKTGIKDSLIR
LSVGIEDIDDLLEDLKQALG
>KECLDBNJ_00390 hypothetical protein
MNTKILFSVLIICLSIPFAGKAQLAFSNEVGVIAGPLLFQSDFGLRNNVDTNINNQGWGI
GIVHYFNFSYRADCNCYTRDRYFNDHFKLRSEADLHYTKFTHEGIESQKDTEEGRDLRDH
TGSSLVFELGMQLEYFPLSIRDFQAGGFRIAPYISLGAHYVGFNPSYESSQDVPGATPED
IYFDDFLVGDGGELGGISDASGNTWALTGSVGIRYKLTVLSDLNLELRYHKYYSNWVDGL
NPDPEFYPPNKYDDSIVWLNIGYIYYLNF
>KECLDBNJ_00391 NAD(P)-specific glutamate dehydrogenase
MTDSIKNFVDSVEKANPNEPEFIQAVQEVAETVIPFIENNPRYQGKKLLERMVEPERAIL
FRVPWVDDQGETQINKGYRIEFNSAIGPYKGGLRFHPSVNLSILKFLGFEQVFKNSLTSL
PMGGGKGGSDFNPRGKSDAEVMRFCQSFMTELYRHIGPNTDVPAGDIGVGGREIGYMFGQ
YKRIKNEFTGILTGKGLSYGGSKIRPEATGYGNVYFTKYMLNNVGEKLAGKTIVISGSGN
VAQYAAEKATQLDAKVVTLSDSDGFIYDEAGIDKEKLAFVMELKNERRGRIKEYIEKYPE
AEFHEGKAPWGIKCDIALPCATQNELDKEDAELLVKNGVMAVGEGANMPCTPDAVAVFLE
NKILFSPGKASNAGGVATSGLEMSQNSMRYNWSAEQVDKKLHEIMYDIHNACVEYGKQED
GFVDYVKGANIAGFVKVAEAMLAQGIV
>KECLDBNJ_00392 hypothetical protein
MFKKNPYLLLFLLNICCVFAQEYSEAWTAYFSYNQITALAEGNDKIFAAAQNSVFSYDLN
TNETQLYSTIQGLSGEAISAIHFSEATGILFVGYTSGLIDVVMPDESVTTLVAIRDKPAI
LPSEKMINSFDEHNNTLYIATGFGISLFDLSRLEFDDSYFIGNNGARLNIKQTAILEEYI
YAASPNGGLRRALKADDNLIDFQNWETLDPTGWEGIQTFAEALWGVKSDQSLQRFDGANF
NTQTTLDRLPVSFLASEDALTISLDSQILIYDASGNLTTTVAALADYPGSYTSAFTSQGQ
IYLGTDANGLLISSTANTTAALQVLPDGPLRNDPFSIEAAPGQLWVAYGDYSDTYNPFPL
KQRGLSHFVVDSGWYNLPFESLLETNSITNITYNPEDNAQVFMSSFNAGLLEIIEEVPLQ
LYDETNSGLSDIPFAPTDVRINGAAFDRNGTLWMTNSLVENALARKTGNQIDGISIASIL
PDFDAVNGYSELVIGRLGNIYFGSSNRGLIGYDPDANSFRLLNAERSNLPSDNVQSLAVD
NNGALWIGTSLGLRRLFSPAQMFENAEIQTQPIIIEESGSTVELLNDQVIRAIAVDGNNN
KWVGTVSSGVFYFSANGQETLQQFSTTNSPLPSNNIQDISIDEESGEVFFATPLGLVSFS
GSAVAPKETLENARVFPNPVRPSFTGSVTIDGLTENANVKITDLNGNLVYEEVSEGGSIQ
WDTTAFGRYRVASGVYFILITAEDAVETKIVKLMIIR
>KECLDBNJ_00393 DNA repair protein RecO
MLVTTKAIVISAIKYGEADLIVRCFTEEAGLKSYILRRILKSKKGKLRTAMFQPASQLEL
VAVHKDKGTLESIREAKVTQPYLSLHTDVLKSSVVLFLSEMLRNAIQEEEENRALYAFLE
HAFLWFDLHEQTANFHLLFLLELTKYLGFYPDTSELHHAHFNLETGIFEPVESFYSISEE
NLHTLKQLLGINFDALATVKLNQKRRADFVNMLLAYYELHLHGFKKPKSLAVLTALFN
>KECLDBNJ_00394 Colicin I receptor
MRLPLTLLLFCVFSLTLHAQTIKLLDKDTQAPVANAALYNTSKATYVVSDEEGNADVSAF
TKSETIFITHVSHITLKTTKAAIVAEGNVVYLDDNENQLNEVVLSVSKFEQESKDIAQKI
VSLDAEDVELKNPQTAADFLSQSGQVFVQKSQLGGGSPMIRGFSTNRLLLTVDGVRMNTA
IFRSGNLQNVINIDPFTIDQTEVILGPGSVVYGSDAVGGVMNFYTKKPAFSFEEGTAFSG
MALTRYATANNEKTGHIDFNIGAKKWAFLTSVSYSDFDDLRMGSHGPEDYLRPEYVVTQN
SVDTVVENDDPNVQTPTGFDMINLTQKVRYMPNSIWDFNLGLHYSNTSDYARYDRLTRTR
NGQLRSAEWYYGPQLWFMGNLQIDKKGNGDFYDDAKLTAAIQYFEESRNDRDFGATTLYT
TQEQVNAYSLDLDFTKKMGSNQLFYGLEYVYNKIGSYGKQTDINTGDQAATATRYPDDSS
WQSLAAYLSGQFNLAESLTLQTGVRYNHILIDATFDDNFYDFPFEKADVSFGNFTGNAGL
NWQTAENFNLKLNLGTAFRAPNIDDIGKIFDSEPGSVVVPNPDLKAEYAYNAELGAAWRI
DEKLRLDVATYYTHLNNALVRRDFSLNGETTVDYQGEPSNVQAIQNAASAEVYGVEAGLE
YLFTKNIKLTSQVTVTEGSQEEDDGSDAPLRHAAPLFGNTHLIYRMKRWKFDASAEYNGQ
FDYDELAPSQQGNAYLYALDADGNPYSPRWYTLNVYSEYQIAQNWKATAALENITDQRYR
PYSSGISAPGRNLIMALKYTF
>KECLDBNJ_00395 hypothetical protein
MKHLFFVVFFLVFAGCEISNERKIVSKETAINSEIKNEESFNRGFIKLNKQYYISQNTKS
ISNDELIQLGDIEPPYSLIKNRGNDTLIVIKKSDTLFFKLIDYSKDNQYDPTFKDLIRSL
FGDSIQ
>KECLDBNJ_00396 hypothetical protein
MKTLTAPKISLDLLQEILPTGQLVTHHKGDTLCTIHKKVKHLFWLIDGNLDFYTQQQNPQ
QEIQVAHCEIPFTTLGWNGFFTPERYTFSAKIASDQARFYKVPLKDFKADIPQVNSLLLT
IGQNNYHLLKNALCKQASLLQPRNFQIPKDEHYYVNASIEKSEIVQLMRRSPFLDQFSEL
HLGKLAKLAQRRDYEPNEIIYAQDNASEGLYILIHGEVAIKRIEGKVDISQRSISNSGFI
FGWSSLLNLPDICNAITTEKTAVYFINHLDLHQLLEEDDRLKKRFYHRLIWLIGNQINAA
FIRYTSLLGKHSIDAVYQLIENNRSRLTVNSGLHSVFHLLKDQTTKAFAYETLQNLVTQG
SSLERHIASLSLEFLKHDRREHQFKNALRNIYEAVAEKNPETSPQYKRKACAQATRETLK
QVMVHVEGLENLPEDSGHIFIYNHLLNHPFYTLNNQFQITLDSHFISVLLDDKYGEPGIR
TVRIAQGQEYGHQNYYENLGYINVYTKESELPEAAAKTSNRSIFYTAASEFLKNKKNLII
SPEGTSYTSEESPGAFKTGAFNLALNLKTEPLIVPIVLVNFDKRINDTLFYCNILKPFKM
SDHVAKNDPVLVKAFVEDYQKKYADYVAEAREKVKRLMTSNFSAVPEEEPPVMWANEIKR
LRRRVEKLKNQEDLYVFYGSSSVRLWVHMQEDLAPMHTLNLGFGGSTYAWCLHYFEEIFQ
DVNPSKLVLYAGENDITQGRTPLEVLADFKELIKAVKTKYPKVPLAVISLKPSVERAHLI
PQFMELNELLSEYVITGLDAQFINVFSQMISLDDKPNPELYMSDGLHLNKKGYAIWSEVI
KQALQKPV
>KECLDBNJ_00397 Esterase EstB
MNTFTTFMLLCFTLGALAQNRTFTAPLDTQPVTNAAIDARVDSIMIQAIEAKAFPGATLL
VAQSGNIIFNKTYGFHTYDSVQKVAPGDLYDLASVTKVTAALPAIMKLIDEGKLDLDEKF
STYWKPWKRRKDKRDLTLREILAHQAGLEPYIVFLNDVLKEDGSFKRRFVRSEKSRRFSV
ETYNGLFLNKRFVRKMYRKINRSEVSEEKKYKYSGLTFLLYPQIVENLTGIPYEQYVQEN
FYTPLGAKNLMFNPEKHHFPESRIIPTEEDSVYRKAYVKGWVHDENASLLGGVSGNAGLF
ATAEDLAKLMQMYVNMGVYNNKRYISEATLKEFTRVQYPENDNRRGLGFDKPYLNNAENA
LPDSYPNPEVSASSFGHSGFTGTFVWADPEHELVFVFLSNRVYPTRTHTAIYDLNVRPRL
MHVFYQELQLTK
>KECLDBNJ_00398 Isoleucine--tRNA ligase
MSTKFPEYKGLDLPKVAEEILAYWKENDIFEKSISTREGNEPYIFFEGPPSANGMPGIHH
VMARAIKDIFCRFQTQKGKQVKRKAGWDTHGLPVELGVEKELGITKEDIGNKISVSEYNE
ACKNAVMRYTDVWNNLTEQMGYWVDMEDPYITYKPKYMETVWWLLKNIYNQGLIYKGYTI
QPYSPKAGTGLSSHELNQPGTYQDVTDTTVTAQFKVVEDETYKASPLAAFDGTKYLMAWT
TTPWTLPSNTALTVGKKIDYVLVKTFNQYTFEPIQVVIAKALVGKQFTKKFFAAESEGDF
GNFSEADKKIPYQILSEFKGSELLELRYEPVIDYVQPHDNPQDAYRVIAGDFVTTEDGTG
IVHTSPTFGADDAMVAKQAEPQIPPMLVKDENGNLVPLVDLQGRFRPELKEFGGKYVKNE
YYDEGEAPEKSVDVEIAIKLKEENKAFKVEKYVHSYPNCWRTDKPILYYPLDSWFIKVTD
VRDRMHELNLGINWKPKATGEGRFGNWLANANDWNLSRSRYWGIPLPIWRTEDGKEEIII
GSVSELKEKIAEAVEAGVMDSDPFADFVPGDMSEANYDLIDLHKNVVDEIKLVSPSGKPM
RREADLIDVWFDSGSMPYAQWHYPFENKEMVEETWRKADFIAEGVDQTRGWFYTLHAIAT
MTFDDVAYKNVVSNGLVLDKNGQKMSKRLGNAVDPFTTLNTFGPDATRWYMISNANPWDN
LKFDLDGITEIQRKFFGTLYNTYSFFSLYANLDNFTYAEADIEWKDRPEIDRWILSELHT
LIAQVEKFYSEYEPTKATRAISDFVQENLSNWFVRLSRRRYWKGEYAHDKISAYQTLYQC
LVTVAKLGAPVAPFFMDRLYKDLNGLTNKEAAESVHLSDFPESNTAFIDTTLEHKMQKAQ
TISSLTLSLRAKEKIKVRQPLQRIMIPVLDEAQREEIIAVQDLIKSEVNVKEIELIDDAS
GILVKNIKPNFKVLGPRFGRDMKVVANAINAMSAQDISTIENEGEITVDINGKSVTLAPE
DVEITSQDIEGWLVASSGSLTVALDVTLTDELKKEGIARELVNRIQNLRKDSGFEVTDKI
EVQLQRDGKVEQAVNDNLEYIKRETLTAKLDVAEQVTNGIAIAFDDVETKLAIKKQ
>KECLDBNJ_00399 General stress protein 16O
MATDTKERYSDAELEEFRVIIQQKIDKAQNDLDLIKSAYMNDGNNGTDDTSPTFKAFEEG
SETMSKEANSALAIRQEKFIRDLKNALNRIQNKTYGICRVTGKLINKERLKLVPHATLSI
EAKNMQK
>KECLDBNJ_00400 hypothetical protein
MVLTEPAEHLKGIFIESDQIFQIYVKATNSDQLVISTEVEGETFETLEIDTSLQNDLLYI
TTGRSVGFKAFDDKLAAHKVLSVVLHIELPANKELWVNSSLASVEAQGAFSYLNLNLSGG
RVNLLDFTGSGVVNTLRGAIDVETRTTKIEASSRNGSLHVATSPVSLYKLTLKSVDGSIS
VTQSE
>KECLDBNJ_00401 Lipoprotein signal peptidase
MSLKKAVGIIVLILLIDQISKIYIKTHFQLQEQIVVFDWFRILFVENEGMAWGAKIPGNY
GKIILTLFRIGILPLIGYWLYDSVKKNGSRILIVGIALIFAGAFGNIIDSIFYGVIFDSS
AGQLATFLPEDGGYANVFYGRVVDMLYFPIWEGYLPEWLPIWGGDYFTFFNAVFNIADMA
ISTGVGLLLVFNKRAFAKDKA
>KECLDBNJ_00402 Sensor protein SrrB
MSEKSQNGFFSFLNKKPTTTTKDQEESFFYEQIAAMVGAGSWRIDFINKKSFIDDQMRNI
LETPENYTPSLKHTLHFFDMEYHDVVVNSFNQLSSGTPSFDKVIKMVTYTNKTFWAHAIS
KPIQDKKGKVIGLRGVVVNVDKEKERELMLEKAIETVEANNSRLFTFADYVSHNIKSHVN
NLELTSQLVDVTKLPQDQKELFNNYKEIAESLNGTVARLKEVVSIQNRAAQPLEAINLEE
AFERAKTKLRTLIEQEEAYLYCDFSEVPTIEYNPSFLDNILFTLIKNGIINKSPARKPEI
KAYCLENKKKLSLIIEDNGKGYDLDRNKDQLFHMTRSSDNNENSQSVGLFIVKNEIEALG
GKIEVTSKLGYGTKFIITL
>KECLDBNJ_00403 5-formyltetrahydrofolate cyclo-ligase
MEKKELRAKYKQLREALTPVACDEKSLAIANKLLQMDIWGFETYHVFLTIEKLKEINTEY
LLNILNGKDKNIVVSKSDFEASTMQHFLLTDNTTLKINSWGIPEPQNGFEVQPQQLDVVF
IPLLAFDKQGNRLGYGKGFYDRFLASCKPDCLKIGLSFFEAEDALEFSGYDIPLTHCVTP
NKTYRF
>KECLDBNJ_00404 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MTGFDDNDVLHILGEKIAPGQRRTLNFNLAKLYTTTSVEVPIIIQRAKKPGPCILITAGI
HGDEINGVEIVRQVISKKINRPARGTIICIPVINVFGFLNMERAFPDGRDLNRVFPGTQN
GSLASRFAYQFTNKILPLADFCMDFHTGGGSRFNVAQIRVDPDKEELMQYAKLFGAPFIV
YSKNISKSYRSTCEKMNIPVLLFEGGKSQISDKDIARAGVHGVMRILSHFKMLSKDFEAP
QQSKDSITIKSSSWLRAKYSGLLHLKSTCGDFVEKNEVIATITDPYGTFRHKVKASNDGY
IINTNEASLVYQGDAIFHISTELV
>KECLDBNJ_00405 Ribosomal protein S6--L-glutamate ligase
MNIKILSRNSGLYSTARLIEAAKKRKHNVEVIDPLKCDLIIEKKKPSVYYKGRYLSDTEA
IIPRIGASITYYGTAVVRQFEMMGCFTTTESQALVRSRDKLRSLQILSRARLGLPKTVFT
NYSRDVAEIIDHVGGAPLIIKLLEGTQGLGVVLAETKNAAESVIEAFNGLQARVIVQEFI
KEAKGADIRAFVIDGQVVGAMKRQGKEGEFRSNLHRGGTAEVITLSDEEENAAIKAAKAM
GLGVAGVDMLQSARGPLILEVNSSPGLEGIEKATGKDIAKSIIRYIERGV
>KECLDBNJ_00406 hypothetical protein
MEKVVIGRTDRADFPALGLSDIDVKIDTGAYTSSIHCNHIREEDNILRCTFLDPKHPEYN
GKEMQFESYDITAVKSSNGEIQYRYVVQSNIRLFGKVYKISLTLSSREDMRFPVLIGRKF
LTKKFIVDTELTDVSHAQQTL
>KECLDBNJ_00407 UvrABC system protein C
METPELEIQLKTLPNSPGVYQYYDKKGKLLYVGKAKNLKKRVSSYFNKKHDNARTHLLVK
KIANIKHIVVNSETDALLLENNMIKNYQPRYNVMLKDDKSYPWICIKNERFPRVFPTRRL
IKDGSEYYGPYTSMKTVHTLLDLIKGLYPLRTCNYDLSKEKIESGKYKVCLEYHLGNCLG
PCEDKISAKTYHDNIDAIREIVKGNFKDSLHRFRSQMKAHAEAMEFEDAQRIKEKIEVLE
GYQAKSTVVNPSINNVDVFSIVSDEGYGYVNFLQLSHGAIIRSHTLELKKKLDESDAELL
AIGIIEIRQRFNSQSSEIYVPFELDLGDGIRVTVPKLGDKKRIVELSERNAKYFRMERFK
QTKIVDPDRHVNRLMAQMKSDLRLSVEPRHIECFDNSNIQGTNPVAACVVFKDGKPSKKD
YRKFNIKTVTGANDFASMEEVVFRRYRRLLNEDEPLPQLIIVDGGKGQLSSGVKALETLG
LRGKIAIIGIAKRLEELFYPGDSIPLYLDKKSETLKVIQQLRNEAHRFGITFHRNKRSKA
AINTELETIPGIGEKTVIELLRHFRSVSKVKKASETALSEVIGPAKAKIIIKHYQQTTNE
N
>KECLDBNJ_00408 putative NTE family protein
MRINYSLLLLVLVHWAVIAQDSTAVDFSKIPQGEELKVGLVLSGGGAKGLAHIGVLKEIE
AAGIEIDYIGGTSMGAIIGGLYASGYNAHQLDSIFESVDFEKLIQDDLPRSAQSFYERAD
RERYAIALPFEHFKVSFPSALSKGQNIYNLFTKLTHHVKETDDFSALDIPFFCVATDAEK
GQAIILDKGCLPEAITASGALPSLFSPVLLDDRVLIDGGVVNNYPVEELRKRGANFIIGV
DVQDGLRGKDELKSAPEMLLQINNYRTIEAMRDKVAQTDIYIKPNIEGYTVVDFDRGAEI
IKGGQEKAEAYDDAFRKLAALQHETYTKPELKLNQHDTLRIKSVAINGNVYYTRSYILGK
LKIKTPAKMTYQELFDGINNLAATNNFQRINHRLEQYDSGESHLIINLTESETTTYAKAG
IHYDDIYKSAALINVTKKRLLFKNDIASFDLALGDNIRYNFDYYSDNGFYIGFGLRSRYN
SFESRVDARFVEEVSDLPLENFNSLQIDYTDFTNQVYLQTLFQKQFALSLGLEHKFLKID
TESIRVDEDNEGKLYFDNSHYYSTYGQLLLDTFDNKYFPTSGWYFNGDFHLYLFSSDYNE
NFEEFSIGKAEVKYAKKLFPKFSMQLSAMGGFKIGATGNGTLNFVLGGWGNDFINNIVPF
YGYELISSNGDGLVKSEITFDYNFYRKNHLNFGANFANLENDLFTTGNWLSAPDFTGYYV
GYGLETIVGPLQTKISYSPEIEDVFWNFSLGFWF
>KECLDBNJ_00409 Homogentisate 1,2-dioxygenase
MPFYHQLGKIPHKRHTQFRKPDGSLYYEQLFGTIGFDGMYSNMYHEQRPTQVKEIKSSKS
VKPKVAKANHIQSYRFRGFEIKPEADYLDSRKPVLTNSDCTIILAAPKSKTQDYFYKNSD
ADELIFVHRGSGKFRSHLGNLDFKYGDYLLIPRGTIYKLDFDTEDNRLFIVESRRPIYTP
KRYRNWFGQLLEHSPFCERDLRRPYELETNNESGEFLMKIKKQDDLFDMVYASHPFDVVG
YDGYNYPYAFSIHDFEPITGRVHQPPPVHQTFETDAFVVCSFCPRKYDYHPQSIPAPYNH
SNIDSDEVLYYVDGDFMSRNDIEAGHISLHPAGIPHGPHPGATERSIGKTETEELAVMVD
TFKPLQICEDAMPIADETYYKSWLEH
>KECLDBNJ_00410 4-hydroxyphenylpyruvate dioxygenase
MSKELKSVDYGLEKIFEGAQDFLPLLGTDYVEFYVGNAKQAAHFYKTAFGFQSFAYSGLE
TGKKDRVSYVLKQDKIRIVLTSPLGSASPINEHIVKHGDGVKVVALWVEDARSAFEETTK
RGAKPFMEPQAETDEHGEVVRSGIYTYGETVHMFVERKNYNGQFLPGYRKWESDYNPEPT
GLKYIDHMVGNVGWGEMNTWVKWYEDVMGFVNFLTFDDKQITTEYSALMSKVMSNGNGRI
KFPINEPAEGIKKSQIEEYLDFYEGPGVQHLAVATDDIVKTVAALKARGVEFLPPPPQAY
YDDIPRRLGAHMDTMKEDLTKLQELSILVDADEEGYLLQIFTKPLQDRPTLFFEIIQRMG
AKGFGAGNFKALFESIEREQAQRGTL
>KECLDBNJ_00411 hypothetical protein
MKNKYLVLLMLLVSGLTYAQDAAFQDGEWFRFRISYSGWWKAGEATLSVTNETLKGKPVY
HVKGKGVTTGMTKLFFGVEDYYETYIDKKTTLPYRFIRKIDEGGHTKDKIIDFNQQSNVA
TVNDKKHNEVKTFQTEPNIHDMVSAFYYLRNSIDSENLKDGDETVINMFFDQENFKFKLK
FLGREEVKTKFGKVKALIFRPYVQAGRVFKEKESLTVWISDDQNKIPLQIKADLAVGSLK
ADIDAYKGLKHPFYIIQD
>KECLDBNJ_00412 Tryptophan 2,3-dioxygenase
MTSKSSRETQEQLDALKDKFDAMGQNLDHQLEGFVHSKPVNYWDYIQVDALLSLQNQRTL
LPDEMVFIMYHQINELLFKMILWEIEQVAYEPELTTELFSEKLNRISRYFDMLTSSFTIM
REGMNMEQYLKFRRTLSPASGFQSAQYRFVEFGSTELLNLIDARFRKDFAQEDETDPLYY
DKAVEHLYWQAAGKDFQTGDKSYTLKAFELKYKEDFIRFLKRYKTLNLWARFKTLPLSDQ
KDATLLAAMRHYDYTVNITWVMSHYHTALHYLNQGKEPLEATGGSDWVKYMHPKYQKRIF
FPDLWSEQERAEWGQNI
>KECLDBNJ_00413 Murein DD-endopeptidase MepM
MKKLSIVLLAMLTLMSCADDESKEKEPVKKEVKKPVNKRFGYVLDDYEVVSDTVQSGDSF
GQILFENGIDYGTIQQITDSVKNTFDTRKIVVGKPYTLLKSKDSTNQAQVFIYEQNRIDY
VVLDFKDEVVKAAAKKRPVTIKERVAHGVINDNLSSTFDDLGVNILVAYGMADIYAWTID
FFRLQPGDKFKVVYTEKYINDTIPAGFGEIKASWFEHKGKPVYAFAYQADSINGGRRDYY
DQDADNLRRAFLKSPLKFGRISSRYNLKRRIAYYGNRIRPHKGTDFAAPVGTPIMATSDG
TVIASEYRGGNGNYVKLRHNGTYDTQYLHMSKRAVSRGDYVRQGEVIGYIGMTGNTSGPH
VCYRFWKNGKQVDPFSIDLPTSEPLAEELQPAYFEYIAPLRAELDAITFQKST
>KECLDBNJ_00414 Glucose-6-phosphate isomerase
MQKVNPTQTKAWKALQAHFEDIKDVKMKNLFEDQSRAEAFTLKWEDFYVDYSKNRITEET
KSLLLDLAKEMNLEEAKAAYFDGAAINETEDRAVMHTALRQPSTASVTIDGEDVIPEVNA
VKEKIKGFCDTVISGAHKGYTGKAITDVVNIGIGGSDLGPVMVAEALAYYHNHLNVHFIS
NVDGDHVHESLKDLNPETTLFVIVSKTFTTQETLSNATTARKWFLSKVAGAVEDGEAVAK
HFVAVSTNETAVKDFGIDPNNVFTMWDWVGGRFSLWSSVGLSIALAVGYNNFESMLAGAH
KADEHFKNTPLEENISVMMALVTVWYNNFFGAESEAIIPYTQYLHRFPAYLQQAIMESNG
KSVDRNGKHVDYQTGQIVWGEPGTNSQHAFFQLIHQGTKIIPTHFIGYKEALHGDKDHHN
KLMANFFAQTEALMNGKTEAEAKAELEASGMDVAAIEKLVPFKVFDGNKPTTTILIDKLT
PESLGALIALYEHKIFTEGILWNIFSYDQWGVELGKQLAKNVLTDLNSDSIASHDASTTA
LIKAFKS
>KECLDBNJ_00415 TonB-dependent receptor SusC
MKKITSSLTLVFLLLTAFMQAQGTIRGTVVDGENGTPLPGVNVVVEGTTNGVSTDFDGVF
EIQVVENTGSLRVSYVGFKPSTLAFDLSGKKVVDLGTINLEMDSDALDEVIVKAYSLAID
RKTPVAVSTIKAETIQNELGSQEFPEILKTTPGVYVTRGGGGFGDAELRIRGFNSENVAV
MINGIPVNDMENGRVYWSNWAGLSDVASSMQVQRGLGAAMIGLPSIGGTVNIVTKSTDIE
KGGNVMMTTGNDGYTKYGFKLSTGLLENDWAATVSLSRTTGEQFVDATTIDAYSYFLNVA
KKLGDNHELSFTAFGAPQRHGQRQNRLLIDDYRRSERGIRTNTDWGYKNGQLVNIEDNFY
HKPQMSLNHYWTINDISSLTTAVYYSFGTGGGGGTAGTNKFGKYDTNYRDEVFGPVDLDK
IVAENKALGQATSAETFLRASRNNHQWYGALSTYNTELSEYIDLTAGIDLRFYKGDHYTE
LTDLLGAAFYIDNNDVNNPNKVVREGDKYNYYDTGYTNWQGLFAQAEYDKDALSAVISVA
ANNTSYKREDYFKYTPDDPLRETDWVNFTAFSTKGGVNYRLDEKHNVFGNLGYFERAPFN
EAVFINNRNNVNEDAENQKIFSAELGYGYRGDKFRADLNVYRTQWMDRSYTLTRTADNIQ
YTANILGVDALHQGVELELQYRPVETLTLTGMASLGDWQWANNVNNVQVFDDQQNPIGDP
IDIYLDGVKVGNSAQTTFALGADYAVLASTTVRASFNYAADYYADYDVTGRSVEGLPQTW
KMPDYGVFDLGLTHRFNFGGFNTQINANVFNVLGTEYISDAQDGDGSVAETALVYYGPGR
TYTIGAIINF
>KECLDBNJ_00416 hypothetical protein
MKKLNYLFTTIIMAVLALGCDPVEDINDSLAENEAGIVDEFSYTLTEDDYKETLGLDYAN
FNTIDDARDLIPQVLEENFPFLGANSLSTVTYDLYQPVQTERSLIVYTVTTEDYDSYPDT
EEFDNFDDEDQIYTFLDDKYGDVDNRTLISLTYKFYDGSAQTLNNGFLRVNGSWQFALGL
TNAEYNEVGQGFANFNTEDEALRKLPIFLKDKFKYDDVAEGTIKSVMYKLYTTDEDDIDN
DGSVEDRATYSYIANFILIGSEWEVYNNVVSQTLQFGNDGSTWIPDNTISYSLVAADYAF
IASELGDTYPAQTSSMTQYGNMDRRSGNAAFWSDDMILEAFNLLLNDLDPSAEEGQKYAV
TFDIYNGSNTTETFFLIKTDGVWVMQ
>KECLDBNJ_00417 Extracellular ribonuclease
MKNKNTSKAIVKFISALLLVLYWGCSSGDDSVENPEPEPVPELQEPIAVEDSFSLTENQE
IVLEGFIDNDDVAEGARITSVVDVSAAGGTIVDNRNGSYTYTPKSNYVGEDTFTYELCLI
ADTSICSTGTVNLTIEDAGDPVANDDEVSVAKNKSIILSNLLGNDELIDGAVLTSVTAGA
GLVELDDNGLVTYTPPSNFIGEDRFTYAICDNDAVPTCSTATVTVNIVEAIAFNIPSELV
DYYSDASFFQDGGLTSSSLTALTVSKHTTILTYFERHEYLYDADADLDNQANVILMYSGE
SRDRREYTSGSNSHTPQTFNTEHIFPQSRLSTEEAVTDLHHLRSTDDEVNSLRLNYPYTD
GSGAYQLVNGNSWFPGDEWKGDVARMVLYLNVRYGEDYTKVGTLDLFLKWNREDPVSDFE
RQRNEVIEGAQGVRNPFIDNPYLATLIWGGTPAENTWE
>KECLDBNJ_00418 hypothetical protein
MYTTIQFVHSYWAYLVLIVLTLTTINSLISYFGGKEFGARDFRLALFTLIVTHIQLLIGI
VLYFVSPLGAKAIASQGMSAAMSDPNLRLYVVEHPLAMIITIVFVTVGYSKHKKKLTSKP
KFKLLAIFYTLGLLVMLTRIPWSNWF
>KECLDBNJ_00419 Xaa-Pro aminopeptidase
MEFNRLWATEFLNLAKFNLDMKYDLIDRQLFIKNRKNFMEAMKPSSLAVFNSNDIYPIGA
DSTMPFQQNRDLFYLSGVDQEESILVLFPYCPKQKHREILFLKETNDHIAVWEGEKLTKE
KALEVSGVETVYWLQEWDKVFYELMTQAETIYINTNEHYRANVETETREARFNKKIKEQY
PAHSVAKSNPILQRLRSVKDAIELDVMQQACNITEKGFKRVLQFTKPGVMEYEIEAEFMH
EFLRNRSRGFAYTPIVASGNNANVLHYVVNNAECKAGDLILLDIGAEYANYSSDMTRTIP
VSGKFTERQKEVYNAVLRVKKEATKMLTPGTLWGPYHEEVGKLMTSELLGLGLLDKADVQ
NENKDWPAYKKYFMHGTSHHIGLDTHDYGLLHEPMQANNVFTVEPGIYIPEEGFGIRLED
DVVIQENGEPFNLMRNIPLEIDEIEDWMNR
>KECLDBNJ_00420 hypothetical protein
MQTRLFFSLFLLGICFSTQAQQTATAAQQVKTSLEAKDQMLKNSIVKNIPFTNVGPTIMS
GRVVDIEVNPENSTEFYVAYATGGVWHTSNNGNTFDSVFDTAPTQNVGDIAVNWSANIIW
VGTGETISSRSSYAGIGILKSADGGKTWEQKGLLDSHHISDIVLDATNPDVAVVGALGHL
YSDNEERGIFKTTDGGDTWEKTLFINDKTGIISLAEAPENPSVLYATAWERERAAWDFIG
SGENSGIYKSTDAGDTWELVTTGNGFPQGKGVGRIGVTVVDENTVYAVHDNQDIREEAKE
RGAERDDKALTPETFKGMSKGEFLALENESLADYLRSYRFPRQYEVAKVKAMVEGDELKP
SDLFLYTYDKNAADADGEVIGAEIYLTKDGGKTWKRTHDGYIDDFFFSYGYVFAEMDVNP
QDQDEIYLVGVPLIKSTDGGKTFTYIDEPNVHVDHHVIWVDPKMPNHLINGNDGGLNMSY
DAGKSWNKLNSIPLGQFYAINVDYEKPYNVYGGLQDNGTWKGPHTYSYSKDYEAEGQYPY
KSIGGGDGMQVQIDRRNSNIVYAGSQFGYYNRMNLETGERSFIKPSHDLGEAPYRFNWET
PILLSPHNQDILYMGGNKLMRSMNQGDDWTPISPDLTAGGKKGNVPYGTLTNISESPFQF
GLLYTGSDDGVIQVTQDAGGSWDIISAGLPQNLWVSKVIASSHKKSWVYATLNGYRYDDF
KPYVYVSDDYGKNWKDISSDLPLSPVNVIIEDPVKENILYLGTDDASYISFDQGASWELL
DGSMPNVAVHDMVVQTEANDLVIGTHGRSIYITNLDEIQKFDTKNASALQLFELDAVDYS
TNWGRSWSAWRAANTPEIKIAVYAPQSGKATLEILSSEEKSIKSWQVDVEKGFNYIPYDL
SISEAGKKQLERETKDLKISKAQNEVFYIAPGAYKVQVSLNGKSQTTPLKIDEGSRRRDR
AEAAANAPEED
>KECLDBNJ_00421 hypothetical protein
MELSLSIPALLFPAISLTMLAYNARYLAIAALIRELYKRYQEESSSPIKAQIYQLRRRLG
IIKAMQAMAIVSFLLAVITMFFIYIEKSVWANVVFGVSLVALMISLALSFTEVQLSTQAL
EIQLNDMDD
>KECLDBNJ_00422 hypothetical protein
MGIISSSIARKVAMALSGLFLVLFLGQHFTINLTSTFSPETFNEFSHFMGTNFLVQAILQ
PVLIFGVIFHFVMGFILEARNRSARKVSYVSYKGNTNSSWVSRNMIYTGIVVLAFLGLHF
YDFWFPEIAYKYIEANPSDATRYYGELVEKFHSPVRTGLYVLSFVFLALHLYHGFASSFQ
SVGFNNKYARGLKKFAKVYAIVIPAGFIFIALFHHFNH
>KECLDBNJ_00423 Fumarate reductase flavoprotein subunit
MSAFKSNIPEGPLKDKWTQHKNDINLVNPANKRNIDVIVVGTGLAGGSAAATLAELGYNV
KTFCYQDSPRRAHSIAAQGGINAAKNYQGDGDSNYRLFYDTVKGGDYRSREANVYRLAEV
SANIIDQCVAQGVPFAREYGGLLDNRSFGGVLVSRTFYAKGQTGQQLLLGAYSAMNRQIN
RGKIKSYTRHEMMDVVLVDGKARGIIARNMVTGEIERHSAHAVVLASGGYGNVFFLSTNA
MGCNVMAAWRAHRRGAYFANPCYTQIHPTCIPVTGDHQSKLTLMSESLRNDGRIWVPKKK
EDAEAIRAGKLKPTQLKEEDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGFGVNKTGE
AVYLDFSSAIERYGKEKAYTSGHKNPSKEEIIKLGKEVVEAKYGNLFQMYEKIVDQNPYE
TPMMIYPAVHYTMGGLWVDYNLQTTIPGCYAVGEANFSDHGANRLGASALMQGLADGYFV
LPYTIGDYLSKDIRTGKISTETPEFDAAEKDVKDRIARLMNASGQHSVDYYHKKLGKIMW
NKCGMARNEQGLKEAIEEIAELRKDFWANVKVPGAAESKNAELEKAGRVADFLELGELFA
KDALHRNESCGGHFREEYQTEEGEALRDDENFKYVAAWEYKGEPKEAQLHKEDLEFKNIE
LKTRSYK
>KECLDBNJ_00424 Fumarate reductase iron-sulfur subunit
MKLTLKIWRQENANAKGKMVTYPIDGIEDDMSFLEMLDVLNEELIAKGDDPVEFDHDCRE
GICGACSLQINGEPHGPDRLVTTCQLHMRKFKDGDTIVIEPFRATAFPVIKDLIVDRSSF
DRIQHAGGYISVNTSGNTIDANSIPVNKHDADDSFAAATCIGCGACVAACKNASAMLFTS
AKVSQYALLPQGQVEAVERVENMVRQMDLEGFGNCTNTGACEIECPKGISLENIARMNRE
YLSATAKG
>KECLDBNJ_00425 DNA repair protein RadA
MAKVKTTFFCQNCGAQFAKWQGQCTSCKEWNTIAEEVVQKVEKTGWKSEPQSTKRVAKPQ
RIKEIDTTKDARLNTENNELNRVLGGGLVPGSLTLLGGEPGIGKSTLMLQIALTLPYTTL
YVSGEESAQQIKMRAERINPAAENCLILTETKTQNIFKQVEAVNPDIVIIDSIQTLHSDY
IESGAGSISQIRETTTELIKFAKETATPVILIGHITKDGNIAGPKILEHMVDTVLQFEGD
RNHVYRILRAHKNRFGSTSELGIYEMQGSGLREVSNPSEILISKNDEDLSGTAIAATLEG
MRPLMIEIQALVSTAVYGTPQRSATGYNAKRLNMILAVLEKRAGFRLGAKDVFLNITGGI
SVDDTAIDLAVVAAILSSNEDISVAKDICFAAEVGLAGEIRPVTRVEQRILEAEKLGFGT
IMISKYCKVPKNNYGITIVRVAKMNDVVEWLFG
>KECLDBNJ_00426 hypothetical protein
MKKILLLILLAYSSINAQVLYESVPSSKFNEPRNVKIQLPRNYEANEDKYYPVILVLDGD
YLFEPVAGSADYYSYWEDMPQAIIVGVMQPDRMEDTVYDDANFLPTGQGADFFEFLGMEL
LPWLNKQYRLAPFNVVVGHDATAGFANYYLMKNPPLFNAYISLSPDLAPQMNERLTTILK
QTEQQIFYYQATGTEDIPSLREETLALHQALSGIENEKFHYYFDDFQDATHYSLVGRAIP
KALEKVFAVYRPISKKEFTEKILKVDSPFDYLIEKYTVMQNLFGLDDKIRINDFIAIAAA
LEKKSDWDGFENLGKLASKEYPETILGPYYLGRSYEGNGEPKKAMRTYEGALVLKEIGDI
NKDILVARSQQIKDDFGY
>KECLDBNJ_00427 hypothetical protein
MKVAIPLGIGILLIYYSLSSATTQERAILWNNIKDAPPVYIAVSLMFGVLSHLSRAYRWQ
YLLQPMGYHPKLSNRFMAVMAAYLANLGIPRSGELLRGALLTTYEDVPFEKAFGTIISER
IADFLMLLLVVSIAIVLQTDTLLSYLHEQNINPLYTVLFLAAGVLLIALGFKIIQRAKTG
ILAKLKDFMAGLVEGMKSILKMRNKWAFIGHTFFIWIMYILMFWVIKFTIPEISYASTGV
ILAAFVIGSFAISVTNGGIGVYPISIGALFIFFGFSKEGGEAFGWIVWGSQTLLVLVLGA
LSFLLLPILNRKK
>KECLDBNJ_00428 Aspartate 1-decarboxylase
MLVNVVKSKIHRVKVTGAELHYIGSITIDEDLMDAAGVIEGERVQIVNVTNGERLETYAI
PGPRKSGEVTLNGAAARKVAKGDILILITYAFMELEEAKAFKPSLVFPNEETNLLN
>KECLDBNJ_00429 Pantothenate synthetase
MQIASNIVILPPVNLIGMHVYTNRPEISSAVAKHKEKGLKIGFVPTMGALHRGHGSLFNF
ALENCDVVVVSIFVNPTQFNNPADLETYPRDLQADLEFLEHINPNLLVFAPSTTTIYGSQ
IKALDFNFDGLDQVMEGAFRPGHFEGVATVLKYLFEIVNPDMAFFGEKDYQQLQIVNKLV
EIENLPVQIVGCPISRHDDGLAESSRNKRLTVKQREASPFIYKTLMQAKEHFNDQSVEDV
VHFVEQEFKGKEHLELEYFEIANATTLKHATTKKAEDKYRAFIAVFAGDVRLIDNIALN
>KECLDBNJ_00430 Glycogen synthase
MKNKRILYVSSEVIPYLPETEIASMSFEVPQMVNSKGGQIRIFMPRYGNINERRHQLHEV
IRLSGMNLVINDFDMPLIIKVASIPKERIQVYFIDNEEYFKRKATFTDEDGNLFADNDER
AIFFAKGVVETVKKLNWAPDIIHVHGWLASLLPLYLKQFYASEPLFKQSKIVTSVYNTGF
DDTLNEQLIDKIAFDGIDKDSISELEKPSYENLMKIAIKNSDAAIVGSAELSEDLSKYLN
VTKIPVLPYKKREEFAQAYEEFYTTKVLD
>KECLDBNJ_00431 hypothetical protein
MKLNTVLTRTLGLLMLLFVFFSCEDDFLEVGSGLVDDSNFTSGNESYPVTAYSERFFDSL
GVQTNGLSAGVLGYYQDSIYGSTTASTLSQVSLSTYNSTFGTNPVVDSVVFTMPYFSTGS
VNSENETVYELDSVYGSDPIRVTAFRSNYFLNSNNGPDFENGAVYYSNDLTEFNGVEGDT
LMQQTFVPSNETVVTTVPATTDGEDDEVTSNSPRLRIRLDETAYGETYWQENILDRGGED
VLFNANSFRNYFRGVYLKAEPVNGSGSYFLFDKANTSIAIYYTSGEEDSRNQSSVTLSLA
GNGVVGYQNDFKSEIKTELTGIDKENGEENLYLKGGQGSMAVIELFEDVDDDANGIPDEL
DALRAQPRLIREANLEFFVDQDKIQQYAGASVSEPQRVYIYDLETNLPLRDFSGDATISS
SGTITAVGTTHLGPLETDDNGQGVSYKIRITEFYKALLDPENDTPTTKLGLVVTQNVLST
ATAAIEGKTDSDIPNRVPYASVIANRGTILYGSSVNVPEAKRLKLKVFYSEASN
>KECLDBNJ_00432 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGHRQAYPVVIKGLQRLEYRGYDSAGVALFDGEEIQLCKTKGKVDDLKTKVES
TITAEGTLGIGHTRWATHGVPNDVNSHPHFSNSGDLVIIHNGIIENYDAIKQELTKRGYT
FKSDTDTEVLVNLIEDVQSNQKVKLGKAVQIALNETVGAYAIAVFDKKKPNEIVVARLGS
PLAIGIGEDEYFIASDASPFIEYTNNALYLEDGEMAIVRRGKEVKVFNIQDDALVSQPYI
QELKLNLEQIEKGGYPHFMLKEIYEQPQAIRDTFRGRMRENKGVIKMAGVDDHIDKFINA
KRLVILACGTSWHAGLVAEYIIEELMRVPVEVEYASEFRYRNPVIDKDDVVIAISQSGET
ADTMAAMKLAKEKGAFVFGVCNVVGSSISREAHAGAYTHAGPEIGVASTKAFTTQITVLT
LLGLKVAKAKGRISTSDLHMHLEELRLIPEKVEEALKSNDHVKEIASVYKNASNCLYLGR
GFNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEHMPVIVIATRRGHYDKVVSN
IQEIKSRKGKIIAIVTKGDVTVKGLADHVIEVPEVMDSMSPLLTTIPLQLLSYHIAVMLG
KNVDQPRNLAKSVTVE
>KECLDBNJ_00433 ATP synthase subunit beta
MSKVTGKVAQIIGPVVDVEFANNADLPKIYDSLEITKADGSLLVLEVQSHVGENTVRTIA
MDSADGLSRGAEVVATGAPIQMPIGDDVYGRLFNVIGDAIDGIGDLPKAGKDGLPIHREA
PKFEDLSTSTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGL
SVFAGVGERTREGNDLLREMLESGIIKYGEDFMHSMEEGGWDLTKVDKAAMKESKATFVF
GQMNEPPGARARVALSGLTIAEYFRDGAGDGQGKDVLFFVDNIFRFTQAGSEVSALLGRM
PSAVGYQPTLATEMGAMQERITSTKKGSITSVQAVYVPADDLTDPAPATTFAHLDATTVL
SRKIAELGIYPAVDPLDSTSRILTKEILGADHYNCAQNVKELLQRYKELQDIIAILGMEE
LSEEDKLAVSRARRVQRFLSQPFHVAEQFTGIPGVLVDIKETIKGFNMIMDGELDHLPEA
AFNLKGTIEEAIEAGEKMLAEA
>KECLDBNJ_00434 ATP synthase epsilon chain
MHLEIVSPEATLYSGEATSVILPGTDGAFQLLDNHAAIVSLLEEGVVKVKGATLSDKAKK
HFTAGKEAGEFVLAIKSGTVEMKDNKVIVLAD
>KECLDBNJ_00435 hypothetical protein
MIKRFFYWHCKSILATMKSADTLILNQMNRSLIVRILAALLFTFACFLLFLIYFITFKIG
YDLSKERDFVSWGKDLKSVLVFLILAIGLGFYLVKRKRIIFNTKTHKYKVEYYLGPFYWG
HWSDYEALKMVGIFKNSKGIYEVNIWFTNSRHLKFERFHNEEDALAEAKYIAELFTLKVW
NASDPKKGYYLD
>KECLDBNJ_00436 Kynurenine formamidase
MASKEIIDLSQEIYDGMPVYKSLSPVSMQVYATHEQWDGDENPTTQTPSVHQITMSEHTG
THVDALNHMDRKNAGESIDTMPLSMFFTEGICLDFSYKGLQELITTEDIKEACLKADVNI
KKGDTVLLCTDHYRKHFNTENWPKGPGITAEAAQYLGRLKIAAFGVETMSPGVPKVSNTE
VHKLCGELGFTHYENMINLHKLVGRGRFQFIALPLKIRGGTGSPVRAVAVFEN
>KECLDBNJ_00437 hypothetical protein
MKLWIALLLLSLSLQAQTNSYEISFDNAVHHEAVVKVQFPHVKSKNLRVQMSRSSPGRYA
IHEFAKNVYGFKATNGAGESLEVKRDDPYSWIITNTDGTINVEYILFANRGGGTYSQVDL
THAHLNMPATFMYAETLQERPIEITFDARKDLDWKVATQLKHEEDNTFSAPNLYYFMDSP
TEISNFREREFKVDGQTIKFVLHDPDPESDFDTYWEKVKAIVLQEKAVFGELPIYDFDEY
TFLACYAPNVSGDGMEHRNSTILTDTETLANGGMTGNIGTVSHEYFHSWNVERIRPADLE
PFQFNQANMSDCLWFAEGFTSYYTNLILERAGVISAEDYVNGLNGTFNYVWNSPALQYFN
PIEMSNQAPFVDAATSVDPVNRENMFISYYSYGSVLGLALDLSLREKNLNLDEFMQLMWK
RFGKTEVAYTVKDIEATLADYAGAAFAQGFFAKYIYNSEMPDYKNLFEQVGLQLDRASEK
PYFGASFKATENGLEISRNTFKDSPAYQADLDKGDVIASIDGIAMNSNDAFKNLLNSKNI
DDVLQVTFERFDEVFTTQVRLTADPTYTISIAPDAKKSAIQIREKWLAKK
>KECLDBNJ_00438 hypothetical protein
MPIIINLDQVLADRNKKSKELAEMVGITEANLSILKSGRAKAVRFSTLEAICKALDCQPG
DILAYTEE
>KECLDBNJ_00439 hypothetical protein
MNTIRPHLRSISIVLSLAQLYFVFKSASLVILAILGTSSGDEVLVDILKNDFFTKSNDTP
SNYLAAVFLLLIIGLNIFLIFRLWLASKIIRKYQVGKLLTLGHSKDLEKVGKGFDYYSFL
WYATHLIFGTFFFNDLTAFYKTLPYALIFFLLGKVILILSSISAKAEILKEENDLTV
>KECLDBNJ_00440 hypothetical protein
MKLNSIFKGLIDLAFYLMVPIVVFFPGTILYILIFPQQSIIKVNLPYTEQGFGSGALLFT
ICFFILFLLFFAGFFQLRKFAGQLLKKKLFSSEVIKSTKKVGQFFTACGLGSLIFVVINA
LLTNEGTISISFGTSNLSLLLFLLIVGVLFLLLSDAFARALKLKEENDLTV
>KECLDBNJ_00441 8-amino-7-oxononanoate synthase
MLPKKLQEKLNQRRETNALRQLKVPNAELVDFSSNDYLGFSKNPVIFSRAGEILKEHNLE
LNGAAGSRLLSGNHKLYELTERFIAKTHKVEAALIFNSGYDANVGFFGSVPQRGDVILYD
EFIHASIRDGIQMSHAKAYKFKHNDLNDLESKLSLRAQSRSLEKANDSQIYVVTESVFSM
DGDSPDLLKLVGLCEQFSAQVFIDEAHAIGVFGTGIIDDLGLGNRVTRLVTFGKAMGCHG
AAILGSEILKSYLVNFARSLIYTTALPPHSVATILAAYEHAASDAKKSNSALIKLRKNIQ
YFCEELKKQQLQEFFIKSDSAIHCAILPGNARVKHISATLLEAGFDVKAILSPTVPAGQE
RLRICLHSYNSQNEIKILLALLAKSLE
>KECLDBNJ_00442 ATP-dependent dethiobiotin synthetase BioD 1
MEKQTFFITGISTEVGKTVASAIVTEALEADYWKPIQAGDLDHSDTHKVKEFVGNDKTVF
HDNAFKLHTPMSPHAAADIDGVSIKASEIKRPETENNLVIEGAGGLLVPISETETILDLI
QPEDKVIVVSRHYLGSINHTLLTIDKLKQAGKTIHGILFSGEEHPTTESVIAKMSGVVIL
GRIDEEPYFDKMVVKEYAELLRARLQ
>KECLDBNJ_00443 hypothetical protein
MKQSYVYILTNTYRTTFYIGVTSNLQQRIVDHKEKKGSAFTSKYNVCGLIYFEEFSDINQ
AILREKQLKNWKKDWKLNLIKEKNPKLQTLNIFS
>KECLDBNJ_00444 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MNLTERDKQHIWHPLTQHKLHPEAKPIVKAKGALLYDEEGNTYVDAVSSWYTAMYGHCND
FIVERVHRQMQQLDQIIFSGFTHEPAIELSEKLMAILPENQQKLMFNDNGSTSTEIGIKM
ALQYHYNKGQTRKTLLAFEEGFHGDTFGAMSVSGLSIYNGPFEEFFIDVKRIPLPTAANQ
EELIKAIEAFHAETPLAGFIYEPLVQGAAGMKMYQAAHLESILQKCKELGIILIADEVMT
GFGKTGSFFASDFIEVKPDVICLSKALTAGLVPMGVTTCTQAIFDAFYDDDIGKGLFHAH
TYSANPIACATAIAALDLLQSEEIQQNIKQIQNWHAAFATEIEKHPKVHSTRQQGTIFAL
ELDVPMERYGNLRYKIYERCMAEGVYLRPLGSTIYILAPFVTTQEQMQKVYAAIKKVLDS
F
>KECLDBNJ_00445 hypothetical protein
MNELVTEERSWWSRNWKWVVPVGGCFTFIVIGVLVLGGAIFGFVKSVQNDSGGNDALEIA
KSNPQLIEVLGKPITKDGMGSYSVNYKNGHKTSEATIPIEGPNGTATLHVKTSGSDDALI
YEIFEVQVDNTGELIDLNQNQLDQGAY
>KECLDBNJ_00446 3-oxoacyl-[acyl-carrier-protein] synthase 2
MQIKIEDVKHVIAITGMAAISAADTTENQLGKHALSYDDQLEAWVGKLPSALKAEIEAIR
AENRNYQALDASVLYSMYVSRLATQQAGWQQGSDFGINIGSSRGATQLFEQYFEHFLQNN
KSEPLASPTTTLGNLSSWVAQDLQNNGPDISHSITCSTALHAMLNGVAWLQAGMCDKFLV
GGSEAALTPFTIAQMKAIKTYSRAPADAQFPCLALDLDKTENTMVLGEGAAAVCLEKGMN
ENALAYITGVGYATEKLKHAVSISAEALCFQKSMRMAIEDAFGTGQDDEISAFAEMKNDD
QILTFAEMTKKVDAVVMHAPGTIAGDKTEYLAIKKIFGERLPLLTTNKWKIGHTFGASGL
LSFDTAMHMVQRGEYEEVPFISAQKPPQQIKNILVNAVGFGGNAVSILVSKA
>KECLDBNJ_00447 Biotin synthase
MRHNWTREEILEIYNKPLMELLYEAATVHREFHDPNTVQVSTLLSIKTGGCPEDCGYCPQ
AARYHTDIEGNDLMRVSHVKAQALRAKAAGSSRVCMGAAWRNVKDGEEFDQVLEMVRTIN
KLDMEVCCTLGMITENQAQRLAEAGLYAYNHNLDTSEDYYKDVISTRAFQDRLDTIGNVR
KTNVTVCSGGIIGMGEKVEDRAGMLVALATLDPQPESVPINALVAVEGTPMEDIEPISIW
EMVRMVATTRIVMPQTQVRLSAGRTQMSREGQAMCFFAGANSIFAGDKLLTTPNPDVNED
MEMFKLLGLNPQAPFVKKAQPETVEAADSKHLPKGEKPKWSRPGHTIPRNEEAKAKAKA
>KECLDBNJ_00448 hypothetical protein
MKLTEIHRVKSITKAEFVKNYLKPQKPVVIENLIGDWPAYDKWSLDYIKEIAGDKEVPLY
DDRPVTHEDGFNQAHAKMKMADYVDLLKREPTNYRIFLYNIMKEVPSLKKDFKFPKIGLR
LIKQIPMVFFGGENSKVFMHHDIDWANILHFHFHGKKRCILFPPDQTENLYKVPHSLITR
EDIDFDHPDYEKFPVLKKAEGLVCDLKHGETLYMPEGYWHYMKYVTPGFSMSLRALPRKP
KHLLQAVYNVFIMRHYDNLMRRRKGQAWIDEKNERAIADTHKKHGLAV
>KECLDBNJ_00449 Regulatory protein RecX
MKSQPRILNQQPTKTYTVEEAKRKLEAYCAYQDRCHKEVREKLIQMRMIPDAVDAIIYHL
LQHKFLDEERFARSFARGKFRHKKWGKNRIKQELKQREIGTYLINKAFTEIPEKEYRNTF
DKLALKRFDQLTEKDKYKKRKKLADYLLYRGWPGDWVYEKAKELIP
>KECLDBNJ_00450 Ribonuclease G
MNNELIIRSSSTSVDFALLKDGKLIELHKDEEDNQFSVGDILIAKIRKTVSGLNAAFVNV
GYEKDAFLHYHDLGPQLPTLLKFVKRVSTGKLKDFSLKNFPTEKDIDKNGKIADAVKSNQ
SILVQVVKEPISTKGPRISSELSIAGRYVVLVPFSDRISISQKIESREEKARLKRLMQSI
RPKGFGVIVRTVAEGKMVAELDKDLQNLVDRWTAMCKKLHNAHLPSKVLGEMNRASSMLR
DLFNDSFTNICVDDETLYYQIKDYLQEIAPNKESIVKLYQNTVPIYEKHGIERQIKTSFG
KTVSMSRGAYLVIEHTEALHVIDVNSGNRSSKAKSQEDTALEVNLIAATEIARQLRLRDM
GGIIVVDFIDMSKAENRKKLFNHLRDEMSDDRAKHKILPPSKFGLIQITRQRVRPEMNIK
TREKDPNGDGEIEAPISVVNRIQADLIKLFKKDYKKITLHTHPFIAAFLTKGFPSVRSKW
FLEHKKWVKIMPRDAYTYLEYRFTKDGKEIR
>KECLDBNJ_00451 DNA-binding protein HU
MTKADIVAKISEKLGIEKNDVQATVETFMTEVKNSLEGGDNVYLRGFGSFIIKTRAEKTG
RNISKNTTIKIPAHNIPAFKPAKVFVEGVKSNVSVDEN
>KECLDBNJ_00452 Adenine DNA glycosylase
MLNFSKKLIHWYLQNKRELPWRQTQDPYSIWLSEIILQQTRVEQGMPYYFSFVETYPDVK
ALAAAREDDVLKLWQGLGYYSRARNLHATAKKVAYDLNGVFPDTYKELKKLKGVGDYTAS
AIASICFNEATAVVDGNVYRVLSRIYGIDTPINSTPGAKEFKALAQELIDKKDPATFNQA
IMEFGATQCKPKNPYCLHCPFSESCVAFQQGRIADLPVKKGKIKVRDRFFNYLIFITPKG
ETLIQQRKEKGIWRGLFDFPLLETEKDLQKEHFRESVNKLMILGKDKSVKFEALPVEEII
LQQRAPIIHKLSHQKLHVKFWVIKLSEASGLQMIAYERLGDFAVPRVIDRFLEDFDFKDF
LE
>KECLDBNJ_00453 Single-stranded DNA-binding protein
MSGTLNKVMLIGHTGDDVKMHYFEGGGAIGRFPLATNETYTNRTTGERVSNTEWHNIVVR
NKGAEICEKYLKKGDKVYVEGRIKTRKWQDESGAERYSTEIQCTDFTFLTPKDASGMTSQ
STGAQPAQSTAPASTPKPSPSPVSPGYEDDDEDDLPF
>KECLDBNJ_00454 Magnesium and cobalt efflux protein CorC
MDPDPPSLLIIQQSFSVTTVIEIVAVIVLLICSALISGTEVAFFALTPADLELDVEKQTK
KESLVVRLLEKPKKLLATILVANNFINIAIVLIFASLGETLFAGLEQYQFWIINLRFLVE
VVAVTFLILMFGEILPKVYASRNKVAFSGQMAYPMLVLDVIISPLSIPMRAVTLFLQDRF
GKQKANISIDHLGQALELTSEDDTSVEEQKILKGIVSFGNTDTKQVMKPRMDIFALNEEL
TYQEVIPLIIENGYSRIPVFTENIDNIAGILYVKDLLPHIDKETFEWTSLLRDPYFVPEN
KKLDDLLNEFKDKRNHLAIVVDEYGGTSGLISMEDIIEEIVGDISDEFDDEDIIFSKLDD
NNYIFEGKTSLKDFYKVIRLEDNTAFEDNKGEAETLAGFLLEISKGFPRKNEILNFEHYA
FTIEVIDQKRIKQIKLTIKDID
>KECLDBNJ_00455 hypothetical protein
MKQFRKYCFIAFCCGILFSCKEEVLPKPDGFLALDYDKPDYTAYTSTDCPYEFMKNTKAV
VRYKNDCSAVLEYPEMNGALYLTYRPVDNNIKELLVDAQKLTYEHVVKADNIAEEKYVND
YHGVYGMFYDVAGNAASQSQFYVTDSTSHFITGSIYFNVTPNYDSILPAAAYLKYDIRHL
MESLKWKK
>KECLDBNJ_00456 putative amino-acid metabolite efflux pump
MQETNKKWLYLFILSLIWGTSYILIKKGLVGLTPLQLGAFRIIFTTIFLFLIGFKKLFKI
SKQQWGWVALSALLGTFLPVFLFAYAETQIDSSIASILNSLVPLFTIVLGFLLFKIAFTR
NQIIGVVLGLLGAGILIFQGAEVNPEQNYLFAGFVVIAALCYAGNANILKAKLQEVSSLA
IAVGNFSVMLIPAVIVLYFSGGTQLNIEDPKIKSSLIYVLILAFFGTALAKILFNKLVQI
SSAVFSTSVTYLIPIVGIFWGLLDGERFTLIHLVGAGVILTGVYLVNANRKQKKTNG
>KECLDBNJ_00457 hypothetical protein
MKNIFFSLLFICSLSAVAQIDRSTQPKAGPAPEINLSEPETFTLKNGLKVIVVENHKLPR
VAYTLTLDNPPIAEGDKTGAAALAGSLLGQGSQSISKDDFNEEVDYMGARMSFGSQYASA
SGLSQYAERILELLADAAIHPNFTQEEFEKEQTKLIEGLKTNEKSVAAAAGQVSRALLYG
KNHPKGEFETQEGLEKITLADAKAFYKKAFIPNNAYLVVVGDVDYKDIKKWVSADFKDWK
KGTTLSNDFATPQNVSTPEIDFVDMPNAVQSQVIVQNLVDLKMSDPDYFPVLIANQILGG
GGEGRLFLNLREDKGYTYGAYSSISDSKYGKTSFSASASVRNMVTDSSVVAFLEEIDKIR
QEPVSATDLKNAKAKYVGSFVRSLEQPSTIARFALNKETENLPDDFYQDYLSKVNAVTVA
DVQRVANKYFLGDNARIVIAGKGSEVLENLEKVTYKGKTIPVKYFDKKANAVEKPTYEVA
LPEGVTATTVFNNYIEAIGGKEAVAGINSIVMMGEGSVQGTPLKLTIKKTNKDQFLQEIS
VMGNVMSKQVLNGDSASISAQGQTMNPSPEQVEALKKEAAIIPEVNMINDASIKLLGIEK
VDGKNAYAVALTDTKKAFYDTESGLKIKEETTQEMQGQTFVQTIQFDDYKPAGAIVVPYK
LSQSMGPQNIEFTFSEIKVNEGVSDADFQ
>KECLDBNJ_00458 putative zinc protease
MKKTLFSLASIFAMSLSIQAQEVEFEEYDLDNGLHVILHQDNTAPVVTTSVMYHVGGKDR
EDSRTGFAHFFEHLLFEGTENIENGKWFEIVSSNGGTNNANTSQDRTYYYEVFPSNNLEL
GLWMESERMLHPVIKQDGVDTQNEVVKEERRLRYDNSPYGQFLFAISEQLFENHPYKDPN
VGYMEDLDAASLQEFKDYFDKYYKPSNAVLVVAGDIEVDETKKLIEDYFGPIPSGPALER
SYPTEEPITEATRSQFYDSNIQVPAILTAYRTPGYGDRDAYVLNMISSYLSDGKSSKLYK
KMVDDEKKALQIGAINLEQEDYGMYIIFGLPLGETSLDTLIEGMEEEITKLRNELISESD
YEKLQNKAETNFVNSNSSVEGIANTLARNYMLYDDTNLINSEIEIYRSITREEIKEVANK
YLKPNQRVEVEYLPKKEDQ
>KECLDBNJ_00459 hypothetical protein
MLKIALPIRFGIAISAGLIAYFLVLALFELHTNPLFSLFNGVITGFGIYEAIKYYKLSKG
KDFEYGDGFSVGVVTGFVATIIFTAFFALYAGNLNPDFLSNMIAAWETTYNTSLGSVIFV
VAIMGFATSTVLTLSFMQLFKPSWNLKKKPKTTQA
>KECLDBNJ_00460 50S ribosomal protein L21
MYAIVEIAGQQFKVAKDQKVFVNRLAGEEGDEVSFDKVLLAGDGDNITLGAPAIEGALVG
AKISRHLKGDKVIVFKKKRRKGYKKKNGHRQSLTEIIIGDISLKGGKKAAPKTEKKEVKA
EEPKAKKAKASSKGDDLKKIEGAGPKAAEALVAAGIDTFAKVAKTSPEKLSEVLSEASSR
LSHIVTETWPKQAALAAEGKWDELKELQDRLDGGVEK
>KECLDBNJ_00461 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIFGGQAAVAGNIIVRQRGNTHHPGDNVYGGKDHTLH
AKVDGIVKFTKKKDNKSYVSVVPTAEA
>KECLDBNJ_00462 hypothetical protein
MLRYLFFILFSCVAGSIQAQQIEERFQVFEDSVFYAYKNELDSAKNSQDAAQLSLAHFNL
ARFYKQSQIYTEAVTHYNAALENTQQSSQTTATIQNELAELYIALNNYSKAIEFLNSSLG
YSEAQQFLQLQAKSYQLLGTCWEKQEQPQKALEFQQKSLQIYQDLVDVTGEAIVLENIGS
IYEDLKDYDKAYTYFEKAFSYFKNTEDERQVNALNNLADVYRKKGNYAQAIVKTTEALEL
AEMFQNAHQIESAYKDLAKAFALAQDFKQAHHYALAYQDLVEQQFYSQNFNQLNALQTVY
DTKEKQAKIDLLQAKNKTAQIKFIALILTIFVLVATAGLLFYIQKRKRQARLAVELYKQR
ALEAELETKAAQEQNLQNQIQLKTATLSKYSLSLAQKNKLLEEVSGTLQKLSTRKRMDIP
AKLHELSNDLNTHLQEENEWEQFMGLFNEIHPDFTRKLNQAALQKLSATELRLCLLLRLD
LSSKEIASVLRITPDSVRVARYRLRKKLPLEREDELVNFMLKL
>KECLDBNJ_00463 Colicin I receptor
MKIITSLKLLVVTLLFTLNYSGLSAQEGIIQGVITDEYGINVPGAAVMIDDLNKGAVSNQ
DGKFTFVEIPEGNHTLTIKYLGFADFTKEVMVTAGKTTSVSILLASEETQLDDVQLVGFS
AGGQARALNTQKNNVNITNVVSTDQIGKFPDANIGDATKRIPGITMQVDQGEARNIIVRG
LAPQLNSVTLNGSRIPSAEGDNRNVQMDLIPSDMIQTIEVNKAVTPDMDADALGGSVNLV
TRSTPQSFRLSATGGSGINFITDKRILSGSFLVGDRSKDKKFGWMVSASINDNDFGSDNV
EAEWTDTFAYTNAAGEEVEEDVNPYASVYENRKYLVQRVRRSFSANFDYNFDENNEIYLK
TMYNWRDDRENRFAYSSEVLDAEDIMEGDFEIVNGTPSRFPVEAKRETKGGIPGGRIQNR
RLEDQRMQNYSLGGNHLFGNLKFTWMGSFAKASEERPNERYLVYATEYGVNNEINDTRKP
IHTPVAAEDLSEFELDELTEEYQFTEEKDINFFANFELPADFFAQGDGTVKFGVRGRFKN
KNRANNFFEYSPLTGALDNLAMVDQRAYTGDDFLAGAKYRPGVFASPEFLGSLNLNDAAA
FEGEALPDEYLGDNFDVTENVYAGYVMTNQKLSDKLSVLVGLRVENTRIESTGNNFDVDE
PEAFTQINDESSYTNVLPGVHFKYNASENTVLRFAWTNTLARPNYIDLVPYRQREDDEVS
IGNPQLNPTTAMNFDFMAEKYFSSVGILSGGVFYKDLNDFIYTSVSEEESTGYELYQPLN
GDKARIFGAEVAFQRQLDFLPGFLKNFGIYVNYTYLNSEAKGIANEDGDMRGDLDLPGSS
PNMFNASLSYADKWFSARLSGNYSDAYIDELGGNAFEDRFYDEQFFLDFNATVFLSRNLQ
VYANLNNITNQPLRYYQGVKNRTMQMEYYSTRLTFGVKYDLF
>KECLDBNJ_00464 3-phytase
MKNLKYIAGIGAAVVLFSCGSKKSQLPEIKPDIITEHVKYDTDDPAIWINPEDASQSIVF
GTDKDTDGGIFAFDLEGKIIPEKSIPNIQRPNNVDLRYGFPVTDSTQTDIIAFTERERKM
LRIYSVPDMKPLDGGGFPVFADDANEAFQYPMGVSLYKSAVDGAFYAIVGRKTGPTENYL
YQYKITTQADSLVGFDLVRKFGNFSGKKEIEAIAVDDAMGFVYYSDEGDSVKKYYAEPAK
GNEQLAAFGQEDFLEDIEGIAIAAYEDGSGMIIVSDQQYGQFNIYDRKTNELIRAVNLTT
TETDGCEVVTVPLNDTFKNGLFVAMNDDGTFYYYDLGKLK
>KECLDBNJ_00465 hypothetical protein
MISTTTFAGFPVERVAKATTEVNAADEASSELISPAAVAADRQTVAILLWLFLGAFAAHR
WYLGSPILWNIVFILTAGFFIVGWVIDGIEIITGTYPGL
>KECLDBNJ_00466 hypothetical protein
MRNPSFRLFLFLICLTFGSSLKAQEYEFFGVIKLNDTSFISYKVLFDRVNDSIQGYSLTD
FAGKHETKSNIKGYYNEAENLLSFEEYDIVYTKSPVVQKDFCFVNFEGKVRNLDRVKAFS
GDFKGLYADGTSCLDGMIIVNSGQEVKKRVEKIDKVVQRSRKFSDSIKKNIKVVKVLDTL
TRNIIAKNENLNIFTRDQKIKLAIYDAGKEDGDVINLFVDDKPVLENYTVLHEIKHLEFD
LKNAETKIRVEAVSEGTSSPNTVRLEVEDSRNFVRTITNLKEGEHAQMTLVKK
>KECLDBNJ_00467 Adenosylhomocysteinase
MSTKTVQYVPYKVRDISLAAWGRKEIELAEAEMPGLMALREEYGAEQPLKGARIAGCLHM
TIQTAVLIETLVALGADVTWSSCNIFSTQDHAAAAIAAAGIPVYAWKGMNEEEFNWCIEQ
TLFFGEEREPLNMILDDGGDLTNMVLDEYPELAAAIKGLSEETTTGVHRLYERMNKGTLP
MPAINVNDSVTKSKFDNKFGCRESAVDAIRRATDVMLAGKRVVVCGYGDVGKGTAASFRG
AGSIVTVTEIDPICALQAAMDGFEVKRLETVLDKADIVITTTGNKDIVRAEHFKAMKDKT
IVCNIGHFDNEIQVAWLNENYGDTKDEIKPQVDKYTIDGKDIILLAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWKNSDNYENKVYMLPKHLDEKVAALHLEKIGVELTQLNEEQA
EYIGVTVEGPYKPEYYRY
>KECLDBNJ_00468 hypothetical protein
MPLFKTITPNPSTQVYIWKVEESVEALSENVNLTPHCQARFESMKSQLHQRGFLSIRHLL
HVAGYTDQDLYYTENGKPHLKDGKYISITHSYNFTAIIVSETVEVGIDIEMQRDKILRIA
SRFTPLKEYRTLANDDAVIRKLTIVWGAKEALYKIYGVKGLSFLQHINVTDFDFEDYKTD
AVINYHGKHSKYAIDFLEFEGFTCVYAQAL
>KECLDBNJ_00469 Geranylgeranylglyceryl phosphate synthase
MIEKLAHSGTSIYSALLKSIEAEKPLFAILFDPEELSETLLTQQLSKLPVFTTHILVGGS
TATQAQTQVAVNLIKQKTSLPVLLFPGDYRQITAEADGILFLSLLSGENPEYLIRQQIQS
VGKLRASALEIIPTGYILIDGGKQTTVERVSQTQAIPQEMVQRIVDTALAGEYSGKKLIY
LEAGSGALNPVSVEIIQAVKDAISIPLIVGGGIRSQSKLEAIYAAGADLVVVGTAFEKGD
F
>KECLDBNJ_00470 Nicotinamide riboside transporter PnuC
MNAVFDFFFGQYAEYETSSIILEIIAVIFGLLSVWYSKQNNILVYPTGMISTSIFVYLLL
KWGLLGDMMINVYYFSMSVYGWYVWTRKVDATHVTPIARATMKDHLWSGIIFVATVLFVF
AVYTYFEKWTSWTAYVDTLTTAIFFVGMWLMAKRKIENWIYWIVGDIISVPLYFYKGFTF
TSFQYLIFTVLAIYGLIAWKKYLNNTPETA
>KECLDBNJ_00471 Trifunctional NAD biosynthesis/regulator protein NadR
MSKALAKQYEAAWVPEFAREYLQQKWDQEQKICEPKDILPIAIGQMKLENAAANSRKKLV
FCDTDLLETKVYSEAYYDGWCDEQVVAAALENEYDLYVLTYIDTPWQADDLRDRPEQREE
MFALFENALIKNNRPYILVKGSIEERIKRITNHLNSILN
>KECLDBNJ_00472 hypothetical protein
MNFTDQEINEIKDHGLTIEQVKSQIDLFTNGVPNVKLVAPATVADGIFKLTEEEELKYLD
FYESHKKELDLLKFTPASGAASRMFKKIYQFLEDYDASKDTIDEYLERTGDKHMKNFFAG
YKKFPFYNHIIDGLDEETKKDENATKYAFIKTMMAEDGENYGNLPKGLIPFHYYGSYMAT
AFEEHLHEAAAYAAKNGQADLHFTVSPEHKDAFKKEFDKIHASVSNTTNVSFDVDYSFQK
PETDTVAVTMDNKLYRKGDGSLLFRPGGHGALIENLNDVDADVVFIKNIDNVLVQDNIQA
LSRTKRFLAGLLLKKQESIFKYAELLDKDSIAEGELEELVTFLQEDFSTRIDEAYASFST
EEKKSYLKELLDRPIRVCGMVKNEGEPGGGPFWVEDESGKVALQIIESAQVNDKDAKQEE
IFKNSTHFNPVDIVAGVRNYKGEKYNLLDYVNPDLAFIAYKTDGGNEIKALELPGLWNGA
MARWNTLFVEVPLETFNPVKTVNDLLKPSHQAQAE
>KECLDBNJ_00473 Peptidyl-tRNA hydrolase ArfB
MNKEALLKECDFKAVRSSGPGGQHVNKTSTKVILHWSLKDSNVFSEEEKERLFKRLKSKL
TSDDQLVLSYDQSRSQHKNKDEVFKNLVRLLENGLLKPKRRKKTKPTLASKKRRLDSKKR
NAEKKANRKPPSF
>KECLDBNJ_00474 hypothetical protein
MTVAAAATMLFATQNIKAQETTEDVAMMQTEVEAPVQDGFEKIEASALPEMVTNAVATDK
AGATVAEAYYNEELMVYKLVLEAEGAEPETAYINEEGKWVKIQK
>KECLDBNJ_00475 hypothetical protein
MKNLVMTVAAAATMLFAAENVTAQETQDVAVTTTELQAPVEGYTKIEVADLPVTVTDAVA
EDKEGAKVTEAWVDAENKTFKLTLEAEEAEPETAYINAAGEWIEPKE
>KECLDBNJ_00476 Transcriptional regulatory protein ZraR
MSKILFIEDDVAFCKMLETFLSKKGYELSSAFAAAEAYKILAKDTVDLVITDVRLPDDDG
LSILKHIKEDHGNIPVILMTGYAEVNKAVEAMKEGAFDYISKPVRPDELLKIVDKALQTE
TVSKPEIPKSKPEVSSTTTPNEPLQPTSGFIKGVSDASAKLNQYIDLVAPTNMSILITGD
SGTGKEYVAKSIHDKSKRNGEPFIAVDCGAIPKEIAGSEFFGHVKGSFTGAVNDKVGHFE
AANGGTLFLDEIGNLSYELQVQLLRALQERKIKPVGSNKEIAVDIRVVAATNEDLEEAVK
EGEFREDLYHRLNEFSIEVPRLSERQEDLMLFINLFLDQANKELEKDVEGFSPDAVESLI
QYAWPGNLRELKNIVKRMVLLAPSSLIPKELLPREIRMAKVEDKKDDYALFNAKNEQERI
LDALEKTGGNKSKAARLLDIDRKTLYNKLKQYDIKL
>KECLDBNJ_00477 Autoinducer 2 sensor kinase/phosphatase LuxQ
MKNTKRSITLKVLTGYIMIGLLVVVAIYFIYPQIKTFIYPPKKEQATNQKLTFTSNALSY
LYEAETIGRTAMATGSQRQFKEYQVLVDSIKIELDSLQRITDTKEQNEQLDSIKMLLSNK
TSNIRAMVRLRDEQYSRNYYDEALDELVKEDIYFEDYANDPRLDSVDPYIKSVIVDFNEY
IRKDTRDEDQGLKSMAETVRKTLSNIEARKKELEIDIINRENTLLANDRNINLKIRNLLS
TLEREGSFSARQREAFLNSRIQEITKTLKIIGIISVVLAIGFVIMIFKDASRSQQYSKNL
EQSNATAQSLLKSREQLMATITHDMRSPLNTVLGFTDLLKKTAVDAKQMRYLDTVQKSGD
YILKLVNDLLDFAKLEAGKISIEKIPFNPKKLIEDVIVVSLPQPLKQGVEIRTEIPDELD
AIFLSDPFRIKQILANLITNAYKFTEEGSITIALHKNGKNLRFKVIDTGCGIPKEKQQLI
FKEFSQAEETTQRKYGGFGLGLSISQKLTELLNGKLQLKSIPGKGSTFTLIVPVEQTEQQ
EPADFEEDLSEVKFDALRRILIVDDEPVQQQLTKATLAPFNLKIDTASNGKEALQQIEKN
EYDLILSDIQMPVMNGIEFIKALKANSRSQDIPVIALSGNETLKQADYKHFGFAANLRKP
YKPAALIAILKGLSTAQIEEKQNIPSTATTATTSGRLYDLKQLKAFTADDDASLKNILIV
FAESTAESLSQLKEHREDPEQLNQVAHKMLPMMRQLEADDVVQPLVILEKPDLEDRSAIA
IQDLVQQAIEQTELLLKQLKEDQDL
>KECLDBNJ_00478 Vitamin B12 transporter BtuB
MKTLLFACAATLTTFGALAQQTPQDSTDVEKLDEVLVQSVRVDADSPITYSNLSKAEINE
RNLGQDLPILLNYLPSVVTTSDAGAGVGYTGFRVRGTGNRGINVTINGIPYNDAESLGTF
FVNLQDFSSSIESVQLQRGVGTSTNGAGAFGASLNILTDAATPEAYAEVNASGGSFDTRR
ANVKFGTGLINDHFSFSGRLSAIKSDGYVDRASSDLKSYYLQGEYRNEKTLLKAVVFGGH
EVTYQSWNGIDAQTLAMDRTYNPIGFQYDDDGNFQGFYEDQVDNYKQDHVQLHWNQKYGG
GWSTQLSLNYTMGRGFFEEYVDSWYYANVNFSSDATFDFIGWEPYEVDGELQTDTDLIRR
RWLDNRYYVANLTTNYKSNSVDFDAGVFGSIYSGDHYGEITWARYFAQDEEAGYRYYFGT
ADKNEFTTFAKATWRINDMWSVFGDLQGRFISYETDGINSDIDEFIIDENYSFFNPKAGL
TLTLNEENKIYASYARANREPSRTDFENGNPVPETLNDFELGYRFTKERARVFANLYFMD
YRDQLVLTGAIDDVGAPIRQNSGSSYRLGLEVEAGFQLGRQFAITPNIALSTNKNRDFFF
QRDGELQNLGNTNISFSPEIIAGNRLDFFPVQNLRLSLLSKYVGEQYLGNIDAESSKLDA
YFINDFNVQYDLKNIGFAKRVTLTALVNNIFSEEYVSNGYFFTYDDDFSNPGTVTTIEGA
GYYPQAKINFLIGATVRF
>KECLDBNJ_00479 hypothetical protein
MINPNFFFRTKLLLCFLAFSVVLQSCSSDDNRINNPNVNPISFSVNLNTNLPEYSQLQFP
GNSVYVSGVGIRGIFVINTGAGIRAWEATDPNHVPNSCSTMTLNGTEATCPCEENTYTLF
TGQDTAQELPYTLIEYRVAENGNLINVSY
>KECLDBNJ_00480 Transcription elongation factor GreA
MSKVSYYTAEGLKKLKDELNQLKDIERPKASQAIAEARDKGDLSENAEYDAAKEAQGMLE
MRISKMEELVANARIIDESQLDTSKALVHSTVKIKNQTNGMQMTYKLVAQSEADLKSGKI
SVDSPIGKGLLGKKVGEVAEISVPNGTMKFDILEITRD
>KECLDBNJ_00481 putative HIT-like protein
MASIFTKIINREIPGHIVAEDEQHIAILDINPNAKGHTLCIPKKEVNKIFDLPEAEYMAL
MAFSRKVAKALEKVVPCERIGVSVIGLEVPHVHVHLIPLTTMEDARFISKTKLAQEEFEA
LAQQIQAAF
>KECLDBNJ_00482 hypothetical protein
MASSFVKFGESKLRNNCPKCYAQDGLSFTFYNKIEDNKLLTKATKEVKGELHCSHCSSQI
YPGLWTDEIDRVYLYNLKRIGNPETYTRFKPLAIIILIAIVVVAAAAAFAIYRLKMAA
>KECLDBNJ_00483 GDP-mannose pyrophosphatase NudK
MNDKVRNMKVSILSDNWYTLNKVDFEYLNNQNTWEHQSREAYDRGNGAVVLLYNPDQKTV
ILTRQFRMPTYLNKNSDGMMIEACAGLLDENDPKTAIIKEIEEETGYRIKTVEKVFESYM
SPGSVTEILHFFIAAYSESQKVSEGGGAVDETENIEVLEYSFQDALALIKTGEIKDAKTI
MLLQYAQINLADLMK
>KECLDBNJ_00484 Sporulation kinase A
MNFNKDQRFIRWFIIFAAVVITALILWNVSLFFDQLKQAERDRMEIWATSMEAFNTEDIN
QYYALSQKINSKNQYIPIIITDYKDSIVNSINIPENILENPIRSQELLLEMATENDPIRI
DILGGELWYAYYGHSPVINQLKFFPVVLVIIVILFIAVIYFFYATSKASEQNSLWAGMAK
ETAHQIGTPLSSLVGWTEILKAEQVNPDYIEEINKDINRLETITGRFSQIGSIPKLDPKN
IITETQEAFEYLANRSSKLIDFEIDVPQGQLFVMLNKELYAWSIENLVKNAIDAMKGKGK
LTLTVKRDTRFAKILIKDTGKGIPKMNFNTIFEPGYTTKKRGWGLGLSLTKRIIEEYHDG
QVRVLHSELNKGTTFQIALKLIDE
>KECLDBNJ_00485 hypothetical protein
MSTETLSIDPKTSENARVYGLLSAAVGPRPIAFASTLDAEGKPNLAPYSFFNVFSSNPPI
VVFSPVRRGRDNTTKHTLDNILATKEVVINVVNYAMVHQMSLASTEYETGVDEFIKAGFS
KELSEAVKPFRVKEAPVQLECKVNEVVALGTEGGAGNLVVCEVLRIHIQKAVLTEAETID
EHKIDLVARMGGNWYTRAIEGMFEVPKPLRNLGVGVDALPEAIRLSTVLSGNDLGRLGNI
EALPDEEAVKAFLSENEDLKEVVSSGNQEQLHQAIKELVNQDRTGDAWKLILA
>KECLDBNJ_00486 hypothetical protein
MEVQGKIKLIGDVQTFGNNGFRKREVVVTTEEQYPQPIMVEFVQDKTDLLNNFNVGQNVK
ISINLRGREWVNPQGETKYFNSIQGWRIESLESAAPSAGIPPVPPADQFEPASDFDDDDH
DDLPF
>KECLDBNJ_00487 Leucyl/phenylalanyl-tRNA--protein transferase
MSPARLIDAYSQGIFPWYNDGQPVLWWSPDPRMVLKPQEVHISKSMRKVLRDAKFKVTYN
THFLDVILNCKRIKRDDQDGTWITNEMVEAYLNLHKLGYAESVEVWQDEVLVGGLYGVNL
KEKQVFCGESMFAKASNASKVALISLAHKLAQQDYKLIDCQVYTTHLESLGAREITREAF
LSYLR
>KECLDBNJ_00488 DNA-3-methyladenine glycosylase 1
MTKHRCGWCVGDPLYEAYHDQEWGVPVYDDQTIFEFLILETFQAGLSWITILRKRENFRE
ALDAFDYKKIAAYSDVKLEELLQNPGIIRNKLKVKATVSNAQAFIKIQEEFGSFSKYIWS
FVNHKPVQNSVKNYKEAPATTAISDALSKDLKKRGFKFTGSTVVYAHMQATGMVNDHEVN
CFRYAEVSKLQ
>KECLDBNJ_00489 hypothetical protein
MTITTLERQELVTEARKNALTYADYRILVAKHAQSFTSTGHTQTEALSNYTVLNDRRMKR
WDKTLKFTPAQEDELKNYTRPVNWLVLTESWCGDAPAAVAVMHKMAELQPAINFKLVLRD
DHPQLMDAFLTNGGKAIPKLIVQNPENNAVVTSWGSRSKAAQQLVTDFKAENETITPEFI
NTLQKWYNDNKGQAVVEELLAILKEFNLETQN
>KECLDBNJ_00490 hypothetical protein
MKLSPQDKAMLITFSGASILAVVFLFFTIKPYDTSQVEEFIPIPIIAEELPEEELLEQTE
EEQPQSQEITNQAQSSSRLVREANRFFSQQNEVENALKSDTETADPSEDTDGDDEAFPDY
RERIAMLRQKRAAQQSAGTSDDAKEVSKVNTSSYRRSTVTYQLKERNAIQIPNPVYTCDA
TGRVVINIQVNGVGGVTKVTFNKSASTTANGCLVDQALEYAQQAIFNKSTRDSQLGSISF
EFQG
>KECLDBNJ_00491 tRNA pseudouridine synthase B
MQFTEEYFKEGQVLLFDKPLNWTSFQLVNKVRWLIRKTFKIKKIKVGHAGTLDPLATGLL
IICTGKFTKRIEEFMGQEKEYTGTIVLGATTPSYDLETEIDQTFSTAHLNDELIKKTTAQ
FTGSIQQQPPVFSALKKDGKRLYEFARAGEEVEIPSRTVEISEFEITRIEVPEVDFRVRC
SKGTYIRSLAHDFGKALNSGGHLSALRRTKIGDFNVKDATSLESFEAALKQAETSNN
>KECLDBNJ_00492 Undecaprenyl-diphosphatase
MDIIDAIILGIIQGLTEFLPVSSSGHLELGKAILGDSTLPEESLLFTVVLHFATALSTLV
VFRKDILDILKGLFQFKWNEETQFAVKIIISMIPAVIIGLFFEEQLESLFGGNILLVGMM
LIITALLLWLADKAKDTQKPVSYSNAFTIGIAQAIAMLPGISRSGATISTSVLLGNDKSK
AARFSFLMVVPLIFGKIAKDLLSGEITTESGNFTALSIGFVAAFVSGLIACTWMIKLVKK
SKLSWFAIYCLIVGIIAVGFGYYNL
>KECLDBNJ_00493 hypothetical protein
MGEQKRKKQNELHRSSFIFKKKNYKVMLIGLGVIALGFILMSGGGSDDPTVFNPEIYNWR
RIRLAPALVLIGFGIEVYAILLNPDKKKNAN
>KECLDBNJ_00494 Cell division protein FtsX
MASSFEKFQRRRLISSYFSVILSIALVLFLLGLLGLLVLNSKKVADHFKEQIALTIYLKD
DAKDVEIKQLEKTLALADYTKSTQFVSKDEAAEEHSKEIGENFMDFLGYNPLQNSIDVYL
KADFVDAAQVKEIADNLLAKDFVEEVNYDQPLISLLNDNIKKISLWVMVISGVFTLIAVL
LINSAIRLSVYSKRFTIKTMQMVGATKGFIRRPFIWLSMKLGMVGAVIALAGMAAVLYYL
NQTFPELELLADPVILAILFVGVFLASVLITWFSTFLATQRFLNLRTDELYY
>KECLDBNJ_00495 2-dehydropantoate 2-reductase
MNILIYGIGGVGGYFGGKLTKTKNHVTFIARGKHLEAIQKNGLEVTSYKGDFVAEPDLAT
DDLNEIPTPDLVILGVKSWQVPETIEALKPYVKAETLFLPLQNGASNAEKILEVLPDAQV
LGGLCRIVAFKDGPGKIKHPTFEPSITFGELDGSLSERAKELQALFEEAGFTAHLVEDIQ
VEIWKKFLFICTISGIGGLTRVPMGKIRSSAYLFKMMQDTAKEIFNVAKAKGIALTEKHM
EAVFEAIQNQGAEVTASTQRDIMEGKPSELNNFNGYIVREGKRLGVSVPVNEMIFECLLP
MEKEARS
>KECLDBNJ_00496 Leucine--tRNA ligase
MNYDFNAIEKKWQKYWSDQGTFQAKNNSEKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
YARYKRHQGFNVLHPQGYDSFGLPAEQYAIQTGQHPAITTETNIARYREQLDKIGFSFDW
RREVRTSNPEYYKWTQWIFIQLFESWYNNDTNQAEHIDTLIAKFEAEGNASVNAVCDEDV
EAFTAEDWNSASAKAKQELLLKYRLTYLAETEVNWCPALGTVLANDEIVNGVSERGGHPV
VRKKMTQWSMRISAYAQRLLDGLQDIDWPQPLKDSQTNWIGRSKGASVQFKIQNSEFKIE
VFTTRPDTIFGVTFMTLAPELDLVKEITTPEQKAEVDAYIEATAKRSERERMADVKTISG
AFTGAYAEHPFTKEPIPIWIGDYVLAGYGTGAVMAVPCGDQRDWDFATHFNIPIKNIFDG
VDISEQAYAEKDKTPLKDSDFLNGLAYKQALPKAIEALEKLGAGKGKVNYRLRDAVFSRQ
RYWGEPFPVYYVDGMPQMIDAAHLPIHLPEVEKYLPTEEGEPPLGRAEVWAWDTKTHAVV
SNNKIDHETVFPLELNTMPGWAGSSWYFFRYMEKALRDEAFASKEAMEYWQNVDLYIGGS
EHATGHLLYSRFWVKFLKDRGFAPVEEPFKKLINQGMILGESAFLYRLSSNPEFFVSFEI
VKDYLNDETNKKAVNTILSYTGDNSISFNKIHVDVNLVDTSNCLNVIEFRNWQPEYHSAK
FITYDNQTVKVSREVEKMSKSKYNVVNPDDICEEYGADTLRMYEMFLGPLEQAKPWNTAG
ITGVHNFLKKLWKLYHQVDKAGNLGDFEVSDARASREAMKTLHKTIKKVQEDIENFSFNT
SVSTFMIAVNELAAAKCNNREVLEPLAVLISPYAPHIAEELWILLGHDESIATAAFPEFD
EKHLVESSKEYPISFNGKMRFTMELPLDLSKEEIEKAVRAHEKTQEYLGGREPKKVIVVP
GKIVNFVG
>KECLDBNJ_00497 hypothetical protein
MMGYYILIGAIALVSWLVSNKLKSKFKEYSQVHLQNGMSGAEIARKMLSDNGITDVKVIS
VQGQLTDHYNPAKKTVNLSEPVYNQRNAAAAAVAAHECGHAVQHAKAYSWLTMRSKLVPV
VSVASRMSMFVIIGGIVLMSIIGSGLGMTVAIIGLGLFAMGTLFSFITLPVEYDASNRAL
AWLESANMLTPREHDGAKDALKWAARTYVVAAIGSLATLLYFALQIFGGRR
>KECLDBNJ_00498 hypothetical protein
MMLTKAHLKKQIDSLPDEFSIDELVERLFLIEKIENADRQSEAGEVLTENQLMQELNNWF
K
>KECLDBNJ_00499 Tyrosine--tRNA ligase 1
MITNFVEELQWRGMIHDVMPGTEEHLMEQMRSAYVGIDPTADSLHIGHLVGVMMLKHFQA
SGHRPIALVGGATGMIGDPSGKSDERNLLDEETLRHNQEAIKEQLSRFLDFDSDEENAAV
LVNNYDWMKDFSFLEFIRDVGKHITVNYMMAKDSVKKRLSAESAEGMSFTEFTYQLVQGY
DFLHLYREKDLTLQMGGSDQWGNITTGTELVRRIGGGKAYAMTCPLITKADGTKFGKTAG
GNIWLDAERTSPYRFYQYWLNTSDEDAAKYIKIFTFLGKEEIENLIAEHQEAPHQRALQK
RLAEEVTISTHGVENYENAVKASEILFGKSTAANLKALNEKTFLDVFEGVPQAEVSRGEI
EAGLDMVNALAEKTGFLKSNGEARRALKQNSISVNQEKVAEDFTITTDDLINDRFVLLQR
GKKNYFVIRILD
>KECLDBNJ_00500 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MPNFVAMILVTGGTGLVGSHLLWQLVAQGENKIRAIYRTEAKIKAVEALFQWKNEREGTD
EFKADFWQIEWLQADVTDIPALTEAFAEITRVYHCAALVSFNPKRFDELQKNNVEGTANI
INLCLKHQVEKCCYVSSVAALGDSVKAITEETHWEANKENSVYGISKFASEMEVWRGTQE
GLDVVIVNPGVILGEGFYDSGSGTIFKQIANGLKFTVPGATGFVDVVDVVRAMIALMQSD
VLNERFILVGHNLAFETVLKKTATALGVKAPSKMLKKWQLDLAWKIDWFLSLFGKRRQLT
KSTAKSGYTKTVYEAEKLKTPFPEFEYTPIETTLSRVAKHFNYSQELK
>KECLDBNJ_00501 hypothetical protein
MIKKGYILLLVVLAVVSCHDIERPKKPDNFIEREKMTDILYDISLLRALKTYSVNDMRAL
GLEPDTFIYDKYDVDSLQLAQSIDYYSVNFNEYTSIWEEVNARLTAQRDEIQFEQNDLDS
IRIEESKRRRDSIKKANQPRPDIELENDSILAPVSS
>KECLDBNJ_00502 Allantoinase
MEKVLIKDAHIVNEGTIMRGDVYIEHGIIVEISQNLSVKGPDVHVFDAEGKHLLPGVIDD
QVHFREPGLTHKATIGSESRAAVAGGITSFIEMPNTIPQATTIEKLEEKFTRAAETSHAN
YSFMFGGTNDNLSEIKKVDKSKVAGLKLFLGSSTGNMLVDDEEVLREIFKSTDLVISVHC
EDEETIKKNLAIYKERYGDDIPINMHPIIRSEEACYLSSSKAIALAKETGARLHVFHLST
AKEMELFSNKIPLKDKKITAEVCIHHLWFSDEDYEDKQTLIKWNPAVKKKTDRAALWEAL
LDDRLDVIATDHAPHTLEEKQNVYTKAPSGGPLVQHALPAMLEKYHEGKISLEKIVEKMC
HNPAILFEVEKRGYIKPGYYADLVLVDLNNPWTVTTDNILYKCKWSPFEGNTFKSRISHT
FVNGQLAYKNFKVYDEKHGKRLTFNR
>KECLDBNJ_00503 Polyprenol monophosphomannose synthase
MAGSLVIIPTYNEAENIEKLVRNIFAQQRAFEVLVVDDNSPDGTAALVKNLQQEFIGQIH
LLERPGKNGLGTAYIAGFKWALERDYAYIFEMDADFSHAPNDLIRLYNACAKGGADLAIG
SRYKTGVNVVNWPMGRVLMSYIASKYVRFITGLDIADTTAGFICYKREVLEKITLDKIKF
VGYAFQIEMKFKAHLLGFKIIEVPVIFVDRTKGTSKMSTGIFSEAVFGVLGMKFKSLFKS
YDI
>KECLDBNJ_00504 hypothetical protein
MQALERSFISNDWITIVFVTCLVLIAVAKAVYETRFVDFVELLINEKYLLKANKDIRFEN
PFNLILFTIQFFSISLFIYIVFNELNVLTDASNFLLYVRIVLAYVVFVSLKFFIERMLGV
LFNGEQELNSYQFSKLSYRSYFALLLLPVNAIFIYALAPGFIAIVIIVILFLIFNVISLF
NTYRRYENMIYNNLFYFILYLCALEIAPYFILYKVFSFI
>KECLDBNJ_00505 hypothetical protein
MSMKVKTILVSQPEPKVENSPYFELQEKKKVKVDFIPFIHVEGVSGKEVRHQKIDLSKYT
AIILTSRNAVDNFFRIAEEMRFKVPDSLKYFCQSEAVAYYLQKYVVYRKRKIYVGKRTFT
EMSPILKKYKNEKFLLPSSDSLKPEVPNVLNDLNLKWDRGIFYRTVVSDLSHLKDVTYDI
LVFFSPSGIKSLFENFPDFKQNDTRIAVFGNSTIRAVEEAGLKVNIKAPTPETPSMTMAL
EKYIDDVNKK
>KECLDBNJ_00506 Phosphoenolpyruvate carboxykinase (ATP)
MAPTALFTKTIAMTQYGIKNATIHYQLPPEELHQICVLLGQGTTTDSGALAIETGKFTGR
SPKDRFIVIDEYTRDKVWWGAINIPFDKAKFYRLKEKMTTYLSDRKLYVRDAFACADERY
KMGVRVVNEFPWSNLFVYNMFLRPSEDELENFKEDWLVLNAPGFKADPEIDGTRQENFAI
ISFEEKTILIGGTGYTGEIKKSIFSVLNFVLPTEKNTLPMHCSANVGEDDQTAIFFGLSG
TGKTTLSADPNRKLIGDDEHGWTADDTIFNFEGGCYAKVINLSEAQEPDIFNAIKRGALL
ENVIVDHQKQVDYSNTSITPNTRVSYPIHHIENIQKPSVGNNPKHIFFLTADAFGVLPPI
SKLTPGQAAYHFISGYTAKVAGTEAGVNEPVPSFSACFGAPFMPLHPTHYAEMLSAKMKK
SGVNVWLINTGWTGGPYGIGKRMELKYTRAMINAVLNDSFSPINHEDYHTHSVFGVAQPR
SCPGVPDEVLSPRQTWGNDEAYYATAHKLAVSFKENFKKFEAHANEEILEGQPPLG
>KECLDBNJ_00507 hypothetical protein
MQRTLLITGALLGLTAVILGAFGAHGLKESLTPEAIDSFETGVRYQMYHAFLLLLVGTAL
PLSQKAQKISFYLILIGVILFSGSIYLLTTKPITGIDISAIAWITPIGGALLISAWIAIT
YNFIKLLK
>KECLDBNJ_00508 hypothetical protein
MRNILIIGAGKSTAQLIKYLADKASEEQLQLTVADRDPAQAKRLVGNLACANAITLDIAN
AEERQQQISKADIVISMLPARLHIDVARDCLALNKNLVTASYISDAMLELDNEVKMKGLI
FMNEVGLDPGIDHMSAMRVIDRVRDAGGKMLLFESFCGGLVAPESDTNLWNYKFTWNPRN
VVLAGQGGAAEFIQEGTYKYIPYQRLFRRTEFLDVEGYGRFEAYANRNSLKYRSIYGLED
ILTLYRGTIRRVGFSRAWNLFVQLGMTDDSYTLQDTEAMSYREFTNLFLPYSPTDSVQLK
LRHMLKIDQDDLLWDKLLELNLFDDNRRIGLKEATPAQCLQRILEDQWTLAETDKDMIVM
YHKFGYEINGEKKQIDATMVSVGTNQTYTAMAKTVGLPVGIAALKILNKEITTPGVQLPI
WREVYNPILDELEENGIVFKEYEVPYLGYNPHHQ
>KECLDBNJ_00509 Regulatory protein AsnC
MKIVNEQIAIDGIDKIILRQLMDDARKPILEIARQVGISGAAIHQRLRKLEKSGLITGSK
FTIDPKILGYNTMAFIGIYLDRAMSNPKAVKQLEEIPEVLECHYTTGNWSIFIKILCKNN
EHLMHLLNKKVQAIDGVSRTETFISLNQQIERQIQI
>KECLDBNJ_00510 hypothetical protein
MLPDSIFQIQTQDQFKELALASFNYQWEHNTIYRQFCDHLKVDPADITELDQIPFLPIQF
FKEFKIIASDESVQTIFTSSGTTGSITSKHYVTDLKVYEKSFRESFKLHYGAIEDYTVLA
LLPSYLERDGSSLIYMVDCLIKDSKKPDSGFYLNDYNALSEKLKRLDAAGEKVLLIGVSF
ALLDLVEQFEFTLKNTIVMETGGMKGRRKELIREELHAILKEGFGVTEIHSEYGMTELLS
QGYSNGNGIFTNPPWMQVFMRDTEDALNYVAPGKTGGINVIDLANHYSCPFIATQDLGKK
LDENRFEILGRFDTSDIRGCNLMVL
>KECLDBNJ_00511 Transcriptional regulatory protein SrrA
MKKKEIKILLVDDEPDILEIVGYNLSNEGYQVITASNGKEGVKAAKKNSPHLIILDVMMP
EMDGIEACEQIRKLPGHEETIITFLTARGEDYSQVAGYDAGADDYITKPIKPKVLVSKVK
ALLRRLKEEEEGDSSVKIGDLVINREEYKIIKDKKEMVLPRKEFELLSLLASKPGKVFKR
EDILDKVWGNEVVVGGRTIDVHIRKLREKIGDKKFKTIKGVGYKFVV
>KECLDBNJ_00512 Alkaline phosphatase synthesis sensor protein PhoR
MAVNFKKSYRFAVFSSLMITVALTLFVSVFFYMTASIDWVFTILFALVCFALSFLLIQVR
VERFIYNRVKQIYDDVTLLDVTSLRRGQITTDMSSLTKEVERFAASKKLEIESLKIREEY
RKEFMGNVAHELKTPLFTAQGYILTLLDGAMKDKSVRKKYLKRAGASIERLVYLVNDLDM
IAKLEVGDLNIRYEYFDMVELVNDTFELLEMEAAKKNITLTTDMDYDYPIMVNADRERIQ
QLLTNLIVNSVKYGKQDGTTEISIENLIQNKVIVRVTDNGEGISSEHIPRLFERFYRVDK
SGSRREGGSGLGLSIVKHIIEAHDEKIYVESDFGVGSEFSFTLEKAEELPEAPLVKSDLV
K
>KECLDBNJ_00513 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKLHKTILVAPLNWGLGHATRSIPIIYALIAEGFEVILASDGMALRLLQKEFPQLESIEL
PSYKIEYAKKAKRFKWKMLLRSPKVLKAIRQEREQLKGLVKARKIDGVISDNRLGLFHSE
IPTVFITHQLQVLSGSTTRLTSAMHRNYIKKFDECWVPDFAEESNLSGKLGHPKKFEIPV
KYIGALSRLEPVETTSSYDIMVLLSGPEPQRTELEELLMHELKHYKGQVLFVRGVVEEEQ
TVTRKEQVKIVNFMETEDLQKALCASDLIICRSGYTTVMDLYKLKKKAFFIPTPGQTEQE
YLAKRLHNLGIIPYKDQEKFSLKDLSKAKVYSGFTSSFDQVRFNQGSFRELFGLFKGERK
LRSHSKVAFNINLFVMGFNNVLDDREPKS
>KECLDBNJ_00514 tRNA (guanine-N(7)-)-methyltransferase
MIIIRHFSSQNSNIHGRNKKSELLGSKNKLKRFRENETFENVIQPKREELTDQEFPLKGN
WNRDFFKNDKPIVLELGCGKGEYTVGLAQRFPEKNFLGIDIKGARFWRGAKTALEENITN
AGFLRTQIELVDKAFADNEISEIWITFPDPQIKYKRTKHRMTNPEFLARYKAILKPDGLM
HLKTDSEYMHGYTLGLLEGLGHEILYAHHNIYINHEAPKEVVGIQTFYEKQYLEKGKPIT
YIKFKIN
>KECLDBNJ_00515 hypothetical protein
MEITKLFFITYFAAFLGVLPPGLVNMSVAKTCVHRGMRNGVLVAIGASIVVLIQAFVAIL
LARYIFSHPVVRNTLLRTGIVIFGILAVYFFVAAKKNRVKKVKIPKHSGRRSFAKGLFVA
VINVLPIPYFCALSAAFNITSVSNNGWLEIGLFTLAAASGTFTALYLYVVGFNRIQHEPR
NFAKYSNYFMAALMIVLVILTLIRMLYAKT
>KECLDBNJ_00516 DNA base-flipping protein
MPKPETLNFFQKVYEVARKIPYGKVTSYGAIAKCLGAPRSARMVGYAMNGASAMEDVPAH
RVLNRNGLLTGKHHFPGTHLMQQLLESEGHTVVDDQLQDFKKHFWDPVEVIGFEE
>KECLDBNJ_00517 Iron-sulfur cluster carrier protein
MKLEKLAIYDALKTISVPGEGEDMVTSGAVTNVVTFGDEVIVDITIKNPSLQAKKKTEVE
IMKAIHAEVHQKAKVKVNVRVDAPEKKQVNEIKGKPIPGIQNIIAVASGKGGVGKSTITA
NLAVSLQKMGFKVGILDADIYGPSIPIMFDVQDEKPLSVKEDGKQKMKPVESYGVKILSI
GFFTKPDQAVVWRGPMASKALNQMIFDAAWGELDFLLVDLPPGTGDIHLSIVQAMPLTGA
VVVSTPQNVALADAKKGVAMFQQESINVPVLGIVENMAWFTPEELPENKYFIFGKEGARN
LAEDLDVRLLAQIPLVQSIREAGDVGRPAALQDDTILSEAFETMTRNSVEELVKRNDNLP
PTEAVKITTMAGCAAVKK
>KECLDBNJ_00518 Fe/S biogenesis protein NfuA
MTDTELKGKVEAALEEIRPFLQNDGGDISLLSIEDGTTVKVQLEGACVGCSVNQMTLKSG
VEMTIKKHAPQIERVINIEA
>KECLDBNJ_00519 Hydroxypyruvate isomerase
MSHSKSRRNALKNIALTTGGVSLGISALSCKDANQDKPQATAVEEDQALKGNINHSACYW
CYNSFPLEEFAQEAAALGLKGIDLLKPEEWETAKKYGLECAVATDSFASITNGFNDPANH
KPLQEQYAKLIDQASEAGIKNVIVFSGNKRELSEEEGLVNCAEGLAPLVKQAEEKNVVLI
MELLNSKIDHADYQCDNTPWGVALCERLGSEHFKLLYDIYHMQIMEGDVIRTIQDYHQYF
AHYHTGGVPGRNEITEVQELNYPAIMKAIKDTGYNGFVAQEFIPTYPDKIKALKEGIKIC
DV
>KECLDBNJ_00520 Rhodocoxin
MQDVTITVIDREGVAHALEAPTDMNLNLMEVCKMYELPVEGTCGGMAMCASCQCYVLSEH
KLNEMGYDEEAMLSEAFNVEENSRLGCQIPITSDLHGLEVKLAPES
>KECLDBNJ_00521 hypothetical protein
MLKYISALVAPVIIFAILGCADGDDNTSEIEEIPVNTSEADYTYLALGDSYTIGESVCST
CRFPIQLEEQIEEQTGSTVETDIIATTGWRTDDLINAINTEKPSENYDFVTLLIGVNNQY
QGRSFSQYETEFPQLLMTAINLAKGKKNRVIVVSIPDYAYTPFGQNSGNPEQISEEIDAY
NAYAREVAERRGVRFINITDITRRGIAEPNLVARDGLHPSADAYAEFTERLSPFVLSLLR
EQS
>KECLDBNJ_00522 hypothetical protein
MSSTTRFDRAFANAPVIPFSDESKFILFSDCHRGDNSGADDFANNRNIYFHALKQYYQNG
FTYCELGDGDELWENLSFDSIFESHKNVYGLMQQFYAEGRLHLIWGNHDMVYKNQSYVEK
HLHTFFDRKTDSDQPLFPGIKVHEALILKHTETNQELFLCHGHQADWMNYVAWQFNRFMV
RVLWRPLQGAGISDPTSPAKNYYELIKVERRTKKWITQRDNQFTITSHTHRPRFPEPGDI
AYFNDGSCVHPRSITGLEIENGAITLIKWQIATTEDGFLRIIRIPLEGPQKLTAYQTK
>KECLDBNJ_00523 hypothetical protein
MIKYINKAIAPYQDELLNHTLYKKLRTPADLQSFMQHHVFAVWDFMSLLKALQFDLTKVS
TPWYPIGNPEIRYLINEIVLAEETDINMEGKRQSHFEMYLDAMKKSDASLEQISSFLNHI
THGTDVFLVIAVSDIPESVKEFLRFTFEIIAEGKPHKIAAAFTFGREDLIPDMFSKIITE
IQTNFPKQDLSLFKYYFDRHIELDGDEHGPMALKMIEELCGTDSLKWEEVKHTAVEALRR
RIVLWSGIEQEITDKITA
>KECLDBNJ_00524 Glutaryl-CoA dehydrogenase
MKPDLFEAPDYYNLDDLLTEEHKLVRSAARDWVKRDVSPIIEEAAQKAEFPKEIIKGLAE
IGAFGPYIPEEYGGAGLDQISYGLIMQEIERGDSGVRSTASVQSSLVMYPIFKFGSEAQR
KTYLPKLASGEFMGCFGLTEPDHGSNPGGMVTNFKDKGDHYLLNGAKMWISNAPFADIAV
VWAKDESGRIHGLIVERGMEGFSTPTTHNKWSLRASATGELIFDNVKVPKENLLPNKSGL
GAPLMCLDSARFGIAWGAIGAAMDCYDTALRYAKEREQFGKPIGSFQLQQKKLAEMITEI
TKAQLLAWRLGSLRNEGKATSAQISMAKRNNVEMALKIAREARQILGGMGITGEYSIMRH
MMNLESVVTYEGTHDIHLLITGMDVTGLNAFK
>KECLDBNJ_00525 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MKIGTDGVLLGAWTPVDHNPLSILDIGTGTGVIALMLAQRCDAELVDALELDEDAYEQAV
ENFEASPWGDRLFCYHAHLYEFATEIEDTYDLITCNPPFFEGNAPQAEQQGSAREQARFE
ESMPFELLVASANQLLNPNGMFSVVIPFNREQEFIDLAARGNLFPKKITRVKGNAQVEAK
RSLLLFSRTQNTPQKHELIIEISRHNYTDTYQELVKDFYLKM
>KECLDBNJ_00526 Ribosome maturation factor RimM
MRKEECFYLGKIVRKFSFKGELLAKLDTDEPEMYEELESVFVEFNGNLVPFFIQSCQLHK
STLLRIDFEDVNTEEDAEDLVNAELYLPLSMLPQLEGNKFYYHEIIGFKVNDIYFGEVGT
ITGVNDNTAQALFEIDHKGKEVLIPINDDFIKKVDRSTKTITLDTPEGLIEIYL
>KECLDBNJ_00527 30S ribosomal protein S16
MPVKIRLQRHGKKGKPFFWVVAADSRAKRDGKFLEKLGSYNPNTNPATIDLDVDSSVKWL
QNGAQPTETAKRLLSYTGVLLKNHLAGGVRKGALTEEQAEEKFNAWVEEKASKVEAKKEG
LTKAQEKARKEALAAEKAVNEARIAAAQPEEEVAEEAAPEAEATNEEAPAAEESNEEEAK
>KECLDBNJ_00528 hypothetical protein
MFLEDKILNLTQLTRMSLCLAFEKFVLKHKVHFEINLLNRTTAMIKYLLFAMSVLLFCSC
SDDITFNSPAFQGVRDTVFYKADAMRYELTDAGEVTIYGSLGTQTVQLVLPNYGEGTFEL
GPTNAARANYTNVRGKVFSTNFDGEGEVIVERASDSTYTGTFRFRAVTSVDTTEVYFTKG
VFYEVPYYFEPVPPVLDPVVPNSFYCRINGTAFTPPSVSASAGPNFITGTGANNTANIRL
RLPRTIEKGTYPLTDFTVDSPYQAAYFSGFNTLVQSGTVTITSHNTQEGSIGGTFSFTAQ
GASTIQVTQGTFGFNYL
>KECLDBNJ_00529 hypothetical protein
MGQRVYNILFNLHTVSGIVISVALYVIFFAGSFSFFRDEIVAWERNEQALNEDNLPQDID
QILTHLDEKYVLEGRDVNLKTYYAERAIAVNLSASKDSLAPEKAKQAAFFYIDPVSLEEQ
SYTDAYSLGEFLYRLHFFAQIYYPVGYYLSGFVAFFFLFAIITGVLVHWKKIVSNFYTFR
PWAKLKTLWTDAHTALGILGLPFQFILAVTGAFFMLKALLVAPSVLSLYHGDQAQLYKDL
EYDIPVYEFTYQPIQALPSINTYIEKTQQEWKDYDLNEVAIHNYGDANMQVTLNGKLDYQ
SKFNALGSIVYTPATSEQRIVKDPYQPASYLDAVKNVMFRLHFGDYGGYFLRVVSFILGV
LSCIVIISGVLIWLVARDRKNLPDKKRKFYNRVAHIYMAICLSMYPVTAAAFIAVKVNQG
AGQSFLYWFYFLLWAVLNVFLILKKDLKYMSDFCLLSGGILAFLIPICNGIFSQAWFWQT
FAQGHVQIAFIDVSWIVLAIISFFAFAKSKKSKTKLAYK
>KECLDBNJ_00530 hypothetical protein
MPANSKYLTSSGWQRFGKISAGILGGYLVAQTAHLALAAYLDHVVILITATFSLFIVWAV
LIILAFLAKNPWKIWGLYLAISIVFSVFVYLAPPLATLPS
>KECLDBNJ_00531 hypothetical protein
MSYLALALLICGFYVLYSTSTKMQPKKKHVKPQVFYRYPIRSKISGVLLLILAFILFTIA
MGLATGIFTWFVCLMTVGSLIVLLKPLDLFKR
>KECLDBNJ_00532 hypothetical protein
MKTVYLLVLALFLSASNKALAHYLWVETAATGKQNKKQEVRVYFGEYTYGVIEEVEGNAF
KDVADFKLWLVDPSGKKMQLNTTAKKDHFAAAFTPTEKGAYLVYLENRNINVLDYTEYDF
GIFKPEYQSFKQVLVGTETPVEVKKYTEGLIIKEISNTADAVKLQVFYKGKPLAEGEGTL
SMKDLWTKKVTTDKQGYLNFDKPFDTKYILEITHNEKVPGKFKGDAYEFIWHCATYCNL
>KECLDBNJ_00533 Ferripyoverdine receptor
MRKFLQVLLFLGITLSAAAQDATLKGLVTSQNNTPLTGATIELNQTTLGTTTDNTGAFEL
NRVPAGAYRLSISYVGFQTRYVDVSVSANNTKDLGTIQLVEAQEMLGVVSINGKKHNKFT
RETSVSVSKMPLADIENPQVYNTITSSLLEEQIVTNFDDALKNAPGIDKLWESTGRGNDG
AGYYSLRGFAVQPTLVNGLPALTNGSPDPANIESIEVIKGPSGTLYGSSLISYGGLINIT
TKRPYYDFGGSVSYTSGSYGLNRVTADVNTTLSKEKNIALRVNTAYHTQNSYQDAGFRKS
FFFAPSLAYQVNDRLSFYINTEFYNGRSTNQTMLFLDRGAPLRVTNIDELGYDINRSYTG
NDLYIDTPTYSFQGQMNYKLSDSWTSQTAFSRSNSKSDGYYSYLYEGTQYTTVDEGIVLN
RYISKQNSETIATDIQQNFIGDFNLGTMRNRMVVGLDYLKTNVINNNSAYVSNGGIYIGN
NLQEFNEEVLGITDPANYTDDSGILNQPGTDALLAGSPINPSTTEQEIFSAYASDVINIL
PELSAMASLRIDRFSNANHAQTALSPKFGVVYQPILNKVSVFANYMNGFSNVAPVDEVTN
GVTTNRALDPEHANQFEAGTKFNLLNGRLSATLSYYDIQVKDRALRIDVDATNYFYTQDG
TQESKGFEASFIANPIDGLNIIAGYSYNDSELTEGAADFVGLRPESAGPQNLANLWASYQ
LTSGTLDGLGFGFGGNYASENKIFNRNLGGTFTIPEYTILNASVFYGTPDFRISLKLDNI
TNKEYFKGWSTISPQNQRSLLANFTYNF
>KECLDBNJ_00534 hypothetical protein
MHKILPLSLLILLFTSQMSFSQEDTVEDLFDKPNTAKEKNIWNYFTYDMGNVFAGVGFAY
SRPLHWQGDDFLRLGGVAAGTTGLFLLDDEIRHNFLSHKDDVPDVLLSYGRYAGAPQNNY
GLTGAIYLTGLVTKNEKLRRTGVLMISAATAAGFLQQLSKTLVGRARPGAGFGNHHFKPN
GGSAAYRSFPSGHAVLTFTTSYAIAKQFDNKWVKGGIIAVGLIPGLSRIYEEAHWASDVA
LSWAMSAFIVEAIDKYLDRKYDQKYNPDEDGMAMKKSDFEWNLTFGGNQLGVVFQF
>KECLDBNJ_00535 hypothetical protein
MESDLWRKSIGRCVSILNAYVQRSILKSKKNIYARLGLLTKALFFLCIGVVTALEAFGLG
GFKAGTSTLLNVIVKEEYGRAILILFAAGLFGYVFWRVYESIVDNENYGTSLNGLAQRIA
FCFGGLVYAFIALNAIQVALQASGVYWFSSSDFQDFIHSDLGSVVVLGAAIGMLGGTCNE
FYIAFSRIFTKTIHYDKIPDSFKKWALTFGIVGYASRGFTLGVAALLLLDAAFTNRDISS
ANKEAAFTYMQYNFGTFILGIIALGFIVYSFYVLVEVRYRKIFM
>KECLDBNJ_00536 Dipeptidyl aminopeptidase 4
MNKTLHALLFAFIALGSTALFAQSSALSVEKIMQDPKWMGTFPDRINWGPQSKTIYFNYN
PEENPSDSLYKIEVSNLDKIQKVSLAERKAMTSPYGTWNQDKTIKLYSEDGALHLYDLKK
DTSKELVNLGGRLGNPTFLADEAQIAFEYDDNAYVLNTETGTLKKLTNIQEGKAREDREE
KLSEKNQWLKDENLSLLQIVREREEQDSLSKAYREMTADPEPYTFYHGDKQVAGLQVSPK
ADFVTIMLMERDRGESTDVPNYVDASGYTKNLRARSKVGEDKTVASLAVYNIKKDTVYSV
DTSKLPGITDLPDYTKDYPDKEWEEKEREVIVSQAIFSEDGSKAIVNIRSKDNKDRWIAL
LNLDNGSLETLDRQRDEAWIAGPGIGWSFGGGTLGWLPDNKHIYFQSETSGYSHLYLLDV
TTRTKKALTEGNYEVFDPVLSNDKKSWFLTTSEIGPGERHFYKMPVMGGTMQKLTNLPGN
NEVSLSPDEKYMAIRNSFSNKPWELYFKKTGSSKDAQQLTSGQSEAFQSYDWRVAENIMF
KADDGAMVPARLYVPEASVKNNAAVVFVHGAGYLQNAHKWWSSYFREYMFNNMLTDLGYT
VIDIDYRASAGYGRDWRTGIYRHMGGKDLSDQVDGVEYLIENYDIDPEKVGIYGGSYGGF
ITLMALFNEPETFKAGAALRSVTDWAHYNHGYTANILNEPSQDPIAYKRSSPIYFAEGLE
GDLLIEHGMVDTNVHFQDVVRLTQRLIELGKDNWELAVYPVESHGFIEPSSWTDEYKRIL
KLFNESLLEK
>KECLDBNJ_00537 ATP-dependent RNA helicase RhlE
MSFKKLIEPLKETLQRKGFTAPLPFQKKIFSKIKGGMSMFAIAPEGSGKTTTIVISTIQK
LKGKAFEDAPRVLIFVKDKQAALDLESEFHSYTQGTDLRVYCAYDEKNIDDQRDEIYDGT
DIVIATPKRLNKIFYLNGINLNKLKMCIIEDAGFVFRNSNLAEVTRTPESIGKCQYLVFA
EEFDSRFERWLDSFMFNAPIIKA
>KECLDBNJ_00538 hypothetical protein
MKSLLAGLGLFFCLNLLSAQEVSLMTYNIRMSTESDGADAWSKRKEYLTSQVLFYAPDVM
GVQEALPEQMDYLGKHLTGYKHIGVGREGKNKGEFSAIFYNADRLKVLEDDTFWLSETPE
KISTGWDAALPRICTYALFKDKKSNEKFYVFNTHFDHVGIEARKNASALILAKIKELNPK
NLPAFVSGDLNLEPDSAPIAVLKTELDDTHDLAPNGAFGPKGTFNGFKFTEPVTRRIDYI
FQAKSNNSKVLKHATLSDSKDLHYPSDHLPVYVLIDLKP
>KECLDBNJ_00539 Arylsulfatase
MKKLLSLLLIISALYSCKTETKKTEVAEAKSEKPNIIFIMSDDHAFQAISAYGHPVSQLA
PTPNIDRIAQNGMRMNRAYVTNSICGPSRAVILTGKHSHINGFRQNGDRFDGDQPTLPKK
LQELGYTTAILGKWHLHGYPQGFDHWKIIQDQGNYYNPNFIEAGDTTQIEGYATDIITED
AITWLDQQRDTTKPFFMMVHHKAPHRNWMPALRYANKYDSINFPLPETYFTDHEGSKASK
EQLQTIYKDMYEGHDLKMTKKLGSPELAHNPWTTDFERMTPEQRAAWDKAYQPKNDAFHK
ADLHSKALAEWKGQRYLRDYMATIAAVDEGVGNILDYLEANNLDENTIVVYTSDQGFYLG
EKGFFDKRYMYEESYRTPLLIQYPKAIKAGSHSEALVQNLDFAQTFLDYAEGNNLATDMQ
GQSLRPVLEQHVEADDFREVLYYHYYDFPAFHMVKKHYGVSTKRYKLMHFYDDIDTWEFY
DLESDPQEVQNKIDDPAYANVIKSLHKKLDSVQEVYGLTEKEFERAPAERVAREYKNFER
LRGTPMQ
>KECLDBNJ_00540 hypothetical protein
MKRQISILFVFLFITLVAQAQEKFVGQVYADLVKSTHTYSDTLKLDFYTAKQAENDSDRP
LVILVHGGGFSGGKRDNPMEVKFSQALAAKGYAVASISYNLTRKGKPTGFGCACPASEKM
DTFKQTTSDILKAIDYLKSNAEFHFDAEKIILAGSSAGAEGVLNTAYMANHPDFKYLGDY
PKIAAVVSLAGAVVDVRYITKDNAVPGFFIHGDADNLVPYNSQPHHFCAPDTPGFLPLDG
DAFIAARLKDLDTSYTLLTASQGNHDWANLGYTFVNEIATFINAVVNENQLIQHEEQVEK
K
>KECLDBNJ_00541 Beta-glucosidase BoGH3B
MKNRLSKLILAAVILIGMQTFAQEAQHIPEVEALLKKMTLEEKIGQLNLLTPGGGVATGS
VVSKNVEEKIKAGNVGGLFGVTGPDKIRQAQEIAVKNTRLGIPLLIGSDIIHGYKTTFPI
PLGLSSSWDMELIEKTAQIAAKEATADGINWNFSPMVDIARDPRWGRISEGAGEDPYLGS
AIAKAMVTGYQQQDLTEENTMISTVKHFALYGASEGGRDYNTTDMSRVKMFNEYLPPYKA
AIDAGAESVMSSFNDVDGVPASGNKWLLTDLLREQWGFEGFVVSDYTSVNEMIAHGLGDL
QAVSALSINAGLDMDMVGEGFLTTLKKSVDEGKVSEATITNACRRILEAKYKLGLFEDPY
KYSDSKRPERDILTAANKEVAREAARKSFVLLKNENKTLPLAKTAKIALVGPLANNKNNM
LGTWAPTGDPQLSTPILEGLKNVAPNAEISYAKGANISNDSAFAKKINVFGPRIEISEAT
PEALLAEALANAKTADVVVAVVGEASEMSGESSSRTDITIPESQKTLIQELVKTGKPVVL
VLMSGRPLDITEELALPVSILQVWHPGIEAGNAVADVLFGDHNPSGKLTASWPQNVGQIP
VYHSMKTTGRPAPSTEFQKFKSQYLDAVNAPALAFGYGLSYTTFEYSNLKLSSKSIGQNE
DVTVMVDVTNTGAYDGEEVVQLYLHDVVRSITPPMRTLKGFHKVFIKKGETKTVTLTLKA
EDLKFYNGSLEFISEPGEFEVFVGGDSNAALKETFTLN
>KECLDBNJ_00542 hypothetical protein
MKIQLSILFLLFTTTLAIAQDSFEQAVYHSEGDSLQYRIQYPLNYDQTKKYPLVLFLHGA
GERGSDNQSQLTHGSALFANPGMRNAFPAIVIFPQCPKDSYWANVDVDRSNYPIGITFHP
DQKPTPHLKMAGELVSSFIEEGKVDTSRVYIAGLSMGGMGTYEMVQRHPDTFAAAIAICG
AGSTEPVKNYALKTPFWVIHGADDNVVKPTYSLQIANAMLEAGAKPRVTVYEHANHNSWD
PAFEEPDFLQWLFSHTKN
>KECLDBNJ_00543 hypothetical protein
MTDDELLDLTQEETFKYFWNFANAESGGARERYLPANPSQNQNIVTTGGTGFGMMAILVG
IERGFISRTEGFNRLTTLLNFLENADRFHGAWPHWLNGSTGEVIPFSDLDDGADLVETAF
LAQGLITVGEYFKSGSSDEQALATQAFELVSAVEWDWFTQGENVLYWHWSPNNEFAINLK
LQGYNETLITYVLAAAAENFSIEPEVYNQGWAQNGGIASSANAYGYPLEVKHAGAEQTGG
PLFWAHYSYLGLNPFGLSDAYVNYETATVNHALSDYAYCVQNPLGWRDYGQDLWGLTASY
TLNADGSLGYKAHRPGDDTGVISPTAALSSFPYTPQESMAALRSFYDLENILLGPAGFYD
AFSPQQNYAVAEAYLAIDQGPIIVMIENYRSGLLWRLFMQNESVQAGLEKLNFNYTIPQ
>KECLDBNJ_00544 hypothetical protein
MRFILIVVIFAAFVACKDQNTTEENREVAATTSQTSIDEEQLLDEVQKQTINYFWDGANK
DSGLAPERIHMDDIYPSDDKNVVTIGGTGFGLMAIVAGAERGFIAKDSAFVRLQKMVDFL
DKADRFHGAWPHWLEGTTGKVKPFSKNDDGGDLVETAFLVQGLLTVAEYYKNGFEEEQAL
AAQIQRMWEEVEWDWYTQGEDVLYWHWSPNVGWKMNFPVGGYNEALVMYVLAAASPTHPI
SKEVYEKGWAVDGQIAKDTTMYGMRTILNHYEHNDDAPVGPLFWAHYSYLGLNPKGLTDQ
FGDYWKLNVNHAKIQYEYAVDNPKEFKGYGPDLWGMTSSYSMKGYAGHRPGNDLGVISPT
AALSSMPYTPKESMAFLEHLYTDLDSLVGTYGPYDAFSLQEDWYLPRYLAIDQGPIPVMI
ENYRSGLLWDLFMKNEDVLNGLQKLGFSSPYLKTEED
>KECLDBNJ_00545 SusD-like protein
MKFIYKTLLLSLFSGLVFSSCDDFVEDVDIVDPTAENSDDYLPVEFLTSVYGMHTDFSYA
FSYLGITDMISDNSDKGSSPTDTGTDKRALDNLDFTSSSVSVTAMWTQWYKTVGRASQAI
EIAQNYEGQTEVPNARVIGEAKFLRALNYFWLVRSFGAIPIQEVDLVERAPVDEVYAYIE
QDLLDAIDALPLKSDYSSTDLGRATKGAAQGLLAKVYLYQERWQDAADMANNVITSNQYS
LDPDYANIWRETGENGPGSLFEIQARGEIPQHGVQQYSQTQGARGTNGWGWGFNSPSQNL
EDAFNAAGDEIRRDATIIFAGETLFDGREVNAGVENPRYSEKAYSSINAGQGDGDKNIRV
LRYAEVLLIRAEALNELGQSSAALAPLNQVRTRVSLPAITSTDQGSVRQAIWTERRLELA
MEHDRWFDLIRTGQAEAAMAADGKTFVTGKHELFPIPNNQLVQTPEMSQNPGY
>KECLDBNJ_00546 TonB-dependent receptor SusC
MKLKITLLFLLSLITFSVSAQETKTVTGTIRDTRDVPLPGAELKVVDKNEYAVTDFDGNY
SLEVAVGDQVRITYLGFQTQTFSITNDDVYDIALQDESSELDEVVVVGYGNQKKSDITGA
IVSVDSEEITKQPATSALTSVQGKVAGVNIIANDAPGSTPTVLMRGLGTAEGGRSPLYIV
DGQPLSDITSINPNDIESIDFLKGASYANIYGIRAANGVILITTKRGKQGKTIFNFESYY
GAKTILNPVKMANADQYIQYFNEESAANGGFLLQQNQRYNTDWYDELLQTGTINNNSFSV
SGAGENIDYFLSYNLYQEKGILEDQKYNRGTIRSNNTYHLFNDRLRFVQNLNVAYTNETP
KPFGAFSTAYRQSPLVPVRYDNGRFGQSFVNQSTGVVGFTTQPGETLGRLNSHGNPVSQV
YYQDQQINTTSLQGQIAAELDITDDLMLTTRFGATKYYATSKSFTDIRDQWLNADPNRTE
AFFDAQRVPDEDGVVSTEYANNSYTIRRTESYRWNIESFLTYDKTFDKHNLSATVGISRE
NYQGGEFTESQAYDVEADPNLRNFNLRTSQLFNDNVTGDTYQSTNLQSYFGRVEYNYDQR
YYVRAVLRRDGTSDFATGENNFFGYFPAVSLGWTMTNEAFMEDNGVLDNLKFFAGWGKLG
NQAIPFNVQSINRGDGSRNTNYVFGPTQSLIVGSALGTPAVPLSWEVTEEFEAGFDFALF
NRKLSGTIDYYNRLNTNAILNVRPLLNSEYANNYFDEAAEISNSGFEFLLNWRDQIGSDF
TYNIGVNLSTNKNRVQNVKPAYDGAIGGSLGNGRITKRLSEGEPIFAWWMYEADGVWQTQ
EEIDNNTSIAGAAPGHLRYVDQNEDGIIDDRDKKHFGSYIPTYNYGINIGANYKNFDLSV
SGFGVGGNKVYNGLYNTRIGGENISEEIFNNRWTGPGSTNVHPGADRDVEASSYYLEDGS
YFRINNITVGYTVPEITNFINSARLYVTLQNPFMFTKYSGFTPELNQNGDPTNTTGIELS
AYPNTRSFIVGANFKL
>KECLDBNJ_00547 hypothetical protein
MFLKLHHRFVFVALGLLLSLCASAQNFLPPVTNYNSTTYNAASQNWGLSTDNDGTLYAAN
NDGLLRFDGERWEVFTLPNKTAIRSVFCIKDRIYTGSYEEFGYWTEDAYGSLQYTSLSKL
ISTTFANEEFWQITAWQGAIVFRSFGNLYVYNGQTITTQRPQTIITAMQVHNDKLLLGSN
YGEIFEFDQDRFQSYAENSISASSIIELSTYDNQLLAGTRRQGIYSLKNGVFSPWGSEAL
KAFLAVNELNKIQPVDQDLVILGTVKGGILYYNPKTGALKNHFRQNGLQNNTVLSLHKDR
SKIWIGLDNGIDVVVPNTAIQYLLDNTGQLGAVYDIASLGGSLYVGSNTGVHKITEQGIF
FIPGSQGQVWSLTKIEGRLFVNHNLGLFELKNDALKLVSGVSGSFGLTAIPQSSSYFNTT
YNGLRKYTLTEGTLLNQPLAEGGGAPVEHVIFEDQNYFWAAHPYKGFYRAQLNNQQQRVE
NKESYIDYEALAAYKTEIHKLEGEIAFYNAGSWYRYNSISDTLEEFEDLKAYTSYALLSN
QDNSYWFKNRNGAGLIYTNFSSDSIFIEELLLESRIIKNYEKIVKRNDSIYYITLNEGFA
RLNLAQLQRDNANQNLSTPLLNGIKTNNKALALDQSIEIPFKEAGQIEIAIAAPQLHNPK
FFYSLSNGLSGQSNGTLNFQNLQAGSYTLKIWPELNGQRGDQPLNVTFLIKRPWYLSNLM
IVVYVLLLFGVIFLVAYINKQKLNKHRRELEERLVKEQERKNQLAERNSLLEEINAKRKE
LANTTYLAAKRNSSLIDIKNDLEAVKDKGDNQKKVNSIQNKINHIIDAKDNWKVFETTFK
EINNDFFQQLLENHPTLSSKDLKLCAYLKMNLSTKEIAPLMAISVRGVEIHRYRLRKKLD
LKSGKNLSKYLIKNY
>KECLDBNJ_00548 hypothetical protein
MKSLAYFLRTNFKTVSFGWVLTFLSSFGQTFLISLYVPELIKTFAISEGTFGSIYALGTV
IASVVLITVGHTIDHKPVKKVVFLNFIGLILSCLLLSFSAYHIALLIIAMIGLRLTGQGM
LSHISQTVMSRFYGANRGKALSIAALGFPMGEAIFPICITTLIVTFGFEVAAQASAAFLI
LYLFLLSFRDLSYFDTEQSIAQKPSLKVLAKDFGGIIKDRRFAIMMPSTFMLSFTSTAVF
LYQYTFVEEKGWSVSLYAAFFTGYAITRFVMSIVGGLWVDKFTAKKLYRFFLIPQALGLL
PFAFMDSIIGALLFLIATGITTGVAGTVKSAVLAEVYGTQKLGAVNSLFSMSMILSTAAA
PLLIGFLIDQGVAFPYLMITLFGLLVLAILNSQRLGSVPPASL
>KECLDBNJ_00549 hypothetical protein
MNFISYTSAILIALLTFGTFETPKPKKKKGNTLEIVKTWELPDALEEVSGIAWVSDAKIA
AVEDEDGLIYIYDLAKNKIDKTIEFADDGDYEGIAVTGEDAYVMRSDGLLFEVQNYATAQ
PVTKTYQSAMSHKNNVETLSYDAKNQRLLTAPKDLDPNDEDIKGIYAFDLKQHLMLPDLV
ARIDMKDKAFKKFEKNKAYRTFRPSDLAIHPKTGEIYMLEGVNPKLITLDKTYAIKKVYE
LDKDDFAQPEGITFSPDGTLFISNEAHGGTANIHQVELD
>KECLDBNJ_00550 hypothetical protein
MTMNKCFTIAFLILATSSLLAQTNALSNSPYSVFGIGIPNTFTTGKTNALGGAGIALKSD
NSLNNLNPASLGAMPLKHFYFDIGYKTQLYSLSQGAGSSKQSNSTFSNLAMAFPVTKKSA
VSVVLSPYSNVGYDITGISRSIEGSTSFYTSDVTANGSVNSLDLNYGYNFFDRLRLGVTG
SYFFGKTEQTEYNSIVGYALDIQRENRYNGFRLGAGLQYDVTESISIGSTVKLPTALEAT
QNSIITQDYDDAITEETSVKDFELPLEMGFGTEFKFGKSYAVYADYSRKLWSQTEQESSL
NTYKDQDSFKAGLNFTPRPGGLYYWQNVEYRAGFNYDTGYLNIAGSDVSSYAVSVGLGLP
VSRSGSKLNLMYSYGRNGEIANGLIRENIHSLSLNFSLDGIWFMKPKYN
>KECLDBNJ_00551 hypothetical protein
MLCPLGVLLLLLTSCAQDDSSFPVGEDWVESDTRVLYIDTMTVSSSTFKFDSVQVSSTDR
LLLGAYTDPIFGKTTSKIYTQLSNSTYTLDSDAVFDSIALILNYDDYFYNDTTQVQRLKI
HEVLQDIKATEDGYFYNTTSFNYDENTVGDVQFVPRPIDEDSLHLRLDDDYGQLLFSEIQ
ENEINNSDEFLRYHRGLLLDPGSDNTTILGILPTSTLRIYYSLPNEVEVDESESFDMTFN
SSYTFHNISSERNGTYFSTLEEQEDEVASNATNMMSYVQGGVGLATRIDIPNLAGLDYIE
GKGTLLSANLVISLNTATESTSLPAQETLSSYIIDQKNVALGTLYDYEGSEATASIAAES
DEFSQRTYALPIHYFLDEKRTDSNGDNWYLALVDPENNQSVNRYAFFGEHAADDDLKLQI
ILIYAVYDDE
>KECLDBNJ_00552 hypothetical protein
MHRYFIMIFLIAHTISYSQDSVLQAELAYALIPASNQRVSAQQVEAALKVPLDFGTVQLQ
PTIGLRNYDFEFWESMTFNTHPIDNVNNFFAGVDATHSLDEQWQLDAWGEASWASGINAN
ETVLTGAAALQYTLKTFPAHLRLGIQYDTPLGDRELLPLVELAVSTHQFYLQLGFPESRI
SYALSESSTLSTHFDFEGDYFYVPQTVDFAAQTANQVGIARQKLALDYAYTIDSMWSFSL
SAGYLFQNELKFYDSAQHTVNTLNMGAGPVFSTGIKFNFSKQ
>KECLDBNJ_00553 N-acetylneuraminate epimerase
MKRMTNNRIVLTLTAFCALALGSCSSDDSGDRGNWKQRSVFDGVPRSNVAAFTIGSYGYM
GTGYDGDDYLTDFWQYDIENDYWVQKADFPGTARSSAKGFELDGLGYVGTGYDGDFELAD
FWEYNPDSNVWTQKADFGGGVRRAATAFSGSGYGYLGTGYDGDNDKKDFWKYDPATDSWE
ELVGFGGDKRRDATAFELNGLIYFGTGVSNGLYLTDFWSFDTSADTWTRLTDLDEEDDYA
ITRSNAVSFSIDGLGYIVAGYSGGAIASTWEYDPLSDEWENITALEATARQDAVSFTTGT
RGFVALGRSGSLYLDDAYELFPQEEYDDED
>KECLDBNJ_00554 hypothetical protein
MRLRAGLLYIGITLCIVLIAGVLWFINEEQTVYTHVFETESGFGYAIIDHGQILIRQEHI
PAIAKEQGFCSATDAERVGDLVLQKINRKLNPAITQKELQELGVRIDCNQ
>KECLDBNJ_00555 Sensor histidine kinase YehU
MSRKVLLHAGVWLIFLSLLTVEIYWNAERFPMFAASALVLNMLLFYLNYSVLVPRFLLRK
KTKTYILSIVLALAITLCFREFVIVDQPPEGMRKPLGPLGPEPPFFNILKFLFPFFISLS
FVVIGTAVKVYEEWNRSLVEEKEIEAFKTRTELHYLKNQLSPHFLFNSLNSIYSLINAKS
EEASEAVIMLSELMRYMLYQADSEFVALADELAYTQNYVRLQRLRIANNENVTLNIHGAV
THQKIRPLLLISFIENAFKYGTDYKGNTEVRIVITVKDQTLEFECRNLIGARKRDQHNSG
IGLKNTTDRLELLYAEKHHLKVYEEDSKFVVHLKLNLD
>KECLDBNJ_00556 Transcriptional regulatory protein YehT
MRCILVDDEPLALDVLSSYLEKVEGVQLVARCTNPLEAIRILSEEAIDLVFLDIEMPNLS
GIDLVKSLDRLPQFIFTTAYPQYALEGFDLNATDYLVKPVPFPRFLKAIARAKEKHEAGQ
KPTEIKANATLAVPQESLPDFIFVKSEYENIKINTADIKYLQGLKDYIKIYTNQGDKAIL
TLSSFKELLDKLPGSHFLRVHRSYVVNINAIRAVQKSKILIGDIRIPIGETYKEEVLKQL
NIS
>KECLDBNJ_00557 hypothetical protein
MIPTAQAPAQFYRKRQADDRGREIRAIGNPKTATTFELFADIFIPPGTMHNKWITTTGTL
FIVPLFGAIECNINTDETFIHINQVAQVSVKAGTKLRFKNVYPDHSVRFLLFLIKSDSEA
PFQIQDYTLKAINKLHNLDVQASAAVHLGQFEGREETVYHYKKENTSVFAYVLQGAFEFQ
NRLVETGEGICLWDQQAIALEALANNAYLVLIEF
>KECLDBNJ_00558 Chlorocatechol 1,2-dioxygenase
MDRKEFLKGIGLMGLAATGVGLFACSSDNDALTTTDSNTGSSGATDVTSTSSECAVTNSE
TAGPFPTNDPEDLERVDITGDRTGVALAINLVIRDVNNACAVLQNAIVDIWHCDADGNYS
EYGGSGMQSTNYQNYHFLRGRQISDADGLVKFQSIFPGWYNGRATHIHVHIYNTTGTSLL
VTQIAFPEGDDSAVVAVNAASDYGYTKGMSGYTYNAYDNVFSDGIANELATLSGSVSEGY
TLDHIINVKA
>KECLDBNJ_00559 Sensory transduction protein LytR
MIKAVAIDDEPLALQILEALCARIEYVKLLKTFTSQAEAQRYLNKFEVDLLFLDIQMPRQ
NGIDLYKSLKQETKVIFTTAYSEYAVEGFNVSASDYILKPIAFERFEEAVAKVKRTLDLE
QQNTSANTHLTIRADYKLYNIPLEEIVFIEAMDDYVKINRVDKSTVVARSTMKAILKKLP
ETLFARIHKSFIVNTAKVEAVQAGSIEIAGKEFPIGTTYKDQVNKNF
>KECLDBNJ_00560 Sensor histidine kinase YpdA
MKLRTPLAQIFIGIVLLSIPFITSPDLQSGIKLLQIKPFQYNFIGYLLLLVFFYVNYYVF
IPHYYIPKKYWMFTGFLMISYVIITYVPDLFFDIPKPTGPGAGGPPPQGMRPPDGMQPPG
GMPPAGVPNPNEPSTLFSFRESYIIQFLIVAGLSLLMRLNAHLKQIQQEKLIAEVSYLKA
QINPHFLFNTLNSLYALALRKSDEAPEAILKLSGMMRYVVTESKHTKVPLKKEFAYLKDY
VALQKLRLAQDVKLTFNITGDPKHLEIAPLILITYIENAFKYGINPDEDSEIIINVEAKE
KGIALHVSNRIVVDKTLLPEISEEGHKNTRKRLDHLYPSKYKLSIDEDGEMYRVKLYIEL
L
>KECLDBNJ_00561 ECF RNA polymerase sigma factor SigW
MQHQVLQSNDQELQQLLRTQPKLGFDRVFETYWQRLFSYAYQIYADESICEDIVQEVFVS
LWEKLEHTSIINLEGYLFRAVKYKVFNHLRDLKFTQEHQEVLEQIAMPARAEANLDYDDF
ENLVHREIDKLPPKCKTVFMLSRFEEVSNAEIAQKLNISIRTVEKHISDALKHLKSNLPV
QELSLIVTLMFQ
>KECLDBNJ_00562 hypothetical protein
MTQNELKTLAEKHRLGTATKAEEQLLHQFVDTLQQQPKKQFKPSAQNRLRIVKGIEAKIA
TTTKPAVNYKKILAYAAVFVGIISMAAFSTSLFESQWVTKQTGKGEKRSLTLADGSVIIL
NANSSVQYAKDFTSSRQVHLTGEAYFEVQRDTAHPFTINTGAIQTQVLGTTFNINAYQPD
EVSVSVNSGKVAVENRQTKQKVLLKKDQQVLFKGTAAPVATAANSEDQRAWTRNIIALNN
TSLAKTAGILENWYDVEIDFEDATIEELKITGKFKEEPLETVLQSIALINNLKIDTLTQK
HFVIRKNNTTP
>KECLDBNJ_00563 TonB-dependent receptor SusC
MKTKLQILRKSTFHKVHFLAFLLLFVSMATSAKTKNQAIDEVFVTTRLQDASLKETFAAI
EAQTDFTFVFDSALLKETAAVTLIVNDARLSTVLQQITTQTGLSFTQINNTITVVKTSQQ
QQVNGTVTDQEGVPLPGATVMEQGTSNGVTTNFDGEFSLAVGANATLEVSFVGFETQTVA
ANPGTAIRIVLQENVNALNEVVVTALGIKREEKRLGFSQATIQSDNLAQAVPLNWSSGLK
GKVAGLNIVSSGSGPLNSQQITLRGNNSLNPNGNNALIVVDGVPVNNEMTTSGSSASYIG
EDSPIDYGNAISDLNLDDIESVTVLKGPGATALYGSRAANGALIITTKSGKKTSGLGLTY
TSSVNLDVIQRWPDWQYEYGQGTGKSFNDAGEPYYSYGGSEDGNNTGSTSSAWGPRFDGQ
EYFQYDPTVEGQSLERQPWRAYKDNRKDFWRTGVTFTNNLSLQGGNDKGSMRLSVGHSKN
EWIMPNTGYERITASVNSNYQVSEHIKIGSVINYNNRSSDNLPSTGYNNGSIAYFMIFQN
PNVDLDWLRPIWQEGQNQIQQIQPFSSYIDNPFLIAYEATNPLASSQIVGNVFTNIDLAP
NLDLMLRASLNTYNQDREQQRPYSINRYNQGFYETQDIWKQEVNTDFLLSYKNQLTQNIG
LNASIGGNAMDYKYRRTDASVNGLVVPGVYKLANGINNPIVQTYDRNKKVNSLYGLISLS
LDNSLFLDLTGRNDWSSTLPTANNSFFYPSANASVILSELFSLPKAVDYLKYRFSFAEVG
NDTDPYKTSKYYSQSAFASSATVPTNLYNANFKPEITTSYETGIEARLLKSRLILDATVY
ETLTKNQIISVPLDITTGYSSGVLNSGEVRNRGVELTLTGKIFDTDSFKWSSTLTFSRNW
NKVLELADGIDGQQEIGSGGNATLLAKVGGTTTAIYGYGFVRSPEGEIVYDNGGLPAYPD
EIQYIGDASPDWKAGLYNSFSLGPVTLNVMLDGQYGGIIYSQSHHKLTQQGKLRSTFMGR
EEGFIVGDGVVLNDDGTYSPNTTEAITPDWYNRYYRRANVESNSFDASFLKLREVSLQYA
FPKRWLGNSGITALNLSVFGRNLATISDFPIYDPETAALNGDTILPGIEMGQMPSPATYG
FNLRVNL
>KECLDBNJ_00564 hypothetical protein
MKNLKTLFTGLSVLWLLSACTGNFEEVNEDPNRIAEISPGTLINPIIYGLASHNAGRAHA
ITFDLMQVTLPFPSVSGGLHRYDVSQNIGNSSWYNYYRWLNNIKEMETASLAAEDPNYEA
VALTLKAWVYANLTDLFGPVPMTEAVNGEAGNLYPTFDSQQLIYETILADLERANTLYDQ
DLDMVYAEDILFANDVSLWQKFTNSLHMRLLLRISNRTETNAFQKLTAMINDPETYPVFE
TVEESAVLQVTGVTPNISPWGRPQDFPLGVKMAAFFVDNLNALEDPRRPIIQTGAQDLDN
NPIGYKGIPSAYAGPESQFEFNASTLNRAQVENPMQIFLMTYAEVEFIKAEMAQRGYTTN
AQEHYEAGVTAAITQLGATTTEAYFDNPVAAYDGSLEQILLQKYYALYFVDYQQWFEFRR
TGLPELPTTEAMLNDAMMPSRFFYPSDVQISNQANYQQALELLGGPDNINTKVWWDNN
>KECLDBNJ_00565 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MINTLKLTLLAGLLTAGLTAQEQAKGYVFEDLNANGKKERKEKGIPNVAVTNGEAVVLTD
AKGRYALPVADGDAISVIKPAGYALPVDANNLPQFYYSYRPQGSPQSDFKGIAPTGKLPR
SLDFALTPTDEQQSFTALIFGDPQPYTQQEVDYFAQGVVAEVEGIQDVVFGLSLGDLVGN
DLDLFNPYIDAIKRVGIPWFNLMGNHDMNFDAEQDALSDETYEAHFGPANYAFNYGKVHV
IVLDDILYPDPRDGKGYWGGFREDQLRFVENDLKHVAKDQLILLAFHIPLSEPEGDPFRD
ADRERLFKALAPFENTLSLSAHTHIQRQDFFTKEDGWLREKPHHEYNVGTTSGDWYSGKL
NAAGIPVSTMRDGTPKGYAFIHFEGNQYTVDYKVAGKPEDFQMEIFAPKVVAQGRNTKAG
IYTNFFMGSATDTVEYRVDQGEWKLMQYVEEQDPAYELSVYEWDTAEQLIPGRRSSNPIK
STHLWRGSVPAKLEKGTHTVEVRTTDRYGKTHTGTTSYRLE
>KECLDBNJ_00566 Glycerophosphodiester phosphodiesterase
MSTAQKDSLNIQVQGHRGERGNLPENSIPAFLGALRKGVDVLELDVVISKDQQVVVSHEP
VMLPLYMLTPEGDSIATEDAEKYNLYTMDYAKIKQFDGGSKGNVRFPQQQKMKTYKPLLS
EVFETVAATIKAESLKPVKFNIEIKSVPEEYDVFQPQPEAFVALVMQVIQKHTMEAQVNV
QSFDPAILEVMHKNYPDIELAYLVGENSYAENKTNLTFQPEIYSPYFKLLDATEVAQIRK
DGLKVIPWTVNEPEDIEQVIALEVDAIITDYPERVLEQLK
>KECLDBNJ_00567 hypothetical protein
MNYKPKSIRPFIGAKDFEISRAFYRAMGFEEVLLPPKMALFRIGDFGFYLQDYYAKDWVD
NTMLFLEVEDLVAHLVQLKALALPDRFPGVRVSDIVHNDWGSEFFVHDPSGILWHIGSFK
N
>KECLDBNJ_00568 hypothetical protein
MAVLYLAAPVHTEVLQWVHDLEHEFDHITQSEHQHDFFSAEKLLAEAGHDHRTLEYIKQV
LEPFKDDLQKEKKQSQPLKIDKHLCTDRIEHSTQKTTAFKKQYFDFRISIHRPLSLLQPV
PPPEV
>KECLDBNJ_00569 Vitamin B12 transporter BtuB
MKSMYIVLLLCCASLSAQNLTGTVTNQAGQALENVNIYNLNNGKHAHTNANGTFSLPAVA
VQDSIAFSRLGFATQYLVVKKLNGLNISLAEASTALDQVVLTSEVNSLSSVVAVDLKLNP
VKSSQEILRKVPGLFIGQHAGGGKAEQIFLRGFDVDHGTDVAISVDGMPVNMVSHAHGQG
YADLHFVIPETIDNIDFGKGAYYADKGNFNTAGYVDLRLKESLDASSLSLEAGQFNTSRL
TGMFNLIDEQNHSAYLASEMYLTDGPFDSPQNFNRINVLGKYTYTDANKDKITLTASHFQ
SKWDASGQIPQRAVDQGLIGRFGAIDDTEGGQTSRTNLTLQHLKNLAHNAVLKTNAYISK
YDFELYSNFTFFLEDPVNGDQIKQQEERFIAGLQSTYERKHIALGETRLDYQAGVGFRYD
NVDDMSLSHTVNRQTLLDRLAFGDVDELNAFAFLNTEFKTGKFTFNPAVRLDYFKFDYYN
KLTEAYDNQSESKVAFSPKFNTVFAPSQNWQLFLKTGIGFHSNDTRVVVANGGEEILPAA
YSADLGTIIKPMPRLALNATLWTLFLDQEFVYVGDAGIVEPSGKTRRMGVEAGARYQLTD
WLYVFADANYTHARSTEEADGEDYIPLAPKFTSAGGLSVDNLSGFSGSLGYRWLGDRAAN
EDNSIVAEGYFVTDFNVNYTIENWTLGVIVENLLDTSWNETQFATESRLFNEPASVEEIH
FTPGTPFYLRGKITYRF
>KECLDBNJ_00570 hypothetical protein
MFKPSILLLVGLLVQFSFGQHTPTDKTYSFEDCVTTYSEEQAQETQVGHQFYFADKNFTD
GRTIKLSVVDPGKSTHAPHQHPQDEFFFVLEGTAEFYLDGKTVEVGPYTSLYCPSNSMHG
ISNAGDTQLKYLVMQKYEQ
>KECLDBNJ_00571 4,5-DOPA dioxygenase extradiol
MQLRDLSRWNASLPNTEKMPVLFLGHGSPMNAIEENQFVTEFRKLGQELTRPQAILCISA
HWETRGTFVTAMEHPQTIHDFGGFPQALFDVQYPAPGSPQLALATQKLVTSTKVHLDDKW
GLDHGSWSVIKHMYPDAQVPVIQMSIDYTQPARYHYHLAKELAALRHKGVLIVGSGNMIH
NLRRVAWDKLNAPYAYDWALEARETMNNAILTHDHQTLIDFRKQGTAFDLSIPTPEHYLP
LLYTLALQDDHDEVQLFNDEPVGGSLSMTSLKIA
>KECLDBNJ_00572 Carbohydrate acetyl esterase/feruloyl esterase
MKKYIVVALLCLTGLVQAQEALFSGQQVSSPQVNDDKTVTFRLSAPQADTVQVTGDFLPS
VKVDTPMGKVDGPGKALLTKNEEGVWSFTTSVLAPELYSYAFIVDGFKTTDPANPFLIRD
VASVTNIFIVSGKQADLYRVQDVPHGTVASRWYDAKTLGFDRKISIYTPPGYESSTAEYP
VLYLLHGAGGDEEAWLSLGRTAQIMDNLIAQGKAEPMIVVMPNGNVGQDAAPGAGSDGYY
TPQFMTPETMNGKYEAQFKDIISFVESNYRIKADKAHRAIAGLSMGGYHSLHISRYYPNT
FDYVGLFSAAIMAREDKSGAGVYDNFEETLETQKDNGYQLYWIAIGKTDFLYEANEEYRA
MLDKMDMPYEYTESEGGHIWRNWRVYLSEFVPLLFED
>KECLDBNJ_00573 hypothetical protein
MHDKHLYEYAVIRLVPQVEREEFFNVGVVLYCKRPRFIGMRFQLDAKKLEAFCPELDVEQ
VQKNLEAFKAICAGAQNGGPIAQLEPAERFRWLTATRSSVIQTSKTHPGFSEDLEATLEC
LFTELVV
>KECLDBNJ_00574 hypothetical protein
MATLPDLRHVNVTRYITPLREGGSLPAVADADDGFKYVVKFRGAGHGPKALIAELLGCEI
ARFLGFKVPEVVFADLDEAFGRTEGDEEIQDLLKFSQGLNIGLHFLSGAINFDPVVTSVD
PQLASEIVWFDAFMTNIDRTFRNTNMLMWHRELWLIDHGATLYFHHSFTNWEQSAATPFA
MIKDHVLLPQASQLDEANIKLKALLTDDVLQHMVSLIPDTWLDWEGYEESPNALRQVYFQ
FLSTRLTHADLFTKTAQDARQTLV
>KECLDBNJ_00575 hypothetical protein
MRVYGACKHCKHELQFRISVETRVALAMREGKYHSKTCKACGKNTTFFVNERYAKSSKAL
LLTAGLIFALGSGIAGVACYYAFLNSTNLAVAGCFGLLLIPGWAWFIIVKGDRDRVRAFN
YSYTKQ
>KECLDBNJ_00576 hypothetical protein
MKQIFFFILTLMLLGCNDSDKKLDKNLKEVFEKSKEEKKPRDKFPTYIKIDTFYTKPSHF
NDLIVGNSKVSDSLSSACSCDNNVKNNSIKIQIKTAIPTKNKLNTLPKDHVDRYNKLKGL
YTPSLNPLSFEGQLKYINFELKDSTVLKANVISRSTELEYNGKDFKKDTVNQYQIKISRF
KYHNASRVYGEFKIIVQEGFGFNPNDTIIRGSFQCMNWKINEEESIKNYKF
>KECLDBNJ_00577 hypothetical protein
MRYLLVLLLAVVACKQTAQEPESTMDYKQIHDSAVFIDTHNDMLTKMVEDSLMLDSDLTG
ITHSDLSRMRGSGLDAQFFSVWSDGTLEAPFDYANRQIDSLDAVIARNPDTMLKATNTAT
IQEAVAQQKLAALIGVEGGHHIENSLDKLDSLFARGVRYMTLTWNNSTAWATSATDEWEI
EGARNSEGKKGLTAFGKEVVQSMNRLGMLVDVSHIGVQTFWDVMEETTKPVIASHSSALA
LHTHPRNLNDEQLKAIAKNNGVVQVNFYSAFIDSTFTRKHEAFMLKHQDKQNSLVAAGLN
DYAVKAALYRQFPQEAEALRAPFEVLMQHIYYIVDLVGVDYVGIGSDFDGISFPPQQLDD
VIGYPLITKALVEKGYSQEDIHKILGGNLLRVLKANEVKL
>KECLDBNJ_00578 hypothetical protein
MEVSNDILFTSVVKQVNAAAVGSEALHPTSATRGMHKRSGLLSAE
>KECLDBNJ_00579 hypothetical protein
MKPFSLALLLAFSVLSCTTRAQEHKITNDRFWNTVDGEPIYSQGGGIFQFTDPQSGTPKY
YWYGVHYQEAETYRNDPSVTLERNHFEGVTCYTSTDLVNWTFEKHVLTKEAVNFEENPTW
LGRMGVAYIEALEQYALLIQHGKNVMIALADSPLGDFKVHRHIDMTSRIGTPNTGDQTVF
TDPDTGVSYLVYSYGQGRNKIYISEIGVRDGKVDLLEVHEIFRGASREGNCMFKYNDKYY
MAASNIYGWDGSFAYYLVADDIYGPYKPTNEMQVMPGSEQDYAHVSQTGFFYTVRGSEQE
TVLFCGDRWAEFAGNGLGYNQWVPLSFDGETPYFNSLHSWKLNETTGTWSVAADNNYIKN
PSFEADRRHIPSNNKPVQEQLLGWHTEILQGNPISTTEATSPVLNHFNTQKDRQHVIGEK
SLHISDQVPFERRITQELSSTPYVNLPNGKYRLSATIKNTTGFEELNLYAQSDTQTFKTS
FNTSNPEWTTITIDEVAVVNGSVTVGIYVKGAAGAEAWVDDVRFELLD
>KECLDBNJ_00580 hypothetical protein
MGQFIEDQIGMISGAVGPVVFVKGNDGKGIVRSKPTPSKAPASPKQQQTRNKFALMKHFT
GLLYPILKECYTDFLGKDNARDAVRSYYMAQVIVQEQDAWRIAYEKVLISTGRVRAYVPV
SQSRDAQQVVLHWQETTQQPFAESGDLLSVLLYAPDTEDFVFYKACTTRAAGTHTLELPE
ALSTLPLEVYTTFSTATETDYAYSTYLGRMV
>KECLDBNJ_00581 hypothetical protein
MEPIIISPKEENKFVEKLLEKIDSEFESEQVPVKIEKYSEPLNCFGNVDKKIELDGGKVH
YGWVIYQTDILCEAERHAVWENENEELIDITPREIDFEEIMFVSDNNFEYKGQIIDNYRV
NTTKNKVVDHFIKVCETLSKFYSLGKRKNDWELEIESHIRNIIYEYEDLKSQLELYISRG
GNLRTKCICGGNKNYKNCHGKTLMERIDNDYKNIIKNK
>KECLDBNJ_00582 DNA replication and repair protein RecF
MGIQLKQLRVHGFRGLDNLEIDFEPTTVLVGTNNAGKTTLLKSLQLALSNTLQITDDDFH
FSDVVIRDKIIIDILFTSIDAEGNPVSEFEDKWATVFTTERISFDADGNQFLAFRTVIKE
NLIRKTYKKKQYVIDEWGDFQDETEGFWHQKEYENELSFYFDEIPFFYLDANRDILDDLK
SKTSFLGKILSSIAYDQADKELIENLIKDLNKETIDRSEILTNLHSTLEELDTAMDNPQN
TVDITPFTKKIRDLNKGVKINYSQFSMEYHGMGTRSWSSLLILKAFILQNQSLAESSQVA
YYPIIAIEEPESHLHPNAQKKLYSQIKNIVGQRIIATHSSYIAGSAKLKEVRSINKITSN
ISIGKFLESDFESEDIRKIYRQVINTRGELFFSKLVILFEGETEEQALPITIKRHLNKNP
IELGVDFIGVGGSGNYLPFIRFFEAFNVPYLIFSDNEAEANAIVTNQIAKSKLNDINKVV
FLNTGNDFEKELCDNGYIEEVKKAYYHLILSECANEHHKEAKKAELDQIPEADYYNLVTS
LKTQFAPVIGYELYKSDKPLPPKIVELFDKVNLIINPTENAAN
>KECLDBNJ_00583 ATP-dependent DNA helicase PcrA
MQQINLSPKQQEIVGLNEGAFLILASAGSGKTRVLTERIKRLSESPNGKILAITFTNKAA
AEIRERLGTSDRIKKNVFVGTFHSFCQSILELRFKLLGYSKMPHIFEDDADRIELIKQAI
KSVPYFDSIYNDLEPKKKNQYTYNALQFISTVKREVLTAEELAEGSENNEYEYLYETYQD
ILKSNNAIDFDDIIRLVYELFTNNESVANLYRKSYSYICIDECQDLNKLQYYLLKSLCGN
TFKSIMMVGDPNQAIYGFNGSAASFMEEDFVSDFAANKITLDENYRCSKSVIEASNVLMN
LEVEVVNFVIPGVFEIYEASSENDEAQFVVGTIKKLLKATTHKDIEGDITFDKISILGRN
KYVFTQVEEELRAESIPFYYKSGNASIKFSSASMKAFDLFFRVKINPLDKLHQKRLEDML
KVGDINSSEELKSSKLPIASDIKCLLDNASIDNFHIKINELKSIFNNSDLEDDEKKLTLD
ELNDLENHLVQYKKQNLKPSLDGFKSALALGLTNNSTNKETGICLSTVHTMKGQESEIVF
LIGMDDGTFPDFRAVNKGGEELQQEKNNTYVAFTRAKRFLYVSYPKKRLMPWGDHKAKTI
SRFLKPLV
>KECLDBNJ_00584 hypothetical protein
MYRFSFKSVSLLLGVLVLLTSCLEVKEVDRYPYTQGELMGSWETEIPQHQDEWTGITGVD
LLANNQATIHLVDATGRHEHSGTWNTGKKKAVGPVNFKFDLMLSYEEDPQHSKTFLGVIR
VEDDHLVFSAHNLELHKQE
>KECLDBNJ_00585 Multidrug resistance protein D
MHLRDASPQRKKIATILTFLSIPLSGFMTDIYLPSFPSMARNLSVSEQSIQLTLTCFFLS
YGFSQLFVGPVADSVGRRKPMLISLAVLLLSSLAVTFTGEVLVISLLRIVQGIATAFIVV
AKRAYFVDLFDDEQRKHYLSYFTIVWSCGPIIAPFLGGFLEEHLGWQSNFYFLAIYAAIL
FVGELVFSGETIRNYKKFNLKKTGLLYLAMLKNPGFILGIGVLGCAYSVVMVFNIAGPFV
VEQHFNYNAVIIGYCTLVLGFAWMIGGILSKRFTPVNFTKKIRLVSLTQLVLIGLFIGLG
SMIDNLILLVGFAFIVHICSGFLFTNYFTQNMVFFPGNAGIAGGLMGGLLYIITSMGSFV
ISHSGSITNTLDMAFRYLLIAAPLAVVIFFSLRYFKKRDLRKRQSVLKVQG
>KECLDBNJ_00586 Peptide methionine sulfoxide reductase MsrA 2
MKNRIILSALLAATIALSLLFNGCADATKSNDTAQTTNAVALNTTGTAEEAAVPAETPVP
QDRAAAYFASGCFWCVEAVYESVKGVDEAVSGYAGGHTKNPTYEDSNTGRTGHAESVKVI
YDPSVVSFSQLVDVYFGSQNPTQVNGQGPDQGSQYRSIIFYQNDAEKEIIEQKKAALAKE
LGEPVAAEVKPFEKFWIAEAYHQNYEVQHPENPYIQNVSIPRLNRFKAKFPELLKVNSH
>KECLDBNJ_00587 Thiol-disulfide oxidoreductase ResA
MSTRLKRILRYALFVGILVLVYTQGWHIPVVTTLQRGILKTGIMNPQLKEVPDTNGKTRV
KGTKSEAVVPGDLADLNVQFFDENDQLVSLKDMPKQPYFINFWATWCPPCVAEMPGIAKL
YADTKDEVNFVLVSFDTDFEKAKAFKAKKGFDFPIYRIAYDLPEMYNTGSLPTTILINAQ
GQLALTHMGMADYDTEEFREYLEELK
>KECLDBNJ_00588 Aldose 1-epimerase
MLTKRTTLILRYCLIAALGVSLYSCKESENKTTEPQKLVEEQTETSLLDAAAFEQTINGK
KTNLYWIENKDIKVAFTNYGGRIVGLWVPDQEGAMTDVVVGMAGVQAFADASEPYFGATI
GRVGNRIANGKFTLDGKEYQVPTNNGDNALHGGDQGFQYKVWDARKPNAQTLILTYRSPD
MEMGFPGNVDVKVTYSVTADRELKMEYEATTDQKTVVNLTNHAFFNLNGEGSGSILDHSL
VIHADQYTPVDSGLIPTGTLDSVAGTPFDFTQAHTIGERIATANEQLTFGKGYDHNYVLK
EASGTLKPAAKISGDQSGIVMEVFTEEPGLQFYSGNFMESKNTFKTGAKDDFRTAFALET
QHFPDAPNQPEFPSIVLEPNETYATTSVYKFSVKGS
>KECLDBNJ_00589 hypothetical protein
MKKTLLVFALALGFFGFSQSGANLDANKWSKEKAKAWYAEHDWITGANFIPSTAINQLEM
WQEATYDPETIDRELGYAAGIGFNTMRVYLHSLAYKADKAGFKKRVEDYLSIADNHDIKT
IFVIFDDVWDANPKIGTQRDPKTGTHNSGWMQDPGYPASNEMANSPELKAYVQDIIKTFK
DDDRILFWDLYNEPGNNGKNTESLPLLTNVFKWAREINPSQPLSAGLWSWGYKELNTFQA
QHSDIITYHDYENADMHRRVIELLKTHDRPMICTEYMARTNDSRFSTTLPMLAENNIGAI
NWGLVNGKTNTIYAWNTPIDSGEEPVEWFHDVFRKDGTPYRQDEVDLIKKLNDAY
>KECLDBNJ_00590 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MMINPLLKTNIFQYLSLCMLLSSSTLAAQQFQNPLLDSGADPFSVYVDGYYYYTHTMGNR
VVLWKTKNLANLREAESKTIWTPPAGTMYSKNVWAPEIHYINNTWYVYVAADNGTNENHR
MYVLQNTSANPLNDQWEFKGKLAAPSDKWAIDGNVFEYNNQLYMAWSGWEGDTNGQQDIF
IAKMSDPTSLSGKRVKISSPTYPWERNGDLGTAGNPEQVFVNEGPQFLEHDGKLFIVFSA
SGCWTDYYALGLLSLEGTDPMDASAWTKKEEPIFQQTPENGVYAPGHNSFFKSPDGKEDW
ILYHANSNPGEGCGNKRAPRMQRLYWNEDSTPFIGTPLPTTVLLPIPSEKF
>KECLDBNJ_00591 hypothetical protein
MITFSKIQNDFTHNIIGYSAIGIILSTCLGSVAIMTTLMHGHTLLQMLFVMITVVFCSLH
NASILTVQKPQLIFKLLVASTVVNTLIIAGGMLL
>KECLDBNJ_00592 Oxygen-independent coproporphyrinogen III oxidase
MTSLVRKYNVPGPRYTSYPTVPYWDQETFSLKEWKATFKASFLESNKREGISLYIHLPFC
ESMCTFCGCTKRITKNHSVETPYIDAVLKELALYRSFVGERPVLQQVHLGGGTPTFFSEE
NLARLINGIFKHADKAPQCEMSFEGHPNNTTLEHLETLASFGFKRVCYGVQDYNETVQKA
INRIQPFAHVQRATDQARQAGYTSVGHDIIFGLPFQKLEHVKNTLEKTIQLFPDRIAFYS
YAHVPWIKGNGQRGYDEAHLPTAEAKREQYEVGKQLLAEAGYVEIGMDHFALPTDDLYHA
QQEERIHRNFMGYTASKTLVMLGLGVSAISDSWYGFAQNVKGIQEYYHLLENEILPVFRG
HLLTEEDLKIRQHILNLMCHFKTSWETPSLYFDELPEVLIKLKELEADGLLIFENKGLRV
TEKGKPFVRNVCLPFDLRLQRNKPETKLFSMTI
>KECLDBNJ_00593 hypothetical protein
MIWTALLFGLLGSFHCVGMCGPIAFLMPVDRNNPVKRFFQVLSYHSGRLFTYAMLGLVLG
YLGRGLQLFGLQQQVSIAVGVLMILVILIPQKRMGTYSFSKPAYRLVSRLKTALGVQLKK
KKAATFFTLGLLNGLLPCGLVYMAIFGAIASGGGVQGGVYMLFFGLGTLPLMTTAIYLGN
FLKGKTKQLLVKAIPVAVVLMGCLFILRGLGLGIPYISPSNQVAVAEVAATHSCH
>KECLDBNJ_00594 hypothetical protein
MKINWGTGLVMGMVLFIGFIMFFVITMTTDDKYSHDLVAEDYYKQEMQLQETIDAAINEA
QLETPVTGKKTEAGYALQFPETFDPKEITGKVFLYRPSGKHLDFDIPIALSTSTLLIPDS
RLLDGRWNITVNWAYQGKKYRFEKAITY
>KECLDBNJ_00595 hypothetical protein
MSTKSNQNCCLGCKSGYPGQNHNCKVRLLKEAEERKALSQEELAEKYA
>KECLDBNJ_00596 Putative electron transport protein YccM
MASQDQEHFRDSIGTINEEGKRSWVYPKKPVGKRYEYRKLVSYVLLIFLFGAPFIYINGN
QFLMFNVLERRFNIFGFPFWPQDFHLFVIIMITGVVFVVLFTVAFGRLFCGWICPQTIFM
EMVFRRIEYWIEGDRGKQMRLDKMSWNAEKLRKRSIKWSIFFVISFLIANVFLAYLIGSD
RLMQYITDGPANHVGTLISLLIFTSVFYFVFAWFREQVCIIVCPYGRLQGVLLDNKSIVV
AYDHKRGEKEAGRAKFKKSEDRAATGKGDCIDCAQCVQVCPTGIDIRNGTQLECVNCTAC
IDACNQMMEAVNLPKDLIRYASEENIEKKSKFTFNARLKGYTAVLVILLGVLTGMLFLRN
DIEATVLRLPGQLYEHKGEDIISNVYTYKLINKTTKEIPEVHFELISHKGIIRVVSHDRI
QVPEQGLAEGTLFIEVNSHTLKDEKEKLKIGVYSEDQLIETTTTVFLGPRSYK
>KECLDBNJ_00597 Cbb3-type cytochrome c oxidase subunit CcoP2
MRSIASLIRILVFASFAYLFLNYVGTPEDEASVFTTQNWLWAIYAVLVFMYIAFEICIES
LRAVLFKTLKPEAQAHYQAEVAAKKEQRTAWFKGLYAKLTRVKAIEEEDEIILDHNYDGI
KELDNNLPPWWVYGFYATILFAAIYLIRFEVLDGDNQIDEYEQAVAQAKIEIEAYKKTAK
DLVDENTVELLTDASDIKAGENIFSGNCVACHKAGGGGGIGPNLTDDYWILGGGIKNVFH
TISEGGRAGKGMIAWKTDLKPSEIAQVASYVLSLHGTNPADAKEPQGDLWVDENAPIEEA
QVTQDSTQIEVLLETETVTGDIIQTKE
>KECLDBNJ_00598 hypothetical protein
MLKFVKQNLENIDGVSIYPTISLLIFFLFFVALFLWVFTAKKEHINEVSNIPLDDQLKSE
HS
>KECLDBNJ_00599 Cbb3-type cytochrome c oxidase subunit CcoN1
MQTEQFYYDNKIVRKFINATIFWGIIGMSVGLLLAFMFLFPNLTDGISWLSFGRLRPLHT
NAVIFAFVGNAIFAGVYYSTQRLLKARMWQDWLSNFNFWGWQLIIVGAALTLPLGYTTSK
EYAELEWPFDIAIALVWVAFGANLIGTILKRRQRHLYVAIWFYLGTFVTVAVLHIVNSIE
IPVSALKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
VHFWSLIFIYIWAGPHHLLYSALPDWAQNLGVAFSVMLIAPSWGGMINGLLTLRGAWDKV
RTDPVLKFMVVAITGYGMATFEGPMLSLKNVNAIAHFSDWVIAHVHVGALAWNGFLTFGM
VYWLVPRLFKTKLWSTKLANVHFWVGTLGIIMYALPMYVAGFVQASMWKQFNPDGTLTYG
NFLETLTEIIPMYWMRAIGGSLYILGAFVMLYNVFKTVKSGSKVTDELAEAVPLQRVTSK
RTAKEGYHTWLERRPVKLTIFATIAILIGGMVQIIPSLIVDDYVPVISTVKPYTPLELEG
RDLYIREGCVSCHSQMIRPFRSEVERYGEYSKSGEYVYDHPFLWGSKRTGPDLLRVGGKY
SDNWHLNHMYDPQSTSSGSIMPSYSWLIRSELDKSKTEDKMRAMQKLGVPYTVEDIERAQ
QWMLEQGTQIEQNLYTDPDFADTYESDKAYAQENGEDFVEMRNREIVALIAYLQRLGTDI
KIKNSPEVSAAKTE
>KECLDBNJ_00600 hypothetical protein
MSIIYMLLAISVVVAVVFFVAFILSVRQGQYDDTYTPSVRMLFEDELVKAASKTSKATPQ
PKTQNNANRKLK
>KECLDBNJ_00601 putative copper-transporting ATPase PacS
MENCYHCGDPCLSDSITHQDKMFCCNGCKTVYDILHENDLEYYYNLDQNPGISPKAVQGK
FDFLTNETILDKLLEFNEQNTQIVSFTIPAIHCSSCIWVLENLNKLNAAIKNTQVNFPEK
SIRITYDASVIALKQVVELLCMLGYEPAISLEDFNKKEKKTDRSLIYKLGVAGFAFGNIM
FLSFPEYFEVEEFWLDQYKHLFRGLMLAFSIPVVVYSAQDYFRAAYKSIRSKLLNIDVPI
ALGILVLFVRSCAEVLTQTGTGFFDSLAGLVFFLLLGKFFQQKTYAFLSFERDYKSYFPI
AVTLLKPAKHFKNRYLEQQVPVYELKPDDRILIRNGELIPVDGILLKGEGLLDYSFVTGE
AEPVAKNAGDTLFAGGRQQGGIIEMRVTKAVEQSYLTQLWSNEAFKKEKQTHLNSLTAQI
SKHFTWGVLSIATLAGLFWLMYDPSMALNVFTAILIVACPCALALSAPFTLGNLLRITGK
HKLYLKDAAILEQLADVDHIVFDKTGTLTTSAETAIRYEGLALTEDEESLVTSTLRASNH
PLSRSLYAILKNHDIQTLDEFEEEVGHGIYGTANHNSVKIGSYDFVGGRNANWIFKNGKR
TVVHISTNATYKGCYVFYNRFRESLPAVFEALSTTADLAILSGDNTAEKQTLERLIKQPV
QMHFNQKPDDKLNFIKSLQQQGNRVLMIGDGLNDSGALAQSDVGIAISENINVFSPACDG
ILDSSRFKDLPQFIQLAKRGKRIIKWSFVCSLLYNLAGLVLAISGNLKPVYAAILMPLSS
ISIVIFTTLSSYFYGSKLKQQEKTEAISKS
>KECLDBNJ_00602 Transcriptional activator protein Anr
MAAHEESRCENCIIRQLNSLKALKKEELKAISDSKETRTIKKGEPLFKEGEKLNGVFCVR
NGVSKLSKISDNGKDQIVKIASKGEVMGQRSVIAEEATNLSAVALNDMEVCFIPKTNITA
RIEDNPAFTQAILKYMAQELKLADDVIVNMAQKTVNQRLAEVLLYLDKTFGQDDEGYLAL
ILSRSDIADVVGTATELCIRTLAKFKKEQLLETKGKRIKLLDKKGLTQIKEGF
>KECLDBNJ_00603 TonB-dependent receptor SusC
MNFKNNTITYKNIVAFASIVFFSTQTQAKTPYLALKTSIAPVASATLQQTITGTVTDSDG
VLLPGASVMLQGTSIGTTTDFDGNFSIDASAGDVLEVSYVGFETQTITVSQQTNYNIQLA
ANTSELDEVLVVGYGTQKKSDLTGAVSSVVADEFNKGVVNNPGNLLQGKVSGLNVTNASG
EPGAGQDIIIRGVGTLRSGTSPLYVVDGFVLDNSGNGLATNPLNFINTQDIESINVLKDA
SAAAIYGSRAANGVVVITTKKGKAGRTQMNFSASTAIATIANKIDVFSADEFRTIVPQIG
GSLSDNGANTDWQDELTRTAITNNINFSMSGGTATTSYFASIGVDDQEGIINNSDLKRYS
ARANVTQKGWDDRLKIDLNLTATRTENTRPNIGTMVSNMLSLNPTTPAYTNGEPTVFGTG
INPLIIEDIYGDYSNNNRMIANIAPSLEFVDHLTYKLNLGVDYSTTDRDIQYIPYSADPD
YAQGSITTSFTINRNTLVENTLTYDNTFGDHGLTVLAGHSYQKFYIHEKGFYFENFPDNG
IEPRYQLEAARGENATQYSDAVSNELQSFFGRVNYTFQDKYLVTATLRSDGSTKFGENNR
YATFPSLALGWNIFKEDFMADSGINNLKLRASWGKSGNQEIPSKQTRLSYGESFADDDIY
PLNEGITTREGYDYGLVFARTANPDLQWEETTQTNIGLDFGFLDYKLSGSVDYFLKETND
VLLYFSTQDPIDEVGYKWQNIPDMKIKNSGIEVALDYQSDRSRDFSFNIGGNISYIKNEI
TDSPFTIVTTGTASGAGQTGATINGYMNNQPIGNFFLREFTGIGADGLSTYTDLNGDGQI
DDSDRISAGSAVPDILYAFYLKFKYKNFDLGLNFNGVSGNEIYNHTRMSLFNKTQLSNSL
NTTDQAIEFANEDPSNTNTVSTRFLENGAFLRLNNATLAYSLNPEVIGMDKWLDNVRLSV
TGQNLFIITDYTGFDPELNTGSSTDSKSYGIDYYTYPKARTVVFGLNVSF
>KECLDBNJ_00604 Starch-binding protein SusD
MNYRIFTLVLGLSALLFSSCTDLEEEILDESLTGTDGLAEPVTGSISAAYGILPQTFRHT
RYFGLQEIPSDEAILPPRTGLGGTQWADNDTYTTAHRHLMSSSNSLVTESWSYLTTALFR
TVAAIDVLTPLAEAGDAEAIQGLAEMRALRAYENMLFLDSWGLTFRKEATSETSEVLRGA
EAVTYIEEEFLAALENLSTTNGPGRMTQDAVYGFLAKLYLNAGVYRDPYGTPVFTDEDMA
NVVSYTDRIINNGSYALSPEYFDLFNDENHDNAELIFALDLRGVLNNDHNRWAYWSMSGS
LFPRPGDFYLSMDGTDGPAATPEFYQNWVDAYGNVDPADADARFYQKNAQVPAELEDISD
LTPYSKDTLGLSTDKDHYFIAGEDFEIDRGIIRGTMWAPRKENFRSGSFMTGTDGNGNSG
FRIYPLAEARENGSDPEDIVYYVDHTLDISLDGSAGYASGYRFAKWQFSKTSDDGNNYSN
VDLVLLRLADVYLMRAEAKLRMGDAAGALTDVNTVRTSRNARPEQTPAALTQITLPTLLR
ERGFEFYWEMSRRSDQIRFGTYEDSWTSKTDSDVHHRLFPIPQEAIDGASNTPGYLEQNA
GY
>KECLDBNJ_00605 Alkaline phosphatase 4
MKNYLISASVAISALIMQGCSTTQNIKQEASSDEPLNVILMIGDGMGIPQVSSAFYFGDR
NSNFERFETIGLHKSYSTSHLITDSAAGATAFSTGEKTYKRAIGVSKDSIPKETILEKLK
AEGYQSGLISLTSITHATPAAFYAHVKDRDMHEEIAAQLATADVDFLAGGGRKFFSQRSD
DQDLFQTLLNRNYNLDTLALSKSKPGMRNAFIIEEEGLPSKTEGRGDFLKDASLEALSYF
DANNKPFFLMIEGSYIDWGGHAKDAEMMIQEVADFDQTIGAVLDYVEAHPNTLLVITADH
ETGGASIGKYYEVDEETGKKTEVPEKVAVYFITDQHSGELIPVFAAGKGADHFKGIYQNS
AIYHKILNAIKAQK
>KECLDBNJ_00606 Alkaline phosphatase
MKNSILILFLCLCCLSFAQQKSNYKVHAHNDYAQEFPFWEAYIGGASSIEVDVFLKENTL
FVTHSENEINKANTLDKLYLQPLKQLQTEGRLRNLQLLIDIKSDAEATLKSIIKTIEKQN
LAEVEGLRFVISGNKPKATDYSEYPDFIRFDHQNLEDLDSIDLSKVALVSVNYKNYSVWN
GFGNMVAPELEKVEAAIAKAHAVKKPFRFWACPDTKIAWTRFANLGVDFINTDKPAEAVS
YLKTLDQNTYVNPQQIEVYQPEYQFDYEGTPVNVILMIGDGNGLAQITSAQVANGGNLTV
TQLKDIGFSKTAATDDLVTDSAAGATAMATGVKTHNRAIGVDPDDQPLQNITELLGGKGF
ATGLITTDAIDGATPASFFAHRKERDDAKGILSDLEGSEIDFFIAGGKSKAALVPDSYQV
KTLADFNSIEEKTAIYVGDGKVPSIADGRGPLLPNSVKQSLEILENNQKPFFMMIEAAQI
DSNGHANNTSGIVQEMLDFDQTIAEVLKFADKTKNTLVVITADHETSGFGIISGDLNRGE
LHGEFLTTNHTGIMVPVFAYGPQAEKFRGAYENTEIFHKILAALE
>KECLDBNJ_00607 Arabinoxylan arabinofuranohydrolase
MKSSFASSLFWMVVFTFSLQCVAQKPLEAYLFAYFEGSGADQEAIRFAVSDDAIHWKALN
KNNPIIPSAAISNTGGVRDPHLLRGAEGDGFYMVATDMFTKKDGWDTNPGIVLMHSDDLI
NWQSTAINLEKSYPKFKNTKWVWAPQTFYDTKKKKYLVYFTVRSHDNLKLDFYAAYANKD
FTDFEAEPKLLYSAKDGAIDGDIIYKDGTYHLFYKGNTKDAAGTEIQNGIKQATSKKLLG
PYTESFEYIDFYADKKTTVEGSSVFKLNDKDEYLLMYDLYSSGRYEFQRSKDLYTFTKET
ESFTKDFHPRHGSVISITKEEAQRLDQKWDGVPVSLLTDAKGRYRFQSQGNPIIQHKYTA
DPAALVENDTLWLFTGHDYAGGQKGYKMKDWLVYSTTDLKNWTEHPIPLKIEDFTWATSG
DAYAGHVAKRNGKYYWYISTNWNGIGVAVADKPEGPYKDALGKPLLTNEDCFASSHSWTC
IDPAIFIDKDDQPWIFWGNGVCYYAKLKDNMIEIEGEIKTIDFEGLEFTEAPWVHERNGK
YYLTYATGFPEKIAYAVADKVDGPYTYKGILNEIAGNSNTNHQSIVEFKNDWYFIYHNGG
IQPDGSSYSRSVCIDPLHYNEDGSLERIQMTTEGVQAKN
>KECLDBNJ_00608 Colicin I receptor
MRLQVLLMKQNLLILFLLLPVIAVAQYSLSGIVKDANGYLVEGAQIKLSKGSFKKEVRTN
SAGFYNFKNLAIGTYLLEIASGDFIAFDQAFIEGASLRKDIRLDNAKDYELDEVAVRAES
IKTTMEKKGFAVNVVSTEEAAQRNIQTNELLNTTVGVKIRQNGGLGSQVQYSLNGLSGSA
VRIFIDGIPISTFGSAFNLNSIPPSMIQQIEVYKGVVPGHLSDDALGGAINIVLDKSAGT
NLNASVSYGSFNTLQASVNGLYRFEDSGFTIKASGFHNYSDNDYKVSGRSIVVTGLGGVQ
TPITARRFNDAYRSTGGVVQVGYTNVDWADQFYLGFTGSDDYNEVQHGAFMTIMPYKGRF
YESDVALANLTYQKKDLFTKGFEVNINGYYGTRNRQLSDTVAAAYSWNGERAIDFRGDEY
EYTWGSQQEGGPTLAKISRNVASIRTGLAYAFNDNHKVLLNHVYSGIDREDSDALRPLLE
NTFVGTRDLHKNIVSLTYEVNAFNDRLKASLFGKYYQQKTISKDPAVVTNEAGERVIVDE
VVSSNKEFQGYGFAASYGLTPEVFLLASAEKAIRLPNETEIFGNDGDNVVANSSINPEQS
NNYNLGFRLGAFNFNKHRVTLSTNFFTRNIKDRIGLPIETSLNVDDELIVYVNQGSGTSQ
GFDAQVNYVYNNNLSANFNISKFDLEIENRGTSVAVPNTPFLTMNGNLRYSLKNLLQKQS
RVDLFYTLYYTGEFSYLVPQGSNTVGDDFFKVPEQLAQDFGMSYFFPNKSFVLSFDVKNI
FDKPVYDNLSVQKPGRAFYLKLNYSFNKF
>KECLDBNJ_00609 hypothetical protein
MKRVYLNFKAFAVVTLAMGLMTACSTDDSADAGGEEPEEEASRWITVAAARMGDNPGDGN
GGTLIYALDSEEAKDPTISIEPFDNGFIVPSNRTARLQASEDGTTIFNISYAGDTGGNYT
KYNVEGGQDFVQTGSEISIAPYVGSAPRWIKLFDGDQTGAAVYVSTENQFNDNGTPEDET
DDFYERTEATMGIVTLDLVNSQILNFQEHSVPLSAEEEAQGYYISRIDMPTLNAAGDKLY
IGARLSKVDPETGERDSNGETLASKSIVLDYPSLMNPVVITSGVGLGNTNGYRSINAFEY
NGAVYQANQGDPQGSHILRIGSNNQYDDSYEFNLDEALGVEEAYILAWRPAANGKAVLAY
RHAGSAEGVAGAQGFFALVDLEARTAQQITEIPYDPDFYLFQYQGFAVNGDEIYVTQAPV
GQNGNIYVVNTATGEVTKGAELVNVEGSHFIGAF
>KECLDBNJ_00610 Sensor protein ZraS
MTYKRYTAGLLLRVLLLLAALVVLAFGVVKLNTYAILAGSLSGIVLLYFLHKFLIRRFVA
MDDFFEAVKYRDFSRWFSEKHGPQDLRNLHKGFNAVNKTIKAINNERQAQFVYLQKILEM
VDVGIIAYNLDSGAILWANESILSTLDLPAFKNIHFVEKRRPKLYEELFDTYRTEATSIS
ITLKNEHLKVLISETVFQVEEDAFKLVVLQNIEDTLNQNESDAWKKLLSVMTHEIMNSIA
PISSLAETLQQHIAASKTNQETTIDLDDLHAGISSIKKRSEGLMKFAKTYRSLSKVTHLN
LETVSVNELFTNINDLLQPTLADKPVELSFAMDQPEMLLEIDSYLIEQVLINLILNAIDA
TKTVAQPKIYVNATQNAKGRVQLKVLDNGSGIPEEIKESIFIPFFSTKKTGSGIGLSLSK
QIMTLHKGKIQLKSEPDAGTEFTLQF
>KECLDBNJ_00611 Transcriptional regulatory protein ZraR
MQLKDAHILVIDDDEDVLTALRLLLKPKVKQVVVEKNPNALQGLLNAQDFDVVILDMNYN
GLVNTGNEGIFWLNKIKSWKPATDVILITAYGDIDLAIRSLKEGASDFLVKPWKNEKLLD
AISEILTKKRKNKNLKIKLDSATEIIGESEPMQELFVKLKKVAPTDANILVLGENGTGKD
LIARSIHENSLRKDKPFVKVDVGALTESLFESELFGYKKGAFTDAREDRKGRFEAAHGGT
LFLDEIGNIPLRQQARLLTVLQNRHVTPLGANKAIPVDIRLICATNLSLKDLADENTFRK
DLIYRINTVDLIIPPLRERQSDLSLLAHYFVKLYAEKYDKASFELDPGFIKKLKEHPFPG
NVRELQYALERAVIMAEGGILHAEDLAFSPIEQQPETELKLKTTNLDAVEKNTILKVIEK
NKGNISKSAKELGITRTALYRRLNKYDL
>KECLDBNJ_00612 Macrolide export protein MacA
MDIPLEKKRFTTSKILMIVGAMSIVVLILFVILSTTGNAKLNVQKERISIATATQGVFQE
NIPVNGVVMPITTIYLDALEGGRVEEKFVEDGAIMKKGEPILQLSNTDLELSLVNQETQV
YNLLTQMQISQNAARQNTINKLNQYTDVENSLIEAKRLYELNKKLYDKDAIARQDLIKSQ
NDYNYQKERMQLAKQILEQDSLAVKQEKNQVSSSYQRTQNALELMRRKVADLVVKAPVDG
QLTSLDAEIGQSKNKGERLGQIDVLSGYKVRVDIDEHYISRIYTGQTGSFDFDGKTYTLV
IKKVYTQVTNGRFQVDMEFESEVPEGIRRGQTLQIRVALSQEKQALLIPKGGFFQETGGN
WIFKVSEDGASAYKADISLGSQNTEYYEVLSGLEPGDRVITSSYDNYEEVQELVLQD
>KECLDBNJ_00613 putative ABC transporter ATP-binding protein YknY
MIKITDLEKYYATEEVRTIALNKLSFQVQEGEFVAVMGPSGCGKSTLLNILGLLDDPDGG
SFIFNGIEVAGFNERKRADLRKHNIGFVFQSFNLIDELTVFENVELPLIYTGVKPAERKK
RVDEVLEKMQIMHRRKHFPQQLSGGQQQRVAVARAVVNNPKLILADEPTGNLDSSNGNEV
MDLLTELNEAGTTIIMVTHSEHDAKYSHRIIRMLDGQKVTENVLTEYKSKTLEV
>KECLDBNJ_00614 Macrolide export ATP-binding/permease protein MacB
MLKNYFKIAWRNLKKDKSLFFLNSSGLAIGIASCLMISLYVWDELSYEQSFDNADRLARV
VLRGNVNGEELKEAMVAAPVAKSFKADFSQVKNATRLSMVYNPQVQYKNTSYEELKAAYV
DPNFFELFHLNFLKGNPKTALENINSIVLSASEAKKYFGTENPIGKRIQFQDIEEALEVT
AVLEDLPQNTHLQFDVFIPMQHNTRSTSNSWVTSGFATYLELQPETDLAQLEAQIPALLE
KYIGDQVKQAIGISYEEFQQNNKLGLFLQPLTDIHLYSDFSPNTELSPTGDIKYVYIFSA
IALFMLLIACVNFMNLATATATKRSREVGIRKVLGSAKKQLITQFLTESILTTTFATLLA
IGIMALLLPAFNTLAGKELALLDFISVQNILLLIVFILGISLFAGAYPAFVLSGFKPLAA
ITSKVSRSGRTTSLRSGMVIFQFVISASLILATIVVYNQMQFIQHKKLGYEKGQVIVLRD
AYKMGSERVNAYKEELLQNPGIASISRSAFVPAGETDNHLRGIFKNNTYLRKFFFYDVDE
QYIPTLGLELIEGRNFSTELKNESDKVILNEQAAKILGLGENPIGATFERAADAENERLT
VIGIIKDFHFKSLHSEIDPLVLAYNPYGGLIVKTKNADVAGILDFAEEKWATFNPEQAFI
YSFLEDSFEETYRKEEKMGVILSIFTMLTIFVACLGLFGLITFATEQRFKEIGIRKVLGA
SVTEIVALLAKDFIKLVAIAFLIAFPIGYYLMQKWLQDFAYRVDLELGQFVLAACITLFI
AMATISFKSIKAALQNPTQSLKTE
>KECLDBNJ_00615 putative ABC transporter permease YknZ
MFRNYIKIAWRNLKKDKFYNLISLLGLTMGLTIAIFIVIWIQSELSYNSFAGNHNHVYRV
SSNIKSGGTVQTWGSSTGPVAAYALSDIPEVKRAVRLRQNWSNRLYTVKNTDYELTGAYV
DAAFFDLFARKLLAGNKGDLLNDANAVVLTKAIAEKLFGTTDVVGKTLEADHQEHYIITG
VVEDVPENSSVAYELFFSIESLKAGYATSKYWKSLDTDWGNFNYITYLELRSVDDVAAVT
QKLTQIQQQNDPNADLFDDKAAYYLQPITAMNLYNSAGEPRGINTVKIFGIVLLLILAIA
CINYVNLATARAFQRAREVSIRKIIGAGKRSLFGQFIAESILFFSIAIFLAVGLAFLLAP
TFTQLSEKSLRLELIQGPLPLYILGIFIITLVVSSIYPALMLISFKPLEAIKGKVGGVSR
GTLRKVLVTVQFVFSVMLIIGTLVIGRQLDFLTEKNPGYDRSQVLNFWMSGSMQEHAETV
KQRLTNIPGVTGVSFASNPIIDNQNSTGDIKWGAGEVDHELVVTPMAIDEQFIPLLKMNL
IAGENFKGISTDSTHFIISQTAAKAMGMTNPVGQNLELYETKGTIVGVVEDYHFRDLKSD
IGPAVMYYAPDAYRVYLKTSGTNTTGTIAAVEELWKEYTPDFPLDYSFLDASYEKMYRED
QRTGKLFNLFSVIAILVSCLGLFGLTTYAAQLKKREIGIRKVLGASVFQVTRLLSKDFLI
LVVVAAVVAIPLAWYVMQLWLQDFVYKTAMSWWIFALAGGITLLIAMLTVSFQAIKAAIA
NPVKSLRTE
>KECLDBNJ_00616 Macrolide export ATP-binding/permease protein MacB
MFRNYIKIAWRNIWKNKLFSAINVISLAIGLSASFVIGLMVYYDFSFDTFHEDGDRIYRV
VTDFETPQGNYKNGGVTPPMRIAAKEQLTGVEQSAYFYNWWISEAKAEANKQTFKDPEHI
ILAEASYFDIFQYNWIAGSKAMALQQPNSVVLTRKRAEAYFPNLPLAAVMGQSLVYDGTI
SATVSGIVEDYDKRTDFYFNEFISLETAKQTESSDEILGDEWENTNNASQLYIKIAQNST
PEQIKTQLAALSEAHVDSEMIKYNNKRIFNLQALSDLHFDHEYGAYDYSGYEADKGILIS
LVFVALFLLLLGSINFINLNTAQAASRAKEIGVRKTMGSSKRQLVLQFLGETFLLTLIAA
FCSVVFCVLALKTFDSFMAEGIDLSLMVTPWFTALVVVLIVVITLLSGFYPGVVLSRFKP
ARVLKGSVSSSKEKGVLRQVLTVSQFAIAQVFVIATLLVGKQIYYMLHQDLGFNAEAVAY
LQTPWDDFSIDKRLVLEQELKRIPEIQNVSLGGMPPASFNMATRMGIFKKDGQELIQELQ
ILNGDTEYLKLYDIELLAGRPALNDTIEEYVINETGMRAFGFKDPEEIVGQYLELNSHQR
LIVGVMQDFNQRSLKDKVMPLMLTGDTSRDRRTNFRTLHVKLTGASSGWQNTIAKVEQLY
QEVYPGEEFRLSFVDESISRFYKQEQRIATLLNWATGLAVLISCLGLLGLVIHTTSRRTK
EIGIRKVLGASILQINALLCTDFLKLVIVAYVIALPIAWWGLHQWLEDYAYKTEMSWWVF
ALSGLGMMLLAVLIMSFKTLKAAIANPVKALRTE
>KECLDBNJ_00617 putative ABC transporter ATP-binding protein YknY
MLLQLNHIYKWVKQGGKRVFLLNDISLQVEEGEFISIMGPSGSGKSTLLNVIGMLDEFQE
GEYNFLNESVHTLKEKHRSKLYKEYIGFVFQAYHLIDELTVYENIETPLLYKNIKSSERK
ALVADMLDRFNIVGKKDLFPSQLSGGQQQLVGIARALIAKPKLILADEPTGNLNSKQGEE
IMQLFKELNQEGVTIIQATHSEANAEYGNRIIHLLDGSKTKA
>KECLDBNJ_00618 Toluene efflux pump outer membrane protein TtgC
MFIKSLKLAFIACACSYTLNAQETQNISLQECVEIALTHNLDLKAAGLRAETETIQFKQS
RNALLPSVNANYNLGLSNGRSIDPFTNSYVNEELTYSNAGLSINTTLFDGFRILNTLKQN
RLNKAAAEMEIEEARQNLVLDVTLNFLQVLNFRELVKLAETRLITSKEQLNRLQKLQEEE
TGDPVAYHDLQGQVALDQSAVNDANNSLNNALTDLKFLLNTERSIEASQLVLLLDFELRE
KTVDGVYEAALHNLAAVKAKELREEAAAKGVAVARAQYTPQISLFANFGTNYSSAARLFQ
DAGTQTVQTGDFVTVAGTDYAVFTQEGLFNALPIAYTDQFNNNLNSAAGVSVNIPIFNGF
QAKNAVQLQKVNRDQASVVLEQTKRALKQNISKTYADLQAASKNYHFLEDQVRAYEESFR
INEVKFNLGVSTSVAYITSKNNLDNARINLTNARYAYLLTSRVLDYYSGVIPF
>KECLDBNJ_00619 hypothetical protein
MFRLLLCLPLIWFCACTQSNEHLDPTSKNNDSLAFYNNEAREAQYSMQERLEFANRAFEG
VREQPKHPLYTKILYNKNWLHYSLGQYDSLVHYDAVMQKNAAVNTAPKEMGMQHYLLGYY
FELVKHQSDSAFKRYNRSKTYYQQANDSSGTGTALLNMGGIQYKKRDYFGSKETLTEALK
YIKKETDSVTYWSAMDRIAQSHRHLHNYEEALAFYANITKEAPKANLSVYKNNYATVYID
LKKYQKAIAILEPLVLDTLANSETTQARVLDNLTYARWSSGVFVKPQDFLKPLEVRKLQD
DKRGIISSYLHLSEFYLKPQPELARAYLDSAKIQAKEINSSGGELEVLVFKMQLEPQNAA
LKERYIKLRDSLYESELKVKTQFAKYKYDDELKEQSILRLENEKNLRELELAQERFTKLW
IIAALVVAILLILLIYYVQRYKARQLKIQHNIDRLSAIYDTEAAISRRLHDDFGSGLNTA
MLLLQRQENIDAILDQLEKLYNQSRDFSRSLNDIDTGAGFKDALSLMLRSQVPQDTNLLL
LGFHKIDWDLVRPVNKITLYKILRELMLNMRKHSAAKRVTLKFEMHSKHLKIMYSDNGKG
ASHEALQLKNGLRITEKRIEAIGGSISFETDEQSGFTSHIKIPF
>KECLDBNJ_00620 Transcriptional regulatory protein RcsB
MFKKILIAEDFQGDNKSIVDTLKERMAITEIQEALYCDTAFSRVQVALNEGAPIELLITD
LSFKPGTLPRKLTSGYELIKAVRKVDPNLKIIVNSVEDNPVRIKKLVEEDQINGYVCKGR
KSLNELVEAVYAVCNDEIFISPQIDWNTQHNVVELEELDLLVIKDMAEGFSKREIRDRLI
KAGVKPNSESSLDKRVSKLFVQFDVKNSTHLIAKLTRQGII
>KECLDBNJ_00621 Quercetin 2,3-dioxygenase
MQSNVGLVIEEKAADIGNFMVGRLLPFRKKRAVGPFLFIDHMGPACLKEYQNLDVPPHPH
IGLSTLTYLFEGSIFHRDSLGNAVEIKPGAVNWMTAGKGVVHSERTPEYLRDESKFLHGF
QIWVGLPKALEQGAPSFFHIEKEALPAWEEDGIHYKLIAGKIKDKEAPVPVHSPLFFIEI
QTEDAARIAIGDRLFGEVAMYVLSGEVRIEGNTYGTKQLLVAKKASLCAFETTQATTLYL
FGGTPFEEERFMFWNFVSSDKAVLEQAKTNWKEQNLEAFPKISGDSEEYVPLPEPKRFK
>KECLDBNJ_00622 putative acyl-CoA thioester hydrolase
MTLEQRIAKAESRIFKAVFPNTTNHYDTLFGGTAMQLMDEVAFITATRFTRQTVVTVSSD
KIDFNKPIPAGTIIELVGQIIHLGTKSLKVGVSIYVEQMYSEHREKAIQGEFTFVAIDEQ
KNPVNVLK
>KECLDBNJ_00623 ECF RNA polymerase sigma factor SigK
MVQKLAKGDERAFKFLYNKYYNDVYRFSLSLLKSSANAEEILQDVFLQCWLNRGYLDHKK
SFKSYLFTCVRNAAFNALKKKAYENKLKSSLELKIESSANTTENNLITEDYNRLRIKAID
SLPPKRKLIFEMSRKEGMSYEDISRELNLSISTVKNQMSKALENIRTYLHMNSDLPIGVL
LLVLFQI
>KECLDBNJ_00624 hypothetical protein
MSDSKQEIRDLLKKYALNKCTSVEIARLTTLFQQNEIDETDIDVVHILDSLGDTCNLDKG
RAEKIYQEVIRLGDKRKYAVIKLRNRVALISAVAAVFVGLISFILVKNSLNNIERPSLDA
LIVNEEVLLETGNSQFEVTLTDSQEDSISVSGKMVARISNNTIILPQISNLAKNIEFSTL
KVPYGKKARMILSDSTKVVLNAGSQLRFPNHFSFKGARKVELIGEAYFEVTKNKEHPFIV
ETKNLDVQVLGTQFNVSAFQNESKTNVVLVEGLVQIDFQSKEPSAILNPGEMAIHDAKVN
KSEIHQVIPEIYTSWMDDKLIFRNIEFDELLTRLERHYNVSIVNDDAELGKEIFNANFGD
SNIDEVFEYFNEIHKIDYQISGNKIIIKN
>KECLDBNJ_00625 TonB-dependent receptor SusC
MSYPKSFSMKILLLYFLTTTSLFQASEKNPKNLITLKLSDITIGQLFDQIELSTDYRFVY
KVQDIDLTKKIDVDAKNQDIETLLTDVLATLQTSFTLNGKQIILKQDNKTNISISYSDNI
EVQKSVSGTITNDLGNPFPGVYIVKKNTNDGTLSDLDGKYTINVSPQDTLVFSYLGYTTT
SRIVGQQSTINVQMKQSTSELSEVIINGIFERKAESFTGSAVTFTKEELSRVGNQNIFQT
IQNIDPSIAILDNFELGSNPNALPDMQIRGTSTFPGEGVDGFKGNYLKSPNQPLFILNGF
EVTVERVFDLDFNRIKSLTILKDAASKSLYGSRAANGVVVIETDQLKNSETRITYNAMMD
VELPDLSSYNLTNSLQKLEAEQLNGFYEARNVEDYIELQQLYNSRLKLAKEGLNTDWMAL
PLRNAIGQRHSLGVELGGQNLRVFANLNYQKKAGVMKDSYRENIGGGITTMYSIDNLKFR
NITTVISNSAAESPYGTFNEYAIMNPYWRAKNIDGTIPYYAEFFDADNNYTNPLYNSTIG
VKNESSYFNFINNFYLEWQLIPSLKTIARIGVDVKRNDADEFYPGQHTQFDNYVDDERKG
SYQVNNGKSTFLTGNLNLQYSRNFGKHFVFGNASFDINERKYEELQHLAEGFPSSRLNNI
TFARAYALDSRPIGISGISRELGFLAVGSYVYDNRFLSDLTLRSSASSQFGADKRWSTFW
SLGLGWNLHNESVFRKSVFEQLKVRGSLGSTGNQNFNTNQSIVTYAYYQDAFYQDFPGSY
IFNLGNPNLQWESKFDYNIGLDTKIGGLSLRFDYYENYTENLITDVSLPYSNGFDSVKEN
LGKVKNSGIDANATYLIWSNGTNFLNVNFGIATNTNKIVELSNAMRSFNESQEELAADEE
NNTPVLRYEDGMSMNAIWAVQSAGIDPASGREIFINKDGSTTYEWDATQMVVVGDNNPKY
RGVVGISGEYERFGLSVTARYLGGGQLYNQTLVDKVENVDMNYNVDERVLTGRWQYQGQQ
SYFRGIRVFNYATNGYTFDRSLTKPTSRFVQDRNELDIAAISAYYDFGKSINKALGLERL
RLGFNMNNVVKFSTIEIERGTLYPFSRTMSFSLTATF
>KECLDBNJ_00626 hypothetical protein
MCLVLVLGAGCENDWLDEQSSNQLTAEEQFETIDGFKDALIGSYIGLTAEELYGKDLSWN
IVDLLSQQYAALPVQAQYAGIQQFQYETLRSAGQIEASWSGAYNTIANVNLALEMTEKNR
SVLGDINYRLIRGELLGLRVFLHFDMMRLFNAGNLENRPELFQEYAIPYVTTFDKEIKPQ
LSFSETFEMMEADLQESLSLLEEDPVFSEQSDNYYAEVNRDGFYNFREQRMNYFAVKALL
ARVLQWQGDQEAAGTVAQEIIDDSFAMLIDSDSHPVSTDRILYQEVLFMIDVEGLIDDIN
PLLRAEGDNANYDALYYTSNYVNETFETENVNVGVPDVRFNTLMQTQARGVVNLKLFQNN
MRAENYNQIPLIKLPEMYYIAAEAYAKSNMLDQAVELLNTVRSSRGIIEQIPSDASQEDV
LLEVYKEYHKEFLGEGQWFYYLKRNGIAEIPGVFDNTITIDDQEYVLPYPDNEVEFGNRN
>KECLDBNJ_00627 hypothetical protein
MKIFKLIFSLVFIIVLSSCEKDELTGFSTAPAINFINDSTQYSFIQEPADEHIVEIPVFV
TGDSTSYDRFFNVEVLNDPETTASESQYEIVEGIIPSGSFSGNLKVEVRKSPALDESSVA
IKLLIVSSDDFVAGAEESNQTKLIWTNKIVIPAWTYFRYFFTAYPSSRAYRIFIEVTGMT
TFSLADYREVGPTGAQALGRAYGDYIRAYNAEHPGEPLVHDDGPNAGEEILPVY
>KECLDBNJ_00628 hypothetical protein
MRIILRITYALLLTIVAQSCFEDNSGFDINTIDGVVIDTTGNSELTVFQFDNLVVEPNVV
YAGNEENLAFEWKINIAPTDTIFDILSNDKNLDAPIAYRPTDAIRNHELILTVTDTQTDI
DYIMAWPLKVLNNIGQGIVVATTSDGMSTDLSHIMSEQVTSDFDGLDVKYNVYSSLNDGT
INGVTKQLKYYSIYGQDAVLGITDNSIYKINTVDFTLGGTNGELFYVDRPVYSPQALGQV
NQGSLFINNGNLTATYFGASQKFGVAFDSEFTVPGIIAGKTVQSPPVTIMFYDEEVDEFV
YQPSITQFGDSNMYAMPNSNDGAFNPSTVDDKINLAASVGTDGNFRHLLKDENSGDVGLY
IFDSGESVYPDVIPPSAIGYYDLSEAPEIQNAKFFVFVDNQRILYYTTDTKLYAVLYSTA
TATIQERYTLSEGERFTTLQIYQDADYPFGSDYLPLNNRALLASTYDENEGRVYLMPLIN
TGVGNVDVDNIQIWEGFDQVTALTSQF
>KECLDBNJ_00629 hypothetical protein
MQKIYKIAKVELNILFFSPIAWLVLILFILQCGLTFVDLIDARETSQQLGSNLKSLSEDV
FGGNKGFFSSVQNKLYLYIPLLTMGLISKELQSGSIKLLFSSPVTSRQIILGKFLAMAFY
GLLLVGVLLLIIIAAAFSIDNLDVQYLLGGVLGLYLLLCAYSSIGLFMSSLTSYQVVAAI
STLAVLAALNYVGTIGQSIDFVRDITYWISIAGRADNFINGLVSSKDLIYFLLIIGLFLS
LTVMRFDKGRKQTSQATKFSSYTILIVGVLIVGYVSSLPLLDVYYDTTRFKRKTLTDTTL
QLINRLEEPITLTTYVNVLNGYAHIGAPKYRIFEFNQFSKFTRFIPEIDISYIAYYDSTY
TSRDATIDSFEKEARKSAVAYGYDFNKVLSPQEIRSRVDLRDENNFFVRKVGYKGKTTSL
RMFYDQIGYPQEPEIAAAIKRLLENPVRVGFLNGNGERDITRAADKSYYELTSALQNRSA
LVNHGFDMDIIDLDKSSKELDSLDVLVIADPLIPYSENQILQVKKFLDRGGNALIAGEPG
KNQMLDPFLRYLGVEFDEGILLQESEKFEPDLVQTEVTQESKLLGINMEEKDVISFSGTT
GIKILSDTNFEITSILKPKYSKVWQENLPLDIKSDSLSYEENKKIEPQLAVAMSRQLNKK
SQRIIISGDADFMSNGEIRRFNLTNRNSAFTKQLFRWLSNDRFPIDVTRKETIDNTVTIN
QKGIQFLQLFFTIILPVVLGIWGIGLLIKRKRQ
>KECLDBNJ_00630 putative ABC transporter ATP-binding protein YxlF
MNKVIAKVENLSHKYSRDWAIRDINFEVFNRGILGLLGSNGAGKSTTMNILCGVINQTEG
NAFIDGINMRSKPVEAKKLIGFLPQKAPLHIELTVDEYLTHCAHLRSIPKVEIPDALERA
KAKCGISHFSKRVLRNLSGGYQQRVGLAQAIIHNPKLVVLDEPTNGLDPNQIQEVRKLIK
EIAEDRAVILSTHILSEVQATCDHIVMIEQGTIVFSDSMYAFNNYIAPNSLIMEGEVLPS
KEELLNVPHIEKVEIINSNKIRLRFSNADHITQTLIHKSVEKGWDLKEIYLEKTDLDGVF
AQLSGKA
>KECLDBNJ_00631 hypothetical protein
MKKILKIARLELSIMFYSPIAWLVLILFIIQSGVIYAEMLYDQETRQQLGRALPVMTKAL
FAGEDGVLAKIQGTLYLYIPILTMGLMSRETSSGSIKLLYSSPVTVVQIALGKYLSMVGY
AFLLCLVLATFIITAYYSITGLDIVFVLGGILGVFLLICAYSAIGLFMSSLTNYQVVAAV
STLAVLAVLNFIGGVGQQYDFVRDLTYWFAISGRSENMVNGLIISKDIIYFILVILMFIS
FTILKLKDERNLKKGFAKWSRYGLLILVVTIVGYLSSRPVFTFYFDSTRFDDRTLTESSI
ELIEELEEPITITTYVNLVHYSAKQGSPLNRINDLHHFDQYRRFIPEMEMPYISYYDTLP
YKTDTTKTLLQKAKTAASAHKFNFDEVLSPKQIRSKIDLLPEQNRLVRFISYKGKTTPLR
MFDDLLVYPNEKEISVAIKRLLYGPSVIGFAESNGERDITSVESADYKIFTNGTNIRGSM
VNQGFKPKAINLESVAAIPEDVEALVVADPRAAYNEKELDILQNYIASGRNMLLAIEPNS
PYLNSILDTLGLGVKPGVLLEESEDYEADLIQAQYTKEVSDIGIRFRDNFIVSMPTASGL
IIKDSTASYQIKTLLKSNPNRVWSETEDFDLEKEQVTFNPERNSKVELPLAIAITRKQNG
NNQKIVIVSDADFMSNAEMARNNLNTRNSIFTMGLFKWLNDDKYPFSSSRPSAIDKSIKV
NRTGILWIKGVYMGLFPGFIAVIALLLLIKRKRN
>KECLDBNJ_00632 putative zinc protease
MKNIILKALFLILSLPNVLEAQETNNEKTLPLDQEVLMDSLDNGLTYYIKENDEPNNRAY
LYLVLKAGSLQETDEQSGLAHFTEHMAFNGTEHFPKNELIDYLQSAGVRFGADLNAHTGF
DQTVYKLPLPTDDNILLESGFKILSDWSSKMLLNEEDIESERGIIIEEERQRGKNVNERL
SKQLLPVLLEDSRFLERIPIGKIENIKNFKTSQLRDFYNTWYQPYLQAVVVVGDIETDQA
ESYIKKYFGEIRSKNLRNYPKDYTIPNNQNSKVKIVTDPEFSYNVVSVVYKHRSKPLKTE
ADFLQAIKRSAVNAMLGARIREIIQKGNAPFLNASMKYGGYQGGIGGLDAFNIQVVAKDA
STIKKAVKAVMQELERAERYGFNVTEWQRVRENFLTSINNTFAEKDKIPSESYVNTYVNH
FLKDEPILSIDFTHSFYNEKLNEISVEDLNSIIKEWVSDENQIIFLQASSSDANILPDEE
TLKEWVNGEFEQLNAYTDDVIEGALLEQKLPQSSIRSEETLDAIGAKEIILENGLKVILK
PTDFKNDQILFTGFSAGGTSLANSEYLPAAKIADNIIPASGISKFNATQVQKMLAGKTIS
IRPFISTYSEGISGASNQEDIEQTLELTYLYLTQPKFDTTVFATFKQNYEVSLKAKTINP
IAVFQDTVTKVMQGESSWVKPLTVKELDEADHQQALSFFKDRFDDAGDFTFVFVGNFDIE
KITPLIQKYLGALPDSGIKESYKDVGIGALQGEVEKKLYKGLEDKATVVLIYHDLFKYSD
LNIKALQATKIILEDKILKRLREKEAGVYSPSIGLSLSRIPKPYYSLSISFSCASSRAES
LIAAAKEEIGKIIKSGVSLEDLNKFKAQELRQHELNLRNNNFWLSYIKNSYDYDLDLNRL
KQYKKQLNSLTTSEASKKLKEYLTTKNQATLILYPENLDE
>KECLDBNJ_00633 hypothetical protein
MDHYTRKKFYELVWSKPLTKITEELEIDYHTIVALCKKHDIPRPPSNYWLKLKFGKQAAQ
PELPNPDDERIIWGAINEEQDPYSWIYLRGKALEKHIKKEIEEDQSLDLNVSQRLSKPDR
LVEDYLRITEERKKARKRGQYLSSYDNPTISINTSKEQEARALRFIDYLIKNLRLRGHHF
EIRNYHYEICIYGVSYPFSLREVNKRVPRSDGWGSDYIPTGKLALKIDSWSGKEWQDQKT
LTLEHKISDIIARLEYLAKKERAESIYRDVKNRRNKVESEKAEALKRKRIEEDQKFEKLL
QLADQWKRVENLKEFILVLENNRLVDSDKEQVIQWAKNRIEKLDFIGSIE
>KECLDBNJ_00634 hypothetical protein
MPKRFSRINFHTETVKRFKKYALANDANYTETLDAILDFFEQNSINPFEPFDDSKQRLET
LINKRMDGVEAILRRIETEQTKPTKELLDRLFNQKEEEQPNFVERKF
>KECLDBNJ_00635 hypothetical protein
MPQELHKYPDAFLNYIMCMLFCCTYSIAQEQTKLDGVIPKITHYDRTDFEADGQFWTMTE
DDDGILYFGNNDGVIIYDGERWQKLTLPNHSTVRSLVKDNNNVIHVGGYNEIGVIKKDEN
GNYFYASQVDELQLETDNLENFWQAHNFKDAIIYRTFRELIVVSDNTTTHIKANSNFLYS
GTVNGHLYVQDQGTGIFEYDPSSSNLQLLFKADNLSSSIIAFLPTKVKEELVILTKNGEL
YLANRATKKITFIKSLFKKEQQELILTAVFFKDHYLLGTLSSKILKINQNFELETNDISF
SKLNNSTILSIYPQIDKDRIWVLMNNGIDFVEFNSPISQLFDSSSISDMHIFEGYLYLAT
NTGVYYSLFDIDTYSTNDLNFKKIPDLEGQAWSIQQLNGEILVGHDKGLFRLDNFRPKRI
GTIHGIWKVLKLKGYDNTFLAATYSGIYPLSYNESWTIGNKIKGFEESSRDILQIDSSTN
FWICHGYKGVYKLKLNPELTRVFAVEHYTDQNGLQSSFNVNVTAFDKDIIFTTNTGVYTF
DNKNTLFTPHDSLNSILNPKLNTRKLLQHSDKVWFVQDDEVGYFKKNEENKLHKNLFLDL
KGYLNRGMESILPLDNHHVLIGATNGVFLFDLSKRNLSSAKTILRNVSYKEKGQISSSIA
LKNTEQLPTNIEMLRFEFAAPRLTPSSQKEFQYMLDGIDSNWSSWSTNAFKEYTHPAPGS
YTFKVRSRNYLGQTAEEASLSFSIPQPWYSTRLAYLLYILSFIVALFITRRLVNKKIDRE
RQKEKLAAAKSKKLLELEIEQLKLEKDKARIKKHKEQLEQDNLTKSKELANYTMLLVKKK
EIFTDTFNALKDFKNSLKTQAARKRLQEVLFNLNQHRMGEEYLNVFDVHFEKVHENFFKK
LKEIDPGISKRELRLCAFVKMNLTNKEIAPLLNISIRGVETARYRVRKKLDVNDENFNSF
LENLSKSAA
>KECLDBNJ_00636 TonB-dependent receptor SusC
MRIKNYFLVMFLLAVSGLSAQVNTITGTILDANAMPLPGANILVKGSTQGTQTDFDGNFS
VEASPDDILVISYVGFVTREISVGQQTDLKITLAEDAAALDEVVVVGYGTQKKSVVTGAI
SSVKASEIENLPNNRIEQSLQGRTSGITIAANSGQPGSSSTIRVRGITSFGNNEPLWVVD
GVIVDAGGIGYLNQSDIESIEVLKDAASQAIYGARAAAGVVLVTTKKGKLGKLSVSYNGF
TGLSGPARKLDLLNATEYATLFNEKYANDYSGAPQDFALPFPNPESLGEGTDWQEVIFNN
SAKKENHEFSLSGGNDVSTFYMSFGYFDQEGIVAKDISRYRRQNIRLNSTHHINDFITVG
ETVGYSNEKSTGIGNTNSEFGGPLSSAINLDPITPVVITDPAVANSGLYTNDGIIRNPNG
NPYGISNFVIQEMTNPLAYTQTRLGNYDWADNFVGNIYVNLEPIEGLNLRSTLGGKLAYY
GYESFTPVSFLNTSTITAQNNISRGSNRGFGWNIENTLSYTKQLGDHDFTILLGQGSYSE
NDTKGENVTYNDIPVNSREDAAFIQVPDDQIIASAYIGTEHRVTSLFSRLSYNYKEKYIF
TGIIRRDGSSRFGANNKYGYFPSFSLGWNPVNEDFWKENDFVNQFKLRGGYGVVGSDAIG
DFRYLSTIGAGRNYTFGNVSAVVIGNSPNAPANPDLKWEETRQSNIGFDARFFNTLTMTV
DFYNKKTVGILQDVRLPGYVGATGSPAANVADMVNKGFDIEMGYSDSFGDLNVSLRGNLS
YLQNEVVYLGNGIDFLSGGAGFQSSTYPITRTAVGQPYNSFFGFQTRGIFQNQEEIDSYV
NSEGVVIQPNAVPGDFRYEDIDDSGSINADDRKFLGSSIPKYTFGLTLNLDYKNFDLLVF
SQGAAGNKIFQGLRRLDISNANYQTEALNRWTGEGTSNSFPRLSNDDNNNNFTNPSDFYL
ENGDYLRIKTIQLGYSLPRNVIDNVGLTRLRVYLTGENLFTFTKYTGFDPEIGGGIFGID
RGFYPQARTGLVGLNIQF
>KECLDBNJ_00637 SusD-like protein
MKLKTILYPAVGILITASVLSCSKDYIELDPLGQPLVDNYYSNEDEAYSGLVAVYDIMGK
QSKSFENMITMMNAGSDDHFAGGGGPSDGVGIQSFSNYTIDPATIPGSFWNDYFQGIFRA
NILLQKLPEVPMDDALRARFTAEAKALRGYYYFELVRLFRNVPLFTEPILTSEIYNVEQA
APEAVYAQIETDLSEAFQDLPARITDLENEAGRLTQGSVQALLGKVYLYQGKNQLAAQEL
SEVNGTPGGTSKYGYQLVANFEDLFNLNNTFNSESILELAATSLANVDYNVWGGGQNEGN
TVNQMVGPRGYSRTAGSNAPDYAGGWSFNTVTQGLYDVLDGDPRFDATIADLKALEAAGE
ATYTPGNKDTGYFLKKFMPLNADKSTGGGNVELNYRQNVYIIRLADTYLLEAEALGASGA
RAQALLDAVRARVGLAPVPVSMDNIMLERRRELAGEGHRWFDLVRTGRAASALSDRGFTA
GKNEILPIPLNELENTLIVQNPNY
>KECLDBNJ_00638 hypothetical protein
MRLNTIKSHLYFLLGALVFFSACQPEEVTDGNGLSDSNVDASFTIESVSGEPNRFVLSAN
RENVLKFLWNTGDGFYEGAATEELFLPDAGTYSITHQAYGRGGIINETSQDVTVATSDPV
AGNLIKGGSFQTQADHDEWTILQISDSGTYWTFNEGSANVVGSGYNQQGIYQAIEVEANK
DYTVDMKVFGSGATNTWFEVYVSSTPPVQNQDYSAEGRRMGLSTWDGCANGPFEGKLSNV
GCVGSGNTVNFSEDGTVYLVIKSGGENMGSTGISITNVEFRGSVN
>KECLDBNJ_00639 Glucuronoxylanase XynC
MKNTRIYLIRWSFFMLLSVIGFGCSSSSTEEEITEEPEQPETPSPPASETNDMDFWLTKG
DRSVTLKKQDDILSFNSNPNGNATISVDATTTYQTIDGFGFSLTGGSAEVINSLSAADRQ
NLLQELFGQDASDIGISYLRISVGASDLNAEPFTYNDLPSGETDLDLSEFSLEKDRGVID
LLKEVLEINPNIKIMSSPWTAPIWMKDNNSFVGGRLKEEYYQVYAAYWVKYLNAMKAEGI
TIDALTPQNEPLHGGNNPSMEMSASEQTEFIKNNLGPALREAGIDTKIVIYDHNCDNPQY
PILILNDAEANAYVDGSAFHLYAGDIAALSTVHNAFPEKNVYFTEQYNSSTDEFAGTLKW
HLKNVIIGSMRNWSKNALEWNLANDATFGPHTEGGCTICKGALTINGSSITRNVGYYIVA
QASKFVPAGSTRIASSIQGALQNVAFSTPDGKKVLIVENDGDTNLPFNIKENGKWVTTSL
DAGAVGTYIWE
>KECLDBNJ_00640 Endoglucanase C307
MGHDFLRRWGSRNIYLGVSMSIKILKVCLIILLLVQVEGTSQGFLKAEQTQIVNAKGDPV
ILRGIGLGGYMLQEGYMLKVPFSGQQYIFKEHVQKLIGKEKTEEFYDAWRENHIQKRDVD
SLKKWGFNSIRLPLHYNLFTLPVEDEIELGENTWLEEGFKLTDSLLSWCKANKMYLILDM
HAAPGGQGHDVNISDRDPDKPSLWESKANQDKLVAVWEKLAERYKDEVWIGAYDLLNEPN
WTFEPNKNQNGIEDTHNKPLRELLVRLTQAVRKIDTNHIVIIEGNGWGNNYRGMLPPWDD
NMVLSFHKYWNYNDTSSIQQFLDYRKQYNMPIWLGESGENSNVWFKDAITLMEQNRIGWC
WWPLKKLGHNNPLEIKINEGYQHLLKYWSKKAQKPSEEEAYAALMQLTENLKIENCIVHY
DVLDAMLRQPNSQQAIPMASNELENELLIEAVDYDLGAEGVAYQDNVSANYHISTGGNRQ
SWNLGRTYRNDGVDIFLDSAGLEYVGDLEKGEWMQYTIEVKEPELYTIVFNVNSSNEKGK
LSALVNTEITKQISIANTLNNWDWTRPVSIPLKRGQNKIKILIDSGGFNLKTIKISKTK
>KECLDBNJ_00641 Glucuronoxylanase XynC
MRLNLFPYLFACFFIVLSCTKETNNSDEAILYLTSLDKKSLLEKQEINAHTIDTSLIDKV
IKVTDSVQYQIMDGFGYTLTGGSAMLIHKMSKSARSGLLNELFSKEGLGVSYLRLSIGAS
DLDSAPFSYNDLPKGKTDVDLEKFSLAQDTVHLVPVLKEILSINPQIKFLGSPWSPPVWM
KDNQDTRGGSLLPEYYQVYANYLIKYIQAMRGEGIEIDAITIQNEPLHPGNNPSLLMKAP
QQADFIKNHLGPAFKNEGIDTKIIIYDHNADRPDYPINILNDPDAAKFIDGSAFHLYGGE
IEALSEVHQAHPDKHLYFTEQWVGAPGDFSKELTWHIENLIIGAPRNWSKTVLEWNLAAD
QNQNPHTDRGGCDRCLGAVTINGDKVTREPAYYIIGQASKFVPPGSVRIASTLVEEIPNV
SYKTPDGQIVTILQNTSEEEKEILIKSDQANIHLKLAAGDIGTLVF
>KECLDBNJ_00642 Glucuronoxylanase XynC
MKNYSYFLITMFLVICVSVSAQSSDFAEGEIKVYTTSENSNLRLSETQTLKFVDAAQPLE
TEISVFVNTSKTYQTILGIGGAITDASAIVFNGLSSIKQQELLDAYYDIEKGIGYTLLRT
TIHSSDFSPESYTYVTEGDAELKSFSIAHDKEYRIPMIKRATKTAEGTLTLYVSPWSPPA
FMKTNGSMLRGGKLKPEFRQNWANYYAKFIKAYEAEGMPIWGLTIQNEPMATQTWESCIY
TAEEERDFLKDYLGPTLEKEGLGDKNIVVWDHNRDLMVNRSKVIFEDKEAAKYAWGTGFH
WYETWTGAAPLFENVNRVKEAFPDKNLMFTEGCIEKFDSEKYQYWPNGERYGEQIINDLN
NGTVAWTDWNILLDQNGGPNHVGNFCFAPIHADTITGDLIYTPSYYYLGHFSKFIRPKAK
RVGSAVSRNVLLSTSFVNDNGTMATVVMNKTNDLIKYTLYINQSEVTLDIPAHSIQTLIY
>KECLDBNJ_00643 Tyrosine recombinase XerC
MTTSISILFYPKTSARKSLKNPTIYARITVNSKRSEFSTHHKASNKWDPKLGKMTGYSAE
ARMINRHLDDIRIKVYEIFDRLSREGKPISAQIIRDIYQGKDDEQRCLLEIFQEHNDRIE
SLVGKGYSQGTLQRYKAARTHLENYLLFLKKAGDIPLREIDYQFISGFEHYLKSEKNCAH
NTATKYIVNFKKIMRIALANQYVDKDPFFHWKSSWQTKEREFLTSDELNKLAHKEFSISR
LEQVRDIFLFCCFTGLAYADVNKLSPNDIIPGINGQQWIKTKRQKTNTLSSIPLLPTAFE
ILEKYKHHSCRTEQQKLLPVLTNQKSNAYLKEIADVCGIHKSLTTHLARHTFATTVTLSR
GVPMETVSKMLGHTSLKTTQIYAKVLDSKISSDMELLKQQGTLINPKGEKIN
>KECLDBNJ_00645 hypothetical protein
MIDLQAHLNSIAGFNNLELLAGQVVEGFISGMHKSPFHGFSAEFAEHKVYNTGESTKHID
WKLYARSDKLYTKRYEEETNLRCHLILDNSSSMHYPALKQTDLNKPNKIAFSVLASAAIM
QLMKKQRDAVGLSIYAEQFEYYAPEKGSERHHHMLLDQLNQVLIKSEKSQKTDTYANLHF
IAEKLKRRSLVFLFSDLFQNELQQEKTFEALQHLKYNKHEVVLFHTYDSATELNFDFDST
PKRFEDVETGKFIDIFSDNVKEGYSKAVKDYFSAIKLRCAQYNITYVNADIQRGFAPILS
TFLVERKQFL
>KECLDBNJ_00646 ATP-dependent Clp protease proteolytic subunit
MENKKGKPQDLIDAKLLEERKVFLWGQVDDKSAKHVVDRLLYLDALSNDEIQFYINSPGG
YVTSGFSIYDTIKSIKSPVSTICTGLAASMGSILLSVGEKGRRFIQPHARVMIHQPSGGA
RGQASDIEITAQEILKTKELSAKILADNCGQDFDKVMKDFNRDHWMGAEESVAYGIVDGI
L
>KECLDBNJ_00647 Thioredoxin
MALEITDANFEETVLQSDKPVLVDFWAAWCGPCRMVGPVIEEISTEYDGKAVVGKLDVDA
NQEFAAKYGVRNIPTVLMFKDGEVVGRQVGVAPKNVYTEAIDGLL
>KECLDBNJ_00648 1,4-alpha-glucan branching enzyme GlgB
MQTTIEKSAGMGAVYKDGITTFRVWAPNADKVSVVGEFNDWDETANELTLEENGYWSTIS
EQAKEGQEYKYRIQNGDQSFYRNDPYAFEVTNSNGNSLIRTLDFEWDDADFEIADWNKLV
IYELHVGTFNRKQKDQVGTFADVVEKLPYLKELGVNCIELLPVAEFAGGISWGYNPAHPF
AIEQDYGGPEGLAHIVNEAHKQGIAIIMDVVYNHFGPSDVDLWQFDGWSENNKGGIYFYN
DHRSATPWGDTRPDYGRPEVRQYLRDNALMWIEKYHCDGLRLDATSYIRYEGGGLGEDTA
IDEGNQMMREINQELQAKYPKVITIAEDLKGDEFITNGIAYGGVGYGAQWDMHFVHPVRE
VLQSVSDDGRDIQKIVDALEYTYSGNKFKRIIYTESHDEVANGKARVPEEIQPGDAESKF
AKRRAVLGLVLTLTAPGIPMLFQGQEFLEDEYFQDTEALDWEKENRLSGIRELVSDLIKL
RIGASGGANGLLGQHLEIIHFNPENQILAYKRGGSEEEQTLVILNFKNQTYEHYGIGIAE
DKNWKLRINADWKGYDIDFSELEVTDLKIEKTETDGRPLTGSFNIPAYGALIYTAE
>KECLDBNJ_00649 hypothetical protein
MNLCKLCKIRNADKENSHIIPKFLGKPLFKSPSHRAAMEINKGGRNKKIQDIPKEDFILC
SNCEQKFSILETYFARKLKSINDFKNRKNDFRFTQVHSNNLLIPENLDPIFFKLFTVSLF
WRVSISTLFLYEKYKLPELIEEEFRVFLSKNLKEKHRDLIEVLPKIKNTPNYHFVVFKPE
FNNRDFIGGLTAYQTSKNIYTIFTSDLVFQFYSELIQTDPIIDLISNLQDEEVRIILSSN
ENWKALGSAVIKKVINSTH
>KECLDBNJ_00650 DNA polymerase III subunit alpha
MYLIFDTETTGLPKNWNAPITDSDNWPRAIQIAWQLHDDMGNCIEHEDYLIRPDGFDIPF
DAERIHGISTELAQRDGLPLGEVLGKFKAALERTKFVVGQNVGFDVNIMGAEFHRLDVSN
QLQELPVLDTCTETTAQLCQIPGGRGGKFKLPTLTELHQYLFNQPFAEAHNATADVEATT
RCFFELVRRRIFTQEELDVPAGYFENFSEANPQPIEFIGLKHINLKKASDEIRKELQKAD
QADISKEEIKENKEQLAKVDFVHLHNHSQFSILQSTASVHDLVAAAKKHKMPAVGITDMG
NMMGAFHFVKALTAQNKAAQKKNDELLEAGEEPTETIIKPIVGAELNVCQDHTNKSQKDN
GYQIVFLAKNKRGYHNLAKMASLAYTDGFYYVPRIDREIVERYKEDIIVLTGNLYGEVPS
KVLNVGEKQAEEALLWWKETFGDDLYIEVMRHGQEDEDRVNQTLIEFSKKHDVKLVATNN
TFYIDKEDAPAHDILLCVKDGEKVATPKGRGRGYRFGLDNEEYYFKSADEMKALFTDLPE
AISNVDEIVDKVEAFVLARDVLLPAFTIPEEFQFEEDKQDGGKRGENKYLKHITFEGARQ
RYPEITPDIEERLNFELSVIENTGYPGYFLIVEDFIREARNMGVSVGPGRGSAAGSAVAY
CLGITNIDPIKYDLLFERFLNPDRVSMPDIDIDFDDEGRSRVMDYVIDKYGANQVAQIIT
YGTMAAKSSIRDTARVLDLPLSDADRIAKLIPNMSKLAKIFGQSEADLKKKFRSEDLVKV
NELLNLAEGDDLEGQTLRQARQLEGSVRNTGIHACGVIITPDDITNFVPVSIAKDSDLYV
TQFDNSVVEEAGLLKMDFLGLKTLTLIKDTVKLVKHKHGIDLDPDSFPLDDEKTYELFQR
GDTVGIFQYESPGMQKHMQALKPTVFEDLIAMNALYRPGPMEYIPSFIARKHGEEEIQYD
LPAMEEYLEETYGITVYQEQVMLLSQKLAGFSKGDADVLRKAMGKKIFALLEKLKPQFLD
GGEKNGHDRKILEKIWKDWEAFAAYAFNKSHSTCYAWIAYQTAYCKAHYPAEYMAAVLSN
NMNDIKQVTFFMEECKRMGLEVLGPDVNESFRKFTVNDQGAVRFGMGAVKGVGANAVKTI
VENREDGPYRSVFDLAKRIDLRAANKKAFESLALAGGFDSFMATHRAQYFKDEGDGITFL
EKAVKYGAKFQENENSAQVSLFGEASEVQIPEPVVPPCEEWGTMEKLRREKEVVGIYISG
HPLDDFKLEMDNFCNGKISDFNNLEMHLNRELTIGGVISDVQHRVSKNGKGWAAFTVEDF
DESFEFRMFGEEYLKFRHFLIPNSFVHMRVFIREGWTNRDTGKKGDPRMQFNNFMQLQDV
METFSKKLTINLDLQEVQGDRIEQLRETLFNHRGDHNLHFYVFEPKEKIALQMPSRKKKV
KISSALLNELKAQRFSFKLN
>KECLDBNJ_00651 hypothetical protein
MKFTEKISNNLNELLTKNYDAEAGYKLAEENVKDNTLKEYFGRKAKERYDFGHQIKNEIK
VYGESPDKGTSVAGDAHRLWMNVKSTLSKNSEEAILEETIRGEKNAIEEYQSILSNPNLP
PTTEAILNTQLDLIKGTLEEVKAFEVMA
>KECLDBNJ_00652 hypothetical protein
MSYSDKMGEKLNELLEKNYDAEAGYKNAAEKVQNSALKNYLLSRAQDRYDFGHELKAELK
TFGQEPEKGTSLAGDAHRLWMDLKTALSSDKDEAVLEEAIRGERAAVDEYDEILKEESLP
SSTKSIITAQRNSVKAALNEAKALEVLA
>KECLDBNJ_00653 hypothetical protein
MLKRFSLVLAAGLTLYGCKTQKAATTPAAESSTSQKSKLKPYNKVITAEAESDNGLFTTH
RLDDHLYFTIPDSLMGKDMLLVSRIAKVPAGYGGGYVNAGSKVNEQVIRWSRRGNFVDAR
VINFENQSDQDSPINKSVEANNFFPILFSAEIKALAKDSTGVVIDATDLFTQDITAINAV
SPRLRKQYKVKRLDDKRSYIESAHAYPQNIEIKHVMTYDTEEPPERDQASTLTFLMNQSM
ILLPEDKMQPRIADERVGWFTLRKYDYDSDALKSDDYRILRRWRLVPKDIEAYKRGELVE
PVKPIIYYLDPATPLKWRPYFKQGIEDWNAAFEKAGFKNAIIAKDPPSPEEDPEFSPEDV
RYSVIRYVASTTRNAVGPSVSDPRTGEILESDVIWYHNHLRSYRNRFMIEAGAQNPAART
LETPEAEIGEMMRMVIAHEVGHAIGLPHNMKASSAYPTDSLRVASFTQKYGLTPSIMDYA
RVNYVAQPEDKGVRYIRMMGPYDYYAVNWGYRYIPEAETAEEEKPTLDQWILEKAGNPWY
EFGSSTGVDPHSQTESLGDDNIKASLYGLANMKKVIPNLIDWTTKDGYGYDDLDEVYGEL
TRLWRGYVYHVITNVGGIYETRKTADQDGVVYEPVPEAIQKEAVAFLNEHAFTTPEWLLD
KEILNRIESDGAIERIQNLQTRALNSLLSVDRINRLVSTVEQEGAEAYSPIELMTDLRKG
IFSELYAAQKTDAYRRNLQRAFIDIASEYIKKEKADDDEVLKSDASALMRGVLNQMRRDL
NTRKNYSGDTITQYHFEDLIARIDTAFDRD
>KECLDBNJ_00654 hypothetical protein
MIFSKFFNKSSNLDKELDRNLLFAPNYLIREQKVNNNTQYIFGGHSIITIEQTQGKNVGL
FFNRTRTSKSNKLNLNPKNELHLGFQTIAEVNYLILGTRQHLSHVKPGDLLEICFNDDSK
INLTLESTDEKATVNKGYACNVRAKINAKELKHFQKKMMNTYKLRLNASGETVDGSFDKE
FCQKFREVAQSYVFCLENYY
>KECLDBNJ_00657 DNA mismatch repair protein MutS
MKQYNSIKTKYPDAMLLFRVGDFYETFGEDAVKAAGILGIILTNRNNGSERSELAGFPHH
SLNTYLPKLVKAGCRVAICDQLEDPKQTKGIVKRGVTELVTPGVSLNDEVLQSKSNNFLA
AIHYGKRHLGLSFLDVSTGEFLTAQGDVAYIDKLLQNFAPSELLISKKNKADFKEDFGTD
YHIFYQEDWVFKPDYAQESLNKHFDTKSLKGFGVEHLEEGIIAAGAALHYLSETRHDKLQ
HISSIGRIAEDAYVWMDRFTIRNLELYQGTSVKSITLLDVIDKTISPMGGRLLKRWLALP
LKNLEPIKERHEIVDFILNHPDFYDKVSAHIKKIGDVERLISKIATGKVAPREVILLKNS
LEAMIPIKALAQNSENKALQILGEKINNLEHLRDKIKETLTEDAPVSVLKGNTIAEGFHT
ELDELRNLATSGKDYLDKMLERETERTGITSLKIASNNVFGYYIEVRNTHKDKVPVEWIR
KQTLVNAERYITEELKEYEAKILGAEERILGIEQQLFAQLVSWITQFIEPVQTNAHTLAQ
LDCLRSYACLAKENGYCKPSMDDTYELEITEGRHPVIEKQLPISEPYIANDTYLDRDTQQ
MIMITGPNMSGKSAILRQTALIVLLAQMGSFVPAKAARIGLVDRIFTRVGASDNISMGES
TFMVEMNETASILNNISERSLVLLDEIGRGTSTYDGISIAWAISEYLHEHPARPKTLFAT
HYHELNDMGETFNRIKNFNVSVKELKDNVLFLRKLIPGGSAHSFGIHVAKMAGMPQQVLH
RANKMLAQLEQSNRKEEHRDALSTVEDDEMQLSFFNLDDPLLEEIKDEILHTDIDTLTPV
EALMKLNEIKRMLVRNKKNQVS
>KECLDBNJ_00658 Putative TrmH family tRNA/rRNA methyltransferase
MNRKLKNSELDRKSVEAFKEAEKTPIIVVLDNIRSLNNIGSVFRTADAFLIEAIYLCGIC
AQPPHKDITKTALGATESVRWSYFESTLDAVKELQENQYQVVAVEQAEQAVMLNDFVVEA
HSKYAVIFGNEVKGVKQNVVNAANTVLEIPQVGTKHSFNISVSVGIVLWDMYAKLLKSS
>KECLDBNJ_00659 hypothetical protein
MKTKAFDYASYVRGIKDGRRFGIFMGVIIGFAIMIAVLGIIYFS
>KECLDBNJ_00660 Deoxyguanosine kinase
MGRERKQQAGYSDRPIDIDLLFYGDSIVETKKLTLPHPQLQKRNFVLFPLRDIAATFKHP
LLKKTIEELTAETPDAEIPEKQSKWLKNPQAAYTFSTHNYIAIEGNIGAGKTTLATKISE
DFNAKLILERFKDNPFLPKFYEDQARYAFPLEMSFLADRYQQLLDDIGQYDLFKDFMIAD
YDSQKSLIFAKVTLSEEEYSLYQKLHGIMYREIARPDLYVYLYQNTERLLENIKKRGRSY
EQDISESYLVDINKGYLNMIKNKRGNNVKIIDISGLDFVENRADYLKVLDALQAME
>KECLDBNJ_00661 hypothetical protein
MSQRDALAAYRIYFILGALFICSLVVSNLIFQKFFYWDFFGLYKFEISVGILPYPITFLI
TDLISEIYGKKKANQVVTAGIFASIFSLLIVYTSAVVPATDWSPVDNALFDKVFGATVVA
VMASMMAYLFAQYIDIQLFHFWKRLTKGKHLWIRNNFSTFFSQFVDTATVLLLLCAFNKI
EWSLFGTLLLSGFLFKVLVAVCDTPFLYLGVYLFRKRFKLAPGEEIGAELNAFQKEEKL
>KECLDBNJ_00662 hypothetical protein
MKKVFRIIGIVLLVLIIGLIAAPFLFRGQLEELLKKSINENLNATVAWEDFDLTLFSSFP
DAAVQVQNFSVVNNAPFAGDTLASGATLQLDMGVMQLFKTSSGKPIQIDAIRLDEGFVNI
KVDSLGNANYDIAKESPATTASQDTLADSSGGFSFDVQHYELNNSRINYLDESTQTFLRL
TEVNHEGDGDFSAAVSNLNTTTTALASFDFDGVNYLNANKIALDAVIEMNLEEQRYTFKE
NEALINQLPLVFRGFIQVNENNNELDLAFETPSSDFKNFLGVIPEVYAKNLDGVTTTGDF
KVNGRINGVVDETHIPMLDIAIQSNNASFKYPDLPKSVNDIIIDAQIMNETGNVDDTYLR
LGNLNFRIDQDVFNAKGRIDRLTTNPLVDLALKGKLNLANLEKAYPLELDQDINGLLTVD
MTANFDMESVEKERYQNIKSSGTASLKDFKYVSPELPNALNMASANVTFNPGTITLNNLD
AQTGQTDISAKGSIENLIPFVLSKEDLKGRFTVNSKVINLADFSVVEEESAAATTAEKSA
STSATASGDTAIKIPSFLDATLDFKAGKVIYDNITLSNVSGNVTVQNETASLNNIRSDIF
GGAIGLNGNVSTKSATPTFEMALDLKSVDISQSFEGLEMLQQLTPIAKALQGALNTNIQL
KGNLTDDLTPVLSSLAGNALAQLLTVEVKPEKMKLISALDDKLDFINLQNLDLSNLKTQL
SFDNGLVTVKPFDFNIKGINVGVSGTHSLENTMNYTLNLKVPGSYLGSKVGNTLASLSNA
DLESYTVDLPVTLSGNFTSPQVSLNTQQAVTNLTQQIVATQKDKLKQQGEDRVKQALSGL
LGGTKTTTDSTAVKTRKDSVSTTTKTTTEKVVKDVLGGLFGKKKATQDTTKTNN
>KECLDBNJ_00663 Photosystem I P700 chlorophyll a apoprotein A2
MQVISSKRFLHFFLFLSLSLTYAQEKELDKAAKKFESYAFIDAQKIYLRLAGEGYESEEL
FKKLGDSYYFNGKYEESAKWYKKLYDKYPESLTPEDLFRYAQSLKGVQQYEASDRIMELF
RKEKGEDSRAELFNEEPDYLEEISYSESEYEVENLRRTNSRLSDFGPMIYENKLIFSSAR
DTGSTARYIHKWNNEPFLDFYQAPIDVETGDLGAVEKFGGILNSRYHESSPTFTSDGNTM
YFTRNNFSQGVKRSDKNGTVRLKIFKSVKKGGNWSAPVELPFNDDDYSVSHPALSPDNKK
LYFASDMPGTVGFSDIWVVDILGDNEYSAPENLGPIINTEGRENFPYISKKGNLYFSSDG
RPGLGGLDIYVVATKKNGDVAYVINLGKPVNSPQDDFAFIVDDYRNMGYFSTNRYYGMGS
DDIFKFTRKPVEIPVCESLITGTVRDKETELPIPTATVSILDLEGNVLASTPVNENAEYS
LSVICGQQILIRASEPEYYSAEELVTVPKDGDDMVVDLYLEPRITKINQGDDLAKLLDLK
PIYFDFDRFNIRPDAAEELTKVLAVMESNPTLVVEIRSHTDSRGIDSYNLSLSDKRAKST
ADWIVSRGIDPTRISGKGFGETELINDCGNGSDCTEEQHQLNRRSEFIVISF
>KECLDBNJ_00664 Putative NAD(P)H nitroreductase YdjA
MLDQIIKNRRSIFPNQFSGKAVSKEEIKILLEAANWAPTHRKTQPWRFKVFREDSLSVLA
EFIEKAYTTTTPEHQFSAFKLKKTLEKVTTSAAVIVICMQRDPKESVPEWEEVAATAMAV
QNLWLMTGELGLGGYWSSPGYRTAMHTELKLNTGEECLGFFYLGAYKEEPLAGERDAIED
KTVWF
>KECLDBNJ_00665 Adenine deaminase
MRITLLSLALALLSNIAFAQKTYLHVGKLVDTKNGKVLNEQTIIVSGDEIEDVIDGYESG
AGKVIDLKDKVVLPGFADLHVHIETETSPTRYLEGFTLNEADIAYKAQELALRTLNAGFT
TIRDLGGSGVNVSLRNAINTGKVLGPRIFTAEKAIGTTGGHADPTNGYRKDLMGDPGPKE
GVVNNVDDARKAVRQRYKNGADWIKITATGGVLSVAKNGQNPQFTEEEIEAIVTTGKDYD
LQVAAHAHGDEGMQRAVRAGVKTIEHGTLMSEETADLMKKHNTYYIPTLSAGKYVAEKAK
IKDYYPAVIVPKALEIGPQLQKTFAMAYNKGVNIAFGTDAGVFPHGENAKEFGYMVEAGM
TPMEAIQSATIETAKVLKAEDALGQLAAGFKADIIAVDEDPLQNINTLNEVTFVMKAGEV
IKE
>KECLDBNJ_00666 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLKGQYEPIKEQVNRTIQEVIDTTAFINGPEVHGFQKDLEDYLNVKHVIPCANGTDAL
QIAMMGLGLKPGDEVITADFTFAATVEVIALLQLTPVLVDVDPVDFNIDIEAVKKAITPK
TKAIVPVHLFGQVANMDALLELAEEHNLFVIEDNAQAIGADYKHKDGSTSKTGTIGHVGS
TSFFPSKNLGCYGDGGAIFTNDDALAHTIRGIVNHGMYERYHHDVVGVNSRLDSIQAAVL
RAKLPHLDNYNARRRAAALKYTEHLEDHPKVITPNIVSGDPNAHVFHQYTLRLQGVDRDA
LVKHLNANDIPCGVYYPIPLHKQKAYADARYNEEDFSITNQLVKEVISLPMHSELDNEQI
EYIVTKILEFID
>KECLDBNJ_00667 3-deoxy-D-manno-octulosonic acid transferase
MYFLGRKGYFCVLMRHLYSLLISLFHALLPVLGVFVKSLKEFYQVRRGIFNVLEEKLSAQ
DQTIWVHAASLGEYEQAVPVLEELRAKYEDYKIVLTFFSPSGYTVKKATPLADVVTYLPL
DTSRNAQCFLKLVKPELAIFIKYEFWPNYLNTLHKLKVPTLLVSGIFRADQPFFKFYGRW
MTQSLRAFDYFFLQNASSLNQLQQLGFKNAEVSGDTRFDRVHRQLSYDNFLQEIERFKGT
DLLLVCGSTWPEDIALLSGFINTASGIKILIAPHKVDKDRIQELEQVLKRPSKRFSDLQS
DKNFDADVLIVDAIGFLSKIYAYADLAYVGGAAGTTGLHNILEPATFGVPIITGIHIEKF
PEAQDLRTLAGLFTVANVEETTALLQKLTTDANFRLKTGIISGNFISNNTGATPKIMAYI
DQTLTA
>KECLDBNJ_00668 hypothetical protein
MNFQNLYAFLRALQKNNAKEWMDDNRKWYHEIRDSYIEWLTQMDLKLSEIDPNYTHTPGK
KAINRINNNLLYHPNKPIYKDHFGAGLDQETKQGDFYIHLGTSESFIAGGFYKPKSALLK
SIRQAIDYNGEELKAILNKPSFKEVFGNLVDDGDSLQTAPKGFSQDHEHIDLLRRKTFAV
QHNLTQKTVMSADFDNQVIKIYKEMLPFRTYLNQAVSV
>KECLDBNJ_00669 hypothetical protein
MKKVIGIFVLGLLAFNTYSCREQEEKETVVVKEVEVEKDDEGILERTAKKVDAEVNKEID
EEIENIGDDNK
>KECLDBNJ_00670 hypothetical protein
MKKISFLASLLLVVSISFTACREQSEKEKLVEEMKEEGAEIDTKTDDDGNYKIKMESEEK
EVKIKEDADGDTKIKVDY
>KECLDBNJ_00671 hypothetical protein
MDFFLSLNRIYSELFYFYAMGINEVSGDIRRFKQVREEQNLTQSEFAEALGIKNSTADIE
RGRTKLSGQVVTELLRLYNINPLWLFGYSNQKLLHAGKGDVSPKVVTVDLADNENLVMVN
QKAAAGYPHNVQDVDWYQQLPAFDLPLPQYRNATYRGFQIEGDSMLPNFMPDDWVLGKAI
ASMDEASTNRVYVVVLPDAVVVKKLQKLPDPSKVLLISLNQEYLPFEVQVSDIQELWQVN
SKLTFHLDSPSESSLLKELQQGMEELKSQMRNLK
>KECLDBNJ_00672 hypothetical protein
MNFERIKEKLNILADAAKYDVSCSSSGSKRQNTSKGLGDSSGMGICHSYTEDGRCISLLK
ILLTNHCIFDCAYCVSRKSNDIKRAAFKIQEVVDLTINFYRRNYIEGLFLSSGIFSSPDH
TMERLIAVAKKLRLEENFNGYIHLKSIPGCSDELMREAGLYADRLSINIEIPTVSGLKLL
APEKNHKDFIKPMEKVKNEILQYQEDKKLSRKTPIYAPAGQSTQMIVGATGESDKDIMYS
AVHYYSTYKMKRVYYSGYVPVLKDERLPALGTEVPMLRENRLYQTDWLLRFYGFDVRELL
NKEYPNLDVDIDPKLSWALRNMHLFPVDVNTAEKRMLARIPGLGMKSVYKILNARKYRRL
NWENLKAIGIAFNRAKYFMICDSRDWERRDLEPARIKSMILQSSQSKYQKMYNNQLTLF
>KECLDBNJ_00673 hypothetical protein
MQAQKLIYDGSFEGLLTAIFVVYEERIPNAEIVEERFYEPDFFAEKNHIYTDETKAARVW
DKLKQFPQFSATVYRSFLTELREKESYILKAIQYVLKTKNAKDYGEPAVLKLAQWTKQIG
REKHRMEAFVRFKRTKDDLYIALVAPDFNVLPLIAKHFKNRYADQQFVIVDHKRNYGIYY
DLKSITFVTLDFDANNLKDGLHEEEQYYDEMWQDYFISTGIKSRINKKLHQQHVPKRYWK
YLNEKNPL
>KECLDBNJ_00674 hypothetical protein
MKRLYYSVMALAILGAVSSCRETTQEKTEEAVEAIGEDVEQAAEEAGDAIQEGADELNDE
IQGNDDH
>KECLDBNJ_00675 hypothetical protein
MKKFMYSAFALLLMVSVSACRETTEEKTEDAMESAADDMGDAMEDAGDAVEEAAEDTGDA
IEEGAQEVEDEVEGNDDM
>KECLDBNJ_00676 Malonyl CoA-acyl carrier protein transacylase
MKAYIFPGQGAQFTGMGKDVYETSDVARELFERANEILGFDITKIMFEGSAEELKETKVT
QPAIFLHSVALFKALGHSAVPQMVAGHSLGEISALVANGVLSFDDGLRLVSQRAQAMQKA
CDSVPSTMAAILGLEDELVEAVCADVDGVVVAANYNCPGQLIISGEIEAVNEACERLKER
GAKRALVLPVGGAFHSPLMEPAREELAAAIEKTTFSTPTCPIYQNVSTTAVTDPAEIKKN
LLFQLTAPVKWTQSVENMLKDGATEFIEVGPGKVLQGLVKKVDRQTATSSATI
>KECLDBNJ_00677 hypothetical protein
MMKHNQYFKIAAFLVCVFSTYAVSAQFDAISNLPLQKNPKYQWANESKKASIKESKMQVD
FYLNQKDAENYIYIVDGQVLPVNDFKEYKESILKQARAINFVKGIDSVMGYPSHRKRMLI
LITTQTVED
>KECLDBNJ_00678 hypothetical protein
MLDADFTIHLNQSFSFSIKQATPLSGGDINAVFLLTTDQGNFVIKINDAQRFPEMFSLEK
LGLESLAQSKSFITPKVLGVGTFETKSYLLLEHIESGKPSADFDEIFAQNLAKMHQTTSA
FGFQKDNYIGSLPQYNTEEASAADFYIKQRLMPQFKMAADRGFSFGNVDLLYKSIPDLIP
DEPAALIHGDLWGGNFMVNSDGNPVLIDPATCYAPREMDLAMMRLFGGFNENIFDKYHEV
FPLCEGWKARIRLWQLYYILVHVNLFGGHYYNTANSILKTYI
>KECLDBNJ_00679 Dihydrofolate reductase
MKITLIAAAAENNALGKDNDLVWHLPDDFKRFKKLTSHHHIIMGRKTFESFPKPLPNRTH
IVITRNSEYDAGEGIIVVDSIDAALDAVMNDDNPYVIGGGEIYKLALDQATHIELTRVHS
SFEADAFFPEINENDWELVAETFHPKDERHDYAFTYLTYARR
>KECLDBNJ_00680 hypothetical protein
MFSKKQESTKIDREQRELIEHAQFRIKQKKNLFRHFIVFLAGAVLLIILNKFLDFGTNFR
PGQVDWFVWAVLLWFFLFLIHFLNVFLFSSFMNKKWEHEQLDKLVAKQKEKIAKLQNKVD
QEHPLPNSTEPKAINPNPPLNP
>KECLDBNJ_00681 hercynylcysteine sulfoxide lyase
MKNLKKEFPVTANYTHLNTAGSGLLSETLLDFRQNHDLDYLVYGSVIKDKQDKFISGVRK
DVGSFFKCHPSRVALVPSFSIGFNFLLDALPSKTKVLLLQEDYPSINWPVEARDFEICYA
AIDEHLEENILQAVEREKPQILCLSLVQYVSGVQIDFEFLKKLKENFPDLIICGDGTQYC
GVEEFDFEQSGLDILGASTYKWMNAGYGNGFFLFKEAMQEVLKPKAVGFASIRGLYKEEN
EHALIGKFEPGHIDTLNMGSLQAAIQLVKKVGYSNITEQINTLKKQALEAFASRGLLDDF
VTQRKVHSSIFNIKGDQKLFEKLKAKDIICSQRGNGIRISFHYFNTESDLEQLLKLI
>KECLDBNJ_00682 hypothetical protein
MPITKQFLKSKPECKVTFTVLDTDASSVAVAGDFNEWEKVELKKLKNGSFKGALNIPVDA
SYEFKYAVDGQWMNDPEADSYQWNDFAGADNSVLSV
>KECLDBNJ_00683 Histidine N-alpha-methyltransferase
MKTTTALHFKNTFEKEVYEGLTAFPKRLSSKWFYDKKGDKLFQQIMDLPEYYLTGCEFQI
IDQYKNEIATLFQESKGFDLIELGAGDGKKTKILLEEFLKQQLDFTYKPIDISQNMLEEL
EGAILKKWPEINIKVKQGTYFEILEKLNNQPSDRKKVILVLGSNIGNLTHPQAIDFLKNI
RNSMAEQDLLFMGLDQKKDPEKILKAYNDSQGVTEAFNKNILHRINKELAGDFDPETFKH
WPTYDPETGTTKSFLVSTKSQQVTLKNLNLQINFEPWESIHTEISQKYDDDVVNWLAQEA
GLKVVTQFTDAQSQFTDYIFKTDS
>KECLDBNJ_00684 Hercynine oxygenase
MLTTTTTLLDFLLETRTHTETLCKPLEIEDYVVQPIVDVSPPKWHLGHTTWFFEDFILKK
FKTDYKEFDPNFSFVFNSYYESMGARVVRTDRGNLSRPTVREVYDYRAYVTNQLQELLEQ
NTASDELQSLVEIGIHHEKQHQELLLTDIKYILGNNPLQPIYSESFSENPASNQSTTWIE
IPEGIYEIGHNGEGFCYDNELGKHKVFLNDFKISNQLVSNKDYLEFIEDGGYDQVLLWHS
EGWDWVKSLHTKAPQYWQQQDNLWFYYGLDGVQPLNLEAPATHISYYEAFAFAQWKTCRL
PTEFEWEVAHQTLNWGARWEWTESAYLPYPNYQKAPGALGEYNGKFMVSQKVLRGGSIAT
SNKHTRPTYRNFFHPQLRWQFTGIRLAQ
>KECLDBNJ_00685 hypothetical protein
MRSLLLITCFLVCAFSFAQEGVLVSGNGITINEIPPVWPGCTGSTAEKKACFKKQLVQHV
VSNFQFPKGYKKGSVKEKVVVDFVINEEGKPQILGVKGGTKVLQEEAKRNIMAIPQMTPG
QAGGKPRAIKYSMPFTF
>KECLDBNJ_00686 Thymidylate synthase 2
MKQYHDLVKHILDHGTQKGDRTGTGTLSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELL
WFLKGDTNIEYLKENGVRIWNEWADEEGNLGPVYGHQWRNWNSEEIDQIKEVIDTLKNNP
NSRRMLVSAWNPSVMPDTSKSFSENVANGKAALPPCHAFFQFYVAPGDPEAEDKRPKLSC
QLYQRSADVFLGVPFNIASYALFTMMMAQVCDYAPGDFIHTFGDAHIYNNHIEQLNLQLT
RELRNLPTIKLNPEVKDIFSFKFEDFQLENYDPHPHIKGKVAI
>KECLDBNJ_00687 hypothetical protein
MVLKSNSYSFGEAKYFESFVHIKFNEDLDEVKLEYSKQIFKDIEAFYDGARYALISERGL
ATAFNPINMKSLNLSKMYALAVVSPEGSQRREELVVEQGYYKGSFAFFTTYKAAEEWVLT
F
>KECLDBNJ_00688 Putative nucleoside permease NupX
MRKLLLLLLVSVISTLSSVAQSAQEILPVAESKVIIPNAGFSFDSLWRGVLGMICLLVIA
YLFSTNRKAINWKTIGIGLGAQLLLAIGVLKVPFVQKSFEFVGKIFVKILDFTAAGSEFL
LGGMMDTESYGFIFIFQVLPTIIFFSALTSVLYYLGIVQVVVKGMAWVLTKLLGISGAES
LSVAGNIFLGQTEAPLMIKAYLERMTRSEILLVMVGGMATVAGGVLAAYIGFLGGDDPAL
RLEFARHLLAASVMAAPGAIVISKLLYPQQMPVDPNVEVSSDKIGSNILDAIATGTTEGL
KLAANVGAMLLVFVAFIAMINWGFGKIGEVTSLNDFLAANTPYTSFSLESVLGTIFAPLM
WLIGVASEDIMLMGQLLGIKLAASEFVGYIQLAELKNPVNGLSFTYQKSVIMATYLLCGF
ANFASIGIQIGGIGSLAPGQRKTLSEFGLKAVLGGTLASLLSSTIAGMIIG
>KECLDBNJ_00689 hypothetical protein
MSLVRLNIKGISYSQTQNGAYALILSEVDGDRKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKNFADRFDIQVKQVIIHKLVDGVFYSSIICERDSIEEIIDARTSDAISLALRFNA
PIFTYKNILDKAGIYLKGTDHDVSKEAEDDVLVDQLVVEEEEEKPSAASNDYKKLSLSEL
NSLLEQAVAAEDYEAAAKIRDEISKRN
>KECLDBNJ_00690 Caffeyl-CoA reductase-Etf complex subunit CarE
MSVLVYTESEEGKFKKTAYEVVSYARGIADMMSTTVTAVAVNAEETASLGTYGADKVVHI
KSDKLSKFTANAYAAAVTEIAKNEGSKVVVLSSSANAKYLAPLLAVDLEAGYASNVVALP
ESASPFKVKRTAFTNKAFNHTEISTDVKIIGLSKNSFGLKEAQKDATETSFDPSLDDSQF
KVEVQSVDKVKDKVTIADAEIVVSGGRGLKGPENWGMIEEMADILGAATACSKPVSDMGW
RPHSEHVGQTGKPVASNLYIAVGISGAIQHLAGINASKTKVVINTDPEAPFFKAADYGIV
GDAFEVVPKLNEKLKEFKANNS
>KECLDBNJ_00691 Electron transfer flavoprotein subunit beta
MKILVCISHVPDTTSKINFTENDTKFDTNGVQFVINPNDEFGLTRAMWFKEKQGATVDII
NVGGPETEPTLRKALAIGADTAIRINTEALDGFQVAKELSAVAKEGNYDLIIAGRESIDY
NGGMVPGMLASLLGASFVNTCIGLEVDGDTATAVREIDGGKETVTAKLPLVVGGQKGIVE
ESDLRIPNMRGIMMARKKPLEVKEPQGASTETSAVSFEKPAPKGDVKLISPDNLDELIDL
LHNEAKAI
>KECLDBNJ_00692 2-oxoisovalerate dehydrogenase subunit beta
MKTIQFREAVCEAMSEEMRRDEAIYLMGEEVAEYNGAYKASKGMLDEFGPDRVIDTPISE
LGFAGIAIGSAMNGNRPIVEYMTFNFSLVGIDQIINNAAKIRQMSGGQFNCPIVFRGPTA
SAGQLGATHSQAFESWFANTPGLKVIVPSNPADAKGLLKSAIRDDDPVIFMESEQMYGDK
GEVPEGEYLIPIGVADVKREGSDVTIVSFGKIIKEAYAAAEELEKDGISCEIIDLRTVRP
LDINTVIESVKKTNRLVILEEAWPFGNVSTEITFQVQEKAFDYLDAPIVKINTADTPAPY
SPVLLKEWIPNSNDVVKAVKKVLYR
>KECLDBNJ_00693 TonB-dependent receptor SusC
MRQSLNLLLFLFIPVLLLGQTKAGGLVFDSAGNPVPFANVVFAGSSEGTITNEDGRFYLQ
SDNTYDALKVTFIGFRAKEVSLPQRVNYNLEITLEEETESLSEVVVYSGKQPKKNNPAID
ILRKIWANKRSNGLNQFDQYAYDKYEKVEFDLNTIDSSLINSKIFNKMEFIFDQMDTSRI
TGKTYLPIFINERSSEVFGDNILDKEKEELKGNRNSGFSTNQTLIAFIQELYNEFNIYDN
YLKFFDKSFVSPLSTTGIDTYNYVLADSSYIKDKWCYNIIYYPRRSNELTFKGDFWVNDT
TWAIKEINLQVNKSANINWVKEIYIEQEYDVLNDSVFLITRDYFLSDFALRKKEGSRGVY
GKRTTLYDNYVFDKPKEEDFYDERVTRYDESVYTQPDTFWDENRMEPLSKDEKGVYVMLD
SLQKVPKFQAFYSVSSAMVSGYYEWDKANLDIGPLFSAFGFNDVEGLRLRGGARTYFDQN
DPWRLEGFGAYGFRDKKFKFGLSGKVLLDHKARLIVSGGYRQDVEQIAASLTTSTDVLGR
NLASSSLVTVGNNDQLTSIKLANFAIEAEFLKNLKIRGDLSYRTLESASPTFNLDYYTDF
TQTEVRSDVKQAEIVLSGIFEPGKHTSGYGVERTVTNEWFPTIYFGYTKGVKGLVNSDFD
YEKLQVSYRQPWRMGGLGTFSSTIEAGKTFGEVPLGLLSVVPGNQNLFSIYGTFPQLNYY
EFVTDTYATLHLEHNFGGRIFGRIPFLRKLNLREIIGFRGAWGSISDENQLINASNIEYI
APNDEPYYEYSFGVGNILKVLRIDFNFRGNYLDTPDARSFGVTGALEFSF
>KECLDBNJ_00694 Inorganic pyrophosphatase
MTADSISTFDVLIEIPKGSRNKYEYDFKLKKIRYDRMIFSSMMYPADYGFIPETLALDGD
PLDVLVLVTEPTFPGCVMEVKPIGVFHMTDEKGPDEKIICVPVSDPIASRISDLSELNPH
LIKEIGHFFQVYKDLEKKKVDVGGFGDVNEAKEIIKQCIDRYADSDVPKEEVSIE
>KECLDBNJ_00695 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MESNIIYVPIVLAVLGLLFMFIKMAWVKKQPAGNDKMQSISKSIKEGALAFLAAEYRLLL
VFVVIASVLLYIISNVVATTSWLIVPAFIIGAFFSALAGNIGMRIATDANARTAEAAKTS
LPNALKVSFGGGTVMGLGVAGLAVLGLSLIFLFLMGSFLTEGGNFYNEMTIVLETLAGFS
LGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVAGM
GADLFGSYVATVLAAMVLGNYLVQDMSQGALFTDAFNNMGPILLPVVIAGVGILASIIGT
FLVSIKNNEAKESQVQKALDMGNWVAIVLTLIASYFLIDWMLPETMSMQFFGEGYKDIPS
LNVFWSACIGLAVGALISVVTAHYTSLGKGPVLDIVKNSSTGAATNIIAGLAVGMKSTFL
SVILFAAAIYGSYELAGFYGVALAASAMMATTAMQLAIDAFGPIADNAGGVAEMSELEDH
VRERTDILDSVGNTTAAVGKGFAIASAALTALALFAAYVTFTGIDGINIFKADVLAALFV
GGMIPVIFSALAMQSVGKAAMQMVQEVRRQFKEIPGILEGTGKPEYGKCVAISTQAALRE
MILPGLITIIVPIIIGLIFGAEPLGGYMAGVCVSGVMWAIFQNNAGGAWDNAKKSFEAGV
EINGKVEYKGSDAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLVGLVIAPILGGHSEGL
ATNQEVKVEVQMQQESNGLYSALITETKTIDGKLQVTEKRLQGSEEELKKQIAEYNTKSH
SASEKHVVKEIKFEEKE
>KECLDBNJ_00696 hypothetical protein
MLKDVLQKLKLHPQDPLQIHGYQTYGTNEHLYLLGRALEDEGVNLDKTGLANAFKNAYKQ
FRSDELPFAKLKIKLPDDRVFYVETNAEGYFKFDKAVKDLQDLTNEQGWLQLELAYDDEN
QKRLIKNNNRFPGQMLIPSRKAEFGVISDIDDTILKTGVTSLLKWRVIFNTLFTGVGKRT
PFKGAASFYKQLHLGKSGNASNPMFYVSNSPWNLYHYLQAFIKHNNFPKGAILLRDFRTP
FDRTPKPEKPHKQREIRNILNTYPDLQFVLIGDSGEHDADIYIEIAEEFPERIKAIYLRS
VNHEKRVFRVRGLLERFELTPALLVKDSQTAAEHARELGLIQ
>KECLDBNJ_00697 Succinylglutamate desuccinylase
MSLEKKYPRILGQYTSNKAGPLLFITGGVHGNEPSGVQALQKVFAQLKKEQPEIKGTVVG
VSGNHKALQENVRYIDEDLNRTWTEKNIASKKQDSHEKKEMFSIIEVLEQFPKTDFEKRY
FLDCHTTSSASKPYISVQEVQDNDAWAHRFPPYIIRGFSDIVYGCIDHYLSRIGVTGFVF
EGGQHTSPDAVKHHEGMIWLALSKACDLDLNTLEKYPEAATYMEAMRAEQKTFEIEYRHE
IKDGDSFKMEPGYENFQPIKKGELLATHNGSEVRSEWDAFIFMPLYQDQGNDGFFVVREV
>KECLDBNJ_00698 Glutathione synthetase
MKICFVISDVATEPVGTSVVLMRKAHQRGHEVYVMNVGGFNFYQGGPIKLTCKKIPEDLK
YKTPQEFWEQVQDEQLAWTKADSSKIDVVFLRNNPTEETDDRHWAEHSGIAFGRMLQEQG
VLVLNDADAMSNAFIDKLYFEELPASIKPKSLITRDKDELLKFWKKCDKKIVLKPLEGSG
GQNVYLIDEEKKNFNQIITSLTELGYVIAQEFLPEVSKGDVRIILVNGRILEENGKLAVI
RRVNSDKTEFRSNLSLGAKAKPAKLTKAMEHIVEITAPKLIKDGFFFVGLDVVDDKLIEI
NVLSPGGLDYCEAIGLPEFTDPVIEAIERKVAYKKHYTHGFSNRELASMH
>KECLDBNJ_00699 hypothetical protein
MTSETSELLADLEPGKRTMSDLPYGGFLVLEHDVPALLIYRKKPKDKSTMRLARTGASYL
IIGDSHFEYFREFIKELTTKMADRFGSFILLELYKGEPASTDFIIKGPSHKLPASLETLS
EELSAIDSRRYDLKLGAQINHTKNRQKPGDEPLFDIDELKAAGGTLLGLELPPVYCNKSG
KMYPLYFRMFRDKLAKAIQKTIYEFIRVQTTSDIHSYHNLGRRRIHKEVLKIDRQITEIQ
SRYQFLLLVAPVNIQALRYKFFETNFEEIDTYHYRLLPVDPDLLKRELYNLRIDEIDDPS
LSYLYNEKREELDKELTMLKERGSKNFFYSSIRLYQGVPRNVLAEAKLILETIPENHEES
TEKTIDAHQFQELAKVEFEYFKKQAPHFESNIHIRDDVNIIMVSNGELYLPADYKMTQIE
AQALIQHELGTHALTHFNGSQQPLSQLSAGFADYDATQEGIAVLSEYLGGGLTGNRLRIL
AGRVVAGEDLMNGADFKSVFHHLYTDYGFTKERAFNITSRMFQGGGFLKDIIYLKGLVEL
RDYLGNGGDLQPLLAGKFALKHVDIINDLTQRKLLNAPKIIPRYFENTNFSTKLNAFKEG
ITLSKMI
>KECLDBNJ_00700 Deoxyadenosine/deoxycytidine kinase
MHIAIAGNIGAGKTTLTRLLAKHYNWQPQYEDVVDNPYLDDFYNEMERWSFNLQIYFLNS
RFRQLLEIQESGKDIIQDRTIYEDAHIFAPNLHAMGLLTNRDFHNYASLFELMESVVQGP
DLLIYLRSSIPNLVAQIHKRGREYENSISIDYLSRLNERYEAWIHDYNKGNLLIIDVDNI
NFVDNPEDLGDIINKIDAEINGLF
>KECLDBNJ_00701 hypothetical protein
MRNVLLFIFFCISTLCAQDSLEVSALPLDTAVSLKAETFIGVDSYNNFYYVKDRALYKKS
KDKTIQFSDLRLGAISTVDLLNPLLITVFYAETNTAVILDNTLNEITRVNFNAIENFRNV
SHARTASDRRLWIFNTDLQRLELFDYQNNRVDSNFTPQPDIAVELASDFNTCWVLTENNL
YHYNQYGSLLEKLPATSLANIAVLDESLFGIQDKKLYIRTKQSASWQEIKNLPQDTKAFY
LKAGNLYLYRSEKISTYTLKLPKS
>KECLDBNJ_00702 Response regulator MprA
MPNTTHLLLAEDEAALGQIVKESLESREFTVDLAEDGEKALKLFEQKSYDALVLDVMMPK
KDGFTLAKEIRAKDDSIPIIFLTAKSQTSDVVEGFSIGGNDYLKKPFSMEELIVRIHNLV
ARKKLQSQSEVLTLGEYQFNFPKQILQFQTEEPVLLTHREAHLLFHLIKNKNQVLDRSLI
LNKLWNSDDFFAARSMDVFISKLRKKLSKDERIQIINVRGFGYKLTC
>KECLDBNJ_00703 Sensor histidine kinase ResE
MQNRKYSYLIYFIAAVIVVTLAIQIYWNYKNYQASRQQLINEIQTSLDFAIDNYYIDLAE
KNTIGLSYEGNILENKGLDTITKRIDISSQGFKGLDSLKPQDIHDIKIFKGVQALNMDTL
ASELRVSLDERRDVVKSFLNPRNTDSLKGKFALANRIIISISTDSIEIPEMNNYIQEQLN
QKNLSVDYGYRFLNKKGLKQYFNLSQIDTTNLKAEAKSGYLPNKSTFTLFYDNIEQEVWK
RNLLGILLSALLMTAVIACLLFLLKIINRQKQLAEVKNDLISNITHEFKTPIATISVALE
GIKNFNRENDPVKTGNYVNTSTAQLDKLTMMVEKLLETATLDGEELALNKEEINLNEILE
NLVQKHQTLAPEKSIRFTALRENNWILGDAFHLDNALNNLLDNAVKYGGDTIEVTLNSRN
GSYSILVSDSGTSLSKAEAKQIFEKFYRVPKGNTHDVKGFGIGLYYTQKIIEKHGGSIDV
SVTSQTTFKIDLPNA
>KECLDBNJ_00704 hypothetical protein
MNFRFLTIVVFFLAFAEALMAQDFQGVATYKSRRKVDLKMNGENMSDAMQEQIAAQLKKQ
FEKTYTLTFNRNESLYKEEEKLAAPDVASSSGIQIKISQSRDILYKNTAAQRYERQEDVL
GKIFLVKDSLSKPQWKLEKETKSIGDYTCFKATRIEEVNSQTFSSESMKTVDTSFTKTVT
VWYTPQIPVSHGPGMNWGLPGLILEVQDGDQTILCNQIVLNPEEKIEIKAPENGKVVGEA
EMKTIQDEKMKEWIERNSSTREDGKSFTIKIGG
>KECLDBNJ_00705 hypothetical protein
MKLQSLFLALALALMTSAINAQQFDGGVATYQSKTSFDFENFGGREMSEQMKKQFAERMK
SRLEKTFTLTFTKDESIYEEEEKLEAPGAGGGMRFMGGGFAQGGIYKNIAEDTYARENDL
MGKSFLVKDTLNKLDWKLEKESKMIGQYAAFKATAVRKIETSPFEAMRPPRPGAEADTTA
TSPKEEVITAWYTPQIPVSQGPDEYWGLPGLILEVSAGRTVILCNKIVINPKEGLAIEKP
KKGDEVSREEYQEIVVEKTKEMAERFGNGRRRGPGGRG
>KECLDBNJ_00706 TonB-dependent receptor SusC
MKYLLFLVMGFSLSISAQSVRVSGTVKDSIGTPLELANVIATRTDTGEMESYAISNTQGR
YQFNLPTGAKYSLVASFLGLAPTTQELDITPGADDISLDFVLYPAENQLDDVEIVYEMPV
VVRGDTIVYNTDSFTNGTEQKLGDVLKKLPGVTVTDDGEIEVEGQTVSKVMIEGKDFFDG
DSKLATKNIPADALKKVEVLKNYNEVDQMRGLGNDQDNVAINLKLKEGKKNFWFGELQGG
IGDGEQTRYLGSAKLFYYSPKGSINLIGNSNNTGDVPFTFRDYFNFTGGFRNFNSRGGTS
FNISDSGLGFLVSQNNRANEIKTNFGAANFSYEASDALDLSGFLLFSDNSTDFIQRSLRN
YIATGATEVNTQNSNQSNQLGMAKFSAIYKPSDKLQLDYDVLAKKSQQEELTDALSVFTD
ENGVTNNPIDENKDNNPFSLNQNLNAYYTLNEKNIFAGFVQHLYQKEDPFYQAIVTQQPF
AQILPLDTNQDRFNINQDKMIETNKLDSKIDYYYVINDKSNLNLTLGTTQSRQDFNSAIF
QILDNGNQNEFIDASLNNDVVYRFSDVFLGAHYKFKTGIFTFTPGVTLHNYNVASEQLGI
ETSENEWKLLPDLYAIAEFKQSESLRLNYQMTADYTDVNNFAEGYVFNNYNQMFRGNRNI
ENAIFHTARLNYFNFNMFNFTNLNGGVSYTKRVDAIKTSTAIDQINQASSPINSNFVDEV
LSANGRFQKTFRKWKANLSANVSYSELNNIINTQPTLSQNFTQNYQGSVETNFKNAPNFE
VGYNRSINNYQNGNSDRVFYTDRPFANMDVKFLNGFTLTADWSYYNYYDKDDTVQNEYSF
FEASLRYQKPESKWEFRLDGTNLFNVDSLNNDSFNETFSTTTEYFVMPRIVMLSVKYNL
>KECLDBNJ_00707 hypothetical protein
MDQAKYDQMETMLHKLEDIKNSQESIIDKINHVITDLFQNPDKDLEKAMEDAHQKASDNV
EKIAEATEEYQMKMNKLEQA
>KECLDBNJ_00708 Glyoxylate/hydroxypyruvate reductase A
MALLLIRNNKDYQPWIEALHKADPSIEVVTPETIKDPADAKMAITWKAPKGSYAKYPNLK
VIGSMGAGVDHLFEDESLPKDVILTRVVDDKLASDMQEFVAALCLNHIRNLKTYARLQKE
NTWKPTDYKRAKDVTVGILGFGTLGQAVGTMLKAIGFNVLGWSSSAKNVDGIKSYTEDEL
DTFLLKSEILVCLLPLTENTKGILNKDLFKKLPQSAYLINVARGGHLVDDDLIEALNNKQ
LSGAALDVFHNEPLPEEHPFWQTENIIITPHIASMSNAASVSGQVTENYQRMQNGEELLN
QVQAKKGY
>KECLDBNJ_00709 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKIADQISDTLLDNFLAFDPESKVACETLVTTGQVVLAGEVKSDT
YIDVQNIARGVINDIGYTKGAYQFSGDSCGVISLIHEQSQDINQGVDRASKEEQGAGDQG
MMFGYATKETENYMPLALDISHRIMIELAKLRRENKDITYLRPDAKAQVTIEYSDDNVPQ
KIVAIVVSTQHDEFDEDEKMLAKIKEDIISILIPRVKNDLHPELAKLFNDDIVYHINPTG
KFVIGGPHGDAGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYASRHIAKNLVAA
GVADEVLVQVSYAIGVVKPTSIFVDTYGTSKVELSNGQIAAKVRELFDMRPAAIEDRLKL
RNPIYRETAAYGHMGKDPRTITKVFESPYSGRIEKEVELFTWEKLDYVDQVKEAFGL
>KECLDBNJ_00710 Bifunctional aspartokinase/homoserine dehydrogenase 1
MLQKLKIENFTTQSGYQLDLQLSYETFGQQLGEAPVILVNHALTGNSHVSGPEGWWNEII
GDDKCIDTRKYSILSFNIPGNGYDGFLIENYKEFVAQDVARVFLKGLELLEIESLFAIIG
GSLGGGIGWEMLTLQPAITAHFIPVASDWKSTDWLIANCQIQEQILNNSSQPVHDARMHA
MLCYRTPESFKNKFQRSTNEDLNIFNVESWLDHHGHKLKDRFQVSAYKLMNQLLKTIDVT
RGREGFNEILSTVEANIHIIGVDSDLFFTPAENRETYKQLAQHKNNVTYGEIHSVHGHDA
FLIEFEQLEQLLYPVFREDTAKLKILKFGGKSLANGKGLDTVLNIIKSKVANGEHIAAVL
SARGGATDELEAILEAAASGQAYKHQIEAFKSYQQSDFDVDLTEEFSELQRLFDGVALLG
DYSKKVKDEVLSFGELISVKTVTHLLKKEGVKAQFTDSRKLIKTNGVFGNAQPNDKLSKE
QVVKHFTKYNGDTVNIVTGFIASDDNNQTTTLGRNGSNYTASLLANYLDAGELQNYTHVD
GIFTANPDLVPGAQKIERLTYSEANELANFGTSVLHAKTIIPLIEKNIPLRILNTFNADD
SGTLITAQEEKEGIKSLSVLSEMALINLEGRGLLGKVGVDARIFRALGNSGVSVSIIAQG
SSERGIGLVVEAKQAQLAISALRFEFEADFQNQDVNRIEIIDEVAVISIVGQDLSSFHKP
YSELIKNGIVPLLFNNTVTGKNVSVVVRKPQLTKALNVVHGEIFGIAKKINIAIFGHGLV
GGTLIDQIVASAAAIQDRKGIALNIFAVANSKKILFDKDGVSESWKTDFDAQATEGGIQE
VIAFAKANHLANLIAIDNTASATFIKNYIDLAKNGFDLVSSNKIANTVEFDFYQKLRRVL
DDNNKRYLYETNVGAGLPLIDTIRLLHLSGDNITRIKGVFSGSLSYLFNTFSVEDKSFSE
VLQEAIDKGFTEPDPREDLGGNDVGRKLLILARELDLHKEFSDVQIENLIPEPLREGAAS
DFLGRLKELDPVFEARKKALKEGEVLRYVGDLYGDLSQEDGGTLEVKLVTVSKNSALGQV
KGSDSIFEIYTESYGENPLVIQGAGAGAAVTARGVFGDILKLAERNS
>KECLDBNJ_00711 hypothetical protein
MKVTLDRKNNDYLFEAKGASGNSVMIDNKTVDEVKGSSPMELLLMGVGGCSAIDIISILK
KQKLEIDTYHVEVEGDRKEVGQAKPFSAMRVHVYLEGDIPPAKALRAAQLSFEKYCSVSI
TLQAGVEVTYKVFLNGEEVE
>KECLDBNJ_00712 O-succinylhomoserine sulfhydrylase
MSKHFETEAIRTQLNRSEYLEHSVPLYLTSSFVFEDAEDMRASFTEEKERNIYSRFTNPN
TSEFVDKICKMEGAESGYAFATGMAAVFSTFAALLDSGDHIVSARSVFGSTHSLFTKFLP
KWNIETSYFKVDEVDQVESLIKPETKILYVESPTNPGCDVLDLEHLGNIAKKHNLIFVVD
NCFATPYLQQPIKFGADIVIHSATKMIDGQGRVLGGVSVGRADLIREIYLFSRNTGPALS
PFNAWVLSKSLETLHVRADRHCENALKVAEFLEGHDKVNMVKYPFLKSHPQYEVAKKQMR
HGGNIVAFEVKGGIDAGRKFLNSIKMCSLSANLGDTRTIVTHPASTTHSKLAEEDRLEVG
ITDGLVRCSVGLEHVEDVIADLDQALNA
>KECLDBNJ_00713 HTH-type transcriptional regulator CymR
MLSKKTKYGLKALAYVAKHKGEDPVQIGAIAKSENISQKFLESIMLTLRKAGFLGSKKGK
GGGYYLRRQPEEIKMVEVMRILEGPVSMVPCVSLNFYEKCDDCPDETTCSVHSLMVQLRD
SNLAVLNKNTLADLIAE
>KECLDBNJ_00714 Phosphoadenosine phosphosulfate reductase
MTDDQLLYIKAHLDEYNEMLRDKGPEHIIRFILSSSKRPILTSNFGPYSASLIHAVSKQK
NGIPLIWCDTGFNTQQTLSFADRIKQSLPIQLKRYQPSKRYSENELPSESGEAFQSFVND
VKLEPFKRALTEHNPDVWFTNIRRGQTAYRDTLDILSLTNDGILKVSPFYYWSDTELRAY
LSQHNLPNEFIYFDPTKPKSNLECGIQFK
>KECLDBNJ_00715 Sulfite reductase [ferredoxin]
MQSFRTEIENPVVERDIIELERKIKLFKDGKIDEERFRSLRLARGVYGQRQEGVQMIRIK
LPYGKVTSDQLLRISDVSDEYSRGKLHITTRQDIQIHYVSLDRTPELWAELEKSDVTLRE
ACGNTVRNVTASPDAGINPDEAFDATPYAHATFQFFLRNPICQEMGRKFKMSFSSTDDDT
ALAFIHDLGFIPKIKDGEKGFKVMLGGGLGSQPRHADVLTEFLPVNQLIPTIEGVLRVFD
RHGERSRRLKARMKFLIKDLGLEGFMDLVAEEKKALSYKTYEIDTSAYDKPVTAPLTEAP
EVIIEDVKAYEAWKATNVFKQKQEGLYAIGIKVRLGDFSTEKARALAALIKKYGGDELRL
TLRQNILLRHIPEGAIPFFYSQLANLGFARPGYETTTDITACPGTDTCNLGIASSTGIAD
KLEDVLVEEYPEYLNNKEITIKISGCMNACGQHNMAHIGFQGMSVRTPEKLVAPALQVLL
GGGVLGNGDGRFADKVIKIPSKRGPQALRAILDDFKANAGSQDFLSYYDEKGQRYFYDFL
KPLSETDNLVESDFVDWGNDEKYIQEVGVGECAGVVIDLVQTLLLEAKEKLGNAIEAFES
KNWADSIYHTYASLVNGAKAILLSENVKTNTQANIIAEFDKTFGEDAVLKAETSFADLVY
QIQNNEPTQEFAEAYIANANAFFDRVDAFRKNQLAHAN
>KECLDBNJ_00716 Uroporphyrinogen-III C-methyltransferase
MQIKNPKLTVVGAGPGDVELFTLKGIRALESADVVLYDALVNPELLEYANNAELIFVGKR
KGCYAYQQEQINDLIIARAKSHGHVVRLKGGDPFIFGRGAEEMEVAAAAGLEVAMVPGIS
SSLAVPAYQNIPLTKRGSSESFWVITGTTRHHKLSNDVKIAAQSSATVVILMGMSKLPEI
TQLFCESGKKDIPVAIIQNGTTPEERVAVGTIDSIQEEVEKLKLSNPAIIVIGEVVRNRA
QLLNLQVELAQTS
>KECLDBNJ_00717 Siroheme synthase
MAAERNNLYPVFLKVRNLQVLIVGGGNVALEKLTFLTKSSPDAVVEMVAPFFREETLEMA
KKFNVKITKKRFTRSMLKKRHVVIATTDSPAVNQRVYRAARKRFLLCNIADVPELCDFYM
GGIVTKGNVKIAISTNGKSPTTAKRLRQFFEEVIPDNIDDLVQNLNEYRKTIKGDFEEKV
ETLNEFTKGLISKN
>KECLDBNJ_00718 Ferredoxin--NADP reductase
MIKTDILIIGAGPTGLFTVFEAGLLKLKCHLIDALAQPGGQLAEIYPKKPIYDIPGFPEV
GAGELVDNLLEQGKQFQPGFTLGERAETIEKQEDGSFIVTTTKGTKHQAPVVAIAGGLGS
FEPRKPVIPNIHEFEDKGVAYMIKDPEVYRDKKVVIAGGGDSALDWSIYLADIAKEVTLV
HRRNEFRGALDSVEKVRELKMLGKINLITPAEVVGLGGVDELKEVVIEKNEEQISVEADA
FIPLFGLSPKLGPISNWGLEIEKNAIVVDNSLDYQTNIPGVFAIGDVNTYPGKLKLILCG
FHEATMMCQSAYKIINPGKRYVMKYTTVSGIDGFDGSRKEAEKAVVQAIE
>KECLDBNJ_00719 Adenylate cyclase 2
MTTKPLKVMLVDDQKMANFINKKLIEISGFSSHIIDYTIPNAALSNLDKDQPDLIFLDLN
MPEINGWTFLDILEKDERPTRVVIVTSSTSSIDKEKAQKYARVIDFLTKPLTKNTILSLK
SKLDLAG
>KECLDBNJ_00720 hypothetical protein
MNLSGAKYRITYEAFSKFSGNLSKVESLEELGKIISRHLKYLFNYKVFKIMILHEQSLAG
YTFLPGKTITHTQQQDLEPYERLLLKDKIPFVNSIDSTELPEYLKDVKLNNGNLWGWFLA
YSEYQICISLVSDDDTYFSSSDVDIVHLLADSVASKYRQISLSEILQQNNIHLESLVTEI
ACKNKEIKAINDNQQLVIEARTEELLQKNKKLFELSRLNAHDLREPLSRVLGLLELAEHL
PQDELRSSILPKIKEASGHLDQVIQRVVTQSEKELINIKSSQP
>KECLDBNJ_00721 hypothetical protein
MSNTTTSQSSRFKIVNYEDATPEVQAIYDDTKRTLQLPFVLNWFKCQGSNATLLNGNWTK
LKSTLMMGDVPNVLKQLIIYKVSKERNCEYCAHAHGIFADSMSAMISDNPSFRATEDLES
PLIPESFKTAIKIVTKAALHANQISDADFKQLQEVGFDEGEIQELMAQADLVNMLNTLAD
VSGIKIDNELMEAQA
>KECLDBNJ_00722 hypothetical protein
MLVGFFNLVKIYKLFFTRSYSVLRRKSDLKNDNIYALKIAFCQCDLQYLHPSSLFIAVIK
KGRGIRPDETLATLLLEKVLHSTLHQR
>KECLDBNJ_00723 Methionine synthase
MSKNNIQEELKKRILILDGAMGTMLQRYKFTEEDFRGERFKDWPTPVQGNNDMLSITQPD
AIAQVHAKYFEAGADIVETNTFSGTTIAMADYGMEEFVYELNFESAKIAKKVALEFTALE
PEKPRFVAGAIGPTNKTASMSPDVNDPGFRAISFDELRIAYKQQAKALIDGGVDILLVET
VFDTLNAKAALFAIEEIKEERNIEIPVMVSGTITDASGRTLSGQTAEAFLISVGHLPLLS
VGFNCALGAKQLTPYLEVVSGKSNFAISAYPNAGLPNAFGEYDETPEEMAAQIKEYLDKQ
LINIIGGCCGTTPEHISAIAQLVKEYKPRPLPQATNA
>KECLDBNJ_00724 Methionine synthase
MEADLNKAKKNETARFLRLSGLEPLIVTPESNFVNVGERTNVAGSRKFLRLINEEKFDEA
LDIARDQVEGGAQIIDINMDDGLIDGKKAMVTFLNLIAAEPDISRVPIMIDSSKWDIIEA
GLQVVQGKCVVNSISLKEGEAEFIDHAKKIKRYGAAVIVMAFDEVGQADNYDRRIEIVKR
SYDILVDQVGFPPEDIIFDLNIFPVATGMEEHRLNALDFIRATKWVKENLPHAHVSGGVS
NVSFSFRGNNVVREAMHSVFLYHAIKAGMNIGIVNPTMLEVYDDIPKDLLEHVEDVILDR
RDDATERLLDFAESVKGTAKEKTVDLSWREEPLQDRITRALVKGIDAYILEDVEEARLAS
EKPLHVIEGHLMTGMNVVGDLFGDGKMFLPQVVKSARVMKKAVAYLLPYIEEEKLKNPPP
ASEKEKSNLVLMATVKGDVHDIGKNIVSVVLACNNYEIIDLGVMVPPEKIIATAKEKNVD
IIGLSGLITPSLDEMVFLAKEMKRQDFKVPLLIGGATTSKAHTAVKIDPEYPESVVHVND
ASRAVTVVGDLLNPDSSVTYKAGIKEEYALFRERFLTRGKKRDFLTIEQARENKWKLDWD
AFEAYKPNQLGIQVIEEFDLDKLVPYIDWSPFFRSWDLHGKYPDILEDDVVGAQAQELFA
DAKEILKKILDEKLLKAKAIFGLFPANTVNNDDIEIVTSGAVENEEKFIFRTLRQQSKKA
SGKPNIALSDFIAPKESGKQDYMGCFCVTAGFGTQELAVKYEAEHDDYNSIMVKALADRF
AEAFAEYLHERVRKEHWGYASDEALNNDQLIKEEYKGIRPAPGYPACPDHLEKLTIWDVL
QVKETIGVELTESLAMWPAASVSGYYFANPQARYFGLGKIKMDQVSDFANRKNIETRLAE
KWLNPNISDD
>KECLDBNJ_00725 5,10-methylenetetrahydrofolate reductase
MKITDHIKNANGKTLFSFELIPPRKGKSIQELYNNIDPLMEFKPPFIDVTTSREEFVYIE
KDGLLDKKVTRMRPGTIGICASIKHKYNVDTVPHVLCGGFTKEETEYLLVDCHYLGIHNL
MALRGDAMREEQYFKPTPGGHEYALGLVEQIAEMNKGRYLNGMVETSDCSDFCIGVAGYP
EKHLEAPSLKTDLKRLKQKVEAGAEYVVTQMFFDNKKYFEFVDLVRAEGIDIPIIPGIKP
IAVKRHLQLLPQVFKIDLPQELIDAVEACKTNTDVRQVGIEWAIQQSKELMDGGAPVLHY
YSMGKSDNIKAIASELF
>KECLDBNJ_00726 hypothetical protein
MNYKFIVALLCFVSVYSQEEVKPYSFDLNYTYGSILEHNKDISHLITGHPTGFILAYNRR
TYGFNDWEARYNYPDYGFSFVSQDQKNPYLGENYGLYGHFNFYALNRHLMVRIAQGIAFT
TKPFDIDDNFRNNAYGSTLLSSTYVMLNYQQPNIIDRIGLQTGITLVHYSNANVRAPNAS
TNSFTFNIGLNYQLDDDEFPEYIPKVKSRYTEPIKWNLALRTGVNESDYIGLGRRSFLVV
SSFLDKRITHKSSLMVGADLFLSPFLKDQIEYESIAFAQQYGTKGDEDWKRAGVFVGHEL
HFNKNSFVTQFGYYAYYDYDFEGRVYFRGGLKRHFTENIFGAITLKSHGAKAEAVEFGIG
IRL
>KECLDBNJ_00727 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MTKKFYFVLASIFIVMLVGISQGGLTESSEARYAEIGREMALSNDFLHPRMLGIGHYHKP
PVTYAITALGYKVFGFNEFGARFFLAVALLLQLLLVYKMGKLWFEDRKTGIFAALIYFTF
PIVLASVLNLTTDAYLNTFILSSIYCFLVAKLKKKKGFLYLGYALLGIAFLIKGPVAFLP
VALFMICYKISTKEPIKPSKHTVLGILLLLGISASWFIAIVLEKPNLLDHFIEDQIVKRS
VDASQFKRSKPFWYYLAFAPLLCLPWTVPFVYVLIAKRKRLTFTPQLKTLGFSCLAILLV
FSLFSSKLIFYILPLYPLLALFFAGVYKQVLEHEKNYFLLTYKVGFGILTGMAIELLCIP
TFEYKIWFSILALAAIGSYFYWWNFKTKASKSTRLFALSTGATLILLLLYFSFAPQNELL
LRSFKPQYAFIEKQRKDTKDYKVIVYDYRLPSAAFYLGDRIVTVTNTNYESLRDTRFERD
SSWTQSYIDLRDPNNYERFKSLLKDSTNIIITKDRRPIPDSLEYLTKHFEVEAFGDWRVH
Y
>KECLDBNJ_00728 hypothetical protein
MQKIILVLFIVLVSCNSENAEDCFQTSGETVEVEYEVPEFTKLRAEAEVIVHIKQGEEYK
VLLRTGKNLVNEALIEVQNGVLVLRNDNRCNLVREYGNFEVFVTVPNLTEIRHNSSREIY
SDGTLVFPELYLVSNTSINLDVILRKNGEFHLDLDTENLRIDANGKSVFYMTGEAENMNL
GFQNENPRFEGRDFVVQNIDIYHRAPNKMIVNPQQSLTGVITGTGDVIAVNRPPIVDVEE
RYTGRLIFED
>KECLDBNJ_00729 hypothetical protein
MFSFGLSAQELDFTEEKKPVSLDASFFYGSILEHNPDINHLITGHPTGFILSYNRKTYGF
NEWERRYNYPDWGFSMAYQDLHNEYLGENISFYGHFNFYFLNRNAYFRIGQGVAIAGSPY
DPETNYINNAYGTKLLSSTYIALQYNKQNLYKGFGLNTGFTIIHYSNANLRAPNNSTNTF
AFNVGVNYNLDYEEFPDHIPEGERTKFTEPVHYNLVLRGGANESDIVGQGQFPFFVVSAF
ADKRINHKSTLVAGTDVFFAYFFKELIKLQAASFPELGVSGDEDWKRVGLFIGHELRFNK
VAFVSHLGYYIYYPYEFENRLYNRLGLKRYFTDDVFAAVTVKAHGAKAEGVEFSLGYRF
>KECLDBNJ_00730 hypothetical protein
MFRFLVLLAIAVCVTGCKDLETKKVSSEVLAEEELKAINMSEVDEYPSFASCDTLEDQNA
RYQCFKTELALNFQRQLSNKMVIVESELNDTIWLYLSISEVGNLNIDRAEIPDTIALQLP
ELERWLKDSLDSLPQISAANKRGIPVKTAFKMPVVVKVD
>KECLDBNJ_00731 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MILVAAFIFLYTILIAALCVGFFRWKPFLPEQVSTENATCFSVIIPFRNEAKHLQALLES
LNNLNYNDQHFEVLLVNDASTDASLAVIEAFQNTSKLHIKVLDNERFSASPKKDALTKGI
SQAKFEWIITTDADCTIAPGWLAMYHQAIIQKSELQFIAGPVLFSNAKNSLLGSFQQLDF
LSLQGATIGSFGLGQAFMCNGANLAFAKTQFQQLNGYQYTDHIASGDDVFLMQKFIKNDA
KQVGYLKTSKALVITAPQLHLAALIAQRKRWGAKASAYTSVFAILTSIVVFTGNLAVLLL
PFYASAGWILLLKVGIDVVLITQTAREFNQKKPLWHLIWVVFVYPFFTVFIALASQTGSF
VWKGRTFKK
>KECLDBNJ_00732 Crossover junction endodeoxyribonuclease RuvC
MKSEKIILGIDPGTTIMGFGLIKVVDKKMQFMQLNELMLKKYDDPYVKLKLIFERTVELI
DTYHPDEMAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRQIPVTEYLPKKIKMAITGNGN
SSKEQVAKMLQSLLGLKTLPKNLDSTDGLAAAVCHHFNSGKTVAGKSYTGWEAFVKQNEK
RVKK
>KECLDBNJ_00733 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MAGLYIHIPFCKQACHYCDFHFSTSLKKKSELVNALCKEMVLRKEEIRGPLQTIYFGGGT
PSLLDAEDLQQIFKTIDDHFEVVEAPEITLEANPDDLTEAKLIMLAASRINRLSIGVQSF
FEEDLKLMNRAHNATEALRCLQLAKQYFDNISIDLIYGMPDMSDARWQENLDQALALGIP
HISSYALTVEPNTALQKFIEKGVVKPVDDAVAQRHFEILLAKMEQAGFENYEFSNFGKPG
YFSQNNTAYWTGKPYLGIGPSAHSFDGNTRSWNINNNPKYIKAIAADSLPIERETLSTTD
KYNEYVMTGLRTIWGVSLEKIEKDFGLKFRTYVLQQAQKHIEEHLLFLDDDRIVVTKKGK
FLSDGLASDLFILNLS
>KECLDBNJ_00734 Kynurenine formamidase
MQAKITINQTEYSVDFSKPIDLSIPVISGEENPVAWYLEAPKIEPVKEGKWVAAVEQGSV
VNFNNVYLNPHAHGTHTECVGHITEKVHSINEHLKTFMFTAEVITLVPESFADDLVFTKK
QVAKALASNTPEALVIRTLPNTSSKKSRKWSHTNWPYLMADATAYIKECGVKHLLIDLPS
VDRERDEGVLASHKAWWYTGGKIRFDATITEMIYVPHTVKDGSYILNLQIASFENDAAPS
KPILYTLES
>KECLDBNJ_00735 hypothetical protein
MVKTLLKLEELGALLLAVYLFSTLDLSWWWFIGLFFVPDIGMLGYLVSPKVGAWCYNMFH
LKSLGVALYLIGILLDFEYLQLAGIILFAHAAFDRILGYGLKYERGFKFTHLGEIGN
>KECLDBNJ_00736 hypothetical protein
MEYLFIGLAIGSIVAYFIFTRFNKTKKQQNAQEQSVVLMEKIRSVCKFITVEGDFSEIYH
YQNVKDKWLNLFLGSKKALVLIDAKAYVGFDLTKIKMQPDIKNRTIILTDFPQPELLSIE
TDFKYYDKKEGWANPFTSTDLTEINREAKQHIVDKVPQSGLFGEASNQALSTVALMENLV
QTIGWKLDYKALETATKPQLKDKNESKAI
>KECLDBNJ_00737 putative N-acetyltransferase
MSPKQFSVKEVQEKDWPVLKQLVDEVWPATFKDILSEAQISYMMEMMYSVASLKKQTETG
SIFYILYSNDAPCGYLAIIPQYTNEKLTTRGTITKVDKIYVLPKTQGTGAGRFLMDFAFA
QAKKTGALGVTLNVNRDNKATSFYEYYGFKNMYSEDFDIGKGYLMEDHIMYYPF
>KECLDBNJ_00738 hypothetical protein
MNIECYRTYCLKKLGTTEHFPFDKDTLVFKVMGKMFALSSLTSWENGEPRINLKCDPEEA
VLLREKYPESVLPGYHMNKQHWNTVVLNGELTTKELQEFIDHSYELIVSSLTKKLKEELK
RLD
>KECLDBNJ_00739 DNA mismatch repair protein MutS
MQQDPRAHYTSKITIYQEQLKKMQALLLSSSMIRLAVFLMGVAAIYFLWGNTRVILAIIV
AEIALFLFLVSRHSQLKYKRDFLQEMIAINETELRVLDRDFYDLPDGDTFKDPGHEFSQD
IDLFGRGSFFQYLNRTGLASGAQKLAALLTANDIDDIPQKQEAVKELATQSDWRQEFRAT
ARLVKVNYDTRHILNWLKGYTNFAPKIMQWLPNIFTGISLILFVLAYLDLIPGTVVLYWF
FAGLILNGFFVKKVNDLWDKAGKTQTTFEQYFKLMLLLEEQEFTSVYLKKEQDKVKSQKA
KASAVIEQFSKMLGILDQRSNMLVGVFINSFFLSDLRQSYRIERWIALNADEVANWFEVI
AFFDAQNSLANFSFNHPDYAFAEIKKGKHTLTAKALAHPLLDPKKAVANDFDIDSEQFFI
ITGANMAGKSTFLRTVSLSIVMSNAGLPICAKEAVYDPIKLITSMRTSDSLTDDESYFFS
ELKRLQFIVNAIKTDTYFIILDEILKGTNSTDKAIGSRKFIEKLVASNSTGIIATHDLSL
CEAADELDDVKNYYFDALIINDELFFDYTFKKGICQNMNASFLLRKMQIIDA
>KECLDBNJ_00740 hypothetical protein
MDSLTQIVLGAAVGEAVLGKKVGNKAMLYGAIAGTIPDLDTIWGKFLDPLTAIEIHRGIS
HSIIFSIVMAPILGWLVAQLHKKAQAGWKDWSWLFFWGLVTHPLLDAHTTWGTQLFWPLD
LRLAYQNIFVIDPLYTLPFLIFLILAMRLPKASRKRRKWNNLGLIISSAYMVLTLVFKGI
SYQKFTEALANEKIEYTQIDTRPAAFNTILWHANIDVGDAYLLGDYSFFDSQPISFKYVP
KDPQLLGDLRNSETIERLDKISNGWYAIEKRDGDLYYNDLRFGVYDLDAKDLRFVFSYQL
IPAGDDLKIQEAERDPEAMKQVLKSLWSRIWGN
>KECLDBNJ_00741 hypothetical protein
MQYKLSEIAPKEIMPGYHGKLVHTQNTSLAFWEVEEGAQVPEHSHMNEQIMHVIEGEFEF
TLDGTTKVYHPGDIVVIAPHLSHSGKALTPCKLLDVFSPTREEYK
>KECLDBNJ_00742 NADPH-dependent reductase BacG
MNIDLSGKKALVGASTSGIGKAIAMQLAASGARVTLMSRSLEKLESVKQSLSTENGQQHQ
ILQVDFTDYAAFKSNITAYFVKNSVDILVNNTQGPPSGTALEKKVEDYQQAFDLLFKTVV
LTTELALASMKEKQWGRIINVASVSVKEPLSFLVLSNSIRAAVVTWAKSLATEAGTFGIT
VNSILTGYFNITSLNAKKAKEQGVSEGEILKQLEASVPVKRIGDPAEYGYLVAFLASDRA
GYITGTQIPIDGGKLNSL
>KECLDBNJ_00743 hypothetical protein
MILNLLNFCYRKLLPLIIICLANTDLQAQIHPENESTKSKLTFDQNTDLTIYENLGFFRK
FKNTLTFYNNKLEMSFSGNLVEQGLANSFISPDLQLQAELELTYKLRDNLSINSFGKYIT
NPLNNGGNGQTRYNPLFEQSEIGLEFKTELQKNIQLEVGDKILLDNNNLNLKSPMRVYTR
LLKKF
>KECLDBNJ_00744 hypothetical protein
MNKGVFAMVMSISLFAANLIALHYYQISDFFYGIGIGISLGLMLVALKRIALLKG
>KECLDBNJ_00745 HTH-type transcriptional activator RhaS
MKVLPFKIPKSGNNALILQEDLEPLFYDKLHQHPEIQMSYILSGTGTLLVGDTVSRFNPG
DVLIFGGNLPHVFRSDPNPEGLSHMLTIFFNRESFGASFFETEELKEFDLFFKQAASGFR
IIDTQSRFKNYFTSIASAPNLERFMRFMQLLYAIYSAPKELLSNFTKNTKYTDTEGQRMS
NVFDYCLSNFKERISLEEIADVAVMSPTAFCRFFKERTNKTFNQFLLELRIEHACQLLRT
PDSAESIASIAYACGFNSVSNFNRYFKKQKGVSPRTYKSAETTG
>KECLDBNJ_00746 putative DapA-like lyase
MQINWEGVMPAVTTKFTADDKLDLDLFKVNIKAQLDAGVHGIVLGGTLGEASTLTDEEKS
ILTRKTVEIVAGSVPVMMNIAEQTTKGAIAAAKQAEEDGAAGLMMLPPMRYKASDREVVA
YFKAVAQSTSLPIMVYNNPVDYKIEVTLDMFEELLEEPNIQAVKESTRDISNVTRIKNRF
GDRLKIMTGVDTLALESLLMGADGWVAGLVCAFPAETVAIYELQKAGRIDEALAIYRWFL
PLLELDIDAQLVQNIKLAEVYTKIGSEHVRAPRLPLAGTRREEVIKIIEEGLANRPTLPE
YKGLNTQQELA
>KECLDBNJ_00747 Alpha-ketoglutaric semialdehyde dehydrogenase
MITGKNYIGSKISAEGKTTYTTINPKLNIENEWQFTEATESEVDAAAQLAAEAFEVYKHK
SDKERATFLRAIGEEIEALGQQLIDTYTTESGLPEGRAMGERGRTIGQLNAFASLLEQGD
WVQATIDHGNPERTPAPKPDLRKMQIATGPVAVFGASNFPFAFSTAGGDTASALAAGCPV
VVKSHPMHAATGELVSSAIIKAAQKTGMPEGVFSNLNSKGIAVGEQLVKHPAIKGVGFTG
SIKAGKALVALGANREEPIPVYAEMGSINPVVILPEALKVNGESWAQKYAGSINLGAGQF
CTNPGLILGIEGDELETFGKNLAAHLGEQPAHCMLHPNIQSAYENGKQNMIDAAGTEVLA
VTLEAEGANDGKPALVKVTGDDFLANTMLHAEVFGPFSILVSCTSKAQLLEVLNALEGQL
TGSLIAETSEVAAYTDVIDALRSRVGRILFNGVPTGVEVCPAMHHGGPFPSTSDAKFTSV
GNDAIYRWVRPVSYQDWPQELLPDALKEENPLGIFRKVDGNYSKA
>KECLDBNJ_00748 hypothetical protein
MRHYLLLFIISSLTLSVSAQDAVSLDSIITEYQSQRDYNWQDYPLGRYDEEVPKKRADFA
QVLLNKLTKVDASALNRSETISYKLLQFILQDQIDEYTYKMYLNPLQADQGFHLNLNYQV
RPINSYQQAVGYLNRLKAIPYFTESQFALMRKGLKEGINQPKIIFNGYESTYNTHIVEDP
TESYFYSPFLALPESISAARKDSLLNAAQQVIADSVVPSFKKIKTFFETEYLPQTRDEIG
VSSRPGGKEFYQNRIDFYTTSKDYTAQSIHELGLKEVARIKAEMEKIIEEVDFEGSFADF
LEFLRTDDQFFVTTEDALLMHARDIAKRVDNELPAFFSKLPRQPYGVIKVPDAIAPKYTG
GRYSGSSINGTQAGHYLVNTYKLDSRTLYTLPALTAHEAAPGHHIQGALNQELSDSIPQF
RRNLYLSAYGEGWGLYAEYLADEMGIYRTPYEKFGQLTYEMWRACRLVVDTGIHAMGWSR
QEVVDYMSQNTALSIHEINTETDRYIGWPGQALSYKIGELKIRELREKAKNELGEDFDIR
AFHEVILGEGTVTLPILEEQVNAYISKAKEALVK
>KECLDBNJ_00749 4-hydroxyproline 2-epimerase
MAVHTFECIDAHTCGNPVRVVKTGGPALAGKTMSEKRQHFLKEYDWIRTGLMFEPRGHDM
MSGSILFPPHDPANDFAILFIETSGCLPMCGHGTIGTITIAIEEGLVIPKTPGKIRMEAP
AGLVEIEYQQTGKKVDWVKLTNVKSYLAARDLTIDCDELGTLKFDVSYGGNYYAIVDPQE
NFSGVHDYNASKIISLSKILREKINAKYKDHFVHPENETIRDVSHMLWTGNPLDPSSSGR
NAVFYGDKAIDRSPCGTGTSARIAQLHAKGIIQPHTDFIHESFIGSKFTGRVEEVTRVGD
FEAVIPSIKGWARVYGHNTMTIDTEDPYAFGFQVL
>KECLDBNJ_00750 Prolyl tripeptidyl peptidase
MKFVKFSLFFVVGLLFSSFSSVAQEQMTLADYEQANAYTYANLWNKKVFNLSTSVAEFED
HSGIWFVNYTEAGKEYKTLSFKNLEVQPLFDQSKLAKALSEILNEDKDAAQLSVSKIEKT
NDGLSFEFENTRFTWDGTSLEESKEKTFKNSRDWRNQMESTSPDKKWIAFTRDHNLFIRD
AQTEEEIQLTTDGQKGYDYASSIGWFDIIEGEGTERPKHFGVQWSPDSKYLVTQVVDTRN
AEKMYLLDYSIDSLYKPKLLSYYRGSPGDTTMVTYKPVFFDVESQKQLAIDLPKKVHVNG
IWLKFQDKEPHKMIASYRSRGYKEQFLKVVDLDEETVQPLYEESTQTSIDNFNYREIEGW
DDLVVISEREGWKQLYLVNKDSGKITPLTNGEFVVNDIVHIDEKDKVIYYTASGVDAAMN
PYHQKLYRVSLKGKISELTPENANHEITFFEDADYFVDAISKVDQPTKTVLRSKKNGKIT
ATLTTANTAQIEAEGWQMPEVFTLTGKDDKTPIYGAFWKPVNFDSSTKYPVIDATYTGPH
TQRFPKSFSQALSNQAMANLGFIVVAIDGLGTAGRSKAFRDVSYMNMGDNLRDHVNAIKY
LGEKYAYVDAERVGIFGHSAGGFDAAHAVLAFPDFYKVAVASSGDHDFRMEKAWWPEMYM
GYPVDERYEEVSNITMAPNLKGKLLLVHGGIDDNVNPSATFKLAEALIKADKQFDMLIIP
SQRHGYTGKYSTYFQKKRWNYFIENLLDKQTLWGFNLD
>KECLDBNJ_00751 D-amino acid dehydrogenase
MSKKCVIIGGGIIGLSSAYYLQKAGHEVTVIDQGSMDSGASYVNAGYLTPSHIIPLAAPG
VMQQGIKWMFSSKSPLYIKPCLNADFLKWTMAFNNSCSEENVTKAIPAIRDINLLSRDLY
SDIKEEEHFNFQLKKDGLLMLCKTEHMLEEEAHVLALANKEGLPARMLSAEEVQQKMPNA
KLDIKGAAFYECDHHTTPGEFMEELKTLLQAKGVHFVKNEKVTGFDSSSGTLSNVKTASG
KTFVADEVILATGAWAGELNKKLGLKILMQAGKGYRINSTTETGITLPSILCEAKVAVTP
MNGFTRFAGTMEIAGINHDINKTRVEAIAEAVPRYFNNVVISEQEKDEAQCGLRPVTPDG
LPYIGRPSKWKNLTIAAGHAMMGWSLGPGTGLLVSEIIDGKKASLDLSVYNPDRRF
>KECLDBNJ_00752 hypothetical protein
MLKKFFILCSGADHVLLDSCAPGEQNKYAGIGATVFFTALMAFIASGYALYTVFDSISMA
VAFGFVWGLLIFNLDRFIVSTIKKRDNFLDEFLQALPRLILAVIIAVVISKPLELKIFEK
EIDRVLLEQKNDLTLANQNQIADQFTPAVAALDSEIEQLKGEVTTKEAEVNALYDIYITE
AEGTSGTGKLGKGPVYQEKREKHDAALAELQQLKQTNAEKVAALELEKDNLAADYETRVT
ETQPIIDNFDGLMARIDALETLPWLPSFFIFLLFLAIETTPIFAKLISPKGEYDLKLSDA
EGELKSWTTQKANQRKNLIDADNVINDKVYGDLTEEDELYNYKKKMARDLMQKQQDAFYK
RQSKLL
>KECLDBNJ_00753 hypothetical protein
MAAYLIKSILCLLVLWGFYKVALEQTAAHHFKRFYLLGSLAISVALPLVTFSYTVEVAPQ
PVGAETHFEPAAFTEAPITTRTAQSTNWLLLSLALVYGAGVLLLGFRFLCNLLRLREKVR
RNEHIKATSHINVLLLEQVVPHSFLKYIFLPKTDFKNNTLPAEVLHHEQAHVIQKHSWDI
LLIEFLQVVFWFNPVLMLLKKSVALNHEFLADQAALDQNNNLTNYTNLLFNYSGGAHHTA
LSSPINYSLTKKRILMLSKTRSVKKLTARIALFVPVLALCVYFFNQEIVAKPVVLKESSS
MLGKWIDRKNEFTQFTIYNQNEQLWMKFHKDTFELSPEGKNLYNLVWKNKPSSASKKQLF
LSFKPENNELLLNDNSFIRPENTYGKIFTGDWEGIDIDQKFYVRSENGSTIWTIEDQFGT
NRYYPILTSTGFYFTYGNKDVYFTVDGNRMTSSEGFTYKKVKEAPKLITVYVINNRVSLI
SQSSSKDKLVEHLNAITADWSPESYKNYILDVKAQDGMNRFLKELNKEFLKTNLYKINSS
QDLLSETSTIQTEKVLNITVTGSDVYLNGKETTVETFANDIDALSKNWTLSEKKNYSVHV
RTSNPAANLWQKLQEAFETTALYKANPKGLVPPPPPPAPAPPKAGSIPPPPPPPSTNSIF
EEVTVQGLPAPPPPPPAPKEMVRLAKDNIYYNDKKISAEKAQELIENSDAYNLMFNSNKG
SHVLIIKDKN
>KECLDBNJ_00754 Methicillin resistance regulatory protein MecI
MSLSNAEEQLMQILWKLDKAFMKELIEAYPEPKPATTTVATLLKRMQDKGFVDYVQYGRS
REYFPLVKKNKYFSKQVNGMIKNFFNDSAAQFASFFTQETDLTQQELEELKKLIDERLKS
QK
>KECLDBNJ_00755 hypothetical protein
MYRVLLLEIRKSLGSTGTFNRKLATIKKLDAFKYIP
>KECLDBNJ_00756 hypothetical protein
MSLEQDLRDRSGNVCELSGSTEDLDIYAVPNSPDLPEVQTHIFISETCRMQLEDKAAIDP
NHWRCLNDSMWSTVPAVQVVAYRMLHQLRAEGWPQDLLDMMYMEETVKDWAKAGISDETE
TKGLVHRDSNGVVLEAGDSVVLIKDLKVKGSSMVAKQGTAVRRISLDHENEKYIEGKVDG
QQIVLVTDYVKKI
>KECLDBNJ_00757 hypothetical protein
MNNKKEKLARAGMVAKGAVYALIGVLTAMAAFNLGGSKSGSDNALQFLAGQPFGQVLLGA
LAIGLFGYAFYRIYEPVNGPGASWSEAKGFIKRAGFIVSGIFYGALGFTAAKMIVSGSSG
SGGNSAVSTLMSKPYGAYIIGFVALCLLGKALFQIYKAYSGKFREDVKESSLSQKERKAL
IRAGKIGFTSRGIVSGILAFLFFKVALGNGADAGGKVAAFDFLQDNFGAAVMGIVALGLV
AYAVFMFIQAKYAQIRI
>KECLDBNJ_00758 Succinyl-diaminopimelate desuccinylase
MKDIKTYVDKHQKRFLDELIALLKIPSISADKAYKKEVFNTADAVAERLKEAGCDLVEIC
ETPGYPIVYGELIKDKNLPTVLVYGHYDVQPPDPLDLWDSAPFEPVIKKTELHPDGAIFA
RGACDDKGQMYMHVKALEYMTQNDDLPCNVKFMIEGEEEVGSENLGWFIARNQEKLANDV
ILISDTGMIAKDTPSITTGLRGLSYVEVEVTGPNRDLHSGLYGGAVANPINILTKMIASL
HDENNHITIPGFYDKVEELSAEERAKMAEAPFSLENYQKALDIDSVYGEAGYSTNERNSI
RPTLDVNGIWGGYIGEGAKTVIASKAYAKISMRLVPDQDWKEITELFKKHFESIAPKGVR
VKVKPHHGGQAYVTPIDSLGYQAAEKAYEKTFGKTPIPQRSGGSIPIVSLFERELNSKTI
LMGFGLDSDAIHSPNEHFGVWNFFKGIETIPHFYHEFTKLKMAEK
>KECLDBNJ_00760 General stress protein 69
MKFNYVGDTGLMVSELCFGTMTFGGVDAGTWSQIASVPQKEVNQMLKAVFDAGINFIDTA
NVYSFGQSEQLLGQGLKDLGINRDEVVVATKVLGPMSESPNDVGLSRYHIFNSVDASLKR
LQLDHIDILYVHGVDAKVPVEQILQSLNDIVATGKVRYIAICNWPAWMVAKAQAIAAHKG
WQKFIGLQYYYSAVSRDIETELVPMAQDHNLAIFPWSPLAGGFLTGKYSREGSSEKGSRR
ADFDFPPIDKDKAFNLVDVMQELATVHQVSVAEIALAWVRHQKGVTSTIIGAKTIDQLQS
NIKSTKINLSKENLEKIDAVSPKPKLYPGWMVQRQSRYRQ
>KECLDBNJ_00761 Exo-beta-D-glucosaminidase
MRRNFLYFSCFLCLLSIQVLSAQERYELNTDWFCNPISDTKENGNTISQPDFKLKRWMPA
TVPGTVLTTLLNNEKVPDPFYGMNNNKIKDIYDTEREYYTYWFTKDFEETAAPGEQVWLK
FRGINYSADVYLNGKKVNQTPFKGMYLRREFNITSLLNKSGKNRLAVLVHPADEVGNPNG
GQGGDGTIAKGVALQYTAGWDWIQPVRDRNTGIWDKVFIEKTKSVNLKNPHIVTLVPGKR
LPGETQEPATLQVSAELQNTQNTPVSGTLQYQLNGKTIKTPVTLSAKETKEIALPDFSLE
NPKLWWPSGYGAQNLYDLNLEFVVADQVSDSEHLQFGVREIQTSWNAHTRSKEIAVNGQK
IFIKGGNWIISDAMLRFSEERYDAEIRFHRDMNLNLIRIWGGALPERPEFYEACDKYGLL
VIQDFWMSGDCNGRWVDPMKKEDQWTRRQYPDDHNLFIESAADAIKMLRNYASLAIWCGG
NEITPPADILSALKDSILPKYDNTRWFIDYSNSDEMSYNFKGGNGDGPYGIQNINTFWGE
RTWPFNSEVGSVGTGDAVSLKRFLPEDHQVIPQELEGTEKVEDEVWSYHKYIDYGDAMEP
YGSPKDMDDFATKAQLVNYNQYRGLMEGFSSHMWDWYTGVIIWKTQNPWTALRGQMYDYY
LDPNACLYGLRSGSEPVHAMYDPVEQNIMIVNNSFVQQHDLMLRLTAYDMEGNSKMITQV
FNYIEPSSVRQIMSIARYIKVLGAEEGMFLSVQLLDVDQELVSDNFYWLPDASGTYSGLQ
SMDKAQLSAKAKKISATEIELTLTAAEEFPVAFFNRISLIDAKTGERLLPTFFSDNYVSV
TPGDEKKITLSFDQLKNTDAKIEIEGWNVPKQTLDLN
>KECLDBNJ_00762 Carboxymethylenebutenolidase
MKKLQKEDIKQEVFDLYDAYAHNKLERREFVERLSMFAVGSITVPALLSFLMPDYETTRR
IAADDPNLDSKFITYNSPKGGGEIKALLSKPKNTTEKLGGIVVVHENRGLNPYIEDTARI
AALEGFITIAPDALSPLGGYPGNDDDGRAMQRKRDSKEMLEDFIAAYEYLMNHEDCNGNV
GVVGFCFGGSISNMMAVKVPTLKASVPFYGGQPTEDIDQIQAPLLLQYAGLDERINAGWP
DYEAKLKEHNKEYGMFLYPDVNHGFHNNTTPRYDKAAAELAWERTIAFFKEHLF
>KECLDBNJ_00763 hypothetical protein
MNNLNKLYLILVCTFSALGVQAQDQVSLQIIKERDSLLLNLNKQLEDNAIKLKSLQGEFS
DLNPNRTSQRLGSLDSIISKQENRITLLENSRKIQLKLNGQLAFTELMSIHRDIKPSNLL
LSSQEFFSKIAAINNPMNYPAYEAWFKEYQEWYERKKGKDNWLDLINKSITVLNEPASNV
PLYGSLFQTFSTGITSAMEIVGGTGRDLRDKTPEMLNVLNTASQFSQQQSIIDNEWKSIN
EELNKLENEYNRLLEEQAKYYGLDMSAVAQYQNATLDSERETLKNKFRKSINNKISEWEK
QGNKDWLTEVERFMVKTQSLRQRFGQLTLRMKSNIGKYQELITHFSKNDSFAEEFRTKLR
DLESSIDQVDSNFNAVFNPSKYIEDSAVMYITQ
>KECLDBNJ_00764 Transcriptional regulatory protein YpdB
MSLRCVIIDDEPLAINVIKNHIAQLKGLEIIKTFDNAIESLDFLRTTEIDLLFLDINMPV
LDGLSFLKSLDNKPMVIITTAHEEYAVEGFELEVLDYLVKPISLPRFLKATNKAIAKTQE
APKSITENESIFVKVDKKKMKKVYLDDILLVESLKDYIKIITLNGNYVVHQTLGSFTGEL
PSTQFVRIHRSYTANINKVDAVEGNSVEIANKRYTIGRNYLEDAKNAILRNQSGN
>KECLDBNJ_00765 Sensor histidine kinase YehU
MPLRNSFKNNFLLNATTGYKINLTHHVIFWLVYFLFNFLRWGSYYNDYFYSFKANLLGFP
IHISLTYFTIYVLIPMFIYKRKYVLFTLSLISAIFIMVIIKYELTYFLISNNVWPEGPEE
TTSLGVNYVVVMMLGELYVISFGTAIKITIDWLRERQLAASLAKSNLETELRFLRSQISP
HFFFNTLNNIYSLSLEKSESTPETILKLSDLMRYLLYETKEKRQPLVKEIKFIQNYLDLE
RIRYNKKLDLKFEVTGNPKGKKIAPMLLIHFIENGFKHGASKNIGKVKITIDLTIEGSFL
YFRMSNTLPQKELQNKIPNAGGIGIENVEKRLKLGYGAQDYALKIYEEDGEYKVYLKLRL
L
>KECLDBNJ_00766 hypothetical protein
MLKKSFFLIAILTLASCKNDAEPQTELETDLNLTAQVDPFIGTGGHGHTYPGATVPFGMV
QVSPDNGTNGWDWCSGYHYSDSIVSGFSNLHLSGTGIGDLADILFMPTNKEVDLSGSYEK
PADRPYASTYSHKRESAEPGYYSVYLEDPQIKVGLTATKRTGFQKYNYEGAGEASVVLDL
GFAINWDAPTETAITIENETTISGYRHSTGWAKNQKVFYVAQFSKPIARHILVADKKVVD
ADSVSGKTTAAQFFFNIDGSRDVTVKVSVSSVSVANAKENFAEAADVDFETAKTEAKKIW
EKQLEHIVVETPTDSLKTIFYSALYHTQIAPVTFSDVNGQFRQENDSIIDADFTAYSTLS
LWDTFRAENPLLSLLEPEKTSDIINSMLTYYEVHKSLPVWTLYGNETNTMTGNHAIPVIA
DAYFKGIKGFDAEKAYEAMKNTQMRDERGLEFLKEYGYIPFDKIDESVTFNLEYAYNDWC
VAQMAKALGHEEDYQYFNERSKSYEKLYDPETGFMRGKSSTGQWHEPFDPKFSRHRENTD
YTEGNAWQHSWFVLHDTDNFIKLHGGTEPFTGMLEQLFTESSEITGDFTSADISGLIGQY
AHGNEPSHHIAYLFNRAGKPWRTQYWINHILKTQYNTTPNGLSGNEDAGQMSAWYVWSSM
GLYPFNPASAAYEIGSPVYAKSTINLPSGKTFTITAEGVSEENFYIQSATLNGEEFNQTS
ITHEQITAGGELKLVMGATPNKSWGVTADAE
>KECLDBNJ_00767 Sodium/glucose cotransporter
MESIDVIIIAIYLLLTIGIGVYVAKKASKGLDSYFLGGKSIKWYYLGLSNGSGMFDVSGT
AWMVGILFLYGVKSFMFMWMWPIFNQVFVMMFLAVWIRRSNVMTGSEWILSRFGDDKAGR
ASHLIVAIFAVVASVGFIAYFFEGAGKFMTVILPWDVSLVVGDLTLLNAEQVYALILILL
TTIYTIKGGMFSVVSTEVLQFGIMVLAGILVAGYTFFSFTDAEITALIPEEWTRVTFGSQ
LTGFWSGDFEEFNRLIDTQGYKMFGAFVGMSLFKGFFASIAGPTPSYDMQRILSTRTAKD
AAYMSGFTNLVLFIPRYLMIAAIVVLGLVYIAPELANAGGVTSNDLEVILPQVINNHVPV
GIKGLLLAGLLAAFMSTFSAFVNAGPAYIVNDIYKKYFKPEATDKHYVKASHIASFAVVT
LGVIMGFFAESINSITLWITSSLYGGYVAANFLKWIWWRFNGWGYFWGMLSGLVIATLQF
MIDQGASTYTEGSFLFWYSHIPAIYLFPIILGFSLLGSFLGTYLTPPTALKTLKSFYTSV
HPWGWWKPVREQLTEEEQVGKNTDFGLDMFNCIVGIVWQSSMILLPIYLVVRDYEKTAIS
ILVFGVTTLILKFTWLDKVKKLNN
>KECLDBNJ_00768 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MSTTQIPWQDRPANSTDVMWRYDANPIIDRYAIPSSNSIFNSAVVPFEDGYAGVFRCDNK
AVQMNIFAGFSKDGINWDINHDPIEFGAGNTEMIDSDYKYDPRVCFIEDRYWITWCNGYH
GPTIGIGYTFDFKEFFQCENAFLPFNRNGVLLPQKINGKYAMLSRPSDNGHTPFGDIYIS
YSPDMKYWGEHRCVMKVAPFTDSAWQCTKIGAGPVPILTDEGWLLFYHGVINTCNGFRYS
VGAAILDKDSPDKVLYRSQPYLLAPAAPYELVGDVPNVLFPCATLHSVEEDKVALYYGAA
DTVTSVAFGKLSEIIDFVKNNSL
>KECLDBNJ_00769 hypothetical protein
MIKTALSIFLLLISYGSFAQVKPRSYVTHHIDAPLTIDGKAEEEVWEAAPFSESFIDIEG
VKIPKYDTRVKMLWDDENLYFYAELKEPHIWATLKQRDTVIFYNNDFEIFIDPDGDTHNY
YEFEMNALNTVWDLLLVKPYRESAPVVDSWDIQGLQTAVSINGTLNDPTDTDKSWSVEIA
MPWEVLKEASGSNDVPADSFWRINFSRVNWDHDLDGSTYSRKKDASGKFLPEYNWVWSPQ
GVINMHEPEHWGYVYFSTKPVSEEVAFTIPQDEQIRWKLYEFYRAQKAYFSENKTWATSL
DALKAETFQLENKTITPVLENHTYGWSITVESPFSDAVYRIQEDGKYSKLN
>KECLDBNJ_00770 hypothetical protein
MKLKHLIVLLVAIVATSCIDNMHPAGNKDQAEKTQDSSVSEDFKFWTWTTADPKRSDDSY
VEEFKKYAENGLDAVLINTNADAELLARLTPLATAEGLEVHAWMFTMNRPGDTVALKHPE
WYAVSKEGKSTFDHRPYVDYYQFLCPTREGSRNHILGLIDKLTKVEGVSSFHLDYIRYPD
VFLPIGLLPKYDLVQDTELPEYDFCYCDACIAKFEEEHHKNPLESHNTAIDMEWKQFRLN
QIKAVVDDAYEVAHKNGKLLTGAVFPYPEMADHMVRQRWDKWNIDVVLPMIYHNFYNEEI
DWIGFATGQGVKDLEGTGTELHTGIYVPEMSAEDLAKAIQLAKENGAKGASFFDGNALTP
ELLAVIKEANEI
>KECLDBNJ_00771 hypothetical protein
MKYLLLSLSLFISVYGFTQKSLTSSVNPFIGTDGPGNTYPGATAPYGMVQLSPDIGTPGW
DRIAGYFYQDSIISGFSHTHLTGTGAGDLYDILVMPVNSKSSKRIEANGYRPFSAFNHQQ
ESASAGYYQVELTDYEINVELTATPRVGIQRYTFPKDSASQVYVDLGYALNWDRATDTYI
KVVNNTTLEGYRKSTGWAKDERIYFVMQFSKPFKSYTLFEGKNKVDQEATGVNTKIILNY
ATAEAEQLVVKTALSTANIKGAYASMNTEASHFEFDAYRKQTEAVWEDQLSKIKITTEDQ
DQKALFYTMMYQSMLAPTLLSDPKGAYKGADNEVNTAQGFDRFDTFSLWDTFRAAHPLYT
IIQQERLPDFVQSLLAHYKETGLLPVWSMQGNETNMMLGYHAVPVVVDAYFKGFDFDAEL
AYEACKASATAADRSIPIYSKLGYVPATEENEDWSVSKTLEYAYDDWCIAQFAKALGKKE
DYKYFSKRAENWKKLHDNKTNFFRPKTVENKFVEPFVAKEYTRFYSESNAWQYYWFVPQD
IQGLIKKTGGSTAFEQKLDSMFSLYPKPTDKLPIFSTGMIGQYNHGNEPSHHVAYLYNYV
GKPSKAQERIREILKTQYKNEPYGHCGNEDCGQMSSWYVFSALGFYPVNPAQGAYILGIP
LFERAEIKLPGNKKFIISAQNFSDKNTYVKRIFLNGKPLKRGFITHSEITNGGELLFEMT
ADATDQRLEIPKPDQVYK
>KECLDBNJ_00772 Beta-hexosaminidase
MKLIKTLFFFFSIALLGCAESKNPSFTEADLVLIPQPKSLELHSGSFEITRETRFVIANG
SLKELTGIINDLLSNSAGFSLDVVSEETANSIQLSINSELEEEAYTLEVTAEKVLLEANS
KLGFVYGLETIRQLLPKEVESKTQVSDLALYIPNVSINDAPQYSYRGSHLDVSRHFFGKE
YIKKHLDRMAFLKLNTFHFHLVDDQGWRIEIKKYPKLTEVGAYRVDQEDKHWNARTKNDP
EEKGTYGGFYTQEDIKEIVAYAQAKGIRVIPEIEMPAHVMSAIAAYPWLSCTDEPIAVPS
GGVWPITDIYCPGKETTFEFLEDVLTEVMALFPGEYIHAGGDEATRTNWETCPSCQKLMR
EEGLADTGELQSYFMKRIEKFLSEHNRTLIGWDEILEGGLPQKATVMSWRGFQGGWEATK
AGHDVIMTPVSHMYFDYYQGSPDHEPVAFNAFLPLEKVYEFNPVVDSMSVEQKKHVLGGQ
ANLWSEYISTEAHSEYMLFPRLTALAEVIWSPKEKIDWENYTHRVRKMMQRFDVMEINYA
KSAFAVQQESTIDLETGEITVALHSEFPDTEIRYVLGEAELTPEAALYQTPLKIDSTTRV
KAAVFENGKQMGDTMNKFFDFHQAVAKPVTYKFEYSASYPSTGETALVDVLRGSKYFKDG
RWQGWINNSAVVTIDLQELKEVQQVVVGTLEEQGTGIYFPEELKVEVSQDGTNFQQVAET
TRDYQTNPGAKIENFKLDFKKQQAQYLRVTIKPLSETPKGGGAWLFVDEILVN
>KECLDBNJ_00773 hypothetical protein
MMYSRVALLLALCFSFLATAQQKDYTQYVNPFIGTSNFGATHPGAIAPRGMASVSPFNVA
GSQNALEKDSRWLSNPYVNENTFLTGFSHLNMSGVGCPDLGVILSMPTTGELKTEHLQYG
TTYKNEEAKPGYYSVELDKYDVKTELTASTRVGVSRYSFPAGKANLLLNLGLGLTNEHGA
MLKFNSPTEIEGYRMVGAFCYNNAESAYPVYFVARISEAPENFGIWDKPASYEGVEAQWM
GYNGKTRLKEQFMREVVGDSIGAYVQYDFEKPTQVVMKIGVSYVSIANARENLDKEVGDA
TFDEVYQQTKNAWNDKLSVVEVEGDDADDKTIFYTGLYHTQIAPSILNDSNGEYPAMKTR
ATKKTDGTRYTVFSLWDTYRNYHQLMSLLYPQEQLDMVNSMLEIYDQNDWLPKWELNATE
TFTMVGDPAAVVLADTYQRGITGFDVEKAYAAMLKSADARENNPLRPGIAEYIDKGYVSV
DSDVAGPVSTTQEYNIADFSIAQLAEALGKKEDAKRFTKRALSYKKLFNKTSGFLQPKMS
DDTWYEPFDPLAGANFTENPGFIEGNAWQYLFMQPHDIKGMIKLMGGAKNFEAKLDALFA
EDQFDMANEPDIAYPFLYNYLPGKSYKTREKVADLIDTYFTNNPAGLPGNEDTGTMSAWL
IYAMMGFYPMTPGEATYTLSAPQFNKVTIHLNSDFYANDTLVIQNVSENPTKVSAGFSIG
GKSIKKQAITHKEWVNAGEVIFE
>KECLDBNJ_00774 hypothetical protein
MNVYSGKFVMRVLTFVYTKLDKDSLKNTKTG
>KECLDBNJ_00775 NADH dehydrogenase-like protein
MSKHIVIIGGGFAGINLAKKLSKVSYYQVTLVDKNNYNFFPPLLYQVSTGYLDPSSITFP
FRNLFRGQANFRFRMGEFLEVQPENHQIILNNGTLHYDYLVLATGTQTNYFGLDQIEKHA
IPMKTLEDALEMRNLLLQRLEEATRIDDKSQRLPYLNMVVAGGGPTGVEISGVFAELRNH
TIRKEFPELIGSGSRIYLINGGGELLSPMSEKSQQYTLKKLQKAGVEVLLNTRVVDFDGE
KVMMKDGSHIYSKNLIWATGVTGFRFKGIPDIAYERGNRLKVDAYNKVENVQDIYAIGDA
SISTADSDFPTGHPQLAQVAMQQGRVLAKNLDRMAKGKPPKPFNYLDKGSMAIIGSSKAV
ADMPKPKLHFNGFVAWFVWLFVHLFALIDYRNRVRTFYNWSTEYLTQNQDLRLIIRPNTK
RK
>KECLDBNJ_00776 Fructose-1,6-bisphosphatase class 1
MERHTTLGEFIVQNQKDFPYAKGELTSLLSAIRLAGKMVNQEINKAGLAEIRGKAGQENV
QGESQAKLDVLANDMFISTLRDRGDICGLASEELEDFVVFNEEQHKNANYVVLIDPLDGS
SNIDVDITVGTIFSIYRRISPVGTPVTLEDFLQPGINQVAAGYLIYGTSTMLVYTTGNGT
HGFTFDPGIGSFFLSHPNMKYPESGRIYSVNEGNYVHFPQGIKKFIRWAQELKEEENRPF
TSRYIGSLVADFHRNMLLGGVYLYPEGTKAPKGKLRLNYECNPMAFLTEQAGGKASDGYG
RIMERIPNELHERAPFYCGCTTEVEKIEWFLQQKD
>KECLDBNJ_00777 Sulfate/thiosulfate import ATP-binding protein CysA
MIEIDFTKTLDGGAGSFDLELKLALEAGQFTTIYGASGAGKTSTLRMISGLMTPDRGSLV
VNNEVWYDSSKKINKKPQERSIGFVFQDYALFGHMTVLENLIFAKGKNDGTNSIDELLEV
MELQQLEHRKPETLSGGQKQRVALARALVQKPKLLLLDEPFAALDNTIRFKLHEYLKRVQ
ERYDLTTILISHEVGEIIKLADKVVCLEQGRINKIGSPDTVFTNQNLSGKFKFPGVVVKV
EREEIISVVSVRIHTQVVKVVVQHHEAQALALGDQVIVVSKAFNPILYKLEA
>KECLDBNJ_00778 Sulfate transport system permease protein CysT
MNWEPLILTFKLAVLTTFILLVVALPLARWLSTTKAKIKPVIETLVSMPLVLPPTVLGFY
FLMAFSPNNFFGNWLNEWLGVKLVFSFAGLTVASVLYSLPFMVHPLQSGLSSIPRSVTEA
AYVMGKSTWETFFKVQLPQIKPALLTGIVLSFAHTVGEFGVVLMIGGNIPGKTKVASIAI
YDEVEALNYDAAHLYSFILFAITFCILLVVYLVNGNHFKSLYK
>KECLDBNJ_00779 hypothetical protein
MNSFNGNIKTIQVNGNLSLVLVEVTPKLQLKAIVIDTPETATYLQSEASVAVLFKETEVI
IATAEVPQISLQNRIPASIVSVEKGALLTKLKLQSDAGVLIAIISTDSASRLELQEGKKV
IAMIKLNEVMLRGL
>KECLDBNJ_00780 Molybdate-binding periplasmic protein
MRKLQRIYISLLLFTTAFTACKEVNDNPKLTIATAANMQFAMQRLADDFTKDTGVPCELV
ISSSGKLTAQLKAGAPYDIFVAANMKYPQEVYDAGIAATSPRIYAYGKLVIWTLRSELKP
EFATLQSNAVKHIALANPKTAPYGEAAVAALSTLQLEEAVADKLVYGESIAQTNQFIISG
AAEIGFTALSVVKAPSLKTKGFWAPVADSLYKPIAQGVVRISQDAAKKQQAEAFYAYLFT
EEAQKILQDFGYSVGE
>KECLDBNJ_00781 hypothetical protein
MKLLIDISGWAGSFLVVLSYALTLVKNKDFSTYCILMNLVGGMLIAVNCFYYKAIPSLVT
NVIWSIIALLSIYRAKRHWYQDRKRKRKAQGY
>KECLDBNJ_00782 hypothetical protein
MSEDFLIEMGYAGLTGRLKRLSDAFMYQTRDFYREHDSEIEPNWHMIFLLLQKNETMTVT
EIADALQLSHPAIVKLINKMKKRGYINSNLDPKDNRRYNLVLSQKAKKELPVLEAYWEAG
NKALEEMLEHNTLLLEQLEQLEARMAEADFKTRMDKLLINE
>KECLDBNJ_00783 hypothetical protein
MHQRGIDDFVQTLLLLAGIFNAFDRAIEKNLGDSMSLLSVIGFSVFGGALLGWISYYLYA
ALLSWTGKWIGGRASSKELVRVLAYGMLPAITALVFLMLQISIYGEAVFQEDLDLTKGSS
FDKVIYYTSVFCEIVLSIWSFVLILIGISEVQNVGLFKAFLNLILPIFIVLLPILLISVL
YSAIV
>KECLDBNJ_00784 hypothetical protein
MSTKATSDVFFKTDKNAWEQADKGITRQIIAHNNDLMVVSVKFEKGAIGSVHDHVHTQGS
YVVSGKFEITINGKSELLEAGDGFYVPPHAPHGAKCLEAGILIDSFNPAREDFLE
>KECLDBNJ_00785 Mannonate dehydratase
MRWYGHKDPVTLQDIRQVGATGVVHAMHEIENGALWSVEVLKQRKAEIEAAGLTWKVVES
LPVTEPIKTRSGAFQEHIDNYKQSLINLSEIGVEVVCYNFMPVLDWTRTQLAYPLKNGAT
ALRFDWAHLAAFDCFMLRRKNAEKDYDEKILTEAKHFFDKASTEEKQKLEDAIIAGLPGA
EEGYSLEGLQEAIDKYASIDEVKAQEHLKLFLDEILPVAEAAGVAMAIHPDDPPHPFFGL
PRIMSKASDIARLLKDNDSKYNGVTFCTGSFGARADNDLVQMIDDYGSHIHFIHLRSTKR
DAMGNFFEDNHLEGDVPMPAVVHALLEVEKKRGKQLPMRPDHGHQMLDDLKKPLAHPGYT
AIGRLKGLAELRGVIAGIEFMQNKK
>KECLDBNJ_00786 putative oxidoreductase UxuB
MKSLISVENKIIVISGATGVLGESMTRSLAAAGAHVVVLGRNQSKVDALVDSIKQEGDQA
SGVVADVTNKEALEAAKDTIENHLGYIDVLINAAGGNMKGALILPEQSLADADVEEMRKV
IDLNYIGSFLPTQVFLPLLEKSKKGSVLNISSVAAHLPLTRVMGYASAKAGIENLTQFLA
IEFAQKQENPIRVNALAPGFFLTEQNRELLTNSDGSLTDRGEKIIAHTPLGKFGDPQELN
GAIHWLCSDAANFVTGTVVTVDGGFKAFAGV
>KECLDBNJ_00787 Rhamnogalacturonan acetylesterase RhgT
MKHLKTLALCLTLATFSVVSAQDKPTLYLIGDSTMADKKNPEENPEHGWGQVLPELLTDA
IEVSNHAVNGRSSKSFITEGRWETVLETLKKGDYVFIQFGHNDQKFKDSTRYTNPFTQYR
YNLERYVKETREAGATPILMSSIVRRKFNEHGTLEDTHGNYPLVVRMVANDLDVPFIDMQ
FLTERLERKLGPEKSESIHLHFEPGENPYYQNGKHDDTHLSYTGAKMIASLALQEIARQG
LALENYIKPQVLEAEIVTLKD
>KECLDBNJ_00788 Pectinesterase A
MMRTRYGLIFFILMVCTALKLSAQEKPIEVKPYTLETTYEKLKKEYPFIKPIEALKTGDF
KVLEDLAYERVNGRELKADVYIPTAKAEKYPAVILVHGGGWISGSKANVRPLALQLANHG
YVAVTAEYRLSTEAVYPAAVKDLKAAIRWMRDQAEAFKIDKNRIAILGNSAGAQLATVVG
VTGNSELYKDLQDTTSDAVQAIINVDGIVSFTHPESEEGEVAAQWLNGSRSENLKHWEEA
SPLTYVNAKTPPTLFINSTQPRFHAGRDDMLQILNQHDIYNEVHTLPGTPHSFWLVQPWF
DKTLQYSLSFLDRVFNKESSEVYKTLIVAQDGSGDHKSIQEAISNTRDLGPGFVKILIKE
GVYNEKIVIPAWKRKIALIGMSGDEVVLVNSDYSGKLDSLSNKEHNTFTTYTLKVEGQDF
YAENLTIQNTWCEKGQAVALHVAADRAVFKNCKILGCQDTVYTAGEGNRILFDSCYIEGT
TDFIFGQATAFFDACEIHSLSNSYVTAASTPKFQEYGYVLNQCTLTAAQGVDQVYLGRPW
RPYAKTVFIESKLGDHIMPEGWNVWDCDAMFPHKERTVFYAEFQSTGAGANPDERVWWSH
QLYEEEALQYTKEKVLGGKDHWDPDKQISILK
>KECLDBNJ_00789 SusD-like protein
MKKITYIISCLTVLFTVISCQDFLEEENESFAVAEEFYLTGEGYQSLINANYSQLRELYG
NAPWIYVCGTDLFAEGRDAEPTGLSRYSDLNPSSSGVAELYDNAYRAIQLANTAVYYADL
TESTDVLDQQLGEVRYLRANAYFLLVQTYGGVPLITEYFREPVLEFSRESAENIYGFIIS
ELEAALNQVGSGAYQGKVNQRAVNHLLAKVYLTRGYESFGSTADFTTAASYAEAAIAGQG
LNLSFAELWAPGNPTYPIKEETLFSVQYDPASVSTAPFDLGHQQTAYFGPYQGGSEVAGD
APYRTYTLCPTQFAIDLFTEDDERYAATFMTEVYSRYFDFYDVDDTSTLPVAHYYAPAWE
ATQADQDAYLAEHPDATYHPYGSYVPSANPTNDYQTIPLKKFDDPEAPFGQNTSRRDIVL
SRLGETYLIAAEAYLQAGQPGTGLTFLNDVRERAGVVDATLAEFDIDYILDERGRELMGE
YHRWFDLKRTGTLIERASAYHYLVEEGNFNGANGELKILRPIPQSALDLNQNNDFEQNPA
YQ
>KECLDBNJ_00790 TonB-dependent receptor SusC
MMRNTHTNFLIRKKIGLLLVLASCLFSVPGFAQDTRTITGTVTSADDSMPLPGVNIVVEG
TNYATVTDFDGNFQLEVPGDDATLVVSYVGFLTKNVAVGSQSTFTISLETDVQSLNEVVV
VGYGTVKKSDLTGAVGTIGSESLTERNITNPVESLQGLVPGVQVSNSTGRIGDGFNITIR
GQNSIGGGGDPLFVVDGVPTDNIDFLNPQDIERMDILKDASSTAIYGSRGSNGVVIVTTR
SGAGAKGGLTVSVESFVGVKDVARLPKLMDPQTWWDYHQSAYLATAGTDPNTGAVSAETL
ANAVGGNGSNEELLRRVAANQSFDWYDAVLKTGVQQNTYVNASGRAENGLGYNLGIGYQN
ETGNIDNEELNKYTLKLGVDHNINDKFTLGTNVTVTLIDQDQGSDVAMREAFRLNPFLDP
YDLDGVTLFPQPGKLVDENGDFIINKTSTYNPLLEINNSIDNVRRWNVIGNSYFQYQATD
WLSFKTSFAAGYTDTRRGRSWGALTNTGASNNNLPSARLDQSQNFNYTWDNQFNINKTFD
EKHNVSLLGLYSIFSNRNENSYSASRNMPFDTSFYNIGSGEQSTYDIGSGFNKNTLRSYA
LRLNYSFDDKYLLTLSNRWDGSSVFPEDNRWDSFPSAAVGWNISNEDFLAESTTVSNLKL
RASFGYTGNNIIDPYSSLNTLNSQTYYDYAGTVSNGFISTQIANAALRWERTREFNVGVD
FGFLNDRITGSVDVYDRLSDDLLFTQDLPSETGFSNINANVASVNNSGVELALTTRNIQT
EDVTWTTQFTFTKNTNELRTIYGQSEVDDIGNNLFIGESLDAIYNYKFTGIWQADEADEA
AGYGMEEGQEKLLDVNNDGQYTPDGDRIILGSSNPDWTGSFFSSLRVKNFDLSTSVIVTQ
GVLVYSNFHSNFANTRDRGRQKLDIDWYVPANDAGLPARASNTYPQPRNEGSFWRNNGVG
YYKDASFVKVKNIALGYNLGDGALEKLGFTSLRVYANVLNPFVFTDYEGYDPEWAGASLN
TGRPASVTYQLGFNLKF
>KECLDBNJ_00791 Polygalacturonase
MLPILRNRFRYLLLTAIAVGLVSVSCKKKDEQSKADLAQTENVWAQADAIIEEIGTVTFQ
DSVFNINEYGAVADGTTLNTEAFKAAIDACNQAGGGKVLVPKGTYLTGPIHLKSNVNLHL
DADAEVLFTTDKSAYLPAVHTSYEGMEIMNYSPLIYAKGQKNIAVTGNGTFNGQANSENW
WPWCGAERYGHKEGEPQQKDEHNLPTLFTMIEDGTPVEERIFGEGHQLRPLFLQTLECEN
VLIQGVTFTNAPFWVIHPLKSKYITVDGVTVNSHGPNNDGCDPEYSKYVHITNCNFNTGD
DCIAIKSGRNGDGRRVNIPSENIVVENCDMKDGHGGVVMGSEISAGVRNVFVRECTMNSP
NLDRAIRIKTNTLRGGFVENVYVKDVEVGQVKEAVLKINTYYGIYGTQEGDFIPTIKNIN
LENVTVENGGKYGLLIQGREEKPVTGISLKNVSIKNAATPLKIENCEPINYVNTTINNEK
YGEK
>KECLDBNJ_00792 HTH-type transcriptional regulator DegA
MRQKEKVTIYDISKKLNISAATVSRALNDSDRVSLKTKELVLKTAKELNYQQNALALALK
SGRTFNVGVVVPYINHTFFASVIRGIEEELEPKGYHVIICQTHENVESEAKQIKTLLNTH
IDGIFISVSKTTESVKHIEEVRDEGVPLIFFDRKKDISGVSSVTINDFEGAYEATTHLIQ
QGYTNIAHIGGDHKLEIYKHRYDGYIAALKAHNLPVNDDLLLQVNSTVEAGIEAVKFLLK
NNISFDAIFSASDYVALGGMRELRANGFKIPEDVGVVGFSNEPFTKYLERPLTTVGQTPV
LMGQIAAQVFLEQITDVKKNFRVEKKVVLSPELYTRDTSIKKGS
>KECLDBNJ_00793 Altronate dehydratase
MKSKLIKVHPEDNVAVALVDLYAGDTVDFEGKSIAILTDSKAKHKIALTDFKVNDPIYMY
GVLVGKALSAINFGGLLTTENVKHEANSVSQKTETTSWTAPDISKWKDRTFMGYHREDGQ
VGTQNIWLFFPLVFCENRNIELLKDVFEKELSFHKASKQRQLLRNLISGAPEDTAVAEIE
EEQAIFDNIQVKFITHQGGCGGIRQDSVSLSKLLAGYVNNPNVAGATVLSLGCQNLQIDI
FKQALAEKSAAIKKPVLIYEQQQEGTVDEMLSKIIKDSFEGIKKANQIQRKPASISKLKM
GLECGGSDGFSGISANPALGYASDILAAVGGSPILSEFPELCGVEQELVNRCVSDEDAER
FMHLMKAYEKSAVDAGSGFDMNPSPGNIKDGLITDAMKSAGAAKKGGTSPIQAILDYGEY
VTKPGLNLLCTPGNDVESTTAMVGSGAIVVVFTTGLGTPTGNPIAPVLKVASNSTLARRM
PDIIDIDSGGVIRGEKTIEEMGEEILEHVIQVASGEIQSKADALGQDDFIPWKRGVSL
>KECLDBNJ_00794 Altronate oxidoreductase
MKNLTRANTGLTEKLPIKVVQYGEGNFLRAFVDYIIDKLNKEADFNAGVAVIQPLPGGMV
SMLNDQDGLYNLFLRGIKNGEETEEIHTISCVQEGLNPYTDYDKYLALATGEELEFLISN
TTEAGISFDENDTLAGTPHTSFPAKVTALLYKRYTHFEGASDMGLTIIPCELINHNADML
KKIILQYADLWDLEPAFKSWVEEHNSFHNTLVDRIVPGYPKDDIDAYQSQLAYKDNLIVS
AETFLLWVIEGDARLKLKIPFDKIDENILVVEDMQPYRTRKVRILNGAHTTMVPFSLLYG
NETVKETVDDAFTGKFVRDAVFKEINPTLDLSEEELQEFADAVFDRFRNPFIKHLLSSIA
LNTVSKFKVRVLPSLLAFEKEYNRLPENLTFALACLIRFYKGTYKGKALPIKDDAAVVAF
FKEVWQTEDYAKVAQKVLSNVGFWDQDLTAISGLEQKVAIALALIEEYGVEEAYKKYAV
>KECLDBNJ_00795 C4-dicarboxylate TRAP transporter large permease protein DctM
MIEVLILVLVFFVLLGIGVPVAWSIGISCLLTIMVSIDSLASVTTIAQRMATGLDSFSLL
AIPLFVLAGQIMNQGGIALRLINFAKALMGALPGGLIYVNVIAAMLFGAISGSAVAATSA
IGGILGPFMEKENYSKEFGAAINITASTTGLIIPPSNVLIVYSLASGGVSIASLFLAGYI
PGILMGLALMLVATFWIKKKKYPAGERSSLGTILKTFLDALPSLLLLVVVIGGIVTGVFT
ATEASGIAVLYCLVLSFVYRELKVSSLKSIFLSSVGTTAIVMLLIATSMSMSWVMSFENI
PQNVSSALLSLSDNKLVILIIINVLLLFVGTFMDMTPAVLIFTPIFLPVVTSMGVEPVQF
GIMMVMNLCVGLCTPPVGAVLFIGVGVAKTSIQKIMKPLLPLYAVMAIVLLMVTFIPAIS
LWLPSLFE
>KECLDBNJ_00796 Sialic acid TRAP transporter small permease protein SiaQ
MKKRLDKILGGILVFLMASIVIAVLWQVFSRYVLQAASSFTEEIARFLLIWIGILGAAYA
AGQQDHLAINILPPKLNIKNRIKLRMGINILIILFALFALIVGGINLVYVNFELGQYSAA
LGLPLGFVYAVLPISGALIIWYKIIELANPQKYLAS
>KECLDBNJ_00797 Solute-binding protein
MSRLKNFILIVLAVVGLVCQTACKEASDSRVIKLAHGLDVSHPVHKAMVFMGERLKEKSA
GKLSLDIYPSQQLGSERECLELLQIGSLGMTKVSTGVLENFAPQLKVFGLPFLFRDAEHR
FAVLEGEIGEQLLSSSIPQRLKGLTFYDAGSRSFYTKKPVETPEDLKGLKLRVMESQTAM
NMVKNLGGSPTPIAWGELYTALQQGVVDGAENNLPSFYLSHHYEVCKYFVVDEHTALPDE
LLISTLIWDDLSKEEQRWVKEAADESLAFEKEIWHEAEMEALAEIKKAGVEVITPDKEPF
RNRVKSMYEEFSQNPEMKMLIEQIQAVKTN
>KECLDBNJ_00798 KHG/KDPG aldolase
MAKYSRIEVVLQMKENGIVPVFYNADIAVCKQVLKACYDAGLRTFEFTNRGDFAHEVFAD
LNKYAKAELQGMMMGVGSVLDAGTTSLYLQLGADFIISPIVNAEMAKACNRRKVAWMPGC
GSVTEISYAEELGAEVVKIFPGAQVGGPAFVKGVKGPLPWASIMPTGGVSPTEENLKEWI
AAGVHCVGIGSKLFAKNTEGAYDYTAITETISSALDLVKKLRS
>KECLDBNJ_00799 2-dehydro-3-deoxygluconokinase
MRNTPDIITFGEVLLRLSPAENRKLTQAKSLDFFFGGTEMNVGASLAVLGESVKHITAVS
DDLVGEAALASMRHYGLDVADVQKVAHPMGQYILEVGSGMRSSQIAYNRLNGSFANIQPE
NIAWDTIFENAQFFHWTGITPAISEAAYQALKAGLVSAKERGLQITADPAYRSNLWQYGR
KGQEVLKELVSLSTIFIGGVNEINEILGTSYGLDKDGFIAASKKLIEECPSITQIFDKIR
TGMSASWQKIYGRAWVDNTYFETSELEITQVVDRIGTGDAYAAGLIYGLLHFDAEKALNF
ANAACALKHTILGDVNLVSVAEINEVMQGNTGGRIKR
>KECLDBNJ_00800 Uronate isomerase
MSTGTAAQVKNTFIKDSFLLENKYAEELYHTYAAPQPIIDYHNHLPPAEIVADRQFENIS
RVWLNGDHYKWRAMRTLGVNERFITGDASDEEKFMAWAKTVPHTLRNPLYHWTHLELKRY
FDIDELLNEHSGPEIYKEVNRQLQLKENSCRGLLTQMNVETVCTTEDPLDTLKHHQAYDG
ANDGLKMSTAFRPDKAILIEAEDFNSYLDKLAEVSGVSIVLYADLQEALRQRIDFFHKNG
CRLCDHGLNQISWTAFTASEIQEIFKKRRGGASLSSVEIEKFKTAILLFLGETYHELGWV
QQFHLGALRNNNKRMLAQLGPDTGWDSIGDYSQAEALSGFLNALDSNDKLTKTIIYNLNP
SDNEVMATMIGNFNDGSVKGKVQLGSGWWFLDQKDGMEKQMNALSNMGLIGCFVGMLTDS
RSFLSFPRHEYFRRVLCNLFGKEIASGEIPNDMDLVGQTIANISYHNAKEYFNF
>KECLDBNJ_00801 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MSLFSLKGKTALVTGCKRGIGFAMAEALAEAGADILGVSASLETSGSAIEKAVEAAGSSF
KGYQCDFSDRKSLYAFVEKVKSENDSIDILVNNAGTILRAPAAEHSDEYWDKVIEVNQNA
QFILSRELGKEMVKRGSGKIIFTASLLTFQGGITVPGYAASKGAIGQLTMALSNEWAGKG
VQVNAIAPGYIATDNTEALRDDPDRSSSILARIPAGRWGKPEDFKGPIIFLASQASDYMS
GTVMTVDGGWMGR
>KECLDBNJ_00802 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
MTKSEFRYAHHPEDVKRYTTKELREHFLIPELFVKNEINLTYTMYDRYIAGGAFPVDQAV
KLEPIDDLKAEHFLDRRELGVINVGGKGKITVDGEVYELGNKEALYVGKGVKEVVFEATE
EQPYFYINSAPAHHAYPTKKVTKKEAEIVELGDTKYSNKRVINKLLVNSVVDTCQLQMGM
TELQEGNVWNTMPAHTHTRRMEVYFYFDLEEGQTISHFMGQPDETRHVFMKNHQAIISPE
WSIHSGAGTSNYTFIWGMAGENMDYGDMDGVSPEDLK
>KECLDBNJ_00803 hypothetical protein
MKTRILSGAFALAALVACKEKEEKNTVEEIIEIEEVAPETYAEISVKKGGSWKEDTREYI
DGSFENVDELIVPEEHTDHSWYIRYEGPGWENKQTAYRLYLDWRNAIDIFGKKVDTLVLP
YVGTDGFDSYHNNAPWGQDILKAGKSMGIGGYGRFTGDTIAHFDEVQKTSVKVNNEASQS
SVAINYEGWKTGDVTTDLKSVISIFPEDRFLKAELTPSISFDGLATGIVKFEEIPLMQGT
SEDGSWAYISTYGVQTLAGEQDQLGMAIFYKTEDAEVIDGPHDHLVVFKPSTETQTYYIL
SAWDQEHNGIKSKEAFEKGLAEKLAKLDNHGVLE
>KECLDBNJ_00804 Unsaturated rhamnogalacturonyl hydrolase YteR
MKKSSVFYAVLILFIGLSSSCKQSAKQESQEDKAVTENMSLEGKKWSVQMAESIRHRFPE
GYQIDDRTTAKWDYVHGLVLKAFLDLEIVTDSVAYYDYVADYADQLVNEDGSIETYTLDD
YNIDMINAGKLLFEVYERSGNEKYLKAMQLLRKQLAEHPRTSQGGFWHKKRYPSQMWLDG
LYMGAPFYAQYAVTFGDPENLNDVARQFELIQEHAIDPETQLLYHGWDESKEQQWADQET
GVSPNFWSRSLGWYMMALVDVLDYFPEEHPKRKELISYLQQLTEALIPYQHESGLWYQVP
TMGDKEGNYLEASGSSMFAYAIAKGVNKGYLDQRYKAVANKAFDGLTQELIVRNDDGTIT
LTQVCAVAGLGGDPYRDGSFEYYVNERQKDNDPKGTGPFIMAALQLDR
>KECLDBNJ_00805 hypothetical protein
MNRPLLTHILFLCCAIVIASCSSKEFDEYYARPDDLEEPIYQQLEARGNFTVLTQLIEKA
NYKDILGKAGYWTMIAPNDEAFERFFQEQGIANVSAIDSVLANKIVRYALIYNAFRTERL
SDYQSNTGWEEDNAFRRRTAYYDGFEVKTVDGNEIVVAGSNRNNAPDGDPYIPGDNNNKY
LTYFVDEYMTANGLGAFDYNYFFPGQSYTGFNVLGSSMVNADIVAENGIIHEVDEVSLPL
INLDQKLETSSEYSLFRSILEDNLVNYVFDQDATTTYQNFTRNTDQVYIKVYDPALSFSP
NNENYLKEADNDGQSDAYTMFVPENSVLQSFIDEVLLKNYASLDLLPKYVFEDFVNAHMV
QNAVWPSLVEAYSNALEEDIRIDLSTEVNEAQVLSNGFFYGTNKVQESNLFFSVYTSAYL
DPEFTLATRLYNDGSGYREIISNINSRYTLFLPSDDVLRDLGYDYNINREEWVYTNPATG
NTVAGTIARSRLLRVLYNGIIPTPNDELNDLSGSGIIRSGDFDLPGEYIKWENNTVFAAG
NEVLGNRVNIIGFEDQRNGRTYYIDNLLEFSEEAPGLDIMRLAEEPDSEYSNFYNYLENS
LLYDPAAGSITGVELGTSYTFVVPNNAAIEQAVRDGVLPGDSTTGIPDFNPSNGGQQDQV
ADFIRYHILATRTASDDGLISGQIETLRRDGIGEKTYIGLITGPGELSFVDSAGRIADYI
PSASNNLADRSLIHLVDNYLLYTE
>KECLDBNJ_00806 TonB-dependent receptor SusC
MRQLYTTIHYCFTIILFILVSNQTLAQDANMVVRGTILDSSNNQPIPGATIAEQDAENRT
VTGVIADFDGNFAIRVKSRSNKLVISTLGYTSQTIPLSGQSSYTINLTPSVDELDEVMIS
VEKPTESGLLDISERNMTTSTVTVKAADVENTQAASIDEALQGRVPGVDITANSGDPGAG
MQIRIRGTSSITGSSDPLVVVDGMPYETSIPEDFNFGSADEQGYAALLNIAPSDIESITI
LKDAAATAMWGARAASGVLVINTKRGSVGAPKIGYTFTGTFMKLPRTIPMLSGDQYSQLI
PEEFMNRNGTPLNTLTVKEFQYDPQEVYFYKNYGNNTDWVDAISQTGLTGEHNLSLQGGG
EKARYYTSVGYYDSKGVTKGTAFQRINGRLNLDYVVSDRIRFKADIAYTHTVTDRNYVNG
TSSGDRLRSVAYTKMPNMSIYEYDDVGDLTPNYFSPAQNIQGAYSRTYNPVAMAEYATNE
QTGERIVPHFNLKVDLIPRRLISTFDLQFDFNSTKAKAFLPQNATGRPFTETVVNQASDA
DVDIASVTSKTNLIYTPEIGKDHSLQTLLSIQTNDFRYESHQALTSNTASSLLTDPSVPS
RTQNAELQLYNNNSQSRNVAALVNAQYSLLDRYILNVGVRGDGNSKFGPGNRYALFPSVS
TRWRVSGEPFMDNYDFIDDLSFRASYGQSGRAPRYDYRYFNVYGNFNSSYLGMNGVYPQN
IELDNLRWETLTGQNIGLNLQMFNRRIMLDVDVYKNRTKDLLFQNVDLTTVSGYSSLSDQ
NVGTLDNQGWEVGLYTTPIKTDKWKVDFNFNIASNQNIIREISEFYPSESGNVDRNGEFK
RFLQTDNPFGSFYGYRFKGVYPDLESTQARDANGNVITGPNGETVYMRFNYPNTDYIFQP
GDAIYEDINKDGNIDSRDVVYLGNSNPKFTGGFGPSVTFNDQFKLLLFFTYRLDYDIVNG
TDMLTTNMYTYDNQSTAVLSRWRNPGDQTNMPRAVYGAGYNWLGSDRYVEDASFVRFRSA
TFSYNFTKPFLKKWKLDDLRVYVTADNLLTFTNYRGQDPEVNMRGGDPFGIAIDYSRTPP
TRRFTLGIQTRF
>KECLDBNJ_00807 hypothetical protein
MQTRITHILAILLAALSLSCDSYLDLRPENGTVRQEFWQTKEDVQAAVIGIYSAMLNTPP
SESDLTLAEYLFMYGELRGGMVSPAAFTSNDQSDIITTNILPSNSITTWSQFYRIINYCN
TVIDLAPDVLEEDPTLTQEQLNNYLSEALAIRAYLYFTLAKSFKDVPLKLDATLSDGDNF
QLETTPQDQIFAQVLVDLNDAERLSVEDYGNTPENKGRITKFAINAMQADLHLWLENYDE
ALVAADKIINSGQFELIDASPQWFTTVFALGNSTESIFELQYTPENRGPFYGIFLQQPQY
LAAPAVLEEVFGVDFDEPENKDVRGERASLVPGTNEIYKFTGLNEDQRKALQESDTHWFV
YRYSDALLMKAEALNELGRGAEAISIIEDLREKRAAIAQTQEQVSPQDQDGIRRYILAER
AREFAFEGKRWFDVLRNARKNNYAYLDILLGVALRSAPANQQQSILAKLQDPNSHYLPIN
TFELYTNKALTQNPFYK
>KECLDBNJ_00808 hypothetical protein
MKTHLKGFKLTSVFILIALASMVFGCTQEKYKESTDETLNITEFLRANEEEYSLFLEILE
VTDYASFMNTYGTYTLFLPTNAAIEGFLGDVGAGSISDVPLEDLQELAKLHILSDVVTTV
EFNDGKIATPSLQGQFLITGASNINGESSITINKDSRIITSNLEVGNGVIHVIDKALRVA
DKTLAETIDADPELSLFAEAVRETGWYDVLDQPVTYDQDSISSHVSVLAQTNAIFQEAGL
NSIEDLKARYSHLDDPTNPEDSLNLFVAYRIIPELDYLADLAVKSVVLTKAPLEVISVKL
ASDSLLLNEETFNGIFEPGVQINRAQSDITASNGVLHYVNDNFFIKKRFPAPVYFDVADQ
PEYRQLSAVFRKPGNYAELARSELSEVTWEGNEAFKMGYLAAATGDGAQLSQAWHGDVVE
LLRHRTGVINNLAFTTPVIIKGRYKIWVSYRQNARASSSVRVLFNGEALPRLINFTEYGN
TELPERVLESQGYKRHLSVTTSRFNSRLAGIVEVPTTGRHTITLESLAYAGGQSWIDVIE
FRPVDMDQLYPKFEAGGDGLIYE
>KECLDBNJ_00809 hypothetical protein
MIYLNKHTRIFTAGIALLAMLSCSDPWEEHSATTDVNLNSTLNQRITATAETSEFGALLE
ETGYDKVLAGSKTYTVWAPTNEAMATIEADALADASAKKLFIENHIALTAFSSVTEVDTL
TVQMLSHKYLEFKNGSVMADADVVTADQYASNGLFHIIDKALVPKQNIWEYLNTDASAYA
MSSFLIDLNEFNLYQSDSTAKATAALMPELFSDSLTNSFFTNVYNLNNEQNKYTFFLMED
EAYQSEVQKLEPYLIKSNEDSTTTYASYFTVRDLAFHKAIARQNLPDTLTSKFGVKVPID
TNAIVEEVQLSNGIVYVMRSLDVPLETRLLTTLIEGEEPSGFSQGDKRGNTYYREKEDPD
GELFYDIMVQNHEVPLFSIYYNANNLYSTTYEVYWRAINDIQSNTFQQRLRFGGTIQEDG
TVTDPIATLDYTDVPPNTYEEIYIGEFTLDQAGMLDLISLIATNTSSTGANTLTLDYLKL
VPVIK
>KECLDBNJ_00810 TonB-dependent receptor SusC
MLKILQLTCILCLFLYGGVTQGLYAQTSADTTDVASESSKGMAVTGIIKNAANGKGISGI
NIAVPNFSAAISNEDGSFSINVPHLNALLSVSGQEFQSKVYPLNNRSSGIEILLYEANYS
QFYQNSELPGGQALQYTNPKAATTVNFSEGQWGNPVNESVADFLQGRVAGLNSVRKSGVP
GAGANLTLRGFNSLYATNKPLLIVDGMIYDDEDYGSGIIQYTGSSPLSMLEVKDIEDITV
LKDGSSIYGTKGSNGVIIITTTRPVDLSTKIDFTMYGGINQEPNELPVLRSGDYRTYLSQ
LVATRGDTQQQIANYPWMNDDRQSENYYAYHNQTNWQDQVFKSSANQNYFLKIRGGDDIA
KYGLSVGYLNSEGVIRNTGLERYNTRLNAALRLTEKLTVNANLSFIHNTEHLQDQGLAYK
TSPMYLALTKAPFTAINVINAAGEVSPNLSDVDLFNVGNPLAIIENGIGINKNYRFYGNL
DFNYSIAENLQANMLVGLTYNKERESFFIPDFGVADVILPTAIGNNRSGSEVQRLYSLYT
DTYLNYGKRFNNTHGLDLRLGFRTQSNESESDLGLGFNSATDDFTTVGAGSNLLRVVGGS
LGEWKWINGYLSAEYDYLNKYYLTLNGAIDSSSRFGDDIQNGGFNIGDSQFAALGSVSGA
WLLSSEDLFKNASALDLLKLRASYGVSGNDDIGNFTSQQLYVSQNLLGIQGLVRGNIGNP
ELKWETVSKLNLGLDLSLFNERFNASVDVYQNKTSDMITYEPVNTTSGFNYVVSNSGDMQ
TQGIDLSLNTRLVNTSDVKFDLGLNLSRYVNEVTGLPSGPIISEFGGATYITHEGQDANL
FFGYETNGVYANTADAQAAGLSRRMENGALRAFSGGDVIFTDLNNDGIIDDDDRVVIGNP
NPDLFGSFSANFKWKRLSISSLFNFSLGNDLYNGVRYNLEKMSGYENQTIAVNNRWVAEG
QQTTIPRAVWGDPLGNASFSDRWIEDGSYLRLKTLVVAYDVSIDLEHIKSFKVYASANNL
FTLTDYLGYDPEFSATSSIFGQGADLGLMPQFTTIQMGLRLGL
>KECLDBNJ_00811 hypothetical protein
MTLFTNTKYTLKLGALALFLGLGSCQEYLNVEPQDQLNKDQVYRDVFDADAAVVGIYGKF
MGLAEKYVVLNELRADLVSPTYNAGPFYTQLSEHSVTAENPYASPKDFYEVINNCNDALK
NFDLMRADNRLDSNEYNERYSDIGTLRSWLYLQLGIHYGQVPYITEPVENLNDIRNLNQY
PRIQFEELLNELITFTEGLPYTDTYSANSTLLIDVDGYNTGKFFINKECLLGDLHLWRGN
YVQAASHYKVVLETASDSGSDSERYDVYRVKYAEIASNNDLAVGYIRYREQDAQALINNN
TQGWRSMFSREPDALWNTEWIWSLPFDSSFAPENPFINLFSNQNGNYLLKPSQEAMNLWE
DQTQLNGFPYDARGSKFSYSMINGDPVIMKYLYNYLDPVSQLPVDVFQRDGRWFLYRAAK
LHLRYAEAANRDGQHRLADALLNYGLQNEYTVEGVEDVTDIEQTNLPFPYDFDARQGDFP
FYRGNWYRNGGLRGRAYLERAPVYGDSLISIENNLIEEAALELAFEGNRWGDLVRVAIHR
NDPAFLADKIYAKLNAQGNAEASAVRTKLMSQENWYLPFVWNDEE
>KECLDBNJ_00812 Arylsulfatase
MPRFSSIFCLFFSCIVSILVSVSCKENHSTKSEVSNDKPNFLVIIADDAGWNDLGIHGSE
IKTPTLDSLAAQGLLLERYYTYPTCSPARASFLTGRPASRMGIVAPISGRSELNLPDSIT
TLPQALGALNYNTALMGKWHLGLKPESGPEAYGFDFSYGFLHGQLDQYAHTYKNGDSTWY
KNGKFITEEGHVTDLLTAGAIHYLDTLNPEKPFYLQLAYSAPHIPLQEPQEWLEQYSSIA
DSSRRAYAAAMSHMDHGIGKVLQKLKQTQRAENTIILFISDNGAQEQWIPTTQYEGKYGP
NYTLGSNLPLRDFKTSNYEGALRVPAIFSWPKLNAKGSSSNYINVSDWMPTFLQWAQATA
IPPSVDGESIEKLLTSSTSARKKPIYTRGHLQESLIVPPFKLIRTRHLEGQADFELYDIE
SDPSETQNIVLEHPKKVDELKVILKEEFSKDTPQVNVELKH
>KECLDBNJ_00813 hypothetical protein
MSISKTTNQEAKPRGIQKKHIFNFNVDIEAVSWLPMPLKCLSTAFLILALAGCSQHKEKA
LTQISLTNPEDISLTDKAVAIPLEKLEYTASKNYPLLTLDQDTIASQLSDMDADGTADHL
FFVMDFEPKEAKKIQLEWVAEAPQYDLKTSIRFGKREAKDQPVQPALEETLSAQDMPKAL
GFQKYQTDGPTWENDKVAFRHYLDGRNAKDVYGKKTAAISPENVGLDSAGAVVDNYHTME
AWGRDVFPVGNSAGLGGFGVIAKDSIRRLGILVTDTLSNVEQTHFKIIEEGAVKSTMHID
YTNWNTAGNTYQAEETTSIWPGMYAYQNTVSVAGLQQGDTLAIGLSNINNKNGVEELKSE
KWVALIQHDSLTYDRKWVMGSALILPATAYQNYTEAPSTGNFTQSYLAKLNVGNDTPVTY
YGVSGWELSQEPKFKDAAYFKSYVEQLANQLYTEIDIQIEN
>KECLDBNJ_00814 L-rhamnose mutarotase
MPVHAFTMQLKPGFEKEYKRRHDLIWPELQKLLNDSGIETYHIFLDESNLKLFAFQQLKE
GHTTAALPQDPIVKKWWAYMADIMETNADHSPVEIPLNEVFELQKE
>KECLDBNJ_00815 hypothetical protein
MAKILGIGSRVKHAEYGVGVVTNVTSELYWITFIDNGLETVTIDSEMEIIEAVDDEVDTV
SFYEVEKTLRNLLKQYSDISEIVPIADKYKGGTLTLSPADAGLASKDIPIETFFHKIVMV
RDRIRVMEQKINSSKNLDDQEKIDLQQYITRIYVSLTTFNVLFKNSSQNFKGSSK
>KECLDBNJ_00816 hypothetical protein
MTPKYLLNDKGKYLSFIGLLIVINLTVIALTDLETSRLTRLISIGIFFAYYLIKKELLNL
WTVIAFLFFIGRDIFFQFYEEPWGYKSYLILGTLCYLTIVFERLPKISEINFKPGVVLIT
LILVAANTYTLYVIMNMSMVTYTFHDGVEPILLYVYGAAMMVLGVQAIAYNNKYNSNRSL
LYIFFAFGFIFSDIAALFAYYFEFEIFYFFDRFFFLGAMAMLVQYGLNYESVKEEFYQYE
MIDKNL
>KECLDBNJ_00817 hypothetical protein
MKRLVYFTLCCVILLTGKAVHAQHVAFPLPIKKNLVKRLTEQLAPKPETNWQELNRVGID
LSEVAFVNWNAGGSNSISGLAEVVLERNYSDKKRKWRNKLITRYGVNSQEGQELRKTDDN
LELTSDFGYRRDTLSNWYYSAKFRFASQFTNGYKYPDTSTPISQFMAPGYIFLGVGGEYG
QRLDNLSIYASPLTYKSTFVLDQDLANNGAFGVEPAVRDADGNIIREGSNVNSELGILIQ
SSLNAQVMENINLTNLVNLYTDYLKSFGNVDIDWELNLNFKVNSFVLAKVGSHLKYDNDV
KITETNVDGEEVVMGARTQWKQQLGIGVVVDF
>KECLDBNJ_00818 Phosphoribosylformylglycinamidine cyclo-ligase
MSQEISKRYAQRGVSAGKEEVHKAIKNVDKGLFPKAFCKIVPDYLTGSEDHCLIMHADGA
GTKSSLAYMYWKETGDISVWKGIAQDALIMNIDDLLCVGATDNILLSSTIGRNKNLITGE
VISAIINGTEELIADLEKHGVSIKSTGGETADVGDLVRTIIVDSTVTARMKKEDVIDNAN
IKPGDVIVGLASFGQSTYETEYNGGMGSNGLTSARHDVFDNYLAEKFPESFDKAVPEDLV
YSGSKKLTDSVEASPLDAGKLVLSPTRTYAPVIKKILASVDKSLLHGMVHCSGGAQTKIL
HFVENLHIIKDNLFDVPPLFKLIQEESGTDWKEMYQVFNMGHRMELYVDPSLAQDIIEIS
KSFNIDAQIVGRVEASNEKSLTIKSPFGTFEY
>KECLDBNJ_00819 hypothetical protein
MKIRKHIYLLLILAIGLISCSEDTIDFVGQGTLSGRVVSDESKTAISNVRISTNPASSTV
FTDEEGRFTIEPIDEDDYSVQAELDGYVTAFEAVVVSANQTSTVAFELVISKTDNIPPKA
PELIQPADNTLNVDLNTTFVWSSSKNDSDDITYELELRNADANTKEVFTIENDTIFSINE
LTLGTTYFWQVSASDGENEQILSSVKQFTTRTLDDTPFLFTRIENGNSVIYAGAESDDGV
YAEYQLTSSNTNSFRPRANKETGKIAFLRTEGSTVHLYSMNADGSDVKKLTGSIPVNGFK
ISEVDFAWAQNGSAVYYPNYDKLYSISLNGTGANLIYQTPDGSLITEIAVSDFNQNIIAL
KTNNINGYQTNIFTFNTATQMIVNQVLVNYNGAAGGLDLDANGNRLLYTRDLSGSQNNQY
RIFESRVFIYDFSTGISLALETDVDQGENDLDPRWSPSEGQIILTRQANNLTAIPSIYTV
DLNSNNSSSDDDLLFTNASMPDWE
>KECLDBNJ_00820 Curli production assembly/transport component CsgG
MKIYKLFLLFVGGLLLNSCGAYFNQPIIQQEARQGEFSGSTQNLLDLPDAQTPVEVAVYN
FRDQTGQYKSVENGSTFSTAVTQGATAILLKALEDSNWFIPIERENLSNLTTERNIIRNT
KQEYIKNLNPNEPPLPPLKYAGIILEGGIVSYDTNIVTGGLGARYFGIGGSTKYRQDRIT
VYLRMVSTSNGEILKTVYISKTILSQALDASFFRFVKFQRLLEAETGITQNEPVQLAVKD
AVEKAVKALIIEGVQDGYWSAKGGNQVNQELVESYIQEKKEEQSIKLYDRIFQEKQKPNY
FSVMSGVSLIDGDYSQQKPGFYFRADYGHSLTNSFDVELAASLFQANNDYQYKNEYLSVD
LNARFNILPNDNFGPFIYAGPGFIFDHRSEETDQDDLTRSFFKMQYGLGLIYTLNESLDF
KLIAEQNLVLSDLLDGVENGKRDDFYYNIGFGIQYRFGFKKSDNLNSVTNEN
>KECLDBNJ_00821 hypothetical protein
MKYFYFFSFLFIVGGTMQAQQLTYKPINPAFGGDTFNYQWLLSSASAQNGHSASSDSRDE
QTELESFGDNLNRQILSQLSRTLLNAQVESIGDFTEEGTFTFGSLNVEVFESTEGLVINI
LDTSTGETTQVIVPN
>KECLDBNJ_00822 hypothetical protein
MYSTVNAQFINQEIEAKILVEDSGEFYEFLAIAENKSLADQSFKYEFATFIRDKDNRVKK
DSLVGRFGLASQSRERLNKITISRAEERRVIVMLVVYSLEGKPLGQDRVVLNDNNVSESI
VLDKPKHPANNDMAPSQDGFFVQGLVVENSITKMGQDFYRLFYSKYYLSGLKSEKDIVID
ELPFRARTTRISVKVDNQLVWQFFSNPSQEFLKRQSDMAFNRVVAQLQQIQNTKDQITRY
>KECLDBNJ_00823 hypothetical protein
MTYLKTLIVLFFLGIVTNISAQTFATDSKPDVDRDKLSLFNSGVYEIPRVNNSLPKNNQV
YLTQVGEFNTININTQTNSSDINVRQNGSNNDLSFEYIADHAVANVIQNGSNNKVVDYVN
LPGETINLNLTQDGSNLTFDKYGSSTLSESLQFKQTGFSKTLIVRSFK
>KECLDBNJ_00824 hypothetical protein
MKKVILCAGALMFGAVAFAQQNTSTGSQSGTSNTGDVYQAGTMNKANLVQNGTTNASETS
QFGADNLVKVDQVGTSNTSSAIQEGGSDNKAYVDQDDLGNMSTIIQGTGMAAVGNWAKVT
QSGSTDVLTGNYAKVKQTYDQSKADVNQSGDSNMAKVTQVGKPNQPGAPNARFPRNEADV
DQMGTGNKARVNQESYAVSGAKNMATVYTDGIDNLAVVEQIETQGNRATITQENNYAEAY
VDQDSDDNKATITQTGDDVDLVAGAGDKAYVHQMGSTGNNAIINQESIDPYGDPGSYARV
LQDGADNLARVNQTTRGQEAFVHQMGTDNTVDVSQSGYSQYADLYQNGSDHKIDLTQGWS
QGSAIISQFGTGHTATHTQGGGGSNSFTALQEDFPGQGTLDLTPEVRTTPSGY
>KECLDBNJ_00825 Glutamine synthetase
METLRFFALKESLNRKPVTILETQKRSELFGKHVFGKDAMRQVLSQDAFEAVEDAINTGA
KIDRVMADSIAAGMKQWALELGATHYTHWFQPLTGATAEKHDAFFEQTSEGRAIEKFEGA
KLVQQEPDASSFPHGGIRNTFEARGYTAWDPTSPAFILDTTLCIPTVFVSYTGEALDNKT
PLLRALNSIDHHATEVAKYFNKSVTKVTATLGWEQEYFLIDSALAASRPDIMQTGRALLG
HAPAKGQQLDDHYFGSIPVRALNFMKELEQQCMLLGIPVKTRHNEVAPNQFELAPIFEEA
NLAVDHNSLIMDLMDRVASRHNLKVLFHEKPFAGINGSGKHNNWSLATDTGVNLLSPGTT
PMKNLQFLTFFINTIKAVQENEALLRASVASASNDHRLGANEAPPAIMSVFIGKQLTAVL
DELEKVTDGKLSPQEKTDLKLNVVGKIPEILLDNTDRNRTSPFAFTGNKFEFRAVGSTTN
CARPMVVLNTIVAKQLKDFKAEVDKLIDKESMKKDDAIFNVLREYIKSSKKIRFEGDGYS
AEWEKEAKKRKLSNNRTTPEALKVQIGKQVSSLFEEMEVMNTVELKARYDIELEEYIKRI
QIESRVLGAIAGNHIIPTAIRYQNLLIKNVNGLKNIYEADYQELAQEQLELIQKISKYIS
TINKEISFMIEARKEANALDTKERAEVYQTKVLPFFDSIRYASDKLELMVEDKLWPLAKN
RELLNLN
>KECLDBNJ_00826 Glutamine synthetase 2
MGKSKLEYLWLDGYTPTANLRSKTKVEEDFSGKLEDCPVWSFDGSSTKQAEGGSSDCLLK
PVAIYPDPARRDGYLVMTEVLNADGTPHESNARATIDDEDDDFWFGFEQEYFIMDKNTQL
PLGFPVGGYPGPQGMYYCSVGGKNTHGRAFVEEHADLCIDAGLNFEGINQEVASGQWEFQ
LFAKGAKKAGDEIWVARYLLQRLTEEYGYYIEYHPKPIKGDWNGSGMHANFSNTTLRTAG
SKEVYDTICEAFRPVTSEHIAVYGEFNDQRLTGQHETASIHDFSYGISDRGASIRIPIIT
VEKGYKGWLEDRRPASNADPYKVAGRIVKTVKTAEKKI
>KECLDBNJ_00827 Inner membrane protein YrbG
MSIVYVLIGLMLLVVGGEFLVRASVGLSFKLNLSKMVIGLTVVSFATSAPELLVSLQAAL
DGSPDIALGNVIGSNIANIALVLGLTAIISTLGIDSDFFKFNWPVMVLFSLGLYLALVND
AMISALEGFVLFFALIAYLVLLIRRAKNARPTEEGQNDEIDAGLSKTSYFKIVVWLLIGG
SALYFGSEWLVMGAKDLAKSVGVSDYAISVTVIAIGTSVPELAASIIAAMKKEKAISLGN
LIGSNIFNIASVLGLTSMITPIRVLDDSILNNMFWLLGFAVVLLPLGYLPLKLELNRWKG
FILFAAYCVFIGLAFS
>KECLDBNJ_00828 Dihydropteroate synthase
MTSINCKGKLIDFEIPKVMGILNVTPDSFYDGGSYKNEKDILAQAEKMLNDGATFIDVGA
YSSRPGAQDISVDEECARLIPVVNLILKNFPDVLLSIDTFRSKVAQEAVNSGAALINDIG
AGFLDEAMLTTIAKLQVPYIMMHMRGTPQTMKDLTEYEDVVHDVVFYLSERVAAARALGV
NDLIVDPGLGFAKTVAQNFELLNATEKLQVLELPILIGLSRKSMITKTLGVDSNSALNGT
TALNMIALKKGASILRVHDVKEAVQTVRLHQALKGSN
>KECLDBNJ_00829 hypothetical protein
MEQTSAQYDAVIKTCRDLFSKKMSDYGSAWRILRLPSLTDQIFIKAQRIRGLQENAVHKV
DEDESSEFIGIINYSIMALVQLEKGVVDQPDLNLEESLEAYDKQIKITKDLMMNKNHDYG
EAWRDMRISSFTDLILQKLLRVKQIEDNKGKTLVSEGIDANYQDMINYAVFALILIEESH
SNN
>KECLDBNJ_00830 hypothetical protein
MKKLIGFIRVFVGVLFIISGFVKLNDPVGFSFKLQEYFAPDVLNMEFMSPFALGLAIILV
IVELVLGVALIIGYYKRLTMWLLLLMIIFFTFLTFYSAYFNKVTDCGCFGDALPLTPWQS
FTKDVILLIMIVFLFIHIKHIKPFFSNFSRSIIIFATFIACLSFGYYVLMHLPAIDFRAY
KEGVNISEGMTIPEGAPEAVFDYHWKFNINGEEKIITTQGEYPSSDGEFVAVETEVVEKG
YVPPIHDFTIEKDGDNFTEKFLNTPNLIVIIAYDLSKTEWNGWPVIKELTNQALKKGYSV
IGLTASGDASVNDLKEKQNINFDFYFTDATTLKTIVRSNPGIVKLHNGTIIQKRHWNDAD
EIELETLPSAKTSLDLKLKHRLDSIARYDQLYRPILQETDEQKRKALAEKSGLNLEDYSG
DLWKKQRMIDTSNLKIVKHILDTQGYPGKSVVGEPTNLIALDVIEHNPIQIEQYLELFKI
AAEAGEIPKSRVAVLEDKYLMQNNKEQLYGSQAQITAANGFFIWPIKDVAMVNERRKAAG
FERSIEEYVADLMGEDAKFRALKLSEIKRL
>KECLDBNJ_00831 Dipeptide transport system permease protein DppB
MMLDQNEDPEQLAIIKHKYGFDQPVLTQYGYYLNDLSPISIHQNTGNGYTSLASEKYAYT
KLVDFGARSLVLKKPYLRESFQKTGKTVVEVISETLPNTIVLAVSAIFIAISLGILLGIV
SANMRDTWLDKTIQVISTFGMSVPSFFSAILFAWLFGFVLNKYTNLNMTGSLYEMDDFGE
GIHIQLKNIILPAIVLGIRPLAVVIQLMRNSLLEVYNQEYIRTAKAKGLNQRQIVWRHAL
KNALNPVVTAVSGWFASMLAGAVFVEYIFGWNGLGKEVVDALNTLDLPIIMGAVLVIATT
FILINILVDIIYGILDPKVRIR
>KECLDBNJ_00832 Soluble secreted antigen MPT53
MKNTLTILAILLISFAFSQKKSFSEEAIQDKLLDLDGSEIAFKDIIEQHKGQSVLIDIWA
SWCKDCIAGFPDLKKLQQDNPDLDYIFLSLDKEIDRWKAGIKKYDLKGDHYYIKSGWKGP
LCSSIDLDWIPRYILLDASGTIKVYRAITTKDNQLLNQIQ
>KECLDBNJ_00833 Bifunctional PGK/TIM
MRKNIVAGNWKMNTDLADTQELIAGLKKISKTSDAEVIIAPPFTNLYSAFETLKDSDIEV
AAQNMHQSSSGAFTGEISAAMLKGVGVKTVILGHSERRAYFGEKEDLLAEKVNAALENEM
KVIYCFGEELKDRNFGEHFEVVNKQISQALFHLDADAWKHIVLAYEPVWAIGTGETASPE
QAQEMHAFIRKTIADEYSKEIADNVTILYGGSVKPANAKEIFSKPDVDGGLIGGASLKAE
DFMTIVNAF
>KECLDBNJ_00834 Ribosomal protein L11 methyltransferase
MAEVYAEYEFKVNPVNPGAEILIAELSQLDFESFDETDEGVKAYILASLDKENLLDEVFI
LNNPEFEITYSINTIEPVNWNEEWEKNFEPIEVDGICSVRAPFHPKPDMEYDIVIEPKMS
FGTGHHETTHLMIKHLIKIDVKGKSTLDMGCGTGILAIFAALKGAKPVDAIDIDPWCFEN
TVENKSRNDVDFIKAYEGDATMLGDTHYDLIIANINRNILLQDIPTYAKCLNHEGILLLS
GFYTQDIPAITNVCNQHGLNFIMNFEKNNWVACKFVKN
>KECLDBNJ_00835 ATP-dependent Clp protease adapter protein ClpS
MSTREKVQEEVDILEAVDRNNEIVVYNDDVNTFDHVIDTLIQVCDHTPIQAEQCSLIVHY
KGKCTVKTGSYDDLEPRCSALLDAGLSAEII
>KECLDBNJ_00836 hypothetical protein
MLSETFKKVGLLSLGISLALTSCSEDVEETSTATAEPTANLEVSQAIIQQVEDLGMNTNY
VRWDDFYFPDGSSEPRLFLEEDVIITPEELSAMAANVEESKSGKGDSKQYRTSSLVSQGR
TISIIGYTGGSQALSQKERTALQWAVDNYNRLSGVSISFNLTFGTNYQDKDMVVYNNTVN
NPNGAGGSAGFPSNGLPYKFVQIYGLTNYDTNVVEHVITHEIGHSVGFRHTDWFSRQSCG
QNVNEGGDTNHVAGTPTGYDPTSVMLACFSASEDGEFNANDITALNNMY
>KECLDBNJ_00838 Polygalacturonase
MRIYYFLFVLFLSFNACCFAQDSHFTQIQQIEESIETPNIPERTINVLDYGVKADDAKND
KPGFDKAIAALVKAGGGILKVPKGSYLLKGPIHLKSKINLHLEAGAVLNFSDTPSDYPLV
ATSWEGTFIYNYSPLIYAYQAEDLAITGSGKINGNGDGIWATYKIREEADKLASRKMNQQ
QTAVTSRRFGNGHFLRPQLVQFFDSKRILIEGVRFENSPFWCVHLLRSNNITIDGISYDS
QNKNNDGIDLEYASNVVIKNVVFNNSDDNVAIKAGRDTEGRANAATPSERIVVRDCKFKG
LHAIVIGSEMSAGVRDVYVYNNEAWGYLKRGVYFKTNSDRGGYIRNINISNNTFKRVEDA
IFMTANYHGEGSGKHISKISKILLKNLYFDQAENFGIVLEGYPKQPISDIRLENIQITKA
KNALTIRDTEGVQFKNIQIGEAAGTPSSVK
>KECLDBNJ_00839 hypothetical protein
MLELQITNTTDYKLLIDRIEQILIPSKITITAEATTPILLDSDKSVEGTSAIHKYLDELE
SFSKQWYACRCDMFP
>KECLDBNJ_00840 Beta-galactosidase BoGH2A
MLKNTLVHVVLLFTFTLSAQQTRRVVTLEEDWKFHKGEATNAETSDFDDAQWQTVSVPHD
WAIYGPFDKEIDKQTVAITQNGETIPTEKTGRTGALPFTGTGWYRKNFNIDAADLNKKVL
LLFEGAMSEPEVYLNGKKIGEWAYGYAYFYFNISDALLEGQNTLAVKLSNAEFSSRWYPG
AGLYRPVSLIIKDPASIDQWGTTITTPVVTQEVAKVNIKTNFSSKNLSLKTTIYDAQNLV
VAQQQTPVSYDQQFDQNLKVVKPSLWSPENPYLYKVVTQLYSGDDLKDEVATKFGIRSIN
YSAENGFQLNGETRKFKGVCLHHDLGPLGTAVNKAALRRQMQILKDLGCSAIRSAHNMPS
FEQLELADEMGFLFLAESFDEWKKPKVKNGYNRFFDDYAEKDVVNLVRATRNHPSIVMWS
TGNEVPDQYGSAGVKRALWLQNIFHREDPTRPVTVGMDQVKATMESGFGAILDIPGLNYR
VHLYEEAYEKFPQGFILGSETASTVSSRGIYKFPVEKASMKEYPDFQSSSYDLEYCSWSN
LPETDFMMQDDKPWVIGEFVWTGFDYLGEPTPYDTSWPSRSSYFGMIDLAGIPKDRYYLY
RSRWNTEDETLHMLPHWNWEGREGKKTPVFVYTSYDRAELFVNGKSQGIRIKNDSTPQTR
YRLMWNDVIYEPGTLKVVALDKNGKQAAEKTITTAGKPHQIILEADRKTITANGKDLSFV
TVSVVDKNGNPCPTATNALKFKVTGKGNFKAVCNGDPTSLASFYEPQMKLFSGKLVVLVE
STKNPGNLNLEVSGKQLKKATISITTL
>KECLDBNJ_00841 hypothetical protein
MMHATARFDLAIQKLYKAFHNNTLNPECCKSCAVGNILDNTDSWKHLTEGHGSNKLTYVG
KVHQSLGRRFAGYSPLELLQIEAAFLEGCGYSLPLSRRSEITVDRTSKEVMFNGMCQAVA
LLCKLDQIQNVMDYSKLFEFENNQPVNEFLALP
>KECLDBNJ_00842 Hydroxyethylthiazole kinase
MKELLFKNITSVREQAPLVQNITNYVVMNNTANALLAVGASPIMAHAHPEMQSMQAICQA
LVINIGTLDEYWVESMILAVAAANQNNKPWILDPVGAGATAYRDEVLSELLALKPTAIRG
NASEILALAKHNTTATKGVDSTSSSLEAIEAAQFLNKEYGALVVISGAVDIVVSEESVDQ
LKNGDALMTKITGMGCSATAILAAFIAVIPNKKEAALAATSLMAVAGELAAKSSQGPGSL
QMHLLDKLHSITKEEYINTVKILD
>KECLDBNJ_00843 Thiamine-phosphate synthase
MASAFPYRLYLVISEEACQGRNFLEVAEAAVQGGVDLIQLREKNDTTEAFLKKALQLKEV
LQPYNVPLIINDNLEVAQKSAAAGIHVGNSDIAPTKIRTAWESCRILGYSIEYLEQLYNE
QTYTSDYLGISPVFDTATKTDTITTWGLDGIEKIRASTQKSLVAIGHMKASNVKKVIEAG
ADCIAVVSAICAAKNPKSAAKELRLEIEKGLKSRTVKPN
>KECLDBNJ_00844 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MKYYKYPTVLSIAGFDGSGGAGIQADLKSISALGCYATTVLTALPVQNTTGVQSIFSIPT
SVVKEQLDSIFEDIPPCAVKIGMVHTPELVEVIAAKLNEYPDIPVVFDPVMVATSGHKLI
EDATIKSIVTSLFPRADVITPNMDEAAILADMPVESLDDMRLAGTKILKLGCKSVLLKGG
HLKTDLLTSFFFDQDQSVHEFEFEKFETQNMHGSGCTLSSAIASYLAQKHSLSQAVTKGQ
DYVHQAIHHAKDVKIGQGNGPLNHFFNPQKLIKYELE
>KECLDBNJ_00845 Aminopyrimidine aminohydrolase
MSWSKASWQRIEGIYSEILKMPFITQLTDGTLPLEQFQFYVLQDSSYLENFGRALALIAA
RAHDVEDILTFTRFAEGAIVVENALHESFFKEFHIDKSGPVGPTSHHYAHFLKSTAALEQ
VEVAMAAVLPCFWIYKKVGDEIYEKQKEHNNPYQKWIDTYAGEEFSVLVEQAIAACDRVA
ASCTAQQQERMHHAFYTASQLEFMFWDSASALHSWPF
>KECLDBNJ_00846 Deoxyribonuclease
MPNISDTPPEAIQQNINALTTDLAAKIPSKKLDQNLLIATWNIRHFGNLTREWYSGDGDS
PKRDLHSLLCIAEILKRFDIIAIQEVKSNLRALRDTLKYLGNHWSLILTDVTAGAPGNGE
RIAYIFDTRRVQLSGLACELVVPEEQLNAIDGDALRKQFARTPYAVSFKSNQHTFILVTA
HILYGKNTAARIPELKAIAGWLADWTSNLNAYHQDMIVLGDFNINVRGDLLDQSFLSEGL
YVPPQLQDPSVTRSIFNETKYYDQLAWFRDVSTKKELTMQFINGGNYDFLPFALSNRNLS
KRSLSYMISDHYPLWAEFKI
>KECLDBNJ_00847 hypothetical protein
MKTIFTKFSIIAIAVSTLIACNNDDDATPVVVEEPTCSDGIMNGDETGIDCGGSCMPCEM
ASNPGRRADLYVTNNTDGNITKYSVSGDSIVTYTTTSTAAEGIYYDAESDLLVQASRSGL
MLDAYAGTSTLGTASINASFSTFTDLNSPRELAVSGDYYVVADNGENKFFVYYKVGNSFA
LYYTVEVPFPVWGIAFKGNDLYAVVDTTSDLAVYSDFIVNAMDGMMYPSKRVTIEGIVRT
HGLTYDGTNDVMIMTDIGAASNATDDGGFHVISEFSTKFDALSDGEVLPVGMQTRIAGSS
TMMGNPIDVAYDSETGAIYIAEVGNGKILGFTDWGDGGDISPSLEIDLATASSIYFSSDE
TDGNVGMSSMNQTTRLYTTSTADGTITVYDGSGAMVSMISSASASSEGIYYNAFDDALLL
GSRSEGELQYYSDFSTLMSGGSATAAFAADLPTSSSREIAVYGNKVVVADNPANMFYVYS
YNGSSFTLENTFDPGFPVWGITFKGGDLLAVVDTTSDLAIFEDFFSNTMDGALTPTKRVS
IGGIVRTHGITYSAADDVLVMTDIGLAAGGALDGGINVIQDFSAVIEATADGGSISIADQ
NIIEGLSTLMNNPIDVAYDHKTKTVFVSDIATGAVLGFSNALSASGNIAPSVNNTLTSAS
SLYLYNN
>KECLDBNJ_00848 hypothetical protein
METILVAQFFAAFYGFLAIVLGAFGAHALKKKFTSDQMASFETGVKYQMYHAIVLLVLSF
NLGFNTLHEELIINCFVFGTLLFSFSIYGLCITGASGKKWRFLGPITPLGGLLLAVGWLL
LLYHFIENFL
>KECLDBNJ_00849 Adenine phosphoribosyltransferase
MNLKKYINDIPDFPKEGVVFKDICPLLASPKATDYAVDLLAKGLHDINVTKIVGIESRGF
LFGLALAQKMGVSFVPIRKPGKLPGAILQQKYALEYGEDCIEIQEEAIQPGDYVVVHDDV
LATGGTAAAACKLVEQCGATVVQCNFLMELGFLDGRSKLKQYHLHSLMHY
>KECLDBNJ_00850 hypothetical protein
MKKRFFKTLAKINKKVLPSLTKKEVDLAKASKLQLALFGYKLWVTKNALD
>KECLDBNJ_00851 hypothetical protein
MEPLFYLFKATAILSLFYLLYTLLLKHETFFKTNRHYLVLGILASFITPLLILKRTIYKP
MPAMDFDLLANANYTTTVGEEVAPAFTFWEVAFAIYLLGVLIMLGSFILKLSKVVFFLRN
AKKTSAAGHQFIQIDGLDAPFSFFNTIVIDARTHEQEELEMILLHEQAHAKQYHSLDVLL
IQLTLILQWFNPLAWLYKSAIVENLEYLADAATASQVTNHKQYQLALVKVAAPKWAPALT
NSFYQSFIKKRIVMLNKQSSSEFKKWKILLIVPVLGAFMWSFNVKEEVKYLTEETAISAS
STPVMYISPSSNDADLAAIESYFNTEIDDVDLQITNVKRNTQAQLTGFAIATRFKGQADF
KRTLELTKQDDLNNIFKYAISYDKQEIIIVDVNDGQHKTVIAKDGVKGYTLSPQVKNSLT
TTGKQNTMNLPEIIEDAPQPAPQKTQKASGKPFKKIITPTTTEREIEAIAKALDAEYNVA
MQFSRLKYNDAGEISRIKIEIQDRETGNKASASYNRDGNAIEPIAVYRSAERTFGVVSGQ
NSIVQRSAMTAEALAERKEEMQARIEEMEARREEMQARFSDSTERRTEMKARMEERRVAM
QERMEARKAEMKEREEAMRSKMRARMNFKEDSVFMDKERVINASEFKNATNRKSQIIYYR
VRQPQNVSNVIYVIDGKVMDGEDFDFKSIDVKIIDSINILKGEAPFKKYKNYVNEETEGV
IEIFTKQKEK
>KECLDBNJ_00852 Penicillinase repressor
MEKLTNKEEEIMHVLWKLEKAFVKEVQAGLEDENLHYNTVSTIVRNLEEKGYVDHKAFGK
THQYFPIISREAYGKRFWNEATRRFFDSSYKNMVSFFAKEEKITAEELREILEIIENKQ
>KECLDBNJ_00853 Cyclic di-AMP synthase CdaA
MDILENFRILDLVDILLVATLLYYLYKLVKGTVAINIFLGICIIWVMWKITQLLQMEMLS
TILGQFIGAGMFALIVVFQQEIRKFLLMIGSTNIGRKTGILKHFKFLHDEAQDSSKTKVE
EIIDACDKMGKVRTGALIVIQRTTHLDFVKQTGDQMNIEVNRPILESIFFKNSTLHDGAV
IIEDNTIVATRAILPVSNERNIPLRFGLRHRAAVGITEKTDAVALVVSEETGNISYLKDG
EFVLFKNLTELIEILRKDLS
>KECLDBNJ_00854 hypothetical protein
METKPSDGKLVVVSYCRNCFKNLAPNAAFCESCGAKIIKNRITTKNLLEDFNDRFLSIDG
ALPKTFIALFTKPEDVIGGYIDGVRKRYISAFGYFALSLTIAGIYVFVIKEYFLDTLFDQ
LALSSGSDQAQVDLTKKITVGMNEYQGLLSIISIPLLALISRIVFWNYKQFNYLEHVVIY
LYAFSHINIIFYALIILNIWSAPLYSFFSLVGMFGYIIYTGYVLKRLYNLNAASLILKTS
LFLLIGSVLLLILGIVIGIVMVKLGMIDEMLENMQNAQSAKI
>KECLDBNJ_00855 putative ABC transporter ATP-binding protein
MASSKGNAFDFGLFKKLLSYTKPYQARMYFVAISAILISIFAVLRPIYIEYAMDEGMQPK
DMDSLMYYIGLSLLVLFGESIFQLLFIYFANWLGQQVVLDIRTKLFKHMIYFKMQYYDKS
AVGRLVTRAVNDIETIASIFSQGLFMIISDLLKMLVIAGVMLYKSWQLSLIVFAILPFIL
YATRVFQQKMKVAFEEVRTQVANLNSFVQERVTGMKIVQIFSREAVERKKFDEINKKHMT
AWNKTVWYNSIFFPIAEMVTSITIGLLVWYGGLRAAQSDVITIGLVTAFIQFSQMLFTPL
RQIADKFNTLQMGMVAANRVFGILDTDARIEDNGTHLLCGIKGDLSFENVRFSYIDGEEV
LRGINLEVKAGETVAIVGSTGAGKSTIINLLGRFYEIDSGTIKIDGVDISDVQVASLRSE
IAVVLQDVFLFADSILNNITLNNPDITEEDVITAAKAIGVDQFISSLPNGYHYNVKERGA
MLSSGQRQLIAFLRAYVSNPSILVLDEATSSVDSNSEYLIQKAINKITKGRTSIVIAHRL
ATIKKADKIIVMEKGQIVEMGSHKELLQVENGHYRKLHEVQFAANQEPA
>KECLDBNJ_00856 tRNA pseudouridine synthase A
MRYFIDIAYDGTSYHGWQRQPQSITVQEVLEEALTTLLRSEVAVVGAGRTDAGVHATQLF
AHFDWEEKISTEALQHLQFRLNRYLPEALAINAVIPVQPVAHARFDAVRRSYEYKIHTTK
NPFLVNQSYFFEKSLDVDAMNAATQLLLGKQDFKCFSRSKTDVKTYICEITEAGWTQDNT
NLKFTISADRFLRNMVRAIVGTLLEIGQGKIKPEALKIIIASRSRAQAGASAPAHGLYLT
EVAYPKEIFKIYGE
>KECLDBNJ_00857 hypothetical protein
MKKILLLSDTHSYIDNQILKHAKAADEVWHAGDIGDLAVTDALKKVAPLRAVFGNIDDHE
IRKEFPLNNRFICEGVDVLITHIGGYPGRYSPAIREELRANPPKLFICGHSHILKVMPDK
KLKLLHMNPGAIGKHGFHKARTMLRFTVDQGKIDNLEVIEMKR
>KECLDBNJ_00858 hypothetical protein
MIQRIQSIYLFLAALVAAGLHFAIPVYSTAEGAPVYAVDHLELVALFFGSALLSLIALFL
FKNRKLQFVLGRLNIILNFILLGVLVYQSQILSGGAAAPEKGIGMLIPIISIVFIALANK
AIKRDEDLVKSVDRLR
>KECLDBNJ_00859 Transcription termination factor Rho
MFTISELKAKKLPELQEIAKGLDIPKYRSLKKLDLVYKVLDHQAADPKAVAEVIEETSSE
TPTKAKAPQKKTQKSAPKKNTRSADDSKKETTKDSSQNDAKASGKTDDKSEKPQRKPRQA
KATSDNDNSKQSDNNRSKNNRSRKDNNSNANNNSNNNRSAKDNNNSSSNNNNNSNSNSNN
NRNNNNNRNNNNSSNSNNGNKDTRNRYREPDYEFDGLIESEGVLDIMQDGYGFLRSSDYN
YLSSPDDIYVSQSQIRLFGLKTGDTVLGVIRPPKEGEKYFPLIKVSKINGLDPSVVRDRV
SFEHLTPLFPKEKFNIAERQSTISTRIMDLFAPIGKGQRGMIVSQPKTGKTMLLKDVANA
IAANHPEVYQMILLIDERPEEVTDMQRNVKGEVVASTFDKEAHEHVRVANIVLEKAKRLV
ECGHDVVILLDSITRLARAYNTVQPASGKILSGGVDANALHKPKRFFGAARNIENGGSLS
IIATALTETGSKMDEVIFEEFKGTGNMELQLDRKIANRRIFPAIDLTSSSTRRDDLLLNE
NAIQRMWVMRKYLADMNPIEAMEFISDRIKQTKNNEEFLISMNG
>KECLDBNJ_00860 hypothetical protein
MKILACLILCVLTIFTSCKRTNNTEPSNEPIVTKDSTSNSGIVIVGISDDSLAFKNIHIA
DYSQFSGSYYELIQDRSTSKDTTLLKLKPLDTTQILEFWSFGAKTNYNTRFIASPGDSII
IKIKDEAIKFLGDNSPENNFFIELDPDNNDYANTTYTNDLDLYKTQVKSMYLKRKAFFDQ
YVEEHNVSEGFKNLVSAELKQEYLYNLIAPRSKNIDGINGNANTNLILADLIAQDYDIEK
NGIFDMASYLDNIKIEEFQNTNLTANDYFKRNLTQFIRQYFVKSDYLDYTKEKYIAEKEF
IQSNLPKEIQNIALTQILSDYHQKGFGNGRIDKDFLKAEITSLKTKELKKSYRTALEEIE
SDLKQINSQIPTYILEQKLLNTAGDTISLGELVQSKQHLKIIDFWASWCTPCIKEIKETK
SFKTRLKENAELEWIYLSIDESKNNWLDQVNRIKEYTSLGNHFMMTPKSNTALSSFFKIN
YIPRYTLVGTSTNILLSNTPRPSDEFVFEQIITSNEAN
>KECLDBNJ_00861 30S ribosomal protein S20
MANHKSSLKRIRNSETKRLRNRYQSRTTRNAMKKLREADKKEAETLFPSVVSMIDKLAKK
NIIHDNKASNLKSQLAKHVNAL
>KECLDBNJ_00864 Proline--tRNA ligase
MGKNLTTRAEDYSKWYNELVVKADLAENSGVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HENAYFPLFIPKSYFSKEASHVDGFAKECAVVTHYRLKNDEDGSIIVDPEAKLEEELIVR
PTSETIIWDTYRKWIQSYRDLPIKVNQWANVVRWEMRTRLFLRTAEFLWQEGHTAHATQD
EAIAEAKQMMRVYADFAEHFMAMPVVRGTKTESERFAGALETYCIEALMQDGKALQAGTS
HFLGQNFAKAFDVKFATKEGGQEHVWATSWGVSTRLMGALVMTHSDDHGLVLPPKLAPIQ
VVIVPIYKGEEQLDSISQVAKELKRELQLLGISVKFDDRDTHKPGWKFNEYEQKGVPLRI
AIGPRDLEKRTVELARRDTLTKETVSKDDIVSRVQDLLVEMQRALFDKAKNFRDTHITEV
DTYDEFKDILENKTGFVSAFWDGTKETEERIKTETKATIRCIPLNAKEEEGVCVYSGKPA
QMRVLFAKAY
>KECLDBNJ_00865 hypothetical protein
MFNNKITDDMRGLINTPNTFLKPFLGLLALAGLVSCGPSQYTMNDSIYGGRSTVYEEPTQ
EVASTTVNGGVYANYFSQGAADLDAAQQSGDIFTDIDSYSSNAEYTTEQAILDEDLAYQA
QPGWGDVVDDITVNIYPDFYNRIGFGGYYRPFWNYGWGNFGFGFGPGWATPYGGWGGWGN
PYFGYAYNGWGYGAWGYPYNGWGFGYGYPYYGYYGYNTYYGNVFYRNNYYSRYNNNRLAY
SNSRRSSNVYGTNRSANSRISSARSASRRSSEVNYARTSRTYSRNNVGVNTDRISRSSSN
NSARVSSRNRSASSNSIYRSNSRRSSSNTITRSNSSSPVRATRSSTYSRNSVSTPTRSTS
RTMTRSSVPTRSASPARSSGGSRSSGGSSSRGGGRGGRG
>KECLDBNJ_00866 hypothetical protein
MKKILTLLFLAIGAQYSFAQNVADAIRYSTQNITGTARYIGVGGAFGALGGDLSAINVNP
AGSAIFDRSFVSLSLSSGNYDNQTYYNDGITVNDESDLDLNQFGGVFVSQGAAGLRKLTF
GFNYDRTNDFDNGYVASGISSNSISDYFLGYAQGTPLDLLEFQEGETTDDLYQYLGESEN
FGTQQAFLGYQGYLIDPVSSELDNTEYTNAQNGNSFDQEYQYTSFGNSSKFTFNAAAQVS
EALFLGINLNAHTFNFTRQTTLFEDNNSANNAVNSLRFDNEYRAYGSGISAQIGGIYHLS
PSLRVGATYDTPTLYTISEETEQFLSTSGTNGEIVIAPNVINIYEDYDLVTPGKATGSIA
YIFGKRGFLSFDYSYQDYSSIKFKPDNDAFFQQLNTQIDNQLKGVFSYKLGGEFLVNSWS
FRGGYRFIESPYENETTLGDTTGYSVGLGYSFGNTRIDLAYDWMKQDQNPRLYDGAFTNT
AFIDTINTNIVATLSFQL
>KECLDBNJ_00867 GTP cyclohydrolase 1
MKMNFENEELKEIDELGDNHHSTSAITPLRDDAFELSDLEKIELIKEDVTRIMQTLGLDL
KDDSLKGTPNRVAKMFVNEIFGGLNPQRKPKASTFQNNYKYGEMLVEKNITVYSTCEHHL
LPIVGRAHVAYISNGTVVGLSKMNRVVDYYAKRPQVQERLTMQVVQELQKVLGTEDVACV
IDAKHLCVNSRGIRDIESSTVTSEFGGKFKEEAVKREFLDYIKLETPF
>KECLDBNJ_00868 Cysteine--tRNA ligase
MAPLYQKQEIKVYNSINGSKETFTPILEGNVGMYVCGPTVYSNVHLGNVRTFMSFDMIFR
YLKHLGYKVRYVRNITDAGHLTDDADEGEDKIAKKARLEQIEPMEVVQQYTIDFHNILQK
FNCLPPSIEPTATGHIIEQIEIIKEIIENGFAYEKNGSVYFDVLKFNESHHYGKLSGRNL
EDMIANTRELTAQSEKKNAQDFALWKKAEPQHIMRWPSPWGDGFPGWHLECTAMSTKYLG
KQFDIHGGGMDLKFPHHECEIAQSEASHGHNPVNYWLHANMLTLNGKKMSKSDGNNIFPA
QIFTGDSPFLTKGFSPSVARFFVMQAHYRSVLDFSNDALLASEKGFNRLMEAVNLLDSLP
TSAKSSIDIAAWKQSCYDAMNDDFNSPILIAQLFEAAKYIHQLKDGKATISSSDLDAFKT
SVHAFVFDVLGLEDINAAAEANTDKLNGAIELLIQLRKEARANKDFATSDQIRDQLAELG
IQLKDGREGTTYTFA
>KECLDBNJ_00869 Putative membrane protein insertion efficiency factor
MKDFAKKALIFPIRLYQRFLSPLLPPSCRYEPTCSHYSVEAIQRHGIFKGSWLAIKRIAS
CNPWGGSGYDPVPPAKKQSAYKKSKNS
>KECLDBNJ_00870 Prolipoprotein diacylglyceryl transferase
MLPLKMTWNPSTGLDLGFFTIHYYSLMFVIAFSLGWYLMKKVYKNEGVEEEKLDPLFIYS
VLAILIGARLGHVFFYQTELLWEDPLSVILPFRFVPEIEYTGFQGLASHGAAIGMIFAMY
LYNKKILKKSVLWLLDRVILPVALGAIFVRIGNFFNSEMVGKITDSNLGIKFVQDQYNKY
EVQRLTGIPNEYKAYQALTDDPQFANYIAEIPYRFPGQLMESFGYVFVFLILMFVYWKTN
LRKKEGFLFGLFLVLLWTVRFIVEYFKRAQVEGREDWIFGFNTGQILSIPFILIGIFLIL
RALQQKQTPQYH
>KECLDBNJ_00871 hypothetical protein
MYQKFLFIGILGFTLLACKNKEAEETQITQEQITFQQEGKLQIQTEDGSKAYFNIEIAET
NYETETGLMYRESMEQNQAMLFVFEDVRPHSFYMKNTYIPLDLFFIKEDKTIATIIENAK
PMDETSLPSEVPVQYVLETNAGIAKLWNIKVGDTVDWKRLK
>KECLDBNJ_00872 hypothetical protein
MPSRILFLFFVLFSITSNAQRVKYHFDIEGKEIKRKEFDKLWRNRDSAYSRWDYETKDSS
RVARLIPQYQQGVVNRNDLKEYLEKVTNKKFADSTIFFISYTYVNDLCSRYSTNNYTKEV
IDQWKNLTDARKASIEENYPDIVRLDFFEPGIKLQNTPSDGTEYYYSDKENLLREIIFRN
PAFCGSRALIKPNGQTVVYNGESISTQVVQLIENKNWNLFFPEE
>KECLDBNJ_00873 Glutaminase 2
MNYQAILESIQSDLKDYKNTGKVATYIPELGKVDSSKFGLHLNCINGNHYHLGASQERFS
IQSISKVLSLAFALKLERNKLWNRVDVEPSGDPFNSLVQLEYEKGIPRNPFINAGALVVS
DMLMSHLKNPKEDFLQYVRDIAGDQSIDYDTSVAASEMQHKYRNAALAHLMKDFKNINND
VDALLDFYFHQCAIAMSCQQLAQAFSIFLNYSKQDQSQQALAVPPMIAKRINALMLTCGF
YDESGEFAFRVGLPGKSGVGGGIVALHPKHYSIAVWSPPLNEKGNSELGMKVLELFTSKT
EISVF
>KECLDBNJ_00874 hypothetical protein
MQNKGLIRVFAILFGLVCLYQLSFTYFTNQTEEKASAYAAEQVDTTVEDYVDKRGEVERR
YLDSIGNDPIALGITYNDAKEKELNKGLDLKGGMNAILEISVADILRGLSNNSTDPAFNQ
ALDQAAETQKNSQNSFLEDFFDAFEAIPGDNKLASPDIFANTTLGEKVNFNMSNDEVEPI
LAQEVEESINSAFEVLRNRIDKFGVTQPNIQRLDNQSRILIELPGATDIERVKFQLESTA
QLEFYKTHYASNVAPYLLQVNAELKELVAPAEEEEAVAEVDSTESTDDSIEDLLASEEDS
ISPAQANNPLFEVFSFNPAIQQYAQAPIIGYAQVKDTATINRYFSMPEIVRLRPQELRFA
KFRWGITEAETDVVPLYALQSDRSGAPAMDGDVVQDSRQQYTQAGQPSVGIDFEGQGPGQ
WAKLTGEVATEGNAIAIVLDGTVYSAATAKAEISGGATEISGSFTVTEAQDLANVLKAGK
LPASAKIISYDVVGPSLGQEAINSGLMSFVIALVLVLVWMVFYYGKAGLFADVALAVNIL
FIFGILAGLGAVLTLPGIAGIVLTIGMSVDANVLIFERIKEEIARGKSQKDAIKDGFSNA
LSSILDANITTFLTALILFLFGTGPIQGFATTLMIGIGTSLFTAIFVTRLFIDGYGKNGK
SLDFCTGATRNLFINFNKDFLAKRKVAYIISGVLIIVSLVSLFTNGLDQGVDFVGGRNYT
IRFENPVNATEVEQKLIAELESAQAKTYGEANQLKVTTKYRIEEEASEVDEDIQQRLYTA
LEEYLPADLTLAQFVKGGSSDDKVGILEYNKVGPTIADDIKKDSFWAVLGSLVVVFLYIL
LRFRRWQFSLGAVAAVFHDVLIVLGIFSLTYQFMPFNMEIDQSFIAAILTVIGYSLNDTV
VVFDRIREYMKEYGTSRKMGIIINQAINSTISRTLNTSMTTLIVLLAIFIFGGASIMGFM
FALIVGVLVGTYSSIFIATPVMFDTIQKKALKPEKQKEEEEPVA
>KECLDBNJ_00875 Malate dehydrogenase
MKVTVVGAGAVGASCAEYIAMKNFASDVILLDIKEGFAEGKAMDLMQTASLNAFDTRITG
TTGDYSKTAGSDIAVITSGIPRKPGMTREELIGINAGIVKDVSSNLIKHSPDVTIIVVSN
PMDTMTYLVHKTTGLPKNKIIGMGGALDSARFKYRLAEALECPISDVDGMVIGGHSDTGM
IPLTRLATRNSVLASEFLAEDRLNQVMEDTKVGGATLTKLLGTSAWYAPGAAVSGLVQAI
ACDQKKMFPCSALLEGEYDLDDICIGVPVILGKDGIEKIVPVDLSDAEKAKLQESAAAVK
KTNGLLEL
>KECLDBNJ_00876 hypothetical protein
MKKRILICFSILASINLFAQDDDGFEAVITAGAADANTLMGAYIAPAMEGLVYSMSGGWY
HTAKTHKKLGFDITIGVNAAMVPSEKEMFAFADLNFENTITASPGVTPTVAGNGTPAEVT
VVAQDGDTGTFTMPEGVKDDLPLNAMPAPTLQASVGLVYDTDLMIRATPKVGSDDVKGSL
FGVGLKHNLMQYLGPLDKLPLNVSLLGAFTTMNVDYDIEDGSSIDGTGQAAEFKLNSYTV
QGIASLDFPFISIYGGLGYTGGKSELNVLGTYTVEYNAGTETTTLVDPIALSYSPSSVRA
SLGARLNLAFFKIYADYTVQEYSNLSAGIAFSFR
>KECLDBNJ_00877 DNA gyrase subunit B
MSEEANKKQYSADSIQALEGMEHVRMRPSMYIGDVGVRGLHHLVYEVVDNSIDEAMAGHC
DSIKVIINENNSISVKDNGRGIPVDLHKKEGVSALEVVMTKIGAGGKFDKDSYKVSGGLH
GVGVSCVNALSTHLKATVYREGKIWEQEYEKGKAMYPVKGIGDTDDRGTAVTFLPDPSIF
QTTTEYNYDTLASRMRELAYLNKGITITLTDKRQKDDKGEFVSETFHSEEGLKEFVRFLD
GNRQPIIGEVISMEGEKNDIPVEVAMIYNDSYAENLHSYVNNINTHEGGTHLAGFRRGLT
SSLKKYADASGMLDKLKFEIAGDDFREGLTAIISVKVAEPQFEGQTKTKLGNREVTSAVS
QAVSEMVEIYLEEHPDDAKTIVQKVILAAQARHAAKKAREMVQRKTVMSIGGLPGKLADC
SETDPEACEVFLVEGDSAGGTAKMGRDRNFQAILPLRGKILNVEKAMQHKVFENEEIKNI
FTALGVTIGTEEDSKALNLSKLRYKKIVIMCDADVDGSHIATLILTFFFRYMRELVEGGH
VYIATPPLYLLKKGKKMRYAWSEKERDEYNAQMGGSASVQRYKGLGEMNAEQLWDTTMNP
EFRTLRQVTIDNGTEADRIFSMLMGDEVPPRREFIEKNAVYANIDV
>KECLDBNJ_00878 Asparagine synthetase B [glutamine-hydrolyzing]
MCGIVCAYELKQPAEVLRPQLLEMSKKIRHRGPDWNGVYSDEKAILAHERLSIVDPASGK
QPLLSPDGKLILAANGEIYNHQELRKQLKGQYDFKTQSDCEVILALYQEEGPGFVDKLNG
IFAFSLYDAEKDEYFVARDHMGVIPLYMGWDQHGTFYVASELKALEGTCTKIELFPPGHY
LHSSDGELKRWYSREWMEYDAVKENETSIEKLREALEAAVHRQLMSDVPYGVLLSGGLDS
SITSAVAKKYAEKRIESGDTDGAWWPRLHSFSVGLEGSPDLAAAQKVADHIGTVHHEIKF
TIQEGLDAIKDVIYNLETYDITTIRASTPMYLMARVIKSMGVKMVLSGEGADEVFGGYLY
FHKAPNAQEFHEETVRKLSKLHMYDCLRANKSLAAWGIEGRVPFLDKEFMDVAMSINPQD
KMINGERMEKWVLRKAFESYLPESVAWRQKEQFSDGVGYSWIDTLKELVNEKISDEQLAN
AKFKFPIQTPTNKEEYYYRSIFAEHFPSDAAALSVPQEASVACSTKIALEWDEAFKNMND
PSGRAVANVHSDAYKKTELA
>KECLDBNJ_00879 hypothetical protein
MYNAVKPVNVKRILKECTTSNFVFNSIQEVFQIFKPQ
>KECLDBNJ_00880 hypothetical protein
MKSLIIGSFLLSFLIFGNDVNAQKFSELDKSPLDIAMFRAQDKTPRVRVIYSRPQKKGRD
VFATKDGLEKYGEVWRTGANESTEIKFYKEMMVGDTKVPAGTYTLFTIPTEDEWTVILNK
DLDTWGAYGYKEERDLVRFTTPAHKTAAPIESFSISFQPTENGSDMFLGWDDMYIQVPIE
EVEM
>KECLDBNJ_00881 7-carboxy-7-deazaguanine synthase
MTKEATATRVELGELLPLMEEFYTIQGEGYHTGTPAYFIRVGGCDVGCHWCDVKESWDAA
IHPPTEAAAIVANAKKYSKTIVITGGEPLMWDMNHLTGMLKDEGLQVHIETSGAYELTGH
WDWICLSPKKRMLPKPRIYEEAHELKVIIYNKSDFAFAEEHAAKVNGNCKLFLQPEWSVR
EKMTPLIVDYVMANPKWRVSLQTHKYLNIP
>KECLDBNJ_00882 hypothetical protein
MSQTEAFKEHIIQGNLCKGAYITVGAAMLDGQTITGAHVNLPLKTLNRHGLIAGATGTGK
TKTLQVLAENLSEKGVPVLLMDMKGDLSGIAKASEGHPKIDERHAKIGLPFEPKDFPVEL
LTLSEQNGVRLRATVSEFGPVLFSRIIDATDAQAGIIAILFKYCDDKSLPLLDLKDFKKV
LQYATDEGKEEIQDLYGRISTASAGAILRKVVQLEQQGADIFFGEKSFDVDDLLRLDDNG
RGKINIIRLTDIQDRPQLFSTFMLSLLAEIYSTFPEQGDSDQPELVIFIDEAHLIFKEAS
KALHSQIESIVKLIRSKGVGLYFVTQNPTDVPDGVLSQLGLKIQHALRAFTAKDRKAIKL
TAENYPDSEYYDTKEVLTTLGTGEALVSALDEKGRPTPLAATMMRAPMSRMDILTDAEIE
EINRKSALAPKYNDTVDRESAYELLNAKIKKAESEEAKEKAKEERATVSKSSRTSSRSNT
TEKAIIKVLTSATVIRGVLGILGKLIK
>KECLDBNJ_00883 hypothetical protein
MKRIFFAAIITNLLFTSCDSDSSFKVTADRVGELTKETQVNELKTIFSNDSVVDQNSGLS
EELNVNAIEIYEKGGKQLLSLMPTKDGNPKTIKTVQVFDERYTTEEGINLNSTYKDITEA
YEISRIETLISSIVIFVDDINAYFTIDRDELPGELRFNMDAKVTGAEIPNDAKIKYFMIG
W
>KECLDBNJ_00884 hypothetical protein
MSDAKYYIQKTPFVVPTDDGKYIGEHFGKASDGNTAISIAHMIAPPRWSEPFQTPEFDEY
TFIIEGKKQFLIDDEPIILEAGQSIKIKAGTRVQYSNPFNQKCVYLSVCQPAFDFNKVHR
EEE
>KECLDBNJ_00885 hypothetical protein
MIKILALVMVIGGAIALVLGIMGIFGSMSTGVSPWALAILGGIFFLSGISLLKYRKDTDV
IDAENRH
>KECLDBNJ_00886 Arylesterase
MNKLVKKILPKAIGFYINALSLVNPKASARKAFKVFSKPRRGRIGAHHEEFLNPNLEPVV
AVEDLKIQPYKWSGSGKTVLLVHGWESHSHRWKEMIFRLQKEDYTIIAFDAPAHGYSSGK
YFYVPLYHQTLDKMLEIYRPDYLIGHSMGGMTVLYNQSQESSIKTEKLVILGAPDKLESI
LKDYQKILGLNARALEALDRFFQNTFDFKTRDFSSSVFATKIKVPTLVIHDKEDPITPFS
GSQAIHKALQKSQFIETEGLNHSLYDTDVNEKIITFLKD
>KECLDBNJ_00887 23S rRNA pseudouridine(2604) synthase
MSDANVTRINKFLSEVGFCSRREADKLIDAGRVTVNGSVPEMGTKVSSNDEIRVDGKVVG
EKKDAPVYLIFHKPVGIVCTTDTRVEKDNIIDYINYPTRIFPIGRLDKASEGLIFLTNDG
DIVNKILRARNNHDKEYIVDVDKPLDASFVKRMSDGIPILDTITRKCEVEQLGKKRFKII
LTQGLNRQIRRMCEYLGYNVTRLKRVRIMNISLDIPVGKYRAFKPSELSELNNLLADSSK
VFEPEQETGKKPIIKPTGPRRRRRN
>KECLDBNJ_00888 hypothetical protein
MAAQIPSVKNEEQYEALRDKGYSKEKSARIANTPDSGKKGGKAEKYEDRTKQDLYKQAQK
IGIEGRSKMTKQELINALRNN
>KECLDBNJ_00889 hypothetical protein
MPAPFHLAIPVDDVEKARIFYRDVLELEEGRSDTHWVDFDFFGHQLVIHYKPKEEKASAH
HNAVDGKAVPVPHFGVVLDWDAFEQFADTLRAKKVEFVIEPYIRFEGLPGEQATMFFYDP
CGNALEFKSFKDLSQLFAK
>KECLDBNJ_00890 hypothetical protein
MNKLKPELVRQLFLIVLILFLFILIVEEMTPYLSGVLGAITLYVLLRKFYNFLVVKRKWK
EGLAAAVAMLASFVVILVPIGLTVMMLTNKIGKAVRNSERVVEVVKQQVGVWEADLGFKV
SESIDTNSITSWVSTNLQNLAGGTFNVFIAIGIMYFILYYMLINNDKMHQSLYAFIPLNK
ENIARIGHESVAMVKSNALGIPLVALAQGIVALIGFFIFGVPDPFFWFVITAIGSMIPFV
GTLLGIVPVTILLIASGNNLQAVGIAIYGLVVVGSTDNLIRLYVLERLANVHPLVTLIGV
IVGVPLFGFIGLIFGPLLISLFLLVVKIYKHEYGDPEPEIINQIIPDVSENQED
>KECLDBNJ_00891 hypothetical protein
MFQKIKKTNFPPQGKPVLIWDGTCGFCKYWVTRWKMKTKDAIVYKTYQDAHKDFPDIPLK
EFKKASRLIELDGSIYSGPDSAYRCYTYSDSIKWNAHRWYVNNRSFQRLSDHGYNFIAKH
RPEMFKLTKLLFGPNPTDFKPYWVFYILAIILLVFAVFQ
>KECLDBNJ_00892 Polyphosphate glucokinase
MQILGVDVGGTGIKGVPVNLEKEEYLGERFRLDTPVPREPKAMVNTIAEVVKHWDWKGPV
GVGFPTVIHKGKALEHGNLDKSWLGVQVDEMISQKIGLPVNVMNDADAAGLAEMEFGVGK
GVEGLVIVVTVGTGIGSGVFYNGELIPNFELGQMRYKKKKIIEKYASRRVRLDNNMSFKK
WGKRFNKFIQLTMQVSQPEMIIIGGGASKNLDEYIKYLKTDVPIVAAHTRNHAGIIGAAL
GARHLL
>KECLDBNJ_00893 Bifunctional protein FolD protein
MTILDGKKTSNDLKNEIAEEVKAMKERGEKVPHLAAVLVGNDGASLTYVGSKVRACERIG
FESTLIQLPEETTEEELLDHINKLNNNPEIDGYIVQLPLPKHIDEQKVLLAVDPDKDVDG
FHPTNFGKMAQDMPVFIPATPFGIMELLKRYNVETSGKHTVVIGRSHIVGRPMSILMSQK
GTPGDSTVTLTHSRTKNLEELTKQADIIITALGVPEFLKADMVKENVTVIDVGITRVPDE
TKERGYRIAGDVDFAEVSKKADFITPVPGGVGPMTIAMLLKNTLLARARHNDLQS
>KECLDBNJ_00894 Signal recognition particle protein
MFDNLSDKLDKAMHVLKGHGQITEVNVAETLKEIRRALVDADVNYKIAKDFTNTVKEKAL
GQDVLTALKPGQLMTKLVKDELTELMGGEAEGINLSGNPSVILMSGLQGSGKTTFSGKLA
NFLKNKKTKKPLLVACDVYRPAAIDQLHVVGGQIGVEVYSNKEEKDPVKISQAAIAHAKA
NGFNAVIIDTAGRLAVDQAMMNEIAAIHEAIKPQETLFVVDSMTGQDAVNTAKAFNDVLN
FDGVILTKLDGDTRGGAALSIKTVVDKPIKFIGTGEKMEAIDVFYPSRMADRILGMGDVV
SLVERAQEQFDEEEARKLQKKIAKNQFGFDDFLKQIQQIKKMGNMKDLIGMIPGAGKALK
GLDIDDDAFKGIEAIIHSMTPAERTQPSIINSSRKKRISKGSGTSVQEVNQLLKQFNQMS
KMMKMMQGGGGAKMMQMMNQMR
>KECLDBNJ_00895 hypothetical protein
MKNLKTFLSITFLAALLFGSCQNEEDVLIEGNENTNTKQSEPAEYIERSTANDGSEDDIL
DDISCASVILPVVAEVNGQELTIVNEASLTLIAEIFAEFTNDEDEVRFQFPIEMRLSDYS
VVTIQNEQELEALEEACEAADESRDDAISCLEFDYPITVFTFDANAQQTGSVVLTSDQEA
YAFINDLGDDQYFSLQYPISLSGSSDGSITINSDAELIAELQSCESEDDLEEEARDEAED
LREDLEEAITGARFELESGVQAGAEFSQQFANYTFEFTNDKRVVVRNSLTNLVTDVEAFF
NTTSETEVFLELNFTSDSEFSVLNGTFEVVSQSSSTIELQSTTDTTFKLVFSKL
>KECLDBNJ_00896 ECF RNA polymerase sigma factor SigE
MNEQDKHTDLCHEATFKRFYLEFIQAAKNFAFYKCGDEQEALDLTQEAFVKIWNRCNNIE
FKKAKTYLFTTINNSFLNAVKHKKVVLNYQRNQASEESESNEDPQFILREKEFKKTLNSA
IASLTEAQREVFLLNRIDGKKYAEIAEMLNISVKAVEKRMSQALKNLRQQIPEF
>KECLDBNJ_00897 hypothetical protein
MQHQEELLKWLNGDMNAEELAAFKQTQTYKEYHKIATYASRLKPNTLDKEAAYKSFKTKI
TQKPQPKVIKLPYKTWISTAAAVLVILITSYIFLKSDQKIIKATDDFVQITLPDASEATL
NNASQISYNPKDWEDGTRNLELEGEAFFKVNKGSVFKVATAQGTIQVLGTQFNVNHRKGY
FEVSCYEGSVEVAVTLDTLILKPGDTYRLISGKSELKINNDQKQPSWLDYELSFDEVPYH
IVIAALERQFNIQISYPAQLKDQVFTGSFSTKKLESALQGVTLPFGITYKSDKDQSFIFY
AE
>KECLDBNJ_00898 hypothetical protein
MLNKEKYWLIMLLFTSIFGTAQDRSEVDLVTYLDTVETSFNIRFSYQTEAVQDLKLQNST
FEQLDQTLQYITKQTGLTITKIDDRYYSILPRTSSIFCAQILDAATLKPLEGATIQALNK
NASAVTDANGYIELALIKPGDSIKVSFLGYQTEVLKVERLTSNCQQISLAPKSFTLEEVV
IKRLFSRGIRKFPDDRIEINTREFDILPGLTDPDILQTLQILPGIESIDESINNINVRGG
TQDENLMLWDEIKMYHTGHFFGLISAYNPNLTERVEVTKNANSSEYSGGVSSTIKMYTPN
AITEKISGGAGFNGLSADAFLQIPISTKLALQISGRRSFADYFQTPTYTSYFNRSFQDSE
IKNDGSSAENIKSLSDFRFHDYSAKILYDISPKHQLRASFISLNNTLEYSESDVDEQLIN
ESLIDQDNIAFGIHLSSVINPAYDTFLNAYYTQYNIRSTDQDFSNNQVLAQTNQVLETAF
KAKGTWHLNSRMNFEHGYEFTETGIRNTTSVNQPVFQQRKKDVVRQHAIFGDWSLATNNF
RLRTGLRTTYFEKFKKVRLEPRINIRQKIGHFALKTEAALKNQSTTQIIDFEDNFLGVEK
RRWVLVNDNDIPLITSKQISLGVDYTQNNWLIDLTGFYKQVSGITASNQGFQNQFKFIKT
NGSYETKGLEFLVNKTTPKLSTWFTYTLATNVYSFESLNPATFPNNTDIRHSINTGGSYA
LFNNFKIAVSLNYHTGRPYTLPIENAETLPSSSNTYVVNYDTPNAANLEDFMRFDATANY
SFNWDAVTAKFTLGIINILNQTNTIQRYYEVNPDDNTQAIAIQNNSLGFTPNASLRLTF
>KECLDBNJ_00899 Arginine--tRNA ligase
MNLSDKLTKAVKDAVQELFSATLESVEIQPTRKDFEGDLTVVVFPILRVAKGNPAVIGEQ
IGTYVKENLDEIADFNVVKGFLNLVISDAFYLNFFDVIKDQKNFGHEPEAGKAVMVEYSS
PNTNKPLHLGHIRNNLLGYSVAEILKASGKKVYKTQIINDRGIHICKSMLAWQKFGAGET
PESTGLKGDKLVGNYYVKFDKAYKEEQSYLVAQGKTKEEAEKEAPLILEAQDMLRKWEAG
DEEVVALWKKMNGWVYSGFEETYKNLGVDFDSYYYESNTYLLGKDNIEEGLKKGVFYKKE
DGSVWCDLTEDGLDEKLVLRSDGTAVYMTQDIGTAIQRVKDHPDVGGMIYTVGNEQDYHF
KVLFLILKKLGYDWAEHLFHLSYGMVDLPSGKMKSREGTVVDADDLVEEMATTAGNIAQE
LGKLDGYSEVEKQELYKIIGLGALKYYILKVDPKKRILFNPEESVDFQGNTGPFIQYTYA
RIQSILRKAQDTGVAQDYVYEALQPKEKELIKQLALYPETVQLAAENHSPALIANYTYDL
VKEFNSFYQQVSILGADTDAEKSFRVALSKKVGEVIEAAFGLLGIQVPERM
>KECLDBNJ_00900 hypothetical protein
MLLNVSYNNPEVTRKIYTEVGKPFTLRERIKMKGIGSSKLFITATSIEIHNLLILDSYVN
TCNIEMRPNGIIVGFRSLLESYALIIPYYKLRIYKGQAEEYSIYRDQYFIKIRAKANDKA
THKFIKKIMDFKAENLPLGPEDL
>KECLDBNJ_00901 hypothetical protein
MKKAYFIVLILAFNVAYSQENEQEKMISRFVLDLFDKSIDPEIVFDEYISTDKEDNLKAS
VTKRKKLAIQIIKETRKNKKNNGWLIPNPEIRKLNDPKVFPYEELKGLSEIQLQFNTSGE
FKDRIYVLTNDKETEILQYFLMSENKKKIKSFTLFVKAKNSGWFFEY
>KECLDBNJ_00902 hypothetical protein
MFPKSSSIYAFVGVSVTYDSELRDNNEYLFHGSIFKVIKASQLSDIIT
>KECLDBNJ_00903 hypothetical protein
MKILLTGANGYIGMRLIPFLLEAGHELVCAVRDKNRLAVNLRTRSKISIVEIDFLEEPNP
DLLPQDIDAAYYLIHSMTSSTVDFDEKEKRAAENFNIYLSKTRCEQVIYLSGIVNDEKLS
KHLTSRKQVEDTLYQGNFNLTVLRAAIIVGSGSSSFEIIRDLCEKLPLMITPKWVKTRCQ
PIAIRNVIQYLTGVLGNKSCYNNSFDIGGPDVLTYKQMMLLYSKIRGLSLSILDVPVMSP
KLSSYWLYFVTSTSYKLALNLVDSMRVEVITCDTRLQEMLHIKPISYTDAIKLAFEKIEQ
NQVVSSWKDSLVSGRFRKDLNHYIKVPEYGCLKDRQSIKLKNPEQALENIWSIGGKRGWY
YANTLWKIRGFLDKLWGGVGLRRGRTHSNELYEGDSLDFWRVLLADKEERRLLLFAEMRV
PGEAWLDWEIDDDNILHQTATFRPRGLWGRLYWFSMLPFHYFIFGGMIRNIARYEPKTTV
ISNS
>KECLDBNJ_00904 Glycine betaine transporter OpuD
MILLGLAGLIILFTEESYALIETLSTSIRSYFGRFYLILGLVCVLLLVGLAVSPIGKFKL
GRTNEKPAFSRLSWIAMLYSAGMGAGILLRAVQEPVFMQQNPPIATETSAEIQALEFTFY
QWGFTAWAFYAVFALAIGTAVFKYGRPAYTSSTVFTHSKTRASKIGIKSIDLLVILTTVF
GLIAAVALGARQIKGGLDYLNGALLSENVSLVIISAIGVFALISALSGLQKGIKLISRAN
IFLCVTLLFFVFLQGNILSILNQFVIALYHYCIDFIPLSLAYGNFDPGEAFLTDWTYYYW
AFWIAWAPFTGIFIANISRGRTLREIIIGVLLIPSLGSFFWFTVFGQSAFELIDEWGSYN
REFDNVFSSLFIFLSNYPPQSIVNALVILLLLSFLVTSLDSAILVLSLHNSRSENPSKRS
RILWGLLLTLTTIAFTILSFNKENVDVLNTMQKLLIVTSLPLSFFMVWMLFRWIKSLLTK
A
>KECLDBNJ_00905 hypothetical protein
MSQVTDTVLMVRPASFRKNEETAVNNYFQEDLALENEAINAQAQQEFDAFVTKLKAAGIH
VLVLQDEKELNTPDSIFPNNWVSTHKNGDVALYPMYAENRRRERREEFFTLLEDAGFAIK
NVIDYTEAEEEELFLEGTGSIILDRVNEKAYCALSARADEDLFIEFCEDFEYLPVLFTAN
QTVGNERLPIYHTNVMMCIAEEFAVVCLQSIDDKKERKQVINQLKESGKEVIAITEAQMH
EFAGNMLQVKNAAGKRFLVMSASAHQALDATQIASITKYCEILSSDLTTIETCGGGSARC
MLAEIFLPKL
>KECLDBNJ_00906 Arginine deiminase
MIKLNVTDETARLRAVILGTALSNGGVPKLEDAYDPKSLLHIKENTYPKEEDMVEEMNAV
EEVFNKYGIQVFRPKLINDYNQIFARDIGFVIEDTFIKANILPDREQEIEAIEHVLTQID
EDKIIRFPEEAHIEGGDVMPHGDYIFVGVYRGPDYADYIIARTNMLAVEALQNQFPDKKV
VSFNLRKSNTNPYENALHLDCCFQPVGEKYAILHKNGFLEEEEYQWLVDFFGAENVFEIS
SEEMFHMNSNIFSIAPDVVVSEKNFTRLNTWLRSKGITVEEVPYAEISKQEGLLRCSTLP
LVRE
>KECLDBNJ_00907 Citrate synthase 1
MADNAKLTIGDKSYEFPIVTGTENESAIDIASLRAVTGGYTTIDPGFKNTGSCESAITFL
NGEEGILRYRGYAIEDLAEKASFLEVVYLLIFGELPTEEQLTKFHNDIKEENHVDEDVKK
ILNGFPKSAHPMGVLASLTSALTAFNPDAVNVDSEEDMYNAIVKLLGKFPVLVAWTMRTK
MSKPLDYGDDSLSYVENLHKMMFSKPNSEYKVDATIIEALDKLLILHADHEQNCSTSTVR
VVGSSHAGLFASISAGISALWGPLHGGANQAVIEMLEGIKADGGDTKKYMAKAKDKEDPF
RLMGFGHRVYKNFDPRAKIIKKAADDVLEQLGIEDEVLAIAKGLEKEALEDDYFVKRKLY
PNVDFYSGIIYRALGIPVEMFTVMFAMGRVPGWIAQWREMRLRKEPIGRPRQVYIGEKLR
PFKPMNER
>KECLDBNJ_00908 Enolase
MSIIINIHARQILDSRGNPTVEVDVLTENGVLGRAAVPSGASTGEHEAVELRDGGSDYMG
KGVLKAVENVNAVIAQELLGVSVFEQNLIDQTMIDLDGTPNKSKLGANAILGVSLAVAKA
AANELNMPLYRYVGGVSANTLPVPMMNIINGGSHSDAPIAFQEFMVMPVKAKDFTHAMKM
GTEIFHNLKKVLHDRGLSTAVGDEGGFAPTLDGTEDAIESIQKAVENAGYKFGDEVMIAL
DCASAEFYVDGKYDYTKFEGDKGVVRTSEEQAQYLAELASKYPIISIEDGMDENDWEGWK
SLTEKIGDKVQLVGDDLFVTNVERLSRGIENGIANSILIKVNQIGTLTETIAAVNMAHNA
GYTSVMSHRSGETEDNTIADLAVALNTGQIKTGSASRSDRMAKYNQLLRIEEELGTVAYF
PQEKAFKVK
>KECLDBNJ_00909 Carbamoyl-phosphate synthase small chain
MKYQTNRKALLLLADGTIFYGKSVGNKEGTAFGEVCFNTGMTGYQEIFTDPSYFGQIMVT
TNAHIGNYGGNNEETESETVKISGLVCRNFSYNYSRIRVDESLQSFLDRNNLFVISDVDT
RALVSYIRDNGAMNAIISTDVDNVDELKKQLAEVPNMHGLELASKVSTKEPYYFGDENAK
YKVAAIDLGIKKNILRNMAKRDMYIKVFPYNASYEEMKAWNPDGFFLSNGPGDPEPLKEV
IATAQKIINDDMPLFGICLGHQIIALANGISTFKMHHGHRGINHPVLNHGSGKGEITSQN
HGFAVNYDEAINNPEIEVTHKHLNDQTVMGLKMKNKNCFSVQYHPEAGPGPNDATYLFDE
FVDRMSQVSV
>KECLDBNJ_00910 hypothetical protein
MFRQFINLTVFLFTVMSFAQDQERLVNNPDQLLSVSNGVRNSYGSIQSIPPVARVEGSPY
LFDDWIHSARVYATNGQLYMLDNINLNLNTQAFVTKIGQDSLFTFQFNQIDYFEVLGRKY
ESKFTKTGRQIYEILADNGSERLLKAYSVKLVPSSPDPMKNRPTDKYIRRENFYYERDDK
ITLMPLRKSKVLKSFNLEKAKEKELVEYVKRNDLSYGDEKDVIKMMDYANSL
>KECLDBNJ_00911 50S ribosomal protein L17
MRHGKKNNHLGRQTAHRKSMLANMACSLIEHKRINTTVAKAKALKQFVEPLVTKSKEDTT
HNRRIVMSKLRQKDAVAELFRDVAVKVGDRPGGYTRIIKLGNRLGDNADMAMIELVDYNE
LYNLGKTKKKSTRRAGKKSAAPAKTEAPVKETKANDEEE
>KECLDBNJ_00912 DNA-directed RNA polymerase subunit alpha
MALLNFQKPDKVIMIDSTDFEGKFEFRPLEPGYGLTVGNALRRVLLSSLEGFAITSVRVE
GVDHEFSTIAGVVEDFTEIILNLKQVRFKRQIDEIDNETVTISVSDKEQLTAGDFQKFIS
GFQILNPDLVIANMEKKVNINMEITVEKGRGYVPAEENKKQNAPVGTIFTDSIYTPIKNV
KYSIENYRVEQKTDYEKLVFEIITDGSIHPKDALTEAAKTLIHHFMLFSDERITLEADEI
AQTETYDEESLHMRQLLKTKLVDMDLSVRALNCLKAAEVETLGDLVSYNKNDLMKFRNFG
KKSLTELEELVNVKGLNFGMDLSKYKLDKD
>KECLDBNJ_00913 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGDDKSFEKRNYPPGQHGNNRRRGKKSEYAIQLQEKQKAKY
TYGILENQFRNMFEKATSATGITGVVLLQLCESRLDNVVFRMGIAPSRRAARQLVSHRHI
TVNGDLVNIPSYQLKAGDVVAVREKSKSLSAIQDSLANASHVYEWISWNNDSKQGTFVSV
PERIQIPENINEQFIVELYSK
>KECLDBNJ_00914 30S ribosomal protein S11
MAKQNTKGGGKSGKAAKTTKKRKVIVESVGEAHIAASFNNILISLTNKKGDVVSWSSAGK
MGFRGSKKNTPYAAQLAAEDASKVAHEAGLRKVKVYVKGPGNGRESAIRSIHNSGIEVTE
IIDVTPLPHNGCRPPKRRRV
>KECLDBNJ_00915 30S ribosomal protein S13
MARIAGVDIPKQKRGVIALTYIFGIGKSRAQKILAQADVDENLKVNEWDDDQIGRIREAV
GSYKIEGELRSEVSMSIKRLMDIGCYRGIRHRSGLPLRGQRTKNNSRTRKGKRKTVANKK
KATK
>KECLDBNJ_00916 Translation initiation factor IF-1
MAKQQAIEQDGSIIEALSNAMFRVELENGHIVTAHISGKMRMHYIKLLPGDKVKLEMSPY
DLTKARITYRY
>KECLDBNJ_00917 Protein translocase subunit SecY
MKAIETIKNIWKIEELKNRILLTLGLLLVYRFGAQIVLPGIDASQLANLAAQTDGGLLGL
LNAFTGGAFSNASVFALGIMPYISASIVVQLMGIAVPYLQKLQKEGESGRRKINQITRWL
TIAITLIQGPGYITNLFNLLPPEAFVMGSNVTFIISSVIILTTGCIFAMWLGEKITDKGI
GNGISLLIMVGIIARLPQSFLQEWVSRVSESNGGLIMILIELVIWFVIILLSVLLVMAVR
QIPVQYARRTASGSYERNVFGSRQYIPLKLNASGVMPIIFAQAIMFIPGAVIGLSESPTA
QSIASQFTNIFGFWYNLVFGLLIIIFTYFYTAITVPTNKMADDLKRSGGFIAGIRPGTET
SEYLDRIMSQITLPGSIFLALIAIFPAIAVSVLGMQQGWALFYGGTSLLILVGVAIDTMQ
QVNSYLLNRHYDGLMKTGKNRKAVA
>KECLDBNJ_00918 50S ribosomal protein L15
MGLNNLKPAAGSVKKNDSRRGRGEATGNGGTAGRGHKGAKSRSGYSKKVGFEGGQMPLQR
RVPKFGFTNINRKEFTGVNLDTLQEYVDAGRIKDEVTIDVLVENRLAGKNDLVKILGRGE
LKAKLKITVHKFTASAQKAIEAAGGEAVTL
>KECLDBNJ_00919 50S ribosomal protein L30
MAKIKVTKVKSAINRTQNQKRTLEALGLKKMGQVVEHENTPNILGMINKVSHLVSVEEA
>KECLDBNJ_00920 30S ribosomal protein S5
MYQNYKNVELVKPSGLDLKDRLVGVQRVTKVTKGGRAFGFSAIVVVGDENGVVGQGLGKS
KDVASAIAKAVEDAKKNLVRIPLNKSTIPHEQKGKYGGARVLLMPAAPGTGVIAGGAIRS
VLESVGVHDVLSKNQGSSNPHNVVKATFDALLQLRSAETVAKQRGISLEKVFKG
>KECLDBNJ_00921 50S ribosomal protein L18
MAFSKYTRRNKIRRRIRKALVGTTERPRLSVYRSNKEIYAQIIDDTTGKTLSAASSRDKD
FSAEGSKAEVAKKVGMAIAEKAKEAGIEAVAFDRGGYLYHGRVKQLAEGAREGGLKF
>KECLDBNJ_00922 50S ribosomal protein L6
MSRIGKSPVTIPSGVTVEVAEGVITVKGKLGELKQEYSNIDIKVEEGVVVLERSSEKAEF
KAKHGLYRALIANMIAGVSEGYTKSLELVGVGYRAANQGQKLDMALGFSHNIVMDIAPEV
KVETITEKGKNPIVKLTSHDKQLVGQVAAKIRSFRKPEPYKGKGIKFVGEQIRRKAGKSA
>KECLDBNJ_00923 30S ribosomal protein S8
MYTDTIADFLTRIRNAAAANHRVVEIPASNLKKEITKILFDQGYILSYKFEDKTAQGSIK
IALKYDKETKESVIKDIQRISKPGLRKYASSKDVPRILNGLGISIVSTSKGVMTGKQAQS
ENVGGEVLCYVY
>KECLDBNJ_00924 Alternate 30S ribosomal protein S14
MAKESMKARERKREKLAAKYAEKRKALKEAGDYEALQKLPKNASPVRQHNRCKLTGRPKG
YMRTFGISRVTFREMANQGLIPGVKKASW
>KECLDBNJ_00925 50S ribosomal protein L5
MAYISRLKTEYKERVIAALTEEFGYQNVMQVPKLRKIVISRGVGAAVADKKLIDYSVEEL
STISGQRAVATMSKKDVAAFKLRKGMPIGAKVTLRGERMYEFLDRLITSALPRVRDFNGI
NATGFDGRGNYNLGIEEQIIFPEIDIDKVRKIEGMNITFETSAETDKEAKSLLTQLGLPF
KKK
>KECLDBNJ_00926 50S ribosomal protein L24
MTKLKIKVGDNVRVTAGDHKGQEGKVQRVIKDKNKAIVEGINLVSKHEKPSASNPQGGIA
KKEAPIHISNLSLIDGNGDATKVGYRIEGDKKVRFSKKSNEVI
>KECLDBNJ_00927 50S ribosomal protein L14
MLQQESRLRVADNTGAKEVLTIRVLGGTKRRYASVGDKIVVSVKDATPNGQVKKGAVSTA
VVVRTRKEVRRPDGSYIRFDDNACVLLNAQGEMRGTRVFGPVARELREKQFMKIVSLAPE
VL
>KECLDBNJ_00928 30S ribosomal protein S17
MLLKMEKRNLRKERIGVVTSNKMQKSIVVSEVKKVKHPMYGKFVLKTKKYVAHDEQNDCN
IGDTVKIMETRPLSKSKSWRLVEIIERAK
>KECLDBNJ_00929 50S ribosomal protein L29
MKQSEVKELSVAELQEELVKAKRAYSDLKMAHAISPLENPIQLRGLRRSVARIATELTKR
ELQ
>KECLDBNJ_00930 50S ribosomal protein L16
MLQPKKTKFRKQQKGRMKGNAGRGHQLSNGTFGIKSLDSNFLTSRQIEAARIAATRFMKR
EGSLWIRIFPDKPITKKPLEVRMGKGKGAVEYWAAVVKPGRMLFEIGGVAEPVAREALRL
AAQKLPVRTKYVVARDYQAD
>KECLDBNJ_00931 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWESNWYGGNDYGDKLAEDDKIRKYIHARLSKASVSRVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKQITNKEVQINIFEIKRPELDAFLVASSVA
RQIENRISYRRATKMAIAAAMRMNAEGIKIQISGRLNGAEMARSEAYKEGRIPLSTFRAD
IDYALVEAHTTYGRLGIKVWIMKGEVYGKRELSPLVGLAKKQGKGGRGSGAPKSRRRK
>KECLDBNJ_00932 50S ribosomal protein L22
MGVRKKERAEQIKEAKKSLAFAKLNNCPTSPRKMRLVADLVRGQKVEKALQILKFSNKEA
SRRVEKLVLSAISNWQEKNEDASIEDADLFIKEIRVDGGSMLKRLRPAPQGRAHRIRKRS
NHVTVVLGAKDNTQSK
>KECLDBNJ_00933 30S ribosomal protein S19
MARSLKKGPYVHYKLEQKVAANVESNKKTVIKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHVGSKNKGKK
>KECLDBNJ_00934 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGFDAITTDKPEKSLLAPIKKSGGRNSQGKMTMRYKGGGHKK
RYRVIDFKRNKEGVPATVASIEYDPNRTAFIALLNYQDGEKRYIIAPNGLQVDQNVVSGS
GVAPEIGNAMPLSDIPLGTIISCIELRPGQGAIMARSAGAFAQLMARDGKFATVKLPSGE
TRLILVNCMATIGAVSNSDHQLIVSGKAGRKRWLGRRPRTRPVVMNPVDHPMGGGEGRAS
GGHPRNRNGVPAKGYRTRTKTKASNKYIVERRKK
>KECLDBNJ_00935 50S ribosomal protein L23
MSILIKPVITEKATMDSELNSRYTFEVNPGSNKIEIKNAVEATYGVSVIKVRTMNVRPDR
NTKFTKSGMITGKTKGFKKAIVQVAEGDVIDFYSNI
>KECLDBNJ_00936 50S ribosomal protein L4
MKVAVVDIKGKETGREANLSDSVFAIEPNDHAIYLDVKQHLANKRQGTHKSKERAEIAGS
TRKIKKQKGTGTARAGSIKSGVFKGGGRMFGPRPRNYSFKLNKGLKRLARRSALTLKAND
KAIMVIEDFNFETPKTKNFVDVVKALGLDNKKSLFVLGASNNNVYLSSRNLRTSEVITSS
ELSTYKIMNANNVVFLEGSLEEIEQTLSK
>KECLDBNJ_00937 50S ribosomal protein L3
MSGLIGKKVGMTSIFDENGKNIPCTVIEAGPCVVTQVRTEEVDGYSALQLGFDDAKTANK
AAQGHAKKAGTVAKRKVVEFQDFEGEYKLGDAVTVEVFKEGQFVDVAGTSKGKGFQGVVK
RHGFGGVGQSTHGQHNRLRAPGSIGAASYPARVFKGMRMAGQMGNERVKVQNLRVLKVVA
EKNLLVVKGCVPGHKNSYVIIER
>KECLDBNJ_00938 30S ribosomal protein S10
MSQKIRIKLKSYDHNLVDKSAEKIVKTVKSTGAVVTGPIPLPTHKKIFTVLRSPHVNKKS
REQFELSSYKRLLDIYSSSSKTIDALMKLELPSGVEVEIKV
>KECLDBNJ_00939 Elongation factor G
MAQRDLKFTRNIGIAAHIDAGKTTTTERILYYTGVSHKIGEVHDGAATMDWMEQEQERGI
TITSAATTCTWKFPMENAQPLPDTKDYNFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSA
VDGVEPQSETNWRLADNYKVPRMGFVNKMDRQGSNFLEVCKQVKEMLGSNAVPIVLPIGE
EADFRGIIDLVKNRAVVWHDETQGSTFDVVEIPEELKEEAKMYRGMLIEEVAAYDENLLE
KFMEDEDSITEDEVHAALRAAVMDMSIIPMICGSAFKNKGVQFLLDAVCRYLPSPVDKEG
IKGINPDTEKEELRKPDVTAPFAALAFKIATDPFVGRLAFFRTYSGRLDAGSYVLNNRSG
NKERISRIYQMHSNKQNAIDFIEAGDIGAAVGFKDIKTGDTLSDEKHPIVLESMEFPDPV
IGIAVEPKTKADVDKLGMALAKLAEEDPTFQVRTDEASGQTIISGMGELHLDIIVDRLKR
EFKVEVSQGQPQVEYKEAITRVADHREVYKKQSGGRGKFADIVFTLEPAEEGKVGLEFVN
EVKGGNVPKEYIPAVEKGFKTAMINGPLAGFEVDAMKVTLKDGSFHPVDSDALSFELAAK
LGFKAAAKAAGAVVLEPMMKVEVITPEENMGDIVGDLNRRRGQMSSMGDRAGAKVVKAIV
PLSEMFGYVTTLRTLSSGRATSTMEFSHYAETPSNVSEEVIAAAKGTANA
>KECLDBNJ_00940 30S ribosomal protein S7
MRKRQAKKRPLLPDPRFNDQLVTRFVNMMMWDGKKSVAFKIFYDAMDIVEEKKNNEEKTA
LEVWKDALSNVMPHVEVRSRRVGGATFQIPMQIRPDRKISTAMKWLISFARKRNEKSMAS
KLAAEILAAAKEEGAAVKKRTDTHKMAEANKAFSHFRF
>KECLDBNJ_00941 30S ribosomal protein S12
MPTISQLVRKGRAKITKKSKSAALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
KEVNAYIGGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVQGRLQRRSKYGAK
RPKK
>KECLDBNJ_00942 hypothetical protein
MKLNLIIFYATLLIGSSLFGQKIHLQIVDSEKTEKDLLKTFGLKAEFDSFSEAQESLNRL
KDSLYKEGYFQHIVSLTKNNQLIKVTPGNRSDSITLYIKDKNLQLDFTKKKSLVTTKLPA
FLQNITKKETDAGHPLSTTSLKNIRLDNNKLTAELHLERKQQRKVSNFLIKGYPKFPKSF
LKHYARLDTTKTFNRSEIQKKTDNLNNLLFTTQTKPPEILFTKDSTNLYLYIEKNNINQF
EGFIGFASDEETNKLRIDGVIDLQLTNNFNYGESLGFYYKSNGDNQQILELSARLPYLFK
SPISLSANFNLFRQDSLFSNTSQSLSAEFQAAQNLSINTTYNHTSSNVTTSTPDSNPFTK
NSLSLGLTYTNRKNYILLPQITQFKIDIGGARRIDQNTNSQFFTTIEALKTFTISSKQQL
YLESNTSILNSEDYYENELFRFGGIKTLRGFKENSIFSSTYSTLLTEFRQVLTNGLTINS
IFDLAYSKNHINNSENHLYSIGLGASIVTQSGTLKLNFANGTTLGNTPKFSNTILHLTLL
TQF
>KECLDBNJ_00943 TonB-dependent receptor SusC
MKKRLQGFLMLFLALVVQVSFAQTRTISGTVTDDSGVPLPGVNVLISGTTTGTQTDFDGL
YSIEASTGDVLTFSYVGFSPQDVTVGTSSTIDVQLAAGEALEEVVVTAQGIKREKKALGY
AVSEVSSEALEQRPESDVARVLSGKASGVEITAQNGTSGSATNVVIRGYTSINGSNQALF
VVDGVPFASDTNSSGSFVNGNTGSSRFLDIDPNNIASVTVLKGLAAATLYGTDGRNGVIL
ITTKANSGQSSKKKTEITLNQSFFFNEIASLPDYQQNYGGGFNQSFGWFFSNYGPNFNAT
GVDGYLNDPAGIIDANGNVPHPYATNAFLSNFLGGENELYQSFQGVDYAYRPYASVENFF
RTGSVSNTSLNIRGASNDGNMSFNVNFGHTDDQGFTPGNSLTRNTLSVGGLAKLSNKFTV
TGILNYSRTDFKTPPVAASDGNANYGLSVFGQVFFTPISVDLMGLPFEIPETGGSIYYRN
GNDIVNPRWTVKNAQNGQLTNRVFGNAQLSYEFNDNVSVLYRGGIDIYNERNHSYANKGG
VNSDADRFGYYDTWDNNSTTFNHYAAVSGNYDLTADQKLNVSFLLGGSTLGEYYDRQGVS
SSAQIVYDVQRHFNFENQLPIQFSQKRNTIGLFGDLSFEYDNFLYLSLSGRNDWISNLIA
ENNSQFYPSVSASFIPTSAFEGFGGGNSLGLNYLKLRAGLGSSAGFPTGYPTVNTINQST
QVSGGAVGGASGIVTNGVSDALANPNLRPELISEWEVGFDARLLKNRLDVSLSYYDRTTK
DQIVGIPLSTSSGYTGTTGNIGKVEGTGWEVDLGVDIFKSAEPSGFSWNSRVNFTTNKQI
VTELGSDQIVYAGFSNLGNAAIQGEQLGVIVGSRILRDDNGSFVVGNDGFYVSETEVYID
DAGNEVNADTPGARSIAPIIGNPNPDYVMNFINTISYKNLTLGFQVSHVSGGDIYSQTIG
TLLGRGLINPDRREPFILPGVLADGSPNRQQLDNSSFYFDNVLFGPSELRIYDASVIRLK
ELSLGYTMPKKWLEKTPFGTLSITAAGYNLWYDAYNTPDRANFDPNVAGIGVGNGRGFDY
LNGPSSRRYGLSVKATF
>KECLDBNJ_00944 hypothetical protein
MKKIYNVLFIAFLSALTVFQSCETVELEMLENPNSLSPDQANPSLLFNSVQLSYRNGVSS
FNNIGAQLGRIDYMSGRIYFNNYGSGTLNGPWGNLFSSMNPDIAVIEESNTDGSYDYILG
ASKAMQAHLMMLLVDYVGDIVWSEANMPLDFPNPNLDDDAAVYDAALSLLNEASSLLQGA
SVGTSTDLFYEGDGGKWIKFINTLKMRAALTTGDYNGVINATNVIESAEDNFTFAYGTNL
QQPDTRHPDYASDYTDSGAGLYRSNWLMNLMAGTYGDFSGNDDPRRRYYFYRQNAVTPGS
FTLLFWEADENYYLYDGAVDAASLACSAQDVPSHLEFTEQEDYWCSMRLGYWGRIHGNNE
GIPPDSFTRTATGVYPAGGRFDDNLDWVILNPDQSNITFYDAAVGLGRGAGGAGIEPIIL
SSYVEFWRAEAYLMLGQDDPAEDAFEAGVTESVNYVTTFTDPTADTSLAPTAEDISEFIA
DITDEFSDADENTALDAFDWPVEKSKLDILGEQFFIAMYGGGADAFNFIRRTGYPRTLAR
NIDPNPGPFPRTLLYPSSEVNANPNVSQRQDNLTQVFWDAGVTNPAN
>KECLDBNJ_00945 hypothetical protein
MKNILKYILILGLVFNTVSCDDDPDNAIYTVLDYEKGAVLRTIEVINASLNSSDPTSTFA
VTVEEQDELDGGLMESVDIYVSLRDLTSDNGTSDPNRSLVKTVPASDFTEGPVGLPRATL
TATFGEAISAMGITDSEYTAGDVFIFELVLNLTDGRSLGPESSSGVLTGVFFKAPFQYNA
LLTCSPEPGDYTVRMFDSYGDGWQTDCGNGGSGITIVLDSTTLEVGLCSPYGGCNSGAFL
DESQGGCTPNDGYEGVATVTIPEGTVSAEWNFPGDNYGEIRFEVYAPNGDLVYDSGDFGE
QASGLLPITVCAQ
>KECLDBNJ_00946 TonB-dependent receptor SusC
MKIKFTGLLTLFLALVVQFSFAQTKEVTGTVTDGSGVPLPGVNIVIQGTTTGTQTDFDGN
YAISASQGQTLVFSYVGFGDSEQVVGASSTINVSLTAGEALDEVVVTALGISREKKSLGY
ATQEVSSEELTQTRNSNALNALSGKVAGVQISNASGNLGGSSRILIRGIGSITQENRPLI
VVDGIPLDNSNYNSTSTQNGGGGRDFGDTGFDINPDDIASMNVLKGGAAAALYGSRASNG
VIQITTKSGKKGKGEVTVNTGITFEEVNILPQTQKLYGGGGGNYTIGDQGGFNQATINGT
TYNLVDYATDESWGPRYEGQPVLHWDAFEPGTPGYLQTRPWVAPANDGSTLFKTGYSYNN
GVAFSQAGEDSNMRMSINNTQTEGILPNTKLNKTSINFNGSTKIGDKLKVDASVNFTVTD
GFNRPASGYTGESVILQLYQFGQTSLDYDRLKAYKTADGRQRTWNRRAYNDPLPQYTDNP
YWVLNENTAEDKRTRWYGTVGATYNFTDDFYAVAKVYGDTYDFRINQRTAVGSQAQASYS
ESDRDFQEINYEGRLHFDKSVFEDKLSINAFVGGNRRVNEYHFLGANTNGGLVVPGFYNL
SNSVDNPTVSESDSQRQINSLFGSVSLGYDNFAYLTVTGRNDWSSTLPAENNSYFYPSVS
GSFIASQFINADWLSFLKVRAGYAEVGSDTSPYQLSNVFTGSNPFLGSVPFTLVSSNKNP
NLLPEEKRTYEFGVEASFFNRRLGFDVTYYNELTKDLITPVQVDPSTGFTSTVLNAGELE
NKGIEILVNATPIMTEDFSWDVTWNFAKNENTLLSLAQGLETLQLASFPFNGVSLNAVVG
ERYGQIRGTNYVYDDAGNRVVNSNGSYAETQNVENLGSILPDYNMGIRNTFTYKGISLGV
LIDRQKGGVYRSLTNIWGNYSGILEQTAANNIREEGLILPGVTGDVTYNDDGSYTVSNTA
ENTQVISAQQYGTDFYFGNDAQNVFDASYWKLREVTLGYNLPKNWIGNAFSEVRLTAFGR
NLLVWGLDNDNFDPEIATTGSGNIQGSEGGSLPSTRSYGLNVQLKF
>KECLDBNJ_00947 hypothetical protein
MKNKFIILLMLVISAGFSSCDDGLEEVNLNPNDPELVPTANIFASATKSYIDFSRNAFNS
GRLTQNWVEYWGQTAYADEDRYLYRESSAESIYQNTYLVATDFKSIIDLNTDEATMADAA
ASGDNDNQIAASRIMLSYMFYELTNFFGDVPYYSYGSDNENFQALAVDDDLNPVFAPQEE
IYADILNELRESADMINVNAAVFTSGDNIFGGDAAKWKKFANSLILRVANNLRDVDPTTA
TSAINAAIQSGVMTSNADNAVQSYETVDLNASPWWRAFIGRTDFAVTAPFINLLKGETGN
FGLDPRLFEMAAPISVGIEDVKDDNYTTSDDPADYVGAPYAFRNMNALPSTSYSFMSSKV
LRPDYGEVLMEYSEVAFILSEENGFDQANYEEGVRASMEKWGVADADITAFVSTLPAASE
ENVLNQKYVALYMQPNTAYAMYRRTGYPNVLLVPGDTVDLPQNQVDAQAEGNRIESYTFE
SGVNGVTDLPFRLRYPQILQTLNGENRAAAAADLGNGDTILSKLFWDVN
>KECLDBNJ_00948 Putative TrmH family tRNA/rRNA methyltransferase
MSKSTNIYGTRAIIEAIQAGKEIGKIYLQKGLSNPLSKELEKLIREHGISVSYVPQEKLY
KLSDQNHQGAIATISPIQFAEFEATAEAVLAGDKPALFLLLDQLTDVRNFGAIIRTAVCT
GVDAIIIPKSGGAPVTDDTVKTSAGAIFNIPICKVDHIKDALFYLQGSGVQIVAATEKTD
DSIYDLDYSSPTALVMGSEGKGVTPGVLKLVDHKAKLPMAGTISSLNVSVACGAFLYEVV
RQRLK
>KECLDBNJ_00949 hypothetical protein
MSAKKQTSAFQFTTGVVLYPLIGVLTLWLVFWFELKFGFNFTPYGVLPRDLKGLLGIIFS
PFIHSNLSHLWHNSVPVLVLMAGLIYFYKPVAGRVLFWVAIGSGLGTWLIGREAYHIGAS
GVVYGLASFLFFKGIWSKHYRLTAFSLIVVFLYGSLIWGTMPIRDGMSWEGHLSGFVTGL
VLAFVIKSKIAKPVKYVWETEAYNPEDDPFLQQFDKDGNFIDPPLEEDDDEDRLT
>KECLDBNJ_00950 Replication-associated recombination protein A
MNTPLAERLRPKTLADYLSQEHLVGDKGSLTSSIKSGVIPSLILWGPPGVGKTTLASIIA
EESKRPFYVLSAINSGVKDVREVIDKAKNAGGLFTQKNPLLFIDEIHRFSKSQQDSLLAA
VEKGWVTLIGATTENPSFEVIPALLSRCQVYVLNPFSADDLRALLKRAMQQDTILSKKDI
ELQETEALLRISGGDARKLLNIFELLVTTETSEKVVITNAMVQQKVQQNTVMYDKTGEQH
YDIISAFIKSIRGSDPNAAVYYLARMLEGGEDLKFIARRLIILASEDIGNANPTALIMAT
NAFTAVTTIGYPESRIILSQCVTYLATSPKSNASYMAINKAQQLVKQTGDLPIPLALRNA
PTKLMKELGYGDEYKYSHDGAGNFIAQEFLPEEIANQKLYDPGANAREDGIRKFLKNRWG
DKYNY
>KECLDBNJ_00951 hypothetical protein
MNTRHYILLAFIAFISLTSVSAQELKDYKYIVIPQKFEFQDEAGQYELNALTRFLFIKYG
FDAYLENEQLPDDLNASGCNTLYARADISGFLSTKALITLVNCRGKEVFVLPEGKSKIKD
FKGGHQDAFRDAFEELEEEYGYTYSDAIVERAELIEEVEEEEEAPQTLVDAVANNKPPKK
EVVVIAIPKNSDVVIKEEVSTAIDAETNNAATNEAEIEQDIKTVLTSADGAFSMRATANG
FDVYEGSSKIGTATKTSAGSYLVNTSQFTGVGYYNGTEFTVEREIKGVSGLVKMIFTQE
>KECLDBNJ_00952 hypothetical protein
MNCKVGLLFLMLISAFKTVAQIPQLYDADYLPQSLMLNPGNEVDFDKHLGIPLLSGIGVG
VGLRNVSVYDIFQVNENTEINTRIRAKADQLTNKDYGVLHQNLEILSAGFRNKKGNYISF
GWYEALDAVAYFPKDMATLAYEGNQQNLGYSFKASDIKARAEMVSVFHIGMNKKINERLT
LGGRFKIYSGMLSAESTTNTGTFTTYLTPDGNNFYEHRLANIDGGLKIAGTGSFEEFSQS
QILQNSVFSGNYGAGIDLGFSYKLNERWGVSGSLLDLGFIHYSSNTYEYYGEGDFTFDGI
EFIFPSVVDNNMVIRPYWTDLEDEFRENMTFDERADIQYTVLRPVTLLGGLSYAFGERLD
CNCLKPEEDRFRFKTGLQAMAIKRPRGVQAGLTAFLDAPLTSFLNTKLTYGIDAFTYTNV
GFLISAKIRSFNVYLAADNLLSYSNIADSNTASFQIGLQLISNKN
>KECLDBNJ_00953 hypothetical protein
MKLRFTHFLFLLTGLFLGCSEQVDFDQANEVSLTSTQDIDLVYFTLNQDTFVDGTGQLQQ
TGVVEAVKLDFLDDPFFQNHLIKIVFAFKMTNTFPQDLTAVIKFNDSAGVTRESIALEAA
GSPDGTEVISEYEVVKEGAAIDNITNADNVLVEYYLNTEGSPIVGSLTFESKAAYTVEL
>KECLDBNJ_00954 Pyrimidine 5'-nucleotidase YjjG
MTKIKDIEHIFFDLDHTLWDFDRNSRLAFADIFQKNKIDVAIDDFLEAYEPINFQYWKYY
RESRITKEQLRYGRLKNSFKAIGVSIDDHLIDRLSVDYIDYLPKHNYLFDDAVEQLEDLH
KRFKLHIITNGFQEVQQLKLQNSKIDHYFKTVTSSESVGVKKPDSKIFLHAMDQAAAVPG
NSLMIGDNYEADIEGALNVGMRSICFNYHKTVLPPHIHKIDFLSDISRYL
>KECLDBNJ_00955 hypothetical protein
MLLIYTHKITPRLRYTFKHICTNILGIPVKFTTAVDEFIVHDSLKLSYTSKPLGKELHIK
SQEVLFEQGITDIEINMQPWRETKCFFVTGTKSALPFDIFAAAFVLLSRYEEFLPHVKDE
QGRFPATESLAYQEEILTQPVIDIWAGYFKEVLLEKYPDYPFEQRKFSFQALVDVEQAYE
MYGIGIMRWVTSFLIDLVHLQFSRIWLRLRVNLGLRKDPYDTFSWLINVQKNAKFKFVFF
FMVGNYSTYTRNIRYNKKTFRELIKMVGDYSEVGLLLSKEALSVKRQMKLEKKRIEGITN
KQLSAVRCSKYMQSLPEHYREMIQLEMKNDYSMGYPEYLGFRAGTCTPFNFYDLDYETIT
PLLIHPICAQASAFESSASDEKELNQELDTFFEMKKQVEQVKGSFVFSFRNKSVTGKGQD
QGQWKQFFRELVND
>KECLDBNJ_00956 hypothetical protein
MQQNSESFSIKQWSLDDRPREKLLQKGKDALSDAELVAILIGSGSRNESAVALSKRILAS
VDHNLNALGKLSLSQLMKFKGIGEAKAVSIAAATELGRRRQTDKAEEPTKITGSHAVFRL
LQPILGELPHEEFWILYLNNSNKVLHKHQLSKGGMTGTLVDVRLVLKLALERGAVSLILA
HNHPSGGLRPSEADKAITSKLKTAAASLDIKVLDHLIITENSYFSFADEGLL
>KECLDBNJ_00957 hypothetical protein
MESLFTTESYAKTLDRIDALTPSQKPQWGKMTVRQMLAHCQKPLEIALYNKDFGLKSNFL
IRTFFKKAMYDDSSFRKNMPTPKRFKVSEPKDFTTEKAALKELIEAFYQLTPNAHLEPHP
VFGKLTTDQWGKLQYKHLDHHLNQFGV
>KECLDBNJ_00958 Protease synthase and sporulation protein PAI 2
MSTYPPAHHQEAYFKNIIQTLKTFPLATLITVENERPVITHLPLRYVADKGYGKLIGHID
NNNPQVPHLAEGSQVTVLFNGPDTYISPSIYTTSQLPTWNYIKIHLETKVVKTLTNEGLK
SEMVALTSFLEGKEQRYRLEQTDPRVETFVNYVTGFELQITAWEGKFKLSQDKNSIDQEK
AKQALTNNYADLMEDYLTAIYSRHITKG
>KECLDBNJ_00959 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MRVHFIAIGGSAMHNLALALHHKGYEVSGSDDAIFEPSKSRLAKYDLLPVEMGWFPEKID
DQLDAVILGMHAKPDNPELLKAQELGIKIYSYPEFLYEQSKEKTRVVIGGSHGKTTITSM
ILHVLHYHDREVDFMVGAQLPGFETMVHLTEENDFILLEGDEYLSSPIDRRPKFHLYKPN
IALISGIAWDHVNVFPTYENYVEQFEIFADSISRGGILVYNEEDAEVKRIAEAATAPTRK
HAYATPEYTIESGETLLETPEGPMPISVFGKHNLSNLAGAKWICQHMGVDEDDFYEAIAS
FEGAAKRLEKIGETADAIAYKDFAHSPSKVAATTKAVKNQYPDKKLIACLELHTYSSLNA
EFIKGYKGALDAAEEAVVFYTPEAVALKKLEAISENQIATAFDRDDLSIFTDAEDFKTYL
DTKSFDNAVLLLMSSGNYGGLDFDSVQDLLAK
>KECLDBNJ_00960 Lipopolysaccharide assembly protein B
MHLKFLIALLFTASVFGQQADYEKAEAYFKAEKFEHAKPLFSAYLKAHPKHAKTREYLGD
IAAYAEDWDTAIAYYEPLVEEQPSSANYHFKFGGALGMKALNISKLRALTYIDDIKEHFT
KAAELDPKHIETRWALVELYLQLPGIVGGSTKKAEAYAMELQTISPVDGYLARGYVAEYQ
DEMQEAEALYKKAIEVGGSPTTYEKLTNLYEKKNQPQKAIDNAASSLKLHKRNQINYQIG
KIAAEFDMEPELGLASLKQYIKNHSVKDGVPVSWAHFRMAQIYKNLGDKTRATHYINLAL
ADKPDFEQALEEKRRIEEL
>KECLDBNJ_00961 hypothetical protein
MKHFFIFVLAVVAISCGSTRVDYDYDEQIDFSQYQTYNFMPEMDSGLSQLDLKRLMDATD
AVMQAKGFTKSQTPDVLINIIAEEYEDVQRNSVGVGIGGGSYGGGVSVGAGIPLGGNKNH
QTITLDLVDAQKDILVWQAVSDSNIKVGTNPQERVTHYTKIAQKIFEKFPPEE
>KECLDBNJ_00962 GTPase Obg
MTEGNFVDYVKMHVSSGKGGAGSAHLRREKFVAKGGPDGGDGGRGGHIIARANPNLWTLL
HLKFKRHIKAGHGENGGKQTSTGADGEDVYIEVPLGTVIRDTETQEILKEITEEDQEFII
AEGGMGGLGNSHFKTSTNQTPRYAQPGIDGQEVDVTLELKVLADVGLVGFPNAGKSTLLS
VITAAKPKIANYEFTTLKPNLGIVQYRDFQTFVIADIPGIIEGAAEGKGLGYRFLRHIER
NSTLLFMIPADAPDITEQYQILLHELEKYNPQLLDKDRLIAITKSDMLDAELKAELKEEL
DKNLPIEYMFISSVAQQGLTQLKDRLWAMLNRPAVEE
>KECLDBNJ_00963 Adenylate kinase
MITLNGLQFEEYISEEKLLQAIDRVAEQINLDFKGKEPVFLVVLNGAYKFATELLSRFDG
DCEIEFIKMSSYDGTSSTGQVQTHIPLEADLEEREVVIIEDIVDSGNTIEKITQMMVNAG
VNKYRIASLFYKPAAYTKEYKIHYVGLEIPNDFIVGYGLDYNGLGRNLNAIYKLKTTKMT
NLVLFGPPGAGKGTQASFLKEKYNLVHISTGDVFRYNIKNATELGTLAKSYIDKGQLVPD
SVTIDMLSATVDKTPDANGFIFDGFPRTTAQAEALDKLLAEKGTEVAAMIALEVDDEILV
KRLLERGKTSGRKDDADEAVIRNRIKVYYDETAILKGYYQKQDKYFGVDGVGEIKEITTR
LSSVIDAL
>KECLDBNJ_00964 N5-carboxyaminoimidazole ribonucleotide synthase
MTSYFSSDFKLAILGGGQLGKMLLYETRKFDIQTLVLDPNPEAPSRLAANFFQQGNLMDY
DTVYHFGKRADIVTFEIEAVNVDALEQLEAEGITVYPSPKTLRKIQDKGVQKDFYTEKNI
PTAPYKKYPTLADLKLALTANQSSFPFVWKSTQGGYDGKGVQVVRSQEDLEKLVDTPCIA
ERMIPFKNELAVIVVRSPKGEVKTYPVVEMEFHPEANQVEYVICPGRIDDKVATKAREVA
TQVSEAFEHVGLLAVEMFQTEDDEILVNEVAPRPHNSGHYSIEGSYTNQFEQHLRAILNL
PLGETESKIGAVMVNLVGAEGHTGDVYYEKIEDIMALKGVTPHIYGKRETRPFRKMGHVT
IVNSDLSEARNIAEQVKNAIRVITK
>KECLDBNJ_00965 N5-carboxyaminoimidazole ribonucleotide mutase
MVGIIMGSTSDMPVMQAAIDVLEQLGIKTEVDIVSAHRTPDKLFDYGKNAHERGIQVIIA
GAGGAAHLPGMIASLSPLPVIGVPVKSRNSIDGWDSVLSILQMPGGVPVATVALDGAQNA
GILAAQILGASDEAVRNRIVDFKAGLKEKVIKGAASIKK
>KECLDBNJ_00966 Oligopeptidase A
MKNSENILLQSFDIAPFDAIQNADYKPAIEAAIAQARQEIDFITNNPEPATFENTIAALD
YAGYQLDRVTSIFFNLNSAETNETIQKTAQEVSPLLSEFSNDITLNKALFKRVKNVYDSR
ESLELTREEEVLLDKRYKGFSRNGANLAEDKKARLREIDTELSKLSLTFGENVLAETNKF
ELHLTDEADLAGLPESTKEAAAQTAEEKGKKGWVFTLEYPSYIPFMKYAENRELRKKMAI
AFGAKGFHNDELDNQENVLEIVKLRQERANLLGYKTHAHFVLEQRMAKSPENVERFLQDL
LEKAKPAAEREFAQLANFAKKRDGIEELQKWDSAFYSEKLKQELFELDDEQLKPYFKLEN
VIDGVFTIAQKLYKLRFVEVQDIPKYHKDVKTYQVFDDQDNFIAIFYADFHPRAGKRAGA
WMTQYKGQFKKDGVNERPHVSNVCNFTKPTASKPSLLTFNEVTTLFHEFGHGLHGMLANT
TYPSLSGPSVYWDFVELPSQVLENWCYEPEALELFAKHYETGETIPMVLIDKIKKAANFQ
EGMQTLRQLSFGILDMSWHGADPSGITDVKAHEKAAFENTKLYPDVAENCMSVSFSHIFQ
GGYSSGYYSYKWAEVLDADAFAYFKENGIFNAEVAQKFKDHVLSQGGTEDPMVLYKRFRG
KEPNPEALLKRAGLIQ
>KECLDBNJ_00967 hypothetical protein
MNALIIGNVWPEPVSSAAGTRIMQLLESLQAQGYTVSFACAAGRTPYAEDLDALGVQTHN
IQLNNASFDVFIKKLNPDLVLFDKFVIEEQFGWRVKEQCPGALRVLETIDLHGLRKGREA
ALKANEAFSEKYLHTDYAKRELASIYRCDLSLIISEAEMQLLQEIFKVPDAQLLYLPFMV
APITLEEQQAWKPFETRKHFVTIGNFRHEPNWLSVRYLKTEIWPLIRKQLPDAEMRVYGS
YPAEKHTQLHNPKEHFYVLGRAESAHEVIEEARVLLAPLLTGAGLKGKLLDAMQCGTPAV
TTSVGAEGMHGELDFNGSVVDDPKAFAEAAITLYKNKNKFTEAQTNGVNIVNERFSKEAW
NSVFQKRLSDIQANLEKHRLSNFTGAMLWHQSLQASRFMSKWIEEKNK
>KECLDBNJ_00968 hypothetical protein
MEFNEAKAQFLQTWGALGSQWGINKTMAQIHALLMISPDSLSMEDVMEELQISRGNASMN
LRGLIDWGIVYKEYKPGERREYFKADQDVDSLARKIAVERSKREIKPAIRVLEGVKNFDE
TDKSPEALKFKMKTQELHDFVNKADTMLEKIVNQKENWITKTIMKLMT
>KECLDBNJ_00969 hypothetical protein
MNTLNYFIIAGGFGQIFTAMIYPFIRHRVFDWYNDVKQLKPLNQEIAKTYGHYIQGLNFS
FGLIAIVIPKHLANGSALALALTSLIAAYWVGKVATQIAYYPMYDIPKNPIFKIGSYGMN
TLFVFFATLYTALCAFNLYQLL
>KECLDBNJ_00970 Glycine dehydrogenase (decarboxylating)
MRTDVFSLRHIGPRPEEKEEMLKAIGAENIDQLIYETLPDGIKLKKALDLEPALSEYEYA
THINALANKNKLFKTYIGLGYHESKIPAVIQRNILENPGWYTAYTPYQAEIAQGRLEALL
NFQTMISDLTGMELANASLLDESTAAAEAMTLLAAVRSRDQKKNDVVRFFVDKEVLPQTL
SVLETRALPVGVELVVGNPQEFDFSSEFFGALLQYPSASGEVHDYAGFIAKAKEADIKVA
VAADIMSLVLLESPGHLGADVVVGTTQRFGIPLGYGGPHAAYFATREEYKRNIPGRIIGV
TKDRNGDRALRMALQTREQHIKRDKATSNICTAQVLLAVMAGMYGVYHGPKGLEYIATKI
QRTAATLADALESLGLYQLNSAYFDTIRVKTDAATVRKYAEANEINFYYPDAETVSIAVN
EATSLSDLNKVISVFAEALGKEFTHLEALVDEITIPEALGRKTEFMTNEVFNSYHSETEL
MRYIKRLERKDLSLNHSMISLGSCTMKLNAAAEMLPLSDARWGGIHPFVPVEQAEGYQTV
LKKLEDQLTEITGFAGTSLQPNSGAQGEYAGLMVIKAYHESRNDHHRNICLIPSSAHGTN
PASAVMAGMQVVVTKATDAGNIDVDDLREKAEKYKDNLAALMVTYPSTHGVYESAIQEIT
SIIHENGGQVYMDGANMNAQVGLTNPGKIGADVCHLNLHKTFAIPHGGGGPGVGPICVAE
QLVPFLPTNPVIKTGGEQAISAISAAPWGSSLVCLISYAYIKMLGAEGLKQSTEAAILNA
NYIKERLKGAFEVLYSGEKGRAAHEMIIDCRPFKDNGIEVVDIAKRLIDYGFHSPTVSFP
VAGTMMIEPTESESKQELDRFCDAMISIRKEIDQATADNDNNVLKNAPHTMHMLTAETWD
LPYTRQQAAYPLEYVADNKFWPSVRRVDDAYGDRNLICTCAPIEEYMEEA
>KECLDBNJ_00971 hypothetical protein
MKSLKGLFDFYINSSIHVAFAVLALALITEKQLDLELDLYFNLFIFLGTITGYNFVKYAA
LAGLHHRNLTDRLKMIQTFSFICFIGLVYVAYQFTVSFWISCIPLALLTVLYAIPFLPHK
TNLRKVPSIKIFIIAAVWAGVTVYLPVAYSVTNFSTEFYLEIAQRFMLVLALIIPFEIRD
LTYDSNALGTLPQVLGIKKTKLVGLSMVLGCMVLEAFKANAFSTYAILLLTALAIIRSNS
KQPHYYASFVVEGIPILWGIFILAF
>KECLDBNJ_00972 ECF RNA polymerase sigma factor SigX
MADHQLDPQKWVDKYSDYLYNYTIVKVNDKEVAEDIISETFLAGLKSMKNFKGEASERTW
LISILKRKIIDYYRKINSKKGKAEVRMNYADDEEGGDWLEERVADPFDRTAEDELENTEL
GVAIYACLGKLPEKQAAIFRKKTIEGQDTETICKEFDITPSNLWVIIHRARTALASCLEE
NWL
>KECLDBNJ_00973 hypothetical protein
MYEKTFPNKRYAITARFLKNTVPTGAEILDLGVSNPFSEIMKAEGYSVTNTGGEDLDLDT
SAVKNTNAEVVTAFEIFEHLLAPYQVLKDIKATKLVASIPLRLWFAPAYRSKTDMWDRHY
HEFEDWQFDWLLEKSGWEIKKREKFTHPVKKIGFRPLLRLFTPRYYIVYAERK
>KECLDBNJ_00974 Undecaprenyl-phosphate mannosyltransferase
MKLVIIIPAYNEAALIGKTLDSLLAQRFSAEKIVIVDDGSTDETPNVVLEYAEKNPSIQL
IQKSSEAAHLPGSKVVQAFNYGLERLDTDYDILCKFDADLIFPENYLETVVKAFEQNQNL
GMYGGFCYVERNGSWELENLTNKDHIRGALKSYRKACFEAIGGLKTAMGWDTLDELLAQY
HVWEVATNETLHVKHLKPTGHTYSAKAKYKQGEAFYGMRYGLALTAIASGKLAFRKKSFK
LFKDYLNGYFKAQKKHLPFLVTQEEGAFIRKLRWSKIKQKLF
>KECLDBNJ_00975 Alkaline phosphatase PafA
MNLSPLKSLAFGLIALTGTVSFGQKTSQKPKLVVGIVVDQMRYDYLTRFENQYGEDGFKR
LQNEGFDCRNNHYNYMPTKTAPGHTSVYTGTTPQNHGIISNDWYNKFEKKHVYCAEDTTV
ASVGTDAVGPGQMSPRRMRTSTITDQNRLHTQMRGKTIGISIKDRGAILPAGHTANGAYW
FQGGDEGVFITSTYYMDELPKWVKDFNKKKPAKAYMKDWDTYKPIKTYIESGEDLNAYEG
GFRGKETATFPYDLKKLGKENGGYSILKTTPYGNSITTDFALAALEGEDLGQDADTDFLA
VSYSCTDYVGHNFGVNSKEVEDTYVRLDLEIAKLLSELDKKVGKGNYSVFLTADHAAVHV
PSFLSDNKIPSGYFDMRSFRNELETFIQQKYGRDDLIEDISNDQVFFRYTVLADESIDAE
ALQKDIKHFALQHKNISKVFTRAQMEQGSYDSGVAALVQKGFDQERSGDVFFILDPGYLT
GGPTGSSHGTPYSYDTHVPLLFYGNGIKNGHTFEQTVITDIAPTVAALLGIQDPNGTTGT
VISEVLE
>KECLDBNJ_00976 putative phospholipid ABC transporter permease protein MlaE
MGYLKEIGLYFMMLKGVFIKPTKTSVLRNLVLKEIDDLIIGSLGIVCFISFFVGGVVAIQ
TALNMDNPILPKSLIGFASRQSIILEFAPTFISIIMAGKVGSFITSSIGTMRVTEQIDAL
EVMGINSLNYLVFPKIIAMLFYPFVIAIAMFLGILGGYAAAVFGGFATGDQFIQGLQEEF
VPFQLVYAFIKTFVFALLLATIPSYFGYYMKGGALEVGKASTTSFVWTSVFIILTNYIIT
QLLLS
>KECLDBNJ_00977 putative ribonucleotide transport ATP-binding protein mkl
MIEVQNLKKGFGGDELVLKGISTTFDKGKTNLIIGQSGSGKTVFLKCLLGLFRPTEGKIL
YDGEAYSELSSEKQRTLREQMGMVFQGSALFDSMTVEENIMFPLKMFTKQRKAERRERAN
EVIKRVNLINANNKLPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPRTATLIDNL
IQEITHEYEITTIINTHDMNSVMEIGEKIVFLQKGHLAWEGSKETIFKADNDDVTNFVYS
SDLFKKVREAVLKENQ
>KECLDBNJ_00978 hypothetical protein
MEEQKKVGDNVSNEAVKRDAKSLWRSVRVFLSELLDIRSDTDRDSTIEAVKKDISFKGHN
AWILIFSIFVASIGLNVSSTAVVIGAMLISPLMGPIVGIGLSLAINDIETLKRSLINLAV
MIILSVLTATLYFAVSPISELTPELEARTYPTILDVLVAIFGGLALIVAKTKKGTIASVI
FGVAIATALMPPLCTVGYGLAMGEWHYYAGAFYLFSINAVFIALSTFLVAKFLRFPMVKY
ANSKRRRFVTQMASLIALVVMIPSLYLFYILYKEQVFTSATKDYVTRVIRYEGAEVVKFS
QDYKSKRIDVYLIGALVPKAKIEEWYTQLTEDASLADVSLKIHQGSDQSSQMAEQLSSAV
KSGILEDLYVNNQQALADKNSQIQLLEDEINRLKASALPFQSLSEEVHINYENIARFGFS
NTINTNFEKADTIPTFLIEWKPSLSERTKRNEEAKLKAWLKVKYNLDTLSVARY
>KECLDBNJ_00979 Alginate biosynthesis protein AlgA
MTNHNYYAIIMAGGVGSRFWPLSKASYPKQFHDILGAGETLIQRTFGRLSQTVPSENVLV
LTNEKYKGLVNEQLPEVKDENIVLEPAMRNTAPCILLAALKIYKANPDGVMIVAPSDHWI
ENEKAFLTDLNTAFEACAEDTSEEKLLVTLGIEPTFPHTGYGYIQYNASTAAVKGVEAFK
EKPDYETAKQFLAEGNYSWNAGIFIWSARAIIEAFEKYLPEMYALFNSGFEALNTEAEQQ
FILDNYAKAENISIDYGILEKSGHVGVIPATFDWSDLGAWGALYDNLGKDQDKNVIVNAK
TVLREAQGNLIRSEKGKVVVVEGLNDYIVVDSDDVLVIMPKAKEQDVKIIRAEVEKQFGS
DLV
>KECLDBNJ_00980 Protein SprT
MKQILGKYIPEQAVDPVFELIKNFGVHLKIVDERVTRHGDYRRLPNGGHQITVNTNLNSY
RFLITLIHEIAHLVAFVKFGNRIKPHGKEWKYTFQNLMLPFIRPEIFPKQLLPVIANHFK
NPKASSDTDAKLSLALKQFDPPNDKNYIFEIPRGSLFKLYNGKVFQKGERRVKRYECVET
ATGKVYLFQPNAEVELLT
>KECLDBNJ_00981 Diacetyl reductase [(S)-acetoin forming]
MSKKIIITGTSRGIGFEMTKLFASEGHQVLALSRNEKPLKEQALERIEAFPFDISKTEDL
HKVASYVKTEWGGSADVLIHNAGALINKPFESLTQLDFQKVYEVNVFGVAALTQAVLPFM
KSGSHVVTVSSMGGIQGSVKFAGLAAYSSSKGAVITLSELLAEEYKEQGIAFNVLALGAV
QTEMLEEAFPGYQAPLSAQEMAAYIKNFALTGNAFYNGKVLQVSASTP
>KECLDBNJ_00982 Bacterial leucyl aminopeptidase
MNKIILGLLSLTILSCGSTPEVRQVDAAAAANASKEYAVSNEPAESITTSAAPNPNAVTF
KKNVSASAIQKHIEFLASDALAGRKTGTEGIDEAANYIIKEFQQAGVKPYFTSYRDKFDA
KGLDGYNVVGMLEGTDAELKNEFIVIGAHYDHIGTADAVGGDTIANGANDNASGTSAVIE
LAKYFAKSKTNKRSIIFALFSAEEMGLLGSAHLAERLKTTNINPYVMFNIEMIGVPMTDK
DYSLYLTGYEQSNMAQKFNAYAGAKVMGFLPQAKQYNLFKRSDNYAFYEQFKIPAQTVST
FDFTNFDHYHNVGDEAAAMNFEHVANIVNQLIPGVEGMANSATQEIIWNE
>KECLDBNJ_00983 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEVIKMPRLSDTMEEGTVASWLKKKGDKVEEGDILAEIETDKATMEFESFYEGTLLHIG
IEEGETANVDALLAIIGEEGEDISGLIDGSADADSESEDEEETSENDSADDAEASSEEES
DDTSEEETSDDAGSEIPEGVEVVTMPRLSDTMEEGTVASWLKKEGDSVDEGDILAEIETD
KATMEFESFYKGTLLHIGIQEGETAKVDALLAIIGEEGTDVSGVISNFKSGGAKKEAPKK
EEKPKKEAPKKEEAKKEAPKKEAPKKEESKPAKNTSSSDGRIFASPLAKKLAEEKGIDLA
KVPGSGENGRVVRKDIENYTPAASGAGVQQFVATGEESYEDVNNSQMRKAIAKSLGKSKF
TAPHYYLNVEFDMENMIAFRSQFNQLPDTKVSYNDMIIKAVAIALKQHPQVNSQWFDDKM
RLNKHVHIGVAVAVPDGLVVPVVEFANEKSLQQINAEVKELAGKARNKKLKPEEMQGSTF
TISNLGMFGITNFTSIINQPNSAILSVGSIIEKPVVKDGKIVVGNTMTLSMACDHRTIDG
ATGAQFLQTLKTYIENPVLMLA
>KECLDBNJ_00984 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKEITKEVYLNWYEEMSFWRKFEDKLAQVYIQQKVRGFLHLYNGQEAILAGALHAMDLTK
DKMITAYRNHVQPIGMGEDPKRVMAELYGKKTGTSMGLGGSMHIFSKEHRFYGGHGIVGG
QIPLGAGLAFGDKYFKRDAVTLTFFGDGAARQGSLHETFNMAMNWKLPVVFCVENNGYAM
GTSVKRTANHEDIWKLGLGYEMPCGPVDAMNPVAVAEAFDEAIARARRGDGPTFLELKTY
RYRGHSMSDAQKYRTKDEVAEYQKIDPITQVKDILLEKEFATEEELKAIDKRVKKRVAEC
EKFAEESDFPEKEVMYDVVYEQEDYPFLAHKPE
>KECLDBNJ_00985 Cytidine deaminase
MKKIKIESELEVFEDFSELPQEIQRLMEAAFEARDSAYAPYSEFHVGTALLLSNGKVIKG
SNQENAAYPSGLCAERTAIYYAGANFPDETLEVMAISATAKHKPTTTPIPPCGACRQAIA
EYEVKQKQPVVIYFMGASGKIFKSDSLSNLLPFLFTQEYL
>KECLDBNJ_00986 hypothetical protein
MNRSLLVLGFCFTVLQNLNAQEVEGRPITTGVPFLAIAADARAAGMGDQGVATRPDAYAQ
QWNPAKYAFIEKQQGVGFNYTPYLSQIVDDIFLGQITYFNRINDRSAFAGSLRYFSLGDI
ESIQSSNPSQAELENPLILSPNEFTLDVSYALRLGDRFSMAVAGRYLRSNLKLQINDEDA
SAASSIGVDIAGFYQSEEISYDDFNGRWRAGFNISNIGPKIKYDEAGQENFIPANMRLGG
GFDFILDAYNVIGVGLEFNKLLVPSPQDFNGDGVIDGSDTEEYQAIGFFEGMFQSFGDAP
NGISEEIKEVTWSLGAEYKYDNAFALRAGYFNESDLKGARKFATLGLGFRYSAIDIDVSY
LFSTTQVRNPLENTLRFGITFNFGNEYIEY
>KECLDBNJ_00987 hypothetical protein
MQNNYLKFFLFFVLLSVLNTEVFFGQEKTHEISWQDAVNVSFSAKPHQVPGFAPEHFVYA
VRSGVRYADKWKTNETFDLKSVRLERVVYETLSPSALKQLRLEQVPESHNLQVEFSGARG
TRYFEYSFAPIIQQNGVVKRVKRFTIAYDRIRSTISTQHKNPQRSNSILRSGTFYKFYVD
TTGVFKLDYDFLQRLGFNPRTINPQTLKIYGDGGAMLPLKNEDNTVFDPQELAIKVVGGE
DGSFDREDYILFYGEGTRQFNAESLTHVNAYDDRSYYFITADGTSGLRVQSLVEPTTTAT
RTITTFRDYQFYERDEYNLLNLGRRWFATRFDVENLQGFEFNFPNRVADAAVDLRVYTAA
ISESSTYFAVRVNNQPVASLNILPINESVLAREAFYDSYAYPAANPTVTTAGDNISVQLE
YNNSGNPSSEGYLDFIGVGATRNLSGTGGQLKFNGIAPEVSNEIGRYQLQNASGFAEVWE
ITDQSTVRVVDNSEALATLTFQTYLNAAKKYVAIHPDDYFEPLIDPENTSVANQDLKGTI
FQSSGSFEDVDYLIITNDLLRSQAERLANHNRLYRGLRVKVVALDEIYNEFSSGKQDIGA
IRNLVRYVYANASSAENRLKYLCLFGDTSFDYKDRVDRNNNMVPTFNTYYSFSQSQSYMS
DDYFGAMDATEGVIENNSPAGSGGSDRLDIAVGRILADTPMLAKTAVDKIISYDERASFG
RWRNNFVLVSDDVDQPWEFEELESTIDALGDQIQQEKPFINVKKIHADSYQQQSSAGGDR
YPEVNEAIIDALESGALVMTYLGHGGENTLASEFIFTRENAQNLANGERLPLIVTVTCEF
TRFDNPNRVAAGEELFWNDQGGAVGLVATTREISVRLGVLFNEALASNLFSFGTNTIKSV
AENLRETKNQINDDNRRVIFFIGDPAMKLAFAKPDIRLTAINDTPITQQVDTLKALSRMK
MSGEVVDENGQLLTDYNGKLSATVYDKYINQQTLGNDGVTDANGNLLILDFKTLGAILYR
GQASVNDGLFDFEFVVPRDAAIPLGNGRVNFYSVRDGVLEDQAGANEQILVGGLNENAAE
DNEGPIINLYMNDENFVSGGITNTSPTLLVKVEDLSGINTAGGIGHDLIAILDGDEENPI
ILNDFYESDVDNFNIGQALRTLRDLEPGLHTVTVIAWDTYNNSSTADLQFVVAGDEELKL
ERVLNYPNPFVNYTEFWFNHNRPYEPLEVQVQIFTVSGKVVKTINQVVTTTGFLSREITW
DGLDDFGQKIGKGVYVYKITVKSTLTNKKVEKFEKLVIL
>KECLDBNJ_00988 Hercynine oxygenase
MNRNLVFRTLVFGLSTILFVSCGRNGKDYKNSSRATGWSINDRDGGFQANTDYKEQEAAP
GLIFIEGGTFTMGRVQDDVMHDWNNTPTQQHVQSFYMDETEVTNLMYLEYLDYLKRVFPP
EEANYRNIYYGALPDTLVWRNRLGFNETMTENYLRHPAYARYPVVGVSWIQAVEFSTWRT
NRYNEYVLEQEGFTQKGAKYNVDAQSTFDTDTYLQAPSLTYGGQDDVIRGGKASAQREKN
NTPRANPNNPGAGTEAKDIYVQMKDGIISTTKYRLPTEAEWEYAALGLVGLREYNVYRGR
KKYPWDGAYTRSGNRKTRGDQLANFKQGDGDYGGIAGWSDDNADITAEIKSYEPNDFGLY
DMAGNVSEWVADVYRPIVDDEYNDFNYYRGNVYTKNAINEDGTVKILTTEDIVYDTLENG
KIVARNLPGEILQVPVDDEETYLRTQFSESDNRNFRDGDKQSSRYYQSFSDTESDNDRMY
DSPVNRISAGEEGMVKEYDKQNDRTTLVDDEVRVYKGGSWRDREYWLDPAQRRYLPQTMA
TDDIGFRNAMSRVGSKSTKNKSPRN
>KECLDBNJ_00989 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MTIQEIHHLFLESDGISTDTRAIRKNTLFFALKGANFNGNTFAYQALASGASYAIVDEEA
FDTGDKTILVTDVLKTLQELAYTHRKYLDIPILALTGSNGKTTTKELINKVLSKKFNTTA
TQGNLNNHIGVPLTLLSMTKNTEIGIVEMGANHIGEIAELAAIAAPDFGYITNFGKAHLE
GFGSVEGVIQGKSELYEYLIAHKGTLFLNLDDPIQTKKVKSTHSFCFSALEDADTKIVYQ
EAQPFANFEFDDLHVQSNLMGQYNTINLAAAATIGMFFKIDKTAIKEALESYIPTNNRSQ
IINKGKQTIILDAYNANPTSMAAALQNFSDLKGANKIAFLGDMFELGDTAHEEHQIVADT
CANLNIDYTVFLGKNFGKVKTSGYKYENLEALENSGFPEVLQDKLKEATILIKGSRGMKL
EGLLDLLDSNN
>KECLDBNJ_00991 Inosose dehydratase
MSLIKRTTFYNRFFLLLVLTTFAISCGEKKKSDSETTQITTETEEASNFGGLALYTLRDA
MAQDPKGTLQTVAEDGYAYVEAAGYEDGMFYGMTPEAFKSFLDSINITPMSTHQGSVSLE
NANQMIADVKAAGFKYFVVPVPPMGMFTFDAESQTLGMEGTPKELADILTTLGKKCKEQG
LTLLYHNHDFEYKENAEGIIPIDYLLENTDPEFVNFQMDLYWVTKAGADPVAYFEKYPGR
FKLWHVKDMDDQGRFAPVGEGSIDLARILANKEKSGMEYYFVEQDQTFNHEPLEAIKISH
KALGELGFE
>KECLDBNJ_00992 Tyrosine recombinase XerD
MATVRVVLRKKKNKAGRFPIAIRITKDRKSSYLNTGQYIDVKFWDEKNRNVRKSHPNSKM
LNNFISTKVAEANDKVLKSEMNPEYQTVSDIKTKIIATKGLDFFAVAEMHLQNLKNRNKH
HQYDTELGRIKKFKEFLDKDILPFNKLNSTVLKKFETFLLHKKKLAPRTVVNYLILIRTI
FNLAISESIADRGLYPFGKGKMTIKIPEAQKIGFSADEIQKLENANGITEAQQKAIHIWL
ISFYFAGIRVGDVLKLKWSDFNDGRLLYRMNKNSKLVSLKIPDKAIEIFNHYKENSNYNG
LVFPQLKGVNLNNTEEVSKRTQSITRNLNRRLKIAAKSLGIQKNISMHIARHSFGNISGD
KISIQMLQKLYRHSSVTTTIRYQANFIHKDADDALDSVVNF
>KECLDBNJ_00993 hypothetical protein
MVLKVKWIDFKSQIDKYIIEGEALVEKYKSSRTEEEFAELKASKQSWENNVIEFVKKSFE
PEHINFAYEFKAQRGYNLGMKLGIDQKIKNVIQALKDEINGLEYYLKILFISDAIIRADE
IDLEERKTLDTEGKLDFILSKLYDLYDDRKYHSIKWILEGNGIELCGHSEDWDFGRMLEN
RNLIECLNGKDVNAKLTLEGKYAIEQARKAQVTDYSKISSSEEELKALIESVLKEVKKLG
MGQQIIFDEFDELRDDIPKLSKKSFGQLLKSKLYDLVTAKALDKALASEIFKEFTNQVLP
F
>KECLDBNJ_00994 hypothetical protein
MKLFARFRNKLKKLFQKNKQPEYEVTQFVFSDRQRIDGKSTISFFVNNPKPDVSVTRTFE
SEDETVNSLMDNNDFRRMLFENLFPASNSVKYHCGIKEPITVPNKMPGDIDILLFEDGQP
ENTIGIECKIVKSKSSENKPPKINKVNSVQKKGTQQANGYAEIGFSRVYLMVILLDDGRH
YKNPNVMFRSTPTEWLDELYGFDWDSRLDSDIGIIYTHVNQFTSNHINQTKGLGLRVERE
AVTKEQDEGLTEKIQSLIRHAKVLAEYAANLAN
>KECLDBNJ_00995 hypothetical protein
MYGKRIRSNQGAGGYYLCKSCNNLTGSYYGESYKKFAYMGMMAVTNRIWASKVIAFEYAI
QPLNILKQVLSMFMSIDTSDQLLNLERLSKFLLDKDSQALPENIRVFVYHTATKQVRNGW
GMARTEKGFHTLGEITYPPFGLVYALDSEPTRNDFFEISGFKNYVFNQTVQARLTIPFLT
PKTYIPGLYT
>KECLDBNJ_00996 hypothetical protein
MLFLFQGMGTDMDMCEQLEKISNFITHYQEHKVYDGDSFFEFIVEDYFNDDGDKEGHHDG
SEKDKVPNHTHHQCCHPVVFIANSNSIEIKAHWPESKSQFDHYTSQFNSRFLESLFQPPR
V
>KECLDBNJ_00997 Cobalt-zinc-cadmium resistance protein CzcA
MINRIIDFSITNKLIIGLFTLLIAGWGIYSLNQIPIDAVPDITNNQVQVITTSQNLAAQE
VEQFITYPVELAMANIPGVVEIRSISRFGLSVVTVVFEENMGTYLPRQLVNEKLKEAEEN
IGADLGTPSIGPISTGLGEIYQYTLEVEPGYESQYDAVKLRSIQDWIVKRQLSMTPGVVE
ISSWGGYIKQYEVAIDPSVLNSYDLTLPEVFNALQQNNANTGGSYIEKGPELFYIRSKGL
AKDFEDIRQTVITNRNDVPLTVGQIGEVGVGKAPRYGAATKDGKGETVVGIVMMLKDANS
ADVIARVKDNVARIQQTLPEGITIKPFLDRTRLVEKTTSTISENLIIGGLIVIFFLVFLL
GTWRSGLIVASVIPLSMLFALGMMNTFGVSANLMSLGAIDFGIIVDGAVIIIEAMVVLLV
ARLAKLKKLSKEERKSEVNKLAFKSSSQMMNAAIFGQIIILIVFIPILTLSGIEGKMFRP
MALVFGFAIIGAMILCLTYVPMIASSLLYSKKLDKETWGDKFMGWLERRYRPVLDWALSA
KNLVVIGAVVLLGISIFIFSTLGGEFIPKLDEGDFALETRMAPGTSLEEMTKNMGKLEAI
LLDKFPEVKTVVTKIGAGEIPTDPMPIEGADIMVSLKNKDEWTSTDSKEELAEQMEEALS
VLPGVDVEFSQPIEMRFNELMTGVKQDIAVKIYGEDLELLQEKGNQAGEIIRGISGAADV
RVEQVVGLPQIVIDFKRNRMAEYGLTISELNQIVSTAFAGATTGKVFEGERRFDLTVRLQ
EKSREGIASIQNLYVPLANGQKIPLREVADITFEDAPAQISRDDTSRRIVIGVNVRNRDT
QSLVEEMQNTLQQRLDLPPGYSVTYGGEFENLQRAQKRLSLVVPLALVLIFVILFISLRS
LKQSLLIYTAIPFAAVGGVFALWLRGMPFSISAGVGFIALFGVAVLNGLVLISSLNELKA
DGVTDLKTRIRKAAKSRLRPIFLTAVTDIVGFLPMALSGSSGAEVQRPLATVVIGGLFTA
TLLTLIVLPVLYSWFEKPKKIELNPSIATVLILLLVSFSTHAQTGKESKGVSLEQLKQRA
IANNPMLKADSLNISKNRKLQATAFNPSNTSFFYSEEEVPGNGVNQSNLGSGINSYGISQ
NFDFPTTYIQRSQLLKQRTVVSEKSYQLQRNELERQVATAYYKWVNGYQKVQFYNRLDSL
YTNFEKAAKLRYETGETTKLEQLNASSNRKQIELRLKESKVRYNSAVLELEQLTASKISA
EVYPSEIKHTPLLIEDGNDLLTEGNAFLSYRNELVNLAEEETDVQQSQWLPDINLQYSLQ
TIDGTSGFYGFQAGISIPLIFNSQKGNVQALKIERMRQEELFKNEKLTLSKRLATATANY
EQWLQQVAYYEETGLPMSEELFDGASLSFRVGGIDYIEYIQSLSEATNIKINWFDALLNY
NLSVVEVEYLTTKK
>KECLDBNJ_00998 Cobalt-zinc-cadmium resistance protein CzcB
MNYLSKIAAFGFTVLSLTACKDNQTDTAEIETENPEMGHHEEGHIALTQSQAEDAGFTYG
TFDQEEIKTPIEANGAIELPPNNMASISSLLDGFVVKINFLEGDVVKKGQILVELKDPAY
VKLQQEYLSVYGRLSYLKQELDRQQVLNDADVGAKKNLQQAQSEYSAKKAELAALKEQLA
YVGIRASAIENGKIQNRVYLRAPFGGTVTSVSAHNGQKVVSGQEIMQVINREHMHLELQV
FQKDIPKVRKGQRVQFTVPAFEGSPVFEAEVSLVGKNLDMVSKTIRVHAHFKENEMLIPG
LYTEAKIMQDSKKTRVLPTSAIISDKGTSYFFIKTVTNGNEINFEKVAFEPGIKSDQFVQ
VKSYDEIQDTTAIVLKGAYTLKAVMNKSEGGHQD
>KECLDBNJ_00999 hypothetical protein
MNTKRKQDLKEARTLQIWNVIYDVIEVVVSLIAGFTANSSALIGWGLDSTIEVISAGTLG
WRLHGEIKGIDERRVEKRKMITLYVIAISFALICAFISYDSISKLISQETAFWSTIGIVI
LMVSLVVNPILIYYKRKYGNKLDSPALKADAKDTFICLYQTVVVLLGLLLVNWLGWWWAD
PIAALLIVPYAAKEGWEAFTKAKNIKKNLDK
>KECLDBNJ_01000 hypothetical protein
MKEIEKTLENKSVRPTAMRILIYKYLAEKEVAISLTDIETAFAKAERTTLYRTLKTFEDK
GVVHQIDDGTGIQKYALCEPGCNCDLEQDLHLHFHCNNCDETVCLTEHKIPHINLPEGYI
AEDANLVLKGICEKCSGQ
>KECLDBNJ_01001 hypothetical protein
MIQFIDTQKENLIAAMLSDKLDEENLKTVHERIHQIIDKGHKVDFYFEMENFEGYTLKGF
WEDIKTDAAHINDYGKMAFVGEKKWQEWAAKATDFFTSSEVKYFDLKDKEQAKIWISK
>KECLDBNJ_01002 Zinc-transporting ATPase
MKKKKVNLRDIDPKEHKGEHSHDDGHNHSSQEELSNFRTYLPAIFSFVLLIAGIAIDYFD
AFPFFKGWIRVVWYTVAYIPVGFPVIREGWNSILKGDFFTEFFLMSIATLGAFAIGEYPE
GVAVMLFYAVGELFQNAAVNRAKRNIKALLDVRPNEALVYRDDDFVSVNPETVEIGEKIQ
VRVGEKVPLDGILLSEKGSFNTAALTGESKPDTIAKGEKVFAGSINLDGVIEVETTKEFK
DSSIARILDMVQNATARKSKTELFIRKFARIYTPIVVFLAIGLTFLPYFFVDDYVFRDWL
YRALIFLVISCPCALVISIPLGYFGGLGAASRNGILFKGASFLDAMTKVNTVVMDKTGTV
TKGVFKIKEVVNKSAFAEAEFMQYLMAMEEQSTHPIAKAILEYKADGADLEATEVSEVAG
KGLKGTVNGKTVLVGNKALMTSNSIEVPSETDSIVESIVMVAIDGKFAGYVTIADELKED
AHQAIKQIREAGISKIIMLSGDKDSITQQVSKELNIDWAKGGLLPEDKLNEVEELKKQPD
IKVAFIGDGINDAPVLAASGVGIAMGGLGSDVAIETADVIIQTDQPSKIARAIKIGRSTR
SIVWQNIGLAFGVKVIVLILGAGGLATMWEAVFADVGVALLAILNAVRLQRMKW
>KECLDBNJ_01003 Glutaminase-asparaginase
MIHILTTGGTIEGLDYVDGKGISQSNISIQGFLDKANIGFDYTIESVFKKDSRAITNNDR
AQLVCKIKESNATKILITHGTFTMEDTAKYIGRLNLKKTIVLVGSFILGSSENTDAPFNL
GYAISSLQLLKPDVYIAMNGQIFLWNNVSKNLETNKFERNE
>KECLDBNJ_01004 Spore germination protein GerE
MFGTSIHWTTFFYLLIDTFIVLLTLYFSRKKTRSSLRRFLYLGILFIAYNATGGFLPVEN
FPGPFILQYIITYGVAIALCVYIVYYLYKEYDIVVLKFNSSIRNLAILASVSFVVLFLIP
YFLTESLKSARFLFTIPISIIAFIFLFIFYRRIANPSNPNTFIVRRNKLSMVSVASIALL
PICTVIGDYQWITFTVMNLAFFAITAIEADRYLYFIENNNRMYEVFALKKKQRDESVERK
IIYEDLTRREIEVALSILSNLSYKNIAKDLFIAESTVSKHASNIFKKTGVKNRREFLKRF
RKKK
>KECLDBNJ_01005 hypothetical protein
MNSQLLSQKLLKDLDEIKIQNGNIIESAYLSIKACRKLLSAYKKEIIKTKFKTVQDEINF
FKNTKQIPLIKLIYFSEIHSFEIQLPKGDKDAQLKSIKKKINKINRFFLYNIDFGRYVNS
GATHFDKEYYTRDYLETFHITTSKFYFQDPEFCTPRDMLLGKYKAYDYLVTYFDEKKDRV
RNGLNGKHKSIKSMEKIDWPFSNTDYVELLYALCSKGLGKQNNQGIMQVSKKLEQLFNIE
PKDIYKTFQDIKNRKNSRTLFLDELSTSLLIEMDKSEE
>KECLDBNJ_01006 hypothetical protein
MPTSIITTDDLREFKMELLDDIKKLLTRQASGKLKKYLKSSEVMDLLQVSPGTLQNLRIN
GTLPYTKVGGIIYYDSEEIQKVMDANRVHHGLNS
>KECLDBNJ_01007 hypothetical protein
MNYIKLLNAAFEKFYFDDRLNPTHISLYMALFQEWNSSRFMDEFYVNRRELMGVAKIGSK
STYHRCIVELDSWQYLSYFPSNNPYKGSKIKMAIIGTSDEPVVGQYNPILEQLAEQYHPR
GVPLEGHHHPKNGQVVYQHRPTDGQALVSNTNNIKQENNIKQPKGWQAVVLFFEEKGFDA
DEGKKFYEHYADREWKTSDGKPIRDWRSLATNWMDRTELFEEENKPNKKEVSQIKDNLRT
TKNKDYGQPL
>KECLDBNJ_01008 hypothetical protein
MDNPSKIIEGGVEYSLGKFDGKSVLYDFPKILIYLNAKGKLLFGKKFRIYDEDKDILLKL
CSYFIKDKENCNTYGIDIEKGILLSGPVGCGKTSLMKLLRHLVPLQRPYEMIPCRNVTFS
FNHLGFKTVEEYGNTKFYCFDDLGVEPSGRFYGKDLNVMGEVLLSRYELYLDTKRKIKTH
ATTNLNAEELEERYGNRVRSRMRELFNLIAFDKAAGDKRK
>KECLDBNJ_01009 hypothetical protein
MDSFNLYREAKDQYEKLIPERNDGLILLSLYGKFKDKDFTEENIIAAITKVFKDQGNESS
RTEYNRNNAIILRFQESFLWRNTSKRTYQFKKYGLELCQNIEKRLIEKYNPAKIKRFFAE
LYKSLSENIEEGRDFGEWIEDHFELRLPELTTQIEILDQQVNDSVKDFKAGIKSEDQNIL
SSLREIEIRLEIIKEQATELRNAFQISYDIDDLLIGLLEGNNGNINSLDIQRVQNFHNES
RSQLEQVSKRIEKIKPRIREFIYDFNQKNFDRKTKRFIDHLLEKSTVVREGSSKRIILPD
GLKGLAIKFSDHNPKLNIIPNRNISPKLPISVTKKTVDTIKRKELLEKTLKWKRDKEKIS
YWTKLAFKELEEKGKFDFTPLFFKILKEDKITIAVKTAHSIIRKKTAYRNKYKIDIKTEA
QSDTNKKGISIWQMTLQKK
>KECLDBNJ_01010 hypothetical protein
MANDITEKIEPYGFLYNKRAKSIFAKLDYTLRNGIHIQREYPKNVNLYRFLSDADNFESL
KSYYEEFYNLVLVKEGSDFNSYYYLNLNDDGTSNVPSDNREYLKSEFIIIGMLFLKMYKL
DGNIELDSISDFTSLLYEEYDDQKNALRKLINDNSSDKSTDLGDQRFENVISKSFEKFGD
LGWLVWDKDSDKNKFKVMPSFERLRIIYQPQIETIDDLINEVKDAE
>KECLDBNJ_01011 hypothetical protein
MQNNYPRIYSLSTIGIKQHFNADYIFHQYRTDFSGESGSGKSMVADMIQLILVGSGEFKS
ATQGNKHRDVKGMLISRKGKTLARGYVFLNVEIKPKKYIVIGAYIEGTSNAAEMFIIQDG
YDWNELAPLHKPILNKDLIVDNKVDTLSNLCDTIQFARMKSFRRKTYHQILFDNNIVSLD
LTKSETLKTYANILRSFSRGKGFKTESENLKKFLFGDDEQNAILQKYKEEVNNISNDFHE
HIRYTDEIKLINDKQILLKTALEKQKEYKAIYANYISKKFNYWNCFRNKTINQKVEINAK
LEKKKTEQDFVKKEILRLEIIELKELVSTQEKVRSLTEKHKDSNNIEAEFFAISQSKLQI
EVADKWFISNDGQIKKIKEWFAAESSKNENKLALLNFKKYLSDNNILDAFEKSNWLSNYQ
KENALYSEKIEGFERQISELESLSKFSDSSDSESLVNWALDNLTFPLSRIQESTLKYFQK
FGKIKPSETNSSRYVPFPELLFQDLSVNIKKKTKDGFWLNLDGVYEFITYSEDQILNVKS
PESIKESLSKYKENIEDRLAKLRVEIRNEEHLKKTLFNFSNLEKHIELFKRKDKLLNYKI
DDSLANLTQDSFDLILKTYEDKENVLKQYKSLQKEFEEFTSWKSLLEGYRKSIEKLMAIH
FENANSVDTQVVSKKIDSNSQKLLELEKYLKEKKFNKKLFLDSYAKEISTQHKLTKLKYE
LSAKIKELDIRIEDKDKLISVAQEEIEQTELLNEQLFNSSIDLIGNKEELTNPDDGGYQS
VQSKANRSQQAYIEYLKLITKDLPYDETATIGQLANYLLPTVFPSSKVDEDLISNDIVER
LSKLTQDIQEIGSRKVDIIGSVFNDVYNVYRKYLTKINDINEYLKKDNKEITGGNKASLT
FKKSIHYPENWLSTFRKQLQTQMNYTGLFSDLRDEIDINKMMIRAFQKLGGGTKVLPEDL
MNPTSYFDLVFELKLENEDINSGSNGQTYAANALLCLARLSLIEEKGKDGLKIMPIDEAE
GLGSNYDMLHKLAKKEEYQIITMAIETAGEITDDGQYIYIMNENNLANIDSFVPPLGIFS
DKVTEDIEEYINTLSDDE
>KECLDBNJ_01012 hypothetical protein
MNKNVTWKELKALDDIYHLKKSRASIQNHPYIKYLIYDKGILDLKPDNTKVIITTDEFEI
FYEKEFKIAFNEAKRFLIKNDIAPTANKTFTIEEIKSLMLIAENKEELKNNPTTIEDFSN
EFFDISKHLKNRKSVKDAVFKILDIERFSLDKKENQWRLVIDNKNPLAVIMCENKSFLKQ
PWIAKETQTKLWYVGGNNISIIDDIDESDLSKPIYYSCDWDLAGLQIFSRIKTKLKERNR
TIYLLFPNAPHKRVSTYIPYHNSHWDLTKELSGLNLNFFSRNELLLIRSLIDKEEWIEEE
SFDIVKMIKGVL
>KECLDBNJ_01013 N-acetylmuramoyl-L-alanine amidase LytC
MKKWLKNVSFVILLIKSCLLLGQDLDEKKIIVIDPGHGGNDSGAIGVNNLKEKSITLEIA
RLISELAVKNHYKTVKIYQTRYSDTLISLSDRTKLAKALNADLFLSLHCNHSDNPNARGV
EIYLSNTQSKYSGESVWTAFQLQVDLNEKLGLESRGVKFANFQVLRETTDFMPSVLLELG
FLSNEDEGSYLLKPESLDSLASVIWECLIKKLDGYERIGD
>KECLDBNJ_01014 hypothetical protein
MKKTYYLSGFLSLLSTSLFAQIGGIEDSVNDVSDTIRAIFPIILGVIFLIGFLFNAGHFF
GENADLKKGITRVLVFVLIAGAVVGIFTYLIGIVV
>KECLDBNJ_01015 hypothetical protein
MNLSAYQPITDIQDNIVFANNGNVVLCFKGNLPEIYSLSEKDFEDIHGAWFQALKSLPVG
TVVHKQDIYLKKSYSSEQLPNTSFLEKATHNHFNGRGYIEHQCYLFFILTKNKALNNPKY
VNPFRKVSKGIVQQMDDNIKVFANAVSDSVSFINNSRKMRFLSLEAKEIEDLTRSYFNGF
SEGFDTDILLEKKKVTIGDNHFDALAVNSELCFGESVQSSKTNEKFTSDDFVFHQGFIDG
LGLTLNENHIVNQILYLDDKQKWRKLLNKKIEELNKSSNFGSQNKVVLGKIQYILDQINA
DDNARIIRGHLNVVYWAKDKKSLDSITSKIKTEFKELDIIPYYPRGEERKNYILNSYCCF
SSNFSNNDLYVTDLKHALCLFINNTNYKSDDTGIIFNDREHNIPVLKDVWDEQKKRIKAR
NFAIFAPTGEGKSFLANNILRQYFESGVRLVVIDLGGSYTKFAKLYPEKYTVLRYESGKN
LGINPFFISDKNDLTPERLEDLSIFLFELFASDLKVTKAQSVSVKKILRHYYDSTSENHS
LEGFYNFIERHQKDILNTLKIHPDYFNVTSFLHVMSEYVGDGLYSFLFEVSEDQTYKIED
KRLIVFELDEVKDNKEILSVMLKLIKSAIQRTIWRNRAEKGIILFDEFAKQLKFDNVLES
VEFYYQAIRKQNGAIGIILQSINQLPNNSTSASILENTQIIYSLNNEKGYDELVKRLNLS
SHDLNQLKSIKNSLSGPRKYTEMFIKIGKESNIFRLEVPKEVYAAYLTDGKENEEIMKLY
NEHHDMEKAIIQFTSKT
>KECLDBNJ_01016 hypothetical protein
MKTKIKTILFGLAMTAALLIPRGATAQGMPVYDNTNFISLVKQLLESGKQTAEMIKSVKF
LKDAKEAIEKVSSVVQQLRAVEEIAQNNQRLINVMQNDLQDILNSPYIKPEEIDKVMGSF
ETIVQNSLDTVDFIDEVLSSDYLKMSDAERAEILKAKELESKQMVSNITTKTKRYRDIIS
FRKMQDKVNNRETEY
>KECLDBNJ_01017 hypothetical protein
MTATIILGIGLEYIDTVFQTIQASDFSQYTIAGMKTLAVLFFLVNILKKYNEGIADKDGY
TWGLSPGELAKNFAIVLLVIFSTQVLGFFDGILVAIEGQYRGTAPALLPLQMQDIPLEED
VSLFDAASSAMTLLYEALVTPLYGFKILAFILSTILWILDLFIYPLFLAERFFLLGIMQA
FFPLVISLAVFEKFRSLAYTFFKLYAAVYMLVPAFFLVNVFINAIYTEINTNFWVNLFGT
DTGQGFFAPVVQLGSVGFIVFLKFKLYRRATSFTLRLFTN
>KECLDBNJ_01018 hypothetical protein
MKTPYKNIYNVLKLNRFIVLAVVVCSLLSSTFSVWMVFNTNQKALNSAFAINTDGSIIPL
KLVTQKENFRVEALAHLELFHNNFYNIDASNYERNLEKALWLGNSSVDNLYRQKKADGVY
NRLLQYSLVQKVLSIDSKISESNGTYSFTTTTIFEINRGSIIDTYELVSTGNLIMVNRNF
PNNPHGLLITNYFENTLKKLNNES
>KECLDBNJ_01019 hypothetical protein
MKVEKNKIVFAAVLAVIFIFLISYSVMVMGDDESENESLQQTLVPDLEENQKEYESKLDA
INDLKEVRETNAPSIYDEKLIDSLGFYDPDLPEREKERIVDSIYDAGKIKYSEIRYQNLG
QRRAVQQTVPNVDSAEAKRAQKIEAKELGLEHQLFFAAAPKPNEVSIIGNTDETIYVVVD
GDQVVQANTRLRMRLTKSATINGKLMPKNTPIYGFISFQPNRALIEIENIRHHPTKLKAF
DLQDGSEGIYVENNFREEATREVLDDVIGDINIPSVPQVGGLTQVFRRSNRRVKVTVLNN
YRLILKPRL
>KECLDBNJ_01020 hypothetical protein
MKTTTLVFAMILSTFVPRPCSAQDTANAQMTHVLDTIYANDTKNVALFFPEPIRQGITGS
DNFVFTYNREKEQYFGLLQAKPGKESNLLVVNRNGSIFSYIVRYKKQLSKLNYFIPISSS
IGNEKPIVTDSILAESSEERVDNSTYYYQKFCSYLLNRKQRIGRIKKRNEGIVLSIENIV
FDKEELYFVIQIENNSTLDYDLNFLNLSIETRQKGKRKSLQRLYQEPIYKHNLPSKIVEG
QTIRFVYVLPKFSLSNDRRAILELNEKDGERNIEMKLSHRYINNPN
>KECLDBNJ_01021 hypothetical protein
MKNSIVFTLVLLFLSCADSTTKISGPSATAQVVIESFYEKDEETLKANSTSQAYSNYMNT
INMFNAAVKDDSNFTVLQDTIMGDVAWVKYTTAYDKTPGVFKLVKQDGKWLADARGSKDK
SPF
>KECLDBNJ_01022 hypothetical protein
MPETNRIEYKRELSDGLEKEVIAFLNYREGGILYIGIDKDGNTYGLADADSDQLKIKDRL
KNNIRPSALGLFDIVSEERDGNDILKIIVASGPEKPYHLKKYGMSEKGCFIRLGSAAEPM
PQKMIDELFAKRTRNSISKIKAGRQDLSFSQLKIYYEEAGYTLGNAFAKNLELLTEDGAF
NYAGYLLADKNNTSIKVAKYSGKTRTDLIESNEYGHECLVKATKQVIDKIAVENRTATKI
TAKERQQANLWHPIALREAIINAFVHNDYTNEITPKFEIFTDRIEITSAGGLPEGLSKQE
FFEGFSVPRNKELMRIFKDLELVEQLGSGIPRILEHYGKESFNFSDNFLRMTFMAKETAV
EEGGQKGGAIGGVTGGAIDAIDTLTKRQKEVVKLIAANPSITYNEIADALGINESAVGKH
ITAIKNKGVLVRQGGTQGYWEIKLPKT
>KECLDBNJ_01023 hypothetical protein
MENPKPKKTIQEFVPFDYPISSKKRLKRTFDKKERDFLDVLLTRRSSAELGSISLDTISE
LLFLSNNIQQIDIDESGYLISKRTVPSAGGRHPVDILISLPSEDKRLLHYYNPIEHSLGE
LSLSQENLKHFFEDVNMNLPIDKGCLIWFAIQTNKTKTKYTNPESLYWRDAGALLYCLQL
VANYLNLKSCPLGGLAVSSFDQLFDVKNLLSGGGLLIGQ
>KECLDBNJ_01024 7-cyano-7-deazaguanine synthase
MQKNNSAILLSGGMDSIALAYLKRPKYAFTLDYGQKAALAEINAARQVSKELSIDHHIIR
VDCGSLGSGDMSSKPSISMSPVSEWWPYRNQLLVTLACMKGVVLGINELIVGSVKTDDAH
KDGTMEFYSYLSTLVQYQEGAIKISCPAIDLTTIELIRKSKLPESLLLWAHSCHTSNEPC
MNCNGCKKYLFTLQSLNLD
>KECLDBNJ_01025 5-dehydro-2-deoxygluconokinase
MIVVGGTYTEICFEPIWENIYGSGFRAVDLILQNSDFESVEFHTCGDEEIKAHLGYFQRL
NPSLRNNITDISKSPEFHYDYPLRTPMIVPRSDLFSENKPELNVEGKNILFFGLLEASVS
VKGSKVVYDPQSPANPISFSDTGSIADDLITIINIGEAKKLTGLLDLGDIVDYFFDSEKC
SAIIIKMGAKGALLFQPAKKEPVRIPVFKTNSVWTIGSGDVFSAFFAMNWFKGRDIESSA
ILASKATALYCDSKDLSIVDRLKNFSFEKLVIDKVPNGQIYLAGPFFTFSERWLINEVWN
TFKSIGLKVFSPFHDVGHGKAKDVVDKDLQGLDESEIVFAVIDGLDSGTLFEVGYAICQK
KKVIAFVQKEGEESIKMLEGTHCIIERDFTTAIYKLYWELAKK
>KECLDBNJ_01026 hypothetical protein
MSGSSGGGGIPSINRPNQNENCEGLIINTNLASPQPEVVSSLNQGDFLEITIASDQGPIQ
AFDAEGNLAGNIISREQVKLLNCIISGTEYTAEVISISGGQCKIQIRPI
>KECLDBNJ_01027 N-glycosylase/DNA lyase
MYTENDKFDIEYRFGDNIYEEVVACLLGGFGLKSEVGLAAFDRLRRKNLIRSGTKYEDII
SCLEKPFELNGKKIRYRFPNQKSKYITQFLNRNDLDNIPLFDDIELRDWLLSINGIGPKT
AAWVTRNYLNSENVAIIDIHIYRALLIMGLYKQSYSVQKDYVKLEHIFLKFCGELDVLPS
RMDALIWLQMKQANRNVLKLINQ
>KECLDBNJ_01029 hypothetical protein
MKKFLIGLLILIVLLGAAAIYLNTYLENQLKGIIENELPQSLSLEYKDLEIDSWQGNASL
TNATVRINITDTVPKSEVKNATVKLTGFNHWTYFKSKDIYFNEVKIHADTLTHYRQPKNK
EQKKSKDNDSLNNPIAAEKLDRKFKIKDFQLTADYIQILKPESAEVALRTAHFDFSLKNV
TPAQSQRILRPFEYEDVLIKTDSLYFKMNAFDALKIGHLEWNGTALELLETQLLTEVSRS
RLSELIDKERDHVNFQIKRLHFKDLKYGQSEGKFFFNSPKLTLGTPALNIYRDKRVADDY
TTKPLYSKMLRELQFDLMIDTIQIQNGAILYTERVNNEAEAGQLQFDQLNATLTNVGNTY
NSGEKKTAIAIDARFMQHAPITIDWDFDINDPQDKFKLIGTLSHLPANELEAFTGPNLGV
EMTGNVARTYFTIYGTDYSSHIDMQMTYDDFKVSILNKEKKRKKWLVSTLANIFIAKTSK
NEEGGFKEGSGDVNRDQNKSFFNYLWLNLKEGMLKTVTALD
>KECLDBNJ_01030 hypothetical protein
MLKPLSVLFDFSLSDNSIGYIVEGTMDYKAVQELKEAILDKFKKHDSINLYLEDNNIERF
SLDAVFIAGIFPMQHKNQLNKVAMVTNRKWIHAIANFNKAVIGKDLRNFTIDRRMEAMNW
IASQD
>KECLDBNJ_01031 hypothetical protein
MEEHFFQCPYCWEEISMLLDTSVRRQVYVEDCEVCCNPIELTVGYDDGILMTFEVASIEQ
>KECLDBNJ_01032 Outer membrane efflux protein BepC
MKRTRLQFTLLSLLFVLQGVVGVAQEQVLSKAEAIAQTLENNYNIAVAGNSVLIAENNAD
LLNSNYLPTVFGLAGTNYSVQDQSTDRDDGGSFDLNNAKSETYNASVNLEYTLFDGLGRL
YNYRSLKETYNLSKLEARETIENTVLQLFSVYYEVARLTKNVEILEQTLEISRNRVKRAG
YQFDYGQNTKLEVLNAEVDVTNDSINLMNTRQLLQNTKRDLNVVLARDLKEGFAVDTNVV
FIPKIQLESYIDMAEENNVRVLQSESAITLSEYDIQSSKARFLPTVGLSGSYGWNQSISP
ASAFFGGSTRQNTGWQGGLSLRWNLFDGGTSITQFKNAKIAKNNQELLKQQIKLEVARDV
ANALGNYENLVEVFEIQEQNVITNKNNFERSRERFNLGQITSIEFRQAQINLINAQTNKN
LAKYEAKFAELQLLQQIGQLLNIEF
>KECLDBNJ_01033 Swarming motility protein SwrC
MKKIISYFIKYSVAVNVVILAFVIFGIIGILRMRSSFFPLIDSQIITISVAYPGAAPQEI
EEGVILKIEDNLKGLVGIDRVTSTSRENGGSVTIEIEQGEDINVILAEVKNAVDRVPSFP
TGMEPLVVAKQEAIRETISFAVSGATLDLATLKQIARSIEYDLRAMDGISQIEITGFPEE
EIEIAVRENDLLAYGLTFQEVAQAVSRANILTTGGNIKTETEDYLIRANNRAYYGKELTN
LIVRADADGSLVRLSDVAIIRDRFSETPNASYFNGNLAVNVEISNTNNEDLLPTAAKVKE
YIEDFNARYEAVQLDITSDSSVRLEQRTKLLVVNGAEGILLVLLFLSFFLNTRLAFWVAA
GIPVAFLGMFIFAGGFGVTINVLSLFGMIIVIGILVDDGIVISENIYQHYEMGKTPIRAA
IDGTLEVIPPIISAIITTVLAFSTFLFLDSRIGEFFGEVSTVVILTLVVSLVEALIILPA
HIAHSKALVHESEIDIASKKGIDKFLYKLRFFNEKGDQFMSYMRDKLYAPTLTYVLKNQL
LAFCILLAMLVLTISSIMGSVVGVTLFPSVASDTVRIELLMPEGTNPERTDSIITMVEDA
AWRVNEDFTARQTDQMQVVENIIKRVGPGNNKASLRINLLPGEYRDFASPDITNAIRDEV
GPVFGVERLTFGSGGNFGGSPISVSLLGNNTEELEAAKEELRAQLEDNILLRDVVDTDPE
GIKEIQIQLKETAYALGLNLNSVMGQVRSGFFGTQAQRFQRGQDEIRVWVRYDRSDRSSL
NDLDDMRIVTPTGDRIPLREIATYTISRGDESISHLEGQREIQVNADMADPNGSVTDIMA
DIQQNVMPEILSKYPTISVSYEGQNREAEKLSNSANKVVWVILFLIYATIAFTFRSYSQP
FLLLFMIPFSIIGVAWGHYFHDFPINVLSALGIIALIGIMVNDGLVLIGKLNGSLKAGVK
FEEALLDAGKSRFRAIFLTSITTIAGLAPLLLEKSRQAQFLKPMAISISYGIGVATILTL
LMLPLLLSISNTIKTKAAWVRTGKEPSREEVERAIKELKEQDEAH
>KECLDBNJ_01034 hypothetical protein
MLQAVRAIVAILILGIAVTIGYFIATRDKEMPTEIVKEVKTVFVKEVQNRTVPIVIPANG
NLTAKNRLELYAEVQGVFRSSAHDFKPGQQYGRGQTLLNLDASEYYASVQAAKSELFNLI
TSIMPDLRLDYPDYYEKWQRYLDGFDINTSTPELPETASEKERYFITGRGIFSSYYNVKN
LEQRLGKYRIVAPFSGILTEALVNKGTLVRSGQKLGEFIDTSVYELEVAVSKRFSDLLEI
GEEVRLSDRNGIENFMGKVVRINGRVDQATQTIRVFIEVKGSEKLKEGMYLQANLEARDE
PDAISIPRQLLVDNSQIYVVKDSVLDLVEINPVYFSDKEAVISGLPDGTKYLSKSVPGAY
AGMRVKIFEDQATPSE
>KECLDBNJ_01035 putative ABC transporter ATP-binding protein YheS
MLNIHNLSVSFQGEYLFEEVTFRLGEGDRVGLVGKNGAGKSTMLRIISREQEYDTGQIAT
DKDIQIGFLKQDIDFVEGRTVLEESYQAFELIKTLEKRLEEINTQLAERTDYESEFYHDL
MVELNEVQQQYEIHGGYNYQGETERILMGLGFNREDFNRITDTFSGGWRMRIELAKLLLQ
NNDVLLLDEPTNHLDIESIIWLEGFLRNYAGAVVIVSHDRMFLDNVTNRTIEISLGKIYD
YPKPYSEYLVLRKEMREQQMAAQKNQQKEIEQTEKLIEKFRAKASKATMAQSLIKKLNRM
DVIEVDEDDNSVMTLNFPVSVVPGKVVIEADGVKKSYGEKKVLDGIDLLVERDSKTAFVG
QNGQGKSTLAKIIVDEITHEGTLKLGHNVQIGYFAQNQADHLDGSKTVLDTMIDAANEKN
RSKVRDILGSFLFRGDEVEKYVRVLSGGERNRLALAKLMLQPFNVLVMDEPTNHLDIKSK
NVLKEALKRFEGTLLIVSHDRDFLQGLTNTVYEFRNHKIKEYLGDIDYYLEKRAVENLRD
LEKKDPKAKVKAETTVTKDSYKDQKKIKSLSNQLSNIESEVNKLERQMKTMDEELAADYE
KTSSNPDFFDKYQAKKKKVEQLMEKWETISIELESYS
>KECLDBNJ_01036 hypothetical protein
MVTRVTYRIFESAYFCSMKNIFKGNPLYSIFTGSCPVCQQESMYVKSNPYKLSSTLKMHE
RCSHCHTKYKIEPSFFYGAMYVSYAVGIAFAVAAFVISYFFIGTSLVTAFFAIIGTLFIF
APIIMRLSRNIWINFFFDYDPKKTNKAPRTSSENA
>KECLDBNJ_01037 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKQVDYIIVGCGLAGMAFADILERKGHTFTIIDKQTDAASRVAAGLINPVILKRYTMPWQ
GEMQFDLANTFFNDLASRLQVEAVKQLQVYKLFSSVEDQNNWFEASDKPILSRFLNSQLK
SDVAPQVEAKLHCGEVRETLKIDIPKLLDAYRAYLETIGAYAQENFEYEALQMLGEHQVQ
YKDILAKKVIFAEGYGIHKNPFFNKLPLVGNKGEYIDIHAPGLKLTQAVKASFFIIPLGA
DLYKVGATFNWKDKDSIPTKEARKELIEKLKKVLKCEFEVVAQHAAVRPTTGDRRPLLGV
HPQYKQLVLLNGLGTRGTMMAPYLAQQLYAHLELGEALDEELSIMRFPKKF
>KECLDBNJ_01038 hypothetical protein
MKSQMQAFSILCLMILGGAASAQTNILNAKMPGEMFEKTESQIQLDNDKPLPYGYVDSRD
VLWGKNTWEIVDLDERVNFPLYYPVDTNNIGSDRRSLYDVLVKNVKEGKLDIYADSYFNQ
KIELNDIAAAMSRVDTTDLGIEQINAGYEVDEQYIDRRDISAADIEQYWIRGYWYFDKRQ
GELKYRLIGLAPVAPDVNFIDDEDPVMVPLFWVWYPTAREVLHEAKVFNPQNSAQPISFD
HILNSRRFNGVIYQVDNIQGDRQVKEYIADNAMMQLLESQRIKEQIRNFEIDMWNY
>KECLDBNJ_01039 hypothetical protein
MAGGGQSPRQKMINLMYLVFIAMIAMNVDKEILNAFKIFDVKFTSSNARLEQDNQLAMAG
LEEKATEQPAKYQPLLGKAKEVKEISDEFFNYLGSIKDTLTDGIDTSSYANLDKTAVLDE
LWFTGDRYTKQGDAFLAKIENYKSEMKNALGPEFSEVNAIIERTFAVEPQINKDGKKIDW
LRYNFLGYPLAASITRFTQMQNDVRTAESEVYSSLLQGQLSKDVSLSNYQAIVIPEKTAF
FSGENFKGKVVLGRFDNSLNFDKVVINGNEVDNLQAGQVVLDFPAGNVGTRKITGELVYT
EEGEPKSIPINSEYAVINKPNSATISADKMNVVYRGVANPMTISFAGVADNNVSASAPGL
SKGSGSSYVMNPGQGREVTISVSGTLADGTKVSDSKQFRIKDIPSPIGAVRGEDGILKMQ
RNSLEISEVSAKLPDFDFELNLRVTGFKFNVPGQPTVQVSGNKLDSRAKDVLRRAQRGST
VQIFDIDAQIAGNSSYRLKKVSPVLIELTN
>KECLDBNJ_01040 hypothetical protein
MAKKGKLSVTNMIYGLGAAVVIVGALFKIQHWPGGSEILTLGMVVEALVFGYSAFERPTQ
ELDWSLVYPELAGDAPAVKKAKLVEEPTEAKGLLSEKLDAMLKDARIDSELMTSLSTSIR
SFEGAAKGMAPTAEAMNSTKKYSQEMSLAAAQLESLNSLYKVQVEAAGRQAEINNEVANN
AGRLKEQMESLATNLSSLNGVYGGMLSAMNKR
>KECLDBNJ_01041 Serine/threonine-protein kinase pkn1
MKKFIAFIAMVSLLVSCGRNDRGELVGVKGKKWNPEKPYGMTLVSGGAFIMGKSDDDIAA
IKNAPTKTVTVRSFYMDETEITNSEYRQFVSWVRDSVIRARLAIEADLMGETPGTGGIGE
YAFQDYDPNNMTPYEQYMYDNYYSLSDDYSDRKLNWDIDLIEDPMNYPDEYYVSVMDTMY
IPLEEAYNGQRTVDVEKLVFKYKYLDMEAAARQKKGSRKDFIITEETKIYPDTTVWIKDF
AYSYNEPMHNDYFWHSAYDDYPVVGVSWQQAKAFCQWRTDNKNSYKKQRGQELVNRFRLP
SEAEWEYAARGGLEGATYPWGGPYTKNDRGCFMANFKPLRGDYAADQALYTVEADSYEPN
DYDLYNMAGNVSEWVGSSYDPNAYEYISTMNPNVNDTKNERKVVRGGSWKDVAYLIQVST
RDYEYADSARSYIGFRTVQDYLGVDQEVNMRKGPSRR
>KECLDBNJ_01042 Formimidoylglutamase
MAFENLLPISDAVIAHSALLHEQSLFNQIRLHTRQDGLPNLSELQIAIIGVRENRGAADT
QETLIDFAPIRKALYRLFPGNWHTVIGDLGDLEAGDQISDTFYALQDMVAQLVKNNVIPV
VIGGSQDLTYALYRAFDNLDQMVNLVNVDGCFDLGDSSLPMTHKSFVGKIIIDQPYNLFN
YSNLGYQTYYNSQEEIDLMEKLYFDSFRLGNTVSNLSSVEPVMRDADVVSFDLSSVQSEV
LGGMHPEKVNGFNGREACAITRYAGLSDRVSVFGIFEYLLAGNTETASALVAQLIWYFIE
GVNYRMTESLTDRDTDFLHYNVPVDDELLSFYKSTKSERWWIEIPFLEGVNNKLKRHTLL
PCTQEDYENACNQEIPERWYKAKRKNEI
>KECLDBNJ_01043 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGKDFKVESSFGHIADLPTKELGVDVDGDFSPKYTVNKDK
KAVVKKLKDLAKKAETVWLASDEDREGEAIAWHLAEELKLDKDKTKRIVFSEITKKAILR
AIENPRDIDYNLVNAQQARRVLDRFVGYEISPVLWRKVKGGLSAGRVQSVSVRLIVERER
EIQAFNTEDYFRVDAEFANADGKTLKAKLPKNLDTKKEAEEFLKANADATFTVEALTTKP
AKKNPAPPFTTSTLQQEASRKLYFSVSKTMNMAQRLYEAGLITYMRTDSVNLSQDAKQGA
ANEIVSAYGEKYHKERNYKGKSKGAQEAHEAIRPTDFSRHTVNLERDQARLYELIWKRAI
ASQMSEAKLERTNVQIASSNHPFNFTANGEVIKFDGFLKVYLEGTDDEDQEESGILPPLT
EGEALNNLWITATERFTRAPYRYTEASLVKKLEELGIGRPSTYAPTITTIQNRKYIEKGN
VDGTEREYDLLTLKKGKVSAKKLTEKVGSDKGKLVPTDVGMVVNDFLVNHFENILDYNFT
AKVEENFDEIAEGNEEWTKMMKDFYKDFHPQVMNVAENAEREVGERVLGEDPKTGKPVSV
RLGKYGAMVQIGSVEDEEKPRFAGLLPDQQLESITFEEAMDLFKLPRELGEFEGETVEVN
NGRFGPYVKFGKTYVSLPKGKDPLEVEYDEAVVYIKEKQKADAPIYHYEDKPVQKGVGRF
GPYIKWDGMFINVNKKYDFDNLSDEDIVQLIEDKKQKEKDKIIHDFKDEGIRVEKARWGR
SNIIKGKVKIELPKTVDAQKLTLEEVKDILEKQGPKPKKKATKKKTTRKKSTAKKK
>KECLDBNJ_01044 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKIINESKQGEALVLEPQTTNGKKLFIESYGCQMNFSDSEIVASILAKEGYNTTQHLED
ADLVLVNTCSIRDKAEQTVRKRLEKYNAVKKGNPTMKVGVLGCMAERLKSKFLEEEKIVD
LVVGPDAYKDLPNLLGEVEEGRDAINVILSKEETYGDIAPVRLQSNGVTAFVSITRGCDN
MCTFCVVPFTRGRERSRDPQSIVEEVNDLAARGFKEVTLLGQNVDSYLWYGGGLKKDFEK
ASDMAKATAVNFAGLLSLVAEAQPKMRIRFSTSNPQDMTLDVIRTMAKYPNICKYIHLPV
QSGSDRILKEMNRLHTRQEYFELIDNIREIIPDCAISQDMITGFPTETEEDHQDTLSLME
YVKYDFGFMFAYSERPGTLAARKLEDDIPLDVKKRRLAEVIALQQEHSLYNTQKQVGKTV
EVLIEKASKKSDAEWAGRNSQNTVVVFPKEHYNVGDFVNVEILDCTSTTLLGKAVGYSDN
N
>KECLDBNJ_01045 Nif-specific regulatory protein
MESVHAIKQRFGIIGDDPKLNRSIEKAIQVAPTDISVLVTGESGVGKESIPRIIHSLSHR
KHNKYIAVNCGAIPEGTIDSELFGHEKGAFTGATSTRSGYFEEADGGTIFLDEVGELPLP
TQVRLLRVLENGEFLKVGSSKTQKTDVRIVAATNVKMFDAIKNERFREDLYYRLSTVEIN
LPPLRDRKNDIHLLFRKFASDFATKYKMPTIRLEDDAVQNLLKYRWSGNIRQLRNVAEQI
SVLEQNRSISAEKLRAYLPDTGSNLPAVIGQNKKSESDFSSEREILYKVLFDMKSDLNDL
KKLTLELMENGNNATVQEENKSLIKKIYSEDDSDAYESAEDITEVLQLPEESVVSSPMKD
KYHFAEDVEEEETLSLQEKELELIEKSLERHNGKRKAAAKELGISERTLYRKIKQYDL
>KECLDBNJ_01046 hypothetical protein
MKKLQIAFLFLSLLCYNSCGFYSFTGVDIGAAESFYVRYFQNNAPIVEPGIDRDFTFALS
DLIQNQTSLNLSANAESADLIYEGEIVDYYFAPQTATSDNVAAQTRLTIVILCRFTNKSI
ADGSQDFEKRFSFFVDLAGTAQPVGPVLDGAIEEIYERITQDIFQESLANW
>KECLDBNJ_01047 hypothetical protein
MNTETFTYLLEHPDTINSEQTSQLKTVLNEFPFFQAARALHLKGLKNEDSFLYNTQLKKT
AAHTQDRAVLFDFITSDIFNQQDISAQIKAQEAQLLNMTVTDAVDVSAEMEAEELEKANK
VLDPEFFIPKEEPEATQPEEQLQLGKPLDFNKAETHSFSEWLKLTSFNKINRSEEEPQQN
TTDLDAGEKTATLDESVLSSVTSKEVSEPTSEESSTEPEPDAERARRLELIDKFIESNPK
IKVSAPDSSFKKPNLEDRFQPNDSLMTETLARVYVEQKNFSKAKQAYRILSLKYPEKSGF
FADQIRAIEKLQENK
>KECLDBNJ_01048 Protein-export membrane protein SecG
MFFIFLVLIVIVAFLLIVVIMVQNPKGGGLSSSFGGGGSQQIGGVKKTGDFLDKSTWGLA
TALLILILISNVTIFGGRSANESKVIEGEDVENIMPVQDVQAPANAAPASDSTSN
>KECLDBNJ_01049 10 kDa chaperonin
MGVNIKPLSDRVLVEPMAAETKTASGLYIPDTAKEKPQQGKVVAVGSGKKDHDMTVKIGD
TVLYGKYAGTELKLEGTDYLIMREDDILAII
>KECLDBNJ_01050 60 kDa chaperonin
MAKDITFDISARDGIKRGVDALANAVKVTLGPKGRNVIISKSFGGPQVTKDGVSVAKEIE
LQDALENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVQEGLKNVAAGANPMDLKRGID
KAVEAITKDLEKQTKEVGSSSEKIKQVAAISANNDDVIGELIAEAFGKVGKEGVITVEEA
KGTETYVDVVEGMQFDRGYLSPYFVTDSEKMQTELENPYILLFDKKISSMKDLLPVLEPV
AQSGKPLLIIAEDVDGEALATLVVNKLRGALKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGFSLDNATIDMLGTAENVTIDKDNTTIVNGSGNSDDIKARVNQIKAQIETTTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALV
RAKRVLESLEAANADEATGIKIVNRAIESPLRTIVANAGGEGSVVIAKVIEGDEDYGYDA
KTDRYVNMLAEGIIDPKKVTRVALENAASVSGMILTTECALTDIPEEAPTGGGGMPGGMG
GGMPGMM
>KECLDBNJ_01051 hypothetical protein
MKRIYISVVLLALVACGDSKSKQQTVEVSQQETAHKTEAYSSEERNAAFKNPEVAQVYDD
YNLLKTALVNTDAEAAKNAAQVMLKNSEASTLELGFVKAIQGIVDEDDVNIQREHFEAVT
VGVKDLVEENIVSGTLYYQYCPMAFDGKGAYWISNEEKIYNPYFGDVMLNCGTVDAEIN
>KECLDBNJ_01052 hypothetical protein
MKLLLKISIVSAAIFCLIAIRYWQEQLFYDPLLHFFEGEYLQAISLPELDALKLHIHVIL
RFWLNAALSILILVVLFPKKEIFRITLLLYGCLFLLLIIAFVTIIGMYDAQWSMLLFYVR
RFLIQPILLLVLVPAFYYQKLLSKT
>KECLDBNJ_01053 hypothetical protein
MKLFKIVGKYKSVILFILTFLGVYVVLSLLYGFYLSRSASSSYYPDYITHQVAVQSAWLV
DLLGYATQLAPHPEEASMVLGVENVYVARVVEGCNAMSVIILFVAFVMAFFQGWQRTILF
TLGGVILIYVVNVLRIALLSIGLYRFPEAQNLLHDIVFPAIIYGQVVLLWLLWVRNFKKQ
AG
>KECLDBNJ_01054 Free methionine-R-sulfoxide reductase
MTFEALKPEVSKILDSSNLSVEHRLEEICTLLKDNVTYYDWVGFYFKNGDKNELKLSSYA
GAPTDHTIIPFGKGICGQVAVSNQNFVVPDVAAQDNYIACSITVKAEIVVPLFVNGENIG
QIDIDSNTPDPFTEADERFLEWVNEQVSSILA
>KECLDBNJ_01055 Macrolide export ATP-binding/permease protein MacB
MLIYLRVLKESLAFAINALRNNKLRTLLSLLGVTIGIFSIIGVLAAVDSLKQEIKGSLAS
LDNNTIIIMRFSFAPTDIPQWKREQFPDVSYDEYQYIKRNVPDVEAASFSLNVGAESIKY
GDKLVTGVNIIPVTDGYYNIEALQLTDGRFFNESESNSGSNVLVLGQEIAESLFGSLDPI
GKQVRLYGQRFSVIGVLEKEGSSMFGPSKDGMVILPVNVVRRIYGSNNKSAFPQIVVKPA
EGVDIPEFNAVLEQRLRQLRGLKPNDVSNFFINQLSGFTDLIDNITGTMSTIGGFIGLFS
LLVGGFGIANIMFVSVKERTNLIGIQKALGAKNRFILLQFLFESVILATIGGLIGLGLVW
IIAQVMSQFTGDFQFVLSATNIFYGLSSSIVIGLFAGIVPAFMASRLDPVEAIRTGM
>KECLDBNJ_01056 Bifunctional purine biosynthesis protein PurH
MSTPIKAKAALISVFSKEGLEPLIKKFDELGITLYSTGGTEKFIKDLGVPVVPVEDVTSY
PSILGGRVKTLHPKVFGGILNRQDNESDVAEMKEYDIPQLDIVIVDLYPFEKTVASGASE
QDIVEKIDIGGISLIRAAAKNFKDTLCVSSVDDYEEVLELISANEGTTTLADRKRFAAKA
FNVSSHYDTAIFNYFNEEEVVYKASYTQGKSLRYGENPHQKGTFFGDFDAMFDQLHGKEL
SYNNLLDVDAAVNLMAEFQNEAPTFAILKHNNACGLAQRDTLHQAYVDALAGDPVSAFGG
ILIANKEIDKATAEEIHKLFCEVVIAPSYSEEALEILKGKKNRVLLIQKPIALPNDQVRS
CLNGILVQDKDAKTDSLEDLSTVTNNKPTEQELSDLIFASKICKHTKSNTIVFAKGKQLC
ASGTGQTSRVDALRQAVDKAVSFGFDLKGAVMASDAFFPFPDCVELADKAGITAVIQPGG
SIKDQLSIDYCNENELAMVMTGTRHFKH
>KECLDBNJ_01057 Rod shape-determining protein MreB
MGFFDFLTEEIAIDLGTANTLIIHNDKVVVDSPSIVARDRMSNKIIAAGKDAAMMQGKTH
ENIKTIRPLKDGVIADFDASEQMMSMFIKEIPALKKRMFAPALRMVVCIPSGITEVEMRA
VKESAERVNGKEVYLIHEPMAAAIGIGVDIMQPKGNMIVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIIYYMRTQHNLYVGERSAEKIKIQIGAATEDLEVPPEDMSVQGRDLLT
GKPKQVQISFREIAKALDKSILRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRLSQKTDLPVYIAEDPLRAVVRGTGITLKNLNKFKSVLIK
>KECLDBNJ_01058 Cell shape-determining protein MreC
MQQIVNFFIKYRNFLLYAFLLFISLVFTIQSHSYHRSKFVNSANFLSGGIYSSLDNITEY
FDLKVHNAQLVEENNRLRTRLLNTRDSISQKIDTATFHKRFRFTTAKTINNNYTFKDNFL
TLRAGTKDGLKQDLGVITSKGIVGIVDRASANYATVISILNSNSQINAKLKKSNHFGILV
WRGGDPNIVDLIDVQSKAPVQKGDTIVTGGKSTIFPEGIGIGTIKSFELDPSENFYSIKV
ELFNDMTNIGYVYVIENLDRTEIQTLEQQTADEQ
>KECLDBNJ_01059 hypothetical protein
MNNSVTQNILRFVFLVLVQIAIFNNINFLGYINPYPYVLFIILFPIGDNKALLLALSFLL
GISIDMFCNSGGMHAASCVTIAYLRPWILQSIFGLAYEYNAVKVVKAAFGQRLLYTTILV
FSHHLLLFFLESFNFSDIIYILKKTLFSGAFTVLLCIILITLFSVKRR
>KECLDBNJ_01060 Peptidoglycan D,D-transpeptidase MrdA
MRKILLFSIVLISGILLTGRLFYLQILDTSYASLSVNNAIKRIYDYPQRGHIYDRNGSLL
VSNQPSYDVMVIPREVKPFDTTEFCGLLKMTKEALVKRLDKARVYSPRLPSIVIPQLTKS
EYAYLQEKMRKYEGFYIQKRSLRDYQVDYGANFLGYIAEVNRADIEDNPYYQSGDLKGRT
GVERQYEEILRGVKGVKYIQKDRFNRDIGAYKNGSLDTIPKPGKDLTLTIDAELQKYGEE
LMVNKRGGIVAIEPSTGEILALVSAPNFDPALLVGRERSRNFTNLYYDSIAKPLFDRGLQ
AQYPPGSPFKTLNALIALQEDVVDPQESFACHMGYYYGSRGRKLGCHSHPSPLSMVPGIA
NSCNAYFANVYRRVIEKYDTPQEGMDVWHNHLASFGLGQYMGTDLPTGRPGYIPDSDYYN
RAYEYPKYKWFSTATISNSIGQGEVSLTPIQLANVTATIANRGWFYTPHIVKDIEGEHDA
IPEKYRTKNYTTIDAKNYEPVVEGMSGAYNYGTAAGVQIPGIEICGKTGTAENYTKIDGK
RQQLTDHSIFVAFAPKDNPKIAIAVFVENGYWGGRYGGKIASLMIEKHIKGEITRTDLED
WILTHSLEEEYAKPLSGKPFPINDGKKISGKIEEKLKS
>KECLDBNJ_01061 Peptidoglycan glycosyltransferase MrdB
MRSTARNARNNFDWLLIVIYLALVGIGWVNIYSASIDPSGVSNFFDLSNLYTKQLLFIAL
SLLLIVFILSLEAKFFERFASVIYVVSIASLLGLFVFGKNISGATSWYAFGSFSLQPSEF
AKAATALALAKYLSDIQTDVKSFTHQFRAFIIIALPALCIVPQPDPGSALVYAAFFFPLY
REGLSGIYLITGSITIALFVLTLAFGPVYIIAGIVLIAIILLIKNRKKRFGKRYFYILPI
VSILFVLSVNYIFQNVFEQRHRDRFNVVLGKDVDMKSIGYNTYQSEIAIGNGGLTGKGFL
KGTQTKGNFVPEQHTDYIFSTVGEEWGFLGSTLVILLFVGLMLRIIILSERQKSQFSRIY
GYSIAGILFIHFLVNIGMVTGVFPTVGIPLPFFSYGGSGLWGFTILLFIFIKLDSNRVNE
W
>KECLDBNJ_01062 Nuclease
MRRKYTYPLLMMVAITIIYLVNQHLDQKQKERHVDTGAEIKSTALSFLLPEAAPETLVHH
QYYSLSYNEAAEQASWVAYTLEKSQLQNSKSLSRPYFMVDNAVETGAADWRNYKNSGYDR
GHLCPAGDRSFSTQAYNETFLTSNISPQLNAFNAGIWNRLENQVRDWASRYNKITVITGG
LTTNGLGTIGTENVVVPSAFYKIVLRKNDSGYSCLAFLIPHRESDAPLQQFVVSVDEVEN
ATGIDFFPQLEDSVEHKIEAEKPVDRWVF
>KECLDBNJ_01063 Oligopeptide transport system permease protein OppC
MSFIYIVLCGLIALFAYLIAPDDSSNANQMHLAIHSKKPGFRVEMLNVPGPEHQKQSWIG
ALLNGEVNTDTEIPISSWTLHEDEVEYKPYSEDEDLELTKAVALEDFGITEVAKKDFEEQ
FISEKVFFLGTDKYGRDLLSRMLIGTRISFSIGFVAVLISLLIGVVLGAIAGYYGGKIDA
FIMWIINVTWSIPTLLLVIAITLALGKGFWQVFIAVGLTMWVEVARVVRGQVLSVKEAQY
VTAARALGYGNMRILFKHIIPNILAPVIVISAANFASAILIESGLSFLGIGAQPPIPSWG
AMIKDHYSYIILGKAYLAIIPGLAIMSLVMAFMLMGNALRDALDVKGVK
>KECLDBNJ_01064 Tail-specific protease
MIKNVKVLVLALLLAVASCSFTTSDEDPGKDKVLVSLISYVLEKGHYDAKEFNDEFSEEV
FDDFVTALDPLKRYYLKSDIKEFEAYKDQIDDQIRKEDISFFDLAYTRLRERMEESKAIY
DDILSQPFDYSKDETIDTEYENLDYAKNQKELKARWENQLKFNTIGTYYDRIEEEAKKAK
DSTGYTPLSNSEIEKETRETTKQSLVEYFEFADELDREDYFSIYINSIVEEFDPHTTYFA
PVDKDRFDMQMSGQFQGIGARLQKKSNEISITEIISGGPAWRGEELKEGDIILKVKQADE
DVATSVVGMRLDDAVELIKGPKGTVVTLNVKKKDGSIKNIAITRDVVEIEETYAKTTTVD
KDDRTYGVINLPKFYFDMQNAEQRNAATDVKKEIIRLKEQDVDGLVIDLRSNGGGSLSTV
VDIAGLFIKEGPIVQVKSNGADSEILKDKDPEILWDKPLVILVNEISASASEILAAAMQD
YKRAVIIGSKQTYGKGTVQNVYDLNRWLRQNDLGDMGALKITTQKFYRINGGSTQLEGVK
SDVVVPDQFSYIDIGEKDLDNPLPWDKIAAADYEVWDGYIDYDQTISNSNARMAKNKQLQ
LIEENAKWIKSKQDDSVWPLNIDAYSAKMEQNEEEAKRFDSLRDYKSGLTFKSLPYEIQK
FESDTVLKQKRERWHQDLAKDVYMDEAINVLEDLKVNNIRRGKLADVRD
>KECLDBNJ_01065 5'-nucleotidase SurE
MTDQKPLILVTNDDGITAPGIRKLISIMQELGDVVVVAPDSPQSGMGHAITVNDTIYCDP
VKEFQDDTHKEYRCSGTPADCVKIAVQEIMHRKPDICVSGINHGSNSSINVIYSGTMSAA
VEAGVEGIPAIGFSLLDYSIDADFSHCAPYVKKITQEVLQNGLPKGVVLNVNIPKLKASE
ISGIKVGRQANAQWVEDFDKRTNPMGRDYYWLSGEFVNEDQGEDTDEWALANGYVSVVPV
QFDLTAHHFIEKLNDWKFND
>KECLDBNJ_01066 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHAANLMKAILAEDPNADFRFWGGDLMQKVGGTLVKHYRDLAFMGFL
EVLMNLRTITKNLAFCKKDIAQFNPDVIIYIDYPGFNMRIAKWARQEGYKNHYYISPQIW
AWKEGRIKAIKQDVDAMYVILPFEKQFYEEKHNFPVHFVGHPLIDEISARTPVIPENFRK
EHQLDERPIIALLPGSRKQEIQKMLEIMLSVTPDFPNYQFVIAGAPSQDLDFYEPFLKKN
RVHIVMNQTYNLLDVAHAALVTSGTATLETALFKVPEVVCYKGGRISYEIAKRVINLDYI
SLVNLIMDREVVKELIQTEFNTKTLKKALAEILEEEKRKALFSEYYKLEKKLGGVGASAT
TAKLIVNAIQSN
>KECLDBNJ_01067 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MLFSQTDSRLYMTRTSLSIIISIALVSCGGSKKAVKSATTIENTRYIAPEKSSVPTSDPS
TRELMYLSEIKPSEENQLRFNIIKNARQYEGTPYKYGGTTPKGMDCSGLVYTAFLEEGIS
IPRVSRHIAEEGERIKTDDVIPGDLLFFITGRRSRQINHVGIVVDVLPGQILFIHSSTSQ
GVIVSSLNEGYWNNAFKEARRIM
>KECLDBNJ_01068 ComE operon protein 3
MKGINITLCIALLGLISGILLCPFLNFSLLTQFTVFLSCFFNFLSLHYIFKRKHIYSVFT
AFAAFLLFVSIGVLLVTLSDPLLKKSHYTKTLAFEQPQTILLEIDKKLKPGFFDSKYVAR
VLQIQNKPASGKLIVNIEKDSTKPASDLRVGQYILTKTVAQTIAPPRNPFQFDYKAYLEQ
RGIFAAITVSKQELLQLPYSKNSPQSFADHLRASLNAKLDRFTMHPDNRAVLNALVLGQR
QDLSTDLQNDYANAGVIHILAVSGLHVGILMLIVQFLLKPLGNYRRSRILKTLIVLLVIW
GFALITGFSPSVLRAATMFTFIQVGLFFNQRKAGFNALIASAFVLLAIKPRLLFEVGFQL
SYAAVFAILWLYPKFEKLGLPKNKLLQYYWKIILVSLAAQIGVLPLSLFYFHQFPGVFLI
ANCVVLPFLGFILIYGLVLLTAAALNLLPEVAVECYDLILTWLNTFIKGLASLDIFLIEN
IYFSFPLVILSYLLIFSAENFSRRFSFKNISLLLLVLIGFPITLLFSEFTQRQPKFYILH
QYQTSLFSHQNEQLEFTYYTESDREPPQQLLNQFKTHQQVTAVQTAELKHFYQIKEQTIF
RIDSSAVFEISKLEPDFIVLTQSPKVNLDRVTERYPNTVYIADGSNYKSYVARWEATCTK
KKIPFHNTYEKGFYKIE
>KECLDBNJ_01069 Thiol:disulfide interchange protein DsbD
MQRVIVFLMIAICSAGSLSAQEKIKWMSFGEALNAQKKEPRKIFMDVYTDWCGPCKLLDK
NTFQNPDVAKYVNQNYYAVKFNAEGTESIDYQDFVYTNPNYDPKRKGRNSQHLFAHAMKI
NAYPSIVFFDEKGNLIQPLPGYKTPQQLELFLKMIESDDYLEITTAEAWEEYQSNFESTF
KS
>KECLDBNJ_01070 Dipeptide and tripeptide permease C
MATTSTEQFFKNPVLGHPAGLFVLFFTEMWERFSYYGMRALLVLFLTASLFEEGWAWPRE
HALSLYGTYTSMVYLTPILGGYIADRIIGYRMAVVVGALLMTLGHASMAVDSEFALYLGL
FFLCAGNGFFKPTMTSIISEMYANHEHKKDGAYTIYYMGVNAGAFLGILLCGYLGEQWGW
HWGFGLAGIFMFAGMLQFYFAQGIFGEVGKKPVKTESKEVTEDPSVKRNPFTAIDKLLIA
VSALIGLVWIINDPMSKIGGTDVFAFEVASLSGSNFMILLALLVFLILVVARIVRYTTVV
RDRMIAVSIFAFFTIFFWAAFEQAGGSMTIFANDYTDRVLKGSAGTIFRIANTLITIIPL
GVITWVLCLLFKQTFKNYKWANIILGASFLIIWGLVLTMLYEQHTAESPEVPASWFSVLN
SLFIIIFAPLFSKVWESKYNPSVAVKYGIGLILLGTGFAALAYGASDIPQGAQTAAVSII
WLILAYYFHTMGELCLSPVGLSYVSKLVPGRMIAMMYGVWYLAIAIGNKLAGSTGGMIDQ
VTQEYSLSTFFLLFFLIPGGAGVLIILLHPLLKKLMHGIH
>KECLDBNJ_01071 Di-/tripeptide transporter
MAQSAQLPKQKELFGHPVGLYILFFTEMWERFSYYGMRAILVLYLVAETASGNPGLGWTN
AEALSLYGTYTMLVYVSSIPGGWIADKYLGQKKSVLYGGILLVAGHGILAVEQMWAFYTG
LGLIIAGVGMLKPNISTMVGGLYKQGDIRRDKGFTIFYIGINLGAFISSLVVGTVGEVYG
WHYGFGLAGIGMALGLLQYMLGQKYLKRVGNFLGSSTDPEELAASKRPLSKIEKDRVIVL
LVSFLMVIVFWGAFEQAGGLMNIYASEKTDRTLSFALPFIGNEVPASWFQSLNALFIILL
GTSVAGFWAKRKLKGKTATSLFKMTMGLIIMGSGFFFMTAASAQFQANGASAMYWLVLAY
LFHTVGELCLSPVALSYITKLAPLKYASIMMGVYFAMTGFGNKVAGLLGESASELGEYTI
FTGIAVFCIAFALLVLVFRKKLEKLTHGAEDNEREMLEQEEYELADPDIN
>KECLDBNJ_01072 Prolyl tripeptidyl peptidase
MNIRKTTLLLLLLVAGVVTAQQKNITLEEIYDGTFRMQYLDRLHSMNNGKEYAVLNTDRN
TGTKTLDVYSYKTGEKVNTLINSSEIDGLDYFIGYTLSADESKALLSTKLRSIYRRSSLG
VYYVYDLDTKELVQVAEEAIQEPTFSPDASKVAYGRDNNIYIKDLSSGTTTQVTTDGAKN
KVINGITDWVYEEEFAFVRAFDWNANGDKIAYIRFDESEVPEFSMDVFGNELYPSKDTFK
YPKAGETNATVSLHIYDVASTETKAVDLSGFQNYYIPRLEWTPEANVLAVQTTNRKQNDI
NLLFVDGTSAEAKLILSDKDDAYVDVTDNLTFLEDNDFIWTSEKDGWNHIYLYDKNGKLK
NQVTQGPWEVTSYYGYDPKSNRVFYQSSENGSINRGVYSIKVNGKGKEALAAEAGTNSAN
FSTDFTYFINSFSDAETPYVFTLNDAKDGDVVRKIKDNQALKDQFDDYVISEKEFFTLPV
NGEELNAYMIKPKDFDPNKKYPVFMTQYSGPGSQSVANSWSAGNGYWFQMLAQEGYIIVC
VDPRGTGLKGRDFKKMTQKELGKYEVEDQIAAAQALGERDYVDAERIGIWGWSYGGFMAS
NCIFQGADTFKMAIAVAPVTSWRFYDSIYTERYMTTPQENASGYDNNSPLSHVDKLEGKF
LLVHGSADDNVHVQNSMRLIEALVQANKQFDWAIYPDKNHGIYGGNTRLHLYTKMTNFIK
ENL
>KECLDBNJ_01073 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MPHTIQGFSRLTKDEKIAWLTSNFLSSNANATQILKQYWNDDQKLQQLHDEFIENTISNY
YLPLGIAPNFIINNKSFAIPMAIEESSVVAAASKAAKFWMSRGGFKTQILGTEKIGQVHF
TFSGDSKKISAFFEEQKAQIIEDLKPHTESMERRGGGLKSLKLVNKTNALEHYYQLHATF
ETLDAMGANFINTCLEQIAESWQRLYNEKASFKSADQELVVIMSILSNYVPGCVVRAEVS
CPVSELSEADGIDPQLFANKFVQAVRIAEVEPYRAVTHNKGIMNGIDAVVLATGNDFRAI
EAAAHAYAAKDGSYSSLTHATIEDGIFKFWIEIPLALGTVGGLTKLHPLVKLNLEMLGNP
SAPQLMEIIAVAGLAQNFGAVKSLTTTGIQKGHMKMHLMNMLNQFEASEEEKNQAIQHFK
TNKVTYSAVENLITNLRKSAQNA
>KECLDBNJ_01074 Beta-lactamase
MKKSVLLLLMLISSFGFAQQFTEAFQSQVKKAQQAHQIPAISVNLITPDSIFSFVNGKVR
TAKKARIPQDAKFHLGSNSKAITAFIAKHLSEQGIINWDTRFFQLFPELENSSNPAYLDI
TLGQLLSHNAGINAYTKGVDLEKFNTLKGSTSEKRYAFTQEILKEKPSDPGTYSNAGYVI
AALMLEKSTEKPFKTLLNETMNALDLDYFVGFPSKENDTNPWGHINSKGTLTALGPDHEY
KLPAYMSSAGDIAMNSQDYARFLQLHLQGLLGKDNFLGAEAYQELHFGLDNYAYGWGNIS
KNGHQISYHDGSSGTYYCHVVVFPHKEIAVAIMANTATKDAVNAIYTLQKSISDNPENVT
E
>KECLDBNJ_01075 hypothetical protein
MPQHFYGHGKLLITGEYLVLDGALALAIPTKKGQKLTVAEAEQPGITWEGLKESGEVWFT
FHLDYALFKQSQPAASENPEIRLLQILLAAQKLNPEFLKEQPSLKVTTQLEFHQKWGLGS
SSTLIYMLAQWAEVDAYKLLELTFGGSGYDIACAGNDSPILYQSSEGIPQVFQTNFYPDF
SDQLFFVYLNKKQNSREAIANYRKQPEARKKEAIQKVSGITETLLTVDSIFSFNVLIEAH
ERIIASVLNIPTVKQNLFPDFKGSIKSLGAWGGDFILATGGPEAKNYFRAKGYETILSFD
EMIFS
>KECLDBNJ_01076 Chaperone SurA
MAVLNKIRQRSVFLIAIIALALFAFVLADVFKNGGFSTDKSQRILGSVNGEDIEQQEFAQ
LVDNQTARYGNNITNTQAVNAAWEQEVRRIILDEQYEELGISIERDRINDLLKEALQSDP
NFQNENGVFSEQKLREYIATLKSTNPQMYEQWVAYEQQLAKNEQQQIYFDLIKAGLNTSF
KEGQMDFEMENNLRDLEYVQVPYTSIPDEEVTVSKEEITAYIKEHANEFQTEAARNIRYV
KFSEDPTLSDEEAVKANLSELLENRVEYTAATKTNDTVAGLANTTNPEDFVNEYSDERYT
DLYIFKNELPADASDELWALNEGDVYGPYKDGAAFKISKVVAVSQIPDSVQSSHILLTYQ
GLANAGAQTRTKAEAKALADSLAGVIKGNASKLAELAPEYSADGSKEKGGDLGYATKGRF
VQPFNDFIFDGKTGDVGVVESRFGYHVIRITDQKNVQRAIKLATVTKAVEPSQETINNVF
NETTKFQMAVTENKNGFEDVAKEGGYNVRPVNSIKALDETLPGQGSQREIIRWAFDEERK
TGDVERFNVDGGYLVVQLTKKTEKGLLPADEASPRVTPIVRNQKKAAQIKKNISGSDLAA
IASANNVTVQTSPGVNLKNPTLAGSGTEPKVVGKAFGLEEGNVSAPIEGNRGVYVVKVTK
ITPARELDNYASFAVQKQNADRATVNMRVVQALKDASEIEDKRSNFY
>KECLDBNJ_01077 Hemolysin C
METDILIIIISLILSAFFSGMEIAYVSSNKIHIEIEKKQNDLIAKVLTKLTQKPSKFIAT
MLVGNNLALVVYAYYMGGILQSWIEGANFGYPWLTDFFVEFSLLTQTLISTLLVLITAEF
LPKVFFQIYANSLLKIFAVPAYLFYVAFSFISSFIIWISDKVLKKFFKTEGDEVQLAFTK
VELGNYITEQIESVETNEELDSEIQIFQNALEFSEVKSREVMIPRTEIVAVEKEESLSEL
NAMFTETGLSKILIYQESIDDIVGYVHSFELFKKPKSITDILRPVIFVPETMLVKDVLNI
LIKKRKSIAVVIDEYGGTSGMMTVEDIVEELFGEIEDEHDSVVLIEEEVAEGVYKFSARL
EVDYINEAYKLELPEDENYETLGGLIVNHTEGIPEENDVVDIEGYQFHIIQTSNTKIELV
QVRVIESD
>KECLDBNJ_01078 hypothetical protein
MSKYFKYFEYAYLFFAALFLFEAVRIWSTEPNKAYVFLFFVAVAIGMYFFKRRFRKKYEQ
RNQN
>KECLDBNJ_01079 hypothetical protein
MFFSCGNNTEAIQKFNQRSEGPSAEGEGVLLKYTDSGKVVATLKTPLIIEYGLVDLAYEE
FPEGVAVTFIDDNKKENYITSDYAIRYKRTNLIDLRKNVVLITSDSTRLDASQLFWDQKN
KWVFTDKPYTIKFPDDSYNNGDLFDSSEDFKNFISLDNQSRMYVSETATEAPNDSIQ
>KECLDBNJ_01080 Photosystem I assembly protein Ycf3
MMKTKLTLLFIALVGAVNFVSAQATEECITTMSIFSEHAKVKNYDAAYEPFMKLRKDCPT
TSYALYQYGERILHHKIENSTGAEQKAFLADLKKLYKEKKTHFASKAKEGDDIADVALVM
NENNIGTAEEQYAMFNEAWETDKETFNNAKGLYVYFNLAVELQEAGKIELQEVFDLYDAL
QTKITDVQNDYAERLQKILEKNEAGTALTSQEKRVEQIAEVNLSNYSKIAAGINQKLGVL
ADCDRLIPFYEADYEAKKNDVAWVRGAAGRLISKECTDSELFVTLVEQLNTLEPSAKTSY
YLGRLAEQRGEDAKALQYYEESAERQDDPAEKAKVYYRLAENFRGKASYSRARGYYQKAV
AAQPSMGIVYLRIADMYAKSANNCGNTRFEKLAIYWLAADMAARAGRIDPSLADTANKTA
AAYRGLAPTREMIFSEGNAGQRISFSCWVGGSVTVPSL
>KECLDBNJ_01081 hypothetical protein
MIKRILVVVLITITTSAFAQEGNSSPYSFYGLGLSNFKGSIENQAMGGLSILGDSIHTNF
RNPAGYGALKLTNFTIAGSHREVNLESDNQTGSTTSTTIDYLSLAFPVSKRVGVGFGLIP
ETSVDYEIFEGDDEALSQYTGRGGVNRAYLAAGVELFKGFRIGAEGSYNFGSIKNESIQA
NVDQQYSVREINESDVSGFTYNLGAQFETTLTRDYKIFTSASFQPETTLTLENERALESV
IYSRLDNAVIGVVDSQDIPVGDTEFINPNTYSFGLGTGQVNKWFAGGQIEFSETSKMTNR
AFNIANASYDDSFKYRLGGYLVPDYNSLTSYWNRVTYRVGARYEESGLLIENQSIDEFGI
SFGLGLPLGRGFSNANITFEYGQRGTTTAGLVKEDFFKVGLSLSLNPLRPWFVPNKYN
>KECLDBNJ_01082 Type III pantothenate kinase
MINLAIDFGNTRVKYGVFQNSELKLTWAGSVSDAKTKLVELQETYVIDKAMLCATGNSKD
FVTFVKKAGLSIEVLSSQTPLPFANDYETPQTLGVDRIALVAAAQKLYSGNHVLVIDAGT
CVTYDFKDAYDVYQGGAIAPGLHMRFKAMHEFTAGLPLVAYPEAEVPVIGKNTESAMQSG
VINGLIAEIEGVMRWYQLNYKQLTIILTGGDGLFLSSRLKNGIFAHSNFLLEGLNYIIEF
NRD
>KECLDBNJ_01084 hypothetical protein
MKHYLYIIYSKDLDKFYTGETSNIQERIIIHNNHAIKTAYTKAASDWKLMLSFPCKDRTE
ALFLERFIKRMKSKKFIQKIIDDPYLLFNILNKK
>KECLDBNJ_01085 hypothetical protein
MTQLTKTDKISLEDLALIKKSRKDLDEISFLMRALNTIGTPIDSGLELLPKNLQNKVSDT
IQKALQLAVKANLKTLKPEKRSLPSSNLTYKLATGISGATGGFFGVAGFTADLLFSTKFM
MRSIMDIARSQGEDIHSIDTQLACLQVFALGGTSEHDDELDTSYYATRAALHTTMNQASA
YIAENGTKKIIETITAQTAAPIAKLINQVAARFSVQVGEKFAAQAIPVIGAAAGASINVL
FISHFQKMATAHFTLRRLERKYSKALIQETYENLNLNQIA
>KECLDBNJ_01086 Outer membrane protein TolC
MKKYLIILIVLFPLLSRAQEKLEAIQQKLTETDPDQVTWSLQDCIDYAALNNLTVLDAQL
DASSAAVNYKQSKQQRLPDLTGSASESYSRGYSIDPITSNYVNQDIFSTSTSLNTSITLF
QGSQLNNQIDQNALLLDQSALFIEEAKNNITLSLTEAYLQALYYKEAIAVAQNTLTGSQQ
ESKIAKSRYDAGAIAKKDYSDALSQEASNNYELIQAQNSYEAQLLLLRQLLELEPETNFD
IVDPDIDYNGSTLLLNKVDVYHNALNTLPEIAASKLDIDISEKDLEIAKGAYLPTLSLTG
SLGSGYTSIQDMSFTDQFDINFNQRLGLSLSVPIFNRGQTKANVQNAKINIEKANIALRT
QEKELYNKVETAWRNARSSQEQLIAAEAARNAAKDSYELAQKQYEVGAINTTDLVLTQNT
YSNAEQNYIQAKYLGILYAQLLQFYQGNEIKL
>KECLDBNJ_01087 Macrolide export protein MacA
MKTTQSKIILAVILVCVIAGVGYAFFGADSGTTITAETTTVTKGKVTTMVTATGTIEPLT
EVEVGTQVSGEVEKIYVDYNSTVTKGQLLAELDKTNLIAALQQANASYSNAVTQRDYYNK
IYSRQKKLYEEEVISQADFDDAEYNFNNSKISVTQALSDLQEAKTNLSYADIYSPIDGVV
LSKEVDEGQTVAASFETPTLFTIAKDLKEMQVEADVDEADIGNVAEGQRVSFTVDAYQGE
TFTGTVTQVRLDPTEEESVITYTVVIKADNPDLKLKPGLTATVSIYTLELDDVLTTEAKA
VNFNPALNEINTYYKQQGIDKTMSEIPKVSEGKSRVWQYGADGSLKPVEVTLGASDGINI
EVKSGLQAGTKLVYNLKTITASESGAEDSSSPFMPKPPGKK
>KECLDBNJ_01088 putative ABC transporter ATP-binding protein YknY
MSKTIIDIDTLKREFIMGTETVHALKGISYAIKEGEFVTIMGSSGSGKSTMLNILGCLDQ
PTSGSYKIDQVAVNALSRNELAQIRNEKIGFIFQSYNLLPRTSAIENAELPLLYNSKVSS
EERRKRAIDALNLVGLGERLDHTPAQLSGGQQQRVAIARSLVNDPVVILADEATGNLDTR
TSYEIMALFQDLNRKGKTIVFVTHEDDIARFSNRTIILKDGTIISDKINEDILDAAQELA
ALPKEN
>KECLDBNJ_01089 Macrolide export ATP-binding/permease protein MacB
MRILNLLKIAWRAIKLNKMRTFLTMLGIIIGVASVIAMLAVGEGSTQSIKTQISSMGSNM
ITIRPGAGMQGGVRTDPGEMQSLKLEDYESLRDQATLLTAISPQVSGSGQVISGANNWPS
SIYGVTPEYLDIRVLELAEGSMFTSAEVKSAAKVAVIGQTIVENIFPDGESPIGKMIRFN
KIPFKVIGVLEPKGENTFGQDQDDIILAPYTAVQKRILAIDYLQSIVASAVNEEQAPDAV
EEVSAILRENHQITNPQEDDFNVFSMEELITALSSTSEILTVLLVAIAGISLLIGGIGIM
NIMYVSVKERTREIGLRMAVGGKGADILIQFLIEAILISITGGILGVLLGISATLIIQNV
FNWPTIVTLYSVIISFAVCAITGIFFGWYPARKAAALDPIVALRYE
>KECLDBNJ_01090 Sensor histidine kinase YpdA
MHFTRNKRILILLHLMVWAALFFTPYFLAGGQVELSPVAMNTWVPLGLYAVIFYLNYLYL
INAFLFKKKNTVFILINLVLIGLLAFLNYELKEMYLEHILAKNKTIERPPHEGLFIYLNS
ITFVVPLVFALAFKTIEKWKKDETRTQEAEKIKLESELQYLRYQLQPHFFFNSLNNIYSL
VDIAPDQAKETIHSLSKLMRYLLYETATEYVPLQKEIDFLKTYIELMKLRFSSNVIVNYS
FPTVSGDVRIAPLLIITLIENAFKHGISSTELSRIDFKISVEEETIKFVSVNNYYPKDAT
DQSGSGIGLLNLDKRLQLIYGNDHKLKIDVQNDLFISKLNIPVR
>KECLDBNJ_01091 Transcriptional regulatory protein YehT
MSISQEPKLSCIVVDDEPMALNLIESYVQKTPFLDLKGKCSSAIQALKILNTEQIDLIFL
DIQMPDLTGIELSKTLSKTTRVIFTTAFDSYALQGYKVDALDYLLKPFNYTEFLLAANKA
LSWFKLVSTATDTTTTPPKKYLFVKSEYKQVKLELDDILYFEGLKDYIKIYLASQSKPVL
TLKSLKALEQELPSDFMRIHRSFIISLDKIDEIERSQVIISGKRITVSEGYKEAFQNYIS
DNSIQS
>KECLDBNJ_01092 DNA polymerase IV
MNRNILHLDLDTFFVSCERRLNSKLIGKPVIVGGTGDRGVVSAASYECRAYGVHSGMAMR
MARQLCPHATYIRGNASVYTKFSKMVTDILQEQVPVLEKSSVDEFYADLTGMDRFFGCYK
FAKELRTKIIRETGLPISFGLSVNKTVSKVATNEAKPDSQLKVDAGFEKIFLEPLSIRKI
PMVGEKTFRTFCNLGVKKVGLVQQMPVEMMVSVFGKNGRVIWERANGIDRTPIVQYHERK
SISSERTYGRDTTDLIKLKTTIRAMAENLAFQLRAGNKLTSCITVKVRYSDFQTYSKQLK
IPYTAADHNLIPQVLELFEKLYNRRLLIRLVGVRYSGLTEGHYQIDLFENTSRTVNLYKA
MDAIRLRYGDRSIMRAATLGEGSRTIGGQGNPFNGQPPIILAHRHQ
>KECLDBNJ_01093 DNA polymerase III subunit alpha
MYLNCHSFFSLRYGTLSEVQLLDLAVDHKLDTIALTDINSTSAGLNFVRKAKEKKVKPVL
GVDFRNRIEQCYVCLAKNNEGYLELNNFLAQHLHNKTNFPETAPSFKNAFTIYAFERALE
LDKTHFSENEFIGIGIHDLNKLRFSQYSTYHDKLVLLLPVSFNSKRDFNAHRLLRAIDLN
CLLSKLPKEAQALPDELMFDPKKIENLFEEFPQILLNTQALLKQCSIDFKFAKERQNQNL
KTVFGSEQKDYKHLLALCEKGLKERYDEITPKIRERLERELTLIKKKDFVSFFLINWKII
EYARSQDYFYVGRGSGANSIVAYLLRITDVDPIELDLYFERFLNEYRSSPPDFDIDFSTW
DREDVTAYIFREFGKNNQVALLGSYVTFKHSGAVRELGKVFGLPKTEIDKLSSGQFNVSD
LDSIAQLILKYAAYFHKKPNYLSIHAGGILISDRPIHYFSATHLPPKDFPTVQFDMHIAE
DVGLCKFDILGQRGLGKIKDAVSIIKKNQPEAQLLDIRNPKPFFKDPKINAMIARAECIG
CFYVESPAMRMLLKKLAVSDYQTLVAASSIIRPGVAKSGMMREYILRHRNPERRKEAHPV
LWNIMTDTYGIMVYQEDVIKVAHHYAKLTLDEADVLRRGMSGKFRSRAEFQYVQDKFRSN
CIANGEPEEVVNEIWRQIESFAGYAFAKGHSASYAVESYQSLYLKCYFPLEYMVATLNNG
GGFYKAEFYVHEAKMHGATIEPPCINKSQIETTIYDKTIYLGFQHLEGLEKKTMLNIINN
RVHAKYTSYDDFIQRVPVSLEQQELLIRIGALRSLGKDKRSLLWEAHYKENTIPENELQQ
SFFKISLHDFTLPKFHISQYEDAFDYMELLGFSLFNPFFLMKESPHKYILARELPEYIDQ
QVKVAGYLVTCKNTKTAKGLRMNFGTFLDFEGAWLDTVLFPEVAQRSAIYARGLYHIEAK
VTTEFDFITLEVSKIKRLPYITDPRFATSPSDTKTHSLKTGS
>KECLDBNJ_01095 hypothetical protein
MGFRIKLTCIIVLMFGFKMFSQDNSTIRREGGGRNSYEDSLTNRGLKNRAARQRPPLDLY
KIISIENDTTIVDTSLTVEKLYKYNYLRKDNFELLPFANEGQTYNTLAYTFDSEKVMPEF
GARARHFNYMEVDDIFYYQVPTPLTELYYKSVFSQGQNLDAFFTMNKSKRFNFSIAYKGL
RSLGKYQNALTSTGNFRFTTNYQSKNNRYNVKAHYVAQDLLNEENGGLTDQALVNFGGGD
SQFNDRARLSVNFEDAESILDGARFYINQRYDLIKQNDSVNKNRIQIGHILNYEDKFFEY
RQTTPATDLFGESFVTSNLVDRTDYEELNNRVFVEYSNNILGTLNFQANHTYYNYGYNSV
LVREDETIPNALQGGIVAVGASYRKAYKGFQLKGEAQTNVVGDFSGLDFNAEASFKLKDK
AAFSGGIHINSSPANYNHLLYQSSYQNYNWYNAENYENVKTSSLDFKMESKKWFNASASL
VSIADYAYFGRNNAGLVQSFQADANVTYLKFKLNKEFRLGKFGLDNTVAYQNVSSGMSYF
NVPEIITRNTLYYTDEWFQKALFVQTGFRFNYFTEYNMNAYDPVLAEFYVQNDQALGGFP
LLDLFFNMKVRQTRIFFIAEHINSLVSPSDYYSAPGYPYRDFTFRFGLVWNFFL
>KECLDBNJ_01096 hypothetical protein
MKTLRKIIYVGALFALTSCSEDYLEVQPTEVLTDAQVAAATEVNEEAAKGTLLGIYENLY
RYGSGGTTAQEDFGITAQYMQMDILSGDAAHLGKSYNRQVNISELTATLDPDNDVNYRAW
RFLYRIINLSNLVIDASGGNDVVPETETGRYTIGQAKALRGYAYFFLIHAYVNDISDLTK
PVLPLYNSAEVLDQPKSSLQDVFNFVLSDLLDAEILLDGFVREEKIEINQDIVRGLLAKT
YGAMNNWASAQEYAKKVIDAGYPIMTADEVALLPGEDGSVGGFNDINTIPGVIWGINITP
EGQGLASLLSWWGFMDAYSYSYAAVGNPKGMDAGLYSNFREDDIRLNQFSSTLRPLGKFY
YKGAELNGFGLFSGPQANIDSDSHYMRSAEMYLLHAEAAAENGDFAAARTSLKAVLDLRL
DDTSYIDAMPNNQLADEAALQARLELWGEGQSYFIMKRRRETRTRGSNWLDFAGQSFNHN
DERLTYEIPQNEILFNTNLTDQN
>KECLDBNJ_01097 TonB-dependent receptor SusC
MKSKITWCFALGLLFLTQLTFAQQKTVTGTVTDGNSMPLPGVNIVVQGTSVGTQTDFDGN
YSISAEQGQNLVFSYIGFQDQVVAVGASSTISVSMQAGEELDEVVVTGFGNVSKTSFTGS
AKVVEGEQISKKSFTNVSQALAGEAAGVSVFNTTGQPGSTSTIRIRGFGSINGSQAPLYV
VDDAPFGGSLNDINPNDIKSVTVLKDASATSLYGARGANGVIVITTKKGKGRNNLNVSIK
TGTNYQGIKRYETIKSPEEYIGIAWEGTYQRGLLENDGDQGAAIDYANANLFEGANADVS
DISPVYNMWNIGGSDAAAVAQLIDPATATVRPGVTRRYSPERWEDFAFQSSNRTEANVSL
SNSGENSSVYASFGYVDDVGYANNTDYKRLNGRVTATNNVLDIINSTTTINYAQSEQNVN
GTSEDSGSQFWWIDNLPTIYPLYQRDAAGNRIPDPIYGGFLFDYGLEDGRGFGFATNGVA
DSEININKSKANSINFNNDLKIDIVDGLTFENNFGYQYFMSEDIDLNERFYSPAKGEGGR
VSRARSETKNYTIRTGLRYAKQFGDFNLSAFLSHVATGYEFNYLFASRSNLVTSFGTDIR
NGVINNPSDGFTREEKTESYIANVTLDFANKYYLNGTFNRDASSRFVNEKWGNFYAIGGA
WILSQEDFLQNSSAIDFLKLKASYGVIGNSDTDGSYGGLYPGYNIYSINNLNNNISLAFT
TRGNPDLTWESSNQFNVGAEFELFNFVDASVEYYRKSTTDMFFSRNVAPSNGFAVIQVND
GEMLNSGVEFDLDFSLVKSPKFKLNLGINGQLLDNELVALPIDPTTGEEQRFDQEGSYGR
TAGRSLYDWYMPIYAGVNIETGAAQWERYFDDVDNDGTFGADDVVITSLTGYMNDNPDAN
IVQDITEVYAEAADRFVDKTAIPDITGSFRLNAEYGAFSLSALFAYSLGGWSYDGAYANL
MDNDYAGTNNFHVDIRDRWMSPGDVTDIPRQDARFQIQQSATSTRFLTKSDFLALNNIRL
GYTMPTSFVEKMGLANLDLFLSGDNLALWSKRNGFNPSTSVTGNSSIYRYNPLSTIVFGV
NLTL
>KECLDBNJ_01098 Ribonuclease HII
MILKLRSQNKLIECGTDEAGRGCLSGPVTAAAVILPDSFVNKTLTDSKLLNHKSRELLRP
IIEKEALAYGIAQVFPDEIDAINILNASIKAMHLAIEQLQQQPQHILVDGNRFKPYKDCS
HECIIKGDSKFLSIAAASVLAKTERDRYMTDLHMQFPQYNWKKNKGYPTKEHREAIKAYG
LTPHHRKSFKQLPEQLRLDI
>KECLDBNJ_01099 hypothetical protein
MRRLALAFALLFLITNCKQTPTTNTNLLHLIPQKSAAILRIPDWEVFNETLKINEPSAVL
NETGFYNTLLEYADLLKKFAPKDDAYLAFVALGDNDFDLALITKNHPKLLQTDSVFTKNI
TSYEYEETTVNTITSTKSPLYFLNNEDVFIASTSKLILENTILQNNTGRDPIDLSLEQMI
KTSDNGSPNIYVRGSYFKRLFKTIIPDFKFLDSEIPFQWLALDIDLDNKTALSLSGVLTS
EQNGKQTFDLLQDLNPAPSKLIPNAPAQCRGVIGFQYEEWESYKNNLAKKRNASVKGFSV
PLEDYFASINELAVVYTNEQNLLLNYSNDITISEKALAPISTKSETFRALDIYKISDSTF
IKSTFKELLNPPTVNYYCTLGNLIAFAQSQDLIKDYIANYQNEALLKKTPAYNTLAKKMS
DASTLTYYGNTNLLATYLSGKVSKTEAKKLKAIDFEQFPAAMVQLVQADDFTYVNARVDK
ISAANAAAQVVQTASVQLDQDLLNAPQMLRNYRTKGQNILVQDIGNTLYHIDANGKIEWK
KELDGPILGKIQQVDLYKNGRLQYAFTTPSHFYVIASDGTIVKPFDLNYSNISQPLAVFD
YSGSRDYRFVITQGNTLTMLDREANKVKGFDYTEAPTTLFKAPQHIRLGSKDYILVQLTS
GKLEILNRRGETRIPLKETFDFAESPIFQNGSAFLVREKNGSLITISQSGKTSRKALGSG
SEIQYDRLNSTEALLLPEQLSINQKAIPIDLGLYTGLKVIKAKNSYYVAVTDLQNNKSYL
YTSKGTLLSNFPVYGASELDFGTLHNSKDLGLTVKGESDSVLIYQIN
>KECLDBNJ_01100 hypothetical protein
MKTSALFIVSLLYSIFASAQNLCADNQKLTEKTSFEITAYGTSNTLVAVTNFNVSSTFNT
LSGRKAIIAQIDKDAPTQEPQNYYSLECADSTLLINNRNIIPAYVFEEYSNMNFDASASS
IAIPKKLDVGQKLSNAAYEIEVEVAPITHRLHYFLTDRIVTAKETINTPAGTFECYLIEA
KTHMKPRNNNTGSVKQWFAEDIGLVKQVDYNVEGAITGINLLTDLKF
>KECLDBNJ_01101 Octanoyltransferase
MNKQVEVQDLGNRDYKEVWDYQEQLFKDILDLKIKNRREETDFATPNHFLFVEHPHVYTL
GKSGDISNLLVSEEQLKAKNATFYKINRGGDITYHGPGQIVGYPILDLENFFTDIHKYLR
LLEETIILTLAEYGLKAQRSEGETGVWLDVGTPFARKICAMGVRASRWVTMHGFAFNVNA
NLGYFDNIIPCGIKEKAVTSLNVELGRSEVPLEEVKPKLLKHFADLFEAELVEKASV
>KECLDBNJ_01102 Lysine--tRNA ligase, heat inducible
MQLSEQEIIRREKLAGLRKLNINPYPADLYPVDHTSAKIKQDFEDGKKVVIAGRLMSRRI
QGKASFAELQDSTGRIQVYFNRDEICPGEDKTQYNDVYKKLLDIGDFIGIEGELFTTQVG
EKTVMVKQFTLLSKALKPLPLPKVDKDGNEFDKFNDPEMRYRQRYADLVVNPKVKDVFVK
RTKLFAAMRNFFNDKGYFEVETPILQSIPGGAAARPFVTHHNALDIPLYLRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMAFTEKLLEHCATAVN
GTTEATFGQHKVDFKAPYARVTMTDAIKQFTGYDITDKSESELREAALGMGLEVDETMGK
GKLIDEIFGEKCEGNFIQPTFITDYPKEMSPLCKEHRENPELTERFELMVCGKEIANAYS
ELNDPIDQRERFEEQLKLAEKGDDEATEFIDQDFLRALEYGMPPTSGLGIGMDRLIMFLT
NNQSIQEVLFFPQMKPERKKVELTEEEKTIFNILKKEKNLSLDTLKEASGLSNKKWDKGI
KGLTKQKLAKVEKEGENLTVTLIDY
>KECLDBNJ_01103 hypothetical protein
MKKLIAIAALFVATTTFAQEQPRGERFKKMMEATPEEMAELQTKRLTLALVLDDKQQKQV
YDLQLAEAKERKAQWEERAAKKSTREKGVKPTEEEIAAMRESIKERHSEMLDKQIAHQEK
MQNILNEEQFDEWRKLKMKRHDRMAMRDGKRGERSHDRNQKAKWRR
>KECLDBNJ_01104 Glutamate-1-semialdehyde 2,1-aminomutase
MMIYKRSSALFAEAQEVIPGGVNSPVRAFKAVGGDPIFVKEAKGAYLFDEDGNKLIDYIN
SWGPMILGHAYQPVVDAVIERTKKGTSFGTPTELETEIAKLAVKMVPGIDKIRFVNSGTE
ACMSAVRLARGFTGRDKIIKFAGCYHGHSDSFLIQAGSGAVTFGSPNSPGVTQGTAKDTL
LAEYNNLDQVREIFEANKEEIATVILEPVAGNMGCIPPAEGFLEGLRDLCQAHGALLIFD
EVMTGFRLAAGGAQELTGVQADIVTFGKVIGGGLPVGAFAARNEIMNHLAPLGPVYQAGT
LSGNPLAMAAGLAMLQALDQDREIFKRLEQKTEYLHKGIAQVLTENRITHTINRVGSMIS
VHFAEEAVTDFASASAGANETFKKFFHGLLAEGVYIAPSAYETWFITDALTYEDLDATIA
AVAKIAPTL
>KECLDBNJ_01105 Exo-glucosaminidase LytG
MIKKVLTLFILSLLLIGCGGSKRAAKRKVSVRPSRTTETRTAARNNTPPAETTKETERAY
VYAPFDKVEDYIEHFAPIAKEEMRLYKIPASITMAQAVLESGAGNGNLTKKANNHFGIKC
HNWTGDVVYHDDDEKGECFRKYRDPKYSFRDHSLFLTGRSRYADLFDLEPDDYKGWAHGL
RKAGYATDRKYPEKLIAIIERYAMYNYDAEVLGTKIKEYKPEPSNAVSIHTVKKGETLYS
ISRMYNLTVDELKKNNGLNNNTISIGQQLNVTPQYNGF
>KECLDBNJ_01106 D-cysteine desulfhydrase
MNDLGFFTSLEDEPQIQYLRDSLYEEFQVEVAIKREDQIDTYVSGNKFRKLKYNVLEAAK
QQHDTLLTFGGAYSNHIAAVAKAGSRSGFKTIGVIRGEELAQNLRQTLQHNPTLRFAKDY
GMQFKFVSRETYREKLQPKFLQQLKDEFGTFYLIPEGGTNTLAVQGCTEILSEATQDFDY
IACPVGTGGTIGGIIDGSFPHQKILGFPALKGDFLNAEIKKYTDKTNWELVNAYHFGGYA
KVNQDLVTFINDFKKKHDILLDPVYTGKMMFGLRDLIRNEFFSKNTRILAVHTGGLQGIA
GMNQKLLKKGFPLIRM
>KECLDBNJ_01107 hypothetical protein
MLKLSFLLSLFLLSFISNAQVGIGTTNPAGGSLLDIESAEKGILIPRVDIADLSTQAPVT
GDLTSSESLLVYNTNTSTGKGFYYWDGTQWVAVGGNGENIYTTDGTLEENRIVSQEDKTL
QFEGNIGRNAISIKRTNNVTETGVGFQNSGDYYDASIFMESGTNQGLVVATGGNNPDVTA
VGTTAVFNNDQTTSFSNSISVYQNDANVNDITGRLYSTDDDGILDLYENNSYNHRIAANS
STIFNEQGLNLDFRVETDNSANTLFVDGSSDNVGLSTNTPQEKLHISGNNSTIRVDGLSD
TNNAENVTGDFMPVYVDDNGTMVLQPSLVQTYMPVNRVDFLTGNNNTVTSGFNTGASVDR
LLLTETITLTQTSLVQIIYFYSVSITRRNGDAITDGAPRLFRGWVTINNTAEHLAYDTGT
YTNGHDPDPNSQSNYAAGYYYLNGTSYVELPAGTHTFRLYGRGFGSQFDFQMIFGASNYD
RFQIIVHR
>KECLDBNJ_01108 hypothetical protein
MPIYIIFPKIFKHFAGCALWPFVLLKDPKLKQDPIFINHERIHLRQQQELLIVFFYIWYS
IEFVIHLIRLQSQYAAYRAISFEKEAYAKENDLSYLKQRPFWSFLRYL
>KECLDBNJ_01109 hypothetical protein
MKKLKPFLLLAVVAVLSACSSVRVASDYDQSADFTNYKTFAFFKPGIDKAEISDLDKKRI
LRAIETEMMAKGFVKSDNPSMLVSIFTTAEERVDVYNNFGWGWGAWGPWGPWGGGFGNTV
SRTTEGTLYIDLIDATKKELVWQGQGTGYLARNVERKQERINEIVGEIMQEYPPKQMASN
>KECLDBNJ_01110 2,3-dehydroadipyl-CoA hydratase
MSESYVTLDVKNAVGTITFYTPNHNALPTEILKKLERTIIEAGSRRDLRVLVIQSGGDRT
FCAGASFNELIAIKDEKQGKDFFMGFARVILAMRKCPLLTIVRVQGKAVGGGVGLAAAAD
YCMATKYASIKLSEISIGIGPFVIGPAVERKIGVSAFSQVTINAQEFYSAAWAQERGLYA
SVFETVEALDQAIEKLAGDLATYNPEALAESKKMFWSNTEAWDNLLETRAATSGKLVLSD
FTRKKLQSYA
>KECLDBNJ_01111 Phenylalanine-4-hydroxylase
MSQVLDKNIETNPLIERLPAHLKQYIKPQNYDNYTAINQAVWRYVMRKNVAYLSTVAHKS
YLDGLKQTGISIDHIPNMYGMNRILKEIGWAAVAVDGFIPPAAFMEFQAYNVLVIASDIR
QLEHLEYTPAPDIIHEGAGHAPIIANPEYAEYLRRFGEIGCKAISSAKDYELYEAVRELS
ILKEAEDTPQSEIEKVEQRVDFLQNNMGMPSEMALIRNLHWWTVEYGLIGTPQKPKIYGA
GLLSSIGESAWCMTDKVKKLPYAINAAQQEFDITKPQPQLYVTPNFAYLSEVLEEFANSM
ALRTGGPEGLQKLIDSKNLGTIELSTGLQISGVFTEMILYKDKVAYLQTKGKSALSYHEK
ELVGHSTINHPDGYGSAIGKLKGINLAIEDMSPKDLIAYKISEGSIVTLEFEGGIKVSGE
IITGTRNLKGKIILISFKECTVSYEERILFKPEWGIYHLAVGKKITSAFAGPADFNSFDL
IQHKISSTTAKPKMSAQRQELEDLYLAVRNYREGKNTKFAPLAVFDILKKSHQKDWLLSV
ELYELAKDENNTAFMTEILQHLEQVKAQHPKVKHLIEDGLELV
>KECLDBNJ_01112 hypothetical protein
MRKVLIVILILLLGYFTYQYFNAQQEKREQLIEATNLIEKEIKNVGKLAVTEGSFAQVFT
YKNSKQIFNLVEANKKALVVINAKVTIAYDLRALETEVDPENKTITIKKIPAPEININPD
IEYYDVSQDYLNQFEASDYNKIKQRVMTTIRQKVESSELPQNAENRLLAELANIYVVTNT
LGWTLQYNTTPINSSQELKTLLD
>KECLDBNJ_01113 Transcriptional regulatory protein DegU
MPVKIAIVDDKFFLAKAIAEKLSFFKEFHLKFTAEHGADLLTKLDDNPHIDLILMDIEMP
VLNGIEATALVKQKYPQIKIIMLTVFDNDEHIFNAIKAGADGYLLKDTTPDELQKGITET
LSGGAAMNASIAMRTLKLLRNPEAISNLQEREEISLSSREIDVLEQLGKGLSYTKIAENL
FLSPSTVRKHIENIYKKLQVHSKIEAVAKARQNNII
>KECLDBNJ_01114 hypothetical protein
MTPSSASIAHASNNDFYADNEKLYVATDCIVFGFDGEDLKLLIFKRRVEPDSGIWSLIGS
FVQLDENVDDAARRVLKEITGLEQIFLEQSKTYGKADRDPGYRCLSVAHYALIRLEDYDR
ELVESHGAFWYTLKELPTLALDHDQMVADALDKLRRKARQQPIGFELLPEKFTIPQLQKL
YEAIYQRDLDPRNFRKKVLSLKVLVKLDEKDKSGSKRGAFLYRFDADKYEELLESGYNFE
I
>KECLDBNJ_01115 Sensor histidine kinase LiaS
MGLNYRLLVLVFLLFANLSAQTSKAKIDSINAILVQNSAIKTDSLFTIFQQNLENAQTLN
YPKGIGEAFQKIATLYGYEGDLDARLEYNFKALRIFEQHELRMEEAYLNAEIGYQMKRDD
MTKAEAYMNRGMKLAEQEVYENVLDRIYNNYGVLKEMQGQLDSALYFYEKGLELVKKRDF
TEGYPYSYSNLGGVYGQQGKYDLARNYFEKARQIREEIGDQKGIAENFTQIGEVYLAEGK
NQEAISYFKKAVPVAHAQDYRFLEQYTYQQLSQAYKNLRQTDSALFYLERYGVFKDSING
LEVNKKIAELNLNYETEKKENQILEQRAQLAEKDLEVRRKNAFIYGSLALAFILGLLGYL
IYSRQKLKNSQLQKEHELQVALAKIETQNRLQEQRLRISRDLHDNIGSQLTFIISSIDNL
KYQLKDADSGILEKLSMISAFTSTTINELRDTIWAMNKEKISVEDLQTRISNFIERAQSS
KDSVQFSFDFNTKQAPDFIFTSIEGVNIYRVIQEAVNNALKYAEAQNIQVTMQVWDADQF
KVAVVDDGNGFDLKNHQQGNGLGNMKKRVQDIGATLQIETQPTQGTRVILQSK
>KECLDBNJ_01116 hypothetical protein
MTLESTYVLGFLLPVSLLAAVMVLIFLKLKSRDQIRSRQRIKRLGEQLSLAQYQIKYRHK
GLDRYNLLRYNLNDSLCIQSEIDLF
>KECLDBNJ_01117 hypothetical protein
MEKFNSAVFLKVATPDKSNAALYANALFLLVLLAVGFVTPWSIVMAYFLETIVIGLLNAL
KMAFCVGFKRHNGGTQGFGIILFFLVHYGFFVAIQSIFAFTFFELGGSTFFTDGIAVLKN
YWTLLQLDGMWLLLLSIILNNCFSFATDFLGEKRYLKFTASELMIKPYLRIFIQQFVVVL
SGFFLVYLDAGFIAAVLLIILRLGIDMFLVSLRDNSASIDKVADWYASKNAEVSAEEVKK
QLKIFTE
>KECLDBNJ_01118 hypothetical protein
MKLKLHHLKNALLLFFVTAVTWAQKAEAPDYTYDVGAGINDMTLTLGGTLVVCTNDGLVG
IKPGSNELVFNFTDYGSVKPEEVHYIPNSPYLMVDQNGVGGIKALSGFSSKKAVIDYISG
EVIFSTEKNDWKTIQTADVIMPESKLVISGFQKGGGQAESVTPKIAVYDLVTGELDYSFF
LVKPGKTTMKFFAVSGTPLLLKDKLLVPTTQGIYAKTKTGETLWENKVKGVDWMVTNEDE
SDIYAIEMNDAKTNTQVYKIGTNGAEIWKDAPKVQGVVSNFQILPQGLIVVSDKDTSGKS
ILAGRSESKINFLSASTGEDLWDKAPKTKGFVQHFYVMDDGVLFGIHEGGINKVSFDGTP
LFKKPLKTGEDIKLMAETPNGLIYITSEDANIVDLKTGDQVWKKPLKYKSANSVTSAFDA
KNNRYLINADDELFAIDAESSEISTLAKVKFEEKENPNTLTVREDGIYLGSDQNMALLDF
GGDTQYHTYLKSPGRSTFGKIVGGVTAVATTALTMTSAMTAGANMRSHAVNTNNLRNYNE
YGREAKRAQDMFAGMADASFEYLSTRFKATAATENAQFILTKLDDGTGLARVSKANGEIE
KEIVLKDKKPEYKVDDYGGVLYYKADNKTIYAYNLN
>KECLDBNJ_01119 hypothetical protein
MKTITRITSVLLFSLLVLTACSKDDDGGTSAAGDGELTATVDGDSFESFPEATTAVESNS
GGIQILTISGGTMDSENIQITIIGFEGVGTYDLNSVSLGSYTYLEDTSNFNSAMVFTTST
GAASNGEIKIAEYTAGGTVTGTFNFTGYLTSDTSKTVAVTNGQFNVSIQ
>KECLDBNJ_01120 hypothetical protein
MKLQTTIPLKPSGNPIDYHSRLFLVGSCFVENIGAKLEYYKFRTTINPFGILFHPEAIAR
FLEYAVSGKQLSEADLEETQGRFVSFDAHSVLSTSSAAETTKLLNEALVETKRQLAQASH
IVITLGTAWGYQHLGQDKIVANCHKIPQKAFQKELASVEEIAAITRRMLSAIAKVNSQTE
VIFTVSPVRHTKDGFVENQRSKAHLLAGMHQVLDESQHTAYFPSYELMMDELRDYRFYDR
DLIHPNALAVDYIWERFSSVYFSEETQKTMQKVQEIQQGLAHKPFNPDSEAHQKFLNNLE
AKKCALQTDFPHIQI
>KECLDBNJ_01121 Alanine--tRNA ligase
MKSQEIRDQFLSFFKSKNHSIVASAPMVIKNDPTLMFTNAGMNQFKEFFLGNGTPKDTRV
TDTQKCLRVSGKHNDLEEVGKDTYHHTMFEMLGNWSFGDYFKQDAIDWAWELLTEVYKID
KSKLYVTIFEGDDAEGLERDAEAYDMWKKHVAEDRILNGNKKDNFWEMGDQGPCGPCSEI
HVDLRSEEEKAKIPGAELVNADHPQVVEIWNLVFIQFNRKADGSLENLPARHIDTGMGFE
RLCMVLQDKTSNYDTDVFTPLIREIETITHSKYGQSEETDIAIRVIADHVRAVAFSIADG
QLPSNTGAGYVIRRILRRAVRYGFTFLNTKEPFIYKLVNVLVDEMGKAFPELKKQQNLIF
NVIKEEEQSFLRTLDQGLVLLDSIIAETKGKEVSGAKAFELYDTYGFPIDLTALILSEKG
YTLDEKAFQTELQKQKDRSRAAGKIEAGDWTVVEEDSEEEFVGYDTLQTPVRITRYRKIN
TKKEGDQYQLVFNLTPFYAEGGGQVGDKGYLEAANGDVIYITDTKKENNLIIHLSKNLPK
NLNETFTAVVDAKQRYRTQANHSATHLLHQALRAVLGTHVEQKGSMVHSGYLRFDFSHFS
KVTAEELKDIEQFVNARIQEQLPLEEQRAIPYDQAIAEGAIALFGEKYGDAVRTIRFGKS
MELCGGTHAENTADIWCFKIKSESAVASGIRRIEAITGDAVMQYFEEQDEQLEAVRSLLN
NTKEPAKSIESLQSENNELKKQLEVLLAEKAKNVKGELKNEIEEVNGIQFLAKEVDLDAN
GIKDLAFQLGGEVENLFLLLASRQGGKALLSCYIDKELAKAKDLNAGTIVRELGKFIQGG
GGGQPFFATAGGKNPDGIAQALNEVKTYLG
>KECLDBNJ_01122 Murein DD-endopeptidase MepM
MSKVKYYYDKETLSYKKIEKRKGRKLGYALLSIGASFLAGFILLVIYLNIPDLETPREKA
LQRELQNMKMQYGVLNKKLDQVQTVLNEVEERDNTIYRLYFEANPIPDEQRKAGFGGVNR
YKDLEGYDNSKLIIESNKRLDVLTKQLVVQSKSLDEIAVLAEEKEKFLNAIPAIQPVANK
DLTRIASGYGMRSDPFTKERKMHWGMDFTSPRGTPVYATGNGTVERADNNATGYGNHIRI
DHGYGYVSLYAHLYKYNVRRGQKVQRGDLIGFVGSTGRSEAPHLHYEIFKDGQRINPINF
YYGNLSPEEFDVILQKAQLENQSLD
>KECLDBNJ_01123 HTH-type transcriptional repressor BluR
MHVDLPEKLYYSIGEVADAFGVNSSLIRFWEKEFDVIQPKKNAKGNRKFTPEDIKNLELI
YHLVKERGFTLEGAKTHLKENKQETLNKFDLIRKLENIKAQLQQLKDQL
>KECLDBNJ_01124 hypothetical protein
MKKGIIALIVVVILLIIGYSFFKGFYNTGIELQEDATAQWGNVESAYQRRSDLIPNIVNT
AKGYAEFEQKTLTDVIEARSKATSVNIDPTNITPDQLEQFQQAQSGLSSALSRLLVTVER
YPDLKANENFKELINELERTENRINVERNRYNEAIKPYNKHIKTFPNNIVNNFIGNFEEM
EYFEAEEGAETAPEVNFDFNNDAA
>KECLDBNJ_01125 hypothetical protein
MASVVEDFLTAEEEQEVVEAIRQAELKTSGEIRVHLERTCDEQALERAKVLFHQLKMDNT
KEENGVLIYVAVDAKKFAICGDRGINKVVPDDFWQSTKDLMQTEFKNRKFKTGLVKGITS
AGEQLAHFFPWDDDDINELSDEISTS
>KECLDBNJ_01126 hypothetical protein
MIYLPQIRSIRTMLLLAFLFCLSAKGLAQFDIPEVPSKQTSVYDYSNLLNSGQKAALENK
LVRYSDTTSTQIVVVIIPSTKGEDISFLGAKWGQKWGIGQKDKDNGILITLATEDRKVDI
NTGYGIETIITDRMAEQVINRVMIPQFKRGDYYAGLDQGADALFQMLQGEYQGSRQRNEG
PGIRNFLPIIIIFFVIIFILSRSRGGGNGRNGGRRSGAGSLLDVIILSSLGRGGMGGGGF
GGGSSGGGFGGGGFGGGFGGGGFGGGGASGGW
>KECLDBNJ_01127 hypothetical protein
MESFLQLIHQITKYGSEQVADANKLVSLKKSLGDLYALYLNLNSNFDEQLYEEVQRLDYA
EVYAYVKVNFPEFGWYRSSTISFEIDQNPELLVEDAIDDLTDLIIDLSEVAWRLKNTSLN
DGLWYFNTLMKIHSEAHLLNILIYLKALEA
>KECLDBNJ_01128 hypothetical protein
MDGGISFIKACGLLIIALCFVQCSPKLRSSIQNPQPSLGDEAEVIVLPLDDNQELNGIEV
GVLRASDNGLSKDCTYPEMIALLQETARNNGANLIKLIKNKEPDMWSTCSRISAVAYRVN
NPQKYQLEINWSANRKLSWEDFKGKVRKESPYDAESYCSIHYQTGLVTLFSKAEIIVTNT
FDCTRSWVRAEKKTDAILNHEQRHFDLCEIYTRNLRAEFAKHKFYANSQNKLDSLFSEFE
KQYNEAQRRYDEETAHGTKEIEQMGWDSYIDLKLGL
>KECLDBNJ_01129 hypothetical protein
MINRYLVALVLGMFSLCTFSQDFKIIGKLVDKEQQVPLEAATVVLETLQDSTVISYTISD
RNGEFELSGKSNLQKANLFVTFVGYQSYEQQIDFSKTREINLEDIPLEFQVESLGDVVVK
GRAAPVVIKQDTLEFNAASFKTKPDATLEDLLKELPGAEVDEDGQIRINGKPVSNILVNG
KPFFSDDPTIATRNLTKELINKIQVVDTKTESEEFAGEEGDSENKTINITIDEDKNKGLF
GRVAAGGGTDDRFEFAGIGNYFDNDLRLSVLGSGNNINSPGFSFGEIEKMFGNASYISVS
SNGGFNVGGRSFGMGEGIVNSRNAGMNFANDFGEAVETSADYFYSGANTFNETDRVRENI
LPDNRFTSVSNSRTDSNTDNHTANLRFQAEIDSTFMVEYRPSLNYTVGTNSSSGSSVTTN
EAGDLVNDSDYDNFNDRTTRNFSNSLTATKRYGDKGGFIRINGDLQLDETESTDFTNSET
NVYGTDASQILRNQRTNGDNNTDGITTKVKWRIPLISKKLFLETEYEFKNENRTNTQLVY
DFDATTQTYNQLITPQSTDFESTNRSHKPQLGVTYNSKKLRASVNAAYVARKLTGEDLLT
DETGNRVRDIDFENNFDALEAMARLNYNFTQKLSLWSAYRLSNNAPDIRQLSPYLDVSDP
INTIQGNPNLSPTNSHGLNMGINNYDWETRSGLYSYFGFTFTNDQVVNLTTVDDNFVRAT
TFTNVDGVYNGYGNLGYNKDFKLDSLRTLKVEVGMSGSINRFVNFFNADQYASITKSLGP
SLGLRFTWTDWFEIRPEYRISFNETTFNRDFFDGQDFTQHNARLRTTTYFPKWLTWENDI
RYTYNPNVGTGFQRDAVFWNTSLAYSFLNDKALATFKVYDLLNQNTNSRRTATQSYIEDV
QSTVLQQYFMLSFSYKFNTLGKKGEVRENGWWD
>KECLDBNJ_01130 hypothetical protein
MKQILLVVLALIALQQSNAQDFQLNGTIKDNTGVPLESATVYVEKISDSTLVTYGISDRE
GFFEMEGRTDQEKLNLFVSYAGFKPLRKVITITPTVELGDLKLEVQDNLLDEVIVVADRA
PVTLKKDTLEFNANSFETRPDANLEELLKKLPGAEVDSDGAITINGKPVSRILVNGKEFF
GDDPKIATKNLPKEIIEKLQVVDTKTKAQEFTGEAGDSENKTINITIKKDKNKGYFARGT
IGGGTDGRYEMSAIGNIFKDNMRTTVLAGSNNINSSGFDFDDVYGMMGRSGARAVAAGNN
SNGITKSETAGANYSNEWSDQYELNGDYFFDRSNTDTRSRTERENILPDTTYYSSSENTS
NAVNDRHRANARFEVEFDTLTRLSYSPRFTTSKTKSVRNTMASSSDGNRDLVNNTETSSQ
DDVYNVDFRNEVDFIKRFGSRGAFLRMEVSQSYNNQENDNFYFSESEFFGDDARTEVQDQ
FIDEDEREYQYGLEVEQRLVLATDFFMDLAYDFSSSKSTNSRYVYDADSGGAYTALNDTL
SSNFEVNTYRHTPNIGFNYDHEAWRINTNVGLLNTILQNENLLNPASFDNTYNNLYLSAR
VRYELERSKSISIDYRTNANTPSIRQLQPVADRTNPLNIVVGNPALRPAYSHNIGGGFRS
FNFGAGGGSGIFSSFDLSFTENQVVAVSTIGDDLRRTTTYANVDGAMSAGARVFYTKSTR
KEEHEFRYRMSLTGNYNKNVGFTNGTLFNSKRISVSPGIRLTYAIQEVFEVNPSYSLTYN
DTKYSINEDRNEDFINHRVGFEATTFWPKNVIFGNDISYNYNGNVSPGFQNSSILWNTSL
GYQFLDEKATLKVKVYDVLDQVVDTRRIIGDDYIQDTNSLILTQYAMLSFTYKLSNFGGQ
SGRPGGPPRRR
>KECLDBNJ_01131 GTPase Der
MSIVAIVGRPNVGKSTFFNRLIQRREAIVDSVSGVTRDRHYGKTDWNGKEFSVIDTGGYV
RGSDDIFEEQIDRQVELAIDEADAIIFMVDVEAGVTGMDEDVATLLRRQSKPVFLAVNKV
DNAMRADDAVEFYSLGLGEYYTIASISGSGTGELLDALVEVLSEKVEEEESILPRFAVVG
RPNAGKSSFINALIGEDRYIVTDIAGTTRDAIDTKYNRFGFEFNLVDTAGIRRKSKVKED
LEFYSVMRSVRAIEHCDVCLLVVDATRGFDGQVQNIFWLAERNRKGIVILINKWDLVEKE
NKTMREFEKYIRTQIEPFTDVPIVFISALTKQRVYKAIETAVKVYESRSKRIKTSELNDY
MLPLIEATPPPATKGKYIKIKYCMQLPTPHPQFAFFCNLPQYVKDPYKRFIENKLREAFD
FEGVPIAVYFRKK
>KECLDBNJ_01132 hypothetical protein
MYLLMKRICLLLIIALSLHSCNLLSAAGITSGGQPTKETPDKLTSTTANSAENVDHSAWD
ALLKKHVNADGMVDYKGFNKDRGALNKYLTQLSSYTPNSDWSVQELLAYYINLYNAYTVD
LILNNYPVESIKDIDGAWTRSIVPVGNKKLALGGIENGVLRKMNEPRIHFAINCASMSCP
KLLDEAYTAGKINEQLDRATKEFINSDKNEIGKNSVKLSSIFDWYKKDFITTETPTIIDY
VNQFSTTKINAGASVSYKNYDWSLNEQ
>KECLDBNJ_01133 PGL/p-HBAD biosynthesis glycosyltransferase
MISIVIPVLNESENLPCLLDHLKDQIGRVLAVELIIVDGGSNDDTLALAQQFKDTNRLAV
SLITSQRGRAKQMNAGAQAAKGEILYFLHADSFPPKHFDVLIEKEVAKGNPAGCFKMRFD
SKHWWLRLASWLTKFSWRACRGGDQSQFITRELFDEIGGFDESYIIYEDNILINELYARN
SFVVIQQPIQSSARMYEKYGVWYVQYHFWAIYVKKWFGASAEELLAYYCKHLKKPVA
>KECLDBNJ_01134 hypothetical protein
MSILTIILSILLPPLGVALSKGLGKDFIINVILTLLGWLPGVIHAFYVNSRG
>KECLDBNJ_01135 hypothetical protein
MKKLTFFITFCILAICLLGCSATTVVKDKINGVSFVASRDTLQQKNIDPILNIGANAAAI
MPFGFIRDKNHPQLQFNSERQWYGERYEGVKQYIELLHQNAIDVMLKPHIWIWHGEFTGD
MQMNSEADWKLFENSYEEFILLYAQLAEETQTEILCIGTELFNFVDQRPEFWQQLIKNVR
AIYSGKITYAENWDKVDRVPFWSDLDFIGVDAYFPVAEAQTPTVKEAIAGWIPHKKVIAS
LSKQNNIPVLFTEFGYRSADYAGKEPWASDRHEGAMNTKAQVNLYQALFETFWDEPWFAG
GYAWKWFHDHERATATGNNRFTPQGKEAEMLLKKWYLNSVN
>KECLDBNJ_01136 Nitrite reductase [NAD(P)H]
MEHVVIVGNGIAGVTAARHIRKNSDKKITIISAESEHFFSRTALMYVYMGHMRFKDLKPY
EDHFWSKNRIDLKQAYVKKVDTANKTLLLAKGDTITYDTLILATGSVPATYGWKGLELHG
VQGLVSKQDLELLEKNAPNNQACPKAVIVGGGLIGVELAEMLHTRKIEVTMLVREKGFWS
SVLPEADAQMISEHIKSHHINLLHEEELDEILGDAQGNVRAIRTKSGKEISCNLVGITTG
VKPKIDFLEGSGIATDKGILVNRLLQTNQAHVYAIGDCAQQHEAIGLRKPVEAVWYTGRM
MGETVAQTICGTPFEYNPGNWFNSAKFFDIEYQTYGWVFSNKNKKPYEAHFHWKHPDNTK
CITIAYHKETRAFLGINTFGIRMRHDVLDHWLNTRKSVDEVVHNLAQANFDPEFFKSYYS
NINAAFSGANSKA
>KECLDBNJ_01137 Putative electron transport protein YccM
MSSVQRDMSLTGQPPAALNTIQKLATALGVGGLLLLVLAIFNVRLMNQSLWLTTALTSIF
VGIVLFSYGAYADKQAGIKNDGVWFKSISNRGFLAWVAGLALTGFYIVLYFKAELLGLNT
EGENSGLIALFDPLSKILSGNPASQWFVYGTLYTIAILGFGIKFLWKYRHNRYERLRTLS
VMFFQTAFAFLIPEFMARLNSDDFNLPYYDLKNIWPLNYYNFEQYRVDGFISSGSIGLAL
LIFGIASIFVITPILTYKYGKRWYCSWVCGCGGLAETAGDPFRHLSDKSEFAWKVERWVV
HSVLVFVVVMTTAVVATYLGYDSEKYWLTKDVFLIGVAVFLTALFGLIWLFKKEELKQDA
RYGAVGYLVIVLALIGIHFSSGSTLFLIPAETLRTTYGFLIGSIFSGVIGTGFYPIFGNR
VWCRFGCPMAAILGLQQRLFSKFRITTNGGQCISCGNCSSYCEMGIDVRAYAQKGENIVR
ASCVGCGICSAVCPRGVLKLENAYTEKRINSREVLLGNDVDLMDYLNQN
>KECLDBNJ_01138 Negative regulatory protein YxlE
MILGMVGPWQVLLILIFGVFGLILPIIALVDIVRHEFSGSNKIIWVLIVLFFNFLGSILY
FLVGRKQRIN
>KECLDBNJ_01139 putative glycosyltransferase
MTLIKVIIPAFNEEDSIGLVIKDIPNHVDEIIVVNNNSSDQTEARAQEAGAVVLRENRPG
YGLACLKGMQYIAAQEQNPDIVVFLDGDYSDYPEQLDELVTPIIHEGIDFVIGARVKRFR
ESGSMTFPQRFGNWLATTLMRWIFDSSFTDLGPFRAIKYDKLLALHMQDQTYGWTVEMQL
KALKQKLSYVEIPVKYRNRIGVSKVSGTVKGAIFAGVKILGWIFKYSFK
>KECLDBNJ_01140 Beta-monoglucosyldiacylglycerol synthase
MQTVIVIIYTLALTVIFLYSLAQLNLLLNYLKAKKKKDDAPVFDFSKAEEIPFVTIQLPL
YNELYVVERLLDNIAQIDYPLDKLEIQVLDDSTDESLQTTQRKIETLQAAGIPIKHITRT
NRQGFKAGALKEGLAIAKGEFIAIFDSDFVPNPDWLQKTVPYFKDENIGVVQTRWAHLNR
DYSLLTKIQAFALDFHFVLEQVGRNFGHHFINFNGTAGIWRKTCILDAGNWQGDTLTEDL
DLSYRAQLKKWDFKYLEDVETPAELPVAISAARSQQFRWNKGAAENFQKLYGRLLKDPSV
SFKTKFHSFFHLLNSSMFLLVLLVAILSVPILYIKNNNPAYSWYFNVIAAFAVSTVIFFG
CYWVTYKRIHGGGIQNFFKYIGMFFTFFSVAMGFSVHNSLAVLEGHFGKKSEFIRTPKFN
VSKLGEQWSGNIYLKKNLSSGMLLESILFLYFGFAIYSAFKVNDFGLILFHLMLFAGFGF
VAFKSIFSRI
>KECLDBNJ_01141 Alpha-(1->6)-mannopyranosyltransferase A
MAVTLLGFYAAFAYDLERYDFIRLISLYAGAFFLSYKLIQSFKFNVKILLILGIAARLVF
LIALPNLSQDYFRFLWDGKLLAESLNPYLNTPDQWVALGEIPIAQAQDLFNGMGALSRQH
YSNYPPVNQFFFWLSGILSGNSILGGVIVLRICCIAADLGIFWIGRKLLKKLKLPEHQIF
WYFLNPFIIIELTGNLHFEGVMLFFLLASLYLLFRGNWFWSALLMGLSIAIKLLPLLMLP
LFFQYLITAHSKTEENSKPFKLLAEKPLQSLWKLLRYYFVVIGVFILSFTPFFTEELVAH
FSQTIGLWFQKFEFNASVYYIIRWIGFQVKGYNIIATAGKMLPIVVIAGLMLLALIRKSD
RKQHLMNTLLLGTSLYFLCATTVHPWYIATPLLLSVFTRFRFAIVWSLVVFLSYSAYKID
RVEENFWLVAVEYLVVLGFFIWEFYKNNLLEKTR
>KECLDBNJ_01142 Internalin-J
MKTLFVGCLFALCFFCANSQTTTIPDANFEQFLVDQGIDSNGLNGNILNADAQAVTALNI
SINTITDFTGLEAFVNLVTLDAGTNQFATLPLTTLSLLEELVFNQNMVLASLDLSGNPNL
KRFQARANGGSNSGPITVIDLSNNLQLEDINIYNFRNLQNVIFPDTNTVISIYLLMHNDI
TVDFSGYSSLESLSLSTNFNNNYPITATLPSEQNTLKTVAIQGGNIIDVDLSNFLALEAI
SLQSTNTETIDIPQTSTLTAISISDHNIASASFADASMLQNLTITRKQESPGLQLDITQN
EALTTLNASHNYMDALDLSQNTNLSDLRLAHNSFATLETSQNLNLVYLDASYNLISSLDL
STNTILERLILNNNELPGIDLQANILLENLNLGTNKIPTLDVSSNNELRMLYIDDNLFAN
TGLDLTQNPELHYLDASNNQIESLDITQNGKLGSLILHHNLFSGTDIIDQYYDIWNANGA
LGASDELDVSYNLLSGRIPDFTNLAVDRRTNYFELRFNDNYFHFGDFEAEHLSYVDLLNT
YWSSSPSLVLFRAYTYAPQAKVNEVETIAPNAGENITLTTTVRGNQNHYKWFKDGIELAD
APDAPELILTDVNDCDSGIYHSEITSDLVPFENSNAPGSGGKNLLLQRNDITVNVTVNKT
CVSLTNPVNTATDVAINTGIAWENTNGACGYILSVGTSSGGVDLVNNLDVGDLELYNFEN
DLPANQDIYVTIIPYFSDGEISGCTEEMFTTSTLAIPPDCTQLGRPLYGAQEVALTSDLY
WEPANAADNYIVQVGTSSGTDNVLNQTVASTYYEVPEGTFEAGTEYFVTIIPTNTFGNAT
GCTETSFTTETLITPPACTTLMSPADGATDVALDVELSWNASAEATGYLLNVGTSSGGTQ
IIDNLDVGNQTVYNLTENLPENTEIFVSIIPYNSTGNATGCTEASFTTETLITPPACTTL
TSPVDGAIDVALDVELSWNASAEATGYLLNVGTSSGGTQIIDNLDVGNQTVYNLTENLPE
NTEIFVSIIPYNSAGNASGCTEASFTTETLITPPACTTLTSPVNGATDVALDVELSWNPS
AEATGYLLNVGTSSGGTQIIDNLDVGNQTVYNHTDDLPENTEIFVSIIPYNSAGNATGCT
EASFTTDTLITAPACTTLTSPVDGAIDVALDATISWAPADSAAGYIINAGTSSGLSNIAN
QVDVGNTLTFDYALEFFNDQTIYVTITPYNEAGETLGCSEESFSTVSAIDPPPCTTLSNP
SPNANGAFINTSFSWLPVSEASGYYLSIGTNPDATSYIDAFDVGNSTTYYLQDNLPYDTR
IYVKITPYNNGGKATSCEIFSFITQAEPLPPLCTELLNPVPESADNPTDLRFNWASVENV
TGYILNIGSNPNTQDIVSNLDVGNITSYTLNDLLPEETVLYISITPYNTNGTASNCEQFY
FTTATAEETAIFDKKYGFSPDGDGINESWFIPNITDHPDNLVQIFNRWGDLVFEMENYDN
ATHSFTGIANRKVNFGAGKLPEGTYFFRIILTGTNNQPPAEGFLVLKR
>KECLDBNJ_01143 hypothetical protein
MLKYLFTVLLTGSYLIGFAQQQPAFAEYNYNTILINPAHAGYYENSEVTIANLSSFSGIE
GAPSTLNATLNLTLNNDNVGLGGGIMRDEIGVTSTNSAFIAYAYKLHFGVQARAPRFHNF
NPNVLSFGIQAGVYNYTENLRELGITDDPNFQNNIQGTVPTLGLGVMYNRNQLYAGLSVP
NVLGNSLATDKSIKINTIGYAYAGYRLYAGVFDEFEIKPNLLLRYTEGAPLNLDLNTIVN
YKNKIEGGLGYRTSSAVNIFAGFYFFKSFRFIYNYSMPLQESPLPATHGLILSYRFGKGY
NY
>KECLDBNJ_01144 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKISEKHYPYILVAACLLLFFPHLDVLYANIMEARNFNTAREMLEHNNWVLTTMNGEARY
EKPPLPTWLAALSAALFGITKLWALRLPSAIISTVLVLFSFSFSRKRLQLSAKQSLYASL
ILATSFYILFSGRNGTWDIFAHAFMLGGIYYLFQFFSSTDQKYRNAALAGLFIGLSFMSK
GPVSHFALLLPFLIAYIWVFKLHSYKTRIAPFTLMILTALGLSSWWALAIYFGDSDTATA
IADKEATAWANRNTRPFYYYWSFFTQSGIWTIPAFVSLLYPYLKTRVANLKAYRFSLIWT
LAAVVLLSCIPEKKSRYLLPVLIPLALNISFYIEYLVRRFPALSDKRETIPVYFYFSIIT
IAAVLAAPAALFLFADQLEGSLWFWYASLQISSLFIAIIIVKSLQQKRIERAFFAVVIFA
CAIVSFAFPLVELSYTNEDYEQIAPKVADLLHEEKPLYLFENSSPELIWDLGQRVPVLKT
RDGLQLPEQASFYLIVEEERTQEVEELLADYALQRVHCYDGNITTKADRNYKSRRIGCLY
LVKKIDQ
>KECLDBNJ_01145 hypothetical protein
MDSPFWIYSVGFLAQLMFSGRLVIQWFLSEKQKRVLTPSTFWWLSLGASFLLFVYGYLRE
DFAIMLGQSLTYFLYIRNLQLQGQWVKTPKILRWFLLIFPVLLVIYGYNNGDYDVDKLFK
NEDIPLWLLILGSIAQVIFTLRFIYQWIYSERKKKSSLPLGFWLLSLIGGLLILTYAILR
KDPVLFVGHLMGVFIYFRNMRLSIGIDKE
>KECLDBNJ_01146 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MLIFAALFVSMSYRLTVVVPVYNEQDNLLRVEKVFQDYFEIAAVPTQVLFVNDGSKDRSQ
ELIEEICARSEGFQYISFAQNCGLSAAIKAGFDYTITPLVGYIDSDLQTTPEDFNILIKY
IGEYDLVTGHRADRKDSFVKNMSSAIANNIRRAFTHDGMDDTGCPLKIIKTDYAKRIPMF
RGLHRFLPAMIMLQNGKTIQVPIRHFPRIAGTAKFGLWNRLLGPLMDCFAYLWMKKKYIN
YDVAKKSNG
>KECLDBNJ_01147 Beta-N-acetylhexosaminidase
MLFVFFSCKPEKEPRVLNLPKTDLSQADLIPKPALLNASYSAFPLDQFTAIQTAPDSLGF
EEVGIFLSEKIKDRTQLQISVNTEFPEQESVIYIQQSDSLSKINNESYALKINKDSIILS
AASASAAFRGVQTLRQLMPMKASDSIINYPVWPIASGTINDTPFFEYRGAMLDVARHFFT
VEDVKKYIDLLAYYKYNVLHLHLTDDQGWRIEIKSWPKLTEIGGATEVGTEPGGFYTQDD
YKAIVAYAAKNHMTIVPEVDMPGHTNAASVAYPILNGNGKTPEIYRGTHVGFSTFDTRKD
TVYQFIDDVVREISAITPGPYFHIGGDESHVTQKDDYIYFVNKVEQIVQKYDKKMIGWDE
VATADIDTSSVVQFWQSKENAELAVTKNLKVIMSPAKKAYLDMKYDLKSEYGLNWAGYVP
VDTAYVWKPEAYENIPRENILGIEAPLWSETISTISELEYLAFPRAIGYAELNWSLPEQR
DWENYKVRLGNQAPFLESMDVNYYPSPLIDWKTQNKAIKE
>KECLDBNJ_01148 Deoxyhypusine synthase-like protein
MTMKTKGAISQFIEKYYLHFNAASVVDAAKAYEEQLNNGAKMLVSLAGAMSTAELGKIFA
EMIRQDKVQIISCTGANLEEDIMNLVAHSHYKRVPNYRDLTPQEEWDLLENGLNRVTDTC
IPEEEAFRRLQQHIYKIWKEADDAGERYLPHEFMYKMLLSGVLEEYYEIDLKDSWMYAAA
EKNLPIICPGWEDSTMGNIFASYVLKGELKASTMKSGIEYMTFLADWYTNNSENGIGFFQ
IGGGIAGDFPICVVPMLYQDMEREDTPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLD
INTPKFIIESDATIVAPLVFAYLLDM
>KECLDBNJ_01149 N(1)-aminopropylagmatine ureohydrolase
MSTTKNYAGIPDEFAKLETSKIVLIPVPYDGTSTWGKGADKGPQAFLDASENMETYDIET
DTEVYQQGIYLAPAITEASSPEAVVAEVHKTTKDFIKRNKFVTLFGGEHSVSIGAIRAFN
ELFDDLTVLQIDAHADLRQEYMGSKCNHACAMYEASQTTNLIQVGIRSMDALEKTVMDED
KTFFAHEMVQDEYWVDNVIDLCTDNVFITFDLDGLDPSIMPSTGTPEPGGLFWYETMDFL
KRVFAEKNVVGFDLMELCPNEHDKSSDFLAAKLYYKMLSFKFEGEDVEDNYDNTYVANPA
KGGVNKFDLNDDED
>KECLDBNJ_01150 Biosynthetic arginine decarboxylase
MNTKYIDLIDQSFYFPQEEFKLEGNQLEFHDIDLMALVKEYGAPLKFSYLPKISENINRA
KGWFADAIAKHNYKGSYNYCYCTKSSHFKHVLDEALKNDIHIETSSAFDINIVNKLKENG
KITEDTFVICNGFKRDQYINNIADLINGGQKNCIPIIDNYEEINLLTEGIKGDFKIGIRI
ASEEEPKFEFYTSRLGIGYKNIVPFYEEQIKNNDQVDLKMLHFFINTGIRDNAYYWNELN
KCLKVYIRLKKICPSLDSLNIGGGFPIKNSLAFDYDYAYMVDEIINQIKITCDEADVPVP
NIFTEFGSFTVGESGGAIYEVLYQKQQNDREKWNMINSSFITTLPDTWAISKRFIMLPVN
RWDEEYERVLLGGLTCDSDDYYNSEQHSNAIYLPRYKKDKPLYIGFFNTGAYQETIGGYG
GLQHCLIPQPKHILIDRDENGNLTTRIFNEQQKAEQLLKILGYEYN
>KECLDBNJ_01151 Ribosomal large subunit pseudouridine synthase B
MSRHQESKKGGKASGRGANNNRAKSHARGNAPIKKNTTGSSRTATASTGKGGIRLNKYIA
NSGICSRREADLYISTGQVSVNGEIVNEMGYKVNIDDDVRFDGRRINPEAKAYVLLNKPK
GFSVTTSNSKGMTVMDLVASSTKSRIQPVGRLGRNATGLLLFTNDDKVMKKLTNSKTGLP
RLFHIELDKNLKAEDLEKIKKGLTVDGKRLEIEDLSYVDGAPKKEVGLKMRNVGNSIIRS
IFEHLGYQVVRVDCVILGTLTKKDLPRGKYRHLKDQEVHNLMML
>KECLDBNJ_01152 hypothetical protein
MKKLQILVVALVLSTSSLFANTDPKPETASMQLRTQIIELLGTPDLELQQDVLENEIEFM
VTAQGSIVVLNVTTENPAIENYIKNRLNYKEAKVAVGKNKFFNLSYKIVKEI
>KECLDBNJ_01153 Protoheme IX farnesyltransferase
MSRISRRNKLLLLKFLSLFSVVRGYNILIIVIAQYLASIYILSPDLPLREVLFDVNLFLI
VVSTSVVIAGGYIINSFYDSEKDWINRPNKTKLDHLVSQKKMLSLYFVLNFIAIIVASYV
SFFAVLFFSAYIFGIWIYSHKLKKVLFLGNLVSASLALTPFFAVFIYYRNFEKVIFVHAV
FLGLIILMRELIKDLENIKGDIALNYHTFPVVYGEKSTKALISLLIGVIVIPAFLLINKF
DIGLMRYYFYVSTLLLIVFLYLLWWSDAKLHYLLLHNILKFILVLGVFSILLIDPDIVLN
RIV
>KECLDBNJ_01154 hypothetical protein
MKGPLFYSKILLFGEYGIIKDSKGLSIPYNFYKGALKVDEHPDEVAVKSNESLGRFAVYL
KELQEDQPDLVQFDIEALQEDVSKGMYFDSTIPQGYGVGSSGALVASIYDKYAFDKITIL
ENLTREKLLKLKHIFGQMESFFHGKSSGLDPLNSYLSLPILINSKDDIEPAGIPSQTPDG
KGAVFLLDSGIVGETAPMINIFMESMKKEGFRKMLKTQFVKHTDACIDDFLKGDVKSLFG
NVKQLSKTVLRNFKPMIPASFHDLWKQGIETNDYYLKLCGSGGGGYILGFTQDIDKARKA
LAGHKVEVVYNF
>KECLDBNJ_01155 hypothetical protein
MTTTKFHPEPYTQALTTKSVSYESPSNIALIKYWGKHGIQIPKNPSISFTLNNCKTTTTL
SYEKRSEPGDAYELKVILDGKHKPGFEPKIHQFFGRIEAYLPFIKDYAFTIETSNSFPHS
SGIASSASGLSALALCLMEMEREMQPDMTLKHFKQKASFIARLGSGSGCRSLEGPIMVWG
EHADVDGSSDVYGVQYPYQIHSVFDHYQDTILLVDKGEKPVSSTVGHNLMHNHAYAASRF
DQAVENLSRIIPILQEGDLDGFVTLVESEALTLHAMMLTSNPYFILMKPNTLHIIDKIWE
YRRETGVPVCFTLDAGANVHVLYPEKDKEAVQEFIKNDLSKYCQDNRYIFDNVGNGAIKL
>KECLDBNJ_01156 Tryptophan-rich protein TspO
MNTQKTFHILIPITVCLLVGFLSAIATQSSVLTWYPQLAKPAFTAPNWLFAPVWTVLYIL
MGIAAGLVWNKGYYHKWVKTALYHFGFQLILNAAWSIVFFGMHLVLPALLIILSLLILLL
FTFKWFKVVKPEAAYLLFPYIIWVAYASALNFEIWRLN
>KECLDBNJ_01157 Ferredoxin--NADP reductase
MIYDCIIIGGGAAGFFTAINLARQRQDLNILILERGAQVLEKVRVSGGGRCNVTHAIFEP
KPLTGHYPRGIKELLGPFHSFMSGDTMAWFDELGVALKIEEDGRIFPESDSSQTIIDCFL
DQAKKLGVEVSTKMPVAAINKVDDTFQVETKTHTFSSASVVVATGSNAKMIRQLASDGLA
VIPAVPSLFTFNIDDERITDLAGLATPANVRLFDTNNQPLLTGQYAIDQEGVDGPVLITH
WGMSGPGILKLSAWAARELHACDYQFSIRVDWLPEYDRASFGAHLRSLKFDLAKQQVFKR
SPFNIPKRLWKQLVLASTISEALKWADLSKVMLQKLELQLREGQFEVRGKSTFKEEFVTA
GGIDLKEIDFKTYQAKKINGLYLVGEILDIDAVTGGFNFQNAWTGGYIAAQALAQKL
>KECLDBNJ_01158 TonB-dependent receptor SusC
MKQVILRSMLFFASLLLAGMAQAQTVSGTVSEPNGPLPGANVLVKGTTNGTTTDFDGNYT
LNDVATGSVLVFSYVGFAPQEVAVNGRSTVNVTLQEDAAALDEVVLIGYGSTTVKDATGT
VASVTSEDFNQGVIASPEQLIQGKTAGVQISQSSGEPGAGINVRIRGSNSIRSGNNPLIV
VDGVPLTTSGAPAAGDLGVGGGSSRNPLSFLNPTDIESISILKDASATAIYGSRGANGVI
IVQTKSGRGSSGGVWEVSSNVSFSSPAREYDLLTADQYLNALPDYGGDPSLLDFGFASDF
QDFYTRNAISTQNNLSYAHSYTSGNVRASFGYSDQQGVIRNTGQERITGRLNATQRLFDD
KLTLSLQTTLSRVNDQNAPISGQAGSTGDLIGSSITANPTWPVDADFSPGSNLLNPVNLL
RYYQSESNTNRFLANLSAEYKITDAISAKVTGGYDKSDAKTIALFSPEVAGINRVSGNGQ
GTYGTFDQTNKLFEATLSYNKQFENSKIDVVAGYSYQEFAREGINAGGIGFGPDMGLAAS
QLEDQYDLIANTISGSFQNFAYDQDRDYVNRIDFGAPFDSAFVSEPIGTSYSQLFTAYFA
NTFDNTDELQSYFARVNYTLADKYLFTGTFRADGSSTFGPENQYGYFPSGAFAWQIHEED
FIGDNVSTLKLRLGAGVVGNQEGLGYANFIRRTRFSDIGITDNLTVTNSGTQFVGNNNEA
LQWESTLDVNIGVDFGFNNDRFNGSFNLYRKETTDLLLLSTLAAPQVPGIETIFQNLTDG
KVVNQGVELALNYDFVQTEDFTFSSSFNIAYNHNEVLDTDRIIDTGPINGNGLTGAFAQR
LQAGYPLFSFYMAEFTGFDENGNPTYVDVDGNGEGDPDADKKFVGEDAQPDWTAGLSLNA
TYKNFDFAAYFNGQFGFSVYNATDNAFFNAGGITIAKNVTTDVLTSGEAPGSSVAVSTRF
LEKGDFVRLQTLSVGYNVPMSGEGLFDSLRFSVTGQNVFLITGYSGLDPEVSTNTGSLNA
SNIPTAGIEYAAFPRPRTFSFGVNARF
>KECLDBNJ_01159 Starch-binding protein SusD
MKYLKQHFKTSRFLVGVLSLGLAISCTDLEIEETDSRQSPDFQGVGDVDLFIDGIYNSLN
GIIGNQADFFALSEVTTDAALVPTRGSDWGDNGIWRQLHQHDWRTDHQYITNTFNQWNQT
QFAASQALSDLSSPNEEQRAQASFLRALGVFFVLDNFGQVPIRDPEASLLDNPEVITGQE
AVDYIISDLNTAIAGLPTLGPGSGVGTATSDHARASKAAARYLLAKVLLNKHIYVGGEPA
TADMQQVIELVDAIDADGYGIEDDYFDIFRNELDDETIWFIPTSVGNRIWNGLHYNSAPE
IAGGGWNGFATLAEYYDMFEGDPNVNTPGSGQEERRGFVPTEGLAAGSFEGSSDSNDDGF
ADGSNIGFGFLVGQQYDYDGTPLNDRGGNPLTFKRQFTDGNGNVSLINNSETTGIRVQKY
NARYGGFVEHEIFFRYSDAYLMKAEAMFRAGQDPTAMMNVLRGLREATPFTSVTEQDILD
ERGRELYAEFWRRNDMIRFGQYTRGWELKADSQIGNENRNLFPIPASQIILNPNLTQNPG
Y
>KECLDBNJ_01160 hypothetical protein
MTRLYPFFLSVLLAMSFSCSKETTESKFIEAQNTGITFSNDLTNTPQLNILNYLYFYNGA
GTAVADFNNDGLLDIYFTGNQVADQLYLNQGDLKFIDITDKAAIYTAADSWNTGVTTVDI
NADGLLDIYVCTVSGHLDQTGSNKLYINQGVHGTVPMFIESAAAYGLDYSGLSTQASFFD
YDKDGDLDMYLLNHSVHPNASYGRAAIRKIPDPRGGDKLYRNDGNKFTDVTEQAGIFSSK
IGYGLGVSISDLNNDGYPDIYIANDFFENDYVYINNQDGTFSEVNTTQNLLGHTSHFSMG
SDIADLNNDGNTDILSLDMLPENLEVLKASGNEYAYPIYQNQLRNGYDYQFMQNTLQLNL
GNGRFAETAFQSGVAATEWSWSPLMADLDNDGHKDIYIANGILGATNDMDFVNFISNESI
QKRLGKNMSETEMEFINKLPEIKATNYAYKNLGNGTFDDVTAQWTSNQKTFSNGATYGDL
DNDGDLDLVVNNVNQPASILKNTTIETSQRSNGISVHLIGTKPNTFGIGAKITAYTPNHT
QVFENYSTRGFMSAVAPSIFIGLGNATQLDSLKVLWPSGKSQVIANVKTELFLDEKDASQ
TAFKTQAPSDLVWVQDSTAINFQHKDGNSIEFSRDPLVPYANTNTGPAIETGDLNNDGLD
DILILGAKAQKTSIFFQQENGNFTEDFLPESEEDAINEDTAATLIDVNNDGLLDIVIASG
GNEFTSGRQLTPRLYLNSEEGFIKMNKAFEGVTLNASAITAIDFDNDDHIDLAITSDLVP
QQFGATPQQFLLKNDGKGNFADVTQKYAPDFSSAGNVKDLIWVDLDINGFKDAIVCGHWM
PVKIFMNSGEKLKLLNSDDLKNTNGLWNSIRAEDFDGDGDMDLIAGNWGLNTRLTASVEK
PLNLYRFDFDNNGKIDPITTYFYKGTETVLATKDELVKQLPFLNKKFLSYHDFAKAGITD
LLSEEKLEKAEKKQVFTLETTYFENQGNLAFKATALPQMAQISSVKSIITEDFNSDGLLD
ILLLGNDSEISTQLGRLDASHGVFLLNTGSGFNYTGNHTIDIRGAVRSNSKLKIKDDLFY
IIGRNNDKPLFIRKETAHD
>KECLDBNJ_01161 hypothetical protein
MISFKKIYFIGICLAFAACDQDKQENDAAIDQEPTLFTTMSPDETGIDFVNAIKNQSDFN
IFKYRNFYNGGGVAIGDINNDGLADIYLTANMEQNKLYLNKGNFQFEDITEKAGVGGNKP
WSTGVVMADVNADGLLDIYVSNAGNMKGNNHDNDLYINNGDLTFTEKAQEYNLAKSGFST
QASFFDYDKDGDLDVYILNNSNVPVSGLGYAEQRDTRAENWENVPDVFKGVGDLLMRNDG
GTFTDVSEEAGIYGSLIGFGLGVMITDINNDLYPDIYISNDFYERDYLYINQKDGTFKEE
IKEWTSHLSLSAMGVDMADINNDGLQDIFITDMLPEPEERVKSVMEFDNYNVYKLKQSKD
FYQQFIQNTLQVNNGNGTFSETAYYSGVDATDWSWAGLLVDLDNDGYRDIYVTNGINHDL
TDLDFVDFFANEIIQNMAMTGKRQAIDSIIDKMPKKPLPNAVYRNKKDLTFEDAGKKWGL
DMPSMSNGSAYGDLDNDGDLDLVVNNVNMQTFIYRNEAAQQTQNHYLSLTFKGGEQNPFA
VGASVRLYFDDQEIFQELYPVRGFQSSVDYKMTIGLGATQTIDSLRVLWPNDKTQLLTQV
ATNQTLALAQADATETYIPRKRQPQAQLLTELSNEKLKANTENNYNDFDYEGLIAKKLSQ
EGPALATGDVDGDGNEDVYVGAPSGSAGTLYLHQGKGKLNIKNQSAFTEDAFYEDTAAAL
FDADGDGDLDLMVASGGNEVGKKEQLKPRLYLNDGKGNFSKAPEELPSAFQNMSVVAPYD
FDSDGDMDVFIGSRSVVGVYGIDPKQLFLENTGNGFFVNATERLAYDTKDAGMVTDALWL
DIDEDGKADLITVSEWGAPLVYKNSGRRLSLKETSLSDKTGWWNTIAAVDIDNDGDMDLV
LGNEGENLHYLPSEQRPMSMYINDFDNNGTIEQITTMHKNGKDYPLHQKKEITAQMSSLK
KQNLKASDYANRYIDEIFTEESLRNAIKKSVKYAQSMIAVNDGKGNFSLKPLPYQTQLSC
VCDIVATDINKDGLADLIMAGNNFEFKPQYSQLDASFGNVLLNEGDASYAWQNYDKSGFF
VKGEVKHLATFKDKNGITYLIASVNDEKPKTFVLNE
>KECLDBNJ_01162 hypothetical protein
MNKFFSLLILGLSIVSCKDEPELFLNPSPEKTGVTFKNTLEATDDMNILDYLYFYNGGGL
AIGDINNDGLPDIYFSGNQVKNQLYLNKGNLKFEDITEKAGVAGNSDWKTGAVMGDVNGD
GFLDIYVCAVVGLNGLDGYNELFINNGDGTFTERAAAYGLDLDTYSSSAAFLDYDLDGDL
DIYILNHAVHTQSSFGKADLRYERNQQTGDRLMRNDGGTFTDVSEEAGIYGGINGYGLGI
AVADFNLDGYPDLYIGNDFHEDDYYYINNGDGTFTEDLKNHFGHTSRFSMGSDVADLNHD
GWPDLISLDMLPQDEKVLKASEGDDNIQTQRLRTDRYGYHYQFTRNMLFINRDGKDYQET
ALLSGVAATDWSWSALFADFNQDMQQDLFISNGIPKRPNDLDYIKFVSNEQIQSKINNTG
LIDTKALDLMPSGVTHNYVYEGSADLQFKDQSGKWIANDTIVSGATAYADLDNDGDLDLV
TNNINASPTFYINKTDEKANYLKLKLKTQSSNTYAIGAKVYAYANGIKQFKELYTVRGFQ
ASSEPLIHFGLGDAKVVDSVRIIWPDKTSQVLKDISANQSLVVNQENTQAFDYNSLKPKQ
QKLFSKVTNSLGLDFTHIEDAYSDFDREKLIPYQIGDRGPAVAVGDLDGDGNDDVLFGGS
KYIPSQVFIQQDSAFAKTEFPAIKKDSINEEVTAIIADFNQDRKNDLMTGTAGGDFFNRA
KPLIDGLYLNDGAAFSSAAMPELFDNTSVLATYDYDGDGDLDVFAGTQAITGSFGKTPVS
YLLENEIGSFRVAQEFKDLGMVTAAVWSDFNRDGKLDLVIVGEWMAPTFLENKNGRLTKV
DLGTENLNGLWQSVIPFDIDGDGDEDYLVGNWGENSKFKASADAPMVMFYNDFDNNGQTE
TIITTAKEGKYYPLMGLDALASQVVSFRKKYQNYRDFAGQTIEQILSKEQLETSTKLEVQ
TLETGYLRNDGGKFEFVALGRDFQVAPVLSFCKFDFDNDGKEEVLAAGNYFGVQPFHGRL
DSFNGALIKDENTVIPGDQIGLDFARKSIRDLSILSLNGQKYLLATPNNATSQLYKLD
>KECLDBNJ_01163 hypothetical protein
MLKKLSLLVLSAVMITSCSKEEKPLVVTPDDYNNAVDKVTEVIIHDIFSPPVASRIYAYS
NMAAYEVLVQNNPDYKSLAGQINELGETPKPDADAAVNYDVAALVAQMEMAKSLIFSEDR
ITEMRDSLYMQWKEQNPTELEASKAYGLKVADHIKAWMDGDMYKQTRTMPKFSVNPDNPS
RWQPTPPAYMDGIEPHWMKIRTLVIDSADQFKPIPPPAFSLEEGSEFHKQLMEVYDVRNA
MTEEGDESEKMEIAKFWDCNPYVSTHKGHLMFATKKITPGGHWIGIVKIATKKANADLME
TVYVYTKTSVALFDGFISCWDEKYRSNLIRPETLINQYIDDAWAPVLQTPPFPEYSSGHS
VVSGAAAEVLTQIYGDNFQFDDDTETAYGLPVRSFDSFRNASSEAALSRLYGGIHYRAAI
EEGLKQGRQLGQFVSQNLQMKTNTAQASN
>KECLDBNJ_01164 hypothetical protein
MLKKIGVGFLILVAVALIWYLFIKPSDYIINFKVVTTPGTVTQSVKSWNYDVPDSEIIAQ
DGLHKVVQQRHFGDSVVNYTYEAKMINDSVTQVSVGVKDLDHSVVNRLTAPFKNTLFRKR
STENVETFFEILREHLDQIKIEVTGLDQTRSTYVAYVPLKGLQVEKARGMMQYYGYIGDV
LLKNNVELNGPPIIEVTDWDTETDSIAYNFCFPIIRSENLPISKDIKYKRLFQKEAVHAV
YNGNYITSDRAWYALLEYAERNNLKVEHKPVEIFYNNPNMGGNELDWKADIYLPIKQESP
LE
>KECLDBNJ_01165 hypothetical protein
MDEILTYSISVFTGFFAIMNPVSNIPIFLSLTEGASKTEKQTVNKKAVMVAFIIIAIFVV
LGKFIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNVKHLKEPNFDENIAVSPLAIPI
LAGPGTIVTAMNFVSNATYVNIGLVILIFGLMCALTYLAFSLSDFIARKLGNNVISVIGK
IMGLIIAIIGTTMVIQGLKLSFDFLA
>KECLDBNJ_01166 hypothetical protein
MNLYQLKYRPALQQEGKAFKKQEKLNMLLAELETRNLPESLSNTINKKVEKLNDLKGSEK
ELYKAYIKFQHSILRLIKEETGIVKKGHYKHMWTALGMSVFGIPLGIAFSSAFGNMAFLG
VGLPIGLVIGAAVGAKKDKAAAAEGKVLDVEI
>KECLDBNJ_01167 Maltose phosphorylase
MNQDYIIPAPWAVIEEGFEKDRVKSSESLFSIGNGAMGQRANFEEAYSGKTFQGSYIGGV
YYPDKTRVGWWKNGYPEYFAKVLNAPSWIGIKVTVDGEALDLNTVKSVSKFRRELNMKEG
WLGRSFEAELQNGTQLKVKAKRFLSLEHDELGAINYEVTPLNKDVSISYEPYLDSGITNE
DTNWDDKFWNTLEVEEDGNKAYITAHTMKTMFYVCTAMSNTFTVDGKEISLTLKTNKAET
YIGHVYETDIREGETFAIQKYAGYITSFNHDKDELKQAAEAVLDTALEEGFTRLLAKQKE
DWAAIWAMADIVIDGDVKAQQGIRFNIFQLNQTYLGKDARLNIGPKGFTGEKYGGSTYWD
TEAYCLPFYMATKDQQVARNLLTYRYTHLEKAIENAEKLGFKNGAALYPMVTMNGEECHN
EWEITFEEIHRNGAMIFAIRDYVNYTGDFSYVPEKGLEVMIGVARFWKQRATWSSKKEQF
VILGVTGPNEYENNINNNFYTNYLAKWCLNYAVENAKKVSKVFASDYKRIAEATGISNEE
LNSWTEVAEKMYLPFSEENGVYLQQDGFLDKELVTVADLDKAERPINQKWSWDRILRSPY
IKQADTLQGFYVFEDDFSQDELKKHFDFYEPFTVHESSLSPCVHSIQAAKLDQMDQAYAF
YLRTARLDLDDYNKEVHEGLHITSMAGTWLSIVAGFGGMRIKDDKLSFAPKMPKAWDGFS
FKLNFRNQIVKVAVAKDKYTFSLDGGDDLDILVDGKEISISADEPTEV
>KECLDBNJ_01168 Beta-phosphoglucomutase
MGKKGFIFDLDGVIVDTAGFHYLAWRNLAHELGFEFTEKQNERFKGVSRVRSLEILLEIG
DVKATQEQKEGWLVSKNEEYLSYISKMTSDDILPGVLKVLDYLQEKQIPMALGSASKNAQ
PILKRVGLFDRFDSIVDGNHVTKAKPDPEVFTIGADALGVAYTDAVVFEDSIAGIQAANR
VDMVSIGIGDAQVLHEADHNFKDFTEIDTAFLDQLINA
>KECLDBNJ_01169 HTH-type transcriptional regulator DegA
MKRKLTLKSIAKELGVSISTVSKALRDSPEISEETREKIKAFAKLYNYKPNNIALSLKNR
KTNTIGVIIPQIVHHFFTTVIYGIEQEARENNYNVIICLSNNAFDKEVLNMELLANGSTD
GFILSVSKETMMKEDYHHLNEVIDQGMPVVMFDRVVEGIQCDRVLIDDKAGAKKGVTHMI
RSGCRKIGIITSEDYVSVGRLRTEGYLDALDDFGIKADDKLILKLDNIDDLSDKSKKRIE
DFITNNDLDGVFTVNELFAVHASRVINALGKKIPDDISLVCFTDGQLSEHAVPSLTAVSQ
HGEEMGRKAASILINKLESPEDEEEEYSTTYIDTSLVERESTKEVTRR
>KECLDBNJ_01170 Levanase
MKYVHSILLITLIMSSCKKENTANDTPKDTAVKSYHENFRPQYHFSPEAHWMNDPNGLVY
NDGTYHLFYQFYPDSTVWGPMHWGHATSEDLKNWKNEPIALEPDELGYIFSGSAVVDHNN
SSGLGTAENPPLIAMFTYHEPKGAEAKTLDYQYQGIAYSLDNGKSFTKYTGNPVVPNNEN
LIDFRDPKVFWHEDSNKWILVLVAGDRAMIYNSDNLIDWTYLSEFGKDIGAHGGVWECPD
LFPLTVEETGETKWVLFISINPGAPNGGSGTQYFIGDFDGKQFTTSQTDEKWIDLGRDNY
AGITYNNLPDEERTFIAWMSNWEYGQETPTEKWRSAMTLPQKVSLHKNKDYFLANTPVAS
ITEGLSDVSIDISREQNTSSFSYKNLNQAVITFKLPKPLKDFKINVGNADGEELTISFDA
QAAKYSLDRSKSGLTDFSDKFALPIMEAPADFIDSDSAEFQIFLDASSIEFFADNGANAI
TAQFFPEKPYTQFSITTEDEVKNLKITPIPSIWKNNN
>KECLDBNJ_01171 D-xylose-proton symporter
MKAVQKWSVTVALAGFLFGFDTVVISGANLPVKELWNLSPWFHGLFIMSMALWGTVLGSL
TGGIPCDKFGRKKTLFWIGILYFASALGSALSPDPYLFSFFRFIGGVGVGASSVAAPTYI
SEITTASNRGKLVALYQFNLVLGILIAFFSNYLLEGFQGENDWRWMMGVEAIPAFLYTVL
VMTVPESPRWLLHKKKDEQGAFAVLNQVYGKQETQRKIDSIKTELAKTTDDVKLFTARFK
KPLILAFLIAFFNQVSGINFILYYAPEILVKAGLATEDSLLNSISIGVVNLIFTFVGVGL
IDRLGRRTLMFIGSFGYIISLVTVAWCFYSGASPALLLTFILIFIASHAVGQGAVIWVFI
SEVFPNKVRAYGQSWGTGTHWVFAALITLLTPVFLDGEDGIFKDNPWPIFAFFAFMMFLQ
LLFTKFMMPETKGISLEELEEKILG
>KECLDBNJ_01172 Fructokinase
MKESLNAICFGEILWDVFPDGKALGGAPLNLCLRMKSLGVTMQMISRLGQDALAEETREA
IQKFRLDQSLIQEDPALETGKVEVTLDASGSASYNIKKPVAWDAIALTDKNKNAVQQADL
FIFGSLAARSNESSKTLNSLLQLADYAIFDVNLRAPHYEMETLIEFMKQAQMIKMNDEEL
EEVVAHLNITGETIHEQLAEISKHTATEIICVTLGAKGAVLYQNGTLVSNSGYSTKVIDT
VGAGDSFLAGLIYQLFKVENTPEKALAFACALGALVAGTKGANAPITSEQIEAKMRE
>KECLDBNJ_01173 L-2,4-diaminobutyrate decarboxylase
MEAKDIARLELSEQEMRDYGYKVVDAIVEHHLNQHKKKPVAQASREEMDSLLREHAPEAP
TAANEVFNTVMEKVMPFTNIMSHPKFYSFVPGPSNYVSAMADALATGFNVFSGGWAASPA
AAELEIVTINWLLSLYGFPKKRGGGIFTSGGSMANLTALITARNIKCGDDFSKAVIYLSD
QAHSSNIKAIRVMGFRKEQIRLIPTDLEFKFAINKLKNAINKDRLAGWKPFCLLASAGTT
NTGTVDQLTELAAIAKAEDLWFHIDGAYGGAAILAKNGKQLLKGVEKADSLTVDPHKWFY
QPYEMGCLLVRNHKWLSGTFTEVPEYLKDVEGNSSEINFYDHGIQLTRRFRALKFYMSIK
TFGLKAFREAVQYNFDLCEKVESILRKSKKWEVVSPATLAVINFRYNPIDQNLSEQELDA
LNSKISEGVVDSREAMLVTTILNGQTVLRMCLINPRTTLADVEETIALCEKMAE
>KECLDBNJ_01174 Ktr system potassium uptake protein B
MKETLANVFTLKTLFRTAFILSLLGVFAFILDFGYEQSSKLQTFLNAYYLFILFVGIAVT
LVRYFTQSKKLSTQVILFDAASILVILYIIGIHFFGAEAHKHLNFLYSDSWVRAAILLTF
IREFAEQRVNYKKSHLNPAQLFIASFVGIVLLGTFLLMLPKATYDGISFLDALFTSTSAV
CVTGLIVVDTGTFFTPLGQNIIVFLIQLGGLGILTFASYFSYFFKGMSTFENQVVLSDMN
NSQKISEVFSTLKRILIITFSIEAVGGILIFLSLKAENFQDFTDRFFFSVFHSISAFCNA
GFSTLSNGIYDINFRYNYFLQLTLIGLFVFGGLGFPIVINILKYLKYKIVNPIKYWDRGT
LSKPWVLSLSSRITLITTTALSLLGTAVFYANEYHNTLAEHNGFGKFVTALFGATTPRTA
GFNTLDMNQLHFSTLMMIFLLMWVGASPASTGGGIKTSTFAIATLNFLSLAKGKERIEVY
RREIADISVRRAFAIISLSLVVIGFAVIAIAAFDPDKTLLSIAFECFSAYSTVGLSLGIT
SSLSAGSKGVLIILMFIGRVSMLTILIAIFRKMKYKAYRYPSEEILIN
>KECLDBNJ_01175 Ktr system potassium uptake protein A
MKYIIVGLGSFGASLAEKLTAQGNEVIGIDIKMNRVDALKEKITHTICLDATDESTVTGL
PLKDTDIVVVAIGENQGTNVMVTALLKNLKVKKLISRAVNPLHENVLSAIGVDEIVHPEQ
ESAERLAKKLCMRGVVDSFELNEYFSIVEVKLPKQYENKTVEEVQFRERYNLLVLTTLKN
AYVDTEIGKTKTIIDVQSVATPHLLLERGDILVLYGANKDIRKFINS
>KECLDBNJ_01176 hypothetical protein
MKFLKTALALWCILALQQLQAQEDLRSSDLQIEDSTATKYKPFAFNLKAKNMHLWKGLRV
TDAPVLDVDLNYTSRDGKFKAGLWGGAGVTGYYTEFDYYVSYSTNGFSLSVWDINNYSDF
PDAGIFDYDRSTTSHFIDVTLGYEFKPIPLKLSWSTIVQGRDTYVANDGELKNAFSNYVE
VSYGLIQKKDWSISAFVGGAFSFENEAHFYGDKPNLTNVGLIYAREVPVLKKFTIPMAAT
AMWNPEQEYGAIEVAITLF
>KECLDBNJ_01177 putative glycerol uptake facilitator protein
MTPFIAEVLGTALLILLGGGIVANDILNKTKGNGGGWMTITTAWGLAVFVGVVVAGPYSG
AHLNPAVTIGLAAGGLFPWADVPTYLAAEFIGAMIGSSLVYVMYKDHFDATEDGGLKRAV
FCTDPAIPNNFRNIVSEILGTFVLLICVFYFSDAEIADGTGTKVGLGSIGAIPVAFVVWG
VGLSLGGTTGYAINPARDLGPRIVHALLPIKGKTDSGWSYAWIPVLGPIIGAVLAAFLFL
ALN
>KECLDBNJ_01178 Glycerol kinase
MDQFILSLDQGTTSSRAIVFDKKGGIVSIAQKEFKQYFPKPGWVEHDPQEIWSTQAGVAA
EATVSKGLNGKNIAGIGITNQRETVVVWDKNTGEPVYNAIVWQDKRTADYCEELKENGKA
EMIQEKTGLVIDSYFAGTKVKWILDNVEGAREKAEAGDLILGTIDTWLIWKFTKGELHVT
DVTNACRTLLFNINTMEWDEELLELFDVPKSMLPEVKDSSEVYGHTKTTIFASKIPIAGI
AGDQMAALFGQMCTKKGMVKNTYGTGCFMLMNIGDKPILSKNNLLTTVAWRINGKTEYAL
EGSIFIGGAVVQWLRDGLGIINKSEDVEPLAESVESTDGVYFIPAFAGLGAPYWNQKAKG
TIFGVTRGTTDAHIARASIEAIAYQTMDILKSMEADSGIDIKELRVDGGASVNETLMQFQ
ADVLDSVTVRPKITETTALGAAYLAGLAVGFWESKEEIQEMWQEDKRFEPVKPKEDVEAG
IKGWYRAVKALEHWTKL
>KECLDBNJ_01179 Glycerol-3-phosphate dehydrogenase 2
MANIFAREHLTGQLSQTKKWDVIVIGGGATGLGVALDSATRGYKTLLLEQVDYAKGTSSR
STKLVHGGVRYLAQGDIDLVKEALYERGLLAQNAPHLVKNQNFIIPNYRWWEGIYYTIGL
KAYDFLAGKLSLGKSKHINKTKTTERLSTLRQKGLYGGVVYKDGQFDDSRLATNIAQTAI
ENGATLLNHFKVTDLLQNDTGKIIGVEAKDTETDAHYTFSSDVVINATGVFTDEILRMEN
AEAKKSVVPSQGVHLVFDKSFLPGDDAIMIPKTSDGRVLFAVPWHDKVLVGTTDTNLDDH
SLEPQAQEQEIEFILQTFNNYLNKKVTRADVRSIFAGLRPLAAPKDDSEKTKEISRSHKV
IVSETGLITITGGKWTTYRRMAQDTINKAISLKKLPKKACETAHLAIHGATPTEDRTNHL
YIYGSDQKGIASLIKEQPELGEKLHERLPFLKAEVIWAVRYEMARTVEDVLARRVRALFL
DAAAAREMTAEVARLIAAELNRDEAWKLNQIEEFTKLANHYCIEGNTVTA
>KECLDBNJ_01180 Glucitol operon repressor
MERHQEILDLLKKEKHVKVATLCERLDVSAVTIRKDLKLLEDKGLLFRTHGGASLENPYM
NERDVSEKASISAEEKSLIAEAAAQRIQENDSIIIASGTTVQQLAKAIKPIGKLNVITSS
LLVAIELMKHRDIDIIQLGGNIRHRSGSVTGHYAEHILQHISSHQFFMGVDGIDLDFGCT
TTNIEEAILNKKMMEAAQKTIILADSSKFGKRSLAKICELDEISEIITDKDLSAADAERI
REMGIKLTLV
>KECLDBNJ_01181 hypothetical protein
MHLEKIKAHVVVLVLGVFTACQTSETPKLRIVQEGFIYEEAPFPQCHASTLVEAQDGSII
AAWFGGEYERHPDVSIYQSKLTDTVWSTPQKIADGKVENDTLSYPTWNPVLFKNAENTLM
LYYKEGPSPSSWWGKWKTSEDNGASWSAAEQLPDGILGPIKNKPIQLANGSIVSPSSVES
EDGAVWKSHIELSSDNGYSWERVRIPSADTVKVIQPTLIQLKNGNLKALLRSDQNYILES
ESSDQGKTWSEATKGTMLNPNSGIDAVTLKSGNFLLVYNPTEAGADWSDGRNKLNLAYST
DGSHWEDVLQLEDEAEGEFSYPAIIQDSEGLVHITYTHNRSKIKYLQLKLE
>KECLDBNJ_01182 Copper homeostasis protein CutC
MSKKYIKEACVESLAQAIKAEEKGADRLELCAYLAFDGLTPAPDLISEVIKAVKIPVRVM
IRPRNGDFNYSEEELEHMKACIAFCKKEGAEGVVFGVLNESKKLNIEAIEMLTKAAKPLK
VVIHKAIDATPDIDAALKELLQVEGVDTLLTSGGKSNAFDGAENLNRLITMAGNKLEIMP
AGKITQFNLTELHHLVEAEAYHGRLIVGELA
>KECLDBNJ_01183 Beta-galactosidase
MQVVRTNFFALVLIVLSFGFAQAQDDAPFKIENGSFVYNGKPTPIYSGEMHYERIPKEYW
RHRIQMMKAMGLNTIATYVFWNYHNPAPGVWDFETGNRNVAEFIKIAKEEEMFVILRPGP
YACGEWEFGGYPWFLQNIPGLKVRENNAQFLAACKEYINELAKQVAPLQVNNGGNIIMTQ
VENEFGSYVAQREDIAPEDHKAYKEAIFKMLKDAGFQAPFFTSDGAWLFKGGSLEGVLPT
ANGEGNIDNLKKVVNKFNNNEGPYMVAEFYPGWLDHWAEPFVKISASDIAKQTEVYLKNG
VNFNFYMAHGGTNFGFTSGANYNDEHDIQPDITSYDYDAPISEAGWANPKYDSIRALMQK
YAPYEIPEVPEQIPVIEIPQIQLAKTTDALTYIKKQKPVTSDSPLTFEQLEQGYGYVLYK
KRFTQPITGTLKVPGLRDFATVYVNGKKVGELNRVFNSYEMPIKIPFNGSLEILVENMGR
INYGAEIVNNLKGIIAPVSINDYEITGGWEMYKAPFAEVPEVENSTEVKTGRPVVYSGNF
DLKKQGDTFLNMSEVGKGIVFVNGHNLGRYWKVGPQQTLYVPGCWLKKKDNTITIFEQLN
DVAVTSISAQKTPILEDLKN
>KECLDBNJ_01184 hypothetical protein
MNRFYIPFLSFLLCGLVACESSNDGVPEPYGAVPSEDQLAWYDMEMNAFIHFTINTFTDK
EWGYGDESPELFNPSALDVDQWMSVLEETGFSGTILTAKHHDGFALWPSAYTEHDIASSP
YKDGKGDLVKEVAEAAKAHGLEFGVYLSPWDRNRADYGEESYITYYRNQLKELFTGYGPV
FEMWFDGANGGDGYYGGANEERKIDRQNYYDWPTTLKMVDSMQPPVLFFSDAGPDLRWVG
NERGIGGETHWNTITTDTLYAGKAGIEELLQSGTKNGKSWIPAEVNTSIRPGWFYHASED
SLVRSPENLFELYLTSVGRGSTLLLNIPPDRRGLFHENDVASLRGFRKILDSVFAENLAE
KATATATPVRGDKPVYAADKVLDGDAETYWATNDGVTTGSIELNWEAPQILHYISLQEYI
KLGQRVAAFTVSVWEDGTWKEVQNQTTIGHKRILKLNGVETSKLKIEITEALACPLISNI
EVY
>KECLDBNJ_01185 hypothetical protein
MRDLSYSKFFYVLAVLLGSLSGSNGLFAQGGNLHEQSKIYQAPTDPQVKEKLAVWGDQKF
GMLIHWGVYAVPGIIESWQICSEPWLERPEGISYNDYKKWYWNLSSVFNPVNFDPDQWAD
AAADAGMKYVVFTTKHHDGFNMFDTQQTDYKITNGPFKNHPKANVAKYVFEAFRKKDFMI
GAYFSKPDWHSQDFWWDKYATPDRNVNYDIRKYPEKWKSFQDFTFNQISELMHDYGSIDI
LWLDGGWVRPRETVTDEVRAWGAPIPEFSQEVDMPRIAKMAREAQPGIIFADRTVHGPYE
NYQTPERSIPETKLDHPWETNMTLGNNWGYVPNDNFKTSAKVIHSLVEVVAKGGNMLLGV
GPQPDGLLPPDALPILTEIGDWLDTNGEAIYGTHAIDNYHSEATYFTANDKNTFAITLLT
EGEAVPNTVGWEGNLPKKGSSLKLVSTGKKLNYTIKDNVVTVRLPASVRNAAKAALAFSY
KSE
>KECLDBNJ_01186 Beta-glucosidase BoGH3B
MCYIYLKKLFATVFVLVFAVAQLCAQEEVPANAVYKNAQAPIEDRVNDLVERMTIEEKVG
QLTTLLGWKMYTKTGNSVEASEALKEAIATQKIGALWGVMRADPWTQKTLSNGLNPELAA
KATNAIQKVAVEESRLGIPLFLAEEAMHGHMAIGTTEFPSAIGQASTFNPELNKKMAAAV
AKELRAQGAHIGYGPILDLAREPRWSRVEETFGEDPYLISEMGLGVIEGFQGDGIENPES
VISTLKHFAAYGVSEGGHNGGAVHIGQRELMQDYMYPFKKAIDAGVLSVMTAYSSVDGIP
STSNKALLTGLLREQWGFEGFVVSDLASIEGIKGDHHAAATFEDAAALAMNAGVDADLGG
NGFDDELLNAFKNGKVSEARLDEAVKYVVRLKFKMGLFENPYVEEKAPKKMVRSAAHIAI
AKEMALEGVTLLKNENGLLPLSKDLKKIAVIGPNADMMYNQLGDYTAPQEPEFIVTPLEG
IRAKMPKAEITYVKGTAIRDTTQTDIPAAVAAAKNAEVAIVVLGGSSARDFKTEYLETGA
ATVSSKEDQVLSDMESGEGYDRSTLDLMGKQLELLQSVEATGTPTILVLITGRPLLINWP
AKHIPAIIDTWYPGSQGGHALADVLFGDYNPAGRLPVSIPKSVGQSPVYYNHWWPKRRDY
VEETSAPLYAFGHGLSYTTFDYSDLKISQSGNAANTTIKVSVEVSNTGDRDGDEVVQLYL
SDVVSSVVTPVKQLRGFERIHLANGESKTVTFTLTPSELALFDAEMNHVAEAGEFEVQLG
ASSQDIRLKERFELTESIQLTKN
>KECLDBNJ_01187 Sodium/glucose cotransporter
MVALETLDYAIIIGFFATTLIVGLLVAKKSGKSSSEYFLSGRNMPWWLLGISMVATTFST
DTPNLVTDIVRNQGVSGNWVWWAFLITGLLTVFVYAKLWRKSEVNTDIEFYELRYGGKPA
KFLRGFRAVYLGVIFNVMAMSAVTLAAIKIGQIMLGLTPLETIGYAGLVTVIFSTIGGFK
GVVYTDFILFFAAMAGGIGAAYYCVNLPEVGGMEGLMANEAVINKINILPDFNDTTTLIT
LLIIPLAVQWWSAWYPGAEPGGGGYIAQRMLAAKDENHAIGATFFFNALHYALRPWPWIL
VALASIVVYPDIASIHEAFPNIVESKLGDDLAYSAMLTKLPSGLLGLVMASLIAAYMSTI
STHLNWGSSYVVNDFYARYVKPKASQKELVNVGRISTVLLMVVSSGVALLLTNAYQLFNI
ILMFGAGTGLIFILRWFWWRINAWSEISAMFSSGIISILFNFTSLGVVLFGTAEADGVLP
NWSTYPVVVLLTSIVWLAVTFLTRPEKDKTLFDFYKQTQPGGPGWEKIIIKARAQGAALV
TTNQKWSVPAGILATLVGCVTIYGALFSTGYWIYGYYTQASILTLLTLIATIALVKLWQR
IKTRVF
>KECLDBNJ_01188 hypothetical protein
MIIFSPHPDDDVISMGGTFDRLVEQGHEVHIAYQTSGNIAVSDHEALKFAEVAAQIGNGD
KEKFAAIAEQIKNKQRNEIDPVEVRQLKGIIRRCESLGATRFEGVPDEHVHFLDLPFYET
GGIKKNPMSQDDVDIVNELIANVKPHQIYAAGDLADPHGTHKVCLNIIFESLEQLKSEAY
MNDCWVWLYRGAWHEFEMHEIEMAVPMSPDQVLKKRQAIFYHQSQKDGVMFQGEDLREFW
VRAEDRNKETASKYRALGLAEYAAMEAFMRYHF
>KECLDBNJ_01189 hypothetical protein
MEYIGWIGALLFIISYLLLSLDYLSAQKYLYHILNALGALCLVINALVIDDYPNIFVNAV
WGLIALVAVIKRMQPTIKGKSRGKI
>KECLDBNJ_01190 HTH-type transcriptional regulator BetI
MGRKNISEQRRKEIIIAFYEVSRQLGLENASIAKLAQHMDISKGLVLHYFENREELLIGL
NEYILEQHLNVMISEDIGVMNTKEHLVLFIENLFTRAWNSYFDDGVFYSCYALIYRVPEF
KNSFKSYLLELHQVLYQRLLEAKSNSVINNTNLKEVTEVIFALIDGAYYYLGMFEESEAR
YKKQVAIYTKYSLELLNFTT
>KECLDBNJ_01191 hypothetical protein
MHLKKTVLLITLFASIINLNAQLQKTTSIKQKVVFIIVDGIAYDMIVNNPSPRLDEIAGE
GSITQAYVGGLKEGYSETPTISAVGYNSLLTGVWANKHNVWGNSIKDPNYNYPTIFRLFK
DQYPNGKTAVFSTWLDNRTKLIGEGLDQTRAVEVDYKFDGYELDTIRFPHDAKREYIKNI
DALVAKEAAFTIKTQAPDLSWVYLEYSDDMGHGYGDSPQLTAAIKYEDSLIGSIYDAVKF
REQSHQEDWLFLVTTDHGRSPKDGKHHGGQTDRERSTWIVTNSKNTNTYFDTQIPAIVDL
LPTMTSFLNLDVAKDIRSEWDGVSLIDPVDFINVQAEVLDNRLHLEWETLGNKNTQVSIL
ITNTNDKKLGGKDNYTKIGQTSLGSERFDIVLKKGKKLPVKILLQTENTTQNVWIISNN
>KECLDBNJ_01192 TonB-dependent receptor SusC
MKKIFTLFILLVSLVSFAQQTVKGIVKDPNGVPLGGVTVMIPDSSRGTVTDFDGNFSIEV
NSGETLQFSYVGFTKQEVVISNQSVLEIIMAEDAQALDAVVVTALGIKKEKKALGYAVQE
VEGDNLEKAKEPNFVNQLSGRVAGLNIKNSTDLFQNPTIELRGATPLLVIDGIPDRTLDI
WKINSDDIESISVLKGATASALYGSVGRNGAIMITTKRGKKGKLNVSFNNSTLFQTDFIR
VPDVQTTYGNGNRGVYAYVNGSGSGTEGGGWIWGPRLDQQDPTTTSGFYETTQYNSPIDP
NTGELIPIPFTSRGKDNIKNFFETGIIQSNNVSVGWGNDKADVRLSLSNNYQKGIVPNTD
LKNTSFNLAGTIRPTDKLTLNGSLTYNKQFTSNFPEVGYGPTNYLYNLILWTGTDVDIRD
LKNYWREGQEGIQQRHFNISYYNNPYFQAYEYERGYNKTNIYGNASFNYEINDALSLRGR
TGVNEYSLYRTYKEPKSYIGYGNKSRGNFSIAQTEYFDITSDLALHFEKKISDNFGITAE
GAYVNYYRNSKNTSQSTDGLNVPGFYNLANNAGATLLGSNREEKETINSFYGFIDLEFYN
AFYLSLTGRNDKVSTLPEGNNSFFYPSVSGSVVLSSLFEMPQWISFAKLRGSWSRVSEGK
IGSDPYDYILAYEKGTIWNGTPSTYFGSNLLSPNLEPETSDTWEVGANIRTLNNRLGLDI
AYYQARDYNNLIYSPISDASGYSSILLNGNEFQRKGIELTLDATPIKNENFSWNTQINLS
HYRRYQEEIYGDREQTEGYIRVGDRTDKIYTGVYQTNAEGDVIFENGLPVSDPYDRFIGY
DEPDLTYGISNSLQYENISLSFLFDGRLGGLMYSNTNQKMWWGGTSKGTVNQFREDAVNG
ENTYIGNGVVVTGGSVSYDVNGTITEDTRTYAPNDVPVNYISFMQSTSNYHNKNYHYYKE
TFIKLREVTLTYQFNEAFLERTPFKSLDVSLVGRNLWLASDIPNVDPDSGVDNLQAPATR
NIGFNINAKF
>KECLDBNJ_01193 hypothetical protein
MKKYLIIFSLLLLAGCSKVEDLQNDPNRATQVSPDLLLTTIETTAFNNVSLNAALASRQL
TFTDGTNQYQYYNWQRAGFGQYDDLKQVYKMIQESQRTDSQVYQILAKFFNAYYAIELTR
VFGDVPYTEAVGAEIGIYTPSYDRQELIYASALDSLRAAGLELAQNTETIRGDVIYEGNK
KQWQKLINSYSLRVLMSLSNKVDQTDIDIVGRFNEILNNFDQFPIFESNSDNASLVYVDI
QDNRYPLFNDNSLQTAYYMEQTFVERLQNYEDPRLFMMADKKPNASNLNVEDFSAYGGLY
GSAPLSDNGSKAVSGEASRIKPRYYNNPVNEPSILMSYAELQFTLAEAAARGWISEPSEP
YYKSGIAASLAFYGISEAEDYLNNPTIQLNSNEDLESILTQKHIALFLNTGWQSFYDQRR
TGFPEFNVDGGGILNNGLIPKRFMYPQNESINNPENLNEAINRQFPSGDNINASMWLID
>KECLDBNJ_01194 Alpha-N-acetylgalactosaminidase
MNSRRNFIKGSAIVGAGITLAPNLVFPNTKYSSEKLKIAFIGVGLRGTNHLNNAIHRKDT
EITAICDIDPKRIEIALDLIEKDGRRKPLVFGNNENDYLNLLDSKEVDAVIIATPWLWHT
KMAVAAMKAGVYAGLEVSASQTIEECWDLVNTHEATGTHMMFLENVNFRRDVMAVLNMVK
QNVFGEMLHYRCGYQHDLRAVKFNDGKQPYGGGVEFGEKGLSEAKWRTKHSVYRNGDTYP
THGVGPIAAMADINRGNRFTSMTANATKAVGLHKYVVDQGGKDHPNAKIKFKQGDIITST
IECANGETIIVTHDTNLPRPYSLGFRVQGANGLWEKDGDRIYIEGESQPHRWDDSQEWLK
KYDHPVWKKYGEEATGAGHGGMDYFVMKAFVESAIANIAPPIDAYDAAAWSAITPLSEAS
IENNGEPQEFPDFTRGQWVARAPYDWMKAEYKVKF
>KECLDBNJ_01195 hypothetical protein
MIFLLMTLVSLFSCKENEIEENVVYNFTIRIPAGGNSWIQNSAERTQGLVFDTGVHNWIS
TEDVVESYFATSQKGDLQVGLVVKVPDGITNLEVSLDGNVTDIQLSNSSYQDIAVTEFKD
IPIGYHKLEFRALGKTGAYIADLKEILLGGSATDSKITYIKNTEHFYFGRRGPSDHLNFS
IPEEKDLTYFYSEIEVPEGQDKIGSYFTANGFNFGYFGIQVNSETERRVIFSVWSPYSTD
DPSEIPEDQKIILLDKGAVVNAGEFGNEGSGGHSHLVYNWKAGTTYKFLLKGEPSVNDSS
DYTAWFYAPETGEWQLIASFRRPKTTSYLKRFYSFLENFSPSTGNQEREALYKNQWVYDT
SDTWTEVTEAKFTVDATARAGRRLDYSGGSDEEIFFLRNCGFFSDNINPDTLFTRTSSNN
KPSIDFEVLDKLLN
>KECLDBNJ_01196 hypothetical protein
MKTIFKLLFITVILVSCEVERFPYDSIASEELLSGEGGIEAATLGNYAILKGDADGNGFA
PQFHRIAEYPGDNVALSGTTTDALFYSYNYNNLATSGRVNNFWTSGYQAIVGCNKMIELT
TEGESEETDQLIGENYYLRAYAYFQLVNVFGRPYNQGRDNLGVPLKLTSLIDDLPDRATV
GEIYDQVVSDLLKAESLMTVNKSNSYATKEAAQALLSRVYLYMEENQEAIDYAEKVIASG
RYSLLSTDELPNYTRINPDDNSETIFCFKFLEESDYNHGYYTVGSLYANILGSGWGEMYA
SNDFLDLLRKNPTDKRLEFIDPQYSTDANGDLIPAVYWVNENYQYVFRQTFEQGNETYFT
DNGNDYLISSEVIGPQTLYYFTTIAGDKQYVIKDFDMVKRNGYPKFFILKCSLQDDVPQL
WSPVVSRLAEMYLNRAEAYAKLNQVGNALNDINTIRTRAGITTYNDASEFPEGMTILDIV
LQERRMELAYEGHRKFDVFRNGRTMNRRYPGTHLNGNNPYYEIQPSEDRVIEYIPEAQIN
VQPSLIQND
>KECLDBNJ_01197 TonB-dependent receptor SusC
MIKILSTIFFVLCTASAVFAQSAITGIVTDSKSGSPIPGANVQIKGTSTGVVTDFDGNYS
ISAESGQILVFTYLGFKPKEVIVSTMTTVNVSLESSTSELDEIVVVGYTEQKKSSVTSAV
SEVKSKELTDVTTSDVSTMLQGKAAGVQVVQGSGQPGSLPSVRIRGLTSINGGTNPLWVL
DGVIVHGTPNLNPNDVEGISVLKDASATALYGSRGANGVVVVTTKQAKLDQNTLTISSRL
GYSYFNNGNFETMNSQQLYDYYQSFGNQDNIPEGIDESVLANDFDWFENGTQTGVIQDHN
LTFTGGNEKSKTFLSLGYYNETGTLKGYKYDRVSARLNHDYKIGERLTLKPKVAVNYNKR
NNRQHSLYALYTYMPWDTPTDINGTIINPQDLESGQIWYGRDNANYLYNLQYNYSNSREL
NLFSNMDLEYQILPDLKFISTNSVTFYYADGMTYTDPKSTSGLANNGQLYKYNTKRITNF
TNQMLKYSKSMGAHRINALLGYEYQDYKYTSSGATGYGIVSGTTILDNAATPGAVSGTTN
DSALQSVLFNADYGYDNRYLAQFSIRRDGASNFGKDNQYGTFYSGSLGWNIHNESFFKVK
EINQLKLRASYGAVGNRPAALYPQYDLYSLQSTYNGLPAPSPYQYGNDDLAWEISYQTNI
GLDSRFFDRASFSLEYYNKDTSDLLYYVILPSTSGYNGYYENIGGVVNTGFEANLSVDIF
QENQSGFGWTITGNIGTNSNEVTELFEGEDIDRGTKLSRVGEDYNTWFMRKWLGVDSETG
NPLWETVDPNTGERSETTDYNAATKQIVGSSTPDFYGGFSSMMLYKGFSLSANFNFSQGG
QIYHSSRELYDADGAYPTYNQQVLQDGWSRWEEPGDIATHPRALYGGNNLSNKTSSRYLE
DASYLRMRNIRLGYTFSQKWLSDLHMSNFEVYLTGDNLLTITDFSGTDPEVGIDGYASSQ
YPISKRIAFGLNLSF
>KECLDBNJ_01198 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGATGDNLTPLDTVKFAAAYGTWLKAENTNQKLKIVIGRDARLSGS
MVSGLISNTLLGLGIDVIDLELSTTPTVELAVVREAVHGGIIVTASHNPKQWNALKLLNH
KGEFLNAEEGSKIIALAEKEAYDFAEVDNLGSYFVNTNAIEAHIDEVLALEHVAVEAIKA
KGFKVVVDAVNSTGGITIPALLERLGVICIPLYCEPTGHFPHNPEPLAEHLTAISKRVVE
EQADLGFVVDPDVDRLAIVNEDGTMFGEEYTLVACADYILGKTPGTTVSNLSSTRVLNDV
TIGYDQAYFASAVGEVNVVTKMKEVEAVIGGEGNGGIIYPESHYGRDALVGIALFLSHLA
ETRKSCKELRNSYPAFFIAKEKLELPTATDIDALLMQIQKVYANEEVNTIDGTKIIFKNK
EWVHIRKSNTEPIVRIYAESTSLKKARLLTMKVKETLNSFILT
>KECLDBNJ_01199 Glucosamine-6-phosphate deaminase 1
MFTSTIDTATEFEKRFEKINTHVFDNSANASKAVAQQIAALIKEKQSQNKTCVLGLATGS
SPKSLYAELVRLHREEQLSFKNVITFNLDEYYPMKAESIHSYVRFMNEQLFDHIDILKVN
IHIPDGTLAKNEIAGFCTQYEDQIEKAGGIDLQILGIGGNGHIGFNESGSLQNSKTRLVA
LDHSTRIAASKEFEGLKHTPRTAITLGVHKIMEAKRVILLAWGESKSAIIAKAVEEGLTN
LVPASFLQEHQHVDFVLDKEAASKLTRINKPWLVEEVNWTDKLISKAVLDLAISLEKPIL
MLTDADYIENGMSDLLAQMGPAYDINIRIFNKLQNTITGWPGGKPGADDNKRPERALPAK
KRVLIFSPHPDDDIISMGGTFKRLHEQGHEVHVAYQTSGNIAVADDEAIRFAKFITDYNE
AFGISCDEAQRIYNKSFDFLKTKEIGGIDIPELRQIKGIIRRGEARATSHFVGLPDSQIH
FMNLPFYETGAIEKNPLGAEDIALTIDLIEQVKPHQIYAAGDLADPHGTHKVCLDAVFEA
LKQIKHKDFMKDCWLWLYRGAWQEWGIDEIDMAVPMGPDQVIEKRFGIFKHQSQKDGVVF
QGSDSREFWQRAEDRNRETAELYDKLGLAHYAAMEAFVKWEY
>KECLDBNJ_01200 L-fucose-proton symporter
MADTAIQIKEPQDSKNVSIAIIAGMFFILGFVTWINGALIPFMKAINELTDQQSYLVASA
SYISFVVMALPASAILKRIGYCKGMSLGLFIMGLGALVFVPAAEARTYSYFLIGIFIQGA
GMTLLQTAVNPYITILGPIKSAAKRIAIMGISNKVAGALGSLIFGALLLSGIEATQDKIK
LAETSNKNVLLDQMADSVVWPYIIMAICLFIFALLIRKAPLPELEATESDESGAEDSKKT
VLHYPHLLFGVLALFVYVGVEVIAGDSIISYGLAQGFPAEQSKFFTSYTLLAMVCSYALG
IFLIPKYIEQRNALIISATLGIVLSVLIINTTGFTSVLLIAALGIANAMVWPAIWPLSLS
NLGKHTKTGSALLVMGISGGALIPPLYGRLVDVNKADLMQEGTTAAVAAGEAANSGYILL
IPCYLIILLFAIWGCRIKSWSK
>KECLDBNJ_01201 UDP-N-acetylglucosamine 4-epimerase
MKKYVITGGAGFIGSHIAEHLVGEGHEVVVLDSLRTGFQKNIDPFNLKFEQGDIRNIDTV
NKLVSGASAIFHLAALVSVPESISKIAECNAINAQGTINILEAAKRAGKCKVILSSSAAN
YGDNPVSPKVEAMTPEPLTPYSITKLDGEYYLDMYRNQFDVPTTSLRYFNVFGPRQNPKS
AYAAVVPIFILNALQNKPLIIYGDGQQTRDFIYVKDVVAANLLASQTGKGVYNVALGNST
SVLELAEFIIKITNSKSEILFKETRAGDIKHSQANPEKFQKEGFEPKYSIEEGLKETVAF
YESELLAQVKEA
>KECLDBNJ_01202 N-acetylhexosamine 1-kinase
MGLNTNELIASVFNAFNHNCTITDIEEFSSGHINDTYFISTAEGQQFVLQRINDEVFNNV
EELVNNKVKVSKHLAAKIPELDTEEKYRRVLTFLPAKTGAYYYQDAFNKYWNLTYYIAKS
VSFDTVTNKEIAYEGGKLFGKFISQTSDFDACQLVEIIPGFHDVPRRLLQFEQAKKNASA
MRLECAAYQIEKVAALQEEMVLLQQLKDEGKIPTRVTHNDTKISNALFDANNKGLCVIDT
DTVMPGIVHNDFGDAIRTICNTAEEDQKDLSLVSFNVDYYEAYLKGFLEELRDSLSEVEI
QFLPLGAKTIIFIMGLRFLTDYLAGDVYYKTSYDEHNLDRAKNQFKLIESFEDQYNEILK
LSKSIVKVKQL
>KECLDBNJ_01203 hypothetical protein
MSTEMQNSKGPTLVILAAGIGSRYGGLKQLDTFSPQGDTIIDFSIYDAIEAGFKKIVFII
RENLLEEFKEVFEPKLKGKAEVDYVFQELDRVPDAFVDSNRTKPWGTGHALLLTKDVVKE
NFAIINADDFYGRESFIIMANALNDIDSDSYHFNMVAFQLKNTVSDHGYVSRGECKVSQD
GYLEDVTERTHIEKQGDKILVENESGDLELIDPETFVSMNFWGFTPKCFEFGWELFNEFL
ERSKGNIKAEFFIPTVVNEMLQSDKVSVEVLSTPEKWFGVTYKEDKAIAQTEIKKLKDNA
VYPVHLWD
>KECLDBNJ_01204 HTH-type transcriptional regulator MalR
MKENYTIKDIAELAGVSKGTVDRVIHKRGKVSPKALEQVNKVLDKIEYKPNPIAKSLKNN
KIYNIAILLPDADADPYWLPCYEAIKQIEQEFSHFGIKINKGVFKPKSTKSFTKAADLVI
AEKPDAVLMVPLFYKEAEHVAKMCVAAGIKIATFNNYIKEPQINLEIGQDLFQSGRVAAK
LFNMLLGNKATLAVLHIDEAFQNASHMQEKERGFKDYFAQKELAYTINVHNIKKESKIPF
DQTIENFLKSLDAVDGLFVTTSKAYLLANHIAAYLPKSFIIGYDLVAENIKYLEEDKIAF
LIHQDPKKQVYLSLTNLIEFFLFDKPLQESLTLPIDIINTENYPQYLN
>KECLDBNJ_01205 hypothetical protein
MNNTKYIVGRIQNGSSDLRKREETNLWDSANELTNFVSPWDKQPIKPITFKALYDTDYFY
FSFSVEDDSVFTELKDDSKSSIAQSDRVELFIRADAQMCPYYCLEIDTQPRIMDFKAMPN
RNFDLSWNWPEGEIDVKSSVLKDHFKVEGKISLKSLKALNLLKQDARGTFMEIGVYRAKY
NHDEMGNKQATWITWTDPKTPEPEFHIAASFGIFRFES
>KECLDBNJ_01206 Tyrosine recombinase XerC
MRTRLTFSLNFWINGCRAENEEAIIYARITVNGKRANISLKRKVPVESWDSSKGLVRGSK
PFAKSLNKYLDQIRSLIYQSYEDLLNEGNLITASAIKNKFLGEDKRNNTLSELFEYHNSI
SVTSLSNHTLRHYKVTQRYLNKFLIDKYKSDDIYLNKLDYSFIKNFEFFLKSYEPKDHQK
KMGHNTAMKNLQRLRKMLTMAYHHEWIDKDPFIRFKSLYVKNRREFLAQYELEQLEDFSS
FLERLDIVKDIFLFACYTGLSYIDVAKLNKDKIETDLDGQQWIKTKRQKTSIELIIPLLN
KARRILLKYQDHPRVSDMNRLLPTLSNQKTNSYLKEISDFCGIKKNLTFHVARHTFATTV
TLTNGVPIETVSKFVRTYQARHNSNLCSRY
>KECLDBNJ_01208 hypothetical protein
MLKTFTLICALFLSALASANTDEVKPVSEKIIFTSSLDLVVAQQDESLASEDLPDAILRL
YQLEKVKFTDRMIYTHKPLELANIKNPVKTA
>KECLDBNJ_01209 Endonuclease MutS2
MSSQYKIGQGVTLLDDDLSGVITKIEGEKILIISKDGFEFEVSIKEIVPNKMLDLEFDDD
FDDMINEKEKAYSKRKKQPIKNKGVLPPMEVDLHIHHLTKSESGMSAHDKLNLQVDTARR
KLEYAILKRIQRVVFIHGVGEGVLRAELEYLFSRYDTVKFYDADYQKYGLGATEVYLYQN
SKHTS
>KECLDBNJ_01210 hypothetical protein
MRNFYSKLFFLLLPALSVGQLHIKSSTGGSNAYVFNNGEIIYVNQEIGMDGNPDQTGGNL
YLRNEGQLIQGENSSNSGTGIVSVYQENTRNAWDYHMWASPVGDPNESNPNNGNAGNARF
YLDSGNGGGVYQVIDELDSDAATFSASYNGIAAPLTLSTTWLYKYIATQGYSGWSKISSG
NPLLPGEGFSMKGVGSGTTPTSTAFDFRGIPNNGNIEVDVKPTQRTLVGNPYPSALNLSY
YLLYNSGQSVANCLGTYSGTPSTGTEVITGEAFFWESDPNVQSHYLADYLGGYGTFTPLM
DCTSLGEYTSPTYVMYNEDGTVRSDGPSIDTDDPLVNEIERKIAPIGQGFFVLGRDLTAS
EQTAVDGGAPLPTLQVTMKNDFRVFIKETNAVYDPEFKNNSSSKGAKTAQKNGSNSSLNP
GGLTYTEDGILIMPKFVLSTVVNHQYVRTLKGIMYESATLGFDRAGDGENRSSLPSDINF
LLEDSDKSYLMNIFPYQIENKLALKLSGANPTNTYEIKVTDINFTPDESIYLHDKLTDEY
HDILDESYEFELEQGTYTDRFEIVFKDSKTLDVEEVEEVKRSFNIYQNNGRAELTVLNPL
QTELKEVNVFDISGRLLVSKLNEGTSEKVIIPSNAWSDGVYIVRVTTRDNIEYTKKVSVR
NIK
>KECLDBNJ_01211 hypothetical protein
MEEYMLPCLNKKYLGFECMGCGLQRSLVALFQGDFVKAFELYPAIYPLVFLGVMISLNYM
VGVKYGSKIISVLAILSVTTIIVSYILKLTS
>KECLDBNJ_01212 hypothetical protein
MEQQKLPNVTISLILGIVSFIACCFSSGFGGLLFSGIALFLANKDKKLAAPNPELYENYG
QLKTARIIAIIGLILAVIVSIFCIILLIIFGSAEAIQQWALEMQNAQA
>KECLDBNJ_01213 Miniconductance mechanosensitive channel YbdG
MAYQIDTYLKDFSSYVEDLGVVPFYAEMLTVFINAFIFILLIALLDKLLKKLIVEAFKVF
SNKTKTSFDDFLVLTNFPRYIGHIIPLAIFKWFFVELLEDYPTTLYWLLKIFDLYVILLI
LKIIRSLLRTSRDYFQTKQQFHDKPLQSYLQVTMLFLWGIGIFFFILELFDKNAMNFVLQ
LGAASAVILLIFKDTILGFVASIQVSINDIVRIGDWITFSKYGADGTVTEINLATVKVQN
FDMTYTTIPTYSLISDSFQNWRGMQESGGRRIKRSVFIKQNSVKFLTEADLKELKRIQLV
APYIEHMEKEVLRTNKKQGVDQSLAINGLNQTNLGVFRKYIDAYLYENPAINKDLFLMVR
HLPPTAQGIPLEIFCFSTDKRWENYEHIQADIFDHVIAAVPFFGLEIFEEPSSKDITSFL
TQKNQSKE
>KECLDBNJ_01214 hypothetical protein
MTFKNVLQIIGGIAIVLTIAPFIAADYWWIRIFDFPHMQLTIFTAAATLAYFIKFDIKWA
KDYAFMSIMIACLVFQVVKIYPYTPLAEKDVLDSTITDQNRTFKLLVANVLQKNKKHEAL
LEEVEAKDPHILLLLETDKDWLNAIAPTLSKNYPHYKGIPLDNTYGMLLYSKFPLEDPKI
HFQIDDSIPSIESVVQLPSGDRFELYAIHPTPPMPQHNPMSTDRDAEMMKTAFKSRNNTL
PVIAIGDFNDVAWSESTELFKEVSELLDLRIGRGLFNTFSAKSKIMRWPLDHIFVSEHFR
AKTVLRGNAIGSDHFPAFAELTLEPENKAEQMPKPPREEQLERAYDIIKKEATQKDTRKQ
SDNT
>KECLDBNJ_01215 Low-affinity gluconate transporter
MEAQLLFAVFAGIGLLLFLILRLKLQAFLALLLSAIFVGVLSGLPTESVLQSVTDGIGGT
LGFVATVVGLGSLFGALLEHSGGAQAIAQYLLKKFGIKNAPWSIMLTGFFVAIPVFFDVA
FIILIPLIYALQRSTKKSLLLYALPLLAGLAVTHAFIPPTPGPIAVADILNANLGWVILF
GFITGIPTAAIAGPFFAKRIAKRIHIEAPEEIEEEKESFANAPKPATILLIIFLPILLIV
LNTVLSSPLGARIGISETFLDIIQLLGHPFTALILANLIAWYILGVRRNVSKEKLLEIST
KALYPAGVIILLTGAGGAFKQILIDTGVGEMIANALQSDYFPPVIFSFILAALVRIMQGS
STVAMITAAGITAPLVVQNNLNDMKLAILVIAIAAGASIFSHVNDSGFWLVKQYLGLTEK
QTFKSWSILTSLIACIGLVVSTLLWYVV
>KECLDBNJ_01216 Gluconokinase
MSNVIIVAGVSGSGKTTIGRLLAEKLDLDFKDADDFHPAANVEKMRSGLPLNDQDRAPWL
AILAKKIEEWSRADGAVLACSALKEAYRKRLDVNKQVTWVFLDGSYELLKSRMTARKNHY
FKAELLQSQLDTLEPADYGIHVSIAPSPEEIVDEILKAL
>KECLDBNJ_01217 hypothetical protein
MKFGKVNDPGSIDFTLPPDHPDTKIILNSKATKAKPQLYVGCAKWNKQDLKNFYPRGTKD
ELGYYSRQFNSIELNATFYRLFPKDQFEKWYEKVPADFKFFPKVTQNISHLKRLINAPEL
LPEYLDHTLLLKEKLGCIFLQMHNNFQPKNWDRVEQFVAAWPKEVPLAIEFRHTDWFNEE
PVAQKLYHLLETNDIANVLVDTAGRRDIMHMRMTNSEAFIRFVGANHPTDYERLDDWVAR
LGVWIEEGISKIDFFIHQNVEKESPLLATHFIKKMNEKYDFDLHLPGKDDANPTLDL
>KECLDBNJ_01218 hypothetical protein
MPIFAKYQSVTFSIISMKTLAFLSFLLITFSSVAQEELIETMYNQTADEIITKYIDRTGG
IEAWSEIDAIKTKGSFTQGDLSVPITIYNTRSGKQAVVFEYNKKKVTQMAFDGATMWTTN
FLTMEPEISSDDMRKNMLLKRNDFPSPLLHYRENGYKAEYISTVAKNGIVAFKIKLTQEP
KFVNGEEVPNESFYFFDAQNYYPIAIETTQLGQPVSITMSDYQEVEGLYFPFTISQGGQP
IDVKEIILNPEIDYSIFSFPEN
>KECLDBNJ_01219 hypothetical protein
MSSLQFKNYLKNYSKQLLASSLVWFIGMLLVGYAISNSAAPDQLSELRYIPVYAVAFLST
LCVGLCHYLYWQDAAMD
>KECLDBNJ_01220 Protein-L-isoaspartate O-methyltransferase
MKDTTRHQGKRRLLAQIVEKKGVSNTAVLDAIRKIPRHFFMDSSFEDHAYQDKAFPIAAD
QTISQPFTVGFQTELLEIKKGDKILEIGTGSGYQTAVLCEVGAKVYSIERQQELFRKTKN
FLSKLGYRPKRLTFGDGYLGMPEFAPFDGIIVTAGAPYIPKPLLAQLKIGGKLVIPVGDD
VQTMIRIVRKTQTDFEKKEYGEFRFVPLLEDKN
>KECLDBNJ_01221 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKAGVLGAGHLGKIHLKLLNQSERYELVGFYDESETTAKAVAEEFGYHRFDSIAQLIDA
CDIVDVVTPTTHHFDCAEQVIKAGKHLFIEKPIAQTVEQAVAIRELAKKHGVRGQVGHVE
RFNPAFTAVNHLIENPMFIEAHRLAEFNPRGTDVPVVLDLMIHDIDAILSVVKSEVKHIS
ASGVSVISDTPDIANARIEFANGCVANLTASRISMKKMRKARFFQKDAYISVDFLEKKCE
VVRMKDAPEQADDFAMILQNAEGVKKQIYFDNPEVEENNAILDELEAFADAIEQNTTPIV
SLANGTEALRIAMKIIADL
>KECLDBNJ_01222 hypothetical protein
MLAILKKEFHSFFASPVGYLVIGLFLILNGLFLWVFDNDFNLFDYGFADLTPFFQLVPWI
FIFLIPAVTMRSFSDELRLGTLELLLTRPITTLQLVLGKFFGALLLLILALIPTLVYVYA
IDQLGNPQGNYDQGVLIGSYLGLLFLAATYTAIGIFASTLSENQIVAFLIAALLCFLFYF
GFNGIADALNIEILKSLSLQMHFESIGRGVIDSRDLVYFLSITSVFVGLTVLKLESKSVK
G
>KECLDBNJ_01223 hypothetical protein
MIKSNSKNLIFVAIVLIVLVLSQSFNFRLDLTADGRYTLSETSKNIIAKAQDQIVVDVFL
SGNVPDAFQKLQIETRQLLEEYASQNTNIKFAFVNPVPDGVSPEQIAQDFNNRGMRPEQV
QLRDNGKVSQEFIFPWALVSYKGKSIPVPLLKKSLGAAPDQLVSRSVQNLEYAFSNGFYK
ALNPKSKRIAVLKGNGELDDKYIADFFKTLRERYFIAPFPLDSIAQTPDTVLTALNKFDL
VVAAKPTKAFSDAEKYALDQFIMHGGKSLFLLDQVAMETDSLYLRDGMALATARQLNLDD
FFFKYGLRINPVLIEDLYAAPLVLASGEAANSQYTQLPWFYYPLVTPAENHPINTNIDNP
IAFEYANQIDLLNTDLQQTVLLQSSVLSKVNGVPAPVSLESITTEPSPEQYAAGAQNLAV
LVEGKFTSAFKNRILPLENLREPFRESAIKNTAMIVVADGDLIKNDLDQNGRPLELGFDK
FTFKEYGNKEFLLNAVNYLLDDNGLINIRSKSINLPALDIQKISNDRATWQALTIGLPLV
FLAVFALIYTALRRRKYRA
>KECLDBNJ_01224 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQVLGGVINNSNTLPILDNFLFELEESTLKVSASDLETTMIATLEVE
SDDSGSIAVPARLLLDTLKTFPEQPLTFVAGDNNTIEISSNHGKYALAYASGEEFPNAVE
LDDPSKVSIPAGVLATAVSNTIFATGNDDLRPVMSGVFFQFDTEGLTFVATDAHKLVKYG
RTDVQANQTAEFIMPKKPLNLLKGILASSDDDISVEYNDSNAKFSFDNVQLLCRLIDGKY
PNYEAVIPKENPNKLVIDRNQFLNSVRRVSIFSNKTTHQIRLKIAGAELNISAEDVDYSN
KAEERLTCDYQGDDMQIGFNSRFLVEMLNNLNANDVSLEMSLPNRAGILTPVDGLDEGEK
VTMLVMPVMLNN
>KECLDBNJ_01225 hypothetical protein
MRRDFLSGLALGILVGLIIGLSIAQVTGIILGALTSLLAAFFGLRPDKEGESGNKIIIGS
FSLGCFTALLLGIFLRTHDVLAPSLQNEIALYKSVNFSDEEIKELIYFKHFGLVANQKLS
FNKEAANANALKSTLLMADENDLALCAVEVEDLSLIEIEELFIASGGKFLRLFNQLQQNS
MDDSELKSSVLLIKELLCE
>KECLDBNJ_01226 hypothetical protein
MLLLLSLCCLNSVVFGGVKEEISKTIVRVKSGNKYSTGFFYGNGNQIIATLHSIGNPDQI
EVFIPSEKSWCSVRLNRISKKSDLVLLSLSECISANYLKPENITTSTIDTKVFTVGYYGS
NDKYQDRDFTVGLIEGKRLKDLLEPSAEQEIRSLGFPSLDTEIVYLKGQLLHGFSGSPIV
DYRGKLIGIADGGLENGAAGISWCITASALNDLKNATDAFPRSSLKKVNTLFAEEIPPSN
AKTVSNGQFSFQLIKSRTFK
>KECLDBNJ_01227 hypothetical protein
MGMYQIMQALDQEGIAYNNFSFDIYLEATTGATIALPKGMELKQENGLFYATTYDNQVVI
LIALYETYDVMQMSLEFENMLQAATGVYTWQLDSRMSFLIPYYRPDNVVINRKSFFNYQP
NRYLIEALAAKEFTFFGVATVFKESFDFNTYEFTDQDLAAQFVLALQLTTFTN
>KECLDBNJ_01228 hypothetical protein
MMFRLLFFSFMLLSLSSCTDDNNTATTNLVQETATVRLNLVKMSGQIRNSETTGAEMAWQ
EYYILGPEMHFTKVRERDGQTLKSEGTFDIVMINSDKYLQFTHDSDGELVGNCTGDSVEL
LMYTTSDSVQSTWQSCDGPGLYYTFE
>KECLDBNJ_01229 Glutamate synthase [NADPH] small chain
MGKVTGFLEYDRKNEPYKPVEERIQKYEEFTIPLDKPEIKNQGARCMDCGIPFCHSGCPL
GNLIPDFNDAVYRERWEEAASILHGTNNFPEFTGRLCPAPCEEACVLGINEDPVTIENIE
KNIAEEAFKNGWVKPNAPEKRTGKTVAVIGSGPAGLATAQQLNRAGHSVTVFERDEKPGG
LLRYGIPDFKMEKHVIDRRLAILEEEGIVFKCGVHVGKDIKADALKNDFDAVVLSTGATV
RRNLPIPGSDLKGIYQAMDFLPQNNRRVDGLEWKGEEIKATGKDVIVIGGGDTGSDCIGT
SIRHGATSVKNFEIMSKGTPERPENQPWPYWPMRLRTSTSHKEGAERFFSISTKKFVGDE
NGNLTGLVTAEVEWTHKPGERPTLSEVPGTEKEWKADMVFLALGFTGSEPTVAEQLGIKM
DARTNIEASIDNYMTNVPGVFAAGDSRRGQSLIVWAISEGRQAAHHVDTYLMGSSDLPLK
GDGDLPRV
>KECLDBNJ_01230 Ferredoxin-dependent glutamate synthase 1
MEKQGLYSPEWEHENCGAGFICSLEGKQSNGIIHKALEILEKLEHRGAVSSDGKTGDGAG
ILIDIPYDFFKENCDFDLPEARAYAMGNVFLPQKENQRAYCKKIFEEQIEAKGLKLLGWR
RVPVDTGYLGAIAASVEPHIEQIFIGKPNDEMQEQEFMIKLYSARKITEHTILNSKLSER
TYFYLPSLSNKTLIFKGLLMPEDIKYYYVDLLDPKLTTRLALVHQRFSTNTFPTWDLAQP
FRYMCHNGEINTLRGNVSRMRSREELLKSDWFGEEIKELFPIILPGKSDSASMDMVVELL
LMSGRSLPEIMMMLVPEAWEKHQDMTPEKKAFYEFNSCIMEPWDGPASIPFTDGDYIGAV
LDRNGLRPSRYTVTKTGDVIMSSETGVLNIEPKNVAFHGRLEPGKMFLVDMKAGRIVNDE
EVKESIVTQKPYQEWLTKNRVHLKDIPYRDVDFKLEDTDFGLRKNAFGYTKEDINTIIVP
MATKGKEPIGSMGSDTPLAVLSDRPQLIYNYFKQLFAQVTNPPLDGIREELITDLSLTLG
PDTNLMEITPDYCKKIRIQNPVISKEDLDKIKNFDNPDFKVTSIPMLYEAKRGLNGLEDA
LDEMVAKASKGIDDGHTILILSDRGVNDEMAPIPALLACSYLNSGLFRSGQRSKMSIIVE
SAEPREVHHFALLFGYGASAINPYMVNEIIQKEIEAGNLGDIDFTSAVENYNKAIGKGVI
KVMNKIGISTLNSYRGSRLFEALGLNSKLISKYFPNTPSRIEGIGLYEVEQEIAKRHTRS
FGSKHISGKLEIESGGEYRWRRNGERHMFNPLTIAKLQEAVRRNNPSTYKEYSKLINEQS
KKLMTIRGLFEFSNYDPIPIEEVEPWTEIVKRFKTGAMSYGSISKEAHENLAVAMNRIGG
KSNSGEGGEDAERFYKSPNGDWRNSAIKQVASGRFGVTSNYLTSAKEIQIKMAQGAKPGE
GGQLPGEKVNKFIAKTRKSTPYVGLISPPPHHDIYSIEDLAQLIYDLKSANREARVNVKL
VSEVGVGTVAAGVAKAMADVILVSGYDGGTGASPLTSLRHAGLPWELGIAEAQQTLVLNN
LRSRIRLECDGQLKTGRDVAVACLLGAEEFGFATAPLVASGCIMMRVCHLNTCPVGIATQ
NPELRKKFKGQPEHVVNFMYFIAEELREIMAQLGFRTVDEMVGQAHKLDRNKAIEHYKAA
GIDLSPILHNIQVPEGVKIYNTESQNHHLEKSIDFEIIELAHTALFRKEKTTLDLEINNL
NRAVGAILSNEISKIYGEQGLPDNTLKVNFKGSAGQSFGAFATKGLTLKIDGNANDYVGK
GLSGARLIIKVPEEATFEANENIIIGNVALYGATSGEAYFNGVAGERFCVRNSGATAVVE
GIGDHGCEYMTGGVAVILGKTGRNFGAGMSGGIAYVLDEDQKFKSKCNAADLNLDPVTEE
NDKQQLKELITNHYNYTQSALAQRILENWDAYLPKFIKVLPEEYRQALIRLEEEEKLTDL
TE
>KECLDBNJ_01231 hypothetical protein
MKKLILPVMLCLGLSAFAQEEETSWTDGFSLSGSIDAYFRQNITTLNKVTDEGYPAPGSS
FANQPGFALGMANAVLSYEKGSVGAVADLVYGPRGTDAVFGSTTASSSIVNQLYVYWNVS
ESVTLTFGNWNTFLGYEVISPAANFNYSTSYMFSYGPFSHSGLKADFALDDNWSAMLAVM
NPTDWTDFNPAGSYTFGGQLGYSTDSGSTFLNLIYGDQDGDYTDQGLGEGAGSTFQVDLT
TGYDLSDSFYLGLNATYNTTDAGDMGGDDYGFYGVALYAQAALSDSFSLGLRPEYFSEFA
GGAGAIGGYDAAGDANVFAVTLSGNAKVGPLTFIPEFRLDSASEDVFLDSYDGTPTYTGS
LGSFLLAAVYSF
>KECLDBNJ_01232 Nitrogen regulatory protein P-II
MKKIEAIIRKSKFSAVKKALHEKGVNFFSYWDVTGLGNEKEGHVYRGVSYSTSDIQRRYL
SIVVNDDFEQAAIAAILDAAATGEVGDGKIFVSDVKDAYRIRTGKKGPDTLN
>KECLDBNJ_01233 Ammonia channel
MNFMANMLLQEPADAVQAAVDAVNADLGILWIIIAAILVFFMQAGFTLVETGFTSAKNAG
NIIMKNFMDLAVGSLMFWVVGYSIMYGGETILGGFMRDPSDLAFFSEDDWHNLFFQTVFC
ATAATIVSGAVAGRFKFSSYLIISAVLTTFIYPVSGSWLWPFDDQAWLNNLGFIDFAGST
IVHAVGGFAALVAAKLVGPRIGKYGPDGKVNAIPGHNLVLGALGVFILWLGWFGFNGGSQ
LAFGGDDSIAVGSVIINTNLAAALGGIAALFFTWIKYGKPDISMTLNGALAGLVGITAGC
GNVDAFGSVAIGLISGIVVVLSIEFIDKKLKIDDPVGAISVHGVCGFLGTVLVGVFATEG
GVLYGGGFGQLGVQFLGSISMIAWAIVATFIVLFIVKKTIGIRVSEKEELEGLDAHEHGT
TAYNFEVDE
>KECLDBNJ_01234 hypothetical protein
MMLREDKNLLVVAHLSQLLDFVTGIGGFIVPLVLWLTQREKVLNMDEHGKQILNFQISTF
IYSIICIPLILLFGLGILGFIALGLLVLIFPIINAIKAANGEATYYPISIQFLK
>KECLDBNJ_01235 hypothetical protein
MARYLYLTKRTIQEIVQSTNNLNLEIMKNLIYLFIGLLAGVSSATAATLDDTSINRYYDG
SRYIFVEGGVEFSIYPDGEFDFVLPQIAQGVNVNVNAGPVNISYNSGYNYDPYVQYDDYG
AVIQIENVPIYYDNWGRIIQAGDVFINYQNNRIVNVGGLNIFYRGSRFSHVTGYINVYNR
RYVYHPYHNFFYRPFFDRCLVYTTPYRRFYHPVRYDYAYHRSHYMQGYRNGYRNAYHDFK
RPQGRIAHNNARRGSYSKARARVNTDSRSYASRSSTSRATANSRTSRNTANTRQSRSSNN
AIINNRSSRNSDARRATNNTNARVTRNVNTVSRSSNADRNTIRTQRTSTATRNNAVQRSN
QQRTIAQRSTNNRNIAKSRNTSNQRSVAQRPSNTQRVSRNVQTQRTVAKRSTAPQRSVQR
SQSSRSSNAARASNTRKTSSARTSRSSSRGRGN
>KECLDBNJ_01236 hypothetical protein
MGIVASQSFKNLVTTYIGFGIGALNTLVLYVQFFDAEYYGLVGFLLSASTLAMPFVALGV
QNTLIKFYSSYSGRKQDDFLSFMLMLPLLIILPASILVYCFYGELVDFLASKNDIVRPYA
YLIAIIAFSMAYFEISYAWAKTQLQSVFGNVMNEVFHRFCIMLLLVGFALKLFSTEGFLY
GVAVIYALRMLVMMLYAFRLRAPRFRIAIPAEWLSILKYSILIIIAGSVAVMILEIDMFM
LGKLIPIQNVAYYSVGIYIAAVIAVPARAMHQIMYPLTATYINAQRYLELRDLYKKSSIT
LYAVSGLIFLLIVCNINTLYLMLDPAYSKGLYVVLLIALAKLIDNVMGNNNAILYNSDYY
RLVLVLGIVLVVIAVVLNLIFIPILGISGAAIATFVASVVYALSKIYVVQKKFKMHPFTT
ESLYLTIVLILLGVGFYFWDFKWNPVLAIGGKSVILGLIYLTLIYRLKISTEINHWINTY
LLTRKSRSE
>KECLDBNJ_01237 hypothetical protein
MKKALIICYYWPPAGGPGVQRWLKFVKYLREFEVEPVVYIPENPDYPILDESLVDEIPDD
VSILKHPIWEPYKMAQFFSKKNTKQISSGIIKEEGKQSLVQKLMLFIRGNFFIPDARKFW
VKPSVAFLNSYLKDHPVDCIITTGPPHSLHLVGRDLKKLHNLPWIADFRDPWTSIGYHKK
LRLTKFAQRKHADLEFQILNEATQILVTSPTTKSDFEKTTNTPVTCITNGFDDEKVMQPE
LDPVFSFAHIGSLLEDRNPKILWEILSEIKTEIPTFGQDLKIELIGRVGEAVKQTIIAEG
LVDNLMIPGYVTHQEALIKQRSAQILLLLEIDSIETQAIIPGKLFEYLAARRPILAIGPV
NSDITSILEKADGGIYFTYHEKQRLKAFILTKYEEYKNGGISQTNGNLEQFTRKSLTAKL
AELIHTL
>KECLDBNJ_01238 hypothetical protein
MTFSFKKIAPHLVVVLIFIITALLYFSPVLSGKKMFQSDIQQYRGMAKEQMDFRAATGEE
PYWTDAAFGGMPTYQLGAKYPYNWIKSLDLSIRFLPRPADYLFLYFIGFYVLLLVLKLDW
KYAGLGALAFGFSSYLIIILGVGHNAKAHAIAYMPLVLSGILLTFRKKYIWGFILTTVAM
ALEIVANHVQMTYYLMLLVLVLGVAYLIDAFRKNELPHFFKSVGILVLAVVLAIGTNAAS
LMATSEYSAFSTRGKSDLTINPDGTPKTDVGGLDKEYINQYSYGISETLDLFIAGLYGGS
NSEPYDKDSAFTQFLLQQGVPPPQVESIFGQFGLYYWGSQPGVSGPAYLGAVVVFLFVLG
IFMVKGRLKWWLLGGTILSLLLSFGSNLSWFTDLWIDYFPLYNKFRAVTSIQVIAEICVP
VLAVFGLYKILQKTEAKEDKLKALKWTTGITGGLSLIILLFNGSLFSFAGGNDAYYIQNF
GMDFISAVKEDRKSLLVNDTLKTLILVLIAAGLICFYIKQKVSEIQVILVMAILIVFDLV
QVDRRYVNTENFMAARLVEQPFQASEADKQILQDTSRYRVFEQRIGLNGARTSYFHNSIG
GYHGAKPARLQELAEFYLYQGNIQPLNLLNVKYIISQDEEGAEQVQQNPQANGNVWFVQN
VKVVPDADAEILALDSLNTLQTAVIQERFANDLPRNIFPQDSTDNISLVEHQPNYLKYQS
SAQEAKLAVFSEVYYPDGWNVYIDGKPSTYFKADYILRAMMVPEGEHTIEFKFEPQVVKT
GSTISLASNILLILIIFGGVFFTYRKLNSAKTE
>KECLDBNJ_01239 hypothetical protein
MVNFVANIVLMKFIQTLLIILLIFFGLRILFRFLSPYIMRYLAKKVGERFQNMAQGPGYK
EPAAKKEGETVIDRVPHRDQTSNKTVGEYIDYEEID
>KECLDBNJ_01240 hypothetical protein
MPNKLIFSLSLLLCAFVQQAKAQYTETLNSNRPGQSQGAFAVGRGVFQAELGATMGKESH
NLLYTETDNIGAEFQLRYGAIREQLEFNFSGTYLYEDIVPTAGAAEPYSHSGFPIITLGA
KYLLYDPYKNYEEKINLYSYHANRAFKWRTLIPAVSIYSAANYVYEDDNPFLPSSQAGFT
PKVVAITQHNWGRWVWVNNFIYDQFLTDFPTKAWITTMTHSFNSKIAAFAEFQVIISDIY
ADDLFRFGGAYLITKDLQVDVSALINFKETPKRQQLGLGLSYRLDFHSHDELLPQK
>KECLDBNJ_01241 hypothetical protein
MKTKQELTKFVKFPFSLYDKNSNWVPPLVNDELESMDPEKNPVFKNAEARFFLAYKNNKP
VGRIAAIINHIEINEQGKPKMRFGWFDAIDDLEVTKALIAQVEEIGRANNLNWIEGPVGF
SNMEKAGMLIEGFEYLNTMITWYNYPYYKEHFEKLNFEKASEWVEYKIQIPEKSPEKVEK
FARIIVERYNLKLIHFKNSKEILPYVDDMFGLLNKTYNDLSTFVPIQQYQIDHYKDKYIK
YINPHYIKCIENAEGKLIAFAITMPSFSKALKKANGSLWPFGFIHLLRARNNNDTAAFYL
IGIDPEYQGKGVTAAIFQTMQDLFTANGITEVETNPELEENKAIQQLWKKYDHQLHKRRR
TYKRDL
>KECLDBNJ_01242 26 kDa periplasmic immunogenic protein
MKSILILAITAMSTMASAQAIQPTVNVTGEGEVVAVPDEVTIRMGVQTEGKDAKTVKAEN
DTSVDKVLDYLLKMNIPQNQVQTEYVNLNKNYDYNTKTYNYRASQTISVKLKDLSNYDKI
MAGLLSSGINTINGVEFSSSKMEAYEAEARKKAIANAKTKAQEYAQVLGQGIGKAITIAE
LGTSVPQPQPMYKMAMAESADSTQRTLAPGELTITSKIQVSFILTE
>KECLDBNJ_01243 Rhomboid protease GluP
MGDLSIITAIVIGVNVLISIKGFNDYSFFEKYKFNTGAVRRGEQIRVLSSGFLHVSTSHL
FFNMLTLYFFAPIVISFLGNWEFVVIYLGSLILGNLLSYYFHKDEYHYTAVGASGAVSGI
LYAAILLYPDMSLYMFFIPVPIPAYIFGIGYLLYSIYGMRANNDNIGHDAHFGGAVGGYV
ITLLMVPALFQVNTLMVGLLAIPIVILFILNKTGRL
>KECLDBNJ_01244 Lipid A biosynthesis lauroyltransferase
MQRLLYWLVYPLLWIISKLPFWLFYKVSDVIFFILYYLVGYRKKTVRFNLKTAFPEKSDV
ERKSIEKKFYRHMCDMFLEMIKSISISAEELKERFQFDDLSIVEKLVKEQRSSLIMMGHY
ASYEWLTALQFYFDHSGYGIYKRIKNPYFDKLIHEIREKWNSKLLANKEATFIIRKQQRA
GKMATYAFIADQSPKTRKHYHCIDFLGKNVPFFTGVERLAKSEDMPVIYLAVDKIKRGYY
KASFKVITEDPTALPDYQITDEFAALLEAQIKANPEYYLWTHKRFKHAL
>KECLDBNJ_01245 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKPEENLTPIDAVKFAAAYGTYIKKQRNKDMHKVVVGRDARLSGE
MLQQLVMQTLVGLGIDVVDLDLSTTPTVELAVQLEHADGGIILTASHNPKQWNALKLLDK
NGEFLNAEAGAEILKLAEESSVTFAEVDALGAIHKNDAYIDIHIDEVLDLDLVDEDAIKA
ANFKIVVDGVNSTGGIAIPMLLERLGVYVEKLYCEPTGNFPHNPEPLKEHLTDICKLVPE
ENADLGIVVDPDVDRLAFIDETGEMFGEEYTLVACADYVLSENPGDTVSNLSSSRALRDI
TQKHGGTYHAAAVGEVNVVTKMKEVNAVIGGEGNGGIIYPESHYGRDALVGVALFLTHLA
KKKIKVSELRASYPAYFMSKKKIELTPTLDVDAILKEIAQRYQNEDVNTIDGVKIDFENH
WVHLRKSNTEPIIRIYTEAQTQTEADQVADTMISEIKSIAGI
>KECLDBNJ_01246 Acyl carrier protein phosphodiesterase
MNFLAHIYLSGNDTLIKLGNFMADGIKGKQYKNYRPQLQKGILLHRSIDSFTDSHPIVKQ
STKRLHPKYSHYSGVIVDILYDHFLTKNWKKYNKIPLPQYVEDFYDLLDEHYDILTPSIQ
RMVPHMIADNWLLSYAEISGIATVLYNMNRRTKNISGMDRAVEDLQLHYHDFENEFTLFF
EELRAFCSNRIKELDIQFRLKNT
>KECLDBNJ_01247 Gamma-glutamyltranspeptidase
MQQKNALKPPFCSQFLVLSLFLILAACKTETPEPRSIERGKIADSIMVVSAREEASRIGA
EILQKGGNAFDALIAVDMALNVAYPFAGSLGGGGFMVYRKADGEVGSIDYREKAPMAATH
DMYLDNEGNAIDSLSRQGPLAVGVPGSIAGMFAIHEKLGSMPMAEILQPVIELAEKGYQI
TDNQLARFQNYASVFDQVNGKETLYSIGFRESDSIKIKAGDLIKNPQLASTLKRIAANGK
QEFYEGETAQKLVDFIQKHGGIISLDDLKNYEAVWREPIISNYKNLRVIGMPPPSSGGVC
LAEILKMIEPYDLKSFGHNSAKSIQVITEAERRAYADRSFFLGDPDFNEIPIDSLTSEAY
AARRMQSFDFDKATPSAEVKHGAISGYESMETTHFSLIDQYGNAVALTTTLNGAYGSKLY
ADELGFFLNNEMDDFSVKPGVPNMFGLIGAEANKIEPQKRMLSSMTPTIVEKEGQLWMTV
GTPGGSTIITSVLQTILNVAVFDYGMQEAVDAPRFHHQWLPDVVTFEPDAFGKDLLDTLS
NKGYEIRQENSVILGKVDGVLVLPDGKLEGGADRRGDDTAVGF
>KECLDBNJ_01248 hypothetical protein
MKAVLTGDIVNSRAFMGWQDALIEVLNRYGSSPKTWEIFRGDSFQLIVDAALALEAAIHI
KSVIKSNAALDVRIAIGLGECSYDADQITLANGSAFIHSGTAFDAIKNRTLVLQSANEQL
DETLNLMLSLASLTMDQWPPVTAQIVKARLEEPQLNQTELSQKLDKAQSAISKALSRAGY
DEIHSMLQYYTKKIETL
>KECLDBNJ_01249 hypothetical protein
MIVFALKLVLAHILGDFVLQPSKWVKHKMKHGWKSKYLLAHVGVHLIVLLILLQFDPAYF
LGITTIILTHYAIDALKIKFTTKKNSRKLFVADQIAHLMVLNLVLYYYTPYSIDFTEILS
PQSLLLITLLFFVTYVAGILMRVALQPWQDAIEPASKKENVKSTSLAGAGKIIGILERLF
VFTFILLNTWSAIGFLITAKSVFRFGDLTEGKNRRLTEYVLIGTLLSFGIAIGCGLLFRY
LSALDTFNA
>KECLDBNJ_01250 Macrolide export ATP-binding/permease protein MacB
MSGMKSSLRLGWLRKMAWRDFKASAGKLSLFMVSIILGVAAIVSIQSFGETLKDNIALQS
KALMGADFKIDSDHPLTEEAQAIVDSLGGADAEEISFSSMALFPKNQATKLLQVRGISNG
FPFYGKLETQPESAAEDFQEKQGALLDATVMLQLNVKVGDTIKIGEVKLPVLGAVEALPG
SNAVFSAIAPPVVIPYPFIEKTGLVQLGSRIDYEFYFEAPDQDMELLDQAIDNRLDEADA
DLDTHTSTSERLGRRYENFGKFLNLVGFIALLLGCVGIASATTIYIKDKLKSVAILKCLG
ASRKQAFLIYLIQIGVLGLVGGILGTIAGLLLQQLFPILLEGLLPVDVALKLSWPVIFLG
IFIGAFMSLLFALYPLLSTLQVSPLQTLRVSASDNQQSSKTAIAVSLAILTFVFLFAFWL
LEDWKYAASFLGGILVVFSILGGIARAFKRLLRKYFPESWSFTSRQSLRNLFRPQNQTVV
LILAIGVGSFLISTLYFTKDILLAQANLDSEANQANMILLDVQKDQMTEVAQTLSSNELP
PLDQIPIVTMRVQSINGRDNANLKKDTTVHINRWILNHEFRTTYRDSLIASEVLQAGTFT
GTFTEEAEVVPISVSDNFAEDAKVGIGDRVTFNVQGRLLETEIGSIRTVDWSRMQLNFSI
VFPAGVLERAPQFGVITTQVPDAKASAAIQQKLVKAFPNISILDLRQVLSVVEELLTKIS
YIINFMAFFSILIGIIVLLGAVRTSKFQRIRESVLLRTMGAKSKQILRIQGLEYLYLGLL
GTLSGILLSLLGSLLLAYFAFDTAFIPSAIPFLVLLPGITALVLAIGLSNSRSVIKRSPL
EVLRKEGV
>KECLDBNJ_01251 Lipoprotein-releasing system ATP-binding protein LolD
MASILEISNLAKCYTSGSKTLKVLDDINFSITEKETFSIVGPSGSGKTTLLGLCAGLDKP
DSGTVTLNGVELSSLTEDERALLRNKDVGFVFQDFQLLPTLTALENVAVPLELQGVKHAM
KRAAELLTKVGLGDRGNHYASQLSGGEQQRVALARAFANDPKILFADEPTGNLDAETGET
VVDLLFELNKELGTTLVLVTHDMELAQKTQNILTIKGGRIANLTKASV
>KECLDBNJ_01252 Esterase TesA
MKNIIPFYLLFVFLILAACKDANTTNVEENESQNTSETTDAEDQNATSNSILFFGDSLTA
GYGLEDPDNAFPGLIQEKLDSLGLDYNVINAGLSGETTAGGRNRLEWVLEPDVAIFVLEL
GANDGLRGVSVAETRENLQWMIDKVKAEAPQAKIVLAGMQLPPNLGTEYTTDFKNMFPQL
AEENNIAFIPFLLQNVGGIASLNQNDGIHPTEEGHKLVAANVWPVLRPLVQE
>KECLDBNJ_01253 hypothetical protein
MAQKETNLEQLYDYLNDEEDARSCKAIDEESCRETPKNYFLILISNMLTSLGDTLSNPKT
VLTWIMSYVNAPVMLISFIVPIRESGSMLPQLFIAHYIRKRAVRKYIWVLGSFLQFLAIA
GIGLIALSFEGTIAGWLIIGCLIAFSLARGLCSIAFKDVLGKTIPKKKRGKLKGYTSSVS
GILVLAAGLFILYRSKDDVGIEFYSYLIFFASALWLIAALIYANIKEFPGATEGGKNGLK
EAWNRLSLLKEDKPFRNFIITRSLLLCSALTAPYYILLAQRYVGKEAYLLGLFIIANGVA
SIISAPVWGKMADKSSKKVMTYAAMLTAGLGLIVVGLIQYVPGLRDQVWLYPVALFVLGI
AHQGVRLGRKTYIVDMAEGNRRTDYVAVSNTLIGIILLITGGLSALASLISVEVVIVLLS
VLGIIGAFKGSTLPDVE
>KECLDBNJ_01254 hypothetical protein
MAQNKSSKKAAPAKQATKPAAVKPVKTASKKK
>KECLDBNJ_01255 hypothetical protein
MSNPSKIEAYFETEHPFKDAILTLRTIVKQTELVETFKWSAPVYTIDGKNVAGIGKFKHH
FGVWFFNGSLIKDKYGRLHNAQEGKTKALRQLRYTDASEIKEDELLYYLNEAISNQKKGL
EVKAAKPVKKVVLPTELTQAFSENQNLEKAFKALTPGRQKEYAEHIASAKQEKTRRSRLE
KATPLILDGKGLHDKYKNC
>KECLDBNJ_01256 hypothetical protein
MSANKTQPTDASVLDYINAVQHEQRKKDALALYSIFNELLPEPAVLWGDSLIGYGTYHYK
YDSGREGDFFLTGFSPRKQNLSIYIMPGFKRYSELLEQLGKHKTGASCLYINKLADIDLE
ILKKLITESVAYMREKYKA
>KECLDBNJ_01257 Carboxylesterase NlhH
MRLSLSILVASIILVSCGSVKKENVEYLDTAYKASAEAPELNIFQPKDSLVAHDVLIFVH
GGNWNSGNKNTYSVLGRNFAGKDYLTVIPGYTLSPYANYDQMTQEIAKAIKWTHDNAQAY
GGDPNRIFLMGHSAGGHLAALAAMNPNYLENTDYIKGIILDDAAGLDMYSYLQENPPGED
EYYNVTWTTNPDEWKNASPYYFLDENTPPILTLLGTKTIPSLYYYNDLFHKKLLEFQPEA
QLLIMNKNHTAMVTQFFNPLSKYFKEIQNFTSSIE
>KECLDBNJ_01258 NADH dehydrogenase-like protein
MNIPETNQPRIVIIGGGFGGMNLIKKLKKTDYQVVLLDKRNFHTFQPLLYQVSTSGLEPE
SIAYPLRKIIRKQKNMHFRLAEVHRIDTQLQKVRTDIGDLHYDHLVIATGTRTNFFGNKT
IEENAIWMKSLPQALNIRSLMFENLEKANRTEDPVKRKELLRFVIAGAGPTGVELSGAFA
ELRSNVLQADYPDMDTSEIEIHLIEGADRVLPPFSKQSSEKAQKFLEEMGVTIHLETFVG
NYENNRVTTKGDLVLDTATFIWSAGVTGASIEGFEETALLPKLNRYKVDRYNRVAGFQNI
YAIGDIALMETEDFPKGHPQLAQPAIQQGKNLAKNFKKMLRKEELEPFKYFDKGSMATIG
RNKAVVDMGKIHFGGFLAWFIWMFIHLWFLVGFRNRVVTFFNWTYSYLNYDKAARLIVRP
FKQNKIIAEED
>KECLDBNJ_01259 ECF RNA polymerase sigma-E factor
MDPQLEKQFVTQLEANQNIVHKICRLYTHDQESHNDLFQEITIQLFKAYPKFRGDSKFTT
WMYRVALNTAITLYRKSKRRIKTQDYDNVMFKIASTDYDDTIEEQLKLMYSAIRQLNDID
KALVFLYLEDKPYSEISETLGISEVNARVKMNRVKGKLKDLLNV
>KECLDBNJ_01260 hypothetical protein
MDELDFLKKDWKRQEADLPKVSVDTIYKMIHKRSSSLMKWILYVSIFEFVLWTILNITTV
NAETLETLRQIHLYEFEIVGIVLQYAVLGIFIYLFYKNYREVQTTDNTKHLMSRILKVRR
TVNFYVAYNLIIFFIIGMVVFIAMLNFDPKFNDVMIQAEDGTQSMPLGFIAVFIVMLLVL
VALLWAFYKLLYGILLRRLKRNYKELSKLEMRD
>KECLDBNJ_01261 hypothetical protein
MPKVLLVLFIAVLLNAFTVKAQEYTSASIKQTIQDFKKDPRGPYLRIRWFCEDGTMREPK
DPCPEGVDGIQHASYKPLTENLAERNHLFFGEILAAADKNKFWDEAQEQSRLKQYQLNKY
LQSVDNGWILEKAQFYRGAIQSEDEEAWGIEFYEWLLKDDARLDKNYYVIRQSLKDIPHS
GDDNIAQRMRSESKVIAEEFPKFMDVRVKIHGQPEVSDLALVQNFRQEYSDELTPELKEQ
FDALVATLNEYYAPINLERLKNQVASIKGDFDVKQQLLKFTTDFDNNTPAYDIIPEISDL
LCNIRTQVTQVKKASERLTLLDVSLKLEEMLLKKAADWEPEDLRDLLDKNYYLSYATAGT
GLLEVWEWEEVASVIAPINYTTVSLAELNSILNTSRSIVQWSAAMAKANYDAVVEKYAEF
EPLAMGFIDDRVRSSVALPLGKTVSELGDFISNKSNLENDVMQIDEQSAIHGLNPGYALG
ELVVVSGNPDAVEVSNKKIYIFKRPPSDLKPVAGIATVDEGNLVSHVQLLARNLGIPNAA
LSDKNLEDLQEFNGEEVFYAVSNKGTVILKPADEMTSEEKALFSSEERKQTKIAVPIEKI
QLDQKSILNMRDIDASASGILSGPKAANLGQLKKMFPDHVVEGLVIPFGIFRDHMNLPMP
GQGKSYWEFLTEMFETAEAKRQAGTPDAQVVDYQLAKLATLRDAINAMQLKPAFVSELRN
SFASIFGKPIGQAPVFLRSDTNMEDLKEFTGAGLNLTLFNVVEEQKILDGIKKVWASPYT
ERSFKWRQVYLSNPENVFPSILVIPSVDVDYSGVMITKGINEGTDEDLTVAFSRGAGGAV
DGQAAETRLVTANTTKLLAPARQPDYIRLPVSGGTKGYSTSFEASILNEKNIQSLREVAD
EIRSKIPEETNSDPKAAYDVELGFQDDKLWLFQIRPFVENKNALSNGYLDSISPKTNPDE
YIEMDSKL
>KECLDBNJ_01262 hypothetical protein
MKKVLICIPVILLTLAFAVPDSFYPIDGYERTGIDRLAQLEKIVRDSIAYNRIPAGAYLS
VEDIKLRLTAKQDSAIAYMTEDAEFQKKIGGLFYGLDQSYSISVLDMTDSTNLKYAARNE
TRGYQPGSVGKLAILIAMFDQLEKLCPDDWGARVNLLKYKRVKGGPFAVYDHHTIPVYDI
EQDKLTRRTAREDDVFSLYEWIDHMVAVSNNGAASVVYREALLLKVFGEKYFDLTDEEAM
QWFKDTDRGEVTRLANEVVNEPLRAMGITEDEWRLGGFFTNGGERYVGRMGGSIGSPKGL
MKFLINLEQGKAVDSLSSLEMKRIMYQTERRIRYAYSHELDSAAVYFKSGSFYKCDKSKG
ACGDYAGNVFNYMNSVIIVEHPDDGPKYIVCLMTNVLRKNSATDHMYLASRIDKVLQEVN
QPKASATGQ
>KECLDBNJ_01263 hypothetical protein
MKTIQYKKEIQAPATKVYRTMLGLDNIKTYEKWTAAFDPTSTYEGSWEKGSKIYFVGTDK
EGNRGGMISEIVENIPNEFISIRHYGILKGTQEITEGPEVASWAGNLENYSFKEHQGITT
VTVTSEVPEDYLDYFNTTWSKALDKLIELSEA
>KECLDBNJ_01264 hypothetical protein
MKYTTTQSVFRIILGTLMAIAGVGHLTFQRQEFQAQVPRWLPDSAAFMDFVVLASGVTEI
LLGLAMIFITKHRIKVGLILALFYVLIFPGNISQYTNGIDAFGLDTDQKRLIRLFFQPVL
ILWALWSTGALTYLKNKFKK
>KECLDBNJ_01265 Hydroperoxy fatty acid reductase gpx1
MNFYDLEAKTLQGETISMNSFKGKTVLVVNTASKCGLTPQYEGLEALYEKYKDNGLEILG
FPCNQFGNQEPGGADAIEEFCQVNYGVHFKMFDKIEVNGSNTHPVFKYLKKQLGGTLGSR
IKWNFTKFLIDKNGQPVKRFSPLTKPEHLTKDIEKIL
>KECLDBNJ_01266 Organic hydroperoxide resistance transcriptional regulator
MNQETPQLHLENQLCFPLYAASRLMTKMYAPLLKELDVTYPQYLVLLVLWQNGEQTVNAI
GSCLLLESNTLTPLLKRLEQKELLVRSRAQHDERVVLVKLTPSGQALKEKAVSIPQQIAN
LFSDVDLKEEDYATFEKTLAQLVLVLKERSQEV
>KECLDBNJ_01267 hypothetical protein
MQLYVFLIITILLIVKPTVNALFLKGLGADSLAFGYLLIAATAIVTSYFYNQAVRRYSLR
RIMVSSLVFFALAFVFLAVLYKLNAIGAIALYIFYVISGIFAVLTTSQFWLLANMVFNAR
EAKRLFGFIGSGAIAGGIFGGYLTTILVPYIGNGNMLLIAALFIISCIPLLSLIYKKGYV
SRASISESSNHSLGDSAYKLLLKSRHLTYLALIIGLGVIVAKLVDFQFSDFAARSIPDAD
QLASFFGFWFSTFNLVSLGIQLFLTNRVVEKLGVNSSLLILPLGIALGSLLFLTFPELWV
LIIIKGIDGSFKQSVNKAATELAMVPVSLEIKNRTKSFIDVVVDSVATGIAGCLLIFVIK
GLSLPSNYVTVIIIFLILVWIVGIFRVRDSYFKSFRQSLKEAVEVTEGVPRRKRKSPLEL
GKRILSNGNPLQIVEYLNHLNKRNAKILKQKIIPLLNHVDDAVKIAAINQLYHYPEGTAL
EAVRDMVHLKDDEVVYAAMNYLILHTSLNDSRIFDSYLNHSSDYIAHAALLCLAKEARNN
QQIASRYNLELRIELWLAELELPDSDHRPEELSFLLESIGYAQMPQFYSFISANFNNRNP
HIVSHAIIAAGISRAPQFIDALIDFLTVKQYRKDAIAALIAYGESISEILLAREAEKLLK
NNAKKYIPAVIQTFETQASVRVLLRLLQSRDNLIRRASAKSLHKLKGKNPKLNYFPKTVF
RLLLQYTFEYRDIVSSRKVIKSNFNAKAYDRLPEDDQTELLQAREGLLEVLDRQLSLRIE
TIFQLLAVYYSRKDLDVAYKGFVSTDRDTRANAIEFLDNILSPKLKHSLLPLLELAIIED
VDVYQEILEDDISFNKALIKLIEVGDGNLRLPVIYLIQFLGDTSFLPLLAELKITAKNRD
VRSFASLALKKLQPALLDTTTGTSLGS
>KECLDBNJ_01268 hypothetical protein
MRKLSFALVLLVVAMTSKITAQELPFKDCIDAPLEDFNSSVLTTQLYNQIAKDPTMKRLV
DQKKMAVGIVSLDDPNAIQYAGLNGEEMMYAASLPKIAILLSAMDAIEKGELKETAEVKK
DMWLMISKSNNQASTRMIDRLGYDKISSVLTSDRYKLYDQSKGGGLWVGKRYAAAGERRP
DPMKGLSHAATAEQVCRFYYKLVTGKLVSPERSKAMLDIMENPSLHHKFVNTLERIAPNA
RLFRKSGSWKQYHSDSILVWGEDGRKYIMVALIEDPNGEQIIRNLVFPVEKALQKSRTLL
ASATKGAGNLGD
>KECLDBNJ_01269 hypothetical protein
MGLFKTNPFGHYDFIKKWLIRVAGVMSHRRYRGFNALQIDGSEIIKDLPDTNVLFVSNHQ
TYFADVVAMFHVFNASLSGRVDSIKNVGYLWQPKLNIYYVAASETMRSGLLPRIMAYAGA
VSVSRTWRSKGKEIDRPVNLSDTENIGIALHDGWVITFPQGTTKPWKPIRKGTAHIIKQY
KPVVVPIVIDGFRRSFDKKGIRIKKRGILQTMEIKKPLDIDYENDSVEDIVEMIEYAIEQ
HPSFLKVIPQEELEKEEQLNQTRRWDY
>KECLDBNJ_01270 putative Nudix hydrolase NudL
MQFDEFLKQVPKLSNLELLGQEAQFLMAPDERIRALSEMDIEAKKPRWAGVMAVFYPNTK
GETTLVLILRKTYKGVHSNQVGFPGGKAETCDESIKHTALRETEEEVGLPQNEINVVKKL
TKLYIPPSNFWVQPFIGYVEQTPVFTKEDAEVEAILEVPLEEFLADKSVITQRIDTSYGT
MLDVPAFYLSEHVVWGATAMMLSEVKWAFQQIDRL
>KECLDBNJ_01271 Peptidyl-prolyl cis-trans isomerase A
MRTSLYFLLSLILLTGAGCEDKKTKEKAEETQQTETVLDSTPEQKAQAENERLKKKPGSI
IESQAELIPFLTEYGKKNKETRARISTKFGDIDIQLYRDTPLHRANFVLLVKQGYFDETM
IHRNALDFVVQGGNSDGYETPKKRQRIGNYLIPNEASANHTHVRGAFSAAKYLEQNISDA
SSPFEWFIVVPERGAHHLDGEHTVFGRVTQGMDVVDEINKLKTDDNEWPIENVYLKVELL
D
>KECLDBNJ_01272 hypothetical protein
MGKKLPHLNQQLQEFIDAQKIFFVGTAAAEGRVNISPKGMNTFYILNEQEVLWLNLTGSG
NETAAHLLEDTRMTIMFCSFEKNPLILRLFGEAEVYHERDDQFAAYMKYFEETAGSRQIF
KLKIDLVQTSCGFGVPFMDYKGERETLKVWAEQKGESGIKEYWTEKNQTSLDGLETGIFK
D
>KECLDBNJ_01273 hypothetical protein
MENIASIIDILGTIAFAISGVITATKKRMDLFGILIIATVTSVGGGTLRDLLIGKSPVSW
LLDSTFVYIIVATTIVGIIFRKQLRYVRRSLFLFDTIGIALYTVTGVEIALLINLDPVIC
VALGTITACFGGVIRDILCNEIPVIFRKEIYASACIAGGTLYVIMHHYGIAAGVNAVVSG
LVVVVIRTLAVVYEVQLPSIYSKAER
>KECLDBNJ_01274 hypothetical protein
MDNFQIETAQNVSIQQQVAGIGDRILGYLIDLLILGAYWIASIFLLSAYGLDSNSDGSIN
IYFMIVGIPSFLYFLLLEAFWDGRTPGKAALGLRVVKIDGSKPGFGSYFVRWLMRMVDIT
LTSGGVAVFTILLNGKGQRLGDIAAGTTVITERKKVKISHTILETIADDYVPKYPQVTVF
TDADIQKVKTIYTEARLHSKHNVILKLSQKLAATMQITPEETPFNFVDRVLKDYNYYTQQ
>KECLDBNJ_01275 hypothetical protein
MREAAFVKQNKDKWIRFENVLSGNHTDLSPDELSALYLEVTDHLSYAKTFYPQSKTAQYL
NHLASQSHQKIYKTKRESSTRFITFFTQEFPLLMYKYQRQLLISFLVFTLFCVVGAYSAA
TDGAYVRSILGDAYVNMTLENIADNDPMRVYKEMNEVEMFMGITVNNIKVALMAFIFGIL
LSIGSLYLMMQNGVMLGSFQYFFYDKGLLWESVRTIWIHGTIEISVIIIAGAAGLVLGNG
ILFPGTYTRLESFKRGMKDGLKIVVSTIPFFIIAGFLEGFVTRHTEMPDWLAILIITLSL
LLILFYYVVYPRIYFKKQLQPLDERTDHI
>KECLDBNJ_01276 hypothetical protein
MKELITFKKQRELGDIITDTFKFIRLEYKPLFKALLRNAAIPFLVLIAISAYYTSATANF
SFLEGGTFGAANLFLPILALFIALFFYYGVLYGTVLNYIKLYVANQGVVDQDELKRSVKS
ELGSLTGLTFLIFIMMFFGFMLCFFPGVYIAIPLSLAWAILVFENKAVGDSISDSFKLIK
NEWWITFATMLVLGILLYIANIVLSLPVILYSLTKGFLSAETISQGDMSSMFDWVYITLS
VLSSAVQYILAGIFAIAIAFIYFNLNEKKNQTGTFETIESIGSDH
>KECLDBNJ_01277 hypothetical protein
MITKLFYILICLFSFAAFAQNTNDSTTVARQVRYDDSVVAPKYFEEQALEEYRQDDAFDY
VAFVPPDNIWTRFKTWLNDLWSSFIQWLLQGEEVSGILGFLIEALPYLIIILVVALLVWL
FMRIDLGGSPLKTNALNKVILSDEQKIIETQNIQELIDAALKENNYRLAVRFYYLLLLQK
LAQKDIIDWQAQKTNADYVYEIKNDTLRADFTKLTRIYDFIWYGNFNVSSHQFLKAETEF
KKTTADL
>KECLDBNJ_01278 hypothetical protein
MSKRYKVMAGVLIAFLAVLILAEASQPEPINWFKGYGKQDKIPFGTYVFHEQLPSVINAN
RIEEVNIPPFEFLQDSTLPAGSTYFFLNGSVYNDATESNKLLEWVGRGNTLFVSAGSISK
TILDSLWLGLNFYSETANQKKRPLVNFTNPRLKAERPFRLNKDVGTVYFDEIDTLKTTVL
GVFDLIRDNDSSQIKKPKVNFIKTPYKNGTVYLHTFPEGFTNVFMLDSTNAEYTAKALSY
LPDDGTIYLDQYYKNSKEYAVSPLRLILTNKYLKWSWYLLILVAILWVIFEGKRKQRSIP
VIQPLPNKTLDYTRTIAGMYLDKKDNRQIAMHQINHILEHIRSVYTLSTERFSQDFVEKL
TAKSGKPQSEIKTLVDYIILIRQKAVVSEDELIKLNTLVENFKNTH
>KECLDBNJ_01279 ATPase RavA
MEESYKDPENQNTPQDSTDEASENLAFQSRIPLEELRDNVAALKAELAKVIVGQHEFIEL
LIVALLSDGHVLIEGVPGIAKTVTAKLFAKTLNTNFSRIQFTPDLMPSDVLGTSVLNMKS
SDFEFKHGPIFSNIILIDEINRAPAKTQAALFEVMEERQITIDGHRYELEKPFMVLATQN
PIEQEGTYALPEAQLDRFLFKIKVNYPDLEDEIQILKSQNERTGSQAEAINSVLSPEQLQ
EYREQTRKILVEEKILNYIAQITVKSRTHPHLYLGGSPRASLSIMNAAKAFAAISGRDFV
TPEDVKRSVTPVLRHRVILSPEREMEGMTPETVIDMLVQSVEVPR
>KECLDBNJ_01280 hypothetical protein
MRIINFIKNLYLGKRLFFILAVLIVLFLFSYWWHTLFSIALLGTFFLSVAFLFDVVLLFR
NKEGINASRKLPEKFSNSDLNEVPLAIQSKFNFAIGISVIDEIPVQFQKRDFLKTGSIPS
RGKTIINYQLRPVERGVYTFGRLNIYVNSTLNLARRRFTFGKDQEVKVYPSFIQMKKYAF
LAIDNKLTQFGLKKIRRIGHTMEFEQIKEYVSGDDVRTINWKATAKRGELMINQFQDEKS
QPVYSIIDASRVMKMPFNGLTLLDYAINSSLAFSNIALKKNDKTGLLTFSNTIHNHLAAS
SKKTHLNTILEVLYSISTNFLDSDFGRLYAEVKRKITHRSLLLLYTNFEHSSAMQRQLPY
LKGLSQKHVLVVILFENTELEDLIATKAQNTPEIYHKTIAQKMHYEKKLMVKELEKNGIQ
TVLTKPEDLTVNTINKYLEIKARGIL
>KECLDBNJ_01281 Threonine--tRNA ligase
MIQVTLPDGSVKEFESGATPFDVANSISAGLARNVISAKYNNKTIETTTPLTEDGALVLF
TWNDDEGKKAFWHSSAHILAQALEELYPGVKLTIGPAIDKGFYYDVDLGEKSLSENDFKQ
IEDKMLEIARGKHEFSMRSVSKADALAMYQEQENPYKVELIENLEDGSITFCDHDTFTDL
CRGGHLPNTGFVKAVKLMSVAGAYWRGDENKPQLTRVYGISFPKQKDLKEYLELLEEAKK
RDHRKLGKELQLFTFSQKVGQGLPLWLPKGAALRERLENFLKAAQKKAGYEMVVSPHIGQ
KELYVTSGHYAKYGEDSFQPITTPAEGEEFLLKPMNCPHHCEIYNAMQWSYRDLPKRYAE
FGTVYRYEQSGELHGLTRVRGFTQDDAHIFCTPDQLDDEFMKVIDLVLYVFGSLGFENFT
AQVSLRDPENKEKYIGTDENWAKAENAIINAAKAKGLNYVVETGEAAFYGPKLDFMVKDA
LGRSWQLGTIQVDYNLPERFELTYKGSDNEEHRPVMIHRAPFGSLERFVAILLEHTGGNF
PLWLMPEQATVLTLSENYEDYAQKVLTLLENHGVRATIDDRGETMGRKIREAEMQKMPFM
LIIGEKEANDGTVSVRKHGGEDLGTMTVAKFAELIDAEISKTLKKFEV
>KECLDBNJ_01282 Translation initiation factor IF-3
MRLVGDNVEMDIYPTSKALEIAQELELDLVEISPNANPPVCKVMDYKKFVYEQKKREKAI
KAKASKVVVKEIRFGPNTDDHDYEFKKKHALKFLEEGAKLKAYVFFKGRSIIYKDQGQIL
LLRLAQDLEEYGKVEQMPKLEGKRMIMFMAPKKSK
>KECLDBNJ_01283 50S ribosomal protein L35
MPKMKTKGSAKKRFKLTGTGKIKRKHAFKSHILTKKSKKRKLALTHDTLVHKADENNVKI
MLRLK
>KECLDBNJ_01284 50S ribosomal protein L20
MPRSVNSVASRARRKKVMKQAKGYFGRRKNVYTVAKNAVEKAMLYAYRDRRQKKRNFRTL
WITRINAGARMHGMSYSQFMGKVKAANIELNRKVLADLAMNHPEAFEAIVNKVK
>KECLDBNJ_01285 hypothetical protein
MTSKVVYLGNLRTECEHVKSGSTFITDAPTDNNGKGEAFSPTDTVATALASCMLTVMGIK
AAQMEDVHLDGSTAEVTKIMKAEPRRIARVEVKLNLKGVADDKNRKILENTARTCPVLNS
LHPDMEKEIIFNWM
>KECLDBNJ_01286 Autolysin
MKNISILFVVIFVVFSCSSIGQQKYASHQVREGETVSSIANKYNVTVYEIYRLNPEAKSK
LYPGLVLILPGGESAPGGSEISADGKFILHTVAKGETLYKLSKKYDVAESEIKRYNKHLY
SAELRRGETVKIPNTTEAVAEDDSAKPAVTNRKHIVKPKETKYGLASMYGITIAELEQMN
PEIKEGLQIGTILNVPDKSYAKDAVLEESKYGFYEVKPKENFFRLTQRWDMTEDELIALN
PSLNDGLKSGMILKLPKEKLSNTALDVTGEATRLADNLTNRSTKNIAVMLPFNLGKTVVD
TGDVRKKVLKNDRVMNIALDFYSGALMAIDSAKALGISSNLYVFDTQYSRGDGKAGNDRK
IEQLINNGDFNKMNAVIGPLLTSNVEKASQLLRDRAIPVVSPIVPNVSMRSNMFQSRPDD
EILREQMLRYIKQEGKGKNIIVIADSKNTGIKSKLLDLYPSAKVVFPESSDSGYYLRASN
LTSKLSETIDNWVILESNDIALISSVTTSLSTQAASKKITLLTTDKGSAYQSDDISNITL
MRLNFHFPSVARSYTENHAGFVQAYADKYGYVPNSYAVRGYDLTFDTILRLAAAESLYDA
ADAGYITQYVENKFKYVQDPVSAGYFNTAAYILKYGENLEEIVVEIPSDQGSSSYLKN
>KECLDBNJ_01287 GMP synthase [glutamine-hydrolyzing]
MLFLFMQNNVLILDFGSQYTQLIARRIRELNIFCEIKPFNNLPDDLSSYKAVILSGSPSS
VRAEDAPHPDLSQIRGKKPLLGVCYGAQYLAHFHGGEVGQSNTREYGRANLSMIKEDEAF
FEGVEVGSQVWMSHSDTIKALPEGSVRLASTHDVENAAYRIGGEETYAIQFHPEVYHSTD
GKKILENFLINIAKVEQTWTPDSFVESTVAQLKKKVGSDKVILGLSGGVDSSVAAMLLHK
AIGKNLHCIFVNNGLLRKNEFHDVLQQYEGMGLNVKGVDASDRFLSALAGKSDPEEKRKT
IGRVFIEVFDDEAHMVEDAKWLAQGTIYPDVIESVSATGGPSATIKSHHNVGGLPDFMKL
KVVEPLRMLFKDEVRRVGASMDMNPTLLGRHPFPGPGLAIRILGDITQEKVRILQEVDAI
FINGLRDWGLYDQVWQAGAMLLPVDSVGVMGDERTYEKCVALRAVESTDGMTADWVNLPY
NFLQKVSNDIINKVKGVNRVVYDISSKPPATIEWE
>KECLDBNJ_01288 LexA repressor
MSVSKQLKSLREGASLSQKKVAEELGITQGAYSLIENGQNSITTEHLLTLSKLYSVPTDR
ILKGSHNSIMMNSTNGFVPLINVEARAGFIENRDNEQWMSTLDMFKLPGYEPSKDQKLFE
VEGDSMMPTLMHGDILITQHTDDLNEILDGSVAVIVTAKSVLTKRIKKDLPNDAIILISD
NSKYESVSYNLKNILEILVVRGKITSSLNVVDMDANKRVQHLESQVDKLQSDMSKLIEKI
NKLV
>KECLDBNJ_01289 hypothetical protein
MKKINLLLLAVLAIFASCSGDDTVARSTVTIDISGLERLENGAEYQAWISNGAEVISLGR
FTDVNFPKSFEALTGDVEGATQFLLSVEPGNDSSTEISQSILLSGDFVGNAATVDVSQNF
GSYTSASGQFVLQTPTDNVSTNENSGLYWYVPATGQPGLKLPTLPAGWKYEGWVTVPGAS
GDVDLSTGRFTNVNNADESDPFSLNINPAPDFPGEDFINENVLSAYGVNTLPNLVGKQVF
ITIQPIFDNTSSSSSISPFVLRPLVGTVTQEAGSSVTNTMQINTASFPVGRVTRD
>KECLDBNJ_01290 Aconitate hydratase A
MAFDIDMIKSVYSKVAERVDAAREITGKPLTLAEKILYSHLWDGKTDKAFVRGKDYVDFA
PDRIACQDATAQMALLQFMQAGKKEVAVPTTVHCDHLIQAKQGAQKDLKRANETSNEVFD
FLESVSNKYGIGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAIGVGGAD
AVDVMAGMPWELKFPKLIGVKLTGELNGWTASKDVILKVAGILTVKGGTGAIVEYFGPGA
KNLSATGKGTICNMGAEIGATTSTFGYDESMERFLRATDRADVADAANEIKEYLTGDDEV
YANPEQYFDEVIEINLSELRPHLNGPFTPDLATPVGELGEKAAKNDWPIKVDWGLIGSCT
NSSYEDLSRAASIAQQAIDKKLKPKSDFGINPGSEQIRYTAERDGLLEVFENLGATIFTN
ACGPCIGQWDRSDRKGEEKNTIVHSFNRNFSKRADGNPNTHAFVGSPEMVAAIAISGRLD
FDPLNDTLINEDGEEVKLDVPVGLELPTKGFAVEENGYLAPTEDGSKVEVKVATDSERLQ
LLTPFVPIKDSELKEVKLLIKAFGKCTTDHISMAGPWLRYRGHLDNISNNCLIGAVNAYN
KKTNFVKSQLTGEYGGVPDTQREYKAKGIKTIVVGDHNYGEGSSREHAAMEPRHLGVAAV
LVKSFARIHETNLKKQGMLGLTFANENDYDLIQEDDTFSFLDIEEFAPDKPLTIEVTHAD
GSKDTIKANHTYNDAQIAWYREGSALNLIKKQNA
>KECLDBNJ_01291 hypothetical protein
MSDAKAIDALVTRYQDLKKEIGRVIIGQHEVVDQIVISIFSGGHALLIGVPGLAKTLMVN
TIAQALGLDFKRIQFTPDLMPSDIVGAEILDESRNFKFLKGPVFANIVLADEINRTPPKT
QAALLEAMQEKAVTVAGKQYPLDKPYFVLATQNPIEQEGTYPLPEAQLDRFMFAINLVYP
SYEEEVAIVKATTADTQVSVKPLFTAADIVNYQQLIRRIPVADNVVEYAVALVGRTRPDS
TSAPLIVKDYIDWGAGPRASQNLILAAKTHAAIQGKYSPDIEDVKAVAQGILGHRLLKNY
KAEAEGLTLKEIIKSLL
>KECLDBNJ_01292 Chaperone SurA
MQLKTNNLNCITKAFALFLLCGMWSGLTAQEIIDTDAAGDTAQNEEKPLTSGTTFKVDGV
AAVVGEYVILESDIQQAIESLKQQKVEGQDLSTCSVMDKLMEDKLYAHHAVIDSVMINEE
QVRSYTQQQIDYFINQLGSEEKVLKFYRKEKMSDLKKELLELNRNQELAKAMQQNIVEEI
EVTPEEIRSYYKELEEDGLPQFGVELEVSKIQIIPDVPQEEKQKVIDQLNGYRTDILENG
SSFATKAVLWSEDESTRGDGGLIRDVDRKSQFVKEFRDVAFSLQEGEVSKPFETEFGYHI
IKVEKIRGQKIDLRHILRIPKVTAAAENAAKDEIEKIRKRIEDGEITFAEAAREFSDEKE
TASDGGIMINPVTQDRMFELKNLPPELYPKVQNLKEGEVSIAFNNPTRTGKTRYEIYTVS
DRIEEHEADFAIDYVKIKNFALQAKRIKAIEKWKNEKIAETYIKLNGDYRTCDYSSNWIK
Q
>KECLDBNJ_01293 hypothetical protein
MRFSILVLFAALVVSCDLLGSKAPAGVPVARVGNAYLYKEDIEKLITAELSPEDSTTLVN
GYINRWATKRLLVDNAQRNITLDEQDRLNNLVEQYKLDLFSQAYKDALVARSLDSSITDA
EASQFYTENKENFKLNESLLKLRYIEMGENDYNEDEIKKRFTRFNAKDKRFLDSISVQFR
AQYLNDSTWISLDKVIAKIPPVNVENSDQLLNKTEFLQLRDSLGLYLIAVNDRLDRNDDA
PLEYVLPTVKQILLNRRKLDLIKQLEKDITKDAIKNKQFELYN
>KECLDBNJ_01294 hypothetical protein
MEQRIKLIWDFRGPDALKIAEHHVIHLDEYKTAHDLKVNETGVEQKSELYAIAYFIVSKA
QMPAVRDALKPHRGEFCD
>KECLDBNJ_01295 hypothetical protein
MKKIFLPLVACFISFSALAQTKVGTIDSDLVISSLDEVAQVQKDLEAYNAELEKQFKDLV
TKYQTAVTAYQDAEATASEEDKQTKQEEIVGMEQDIQRFRQNSQGLISIRQNELMQPLYQ
KVGQALNQVAQEQNYSQVLTLNAGVAYFDPTHDLTQAVADKLGVTLKVQGQQDQTALPTQ
N
>KECLDBNJ_01296 Inosine-5'-monophosphate dehydrogenase
MTAHETKILGEGLTYDDVLLVPAYSEVLPREVNIQSKFSKNITLNVPIVSAAMDTVTESS
MAIAIAREGGIGVLHKNMTIEQQAVKVRRVKRAESGMIIDPVTLNKEAKVKDAKRLMAEH
SIGGIPIVDSEGHLEGIVTNRDLRFEKDNERAIVEVMTSENLITTSEGTSLAEAEVILQE
NKIEKLPVVTKDNKLIGLITFRDITKLTQKPIANKDTYGRLRVAAAVGVTADAVERVEAL
VNAGVDAVVIDTAHGHTQGVVRVLQSVKEKFPALDVVVGNIATAAAAKYLVEAGADAVKV
GIGPGSICTTRVVAGVGFPQFSAVLEVAAALKGTGIPVIADGGIRYTGDIPKAIAAGADC
VMLGSLLAGTKESPGETIIYEGRKYKTYRGMGSVEAMKTGSKDRYFQDVEDDIKKLVPEG
IVGRVPYKGELYESVHQFIGGLRAGMGYCGTKDVEALKENGRFVKITSSGIHESHPHDVT
ITKESPNYSR
>KECLDBNJ_01297 3-hydroxy-3-isohexenylglutaryl-CoA/hydroxy-methylglutaryl-CoA lyase
MSKPVKIIECPRDAMQGIKQFIPTEAKVQYLQSLLRCGFDTLDFGSFVSPKAIPQMADTA
QVLDRLDLSATATKLLAIVANLRGAQDAVQFDQIAYLGYPFSISEIFQMRNTHKTIEESV
VVLSDILETATKHNKEVVTYLSMGFGNPYGDPWDVDIVGAWTEKLAAMGVRIISLSDTVG
SSDAQTIDYLFSELIPAYPQIEFGAHLHTTPNQWFEKVNAAYKAGCRRFDGAIQGFGGCP
MAKDELTGNMPTEKMLSYFNSVKVDSGIRPMSFESAHNEASKIFHNYH
>KECLDBNJ_01298 Adaptive-response sensory-kinase SasA
MNLKFKKPLIITQTINWFVLLAIVATVNLYSQTPQIDSLKQELKKAANDTIRSDFNERIA
YEYLYYQPDSAKRYIDKALELAQLNNYQRGIAKAYNRMGTYYIVTSKYPDAILEFQKALP
LYKAKNDSLGLSESYGNLGVLEFYLRDYESSEKNFRQALDYVDSVNNRNQYIKYIVNLSG
VFREKRVLDSAVYYSKKALYLIKGGGDPRIAGVAYFNLGTARYFLGSYDEAIANLNLALQ
SSNFPVQFQCLAKSYIAQSYTAQGRLDEAASELLAIEQQVLDLKDQYVILAYYEARQKLH
EANNNTAEALAYAQKYIKLNDEIHNREQSNILQNLKIQFGIEEQQLENELLRSDAEMQAL
QIKHQRYAIIGISVLIVLLFLLLFILYRMYSYKKSANRILKKEQQVLNTSNKNLTAINHQ
KNNLFSIVAHDVKSPVAAVLSSINLLHNNYKNFTSEEIEALSEELKKQTSNLYYLIDSVL
LWAKSQMNGYKFIISEVHPHKVVSEVVEAEDVFIERKNLKIDCVIPKEDIIFTDRQVVIV
IMRNLLSNAIKFTPANGKITFSANRTAEVYELSISDTGVGMSKTDLDKVLIKKERFSVKG
TNDEAGNGIGLILCQEIAHQIGGEIVATSQPGNGSTFTLKLPIIK
>KECLDBNJ_01299 Dihydroorotate dehydrogenase (quinone)
MYKSIIRPLLFNFDPEGVHHFSFKSIKLMKQLGLTRLVKPVFNIEHKALEREVFGLKFKN
PVGLAAGFDKDAKLYQELSDFGFGFIEIGTLTPKPQPGNPKKRLFRLKEDKAIINRMGFN
NGGVAAAVSRLKKNKNVLIGGNIGKNKVTSNEEAFNDYKICFEALYDYVDYFVVNVSSPN
TPNLRALQDKEPLTKLLAGLQELNKTISQKPILLKIAPDLTDEQLNDIIEIVQDTKIAGV
IATNTTISRDGLQSSNKEEIGGLSGSPLRDRSTEVIRFLHQKSQGAFPIIGVGGIHSPQD
ALEKLEAGASLIQLYTGFIYEGPSLIKRINEEIIKQS
>KECLDBNJ_01300 Peptidase T
MIQKDLFIKRFISYVTIDTQSDENSSSTPSTQKQWDLANKLHQELLAMGLDDVSIDQNGY
IMATLPATVAKPLPTIGFIAHYDTTPDFSGTNVNPQIIENYNGKDIVLNEALDIILSPDD
FDDLLEYKGQTIITTDGTTLLGADDKAGITEIMEAVQYLKNHPEIEHGPIRIGFTPDEEI
GRGAHKFDVEKFGAEWAYTMDGSQIGELEFENFNAAGVKVFVKGKSVHPGYAKGKMINSI
HIAQDFISSLPRLETPEHTSGREGFFHLNGIHGDVEETVLEYILRDHDKEHFEARKEVLN
NLAAEINSQYGLELISIEIKDQYFNMREKIEPVMHIVELAEKAMHAVDVEPIIKPIRGGT
DGSQLSFMGLPCPNIFAGGHNFHGRFEYVPVESMIKATEVIIKIAELAAKK
>KECLDBNJ_01301 putative FKBP-type peptidyl-prolyl cis-trans isomerase
MRLTNTTTYFKLFAASIGLATLISCGTDDTNYETPITETDEEAFERNEAEILAYIEANEL
EATRTDSGLYYVIETEGTGETPSSSANVTVTYKGYFLNDSVFDQAVNPIEFNLANVIAGF
REGISLMKEGGTATLLMPAKLAYGASGAGPIPPNTALVFDIELIATE
>KECLDBNJ_01302 Ornithine aminotransferase 2
MTTVDQLTSQEAIALEDKHGAHNYHPLPVVLKRGEGVYVWDVEDKKYYDFLSAYSAVNQG
HCHPAIVGAMTKQAEVLTLTSRAFHNDVLGRYEKYATEYFGFDKLLPMNTGAEAVETAIK
IARKWAYEEKGVPEQDAQIIVCENNFHGRTTTIISFSNDEDARKNFGPYTPGFIKIAYND
ADALERALIENKNVAGFLVEPIQGEAGVFVPDEGYLAKCKALCEEHNVLFIADEVQTGIA
RTGQLLAVNHENVNPDILILGKALSGGAYPVSAVLANDPVMNVIKPGQHGSTFGGNPVAG
AVAMAALQVIQDENLAENAEALGKLFRAKLNEYIETSTIVSLVRGKGLLNAIVINDSEDS
STAWDICMALKENGLLAKPTHGNIIRFAPPLVMNEEQLLDCVSIITKTLKAFEK
>KECLDBNJ_01303 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MLVTDAGAKGKSIAKAPDGRVIFISNAVPGDVVDIQTMKQRKAYYEGKAIKIHEYSPKRT
EPVCKHFGTCGGCKWQNMHYDYQLEYKQREVVNNLQRLGKIDLPDITPISGSKDIYFYRN
KMEFSFSDSKWLTLKQIQSDEIIEDRNALGFHIPGMWDKILDIDKCHLQRDPSNAIRNGV
KEFATKNNIPFFNARNQEGLLRTLMIRTSSTGELMVLVQFFEDAEAQRKLVLEYLKETFP
EITSLLYVINEKGNDTIYDQNVICYAGRDHIFEEMEGLKFKINAKSFYQTNSEQAYELYK
ITRDFAELKGDETVFDLYTGTGTIAQFVAKKAKKVIGVEAVPDAIIAAKENAQLNEIENV
EFYVGDMKNVFNDAFIAQHGQPDVVITDPPRDGMHKDVVAQLIKIKADRIVYVSCNSATQ
ARDLALLDPYYKVERVQPVDMFPQTHHVENVVLLKLK
>KECLDBNJ_01304 hypothetical protein
MLKNGILLVFIIALIAISCERDDICAASTPTTPVLTIGFQDADNTTEDKELNITIYKVDN
SDSLAYTSASTVEIPLRTDTTATVLVFVKNPNNLVAAEDPNNADTVTFKYTPQEEFISRA
CGYRVSFSNLTIQNNPGSDGRWIDDIIINTRTITNNDTTQVYIRH
>KECLDBNJ_01305 hypothetical protein
MTGFSLSAQDKQGITQESITDSTAVDSLASKPKTNKYGLRVGIDLSKPLRTILDDRYQGF
AILGDFRIKDRYYVAAELGTETRDFNEPTYDAQVQGSYLKGGINYNAYSNWEGMSNLIYV
GLHVGFSTFNQDLNNYTIYTTNTFFEPDVRTDPRNYSNLNLIWAELQMGIQVELFNNLYM
GLNVQLKRILSQKSPDNFTNLYAPGYNKVTFDNVYGAGYGYTISYLIPIFKK
>KECLDBNJ_01306 hypothetical protein
MGLRSRIRIINTFIKNPDDTPYAISVWEKVKFLVSGIIYDFGFAFLFLILMSLIEPLTKG
YENVLNQELYSFWMSILLITIVPPILEEFVFRFPLKYKRNYLLRLIAYLFKLDIETFWKK
HLRIIVYIFSAAFGFVHMSNYSNVDLWFFILSPILVGAQLFAGIIFSFFRLKLGFIWAIL
GHFSHNFILIMMAFLFYHNVMIPLVDDDAVKIEAAGLAFEVEETSILHFDTTQQGNLLCL
EAQNYSLQKLVDSLYTSDTLKLRDNELINLHLLSKQDSGYTKLKFLETLQEHYVFKKVVD
STRNQK
>KECLDBNJ_01307 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MIKEISSTQNPTIKHLVALQEKSRIRRKTGEFLIEGVREINLAFDAGFELTQIFFCPEIA
QTEALEELQTKISSTTEQIVVTEEVYKKIAYRSGTEGIIASAKAKKNALNDLDLPENPLI
LIAEAPEKPGNIGALLRTADAAGVDAFILANPRTDLYNPNIIRSSVGGLFTIPVATGSTE
EVINFLKHQNISIYTAILQEAISYEKQDFTTSSALVVGTEADGLSEEWRNAAKQNIIIPM
QGRLDSMNVSVAAAILIFEARRQRGFTL
>KECLDBNJ_01308 Protease HtpX 
MTPTLVFYIIIAFIILSFVIDQMLDWLNAKHFDDPIPQELADVYDSETYRKSQDYKKVNA
KFSTLTSSFMLVITLLFFALDGFAFVDQIARSISDNEITVGLIFFGIIMLGSDILTTPFS
YYKTFIIEERFGFNKSTPKLFLADKLKGWLMTIIVGGGLLALVIWFYQISGSLFWVYAWI
VFAVFALVMNMFYAKLIVPLFNKQTPLEEGSLRNKIEQYAATVGFKLNNIFVIDGSKRST
KANAYFSGFGSEKRITLYDTLINDLEEDEIVAVLAHEVGHYKKNHIIVNLFASVILTGFT
LWLLGIFISNSIFSEALGVAEPSFHIGLIAFGILYSPISGITGFLMSVLSRKFEYQADNF
AKNTYAGDPLISSLKKLSRNSLSNLTPHPLYVKLHYSHPTLLQRYRNLKG
>KECLDBNJ_01309 GTP pyrophosphokinase
MTPVDIEKENKELARQYKELLRISYRTLSDDDKKLIRQAFDVAVDAHKDQRRKSGEAYIF
HPLAVARIVASEIGMDATSIAAALLHDVVEDTIYTLEDLEERFGPTVARIVDGLTKISNL
KKHRDVSLQAENFRKMLLTINDDVRVIIIKIADRLHNMQTMDSMRPDKQIKIASETLYIY
APLAHRIGLYNIKTELEDLGLKYTEPEVFKDISRKMKETKEQQDQYIEEFTQAVQNSLDK
EILDYEIKGRPKSIYSIRRKMLKQNIPFDEVYDKFAIRIIYKATPESEKFLAWKIYSIVT
DHFRPNPTRLRDWISSPKSTGYEALHITVMGLKGRWVEVQIRSERMNEIAEKGYAAHYKY
KQGSSTESEEDKTLDEWLNRLQDALENNETNAVEFVEQFKLNLYNKEIFVFTPQGDLKSL
PKAATPLDFAFSIHTEIGMHTRGARVNGKLVPLSHELKSGDQVEIITSEHAKPNNNWLDY
ATTARARSKIKSSLKDEKKTIAEDGKVILTRKLRSQKITLDENIINEMVIYFKLKTSLDL
FYRVGIGTIDNKMIKEYAASRSSAIVSFFKNKIRKAPVAEHVDKDEITDKYDLLVFGKDE
QKLDYTLAACCNPIPGDKVFGFTTVSDGIKVHKQNCPNSISLQSNYAYRIIPAKWIDSSA
QEFRADLELTGIDTLGLVNHVTREISEHMHVNMRGLNFTTNDGVFKGNITVIVQNKKHLH
RLIENLKKINGIDKVIRL
>KECLDBNJ_01310 Ferric uptake regulation protein
MRNFANIIMIPKATINKDQEVVKNVFTKFLEDNGHRKTPERYAILQEIYNYNDHFDIETL
YISMKNKKYRVSRATLYNTIELLLACGLVRKHQFGQNQSQYEKSYFDKQHDHVILTDTGE
VIEFCDPRIESIKKTIEEVFDIKINKHSLYFYGNRKQDNSTENTTEDNNS
>KECLDBNJ_01311 Adenylosuccinate synthetase
MAVDLLLGLQWGDEGKGKIVDVLTKDYDIIARFQGGPNAGHTLEFDGIKHVLHTIPSGIF
HENAINLVGNGVVIDPVIFKKELDNLAQFKINVKEKLLISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGIRVGDLELADWKERYAALRDKHIDMIDFYDAKIEY
DLEELEAEFFKAVEVLKELTFIDSEEYLYQAQQAGKSILAEGAQGSLLDIDFGTYPFVTS
SNTTAAGACTGLGVAPNQIGDVFGIFKAYTTRVGSGPFPTELFDEVGETMGRVGNEFGAT
TGRPRRCGWLDLVALKYAVRVNGVTQLMMMKGDVLSGFDTLKICTQYKYKGEVIDHLPYN
IEPENVEPVYSEMQGWEEDLTKMKGDEQLPKELNAYIEFLEKELNVPIKIVSVGPDRTQT
IHR
>KECLDBNJ_01312 hypothetical protein
MKLFQCSNCKNPVYFENTTCEKCGNNLGYLNAIEGIVSFPADQKTVITPTKEKTALTYCA
NRQYNACNWLVATESPTPFCEACSTNRTIPDLSIPENKLDWQKIETAKHRLFYALHKLKL
PTKFIINKQPLNLTFDFLAPDPSNPSAIKTGHANGLITLNIQEANAAHREYIKEQLSERY
RTLLGHFRHEVGHFYWEVLIQPNAKNLEEFRALFGDDTQDYGQALEAHYKNGAPENWRES
YISSYATMHAWEDWAETWAHYLHLMDMLETSYSFGLSLDPEISKVRNLEVACDFDPYEEK
DFQKIIKHYLPLTYALNSLNRSMGHQDAYPFVLSPPVIEKLTFIHKVVRL
>KECLDBNJ_01313 hypothetical protein
MFEVELTARLKNYTETRAQILALAIDSHYKLDYDDRYYDINGTLTQGDQEFRLRTKNNLD
SGEAKHYLTFKDKAFEQVTRSKPEYETLVSDHYNTEQILFKLGYQKSAHYAKHCEIFNLK
YRNASIEIALVQFDELADAFIEIETNTLDKAETDTLFEKLYMLLEEIGLSKDQLTKEFYI
DMIKAVQSK
>KECLDBNJ_01314 LPS-assembly protein LptD
MPNFFRKSVLLLLILFSISLSAQEKKELDITSDISQIDEVKYPGALVMYKNTKQVYIQHE
GIEMWCDLAFHYKDENFVRAIGNVRMKQGDTISMRSNYAEYNGDTQFAWASGGVNLRTPT
ATLDTDTLYFNRIKQQAYYRTGGTLRDTASVIESKIGRYFLDQDKYSFIQNVVVTNPEYV
INSDQLDFYSETGAAYLYGPSTITSETSTVYCERGYYDTRNDNGYFVKNSRIDYDNRTVY
GDSLYFDRPTSFASATNNIRVIDTANNSVIKGHYAEVFKEKDSVFITKRAVAITVQDQDS
IYVHGDRLVVTGIPEKRIVRGYYNVRLFKSDMSGKCDSIHINQANGLTQMIGKPVLWSDL
SQMTGDSIHLKSNTKTEQLDSLHVFENAFLVQQDTIPLFDQEKSGFNQVKGDVLYGTFQD
NALHQIDIIKNAESINYMRADDGVLQGIDKSKSASITAILEDNALVEITKFKQVDGEVYP
LSKFPKESREFEGLNWRGEERLLTKEDIFKGEAPFTLTKIEGIPLPEIDEDFFDNTIPEE
ELDIPEASKLNPSDLKNREEDAPTIGVPINEKATIKKDSLAPKPSKPAGKQPLKQLPTLK
VQDSTDNES
>KECLDBNJ_01315 Putrescine aminotransferase
MKADFFKYQAQTSPHPLAMEVSHAKGSFIYDTTGKAYLDFVAGVSAASIGHCHPSVVKAI
QEQSEKYLHVMVYGEYAQDPAVELTRLIAANLPDPLEQTYLVNSGTEAIDGAMKLARRVT
GRSKIISANQAYHGNTFGALSLMNYEERVAPFRPVVGAISHINFNSFEDLEQITNEVAGV
VLETIQGGAGFIQPEHGWLAAVKKRCEEVGALLILDEIQPGFGRTGTFFGFENYHVVPDV
VVMGKGMGGGMPIGAFTASTAHMRLLSDNPKMGHITTFGGHPVIAAAALATAKTILDGEL
IQQTLEKEKLFRRLLKHDLITEVRGKGLMLAAITPSAEITTEAILMAQDEGLILFWLLFE
TKAIRITPPLTISEDEIIKGCEILLKVLDKIATKLS
>KECLDBNJ_01316 Beta-barrel assembly-enhancing protease
MKFNQEHEENNFPLTRFESMLKTNDVLFFDSDEFENIVNHYLENGKIALAKKAVKLGLDQ
HPSSSNLKLFKIEILIFENKLDEADRLLAELYELEPQNEEVYIQKANIFSKRDDHKKAIE
LLETALELTDADADIYSLIGMEYLFMDDFQNAKYSFMKCLEVDEDDYSALYNVIYCFDFL
EQHEEAIDYLNMFLDKNPYCEVAWHQVGKQYFDLKNYNKALAAYDFAIISDDTFIGAYFE
KGKVLEKLGRYNEAIENYQITLGLDDPTSFAYLRMGKCYQKLHCDDLAIEFFLKTVKEDP
LLDKGWIAITDFYTKKMDYQNALYYINKAINIDGENVLYWKRYAKINNRLKFYEEAERGY
RKTLELGNYELDTWLTRCDILIYLGEYEAAVTNLFEAIEFYPESPQIEFRLAGLYFSLNQ
EEKGHFHLENALRLEPDYDIILEELFPFVYAKRSVLKKIKKAKKS
>KECLDBNJ_01317 hypothetical protein
MSQNRSLLNYAVITLKGLAMGAADVVPGVSGGTIAFIAGIYEELIATIDKLDTSFFKVWK
NNGIKAAVNAYNLKFLGALFLGVILSILSLAKLITYLLEEHPLLLWGFFFGLIVASIVYI
GAQIKKWNFGVILSGVIGIVISYYITIAEPLSTGASYWFIFLSGFVAIIAMILPGISGSF
ILLLLGSYSIVLGTVRNFVDALLAFDFSALKDAALKLVLFMLGCVVGLKTFSKVLTYLFK
NYQNLTLALLTGFMVGALNKVWPWKEVLSYRTNSEGHQVPLIEKSILPQYFEGDPKVLLV
CILALIGFLTIFLLERFANSKQENGI
>KECLDBNJ_01318 hypothetical protein
MESKHRSFPDKVWLVLKGLAMGAANKVPGVSGGVVAYVAGFYEEFIYSLQKVNKNAFKLL
LNGRFRSFVRYVNGRFLFLLILGMIISYFSVSKLLDIAIDHYPLYVWSAFFGMIIGSIYY
IAKDFNDWSQRNIIILALGIITGILISLLEPATQNDNLIFVFFCGIIGVSGMTLPGLSGS
FILILLGNYVLLLVDSVNALYDTLSDLIQADFSFINDPHRLRLLQVMAVFTLGSVTGLVT
LSNFLGYLLKHYKHATNAAIIGFIAGSLGVVWPWKNPVFERNALGEINYDRVGDPILTNY
DRYWPESFSAENIIATIFILLGIFSVVALGKYGEKTRVQS
>KECLDBNJ_01319 Shikimate dehydrogenase (NADP(+))
MIKLGLIGKNIDYSFSRKYFTEKFEREAIDGSYVNFDCQSPDEVKQLLERTDCSGFNVTI
PYKETVMPYLDELNKHASSIGAINTIKRLSTGKLKGFNTDYLGFRRSLKPFLEEQNHTHA
LILGTGGASKAIAYALELEDISFKFVSRKPEKDQLAYDALNGAILSKHTLIINTTPLGTY
PNITDCPKIPYRLLGKYHLLYDLVYNPVETQFLKNGKAQGARISNGYEMLKLQAEAAWQI
WN
>KECLDBNJ_01320 hypothetical protein
MSEEKKASDKDEKIDNDKAQTSSQIESQQPSENSETPENPSEQQDEALVTESIDVIQSAK
NEEHDDEEFVAEESDEDEETDPNDLDAALNEDSEDESTSERHNIPKKEYDSLSKEELIKE
FKYLLNNHKIQAIKEHVTELRAAFISQFEEEQEEAKEKFLEEGGNIIDFRYYSPLKKEFN
TLYFEYREKRNNYYKNLKKDLNANLETRNALIEELKELKNEVGGEDSINTTFEKFKDIQE
RWRNAGNIPRDRYNLVWNNYHHHIENFYDFLHLNREFRDKDFKENLDKKLKLIEQAEELA
KEPDVNRAFKELQMLHKIWKEEVGPVSKEYREEIWEKFSAATRKIHDARQEYFKNIDKIY
EENLEKKQEVIAKIEDIAANPATAHSGWQKQMKEVNTLREEFFKIGKVPKRDNEPTWKAF
KKATREFNHNKNGFYKNQKKQQYENLQKKLELVQIAEDNKDNEDIKVTIDLMKRIQADWK
KIGHVPRKDSDKIWKRFKKACNHFFDRLHAEKKEILEEEKGNLEEKNALLDKVKAIELSG
SHEDDLKTIKSIIKEWKDTGRVPHSKKSIEQDFNKVLDGLFKKLDLGKKESELIKYENRV
AAIADEDSNQALNKEHYFITKKIDEIKAEINQLENNLGFFQHVADDNPLVRDVHKNIADH
KKNLEIWKAKLAKLKSLY
>KECLDBNJ_01321 hypothetical protein
MNISKFIYFGAIGLLALTSCDDDTDDAGNEINGTADLYATSHTDGSVTKYDLLRGEITTY
GTASADAEGIYYSPDDDSFTIAARGATQTSLQSYLSVSDIIEATISLDVDIMGPTVLQSP
RDLAVNGNIYVVSDNANANGRFFVFEKDGDSFTLRNTVTVDFAVWGIEFVGNDLYAVVDS
SSDLAVFTNFASTNTTDATVAASKRITVEGIVRTHGLDYDGGTMIMTDIAAASGGDFAVD
GAFHVITNFDSKFDAVDNGGTLAVTDQVRYEGDATLMGNPVNVVYDAETDAVYVAELANG
GGQILTYGNVSSSAGGNVAPNSATALSGVSSLYLYKD
>KECLDBNJ_01322 hypothetical protein
MRKLALFIYTALGWKINGTFPSEVKKMVVIAAPHTSWHDFYMGLLFRSVIDVQINFLGKK
ELFKWPFGWYFRKVGGIPLDRFKSENKVDRIARMFEDHDTFRLALSPEGTRKKVDHWKTG
FYYIALKAQVPILPITMDFGKKEHRIGRPFYPTGNCARDLRQLQLFFKNVEGKFPERS
>KECLDBNJ_01323 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MTQRLKTIAMIPARYEASRFPGKLMKDLGGKPVILRTYEAAVNTKLFDTVYVVTDSSVIY
DTIVSAGGQAIMSIKEHSCGSDRIAEAVADLDIDIVVNVQGDEPFTNVEDMRNVLQVFYE
EDAAQIDLASLMTPITKIEDIENPNNVKVIVDQADFALYFSRAAIPFRRDRDVDVTYFKH
KGIYAFRKQAVLDFAKLPMRLLEASEKIEAIRYLEYGKRIKMVLSHSPAIGIDTPQDLEE
ARAILEKRQP
>KECLDBNJ_01324 hypothetical protein
MELAISICLGIGLAAASGFRIFLPLLALSTAACFDVIQLSTWEWLGNWQTLVLLGVASVF
EILAYYIPWFDNALDTIAVPLAAVAGTILFFVSLGDYGPWVSWSLAIIGGGGTAGLIAGS
TAALRATSSATTLGIANPVFATLEAIVSTIFAIVAIFIPILAGVLVLLLGYQIYKWYHKR
KLKKNSLQ
>KECLDBNJ_01325 ATP-dependent RecD-like DNA helicase
MELDQHAFYKLLLKDFPFTPTQKQDILLQQLSDFIFEPKNNSIYVLKGFAGTGKTTVIGT
IVKNLWKIKMSSVQLAPTGRAAKVISNYSDKPAHTIHRKIYYPKKERGGGVSFTLQRNKH
RNTIFIVDEASMISDNAAESKLFENGSLLDDLMAYVYSGHKCKLLLIGDQAQLPPVKMDL
SPALDARNLQLQFDKTVKSIELDEVMRQAETSGILKNATRIREFLNDELYEDFKFDLSGQ
DDVVRLIDGHEIMDALGDSYREYGNEGTAIIVRSNKRANLYNQQIRSRILFKEEEVSAGD
YFMVVKNNYFWLDTKSEAGFIANGDIIEILEIFSIKELYGFRFAEVKIQMTDYPNLAPFE
TVLLLDTLTSETPSLSYEEGNTLYQEVMKDYADETSKYKKFMKVKNNKFFNALQVKFSYA
ITCHKSQGGQWETIMVEQPYLPNGMDKDYLRWLYTAVTRARKKLYLIGFKDDMFIEN
>KECLDBNJ_01326 hypothetical protein
MKIVIQLVLWVVIGVLGYLLFNAVYGEVKFNDLKVVRYQKAVNKLKEIQKSQMAYKQITG
KFAEDFDQLIAFIDTAEFVLTERRDTLVLDEEATRRYRVDTNKEITIIDTLGFRSVKDSL
FQGTDRYKTMMNVPAPVADAKFEMEAGTILKSDVPIPVFEAKVSKDILLADQPKDYVAKE
KQVVSVEGVNGAYLTVGSMTEVKTAGNWPKSYGDAED
>KECLDBNJ_01327 hypothetical protein
MQRTKNLENPENLIVSIQVSLDGFSFYIKNQEHQCVEAKSIAFARSLSPEKALIEIKKII
EATPNLQQNFEEVVVVYVNELFTVVPQALFDEKHLTDYLKFNTKILKTDFIVYDELEALE
LVNIYVPYANINNFFFDHFGTFTYFHSQSILLNNTLAVASTQTAEVFVHVRPHTLSVIAY
QEKKLLLSNQFNFDTPQDFVYYILFCYEQLQLNPEIHPLVLSGAITKEDANYEYIYQYVR
EVRLVAPETTTPEELKNTILNYPLSL
>KECLDBNJ_01328 Ribosomal RNA small subunit methyltransferase D
MRIISGSYKGRRILAPKKLPVRPTTDMAKESLFNILRNRYTFSTVSVLDLFSGTGNISYE
FASRGSENITAVDANASCARFIQQTSDDLEMQINVIKSDVYSYLARGSANYDIIFADPPY
DFETSEFLKIVDLVLENELLTDDGTLIIEHSKHTDLQEHSNCFETRKYGGSVFSFFNKNS
>KECLDBNJ_01329 hypothetical protein
MKPLKIIKLNFCVLRFYDHFVISEIHDGVNLTQEHIAQAHKIITDFFGPATYYGYISLRI
NDYSVNPTDYLSCPFYDYIAGMAVVSNRAIKREAAQFEKAFFKKPLEVFFTLEEAIDWIK
RLPKTDLNKKADL
>KECLDBNJ_01330 DNA polymerase III subunit tau
MPIDTALFIFVTVRNYSDFYLNNHQISALEQFIVSARKYRPATFKDVVGQQAITNTLENA
IANNHLAQALLFTGPRGVGKTTCARILAKKINQEADEIVDEDEDYAFNIFELDAASNNSV
DDIRNLIDQVRIAPQVGNYKVYIIDEVHMLSSAAFNAFLKTLEEPPKHAIFILATTEKHK
ILPTILSRCQIFDFKRITVKDIREHLVDIAKQEGITADEEALHIIAQKADGALRDALSTF
DRVVSFSGENLTRAAVTENLNVLDYDTYFETTDLILENNIPQLLLSFNDILARGFDGHHY
IAGLASHYRDLMVCKQPATIALLEVGDQTKKKYHEQAQKTSFNFLMQALELANECDLKYR
TSRNPRLLVELCLMQMASITFDGEKKKPVIS
>KECLDBNJ_01331 hypothetical protein
MQAAWKEYVAKLQKKGEKILASNLETDTPTLKGTAIQIEFPNDTMRVELERAQHGLLEFL
KRKLQNYDITIDITVNEAAERKYAYTTREKYEKLKDKNPDLDLLRKTFDLDI
>KECLDBNJ_01332 hypothetical protein
MLGLKLPTDPRWVNIVEMNIDDILTDHAFCEQKATSTAISLIVSFPEYTELVQEMIALVK
EEISHFKLVHDKIIARGKTLGQDRKDAYVNKLLKFFPKGGSRTTQLVHRLLYAALIEARS
CERFRLLSQELEDEELCTFYHNLMVSEANHYTMFLGFARKYGDEKEVNKKWQDLLDFEAE
IMKDLSKEGTIHG
>KECLDBNJ_01333 hypothetical protein
MKKFLLGIFLLAAFNSFAQGVRYGAKIGMNVSTLSGDAFDDSSSRYGFAAGVFAEIPLGN
AFQFQPEFLYSGQGIKPNTGPEYNFGNGEDGLPMRPFDERAELDYLQLPLLFKKNFGKFN
IHLGPQVGVAVWNSDNHEVYKNFDYSGIGGIGVQVFDFLSIEARYSVGFRNVIEERYSGI
EGKNQYFALMASYRL
>KECLDBNJ_01334 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MIQLKKYGAIDIGSNAVRLLVANVIEVEDRDPIFRKSSLVRVPIRLGADVFKEKKISEEN
IERMIDTMEAFKLLMKAHKVVDYKACATSAMREATNGSEVVKTIKKKTGVQITIIDGSDE
AAIIANTDLKSLIASDRSYLYVDVGGGSTEFTLYSAGEVVASRSFKLGTVRLLEGLVGHN
TWTEVENWIKEVTAGHTKIELIGSGGNINKIFKLSGKKDGKPLTYFYMVTFYEFLQSYTY
EERVTELGLNLDRADVIIPATRIYLSAMKWSRAKNIHVPKIGLSDGIIKSLYNDKKLPV
>KECLDBNJ_01335 Polyphosphate kinase
MDNRINMATLEADETRYINREISWLQFNARVLQEAADETVPLIERLRFVGIFSNNLDEFF
KVRYATVKRIVEAGKKGRKALGVYAADELLEKITRIVIQQQEESLNIIDDILQRLKEEGI
YVIKENEVHFPEHSEYIKSFFTEKVSPALVTIVLSDDLELPRIQDLEAYLTITMKKKGSK
KPIYALVEIPSELDRFVVLPQVDGNDYIMILDDLIRYNLESVFSIFEYDEISAHMIKITR
DAELDLESDLGKSFIEKLSKSVKGREDAEPVRFVHDQTIGDDTLAFLLNKLGIENTDSII
PGGRYHNRKDYMDFPSLGRTDLLYAKQKPLPIKGISLNDSMFKKVAEKDFLQYTPYHTFA
YVIKFLREAALDPKVKTIKITIYRLAKLSHVASALINAAKNGKEVTVQIELRARFDEESN
MRYANKMQDEGVKLIFGVPGLKVHSKVCVIERLEGSRLKRYGFISTGNFNGMTARIYTDY
TLFTANKQILKDLSKLFNFFDTNYIVNTYQHLVISPHYARNTFYKLIDNEIKKVKSGGKG
YIRLKLNSMSNYAIIDKLYAASNAGVKIDMIIRGVCCLIPGVEGMSENIKLISIVDKFLE
HPRVMIFGEEGEEKVFISSSDWMTRNLDNRVEVTCPIYDEDIKQEIIDTYTICWNDNVKA
REITAKQDNAYRKNDEAPLRSQFATYDYYLNKLT
>KECLDBNJ_01336 hypothetical protein
MKTLYLVRHAKSSWEFDLDDHERPLNERGLSDAPKMGAYIREKITLPQRIVSSDAVRAKT
TALLYLKELGIPEERLELSHQLYDFNGTGLDSFIRSCDDEIDRLMVFGHNNALTYWVNQY
GNKPIDNVATAAFTEITFNVKHWSEIDLGETKLYIKPKQIK
>KECLDBNJ_01337 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MAEDLSDYRKSYEKSELTISQSENNPFEQFKKWFQETEAVAAESEVNAMTVSTIGLDGFP
KSRVVLLKSYDENGFVFYTNYESEKGQAIAQNPNLCISFFWPQMERQVIIKGRAEKVSEA
TSTAYFHSRPAGSQLGAWTSPQSEVIPDREFLEQRLADLEKKYAATEIPKPPHWGGYLVV
PTEFEFWQGRPNRLHDRLRYTPGGVHWKLERLAP
>KECLDBNJ_01338 Ribonuclease Z
MKLTILGCYAATPRSFTNPTSQVLQIKNHLFLIDCGEGTQVELRRNKVKFSKIKHIFISH
LHGDHFFGLVGLISTFRLLNREKELHVYGPKGIKQAITLQLKLSNSWTNYPLYFHELESK
EPQLIFEDEKVSVETIPLKHRIYANGFLFKEKPGERKLNMNACLQHEIDVVYYRKIKAGG
DAILDDGTVIPNKELTFDPDPPRSYAFCSDTIYKPDNLPQLKNVTFLYHESTFLEAHAKL
ANPTGHSTAREAGLMAKGANAQYLILGHYSTRYPDLTLFANEAKAVFENVLTADDGKVFD
FDELPV
>KECLDBNJ_01339 hypothetical protein
MIITEKDTYTILADEENGVKSFASFLDFIVPKAHAEKNLVIDLLKYETLTLEELLYFLPL
SNAQRAAQKSFVLVNKAVHVDHVPEELMVVPTLDEAKDVIDLEEIQRDLGF
>KECLDBNJ_01340 Aspartate carbamoyltransferase
MSELSVNHLLGIKYITKADIDLIFETADHFKEVINRPIKKVPSLRDITIANLFFENSTRT
KLSFELAEKRLSADVINFSAGASSVKKGETLIDTVNNILSMKVDMVVMRHPNPGAGVFLS
KNIKASIVNAGDGAHEHPTQALLDSYSITKKLGEVAGKKVVIVGDILHSRVALSNIYALK
HLGAEVKVCGPKTLMPKYIESLGVEVELNLRKALEWCDVANMLRVQNERMDISYFPSTRE
YTQQYGLDKELLDSLDKEIVVMHPGPINRGVEITSDVADSGQSIILNQVENGVAIRMAVI
YLLASKIKQQ
>KECLDBNJ_01341 Bifunctional protein pyrR
MSQKVLLNAKEINIILNRLACQLIENHKDFKDTVLIGIQPRGIYVAERIKKLLETDYQIP
EIKLGYLDITFFRDDFRRSDKPLEANKTKINFVVEDKNVVFIDDVLYTGRSINAALTAVQ
SFGRPKNVELFTLIDRRFSRHLPIQPNYRGRQVDAINEEKVLVKWVENGGEDVVYLVNK
>KECLDBNJ_01342 hypothetical protein
MILYESKNIHAKSIKQSWRLCTFGTVLAQHYLKKNLKNYSYIFFLFFCGNLLAQTTETTE
QEPDTTATEYYLVDGDSIARSAIFLDDVVVLGRLKFDDNTARRRYLILRRKTRKVWPYAK
LAGERLVELNERLDSMKTKRDRKRYTKIIQRYVEDEFKEELKKLTRTEGQILVKLMYRQT
GQTTFDLIKNYRSGLKAFLLNTTASFFDISLKEIYDPADVQEDYLIEDILQRSFQAKVLE
PQDPAIDVNFLELENKWRKPSKGIK
>KECLDBNJ_01343 Putative aminopeptidase YsdC
MSKSILNKKSLDFLESYLNNAAPTGYEWEGQKIWMEYLKPYVDTFITDNYGTAVGVINPD
AKYKVVIEGHADEISWYVNYITDDGLIYVIRNGGSDHQIAPSKLVNIHTKKGIVKGVFGW
PAIHTRDKSNEKAPSLDNIFIDTGCKTKEEVEKLGVHVGCVITYPDTFTVLNENKFVCRA
LDNRMGGFMIAEVARLLKENKNKLDFGLYIVNSVQEEIGLRGAEMITHTIQPNVAIVTDV
THDTTTPMIEKKTNGHAAIGDGPVISYAPAIQQKLRDLIIDTAEEKNIPFQRAASSRATG
TDTDAFAYSNGGVPSALISLPLRYMHTTVEMVHRDDVENVIKMIYESVLKIKDGQSFSYF
D
>KECLDBNJ_01344 hypothetical protein
MTITEEKLENILSSPEEAARIADLIYVTDEHLTICRKKHGKGFIYCKNNKTIKSKELLKR
IKELVIPPAWQDVLIAEPANGHLQAVGRDEKDRKVYLYHETWNKLRNETKFLKLAAFANV
LPQIRKQVDQDLDAPEMTKRKVLALVVRLMEETHIRVGNDCYAKRNKTYGLSTLRTRHVK
TTESDIRFQFVGKKGKEHDIAITDEKLIDLVNQCEEIPGWELFQFYDSDGSKDHVDSTMI
NEYIHDLSGDLFSAKDFRTWAATKIFFECLRDLGYIAEEKQNAKNLLTAYDAAADGLGNT
RTVCRNYYVHPVIPEAYADGSILPYFEKVDRIKPKSGSHLSRTEMVIKEMLANYEVNI
>KECLDBNJ_01345 UvrABC system protein A
MAESQEYIEVYGARAHNLKNIDVQIPREKLVVITGLSGSGKSSLAFDTIYAEGQRRYIET
FSAYARQFLGGLERPDVDKIQGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRLLYARAS
DAYSYETGEKMVSYSDEQIKDLIKTEYAGKRVNVLAPVIRSRKGHYRELFEQIAKQGFVK
VRVDGEVRDIEKGMKIDRYKTHDIEIVIDRLKIEEGQDIDKRILETINTAMYHGEDVMMI
LDHDTNEARYFSRSLMCPTSGVSYPNPEPNNFSFNSPKGACPKCNGIGELRVVNEDKIIP
DPKLSIKNGGLAPHGNQKSNWIFKQLEIIAQRFDFKLTDPIKDIPKEALTMILYGGKEKF
TVDSKTLGVSRNYKIDFEGVANFIESTYNNNDSASLKRWAKEYMEKVVCPECEGSRLRKE
SLYFRVREKNIAELAQMDVLELAAWFKDLPDNLSDKQTAIATEILKEINARLQFLVDVGL
TYLSLNRSSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNEKLINSLESLR
DLGNSVLVVEHDKDMIERADYVIDIGPFAGKHGGEIISEGTPKQLVKQHTLTAQYLNGEK
EIAVPAERRKGNGKKIVLKGATGNNLKKVNVEFPLGKMIVVTGVSGSGKSTLINETLYPI
MNAHYFNGVKKPAPYKSIKGLDECDKVIDINQSPIGRTPRSNPATYTGVFGEIRSLFAQI
PEAQIRGYKPGRFSFNVAGGRCETCKGGGLRVIEMNFLPDVYVECETCQGKRFNRETLEI
RYKGKSIADVLEMTIDEAVPFFEHIPKIYRKLKTIQDVGLGYISLGQQSTTLSGGEAQRI
KLATELSKRDTGNTFYILDEPTTGLHFEDVRILMDVLNRLTDKGNTMLIIEHNLDVIKMA
DHIIDIGYEGGRNGGQLVAKGTPEEVAKDKKSFTAKFLRNELN
>KECLDBNJ_01346 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MRTEQKPKGWNEIKTNDSWAIFKIMGEFVSGFEKLSRIGPCVSIFGSARTKPDQKYYKLS
VAIAEKIVENGYGVITGGGPGIMEAGNKGAHLAGGTSVGLNIDLPFEQHDNPYIDGDKSI
DFDYFFVRKVMFVKYSQGFVVLPGGFGTLDELFESITLIQTHKIDKFPIILVGTEYWQGL
FDWIKNTLLDKFNTISPGDIDLLHLVDTEDEVLEVLNNFYNEYELSPNF
>KECLDBNJ_01347 hypothetical protein
MKTLLQALLLCLGLFPFTSEAQNRIEITARLVEEEKSLFIQQDIYFKNTSKDTLTELFFN
DWAHSFSSKQSKLGRRFAENYDRRFHLASDDARGASKINSIIGESFRNLTFTRLEDAEDV
IQVALINPLAPGETTQLKLNYNIRIPDAKFTGYGALDNGDFNLKYWFIAPAVYDGTWHYY
SNKNLDDLYMAPTDFSIQFSFKKNYRFINELEQTNATVSAQNNYKTVYLEGNSRNNTTIY
LRQISEFQITETDDLTVVTNITDDKVIAEREALIIDKISHFLVAELGEYPFKQLVISNID
YAENPVYGLNQLPDFLSPFPEDFKYELKILKTAIDNFIDRTLFINPRDDRWIADGIKMYT
MMKYMDHFYPNLKVVGTLNRYWLARQFHLSDLEFNQQYNLLYMHMARMNLDQPLTTPSDS
LIKFNKNIANAYKAAAGMNYLSEYLGNTPVEQSIDQFYLENKLKLTSSTAFEQILRANTS
KDLDWFFNDYVNSRKIIDYKFNEVKREGDSIKIELKNKTKSQMPIPVYGVNKDKIVSKTW
VDGFEKEQHLSIAGDSIDRVVINAEGFVPEYNRRNNYKKINPFLGVNKPFQFKLLQDLED
PSKNQVFFMPVVEYNFYDGLKLGAKMYNKTLLSKAFNYRIEPQYGLKSNKLTGSAGFTYT
QNVNEGNLYAIRYGISGSLSSYAPDALYKSYSPFITFGFRTDDFRSDKRQFLTVSNINVY
RDESDVITNDDPNYSVFNVRYTNSDPGVINAFTYDTDFQLSQKFSKFALTAKYRKVFLNN
RQFDLRFFGGIFLYNDTRSQGDYFSFALDRPTDYLFRYNYYGRSENSGIFSQQLILAEGG
FKSKLDTPFGNEWLTTVNTSTTLWNFIHGYADIGLVKNQGSSARFLYDSGIRTVLVEDYF
ELFFPVYSSNGWEIGQPNYDQKIRFIVTLDLRTMLSLFTRKWY
>KECLDBNJ_01348 Pyruvate dehydrogenase E1 component subunit beta
MHTQSEPTSEISFDDFKATVLNDYRIAVTSRECSLLGRREVLTGKAKFGIFGDGKEVPQL
AMAKAFKKGDWRSGYYRDQTFMMAIDHFTIENFFAGLYAHTSLENDPMSAGKQMGGHFGT
HSLDENGKLKNLLEQYNSSADISPTAGQMPRLLGLAQASKLFRQVPEMNTDGLSNEGNEV
AWGTIGNASTSEGMFFETINAAGVLQIPMVTAIWDDDYGISVHAKHQTTKENISEILSGF
QRNEEENGFEIIRVKGWDYPALIDAFEQAGKIAREQHVPVLLHVTELTQPQGHSTSGSHE
RYKSKDRLQWEKEHDCNTKMREWMINNQIATDEELTDLEKDIKRKVREGKRKAWESFLNP
IKAEKKTVVSFIDTIISESENGQFIKGIKQTLVDEKDPLKSDVLIAARKTLRFVAQEQSE
AISALKDWVTKFIAKEQPNYSSHVFSEFDSKATNIAEELPQYADDAKTVDARIVLRDNFD
ALFSKYPNSVVFGEDTGTIGDVNQGLEGLQDKYGELRVADAGIRETTIIGQGIGLALRGL
RPIAEIQYLDYILYAMATLSDDLATLRYRTHGKQTAPLIVRTRGHRLEGIWHSGSQMGAL
LGLLRGVYILTPRNMTKAAGFYNTLMQSDEPAVIVECLNGYRLKEKLPTNLAEFKTPIGK
VEVLREGTDITVLSYGSTLRLVELAAKDLQAVNISVEVIDAQSLLPFDLNHDTVKSIAKT
NRILVVDEDMPGGASAYLLQHILDEQKAFRHLDSAPQTLAARPHRPAYGTDGDYFSKPSA
EDIFEKIYQIMHEVNPNAYPQIR
>KECLDBNJ_01349 hypothetical protein
MSKPFETPQLQSKLGILFIFLSQAYKFLRAFGAAFLYFLIKGFPSEVVLPISIGLVVLLL
AILGYSVLSYKKFRFYIDYKNAEFILEQGVFATKVTSIPFSKIQQVYFKRSLLQRVIGVN
SVVVDSAGSSAQEIDIKALSDEDGKELQQILMQAVKEEIGTSEASEPNESQPENTASKQP
EALWTHRLSPLALLKLGITSNYFRGVWLILLFVGSLYQQLGDFELLQDDQYTEGIKGYFD
AYSKPIELFLLTALVFVGVFILGMLISCIEIFIKYFDLNLKQTKESLELAMGLKTNTKVS
LKPRRVQLMRVVTNPIQKRLNLNEAQIAIASSQDDLNKAKITIPGLERAQVEKVKRFLFS
HQMRPGRIFKPAFILYVRLLIIAGLPLLLTALVASFLVPNYMTEILSILFIIFGMLIIPY
QYYWYKALALEITPEFVILRKGVWNQKTEIIELFKLQSVTVSQPVWYKKRDLYNYTFHTA
GGDLSFPVTSAEAQRYINYALYRVEVSREAWM
>KECLDBNJ_01350 hypothetical protein
MEYKFTNAPVDLDALPDHQQLVYTPTLKARLYKALLVIGLFYIVLIVGVLLLRTVSDVKY
LIPALFIGVTFVFMLMAGYQFLLQKQIGYALREHDIAFRRGVIFEKITLIPFNRIQHIST
SAGVLDKAFKIANLNIFTAGGSGSDINIPGLNPDMAARLKDKVAQHLTEADV
>KECLDBNJ_01351 1,4-dihydroxy-2-naphthoyl-CoA synthase
MQEPHWETVKEYQDITFKKANGVARIAFNRPEVRNAFRPKTTSELLDAFHIAQEDTSVGV
ILLSAEGPSPKDGVYSFCSGGDQRARGDQGYVGEDGYHRLNILDVQRLIRFMPKAVIAVV
PGWAVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAFEMGMVNAVIPHDELEATAYEWAQEILAKSPTSIKMLKFAMNLTDDGMVG
QQVFAGEATRLAYMTEEAKEGRNAFLEKRKPNFDKKWIP
>KECLDBNJ_01352 Conserved virulence factor B
MLELGEYHKMIIDRDVSPGLYLRDEEENEVLLPGKYAPEGFALEDEIEVFVYLDNEERPV
ATTLKPYIEKNGFAYLECTSVTKIGAFVDWGLDKELFVPFSNQVTPMHEGNWYLVYMYLD
ERTNRLVGSSKFNKFLDNTEVTVQKHDKVDLIISHFSEHGAHVIINERHQGLIHKDTIFE
DIRVGDRLPGYIKRVREDKKIDVLLQPEGYKSIEPNAQFIYDELKANGGSLPIHDKSSPE
DINAYFGISKKLFKKAIGALYKDRQIKITDQGIELTNKDA
>KECLDBNJ_01353 hypothetical protein
MSKRDEMIAKYATDLKEKMGHDADMDLLTKVTIGCGPSIYNKDSATVSAGSESELETVKK
NFLIKKLGLEDGPALMEGLHKVLEDYGKSNRNKYRAVVYYLLTKHFGKEEVYS
>KECLDBNJ_01354 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MKYSSIPVAQSVVLLCLEKGINHIVISPGSRNAPLTIGFTHHPEMKTYSVVDERSAAFFA
LGIAQQIQKPVALVCSSGSAVLNYYPAISEAFYSDIPLVVISADRPIERIDIGDGQTIRQ
RNVFENHILYSANLYSEYVPDSTLTDPKLIQKQREATKHNQQEINKALNEALSGQGPVHI
NVPFYEPLYNTTEEKLVNPIIVEEPVKSMELTEAYLQPFVKKWNSAKRKLVIVGVLQPNT
IEQQFLDTLGDDPSVLVFTETTSNLHHPNFFTRIDNIIGSLDDNGFKNLQPELLVTIGGM
IISKKIKAFLREYQPDQHWHIDPKKAYDTFFCLNKHFKVPVNYFWNQFLPQTSTVSSDYQ
KEWLAVRTQRDLKHQEYIQDMGWCDFKAFDRILSRLRSGSQLQLGNSSTVRYVQLFDIDK
TLKVFCNRGTSGIDGSTSTAVGAAVGSAMPTTLITGDLSFFYDSNALWNAHLPKDFKIIV
VNNSGGGIFRILPGDKTSQAFETYFETVHNLDASHLCKMYGLAYFSAENEGELAEAQVAF
YAENDRPCLLEIKTPRIENDQVLLGYFKYLR
>KECLDBNJ_01355 Isochorismate synthase MenF
MSQEELASQLENHFKKQLPFVIYSKPGAAALQVIFQEDKKLHTTSTYEEEGFVFAPFDSN
QPGILIKGKPTEIIVSSAAVEFNSVEKTIETKDADQHIALVEKAIETITDSDLKKVVLSR
KQNISIEASSPIPLFFRLNQKYPTAFTYLWHHPEVGTWLGATPETLLALKGQRLETMALA
GTQSYSGSTDVDWGLKEQEEQQMVTEEITSKLAGFDFKAFRVHDRETYRAGGLLHLRTKI
TGNLAPTENPLKALLNALHPTPAVCGLPRDLAKSFINEQESYDRAFYTGFLGEINQLQDH
SKRRTRRNVENLAYKTVKKTSELYVNLRCMQFKPQMASLYVGGGITAGSDAKQEWQETVN
KAQTIASIL
>KECLDBNJ_01356 Putative esterase
MFQDNKEEALKRCNAICKNTLMETLQIEFTDIGEDFLTARMPVTSKVHQPDGVLHGGASV
ALAESVGSAASMMFLDVEKVFIRGIEISANHVKSISEGDVFAKATYLHKGRTTQLWQIKI
TNTAGDLISLVKLTTIALPKK
>KECLDBNJ_01357 hypothetical protein
MNEEKSVSYTTTNTYQTLNTLNDQTKNIWIVCHGLGHLSTFFIKHFESLAPDPNYIIAPQ
APSKYYQDKSYKYIGASWLTRENTEIEIENVLNYLDQVYNKELSSVDLQKYTVVLMGFSQ
GVSVITRWLAHREISCDVLILHSGKIPADVKHIANQPKRVFSIYGNEDPLISKEALRQQQ
QLAKSLFNASMEEVIFDGTHVVHEASLQQIANTVLNTL
>KECLDBNJ_01358 hypothetical protein
MKSIFTLFAVAFLSLTAFAEVSNTQKQALIDLYNATNGSEWNTTWDLSADVATWHGVRVV
NNNVVGLNLSMNNLNGQLPETLGDLDSLVTLELFFNRIQGEIPTSIGNLKNLKVLVLNGN
MLDGKLPKTIYNLTKLEQLMLTSNNLSGSISNEVSNLKNLEILNLFDNNLNGNLPLAVLK
LENLKELNLSNNQLAGTVPAGIKNMKNLKTLALAANNFENYNEGVAFNEDLNTTNPLASN
E
>KECLDBNJ_01359 hypothetical protein
MNQRLLQFSIFFSIVSFQLLSAQNSKSAKGFKDYFPIAERPFLAAGTGNNPYERILLEAK
PVVYYSIYNDIREALNRDTIVAGDAVYLSIQPHLRIYDENSKPVKTPSYKAFIGWQSIIK
TENNNFLTAAIETGHYSNGQSKSAFSEDFEDNTPESRALYDDITDDTNLSEILNRSSGNF
STNLTRLSLNYRINTFDKDNYPLQSHSFTMAYQIYHNRFLGVFQFGGYNPEDIDIYGRHQ
IEAWYEFTAHFKKMRYSLSQRVFLHPDVHPSAELYRSETSATLYPWDGDLGIMARFSFGF
DDYNYRFVDSYPRFSIGLTWDWFTPFVVKPRRMQVPQN
>KECLDBNJ_01360 hypothetical protein
MKFKHLAFLLVFFIATTLSAQGTVAHINMEEVINLMPQTSEAEAELNRLRQAYQRDFETS
YREYQAKFVKYEDEASTLSPAENEKRKSDLELIERNLAQTQQNIEKQIAEKRKLLFEPVK
QQARELVTKVADNLGFLYVLDSSKDAGLVMAKGKDLMPEVKRTLGM
>KECLDBNJ_01361 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVMEGNEPVVIPNAEGKRTTPSVIAFVEGGEIKVGDPAKRQAVT
NPTKTISSIKRFMGNKFSESSKEVDASAYQVVKGDNDTPRVDIDGRLYTPQELSAMILQK
MKKTAEDYLGQEVTGAVITVPAYFNDSQRQATKEAGEIAGLKVERIINEPTSAALAYGLD
KKDSDQKIVVFDFGGGTHDVSILELGDGVFEVLATDGDTHLGGDDVDSKIINWLAEEFKA
EEDMDLRKDPMALQRLKEAAEKAKIELSSSNQTEINLPYVTATASGPKHLVRTLTRSKFE
QLIDDLVKRTIEPCESALKAAGLSKSDIDEIILVGGSTRIPAVQEAVEKFFNKKPSKGVN
PDEVVAVGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGGVMTKLIEANTTIPTKKSQVF
STAADNQPSVEIHVLQGERPMANDNKTIGRFHLDGIPPAQRGTPQIEVTFDIDANGIIKV
SAEDKATGKKQDIRIEASSGLTEEEIQKMKSEAEANAEADKKAKEKVDKLNEADQMVFQT
EKLLKESGDKLSADNKTKIEGALEELKKAHATGEVEKVQPALDNLNEIWKSASEEIYKAQ
AEAQGGAQPGPDAGQAGGGNAEGASGSDVEDVDFEEVK
>KECLDBNJ_01362 Dihydroxyacetone kinase
MKFFINEPQNVVNEAIEGILTDPKLTKLDNFPEVRVVLRKEIDANKVSVISGGGSGHEPA
HAGFVGEGMLTAAVCGDIFASPSVDAVLSAIVATTGDQGCLLVIKNYTGDRLNFGLAAEQ
AREMGYKVETVIVGDDIALGEDVEQRGLAGTLFVHKVAGYLAEAGKDLEEVAAMAQKVAS
QTCSIGLSLEEGKKFEHPEASRLEDSEAELGLGIHGEPGVEKISIQNADVLVEKMLKKLT
QFLPHEEQEYALLLNNLGSVTPLEMSILLNGISKSELAKNVKLLVGPAQLMTSLNMNGVS
ISVLQLDDEITEALTAKAQPAAWMIRTYAEKSSVESPELPKTLPYKASSNSEVSKAINAI
TMMLIESKDELNAIDEKVGDGDAGSTFATGAKKLQEVLDKLPLADYSELLITIGRILARE
TGGSSGVLLSILFTRAGNAYKESQHLGKSLLEGLNKMKEFGGAEEGQRTMIDALQPAFEA
LAEDKSITEAARAARKGADKTKEITQTKFGRSSYLSENSLEGIPDPGAEAAARVFEELA
>KECLDBNJ_01363 L-serine dehydratase TdcG
MKKIESISVFDMLKIGVGPSSSHTLGPWRAARRWISKLKDKGKFDNVERITVELYGSLTL
TGKGHATDIAVLLGLEGLDPQKFPIEDISGVIERIRKERKLSFNSERLLDFDSETQIIFN
KKFKPFHPNGITFRAQLSSGKRTTDTFYSIGGGFVVQEERKRSKIKQEQLKGFPYPIQSG
KELLAYCKAENLKISELVLENEKSLNTEEEINFRLKEIWNVMLDSMYTGCHTEGTLPGGL
NVRRRAFDSHKNLIGDCNYTNAEEWITAIRGTEVKFRQILKWVSCFALAVNEVNASLGRV
VTAPTNGSAGVIPAVMMYYMVIENHDANFEDIRQFMLVAGEIGSLFKKGATISAAMGGCQ
AEIGVSSAMAAGALTELMGGTPEQVLMASEIAMEHHLGLTCDPIAGLVQIPCIERNAMGA
IKAINACEMALDTDARNAKVPLDKVIETMWQTAKDMNSKYKETSEGGLAVNVALSDC
>KECLDBNJ_01364 hypothetical protein
MRGSCYLFYFLVLFGFQICCGQQTIDTLRAPGFGVDIRFLDPLDPGHKSVIRSVPFTVFE
TKNESNAVLPVEKASELRYEFVQTAYDFEQKILGLDAEDLVASANFSQAYNSTADAEKKD
QLLYVYTLRKKSLFALELQQNQISEKFKDAVARLGRDLTAEGFLSWFGTHYTTRVTYGGL
FLTRNIIRSENFVNSPYSEKEFKTKLLIAVGEQQRGDTLTDPYIQLGPPQRFTRGGDSKE
IWDERWEQTVTPENAQIIEATYKPLTTLLTPQNFPELEDIAEKRVLLETALARAESRVKN
WQAQEHSSSFFQKYSLRFRQKAISVVKNSMGTAEESSRTNYVGDLFFGSFNANGEPMTTK
PLIEYQGIDLNTLLTDEEIALNKILDFTISPEELKGSYVSIWDDTKKLVKGENRTTLFIS
GPETARTAFKEALVQPVFKEVQITTIDNDVFTIKYSLEQLKEHTLIVASGNPYNYALDSE
LVAAAARGDTLAIVEKYLAGASRAVDGVIAAAVQNFDDAAVLNTIFDFGVQPTTSDLDLV
FDPDYFSKEKALTLLERGAKPKNNMIFKAVAYKAPEVIYALLREGAKPVNNDIAFAVRNK
DYKAVKALMSDGITNFTADTEMLALAVTNADADLVEQFIEFGAEANATILEEALKSEDSE
LLDQIKMVTTTSAQVLEVVAQADDTTLFSYFLQQGEAQLSDKVITTAITNSNLAILGQAL
DQEDRADFSLEQAILFKSTPAVRLSLEHGANAAPAFDYAAAENDFTLFKESLDRFNGDPK
TALRVAVKYNQTDFAKYVFQQKEAEVDPNVHLTEVVKNENQELVEFLISKRADPQLAVDA
AIQSGNSSITHYLIEKGAVVENPNLLKSASKNQNIELAKVLLETRQMDPDAIMLDLIALK
DAKLVETNLSYGAQADAAALRAAVDSKSEEIALKLIELAANDLLTNTLIFNAVKNGMPQV
VSHLIDRVSNPDYAYKAALETKQAEMLNLSIAKGAMTEDQDLFRVMRADFQEAVPVLLDA
GLDPKVLDLEGNTLLHYVVFKSDKEDLQLIEDLLDYGLNINAKNKIGETPLHWAVKGGNQ
NTEIIKKLLANGALVEAQTIKRQTVYDYAEDKSIRQLLKESIYR
>KECLDBNJ_01365 hypothetical protein
MKRIITLVFIISFSCVKAQEPEQAKEVVIAFFNAFHQQDTLAMKELVYDSIKMQSIGLSK
SGSVKLSTSSFDSFLKSIAGIPDTVNFEERILDYKVRVDVLMANVWTPYEFYINNEISHC
GVNNFQMIWDDNTWKIFYIVDTRHQEGCK
>KECLDBNJ_01366 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSAAKKEYKRITVKSLTEMKSQGEKIAMLTAYDYTTAKILDRAGIDVILVGDSASNVMAG
HETTLPITLDQMIYHASSVIRAIKRSLVVVDLPFGTYQSDPKEALRSAIRIMKESGGHAL
KLEGGKEIKESIKRILHAGIPVMGHLGLTPQSIYKFGTYTVRAKEESEAQKLKEDALLLE
KLGCFAVVLEKVPSKLAKEVAESLTIPVIGIGAGNGVDGQVLVMHDMLGMSKEFSPRFLR
RYLDLHTLMTGAFEQYITDVKAVDFPSEDEQY
>KECLDBNJ_01367 putative RNA pseudouridine synthase
MVKSYIAEKYNKPGAVYLGVVHRLDRPTSGIVIFARTSKALPRLNKLFAAKEAKKTYWAL
VKENPPKNSDRLVHYLKRNPKQNKSYSHINEVPDSKKGILEYRVLKKLNTYSLLEVDLHT
GRHHQIRSQLSAIGCPIKGDLKYGFDRSNPDGSIHLHSRKLTLVHPVQKKEMTFIADPPL
DDNLWRACLSD
>KECLDBNJ_01368 hypothetical protein
MAIRLGNSCSNCENLTASNQCKLHDVQVTAGYTCDSFSMKAELKNDPNCANCARFHGPTC
ANPQKAAPEMLCSHWAPHNNAA
>KECLDBNJ_01369 Threonine/homoserine exporter RhtA
MTQTQNSYIKNILQLNLAMLLVSTSGVLGRAVTLPPVVTIGWRALLAVGFLFLFLKWKRI
SLKIDREDRFKVILGGILMGIHWVAYFKALQLSNVAIGMLTIFTYPALTSILEPLLLKLP
FQKIHLFLGLLVLAGIAFLIPDLDFENEYTQAVAFGLGSALAYALRNILMKKQVEKYHGS
LLMTYQALIVGIALIPLSFQTNVEALQENLVWLLALALLTTALGHTLFLMTFRHFSITTA
SIISSVQPVYGIALGILLLGEMPQWSTIIGGVLIISAVIIESLRNVKPKA
>KECLDBNJ_01370 hypothetical protein
MRKIITTANDSKDSLYVLIKSLSKSEKRQFKLYVGRLDGNADSKYLQLFNLLDKMNTYDE
SEIFKQNIVKKQQLSNLKAHLYKQILISLRLSPAHQNIRVQIREQLDFATVLYQKGLYQQ
SLKLLEKAKHMAIENEEKNVAYEIVELEKVIESQYITRSMSTRSEELANEAKILSQQNLM
TSKLSNLSLQLYGLMLKTGYVRSDEEKREITQFFTKSMPKYKMSDLGFREKLWLNKAYLW
YSFLIQDFLSCFKYATRYVELFEETPSMIARNPVFYLKGNHYLLESLFFLKHHTKFEEVL
ARLETRLASTDFPHSDNLEILEFLYVYSHKLNHKFMVGDFSTDDGLIEKIEKYLKQSGQR
MDEHHIMVFYYKIASLYFGNGQNKKCIEYLGKIINNKSLKMREDLMCFARILNLVAHYEA
GMDYHLETLLRSTYKFLIKMDDLHEVQKEMIKFLRNLGEIFPGELKNEFKKLRNRLEVYE
DDPYERRAFLYLDILSWLDSRIENRPVADIIKEKASLLNR
>KECLDBNJ_01371 2-isopropylmalate synthase
MTDNKVQIFDTTLRDGEQVPGCKLDTQQKLIIAERLDLLGVDVIEAGFPISSPGDFKSVE
EISRLVKNATVCGLTRAVKKDIEVAAEALKHAVKPRIHTGIGTSDSHIKYKFKSNREDII
KRAYDAVAYAKTFVEDVEFYAEDAGRTDNEYLARVCEAAVKAGATVLNIPDTTGYCLPEE
YGAKMKYLMENVKGIDKAILSCHCHNDLGLATANSIAGVVNGARQIECTINGIGERAGNT
ALEEVVMILRQHPDLGLDTNINSRLLWDTSKMVSDKMGMPVQPNKAVVGSNAFAHSSGIH
QDGVIKNRETYEIMDPEEVGVTESAIILTARSGRAALAYRSKKVGYELTKLQLDDVYEVF
LKFADKQKEIHDEDIHEIMKEAKIQTQVEA
>KECLDBNJ_01372 3-isopropylmalate dehydratase large subunit
MAGKTLFDKVWDAHVVDTVPNGPQVLYIDKHLIHEVTSPQAFSELEERGIAVARPDQIVA
TADHNTPTVDQHLPVRDVLSRNQLKQLSENCEKHGITLYGLGHKYNGIVHVMAPELGITQ
PGMTMVCGDSHTSTHGAFGTIAFGIGTSQVAQVFASQCLLLTKPKSLRVNVNGKLKPNVL
PKDVILYVISKIGTNAGTGYFCEYAGNVFEEMSMEGRMTVCNMSIEMGARGGMIAPDQTT
FDYVQGREFAPENAEWEEKLAYWKTLPTDADAVFDKEYSFDAEDIEPMVTYGTNPGMGIK
VTGTIPDKEDVNLDKALAYMNFKKGESLIDKPINYVFIGSCTNSRIEDFRIAADFVKGKQ
KAPNVNAWLVPGSQQVAKQLVEEGLDKVFTEAGFALRQPGCSACLAMNDDKIPEGEYCVS
TSNRNFEGRQGQGARTILASPLMAAATAVAGKITDITKQLN
>KECLDBNJ_01373 3-isopropylmalate dehydratase small subunit 1
MEKFTKLTDTAVPLPIENIDTDQIIPARFLKSTDKKGFGDNVFRDWRFKQNGEVNEDFVL
NDPTYSGPILVAGDNFGCGSSREHAAWAIAGYGFKVVISSFFADIFKGNALNNGILPIQV
TPEYLKELLALVAEKPQTKLTIDLENQLLSTPAGELEFEIDPYKKVCMINGYDDIDFLIS
KKDKIEAFELERSF
>KECLDBNJ_01374 3-isopropylmalate dehydrogenase
MKFDIALLAGDGIGPEVTEQAVKALDAIADVYNHTFKFNKALVGACAIDETGDPLPEDTI
KLCQESDAVLFGAIGHPKYDNDPSAKVRPEQGLLKLRKSLGLFCNIRPVKAYERLIENSP
LKKEIISGTDISIYRELTGGIYFGSKELSEDGQVASDGCSYSVEEITRIAHLAFKEAQNR
RKKLTLVDKANVLETSRLWRKTVTEIAKEYDDVELDFLFVDNAAMQMILNPSQFDVILTE
NLFGDIISDEASVIGGSIGLLASASIGSTVGMFEPIHGSFPQATGKNIANPLASILSAAM
MLRHLDLQKEADAIEKAVEKSLELGITTGDINPKKPYSTTKVGDFIADYITHPEDSNRNF
RNIHAGQSTII
>KECLDBNJ_01375 hypothetical protein
MLFVYILIGILVLIAILHLTAKKQYVVKRDINIQKPADKVFEYLKYLKNQDHWSPWSRKD
PDMKKVYEGVDGTVGFVSKWDGNKEVGSGEQEITGIIPGKRIESQLRFIKPMKSTSDAWL
AVSTPNPGITNVAWGFSGKNKFPFTVMTYFMSMDKMVGKDFEAGLKNLKEILEDN
>KECLDBNJ_01376 Solvent efflux pump outer membrane protein SrpC
MIKKINKTQFLYTVMVLFILAFSACKAPGLAEREVDLKDLPQSYTNYAVTDTTNTALIHW
KQYFTDPYLTVLIDSALANNQELNIMLQEIAISKAEIKAKKGEYLPFVGFGAGAETEKVG
RYTSQGANDANTDIRPGEEFPEPLPNYDFGLKATWELDIWKKLRNAKKAAVFNYLSSVEG
RNFMVTQLVGEIAENYYELLALDNQLEILNRNIEIQNNAYRIVRLQKEAARATGLAVSKF
EAEVLHTKSLQFDIQQRIVEAQNRINFLVGRFPQHVARSSQDLMAMKPAVIQSGVPAQLL
ENRTDIKQAELALEAAKLNVKVAKARFYPSLGISAGVGFEAFNPKYLLDTPESLLYSIAG
ELTAPLINRNEIKAAYAGANAKQIQAVYDYEQTVLNAYIEVANQLAKVDNLEQSFALKSQ
EVDALNRSVNISGQLFSSARADYMEVLMTQRDALESNFDLVETKMAQMNAYVHMYQALGG
GWN
>KECLDBNJ_01377 Efflux pump membrane transporter BepE
MFSRFIHRPVFAIVISIIIVFIGSLAIKQLPISQFPQIAPTTVNIFIAYPGASADVLVKS
TLVTLENSINGVQGMRYMATDATSAGEATLRIIFEPGTDPNQAVVRVKTRVDQVMPLLPE
LVQREGVVITPIQPSMLMYVNLYSKEKSMDEKFLYNYANVKMIPEINRLKGVARSQILGS
RRYAMRVWLNPDRMRAYDVSVDEVMEAMQEQSIVGRPGRLGRSSGIEAQSLEYVLTYKGR
YNEPEQYENIIIRANSEGESIRLKDIGKVELGSEFFDIYSNLDGHPSAAIVLKQNYGSNA
SDVIDEVKEKLEEMRADFPPGMDYKISYDVSKFLDSSIEQVIDTLRDAFILVALVVFIFL
GDWRSTLIPIIAVPVSLIGAFFVIQFFGISINMVTLFALVLAIGIVVDDAIVVVEAVHAK
FEEHPHISPYLAVKQVLGEISGAIIAITGVMVSVFLPISFMSGPVGTFYRQFSITMASSI
VISALIALTLTPVLCAMLLKNNHGQEKKRNLFTRALDKFNSGFDKLTGKYVAVLKRIVSR
RWLTFGILIAFCIGIFLESQVLPSGFIPSEDQGTIYAIIQTPPGATLERTNKVSLELQKI
AEEVDGIESVSSLAGYEIMTEGRGSNAGTCLINLKPWSEREHDVTKIMEELEEKSKGLGA
IIEFFEPPAIPGFGSSGGFSMRLLDENTETDYQDFDKVNQEFVDHLKARKELTGVFTFFA
ANYPQYELEFNNDLAMQKGVSIGKAMENLNIMIGSTYEQGFIKFGRFFKVYVQSDPKFRR
LPSDVLNMFVKNEDGEMVPYSAFMTLKKTQGPNEVTRFNMYNSAAIRGLPAPGYTTADAI
EAIREVAATTLPKGYDIGWEGLSYDEANRGNESVYIFLIVLVFVYFVLAAQYESFIIPLS
VVFSLPVGVFGSFMVLKMMGLQNDIYAQIGLIMLVGLLGKNAVLIVEFAVLKRSQGATIL
DAAIEGAKVRFRPILMTSFAFIAGLIPLLLASGAGAIGNHTIGASALGGMLFGTIFGVII
VPGLYFIFGSLADGRKLIRDEEDGSLTEGFVHEIDSFSNSEEDDQEDK
>KECLDBNJ_01378 Toluene efflux pump periplasmic linker protein TtgD
MKKILMMLGLGTMLFHVSCKSEHHEKEEETTFYVTNPMRKDTVITKDYVAQIHSSRHIEL
RAQERGYLQKIFVDEGQSVKKGQLLFQIMPKLYEAEMQKAKAEAQFANIEYQNTKKLADS
NVVAPNELAMAKAKLEKANAELALSQVHLEFTQIRAPFDGIVDRFHVRLGSLVDEGELLT
NLSDNNIMWVYYNVPEAEYLDYKAALKDATKPEVELLMANNKYFGHKGIVETIEADFNNE
TGNIPFRATFPNPDALLRHGETGNVHVTIPLENALLIPQKATFEVLDKKYCYVIDDEGVV
HSRQITIAEEMPHLYAVSDGLSTDDKILLEGLRLVRENDKVEYEVEEPSEAMAELALYAE
>KECLDBNJ_01379 hypothetical protein
MKFLFSFIVFLAGFVQLSGSSYLPADSAMQSNAFEETLINDLNQPHFDVVHSQNLELRIA
EFEIEESDRSISKASQSLATAVLATQTSVPRCFYFKYKYLKTKARSSLSASVKPYLLFQV
FRL
>KECLDBNJ_01380 Argininosuccinate lyase
MKLWDKGADIDTKIIDFTVGNDREIDVHIAKYDVQATRAHVKMLNKIGILTDEELKSLLP
QLDILEAHTQNPDFFIEPEYEDIHSKLEAELTLILGDTGKKVHTARSRNDQVLVALQLYY
KEQLQQIKARTVSLFETLMHLGEKHKDKLLPGYTHLQVAMPSSFGLWFTAYAELLIDDVI
LINATQDIVDQNPLGSAAGYGSSFPIDRQMTTKELGFATMKYNVVAAQMARGKSERTLAS
TLGSLANTLSRFAMDVCLYMSQNFGFVSFPEHLTTGSSIMPHKKNPDVFELIRGKCNKIQ
SLSTEMVLITNNLPSGYHRDYQLLKENTISAVETIKDILEIFDYAIGQVIVKEIDLNDEK
YKYLFTVDSINDLVVEGKSFREAYQQIGSQVQDGTYKPEAGKNHTHIGSIHNPGFAEIKA
KMRKVSTALDIK
>KECLDBNJ_01381 Acetylornithine deacetylase
MNREQLTQEAIELLKKLIATQSFSSEEEGTAAIIEAWFNAHDIPFKRQANNIWATNKDFQ
EGKTTLLLNSHHDTVQPNNGYTRDPYSPDVEDGKLYGLGSNDAGGCLVSLIATFTYFYAQ
ENPKYNLVIVASGEEESSGPNGLNSMLKVIPPVDVAIVGEPTLMNLAVAEKGLVVFDAKV
KGTPSHAAHPNDNNAIYNCIEVLEWFKNFKFEKSSDALGDVKMTVTQIKGGKQHNAVPAD
VELVVDVRVNDAYSNKEIADLLQEKAPCDEIIPRSLRLNSSSIPVDHDLVKAGIALGRST
YGSPTLSDQAVLSCPSLKLGPGDSTRSHSANEFIYVNEIEEGIEIYIDLLKSIL
>KECLDBNJ_01382 Acetylglutamate kinase
MKKLNIVKVGGNIIEKEEDLQSFLDAFAALPEPKILVHGGGKLASQLAERLAIPVNMVNG
RRITDAETVEVITMVYGGKVNKSIVAGLQARNCNAIGFSGADGNTILSVKRPVKEIDFGF
VGDVVAVDSEMIDKLLSIGITPAFCAITHDGNGQLFNTNADTIACELARGLSANYEVTLN
YCFEKNGVLLDINDDTSVVKDIDSAKYAEFLEEKIIADGMLPKMENCFYALKGGVQQVRL
GKPEMLHHKDANFTTLRL
>KECLDBNJ_01383 N-acetylornithine carbamoyltransferase
MKKYTGLDDITDLQELIAEARALKANPYAYEHLGKRKRLVMLFFNSSLRTRLSTEKAASN
LGMDVTVMNFNSDAWKLEFEDGTVMNADTSEHVKEAAKVISQYGDVIAVRAFPTLTDKAK
DESEYVISNFVKYATVPVVNMESATAHPLQALADAITITELSQKKRPKVVLSWAPHPKAL
PHAVANSFIGMMQKMDVELTVTHPKGYELSDATMKDTPVVYDQDEALKDADFVYVKNWSN
YENYGKVLATVDSHSSWTITDEKLGNAKFMHCLPVRRNVIVADEVLDGKQSVVIEQANNR
TFSAQVVLKKILENLN
>KECLDBNJ_01384 Acetylornithine aminotransferase
MSLFDVYPLYDVTPIKAQDVWVYDAAPTKYLDLYGGHAVISIGHAHPKYVENLTKQLGDI
GFYSNAVKNPLQEALGEKLPLQANCPGYQLFMCSSGAEANENALKMASFVTGRKKVVAFH
NSFHGRTSAAVAATDNPKIVAPINAQQEVEFLPLGDLDALAAVLAKGDVCAVIVEFIQGV
GGLDISTAEFYEGVDKLCKETGTCLIADEVQAGFGRTGKFFAFQEYNVEPELISMAKGMG
NGFPVGGILIHPSIKAEYGMLGTTFGGNHLACTAALTVLEVLEEEDLMTHALRVSDHFKA
KTTEIPQIKAVKGRGLMLGIEFDFDTAALRKKLIYDQHIFTGSAKNKNLIRILPPLTVQN
EHIDQFFEALKIELNNL
>KECLDBNJ_01385 Pyrroline-5-carboxylate reductase
MKIAIIGTGNLGLSIAKGLITNNAITSLYMTRRNPAGIESYAEYKNVFVTSDNVEAVQKS
DILIFAVQPAQLGSILHDIKNELTDKHVLISTITGYQISQIEDIVGTDQFIIRAMPNTAI
AVGASMTCLASNEKGMKRIKIAEAIFNRLGNSLIIPEKQMQAATVVCASGIAFWMRLIRA
TTQAAIQLGFDAKEAQELAMHTCNGASKLLIDSGNHPEEEIDRVTTPKGCTIEGLNEMEH
KGLSSSLIQGMVASFNKINVIKTDQK
>KECLDBNJ_01386 N-acetyl-gamma-glutamyl-phosphate reductase
MIKAGIIGGAGYTAGELIRILLNHNYVDLSFVFSTSNAGNLLSDVHQDLLGSTDIRFADT
VDFNVDVVFLCLGHGNSTAFLDKNVFSEETIIIDLSNDFRLKPDAEFQGREFIYGLPELN
KDEIKQAGSIANPGCFATAIQLALLPLADSKNITSDIHINAVTGATGAGTSLSATTHYTW
RDNNFSYYKPFTHQHMGEINQSVKSLQSGFDKEIFFLPNRGNFSRGIFATAYTKFEGDLE
AIKKIYTDFYAEAPFTFVSETDIHMKQVVNTNKCLIHLHKHNNQLLITSCIDNLLKGASG
QAVENMNLIFGLPQTEGLNLKGSYF
>KECLDBNJ_01387 Argininosuccinate synthase
MKKLVLAYSGGLDTSYCAKYLSEEKGFEVHAVSINTGGFTQEEIDEIESKALKIGAKTYK
NVQAVDRFYDKVVKYLIFGNVLKNNTYPLSVSAERIIQAVEIINYAKSIGAEYVAHGSTG
AGNDQVRFDMIFQTLAPEIEIITPIRDLKLSRQEEIDYLKSHGVEMSWEKAQYSINRGLW
GTSVGGSETLTSHQGLPESAFPSQVEKSEAEKVTLTFEKGELTAVNGKSGSPVENIEALQ
KLAAPFGIGRDIHVGDTIIGIKGRVGFEAAAPVIILKAHHLLEKHTLTKWQMQHKDYLSN
FYGMHLHEGQYLDPAMRNLEAFLTDSQKNVSGEVYVTLQPYRFTLEGIKSDHDLMNASFG
AYGEMNKGWTADDAKGFIKITGNQNKIYNHVNGDS
>KECLDBNJ_01388 hypothetical protein
MEIIIANKSHAGYAQYICDTIAESAKVRGTGIAKRTPEYVITKMENGNAVIALDGEKFAG
FCYIEAWGHGKFVANSGLIVHPDYRGSGLARQIKEAIFNHSRAKYPDAKVFGITTGLAVM
KINSDLGYRPVTFSELTDDPTFWKGCQTCRNYDILQRTEQKMCLCTGMLYDPEKEEKKKQ
EIEDKINQRVREKEEVNPKAFTRLKSIKEHLFLKKDKKKEE
>KECLDBNJ_01389 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MKQLPTDIPDQFKVDSIEQRTYLIDGKMHNWNGETADVFSSIHTEKDGERQPTRLGSIPS
LGESEAIAAVDAAHKAYDRGQGLWPTMKVADRIKCMETFVTKMKEKRELIVKLLMWEIGK
NYPDSQKEFDRTVEYILDTIEDYKNMDRESAKFYKEGGIHAHIRRGPLGVVLCLGPYNYP
LNETFCLLIPALIMGNTAVFKPAKHGVLLITPLLEAFQESFPAGVVNILFGRGRAVATPI
MKTGKVDVLALIGHSSSANSLQALHPKQNRLRLVLGLEAKNPAIILPDADLDLAVAECIA
GTLSFNGQRCTALKVIYVHENIAETFNRKYAEAVDALKFGLPWEDDVKLTPLPEPSKPDY
IQQLIDDAKAKGAKVINAKGGERSENFIWPAVLFPVTKEMEVYKEEQFGPVVPVLTFKHI
DEPLDDMAESNYGQQVSLFGKDVKALAPLIDTLVNLVCRVNLNSSCQRGPDVYPFTGRKD
SAVSTLSVHDALRSFSIRTFVASKDNAYNNAILNELLDTKKSNFVSTDYLL
>KECLDBNJ_01390 L-threonine dehydratase biosynthetic IlvA
MHFETGLLNPNTFILGDLKTTFFPDLEQIKEAAKTLEGVAALTPLMPSLNYSRKFDANVM
LKREDLQQVRSYKIRGAFNKINSLSDEERAKGIVCASAGNHAQGVAFACAKLKINGTIFM
PSPTPKQKIEQVEMFGGEYAKIVLTGDTFDDAYKASKIECDALGKIFVHPFDDEKIIEGQ
ATVGLEIIEQSKDEIDYVFVPVGGGGLASGLSTVFHLLSPNTKVIGVEPEGAPSMSTSIF
NKENTTLSLIEKFVDGAAVQRVGDRTFAICKEYLEKMVTVPEGKVCQTILDLYNKEAIVV
EPAGALTLSVLDQFADEIKGKNVVCIVSGSNNDITRTAEIKERALLYRGLKHYFIIRFPQ
RAGALREFLNEILGPEDDITFFEYKKKTSREDGPAVVGIELKDRKDLDPLIARMKSRNFF
GEYLNDKPDLFEFLI
>KECLDBNJ_01391 Ketol-acid reductoisomerase (NADP(+))
MSNYFNTLSLREQLAQLAKCRFMESEEFSNGVEALRGKKVVIVGCGAQGLNQGLNMRDSG
LDISYALREGAIKEKRASYKNAVDNGFTVGTYDELIPTADLVCNLTPDKQHTSVVNTIMP
LMKEGATLAYSHGFNIVEEGMQVRKDLTVIMCAPKCPGSEVREEYKRGFGVPTLIAVHPE
NDPEGKGLDQAKAYAVATGGHRAGVLESSFVAEVKSDLMGEQTILCGMLQTGSILCFDKM
VEKGIDAGYASKLIQYGWETITEALKHGGITNMMDRLNNPSKIKAFELAEEIKDITRPLF
HKHMDDIISGHFSKTMMEDWANDDANLLKWRAATGETAFEKTPAGSQEISEQEFFDHGVL
MVAMVKAGVELAFETMTEAGIIEESAYYESLHETPLIANTIARKKLFEMNRVISDTAEYG
CYLFDHACKPMLTEFMKGIDTDVIGKAYATDNSVDNKTLIAVNDAIREHEVEAVGAWLRE
SMTAMKDIKTVASGEAVTA
>KECLDBNJ_01392 Putative acetolactate synthase small subunit
MSEIKTYTVSIYTENNIGLLNRISAIFQRRKINIESLNTSISEIEGVSRFTIVINLTEER
MKKIIGQLEKQVEVIKAFYHTDEETIFLETCLFKIKSDLLFEERQIQNIIKESSARIVTV
NKEFFVLEKAGRRSEIELLYRELSAFGIMQFVRSGRISVTKDEMKISKMLAEFAE
>KECLDBNJ_01393 Acetolactate synthase large subunit
MDNTQTIKLQDTAVEATQRLTGKEAIIKCLLAEGVDTLYGYPGGAIMPVYDELYKYQDKL
HHVLTRHEQGATHAAQGYARVSGRVGVAIATSGPGATNLITGIADAQIDSTPMVCITGQV
ASHLLGSDAFQETDIIGISTPVTKWNYQITKASEIPEVMAKAFYIAKSGRPGPVLIDITK
DAQFEEFDFAYKKCTAVRSYKPVPKLNPEALQAAAEEINNAKKPMIVWGQGVILGKAEEE
FKAVVEKSGVPAAWTILGVSAIPTDHPLNVGMVGMHGNYAPNLLTNECDVLIAIGMRFDD
RVTGDLNTYAKQAKVIHFEIDPAEVNKNVTADIAVLGNSKETLAALLPLLEEKKHTEWLN
RFKELYQVEFDKIIKDDITPEKEGLTMGEVLEGINKVSKGDAVIVSDVGQHQMIACRYAK
FNQSKSNVTSGGLGTMGFALPAAIGAKMGAPERPVVAIIGDGGYQMTIQELGTIFQTKVP
VKIVVLNNDFLGMVRQWQQLFFDRRYASTELINPDFVAIAKGYYIDAKRVSKREDLAGAI
EEMLASDGPYFLEVTVEKEDNVFPMIPTGASVSDIRLE
>KECLDBNJ_01394 Dihydroxy-acid dehydratase
MELNKYSKTVTQDPTLPAAQAMLHAIGLTDDDLKKPLIGIASTGYEGNPCNMHLNALATH
VKQGAANADLVGLIFNTIGVSDGISNGTPGMRFSLPSRDIIADSMETVVQAMSYDGLVTV
VGCDKNMPGALIAQLRLNRPSILVYGGTIASGCHNGKKLDIISAFEAYGQKVAGTIDDNE
FKEVVHKACPGAGACGGMYTANTMASAIEALGMSLPFNSSNPAVTDANIKEQECVKAGEA
LKYLLEHDIKPSDIVTKQSLENAIRLVTVLGGSTNAVLHFLAIAKAAQVDFTLEDFQRIS
DNTPLLADLKPSGKYSMEDLHGVGGIPGVLKYMLDNDMLHGDCLTVTGKSLAENLKDVPN
LIDGQDIIRPLDKPIKDSGHIRILFGNLATEGAVAKITGKEGLSFTGTANVFNSELEVND
GIKSGKVKKGDVVIIRYEGPKGGPGMPEMLKPTSSIMGAGLGKDVALITDGRFSGGSHGF
VVGHVSPEAQVGGNIALVENGDIISIDAVKNTINIDITDEELAKRREKWTAPELRFQRGA
LYKYAKTVSSASKGCVTDEM
>KECLDBNJ_01395 General stress protein 69
MKFRRLGKTNLKISEISLGTWQVGGKWGSGFDDNKAEHIINTAIDQGINFIDTADVYENG
LSEAAVGRVVRSRSEEVYVATKCGRQITPHVDAGYTVKALRKYVEDSLKNTGLERLDLIQ
LHCPPTDTFYRPEIFRLFEDLKQEGKIANLGVSVEKVEEGLKAMQYDNVTTVQIIFNVFR
QRPAGLFFREAEKNDIGIIVRVPLASGLLTGKFDQNSSFDKEDHRNFNRNGEAFDKGETF
SGIDFEIGLQAVDELKSIFPKVENLAPVALQWILQHPQVSTIIPGASKVEHLMSNLSLYE
RPDLTSEEIEKMNAVYTEKIKPLVHQKW
>KECLDBNJ_01396 hypothetical protein
MATPTKKGNLYKLSLEQLGVLKEEKRVDTALELEFSNHDELFEIIERVKTKQLFATAEES
TEFALGLKLFTEVMLRNKKHPLFEDLRPHIIDFMKKLKSS
>KECLDBNJ_01397 Aminoalkylphosphonate N-acetyltransferase
MPKVTIRRVTKSDTDFILNLLPSLMDPELPHWRDPEVMLDIDQRILKAEIEEGNKDNAIF
IAEDAQDHQRLGFIFLEIGTDYYHREPHGHIADIIVAPEARGRGIGKMLMQKAEEWTKDC
GYSLLTLNVFDDNKKARKLYQSLGFTPDLTKYGKIL
>KECLDBNJ_01398 Succinate-semialdehyde dehydrogenase [NADP(+)] 1
MITSINPYNQEVISEVKELTKAELVEHIEIAHERFLSWRKTTFEERAALMQAAAADLNEH
KEAYAKTISLEMGKPIKQAIAEVEKCAWVCEYYAENAPKHLAPKSIEADAVESYVSYEPL
GVVLAVMPWNYPFWQVFRFAAPALMAGNIGILKHASNVMGSAQNIQKVFERAGFPKGCFT
NLPIASAKVESIIKNPKVKAVTLTGSKPAGSAVASVAGSEIKKSVLELGGSNALVVFEDC
NIEEAVKTAVQARFQNTGQSCIAGKRLLLHKNIAEEFTQKFVEEVRKLKSGDPADEETFI
GVMAREDLAEELHEQLTKSVKQGAVILVGGKRDGAYFEPTVVTDVTPSMPIFKEETFGPV
IGITTFKNEDEAVYLVNSSNFGLGVSIFTEDFEKAKKLITLFDDGAVFVNELVKSDPRLP
FGGTKISGYGRELSEDGIKEFVNKKTVYFNSYS
>KECLDBNJ_01399 hypothetical protein
MNSRDSQLLALRPEILSARVDDTMSADEQFQNGTLRPVVKLQNELLLEAFRNYIKKHKNV
FYTLNIDRRMQYIENAIQKDIKFRNSLKGMVIGQFTVEEYQKYIQNSSALNKRMMNLVKE
RIQSNIQLLERELV
>KECLDBNJ_01400 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNVGVVNVPDPRLSKLEELVKPER
VVPATVDIVDIAGLVKGASKGEGLGNQFLGNIRETDAILHVLRCFDNDNIVHVDGSVNPI
RDKETIDIELQLKDLETVDKKLEKVKKAARTGNKEAQKEESVLAQIKDALEQGKSVRAVV
FSEEDYAEFVKPLQFITDKPVMYVCNVDENSAVSGNKYVDQVREAVKEENAEVLVLAVGT
EADINELDDYEERQMFLQDIGLEEPGSSKLIRTAYKLLNQQTYFTAGKKEVRAWTTKIGS
TAPQAAGVIHTDFEKGFIRAEVIAYEDYVSYGSETKVKEAGKMGVEGKNYIVKDGDIMHF
LFNV
>KECLDBNJ_01401 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWRYSDGTDLEGKIVLPNGREVDADETQEPI
SDEVYYIAPDKCTECMGFHEEPQCAAVCPVDCCVPDEDHVETEEELLGKQAFMHHN
>KECLDBNJ_01402 hypothetical protein
MDLNQRITAFSNLSLFLKNFLSDATKCEATLNDFEHLKEELQQVIQTANRHNAWFTPEHI
TQALSSWSAALQKDNLTTWLDAYAITSSSEKRVAVIMAGNLPLVGFHDFLSVLITGHHLV
AKLSSDDQLLMPFLARVLIIIEPGFDSKITFTKEKLPQFDAVIATGSNNTARYFEYYFKN
KPSIIRKNRNAVAVLTGNETPQQLEALGDDIFGYFGMGCRSVAKLYVPQNYDFDTFFQAM
FKQQDVINHHKYANNYDYNKAVYLMSLFPVLDNGFMVLKEDTNFSSPISVVFYERYTDVE
TLKAELQSKADQIQCIVADDFSDEDVAFGQAQNPKLYDYADGVDTVAFLLKL
>KECLDBNJ_01403 Phosphoserine aminotransferase
MKKHNFSAGPCILPQEVFKQASEAVLNFNNLDLSILEISHRSKDFVDVMEEARELALELL
GLEGKGYKALFLQGGASMQFVMTAYNLLENKAGYINTGTWSDKAIKEAKIFGEVVEVASS
KDKNYNYIPKGFDVPKDLDYLHLTTNNTIFGTQIKDIPTTDVPLVADMSSDIFSREIDFS
KFDLIYAGAQKNMGPAGTTLVVVKEDILGKVTRQIPSMLSYATHVSKGSMFNTPPVFAVY
VSMLTLRSMKAKGGISAAAEENEKKATLLYSEIDLNPLFKGYAAKEDRSLMNATFNLTED
NLKETFDTMLKEAGINGLNGHRSVGGYRASMYNALPLNSVGVLVDVMSELERKA
>KECLDBNJ_01404 Hydroxypyruvate reductase
MKVLANDGISQSGVDALKAAGFEVITTKVAQEQLINYINENKVDALLVRSATKVRQDLID
ACPDLKLIGRGGVGMDNIDVQYAKDKGLSVINTPAASSASVAELVFAHLYGGVRFLFDAN
RNMPLEGEEKFGALKKAYAKGVELRGKTLGVIGFGRIGQATAKVALGAGMKVIYSDPYME
KAEVKLDFFDGQEVAFKFESKAKEDVLAEADFITLHVPAQKEYVIGKAEIEKMKDGAALV
NAARGGVIDELALIEALDSGKLAFAALDVFESEPKPEIKILMHPKISLSPHIGAATNEAQ
DRIGVELAEQISSILKA
>KECLDBNJ_01405 hypothetical protein
MSGLLDLLNSDLGKQLISGASAQTGASESKTADVLSMAMPLLLGAMKKNASSQEGASGLM
GALSGKHDGSILDNLGSILGGGSVDQNVIQDGAGILGHVLGGKQPMVENALSTKTGLDAG
TVAQILKIAAPILLGIIGKQTKENNIQDQDGLTGILGSMLGGQPKENQSLIESLIDSDGD
GSVLDDVADMVLGSNKKKGGLGGMLGGLFGK
>KECLDBNJ_01406 hypothetical protein
MKNLIYVVIALVVICGCASSQGEKKLETSDPLSTSNDTVRIANDSLEYEIIIIEPGYNAF
LNSIARPEGYYSQNYLENKNRFIVPEYNQRVLQPFRYNNNLYPQQIDYNSSVDYGYEVNY
KLYYYFVYFCRKYNQRFSVPTRI
>KECLDBNJ_01407 hypothetical protein
MKKFKEHWEITQNWQLIYPILGIILSLACGILIARRLDFFLEPGALQTVYLVILTLVLTY
LIIKLSLYCFKKLKNRWILQYRWQFIAAFIVFAITGSTAGRISSPVMQALGLGSDSISGW
IYWPLRIIIIFPLYQVLLLIVAWIFGMYSFFYAFEKKMLSRMGLGFLFKN
>KECLDBNJ_01408 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKILSKEQVYQADKATENAENIPSYNLMERAGGYAFEFMHQRLQGQPVPVKIFCGIGNNG
GDGLVIARYFVEHQYPVDVYVVNYSDNRSKDFLLALEELKKVTRKWPQVLKSEDDLPQIN
REDLVVDCIFGIGINRPAPKWVQQLFVNINQSGAYTVAIDVPSGMGVDVYIKDSEVIKPT
IVLSFQTPKLAFFLPQSGKYINNWTVLDIGLDRNFMNSVQTQAQLIDKAEAQQMYKPRTK
FSHKGTYGHALLITGSYGKTGAAVLSCKGALSSGAGLVTAYTTQHGLPILQSSLPEAMVL
ADRYNGKYLEEIQFDLAPTVIGVGPGLGTEKITQQALKTFLKANKIPLVVDADALNILSE
NQEFLEFLPKYSVLTPHPKELERLIGTWEDDFEKLKKAEAFSKKYNCVLVLKDAHTITVF
DGKYYVNNTGNPGLATGGSGDVLTGIITGLMAQGYDALTAAIFGVYLHGKAADIAINHTA
YEGLTASMITEFLGQAYLDLFAQPEQKQ
>KECLDBNJ_01409 Bifunctional aspartokinase/homoserine dehydrogenase 1
MRVLKFGGTSVGSVANINQVINIVKNGAQDQHIAVVVSALGGITDLLMQAGTDASNKDDY
NTAFKDIEAKHIEFTRTLIPDSDEALDEIKNLLKSLESLLQGIYLINELSPKTVDKLLAY
GEILSSSIIARAMYAQGLDAVRKDSRDLITTNDKHTKAGVNYKVTNSQIEYYFTKAKQKI
TVLPGFIASTANGDTTTLGRGGSDFTAAIVAAALDVDQVEIYTDVSGMYTANPKMVKQAK
PIESISYHEAMELSHFGAKVLYPPTIVPVMSKNIPIRIKNTLQPEEPGTLIHNQNGQSTN
PIKGLSNISNVALLTLEGGGMVGIPGISKRLFETLSNQGINIILITQASSEHSICLGVME
DDAGKAKNAIDEEFEYEISLNKIDPLTIEIGLSIIALVGDQMKSHQGISGKMFSTLGKNN
VNIRAIAQGASEKNISAVIAQKDVKKALNSLHERFFEAQRKQLNLFITGVGNVGEKLLNQ
IQQQQEYLKKQLNINMRVLGLSNSRKMLVDESGIDLQNWSALLDAGEPATLDGFLDHVVE
LNQRNSIFVDITANADVADMYGKYLKQSVAVVACNKIAAASDFKNYSELKRLSKAYNAPL
LFETNVGAGLPIIDTLNNLIASGDRVNRIQAVLSGSLNFVFNNFKSGDSFHDVVQAAKAE
GFTEPDPRIDLSGVDVARKILILARESGLKINLEDIENEPFLTENNLNSSDVPHFFETLK
EDAAHFEKLVAQTEAKNCRLKYVAQLDNGKASVGLQEIPEGHPFYNLEGSDNIVLFFTDR
YPTQPMQIKGAGAGGDVTASGLFADIIRTATF
>KECLDBNJ_01410 Homoserine kinase
MKEIRVFSPATVANVNCGFDVLGFALDGLGDEMVIRKVPEKGIKITEITGAELPFEAKEN
VVGVAGLAMVEALDLDYGFEVEIHKKIRLGSGVGSSAASASGIVFGINQFLDEPLSNLEL
TEFGMKGEAVASGNEHADNVAPCLYGGFTLITGYEPLKIVSVPVPEELYVTIIHPHITIK
TKEAREILPKEVSLKNAIKQTGNLAGLIAGLYTKDYDLIASSATDVLVEPYRKNLIPDFD
FYRETALKNGGIAFGISGSGPSMFTLSKGLQNAGAVEFALRKALKEKNMRSDSYVSPVSK
HGNRILEKN
>KECLDBNJ_01411 Threonine synthase
MNFYSLNGKAPEVGLEEAVVRGIAPDKGLYFPESITPLPQSFFDNIENLSNNEIAFTAIR
QFVDGVIPDEALKDIIADVLSFDFPVVEVEENIGTLELFHGPTMAFKDVGARFMARCLGY
FSAQKETQEPVTVLVATSGDTGGAVARGFLNVEGVDVVILYPTGKVSDIQEKQLTTLGAN
ITALEVDGVFDDCQAMVKTAFLDEEITSQRKLTSANSINIARWLPQLFYFLFAYKQAKSK
GKELVFSVPSGNFGNICAGMVAHKLGMPVKHFVASVNSNDIVPEYLKTGEYKPKPSVATI
SNAMDVGDPSNFIRIQKLFNNDLEALSQKLSSFSYSDEETKAAMQKIYAETGYIADPHGA
VGYLGLKHYLKDHPDAYGIFLETAHPVKFLPVVNPVIDAEIEIPEQIKAVMDKEKDAIAI
KNYDEFKSFLLS
>KECLDBNJ_01412 Aminomethyltransferase
MKSTALTKIHESLGAKMVPFAGYNMPVSYEGVNAEHETVRNGVGVFDVSHMGEFLAIGER
ALELLQKVCSNDISKIKVGGAQYNCLPNNEGGIVDDLIVYRIRENEYLLVVNASNIEKDW
EWISSHNEFGVELKNISDDYSLLAIQGPKAIEAMQSLTETDLSAIKFYNFEVAPFAGIDH
VIISATGYTGSGGFEIYCHNDHAEQLWAKVFEAGKDFGIKPIGLAARDTLRLEMGYCLYG
NDIDDTTSPIEAGLGWITKFTKDFVNAEALKAQKENGPERKLVGFELTTRGIPRKDYEIV
DADDNVIGVVTSGTMSPSLSKGIGLGYVKTSNAKPDTEIFIKVRNKSIPAKVVKLPFYKA
>KECLDBNJ_01413 hypothetical protein
MGASGFLGGALYKELHRYYDTYGTYHTGRIYSDNQHFIHFDVAQDSIYEVLNQVRPTVVI
SALRGDFEGQVEAHEDLCDYAQRTGIYVIYLSSANVFDAFVNYPSYEYDKTLSESKYGKL
KIRCENFFLNYLPEEQYAIIRLPMVFGMNSPRVRAIKNAILLQEQIEVFPHLIMNTTTDR
KLAQQIHFIINRSRFGIFHLGSNDLIHHQEFINEIIAKLDIKVKPQFKLVYTSNFDRYLA
VLPKDNKLPKHLSITNEEVVAESQAY
>KECLDBNJ_01414 hypothetical protein
MNVKKLLLYAAVLLLQFFGIKWIATYPEAVERYYSTGLFEYISVLFRYLFGWIPFSFGDV
MYTAIIIYAIIALVKLIKNRFKTLGIFCTKALLFANLIYFAFHFLWGFNYYRLPLHKALN
IENEYTTEELISLTQRLIKEANALHETLQPTDSLPVEFQQNLEEIFDKTPDGYAIVEDNF
PELEYHPKSIKNSLYRYPLSYMGFGGYLNPITLESQVNGLLPAHRWPLVSCHEEAHQLGF
AKENEANFIAVMATTNNPDPYFKYSGYIFALRYCLNDVYARNPAAGELLTNKIRPGILAN
YRQSRDFWIAYQNPLEPLLAKFYGGFLKANNQPAGMQSYSYVVALLVNYFKSRPQLP
>KECLDBNJ_01415 D-hydantoinase
MNKKLFFTGWLLFVFCMVSGQEYFPVNDGVKSINTNYTLFKNATLHPSPGKTISSGSLLI
KDGKIVSAGKSVNAPKNAVVIDLEGKHIYPSFVETYSSFGVKIPERSFGGRSPQYEATRA
GYYWNDHVRAETNALNEFEYDNKAAKALVEAGFGTVSTHMADGLARGNGILVALNSDGNT
AERLLDTRSAQFFSFEKSNLSQQSYPSSIMGSTALIRQMFEDADWYEAGNIDTRDLSLEA
LNANMDLPQIFYGDGLYDDLRIASLSQETGVPFIIVGGGDEYKRIDEIKATGAQYIIPVN
FQDAYDVEDPYQASFVSLSQMLEWNQEPTNPAKLQEAGLTFAITTNDLKSPDMLFPMLRK
AFKYGLEEETALAALTTIPAQLLGKSEELGTLNQNAWANFLITSGPIFDKETILYENWVQ
GAQNIIKDASVIDIDGSYTLTTGGKSYDLTISKSTEKPSVTAKDGETKLGSKIAYTDGWL
NITFTGDADKKEYTRIIAQASNTTPWNGKAILPDGSESTFSISKKASTEEEEEKEEDKEE
ITPEVMPLTYPNVAYGYDEQPQAETILFKNATVWTNEEDGILEETDVLVKNGKIDKIGKD
LSAGGAKVIDATGKHLTSGIVDEHSHIAAFSINESGQNSSAEVRMRDAVNPDDLDIYRDL
AGGVTTIQLLHGSANPIGGQSAVMKLKWGSSIDEMVLENTKFIKFALGENVKQSNWGSYS
RFPQTRMGVQQMFTDYFQRAKEYEAKKNSGEPYRTDYEMETLMDVLNEERHITSHSYVQS
EINMLMKVADSFDFNVNTFTHILEGYKVADKMAEHGVAGSTFSDWWAYKYEVNDAIPYNA
AIMWSQGVLTGINSDDAEMSRRLNQEAAKTMKYGGVPEEEAWKFVTLNPAKMLHIDDRTG
SIKVGKDADLVLWSTYPMSVSAVAEKTLVEGAVYFDIEKDKELKEKVEAKKNKLTTMMLS
AKNKGLKTQPAKKEEKQRLDCDTLETLY
>KECLDBNJ_01416 Imidazolonepropionase
MKTIKKLYLLLFFAVFTLQAQQTPAPVQKGDITLTGGVAHIGNGEVIENSLIFITDGKIV
GVYDATTTKRPLKGEIIKIDGQHVYPGFIAPDTTLGLVEISAVRATEDQDEIGEYNPHIE
AIIAYNAESKVVESMRPNGVLIAQTVPQGGTISGESSVVQLDAWNWEDAAIKRGDGIHLN
WPSSFRRGRWWMGEDAGYSPDKNYASEITQIKDFIGQSKAYEAGDSSIKNLPFAAMQGVL
DGSQNLYVHVDSEKEILDVLKFKEDMSIEKLVLVGAYRAYKIADAIAKAEVPVILARVHS
LPEAEDDDYNISFKMAKTLVDAGVKVALGNSGEYWQARNIPFYAGQTTAHGLSFEDALQL
ITKNSAEILGLGDQLGTLESGKDATLFVSTGNALEMKGNNLTHAFINGRSISLESHQTEL
WKRYMEKYDRTE
>KECLDBNJ_01417 Photosystem I assembly protein Ycf3
MKTKSLLLAALSFTAVTFAQKKEIRSAEKTVDDENYAQAQTEIAAVESMMGEMDEKEKEY
YYFVKGRAFLGGEKNTNADELLKAMEAFAKVSEFNDGDKYGDEATQYKQTAMNAIISSAV
DDQNAQKYDAAASKLYKLYTLTPKDTSYLYFAASNAVNGQDYDTALDYYGQLKELGYTGI
ETKYTAKNKESGQVESFPDKQQRDLFVKSGSHEDPKTEVTESRSGEIAKNIALIYIQEGK
NEEALSAIKDALAENPDDDALIRSAADVYLKMGMTDEYEAALQKVIAKDPNNPGLYFNLG
VGAADAGNTEKALGYYKKALEIDPNYAGANLNIAALMLSQDKDIIEQMNSLGNTKADNDK
YEVLKEERLKLYRDAVPYLEKATSGENPNIEAVRTLYNIHVQLGNTAEADEYKAKLDAMQ
G
>KECLDBNJ_01418 DNA gyrase subunit A
MAEGEKLIPINIEDEMKSAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGVRSNT
SHKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQEWSLRYMLVDGQGNFGSVDGDSPAAMR
YTEARMRKISEEMLADIDKDTVDHTLNFDDTLKEPTVLPTRIPGLLVNGASGIAVGMATN
MPPHNLTEVVNGTVAYIENNDIEIDELMQHITAPDFPTGGTIYGYDGVREAFKTGRGRVV
LRAKAIIEEVKGRECIIVSEIPYQVNKADMIKKTADLVNEKKIDGIASIRDESDRKGMRI
VYVLKRDAIPNIVLNTLYKYTALQSSFSVNNIALVNGRPEMLNLKDMIHHFVEHRHEVVV
RRTQYELKKAEDRAHILEGLIIASDNIDEVIALIRASSNAEEAREKLIERFELTEIQARA
IVEMRLRQLTGLEQDKLREEYEELLKTIEDLKDILARKERRMDIIKEELEEIKAKYGDER
RTDIDIAGGDVSITDLIPDEKVVLTISHAGYVKRTSLMEYKTQNRGGVGQKGSTTRNEDF
LEHLFVGTNHQYLIFFTEKGKCFWVRVFEIPEGSKTSKGRAIQNLINIEPDDKVKAFICT
NDLKDEEYINSHYVIMATKKGQVKKTSLEQYSRPRTNGINAITIKDGDELLAAKLTTGDS
QVMLAVKSGKAIRFEEEKTRPMGRNASGVRGITLADDNDEVIGMVAVNDPESNVLVVSEN
GYGKRSLVEDYRVTNRGGKGVKTISITEKTGNLVAINNVTDEDDLMIINKSGIAIRMEVS
ELRVMGRATQGVRLINLKKGDTIAAVTKVKKDEDDIEDEELDGVEGATDTSESTEEPTNN
KPSSDEEE
>KECLDBNJ_01419 Negative regulator of genetic competence ClpC/MecB
MDDNFSPRVKDVIAYSKEEALRLGHDFIGTEHLMLGLLRDGSGKAIEILQALDVDLSHLR
RKVEILSPANPGSGLASNEKKNLHLTRQAERALKTTFLEAKLFQSSSINTAHLLLCVLRN
ENDPTTKLLNKLKVDYDNVKDQFKLMMTSDDDYIEPIKNESFSEDDSTAESSKENPFNAP
GNKSNKKSKTPVLDNFGRDLTAMAEEDKLDPVVGREKEIERVSQILSRRKKNNPLLIGEP
GVGKSAIAEGLALRIVKRKVSRILFDKRVVTLDLASLVAGTKYRGQFEERMKAVMNELEK
NSDIILFIDEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKDGAL
ERRFQKVIVEPTNIDETVEILNNIKDKYEDHHNVIYTPEAIKACVTLTNRYMTDRFLPDK
AIDALDEAGSRVHIVNIDVPKKILDLERQLEEVRERKNSVVKKQKYEEAAKLRDDEKNLE
KELAVAQQNWEEDSKQHRETVTEDNVADVVSMMSGIPVNRIAKTESNKLAELPKSIKSKV
IGQDDAVAKVAKAIQRNRAGLKDPQKPIGSFIFLGQTGVGKTQLAKILATELFDNEDSLV
RIDMSEYMEKFAVSRLIGAPPGYVGYEEGGQLTEKVRRKPYSVILLDEIEKAHPDVFNML
LQVLDDGYITDSLGRKIDFRNTVIIMTSNIGARKLKDFGQGVGFGTAARKEQAEENAKGI
IQQALKKAFAPEFLNRVDDVIVFNALDRKEIHQIIDIELKKLYARIETLGYHLKLSDKAK
DFISDKGFDKEYGARPLKRAIQKYIEDALAEEIITSNISEGDRIFMDLEDGKEELSISIE
KTENSAQS
>KECLDBNJ_01420 hypothetical protein
MKIEKRLDLGIGVIEFTKNIAMGYVNPSVNFDDKERKAFLEACLKHFDGKPFGYISVRKH
SYSINPLIYTQLNTVESLKAFAIVPFSKLSKDIAKIEGKFYHNPFGIFDDLEEAVKWMEE
KIEEAS
>KECLDBNJ_01421 hypothetical protein
MRTLNYNLLFKGLFFDAIGMLTMAIPVVGPFLDLAWAPVAAKQMTKMYPGRNGKFASILV
FIEELLPFTDIIPSFTLMWIYTYLLSSEPKRNLKTIPIKVNR
>KECLDBNJ_01422 GTP cyclohydrolase 1
MAPYRKFEEYNISVQDDVKDRYKAIISDLGEDVNREGIVKTPERAAKAMMYLTSGYDMDA
SEILKGAMFKEDYNEMVIVKNIELYSLCEHHLLPFFGKAHIAYIPNGHIVGLSKLPRVVD
VFSRRLQVQERLTHDILECINTTLKPQGVAVVIEASHMCMMMRGVQKQNSTTTTSGFRGQ
FEHNETRNEFLKLIGSDLS
>KECLDBNJ_01423 Peptide methionine sulfoxide reductase MsrA 3
MKENLMKATFANGCFWCTEAVFQRFKGIYNVKSGYTGGTIKNPPYREVCQGRTGHAEGIQ
FDYDPEIISYQELLEVFFTTHDPTTLNRQGNDVGTQYRSAIFYHNEEQRQQAEDYIAYLD
EQAVFDAKIVTEVTPAKPFYIAEEEHHSFYNKHTEQGYCQFIINPKVNKIKKLYQDKLQE
VYL
>KECLDBNJ_01424 Lipoprotein-releasing system ATP-binding protein LolD
MIKAENIYKSYGDVQVLKGVDLLIENGEVVSVVGASGAGKTTLLQILGTLDRADKKANTS
LQINDTQIANLNEKELSKFRNLNIGFIFQFHQLLPEFTALENVCIPAFIAKKSKEEAEAK
AKELLSFLGLSHRIHHKPGALSGGEQQRVAVARSLINEPALILADEPSGNLDSESAENLH
QLFFKLRDTYNQTFVIVTHNEDLAAMADRKLTMVDGKIIS
>KECLDBNJ_01425 hypothetical protein
MAKSSLRLKKSELKEFLDEKAALYESPKFIGTDPIQIPHQFSKKEDIEIIGFLVATIAWG
NRKSIIKNGNSLVELLDNSPYDFVLNHTEQDLERLQHFVHRTFNGNDLITFIKGLQHIYT
NHLGLEAIFSGYVMNNELQTAIHHFKKHFFEIEHEPRTLKHVSDPLKKSAAKRINMFLRW
MVRPNTAGVDFGIWSSLSPAFLSCPLDVHSGRVARQLGLLKRKQNDAIALAELDKQLRRL
DPIDPVKYDFALFGLSAFEKDLF
>KECLDBNJ_01426 Sensor histidine kinase RcsC
MQKPALPANEQIRLSELRQLALLHTEPDPNYDTITRLAAAICEVPIALVSLIDADKQWFK
AKIGWDLCDTARDISFCAHAILQPREITIIPDSRLDERFKGNPLLTSDYPVIFYAGVPLL
SKTGNPIGTLCIIDHKPRNLSEAQISALKDLALQVENLFELRRSNLQLQEVEQLLTKKNE
QLKKFAGTVSHDMKMPLANMIVTTDILRAKYAPKLDAQGIDYLSYLKQSSFSLSDYIDNL
LSYYESEELQVKNLEKFDLHHLLEEIIDLLKISEDYIINLPESGIELNSSKSAVQQILLN
LITNSLKYNDKETGIITINSVEDHAYYYIQISDNGKGIAADKLDSIFDLFSIASETDNKG
KKGNGIGLSTVRNLVHSLGGIISVSSTEGEGATFDFTIQKVSA
>KECLDBNJ_01427 Phytochrome-like protein cph1
MSIVKIDEKKRQKAVDSYKLVGTLPEKSYDNITQIASYICGTPIALITMLDYNRNFLKSH
YGVPFNESPREISFCTHAIQTHDPIFIIPDAREDDRFKDNPLVTGPMKAIFYAGVPLVDK
GGHALGTLCVFDHEPRTLNEHQVSTLIALASQVVNLFELRRQNIENKALQKNLLKKNSLL
KEFAGVVSHDMKMPLANIITTTDILKAKYKELLDEKGLDYLNYLKSSSFSLSEYISGILQ
HYESDNLTIDQRDSFDIHDLLEEVEDMLNHDYKTVIHLPEANHIISCNRAALHQIFINLL
GNSIKYNDKEEPEITVTFTEDSDFYRFEVIDNGIGIPQDKIDKIFELFSIVASKDKNGNR
GNGIGLSTVKKLVANLGGRISVASVEGEGSTFSFSARKQDIPTQIAGPENDTSALKN
>KECLDBNJ_01428 hypothetical protein
MQFKNPEILYALFLLLIPILIHLFQLRRYKKTPFSNVAFLETVIQNTRKSSTLKKWLVLC
TRLLALTFLIFAFAEPFIPNSQRALQPQETVIFIDNSFSMQATGKKGNLLTEAKQELLAA
LHKDERYTLVTWDDVLRDFDPVTDRNELLDLDFTQKTIDVQSLRMRLNNVFSTKDESSRQ
RILISDFQDTGWSSQLDSLNKTEHRILLEPTSLENISIDSLHLNSVSAAYSLDVFLASTT
PIDQDVPVSLFDKEKLIAKGSANFESSKHSKIEFQLTSGAAIQGRLSITTPDLKFDNDFY
FSINTTEPLKVLAVSNAEDTFLSRLYQEPQFSYTNVAEDQLEYSILDDQDLIILNEPQRI
TTALINALKKHTQNGGTLLLIPNMNAAATNYNNLLNAYGFAGFQSKIEAPQRITTINYDH
PLYQNVFTKRSSNLQTHQVEAYFPIATTDAILSLENNAPFLAENNRLYLFTGSLSSTNSN
FINGQLIVPTFDKIATEALKLPQIYYSIGSKTTFDITTPLPDDVVLTLEQQEQAFIPLQQ
KRGDKVSIDTQEGIKNDGLYAVKYKQDTLAMVAYNFDRAESNLRPLEAITAENIDFETNI
PDLFNKLEQDTNLNLLYKWFVIFALLAFLAEMLLLKKFK
>KECLDBNJ_01429 Dihydroorotase
MNARITKATLLDESNEHHGKQVDLRIENGIITEIGTDLTPKNNEEELQFENLSVSPGWFD
SSVSVGEPGFEERETIINALKVAGKSGFTAIAVNANSAPVIDNNASVAFLKNKAAGNAVN
LHPIGALTKNAAGVDLAELYDMQQAGAVAFGDYQHAISNPNLIKIALQYAQGFDGLVLSF
PQEDDLIIKGVANEGETAISLGLKGIPSLAEHIQVARDLYILEYTGGKLHIPTISTAQSV
ALIKEAKAKGLDVTCSVAIVNLFYTEAMLNEFDTRYKVLPPLRTETDRQALIAGIKDGTI
DMVTSDHNPLDIELKKLEFDHAKFGTIAQEATWGALLTLVSEKRAVKLLTAAQERFTQVK
SKIEIGQPANLSLFTTKGTTVFVKEHILSKSKNTAFLGAKLKGKVYGIISNNQFIAS
>KECLDBNJ_01430 hypothetical protein
MTTEDIKNGKTSAIVAYLTMLGAIIAIFMNMEPKNPFARFHIRQAFGIFLTFFALGFLVS
FLNSWPASFGFYIFIFILWGYGFVNAIQGNIVPVPLLGKYYQKWFRFIE
>KECLDBNJ_01431 Carboxylesterase 2
MAQLSLEHLIQRPKKTSEKPPLLLLLHGYGSNEQDLFSFAPELPEEYFVISAKAPMAMQP
FGNAWYTIYWDATDGKWSDDEEAISSRELIKTFIDETIDAYNLDAENVTLLGFSQGCILS
YAVALTYPEKIKNVIGLSGYVNEAIISPKSDLSAYKHLSVFSSHGTVDQVIPVEAARKIA
PYLATLGIESNLKEYPVGHGVAPQNFFDLKDWLLQH
>KECLDBNJ_01432 hypothetical protein
MYLFLFTALWVVFQYVNSTKVYESQEKHIAKLEQQLAEADSLQAVREDGGERYFKLKGNE
QAYDYFERFGVAVDDLEAKIESAIISKNTTEGNALIPYENATGIFQINKVEVLNHKWVIA
DFSDGKRWGELILLYSIDKEGNITFETLQSVIYP
>KECLDBNJ_01433 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MRITFLGTGTSQGIPIIGSTHPVCKSKDPRDKRLRVSLLIEFEGANYVIDCGPDFRQQML
THNVNHLEALLFTHEHADHTAGLDDIRPFFFRQGDIPVYAHQRVIGELKKRFEYIFKTEN
RYPGAPAVALFEVINNQPFIINNLQVEPINVMHGKLQVFGYRFGSFAYLTDVKTIAAEEK
QKLRDLDVLVVNALREEPHYSHFNLEEALAFVAEIKPKQTYFTHISHLLGFHAEVEKQLP
DNVHLAYDGLQLEL
>KECLDBNJ_01434 hypothetical protein
MPITIQGDKEFENIPSITNKALRINLNENIYGTFAEIGAGQETVRHFFRAGGASGTIAKA
MSAYDKDFSDAVYGVEQDHRYVTEARLKKMLAHETNLLENRISREKHPNKIYFTYANTVA
TIDFAKKYKGHGWVGIKYQVEPQAEFNEIILHVRFHETDARLQQLTLGTLGVNLIYGAYY
KYDSPKKLLRYLYDHIDKDQIEIDMINFSGPVFSKVDNRLMSLQLVKNGFTDAVMFGADG
NNILAAKILYKKNILALRGSFRPVTKVNTDMYRKSLEIFLNENRVKEDNTEVIFEITLSN
LRAEGEIDEEDFMARARLLCNLGHTVMISNFQEYYRLVEYFSRYTKERMGLAMGVNNLID
IFDESYYRHLSGGILEAFGKLFFKDLRVYLYPMRDPETGEFFTSENLKVHPRMKELYKFF
KYNGRVVDIEDYNPDILNVFSRQVLKMIANNEEGWEAMLPKGIAQQIKEQGLFDYKSKTI
EQS
>KECLDBNJ_01435 Histidine--tRNA ligase
MAQKPSIPKGTRDFSPEEVLRRNYIINTLRTNFELFGFQPIETPSFENSSTLMGKYGDEG
DRLIFKILNSGDYLNKVDDAVYTAKDSTKLTAEISEKALRYDLTVPFARYVVQHQNEIEF
PFKRYQIQPVWRADRPQKGRFREFFQCDADAVGSDSLLQEVAFVQLYDAVFTDLGLKGTT
VKMNNRKILSGLAEAIGAADKLIDFTVALDKLDKIGEEGVVKEMLAKGISEEAITRVKPI
FNVSGNFAEKLNLLKDLLADSEVGKEGIEELAYINEKIAALGLATVTLDLDVTLARGLNY
YTGAIFEVAAPEGVKMGSIGGGGRYDDLTGIFGLKNMSGVGISFGLDRIYLVLEELGLFP
EQAIKGTKLLFINFGEAESLYCLKAVKSLREAGITSELYPDAAKMKKQMSHADKRNIQFV
VLAGTQEMEEGVYTLKNMKTGDQTRVDLNELIKALA
>KECLDBNJ_01436 Macrolide export ATP-binding/permease protein MacB
MVQTGKFMFSLFRENIRIAYDSIRSQLLRTILTVVIIAIGITALVAILSLVKALENTISS
DFSSMGANTFNIQRYDRTTRSQGSGEKQKVNPVIRYTEVRDFEDRYTYPFTQVSVSFTGT
SSAEVKYENLDTDPEVTVLGANENFLDNAGLELDLGRNFTLFDIKNNNNVCVLGSDFKNG
LLKNVNPIGQTISIRGAKFKVIGVLEEKGSTFGNNQDLRVIIPIQVARSLFTQANINYAL
SVKVDDKEMFEGALDEAIITFRNLRKLAPVEENNFGISRSDDLLNQIAEISGYLSLAAWV
ISLITILGSSIALMNIMLVSVTERTREIGVRKALGAKKSIIAGQFLMETIMIGQFGGILG
IILGIGIGILISTVANFNFTTPWMAMLAATAVTLLVAVIAGLFPALKAAKLDPVESLRYE
>KECLDBNJ_01437 hypothetical protein
MKYIRLSKEQLDEMHQEFINFLASQSITAEEWDTIKKNQPETAEQELDVFSDLIWEGVLS
KVEYLEHFSPQHMFLFKVGALKISMISIEVENKSIDITTPQGYKWLQDNFMKDEVNLYSS
SKLLSDDRNNDIFVLIRQGANITKGELYRWFEKFVEVE
>KECLDBNJ_01438 50S ribosomal protein L9
MEVILKKDVDNLGFVDDLVTVKNGYGRNYLIPQGYAVLATPSAKKVLAENLKQRAYKEKK
IVDAAQAQAAKLEGLEVKLTAKAGEADKLFGSITDADLSEALAKEGVEIDKKYITIAGGN
IKRLGQYEASLRFHRDVVKNFTFDVVAEA
>KECLDBNJ_01439 30S ribosomal protein S18
MASSIEQQAKAKKDGEIRYLTPLNIETSKTKKYCRFKRSGIKYVDYKDADWLASFVNEQG
KLLPRRLTGTSLKYQRKVSVAVKRARHLALMPYVTDLYK
>KECLDBNJ_01440 30S ribosomal protein S6
MNHYETVFILNPVLSDDQVKETVKKFEDFLVSNGAKMISKEDWGLKKLAYAIQNKKSGFY
HLFEFTVPGEVIANFELEFRRDERVMRFLTVKLDKYAIEWAEKRRKRNKEKA
>KECLDBNJ_01441 hypothetical protein
MNYTKKLVNTFIVSSFGKLTLSQNFTFGRINFRLCGC
>KECLDBNJ_01442 Transcriptional regulatory protein YpdB
MEELILDCAVVDDSSLQRLAIVKMIKDHPNLRLAAQYNNAIETKNGLLETKVDLIFLDIE
MPILTGFDLLDDLVHKPQIIFVTGKTKYAYKAFNYNAIDYLRKPLTKDRFLNAVHKAINL
HRLKTEGSVEDDDYIFVKSNLKKKKVFLNDLKFIEALGDYVKLVTYNEPIIVLSTMKAFE
AQLPADRFMRIHKSYIINMDKVEKYNSRNIEIEGDKIPLSRHKKTKLMEALSK
>KECLDBNJ_01443 Primosomal protein N'
MYFVDVILPIPVENAFTYRISEAEYAFIKPGMRLAVPFGKSKIYTALAIAVHQVEPRIYE
AKEIEQILDEIPIVNLAQLNFWKWMANYYMCTLGDVMRAALPGAFLLESETIIKRILKND
FEPYLDEIDEDGLTILNAFEGSSILRISEVMNALNKKKVLPSINKLIDLDLVAIDQEIYE
SYKPKLVKYVRLTSIYEQEEKMHEALDDLGRAPKQRELLLNYFTQKARSQKPIKAKELQK
QSDATSSQLKALVDKGIFEIYKIQQDRISYSGKEQDQVKALNEEQARALTEVKASFNSHD
VCLLHGVTASGKTEVYVNLIKDYLAEGKQVLYLLPEIALTTQLVARLKAYFGNQLSVYHS
KYSIHERVEVWNNVLNKAPKAQLILGARSALFLPFENLGLVVVDEEHESSFKQYDPAPRY
QARDSSIVLAHQQGAKVLLGSATPALETFYNASVGKYALVTMKKRFGNILLPENTIIDIQ
EKHRKKRMTGHFSDDLLRAITDTLELGEQVILFQNRRGYSPIVECNTCGHAPQCPNCDVS
LTYHRHRGQLRCHYCGYHIAMPQKCMACGSEELDTKGFGTEQVEAELKELYPDHNIGRMD
SDTTRGKHGFEKIITAFEQGELDILVGTQMLTKGLDFRNVTLVGILNADSMLNIPDFRAH
ERSFQLIQQVSGRAGRTEKRGNVLIQSFNPHHQILQQVSMNDYEAMYKEQLEERHIYKYP
PFCRLIKITLKHRDFQKIEEASMWMGQALKNVFKDQVLGPEPPPVSRIRNEYYRNILIKI
PRKQSLEKTKKAILKVRTTFLSISQYRSVKIILNVDNY
>KECLDBNJ_01444 hypothetical protein
MKKISAFLIMMLVCTAGVFAQDVTGKWKTIDDETGDAKSIVEIYKQDGKVYGKIVEILNK
DRQDAKCVDCPGADKGKPINGLVIIKGLEKDGDEYNDGKILDPQSGKLYKCLIELENADK
LKVRGYIGFSLIGRTQYWHRVK
>KECLDBNJ_01445 hypothetical protein
MAEEWDDKLKTIPFLLPVVKWAKGIILPGFEGLSLYDFWEMYAIGILKGTFATRASAIAF
SFFMALFPFFLFVLNLIPYVPINGFQSDFLSFINNLLPPQTQEFFDPILLDIAANQRGGL
LSFTLIFAIFLMANGVNAIFTGFEYSFHSITNRSIFRQYAVALGVSIMLALLLLLVVIAV
LYLQFSITELKRRGIVNEDNLWISQLGSYIALIVLIYTVVATLYYFGTKEGKDTRFLSIG
ATLTTILFIVTTYLFGIYINNFATYNQLYGSIGALLIMMVYIWLNANLLLLGFELNASLY
RLKRRRDYKKAQLSSN
>KECLDBNJ_01446 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISEAKLNEEIAAIIANAIREDVGPGDYSSLACIPETATGKAKLLVKEKGIIAGVAFAQK
VFAYVDNQLEVEVKIQDGAEVKVGDIVLYVSGSSQSILKAERLVLNGMQRMSAIATKTNA
YTKLLEGTKAKILDTRKTTPGFRALEKMAVKIGGGENHRFALYDMVMLKDNHIDFAGGID
QAIEKTKNYLASNNLDLKIIVEARDLDEVNAILKAGGVYRILLDNFNYEDTKTAVKIIGE
QCLTESSGNIHEETLAEYAKCGVDYISSGALTHSVYNMDLSLKAV
>KECLDBNJ_01447 Ribosomal RNA large subunit methyltransferase H
MNIKLLCIGKTDDHNLESLILVYTNRLKHYVNFELEIIPDLKKTKNLSEEQQKEKEGELI
LNKITPQDQLILLDENGKELSSVKFADYLQKKMNSGIKTLVFVIGGPYGFSEAVYAKAQG
KVSLSKMTFSHQMIRLFITEQIYRGFTILRNEPYHHR
>KECLDBNJ_01448 hypothetical protein
MQPELLEIEPRKIIGKCLTTTLSFDDTAALWKDFMSRHKEVKNRIDSGFYSMQVYPFGMN
IERFDRETEFERWAAVEVTSFDLVPEGMQTKIIAGGLYAVFTHVGPVKKFVETSNYIFDT
WLPQSDYKLDDRAHFERLGAKYYGPEHPESEEEIWVPVSAKS
>KECLDBNJ_01449 hypothetical protein
MVILGKTNIMKPRKLIKRFFLFTSAMQVGYYAVVYADKYKEDIKRVIKRS
>KECLDBNJ_01450 hypothetical protein
MDFTNPLIYGVPCFLGLILVELTYSKHHDNDELYHWKDLGASLTMGIGSTLIAPLIKTVT
VILLFNWVYDIFNPVVDGVRTNIFGWESFGYAWYFWILCQLADDFSYYWFHRQNHMVRFF
WAAHIVHHSSENFNLGTAVRNGWFTIFYKPLFYIWIVAIGFPPEMLVVCLGIEALWQFQL
HSQYVPKLGIIDKIFNTHTMHQVHHARNLEYMDKNHGGFLNIFDRMFGTFKELDEEIEIE
YGVTKSPDSYNPLVILTHEYKDIWKDMKRSPKLKHKFMYAFGPPGWSHDGSTLTIKQMRQ
KLKEERVQQQKQRELELEVAE
>KECLDBNJ_01451 Nucleoside triphosphate pyrophosphohydrolase
MNNRASQLRAIDRLLTIMNELREQCPWDRKQTLQSLRHLTIEETYELGDAILDNDLEEVK
KELGDLLLHIVFYAKIGSETEDFDIADVANGICEKLISRHPHIYGDVAVENEEDVKRNWE
NLKLKEGKKSVLEGVPRSLPALVKASRIQDKVAGVGFDWEEPQQVFEKLQEELAELQEEV
EARDQEKIEAEFGDVMFSMINYARFLKVDAESALERTNKKFIKRFQYLEQKAKENNKALR
DMTLREMDVFWEEAKKL
>KECLDBNJ_01452 hypothetical protein
MSLDKIVSISGKPGLYHLRAQTRSGFIAESLTDGKKIPVGLRHNVSVLSEISIYTLDGEA
PLRDVFAKIAEKENGEKAISHKVAKDELEAYFFDVLPNFDEDRVYASDMKKVIQWYNLLQ
ANDLLETAEAPAEPAKADEEE
>KECLDBNJ_01453 Peptide deformylase
MILPIVAYGDPVLRKKAVEIPQDYPELKELVANMFETMYGASGVGLAAPQIGKAIRLFVV
DATPFADDEDLSDEEQERLKTFKKAFINPQILEETGDEWAFSEGCLSIPGINEDVFRCPN
IKIKYQDEDFNEYVEEFDGLLARVIQHEYDHIEGILFTDKLSSLKKRIIKSKLAGISKGK
VNADYRMRFPAVKKGR
>KECLDBNJ_01454 Putative pre-16S rRNA nuclease
MGRILALDFGTKRTGIAVTDELQLIASGLTTVNTTDLLDFLKKYFSEENVELILLGEPKR
MNNEASHVETKILKFRESLEKITSIPIKRVDERFTSKMAAQTMLDSGLKKKQRKNKALLD
EISATIILQTYLYQ
>KECLDBNJ_01455 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MQQVKNLIEAAWEDRSLLSDKVTQEAIREVIELIDGGTLRVAEPKGDDWQVNEWVKKAVV
LYFPIQKMEKLEVGIFEYHDKMPLKKGYQDKGIRVVPNAVARHGAFISKGVIMMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDNAFIGSRCIV
VEGVRVGKEAVLGANVVLTASTKIIDVTGDEPKEMKGAVPPRSVVIPGSYTKKFAAGEYN
VPCALIIGTRKESTNKKTSLNDALREYDVAV
>KECLDBNJ_01456 hypothetical protein
MKILVIQQKMIGDVLTSSILFRAIREQFPDAELHYLIQPHTLPVVENNPYIDHFIFDRTT
TDAKNVSLGAFAKYITAQNFDYIIDVYSKLGTAYLCLRSSAKSIGYRKWYTQFVYNQTIS
YLKEPKTNAGLAIENRMRLLQVLPGKFPDSLKPKIYLSAEEKQNALQFLKEADVNLQAPV
YMIGLLGSSASKTYPLEYLAELLNVLITEEPEAQILLNYIPNQKEEVNTFLSNCSTALKS
NIFANVYAKNLRDFIAVLAHCKALIGNEGGAVNMAKALDVPTFAIFSPWIAKDAWALYED
DSNVAVHLNDFKPEFFQKKSNKHLRKESEMLYQQFSPELIKPQLATFLRNLS
>KECLDBNJ_01457 Spore coat polysaccharide biosynthesis protein SpsA
MKQKPEVSIIISTYNSVEWLKKTLWGYAYQDFKDFEIVIADDGSGVETKEAIAQLSPLFD
RPIIHVWHEDIGFRKTIILNKAVEACSAEYILMSDGDCIPKANFVQVHLKHKEPGYFLSG
GYFKLPMSISQAITQEDIKKQHCFDLKWLKAQGLKDSIKNKKLSAGTFESKLLNLVTPTK
PTWNGHNASGWKQDILAVNGFDERMQYGGEDRELGERLFNKGLKSKQIRYSAVCVHLDHA
RGYVKEEMLVKNAAIRKETKLQRKTYTPFGIKKDS
>KECLDBNJ_01458 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MEKLTAIIPVFNEAHHIEAAIQSVLFADEILIVDSFSTDETLSIAKKFPVKILQREYEYS
ASQKNWAIPQATHNWIFILDADERVTPQLQEEIQQILSNPPQDLVGYWVYRNNHFIHKKI
KYSGWQNDKVIRLFKKDFCRYKDQHVHAEISTTGKLDYLQHTLQHYSFNSIQQFTAKLNK
YAVWQAKDYDARTGKLTPYHFIGKPVWRFIKHYVIQQGFRDGVPGLTISYLQAYAVFMRY
VNLWILRNSKKT
>KECLDBNJ_01459 hypothetical protein
MKVTVHKSVKSNLLKLKEFFLNFEQEGKILADGNRNQIKIFDLDDTQITIKAFKVPNFVN
KIAYQYFRKSKAQRSYEYACKLLDLGVLTPFPIGYGIASNGLLFGKSFYACKLVNADATF
RTLINEEHFPDRIEILKAFTRFTYEMHEKQIHFLDHSAGNTLIVITENGYEFYLVDLNRM
EFKPLDFETRIQNFARLTPKKEMVDIMAEEYARVGNYDMGQTKAAMWKATEDFQNHFAKK
QAFKKKVKFWKK
>KECLDBNJ_01460 Alpha-maltose-1-phosphate synthase
MKQIFLESHNIKNQFSGLGQFNYHLIKGFYQNAQSDFKFTLHSNISAKLKSEFGTHFDYQ
HYFSFTRYKALRLPFKYDLWHSLNQNTKVEPRFKMPYVLTVHDVHFAEGPDSTDKTARIK
RFEAKLKRADALVYISKFARQATQQCFDTSDKPEYVIYNGNPMLDTSIPEDFIPDTAPKK
PYLFTIGEFTARKNFHALIDMLQHLPDYELIIAGNSDRPYTEKIKETISKNKLQNRVYLP
GKISEMEKKYHLKNSAAFVFPSLKEGFGIPIIEALRYGTPVITSNNTSLPEVGGDFATYW
EHYDPKYMAEKVLEGIANFQDQSVINAGISHAKSFNWNATAKEYLNVYRSVLNK
>KECLDBNJ_01461 Threonylcarbamoyl-AMP synthase
MAMKKYDQNILNEVNESLGVLKRGGLLLYPTDTVWGIGCDATNANAIDKIYALKKRKESK
ALICLVSDMKMLNQFVEEIPEVAYNILKYASQPTTIIYDKPIRIAENLLGEDNTLGIRIV
QDEFCRTLIKKLGKPLVSTSANISGEKTPMRYPEISQPILEGVDYIVNLQRKHLSTKSST
IIKLSNDGQVKILRK
>KECLDBNJ_01462 Multifunctional CCA protein
MPVPNFPEALKPKIFEVITQASEELNLETYVIGGYVRDFLLKRGSAKDIDIVAVGSGIEL
AEKVASLLPHKPKVQVFKTYGTAMLRDGDIEVEFVGARKESYNENSRNPVVENGSLEDDQ
NRRDFTINALALSLNKNTLGDLIDPFDGIVDLEREIIRTPLDPDITYSDDPLRMMRAIRF
ATQLDFTIERKSLEAISANKDRIKIITKERIVDELHKIMLSKTPSKGFLLLEKTGLLPYI
LPELTALKGIEEKEGQKHKDNFYHTLEVVDNISENTEDLWLRWAALLHDIGKAPTKRFHK
KIGWTFHGHEFVGSKMVFKLFKRLKMPLNEKMKFVQKLVLMSSRPIVIAEDFVTDSAVRR
LIFDAGDYLESLMTLCEADITTKNPKRYRKYHNNFKTVRQKIEEVEERDHVRNFQPPVSG
EEIMSTFDLQPSKEIGIIKEAIKEAILEGEISNEYEAAHAFMLKKGKELGLEAVKS
>KECLDBNJ_01463 Heme A synthase
MYRKSIIVALVLIYLVIIAGAVVRMTGSGMGCPDWPKCFGYIIPPTSETELEWTPGRTYE
KGQVIIVEETLRVAKSDFTTTETFNPQNWNGYEKHDYAIFNPWHTWIEYINRLCGALAGL
AFLVMLGAAIFKERKRKRILLSLFAVFLIGFQGWVGATVVYSVLSPVRITIHMVIALLLV
ALLIYMLYESSKIKHRYTFDKAFRNGMSIAIVLTMTQIILGTQVRQHIDEQVDLVGYAAK
SLWLDNPEITFYIHRSFSIIVFLLNAWLFIRTRKLNLGHRSFNWVVLLILIEIATGVLMN
YFEFPFLTQPIHLVVASVLFGIQFYILLTATRKEKSIELA
>KECLDBNJ_01464 hypothetical protein
MIYRFRVILDTEEDIFRDIEIEQQATCEDFHNTITQSFGFDGTEMASFYISDDEWRQGEE
IPLFDMSESDLPLRMMNETLLEDVLSEDQTRLIYVYDFLNLWTFFVELAEIAEPQDGVSY
PNLMYVHGQIPAEAPPADFSGDEDDFDEDDPFADDDDDYDIEDYEGLDFDENWN
>KECLDBNJ_01465 hypothetical protein
MINLYSAQIESLSIHRIGNKSRNEGAFLSKERYHLNDEITPLIKEFFFKPFRDKEENYYQ
FVHEADLEFHSLSNLAASLFNDPRQSHEISIEIAKLLYEQSSHPHIKPGEVYVAHIENAM
MDNEKVDAIGIFKSELKQDFLQFQEGETNLQMHLEQGVNLSKLDKGCLIFNKNAENGYKI
LSIDSNRYDTKYWLENFLGVDILADENFYTKKYLKFCQDFAKDVVLPAEDKKEEVMFMNR
AVNHFAKNDEFVEQNFMNEVMENPALIPEFNNYKMEKAPKYKIEDLTTFPISNTAVSGAR
KRIKSVIELDTNVQIKLDFVNPESAEKFVEKGWDEERQMYYYLVYFNKEQKS
>KECLDBNJ_01466 UvrABC system protein B
MKFNIQSEFKPTGDQPSAIEQLVGGIDAGERYQTLLGVTGSGKTFTVANVLQEVQKPTLV
LAHNKTLAAQLYSEFKAFFPNNAVEYFVSYYDYYQPEAYIPTSGTYIEKDLSINEEIEKL
RLSTTSSLLSGRRDIIVVASVSCLYGIGNPVEFQKNVIALERDMVISRTQLLKRLVQSLY
SRTTAEFNRGNFRIKGDTVDIFPGYDDHAFRVHFFGDEIEEIEAFDVTTNEVLEKYDRLN
IYPANMFVTSPDVLQNAIDQIGFDMVKQVDYFKEIGKHLEAKRLEERTNFDLEMIRELGY
CSGIENYSRYLDGREPGTRPFCLLDYFPDDYLMVVDESHVTVSQVSAMYGGDRSRKENLV
EYGFRLPAAMDNRPLKFEEFEALQNQVIYVSATPADYELQKSEGTYVEQIIRPTGLLDPV
VEVRPSLNQIDDLIEEIQKRVEKDERTLVTTLTKRMAEELTKYLTRVDIRTRYIHSDVDT
LERVEIMSDLRKGIFDVLVGVNLLREGLDLPEVSLVAILDADKEGFLRSNRSLTQTIGRA
ARNINGLAIMYADKITQSMQETIDASEYRRQKQIAYNEEHGLKPMAIKKSLDNALAKKEK
FKFEAEELTYMAAEPDTAYMSKPKLEQLIRDTRKQMEAAAKELDFMEAAKLRDRIKSYQE
QVKELG
>KECLDBNJ_01467 hypothetical protein
MRQLILFGLIGLLLGSVARSQGQANNWYFGGGAGLNFSSGTPRALTDGSLYTLEGCASIS
DDDGNLLFYTDGSTVYGSDHSILQNGTGLFGNSSSTQSALIIPQPDTPGIYYIFTVDAVT
RVGEVHQGVNYSIVDFTSNPDGIVRDKNTRLLNYAAEKLSAVIKSCDDNSVWLVTLSSAS
GTQTTVNTFYAYQLSSAGLNTTAVRSNAGFNSNDPRGNLKFSPDGTKLAIANAADGLYLA
EFDSESGQVFNTQRLTINGSNFAAYGVEFSPNNQYLYSASSNNADTELGAGNHFSSLIQY
DLEAADISGSQVSLNESGYFRGSLQLAPNGKIYRALSASYTEGLNYLGAIENPNAAGLAA
SYNDRAVNLGSGISYQGLPPFNQSLFNELDIIQNDLSSTELSLCDGDNYVLGYDPVSGAS
YSWYRDDVLIPGATSNQLSIRQPVAASLPYTETYEFRLDPNDGSCEKVGVAEVTYYAYPP
TVSRISLIQCEDAATADGLSIFNLTEVESTLTGGDTTFEVAYYQTIADANTSSNPIDPVG
YENTTPVETVYARITNPAGCSIINTIDLQVSSTTANTALLEGCDLNDTGFAEFDLSQADA
QVLGGLTGSYDVHYYPTEEAALLEDSALELPQLYTNQTAYNETVFARVENNNACFAISTV
ELNLIPRPDFSLAAEAIYCAASFPEIQTYSPDYTNLDASRTYSYEWFPEGQTTPYLETNL
PGSHTIRVTDVNTGCYREATITIIEEEIPIIENIEVTDATENNTATITLSGNGAYEVALD
DEIGPYQDDLYFDGLAPGFHILYVRSKNGCTAIAQEFSIIGFSKYFTPNGDGYHDFWQVQ
GISAMVQPGTVIRIFNRYGKLLKELNPLGQGWDGTFSGTNLPADDYWFSVLLEDGRLFKS
HFTLKR
>KECLDBNJ_01468 hypothetical protein
MLRLLTIEFYKLKHSRSSKVLSIAYFVILSFIALIASIEFNLGDFQIRIADQGIFNFPFI
WHFNTWVAATLKFFLAIVIVSMISNEYSNRTLKQNLIDGLSKKEFMLSKFYTVIAFAALS
TLFIFVMTLILGYSFSDYTEFSIVTREMEFLLAYFFKLVGFFSFCLFLGVLVKRSAFALG
FLFVWWIFENISYGILRWQINAETADAIVQFFPLEAMKNLINLPFQRLNFIETAANQLQA
DIQIDYAVHWYEVGIVSVWIFLFIYGAYRLLMKRDL
>KECLDBNJ_01469 ABC transporter ATP-binding protein NatA
METILTLNNLTKHYGKVKAVNDLSFTIEKGNVYGILGPNGSGKSTTLGMVLNVVNATSGN
FKWFDGTDTTHNALKKVGAIIERPNFYPYMTAAQNLELVCTIKDVDPSKIEEKLEIVHLL
DRKDSKFSTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHQIREIIKNIASGGT
TILLASHLLDEVEKVCSHVVIIRKGVKLYAGPVDELNASHGFFELRCERQTELIQVLERH
QDFASVKEENGLVTAFLKNPLTAEELNTLLFTQGIVLSHLVKRKESLEEQFLQLTANLN
>KECLDBNJ_01470 hypothetical protein
MEDKLMSRKKPTYPIGERLEEYLNKYNRLTQIPVFYDDLLRFSGGINIYDKNDKDTLWIS
VYYPEHERKEIEESLKRVYAILHSDGNENVLPFLSVTAIDYCTFGNSKPFRIKVNNIFND
NYTYFYVKKADASRIYGLDLEHILSPNRINFLVYKDTLIEEHIVGIPGDVFISDYLEECD
DVGKAQLAKEFVKFNERCMILLLGDMRSYNYVVIPTHDFDHIKYKIRAIDFDQQAYEGNF
KVYKPHIFKENFRMVELVSNRLRDKSIEQYREEERAVLAKRIITSKNRLRRLLKCMTHDN
ISTEENLKELRSQLYDYTMDMKFKRAKSMGQIVKTALAFVKRNYEDVSMKRIMEARQ
>KECLDBNJ_01471 Endoribonuclease MazF
MELNQYSIVLVNLDPTIGSEIKKTRPCVIVSPNEMNKYLNTIVLAPMTTNLKRYPTRVAV
KHNGKNGMIAIDQIRTVDKARIIRVFENLTKAEIKKCKEVLRETFVD
>KECLDBNJ_01472 hypothetical protein
METSIIKIGNSKGLRLSKTILEKYGIKDKVELILEKGQIILKPIKTPRKDWEKEFKKMSE
NGDDKLLMNDVFDDENLEEWS
>KECLDBNJ_01473 Trehalase
MDNLNYGIIGNCKSAALISDKGSLDWCCLPIFDSPSVFAKLLDEEKGGSQSFEVSDAYTI
TQQYMWQTNILRTMYDNGTDAFEVFDFMPRYEKRSGSFYAPPDIIRFIRLVKGAPKFVCN
YDPKLEYASTETITVNKGEYIESYTNEGKYDSLYLYTNLEKEAILTKKEITLDGNAFLLM
SYHEKLMEQTLDRAYLKFQRTKVYWMNWSEATTKYPLYQNEIMRSALTLKALTFEKSGAV
LAAATTSLPETIGEVRNWDYRFCWVRDASMVIRVISNLGHTKYAQNFLQFIIDTLPDKDE
KMQIMYGINGEKELTEHTLDHLSGYKNSAPVRIGNAAYVQKQNDIYGILMEVIYQQFIQF
ETTLENSEELWTVVLGIVKIVKRHWQEPDKGIWELRTEDRHFTFSKLLCWVAVDRAIKIA
EVLNRRRHLEDWDVLRKEIHDEIHDNAWNEDMQAYTQYYGSKDMDASTLLMEQYGFIDAK
DPRFVSTVEATERELCKDGLMYRYKNEDDFGEPSSSFTICTFWFIDSLYKVGQKQKAIKY
FDQLLSYSNHLGLFSEDIDFKTKRLLGNFPQAYSHLALIETATNFAKYGQEDEEETQFKP
ILY
>KECLDBNJ_01474 Trehalose-6-phosphate synthase
MSKTIIISNRLPLQLQIDNYTIKATPSVGGLATGMKSVHRDSNGVWIGWTGLTEEETPEE
LVDEVVAAAKKEQCVPVSLTEKDINGFYYGFSNRTIWPLFHYFMEYTEFEKESYQTYVEV
NKKYANVVLENIEEGDTVWVHDYQLMLLPELIKKERPDVQIGFFLHIPFPSYEVFRTLPW
RVEILKGLLGSDLIGFHTYDYQRHFLSSVSRILRQEVSFNEITLKDRIVTVNSYPMGIDY
EKFSEAAAKHDAAKNQSELQRRLDLHIDSTPDAKMILSIDRLDYSKGIANRIRAYEYFLE
KYPEFKEKVRLVMLAVPSRSNVPQYQLLKKEVDELVGRINGKFATVSWTPIWYFYRSMPF
ENLIDLYTTCDVALLTPIRDGMNLVAKEYVATRTDKTGVLILSEMAGAAQEMSEALIINP
NNFEEIADALKQAMEMPEAEQIKRNKFLQKRLKRYNVEKWAHDFMHSLEDTAHKSDIVKA
IRMRQDQEEEMFNAYKASQKRILFLDYDGTLRGFVNNPEDASPDEELLELTKTIHSQENT
EVVIISGRDRHTLGTWWQDVPITLIAEHGVWKRPVGGEWAVTENLKNDWMETVRPILEKY
VDRTAGTFIEEKNYSLAWHYRNADPDLGEKRASELSTVLKELSANNELGVLDGNKVLEIK
DSTIHKGKAVTKHIFGKDYTFKFAIGDDWTDEYMFHDLPDDAFTIKVGLQKTAAKYYVDD
TDRVRDLLKKFAAS
>KECLDBNJ_01475 Bacterial leucyl aminopeptidase
MKYPFTLAFLCCFTALFAQNNVPSETDLRIYSIIDAVSADRIEKDVRTLAGFGTRNTFSD
TLSDTRGIGAARRFIKADFEKTSENCGDCLEVFYQKDLVTPSMGSRIPKQTYVVNVVAIQ
RGTKYPNRFIIMSGDIDSRGSDATDFTTDAPGANDNASGMAGTMEAARVLSKYKFENSII
YVGLSGEEQGLFGGKGLADYATAQGWDIIGILNNDMIGNIKGVDGVISNRDFRIFSEPVP
ANETENQRRARRFYGGEVDGNSRQLARYVHKNVKDYMPEMNPMMIYRLDRFGRGGHHRPF
NDLGFAGIRIMEAHENYTQQHQDIRTEGGIAYGDVVEHVNFPYAAKLTAVNAINLASLAW
APPAPETVEIGGIVEADVKLKWSKVDGAFGYKIYWRDTTSPTWDHSRYVGDVSEITLDGI
VIDNSFFGVAAVGANGHESVVVFPNAIMR
>KECLDBNJ_01476 hypothetical protein
MHKLFSMLLGFFCLTAFAQEHQFTHEDTLKGSITPERAWWDVSHYSLKVTVDPDNKFISG
SNTITYKVLEPYQTLQIDLQEPMKILSATQNDKKLAIKKDGAAYFISLQKKQKKEASNKI
TIAFEGKPVEGARLPWDGGWTWQKDAKGKAFAANANQGIGSSIWWPNKDIPYDEVESLDL
YITVPKGLTAVGNGTLVDSSSTTDKNRFHWSVENPINSYGISADIADYAHFSETYKGEKG
PLDLNFYVLKENLDKAQEQFKQVPMMLEAFEHWFGPYPFYEDGYKLVEVPYLGMEHQSNV
TYGNKYENGYLGRDLSGTGWGLKFDFIIIHESGHEWFANNITNKDVADMWVHEGFTAYSE
NLYLDYFFGKEASADYVIGTRSAIRNDRPIIGTYGVDHEGSGDMYYKGANVLHTLRQLVE
DDEKWRTILRGLNKEFYHQTVTTAQIENYISEQSGIDLTEFWEQYLRTTMIPELEYSIDG
NTLKFRYADIVEGFDMPIQIHVNEQKEWIYPSAAWKTKSFDAPITDFNIDRNFYIEFEEI
N
>KECLDBNJ_01477 hypothetical protein
MTKPKRPLLYFKNAEEWRAWLHENHESDTGVDLVFYKVTSQQPSMRWEEAVQVAICYGWI
DSTVRKIDEDRRKQYFCKRNAKSVWSAVNKAYIEQLVQDGLMHKSGHKSIEIAKENGSWT
ALDDVENGIIPEDLQEAFNNIPKAFENYENFARGYRKSYLYWLNQAKREATRQKRIEQII
TLCEQNLKQRL
>KECLDBNJ_01478 Aldose 1-epimerase
MKLNRNLLLVPVVLGMALSMVNCKNEPKKEETAVVAEMPEASITKSDFGMTPDSIAVEKY
SLVNANGMEVDIITYGGIITSLKAPSQDSTFQDVVLGYDTLEEYTTTGNPTFFGALIGRY
GNRIAKGKFSIDGEEYQLPTNDGPNSLHGGKGFDKVVWTAEEIEDGDNVGLKLTYTSPDG
DQGYPGNLETTVVYTLQADNTLKVDYEATTDKATVVNLTQHSYFNLSGDFDNTILDTEVM
LNADHYLPVDETLIPTGELRAVEGTPFDFREAKAIGAEIEAENDQLKKGQGYDHCWVLND
ESGAMHLAATAYDPRSGRFLEVMTTEPAIQFYTGNFLDGTLPQKGGEGTYALRSGFCLET
QHYPDSPNQSEFPSTVLKPGETYSTTTSFKFSVK
>KECLDBNJ_01479 L-arabinose isomerase
MNYNIDHLEVWFVTGSQHLYGAEALKQVADHSKKISEGLNDAAAVPVKIVYKDLVTTPTE
ITDLCLEANSNKNCIGLILWMHTFSPAKMWIKGLNILQKPVCHLHTQFNAEIPWGEIDMD
FMNLNQSAHGDREFGFMMSRMRKKRKVVVGHWQDARVQKKLGVFTRVALGWNEFQNLKVA
RIGDNMREVAVTEGDKVEAQMRFGFTVNGFDSSDIVAKINEIKQEDLDALLKTYETEYEL
HDSIKEGGEKRQSLVDAAKIELGLRAFLEEGGFGAFTDTFENLGELKQLPGIATQRLMAD
GYGFGGEGDWKTAALTRAMKVMAIGLEGGTSFMEDYTYHFTPQGSYVLGSHMLEICPSIA
DAKPKCEVHPLGIGGKEDPARLVFNSPAGPAINASLVDMGNRFRLIVNEVEAVKPEADLP
HLPVARVLWDCKPNLDIAATSWIHAGGAHHTVYSQAVTTEFMEDFADIAGIELLVIDDQT
RVRDFKDTINANEAYYHIFQHRM
>KECLDBNJ_01480 putative symporter YidK
MGLITFAAFTLLVAVISYFASRKTDETTSDGYFLGGRSLTGPVIAGSLLLTNLSTEQIIG
TNGVGFSEGILIAAYEIVAAVAMVFTAFVLLPKYLKGGISTIPQFLEKRYGKLTKTIVSI
LFLMAYAISMLPTVLYSGALAINTMFDIPERMGLDPEAALWVTVWGIGLIGSIYAIFGGL
KAVAVSDSINAVGLIVGGLLIPVFGLMAVGNGSVFEGLNVVTTNLPEKFEILGGPNSSVP
WTTLFTGMLIVNFYYWGTNQAIIQRALGAKNLAEGQKGLCLAAIVKILGPIIVVLPGVIA
FEYFNGNLDNADEAYPMLVKAVLPTAFVGFFAAVLFGAILSSFNSALNSSVTLFGLDLYK
QYFNNNASEKQVVRAGKTFGIFLAIFSMALAPLLYGVEGGIFNYLQELNGSFSVPILAII
LVGYFSKRVSGKAANIAIVFAVVTYLVTLYVVKPIIAGNAVAAAELSGVTDASELAMVAK
DAFPSFLHIMGIIFVLVLIILFTVSKFFPRQTDYLEEYTRQVDITPWKYLKPAGVVICIA
VVSIYVYFS
>KECLDBNJ_01481 L-ribulose-5-phosphate 4-epimerase UlaF
MYKSLKEECYEANMELDALGLVIYTFGNVSAVDRKNGVFAIKPSGVPYETLKPEDIVIVD
YDNNIVEGVKRPSSDTKTHAYLYKHWEDVGGIAHTHATYSVAWAQAQMDIPIFGTTHADH
LTADIPCAPPMHDDLISGNYEHNTGIQILDCFKDKGLDYKEVNMVLLGNHGPFAWGETAA
KAVYNSKVLEEVARMAQLTLQINPNAPRLKDSLIKKHYERKHGKDAYYGQGC
>KECLDBNJ_01482 Ribulokinase
MKEYVIGLDYGSDSVRAVLIDAVTGTEIEAEVSYYKRWKQRLFCDASENRFRQHPLDLLE
GLEATIKAVVSRSGVSAEAVKGICIDTTGSSPIPVTKEGIPLSLTEGFEENPNAMMVLWK
DHTAIAEANEINHLARTWGGEDFTKYEGGIYSSEWFWAKILHVVREDEPVKQAAYSWMEH
CDWITFALLENVALEDFKRSRCAAGHKAMWHESWGGLPPEEFLEKLDPYLAELRGRLYTE
TFTSDEVAGHLSAAWAEKLGLSTATKIAVGTFDAHAGAVGAKVEEHTLVRVMGTSTCDIS
ISSPDVVHDKTVRGICGQVDGSVIPGAVGLEAGQSAFGDLLAWFKDVLSWPIDNLVLTSD
ILSAEQKEQLKEEIESDFIRKLSDAAEAIPHNEAIPVALDWINGRRTPDANQELEAAITN
LNMGTRAPHIFKALVNAICFGSKKILDRFDEEGIEIKSVVGIGGVARKSKFIMQSLANTL
NVPIKVAASDQAPALGAAVYAAVAAGIYPNVIEASKTLGSDYEAEYLPQEEHLAEYAELM
QRYEVLSDFVEKNITKSKKNIKEHV
>KECLDBNJ_01483 Extracellular exo-alpha-L-arabinofuranosidase
MITQTIKKAGLAAVLAGTFLAGNTLFAQKELTVDMSETIAPIQPTMYGIFFEDINFAADG
GLYAEMIKNRSFEFTIPMMGWSQPNSDRHSYNNESGYALPVKYFEGEGNLNFLRVQVKNA
EGYELHNEGFRGMGIKEGDTYRFTFDAKQMEGAVSAVKAELLDEEGNTIAEASIPVSGSE
WANYKAEIVPSKTVMKGSLKLTFEGTGELGLDMISLFPTDTWNGRENGLRKDLVQLLYDL
DPGFLRFPGGCIVEGRTLARRYQWKKTVGPVDERPSLVNRWNTEFDHRLTPDYYQSFGLG
FFEYFQLSEDLGAEPLPILSCGIACQFNTGELVPMDELGPYVQDALDLIEFANGSTDTPW
GKVRADMGHPEPFNMKYIGVGNEQWGPEYIERYKVFNEAISEKYPEIIIVSGSGPFPDGD
YFEYGMKELKEIGAEIIDEHYYRSPEWFRENATRYDSYDRNGPKIFAGEYAAQSVAIASP
DNKNNWETALSEAAFMTGLERNAEVVQLTSYAPLMAHAEGWQWTPDMIWFNNLESYGTPN
YYVQKLYSTNKGTDLISVTQNGEDLVGQDELYASATLDSEAKEVVLKVVNTSSDAQEVKL
NFKGKSIKNKGKVIVLKEENLTQENSFDAQEAISPSTEEIKVKGDSASYEVAPYSLNIIR
IPVK
>KECLDBNJ_01484 hypothetical protein
MSLIKMKYVVVSLFLLSAFAKAQEKVSLFPLNAVSVESGVFKEAALTDFNYIQALDADRL
LAPFLREAGLEPKADSYTNWENTGLDGHTAGHYISALSMYYASTSDPKAKEMLEYALAEL
DRVQKANGNGYIGGVPGSDALWAEIKAGKINAGSFSLNDKWVPLYNIHKTFNGLKDAWIH
AELPQAKRMLIELTDWFLDITADLSEAQIQDMLRSEHGGLNEVFAEVYAITSDKKYLKLA
EDFSQHALLKPLAANEDILTGMHANTQIPKFIGFERISQLEEAKDYHDAASNFFDNVTTR
RSISIGGNSVREHFNPVDDFSSVVSSEQGPESCNTYNMLKLSKLLFEDTSEEHYIDFYER
GLYNHILSSQNPDGGFVYFTPIRPGHYRVYSQPETSFWCCVGSGMENHTKYNELIYAKKE
DKLYVNLFIPSEVNWEEKKATLTQKTNFPEEATTELIWNSKKKTKATLMLRYPQWVNAGE
LKVYVNDKLEKIDATPGSYVSLERKWKNGDRIKMELPMHLSLEELPDDSGYVSVKYGPIV
LAAVTGDANQDGLFADDSRGGHIADGPFLPLTEAPMFLTKDGESLLNEIKPVEGDPLHFK
APDLFYPETYSDLVLQPFYKIHEKRYSIYFKKQTPEGLAEEQRKLEEKQKAEAYLREITL
DFVAPGEQQPESDHGILSENSNSGLNQNKHWRDATGWFSYDLRNKEAKAKTLRVTYFGKD
AGRKFKIMVNETTIAEPHFKGTRGNDFFEVDYTIPQELAATNEILTVRFEAEKGSTTAGI
YGVRLLSIPATKE
>KECLDBNJ_01485 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase ArbA
MKTLFTFFSLLVFNSLFAQDIRVHDPVAIKQGDTYYLFCTGRGISVFSSPDLKNWEKEPQ
VFTEEPVWADDVAADFNNHIWAPDITFHNGKYYLYYSVSAFAKNTSAIGLTTNTTLDADD
PNYKWEDQGIVIQSVPNRDLWNAIDPNLIFDENDTPYLAFGSFWEGLKMVKLSEDLKAIA
QPQEWHTIARRERSFDLADANPGDAALEAPFIFKKGDWYYGFLSWDLCCRGENSTYKVVV
GRSKSASGPYIDKDGVALNNGGGTLIIEGNENWYGAGHNSTYTFDGKDYIIFHAYDANDN
SAPKLKIAELQWDAEGWPTLKDNVLD
>KECLDBNJ_01486 Arabinoxylan arabinofuranohydrolase
MKKQIYTVLAVTALLASCKTTAQIEEVSVERGQALFEELETSYNNPIIKDKYTADPAALV
HDGRVYIYAGHDMAPDNEERYIMDEWLLYSSDDMINWKEHPVPLKPTDFDWAIHSAWAAE
VVEKDGEFYWFVTVQHDESKHGKAIGVAVAESPEGPWKDAIGKALITNDMTTQTGISWDD
IDPTVFIDDDGTPYLYWGNQVCKYVKLKDNMIEMDGPIHTVDLPKFTEAPYIHKRGDWYY
LSYAYDFPEKTAYAMSKSITGPWEYKGILNEVAGNSNTNHQSIIEFKDKWYFVYHNGSIP
THGSSFHRSVCVDRLYYNEDGTIKRIVMTSEGIQPEN
>KECLDBNJ_01487 Extracellular endo-alpha-(1->5)-L-arabinanase
MKRNDENTSLLRKGLLVFWCALAISCSSDSPVEETGGEPETPTTPEEEPEEPVAAKVYTV
DNITDTYYDVAGVENVANWGPYNVHDPSVIKVGNTYYCYNTDVSFGSDVRPGIQIRKSED
LINWEWIGWAFNGLPAKGAAYIRSKGGTPFQALWAPYVMKVGDEYRLYYSLSSSTGRLST
MGLATSDSPEGPWVEKDLVVSSEPGGPVQTNAIDPSVVVTPAGEHWFYYGSAYDGIYKLK
LNPQTGLAASPGDTGSRVAQRGFTNGIVNGNIEGPEVIYNEDQNKYYMFIAYDWLQTKYN
VRVGRSDTPDGPFYDYNGLDINTEEDNGPMILAPYRFDEHSGWQGVSHPGVFKDDSGQYY
MAHQGRPGENSFFMVLHVRKIHWTEDGWPIISPERFADVAQTTITDTDLVGNYEQIIFGY
TVTPGYADEQRYPDFQNSIDLTLNADGSINTNANDVWSYDAPWLTLNFGDGTFVDKLYVE
RGRDWENEVESTILLSGLNNEGTAIWGKKIN
>KECLDBNJ_01488 Intracellular exo-alpha-L-arabinofuranosidase 2
MMNKLQLVGAFVIAFCSVTVLNAQDATITVKPSEDAPTISKHIYGHFAEHLGRSIYDGFY
VGEDSPIPNTDGVRNDLIEALKAIKIPNLRWPGGCFADTYHWKDGIGPQEDRPTIVNTWW
GGVTEDNSFGTHNFLNLCEALETEPYLAGNVGSGTVKELADWVQYVNHDGTSPMADLRKE
NGREKSWGVTYWGVGNEMWGCGGNMEPEFYANLYRQYATFMGSWNNEAGLYRIASGANSA
DYNWTEVLMKNIPKNLIDGVALHHYSVIDWGAKGPDVTFSEEQYFTTMKSSLFMDELITK
HVAIMDKYDKNKEVDLVVDEWGGWYEVQEGTNPGFLYQQNTMRDAMIAGTTLNIFHNHSD
RVKMANLAQTVNVLQAVALTKGEQMILTPTYHILKMYMVHQDAQLIPMDLDTPDYELNGD
KLPAISASASKDAEGKTHISLVNIDAHKENTVSIDLSELDIKDFSAEILASEKLQDHNSF
EDPKHIMPEVFKDFKFKKGVLEVTLPAFSVVVLEGK
>KECLDBNJ_01489 hypothetical protein
MKIKNLFVLVFAVVVSSCADNKKSETLFERLSASYTGIDFENTITTNDSINILNYEYLYN
GGGVGVGDFNNDHLPDVFFSGNLTSSKLYLNKGAMQFEDITTTSGIDTSGKWTTGVSVID
VNQDGYDDIYLSVGGMGNKSEFPNLLYINNGDLTFTEAATEYGLADQGESIQAVFFDYDL
DGDLDMYLLTGGGFENSAISVRPMQTNGSARNTDRLYRNDYNEQLGHPVFTNVSAEAGIT
FEGFGLGVSVLDANNDNWPDLYISNDYLSRDLLYVNQQNGRFNEEGLNYFGHMSHFSMGN
DVADIDNDGFTDVITVDMLPEDLKRRKLMSGANSYDIFQIALRYGYGHQYMRNMLQHNNG
DGTYSEIGQFAGIDKTDWSWAPLLADFDNDGFNDLYITNGFGKDITDIDFVKFRESRSSS
FGSGGQLQKAVKDCLATRPAIKVANYAFKNVDGQSFTKSTEAWGFDEASISSGAVYADFD
NDGDLDLIASNINAPAFIYKNTLTDSLGPDSNYLKVNLKGLKNNLKGIGASVRVYSDNTE
KIRVNNPVRGFQSTVSTTLHFGLKNRKTIDSMIVQWPDGKLAIMRNIEANQQLTLSYEDA
QELKDVPVKKPGILTSVETINYEHIDRFNNDYATQPLLMHKYSEQGPSLAVGDLNGDGLE
DVFIGGSYGENSTILYQQKDQSFKKQELPETELFEDGQAVMFDANNDGKLDLYVTSGGTE
RYAGHEAYQDRLYFNTTSGFVAQPLPEMLTSTLAVTAADYDNDGFVDLFVGGRVVPGKFP
TAPQSYILKNNGGNFVDVTAEVCPFLQNAGMVTAATFKDYNKDGKVDLILAGEFMPITIL
ENEGGTFKNKTEALGLSKTTGLWNRMAAADFDNDGDIDFVAGNIGLNTVLNSGQHQALKV
DFADFDNNGYVDPIFSKYEEGAYFPIATLDQLTQQLPQLKKKFLYYHRFAKANTSELLQL
LKTPYQTLKAEELRSILIENTETGFIIKPLPNAAQLAPVNAMLCEDIDQDGYLDLLLVGN
DYSAEVNGGRYDASFGTTLLNTQDGGFKEFPRKRSGFTLKGDSKSIVKVPVSNDDLILVG
RNGDTIATFKYSNKNTHNSNTK
>KECLDBNJ_01490 SusD-like protein
MKKHTIKVFLIALTTSLFYSCGDELEIINPNRLAADAYYTNEDQAIAAVDAIYNTLIIDG
LYQRMTPVIGDGRSDETKSRSPWAFLQQTSNFTVPGTDDAVGWCYEGYYITVNRANQALE
NIPLIEEMDEDLRGRLLGQAYFLRALAYFNLTNIYDNVPLVLSVPKSEDDFFPSNQEVTQ
ATIYAQVEADLTEAIASLPADYTSVSGADSGHVGRATLGAAQSLMGKLKLYQGDYDTALP
YFRTVVESQRYDLAANYQDLFSQDPSVEAANPGRIFWAEFTQSLNSVFNWGGDPSVNWRQ
FIALAPTYSGADFYDFFPTQFLVDELSSERTVDGNLDPRYAATILSYNEEEGLTQAYGRD
YFLDRNLNYIAKYTLANSGGDPFTAGINYHVIRFADVLLMYAECLANTGDIPTAAAQVQR
VRDRANLPDREAEFAGYNLTQFMNQLAHERVTELAIEGLRYYDIKRWGWLEDSSRLSQLQ
ANDDEFDTFANGREYQPLPQGELDRNPNLVPNSAN
>KECLDBNJ_01491 TonB-dependent receptor SusC
MKQNKLYDCLCVFEYLFKKGIFLLAIVLAPIMSAQAQESKTITGTVLSSNGNMPIPGVNV
LVEGTTTGAVTDFDGNFSIEASANDVLVFTYLGFQEQRITVGEQTSLTVTLEEALSSLDE
VVVVGYGTQRKSDLTGAVSVVDTEEMTKQASNDVTQMMQGRVAGVTITSDGQPGASPSVR
IRGVSTFGQGASAEPLYVVDGFPISGGIRDINPNDIKSIQVLKDATAGAIYGNRAANGVV
IITTKSGAKGKKFAVEVNSYYGIQTITQKLPLLDREGYQMINSELLTNAGQPLTPGNDPS
SDLYIDDIDTDWQDEGYKDGYIMNHNFNISGGSEKTSYFVSLDYLDNEGTLVGSGPDYKR
YSFRVNSDTEVGKFNFGENVYIVHSDENPLFNTTTIGLPGGRPSLVNDLLQAAPTIPVYD
PNRLGGFGGADATIHQSITLNVPGINTLIENQTKVNRVLANFYAQFEPIEGLKLKTNLQY
DNTDIEDQLFVPQYDLGYFFPNPTAQLQYGSRKSSSFLIENTINWTKEFGKHNLTVLAGQ
TYQKFNARNVSATGVGLTAPYVKNLVNAENFSVNDDIQNSAISSLLGRVNYSFDDKYLLT
ANIRRDGSSKFREELRYDYFPSVGLGWKIHNEFELPEFITALKLRGGIGEVGNQEILNYA
YQNTINRGIPYSFAYGRAIGAAVTALVDQDIKWETRVTRSVGIDATLFNGGVDFTAEYYS
NTSNDVLTYVPIPISNGSIGSQLLTNAGSIKNSGIELSAVIRKQFGDFYLEVAPNFYTVN
NEVLDIGGLDLISSTGARTVVGRSLGEHYGWVYDGIFQSQEEVDNAPFQTPGTAAGDIRF
RDLDGDGSITDEDRTFLGSALPTFNYGINISARYKDFDFTIFGQGAGGNYINSNLYKGLM
PTTGYTNWHEDILNRWTPENTNTTIPRVVFLDPNNNGRDSNRPGWLQKGDYFRINTISLG
YTLPDTFVENIHMSSARFYVTLQNVAVLSSYKGYNPDFQAGVLSPGFDYGTYPRPLTTML
GAQLKF
>KECLDBNJ_01492 hypothetical protein
MTDQLNNYNSEDKVLLAVDCIIFGFDQEDLKILLIKRDFEPEKGKWSLIGGFLKNTETLD
DAANRILHHLTGFDKIYMEQLYNFSKVDRDPAERTLSVAYYALINIEDHDEHLIEQYSAQ
WFSIEEAPSLIFDHDEMVRKAILRLRRRAISKPIGFELLPEKFTMRQLQKLYESILNEKL
DKRNFINKVNGLDVLVKLEEKDMSSSRKGSYLYQFDKEKYDRNVEDGITFKI
>KECLDBNJ_01493 HTH-type transcriptional repressor CarH
MNTVKTNFSIKDLESFGGIKAHTIRMWERRYNLLDPDRTPTNIRTYSLDDLQKLLNVTFL
LDHNYKISKIAKRSSDEIASLVAEIVEEQDLGANHHAINSFKIAMMNFDQRLFSQTYNHL
RQTLGFSELFFSVFIPLLEKIGFLWQAGVVNPAHEHFISNLIKQKILLNLDACINTVEQK
SDNLFVLFLPENEIHDLGLMFLNYELESRGHKCVYLGQNIHIENLKYIVKTHNNPHFVSY
LTVNPCDMGVAKFAEHFNKTIEEEHIPLYLLGRMVQKIEQQEMPENVKIIKSIEALSDVL
N
>KECLDBNJ_01494 Dehydrosqualene desaturase
MPKKITILGSGFSSLAAASYLAQAGHEVHIYEKNATLGGRARQYKRDGFTFDMGPSWYWM
PDVFDRFFADFGKKTSDFYNISKLDPAYRVYFGKHDSIAIGDSLGKIKETFEAIEPGSAQ
KLQEFIDDAGNNYEVAIKDLVYRPGVSPLELVTPQTIKKIGSFFSTISRDVRKAFKNPKL
IQILEFPVLFLGAKPSDTPSFYSFMNYADFGIGTFHPKNGMHAVIEGMITLAESLGVQMH
ANSTVESIVTENNIATGITVNGKTIKADIVLSGADYHHTETLLPKNLRQYSETYWGKKTF
APSSLLFYVGFDKKLEHVNHHTLFFDTDFDKHAVEIYDKPKWPDAPLFYANFPSISDMAM
APEGKEAGFFLIPLAPGLHDTQDLREEYFDRIINRLEELTGQSVKKNIIFKESFCVKDFV
EQYNSYKGNAYGLANTLLQTAFLRPKLKSKKVANLYFTGQLTVPGPGVPPALISGKLVAG
LITKNDKKKK
>KECLDBNJ_01495 15-cis-phytoene synthase
MKQIFDNVSLACSETVTRSYSTSFSTATRMLAPSIRQDIHNIYGFVRFADEIVDTFHAYD
KESLFNRFEADLENALEEKISLNPILNSFQHTFHTYNIEKHLVDAFMNSMRLDLSKSKYL
TEEEYKNYIYGSADVVGLMCLTVFVKGDREKYDELKDCAMSLGSAFQKVNFLRDLKADHE
ELSRTYFPNTNLNELDEASKQKIIVEIEADFAKGLAGICKLPVEAKFGVYTAYRYYRKLL
SKLKSTPSLEIKNARIRVPNYVKASLLARSYVKYRLNLI
>KECLDBNJ_01496 hypothetical protein
MQIALWILVFLLTFALMEFMAWFTHKYVMHGFLWSLHRDHHHKDHGSWWERNDFFFIFYA
LISIGCFLLWQYENVWIGLPIGLGIFAYGVTYFMVHDIFIHQRFKLFRNANNWYAKGIRR
AHKIHHKHLGKEEGECFGMLLPPTKYFKK
>KECLDBNJ_01497 hypothetical protein
MSFLTASWKKLCFANYAIDPEILLPYVPAHTELDFFDGKCYVSLVGFLFDDVKLKGITIP
FHKRFEEINLRFYVKHFDGKQWKRGTVFISEIVQKPAIAWVANTLYNEQYSVYKMHYKHD
LNHDENFFSYGIELEEQWQLFQVATAPEPTTYAPGSITEFITEHFWGYSRKSATESWEYE
VKHPLWKAYDVLDYEIIFDFEKLYGEAFAELATRDPDSIQCMDGSAISIEGKKLIK
>KECLDBNJ_01498 Putative cysteine ligase BshC
MSVKHIPYKNTGYYSKLICDYLEQKEELKSFYGHFPNLENFKKQIADKKFSTENRATLVK
ALHRQYQNLNSSDEVTKAINLLSEPQTFTVTTGHQLNLFTGPLYFLYKIISTINLAKKLK
ETYPEQDFVPVYWMATEDHDFEEINYFRIHGKKIQWNRPDTTDNDSGAVGQLNTEGLEQI
YELICAEFGNTNSARDLCKLFEDAYLKHNTLTEATRYLANELFAAYGLVIVDGDDADLKR
IFAPYMQNELVTQTAFDAVQTQAEKLEEAGYGVQVNPREINLFYLAEGIRERIIEKEGRY
FVNDTDIAFSKDELLEALAERPEAFSPNVIMRPLYQEVILPNLAYIGGGGEIAYWLELKS
FFDKVEVPFPMLMLRNSAVLITEKQEEKLQKLDLSIEELFLSQNDLVNRKIRRISNINVD
FTPQKEHLVKQFEAMYSIAQETDASFLGAVKAQEVKQLKGLEHLEKRLLKAQKKKLSDHV
KRFTSIQNELFPQENLQERVTNFSEFYLHYGKNLIPQLFEALDPLDYRFTVVTQ
>KECLDBNJ_01499 hypothetical protein
MHKFTYLFAFLFSILSVAQDLKSPEEFLGYQVGTQFSRHADVVAYFKYVAEHSDWVTFYE
YGKTNERRPLTYAVITTPENQANIETIRTNQLKNAGLTDGSASPDKAIVWLSYNVHGNEA
SSTEASMLTLYKLITTKKDWLQNTVVIIDPCVNPDGRDRYANWYNKVKATPYDTNPDAAE
HNEPWPGGRANHYLFDLNRDWAWATQVETQQRLKVYNKWMPHIHVDFHEQGINSPYYFAP
AAEPYHEIITPFQFEFQREIGTNNAKYFDENGWLFFTREVFDLLYPSYGDTYPTYTGTIG
MTYEQAGGGRAGLGIEKADGTVLTLVDRVAHHFTTGLSTVEVAAKNVDRLNTEFNTYYSN
PDVEFKTFTLTGELDHLNALAALLDIHQIEYSFTGAGKASGTAYGDADKTSLSYPKAITL
STDQPKGKLVHVLFEPEAVLTTPLTYDITAWSLPYAYGLDAVASTKGASSASEYVASSTQ
NSVSKSAAGYIAKWNSMRDARFLSALLQAGIKVRFTEEAFTNSAVNYPSGSLIITRSDNP
SENFDTDLVAIANEFERSITAVPTSFATAGPDFGSSAVKLINKAKIGVLTGEQTSSLSYG
ATWHFFEQQLQYPVTSIDASDLGRINWSDYDVLVLPSGRYNFNDNVLQDLRAWVRSGGNL
IAIDNALRVFANQEGFNLKTAITEAPKDTITAKTIAYADRQKESAKNLISGSIFKTNIDT
THPLAFGYSDTYYSLKIGSDAYALLDRGYNVGYLDAEPKRVSGFAGEAALKDLSNSLVFG
VEPMGRGTITYMVDDPLFRAFWENGKLFFANALFLNNPNNYRK
>KECLDBNJ_01500 hypothetical protein
MTPLEFKLIESLILLFVLGIIRYVVSKLIVSRYRRANFDITRKQLTIKVLNILFFMVLGF
CLAVIWGLSGQDVIAGIGSVITILGVAFFAQWSLLCNITSGLILFFNHPLKIGDYVEIVD
KDFPMSGRVENITLFFLHLRNKDNHVYTLSNTIVVQKTMRIMKPEEFFEEIEKLEEDKNT
PGAESALD
>KECLDBNJ_01501 putative zinc protease
MKNTFLYLLLLSFSFIACDQEKKTKPESNTTETEFKVDYEEYTLDNGLTVILHKDTSDPV
VGVALTAHVGSAREKEGRTGFAHLFEHLLFLESENLGKGGLDQLSARVGGSGANGSTNRD
RTNYFQTVPSDALEKMIWAEADKLGYFINTVTDPVLAKEKQVVKNEKRQSYDNRPYGHER
YVIHKNLYPKEHPYNWQVIGSLEDLQNATLADVKEFYNRWYVPNNVTLTIAGDFDTTQTK
EWIQKYFGEIPRGEAIAPLEKQIPQLTENKNLYYEDNFARLPQLTMTWPATPEYTEDSYA
LEVLTTYLSDGKKAPLNTILIDELQLASNPRMYYSGSELAGEISLSVRANSGVDLDSVKV
GIDQALALFESNGMTAEDLERIKAKQETRFYNGLSSVLGKGFQLAQYQIFAGSPGYINED
IKQIQKVSLEDVQRVYEAYIKNKNYVVTSFVPKGEATLALADAQEAEVVEEKIVNGAEET
FDPSIAAEYERTPSSFDRTVEPPYGESPQLKVPEVWEKELENGLKIYGIENTEVPLINFS
ITIAGGQISEPENQSGVANLTAELLTKGTQNKTTAQLEEALDILGASVRVYAGQEATTLS
GTTLARNFDKTMQLVSEMLLTPRWDAEEFQIAKKNVLTSLEQQKADPGSIADLAFAKAIY
GPDHTLSKNILGTTASVEALSLEDVKQFYETYAPNLSTIEVVGALDESSITNALAPLTQE
WKSKDISVKMPIVQANLERGMVYFIDVPGAKQSQLRFGYAALSAKDPDFLPAQMMNYRLG
GGGFASELTQMLRETKGYTYGVRSRFAGSALPGPFIVSSGVRSNVTAESTQLVREIMRSY
AEDFDADDLELTKGYFIKSNARSFETPYAKLGYLTEIATLDFEPDYILDQQETVKEITLD
QIKELANTYADPEKLIYVIVGDAKTQLKKVQDLGLEVKLVNQNLEAQEALKK
>KECLDBNJ_01502 hypothetical protein
MHYRFLLLVILSGSLFGQQRLEGYVYSAKDSTVLEAASIYFDGTTVGTITNKNGHYSIPV
QEGITSPLVITMMGYAPVYLNKFANGAMPPVYLSEKTETLDQVFLETDPWSRQRKLDVFR
TQFLGNSSEAQKCRILNEDALGLHYSPSKLKLSAWANEPLIIENKHLGYTIRYTLTDFYV
AYDKGRSTEYPIMNMVYYEGFSFFQELKEKTRRKFLKNREDSYNGSVLHFMRALAQKQLH
ENNFRIFYKKFETPPYLHFEFRKILDRTYVKLDVETLSILYDNAEQSSIQANETFVIDAF
GNHSPPSAVIMSGAMSYRRFAFTLPLDYKLQSQ
>KECLDBNJ_01503 hypothetical protein
MKAITSKIHKKQRNALIVYGLFYLIMGIIPQFNEESSLVSWSYIFVGVVMLGTIGYQAYK
GNYFSIIKWNDNILAFKSPESKFVHFKRSAIKSVKLTDKSLTINAGLGDGEMLDLDYFKA
EDLEFFKKDFVEGGLTETEAYNLAEA
>KECLDBNJ_01504 Ribosomal protein S12 methylthiotransferase RimO
MRTKTLKKNKINVVTLGCSKNVYDSEVLMGQLRANNKEVVHEEEGNVVVINTCGFIANAK
EESVNTILDYVQKKEDGVVDKVFVTGCLSERYKPDLQKEIPNVDQYFGTTELPGLLKALG
ADYKHELIGERLTTTPKNYAYLKIAEGCDRPCSFCAIPLMRGGHKSTPIEHLVTEAEKLA
ANGIKELILIAQDLTYYGLDLYKERALAKLLSELVKVEGIEWIRLHYAFPTGFPMDVLDV
MNEEPKVCFYLDIPLQHISTKLLKSMRRGTTYEKTNALLKTFREKVPQMAIRTTLIVGYP
GETQEDFELLRDWVKEMRFERLGCFTYSHEENTHAYTLEDDVPEEVKMERANEIMAIQSQ
ISWELNQEKIGKEYRIVIDRKEGNYFVGRTEFDSPDVDNEVLIDATKHYLKTGEYVTVTI
TDAEDFDLYAAPLSN
>KECLDBNJ_01505 hypothetical protein
MRALFFMLMVLGLIACSSDETNAPENPTDESLYFPPLSGTEWATSDPADLGWNTAKIAEL
ESFLTATHTEAFLILQNGKITYEAYFNEKTATDLFPWNSAGKTLTAFTVGIAAQQNLLDL
NDKTTAYLGRGWTSMTAEQEDAILIKNQLTMTSGGDFTAENTVCYDPECLYFKTAPDSEW
YYYNAYYTLLQPVLDAATSNGFEAFFENELKTKIGLDGRWVSLGYNNVYFSTAHSMARFG
LLNLNQGSWDGIQLLNSAYYEAMTTTSQELNPAYGYLWWLNGKTHYQLPGSTQTFTGKLI
PNAPDDLIAGLGANDKKLYVIPSKKMVIVRLGPAAYSEDLGPTSYDNDLWGVLNEVF
>KECLDBNJ_01506 Glutamyl-tRNA(Gln) amidotransferase subunit A
MKQILLLLSFAFLFSCKETSSNASTKEATQTLNDSTVQEREYAVLDSKVLTDETLWKSFD
FEVKMFTETKYDKLKPFIFEKTIPEIQQAVAQGQLTYEELVLFYLSRIKKYDRNNDLSLN
SVIALNPKVLDQARELDKNRANDLDPYSIYGMPILLKDNINAADMPTTAGAVVFEDNDTG
DAFITQKLKEHGAVILGKANLSEWAYFFCGDCPSGYSAVGGQTLNPYGRKIHDTGGSSSG
SGVAMAANFAVAAVGSETSGSILSPSSANSVVGLKPTIGLLSRGGIIPISSTLDTPGPMT
RSVIDNAILLQAMTGLDEDDAAAVNLKAASTDYVNGLKDLEASAYLSEKRLGYYTNYDDT
LYLQAVEALREAGATLIPIERPEVDLPQFTRVLNLDMQKDLPAYIANYGSKNLAVKDLKD
ITGFNKKDSLIRMPYGQKLLYGVLADSASAEEFTAIKDTLERNGRRFFDEPMKANDLDAV
LSINNYMSGYAAVAKYPAITVPMGYQEDNRPMGLTFIAPTLSEAQLLELAYAYEQISKMR
KTPTNFEE
>KECLDBNJ_01507 Signal recognition particle receptor FtsY
MSFFKKIFSKEKKETLDKGLEKTNANFLNKLGKAVAGKSKVDDEVLDDLEEVLVSSDVGV
ATTIKVIDRIEARVARDKYLGTEELNTILREEIAGLMSETNTGDATDFTVPAKKPYVIMV
VGVNGVGKTTTIGKLAHQFKQKGLKVVLGAADTFRAAAINQLQIWADRVDVPIVKQQMGS
DPASVAFDTVQSAVKMDADVVIIDTAGRLHNKINLMKELTKVKRVMQKVIDDAPDEVLLV
LDGSTGQNAFEQAKQFTAATEVTSLAVTKLDGTAKGGVVIGISDQFQIPVKYIGVGEGIE
DLQVFNKIEFVDSFFRN
>KECLDBNJ_01508 hypothetical protein
MAKKSVATLQTGSKRLTKAIKMVKSPKTGAYTFVEAVMAPEMVGEFLDKK
>KECLDBNJ_01509 50S ribosomal protein L33 2
MAKKGNRVQVILECTEHKASGKPGTSRYITTKNKKNTPDRMELKKFNPILNKMTVHKEIK
>KECLDBNJ_01510 50S ribosomal protein L28
MSRVCELTGKKAMVGNNVSHAMNKTKRKFDANLIKKRFYIPEEDKWITLKISTAALKNIN
KKGITAVLKEARAKGFLTK
>KECLDBNJ_01511 Nicotinamide-nucleotide amidohydrolase PncC
MRAHIITIGDEILIGQIVDTNSAFIAKELDKIGVEVYQISSISDSKEHIVHCLEEAQKTA
EIVLITGGLGPTKDDVTKHTFCEFFDDVLVENQAVLHNIERIFKHHVNRPMLPANRSQAL
VPSQATVLMNHNGTAPGMWMKSGKTVFVSMPGVPFEMKGLMTSEVIPRLQKEFSRPFILH
RTLQTYGMGESEIADRIAGWENALPADIKLAYLPALGKVRLRLSTKGPDKALLEQRLDEQ
IKGLHALIGEIIVGYDDGESIEAVVARLLTERHRTLAVAESCTGGQISAAITSIPGASAY
YKGGMVTYATHSKVELLKIEQKLIDEHSVVSAEVAEAMARSVQQWYGADYAIATTGNAGP
TKGDSDADVGTIYIGIASPSGVVAHKFMMGSQRERVVSKSVNKAFELLQKEILKNS
>KECLDBNJ_01512 hypothetical protein
MPTHYDLYQLEDMSGGDKEFMKTVVEAFLTEIPPDLESMQMAIDNDNHKMAYQFAHKMKP
NLEMFGIDLIREISAMERWADSNKPTSAIRPQLNTIVTYINNAIEEMRKDWKM
>KECLDBNJ_01513 Ureidoglycolate lyase
MKIICIGQNYSDHIKELNSKASSEPMFFLKPDSAVLLKKHPFVIPEFTNEVHYEVELLVR
INRLGKYIQPKFAHKYYDEIGLGIDFTARDLQRECKEKGHPWEKAKGFDGSAVLGDFWVP
KEKFKELNDINFHLEKNDKIVQSGNTANMIYDIDTLIAHVSQFMTLKIGDILFTGTPAGV
GPVAIDDRLTGYLENEPIFTVNIK
>KECLDBNJ_01514 hypothetical protein
MSRVFFLFGFLLASSLIFAQETAFRGKVIDANSKEGVPYAHLILPELKRGTSADVHGDFR
FEAGQVAQSMQVLVSSVGYETRTLTLGTMSEAIALQPSLNALREVVIYDLQDRRSKRINP
FVGAKIVGLGNFSGGAYPSALARYYARPKKFDQGCFLKNLEIDFYRVLGADNPAAKFRLR
ILEVAEDGLPGTDLLDDGLVLEKPENAAKMKVNMLPYKLSVPSEGVYIVVEHLFIPENKF
TEIVSVQNNEGNYINYEVERYAPIFKGVEIARNQSNPLCFYKSLTGWKPVTQLDTAGSAL
AGNAPAPAFKVLFTD
>KECLDBNJ_01515 DNA polymerase III subunit epsilon
MNLNLTRPICFFDLETTGINVAKDRIVEISVLKVFPDGKEEKHTWLVNPTIPIPAETTAV
HGIKDEDVADKPTFKELATEINNLIKDSDLAGFNSNRFDIPLLAEEMLRAEVDFDMKNRN
AIDVQTIFHKMEQRTLSAAYKFYCDQTLEDAHSAEADTIATYEVLKSQLDRYEDLENNMK
SLAEFSARKKFADFAGFIAFNKEGEEIFSFGKHKGKKVEEVLENEPGYFGWIQNADFPLY
TKKVLTAIKLRKLNTKLF
>KECLDBNJ_01516 Blue light- and temperature-regulated antirepressor BluF
MISHIAYLSTQSFILNDSDLESLLQHARTSNALLGLTGILIHLDGHFIQFIEGDQPALEQ
IYKKITTDPRHFDLKILSEGSSTKRCFGAWDMYYKKLTNTQLNSLEASKNLKSYDHLKPL
SAEAAEEVPALQLLHNFVEALS
>KECLDBNJ_01517 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MGESVAEATVTNWLKEVGDTIELDEPVVEIATDKVDSEVPSEVEGVLVEKLFEADDVVQV
GQTLAIIETEGEGDATPEPATSEANEDNTSKQVAEQMLTEAKETTSTPSISNDGERFYSP
LVKSIAQEEGITQEELDQVEGTGLEGRVTKDDILTYVAKRKDGEVPSKPAAKPTQAVKQE
TPAAPVSVNGGDEIIEMSRMGKMISKHMIASVQTSAHVQSFIEVDVTNIWNWRNKVKNEF
QKREGEKLTFTPIFMEAVAKAIRDFPMINISVDGDKVIKKKDINLGMAAALPDGNLIVPV
IKKADQLNLVGMAKAVNDLASRARAGKLKPDDTVGGTYTVTNVGTFGSVMGTPIINQPQV
GILALGAIRKIPAVIETPEGDFIGIRQKMFLSHSYDHRVVNGALGGQFVQRVAQYLEAWD
VDRAV
>KECLDBNJ_01518 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MLLSVIILSYKVPYYLQLCLESVQRATQDIEAEIIVADNNSSDETAHLVTTYFPQVHFIE
NSENLGFARAYNQAAQQAKGRYFCILNPDTVLPEACFKTLLAFAEKQQNFGALGPRLIDG
AGAYLPESKRNIPNPKVALKKMTGDTSSYYANQLAQDEVGLAPVLVGAFMLITQSAYHEL
GGFDEAFFMYGEDIDLSYRLLQLGYANFYCGNLSVIHFKGESTIKDRRYFRRFYKAMHIF
QRKHFSQGFVSDKLLALVLNFLAFSKKQEALYKTMSEESLERAYWCSDSEIPKGLVTKLE
PQMKCESVRLDQITTKLPPGILIFDMNALSFTEVISTMQLLKNSKNRFRIRPSNCNFILG
SDASTHRGALLKW
>KECLDBNJ_01519 Recombination protein RecR
MEFSSKLLEQAVYEMSQLPGIGKRTALRLVLHLLRQPESQTEQLTEALTGLRSGIKFCKN
CHNISDTELCEICANPNREAAIVCVVEDIRDVMAIENTSQYRGHYHVLGGKISPLDGIGP
QDLNIYSLVEKVKKGEVDELIFALSSTMEGDTTNFYIYRQIESFGIKTSTIARGIAVGDE
LEFADEVTLGRSILNRIPFENSLKQ
>KECLDBNJ_01520 UDP-N-acetylglucosamine 2-epimerase
MADSSAKRILFIFGTRPEAIKMAPVIKAFKSNTSLITKVCITAQHREMLDQVLDFFSITP
DYDLDLMQKNQDLYTLTSRALLALKVPLEDFKPDLVLVHGDTTTTMTASLAAFYAGINVG
HIEAGLRTHNLHSPFPEEFNRQFTGLVANIHFAPTTQAKANLLKERIPEDCICATGNTVI
DALQETVKKVQQQNPDFAENIPFKTKKIILVTGHRRENFGAGMQRICQAVAQLATQRDDI
HFVYPVHLNPNVKSVVHTILGNHPNITLIPPLEYPDFVWLLDKSFLIITDSGGVQEEAPS
LGKPVLVTRDTTERPEAVTAGTVKLVGTDAVQLKMEVLRLLEDAEAYKTMSAAHNPYGDG
KAAQRILDFVLHYFKA
>KECLDBNJ_01521 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MSIAIIGLGYVGLPLARLFATKYVTIGFDINTERITQLKRGFDKTDELEKELLDEVLLAE
LVDQPGLYCTAEVDDLTSCTTYIITVPTPIDENNNPDLTPLIKASKLVGSYLKDGDTVIY
ESTVYPGVTEEICVPILEETSRLTFNSHFFVGYSPERINPGDKTHTVDKIRKVTSGSTPE
VAEKIDALYASVISAGTFKASSIKVAEAAKVIENSQRDINIAFVNELAKIFNLLNIDTQA
VLEAAGTKWNFLPFKPGLVGGHCIGVDPYYLAQKAKQVGYHPEIILAGRKLNDSMGPYVA
SQVVKLMAQKDIKLKNSRILVLGITFKENCPDVRNTRVIDIITDLQEYGAKVSVYDPQAD
AHLVKEEYGIELLPSIENQKFEAIVLAVAHRDFEKLDLEKLKNDAAVVYDVKGFLKEGAD
GRL
>KECLDBNJ_01522 UDP-N-acetylglucosamine 4-epimerase
MNLQPLKNKKTLVTGGSGFIGSNLIEALLQAGASVRCLDNLSTGNKENIQDFLALDNFEF
IEGDIRDLETCKQAVAGCEFVSHQAALGSVPRSLKTPLLTHSVNVTGFLNMLEASRLEGV
TRFVYAASSSTYGDNEALPKIESEIGKPLSPYAVTKLINEYYADVYKRNYGFNTIGLRYF
NVFGPKQDPDGAYAAVIPKFIAALLNQESPVINGDGSFSRDYTYIDNVVQANLLALTTEN
PLALNEIYNIAYGARTSLTELVNLLKERLLNYDSDLVKVQPKYGPERPGDVPHSLASISK
AKNLLGYDPDYDLDAGLRKAIMWYRAHLKTVKEDK
>KECLDBNJ_01523 DNA protection during starvation protein 2
MNYLNLDKNRTKETVEQLNTLLADYHLYYQKLRNFHWNVVGENFFDLHEKFEEMYNDTLI
KIDEVAERILTLRYQPVSHLSQYLKMANIEESPSETADLEMIDILLNDHGKLLTQMRKTV
EFADKGGDEGTIDLLGAYIRELEKTSWMLDSWRMTKSGTHKKS
>KECLDBNJ_01524 Small-conductance mechanosensitive channel
MLLLQEETRNSDLTFLGFDLYKLIEKLQSWGESIILKLPNFLVAVLVFIIFWYVAKYVSK
FVRNILMRSVSQDSIKTMAGQTAFAITVLIGFFIALGVMDLDKVLTSVLAGAGVVGLAIG
LALQGTLNNTFSGVILSFMPKLQLGDWVESNDYAGVVEEITLRNVTLKQSDNNYVIIPNS
SIVDSPFKNWSQTTRSRVFINCGVGYESDLEAVKKLTLETLTKEFEQQSPEEIEFYYEGF
GDSSINFVARFWAPVTKRRDMLIAQDRAIIAIKKAFDANDINIPFPIRTLDFGKNKFRSE
TITIANSNGSDSAEA
>KECLDBNJ_01525 hypothetical protein
MRTFLFFSLSLLLLCSCQDYGKLEKKGDLDRSLAEISGLAVFSNDSLIYTATDHGNPNSI
YGLNPSGNIIREITISNAPNEDWEDLTKDSNGTLYISDTGNNENDREDQFIYIIPNFANL
AQQRESLKAQKITFTLSDQENYPPSLKNLNFDIEALIYKDEYLYMFTRNRSRNFDGITKV
YKLPALPGTFEAELIDEYYVCDDLNTCAITGADISADGSKIALLTTNKVLILSDFDGERF
FSGNIKTYDLGYNSQKEGVSFKNDSTLYLVDERRAQTGGNFYEFSLD
>KECLDBNJ_01526 Secreted effector protein PipB2
MLEERLSQLEAENLKLKEQLDRQENKKKNRRKLGWNFLKRSSGMILGAQLKKSIEKFLDE
IAEQQRVSRETLSDLLSSIIIRLTRVGFLLILTAILPSILLIFQTYYLGKQNTLITGQSE
MFKQQNKRLDQQTYLQEADRRGQTLLIMDNMLKEINTDVSRSSANAIDDATAGRLISLSK
MLKPYKYLENDSLIARVTSPERGYLLVSLLETGINLNTSTRSRSNGRLIERLDFTYAELR
NLSLKGADLIQIDLANADLRNSSFNGTDFEKANLQNAWLHETNLTYASFKEANLEQAILQ
NAILDYANLQNANLSSADLRNVSLLKTKVLAADLTNARVNETFERDATQQLNKDQSEWLF
SNFEVVEIDDDHYQLLPIDN
>KECLDBNJ_01527 (R)-stereoselective amidase
MKEIDNIDNMESSEKRERIDTINLEYLKVKDFEELKEIMIAVYPNIPDPYWKKKDLQKLV
SIFPEGQVVVKVNGEIAGCALSIIVDYDKFSDAHTYMQITGNESFSTHTPKGNVLYGIDI
FISHKYRGMRIGRRLYDYRKELCENLNLERIVFGGRLPNYHQYAKDLSPKAYIEKVRSRE
INDPVLDFQLSNDFHVKRIITNYLEGDKQSKEYAALLEWDNIYYQKPAKKPNAIKTVVRL
GLVQWQMRTYKNFEELFEQAEYFIDTISGYRSDFALFPEFFNAPLMAAYNHLSEPEAIRE
LAKYTERIRDRFSELSVSYNINIITGSMPYMEDGTLYNVGFLCKRDGTIEKFYKLHVTPD
EAKAWGMSGGEKLKTFNTDCGKIGILICYDVEFPELGRLLADEGMDILFVPFLTDTQNGY
SRVRHCAQARAIENECYVAIAGSVGNIPKVHNMDMQFAQSMVLTPCDFQFPTNGVKAEAT
PNAEMILVADVDLDLLKELNQFGSVHNLVDRRKDLFQLKWKKK
>KECLDBNJ_01528 hypothetical protein
MIKNNILLTLVILLLFSACATYTSRYKDGVEQGIYPTSKKIDRTFYLLGDAGNSEMGEST
EGIKLFKKFLDKANDDSSFAIFLGDNIYPVGMPPEGDEERALAQHRLDAQVETFSEYTGT
PIFIPGNHDWYNNHLHGLNRQEEYLKKITGLDDIFLPKDGCPLVSYDINETVHMLLIDTQ
WYLEDWDKSPKINDNCDNIKDREKFFIELEGEIKKNQHKTLVIAMHHPMFTNGVHGGKFA
LDKHLYPSQQKIPLPILASLVTQIRTQGGVSKQDRFNEKYNELMKRLRVLAQTHNKTIFV
SGHEHGLQYIEHDEVRQVVSGSGSKSSYAYLGNDGLFSSDYEGFAKLDIFEDGSAWVQYY
GTDQENGEPVLFFQKEVFPPDPISDYSRLSTSFPQTIKTSVYSIEETERSELFESVWGEH
YREVYGKQVTAPVALLDTLYGGLEVVRPGGGHQTVSLRLKDKSGREYNMRALRKSAVQFL
QKVILKENADVEEDLDNTLPESLIQDFYTSAHPYGAFAIPRLSEAAQVLHTTPKLYYVPK
QPALEKYNEDYGDQLYMIVERPAKEYSGATFSYPDDIESTDDILDKLRSDEENIVDEQAY
IRARMFDMLVGDWDRHNDQWRWAEYKDQNGKDIFVPIPRDRDQVFTNFDGAILDIARTLF
GMARQFQVYDENLDDMKWFNNAGIKLDRALAQRSGRAVWHKEAQFIKDHVTDEVIEEAFR
DLPPEVRSGESIDEIKKNLKGRRDNLVAIAESFYDYLVELQMVVGTDKDDYFEITRADDA
TRVQVWRIKKGEKADLMHDRTYASNETKQLWIYGLDDDDVFEVNGAGRNPIFLRIIGGQN
NDVYRINNGRKIKVYDHESLPNTIEARGGANFRLTDVYDYNTYDYQKQILRTNGLTPAFG
YNPDNGVSLGLTDVYTVQGFRQNPFSQQHRFKMLYFFATSGLDFTYNGEFAGIMNDWNLT
LGARYTTPNYARNFFGYGNESVNNDDALGMNFNRVRLSRMEASVGLLRNSDYGSTFSIQA
LFEGIRVADNALRYIDFVDIIEQEERKYFGTVDATYEYHSADNALAPTRGMDFILNGGFT
NSLSDSGNRFAYLNPSMGFYNAISANRKLVLKTLARGQFRFGDDTEFYQAATLGQSSGLR
GYRFDRFTGNSAFSATGDVRYAFDTFKTGFLPLQIGVFGGYDIGRVWSDVDQDSEKWHDS
YGIGFWVNSADALSGTFNLFKSSEGYRVSFGFGFNF
>KECLDBNJ_01529 hypothetical protein
MAETAEKPIKSFSKADQFVLELFKEKLPNSYLYHNYNHTVRVVKSTKEIIENSQINVKQK
EALILAAWMHDTGYTVTRDGHEEASIDIAKEYMTKEGVDAETQKLVVELIASTKMGVEPK
NELECILKDADNSHFAKEYYAQTSEFLRQELLLTETKKFTPAEWREENIQMFTHKHKFYT
DYAARNWKNQKDENLISLLKKEKKKKKKYRKEEVKAKLKAKFKDESPDRGVQTLYRTTLR
NHIKLSDIADTKANILLSVNAIIISLALSNMIPKLDAPSNRHLLIPTLILVVFSVASIIM
SILSTRPNVTSGEFTREQVKKKQVNILFFGNFHKMKYDQYQWAINEIIYDKDYIYEALTK
DLYLLGVVLNKKYLLLRKTYTVFMVGIIVSVISFIIAFWLI
>KECLDBNJ_01530 hypothetical protein
MEDLQEFPLQVQLSFSKLLEEFKVRMQQSQNEVTKDYLKAVLDYAESYPELINGIEHTDK
IDEYEEVLSTLLDNLFPAALTKNEIKAATMPFMNKIFNPTKRFAAIMKDAGEDFDLSIRN
LDPAYYYIIGCVVILNSYYNYDIDFKRPVFYEIPDKNGVIRTYRASINADFTFCEPTEEA
VEITPEIVDKLIENGNDFKLWKEYFPPNSWILKGITILNLTDVTVDDSISDLKSTLLAQK
NIKKDAVQQFQSIFSSIFNIPDLQVGFTEFDKDEECFMRMNNGIGYSFILNDKMRTDCRQ
SMCDCSYDTLIKDKKYFVIPDVDEYAVKHKTNLLAKNLQEQGIKSCILAPISRGNELLAV
LELVSSKRNSLHSLNATKLDDVMPYIVSTVERKKFELENRIKAVIQSECTSIHPSVLWVF
EEEARRFIANQNQGKFAAFKDIAFEDVYPLYGQIDIVGSSEERNKAIQQDILIQLKMVYD
ILDLAIATAPMPIYEQVKFRIEEFTAEITERLNANSESEVFALLQEEVNPLLSHLNTKIP
ELKKAIDNYKASINKDTGLIYENRKNYDDTVQLINQNLATFLDRKQQEAQQIFPHYFERY
KTDGVDHNIYIGASMTPKEKFNKVYLYNLRLWQLCTMCEMENHFYHKQEGAELQLDAASL
ILVFSTTLSIRYRMDEKKFDVDGTYNARYEIIKKRIDKALVKGTDERITQKGKIAIIYSQ
DADAEEYTRYIHYLQRKEYLGTEVEYLELEDVQGVVGLKAIRVNVLYTSKLPRTNEEETI
TYEDLMEILD
>KECLDBNJ_01531 Thiol-disulfide oxidoreductase ResA
MNKLFLVVATAIVLISCASEGKFKITGTTPDINNGTNVFLQKIDANNQLQNVDTTVIKEG
KFNFTPEPVAAPEMMVLSFEGARGNVILIAENEEITVKAYKDSLYTSEVKGGSENDFFKL
YYDDVVASNKEKQKLQEEGMAAMQSGDTSKVTIIRNEFDQINEADTRRRLKLIEEHPGEF
VSVIILSDLVGTRAIDSGEAEALFESLDTTLQETEKGKKLSEMIAQLKSQEAAASQAEIG
NKAPEFSAPTPDGGDLALKDAMGKYTIIDFWASWCKPCRQENPNVVSVYNTYHEKGLNII
SVSLDRASAKDKWLAAIENDKMDWYHVSNLMEWQDPVARKYGVTAIPATYLLDENGVIID
KNLRGDALVSKMQELLGEG
>KECLDBNJ_01532 hypothetical protein
MLKPSFLNAAKALIVSLVFAQNIQAQTTKLFDLLPASTTQVDFVNALNDSQTANILIYAN
FYGGGGVGIIDVNNDGLEDLFFVGNLVPNQLYLNKGNFRFEKITEEAGIDFDGGWSTGVT
IADVNNDGFQDIYISRELYDDKPELRANLLYINNQDNTFTESAQAYGVADEQRTRHATFL
DYDKDGFLDLLLLTQPPNPGSYSDYKGTDLLKKEFHIKLYKNNKGTSFTEVSEAAGVSKS
GFPNAVSASDFNNDGWTDLYIANDFAAPDFFFINNQDGTFTYKTEEAFQHIPYYSMGVDV
ADFNNDNLLDLFVVDMVAQDNYRLKSNMSGMNPKAFWKVVDDGGHYQYMYNTLQMNNGSG
TFSDIGQYTGMAATDWSWANLIADFDNDGLKDTYVTNGLLRDIRNTDADKEVAHYINQLT
FKWVQEHPDGGGIESIFDILKIDDVVKLIPSQPLKNFAFKNQGNLKFTEAQQDWGLDQPS
FSNGAAYADLDNDGDLDIVVNNINAEAFVYRNNSEKNIKANYLRVKPIGLNKLATLGARV
SVFIDDETQMQELTNVRGIYSTSEQVAHFGLGEKALVDSLVVTWPNGKQLRLKDVKANQE
LTLSIEDAVEGAQDLYTFGLKTEIFEEVTAQFPLQLETAENEYDDFKEQVLLPHKLSQFG
PALVKGDINNDGLEDLFVGGAAGVEASLFIQTKEGAFMKLASSALANDANHEDLDAVFVD
INADGFQDLYVVSGGNEEEAQADFYLDRLYLNNQNNGFVKTAITDLRPESGSKVLPADYD
GDGDIDLFVAGRINPHQYPLPATSQLLINESGTLSNQTTTIAPEFKDLGLVTDAVWSDVD
QDGDLDLLVVGEWMPVTVFLNQNNQLVKQDFESLADTSGWWFSIEKGDFDKDGDEDFIIG
NLGENYKYQTSIEKPFDIYYDDFDDNGRGDIVLGYYNGDGHFPLRGFSCSSEQIPSLKKE
IKQYNIFASLEIDEVYGKKDLARSLHYKADTFSSIYLENTGGDFKVHQLPELAQLAPTNT
MVIEDFNQDGNLDALLAGNLFVSEIETPRADAGTGILLLGNGQGDFTAKASKDTGFFANR
DVKQLLPIKVKEQSYILVGNNNDKVQAFEIK
>KECLDBNJ_01533 hypothetical protein
MKKYIKLIAAVVVLGLASCDNDFTDINTDPDKASGEIFDPNLILPDALYNYANSTTGYRG
PILFQSMWVQLMASTSTIANYYVNADKYVASGSTPGYATNIWSDNYRVASEMYQMKKLAI
EQGYSNLANIADIVKIQSIAFMSDVYGDVPYSEALQLEDGVSRPSYDDQATLYPQLLEEL
NTAVSALDTSADSPTNDIFFNGDISQWRKFGYSLMLKMAMRLVNVDAALAQSYVETAAAG
GVFASAADEAILLTDNSTGFHNSNSAALATASDYYEVRWSDVMIDYLNSTDDPRLGVIAE
VPEAGLAANQNASLAGDSDPSIQLGMPNGYDLNGGATDISNSPDYPGPTGTGDDQAPIGA
YSRPTGMYRNLEAPVFVLTYAETQLLLAEAALRGYNVGGTAAEYYANGVSGAMTAINKYG
GSQIAAADITAYVAANPLDVSSTEAALEMINVQYWATTGLLGNFTEAWSNWRRSAYPELT
PVNYVGNFSNGTIPVRQIYPADESTYNPENYEAAAAAMGGDVWTANVWWDNN
>KECLDBNJ_01534 TonB-dependent receptor SusC
MNVKVKYILGFVLLLFMQGVVAQTITGTVTDNTGMPLPGANVIEKGTTNGASTDFDGNYT
IDVSSSDAVLTFSSLGFLSKDVTVGNQTVINMQMEEDAQQLSEVVVTALGISKEQRKLGY
SVAEVGGEGLTQARETNVANGLSGKVSGLVVKQTNSGPGGTAKILLRGVASTAGGSTSPL
FVIDGVPMDNTQRGSAGEWGGSDAGDGIGNINPDDIEKMTVLKGQAASALYGARASNGVI
LITTKKAKKGDYNINFNSNFTMEQAMDLTNFQSEYGQGINGVKPATAAIAQATNRRSWGA
RLDGSDVIGYDGNTYSYSKADNSYIDFYETGTTFTNTLSVSKGVGDGAFRLSLSNLSSES
IVPNSGLDRITVNLTADQNITDKLNVSATVNYTDERYDNQPFLSDGPKNPTNFILLAPNV
DHTIFAPGYDENGQEIIFSDDNYATNPYFITNQGVNDPSRKRFISILSTKYSFTDKIYGL
LRLGNDTSNDKFFSIDPYGLGYLSEANSNGNLSGKGQSSRSELNVDGIFGANFNLTEDFE
VDALAGATLRRNKYEIVGVSGGPFIFPYLYSPLNVVNIGRSYDYEEKEVQSAYYSFDFSY
KRFLTLTTTGRYDVYSTLPEDNNSIFTPSVTGAFVFDDILNIDALSFGKLRASYAVTSGE
PGSAYQTSFYYTAGNSINGVATGSSPSDLPNLTLKPFTTDEVEVGLNLQFFGNRLGLDLA
YFTKTSHDEIQNANYSAATGFSSGVVATGSIRNQGLEVLLTGTPVRTENFTWNTSLNMTS
IKNEVLQTDADNNPITLGTNRAVVGAATTAFVVGEAGPQIRAYDYAYNEDGSIQYDSDGL
PVRGELKSFGQVLPKFYGGLNNDFSYKNFNLSFLVDFNYGNKVLSATEYYARFNGLTKET
LVGREGGLTNNGVTVDAQTYYQTEIQRINSKSVVDGDFIKLRQVTLGYSLPDSLFENMKF
FEGVDISLVARNLAILWRKAENIDPESSFGSTINFIGIEGGSLPSSRSLGLNVNFKIK
>KECLDBNJ_01535 Putative pyridoxal phosphate-dependent acyltransferase
MKDLFDKIYKDKGPLGKWAAQAEGYFVFPKLEGPISNRMKFQGKDVITWSVNDYLGLANN
AEVRKVDADAAAQYGSAYPMGARMMSGHTSLHEQLQDELAAFVQKEAAYLLNFGYQGMVS
TVDALVAKDDIIVYDVDAHACIIDGVRLHMGKRFTYKHNDIESIEKNLQRATKLAEQTGG
GILLISEGVFGMRGEQGRLKEIVALKEKYNFRLFVDDAHGFGTLGATGAGAGEEQGVQDG
IDVYFATFAKSMASTGAFIAADQEIIDYLKYNLRSQMFAKSLQMQLVVGALKRLDMLRTM
PELREKLWENVNALQNGLKDRGFDIGTTQSCVTPVYLKGSIPEAMALVKDLRENHGIFCS
IVVYPVIPKGLILLRLIPTASHTLQDVEETLDAFSAIRERLENGTYKRLSAGVQASMEA
>KECLDBNJ_01536 Putative cystathionine beta-synthase
MKEHLNVYNDVLQLVGNTPLVRLNRITKDLPGSYFAKVEAFNPGNSSKDRIALYIIEDAE
RKGILKPGDTIIETTSGNTGFSIAMVSIIKGYKCILAVSSKSSKDKIDALRAMGAKVYVC
PANVSADDPRSYYQVAKRLHSETKGSVYINQYFNQLNAEAHYASSGPEIWKQTEGKITHL
VACSGTGGTISGTAKYLKEKNPNIRILGIDAYGSVLKKYHETQEFDKNEIYPYRIEGLGK
NLIPTATNFDVIDYFEKVSDEDSAHTARKICKTEGLFVGYTSGAAVQGTIQMAEHGEFDE
NSKVVIMFPDHGRSYMSKIYSDDWMNEQGFFDSQNEFAAQKIEFIK
>KECLDBNJ_01537 Dipeptidyl aminopeptidase BI
MIVAITAIFAFCMKNELEALNASVLPPDAKQIPHELEKHGDIRIDEYYWMNERDHPDVIA
YLEAENAYYEQMTAHTKPLQQQLFEEMKARIKEDDSSVPYKYNGYWYYTRFETGKNYPLY
CRKKEEMSAPEEVMFDNNVMAEGHSYFKQAGYSVSENNEIAVFGIDTVSRRQYVLQFKNL
LTGEVYDTKIENTTGRAIWAGDNKTIFYTRKDPQTLRSSQIYKHVLGTNPDTDVLVFEEE
DETFDVGVFKTKSRDYIFIGSSSTLTTEYRFTEAKGPDFEFKMLQERTRGLEYSVSHFKE
HFYLVTNKDEATNFKLMKTPVSQTSKEHWVDVIAHREDTLLEDVEIFEDFLVVEERNEGL
NKINIKRWDGTADYYLPFDSETYTAYIGINPDFDTQYLRYGFNSLDTPPSVIAFNMITKE
KEILKEVEVLGGTFDKNNYESKRLWATADDGVKVPISIVYKRGITLDGSHPLLQYAYGSY
GITSDPSFSTSRLSLLDHGFVFAIAHIRGSEYLGRNWYEDGKLLKKRNTFTDFIACSKYL
IFEGYTNAGNLYAYGGSAGGLLMGVILNLAPELYNGVIAAVPFVDVVTTMLDDSIPLTTS
EYDEWGNPNEKIYYEYMKSYSPYDQVKVQNYPNILVTTGYHDSQVQYWEPAKWVARLRDK
NIADTKIYFETNMDAGHGGASGRFEALKETAKDYAFLIDLAGKAK
>KECLDBNJ_01538 Nucleoid-associated protein YbaB
MFGDMMGMMGKIKEAQQKAEDTKKRLENVYIDEKSSDGLIEVTVSVAGHVKKVDFKDELL
EDKEQLEDYLILTLNKALSRAKTTYDQELAAVAKEGMPDIPGLDMFK
>KECLDBNJ_01539 2-epi-5-epi-valiolone epimerase
MLQHIHHIAIICSDYAKSKAFYTEVLGMQILKETYREERKSYKLDLALNGNYCVELFSFP
DAPNRVSRPEAQGLRHLAFSVKDIEVAIKELQSKGVTTEAIRIDEITGKRFTFFEDPDQL
PLELYEV
>KECLDBNJ_01540 Mannan endo-1,4-beta-mannosidase
MSSRNSIYTTDGSQILKDGNAIDQNGVNALNTFGIDNSSLMQDWNIKIVREFIGNLREQP
ITGNAVRDSKNQWLHSLQQIVEMHRQQGRVTILCPFGWVDTNGNQQLLTGLNPSEQLFFE
AYKERMQAIANQFKGQSDVWLELWNEPYAFDDSNGYTHEMWLKDQLEMIQNLRETGFDNI
ILVPGNGQGQSEDAILVYGDQITTAYDNIVFDLHAYENWLINGNETTIQNRFTKLKNANF
PIIFGEIGVINTSGLMQVQDFLKVANRAKIPTLGWLWKKDQNDQNALMDGQGNPNDLNNN
SWGTTFFNFLTD
>KECLDBNJ_01541 Limonene 1,2-monooxygenase
MKSTNNNTLSSIKYSVLDLVPIVEGISTKEAIDRSVDLAQHAERYGYQRFWISEHHNMES
LASSSPVILINQVAQNTQSIRVGSGGVMLPNHAPLVVAEQFGTLASIHPNRIDLGLGRAP
GTDQRTAMALRRYQQETVQDFPNNIDELQMYLSEENSTAPVRATPGEGLDIPLYLLGSST
FSAQLAGKKGLPYAFASHFAPTHLHDALRLYHQHFKPSAQLEKPYTMACLNIIAADTDEE
AEYLATSAKKFMLGVIRNTRKPLPPPVKSMEGEWSTMERMQIEKMMFYSFIGSKETIAQG
LQTFVEETRVNEIIVIANIYDQAARLKSYQLVSEVFDALEVAV
>KECLDBNJ_01542 hypothetical protein
MKKYIAVVCILLLTISCKQTPKETEETDFPISVGCYGYTQNGSTITFQVTRVDPMVQGTL
IYNWAEKDRNSGSFSGSIDDNIILGTYTFISEGVESTRQVAFKISGDQLIEGFGEVTSSG
KMVAFKNASALNFDGSVTLTKDQCAN
>KECLDBNJ_01543 Ribose operon repressor
MKKKRPSLKDIAEVLNVSTTTVSFVLNGKGKEKKISDELIAKVEAYLKEINYKPNLVARS
LRTGSTRILVFMVEDISNHFFSKVGRLIEDISYKNDYRVLFCSTENDLKRTQDLIQVFHE
RQVDGFIIVPPPGIQEDIENLIESEMPVILFDRKIPEIDCDYVIINNFEGAKNSSEHLID
SGFKNIAFITIDLDQVQMHDREAGYIAAMNEAGLTPNILKLPYNTSTVGSSRETMKEFIN
NSKDLDAIFFATNYLSQSGLKGIHQIDTQLIDKLGIVSFDDSGFFEMYSPTISAFAQPVE
DMAENLMRIMFQKLKNKGNAKPEQLVLEGTLVKRESSKAKVV
>KECLDBNJ_01544 Endo-polygalacturonase
MKSILSSLILISIVLVSNPAKAQDLFPDGTPIPEWFRDTTPTDISALGKQYTITDYGVSR
DSSLVQTRAIQAVIDTAFVNGGGVIIIPKGTFLSGALFFKQGTHLYLEQDGVLKGSDDIS
DFPVLMTRIEGESVDYFPALVNADGIDGFTISGKGTLDGNGLRYWKAFWLRRAWNPDCTN
KDEMRPRLVYISNCKNVQISDIKLKNSPFWTTHYYKSEYIKLLNLHITSPKEPVKAPSTD
AVDIDACQNMLIKNCYMAVNDDAVALKGGKGPHADEDPNNGENRNIIIEDNTYGFCHSAL
TCGSESIHNYNIIFRRSTVDTAHRIFWLKMRPDTPQHYEYITIEDIKGSVRSMVLIKPWT
QFFNLKGEKDMITSVANNITMKNIKLNCEMGFNIEASDQYELSKFTFENIKLNTQNAMLD
NTESINQLTLEKVEVK
>KECLDBNJ_01545 Regulator of RpoS
MQGEVLIVDDDKTICLIHKYLLKTVHNIEPRFYTCAGDALKCIADSPNSSKYIIYLDINM
PVLNGWDFLERLYQFKNKDRFSVILVTSSIDAVDKSKAKDYDLVQGYIEKPLNKPKISTL
DQMIGNFS
>KECLDBNJ_01546 putative diguanylate cyclase YegE
MLNVSEKEKQRLEVVKSYQIINTAAKQDFDELARLASIVCDVPIVLISLMDDCTQHFLAH
HGVDLEEVPREETFCQFLLENEPYEPLIIGDTLQDSRFSSNKYVQNEPNIRFYAGFPLIT
KDNFLIGSLCIIDRVPRELTPKQYEAISCLINQTLQIVELQKNKFDLEKSKKLHKLNANR
LSNIIEAANVATWEWDLKTNYLKYNDKFFEIIGWSEKELGNTSLERMQKELHPEDLQRAL
VKLNDYFDGITDFYTGEYRIKHKNGSWVWILDRGSVVREDHEGNPLVMSGTITDITRRKI
ASERLTLSNKRLKLAQKIAKLGYWEVDKKDHSFYCSEQVYAILELEFYSQELSFDRMMEF
IHPDDQSVVKPYYHDDSFELEADFEFRIITATGKTKWIYASRLVDTDDTSIIEGTLQDIT
SQKALKISLEESELRYTNLFQLMPIPSWIYDLRTLKIIEVNQAAIKEYGYSRAEFLEKTI
KELRPADEIPKLLDVVEDTRRNMGVNKVGVYTHQRKNQSEFTVEIHSNQLKKSNQLSRVV
MAINVSERYQYIKQIEGRNATLQEIARIQSHVVRAPLAKLMGIIQLIQSDLNLGAEEHAF
FLNELLGAAHELDTVVREIAAKASLVETIQSN
>KECLDBNJ_01547 2-amino-3-ketobutyrate coenzyme A ligase
MFTSVRESIQQELEEIKEAGLYKEERIITTPQRAEINTQKGSEVLNFCANNYLGLSAHPD
IIDAGISAIKSHGFGLSSVRFICGTQDIHKELERKTAEFLGMEDCILYAAAFDANGGVFE
PILTSEDAIISDELNHASIIDGIRLCKAARHRYMNNDMEALEEELKKASGARRKLIVTDG
VFSMDGTIAQLDKICDLAEKYDAMVMVDDCHATGFIGESGKGTHEYNKVMGRVDIITGTY
GKALGGASGGFTAARKEIVDMLRQKSRPYLFSNTLAPAIAGASIKAIDMLSESGDLIRKV
QNNAKRFRKEMTDAGFDIIPGEHPIVPIMLYDAKLAQEFAARLLDEGIYVIAFFYPVVPK
EKARIRVQLSAGHEDEHITKAVAAFTKVGKALNVI
>KECLDBNJ_01548 putative epimerase/dehydratase
MSTHKLLITGAFGQLGTALTEALIYKYGSDAVIASDLKVRDDFDCETLELDATNLEAIDE
VVRKYRVTQIYHLAAVLSAKGEQQPLRTWDLNNSTFFNVLEAARLNDVQKVFFPSSIAVF
GPDARQENVAQDFALNPTTVYGISKVAGEHWARYYNTKYGMDVRCLRYPGLISYQSLPGG
GTTDYAVDIFHKAINNEEFVCYLKPDTQLPMLYMDDAIDATIRMMEASKRDIKTVGYNIQ
GVSFSPEIIAAEIKKTFPDFEISYQPDSRQQIAESWPISLDDACARDEWGWEPSFDLKRL
TEEMIYRLELKKNRNLSVFA
>KECLDBNJ_01549 DNA-binding transcriptional activator DecR
MTERLDDTDLKILRILQENAKMTTKEIADQLHLTASPVYERIKRLEQKGYIKNYVALLDK
KKLNRPVTAICMVSLRYHNEGFIETFELQIKELVEVQECYHMAGKVDFFLKIHLESLEEY
HEFVRTKLSKIQNIGVLESYFVLKEIYNTTTIAI
>KECLDBNJ_01550 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKQVSITRRNSLKLFALSGTTILTMPNVLWSAKKIAKPLRFGIITDSHYADRDPAGTRFY
RDALPKMNEAIEALNEADLDFLIHLGDFKDQGVEANPLETLKYLQEVEAVFQRFEGDAYH
ALGNHDVDSIRKAEFLRNIMNAGQELARSYYSFETSAFTCIVLDANYDAAGKDHFYAEGA
NWEDAHIPLEELAWFKNTLTQAQKPVLVFCHHPLYPFYKEGSKFHVTNHQEVQELMEASQ
KVIACFHGHVHKEEFKTIKGIHYITQLGMVDYEGLENNSFSIVELDEAQLKIEGFKRASD
YETRLK
>KECLDBNJ_01551 Putative non-heme bromoperoxidase BpoC
MLCKAQEDQLQLIDLQLANYEYPYEVATIQIEAQNQTLEMAFMDVKPKNYNGKNIMLLHG
KNFNGAYWQTAIAALTAEGFRVIIPDQIGFGKSSKPDHFHYTFQQLAINTKAVLDSIGVE
KTAVLGHSMGGMLATRFALMFPETTEKLILENPIGLEDWKLKVPYKPVTWWYENELKKDY
ESIKKYQLESYYDGNWDPAYDEWVNLLAGWTLNSDYETIAWNAALTYDMIFTQPVVYEFK
NIQSPTLLIIGTRDRTALGKPLVSEEVRATMGLYDQLGKATQEKIPNSELVEIPNTGHLP
HIERFEKFIAPLVSFLSK
>KECLDBNJ_01552 hypothetical protein
MSSDKAPQINLKQSSDEDLVRIVTVQVHKYEPHTVQAAEAEISRRGIDKMRMAHLVKKVA
QDNTAVQEIQDYMSTTWTRFVNFLIDFIVFLLLVLIGSLSLDSVFVTSNSDFLLAVGYGM
VLLIFLLYHGLTEYFFQKTVGKYITKTIVVTKDGEKPDAGTIALRTLCRLIPFDRLSFLI
TKNGFHDRFSNTQVVKDPS
>KECLDBNJ_01553 Aminopeptidase S
MKKQYVLLLLCVWSQIALAQTIQGFTTKSTQDQLALETQFDAKLQKENLDEWMQFMAAEP
HYVGTEYGKKNAEWMKKQFESWGYDVEIDEYQVLFPYPKLRLLELMAPTAFKAALTPEPI
AEDKYTQQGEALLPSYNAFSTDGDVTAELVFVNYGVPKDYEELEKLGIDVKGKIVIAKYY
GSWRGIKPKLAAEKGAIGCIIYSDPADDGYVQGDVYPEGAFKPETGVQRGSVMDMPLYPG
DVLTPGYGATKNAKRLDRKEAPTITKIPVLPISYADAQPFLEALNGPVAPSAWRGGLPIT
YHIGPGPAKVHLKLEFDWQLKPAYNVIAKLKGAVYPEEWVMRGNHHDAWVHGASDPVSGM
VALMEEARAVGELAKAGQQPKRTIVYCAWDAEEPGLIGSTEWVEDHQEVLKDKAVVYINT
DGNGRGFLGVGGSHTLETMVKEIAGSIEDPQTGVSLVERRAAAAKVANRDTDFRLSALGS
GSDYTPFIQHTGIPSLNLGFGGESSGGEYHTIFDTYSHYTRFKDPGFHYGITLAKTAGHI
TLRMANADILPFEMNAWYKTVSEYMDEVTETAEAMRKQAEKQQQLVAENAYVIAADPKDN
LKAPEAEKDIPYLDFSPLQNALASVKSSVHDFSKTDFTSLSASKQKMVNAKLKDLEKALL
SESGLPRRPWFKHQIYAPGFYTGYGVKTLPGVREAIEQKNFEEAQEQIEKLAKTLTAFKG
KLDEIVKMG
>KECLDBNJ_01554 hypothetical protein
MQKKVLIQELRLRLTAKFDQLQETKAGLIESRDSDTKSSAGDKYETGVEMIQQELERTQG
QLDQVEKQKEFLNRISLTPNAVVGEGSLVLTDKASYLIGIPYGELKLETGNVYCISSASP
IGELLTGTQKDEVITFREQKITVKEIL
>KECLDBNJ_01555 Serine hydroxymethyltransferase
MQRDTEIFDLIQEEKQRQLNGLELIASENFVSEQVMEAAGSVLTNKYAEGYPGKRYYGGC
EVVDVVEQIAIDRAKELFGAEYANVQPHSGSQANTAVFHACMKPGETFLGFDLAHGGHLT
HGSPVNFSGRLYNPVFYGVDQETGLLNYDKIEELAVKEQPKMIIAGASAYSREIDYKRFR
EIADKVGAILLCDMAHPAGLIAKGIIGDPVPHCHIVTTTTHKTLRGPRGGLILMGKDFEN
PFGIKLKNGNLRMMSSLLDSGIFPGNQGGPLEHIIAAKAIAFGEALTDDFLHYMVQVKKN
AAVMAAEFVAKGYDIISGGTDNHMMLIDLRNKDISGKDAEEALGKADITVNKNMVPFDTR
SPFVTSGMRIGVAAVTTRGLVEDDMKKVVELIDAAIVNYQDDEKLEEIAGQVNEMMGHRP
LFKH
>KECLDBNJ_01556 hypothetical protein
MPSKANDPKRKTWLETPTHTDFPIQNIPFGVFLTRDDIITIGTRIGDYAIDLGALHQLGY
FEGIPLTDDIFLQDTLNDFIADGRKTWRAVRNRISHIFEESNADLRDNEEHRDIVIFELN
EVEMQLPVQIGDYTDFYSSKEHATNVGKIFRGGENALMPNWMHMPVAYHGRSSSIIPSGI
PVHRPQGQKLPNGATKPIFGPSRQLDFELEMAFITTDANELGQPIPADQAEEYIFGMVLF
NDWSARDIQRWEYVPLGPFLGKNFASSVSPWIVTLDALEPFRTTSPKPEEELLPYLNYSG
KKTFDINLQVSIKPEDKAETIVSKSNFKYLYWNMSQQLAHHTINGCPVNSGDMMGSGTIS
GPTPDSYGSMLELSWKGSKPVKLTEGGDRKYIEDNDTVIVRGHCEKAGAARIGFGEVTTK
ILPVFKHKKK
>KECLDBNJ_01557 Nicotinamide riboside transporter PnuC
MEEFFMNFVWLQWIGTAFGVTQVLLARKNNVNNYIFGIIGILIGIWVLYHSKLYADILLH
LYYLVMSIYGYLYWKFGKEKQEAPIAYSKRDEHLKAGGIVLGCFVLMSYWLTQHTDSDVP
YLDAVVSAFAWAGMWLMAKRKIENWVYLNISNIISIPLLIYKELYIYAGLTVFLFIVGTS
GYLKWRKLIKQNHSHAALARS
>KECLDBNJ_01558 Flavin-dependent monooxygenase, oxygenase subunit HsaA
MQHWHDLKTCNGHQKVFDADTLKAIAAAKLWNIWVPKTHGGLELDLTEGLRTLQQLASID
GSLGWTVTLCSGANYFIGNLQPETAAELFNPNEVTILGGSGGLFGFAEKKGDAYLLNGTW
KYATGAPYLTHFTLNAKIIEDGIELTDDDGAPVFRSFVIPCEAVHIIDDWHTMGLQATAT
QSFVVTDYLVHQDYSFIYNRFYLPQDIFKINFRVFADLTLWINYIGMVQHYLAEASKLLD
EKTLEDPHKTTTEAEDLLYKYANEVEAATADNASFSDVQIEALHTAAAASVKWLSKILME
LHPLLGIKAARVEHPLNQIFRDYFTATQHHIFTR
>KECLDBNJ_01559 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYNSRIAGMGAYVPENVVTNEDLSKMMDTNDAWIQERTGIKERRHIKEGDGNTTAVMGVK
AAKIALERAKMTAQDIDMIVFATLSPDYYFPGCGVQVQEMLEMRTVPALDVRNQCSGFVY
ALSTADQFIKTGMYKNILVIGSENHSGGLDMTTRGRSVSVIFGDGAGAAVLTREEDNNKG
ILSTHLHSEGAHALELSLKGPSTMEWVPELIEKDPQEDIPYYPYMNGQFVFKNAVVRFAE
VINEGLQQNKLTAEDIDMLIPHQANLRISQFVQKQFKLKDNQVFNNIQKYGNTTAASIPI
ALTEAWEEGKIKEGDTVVLAAFGSGFTWASAIIKW
>KECLDBNJ_01560 Dipeptidyl-peptidase 5
MKKLNLLSLFLLLTASVVAQVNLDYQKPPQEILDLVDVPRAPWVLMNTEGDTMLLMYRDS
YKTIAELSEEELRLGGLRINPKTNIGSRTTFYNDIKIKGIEETEAGTISGLPEDAKLSNF
NWSPDESKMAFTNTIEDGVQVWVLDLETATAKRVTEAFVNANMGNPISWFKDGESLLVNM
LPATRKELVNTAEAVPTGPTISTSDGSKAQNRTYQDLLQNPNDVFNFEQLATSALVKVNL
DGTSTLWKDAAMYSDVSFSPDGNYIMTSTIHKPFSYIVPYYRFPETVTVYQQDGTEVKVV
NETPLLEELPQGFMATQTGKRRISWRADQPATLYWVEALDQGDPEVEVEFRDQVFMQKAP
FSAAPQKVIKTINRYSGILWGDANTAIAYDRWWNTRNTKTYVFNPSDGSNMGEVISDRSY
QDVYSDPGNFVTHDNEYGRSVLTLVNGSAYLMGDGFSDKGQFPFIDKMNLKTQETERIYE
SEYTDKLESLQKALDIEAGKILVRIEAPTEYPNYYIRDLNDNSLDQITRFENPFKSIQDV
HKEVITYKREDGLELSGTLYLPVGYDMNKKEKKPMLLWAYPREYKDKSSAAQTTTNPNEF
TYPYYGSMVYWVTRGYVVLDDAAFPIVGEGDEEPNDTFRSQLVANAKAAIDAVDDLGYID
RDRVAVGGHSYGAFMTANLLSHSNLFAAGIARSGAYNRTLTPFGFQSEERNYWEAPEIYY
EMSPFMHADKMKTPLLLIHGVADNNSGTYPLQSERYFNALKGLGATARLVMLPKESHGYA
AKESILHMLWEQDQWLEKYVKNRDVQEIKKQKEVKQ
>KECLDBNJ_01561 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MNLNNIRLEVMQTIGKSMDELIGKYLKSVEENWQPTDMLPDATNPEFIEDVREIQELCRE
MDYDLFTVLVGDTITEEALPTYESWLMSVQGVDQVNGNGWSKWVRAWTAEENRHGDLLNK
YLYLSGRVNMREMEVSTQYLISDGFDIGTGMDPYKNFVYTSFQELATNVSHRRVASFSRK
AGNKQLAKICNTIAKDEARHASAYMDFVRRIFELDPSEMMMAFEAMMKNKIVMPAMFLRE
SGQQIGELWEHFSDAAQRSMVYTTQDYITILKSLIADWNINDIKGLNDKGERARDYLMKL
PDRLERISQRIVVPKRDHTFKWIAT
>KECLDBNJ_01562 Putative NADP-dependent oxidoreductase YfmJ
MGQTILLNNRPEGTPNLGNFKFEEQSVGDPQEGELLVKSKYVSVDPYLRGRMNDTKSYVP
PFEVGKPLTSGIIAEVIESKHPDYKAGDYVSKVMPWKTLQVITTEDLHKVDASKAPLSAY
LGILGMTGLTAYTGLTEIGKPKENETLLVSGAAGAVGSIVGQIGKLLGLRVVGIAGSDEK
INMLKQNFNFDAGINYKTTDDLTAAIKEHCPEGVDIYFDNVGGEISDAVLYHINKYARII
NCGAIAVYNETTIPKSLSVQPFLIKNSALMQGFIVSNYASKFEEAIAQLAEWLKQEKLVY
TETIVEGFENIPQAFLDLFDGKNKGKMIIKI
>KECLDBNJ_01563 hypothetical protein
MKTIAHLEEQIEELPEGYVFTHNDFKEFTENENYVEHFLNTLAKRGTINKLAKDKFYKPE
ILAEGEQLLKPYEVVKDLLYDGEQQVGYLTGASVFANFDFDAVKATQLEVGLAEKRNPIK
RGAFKICFVKQNNPIIAAHIPYFQILDVLRAVHSTNNATPEELCYHMTKRLTALSSPEHK
TIAKLALNYNARTRALTGAMLQKIGYLKEEILTLLKDSIAAYSSFRFHIPSKNLPHAKAW
KIRCD
>KECLDBNJ_01564 hypothetical protein
MKKTILLILLTISITSCKSQEEIDFKVGYLPNYNYTLTQKQISENNVKYIASDEILQNLK
NNGIENPTLTKDTSLLKSVSKTGKLKGNEFPINIELLESNNPSLTSGTKFFGKSIDGKTR
IDSIYSSTMTEEKKRTLLPAMESMMNQIKYPNRKIKVGESFEQKNPMSMPIADVTIEMEI
NSIYTLRKVENGIGYFDLDQVYTIKSATKDYEMELNGIGKGQIDYDIEKQFFTKFYLEME
MNLKTELEVFSIELQTKSITDQTTEIIKASR
>KECLDBNJ_01565 hypothetical protein
MAISNCLFSPTSENPCGFSVWCVLAKLSAKTTQLLIAETVSHKTEKKLWKLI
>KECLDBNJ_01566 hypothetical protein
MEIDLKTFVGLKELYLIDSVPATFESLELITKASTELIQSIYDSKPELGEGEVFIETLSI
KILLATKSIIELGNGTKVSALTKESNVKLLDFASINILTRSIIEAFLTMEYLFYNNLELN
ERNFRFYIWQISGYKARQIFFEKRKGLKENVTEKLKTELSEIERLLSIIEKSPYYADLNR
QNLWKLDKFGLPRLVSWQKLIEQSILKTSLFETSYKLYSNYAHSEFISLIQMNGANTLNK
GSKENDQSILNSLRVVKMINCISMVCLKNKFDFASKVFEKYDEETKTTILFWNEFGTG
>KECLDBNJ_01567 hypothetical protein
MRKVKFKNRNWDTAANLHLPDNFNETLKYTAIVCVHPGSSVKEQTAGLYAQQLAQQGFIA
LAYDASFQGESGGEPRYLEDPAARVEDICYAVDYLTTLNFIDENRIGLLGICAGGGYASN
AAMKERRIKAVATVVGTNASRAFREANFLETLKTVSIQRTTEAKGAEPMITQWTPNSDEE
AKQMGMDEFDMLEAIDYYRTSRGNYPTSNNKLLFTSMSNLIMFDAFHFAEFLLTQPLLVI
VGDKVGAFGSYRDGFELYNKAASKNKNIHVVKGASHYDLYDQPKATKEALDNLVPFFQEN
L
>KECLDBNJ_01568 hypothetical protein
MATLLKLIGVLVIILGCVLTYKPNLLSHTPLPENNYHLIEMRVRWGFLIGLGIFIFAFNH
WNSWKVIISAFLFFLTIGIVIARAFGIIMDVFFIKQILWLSIEFVILIVFGILYKYAHN
>KECLDBNJ_01569 Regulatory protein SoxS
MRTISSLSEFHRLLSIPPPLHPLVSVAMVSEIHATDSEVWKKFSTDFYTISLKNNIQSKI
KYGQQYYDFDKGTMIFTAPKQIQFVEVNKTNTFNETDGTGYVLMFHADYLKKHPLQTTIK
NYGFFSYAVNEALHLSEQEEKNIVELFQKIEKEYQHIDKHTQDIILSQMDLLLNYCNRFY
ERQFITRKAVNNDLLSKIEQLLNAYFNDAEQQRNGLITVEYLANKLNISANYLSDMLRSL
TGQNAQQHIHNKIIEVAKEKLLSTNLSVSEIAYELGFEQPQSLNRLFKNKTKISPLKYRK
SFN
>KECLDBNJ_01570 hypothetical protein
MTINYNEADESIEITDGIKKKSVFGRRRFSIQLKDGKSRELNEIKTQSEFNELKKVFSAI
GIAN
>KECLDBNJ_01571 hypothetical protein
MRKILTLIISGILTFSCSSSLRDFTYLDIDNKEISRSKFRQKRSTNQYLDIQIDSLNQKK
LVERTKTGKLENFVAYRTLVSNKTSEKLDNTKPLVIIYHPGKDACNSSGSATKETLKNWY
GTLEDGVQQLKANAPIYLYKEKEALEKYDGILNWHKDPDGLTEKLFFKYHYPCSSFVVIS
SDGEYVSYFGEFSKEYVWNAINLISE
>KECLDBNJ_01572 D-alanyl-D-alanine carboxypeptidase
MASKRTTTIIRILLFSATLISLYFVPWPIVRAWIKSLPDTIQEQVDKAPDYGFDGIIVYI
DQGGKVPAWYTAGTHSRETQEPARADALFKIASVSKLYTALAVTKLASKGQLDLDQSLAH
YFPELAHRIEYADEITIKMLVKHRSGIPNFTDINSYWAHPEDNNEERLALILDLPADFAP
DTDYAYCNTNYLLLHELIKKVTGQPSFYTIKKEILEPLNLNNTHGSVHDVDLDRVMSGYY
VGYAQDLKTNDNDLMLATAQDLGDFLRALNDGSVFNNQEERDLYASLYEFEHTGLIPGYQ
TIAKYHNELDAVVIQFTNTVDFEGYNWNLSEVMYNKVVKILKQKS
>KECLDBNJ_01573 Modulator of drug activity B
MKNILILNGGHPFAHSPGAFNKTLLETTEAFFTAKKGYTVRTTQVAESYELQEEVEKFTW
ADLIIYHTPIWWFQLPFGFKTYLDKVLTHGHQNGMYESDGRTRKNPAINYGTGGTLHGKK
YIITTSWNAPEEAFTLAGEFFDQKSVDEGVLFGFHKMNQFLGLEHLDSNHFHDVEKNADV
PKALRDYTAFLEHHFEEVLQD
>KECLDBNJ_01574 HTH-type transcriptional activator CmpR
MVNLEWYRTFRAIVEKKTLTRAAEALYASQPGVSVHLNALEAYVGRKLFERTSRKMIPTE
EGKQLYNFVVEALERLEQAEQHFKKSTKETVPSLHIGMCTETFQTILEPEVSKLRFNLVA
KFGGHQDLIKDLNKGLLDLVITPKNNHANTLAEYEAFSKERIVLVAGSKTSLNEVNKLLE
QKDLKALSAHLKQQIWYSASNEMDHFRRFWYDNFKSRADFKPNYILPNIGSIIRCLEAEN
GFAIVPDFLVQEAIAKGSIHLVWQGIKESANTLYFATRSDLQYKEEVNTIKEVFKQKMQP
H
>KECLDBNJ_01575 hypothetical protein
MDAITKERLIKLAEEEIPIHKFLGLKVATLEQDFIRVEVPYRSDFVGDIRKNRWHGGIIA
TIMDSVGGAIGVANFKTPDDSLATIDLRIDYLRGAKAKPLTVEGKLVRMGNRIMVTKMKA
FQETVLVAEGKGVYNFIRS
>KECLDBNJ_01576 hypothetical protein
MNRPTPKQPAPELEFPILGANSWNLKAQQPKNFTLVVFYRGLHCPICKKYLQELQNLLPD
FKERGVEVAAVSMDAEERARLSRQKWELDALTLGYDLPEATAKQWGLYLSEGIKEGEPDL
FSEPGLFLIDNEHKIYYSSITSNPWGRPYLPSFIKAIDFILENDYPARGEK
>KECLDBNJ_01577 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase ArbA
MKIVLLSLLTLIAFNLESNAQEVQTNENGEPPFEPNNPYVHDPVMAKDGDTYYVFGTGVG
ISVMSSKDLKTWKKEAPIFSEVPEWTKEALPGFSNHIWAPDIIFYQGRYHIFYSCNAKPG
KPHAAIGHASTPTLDPESSDFKWTDHGKIVQSVMGRDTWQAIDANAIIDESGTPWLAFGS
FWDGIKLVKLKDDMSAMAWPQEWHSLARRPSTQQPYEYELTDSQIEAAFLYEHNDYYYLF
VSLDMCCRGINSDYKIAVGRSKELTGPYIDRAGFTMLDGNSTVIAIGDGKQFAALGHNSV
YEIDGEDYLFAHGYSIPDDGESKLIITPIHWDNDDWPIIDINERLTK
>KECLDBNJ_01578 hypothetical protein
MPPIPKQEINFSTTTFKKIKEQSSYTTQLVNLGLGCIAFALLLFFIDSNTTPVNQLTVWI
SIIALIGMVFYTISYIYQFFDYEKIETYDRGSITILEEGILIDHKVLVQYAAIEYFSLHI
DAYYEQRINMAMRTPMEQKSLGLKNTISFKTETGKLTRYFKLENKLRKELLEQTLLNLVT
TNRFSRLDAKRTIKLIPERFRAHGRYKEFVIQQIKAGRINCTEGLLLHGYSSDAEAKMLR
SKYCN
>KECLDBNJ_01579 hypothetical protein
MQEQNYSHKGWQRIILFIIPYLFVVGLFQYAGYLIAGLDITDPQPTKSISHQLIIRVFDL
VGTLLVLYFFMTFLDKKPFVALGFQTHKRQREFWTGIAIGFLIMFMGYSILYFSSEITVI
TTDLDATKLIQSVVFFSIIAVVEESIFRGYILRNLMLSMPKYIALSVSALVFALMHAFNP
NVSSFALFNIFLAGILLGLSYVYTKNLWFPIALHLSWNLFQSLFGFNVSGQGFYSVVKIQ
VDQANRLNGGAFGFEGSYIAVIAQLITIAAIAIYYNSKRKTDAVTTSTTEY
>KECLDBNJ_01580 ATP-dependent RNA helicase RhlE
MTFKDLGLIDPILKALTDKGYTHPTPIQQQAIPILLKGKDLLGSAQTGTGKTAAFTIPIL
QQIYNGIGAKKGGRKLKALIVTPTRELAIQINDNVTEYSKYTGIKSTVIFGGVKQASQVL
AMRKGVDVLTATPGRLLDLVKQGFIDLGSIEYLVLDEADQMLDMGFIHDIKKILKLVPHK
RQSLFFSATMPREIVDLSKLILGDFEKVTIAPEKPTAERVDQAVYFVGKRNKANLLKFII
ETEKPQSLLVFSRTKHGANKIVKVLDKAGIQSAAIHGNKSQGARQKALNDFKDGKLHVLV
ATDIAARGIDVSELELVIQYDLPNVPETYVHRIGRTGRAKASGIAISFCATDERTYLKDI
EKLIKQKVHVVAEHPFLSDEASEAGQMKGGDAPEQPKRNNRNRSRNRNRNRNKPKGQNNN
GPKKQTARKPNKRFGSKPKTE
>KECLDBNJ_01581 hypothetical protein
MKKYLVFSFLATILFTACDDTRKAMHDEYLEFVMHTDSLETVHEAMVVSHKAVKADTRTL
AQKLKDVEATDSIAMTDVQEHQMQLKAQATSLAKLKKLIESHADVKGYFMSDSISVEQME
QQLLDMEANNEEIAARLNQIKTELQKIEAEQEILKNQDSEE
>KECLDBNJ_01582 Dipeptidyl-peptidase 5
MLKNIFTLLSISILSLSQVFSQEDNKDPKAWTPEDIVYTESMRSPVFSPDGTMVVWSKSK
AVKKKDRFVADLYLTRLNIQEDDSFLTTQLTYGDDSDYSPIFSKDGKSLYFLSSRDKGKK
LWKLSLYGGEAEEIHEFDNGISSIQLKDENTLFFTAKNGKTLYDLEAEEKEDDVQIIEDS
LHWQPSHIYAFDLKEDQITRITDNEKPIRSYQLSHDGNWLYYTITRSLSYGADAQKDPYS
YLVNLKTGAKKQVLQDFEFPIYDVQFTADDSGFYFGTGFSSDPEWNGAGITELYYYDLAS
AKATKVDLDWKLGVGGGYTVAGNDVIVSLANKATMKLAYYTKKGTSWSRSEMDFDDKNEH
VSLNAITEDASKIVYSYSTASKLPQYLIADLKKAKVSNEETFITLNKKLEKKYMPKSEIM
TWTGYNGDEVTGILYYPNDYQEGKKYPLMLNIHGGPSSQDTDEWSGSWAYYPSILTQKNM
FVLMPNYHGSTNHGLEYTEAIKGNYYEPELEDITKGIDKLVSEGKVDRDQMGTMGWSNGA
ILTTMLTVKYPDMFKVAAPGAGDVNWTSDFGTCQFGVSFDQSYFGGAPWDDTNGKTYNEN
YLIKSPLFEIEKIKTPTIIFHGSEDRAVPRDQGWEYYRGLQQVGKTPVKFLWFPGQPHSL
GKITHQLRKMKEEIAWIDTYLFDKKPTDNEAFKEDSPLAEIFKLEEAQQENGLYGVLNKD
ILIPETVQVKEDSISLGRFEVTNAQFKAFKNTFSFDTGKDNYPAVVSKTDAENYVTWLSA
QTGKTYRLPNAKEAEKLQLKAAKSSKGQNNLNTWAGYDLTADDADLLLQKVKSLNYSLLK
PVGSNKGVKVGDATLYDLGGNVAEYSATGTYDYSAYDFADPYDQKPVSSKHVGFRVVKE
>KECLDBNJ_01583 Tricorn protease 
MKITKYFLNFIVGTVSVTAVAQINQTDTRLMSEPAISDSHIAFIYAEDLWVANRNGSQPR
RLTIDEGVESNPIFSPDGKTIAFSAEYDGNMDIFSVPVTGGVPTRLTYHPYPDIARDFTP
DGKKVVFASQRTLFTNRYTSLFTVALDGGPVSELEIPNAYWASYSDDGKYIAYTPIPDRF
NQWKHYRGGTQTRIYIYDTATQEVVEIPKPAAGSNDAQPEFVGNTVYFRSDRDGEFNLYA
YDVASKQVSKLTDFQDFGLEDLEASSDGMLILEQAGYLHTFNPSNKQLTKLKIGIATDLL
ELRPRFVSGSYYVRSGGISPSGARVVADFRGEIVTLPSEKGDMVNLTQTPGVHETFPKWS
PDSKHIAYFSDASGEYALHIKDQNSSDAAKAIALEGTGFYAHLHWSPDSEKIAYVDNGRN
LYITTIATGKTQKIAQDVLYQPGDYRDLFGSWSADGNWLAYTLITNTNFEQAYVYSLSEN
KSYPISDGLSNVTEPTFDPSGKYLYLTASTDAGPVVNWFDQSNQDMTSSNALYLITLQKE
VKSPFAKENDVEKIAEAEEEQKEDKKEESVPTLEIDWDGIMDRMVSVPVGTGNFMSLAAP
KEGMLYYISYPSYDAPAMLHLYNLGEQKDEELFEVDSFEISASGEKMMYYSNGSWFVSDT
GKKSDQGPLAFDAIKVKIDPKQEWENIFNEAWRVNRDYFYDPGMHGVDWDAMKEKYSVFL
PDVPSKSDLYRVMSWMFAELSVGHHRFDYRGDSRVEKENINGGLLGADFEIKNNRYQITK
IYGGLNWNPDLRSPLTEPGVNASEGDYIIKVNGKEVTGEDNLYRFFENKAEDIVTLTLSS
NANGTNAHDEEVTTIASERALRNRDWVEGNIKKVNEATDGQVAYVYVPNTATAGHEYFKR
YFYPQADKKAIIVDERFNGGGQLADYVIDLLNKPMQSYWNFRYGKDMKAPSASIQGPKVM
LIDETAGSGGDYLPYLFRRNKLGTLVGKRTWGGLVGVLGYPEFIDGGYVTAPNVAFYNEE
GFGIENVGTPPDVEVEQTPKDVIAGKDPQLEKAIEIILQQLKENPPKSLTTPEYPDKTKN
>KECLDBNJ_01584 hypothetical protein
MKNLFQTVILIFTSLYSFSQTTYEAEILQFQNDLNTEYKNPEESPLTPKEQKEFKKHSFY
PIDSTYRVVAQFQKIEDPEEIQFPTSSGAIKTYDTYALATFELEGKTYQLPIYQSHMLRK
MEEYKDYLFLPFTDYTSGVETYGAGRYIDLRIPEGNTIVIDFNKAYNPFCAYSPNYSCPI
PPEANDLKLEIKAGIRGPEEH
>KECLDBNJ_01585 hypothetical protein
MLTFFGLILSLSVAAQEFTRADSLRGSITPQRAWWDVMRYDIEVQPDYDKQFTSGANQIT
YKVVQEKHPDVMQIDLQEPLVIDRILFDDDATELQFKREGNVYWVNTLPQELDSEHTVKI
FFSGNPHVAVRPPWDGGWSFSKDAEGRRLMTVTCQGLGASIWYPNKDHQSDEPDRGASLT
MRVPDALTAVANGRLLDKIEHQDGTTSYKWGVENQISNYTIIPYIGHYENFKEVYPGVKG
DLDLNYWVLDYNLEKAKEYMPKEVRNMLNAFEYWFGPYPFYEDGYKLIEVDNTGMEHQSA
VSYGNYYAGGYRGRDGSGTGLGLTWDFIIIHESGHEWFGNNITTNDLADMWVHESFTNYS
ETLFVDYNYGPEAANAYNYGIRQGIGNKTPIIPAYGVNAQGSGDMYPKGGNLLHSIRHSI
NNDQLFRNILAGLNQTFHNKTVDGSEVQEYISRKADFDYSKVFEQYLTMTEIPTLELFVD
AENNQIKYRYVNCIEGFDLPLSLVGTHEELKIFPVANTWKAVDITMKNQYLLTPDRIEKM
YYLNVALVKEL
>KECLDBNJ_01586 hypothetical protein
MNTYKKALGVFILLFIGITADAQAQEYWDKVKEREATLGLDSGFETLETDQFILKLVKAS
QTVASLAPKSDPGFDFTPGDRLEIRAGNGLYHLGDINFRYRLEGSNEWSTVSTATSRKPV
EAIAKEGALAAANLANTLPEDLPLDITRNYTEADGDLILAFDFQNKTDQPVELGALGIPM
IFNNILEGNSLEEAHAKNVFFDPYIGLDAGYLEVKRLDGKGKTLLVLPENNMPFEAYRPL
LDDPSPRSIVFEGFHEWMANSKAYASDEWKGVKQWNTPTSSFLKPGELKTFSVRLTLAPE
IKKVQQQLTEKDMSVAVGVPGYVLPQDVQGKLFLKYNSDVNSIKVAPEGALSVEKDAAKN
AYDVYTVTGNQWGRARVEIKYTNGKTQSINYKVIKPESELVADFGNFLFDKQWFDDDEDL
FNRAPSLISYDYQNKRQVTQDGRVWIAGLSDEGGAGSWLGGMMKQYLQPDQEQVSKLEDF
VNQTVWGVLQNAEGEHKYGVRKSVLYYEPEEFPAGTYNDTINWNTWAAWNKEGAADPGRS
YNYPHVVAAYWTLYRLSRYHDNLVTQKDWKWYLEQAYQTTLAMTTQAPYYAQFGQMEGSV
FLHVLEDLKREQLTEEATKLEAEMKKRADHWESLAYPFGSEMPWDSTGQEEVYMWSDYFG
YDAKAAVTLSAILAYMPTMPHWAYNGNARRYWDFLYGGKLSRVERQIHHYGSGLNAIPVL
DNYRENPEDLHLLKVGYGGLLGAVSNITEDGFGAAAFHSWPSTLEIDYLSGDYGSNFYGY
AINSSAYLVEDAELGYLAFGGNLTEEKNSVTMQLTTAAKNAVFVQPLALWITLDAGAVQQ
VSFDKKTKEVQLTLAPKSEITPFAYVNLPEEYTLDYEKVRGAYKIPLQAKPITLTLKH
>KECLDBNJ_01587 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase
MNFLTKSLHAVYKINFIGILFVLVSGCAPTEKQPSKVFLSPDKNFAFKDAGWETEYWSNQ
ENYSDSILKDTDAKVLVITHDSLQTGRIFKKVNVKPYAQYKVSGFIKAEDVSTEKSNAGA
GFGLGKFSSRADTVFTGTTAWTPVEMTFNTEGDDSFIIECLLGKNAPASGTAYFKDIKLE
ELSSQTLEPKVSINLEAQKEPMSPYIYGQFIEHMGKSIYGGLWAEMLIDRKFYHKPGTLA
SPWEVSVDSTAITLDEKNGFSEQALPVFKLDGNQIFLKQDSIAVKPNTNYVGRIVYKTKG
SFKEVSIGLEALNSKNTVGFSIPESEAFVTKEFELHTGENSGSLASLEISFEGKGTVTLA
AISLMPEDNIEGFRPDVIALLKELDSPIYRWPGGNFVSGYDWKDGIGNPDARPTRYERAW
NGLEYNDVGIHEFMQLCEILDAEANIAVNTGLGDAALAANEVEYFNGAATTPMGKRRAAN
GHPEPYDVQLWAVGNEMFGDWQLGHMPIEEYVKKHNKVAEAMWAVDPDIDIIAVGYPGEW
NDMMYQNTVENMTYISEHFYRQDWHAGGLLTHVKQMPDAIREIAEEHRRARREIPEIADR
NIKIALDEWNYWYGPHEFGLLGTRYFLRDALGIAAGLNEFSRQSEMYYMANYAQTVNVIG
AIKTTPTDSWLEGTGLVLKVYRKEFGTIPVAVSGAPEPLDVAATLTEDGNYLTLSVINAT
HQEYQLALDFITEDIPTQGIAFVITGANDMVYNDVTHKNSIYLEETSFELEHNSLQVAKE
SAGIYKFKLN
>KECLDBNJ_01588 HTH-type transcriptional activator RhaR
MKVLPFKIPKPGKEALVYQEDHELKFYDKLHEHEEIQISYIAKGSGNLILGDTINDYREG
DILVIGEHVPHVFRSDDNAIDKSIMYTLFFTKNSFGKEFFKLTEMSGIDSFFDEAEYGMK
IETNTESLIRKFSKLKHQSRIERLASFLQILDLIQQSDKTPLSSFVYHKKYTDIEGKRMS
DVYQYTLDHFQENITLDTIAEIANMTKNAFCRYFKRRTNKTFLQFLIELRIEHACKLLYK
EKELSVAAISELCGFQNIANFNRKFKELKHTTPSQYRLHVA
>KECLDBNJ_01589 hypothetical protein
MEHRLFLNRIAECTAQFTPVVDAAYADSDYRFLDLSTTNEILKEVDTSSSEAIQLYINTF
LAKTGGRVAYGGYLEKRSIYDRSLYFNNDNPELKRNIHLGLDVWVPAGTAILAPVAGTVH
SFKDNTNYGDYGPCIVLEHRFEDFHFYTLYGHLSRASLSALTVGQKISAGQTFAHLGTSE
ENGDYGPHLHFQIIKDMQEFKGDYPGVSTHKKLDFYKNNCPDPNLLLKIS
>KECLDBNJ_01590 hypothetical protein
MRIMKCYAKLLAVLVFIPQANAQTINSKLNERFATNANVAILTESQYADIVFEDWNKNEV
EVEAVIESEDLSKEEINQLLKGWQVNVQGNSRAVRIISSGAPSTASIALGDTQVRGINDL
ITASMQQMIQPVMQQPNVSPILQQFASMQIPAEFYKGMNAVSFDYQAYKRDGAKYLEQYK
RKIEQNLGEDFDVVMKKWEQNNKKRVAAGQGLAGSSLLGMPKSPFGKDMNFDSAAFNRDK
KAYVAAMNKKYGTNVSVSQVDQWRTAIEDWGDEFSADMKAWGERFGKQLGGSSEALGATF
GRAIESDMAALGQNVEKAMQSWSNDFAKKLEQMAEAQGGSLKKTVTTDANGNVSTQMTYS
YSGAPSGAAIAVKPKGTFSRKIIVHMPKAAQLDLNVRHGNVKISEATNARVTLAHGDFMA
NTISGEKTLINVAYSPVDVTTWDYGTLRANYIKNCVIDKAKSINVDSRASSIVINELEDA
AVITGSFGELSIPKLGKNFKTLNISVENSDVVLNLPETPFHFNFNGVRSRLNYPRKIEAK
VMEGYNSSMVNGFYKSRNTDSIIAISSKYSDIVLN
>KECLDBNJ_01591 hypothetical protein
MAQDIREMFKNDLSIPDEGLKRGHEARFNARLDAHFGKEAKAKTEGYLWMKIAAVLVVLI
AISGLLLNNPLSTGTQAEQTVEANSLATTQPVKVQLSDFSPEYKQIEDSYLATIHMELAQ
LNVTDDNKAIVDAYMGQLEELNQEYDRLNADLVETGVNDYNIQSLIDNLQFRLDLLNKLK
EKLNELQVSQNNEIQTNTL
>KECLDBNJ_01592 ECF RNA polymerase sigma factor SigE
MQLYNKYSEGMYYVAFRFLKNSFEAEEAMQEGFVKAFTKMHQYNGEVTFGAWLKRIVINK
SIDMLKAKKLELVAINEQVLGTVDEHNDWSVDDGITLDQIKAAIEELPERYRYAVMLFLI
EGYDHQEISEILEITEVASRTLVHRGKKKLQEKLKTKYHGTGY
>KECLDBNJ_01593 hypothetical protein
MKKLYLLVLIPLLGVFSCSQEVEQIPEVSQDLETLYFPSEDRFKTTQTEKVIIDLNDFKT
YAELIAEMDQNACNGKGNILRFTEENTVLKILVFKTCAEESSFACFGHVDLFDFQNDSLR
SNFETNISPQLFTAKIQESLDTQINAPFFNKEDLKSILISIDYSNNRQNTSIENLKNTLR
LITSTMAKVQDAYQLDIPYFIEIDKTNFTPPPPPFF
>KECLDBNJ_01594 Organic hydroperoxide resistance protein OhrB
MKALYKAKATATGGRDSSVSTDDGTLDLDLSVPKGLGGAGGEGTNPEQLFAAGYSACFGS
ALAHVARGKKVDLGDYTVTATVKIGKNEEDMFQLAVVLDCYLPTVDVEEGEALVNEAHEV
CPYSRATMDNIDVTLNLLLDDE
>KECLDBNJ_01595 putative GTPase
MKTPKNKHIDLTAAQKLIKNRKRPIDPQMLSAEILAGNTIALSRAITLIESTTSAHQKTA
QEILAACLPHTKKAFRVGITGVPGVGKSTFIEALGMLAIEQGKKVAVLAVDPSSTISQGS
ILGDKTRMERLTADANAFIRPSPAGDALGGVARKTREAISLCEAAGFDLIFIETVGVGQS
EIAVHQMTDFFLLLKLAGAGDELQGIKRGIIEMADAIVINKADGINTIAAKHAKTEFSRA
LHLYRPKASAWQPKIMLCSALKETGIDEIWQTLLEFEAHTKANGFFESNRQDQNKYWLQA
TVVNALKDRFYKDETVKQQLPKLLDAINTGKVSAFQAAQELLKNFK
>KECLDBNJ_01596 hypothetical protein
MRLDPKDRKFLTDWKEKRETKFQFILGVTLQVILGALTYKLVITYFMGGIFDTTDFILFG
IIGLILGIVVGFLKYRKNEKRYARLKS
>KECLDBNJ_01597 dTDP-glucose 4,6-dehydratase
MKILVTGAAGFIGSHCAERLQAMNHEVTGIDNFSPYYSPDLKDRNAKALERAGIPILIVD
LRTPKDFEKLPTDFDYIFHFAAQPGIAATSSFEDYLMNNLVATKNLIDFALKCKGLKLFA
NISTSSIYGLRATLTEDAAPEPASFYGVTKLAAEQIVLSKTREQKMNTCSLRLFSVYGPR
ERPEKLYTKLIGCGFFHQEFPLFEGSEDHVRSFTFVDDIIDGVVSVIGKEDVVRGEVINL
GTEQEHTTGEGIAIVEELLNTKIRKDIVPKRGGDQMFTKANIEKARRLLNYNPSTTLKEG
LQKQIEWYRQEFVD
>KECLDBNJ_01598 hypothetical protein
MNQLKELDYELYLFLNNLGSETWDPFWLFLTNKWSSIPLYAFLLFLIFKKFGLKGTLYTL
VAVTLLITATDQLANVFKHGFERLRPCGQEGIMEQARFIAVRCGSYGYFSAHAASTMALA
MFVGLLLRSNFKWIFPFLIVWALLVGYSRIYVGVHYPGDVLTGFIIGGLIGLLMQWLHRF
GYAKIFKETY
>KECLDBNJ_01599 hypothetical protein
MELPKFILGDNTDYPESIFVIHTDFPRFIIDLKTDDVEWLEDFDKNDEEELATEAEGLIQ
AATDFYDREVARYEED
>KECLDBNJ_01600 Sodium/glucose cotransporter
MQPTTILLLIAGYFITLMLISYFTGKGGSNEDFFKASKQSPWYLVAFGMIGASLSGVTFI
SVPGWVEASQFSYFQVVLGYTVGYAVISLVLLPLYYRLNLTSIYTYLEGRFGVASYKTGA
SFFLLSRVVGASFRLYLVANVLQLLVFDSMQVPFWVTVTITILLIWLYTFKSGIKTIVWT
DTLQTLFMLTALGVAIYFVSTDLGLQPGGIFNFIAESDMSQMFFFDNWKSEDFFFKQFIS
GAFIAIVMTGLDQDMMQKNLTCRSLKDAQKNMFWFTIVLTVVNFVFLALGVLLTVYAQKN
GIEASKDDLFPYIATKSGLGFGIAICFILGLIAAAYSSADSALTSLTTSFSIDILGIEKK
YDQAKQIAIRKKIHVAASLVLILVIIGFKYLIADESVIARLFVFAGYTYGPLLGLYAFGL
FTKWQVKDRFVPVAAVASPILGYIISQLTLTYLNFEFGFFILILNGLLTFLGLVIIRTQK
H
>KECLDBNJ_01601 hypothetical protein
MKAKKTLVLGASLKPIRYSYMAIHKLVKNNQPVVAIGLREGEVAGITIDTGMPAYEHIDT
VTLYLNAQRQEAYYDYIIGLQPKRVIFNPGTENQEFYKLLQAANIEVDPACTLVLLSTNN
Y
>KECLDBNJ_01602 hypothetical protein
MKSNHGLLCLLFTLCTTLLFAQPKPNEVVTGSVSGVVLDADLNQPIPYATVVITSGEQTI
TGGITNDDGAFEINKIPEGIYTLRVQFIGYEAFERDLKIDRDHRKHDMGNLNLSAVPAEL
DAVNIVAERTTIEQKIDRKVINVGKDLTTAGASAADIMNNIPSVNLDQQSGALTLRGNSN
VQVMVDGKLSNIPADQLLKQLPSNSIKKIELITNPSAKYNPDGMSGIINIVLHKNVNIGF
NGDVSAGLAYEKNPQFNSGLNLNYRNGKFNLYSNYSNTIAKRANYGTIFREGDNSTQFFD
MLNDQNSHLLKVGLDVYLNDKNTLSVFTSQNSFIGTPGGNINIVYADDMTRNLMQDFGAD
MDNYSQQYNFDYKLDFEKEGHNIEFEADYNTFDADEDTFFNFTGATPLPDYEDFVDTKRD
RTTLNLDYVNPLSESEKLEVGLQAILFNTDIGYSSTGQSFNAEGDLVPTPNTLFDYSRDI
YSAYVTYGKNYEKWSYQVGVRAEQVNVAADTNSVRAFTNDYFELYPSAYVTFNPSEKNQY
QVSYSRRIDRPGVGQVNPIREWSSPLVTEYGNVNLRPQFTNSLEANYTRSLDKGSITAGV
FYRIIEDQINQAVYVDRFNLDRMVLTNDNFDSTTAYGFEVSANYKPAEWWSLNASFDLFS
QTQTGISESLDPDIENPTAADIMLTEREVTNSIFNTRIINNFTATQRLTFTAFAMFRGPA
ESIQFRNKSMFMTNVGARYSIFDGKGTISLNYNDIFNTMKARFTAVSPYRVEGQFNWESN
TVYVGFNYRFGDSKFRAKKRKNRDDNEKDGGGLF
>KECLDBNJ_01603 hypothetical protein
MGLFDMFKSQRDIAKEEIKEMNWIPLERMEQLDEIVEISNAVPVLIFKHSTTCGISRMVL
RSFEKAYDYDKKELEPYFLDLKAHRDISNAIATKFNVQHESPQLLLIKNGVVTYHTSHGA
IEAENLLEKL
>KECLDBNJ_01604 Chaperone protein ClpB 1
MNFNNFTIKSQEAIQQAQALAQGYGHQQIENEHIFKAILEVDENVTPFLLQKLDVNVNLL
KQILESTLTSFPKVSGGDIMLSREAGKTVTEASNIAKKMNDEYVSIEHLILAIFKSSSKI
AQILKDQGVTEKHLKAAIEELRKGDRVTSQSVEETYNSLSKYAKNLNQLARDGKLDPVIG
RDEEIRRILQILSRRTKNNPILVGEPGTGKTAIAEGLAHRIIDGDVPENLQEKQIWALDM
GALIAGAKYKGEFEERLKAVIKEVTTSAGDIVLFIDEIHTLVGAGGGQGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEQDKALERRFQKVSVFEPDTESAISILRGIKEKYETHHK
VRIKDNAIIAAVELSQRYITNRFLPDKAIDLMDEAASKMRMEINSKPEELDVLDRKIMQL
EIEIEAIKREQDENKLKSLRADLANLKEERNEINAKWKSEKDVVDNIQNAKQDIENFKLE
AERAEREGNYGLVAELRYGKIKQAQEELEKLQEQLAAQADNSLIKEEVTSEDIAEVVAKW
TGIPVTKMLQSEREKLLHLEGELHKRVVGQEEAIIAVSDAVRRSRAGLQDQKRPIGSFLF
LGTTGVGKTELAKALAEYLFDDENNITRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQLT
EAVRRKPYSVILLDEIEKAHPDTFNILLQVLDEGRLTDNKGRLADFKNTIIIMTSNMGSH
IIQEKFETIKDPETAMEGAKTEVLGMLKQTIRPEFINRIDDIVMFTPLTRKDIEQVVSLQ
LKGVTRMLAKQGITLDATAEAIKFLADRGFQPEFGARPVKRTIQKEVLNKLSKEILGGKV
TTDSIILLDAFDDELVFRNQSDLVEND
>KECLDBNJ_01605 hypothetical protein
MEKKPEFPELPSVEEIKTLINEYENADLKNVSFNKLSVQLRRLKWIPFLTAKLHQGYHIE
RARINRPGEIFYSEKDISYRNDYENIKTYGRANVKHQSLFYGAIESDVIKHPRLVNLIET
SQIFRNLDKIKVDKADFVMTLGKWRIKQDIEVVEMVFNENSIKNSKDVQKSYKHHLERLT
KEHPENLDQFKLILEFFSNQFAKKEIENDTDYMISAAYADFAMTWNNFPGLKYPSVKSDY
QGHNVVLTPAAVEQFLELEIAAMFRVTKNGENSLISPIKHATEFGPLNSNFKWVDYEPKE
YKIEQ
>KECLDBNJ_01606 hypothetical protein
MPHYAQGTSGWTKLKGYQALWDPKIDLGKFYFTTFQGKREETPYMTAENFARVIDILRNE
TPVYGNASTGSVTTQAEEVGEEES
>KECLDBNJ_01607 hypothetical protein
MSSNYKFHNPEGLYFVSFAVIEWLDVFTRDYYKDILVDSLKYCQSNKGMELIAWCIMTNH
VHLIYRSCVGQKPELLLGDFKRHTSKALVRAIQENAEDNRKEFLLKHFQKAAQKSSNVNN
YQFWQHDNHPIELWSNEVIWQKINYVHNNPVKAGYIQNPEDYNYSSAKNYVDEQGLLDVL
VFQYFG
>KECLDBNJ_01608 hypothetical protein
MARQSISFTKPNDDWLKEQVDSQEYTSKSELINDLVRQARKQQAEIDWIRTKLDDAEQSG
FTSESKQEILAQAKSSFK
>KECLDBNJ_01609 Toxin ParE4
MNYRLSNTAKEDLIRIYKYGVYKFGSAQAEQYFENFFLYFDRIAENPYAFEAVDFIKIEY
>KECLDBNJ_01610 Ferric-pseudobactin 358 receptor
MKQLTTLLALTLLSFSMFAQQGNAISGTVVDQNGNALPNANVYLENTNYGTSSNEDGFYQ
ISNISNGTYVLIVSEMGFKTFTSKAITINGAVTLNVKLQEDVSALDDVIISGAGKSEYVE
RNPSASLRLQQDLNKIPQNIQVISADVIKDQQAISMMENITRNVSGAQMIEHWGNFARIN
MRGFRIPPFRNGQNVLSTWGPLAEDMALVERIEVVKGPSAFMLSSGEPGGLYNVVTKKPT
GVSHGEVGLVTGSYNTLRATLDVEGKLSDDNKLQYRFVGAGTTQEAHRAYEDQNRYTFAP
SVKYLIDDKTSVTAQYTFQYYKTRLIGSAYVFAPEEYASLDRDFTLNDPKLGPSIMKEHY
GLVNFEHQLSNNWSVSAQLAYLNYQHEGSSLWLDGSFGVQANGDLIRRVSIWDAKEEKKL
GQAFVNGTAQTGGVSHKILGGLDFGNSSYIADWSTGINIDTEENPFNIYNPQPAAIAPVF
DRSTPLTQRAVGYITYEYLAYYAQDELGFFNDDLRLTLAGRYTEMKTNSYGSISTDKVFT
PRVAVSYSILDNLSAYAMFDQSFLPTQGADAEGNSFDPVTAEDIEGGIKYEFGDGKWNVA
AGYFNITKDKILVPGPDPNYSIQIDSDVTSRGFEFDLRGELFTGLGVVLNYANTNVEDAD
GNKVVGFSKHITNGWFNYKFQERALEGFGVSLGYQYLVDRSTWAWGADGETDLPDYFRMD
GALSWENNKFRVALNLNNLLNEYLYSGADYGSYVYWQSEPGRNFRLSLNYKF
>KECLDBNJ_01611 Isoquinoline 1-oxidoreductase subunit beta
MALIKTKHNRRSFLKVSAAGGAGLLLQFSWFSGLAQSDAQPEDIAFDLNAYIRINGNGTV
TIFSPNPEIGQNVKTSMPLIVAEELDVAWDQVTVEQAPLDTKKFSRQIAGGSQSIRAGWD
GLRMAGATARYLFLNAAAKLWNIPAEDLVTEEGMVKHLPTNKTIAYKELIDEASKIEIPE
EVPLKAPKDFKLIGTAVKNVDGVKIATGKPLFGLDYMEEGAAIAMLIHAPAFGMKLKSFD
ATEAKAMPGIKDVFTVDTSLQNPSWADVNAFNELIVVVGESTWQVMQAKKAVQAEWETEA
TAESTATHLEQFASVFSKGKGEVARQDGDPDAAFANADTVIERTYFGSFLAHNTLEPMNF
FADVKADSARLIGPIQTPEALRGSAAAMLNIPGDNIHVDMTRMGGGFGRRLYGNFGLEAA
AISQKIGAPVKLIYTREDDMTQGTYRPSYTLKYKAALDANKNLTAFEVQGSGIPSSPVFA
DRYPAGTLANYRAENFGIDTNISTGAWRAPRSNFTAGAEQSFIDEVAEAAGKDPIDFRLE
LFDNAIANPVGERNDYDAERYAGVLKLVREKSNWGTEIDGVYRGVSAYYCHNSYVAQVID
LVMDDRGNPVVQKVWCAVDCGIVVNKEGALNQIEGGIVDGLGHAMYSQLTFKDGAPEQQN
FDRYRLIRNNEAPLEIEVFFAENEIAPTGLGEPGLPPVAGALASALYKATSKRYYRQPYM
ILEQETAILG
>KECLDBNJ_01612 Isoquinoline 1-oxidoreductase subunit alpha
MPQYSLMINEQEHQVDVAANTPVLWVLRDHLKMVGTKYGCGIGQCGACTIHLNGNAVRSC
SLPVSAIANASMKITTIEGLSETGDHPVQKAWVEVDVPQCGYCQAGQIMSAAALLNRNAT
PSEDEIKNAMSGNLCRCGTYTRINKAVALAATKK
>KECLDBNJ_01613 hypothetical protein
MPRNLRALLLGLPFLLLAVQLQAQDTSIPNETPKKGFISRYLNRVFNDTVSQEKPQFLIY
PVLGIRPETGLEFAVAPLFVFYANEDTNNRLSEINTYAFFTFNGQYGIRINHAVYSDQDK
WFFLGDLDAERFPLKYYGIGNDVPKDNIALVDATQIQIKERVLRKVLKNFYVGLETDFRS
LSNVSFDAPEDSQEALDIELPFGAEGTTNFGMGAGLVYDARHNVLNERNAFFSELAYLNY
NPFWKSDVKYQTVTTDNRFFTPIGKRDVLAAQVIGQFSFGGEVPFNQLSYLGGENIMRGY
FSGRFRDRNQVAAQVEYRFLPLKLGFTDRLGATVFTGVGEVFDDWNELEMNKIKWSAGAG
ARFLIFREKDIFIRFDYAFTKDGNNFYLSIGEAF
>KECLDBNJ_01614 hypothetical protein
MILRVYLACVILLISGTVFAQKGDPQMQYQLSFPQAEAHYVAVELHLDQQDTTQTTLVLP
VWTPGYYMILDNPAHIIDFEVQASEGVAIAWKKTSKNKWTITHPKNTELEVTYRVYANRT
SVAESNVKETRAFLANTDIFMFPEGQKEAPISVTFQLPETWEHIATGLEKVNQTTFYAAS
ADMLYDSPFYLGNQKMIEFQQLGKAFTLAIATPEGLDEQQFVTDLREIILRTTDLMQHIP
FEEYAFIMMEPGGGGLEHANSQAVFTYGSFDFKTDADYKAFLNFITHEYFHLYNVKALRP
IELGPFDYSKENYTTMLWVAEGFTVYYEYLIMRDADLITEEDMLQYLSSHFQAIENKEGK
EHMSLERSSYDVWNHFLNNDAVSDATTISYYHKGPIIGLLLDLAIRHESENEKSLDDVMR
AMYKTYFREQQRGYTEEEFWETVTQMAGKPLDELRHYVETTETPDYEKYLSYGALKLDLT
ENDDPSTERVERAYQLKRKTPENKLQEEISKALFRNYF
>KECLDBNJ_01615 hypothetical protein
MNTKLARTEKLGYYLTPIEVVFTGFRHNYTDRLKKKQDKELKALKEFGELEKVEELKAIH
KSYGKFYVYCCIALILLAIFIFLFETSINSLK
>KECLDBNJ_01616 hypothetical protein
MKQLLLFSIFFCSLFTSYAQQPTVEKGIFSVNILTPGLEYELGLTPTTTLDFRVGTGFAY
QKGMFGEGYGVYPIFNTQYRYYYNFKKRMDKGKNITKNSANYLALSAAVQTGKPIIGSLE
YYESYFGAIGPVWGLQRYYKGGLKLDLNLGAGYGFNESGESFFSPILGLRLGWLLFKS
>KECLDBNJ_01617 Cyclopentanol dehydrogenase
MQHVILITGSSSGIGKSTAKKLLEKGHIVYGAARRTDEMQELEHLGMHTHFLDLTKDESI
ISCVEHILKKEGRIDVLINNAGYGSYGAVEDVSIEEAKRQFEVNLFGLARITQLVLPAMR
KNKKGRIVNISSMAGKIYTPFGAWYHATKHALEGWSDCLRLELKAFDIDVVIVQPGAIKT
DWGTIAAKNLKEKSGSGPYAAFANAAAEGMHEAYTGDRLTDVDVLGKTIAKAATIKKPNR
RYAKGFMAKPAMALRKWLGDGIYEKLIRSQFK
>KECLDBNJ_01618 Nuclease SbcCD subunit D
MKILHTADWHIGKKLHKHYLYTDFERFISWLIAIIQEEKIELVLVSGDVFDLANPSAEAR
KQYYKALKQLSNLNCKLIITGGNHDSPSMLDAPREILEALNVHILGGMPENPEDCLIPVQ
GKQDNDQLVVAAIPFLRDGDIRAAESGVTYENRIEAIRKGIEAVFTQAAELCKKKFSGLP
VIAMGHLYAAGIESSESERDIQIGNQAAFQASQFGEYFSYVALGHIHKPQRVSAAIPAFY
SGSPLPLSFSERTDEKRVLILDTSTGFEPKSIAIPTFRKLNKVSGDLERIQSKLEALTSE
GELTNLIEVELIEENFDANRIAQLDTLVTEFNTPGLEIVKHRATFKNRLKATGKLFDAQQ
HLEDLKPLEVFTKMLEQNSYDAETKAKVTLAFQELVEHLNTADPA
>KECLDBNJ_01619 Nuclease SbcCD subunit C
MKILKIAFKNINSLRGEHEIDFTQEPFLQNSLFAITGPTGSGKTTILDVISLALFNHVPR
LGKMSTNEVLKKGAILTRNQEDANAQITYQCNQGIFTSRWEISTNRNGNLRDYHMELINT
VSNEILDLKKSDVPGKNEELIGLNYDQFIKSVVLAQGEFAKFLQVPKKERGALLEKITGT
DIYRRIGIEVFLRNKERAKEIDAKRAKIETFREQLLEEDTFATKQKEAETLAETQKQLKQ
SIEQFTKEIELKKKLQAEERELQKTQKELSEVVALQENFEKEKGDALKHHEAIQLFAEEL
NHWQSLQEKQKEKQTEINKATEALEAAKAEREHLTQQISEQFKLTVTPTDFPEKMERYKA
EVRALIDERNALRTAFETSKNPLQTAAREFDLHLDLKDLKGFEAALQEKFTKSNSAYAAL
ENRFDLKNASVAERLATIQSKLKNIRAAEKAHMALSTLQSQRKERNEEYVSLQKQQAQLP
EEVKQLKQQIELKKAQHIAKQKTLEVAQLQKQLEDYRKDLQNNEPCPLCGSLDHPFAAHI
PQEENGLKAAVLQLEHELKTLNKELATKESSLQQLTQQIQQLEHRIKVLDEDLSALQTTF
DAQFKNLMQTKGSATFNELELQLEQQEQELNSAEKLQQNIKILAQIQQQTTDLKGLLAKG
KKKAEAISAVYSGKNFEQDISHNETSWNRNEQTVNQQQKLLTAAKETEHDLVKTLDSLTA
SLVKQLNKKGYESIEDALQKRLNAATAQAWKQELEKINEDALRLKTLRNKLIEEIQILTD
SASEAPLEKLQEQHQEQTETLQQHEHSASVLSRQLLNHKDNLEQIRKLQKQIDQELKDGE
HWLILNNLIGDANGNKFNDFAQDLTLAQLLQLANKRLKHLTDRYQIDQPADDEDDSLVAI
DEHMGGQRRSIKTLSGGETFILSLALALALSDLASRNITINSLFIDEGFGTLDPETLDQT
LDTLEVLQAESSKMIGVISHVDSLKERIATQIQLTQNGQGYSSLKIV
>KECLDBNJ_01620 hypothetical protein
MNFHTRKWIKPQDLNPNRSLFGGRLLEWIDEEAALYAIIQLENPRTVTKYISEIDFKSSA
REGDIVEIGIEPVKFGTASLTLKCEVRNKMTRETIITIDKIVMVGLDENGNAKPHGKTKV
EYVKDRLEDR
>KECLDBNJ_01621 Xaa-Pro aminopeptidase
MFPKSTYVNRRNILKQTLKSGIILFPGNGESSMNYADNWYPFMQDSSFLYYTGIDHIPNL
YFLINIDTGEEILFGNNATPEEKVWIGSAEKLESFAEKSGFSTVKPLDQVASYLKAQLAK
GQQVHYLPPYRSAQKIAISELLDIPLQEVEANKSVALIQAIVAQRERKSAEELVQLEEAV
NITRKMHEYAIINTKAGMTEMQMAGTLNGIAVSGGGGLAFPIILTKDGQYLHNHATTAVL
SEGDLVLCDCGAYNTMGYGGDMTRTFPVGKTFSPLQKDVYNIVLNAHESAIAALKPGTRF
KDIHLLASKKLVEGLTDLGLMKGDADEAVAAGAHTLFFQCGLGHMMGLDIHDMENLAEQY
VGYTPELKKSTEFGLKSLRLGKELQEDFVLTVEPGLYFNPFLIDERRAQKKYMDFVNYDE
VEKFKSFGGIRVEEDFVITKDGSKLLGEPLAKTPEAIEKLRNN
>KECLDBNJ_01622 Prolyl tripeptidyl peptidase
MKAIKLGLLCLFTIAVNSTTNAQDASQLTLDRIYSSEFRGESARAISWIDDGDAFVTIEQ
TEDGQDQLIKYASKSNAQEVFLSAAALTPSGEDQALQIADFSLSNDESKVLIFTNTSRVW
RSNTKGDYWVYDLDTKSLKQLGAALPSSSLMFAKFSDSNENVAYVSGFNLYEENFKTGEV
TQLTTDGTGDIINGTFDWVYEEEFGARDGFRWNPDGKHIAYWQLDASEIGTFYMINTTDS
VYAKPIPLQYPKVGYDPSSTKVGIVNTKTKETTWIPVPGDPIQHYLPALQWIDEDLLLIQ
QLNRKQNTLKIYTYVPSSKALKEVYTETEETWVDLDYPDVSANQWGKNDLLLTPDKSEFL
RMTENDAWRHIYKVSLETGKRTLLTPGDYDVAAFYTATAKEVFFSASPEDPAQRYLFSTS
LKGKGTPKRLTPEEFEGINTYQIAPNGKYAIHSHTSVDEPTTVRLISLPNHKTIKVLVDN
ADLKEKLSSLALPATEFFQVETEDGILVEGRITKPVGFDESQEYPVLFHVYGEPWGQMAT
DNFIGLYDIFLAQQGFVIINMDNRGTPSLKGSAWRKSIYRKVGVVNSRDQAMATKALLEK
WSFLDEDRVSVWGWSGGGSMTLNLLFRYPEIYQTGMAVAAVANQLFYDNVYQERYMGLPQ
ENLEDFIEGSPVTYAKNLEGNLLVVHGTGDDNVHYQNMEYLVNELIKQNKQFTMMSYPNR
SHGIYEGMNTRRHLYTLLTNYLFEHNKK
>KECLDBNJ_01623 hypothetical protein
MILVFAVVVGAVAVPYILFILFGSNTKKLSTFFKTEATKQNLAFDKTEQWASRIIGIDLK
NNVLFYAQLVQEQIVHKAVDLSTISRVNLLEDLQTKRIDGKVSSTLENLTLELIPQNSGA
PILLNFYDSLIDSAQNFEMKRASAWKSDIQNALTAKQAAVVAA
>KECLDBNJ_01624 hypothetical protein
MKAFVKSVFLFLLLLLGAGEFSFGVTPADTFAPVVPGEHRASVQEGNDKAVAVEQLLLTA
PEVSLHQQKDHSFNGSDFWAGLASESTALLTTLNLQYLTLCERITPSLSRLDLIFPFHLF
P
>KECLDBNJ_01625 Cytochrome c551 peroxidase
MKLLTRLGLIVLLCFSACKNDKKADETLTALVDWQPTQDYYKMHLTEAMQYLDSLAVTPA
ESAKAKIYFSKARVAFKKAEPYASYINPVVGHRANGPALPFLTDDSQKVLEPVGLQKIEE
SIYEGIENETTYQKELRLTKGLLEILKGNIAEREINAERFFIATHQQLMRMVSLAIAGFD
TPVSGLGLGETQESLQSLRDVYALSIQERVKAADAQLDLQFQDQVEKAIAFIATNKDFAT
FDRYTFIREYFNPITRSWVAIRKASDVWEPVTNKPYNFDAPTFFEEDSFNVEYFREITNR
NPSEAQIALGKRLFFDKNLSKGKDMACVTCHDPKLAYTDGKVTNMNNTGSPLKRNSPTLI
NSVFQRAFFWDGRAETLLAQISGVFTNKEEFNSTVHEFSEEVLTDSTYYEAFKEVFGTRR
SWTNDETIKALSAYISTLNGFSSKFDKNMRGEENTFTPEEKQGLNLFMGKALCATCHFMP
LTSGTVPPFFTDTEKEVIGVPETAANKELDDDLGFYFMYEEPIQLGIFKTPTVRNAELTA
PYMHNGVYESLEEVIDFYNKGGGGGLGFDLPHQTLPFDNLELTSEEQQALVAFLKTLTDV
PEEVVY
>KECLDBNJ_01626 hypothetical protein
MTTLKKLLFNLMMLASVGVVFIACEGEDGLDGADGVDGVDGTDGVDGQDGEDGEDFTPTA
ELFANKSSLEPLVQMSPAFNFVKPYSLISTSDVIGETNFQMAGSADGAGFLKDPNSDGYI
YVVNNEDHYAVSRIFLDENLIPVKGDYLLNSGVADWARQCSATMWEADIHGGSEDIFLSA
SESYSYKVKAIDPYVETPTPTADFGLAALGEFSWENAVPLPKDAYTGKTVIIGGDDDSSG
SEGQVVLYYSENGDADLEGGKVYVLKLKQISDGNGGVIAAEEGQIYNEGDLDFKATYDVE
FVEIPDAANLSASEMEDACIEVGASAFMRVEDVDYQKGSDANGRNVYFAVTGRGPGAGTY
NDWGTVYKLELDADAPLTGKLTQVVSGNTDTNNMDGNLASLQSPDNICVTENYVYFQEDP
NSFNRNHNSYIYQSDLNGDNIEVVLRLRVDQNLAEDPGVVYNGEFGSLIDISDKIGVDGT
FVLALQPHYWTDDFFQGLDGHIISGRENRQGSQVILLQGLPR
>KECLDBNJ_01627 Putative peroxiredoxin bcp
MNMLKEGDQVPAFTTKDQDGNEVQWSDYADKKVIVFFYPKASTPGCTAEACNLRDNYKEL
QAEGYELLGVSADSERRQTNFRNKYEFPFPLLADEDKTVINAFGVWGPKKFMGKEYDGIH
RTTFIVENGTVTRVIGKVKTKDHATQILTEA
>KECLDBNJ_01628 Endonuclease III
MTKAEKVTFVIDTLKQLYPQIPIPLDHKDPYTLLIAVLMSAQSTDVKVNQITPLLFEVAD
NPYDMVKLSVEEIREIIKPVGLSPMKAKGIHGLSHILIDKYDGKVPESIEALEQLPAVGH
KTASVVVSQAFNIPAFPVDTHIHRLMYRWNLTNGKNVVQTEKDAKRLFPKDLWNELHLQI
IWYGRQYSPARGWDLEKDIITATIGRKSVLKEYYKSKK
>KECLDBNJ_01629 hypothetical protein
MIKAIVYGTESAPAQKQLSGIYAEFEIVKSVELAKNRASGKAIPLDLDDDAIIQFTFSDD
TEWIGNALDIQEIYNTPLNTSRSGEALVFEAKLVETSPSRGIVSEVIIKALHLLKPKAAA
IAAEETAAVLAEAYDKKVMPQPGVFKMDATFQYLPVAKVDKQTTPYLLLIHGTLSNTFAA
FSDLRIGANPIWDQLLQEYASGILALEHRTLSVSPIQNAIDFLESIDKGIDLDILSHSRG
GLVADILAKCDRRNQIIGFSDLELGMMLREDDSTHKLMVKLNKLAQKKQIQIHKVIRVAA
PASGTTILSRRLDHFLNVIMNAMGLAIGAQANVLYTTVRLFLLEVVKQKANPEAMAGLYS
MVPDSAFQKMLNYSANPVESDLYVIAGDAEAGGSLVDTLKVILANLFYWKANDLVVDSNR
MEQGAPRLNGINYFLSKNAATNHFNYFRNQNTCDAILQAAITPPGELANFFIKKRNISGS
RGVLLGLLSMKGVHYEKISGTKPIALLLPGIMGSSLDHNGNPQWIDFRELNRGAIKDDLS
IKTEDVSASGVIKKYYDDFAQHLGKTHDVITFPFDWRKSVKHAAQLLAEKIDQLLVEQTQ
PIQIIAHSMGGLVVRQVMIDFPELWKKLIDKPSTKFIMLGTPWLGSYLIMEVLTGHSSRV
KQLAMMDFKNTKRDLLYVFREYPGIFELLPIENNQKRKFWETDFWKKIKEECDEAMVIPL
KKELDAFKKYREKVLDFVTKIKEEDLKNVYYIAGHAEQTVYDYTSKSRFLSKKKKLVYLA
TTHGDSSVTWATGIPSRLPETNLYYTETSHGELANDPKLFDGIIELLQEGKTQLLSKTKP
VSRAGEVITEMHGVPQPFSNQQEAADALFGITPVQQATAIQQPKVKVEVINADLKVARYP
VMVGHFNNDGVHSAEKALNRCLGGRLMQRYDMGYYPGKIGESEVFFNLNTNPRGAIVCGL
GNTQELTHYLLAKTTEMATLKYAMFMRDNYTLARAKSFAEGISFIFIGTGYGRLQVEDSL
KGILLGVSNANAYIRQHQDGLMPITEIELINHYESLSSQAYWGLSRLQHADNRFSFELVK
GVKSKEGAKKKRAFISDRDDWWHQFNIESLLTKECIKGFAFNSSSGLARIEEEEVHNGLD
QVEVLLERMSHSAAWDKRLSKALFELLIPNRFKDIIRNQNNILLKLDLEAAQFPWEMFHD
FDSDETPAAVNSGLIRQLLTSEYESLPLRASSNSALIIGDPLYNEENLPQLPAAKKEAQD
VNAKLEQAAFETFSLINAEPAEIMLELYTRPYKILHFAGHGLYDLANERVGIAIGDGICI
NPAMIKQLSYVPEFVFINCCYSGTLDAKDSAYTQSRFKLAANVGTQLINMGVKAIVITGW
AVDDAAAATFSEHFYKRMLMGYEFGEAVQMARKMCYQNHGHTNTWGAYQCYGNQHYKFFD
LSKAKDDDYDYVLSSQVYIDLENLYSEVKHNATKKKQGQKRLETILNNAASNNLIDGVIR
EKEALIYDELNEPLKALETFGAVLTLEDANFSLKVLEHFCLLRSHNFSEDAEKRLAELDQ
VTKLAMIGKTTLRLGVVGNAYKFASAYEQPKKRDLYLKFALDYYTEAFMINSDLYDGNSL
DAFSNMVFIAYLLEGYGHGSLKALFERFTTKDPLTYLRDFHKQLDDVDPEDLDISVLLGM
TEVSFCLLLLDKDETQEEQIFAEINKRFNETFRLLHSARQIRIEIAQIEFLTKHTAIISE
KKINILNKIKRVLEEKNKS
>KECLDBNJ_01630 Phosphorylated carbohydrates phosphatase
MKTTKTPDKIAVKALIFDMDGTMIDNMMIHHRAWQKKLKELGLEMTLDEVKRDIHGVNNE
IIKRLFGDRFNAEEIAQIAWDKEAAYREIYADQITMLPGLQQFLDAAKALKIPMGIGTAA
PKENAEFAVEALQLEPYFQTVVHSDMVDRGKPDPQVFEMVAARLQVDLKDCVIFEDSPTG
AQAAANGKAQSVILNTTHTPDEFERISKIQHFMTDYKNIQLTKSDDGAFYLQF
>KECLDBNJ_01631 hypothetical protein
MMERFTFSFKETKISALLVVKSFHLNKNNLTKSVFLTL
>KECLDBNJ_01632 Bacterial leucyl aminopeptidase
MKQIVYMAGVLASVMLVNCGPKMTESSNHSGKEVTLTDVDPMPYAESITADELKEMLYVY
ASDEFEGRNTGEPGQKKAVAYLKDYYIDQDIPSALEDSYFQIVPESFFRAGSGIKASENV
VAYIKGSTKPEEYIVISAHLDHVGVRDDGEVFNGADDDGSGTVGVLEIAEAFNKAVEAGY
RPQRSIVFLHVTGEEKGLYGSRYYAENPIFPIENTVADLNIDMIGRVDDAHKDNENYIYL
IGSDKLSTQLDSISTAVNNKYMNIDLDYTYNDENDPNRFYYRSDHYNFAKQGVPIIFYFN
GTHEDYHKVTDTPDKINYPMLAKRAQLVFLTAWELANREDRIIVDKAP
>KECLDBNJ_01633 Putative ribosomal N-acetyltransferase YdaF
MQKWIAHPLELEDATVKLVPLKREHRDGLLAAASDGSLWELWYTSVPSAETIDAFIATAL
EQQEKGEEYPFSVIDAQSGKIIGCTRFYGMQPQHKRLEIGYTWYAKSVQRTGVNTACKRL
LLAYAFEQLNCIAVQIVTDWFNLRSRAAIARLGAKQDGVLRNHRINADGSYRDTVVFSIT
NSEWHGVKKNLDYKMLTYNCGL
>KECLDBNJ_01634 hypothetical protein
MSSTKIALLRGINVGGHRKVPMAELRQLMTDLGFGQVKTYIQSGNIIFKSPVENTAELAL
KIQNGILERFGFEVPVICLTAETLQHAVKNNPFATEAPPLTQLHLSFLNKVPEKSLAEAL
QEIDLSPDQFHLQNTFVYLNIPGKYHKTKLSNALFEKKLKVNATTRNWKTVMKLITLSE
>KECLDBNJ_01636 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAIGAHPDDVELSCSGVLAKEASRGKKTGILDLTRGELGTRGSAEIRDQEAATAA
KILGLSVRENIALADGFFTNDKESQLRIIEIIRKYQPEIVLCNAVDDRHIDHGKGSKLAS
DACFLSGLKKIETILDGKTQEAWRPKHVYHYIQWKNLQPDVVVDISGFMDVKMKSVLAYA
SQFYDPNNPDNNTPISSKNFQDSVKYRAQDLGRLIGTDYAEGFTVERYPAVDSIFDLI
>KECLDBNJ_01637 Cystathionine gamma-lyase
MADRKLGLNTICTHVGEVEDTQFKGAISPIYMSTSYAYEDVEVKRYPRYFNTPNQEMLGK
KIAALESTEAGMIFGSGMAAVSTTLLAFLSAGDHIVLQKTLYGGTFNLVEEEFSKMGIEY
TFTSGLEQADFEAAIQDNTKVIYIETPSNPLMTVTDMQMVADLAKAKGIVTMIDNTFASP
VNQNPADFGIDIMIHSATKYMGGHSDILAGAVACSEVHMDKIWNKAKNLGGSLSEFSVWM
LERSLKTLVLRVKQQNKNAKKLAKWLDQNGHVKAVYYPGLKTHPDHALAKKQMRGYGGML
SFELSDELDAAAFMKELKLIKPSMSLAGVESTILSPTQTSHALLSAEERENQGIADGLLR
FSVGIEEKEDLIADLKQALEKVVKDSLNFSI
>KECLDBNJ_01638 Mycothiol acetyltransferase
MKLIFDTYQPNYAQAFKQLNLHWLEQFFVVEPHDDEVLSDPDRFIIQPGGEILVALQDQK
VVGVVALMPDEHGIFEMTKMAVDASLRGQKIGQQLLRYTLDFAQQKGLDRLLLYSNRKLE
NAIYLYRKFGFEEIPLEHPNPYARADIKMEIRF
>KECLDBNJ_01639 hypothetical protein
MKNLVLVALAITTLYSCKNQNKAEDESSLASEEATMTTEATTEAEFNITPIEHATAIFDF
GEDVFYIDPVGGTKAFENKPKPQVILITDIHGDHLNEETLTAVADSSTTIFAPQAVVDQL
KGAIKEQVTVIANDETQTWDGYTLTAIPMYNLREEAKQFHTIGRGNGYLIEKDGMRVYFS
GDTEDIPEMRNLKDIDKAFICMNLPYTMPVTSAADAVIDFKPKEAYPYHFRGQNGLSDVD
QFKGIVDSADVGTEVIILDWYPNGAE
>KECLDBNJ_01640 6-phosphogluconolactonase
MKAALLGLSLCTLLSCKNTEKKSETDMTDTAASPRTTFYLGTYTDGESQGIYKAGIEDDG
TFTKPVLVATTSNPSFLALSATKHTLLAVNEDDPGMITSFEVKNDSLVQLSQTETGGAHP
CFVTLNENNDVLVANYSGGNLGLLKLNEKDGSLSALLDVEQHEGQGTTDRQEGPHAHSVW
FLPDGSGIVSADLGTNQLWFSKINNETQKLEPAENQKLDFPEGAGPRHLVFHPANGFIYV
LNELDNTIAQVGKENGQYSVLAVTSILPEGFSEYSKAADIHISDDGRFIYASNRGHDSIA
ILEVDDQGALSLIANEPTKGKDPRNFQITPDQNFVIVANQNSNNLVSYTRDPETGLLTYA
SEIAAPKPVCILFD
>KECLDBNJ_01641 hypothetical protein
MNRFTVIFLSLLASFICYIGIWYTLQWLFPSFEGAVKAATCAVITVFLTPRIHKIDSQTG
KKQTLISWMLVGKSWVV
>KECLDBNJ_01642 HTH-type transcriptional activator CmpR
MRTKLQIFKVVAKHLSFTKAAEQLYLSQPAVSKAIKSLEEEFKTTLFVRKRNAIELTAEG
KAFLIHTQKILSIYAEMDEQFTHKNEAFPEAIDMGVSTTLSDYVIPQVIAQFNLRFPKTK
FSIRAANTEHIEKLILDEEIHFGITEGNTNNNKLSYTKFLKDEIVLVTNAANTSVKENAI
ALKKLKDLPLVSRESGSGTREVIDSFLQQHQIKSIDRNILFNSTEAIKNFLYHSEHFALL
SIHSVADDLKNNRLKIIDIKNFSIERWFYFVRRTGYLSKNIDYLERFIQNRNNF
>KECLDBNJ_01643 hypothetical protein
MKSRYSKLIFFALILLALSGAFTSPLALIAGFLFNLFFKTPYRQKQHQAINYLLKFAVIG
LGFGMFISETIATGSKGFSLTLSTIVLTVFLGFILTKYLKIDLRLGHLITSGTAICGGSA
IAAISPAIKANAKTISVSLAIVFMLNAMALCIFPVLGHAFHLSQEQFGIWCAVAIHDTSS
VVGAALQYGEEALKIATTVKLTRTLWIIPMAVFSMFYFKTKNERVRIPYFIIFFVLAILA
HSYHLLPESWAEGLVLLSKRLLLVSLLLIGINISLKDFKTIGLKPVALALVLWIFIATFS
LLFILY
>KECLDBNJ_01644 hypothetical protein
MKKIYNYLFLLILLISLGCSEDEAINVDLSQFESITERFPYADLTTNIAYDYYELLYSFD
TPGNEELIVSEGSLCVNASNTDACIESFNMLETPFGFAGSCLPSYCFLYIKFQHGDNNTI
LNTPEQLLTFLGTIDTRSEAILWANANGYFHSLDIKEIGAIKATDDHFELLVSELVSGCL
PYQSDQVHLRIDADGKITELDRAVYSYAKNSCI
>KECLDBNJ_01645 N-substituted formamide deformylase
MRAILLGFTIFTLLLSCDQKPTDKMEVDSIFYNGTVYTVNTDFSKAEAFAVKDGKFVAVG
LTDSIQAKYNAKETVDLKGKTVLPGLIDAHCHFYRFGESLQNADLVGTTSYQEILERLVV
FHEKKPSSFIFGRGWDQNDWAVKDFPNKSKLDSVFPDTPVALQRIDGHALLVNQKALELA
KIDKNTQVEGGEIIKENGKVSGVLIDNAMDLVYAVMPKLSREQSIQALKDAQRYCFDYGL
TTVNDAGLDRATIMLIDSLQQADALSMRMYVMISNSPEDVDYFIENGILKTEKLNVRSVK
VYGDGALGSRGAALRAPYSDRHDHYGAMVTPVEDIKALAKKLAATDFQMNTHAIGDSANT
VILNAYAEALEGQSDRRWKVEHAQVISPDDFNYFDDNILPSVQPTHATSDMYWAKDRLGE
RRMKGAYAYKKLLDEAGMIALGTDFPVEQVNPFYTFYAAVARKDLEHYPQDGFQKKDALS
REETLRGMTIWAAYSNFEEKEKGSIEAGKFADFIVMDQDIMTIEEDAIPDLEVNQTWLGG
KQVK
>KECLDBNJ_01646 Vitamin B12 transporter BtuB
MIQKIKSIFTFSFVLAGIGFVHAQEKDNLGTEVVNVVKPYTPEIGDAFKVKATPALNDSV
NTAKKKVTYGIFSVPVASTFTPAKGKAAQVEKAKPVKLYDNYVRLGFGTYTTALAEFYSN
FEIDRDSNFGIYLNHNSSQGDIDGVVLDNQFYDTDLNLNYTSRNRDFNWYTDLDLGHKLY
NWYGLDEFVSASPTLVQNIDPVHSYFQAGLSGGIEFNEGFFEGATARVGYFGDSYESSEI
RAVIAPEFMIPITDQKISIDLNLDYLNGSFDRNYQNSEAIEYTHLIASANPSLQIFLDDL
TLDLGVNVAADLNPDADETDINIYPSVQASYNVVDEYFIAYGGLEGGLIQNSYQELATAN
PFVSPTLDSLSPTDQKYDLFAGIKGKLSSAMSYNLRASYLAEDNRLLYKNNYRSVSEATL
AGAENYQYGNSFGIVNENLKTLSIFGELNFDVNSNLKMRINGEAFSYTTDLEEEAWNLPD
FQASFFADYQIDEHWFAGVTLFYVGARKDQVDVQTSSISSNPQLVELESYFDANAHAGYR
VNDQLSFFARVNNALGNNYQRWVNYPVQGLQGMAGATYRFDW
>KECLDBNJ_01647 Lipopolysaccharide assembly protein B
MTVLLLQLNLENMIKKYACIGLLTLLTLPVLTAQQSAAFTNDLAKYNKALSLYNSKQYLA
AQTLFNEIKQEAKDPTIKGDCAYYIANAAVRLNQSGADAAMQKFVEEYPTSTKRNSAYKD
VADYYYENGKYSVAKRWYEQVDLSRLNWSELERFNFNMGYIHLKTNRPEEAKVYFSRVRN
SEKYGAQAKYYEGFMAYENDNYEEASQLFEEVEAEEGTREDLSYFKADLNFKQGNFEEAI
KLAKEQLPTANRLDQSELNKIIGESYFNLGQFDEALPYLKEYRGKRGKWTNTDYYQLGYA
YYKQGDYDSAIGEFNKIIDGKNSVAQNAYYHLADAYLQTGKKQEALNAFRNAYQMDFEPK
IKEDSGLNYAKLSYEIGNAYEPAPQAIGNYLEQYPDTPERQQLQTLLIDSYITSKNYEGA
MELIENNRNFEDKVAYQKVAFYRGIELYNDGDYQEAIINFEKSLSEPRTPEFTARALYWK
AESEYTINRIDDALLTFKQFEQNSAARALPEYDNLAYNLGYAYFKKKNYNQATKYFSQFT
TSGTDDNVRKMDAFMRLGDSHFIESEYWPAMEAYNAAIAMPGGNKDYATFQKSISYGFVD
RNAQKIEGLSNFANMFPQSSYRDDALYELGNTYVATGDNERGIQAYDRLVREIPKSKFAA
KAQLKKALIYDNTGRSDQALNLFKRVAQDYPGTPEGVQAVASAKLIYIDKGQVDEYGRWA
NTLDYISVEDSELDDAAFSSAEQQLVGSNNAQAIQNFEKYLREYPNGQRAMEAHFYLGQL
YFGQNEYAKTKSHYKYVIDKERSEFTEQALARLGQVYLSESNYADAVPVLKRLETEADSA
QNVIFAQSNLMKSYYELQQYANAVSYADKVLANSKIDNKVKSDAQVIIARSAMQTGDESK
AATAYAEVSKIATGALAAEALYYDAYFKNKNGDYAGSNTSVQKLAKDYSGYKEYGAKGLV
LMAKNFYELNDAYQATYILDNVITNFTDYPQVVAEAQQELKRIKAAESKTNSSLEEGN
>KECLDBNJ_01648 Cell division ATP-binding protein FtsE
MSTPVLQLQNASIFQRESLILSEVSLTINKGEFVYLIGKTGSGKSSFMKTLYGDLPLQQG
QGTIVDFDLTTLKEKQIPYLRRKLGVVFQDFKLLNDRTVKENLKFVLKATGWKNQSEMDD
KIDKVLDKVGMKTKGFKYPYQLSGGEQQRVAIARALLNDPELILADEPTGNLDPQTSVEV
MGVLQEINKNGNTILMATHDYALLLKYPSKTLKCDGNKIFEVVQKTI
>KECLDBNJ_01649 hypothetical protein
MPKIVFSILILFCLTATAQQKYMDYNNQLISERDLEQHYKGRNYFAIETSIPNVTKLILR
TQEDTLQQVESLYAHLEEITGQTLERDKMLAIIYYPGLDTCNDRGSINFGTRKLWYKEME
RKLNRIADINTVYIYKNDEGLKKWRKANWTEDKNQIIERLFFKYHYPCGSFTVVHPSGHY
KSGLGEYSKSWVWKLTEDLVQAH
>KECLDBNJ_01650 hypothetical protein
MIKRLIPQTEKLQIAFEIRIADDASTDAEIQKANALLAEQNQCIYTVFHENRGRTATRHF
LAENALYDNLLFLDADVLPTKSDFLQIFEQNLGRAQVIFGGIAYPKILPDPERALHYTYG
KSREGRSVSKRKKKPYLSLVSQHLLIDKSVFLKYNPAEENAYGLDPYFAHRLEQHQISVL
HINNPTTHFGLETSASYVLKTHQALQTLVRLEHEEKMPRNYRPLQRVAQQVVKRNLQHKI
LRLFKTYEHHILKNLCGNNPSLRLFDLYRLCYYLKLTLEDESN
>KECLDBNJ_01651 Putative glycosyltransferase EpsH
MRAISIIIPVFNKEAYLAETITSVLKQTYTHFEVLLINDGSTDCSLKVMQRFKDARIRII
DQENHGLSKTRNRGVAAAKNELIALLDADDLWLPDHLEHLVKLSENFPDAQLFATGYCEL
FNSGKTVKPKINTAQHEPYQITDFFTESLYQPLVIPSTLAFTKASFNFLGGFNEATTYSE
DVDFLIRANLQFKMAYDPKITCHYRTGVAGQISSLNKSDLQVPKFGQLLRAHPDHQSLHI
YIHTKRYFLCIFYKTEGRLDLFKKLKAKLDPSILNSKQRLLLNAPRFLLISIRKIKVFLL
KKGIRLTTF
>KECLDBNJ_01652 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MMIKRIKLPKIEDRRGNLSVLEKDILPFEFKRVYYLYDVPSGASRGGHAHREQSEFLIAL
SGSFDVLIHDGTKKQTYTLNKPDEGLLIPNGYWRELDNFSSGGICLVLASAVFVEADYIR
DFAEFLQFKK
>KECLDBNJ_01653 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MLTEAGHAVHLVTITDKIGYEFSGRLYNLGKYKNATNGVFNKLKRFQHFKRYLYEQEIDV
VLDFRMRRNALKEYCIQRYLYPGFKVVFMVRSSHLNYYFPKPDFAAKRLFKEAGICVLTE
AMKQSIEQRFGFQKIKVIPNAINVSAYQQDFTSPDDVIRPYILASGRLQKGVKQFDKLIE
TYAKSELPKLGIDLYILGQGEMLSELQQLAEDLKIADKIIFKGFVKHPEPYVAHALFTVL
CSAFEGFPRVILESLACGTPVIAIDCPTGPRELLDGTNGILVPHQDFEALKEAMNRLALD
EPTRNRFKAASQKSIRKFDITQVTPQWQSYLNALYDD
>KECLDBNJ_01654 hypothetical protein
MRILLVGEYSNLHNSLKAGLLANGHEVTLISTGDAFKKLPSDVLIKAKRIEGSRLLQTLR
KGIFELTKFDLATLEIGYRVLDWLVDQTRFDVIQLINEYPFKTPYFIEKRIVKRLRQLTT
KLVILACGDDYIYLNNIDKLAHHPILQHPDIDFPYSEKYLTATHKKYHEFVFELKDLVIS
TDLDYHPIYKGRTDYYGLIPNPVNLNNFSRNQPEKQNRIVIFHGVNRSNYYKKGNYYFDS
ALCIIRKKFSDRIKIICVTSLPYAQYLESYRKADIILDQTYAEDQGYNALEAMAQGKVVF
TGAGASFCERYQVAPNSVAIHTIPDAKKIAQDLEELILNPQRIAEIGTRAKRFVQEHHNH
LEVAEHYVSAWNSIKNDDAVSASSEAQKSDTKNSKPAE
>KECLDBNJ_01655 O-acetyltransferase OatA
MVFLHHIDVLQDALGHAFFYALSGFILSYVYAERFAEQKISLSRFLKLRLSRLYPLYVLT
LLAAVPLSLGFLASNAEQWMLQFVANLFMLQSFIPNAEYYFAFNSLGWSISDLFFFYTLF
PVLLCGFRKYTHRSICGLFSLFFLLILSLMYIIPQELQHWFFYINPLLRLFDFALGMLLY
QLLKKASFGRFDSRFTWYESGSLVLLVIFYTSAALFPKVLRYSVYYWLPMLAVIGVFAQQ
KGALSKLLSKPVFLFLGNLSFGFYLWHQLILRYARRAVNHFEITLADWQFYSMSFMLILL
VCYFSYRFFELPMKQKLRRHF
>KECLDBNJ_01656 Lipid III flippase
MLKFLRQLITQNVLLKVSSFNAMGVGVRLVCGLVSSKLIAFYLGASGMAVLGDLRNFISS
LQSIGQLGISNGVIKYSAEFKTDKTRLQKLISTVLKVGFLASVFLGVLLFFTASVINTQV
FNAEINYTTIIKVFAVVLPFFTLNALMLNIINGIGNYKKVILINSITNVAGVALSAILII
NYQLYGAMLAVVLSAGIGLLITLSTVLKKRSLFRELLQEQIDGSMLRRLASYGGMTLFSA
IVSPWVYIAIRQEIIAVDGLANAGYWDAMLRLSDYYLMFATTLLTLYILPKLSAAISKKE
FRAEVFRFYKTFLPLFGAGLIVLFFIKTWIIRLVYSPSFLGMQPVFIWQLAGDFFRVASL
VIAYQMLAKNKFWLFIGTQVLSLSIIYFSSVFFIQDYGFVGAAMGHLLSYVLYLLVLLFI
FRNALFGKLC
>KECLDBNJ_01657 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIPFLDLKKLNAPHKEVLTAAFKNTLHQGDYILGEAVTRFEHEFAHYCGTNYCLGTGNGL
DALQLIFEGYKYLGKLKEGDDVLMAANSYIATVLAVIHAGLKPVFVEIETSTFNMDLEQL
PEPNSSVKAILITHLYGQLGPVTVVAAYAQKHNLLFIEDAAQAHGATLDTKKAGSFGDAA
AFSFYPTKNLGALGDGGAVTSNDETLITLIKSLRNYGRTSFAENSYAGFNSRLDTLQAAF
LSEKLKNLNAENLQRRAIATRYLAEITNPKITLPFWDTSAQHVFHLFVILVENRDHFLSY
LKKSEVGFGVHYAIPPYQQKALKAYNHLNFPLAEKVAQTCVSIPLNPTLNAEEVTQIISI
LNLYNA
>KECLDBNJ_01658 hypothetical protein
MSQYQIISYSREYKSRWDRFAASLNGTYKGSKNTSFLFQRDFMQYHQDRFEDFSLLIFKD
EKLRAVLPANRVGATLYSHQGLTYGGLVLDAEIRLKEVLELFKELLGFLSQSGIEELELK
MLPQFYQELPGDELDYFLFLTEAKLIKAETTAVIDYRNRIPLNSSRKNAVNQAVKAGFTI
QKTTDFEPFWDQVLIPNLEAQHDAEPTHSLAEITTLAKRFKYNIHQFQVRDAQNQLLAGA
TIFETQVVAHVQYISATPEGKKQGALDFLFQQLIEFHFSHKWYFDFGTSNEQAGTKLNAG
LQFWKETFGARTRIQRTYRLQTKNSFKLENVLL
>KECLDBNJ_01659 hypothetical protein
MKFNFFAVLASLLILCACNADDTEITTTTAALQVAINDTLIVAQRDSAPIEGGREVSVQP
EHGEVLLDAFTIKYVPGVDFTGEDYLEVTNKASNGDANFYITSIDKYTITVTE
>KECLDBNJ_01660 GTP-binding protein TypA/BipA
MDIKNIAIIAHVDHGKTTLVDKIMYHCQLFRENENTGDLILDNNDLERERGITITSKNVS
VTYKDTKINIIDTPGHADFGGEVERVLNMADGVLLLVDAFEGPMPQTRFVLQKAIDLGLK
PCVVINKVDKENCTPDEVHEKVFDLMFELGAEEWQLDFPAVYGSAKNNWMSEDWQKQTEN
IEPLLDMVMEHIPSPKIEEGTVQMLITSLDYSSFTGRIAIGRLQRGTLKEGMQVSLVKRD
GSIKKSRIKELHTFEGLGRIKVAEVQAGDICALVGLEGFEIGDTVADFENPEALKTIAID
EPTMSMLFTINDSPFFGKDGKFVTSRHIKDRLTKELEKNLALRVEETDSADKFMVYGRGV
LHLSVLIETMRREGYELQIGQPQVIIKEIDGVKCEPVEELTIDLPENVSGKAVEFVTLRK
GEMLSMEAKGDRMVCEFIIPSRGIIGLRNQLLTATAGEAIMAHRYKEYQPLKGGIPERLN
GSLVSMEKGTAIPYSIDKLQDRGRFFVDPGEDIYEGQVIGENSRQDDMTVNITKTKKLSN
VRSSGADDKAKIVPAIKFSLEEALEYIQKDEYVEVTPNHLRLRKILLTENERKRSKAI
>KECLDBNJ_01661 2-dehydro-3-deoxyphosphooctonate aldolase
MKLSNIPKIKHTDGNNFFLLAGPCAIEGEEMALRIAEEIVSITDKLKIPYVFKGSFKKAN
RSRIDSFTGIGDEKALKILRKVSETFDVPTVTDIHVNEDAAMAAEYVDVLQIPAFLVRQT
DLVVAAAETGKVVNLKKGQFMSPEAMKHAVTKVTDTGNENVWITDRGTMFGYQDLIVDFR
GIPTMKSYAPTVLDVTHSLQQPNQSSGVTGGRPELIGTMAKAGIAAGVDGLFIETHFDPK
NAKSDGANMLDLSLLEGLLTKLVAIRQVVID
>KECLDBNJ_01662 Thiol-disulfide oxidoreductase ResA
MKHLRLSAFLAFTALSLLSCSDEPKETPLSIGNLELSETKPSPGDSLKIAYTSKDSLVPE
AFYVYTVASSAYPVDLNLVKDGERFTDAIKIPDSADGLIFHFKNGEEYEANGEKGYTVNL
YDAEGEMLPSSKVAIAHYISGRGSYYGIKTESDSTLAAYTQALENDAASSEDWLLPQIYL
MSRSDAEQANTLAQKTIDSYSGKTLTEKDYTTLFRLAQFKKDQPAQDSLLAILKTEYPKN
TWVLNNYVSQMRQAKSVDEQLEILDDFNENSGADGTQKDFLYRTIATTFLENGNIEAYTE
YMDKASDDMSKASILNNLAWERAENGEELEVAETMSKQSLDIIDAQKSDKPDYYTAKQFE
KSLASTKAMYSDTYGLILFKQGKVKEAIAAQEVAVADRATADVTERYLQFLTADEQYDKV
VEKATEYIKDGNGTSATKEYLKTAYTASEQDEDFENYLSGLEKIAHDNALAELKKEMIDE
EAPTFNLKNLNGEEIALTDLKGKTVVLDFWATWCGPCKISFPGMQKAVTKYADNDQVEFL
FIDTWESTSGEAREKGVSDFIASNAYTFNVLMDTPKEEGSREYDVVSAYEVDGIPTKFVL
GPDGKIKFKAVGFDGNTDGLVEELDMMIALASGQ
>KECLDBNJ_01663 hypothetical protein
MLLILRGFNIYGETLPWEQQQTVLETVSSFLNFTKYPPSLDFILLTLGVGALLLYVFERF
EHRWMLVLKTFGSVPMFFYIVHLYVLLLIYVVGVQFFGTNKGDYLGVDHVWMVWAIAAVL
AFLLYWPTKWFSAYKKASSATWIKYF
>KECLDBNJ_01664 hypothetical protein
MTPENALNAKSKRIHAIDILRGLVILLMLVDHTRERFFLHEQVTDPMQIDATSTSLFFTR
LTAHFCAPIFVFLTGLSAWLYAHPRQKPQRSASGFLFKRGLFLILLEVTLINFSWFGSYQ
ALYLQVMWAIGLSMIALALLVKMPRYLIGVLGLLIVFGHNALTPISFTPEEWMYPIWTIL
HDRGYLIQDAMIPVKISYPLLPWIGVIAVGYFAGPVYDAALQVQQRYK
>KECLDBNJ_01665 hypothetical protein
MNPAAHYILSKPEPFKSILLQLQLLVEHTVPEAELLYKWHLPFYYLNGKMFCFLNFRKRF
VDLSFIYGNELIDLEKHLVAGEGRKRLRSLRFDITEAIDAEVVISFLEQAKKLR
>KECLDBNJ_01666 hypothetical protein
MIKNYIYSSLLCTFMFPFLSFGQNKDKPKLELGGALRFNYIYSSWKEEQKTKGGELGYDM
FRINAKASYKKVFLNAEYRLYSDAFGGGFLKQGWVGYKFSEKNEVHAGLVYVPFGIKQYN
SHNWFFNITYYAGLEDDHDMGLKYVHTGANWDYAVAFLKNAEELNFGGDVENSSSRYSYD
IVGRNKETNQFNLKLVRKLGNAAKHRIGFSGQYGSLYNIDTDTNGNHYALALHYEVDYNS
WNLKTEAITVAHNPENETGQSNAIVQMGAYGTPYEVAADFNMYTAALSKTFKVNWGPISQ
LEVYNDFGYMQKKEQEFTDSFQNVTGVLVTAGQVYTYIDYAAGYNHSWLGGNFIDDFSTG
NLDAKWEARFNINIGYYF
>KECLDBNJ_01667 Glycine betaine/proline betaine transporter BetS
MAKKITRSDEKKSIFGLEVNGPVFFTSAIFIIISIALTLIYEKKAEKIFADIQHAVAEKA
DWFFILTINLFLIFLVYLALGKYGKLRIGGQKAKPEFKTMSWFAMLFSAGMGIGLLFFGV
AEPVKHLMSPPTAEPNTVAAAQEAMNFTFLHWGFHAWAVYALVGLALSYFTYSRGLPLTI
RSIFYPFLGDKIHGKIGDAIDVFAVLATLFGLATSLGFGVQQIASGLNHVFGLPDGILTQ
VLLIAGITLVATTSVVLGVDKGVRILSEWNMRVAVVLLLLALILGPTLFIFRSFVENTGS
YLFNFLKISTWSETFSGTSWQNDWTVFYWGWWIGWSPFVGMFIARISKGRTIREFILGVL
LVPSLVTFFWMSSFGSVAIQQALGGDMTIVSAVKDDIATALFVFFEDYPLSMIINIVAVI
LIAGFFITSSDSGSLVVDSLTSGGKIEAPVGQRIFWAVTEGTVAAVLLIGGGLEALQTAT
IVTGLPFAIILLIMCYSLYKGLREDLQKLEKKKSEKQMDDYEEVVKEIVARRNKTE
>KECLDBNJ_01668 hypothetical protein
MDRIKNILVALDLSALDNHLIEYSAFLAEKLNVEHVYFVHNIKKYEISALFEEELSKLNL
DQLIGDELNDKIEERFTGSMSWEVLISEDSNTESLIHYIVNKYQIDLTIVGNKPAKEGTG
VVTSKLLRLLKCSILSVPEAAPLKLDNLWVGTDFSNPSKKSFAFAENLRHQPSTQLSAVH
IYHVPMQFSPYVSSEDAVKKIEKHLEQKSAKFFKKSTSPAPDHSQLLFAKDKSVGDKFQI
ELQKQKPDLLILSDKGSNNISSLLIGSLTEELFDELFSCPLLVVK
>KECLDBNJ_01669 hypothetical protein
MKDRDYLNDISEIKTMMSRSSRFMSLSGLSGILAGIYALVAATYAHFRIAEVSAYTANSN
AGKAIGRFLLSYDAIGDLMLAALLTLALALLTGAFFTIKKAKKRNEQLWNPISKRLLFNF
AVPLVAGGLFCLVLLQYEFIGLVAPTTLIFYGLALLNASKFTVGDIKYLGLANLMIGLVA
TQFIGFGIYFWALGFGIFHIIYGIILYNKYDK
>KECLDBNJ_01670 hypothetical protein
MKNIIQHINKAFDHRVRLGIMSILMVNEYADFNMLKELLGATDGNIASHTKALEKEAYIK
VKKSFINRKPNTRYSTTTAGREAFSKHIEALEKLINP
>KECLDBNJ_01671 Inner membrane protein CreD
MQHQETPSNKIVQWIKTSITARMAMVGFLTLVLIIPLVFVQELIQERARRQQEVIAEIND
KWGEELLVYGPILKIPYKSYTEKAIKNTETQTLTTETVTQTNYACFFPETLDIKSAVNPE
VRNRSIYKTTVFSATAALEGTFSMPDFTEAGVQPEDIEWENARIILKTSNLKGVSEAVRI
KMGTSAYDFVSQYDSAAAHRTLDEVPLHLVQSAFLKTKDVPQEEKIPFQMDLKINGSEQI
RFVPIGKSTSATITSTWKTASFIGDFLPHNTDKFTAAGFNAKWNVLDINRPFSQQFFNTL
PNLTAYAFGVNFMIPVDHYQKSERTAKYGFLVIGLTFLIFFMIQTLSKIGIHPFQYLMIG
IALVLFYTLLIALTEHSNFLTAYLISGSMVIVLISLYTYSILKHLKFALFIAAALTLLYG
FIYVIIQLEQYALLVGSLGLFTILALVMFTSRKIDWNS
>KECLDBNJ_01672 hypothetical protein
MKSYFTRFYIHVRRNFWHALFYLFCRYTLALGFMLAGYVKIIDERFASGLSIKHPMGAYL
EALHHTGFYYPFIGVIQIIAGILLIIPRTVVLGGLLYFPIILNIWVLSWAVRFEGSLFTS
TLMVLANLYILLYNYERLKFILPLPSKALNYNAPLKASEVSETSTLAPDQPLRFTPGIAA
FKNPAISKKFPFVFVGMVLLIAFLTLLSTNRIYEIMPRNSYNDCITRLPAELEENAASFD
FCNCIHNQGKPLEECITEFDQNKNNGNPPVSSP
>KECLDBNJ_01673 hypothetical protein
MKDFIITKYDTLKYLFGALLLCFCLLVFRIKTTHDFFGLFLIWNLFLAFVPLGIAWYLQH
KRLHINSVLKYALLVLWLLFLPNAPYVITDLIHLAYSPLNWFIYDGITIAVFALLSLYFG
FQSLIEVRKLFKPEIAEARLNIFTAGILILCGFGIYLGRVVRFNSWDLITNPLDVFSTIG
HYLINPIENKSVWLFTLGFGIFLNFFFFLFKMWQQNGLLTKSYTS
>KECLDBNJ_01674 hypothetical protein
MPKRGIYFLLFLLLLGVEIAIANFLKTGFIRAYLGDFLVVMLLYCLLMSTLKPSVKTGLV
LTLAIAFAIELLQLVDLTRFFPQEYKQFATLILGSQFSWLDLLMYLLGITCAGITEVVLH
KRYSFPST
>KECLDBNJ_01675 hypothetical protein
MAPLKFALLRERKTPPDRRAVLSPITMSKAQEAFPKASFIVEASPIRVFPDVAYEKAEFE
VKEDISEADVMLGVKEVPIEALIPNKKYFFFSHTIKKQPYNRDLLKAVLEKNIELYDHEV
ITRKSGLRLIGFGRYAGLVGAYNAFRAYGKRHKTFDLPPANTLTDVSALIAQLKKIELPA
IKICLSGSGKVAGGAQEILEAMGIKKVTIEEYLTKEFKKPVYCKIGVMDYAKRKDGVKGS
LAQFIKDPTGYETNFLRFAKVSQVFIAGHFYGDGAPYLFTRGEAKSEDFNIEVIADISCD
IDGPVASTLRASTIADPFYGYDPQTEKEVAFDAPGAITVMAVDNLPCELPKDASEGFGEL
FVERVLPAFFNDDKDGILYRARMTKDGKLTKRFSYLQDYVDGKE
>KECLDBNJ_01676 hypothetical protein
MKKLVGLGVVCALILSSCGANKSKIKGDRDVISVNGTLQTGINTIEIDDEIQVELVQAQS
NDYILTTDRNLVSVVDFKVTDSVLRISTNMEVTSSKALSVYLKLQNPKHVILKNDSDLET
PGQIEVPEFTVTAASSSEIDVNLTTTKSQINLRENANGQLNIRTEQLEVKMSDRTDLRGK
FTAQSARVTMGGSAEFNPRGKTASLNLALTGKADYKGDDFDSKNASATLSDRSNAAVSAE
ESLSVFAQDKAVINVYGKPDISVKALNDDAQINKK
>KECLDBNJ_01678 Ktr system potassium uptake protein B
MKNLLKRYRKFQLRLSPQQNLLYGFLTYTVLGWTLLCIPFFHKQTISALDNLFIATSAIS
TTGLVTASVFDTYNGFGQFVVLLLFQIGGIGYMTFTSFILLSRKSPLTHWHQRVLSAEFT
MPKGFEIKDFLKSVIMFTLIIEVVGALCFYIAFTQAGVDHNFAIWSSIFHSVSAFCTAGF
GLYNDSFEQFAGNTSINIIISTLAICGSLGFIVVTDLWNKITRKSHQITFTTKIIFAAIT
LLLILGTLVIYFFEPTVVAFEENRLMASFFQSMTALTTVGFNTLPIGSFSLSALLITILL
MYVGASPSGTGGGLKTTTLTALIAVIWNRIRANKQVTFFGRVIPKERLSVATSTFILYAT
VLFAATFLLTLTEDLTLEQILFETTSAIGTVGLSTGITGTLTFWGKVVLIFVMFVGRLGI
LTFGLALLARRKKITSVAAEGDLAV
>KECLDBNJ_01679 hypothetical protein
MSNRLIISEKIAHTLIQVCQDVKEFLRLSELHAEPVKINLGLALFSEESSGGIIEFLNTE
NKTEFINKTQLIIKHVEMLGKHYKELIGDPGHKDKIQAQLYELKYHLQELIMEVQAI
>KECLDBNJ_01680 hypothetical protein
MDYLEVLTVFSDPFNQVSVKKITPYFLLCYLQHKVQGKLISKKSKLARLK
>KECLDBNJ_01681 Transcriptional regulatory protein KdpE
MNKAEILVIDDEPQIRKLLQINLESHDYKVLKASTAKEGLILAASHPPDLILLDIGLPDK
SGHQVLQDLREWYTQPVIILSVIDSEDDIIAALDNGATDYLTKPFRTGELLARIRSALRR
SNQSENNAVLSIGNITLDLVARSVTRNDIPIKLTATEYKLLCLFAKNEGRVLTHQYLLKE
IWGMGYVTETQYLRVFVGTLRKKIEEDANNPLHILTESGVGYRFQ
>KECLDBNJ_01682 Sensor histidine kinase ResE
MLILKTRVYSQRTQYFIALIAVLLVGSICFPFAGLIGYRAVALILLLVVSLNAILFDILP
VMLSALLSALFWNFFFIPPIWYLRIATPEDALMFLMYFVIASINAVLTYKIRQVERNERD
QIEKEKAIKLYNTLLSSLSHELRTPIATIIGSLDTLRDQQIKLSTTNHEALYTEIEIASF
RLNRQVENLLSISRLEAGFLQPKYDWIDLNELIFKTVKLSKDDGFTHQILVNTQDDIPLA
KLDPGLLEHILYNLIHNALQHTPKQSIITIDQTISSTHCIITISDNGSGFPEHEIDKVFE
KFYRIANTSVGGTGLGLSIVKGFTEAMNGKIYLKNRKQGGAQFTLEIPCEFSDSLNLEHE
>KECLDBNJ_01683 Beta-galactosidase
MIKQPIMNFKKTTKILGLAISCLFLACAPTAKNDLSSTLFTLQNVDGLAISSLDDAKNET
FLFLEKTEKVSKSQAWQFYKIQDNTYSISNPFTHKGIDNFNRGSSDGNPVILWDTDSHNP
NQQWELKPLDNGRYYIVQKNTGMYLASVKNKKGELQLMQLPDVKQEWILKPSKLPMPKPQ
PLRGENEWENETIFSINKEEGHATYIPYSSVAALQSDLYYQKPWVASNSDLYHSLNGMWK
FKWVKNTTERPLDFFKENYDTSTWEELPVPACWQMYGYGTPIYTNITYPFKNNPPFIQAK
EGYTNAEETNPVGSYKRTFSIPKNWNEKEIFIHFDGVYSGFFIWINGKKVGYSQGANNVA
EFNITKYLNPGENEVAVQVFRWTDGSYLEDQDMFRMSGIHKDVYLFATPQVHIRDYKLQA
DFLQSALTSSRFSANIEISNVSKTTSAPCSVELQLLAPNGSSVLTSTAMIKSIKQQSKQK
LTLEGTVNKPLLWSAESPELYTAILVLKNEDNQVTEVISSKFGFRKIEIKNNRVYVNNEQ
VFFKGVNRHESHPKYGRTVPLNTIIKDVELMKQNNINMIRTSHYPNQPRSYALYDYYGLY
IMDEADIENHGNHNISNNPSWVPACKDRVQRMIARDKNHASILFWSMGNEGGNGANFDSI
ARLSRAIDPTRPVHYEGRSSSADMDSQMYPSLEGMRKMDRNGTQKPYFICEYAHAMGNAM
GNLQEYWTYIENDSERLIGGCIWDWVDQSINRPIPLKGNHTTLENKRSTKGTVPIAYQKT
DPTLDPEKIYYYGGDFDDTPNDADFCVNGIITPDRGATAKLKEVKKVYQYIKVKPQNLDK
GLLLVENKYDFTNLNTFDISYKLLEDGQLVQSGELAKLDLKPNEKGQLKIPLDFNRKEQA
EYLINVQFALAQNTPWAKKGHVVAEEQIALTSKPIYKYTPEDKILGAIELSKNDKYLTIK
GASFSTSIDTTTGIITDLVYNNKPVIYKNAGLKLNWYRSIGNDKYADQNYYSTQYDLQKF
DYEVLKNNTGVHILTEVYATLDNDKNTKIPYKLSYTVYADGTIAIDGIFETPPAEQVIHR
IGLQMQVNPDLEAVSWYGRGPHENYQDRKTAAQLGIYNLNVNDFASEHYTRSQSMGNRED
IRWITMTDKTNSGFKIQSNNQLSFSALHYDDASLWNAKHDFMLNTIQKPQTFLNLDCLQE
GVGNATCGPITLEKYRIPANKTLSYSFTIAPLEP
>KECLDBNJ_01684 Spermidine/spermine N(1)-acetyltransferase
MQHITIRKITGADVIELQRIGKQTFSETFASVNSEENMREYLSIGFAKEKLLIELNNQNS
EFYFAEVNGKIIGYLKINMGSTQTEIKDEQALEIERIYVLKEYQGKQIGQMLYNKAIELA
RAMQLKYVWLGVWEENLRAIRFYEKNGFKTFDKHVFRLGSDEQTDIMMKLELKYS
>KECLDBNJ_01685 Quaternary ammonium compound-resistance protein SugE
MNWVILIIAGLFEVAFAFCLGKANETSGNEMYIWYSGFLIALVSSMLLLMKATQTLPIGT
AYAIWTGIGAVGTVLVGIIIFKEPITLLRLLFLTTLIGSIIGLKVVSPH
>KECLDBNJ_01686 hypothetical protein
MDIDKILDKIYPIRTLSKLKLIECFKEVRHPKNHVIIHSDKVEKDVYFIKKGIARTFSDF
LDGEVTIAFGEEGDTIISLKSYILNQSGYENIELLEDCELYKISVAKLQDLFSTDIHIAN
WGRKFAEQELIKAEQRFISNQLGTATERYLELLKKHPTLLQRVSLGLIASYLGITQVSLS
RIRANIK
>KECLDBNJ_01687 hypothetical protein
MTMNKKENTASLEIFDINTASEKSKTLLQKSKDAYGYIPNLHGVLAGSPNLLEAYQNLHE
LFANSSFNKEELTVVWQTINVEHECHYCVPAHTGIAKAMKVDDAIINALRDQSELPTKKL
QVLHNTTLALTRNRGYISEEELNAFYEEGYTQRNLLDIILGLSQKVISNYTNHIAETPLD
DAFQKFSWSK
>KECLDBNJ_01688 HTH-type transcriptional repressor ComR
MARLKQYNEEDVLFKAMNLFWKNGFEATSVKMLESELGINKFSIYSSFGSKNGLFLSSLK
CYKKELFKLLKPLATDGVGASAIKNYFYDFIEFSKEKEFGKGCLITNTANEMNANTALDI
KNYINSFTMDVKQVFVEVLNRDAQIMKEHIPEKADYLLLAMFGLSSASKMFNRSQLGNFI
EYTFKTI
>KECLDBNJ_01689 Alpha-N-acetylgalactosaminidase
MNSRRTFIKGTAVVGAGISLAPHLVFPLNAKPLAEKLKLGFIGVGLRGTNHLNNAMRRTD
TEITAICDIDPKRIEIALDLIQKDGRKKPLVFGKHEEDYLNLLDSKEVDAVIIATPWLWH
TKMAVAAMKAGVYAGLEVSASQTIEECWDLVNTHEATGTHMMFLENVNFRRDVMAVLNMV
KQQVFGEMIHYRCGYQHDLREVKFNDGKQPYGGGVEFGEKGISEAKWRTKHSVHRNGDTY
PTHGVGPIAAMADINRGNRFVSMTASATKTVGLHNHIVAQAGAAHPNAKIKFKQGDVITS
TIACANGETIIVTHDTNLPRPYSLGFRVQGANGLWEKDGDRIYIEGKSEPHRWDDAQEWL
TQYDHPVWKKYEAEATGAGHGGMDYFVMKAFVESALANVAPPIDAYDAAAWSAITPLSEA
SIANNGEPQEFPDFTRGQWVARSPYNWMKEEYGE
>KECLDBNJ_01690 hypothetical protein
MLRPFIDAHVHLNTNTQAKLQLAAQYDAYFVSINTDIPFFIDLQAQQEMITTLNKSAQRS
FFITSFDTQYWNTPRWLPHAMEQIKAGIAAGAKGVKIWKNIGMDENLKDAQGNFVLLDDA
RFDPIFQYLSDAGILLINHQGEPRNCWLPLEEMTVTSDRNYFAAHPEYHMFKNKHYPSYE
THMAARDRVLERYPKLNYVGLHLFSMEYDLDEVAKRLDRFPNTKTDLAERICHVQLQAMQ
DWEKVRQFFIDYQDRIIYGTDVIDDGSTSAEAIAAKLEQLWQYHWEFFATDHIMEAPAFT
GSFKGLNLPQPVLKKIFYSNAVATYKLDLHQANF
>KECLDBNJ_01691 hypothetical protein
MRKTIIYSFIALSVVLTGCEKDNFDEPAAILEGQITYDGAPVSVRSNSAELELWQDGYAL
NEFIPVYIAQDGSYSVSLFDGAYKLVRKGGDPWQPQLTDTIVINVNGRTELDVPVTPYIT
LTDASYTVSGSSLSADFQINQVVSGSELQEVFVFMSNSVLLDRNINDYAEALPVEALSFG
SPASVSVSIPEDLQNAEYVFVRIGARSSNSNELIYTQAEKIEL
>KECLDBNJ_01692 hypothetical protein
MKIKIVHFLCLAMLVACFSCDNDGWLERDPKNIIDDDQLWNDPELVVSLLANYYDRIPSM
HGVFYSGGMAEIDDAMWSGHFDQNWRNDFQYGNDYGRYWDYTFIRDINLALENLEEFGTE
ISDTQKAQFNGELRFIRAMVYFEMVKRMGGVPLVTEQLIYDYSGNPEYLQVPRAKEYEVY
DFIFEEMEAIKGNLSGNEGSRTRANRITALALESRAMLYAASLAKYNNLMDTPITLPGEE
VGIPASMATGYYEKALAASQEIIEDSGYALYNQNANKQMNFYEMLMDKASSEIIFAKDYE
TSLKTHGFTFENIPRSLTDDNEYPTNLTPSLNLVESFDYLDGSDGTLNIEDTDGTPIVYD
EITGIFDNKDARLYGTVIYPGTEFGGSPVKLQAGVAVYQESGAYELLTAQELGSTYDDGG
LFTGADGPQDNAQFVSNTGFYMRKFLSDASGASLRGVASQNWWPWFRLGEIYLNAAEAAF
ELNQPAVATGYINTLRERAGFPENSIATVTLQDIREERRTELAFEDHRFFDLKRWRIAHE
VWDGDESNENAVVYGVFPYRIVRPGHPDNDKYIYQKLRPTRFRRARLFRFANYYASIDQG
VLNNNPKLVRNPFH
>KECLDBNJ_01693 TonB-dependent receptor SusC
MYNVLKNPKRFRLRYLFLLCLFTAFAQAQDRQISGTVYDDTGMPLPGASVLIKGTSNGTV
TDFDGKFNLSISSTLADGVLLISYVGYQPQELPVTAEDTYEATLKTDEEALDAVVVVGYG
TKREKDVTGAISTIDTEDITRTTSTTTAGALAGKIQGVSVRAQDARPGRGAQLEIRNLGN
PLYVIDGVPYGGDMGRDWVQSTGNSGNDMFNSLNPEDIESITILKDASAAVYGMRAANGV
VLVTTKKGKNNDKPRISISSYYGWQNLTRFPELANAAQYTRGLVEAAQNEGRDPNTVYTP
EELQKWQEGTEPGYQSYDYYDFLMRDNVPQSHINASVSGGTDKTNYYLSLANTNQKALLD
DFGYERTNLQANIESKIANSVKVGAQISGRLEETRDVGLPGGDGYFSAILGVFSNLPTVP
PYANNNPEYPNQTRDFARNPALFKRDIVGYKDNFARNLNVNLFAEYEFGFGLKVRGTHSY
NFSNNKFDGFQYTYDVYTYDEANDTYNATGGADGGWRFQTEREDISTFSQIKLDYAKTIG
DHKFSIMGAFERSDFEQDYLQLGTNPSNNYLPLLEFDQLNSFADSWNYQARAGYIGKLNY
SYKDKYLVELLGRYDASYLYPPGERWGFFPGISVGWRISDEKFFEPLTDVINDLKIRAST
GQTGQEQGVGMFDYIGGYTWNNGNAVLDGNYTTGLRPRGLPITNLSWVTNTNSNIGVDLS
MFKNKLTLTADVFRIRRTGVPAPRYDVLLPSEVGYTLPNENLNENGYNGAEGIITYRGSI
SNDFQFSVSGNMTYSRYKNISTYKPRFGNSYNEYRNSIEDRWGGVWWGYQVVGRFESEDQ
INNYEVNIDGQNNQTLLPGDFIYKDVNNDGIINYMDERPIGYPTNWSPILSYGGTISMNW
KNIDFTVDLAGGSMQSWFQDYELRNPFHAGGNSPAYLLTDRWHRADPYDPNSEWIPGKYP
ALRNGNVGPNARNSDFWLTNVWFLRLRNIELGYTFPESWVSKINADRLRLYVTGSNLVSF
DNVKEYGIDPEISASGAVVYPQQKTVVVGVNLTL
>KECLDBNJ_01694 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MPLSIRFCLIVLLLVNCAVVAQQPADDILLADPTIFEEDGIFYLYGTKEDAAIPGAGFLV
YTSTDLEYWSGPAGATDGYAFKKGAGFGTKGFWAPQVFKHKERYYMAYTANEQIAIATAD
SPLGPFTNSGTALAASVKQIDPFVFFDGGKAYLYHVRLQEGNRIFVAELTEDLSAIKTET
LNECLHATTGWENTQNTDWPVSEGPTVFKKGTTYYLMYSANDFRNPDYAVGYATATHPLG
PWTKYKGNPIISENTTQQPGIGHGDLFTDQNGMLRYVLHMHNSKNQVGPRKTGSVQLRFK
DGILELVPDSFKQIKL
>KECLDBNJ_01695 hypothetical protein
MNILYLHGLDGSLSQPKRSILEQYGAVYAPQLDYRNESNCMHLIYEQFKDHNIDRIIGSS
MGGYMGYYLSNALNCKALLFNPALAARPVEQERMDFDPPSQTKMLVLGAEDTVVPPKQTL
QILSKQALCCDYHISIQQGLAHRIPITTFETAVQRFFTDL
>KECLDBNJ_01696 Non-homologous end joining protein Ku
MRSIWNGSISFGLVSIPIKMYSGSEDRKLDLDMLDRHDNARIRYKRINEDTGKEVEWKDI
VKGFKQDDGYVVLEKEDFEQANLKKSKTIDIEEFIDEAEVADVLFKKPYFLEPQKEGGKS
YNLLRNALKKTKKLGVGTFVMRQKEHLSLVGVYNAALVLHVIRFEDEIRDPGELKLSKTK
VSKKEVDMAISLIENYTEAFDLTKYKDVYNDQLMKIIKSKSTGKVKEPQKFETKPTPAKD
LMAQLKASLEKKKKNKAS
>KECLDBNJ_01697 Multifunctional non-homologous end joining protein LigD
MGLEEYKRKRDFSKTPEPAADIHSKSAGRFVIQRHRASRLHYDLRLEFDGVLKSWAVPKG
PSLNPADKRLAVQTEDHPIRYLTFQGTIPKGNYGAGKMTIWDEGTYTIAPGYPEDALKQQ
FEKGDLKLLFFGTKIKGTFALVHTKRKNADNHWLLIKKQDSYATNLHYDAELLANRDPAS
DTTLVPTQKLTPFQFIRPMLASTTKTIFNDPEWVYELKWDGYRVLAHIKDGKVHLHSRNG
INYTTTFDILKQDLESVEHDTILDGEVVIVDAEGLPQFQALQNYTHTTSGTLRYYVFDML
HLNGHDMLNLPLLDRKSLIPEVIAGCESTLYCSHIEDMGAALYKKAVDAGMEGVIAKHKQ
STYTPGYRSEKWLKIKHRLTEETLICGYTESDSSGKLFGSLILGMYAEDKLKYVGNCGSG
FNTQEQHWLMKQLKKLGVAENPFGKKINLKGRKPNWTSPQLICEVHFSEWTSNRIMRHPV
YKGLRNDKIPHEIHIQKPHSAAKQTQSSAETGLDVGGHQVKFTNLEKIYWPASGFTKYDL
IDYYIQVSEYMLPYLKDRPQSLHRHPDGIDQKGFYHKDHDHLPAWMDTVSVFSKSSDRMI
NYLLCQNEAGLLYMANLGCIEINPWNSRVGKLEKPDYAIIDLDPSDTNTFEEVITVAQAV
KEILDQAGIQGFCKTSGSSGLHIYIPLAAQYSYAEARNFTKLLCMYVEEKVPKLSSMART
IKDRKGKIYLDYLQNRKGQTLAAPYCVRPKPGATVSAPLEWKEVKAGLQINQFTIKTMLD
RLAEQGDLFAGVLGMGIDMAAALKKLDTA
>KECLDBNJ_01698 Putative xanthine dehydrogenase YagT iron-sulfur-binding subunit
MNTNPVHFTLNGKPVKISIEPWTTLLDYLRYHKKLVGTKKGCDHGQCGACTVLVDGNSVN
SCLCLLVSLDGKDITTIEGIGTADNLSVEQQIFIEEDAYQCGFCTPGQICSTIAMRNRGE
INSEEELKDWMSGNLCRCAAYKNLTKAARRIYKES
>KECLDBNJ_01699 Putative xanthine dehydrogenase YagS FAD-binding subunit
MKPFQYTRLSTQDLASGTTLRDSTILAGGTNLIDLMKYGVEKPDRLADIGKLPYAQIEES
DEGLLLGALVTNADTAYHSAVKKTYPLLHKAILSAASAQLRNRATNGGNLLQRTRCYYFY
DTAMPCNKREPGSGCAAINGFNRIHAILGTSASCIATHPSDMCVALAALEAEVHVLRKGA
TLVIPFDQLHRLPGDHPEKDHNLEPGDLITHIQLPTEGFSDHFEYLKIRDRESYAFALIS
VAACLKVSEGKIEDIRVALGGVAHKPWKLKKVEKEMIGKVASTDNFQFFAERLIQGAQSF
GTNDFKILLVKRAIVRALNSALNPS
>KECLDBNJ_01700 Putative xanthine dehydrogenase YagR molybdenum-binding subunit
MLNIGNKQTRVDGPQKVTGKATYTADIAAPFYHAYVLQSTIACGSITAIDTTAAEAFEGV
KAIFTHLNLPERLKNKVDYTDPLAPPGKPFRPFYNNTILYNGQPIALVVAESFEQARYAS
KLIKVTYEEKKFKGSLAENLKNASADRAPEPAKNRGDFTKAFKNSDYTIIREYRQSRNYH
NPMEPHATSVEYNSDGNIVVYDKIQGVASSLKYLKGVFGLGADSVRVKSDFVGGAFGSGL
RPQYQLFMATLAALELKHNVQMVMTRAQMFSFGYRPEVIHTMKLGCSKDGTLTALSHKTV
GETSTFEDFNETIVDWSGLLYKCDNVNLEYELTPVQSYTPLDMRAPGGVSGVYALECAID
ELAHEAGIDPLEFRRKNYVDYDQNENKPFTSKELKACYARCEEVFNWNNRKSLAKTDPHL
LLGYGMATGSWEALQQPASVALSMNEMGTFTIKCATADIGTGTYTVMSQIAADKLGVSLD
KIKFKLGDTAFPDSPIEGGSWTVSSVGSAVAAICEKFQYRIFDVWKRNNPEYQAVAFEAI
SFQDAKLKYGSKTFAFTEIMQQASKDELSIAHSEAPADGQDTHSGYAHCCVMVEVTVDKE
LGIIKVPRLVNVSAAGKIINPKTAENQLLGSMIWGLGMALREEGMVDSRYGRVMNANFAE
YHIAVNADIHDIHTEFVEEHDDKVNPLGAKGVGELGIVGLAAAISNAIFDATGKRLRKLP
MLLDDVLEV
>KECLDBNJ_01701 hypothetical protein
MTPQLQLPSKVALHEALEPLTESLLQVAPVQALYLSVIRQTPDAIYNLLIVVQEAGALTD
LQQQIPVLHVQFPLVRMQVYTRKQLQRLVQEGSVYGWWGYHLGDRIYPRTATETFENCSE
RQLEQLHLKAQQQLEQDAACICKGFDTAVYWFERKDYAASVLALVEVFKTCLALAGKWYT
GRVMEYPSLEAQLVAVRPFLPQLRKLFPTPEAPDADPTLLELLDVWSADGVPKDEVIDRH
TCYQIQMCMERVFTVVDTAARELLEACSPKPTPPEAASPVGATRSPLEQALQEALNYLRE
TYRVHSAYLLYSAQDSRVQAVHCFSATEIQEHQSTAVVLLVTYKSVGVSPSQLTDRVYNQ
TGRRIRICFILETVKRAHKALDFGSNFLQKALGEGKPLCAEDDRLRGFLKQGYLYHSQQV
EKLQKYWDLRSNRAYYLIESTRILDTREDALVQLHMYEEALIQTCLGLIRLFWEYSPAYT
SLNYLLALCRSFTSFPSTLLETTSFKARRRLHLLSHAQQHLRYGSTYTVTDTDANAAYHL
CKRFMQQAEALAAERLHFLKRKAYQREVD
>KECLDBNJ_01702 Antitoxin HipB
MTKDALKKKVGNRIVKLREQKGWTQSDLARECGKDRQAIEKLENGKVNPTAYSLFEISKA
LKIELYQLLKF
>KECLDBNJ_01703 hypothetical protein
MTKRSKTPWPTKDAMQQVYAKKLWGSGNTDFFSGEGSHDTETVQAYLKAVIGFFKNLEAP
PVVCDLGCGDFNVGKELVPYTQAYKAVDIVPELIAHNQKTFTSKQLMFHTLDIAKDTLPE
GDCALLRQVLQHLSNAEIQAIVNKLYAYRYVILTEHLPDQEFTPNIDIISGQGIRLKKKS
GVALQAPPFNFKVKAAKELVSLPAPGVKGRLVTTLYTVV
>KECLDBNJ_01704 hypothetical protein
MDFFNLPNQSKVARVIPKNAFDEYTSTKQKRLLTDLVLRITWTHKLSRETINLEAKEILE
IQVFKVELKQKADISKILDIIDKAIPYHIVFWIEFKQQAYLSSALKHSHPNSDDISVIDW
RFNCHWFNIDTNTYVFNLNKSIDAVFKNMCVQLTGKPLFDQKPFSLILKNEKEINRLENE
IDRLKKSLRQAKQFNKKVELNIELQSKLELLKQVESRTF
>KECLDBNJ_01705 RNA polymerase-associated protein RapA
MKLIDNVNTRLGDDLKDSIKKGSKLSIAASTFSIYAFEALRKELNRVDELRFIFSSPTFI
EEKFQKESRKFYIPHIVRESELCGGEFEIRLMNQLNQRAIAKECSKWVKEKVTFKSNKHN
NQPLNGLIHLKQDEKNAQAYTNVSGFTTSDLGITHKKGFPTLIQKSEYPDSKAYLDWFDQ
IWENEEDLKDVTEKVQQYFESAYKENSPEFIYFITLYNIFNDFLDDLSLDNLPNEQIGFK
DTLVWSKLYNFQQDAVIGAINKLEKYKGCILADSVGLGKTFSALGVIKYYEMRNKDVLVL
CPKKLEANWNTYRHNDKNNILAADRFRYDVLFHTDLSRERGMSNGRELANVNWGNYGLIV
IDESHNFRNNNTVVGKENRYQKLLRKVIQEGIETKVMMLSATPVNNRFNDLRNQLALAYE
GDSENIDQKLDTQSGIDQIFRKAQQAFNIWSKYETEERTTEKLLDMLDFDFFEILDSLTI
ARSRKHITTYYDTSAIGKFPERNKPVSIQSPLTSSNSITYVDLAEKLTLLNLSVYTPLNY
ILPSKVQAYSDLYDKEVRSGSGKLSQVDRELSLRILMRINLLKRLESSVDSFRITLEGII
GQIEQAIKTIDKGVDDDYEGIHKILNDENYDFESNWADEDQVIGKKIKVHIADMDTTKWR
EDLTEDLLILSKLWDRIVDIRGKKDTKLQHLITLVNHKIEKPFNPNNKKAIIFTAFADTA
NYLYENIHEYLKRKYNLNVALITGSRRISSSKQIPADLNAILTCFSPLSKDKEQLYPNIK
ESIDLLIATDCISEGQNLQDCDYLINYDIHWNPVRIIQRFGRVDRIGSKNESITMVNFWP
DVTLDNYINLKQRVENKMLISNMASTGDDNILNTEEKDLEYRKIQLQKLQDEVIDLEDLR
EGVSITDLGLNDFRVDLTNMIKEYGELKNIPEGLHAVVKSGSILQDGVIFVLKNVNTSVN
INKLNRLHPYYLVYIKMNGELILNHVESKKILDAMRMLAKGKKAPLEDVCKELADLTDDY
HKMDDYSKLLKQSIRTVLQKEEEKEVLSLFKSGGTTALQEKIKGIEDFKLVSFLIVR
>KECLDBNJ_01706 hypothetical protein
MSKENKHIIVFEHESLRTDRGEQRLSNDQLEALQLFYGENGVPYYSLIHHGVRFNEYVGV
IQVAKTVIEVLPKADRSNDAERWRNVLISMLYAVGIFDIHAPSNSNLRLRPNSILDLYFE
LFIKEVEYLLHRGLVKKYRKTEGNRTALKGSIQFSKQVSQNLVHPEQFYVRYTTYDKEHG
IHAILYKALKLLSYININVQLNSRLGALLLNFPELYDIKITETLFDRIFLDRKTEPYKNA
LEIAKLILLNYHPDVNRGTNNVLALMFDMNVLWEQFVYVSLRRYKASTTSIAAQNTKNFW
KPLSGFRSKMKPDIVLNKGRQDCVVLDTKWKNLNGYNPSPEDLRQMFVYTKYFGAKKVAL
VYPGAENRNQSGQYYDHSSQESRNLSNEECSVISIGVEKDVKAWQKAIHKNISNWWQFA
>KECLDBNJ_01707 5-methylcytosine-specific restriction enzyme B
MNKEEINSLIQTPWMQGLIASEEFYFQKGQDALKKWIEMDVESELKESLIKYSTNYNQFL
EIAESNPNFKKIKNLLCEIISYCDSNARDKNLLNQYDDNRVLAKASVRMNKWIEGLIRTK
FKNGEIKGASILNALNYLLLPQENSTILSRNHREMISENLFVKSFNSEQFVEELKAYFEQ
CNISVKNQDNYTYLLSCIIYSIKDKWQDDVVGLMASDSTGWQERELILDKQWAGLILWNS
KKPTRGAKVLEFLRDKIEDTGFFPLFYSVKGNAVYCANITDFATNQEELDKIQSQNISLK
NFNSDFSEYRDEKKSAKIVFVAEGIEKIKPISVEEFNFYKCSPPRQDNLSPIKTLAEDQI
KTLPEDHNIATEQNSDKMANELNQILYGPPGTGKTYNTINQALELCGENLTGLSRSDIKA
RFEQKVDDGRIIFTTFHQSMTYEDFVEGIKPIEPEKEGDPVIYRVVEGIFRKLCIEASFS
LAKEEESVATENVLDFSLAFDNFVQELEEKLASEETIELATKNRGKVVVDGISQQGNIII
KHPGKDNIYPVSKQRLSKLHTAFPDLADVNNIDQQFRSIIGGSNSTANWSVLNAIRNNNP
VTKETPKEIRKYSWDDKVQVVKSLKKENFKGKTGEPYVLIIDEINRGNVSQIFGELITLI
EEDKRLGNPEAIQVQLPYSKDWFGVPPNVHIIGTMNTADRSVEALDTALRRRFSFTEMPP
KPELINTEGRAENGILNGIELSVLLETINKRIEKLLDKDHMIGHSYLLSVEGLKGLKSVF
QNKIVPLLQEYFFGDYGKIGLVIGSEFFDIKDNQVDEDFFAPFEDYDSSPLVERKVYHLK
NIQDLSDELFIKALNELQRKNK
>KECLDBNJ_01708 hypothetical protein
MKLQFKEQDFQVNAVQAVVASFEGQPLKTNRFTLERSKELLRKAKQAATGLGTLNFDVEE
EIGYRNASIQIMESQVLKNIQEVQKHNNLHESQKIERPKGVKLGYNLTIEMETGTGKTYT
YIRTMYELHKKYGWSKFIVIVPSIAIREGVFKSFEVTQDHFQERFGHKINPFIYDSSRPQ
DIENFASDSRISVMIINTQAFNARGKDARRIYQELDQFGTRKPIEIIAQTNPILIIDEPQ
SVDGKKTLESMQDFRPLFTLRYSATHKDEYNKVYRLDALDAYNKRLVKKIQVKGINLKGS
TGTNGYLYLESISLSTSKPPYAVIEHEKRTASGAISKKRVKVAEGYNIYEQSGNMPAYKN
QTITEINGYLNKIVVAGEDVYPGDILNDKDEHAFRRVQIRECILSHLQKEKQLFGQGIKV
LSLFFIDTVEKYRVYDELGEQQIGEYARLFEEEYNKVKNEFLDLFEQEYNDFLKDTDPSK
VHKGYMPTNYGEYLKRDDASKVHNGYFSIDKKGRTVDSKVKRGREWSDDVSAYDLIMKDK
ERLLSFEEPTRFIFSHSALKEGWDNPNVFQICALKHAESGSLTRRRQEVGRGMRLAVDKR
GVRQDFDFVGDRVHELNKLTVIASESYEAFAKGLQKEIADTLKERPQKAEVDYFVSKLVT
NEQDEELRLTEDDAKKLQFKLIVSEIIDEDYKITPKGKELIEQGKVPLPEKLEPFKESVC
KLLQTIYTGAEFKPEDERQTVVLNPNKNFAKKEFQALWEKINLKTIYEVQFDTEQLIQDA
KIKIDAQLNIGDRVYEVKTGELEDGSAGQMKEGSLVRESKRQYMKLKNDLYADTVYDIVG
EIEVQTNLTRKTIVAILKKIAPTKFALIRKNPEEFIGKCSKLINEVKASLIINNIVYHKT
EERHDAKTVFTNDKSALRQSDLLKKHIYDFLTSDSKIESDFATALENSTEVVVYAKLPKS
FYVSTPVANYSPDWAIVFDRDKVRHIYFVAETKGSDSDMDLREIEKLKIHCATEHFKEIS
GAEVKFEKVSSYEKLMDIVQLS
>KECLDBNJ_01709 hypothetical protein
MPIDKLDLQSPDRVNENFDKLAALFPNCVTEGAEGRAIDFDLLKQELSHAVIEGNKERYR
LEWPGKREAIVTANLPTTKTLRPVREDSVDFDNTQNLYIEGDNLEVLKLLQESYLGKIKM
IYIDPPYNTGKDFVYKDNFSKDAQEELIESGQKDEYNQRLVANPETAGRYHSDWLSMMYP
RLKLARNLLSNDGVIFISIDDNEVHNLKRVCDEIFGDSNFIANVIWERAFAPKNDAKYFS
DSHDHILVFTKNILEFEIGKLERSEEANSRYKNMDDDPRGPWTSDNLTVKTYSAAYDYEI
KTPSGRMVSPTDGRCWFTSKERMQKLIDDNRIWFGKDGNNVPRLKRFLSEVQTGMVPISI
WPYKEVGHNQEGRQEVKKLFDDKGYFDGPKPVRLLSRILQVANLDEDSTVLDFFSGSGSL
AHTVYSWNAENQERVSFIQVQLPEETDEKSEAYKAGYKNICEIGKERIRRAAKKIKEETN
SDIDYGFRVYRLDSSNMQDVYYKPQDYDQGQLDAFADNVKSDRTAEDLLAQVMLDWGLAL
SLKITPVDVSGKKVFKVAENSLYACFDSDIDEDFAKAIAEDKPMRIVFRDSGFKNDTAKT
NVKQLFKQLSPETEMKVI
>KECLDBNJ_01710 hypothetical protein
MRTFRILLLIPLLSYAQNQAPRALIDKALLDYESEITGSQFVNDKTLNILIGDVLNQYLP
NTKISTQRLSFLLDDDDNSFSLTGNFDPRLTKTSYQSFLASGGLKLKGEPTGSFYNFKDS
NWAENIGAQFKLTWFIPGTLTKNADHQISRLLKTYREKTIKNLALETLETKPLDSQELEE
LIATKEAEYILKNDLYVSMYKFWVTLQGYIPLTKSSNTFTNTTDASIKSEHQFEAWEASL
SINGFYKGKIFSFSFSAIPRVYQNNNILTETVKKRTFTSFEGSPEGQPALTTTDSYYYGA
YEEFTSGQVKAEVASLYKDCIGLSAAVEQNFWYGYDALNWKLGIPLNLKNKDGASSIAFE
IQWREFNKQHYLGISLGKAFGKFLD
>KECLDBNJ_01711 putative cysteine-rich protein YhjQ
MYMPIGNSFRFTAIKKYQSYKINLMNHEELISTLNECANYCNHCADACLEEDHIQMMVTC
IRYDRMCAEVCSSLAKLLSINVPSQKLMALVEYCKNLCASCAEECSSHEAQHCQNCAAAC
KRCVDACSKFLYNH
>KECLDBNJ_01712 hypothetical protein
MKKLFTLILLIALTLTSCASHHGLPKNFNQNTTEVVLTKKNFKVIDLVKGEAQATYVLGI
GGLSKNGLIAEAKANMLRTAQMKGASRSIVNEVVEVKSSGFLFVTKFKVIVSAQIIEFTE
>KECLDBNJ_01713 FAD-dependent urate hydroxylase
MNTPTSHTACPDCHGLGKQNRGLSKRAKQRYQKALEVYQRFPDNPKPVKPKAHLQVCPSC
SGSGLLPAPHPPKPDTTRFPHLAIIGGGIGGTALAVACLHREIPFTLYERDANFDTRAQG
YGLTLQQAHTAVKGFGIDTLEQGIVSTRHIAHTPDGTVLGEWGMRKWDTQNNVTPKRTNI
HIARQNLRLALLEQLSGADAIRWGHQLNGFNQTETGIELKFNSQENATTAHADLLVGADG
IRSSVRELLFEQEPYPLRYLDCIVILGICALSDLQDAAHELLDQKTVFQTANGNERMYMM
PYDPEHMMWQFSYPLAEAEAKNLSAQGAEALKKEVLKRTNWHDPIPQIIEATPAAFISGY
PVYDRELLRPLDFASCGPITLLGDAAHPMSPFKGQGANQALLDALALARRITKVCKPNTS
WKDTNLRKKILTPFETEMLKRSATKVEASAKAARVLHSDQVLQERDGPRGGGRQ
>KECLDBNJ_01714 hypothetical protein
MFYMNFLKILGLMLLLVSTACNSRNTAENEWITLFNGTNLNGWTPKFYHHEVGENYADTF
RVQDSSIVVAYDNYDSFDETYGHFFYDEAFASFHLKFKYRFTDEWMEDAPSYTYRNSGVM
FHSQAPETILKEQDWPLSVEYQMLAEAEPGKSRPTGNMCSPGTDVYYKGEKSNDHCINSS
SPTFRWDTWVDADLIVYQDSLIIHKVNGKEVLRYTNTQIGGDVANGYNPKLKVDGQALKS
GYIGLQAEGQGVIFKDIKLKKL
>KECLDBNJ_01715 3-hexulose-6-phosphate synthase
MAKLQVAIDLLKTEDALALATKVAPYVDIIELGTPLIKSEGLAAITAIKNAFPDKKVFAD
FKTADAGELEADMAFKAGADYITILGSTGNSTIAGAVKAAKAHGKGVVVDTIGVADRVKR
AQEVTELGVAFVELHAGLDEQAEEGYSIQVLIDEAARAGVPVSIAGGVNLDSIKAVKDSG
AVVAVAGGAIYGAEDPAEAAKALRALLN
>KECLDBNJ_01716 3-hexulose-6-phosphate isomerase
MQTLETISSEAALADAIALIYNEHEYLRQGVAFEQLAVLIAPLERAQRIFLMGMGRSGFM
MQALGMRLMHLGFDVHMVGETTAPAITKGDVLLAGSGSGSTTSIVNAAKTAKREGAAVLC
FTTNMESLLADLADVVVVLPAAQKNRQEAEVSQQYAGSLFEQALLLYGDALIQLLWNKGG
KTADQLWQRHANLE
>KECLDBNJ_01717 Arabinose operon regulatory protein
MLSDKVLYIRDLADCPPSYLDDPGRREFFEIVWLQQEDALHPPQYDFQTVNGHWIYLIPP
YRVHQLNKAGKRGVLISFKQELLEDDLKEFLLDVFRIFNLQGEFSCLQVSEEHAQSLSAV
YQLMYAEYDQDAVNLIMLKALLKVLLLKLIELKEQHFTLQDLNEKRVYEFMMLLEKNYLE
ERTAAFYAGKMGLSAKRLNQILKEKLDKTVVQLLHDRLILEAKRQMIHSEHTIKEIGYNL
KFKDRSYFSRFFKTHTGQTAQEFQNQARRYVLKHDNTLYAD
>KECLDBNJ_01718 hypothetical protein
MRTRSIRITYAISFCLLLLNSFSYAQELQQDSLSRWNIDYGNKGVLFTAPDDAFSLHIQS
RLQFRFATPGDNDPVTFDDFNDEKNSVFKINRARLKVGGHAYKPWLKYYWEYELGRGNLL
DFRIMIERWKWLNIKVGQWKVEFTRERRISSGAQQLVDRSILNRSFTIDRQQGIELYGRL
EGRGAADFSYWAAVLTGSGRSNSENDDKNLMYFGRLQWNVLGDDLGFGGISDLQIHKTPE
AQIAFSAVTNRSPFTRFSSSGGGFLTGFETQEPGQYRINQGNFETAFVYRGFSWQSELHY
KEVIDKLDADATTQLRGYYMQAGYFAHQAISWWPKQLEIAARYANFNPNIDSETSLDEKS
LAFNWFFKGHRNKLTAELSSFDYETEDAQLENELRFRIQWDISF
>KECLDBNJ_01719 Inner membrane protein YedI
MASGFFALLDDIATLMDDVSVMAKVAGKKTAGILGDDLAVNAEKASGFMSNREIPVLWKI
TKGSLLNKIIILPVAFLLSAFVPVAVTVILIIGGLYLAYEGAEKIYEFFVPHAHEEERPA
LQNRTEEELLAYEKEKVKSAILTDFILSVEIIIIALGTVTGEELVNQIIVVSIIALVATV
GVYGIVALIVRMDEFGAKLINLNEQDDSFSDKVGKFLVNALPVVIKSLSVIGTIALLLVS
GGIFRHNLHVVHDLFHTWPGMLADLLLGLVIGFVVLLIIGGAKKLFTSASA
>KECLDBNJ_01720 hypothetical protein
MKTIALILMTAVLSLSSQAQEIPKNVQTNFEVHYPDAQEVQWEVTSKAYQVSFVEDQAQH
THWYSADGYLLKTQKSADASVLPEPVQQKIASTYEAYRIAQVTQQVAEGYVTYQLALAHA
EAPALAVQVSHDGRILEKLPLETALSSRQSF
>KECLDBNJ_01721 hypothetical protein
MKNVFMTAILLGSVSLATAQTSANSGVPAPVTQAFSTAYPKATDIEWEQHAFSYEVEFEI
DRLDYEVCYAADGSVVASEQELRETELPAGIQNQLKQKYSGFRFDEAKKYIKDGKTRYMV
EVENTFGKEHELFFDDQNALLNAPKGSRP
>KECLDBNJ_01722 Response regulator MprA
MKILIIEDEPQMLDNMRRTLEQEQYLVESAATYTEALDKIGAYAYDCILLDVMLPDGNGL
KILKELKAQQKEEGVIIVSANDSLDDRIEGLNLGADDYLPKPFHMAELRARVQAVLRRRN
FEGNRNIQLGNVNINPETRQVFIAEEDINLNRKEYDILTYLIANKTRLVTKAALAEHVWG
DHIDQADSFDFIYSQIKNLRKKLEPASINVQAVYGVGYKLEVD
>KECLDBNJ_01723 putative sensor histidine kinase TcrY
MRLLNYTTQYFALLLLGVITIWAVAFYYAMLDEIYDSLDDGLENQKILLLKRAQEDPSIL
AHNDFDKHVYSFTPITAPSFEQQQERYQDTLMYMLNEEDYEPVRIYESAIQANGGYYKLK
IITSMVEEDDLIEDLVSYLIGLYAFLVLCILILNNLLLKRIWKPFHYLIDQLKDFKLDRK
TSLTTAPTKIEEFTLLNTTVTALIASAQRSYEEQKQFIENASHELQTPLAIVINKLELFI
EQQPLSDEQLVQMASVLDNLGRLTRLNKSLLLLSKIENEQFQEEAEVDFKQLLHQSLSDF
EAIAAHKNSALILLEETEMSYRMNRDLAVILVNNLIKNALVHGTPGAPIHLRLKQHALSI
TNQGTPTPLKVEDIFARFKKSGTNEKSTGLGLPIAQAIAVKYQLQLTYSYTEGHRFTLTF
PI
>KECLDBNJ_01724 hypothetical protein
MKYLAHYVIFGALAFSGVLSYAFYKKSIAEEREILENASYNLVNTWEFPELLYEVSGIAW
VNDSTLACIQDEEGVIYNFNLNTSEITKDTRFAKDDDYEAIALNGTMAFVMRSDGHIFEI
ADIMADTLVVSDFKTRFDSKNNMESLAYQPEHDRLITIAKDEGLDEDRYKGVYAIPLETH
EQDEQPLFAIDLKWDAFKALEKKKIENTFKPSDIAIHPKTGDFYIVDGTSPHLLIVSASG
SFKALHELNKFHFAQPESLTFSPEGTLYIANEAANGVATMFEVTLKDKEGVE
>KECLDBNJ_01725 Levodione reductase
MKDQVIIITGAAMGLGLATAELLAKEGAKLVLVDYNDDALKDAEKKLKEINPEVALLSVK
ADVSSEEQVKNYVDQAVKQFGRIDGLYNNAGIEGKQAPIIDYDLDVFKKVIDINLMGVYY
GLRYVIPVMQKQNFGRIVNVASVGGIRGVLNQMPYVASKHAVSGMTKNAALEYGKDGILT
NAIAPGAILTPMVAEAFKQVNPDDPKAAEAEYAKRNPTRALGDPKDVASVVAFLLSKANG
YVSGQTIAIDGGESNMYGNAEN
>KECLDBNJ_01726 hypothetical protein
MKTQPKGHFSHSLNQLLKRYTLSEQDLQTLNAMDENKIVSLAYTDYGGFDEKTGNYYAEE
RDINYKLKVDYLKDEVGGVETLIMLPVTMS
>KECLDBNJ_01727 hypothetical protein
MNHQYAFIRSIFQVRFSLLMVLVLPALQTFAQDKEVEQTFYFTGNTGYAPNATTTSVLEA
ITTMSQKDAKATFVAIGNITQQGYPPKKKDRKEVETFLQQELMEPLEAFNGNVILMPGKN
EWNKNGHENLDDLESFIQDNSEIEFWPNDGCPREIENLDMDNVELLMIDSQWFLEDWDDH
LYLNNKCDIKTRDDFFAKFKDDLKDEQNKTVIVAVHHSILTLSQQNFIENIGGLTVEDYY
STLRQKYAGTLETLASQFPDVIFVSASDRNLQYVFDDGIPQIISGAASEKLDGVRKAKDG
QFASKAHGFARLTVYKDRSSVVEFYETDNGTPKKLFEKEIRRQQPKPQDINSPDISGMGS
TKKASIYTKEETDKSGMYRFLWGDHYRDVYSKEIEAPVLDLSKLPGNVHAISEGGGNQSR
SLRLIDDEEHEYTARELRKSAVRFIQSKITDHYVRDFMENTIAEDIVQDFYTTAQPYAPF
ALNPIFDSLDIYNAQPKIYYLPKQKQLGIYNEDYGDKLYMYEAHAGDENKSFERFGDADD
IISTKDLLAEIQDSKKHQVDEANFLKVRLMDFAVGDYDRHYDQWRWSAFEQEDGTTLYKT
IRRDRDQAFPKYDGLVLGLLKVALIDFRSMEKYDEDVNSVKWLSRYAYPLDQAFLKSLTW
EDWEQQVQFIQERLTNETIATAFASLPEAAQDQSTAAIQKNLKARRDNLMDIARRYYEYL
MRHQILLGTGDKDEFVITRQADGKTSISLTTEDDRSFERTYDKALTKEIWIYGLDDDDTF
KVTGDGNQYIPIKILGGENNDVYDFENTRAVKAYDYKSKNNTFVNSGTRKWLVDSYDINT
YNDASRKLDAFSTLPAINYDQDTGFSAGLSGTYTTYGLANNPFSTQQTLTAKYFAATHGI
ELKYSGEFAHAFYKWNFGLDARYTTPNYAINFFGTGNETTYDRDAVDRDFNRVRISQWSV
NPSLIYREDRVQLRFGPTVESLNTSYSGSGVTGDTNVFAAGDNVFNTQYYAGAEAAFQYK
NKSGAIAFIRRGFQFDLVTGYKTNIDEYDNEFAYVNPTLSVDYPLHPSGMAVLATKIGAE
MNIGDTYEFYHAATLGGNNSLRGFRNERFNGKTAFYQSTDLRVGIAELTTSFIPLRLGVS
AGFDYGRVWVPNEDSEQWHNSYGGSVFLNGFKALTANLGYYRSTESDRVLFTLGWKF
>KECLDBNJ_01728 putative ATP-dependent helicase DinG 
MKEAKFAVIDVETTGGGIKGNKITEICIIVLQDGKELNRFTSLVNPGREIPLYIEKLTGI
NDRMVEDAPYFDEIAPQILELTRDCIFVAHNVGFDYNVVRAEFKEAGIDFNRKRLCTVRL
AKKLIPGLFSYSLGNLCTSINIPHYDRHRAQGDTEATVILFQRCLDLDPDYEVIEEFLNR
KSKESYFPPHFKAQDFENLPHKPGVYFFKDKNGKPLYIGKAIDIQKRVLSHFREKSNRKY
ELLQNTHSIDYELTGSELLALLREAELILKYYPKYNKAQKNPSKPYKLTSYHNKQGIEQF
ALHKNKIAPVSWMQFYTREEAIQFMEHLCEEFELCPKYCGLQQGVATCNHYKIHTCSGAC
SGDLSVADYNLRVSKALDYIHQYEQSCLLVEKGRETGEKSFIYLKQGRFSGYGFIDDAAD
FNHHEDFEHYLIPQKSSAYADRIVRRYLATEKHIVRLPLTSVEQHTQNIFENWFVD
>KECLDBNJ_01729 hypothetical protein
MRIKIDRFVVAIIVVIAIAYFFPQWGVASSPVPLDLISAIGIALIFFFYGLKLSPQKLKA
GLGNFKLHLLVQACTFLIFPLLVLLFRPLLQNETHEILWLSFFFLAALPSTVSSSVVMVS
IAKGNIPAAIFNASISGILGIIITPLWMGLFIDDMQSDFDFTQIYTKLVVQILLPVILGM
LLQRFLGDFVQKHSKKLTLFDKSIILLIIYKSFAESFSDGLFASVSWLDLLLIWGGVLSL
FAVVFWLTGSIAKWLHFSIEDQITAQFCGTKKSLVHGTVFSKIIFTGMPGLGLVLLPLML
FHASQIMIISAVASRFARRVTEQEVL
>KECLDBNJ_01730 Catabolite control protein A
MKQKRPSIKDIAKALNVSITTISFVLNGKGEERKISKEVIKKIEDYVEEINYRPNQVAQS
LRTGKSKILVFMVEDIGNRFFAKIARIIEDIAYEKGYKVLFCSNENNDKRSRELIRVFHE
RQVDGFLIIPSPGIKKDIENLIKSDIPVVLADRYFEDLDVHHVVINNYAAAQNATQHLID
NGYKNIAFISIDTQQIQMKDRARGYRDAVQQAGLSPTVLELPFEEIHKPEGKNKIKALLT
GSNGIDSVFFSTNYLTQASLEIIKELDPKLIYDLGIVTFDDNEFFRINTPSITAVAQPLQ
ELGEELMRIMFKLLKKSDKEIPVIKSVLDAELLPRESSKKK
>KECLDBNJ_01731 TonB-dependent receptor SusC
MKKLLSLIDKYSFSLKVLYRPRESRCNILVLGILLMTLLLSTTSAMYAQEETGITVTGTV
TDSQGVPLPGVNIKEQNTTNGTLTDFDGNYTITVSDGEATLVFSYVGMKTAEIPVKGESS
IDIQMADDAQSLDEVVLVGYGKQKKISVVGAQSTIKADELELPVANLGTMLAGRISGITG
VQRSGLPGYDGADLWIRGISSFGNAYPLVLVDGVERSLDNINPRDIASFSILKDASATAV
YGIRGANGVILIETKKGKIGKPQITLDYFEGVTHFTKTPDLVDGITYMNLANEALTTRGD
LPKYSQEYIDATASGENPLLYPNVNWMDEVFKSYGRNRQALINVTGGAESARYYVSLGYY
NETGLFQTDPNVSYDSGTGFERYNFTSNLTLDLTKTTDINVGIQGYLSDGNYPGTPTSAN
ISLEDQIFGTALEAPPVEYPVLYPGGYVPGRSANGGLRNPYAEVALRGYRTITRTNLNTN
LNLNQQLSFITEGLSLHGLFAFDSFNEQNVARSKRESTYFVDANFPYTEDGGLLLNETYT
GTNFLGYDRSNGGNRRFYTQVSVNYDRSFGKHSVSGLLLANRTDYSNAFAGNFTEAIPFR
NEGLAGRATYSYDDRYFLEVNAGYNGSENFAPNNRYGFFPSLAVGWVVSNEKFFEPIKEH
IDYFKLRYSDGLVGSDSGAGRFAYLNRVESGQDGYYFSENRQYVDGIAQTYYGVDVVWAE
ARKQDLGIEINAFDSRLSLITDFFYERTEGAFLNRSDIPNYIGLTTDPYGNIGVTENKGF
DGTLNYSHQFQELRLSFRGTFSYNKNKIVENGVPEQPYPWLNRQGTGLLANVGYIAERLF
TLEDDLDGDGFITTADGFPTQFGQIQPGDIKYSDLNGDGQIDAFDRKVIGDGDVPALTYG
FGITAIYKGFDASLFFQGQSFSDRFIGGYGIRPFIGDGGEGNIYTTSLDRWTTENNDAYA
TYPRLSFSASGIGQTNNNQNSTWWLRDIDFLRLKTAEVGYTFKETFSKKFGVDDFRIYMR
ATNLFTLSKFDLWDPELNTNNGGRYPNISVVSLGGTFQF
>KECLDBNJ_01732 SusD-like protein
MKKLIVTLILSGLLLSCGDDYLDQVPDDRLTFEETFARRSTVEQYLANVYSQIPSEFAQR
YTTTENSGPWTGASDEAEYVWGFHMGNFLNIGDWNATTQNVSNLWSNFYRGIRSASTFIE
SVDLCQDCDPAIITQYKAEARVLRAYYYFNLMRSYGPVILLGETPIPADADLQALGLKRN
SIEEVAAYITSELDVAAADLEGTSFTGNNAGRMSTPFAMAIKEQTLLFAASPLFNGNTDY
ADFVGTEGENLIPQNYDVNKWKAAADAAKAFIDKYVPNTYSLYERFNEDGSYNPYLSTRD
VMLVDYNSEIVYARPGGANYLHYDMTPYHLGSATEVRGAGGLSVTQEMVDAFFTSNGRAI
DDPQANYVADGFSQFQAPYDFTTRTTFNPWTNREPRFYVGVTYNGSLWLNRNFGDIITKT
WFGGNSGRQAGTNDYPPTGYIARKKLPVGDYRNNNRSLPMLRLAEIYLDYAEALNEYDPG
NPDILTYVNLIRERAGIPEYGSVELDAPATQEAMREAIRKERRVELFLENTRYFDVRRWK
IADEALAGEMHGMDINARTEEEFYNVVTFETRIFRPQDYLWPIPQDELNANPELVQNPGW
>KECLDBNJ_01733 hypothetical protein
MRTLFFNACVIALVSLSLTGCAQDQNKYTLTYTSQDETLDPEIQEGIEEIFEKVYPKLVQ
DFNPAAQEHVTIKIDTTYDGVAYAHQGAITISSDWLHKKPEDLDLVTHELMHLVQSYPGG
AGPGWLTEGIADYVRYKYALDNEGAGWSLTPFSPSQSYENAYRITARFLVWLTQNYDEDL
VVKLDEDLRTKQYTPETWKKYTGKTVDELWEEYAANPKLSI
>KECLDBNJ_01734 hypothetical protein
MKKTIYTVLLVFGVFMMLQSCGDDDSSLVTGEPDSVVNNDPEGSPLRGITLSWNEQDEDV
LRQYFDVSTAVYYDAEVDRAIEWPFNFFSNSWAYVVENYGTYGEKSLLYVIGHGESDSPT
YYKTIFDDDAGNRSLIDLPITTTEGSGATLDVASALMAQVVEHSSNGVHKSPAAAVWGDT
YNQIFTYDLYVNLGLEAEAERVKTAFSATSVNYPNAETFWFRDWFLPIYETYNGGITLNN
FFKVLAANYPIDGTDYARDMNLGELVHFFSGATGEDLEPLAESAFGFDDTNKNELLQARA
EFPNLNYPFDPASELIDVTSEGNATIVVSRDHPNGADSAEGSLKVIDNDYTTKFLTNGFP
QEFYMQQNFEFAQVVNKYTFTSGNDAPDRDFKTWELLGSNDGANFEVLDTRTDQTFTARN
QTREFTFDNDQAYRYYRINVLENNGSTLIQLTEWRLLNLKLLTFGPQDITATAITTVSRE
NRNGADSNEASIRVTDGDTGTKFLLFDFNNPEWIQQEFAQGVRVTKYSLTSANDAPGRDP
VGWTLSGSNDGTNFTEIDSRTGQSFESRGQTREFLITNDTSYTYYRLDILANGGDSLFQL
AEWRLFAE
>KECLDBNJ_01735 hypothetical protein
MNRNSLLMLSLLCLFVFSCKEEKATAQNENDVNAASASLRAPAYPLITHDPYLSIWSMGD
ELNASPTKHWTERDHALTGVLQLDDKFYQFLGSESKVYETILPASDEETYSVSYSESKPD
ENWISTSYDASAWKTGEAPFSENESMAKTVWNTDDLYYRRSFDLETTDLESLYLKLSHDD
NVKVWLNGVQIADINGWQNSYKYLPIPEQAMQTLKTEGNVLAIHIRNTAGGQFLDAGLVT
EAKTQTNSIVKKAKQIDVAFRANQTEYVFDADGTQVNVTFTSPLLIEDLAIYSRPISYIN
VKVAGKEGQQAKVYLGASSAIAINQPVQEVEVSEYQNEGLSVLKAGSVAQPVLEKKGDDL
RIDWGYLYVAAPAENVQQYVSPAAKGLEAFATGSVQDTDAETTGKNLILNTVADLGKIDA
QGAEQVFMIGYDQLEAVNYFGTSLKPWWSKDGATMNAELGEAYANYNGVINKVKTFDQKL
YDDALAAGGKKYADLCVAAYRQAIAAHILVEAPNGDILFLSKENNSNGSINTVDVTYPSA
PLFLVYNPDLLKGMLNGIFYYSESGKWKKSFPAHDIGTYPIALGQTYGEDMPVEEAGNML
ILTAAIAQVEGNAAYAKAHWETLTTWADYLMQSGFDPANQLSTDDFAGHLARNANLSVKA
IMAIASYGKLAAMLGDTATAEKYTNAAKEMAGNWKNIAADGDHYTLAFESEGTWSQKYNL
VWDEILGLNIFDEDVHKTEIAYYLTKQEDYGLPLDSRKTYTKSDWILWTATLADNEADFN
ALIDPVWEFANTTPDRVPLSDWHETTDAHKVGFKARSVVGGYFIKMLKDEQLSK
>KECLDBNJ_01736 TonB-dependent receptor SusC
MKKLLLNSIKWHPLLMLVLGVLCLQNTYAQENITVEGNVSAAGETAGPLPYITILVKGTT
RGTTTDFDGNYSISAAPDATLVFSYVGFKTKEIPVDGQTQIDVQLEEDIAGLDAVVVTGY
STQDKKSITGSIATITSEDLEKVHGGATVSSGLAGKIPGVSFRMNDGRPGASASIQIRNM
GTPLYVIDGIQQDEGQFNNISPNDIESITVLKDASAAVYGVRAANGVVVVTTKKGRKGVK
NTVNVNAYVGWQNWSRFPETVNDSYQWMLGKAEAEVNQYGSTGITPEELEKYRIGEERGY
QSFNWKDFIIKKNAPLTNVNVSATGGSENISYYLSATHLDQESVLGDEFTFKRSNIQSNV
DANITDRLKVGVQINGRVETRKNPGIPGADDYWLPRFAILRNRPFERPYANDNPEYLNDI
GHNETNWALHNFKIGGYAEDIWRVLQTNFSAEYDIPGVKGLKAKGMYSYYIADRVLNGHE
YTYDAYTYDPENDVYNVTGGSSNPWRERRTRKVLRNIYQGQLQYKRKFGDHSVEGLFIVE
RQEARFQEQWVHAVPKTNTLPLIYFSDTDAYDDSDNEEARIGYIGRLNYNYKDKYYLEVS
ARRDASWKFAPDKRVGYFPSASAGWRITEEEFFKDLIGDDSVLNNLKFRGSYGILGDDNI
GIGPYDYLTGYNYNQGVAILDGNPVIASRDKGQPITNISWFKSKITDIGADFYLFDSKLS
GSVDYFYRKRTGLRGRKYDILIPNELGYGLPDENVNSDAQYGIEGALSYATNFGEVTFNV
SGNASISRSKFLESYKPRFDNSYQQYRASSENRYNTIFWGYTALGQFQSQEEIDNYPVDI
DGRGNSTLLPGDIIYEDVNGDGRIDGYDETPIGYNNYNPLINFGFSLSAAYKGFDLRADF
SGASGYSWNQSWEQRWAYQNNGALNKIFLDRWRRADPFDPNSEWIPGKYPALRFNDGGHS
NYNKNSTFWLHNVTYIRARTLELGYSLPDTFLEKINVSRARFYVNAYNLFSIDNLAEFGV
DPEISDDNGLQYPQNKFVNVGVNISL
>KECLDBNJ_01737 hypothetical protein
MKKYIYFLIIPFLLGSCSSDSEFLDREPSNILTQNQAFGSPDIVLSVLADLYNRYYDFGT
VEDWSSLAQFNVAFWSEAGRYGYFQNGGYGYGDWGTWDYGYIREMNLFLERLELSEALDP
ADKARFAAEGRFLRASYYFTMVKRMGGVPLILESETYDFSGDATYLQHPRETEAALYDFV
ISEADAILADLPSDVNTKSRASKGAVLAMKARAALYAGSIARYGASTPQVSLPGGEVGIP
VSRAEEYYTTALSAAQSIINGEVGNYSLYEKKPNLSENFASIFYDKSNNPEAIFVEDYKL
QSGKVHGFTIANQPRFGAEEEEGGRINPALSLVQSFETLDGEYAPLPIEDASGNPIYYDT
PEGVFANRDARLMGTVIVPGSSFKGREVDIFAGIQLADGTIISGDSRGQQKEVMGTDMKV
VGFDGPIDGLEFTAQTGFYIRKYQDPKAGSGQRGTQSDVWFIRYRYAEVLLNAAEAAFEL
NQPAVAAGYLNQVRRRAGITTDLAAADITFDRIAHERFVEFAFEGLHFFDLKRWRIAHEV
LDGTPMDAATITDNIGDATKRLTQPFGLWPYKYYNPGDANDGTYIYKIVKPNRVTSADRF
QFGNYYSEIGAGILNNNPLIVRNPNQ
>KECLDBNJ_01738 hypothetical protein
MKITNYIYLAATALLFASCEIDNYDEPESFFTGNIVYNGEPIEVGAREVRFQLFQPGFGA
LAPLDMHLDLDGSFSGRFFDGDYKLKFINGQGPFKAYEVNEQQGDTIFISLRGNTEMDIE
VLPYYMLSGETFSASSTAVDAAANYDQIITDADARAIEFARLYLNDTEQVSNNGDYHRVW
SDMTVGSGNLSGSTALPDGYAKPYIFARIGVKIVGVEDMLFSPVQKLDL
>KECLDBNJ_01739 hypothetical protein
MQVFKQQIQKLFLSLLLFGLSLYQPIIAQRNLSDYVNTLQGTNSKFELTRGNTYPTTALP
FGMNTWTPQTGTNGDGWKYQYFKETIRGFQQAHQCSSWSNDYAVFSLMPVTQSLKLNEND
RQSGFSHTNETAKPYYYQVNLDNGVNTEMSPTERGVHMRFSFPKNEKSYVVLDGYTGISG
VEIDQKNKRISGYVHNGRGMERFEHFKNFFVIEFDKPFKAFGTWDNTNGAKKESNTSAEG
KGKGAYIQFNNGADVQVKIASSYISQEQAQRNLNNELGKAKNLEATKAAAKQIWNEHLSK
ILVEGGSEEDMKTFYSCFFRASLFSRKFYELNEAGEPYYFSPYDGKVHEGYMYTDTGFWD
TFRAQFPLNALLYPEMHGRYVSALLDAYEQCGWLPSWSFPSEAGSMIGNHAITLFADAWA
KGIHTFDPQKALEAYYHEATEKGPWGPANGRHGHKEYYTLGYVPYPKYGEATAKTLEYAY
DDFCGYNLAKMTNNTFYENVFGRQMYNYKNVWDSGVGFMRGRKADGSWVPDFDAYEWGGP
FTEGNAWHYVWSVFQDPKGLINLMGGEERFNAKMDSVFTVPNTVHVGTYGGKIHEMTEME
MAEMGQYAHGNQPIQHMIYLYNYSGQPWKSQQKSREVMRKLYNYTENGYPGDEDQGQTSS
WYVLSAMGFYSVCPGTNEYVLGSPVFEKTTISLENGKTFTIKAADNSQQNVYINSAQLNE
SAFSKNYLTYQQLLDGGTFNLQMSATPNKKRGIQNTDKPFSLTEY
>KECLDBNJ_01740 Inositol 2-dehydrogenase
MKQKKNSHSTERRDFIKKASIASLGISIVPRHVLGGVGFTAPSDKLVVAGIGVGGKGESD
IKSFADSGLAEIAFLCDVDDRRAANSRARFPKAKYYKDYREMLDKEGDKIDAVSVSTPDH
NHAVQAMAAMEMGKHVYVQKPLTHDIYEARQLTEAADKYKVVTQMGNQGASNNGTRLMSE
WFDAGLIGEIEEVYCWTDRPVWPQGIPWPQTPEAVPSELDWDLWLGTAPYKDYVGGLVPF
NWRGWWDYGTGALGDMGCHLVEVPVRVLNLKYPKDVQCSVGSVYVDEFKRGYFPESCPPS
SHVTMTFPKTDKTKGDIKLHWMDGGIQPARPEELGPNEVFGDGGNGVLFVGTKGKMMCGT
YSENPQLLPTSKTERTQVAEKYERVPGGAGGHYKQWVEAALAGYGKKEVSSPFSVAGPLT
ETLLIANLAIRGFDIRKELENGNVEYPGRYIEMLWDAENMRVTNFEEANQFVKRNYREGW
KL
>KECLDBNJ_01741 Xylosidase/arabinosidase
MKKLLTLLLLSALFTSCAQKKEVANNNPVFPGWYADPEGIIFDDIYYIYPTYSAPYEEQV
FLDVFSSPNLTEWTKHERILDTSAVKWAKRAMWAPSIIKKDDKYYLFFGANDIQSDDELG
GIGVAVSDSPEGPFKDHLGKPLIDKFHNGAQPIDQFVFKDKDGSYYLYYGGWRHCNVAKL
NDDFTGFIPFEDGTIFKEITPESYVEGPFMFIKDGKYYFMWSEGGWTGPDYSVAYAISDS
PFGPFKREDKILQQDPEIATGAGHHSVIHPQDSDDYYMVYHRRPLDETDQNSRETCIDRM
YFDENGRIKTVKITNEGVQAHPLD
>KECLDBNJ_01742 Non-reducing end beta-L-arabinofuranosidase
MSFFAGCLLLLSCDDSQNKNIDITTVDKPSVATTNINYVSNRAPLSPSALIKLPLGAIKP
GSWLKESLQRQADGLMGNLGEISAWLQKDDNAWLSDDGTGAWGWEEVPYWLKGYANTGYI
LQDSSMIKESQIWFEAALKSQREDGNFGPKMFSDRDGSQDFWSNMIMLYCLQSYYEATQD
ERVIDLMTKYFEYQNSVPDDKMLSGVHYWQTLRGGDNLYSVIWLYNRTGDKFLLDLAEKL
HRTNADWSKRDNTLAEIHNHKETREGMEFPDWFSKLVDWHNVNIAQGFREPAQYYQLSKK
EEDLQATYDDFKIIRDYFGQVPGGMFGADENARPGYSDPRQGVETCGMVEQMNSDEHLLR
ITGDIFWADHAEEVAFNTYPAALMPDFRSLRYITSPNMVLNDDANHSPGIANSGPFLMMN
PFSSRCCQHNHGQGWAYFTENLFMATPDNGLAAVLYAAGSVTAKVSDGKEVTVTNDSNYP
FTESLDFTVNTSEAVEFPLYFRIPAWAKNASVALNGEALDANPSANTYLRIEREWNDGDT
ITLILPKELGLRTWEANNNSVSLDYGPLTFSLKIKEEYPTKNSSQTAVWDSKWQKDADVE
KWPSFEIHPASPWNYGLILDKDHLKDSFTIETKSWPEDDYPFTVDAAPIVIKAKGKRIPQ
WTIDQYGLAGELQPSPVKSTEPAEDIELIPMGAARLRISAFPVIGEGNAATTWEPTK
>KECLDBNJ_01743 hypothetical protein
MKKLLLGLCTTLLITATQAQETLVEEVPNPVDYVNPLMGTDSSPGLSNGNTYPAVAVPWG
MNFWTPQTGPMGHGWAYTYNADKIRGFKQTHQPSPWMNDYGQFSLMPVTGGMKFNQDDRA
SWFSHKAEESTPYYYKVYLADHDVTVELTPTERAAQFKMTFPKADSSYVVIDPFDKGSYV
KVIPEENKIIGYTTKYARGKLTNFKNYFVIKFDTPFSDVNTWQNDTLAKGQAEMTADHAG
AIVGFKTEKETVVNAKVASSFISFEQAELNLEREIGKQDFETTKQNARALWNEKLGRIDV
GGGTIDQVRTFYSCLYRTLFFPNKMYEINAKDEIVHWSPYNGEILPGYMFAGTGFWDTFR
ALYPFLNLAYPSINKEMQAGLANDFKEGGWLPEWSSPGYANIMVGNNSASVVADAYIKGL
RGYDTETLWEALVNGANNEGPMTAVGRAGAPYYNELGYVPYDVGVNESAARTLEYAYDDF
AIYQFGKAIGKPKKEIEIYKERSMNYKNLFDPSYGLMRGKNEDGSWQEDFNPFKWGNPFT
EGNSWHYSWSVFHDVQGLIDLIGGEEKFIKKLDSVFSMPPIFDESVYGGVIHEIREMQIA
DMGQYAHGNQPIQHMIYLYNYAGAPWKTQYWARETMDRMYMATPDGYCGDEDNGQTSAWY
VFSAMGFYPVAPATDQYVLGAPLFKNMTINLENGKEIVIKAPENSDENRYIESMKVDGKT
YNKNWLSHEELMKGATIDYEMSDTPNKSRGTKESAYPYSLSNE
>KECLDBNJ_01744 hypothetical protein
MTRITFKGLCTAASLLAAGVFNTQAQEDLAKYVDPMIGTAKMGHTYPGATVPFGSVQLSP
DTDTIPYAVNGRYNPDVYKYCAGYQYEDSTIVGFSHTHFSGTGHSDLGDFLVMPTVGKLQ
LNPGTETNPDSGYRSRFSHDEETAEAGYYAVNLKDYGIKAEMTATTRVGMHQYTFPKSEQ
AHIILDLKSGIYNYDEKNVWTIVRVENDSTITGYRQTSGWARTRKVYFAMTFSKAFKSYG
QEKQKGQVYRGFWGRFDQEHNFPQMAGNDLRLYFDFDTEENEAIQVKMALSPVSTEGALN
NMEAEVPGWDFNTVKQQARNTWNKELQKFTVETLEESDKVNLYTAMYHAFLGPTVYMDVD
GKYMGLDRNVHEADGFTNYTSFSLWDTYRALHPLFNVLQPQRNQDMVQSMMVHQEQSVHH
MLPIWSHYANENWCMIGYHSASVIADAIVKGNADFDQNAALDACVETARVRYFDGIGDYI
DMGYVPEDKSGASVSKTLEYAYDDWAIAQAAKKLDRDEIYKEFIERSTYWKNVYDKSIGF
MRPKLSDGSFKKEFDALNTHGQGFIEGNSWNYSLYVPQDPAGMIDLMGGKEKFSTHLDSL
FTMELPDKYFENTEDISREGIIGNYVHGNEPSHHVAYLYNWTDDAYKAQDKIRMILKQKY
MTGSDGLSGNDDFGQMSAWYLFSSLGFYPVAPGSVDYALGSPAVKEATLNLDNGNTFKVE
AKNQSEKNVYVRKVELNGKELTEPFITHDQVMNGGTLTFYMSRKPNKNLYN
>KECLDBNJ_01745 hypothetical protein
MSKFVQLSVCIVFMVWGSIFKSKAQDWPNLKRYAEANAQVDSIYAKENRVVFMGNSITEG
WVNSDPDFFTKNNFIGRGISGQTTPQMLLRFRQDVIDLNPVAVVILAGTNDIAGNTGPMT
TAQIFDNMVSMVELAEANGIVPIVSSILPAAKYPWKPEVDSVGPILELNTMLKYYCEGKG
LVYLDYFSEMVDEENGLPEALSYDGVHPTDEGYQVMEPLALAAIKEALKN
>KECLDBNJ_01746 N-acetyl-D-glucosamine kinase
MKNIYEDERIVMTLDAGGTNFVFSALQRGEEIIQPITLPSNSDDLERCLKTIIKGFDQVK
AQLNGQQPEAISFAFPGPADYKNGIIGDLVNLPAFRGGVALGPMLEEIFEIPTLINNDGD
LFAYGEAVAGMLPFINESLAAAGISRTYKNLIGITLGTGFGGGIVVNNQICLGDNSAAGE
IWLTRNYIKPKTVVEESVSIRAIQRVYAEQSGTTELISPREIYKIASGEKEGDKQAAINA
FEEMATAVAESLANALALVDGPIVIGGGIAGASKFIVPKIIEHLSGCIYNLENEGMPRAI
SKVFNIDDPAQLNAFTADSEYEVKVPFSTAKAKYNKEKRIAIGISKLGTSTSVCLGAYAL
ALDYLDKKNLYKELV
>KECLDBNJ_01747 Carboxylesterase
MRKLVGFFIVVLSFLEPVVAQEISYKTIENINYYPKALQQSDTYLASQARLDIYYPEDKK
DVPVIIWFHGGGLTGGSKEIPQALKNKGYCIVGVGYRLSPKVKASVCIEDATAAIAWTFK
NIEAYNGDSKNIFVSGHSAGGYLALMSIMDKSRLAKYDINANDVAGLIPFSGHTITHFTI
RAERGIPGEQPIVDAYAPLYFVRNDAPPILLITGDRELEMLGRYEENAYFYRMMKVAGQQ
HIKQYEMQGYGHNMTHPAYPLLLRFVAENSVKSEQ
>KECLDBNJ_01748 hypothetical protein
MKHNASAFRRKILFSFAVTLLSLSNLVTAQQKEAYVENPVAYVNPFHGTAPLTDPDFIGY
TPPEGWRVWAGLTYPGATLPNAMVQLSPITQYGSGAGYEYEDDEILGFTHTNKGHWNLCH
IPILPIAENASVPFKSSFDKETENASAGYYSVYLNDYKVKVEVTSTLRAGFHNYTFDDNS
AHTILFDLGRANHHVDEWQLRQTGRKTLEGFQRTGGDKVYFSVELSEAISELQQVNPNTD
KGYAILNLKASPNPVTLKIGLSFVSTENARENLQQEIGTKTFEEIHQAAEKTWEAVLSKI
QVSGGSQKEKELFYSSLYRSLQWPALRSDHNGEFTDAQGTVQNKGFRYYTNPSLWDTYRN
KLVLLSLLSPEVTGDIIQSLIDKGTQSGFMPTFFHGDHAAPFVAQAYGKGITNFDVKKAY
EQLLNNAYKEGGTRPHIAEYIEKGFISDPDVENPHVETKAKAGVSKTLEYAYDDYSLSLL
AAALNDDNHAKDLAARAKNYKNVFDPKTHFMRGKLADGSFISPFDAEYPYYEYMYREANA
WQLAFFVPHDMNGLVALYPSEKAFEQKLDSLFTLPWNPKHIARNVSGFLGQYCHGNQPDH
EAPFAYYFINKPEKSQHIVDTLLEDYYGVGPTGLAFSGMDDAGEMSAWYVFAASGLYPLS
PADNEYLVSLPVFDRVKWNLGRNSLETSKEGTSRTLKQIQYNGKTLDGYFIDQEQLMLGG
DLKLNVE
>KECLDBNJ_01749 hypothetical protein
MQRRTFIQNTALAGGLTVINPTGLFAESLFKKFPTVRVPEGQRNFESKAIEKAIKEFSKN
VDDQELSWLFNNCFPNTLDTTVTYSKYKGAPDTYVITGDIDAMWLRDSSAQVWPYMQFAD
EDKDLKNLIAGVINRQTRQILKDPYANAFYDDPEKKGEWTSDNTAMLPGVHERKYEIDSL
CYPIRLAYNYWKTTGDTAPFDKQWLAAIKNILKTFKEQQEKDGTNPYSFSRNTSNGTDTR
FLRGKGYPVKPVGLICSAFRPSDDSTVYSFLIPSNFFAVVSLNQAAEMVETLQKETALAN
ELKALASEVKEAIAKYGVTEHEKYGKIYAFETDGFGNHLMMDDANVPSLLSLPYLDAIDV
NDPIYQNTRDFVWSLDNPFFFKGTAAEGIGGPHVGMNMIWPMAITMRGLTSTSDAEIKEC
IKMLKNTHGGTGFMHETFHKDDPTDFTRSWFAWANTLFGELLWKIYQEKPQLLNSI
>KECLDBNJ_01750 hypothetical protein
MKTILNSIKPAVVLLLIAFASCEGRREFDAIVESGVNLDNYDIILLESGNTLDVTATFEP
NVVPQRDYIWEVEDPSVADLQVNEDKSVTLTATGSGETVLRVTAADDSSLTDTAPLKVIA
GPPVDITDQSTISVNREYSGGAEGREGSTKLIDGDLTTKYLSGFVTPFWINLEFEEPIVA
GYYSFTSGNDAPDRDPQDWEIQGSQDGETWITLDSREDYRFSDRTQTREFYFDNNTAYKF
YRLDISSNGGGSLFQMTEWRLFLLPF
>KECLDBNJ_01751 Starch-binding protein SusD
MGVLLTIGCTDLEETTYSELSESNFYKTELELVQANLRPFTHMQAWLAWSGQNGYYYHNE
LSADQTAWPQKGRHGYDNADHIRQHYHTWTDQEGRLNNAWRLMWTGLGFVNTAIESIEAV
DAASIGVTPERLASIVAEAKVLRAYHYMKIMDMWGNVPIVTTVGEPNNPPTASREEVFAF
IEQELLDNVEKLQPLSPQLIGRMSKAVGYSILSELYLNAEVWSGTPRWEESITYADKVIN
GEGGSLTGNIALDQDPLGPFNNTNEDSPENIFQFPFSRQNDFGYSWASFYMGFSNMTAAL
DVNYSGNNAFVVIPTAFNAYQENDIRKQEWFLFGPQYKFGTEEPILGSEEYNGEPFIYVN
NIRRNTEGQTGEGSMTDGEENSGARFHKYRSGRQEDPNYLEGDYVVYRLTELYFNKAEAL
MRLNNGNATQEAVDLINASKVRYFTSDDWADEAYTTTSLTMSELLIERGREFIFEGKRRT
DLIRFGEFTTGSWWDHEPSGDLNLTIYPIPYRQLQANPNLVQNPGY
>KECLDBNJ_01752 TonB-dependent receptor SusC
MDKNFKRFILVFFLALGMTSLHTLYAQGGKTVTGTVTDPGGMPLPGVTVQEKGTTNGVAT
DFDGNFSIDVASNNAVLVFSYVGMTNVEQAVGSQNSFTITMESNEESLEEVVLIGYGSQE
RKAVSTAVTKVDTDDFNQGQVSSPVELIQGKVAGLQITRAGGNNPNGGTAIQLRGVTSIT
GSTSPLIVIDGIPGGNLDLLQQNDIESFDVLKDGAAAAIYGTRGTNGVILITTKKGKKGK
STFNYSSFVSRDYVNSKPDFLSADQFRAAIADGIISANNDLGASTDIFEELVNRSNLTQY
HNFVASGGNENGNYRASLYYKDSEGIALENGREEFGVRASFNQKGLDDKLTFASSVVVNV
NDANLLGGNQFGIVTDWNPTAPIYAPFNTSEEGVLFNQGRYGFYQPENGYNPFSEYANRF
NQRKQITFSGDVKLGYEIIPGLVASVFGSYQRNSWNDRFYRSTQDYQQYNTGSPYFGTGY
AYKGNHIDYTQTVEPTINFTKDFGDHGFELLGGYSYQYSTTEEYSMDNSGFTTDGFEDWN
FGAGNAITDTDLPRPNLSSFKEDNTLIAYFSRLSYNYLDRYFLQASVRHEGSSRFGANNK
WASFPAISGGWLISDENFMEGAAWVNNLKLRAGYGITGNQGIPNYQSIVTLGTGGKYPVF
LDGADGATYYQTYGPVKNPNPDLKWETKKEFNIGVDFGFWFNKLSGSIDYYTRRTEDLLL
SYDVPQPPFVQGSIYTNVGNITNNGLELALSYRVFEEGDFKWNVDFVGSYQNNELTTLSN
QIFSVSELYGGNIGNPGNLGDAIRNTEGGPIGNFYGKRFAGFTVDGKWLFHKADGTIGRA
SDMTEEDKAIIGNGLPKYYASLTNTFRYKNFDLTILLRGKFKYDILNTVDLFYGNPSLLP
GNVLTSALGQYNNITEAPQYSDYYLENGDFVKLDNLTLGYNFNLGENSPFSALRLFGSAR
NLATFTGYTGRDPEVQDTGLYPGIDDRNFYPRTVTVTAGVNVNF
>KECLDBNJ_01753 Fructose dehydrogenase large subunit
MQIQESSKMYDVIIVGSGAGGGMATKVLADAGLKVAVVEAGPHFDPADPKQRTQLKWPYE
SPRRGASNRRPFGDFDSAYGGWEIEGEPYTQKDGTQFDWFRSRMLGGRTNHWGRISLRFG
ERDFKHKSYDGHGDDWPIGYEDVKPYYDKVDKLIGVFGTKENIENEPDGFFLPPPKPRLH
ELFYIKGARKSNIPVIPSRMSMLTKKINDDRGICFYCGQCSRACAVYADFSAGTCLIFPA
QKNGGQVDLFVNAMVREVTTNDEGKATGVSYISKDDRKEYKLKGRIVVLAASACSSARIL
LNSKSAQHPNGLGNSSDMVGRYLHDSTGASRSAFIPDLMNRDTYNEDGVGGMHVYTPWWG
DNKKLNFPRGYHIEVWGGLGMPSYGFGFNPNDLNRFFNQKVGGYGNSLRADIKKYYGSTI
GMAGRGESIAMKDNYCEIDPTTVDEFGIPVLRFNYKWSEYEVNQAKHMNDTFEEIVHNIG
GTMLQDAPSKESNYGLENPGRIIHEVGTTRMGSDPKTSVVNEFQQLHDVDNVFIVDAGPF
VSQADKNPTWTILALSWRASDYIIEQLKQQNI
>KECLDBNJ_01754 hypothetical protein
MDRRDSLKSMFLGSLGTGLLLTGCDPNLGEKEVEIAKAAEDYFGRTPEELELIEKLQSEQ
FFREHEMDTLNVLCALILPANEEYGSATDAGVPEFLEFIVKDMPYLQTPIRGGLMWLDHT
SNLEYDTEFKSTSEENQKAILDTIAFPDPEKPGWEQPVQLQFFSLMRNLTMTGYYTSEMG
IKDLDYKGNQPNIWDGVPEEVLQKHGVSYDPEWIAKCVDQSQRGVTAEWDDDGNLLT
>KECLDBNJ_01755 2-hydroxypropyl-CoM lyase
MKNILPTSTVGSLPKPAWLAPPEKLWSPWKLEGDQLLEGKQDALRISLQEQHSLGIDIIS
DGEQTRQHFVTTFIEHLSGVDFKNRKTVKIRDRYEASVPVVVDEVARQKAVFVEDAQFLR
KQTNQPIKWALPGPMTMVDTLYDDHYKSREKLAWQFAKALNEEAKALQEAGVDIIQFDEP
AFNVFFDDVNDWGMAALERAIEGLHCETAIHICYGYGIKANNDWKKTLGSEWRQYEEIFP
KIQTSNIDIVSLECHNSHVPLELLELIRGKKVMVGAIDVATNTIDTPEEVAQTLRKALEF
VAIENLYPSTNCGMAPLSREVARGKLSALSAGAALVRNELGF
>KECLDBNJ_01756 hypothetical protein
MTNTQDTIKDDFEFTVKRIYFDEDYVPSSSTRTTTNFANLARGARRQENLRNTLTMINNR
FNSLANWDNPDQDRYQVELEIVSVDLDMHDNGATFPAIEVLKTHILDHKTGKRIEGIVGN
NFSSYVRDYDFSVLLIEHNRGKTDFSIPDDFGSLHGTIFKRFVSSETYKKHFAKPPVICL
SVSHNKTYQRTGNHHPILGYEYQVNEASLTESYFKKMGLQVRYFMPRHSVAPLTFYFFGD
LLTEYTNLELISTISTMETFQKIYRPEIYNANSVAGSCFKPSLKNPDHSLTKIEYDREER
SQLAIEQGKFTEEHFIKPYKNVLEQWSANYAH
>KECLDBNJ_01757 DNA-binding transcriptional activator DecR
MSELDQIDLKLLELLQQSGKLTTKEIARQVNLSHTPVYERIRRLEREGIIKKYVALVEAE
KVGKGLIVFCDITIKEHTKEIGHQFVQDIMASKYVCECYNISGNYDFRLKVMVRDMKHYQ
DFVLNDLGSIKNIGSAHSTFVMGVIKHDYAVPI
>KECLDBNJ_01758 Toxin ParE1
MREAKYRISQQAIEDLDHIWLYTLHKWSKEQADTYYKLLIDRIEFIAANFMTGKSVGHLR
KNYRVSVIESHVIFYRKDDTNTVEIVRILHQRMNVKDRI
>KECLDBNJ_01759 Antitoxin ParD1
MGKNTSISLGSHFEEFVNEEVKSGRYSSVSEVIRSALRLFEREELKERELIKALEAGEQS
GFVDDFDSQKRLEALHKKYL
>KECLDBNJ_01760 Inositol 2-dehydrogenase
MKRRDFVIKSSLAAAAVSSASPGFAYINKYVGSSAPIRIGVIGTGDRGGGLISVMNGIEG
IEVAACCDVIPFRLANGMKRAGDSAKAYTDYRKLLEDKSIDAVLVATPFSTHAQIELDAL
AAGKHVYGEKTMAKGYDAVLDVVDAAQGNLVFQTGHQYHSSRLYTHVVDLIKDGKIGEIT
AFECQWNRSGNWRRPVPEPELERMINWRMYREYSGGLTAELCSHQIDFTNWVLGETPSQV
FGTGGIDYWKDGRETFDNVHHLFSYPSGVEATFTCLTTNAKDDYQIKVMGDKGTIILDYV
NGWFYPEGNYTKKRAEVDGVAGATTPWEAGKGIPFEFSHADPSKQALMDLRDAIKNNSKP
ISDLKTGANTAICVQMAIDSMLTNEVVKWNPKHSI
>KECLDBNJ_01761 Inositol 2-dehydrogenase
MTTRRSFINKSILGGTALALSNTAMGMAASSYRNIIGANDRLNVAVAGLGRRLGAYYAPI
ARKESNVRLLYLCDVMEKSRLNALKNFKEHIDYTPVLENDIRKLIEDKDVDILVNATPDH
WHTPGSVMALKAGKHVYVEKPCSHNMNENELLVVAAKKFDKRVQMGNQQRSSLHTIEIID
QIHKGVIGDVYKAVAFYSNTRGETPVQQQAAVPTGLDWELWQGPAPRRAYTSETWDYNWH
WYGWNYGTAETGNNATHELDIARWALGVEFPNYAEVQAEKRHFKNDGWEMYDTMYATFKF
DDDKVINWDGKSRNGYNTYGRGRGTLIFGAEGSVLVDRSNYVLMDRSGKVIKQSEETSES
GLALGGGGDSSTAHMVNFFEAIRGKETLKAPIEDASVSMAMVHYANMAYRVGHGFDIDAK
SGRIYDREAMQLWGREYAPNWEPKI
>KECLDBNJ_01762 hypothetical protein
MNRHLYKGAALFVLASLLITGCKKESDQEPWQDLFDGTSLNGWEQLNGKAAYRIEGEEIV
GTTVANTPNSFLTTTEDYGDFILEFDYKVDPSMNSGVQIRSLSDPDYKKGRVHGYQVEID
PSDRAWSAGIYDEARKGWLYSLENNPKAQQAFKQNEWNHYRVEALGDTLKTWINGVEAAH
LVDDQTASGFIALQVHAIGAEDEPGKEIRWKNLKIISENPREYSKQMRLPAFNTKNNLTQ
AEAASGWQLLWDGKTTKGWKGAKLETFPEQGWQIEDDMLTVMESGGGESEAGGDIVTTQK
YEDFELKVDFKITEGANSGIKYYVDTDLNKGEGSSIGLEYQILDDERHPDAKLGNHEGSR
TLASLYDLIQANPNKPVNPIGSWNTARIVSKDGKVSHWLNDEKVLEYDRSTDAFLQLVQE
SKYKDWPGFGTLERGNILLQDHGNRVSFKNIKIKEL
>KECLDBNJ_01763 hypothetical protein
MKKYIPLFLTLLLAFTSAAQQQLTDYVNVFLGTSGDHGQMSPSATTPFNMMNLGPQTNPH
QHTGYEYYAKQFDGFTHTRMEGVGCTGSGGNLLIKPILNAEVETQLIKKTQDAVPGFYHV
NFENGIDAKLTVAQNLGMHQYTFPNANSGLYIDLSFALSNRFVAETHEIRRNLISGFIDT
KTTCHAGTYRVYYAIKLPEEAQIQNVGEHQLMVKGLGNTAEVQVGFSSVNEGYAKKRITS
DDFETLKESASASWNAYLNTIEVFGETDRMELFYSLMYRTAQSPFLVSEEDGTFRATDGS
VQNEEYKVYNGWAIWDNYREQLPLLSLIKPKTYQNITTSIANLYRFGKKNWATEHETSPT
VRTEHAMVVLLDAYKKGYEVDFEAIKDSLLYEADHLDFGAPDKALESSYDLWAMSEILKA
TGDSRAGKTYLDKALDYKAYWDKDFKDLSKNDVDRMQARGLYQGTIWQYRWFVPWDVNGL
QDLTGGAEAFEGQLDQFFEEFNYNHANQPDLQVPGLYNATRQPWKSQKLFREILLDTVVQ
TYFNDNSKGIDPYVGRIYQNKPKAYLRTMDDDAGTMSSWFVLHSMGLSVANVGSPVYYLT
APIFKEVNLNLATGKTFKISVKNYNKDHFYVKSATFNGKPLNRNWLTHEELTSGGDLIIE
TADTPNKDWGTQNTFITKVELN
>KECLDBNJ_01764 L-fucose-proton symporter
MNKTQAAPVVPKKLLLPFILVTSLFALWGFANAVTDPMVQAFKKVLELSNSQAAWVQMAF
YGGYFCMALPAALFVRKFSYKSGVLVGLTLYAGGALLFYPAATTGLFWFFCLGLYILTFG
LAFLETTANPYIMAMGDQKSATQRLNLAQAFNPVGLIVGLLVAKFFVLDLLQSDDVENFS
ALPEAQKLLIKSADLMVIRNPYVILGLVVLAILVLIAVNKMPQAKGDGSIPSIKDTFSEL
FKNKKYALGVFSLVLYMGAQIGCWTYIYQYAEAKGISSSTAANYQLVAFILFTVGRAIGT
YMLKFMSSGKLLFCFSGLGGLFALGAVILEGHAGLYSLVLVSLFLSVMFPTIYGIALEGL
KEDQAKIGAAGLVMAIVGGALLPKLQGMIIDFGGVGVNDITVLGLSEMNLSFLLPVSCFT
IIAIYGIWIHRKHNIAETL
>KECLDBNJ_01765 hypothetical protein
MNYIPFSNRFFNQRIYYFLSFLVLGTTMFVSCKTETDFKPYDLKTEYLKDPIGLDAAAPR
FTWKIDADSQYHQKEYQILVGQDSAEVAQGTGAVWEHASAEAINLVEFKGKELIPFTAYY
WKVIAKDSSGASSSSEIARFETGMMQTENWQGHWITDTNSIEVKQAPYFRRAITLEKEVS
KATAYITAAGLFEFYINGNKIGNHFMDPVYTRFDKRNAYVTFDVSDAVKESSELALGVLL
GNGWYNHQSTAVWNFDKAGWRNRPRFLLNLKVTYTDGTSEVIATDADWKTSLGQEVFNSI
YTAEHIDARLNQSGWNTTDFDDSAWTPAQVVEAPSKHIVAQAIQPIRLVDTLTPVSITKL
ADTSYVFDLGRNISGITQLKVQGDAGTVFRVTHAEQLDSLGDVDLSNINVHYRSHDDSDP
FQTDIYTLAGTGDEVFQPKFNYKGFQYVRVTSNEPVNLSIENLTGYFAHSDVEQVGEIKS
SNEVLNKIWEATNAAYLSNLFGYPTDCPQREKNGWTGDAHINTETGLYNFDGITIYEKWL
ADHRDEQQPNGVLPSIVPTWGWGYDWGNGPDWTSTIAIIPWELYQFYGDDRALRLNYEAI
KKYVDHITETENEDGLTTWGLGDWVPVKSVTPKEFTSSVYYFVDASILAKTAKLLGNEAD
AKIYADLATRVRSAINKKYLNTDTGIYESGLQTELSSALYFDVVPEHLRSKVAENLAKRV
RADDKHIDVGLLGTKTILGALSENGYADLAYEVASQETYPSWGWWIKNGATTLYENWDID
AASDISRNHIMFGAIGAWMYKGLGGILPDEQAPGFKNIILKPNFVKGLEQFKASHKSPYG
NIVSSWKREGNLVSYTVEIPTNSTASFNLKDFKEVMQEGEALKPELLTLSSGTHHFQIKL
>KECLDBNJ_01766 Endo-1,4-beta-xylanase Z
MRSLHQLVLGLFLLTCTFTYAGKLETVTTHSDVMDKDIKAMVITPDDYNASKKYPVVYLL
HGHSGSYIEWPKRAPQLLEFADTYQMIFVSPDGNYNSWYFDSEVKPESQYETYIAEELVA
FTDNTYSTIKDRSGRAITGLSMGGHGALYLAFKHQDVFGAAGSMSGGVDITPFPNNWELS
EYLGTYAENTERWEANSVINMTPLLTPNSLQIMISCGTSDFFYDANVKLHEKLEYMNIPH
RFLTTPGGHTWDVWRDAIKYHLVFFDSFFNPVE
>KECLDBNJ_01767 Arylsulfatase
MLHKLNPFRKKISLIAGCSLLFINCKNNDTSDKASVSETPEKPNIVVIMADDLGFSDLGC
YGGEVDTPVLNGLAENGLRFNAFYNTSRCCPSRAALLTGQYPHQAGIGQMTMDRNLPGYR
GRLDEQTVTLAEVLKTAGYQTGMVGKWHVSPTEDLGGNEQLEWLNHQTEKETFSDLDTYP
TARGFDKYYGNIWGVVDYFDPFALVNGTKPVKDVPEDFYYTDAIGDSTVAYVDHFVKEEK
PFFLYVAHCAPHWPLMAPEQEIKKYEHVYDEGWQKIREERYKKLIEKGIFKGDTTKLSEF
MFPDLKWAENENENWDSRAMAVHAAMIDRMDQNIGKLIDKLEATGQLDNTVIMFMSDNGA
SSERPSQYGIGFDRPSETRDGREIHYPVKKSEEHLPGPETVMSGIGAVWANVANTPFRYW
KARVYEGGITSPFIVHWPAGIKEQGAVKSQAAHIIDIMPTLLELSGATYPEEFNGNTIDP
YMGKSMVSAFTNTEEAPINETLFWEHFGAAALRQGDWKLVKLDGNADWELYNLKEDRTEM
NNLAAKYPDRLKAMQEEWNTMAKATDVFPN
>KECLDBNJ_01768 Beta-galactosidase large subunit
MKKIRVLAILAFVTTTLTAQWKPAGDKIKTKWASQIDVNNVLPEYPRPIMERDAWQNLNG
LWEYSIEKKGAAAPKSFDGKILVPFPVESSLSGVMKEVGADQEVWYKRNFSVPSNWNNKA
VLLHFGAVDWETEVWLNGVKIGSHTGGFTPFSFDISPFLKSGKQELTVKVWDPTSDGPQP
RGKQVKNPDGIWYTPVTGIWQTVWLEPVSKKHIEDVRTTPDIDQGTISFEVAAAGTTYGD
VVEITILDGSNTVSTTKAAVGEPIVIAVPDAKLWSPESPFLYDTKIALLDNGKAQDEVQG
YFAMRKISKKRDDKGIMRMQLNNKDYFQFGPLDQGWWPDGLYTAPTDEALKYDIVKTKEY
GYNMIRKHVKVEPARWYTHCDRLGILVWQDMPNGDNSHDWQNRDYHKGNEFERSAKSEAI
YRKEWKEIMDYLYSYPSIVIWVPFNESWGQFKTVEITDWTNEYDPSRLVNSASGGNFFQT
GDILDLHHYPAPNMYLYDANRVNVIGEYGGIGLPLEGHLWKTGNNWGYVKFNNSKEVTDE
YVDYAEKLKELVSAGFSGAIYTQTTDVEGEINGLMTYDREVDKLDIKRTNQINTEVINAL
NE
>KECLDBNJ_01769 Sensor histidine kinase TmoS
MKYLKHTTLFLLVFVQIVLGQDYYFEHYTVENGLSHNTVLSSLQDSKGFLWFGTKDGLNR
FDGYAFKRFQNKPNDQKHLLGNYVESLLEYDGHIYAGTDNGLFRYDYKLENFTLLEGTED
IIIQDLEHDAEGNIWYIGNGTIYNYNITTRQTEDFPPSNYFIASELLETPEGGIVAAGLD
QLYRFNPEEKSFESLGFYMPDVELSAFNINILLMLDDNTIVIGSHNYGVLAFDLKTKKTT
SLLPVANPFYIHDLTLKNEDELWVASESGVHIYNLKTKAYTNLKKNISDRYALSDNAVYT
LTVDSSGGVWAGTYFGGINYYAPASRFFTKYFPKPAQNSIVGNAVREIKADQNGMLWIGT
EDNGLSKYNPKTDTFTNFKSEESGGILTHHNIHALMPDGDQIWVSYFDNGIDVIDINTHK
VLKHYQVGTLGKARNNFVFSLVKTTSGKIYAATVRGVKYYDPDQDRFVLCDAFPENYHYT
SFIQDSKGVLWAGTYWDGLYFFNPKTEEKGYFQEENAQGNTLSHNHINGIFEDDSQRLWV
TTENGLNLFNPSTKTFNVFTTAQGFPSNVFYAVVEDNSGKLWATTANGLTAFNSNFENIQ
TFTKAQGLLGNQFNYNSIYKNPSGRIYTGSVNGMVSFDPSSLIKDKNHAPLYLTGLHINN
KEVAVNPEDDILPESIATLNTLVLEPEDSSFSIDFAALEYTAPEVTKYWYKLEGLNTEWI
SLGTNNTVHFTKLNPGEYTLHIKSQNSNGVWSQESQPLNIEILPPFYLTKLAFALYILFA
VLCIAAAFRVYHLYLARKNNRRIKQANDKKEKEVYQAKIEFFTNISHEIRTPLTLIKSPL
EKILKYKDIYPEIADNLKIMNKNTNRILNLVNQLLDFRKTEIEKMSLSFVETDVSQLVRK
TQSRFTEAINDKEMELHLDLEEEVIAFVDPEALKKILSNLLSNAIKYGEKHIYLSLEKAG
QHFKIAVKNDGYLIPESMKNKIFEPFYRLSEGATQAGTGIGLSLAHSLSEMHDGSLKLQT
LDNGLNTFVVELPLHQKKHFELYDHPATTEETPLIPQKPVQASAATKPVIVVAEDNQDLR
EFVTKELQEAYKIYAAPNGEIALQMLKEHSAHLVISDIAMPVKDGFTLCREIKTNIETSH
VPVILLTSKNALSAKIEGLESGADAYVAKPFSVDFLKKQVANLIENRKHIMEHYATSPLA
HMRSMANTKTDDAFIKKLDDTIANNMADSNLNVETLAEIMHMSRSTLYRKIAEITNLSPN
ELINISRLKKAAELLKTENYKIYEVAEIVGYNSATSFGRNFQKQFQMTPSEYVNSDQRIS
>KECLDBNJ_01770 putative rhamnogalacturonan acetylesterase YesY
MRIVSAFLVLFSAVLFTSCDTAQAQKPTVYCVGDSTVKNGSGKGDGGLWGWGDYIGQFLD
TTKVSVKNHALGGTSSRTFQSKGLWQPVLDSLQKGDYVLIQFGHNDSGALNDDSRARGTI
KGTGEETEEIDNMLTGEHEVVHSYGWYIRKVVTEAKAKGAIPVVMAPIPRNDWMDGQVPR
NDESYGGWAKQIAEEEQVTFINLNDKMASEMEKRGEDQVTGHLFYKRDHTHTSAKGAVLA
ASLIAEGLQESDNSLKEYVLENPEITLPQKHNLFIIGDSTVANNGQDGKTGWGVYLPQHI
DTTRMNVYNKARGGRSSRTFRYEGLWDEVKERLEPGDFVLMQFGHNDGGHVDQPKYRGSL
KGMGDETQEVQRDSTGVETVHTYGWYIKQYIKETEAAGATPIVLSMIPRNEWPNGKVERP
TESYVKWAKEAVDEAGGYFLDLNEAVAQKYEAMGKEKVAEFFPDDHTHTNHAGAQLNALT
VAELIEGLRKSDLRDYVFIASEE
>KECLDBNJ_01771 Beta-galactosidase
MNLKTRILSVFLLASSTFICAQQTHKIMLSGPDFEHPKTWDFKVSEGNNSGKWSTIEVPS
HWELQGFGEYTYGRWYKELEQDEPSKEEGFYKLDFEMPASAEGQVVSIHFGGVMTDTEVK
INGEVVGPKHHGGFYEFEYDITEFLNFGDDNLLEVHVWKHSENNTVNNAERKADWWLFGG
IYRPVWLEVKPQTHIDHIAVDAQMDGSLKAVLDLVNPSENLKVLASLSPLEGNETFEVKT
IDLTAENEQTIATQWSKVKPWDPEHPNLYTLKLELQKNGKTVHEVSERIGFRTLDFRKRD
GIYLNGTKLVMKGINRHSFWPEGGRSTSKRISVMDVNLIKDMNMNAVRFHYPPDDHFLAV
CDSLGLLVLDELAGWQNPYDTETGEQLIKEMVDRDVNHPSVIIWDQGNEGGWNYDLDDDF
ERHDPQNRIVIHPWSDFNGWDTHHYPTYLTGVHRFGSGENVFFPTEFMHGTYDNGIGAGL
KDFWEHYSESPLFAGGFMWVYSDEAVLRTDWTGEEKFDSKGNLASDGVLGPHREKEGSFY
TVKEVWAPVQFQPKAITETFDGSFLVTNAYLFSNLNTVTMNYRVMEAGAGTMYNPNTKAR
VVASGAIDLPNAAPGETRKITMPVAADFFKGDWLEITARDQYGREIYTWTWAIHKADYFA
DKLIYQEAVKKSAKATQDENLVTLKSDKVTLKLNAQTGYITEVKSEKRNIPFVNGPKPIG
MKAEVEKVTLTQEGKNAVCRIDYNGGIDHITWTMYPDGRVHMKMIALKNAGRNSGFDGAF
YEGDIDKFGITFDFPEEGVEGITLFGRGPYHTWRNRLQGIEYGIWEKEYNTTITGESFEN
LVYPEFKGFYANFLAGNLQAGKNSFKVFSESDKLFLRLFTPDEAQNGFRGSHFQPSFPPG
NISFMYEIPGQRAFKPLSQQGPSSQPSNIRIKSGDDGISMKLWFDFRTDVDLK
>KECLDBNJ_01772 Rhamnogalacturonan acetylesterase RhgT
MYKIFQMLVLIVASMQSIASQTNTHYFDFGRKATQADATFIATALPYTPASGYGFDLGTA
YRVAIQEEGFKATMPVYFSVDLPEGNYKVTVTLSGKNTEMTVKAESKRLFLAQERIASSK
AAIQTFTLSLFNKTIEPGYDVGLKERELAKLDWDKKLTLEFLGSSTVQSIKIEPVNQTKT
LFLAGDSTVTNQDVEPWASWGQFITAYLNEEIAVANQASSGASLASFRSSRIDKILNQLK
EGDFVVIEFGHNDEKVKGEGAGAYGLYTSIMTDFIKRIKEKGGTPILITPTQRRAFDGKK
LKPTHGEFPDAMRKVAQNEAVALIDLTKMTTKMYEAWGPQLSRKAFVQYAANMFPGQREA
LEDNTHFSNFGANEVALAILSGLRKSDSELKNYIAKDAPSYDPDTPNLPESYTLPYSSLF
ESLKPDGN
>KECLDBNJ_01773 HTH-type transcriptional repressor YtrA
MSQNVNISINEDSRIPKYKQIVDSIINDVAKGKLKIGEKIPSINELSESAYLSRDTVEKA
YKILKERKVIISVKGKGYYTAKTELISRINVFFLINKPSSYKMMIFNHFVNTLGVNAHVN
LYIYHCEESLFVNAIEKNLGAYNYYVIMPHFKDNDLNHISFTPEVLKAIELIPKDQLLMV
DNTKPEIKGNYGSIYQDFKEDIFNALKEGMDKLKKYDKLILVYPEKLIHPYPRRIMHGFK
QFCMQYDFEYEILNEIYDDMDFESRDVYITIEEMDLVNLVRQIRERNLTMGKDIGVISYN
ETPLKELLGITVISTDFKAMGETAAYMVLKNKKEKVKNVFKYIERNSV
>KECLDBNJ_01774 Dihydroanticapsin 7-dehydrogenase
MEKTFSHVDYLWDEQKAAELGDDQVALFLYRSNILGADLRITNYGGGNTSCKTIEKDPLT
NEDVEVMWVKGSGGDIGTLTRQGIAGLYTERLRNLKNVYGGLEDEDRMVGLFNHCIYDLD
SKAPSIDTPLHGLLPFAHIDHLHPDALIAIAAAEDSEKITKEIWGDTMGWVPWQRPGFDL
GLQLEKCLNENPGIRGIVLGSHGLFTWGDTSYECYINSLEVIEKASSYIEKKVKENGNVF
GGQKIESLPADQRKDQAAKLMPLLRGLASSENRMIGHFTDSDTVLQFINSNDLEKLAPMG
TSCPDHFLRTKIQPLILDLDKNADLDDTEAVLAKLEPSFEQYRQEYKDYYESCKHDNSPA
MRDPNPVIIIFPGVGMFSFAKNKQTTRVASEFYINAINVMRGAEAITSYTSLPRQEAFDI
EYWLLEEAKLQRMPKEQPLSRKVALVTGAAGGIGKAIADKLVAEGANVVLTDMSEEALKE
AVATYKKDQVAGAVCDVTSEEAIKKAYKEACLAFGGVDIVIHSAGLAISKALEDTTQKDW
DLLQNVLVKGQFLMAQEGVAIMRKQGLGGDIVNIASKNGLVSGPNNVGYGTAKAAQQHMT
RLLAAELGGDKIRVNTVNPDGVIVGSKIWEGAWAEGRAKAYGIEVKDLPAHYAKRNLLNE
IILPDDIADGVFACVGVLQKSTGNTINVDGGMANAFVR
>KECLDBNJ_01775 hypothetical protein
MNIETQQLQDLNAKNLSTHKSQFDFLTQTLSNSDVDVDQVIKKLADFQVAIPSWALGAGG
TRFGRFSYGGEPASLEQKIEDIGLIHKLTQTAGAISLHIPWDVPEDYNAIKELAALNKIK
FDAVNSNTFQDQKNQKETYKYGSLSNTSAAVREQAIAHNKEVVEIGNKLGSKSLTVWLAD
GASFPGQNNFQTALTHTQNSLISIYEDMPADWKMFIEYKPYEPYFYSTVIQDWGTSLMLA
NGCGERAYTLVDLGHHLPNTNIEQIVSILMLKGKLGGFHFNDSKYGDDDITVGSIKPYAL
FLIFNELVYGMQNNPQNPELGWMIDASHNLKDPLEDLIQSLEAIQEAYAKALLIDQEALR
AAQENNDVTLCQEILQTAYRTDVRPLVQEARLKTGGALNPIAAYRDLGVRDALIKTRGKN
TVATGL
>KECLDBNJ_01776 Rhamnulokinase
MKKTVTAVFDIGKTNKKFFLFDAEFQEVYREYVQFDEITDEDDHPTEDLSALRDWLKTVF
DRMLKTEKYDIKAINFSSYGASLVHLDENRDVIFPLYNYTKSIPQEIIDSFYEKYGPEED
FHQKTGSSSSGMLNAGMQLYWLKNTKPEVFKKIRYSLHLPQYLSFVFTGIPLSEYTSIGC
HTSLWDFEKRDYHDWVYAENLDQILPPIVSTETSINMNYNGKRIKIGVGIHDSSAALLPY
VRSLKNQFILISTGTWSIALNPFVERTLSKKDVADDCINYMRINGKPVKSARLFLGNEYS
IQVKKLTEHYGVDKDYHKTVKFDPEIHYEIVKEFEKLFKWESIVDPEMPEETHLRYTSFE
DAYHHLMMELVLLQVESIKSAKGNMTIEKLFVDGGFSDNDIYIHLLSHHFRTMELRTTDS
SLGSALGAAICISDTQLNSKFLKKNYSMKKHIPFIAK
>KECLDBNJ_01777 (S)-mandelate dehydrogenase
MANSFDTAYPSVDDLRSKAKKRVPAFAFEYLDGGCNEDVSIQRNTSEIRDVQLQPRYLNN
YGQSSTKTKVLGMEFDAPFGIAPVGLQGLMWPNSPAILAKAAHKNNIPFILSTVTTMNIE
KASELTEGNAWFQLYNPVEDAVRNDIIDRAEAAGCPVLVLLCDVPTFGYRPRDFRNGLAL
PPKMSAKNIMQILGKPTWAFNTLKHGQPTFENLKPYTPEGLNLKQLGAFMDRTFSGKLNE
EKIKPIRDRWKGKLVLKGVQSLQDTQDAIRMGFDGIIVSNHGGRQLDAAQSTINSLKEIA
ATYGDQIEVMMDSGLRSGPDIARAMACGAKFTFMGRSFMYGCGALGNKGGDHTIGMLKTQ
FKQVMDQLVCERVEDLPKHLITS
>KECLDBNJ_01778 hypothetical protein
MSQYNQEEETIEEIAGGEFERQAVPQSRLQSWKAFLGMYAGEHAAGTEFVIGPLFLTTGV
SAFDLIVGLLIGNLMAVLSWRFLTAEIGTKFRYTLYFHLEKICGKRLVTAYNLANGVLFC
FLAGAMITVSATAVGIPFDMEMPKLTDTTPNSPTWVIIVIAIGAVISIIAAKGYQTVAKA
ANWMSPVIVLAFIACGVVALIQLDVHSFTDFWNIWGEGSEPFPGQIKYTFWHVVLWSWFA
NAAMHIGMSDLSVFRFAKKPSAGWTTAGGIYIGHYVAWISAALLYAVYLKSPEAQAMLAG
GEAPSVAPGPLANNAIGIFGIIAVILAGWTTANPTIYRAGLAFQAIMPKVSTFWVTILAG
SVATIAGLFPAFAMKLLGFVALYGFILAPIGAIIVFDHFFGKTAGIQPFYAEKTGVKFNW
AVFGAWALSFGVFYFISVQYDVFLSFLTLPAWISCGILFLIFSKFYQTKTAPLST
>KECLDBNJ_01779 Exo-poly-alpha-D-galacturonosidase
MLFSCKEPKASESKTSTPEWISEVGAEEIEFNKKVFYVNDYDAIADGSALTTAAIQKAID
AAAVNGGGTVTFKPGTYLSGSIFIKENVHFNIPEGVKILGSESIEDYPEIDTRVAGIEMK
WPAALINVLDQKNVTIDGEGQVDGQGKVYWDYYWNLREEYEPKGLRWIVDYDAKRPRTFL
LQNAENVFLKDLNIQRAGFWTVQVLYSNHITVDGLTIRNNIGGHGPSTDGIDIDSSKYIL
VQNCDIDCNDDNFCLKAGRDWDGLRVDRPTEYVVIRDCIALAGSGLTTIGSETSGDIRHV
FVSNIQGKGTKTGLKIKSATNRGGTVEDIHMQNIKMDSVGTFMEVSMNWNPSYSYSKLPE
GYDYDSIPKRWKTLLEEVTPPEKGIPTFKDISISNIEVQGAKRAIYVNGMETSTVNTIQL
TDVHIAAQEAGQITYSKDWTLDNVSLNIADGSTLTIENAPAVEFPNTLYIANDED
>KECLDBNJ_01780 hypothetical protein
MKLNVLRHIAFSLCMLQITAARSQATNQFELVTDRQKVSIVYDKDGVALDSIAAHLLAED
IERVSGYLPTVTTNQNAISGNAIVIGNQASDLIQSFSKVSKPQQLAWESYSIELIKPKNG
SITNALLIAGTDARGTAYGVFDISEKIGVSPWYWWADVVPTKQKELTLEINSFQSKSPKV
KYRGIFLNDEDWGLQPWAAHTFEPETGDIGPKTYAKIFELLLRLKANAIWPAMHPSTKAF
FHYPGNLKMAENYEIVLGSSHAEPMLRNNVDEWDHETMGDFNYFSNKKEVLKYWEDRVEE
AQNANGIYTVGMRGVHDSGMAGAKSTEDAANILNQIIQDQRKLLQKHVGNPDEIPQVFTV
YKEVLDLYEYGLELPEDITLMWTDDNYGYIRRLSNAEERQRSGGSGVYYHASYWGRPHDY
LWLSTTHPALIREELLKAYDTGADKIWILNVGDLKPAEYTMQFFMDLAFDPESFRKPDSY
KQHMTDFYEGIFGSDLGAEISSLRETYYDLAWLRKPEFMGWSQTEPTRPTHLTEFSLEEE
NPQRRAAYRQLEHKVQELTNKIDDAQQDAWFQLVTYPILGASAMNHKYLYRDLASFNAKQ
NPELMQNYQDSIALKQQQIQELTKKYNTQIADGKWNKMMHSAPRNLPVYKIPDAVLADEE
VNRKYSKPVISRKVADFSDAANFKEGFPQELTGLGYSKTALQLTPVTQKAYSATDFTGNP
VLHYDINLEQSLDNAVLTLTAVPNHPITGEQQLQIGVQWDDQAIQIIDFKTQGRSADWKT
NVLRNQARASVNLQKLNPGKHQLKLIVIDPGVLPDYFTISAKHQPLPYTFQPQETP
>KECLDBNJ_01781 Rhamnogalacturonan endolyase YesW
MSFQFKKYGLIIVLLCLSQACIAQRLMEHLDRGVVVIPQEDQTAVVSWRVLGTDPDELHF
NLYRQTGEETPQKLNTASISGGTFFIDTDIDWSKKNTWFVTSVLNGKEIKEPGTFSIAAN
AEHKPYLSIPLQTPDGYAPGDASTADLDGDGQYELVIHQMGRGHDNSHRGLTDDPIFQAY
ELSGELLWEINLGKNIREGAHYTQFLVYDFDSDGKAEMVCKTADGTTDALGNVIGDPEAD
WRDTDEKSRTYGKILKGPEYLTVFDGQTGKALATTDYIAPRGDISKWGGHGGNGGNDNTG
NRVDRFTACVAYLDGIHPSFVMGRGYYGRTVLAAFDFKNNKISSRWVFDSENRENPYSGQ
GNHNLSVADADGDGKDEIIFGAMAIDDDGTGMYSTGFRHGDAIHVSDLDPDVPGLERFGI
HEIENGTEGPGIALFSIKDGTVLYTAEPNRDIGRGVAANIDTTRVGAQMWWLGSHDLHDN
KGKVIGKAPRSANFLIWWDGDFSRELLDRTYIAKYGKGMLFKADGATWSKGSKATPSLSA
DILGDWREELLLPSKEGDEMRIYSTTIPTMQRMYTLMHDPQYRLSIAWQNVGYNQPPHTG
FYMGYGMKKAPKPNIKLIPETID
>KECLDBNJ_01782 hypothetical protein
MHASNTKRFLKPLFILFLIGFTWSGRGQQKQEYWHNKPRTLHYKPEGNSFVLVNGSRKFN
RALYGTNTGFRVETGDLPEFALYLPGMGGNFKLGISKEIESKWITEADSITTKYIPGMME
YEIRDALLGNGFLKLSVLASAETEGFLLKVEEHNIPKAVALHWLFGGASGKKFHRDGDIG
ADPEAVFYLQPEYTRHNAYELKENGFRLKFNWDAKSQTNKKTLTASVPEGPLNLGSAHAI
QNPNTLQRATLDSLPVIYGTVDRSAAQTYYWNIEHTINDTSDKALSNASAFKKARFKADT
LANRIKLNTPDPYLNTLGGALATGADAIWEDPAFLHGAVAWRMHLNAWRGAYNADLLGWH
DRAKTHFKSYGNSQVLEPERGPVVLDSSRNFARQKEVLGTAMFSKGYISRHPNRNDRAHH
YDMNLVFIDQLLTYFNWNNDPEFLEEIFPVIERHLAWEKRNYDTNDDGLYDAYAAIWASD
ALQYSGGAVTYTSAYNYRANTLAAKLAERLGKDPQAYLDEAEKIKTAIQQKLWLPDQGVY
AEYQDALGNQLLHTSPGIWTVYHVIDKAVPDAFQQQQALHYIQKQIPHIPVQAEGLPYED
LELISTTNWQPYTWSVNNVALAENLNTALAFWQGGNPEAGYKLFESALVESMYLGASPGG
FQQLSFYDAIRGELYRDFADPIGVASRALVEGLFGIQPNLLEHKLKIKPGFPEDWDHASL
NLPDLDVAFKKTENTTTYTIANKFKTDVDLELELSLNTTAIKAVLVNGNSVNYQLVAEAI
GKPKILIPAGTHKNYTIQVTTEGTTPEKLQSNAFYTQGAAFELKSNKAELLELKDPQGIL
SDTALSTEKLSGNITATTGHKMLFVKLKQNDMTWWQPIEIEIKSKFQILSTQLENDHLAI
TIQNNTDAQISGDLEINHTAAQQISFKARESATIILALAECFPGTNLLELRFASGEKIQL
PFTNWDIPNSSRKQQSMPNISSFFNARVDEVFQQQYLSPRPQSPTLQLPTTGVGNWCYPN
VAEDIHLDDSGLRKASKSGVLEGSNEILYATSSEENALNIAFASKWDNYPDSITIPLRGK
ASHAYLMMAGTTNPMQTQLVNGTVTVTYTDGTTTVLELKNPENWWPIEQDYFTDGYAFTT
GAPKPPRVIFKNGEIKRDFKDYINIHGFTNYGIDGGAGTILDLPLNPQKTLEKLTLEAQA
NDVIIGLMSITLLKP
>KECLDBNJ_01783 hypothetical protein
MKNTFWITTIVFALSLYGCKQEQYKDETADNAINRKAVVTRHNVHISEVDTLASLTVGNG
AFAFTTDVTGLQSFPEYYQRGIPLGTLSEWGWNAKPNDQGYSFEETLKDYDQNGRKVSYA
TQVKSPQHAKEAVEFFRSNPHRVHLGNLGFELTKKDGTPVKPEDLSDMDQTLDLWTGLLT
SSFVVEGIPVQVKTASAPDSDAIAVQVNSALIASGQLKIHLRFAAPTAAWTDYGTQWENP
KHYKSSIAAQDDTSALIERQLDSLNYKVALNWEGTATVSEKKAHYFLVEPTGDQIALTCT
FADSEPKGKNATETIFKNSATAWESYWSNGGIVDFSGSTNPRANELERRVVLSQYLTKAQ
TAGKMPPQETGLTYNSWYGKPHLEMHWWHGVHYALWGRPQYLKNTLNWYESAFDNAKALA
ERQGFKGARWQKMTDPYGDEGPSSVGAFLVWQQPHFITFAELLYRADSSKATLNKYKERV
FATADFMASFPDYDKENDRYVLGPPVIPAQERFEKTETFNPTYELAYWNWALKTASRWKE
RVGESVPEQWTEVLEKLSDLPVQEDYYLATESATDSYTNPEFLTDHPSVFGAYGMLPETS
LLNKATMRNTFDKVWEVWTWEDTWGWDFPMTAMTAARLGMPEKAVDALFMDVQTNTYLKN
GHNYQEERLTLYMPGNGGLLTAVAMMCAGWDGSETKNPGFPKDGSWDVKWEGLEPFF
>KECLDBNJ_01784 hypothetical protein
MLPMLKNLSICLILALAFTSCKAQDPAYIFTYFKGNGEDGLHLAYSTDALHWQSLNDDQS
ILTPEVGEQKLMRDPAVIKGGDGVYHMVWTTGWTERGIGYAFSKDLINWSEQQLIPVMQH
EETARNCWAPEITYDAQNDEYMIYWATTIPGLFPETQSEKDAGYNHRMYYTITKDFKAFT
KAKVLYEPGFNSIDAMIQWDGEKYVMFLKDETREPARKNLKVATAQHLIGPYSEASAPIT
GKYWAEGPTAIQKDGKWLVYFDKYTDHQYGAVQSTDLKNWTDISDQVSFPDGIRHGTAIQ
VSTEELKAIQEVFLDK
>KECLDBNJ_01785 Acetylxylan esterase
MKNYKSVYSVFVWVLGVSFVSMNSLHAQKEVKLWENGVPNSKTDAAYQEVQHADNGQVYG
VDKVTDPTLTIYEPEAVKANGTAVVICPGGGYGHLAIDKEGYKLAAWFAEQGVTGFVLKY
RLPSDAIMEDKSIGPLQDVQRAIRYVREQASTYGIDTSKVGIMGFSAGGHLASTAATHYA
DKVYDATEGVSAKPDFSVLIYPVISMQNGITHQGSKDNLLGKKASRGAAYAYSGEYQVTP
ETPMAFLAHATDDYAVPVENSINYYLALKDAGVPAEMHLYEDGGHGFGMGGTHTADSWPA
ALSLWMKKHDLITE
>KECLDBNJ_01786 Beta-galactosidase BoGH2A
MLLGFAVTLQSLFAQRQTYNFNSDWQFKTGEIEGAEATSFDTEGWTEVTLPHAYNQEEAF
LKSIDEHSTGIVWYRKNFVLPEAAKGQKIFLEFEGIRQGGDIFVNGKQIGLHENGVMAFG
LDLSDIVVFDGKENSIALRIDNDWHYRQRSTNATYRWNNINFNANYGGIPKNVFLHITDN
LYQTLPLYSNLETTGVYVYAMAFDIPQASATVHVESEVKNEYDSSKTFQYSVAVFDLDNK
KVAEFTGAETSLKPGERTIVSAAQRLNDLNFWSWGYGYLYTVKSMLKVDGNVIDEVSTQT
GFRKTEFKEGKVYLNDRVLQMKGYAQRTSNEWPAIGMSVPAWLSDFSNRMIVEGNGNLVR
WMHVTPWKQDIESCDRVGLLQAMPAGDAEKDSQGDHWKQRTNLMRDAIIYNRNNPSIVFY
ESGNESISEAHMAEMKSLRDTYDPYGGRAIGSREMLDSREAEYGGEMLYINKSAGIPMWA
TEYSRDEGMRKYWDEFSPPFHKEGDGPLYKGEPATSYNHNQDRHAIEDVIRWHDYYEARP
GTGHRVSSGGVNIIFSDSNTHYRGEQNYRTSGEVDPMRIPKDGYFAHQVMWNGWVDTEEH
GTHMLGHWNYQPGTQKDFYVVSTGEKVELFINGTSQGFGKKAYSFLFTFEDLRFETGSVK
AVSYDAEGRILSTAEKTTAGTPHSIRLKRLEAQLPFKADGADVALFEVEVVDKDGQRCPI
DNSKIEFELDGPATWLGGIADGPDNYIQSKVLPVENGVNRVMIQSTTQAGSIKIKAKASG
IKNASIQLDSEAFETQNGLANVLPGADLSSYLDRGPTPKTLSFSWKRKPVFIRSARTANE
EDEPYLSYDDNELTEWRNDGQAKTGWITYTLAKEAEVNECVIKLTGWRRKKYPLRILAGD
EVLFEGESWQSLGYITIPLKTVKTDEITVQLAGAQKEEDGFNDIVEVDPNKELDLFKDDK
AAAAKGQLRIVEIEFYEEL
>KECLDBNJ_01787 Unsaturated rhamnogalacturonyl hydrolase YteR
MRKLLVLAVLAAFNFNCAAQQQINRDDVLAKMELANAYFMKKWPDVGKTIITNKERPSNI
WTRGVYYEGLMALHEIYPKKEYYQYALDWADFHQWGFRSGNETRNADDYDAAQTYIDLYN
LQPDPEKLKNTRACMQKFLVTPQNGDWDWIDAIQMGMPVFAKMGVLENDARYFEKMYEMY
MESRNVIGEKGLFNPEDGLWWRDADFDPPYTEPNGEDSYWSRGNGWVIAALAKTLSIIPE
DAPHREQYIEDLQAMAEALVKVQREDGFWNVSLHDPTHFGGKETSGTALFVYGIAYGINN
DLLDREKYLPVITKAWNAMVSESLHENGFLGWLQSTGKEPKDGQPLSYEKIPDFEDYGLG
CFLLAGAELYRLEY
>KECLDBNJ_01788 hypothetical protein
MRFSLFSTVVGCLLFFSCQHQDTQAVATDAALWPELTQTAKPWTRWWWMGSAVDKPNIKE
HLIAFEKAGLGGVEITPIYGAKGEEEQFLEFLSPEYLELLDFTITTADSLGLGVDMVLGT
GWPYGGPQVEREFAATKLVVQKYELKQGEVFDQELKPDAKERQPASLSAVLAYDTKDNFK
DLTSDVTENKLKWTAQDAAYTVYALFTGKTGQQVKRAAPGGAGYTLDHYSKEAFEDYVQP
YDTAFSEIQGHLRAIFNDSYEVYGTDFTPKFFDFFKQWRGYDLKPHINLLLSDSDNDLGN
RVKSDYRETLSDLLLHQFNEPWTDWSNQHGFKTKLQAHGSPGNLIDLYASADIPECETFG
SMPFDIKGFRREEENIRTGDADPVMLKFSSSAGHIAGKPLISSETFTWLREHFKTALSQA
KPEAEELLLNGVNHIFLHGSTYSPERAGWPGWKFYASVNFSPKNTIWKDASALFGYLGNV
QSVLQEGKADNETLLYWPIYDQYNSYKDGNLFFQFKIHSLNEWLLDTPFYETTNTLMDKG
YGVDFLSDAFLKQAKVENGNIVLPGGTYKALVIPDCEFMPLASLEKLVALKNAGASVIFT
GLPESVPGYFEYEQQTAALQDLIAKNNLAITALESGLRAAEVHPETLVESGLKFIRRAQG
NSKIYYLVNHTSEAIDTYIPLSGNVDNAVLLDPLTRKVGTAAVRTTEGQAEVKVQIASGD
ALILKTNWSLPEEHWAYTTPMAEGIPLETEWNINFEEGGPVLPEAATLSSLKSWTKLGED
AEHFSGTASYTTTFTKPETEAGTWQLDLGDVRESAAVWLNDTYVGTAWSAPYHLDLGALQ
AGENTLTIKVTNLAANRLRAKELRGEEWKTFYEINMVNKDYKPFDATVWEPTPSGLLGPV
QLVPLAIETK
>KECLDBNJ_01789 TonB-dependent receptor SusC
MKQLNKWILTCLSILCFTGLAWAQEKSVSGTVTDAQGMPLPGVNVLVQGTQRGTQTDFDG
NFSLQASEGEVLLFSYLGMKSITQSVGSANTYTITMEADSAELDEVVLVGYGTQKKSSIT
TAVATMDTEILNQRPISKVDQAMVGQMAGVRVKQTSGVPGKSFSVQVRGTGSISAGNQPL
YVIDGFPLEPSTQNGNGDFGSGNPLDNINPGDIESIQVLKDAAAASIYGSRASNGVVLIT
TKSGKLGKPKLSFNTYYGINKTVKKLDMLSAEEWVDRASEIIDARWVNSGAGRTADQTSA
ERQAILGGFDTNFIKDDRWFQEGHPGLDYIDWQDEFFRTGEVKSYQLSARGGNEFVNYFI
SGEHLNQDGIALGVNYKRYSARANVEITASDNLKFGVNIAPSYSVTQDPGVEGKDNLMHY
VVSATPISEDGLDYNIGDNTAYAWGRSVPSPIRTIENTIGENKIFRTLTTLYGEYEIIEG
LRIKSSLNLDNTEAKNKYFRPSFVDRNRQAAGSFSAYQKQNFVNENTVNYDLNFNDTHTL
SLLGGASYSIFKYDNQRILAAQGFGSDDITTLNAANNINASGTYTFETKKVLLSYFGRAQ
YGYKDKYLLSASIRRDGSSNFGRDTKWGVFPSASLGWNIDKEKFIADVDFISNMKLRASW
GLAGNNTFSDDYASISRIGFSNYSYGGNFVTGQVPINSANPNLSWEESETINFGTDIGFL
KGRIFTSFDYYVKTNKDLLLSVPVPTASGFSSAVTNIGKVENRGWELELTTRNLQGGALT
WTTNFNISHNTNEVKQLGPDNSPILGGSFDIEHNILQVGQPLYSLYVVQQDGILSQEDID
NGAALYGNQMEGDPKYVDANGDGVISPADRVISGHPNPDYVYGMTNTFTYKGFDLTVLVQ
GQTGGKIYSTFGRAIDRTGQGYQDNHLGFIRDRWRSPENPGNGIEGKAYSTFGRIKNTDW
LYSSDYWRIRNITLGYDLGAVIDTNLFSGLRIYVTAENWFGNDQYYGGFNPEAVNSNGDD
YGAFPLSKSIVTGLNFTF
>KECLDBNJ_01790 SusD-like protein
MKKYITLILLAVLVVSCSDELDQTPISEQGSNNFYRNTADFEAAVNGIYSTLQSYPIYQF
YLSETRSDNLYAVSPTGVRAYDPINAFDRSLATNAIVADNWNTDFTGIFRANTVLDQINE
ELVPDGAVLNRIIGEARFWRAFFYFDLVRTYGKVPVFDRVYTPTETLEIPRAPVAEVYNL
ILEDLNTAIDLLPDSYGSDAQGKVTSWAAKATLGLVYLTRSGPTYGIEGAGLDADEYDLA
VTQFNDIINNGPFAFVSDYPAIFDYNNEHNAEIVLNIEYLSGGLGVGAEYPSLPVPDGYL
RVNGVGFSNGETAKQVATDLINAYEADDLRDDLDIQNGYTDQNGNFNPVPFYTKYLNLER
AGQDRFDWGLNYPILRYTDILTMKAEAILMGANGTQAEVDGIVNQIRDRAGLDPVANVDL
ATLLAAKRLEFAGESRRWYDLVRTGTVVSTINAWIATEDVQNRMQTMDENQILFPVPSSQ
ITVKENLYDQNPGYD
>KECLDBNJ_01791 TonB-dependent receptor SusC
MKQTNKFFLLCFSILMLSTSLWAQEKAVTGTVTDADGMPLPGVNVLVQGTQRGTQTDFDG
NFSLQAAQGETLLFSFLGMKSISQVVGAQNTYTITLEEDSAELDAVVVVGYGTQKQSDLT
GAVSSVSSEELLTQPVSNVFQALQGKAAGVDITSSERPGTVGSVRIRGNRSLTASNAPLY
VVDGVPLLSASSIETINPRDIESINVLKDASATAVYGSRGANGVIIVTTKKGKTGRFTLN
YSGTVTTSDIVDRAPAMSAADFIDFRRWAAYNLDPETYAHPDSPTLANDTNIFDSPLDGQ
TSRDNVLQGWQNGSFDASRVRNTDWTDFVTQTGILSEHTLSASGGTEKVNAYGSVGYVNN
KGTQKGQFYERYTANLSASIKPVDWFQFDANFNLSWSEQDYGFSTLGGRSGSVPNAIYGA
AKNIYNIAVPYDADGNLVINPGGETTIYTIIGEENKSTQLSQTLRALGSLSATFDFGEIY
QPLKGLEYLIRFGPDFRHFREGVYIDGSSSHRINSDGSLGTNYARLNNRRDFSWTLDNQI
NYSKSFGEKHNLDVTLLQTASSWNIESSGMSANNIPKASMLWNNFGAIDLTNSENNVSIG
SNLNERQLSSYMVRLNYGFDSKYLLTVSGRWDGASQLGAGNKWDFFSSAALAWRLDQEDF
LANADWVNNLKLRLGYGTTGNSAVDPYATKGDIISIFLPFNGLSNQIGYTTNEPYYSRSQ
LSLANPNLGWEKTTQYNLGVDFGLFNNRVSGSLNVYKSYTSDLLMSVNIPTLTGFPSTIA
NIGRTNNKGFEASLNLIPVATEKGFQWASDLNVAWQRDEIEELAYGENDMVDNNWFIGES
IGVIYGYDNEGLWQDTPEDQAEMALWNENGYDFSPGNVRPTDQNGDYVMNADDRTILGNT
TPRWTLGWNNSFSYKGFELSTLIISRLGYKANIGGEAMTARSNQREIDYWTPDNTDAAFQ
KPILGQATSGSQDEFSGLLGIQDAGFVKIRNISLGYNFSPEQSEKMGLNNLRVYVQAVNP
GSIYQGAAWYDFDTNSTIFNRSFAVGLDIGL
>KECLDBNJ_01792 hypothetical protein
MKLNILKRSSTILLCGALALGSTSCKDDFLDEELTNQYSTEYFETAQGLEDLTVSLYGNI
RWHFGYEWAYGLTLYGTDEFTNANDLTNEMWNTYDNRLNPVGATPETGAANNNATSPAAL
WDQMYYGIASANTIIANAEVIEDEGIRNRCLAHAHFLRGYNYYRLAAQYGGVVLQLEPAE
GVVRNFTRATDEETWAQVISDFREAYNYFEGEVYTYGKGVTWTKATAAHFLTKALLFRAS
ERNDDWNAEYIQGDLNEAIEAATYAIDARGGLAADYRDLYANWTGVDSEAEQLDEILMAA
PHNADASTTGRFGNRTYNYFTPQFSNFSGGWVRRGVWIGGMDFQRLRPTEYTYAVFDHVN
DSRMWKTFKTVYGVNNVINADAGVELGDPGIVMILNTKDDDTYNDFTFGANIQNPNWSDV
DGRLPEWRQGMRQTETSGSLTSTPGQFVPNSLVLYQNGQYVSPDFKSTPISNFFAGINKT
DDGSRFAEKGDAHRDVTMARLAETYLLRAECYARLQQYGNAMNDLNTVRARAAWKEGENR
SYYIDGSVAFENNSLNTGSAATNYVNSNLNMNTYYLSNPDVEVTTAASDLSLTSFPDNLP
DEDEAVLAALGVSGSYERALHFILNERTREHLGEWMRWETLSRTGTLIQRARAFNPQATN
ITENKHELRPVPQSFIDGLLNEDGSNLSPDMKADWQNPGY
>KECLDBNJ_01793 Histidine protein kinase DivJ
MHSKEYSRIKSLADLDLDYQQLVQDFKLLSELAAKVTGTQLSEVNLIDAYTQWTVAGTQN
QATQKPRETSICNVTIEQEQYFESLVAEDLRFKDSTYVVDEGYVFYYGIPLKLDQNVTVG
SLCVAGKDKTSLTQEQKEQLHLIAKELERLLQQQKQQQLLEQALADSKRMQRRLAHDIRS
PLSGLSQLLSTTSLSSLQRSDLESLLSDAAGTASSLLQLTEAILEDTPLLDQQLHVYDTQ
ALAKKLTDLYSPQAQVKAIAFNVRATPSVLRFPRKNLLPIIGNLIANALKFTPTNGKVQV
AMHLASSQKAKILHVRVEDNGIGMTPETQEAVRTGRAIPRKGTQGETGYGLGLSFVRERC
EALSGTFHLTSQKDQGTTVTLELPVM
>KECLDBNJ_01794 Inositol 2-dehydrogenase
MRTLPRRKFLQKTALASAGLSLTNSLLAQPIHLFSANDRINLGLIGCNGMGWSNLQAHLK
LPNVTCIALADVDERVLNKRALELQKNSGTAPKRYTDYRKLLEDKAIDAVIIGTPDHWHC
LNAVHALQADKHVYVEKPLANSIEECNVMLDAAKRYNTKMVQVGQWQRSGQHYDEAVNYV
RSGKLGPIRLVKCWSYQGWMNPIPVKPNTTPPKEVDYTMWLGPAPSRPFNENRFHFNFRW
FWDYAGGLMTDWGVHELDIALYAMNAGAPKSILASGGKFAYPDDASETPDTLQTVYEFEN
FNLLWEHATGIDGGNYGSTEGIAFIGNNGTLVVNRGGWKVVPERERQNDQWIDKTPEVSW
KDREGNALDNHAKNFVDTIRNNTPTELKCNIEAGARAAITAHMGNIAFKTGNKIYWDEQS
QTFNNPEADALIRANYHNGWELPKI
>KECLDBNJ_01795 hypothetical protein
MLLNLSISPYVLTCLTDVTMFATTLQNFHHELKTQVFVIPETLKKAEVGIEVASKTLICL
KELVEQEDFEDVPHEIHFFKHLKPCPMSYLIYFTEMRTCEMRKPKAGASFQIRFYKKELR
KINKFFNHNMHFVRYMEEEHTYLDHQFFTRNTQQNFPMTPMLYHYDYPDFSSAYDMLWAK
VQAMYRLIHYIRDALKTLNSPSETVPLPQKYHVMLWSGSKTALVELIYALHASQYLNHGL
SDLSTLVASFEGFFNIKLDGVYKTYGEIKARKGSRTKFLEELILKLEYKMRQDDV
>KECLDBNJ_01796 8-amino-7-oxononanoate synthase
MAQIKHNNFRDTVDKVITEAKAEGIVHLRAEDRQHTGRWLTVQGKACYHFGNTGYLGLEQ
NNRIKLGAMQALLRYGTQFPLSKTYISHPLYEELEEKLQLLFKNPVIITKNSTLGHLAVI
PTVVRDEDAVILDHQVHWSVQNAAQLLKVRGIPVQLVRHNNLEMLETLIQKLSSKVSKIW
YMADGVYSMFGDYAPVKALLALTKKYPQLYLYFDDVHGMSWRGANGMGYVLSQLGTLPEH
VLVFGTLSKSFGASGSVLICSNKKFYNQIKNFGGPLTFSAQLEPSALGAAIASANIHLSD
EIYRLQEALNNRIAYFNQQLVMAHLPLIARNSSPVFYIGTGLPATGYFLVKRLMEAGIYV
NLGLFPAVPAKNTGLRITLSNHNAFDDIDQLVEQLISNYDIALMATDNSRSRVGKAFRMD
FVDGKPFATTNQDLQFKEFKSIAETDATHWNTTLGKFNMLTYDGLAYLEQSFTQNQEPEH
NWRFWYIQIVDDANCPVLMTFLTESLWKNDMLAPASVSKLLEHQRKRNPYLQTSRVLSLG
CLFTEGNHLYLNEEHQQVTLALKQLLEYIENLAQTRKVTMTVLRDFDLNYNWSKAILDQG
YIPIDMPDSCVLLDLHHKIEADYTQYLSKRSQKHFKKDIEPYLSLVKSNVVQRVSSANIK
VYYELYLQVQRKNYGLNTFTYPLEAFEVLRSHPNWECILLKAVEDERLLGVMFCYKNYSG
VYVPSLIGMDYKYLEVFKTYRQLLYQTILRARKLNMKQIDFGMSANFEKRKLGAAVLPKQ
AFVQTDDHFFLEELEMMRTGHSG
>KECLDBNJ_01797 hypothetical protein
MRPDYENAYAEYRIKAGILFLYYKPEACLSLKAAEEVVQDRLAVQMGQPYPVYCDVRPII
DSEKEARDFLSQNGNALVRALAFRIDYPVTEIMMQFYLQNGSAAIPTQLVFDIRTAWNFL
SSFRE
>KECLDBNJ_01798 Regulatory protein PchR
MILEMAKGNFNYQIPRTGENNETEAIAASLNMLAQELRVSYNPFIFNAPADSIFKVRHYL
FLINPEHSILSTNFDLDAEPTFVDQNFLHLLTPASKKIFKKRLKQLLKKQYPSVPCRLEL
RASNTLNVPLECTLFKLRYDAVAGNFLVVASRIQSLNPLLKEDASKKEYPIRKLEALKNT
RDIQNIQDVKAYLQDHPEDRIASLKILGVRFGLNEYKLKKGFKELYQTSVFKYQLQQRLH
KAKHLIRSTTDPLSSIALQTGFKSYVHFGQAFKKEFGVAPSQYRKMHQ
>KECLDBNJ_01799 hypothetical protein
MSKAGYIKQVASMGVVPLFMLLWVYAATAKLLEFEAFSIQLGQSPLLSAYAGILVWLVPL
SEYVLSTLLLIPKTKNIGLYGSLCLMTAFTTYIIIILNYADFVPCSCGGILEALSWTEHL
LFNGFCIILILLVLFINRLSFSNQSQHRSLANGLLPLGSGMLFSSVMVIVLFLTSEKQIH
RNNAFIRRYIPHVFDQKQVYDLGVNSYYIAGLTTDSIYLGNSTAPFTLLSFDKNLSDFNS
SQIKLENASDIKFLASKVKVNDSVLLLYDGTVPVLFSGALQSRKITPRRTPFYFTKLQPL
ASNRYAFTSRAAATNENELGLYSYADTSGFKLIPQILERQVDGIFDVEGFLTFNEELQRI
IYVYRFRNEYLIMDTNLNEVHRKKLIDTISIAQLQIDTIAGKGQRKLGSNTIHVSNTIAT
SGKQLYVHSKRLGKYEPELDDGRSIVDVYDLNKGLYTHSLYLQHPGMKPLMDLALKNNQV
YAICGTYLIHYQKTIQNRVTPN
>KECLDBNJ_01800 hypothetical protein
MKNLKKQVFLPVAAIGLALGGAFMTSAAKVNAASNAQVPGYYYDNVQLECRDAGVECSTI
DTGIPCTDGTRNLFELDGTMCETPLYQIPQ
>KECLDBNJ_01801 Dipeptidyl-peptidase 5
MFRLLTTLILFVVGIGIPYAQSKKLPDLDDYKLWYSLKLRSTSPKGTWMELYKDYENLQD
TTEIRSLSGDKQYAFTNIQSVTLDENWCFYKSQTGIGIVNLLEDTQNHFEGYSAYTYIPD
LHMLLLESRSGTIDLKLLNLNNGRQQDLTDLEDYALNAQKTQVVYALQDTSAPRLEVYDL
ETGTRKPIPLKLEPGTHNRLIWNPDSSKIAWYYTPQGTKEPELFCYNLGDKTLMAFNATN
RAEFPADKQVNKPFTHKPFTFSKTGDCLFFRIQSIPRRTLAWGSGVEIYRSKDVYEVMNP
RYVEAHINTADYGVWNLKTNGYQQLTDSLWQTSYLTANDSLILLTHSKPYHPRIKLINDA
DIQLRSTMTGDSIYGASKIEGITSYTGIEPHGRFMYYYKNGRWLIYDIQRKVEIDLSVYI
PTPLSTADPSQSVFPFPYGLAGFDKTGTQLLVYDQFDIWQVDLIKLQAKRLTQGREQGRT
YRLITEPKILQDWEGTSLFTPDVLDLEKPLYLKSSDETYRSGFACYANGKLKNIAFKASR
HYSPKITENGLYYLEENQDLPPRVMFWNRANTTLKRGYQSNRHYTRFTTGKAELLQLDNE
KQMDGLQATLLYPFAYDASKSYPMIIDLYEQNAGAIHHYSVPFLGDRKGINYTRLRSEGY
FVLCPDLTYKSNQPGESSKQSIDLILKEVLNNTAIDSKRIGLNGYSFGGFEVNYIVGSGG
RYAAAVSGGGLSDLTRKYTTVDGVGNTKFYHLENYQGRMQGPYYENQQAYMDNSPIWKVD
QVNTPLLLYAGKEDYHVNRNQSIALYLGLKRAGKESTLLLYPDQGHAFSNLKAIQDVNDR
ILAWFEHYLNGDQKPLWMKANAY
>KECLDBNJ_01802 hypothetical protein
MKPILLYTHLKPFLAFLVLLNLILTGCESFIEVDLPPGQLTGEAVFTDLRTAEAALTDIY
ALQRDQGILSGGRSGISSNLALYADTYEQFGSQSSDPYFFFTHSVSPDTRTIANFWNTSY
NSIYAANALIKGIPGSDALDATAAERPLGEAYFIRGLMHFYLSNLFGPIPYVTTTDYRVN
QELSKKPVDEVYTQVVRDLIQAEALIPESYSSAERTRPNAFAVKALLARVYLYQGEWQKA
YDKAGEVLESELYTLDIPLDQLFLKESKNTLWQFMPQNAGANTLEGRNFILSVLGSNYAA
FNPDFVTSFEPGDLRIESWIDSITQNGITAYFPIKYREELSTASSLEYSKVLRLGELYLI
RAETAWRLNRIPQALADLNAIRLRAGLSSLNAATSEELENLILSERRAELFTEFGHRWFD
LKRWDKAETVLQESKPGWGAQSYLLPIPETELGANPNLLPQNPGY
>KECLDBNJ_01803 TonB-dependent receptor SusC
MKILTTRLTGAAWILVSLFWATGNLLWAMPQQTVFGTITDTEQNPIPGVSIRLLNSNTGT
QTDMQGAFSIQAQPSDTLSISYLGFKTLRLPVGNQITFTITLQQDITDLGEVTINAGYYN
TTRREQTGSIARVTTEEIERQPVTNPLAALQGRMAGVNITQTTGVPGGGFDIQVRGTNSI
GAGNDPLYIVDGVPFSGNSLGIATNNARVIPGSVSPLNALSPSDIASIEILKDADATAIY
GSRGANGVVLITTKKGKGGKTSLSLNMQTGIAEVAQFVDLMDTSQYLEMRREAYANDEIT
TYPSNAFDVNGTWEDNPETDWQEKLLGNQAQFQEVNLRLNTGSAQTRFLIGANLRTENTV
FEGNSDYTKASVLSAMNHQSADDRFAVNLSLNYVSEDNVLPLSDLTSQTRIPPNSPEVYT
EDGSLNWAGNTWGNPYAAILNESYRYKSNNLIANATFSYALTKALSFKANLGYNQIEMED
KRLFPSTRYNPAANRDSRYSVVYSNTASRDSWIVEPQLTYENRWKKLDVSLLAGVTVQQQ
REEQFYVSAQGFPSNQELDNLASATTTTILDNGSSQYRYQAFFGRVNLNWDKKYMLNLTG
RRDGSSRFGTGNRFANFGAAGLAWIFTEEALFKNQNVLSFGKLRASYGITGNDQIGNYEY
LDAYTLSGRSYGDLNGLAPAQLFNPNFSWETNKKLELALETGLLNNRIYVIAALFRNRSS
NQLVGIPQPGTTGFTSLRANLNAEVENRGFELELRSVNLDGKDLRWVTTFNFSLLKNELL
SYPGLENSTNANLLVIGESLNLVQLYELQGVNPETGIYEFRDFNGDGSISFTEDRKYIRS
YDPKYFGGLGNEISYKNWNLSFLLQFVGQDKNGLITNIPGAMINQPVAVLDRWQQPGDEA
TYQRYTTGRNSAALTAYNRFVNSSGNFVDASFVRLKNAYLSYRIPTVSKTITNASIFLQG
QNLMTFTPFEGADPESGFSTNLPLLRQFSLGLQIQF
>KECLDBNJ_01804 hypothetical protein
MSRYKDELNLAKLGANLTKRREGLRLSVEDVSEMTGFSAQTIRNIEAGEESSLSYVIAIC
QALELHPTKAFDFSIQLKPRFKLSAVRAEKTRLTQRIDGFVASDYFKKGRTAKDVVTELN
EVYHIKTTTSAVSVILKRKVDEQRLKITQDGKQRIYKKNS
>KECLDBNJ_01805 hypothetical protein
MKSKRLCIFPKDVQCITGKSERYGRQLLADIKVYHKKEPHQFVTVYEFAAYCGLQVEEVL
GYLD
>KECLDBNJ_01806 hypothetical protein
MNILDRYQKPTPRFFRILRSVGIGLASGGAALLAAPVTLPAFVLSLAGYAVVAGSVATAV
SQAVVADKLPEPEQHVDEH
>KECLDBNJ_01807 hypothetical protein
MRWLWYRSRNRRKMEWVLQRSYYRSGTNGVLFVNGRFLCFTIELPWRENRRSVSCIPEGR
YEVQFRVSRKFGNHLLLVDVPKRSWILIHPANDAQGALQGCIAPVSELSGIGRGLHSRRA
LARLLVLQREAQEHQEAVYLTITYNAHEYLRSLSKTHTTVFPHTS
>KECLDBNJ_01808 hypothetical protein
MAKQAGIIKLKGTIGDIAFYKSGDGHMARFKGGIDKKRIATDPAFQRTRENGAEFGRAGK
GGKLLRSSMQLLLQQAKDAKVVSRLTTVLLAIIKTDTLSARGARNLTQGDLGLLNGFDFN
ANSPLSTTLSAPYSVGYDRATGVVGLELEAYTPHVQIAAPAGATHYKLSCGASELDFEEQ
TSLFKSVTTGILPYQNTEVAATTLEVSLTAGSTLQVVHALSIEFYQEVNGTMYSLQNGAF
NAMAVVQVAQPA
>KECLDBNJ_01809 hypothetical protein
MLAVITLKAKNTYASIFYRLLQIEIVGHFLKSILRMQFFSHLFLQYSEKAPLKIFEALEK
I
>KECLDBNJ_01810 Alginate biosynthesis protein AlgA
MTNHNYYAIIMAGGVGSRFWPLSKASYPKQFHDILGAGETLIQRTFGRLSQTVPSENVLV
LTNEKYKGLVNEQLPEVRDENIVLEPAMRNTAPCILLAALKIYKANPDGVMIVAPSDHWI
ENEKAFLTDLNTAFEACAEDASEEKLLVTLGIEPTFPHTGYGYIQYNASTAAVKGVEAFK
EKPDYETAKQFLAEGNYSWNAGIFIWSARAIIEAFEKYLPEMYALFNSGFEALNTEAEQQ
FILDNYAKAENISIDYGILEKSGHVGVIPATFDWSDLGAWGALYDNLEKDQDKNVIVNAQ
TVLREAQGNLIRSEKGKVVVVEGLKDYIVVDSDDVLVIIPKAKEQDVKIIRAEVEQHFGA
DLV
>KECLDBNJ_01811 Tyrosine-protein kinase ptk
MNELNQQNEEINLREELDKYLRYWPWFLVGVFTCLLIAFVYLKLTIPVYDTVASVIIKDE
ESKGGGLGAGAEFADLGLLGGMSTNSIENEIGLLKSRRLMINTVQALKLNVVYYDLDGVK
TDELYANTPYVIEVVSLEEAALLGAKTKGLHQFTVEHTGSNDELLLTFPESGATQTVRVG
ELFQLEYGTFILKQNPEPVLKERVLIELRTIPSVADSYREAVQINLTDDNATLLELRLGS
PVKQKAQDILDQLIFEYNKEAIEDKNEVAVNTAKFIDERLQIISGELDTVEVGLESFKEQ
NSLTNIETESQLIVENASEYRKREQEIQTQLSIAQSIINYLQEDADTGLLPADIGLEGES
VNAQIASYNELVLERNRILSGATDKNPTVLRLNNQIEQLRQTILGGLERTVSSLEISLRD
LRQQSRFIGAQIATVPNKERQFRDISRQQEIKEALYIFLLQKREENSLSLAATSPKAKIV
DSAYSLNIPLSPKPKIVLAAAFLIGLAIPFLVIYIRRLLNNKIERREDIEKLTKSIPIIG
ELPRIAKGESDLIEENDRSVLAESFRILTTNLQYLLVNAKHEGKGYCIYTTSTVKGEGKT
FTSINLAMTLANTGKKVVIIGADLRNPQLQRYDTESKSFLGVSDYLVNDDHALNTLINDS
KFHPNLKLFLSGSIPPNPSELLRQKKFGAMLDELRERFDYVIVDTAPSMLVADTFLISQY
ADLIIYVTRAGYTEKRLLQFAIDSQNDGKLHDISFVINDVKTANFGYGNKYGYAYGQEKA
SLWERFKKSF
>KECLDBNJ_01812 hypothetical protein
MKSSYFNMLCWVTMILCFSSCVSRKDTTYFYEPDELEVPALIAMEQPAKSFITIQPNDEL
TITVSAIEQEAALPFNPPVVGASNVSNGAVSVGGTPQLQTYLVDSNGNIEFPVLGTIYVR
GLTRVALAEKLKGMIAAYVTNPIVNVKLSNFQVSVLGAVQRPGTYTISNEYLTIPKALGL
AGDMQIYGRRDNVLVMREENGKVTKAYLDLTDNSVIDSEYYYLKQNDVLYVELNDSQRQA
GSLNPNSGLFISVASVLISLVVLFVR
>KECLDBNJ_01813 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MKRSALIVPISILIHLSLLNGMLAWFIPNLYFDINSILFFNATWLLSAYAIDYYPTSRKE
RFFTNIHKPIQLYLLFTLGYFAWFSLSQTPLHSIAYHRNVLLCLFGSLLLYRILFYYARG
KYREVGGNAVNVVVIGRDRNLKKIRKVFDEPDLGYRYLGYFDNGHSKSPTYLGKVEEAFA
YFKRKDVHQIFCIASRLSQPQLFNLMAYADNNLIKLKIVPDNKEIFTRAMTIELYDNVPV
LNLRELPLETPFAKIVKRSFDVVFALLVIVGVLSWLSPLIYLLQRLDSNEPLYFKQKRHG
VNRKVFWCYKFRSMATTADADTKMMTKNDKRVTKLGRILRRTSIDELPQFYNVLLGDMSV
VGPRPHMEVHTEKYQSSVDKYLVRHFVKPGITGLAQVRGYRGEIIQQADIINRTRLDIFY
VEKWSLWLDVKIIIKTVLNAVQGEEKAY
>KECLDBNJ_01814 putative glycosyltransferase
MKISVITIVYNNKATIRSCIKAVLAQDYPDIEHVVIDGGSTDGTQAIIEDYKERLGYYIS
EPDKGLYNALNKGIKAATGDIIGILHSDDFYPKASTLSEIVKAFQSSSADIVYGNGMFVA
REQPDAVKRIYTAKPFRSRYLKYGWVPLHTTIYVKKEVFETYGLFEEQYRIASDYEITLR
WLSNPKLKTYFINDWLVKMRLGGKSTTPALQKIKSKEDLDIIHRYPLWGSITLAFKIGRK
IPQYLIPKLRKLS
>KECLDBNJ_01815 UDP-glucose 4-epimerase
MKRILVTGGAGFIGSHLCKQLLQEGHEVLCLDNYFTGSKEHIVDLLANPYFELIRHDITE
PFYAEVDEIYNLACPASPVHYQYNPIKTIKTSVMGAINMLGLAKRVKVKILQASTSEVYG
DPAVHPQPESYWGHVNPIGPRSCYDEGKRCAETLFMDYHTQNGVAIKIARIFNTYGPHMN
INDGRVVSNFIVQALRGEPLTIFGDGSQTRSFQYVDDLIHGLTRLMGTEAQVTGPINLGN
PQECTMLQLAQTILELTGSASRLVFQPLPQDDPQQRRPDISRAKALLQGWEPQIDLQEGL
RETITYFESVLRRDL
>KECLDBNJ_01816 Putative acetyltransferase
MVGTRLDQFDNRNFSKKAGVVKQFIWLTCNAFILRSGWFPFMTPKIYLLKLFGAKIGNGF
VIKTGVSIKFPWKLIIGNYVWLGENTWIDNLDQVTIGDHVCISQGAMLLTGNHDYTVSTF
DYRNGPIILKAGVWVGAKAVVCPGVTCNSHAVLSVGSVATKDLEAYTINQGNPARPVRKR
SVK
>KECLDBNJ_01817 Glycogen synthase
MKVLHILTSLNPIAGGVAKAVDLAVCALDSVGFASEVVCFDEPEASFLRSKHYEVYALGP
ANNMYSYTENFKEWARVHLRNYDHIILHGLWQYSSYGGYLFWRKYASTSSLWVMPHGMLD
PYFQKAKDRRLKAIRNWFFWKFLERQVVNNSNGLLFTCLDELKLARTTFKPYNPKSEIVV
GLGIDSPISYSYSLSEAFKSTIPALNERPYFLFLGRVDSKKGVDLLVKAYRSLRVKHADI
PDLVIAGPGLESAYGQQVLSDAAGDDRIHFPGMLQGAAKWGALYGAQNFILPSHQENFGI
AVVEALACGTPVLISKQVNIWREIIKEEAGIAEADTLEGTINLLERWLNFSEEQRRLKKD
NASKAYRQYFTTNAFGENLRVLFNK
>KECLDBNJ_01818 hypothetical protein
MLFLQPSIPHYRTDFFRGVAKFYTIKVFVSSDTNRIKESKFELSTFKAVKITSLKIGPFL
LYNPLPFIISKEGVVLMLNFCHLTTWFVLLCRRIVNRDTILWGHGISVKRYMDESSKPSS
LIKWQIKLSNLVWLYTEKEKKIWCNEGISPKKIVALDNTLSDVERILAFKPTKNKAALKI
ENKIKYDRVCIFSARFTLKERRADLLKKIIEATPDVGFVIIGEGPYKPDFSVFDNVYDFG
ALYDNAKKEELFSLADIYLQPAWLGLSIVEAMAYGLPIFTLARSKEIKQCVEYYYLEESK
AGVICEDVDALVTAINSCEQSRLLEMGNSARVYIADNLLMNNMVNNAVESIKSLEY
>KECLDBNJ_01819 hypothetical protein
MTIKNNVSFNNKVFFYLFSVLIFLSSFKAKNAKEEALTYSIPAPLEVLSNLSNYFIVFIL
LVLNIKLLSYRAKISRPLVLLFIFELVLILTEFYIDGDLNSLIINLGFTILIVVFFSRAH
FVFQENVEKYSFFNSIFFGSFCFIFLNAIVVILGLGNVIWNGRLFGLTSHPNFIGLYAAI
FASFTFYKLYNQCNKLKNILFYTISLILGIYIVVITGSRTALLFALLAISSNVFFSLKRY
DSKIMVLLLSSIFVLLFFGYLSIDDLDYTGRSNTRVNAWSNLLKQIEETGLFGIGRGRGY
TANSYFYAVVANGFLGSTLLFLVIIDDVKNLLYTQVYNIFYTSILIPMLICAFLEGFLLD
TISLPILVFWSLQTGLLKVKV
>KECLDBNJ_01820 hypothetical protein
MKKVLIVGYSRSGTTLVSKVFSLIDKVYVEVEPHATWRLGNFRYLNDEDYSISDKIVTRI
REKLLKDVPSDYVFVEKSPINSLRPHLVHAVFPDAKIIFIERDPVKCIKSNYKFAKKGYS
FSLSVILKKYSSTKVKFDKTNNNKKDNFHSKSIKEQIDFKDVFGLSLYALQMSLIKMFKT
VPFGPKIKGFTSIIKQKGLIAYYIEALKSVETYRCDYERLYQDNFKHFYLEDFLANKEIQ
RQMLEFSGVPYNNENLIEIEGLFSKSENSREELLDRQIQKHLDDH
>KECLDBNJ_01821 hypothetical protein
MVKLIYDSNLTGHHLEYILHIAKYVSDTKLEDKYIFVVPVSFKVNNAQIINESKDIIVWE
FLSQGIVDELKNISLLKRSFKEFGLVKQYANHYSVNKVYLLYFNVFQLALCFRKTNFFIS
GILFLQFSRMQKRGLTNYLKYYRKKIITQLYSTNKSIESVFILNDRKSVQYLNKLSDRNI
FKWLPDPIPNYKEEKGFDLFDFYGLDKNTKVFLHPGSITPRKGTYEILGAIDKLSKEVSD
QIAILIVGKANASVEAVIQKKIKNLKNQDFSIIFDNNFVSNERLKSLFLQSYAILIPYKN
PEASSGIFGHALSNRKPMIGNKNGLLGELISDQQLGLTLDEITAQEIADKIAYMIINKRK
VNVNELNLEEFSPDNFVQIILE
>KECLDBNJ_01822 putative glycosyltransferase EpsJ
MKEPFLSIIIPVYNVEDYIEQCLASIYSQDINFLDLEIIIVDDGTQDKSIATVENFLNFP
NIKLIAQKNSGLSVARNNGLELAKGKYVWFVDSDDWLIENSLNVLFESLKKFPEIDIFIT
PLKKVYPSKKISELDLFIDHNLIVKGKNYLFQRFPVGAAQRFIIKRDFLEKTKIKFYPQL
LHEDALFGPQLIYNANLVLVFKNALYNYRIRESGSIMSSWRAKNSFDLIFIHKELVNFLN
QSIENKIDRVKFLNLIHQVILMSFRFAGEKIDSAEFEEFYKNQRKYIKRQFLILLTKDTV
AIFGFKRFLKYLLYYISPLTTFKISNKF
>KECLDBNJ_01823 hypothetical protein
MKVAFYIDTRGIEDVNFDDLDQSNPGIGGSEYALLFLLSHLVKNGQQDLEFLLFSNSIIN
LNFIEPTIVNDLNDSFELAINLQVNLLVLKHNSNLKECINKLKIPTIIWAHNFITFGMLQ
NYCKNEKISRIVNVSRGQLNTYRDHLAFNKSTYIYNAVNTSYFESGLNFFERSKIVTYVG
SIVKAKGFHVLARIWKKVLIIHPNAELHVIGSGKLYNRSQKLGDYGIAEKSYEKEFIKFI
TDENGNLLKSIIFHGVLGKEKNVILEKTKVGVPNPSGNTETFGYTAIEMQGFGALITTRL
SIGYVETVYKKKYLYQEENELETYLISALAQNSNEYENTSKYLKENFDIKIVSERWQNLF
KKIKESEPNSVVPLEYSDNNYTKFKDFLRRIKTTLPFGYHILPSLLFFKSLKHKFKKKFL
>KECLDBNJ_01824 hypothetical protein
MNMNKIFVHIGYPKSASTTLQKNVFEVHSEILNLGLFGTENIGKDTYNISNSNIYLNDSS
LRNFYDTITSSHSIEYSKSNVLEQMQGIFKKYIMDCEGKKKATVFSHELLTSVNFSHPDI
GLKATRIKEVFPNAKIIIVIRNQIDFLLSQYRDQPFDPRNFSCGRHVKPDKWIEIALKND
LPLLKSLKYNEVVKLYFELFSKDNVKVLHFEDLILDKHRFATDLSSFMNISLEETIDSLN
KEKQNDGTTHYHNVFRRILRKYPIVFNISKNIPKNFLIPIKNTIERKMQRGRKARYSFNE
FTIQTLKEYYKSSNVELNDLLDLKDYEY
>KECLDBNJ_01825 hypothetical protein
MLGKTRNSLFSSLEVKKYVSNTGYMFFGKILNSFLALFTGIYIARYLAPTDFGLYQYASS
YIILFGAFASLGLRDIFIKEIVNAQKSESIILGTILNLRILSGFVFSLLAILASYFTNES
DISRLLIIVCSISLIFESAEILDYWFQAKVLAKRSQIANVISLLVASSIKILFIYLSLSV
VYFSISIVLYSAFRLLLMIWQFQKQGAVIKIFSFDLEIIKDFLFHSWPLIIASLSTVIAM
KIDQVMIMQMMSAASTGIYAAGIKLAEASSFLPTIIVTSIFPKLIQLHRKPNFWLRYRQI
FKYVFWALIVLSLMVTFLSGFIINLFFGLEYQGAAQVLAIYIWTLPLSFSGMMTVKYMLL
LNKTKAIFIRQLIATVGNILLNLILIPKYGFVGAAFSTIVPQFLINTFYDFVDKDLKEIL
KIKKEIVTFNFFGR
>KECLDBNJ_01826 3'(2'),5'-bisphosphate nucleotidase CysQ
MDLTNHLNTAINAALEAGKRILEIYHNEDFDVDFKSDASPLTKADTASHHIIMSYLEKTG
IPVLSEEGKDIAYETRNEWEYLWIVDPIDGTKEFIKKNGEFTVNIALIQNGVPILGVIYV
PVLQELFYAAKDLGSFKAFEISTTATESEVLAAGQQLPLAQERRQYTAVASKSHLSRETE
DYIKGLEAEYGEVAMISKGSSLKLCMVAEGKADCYPRFAPTMEWDTAAGSAICKYAGKTV
LDWETKKEMVYNRADLLNNWFLVE
>KECLDBNJ_01827 Bifunctional enzyme CysN/CysC
MGLQHEEKEILRFTTAGSVDDGKSTLIGRLLFDSKSIYEDQIDNLQKISEKKGISHLELA
HLTDGLKDEREQGITIDVAYRYFATPKRKFIIADTPGHVQYTRNMITGASTANLALILVD
ARKGVIEQTKRHSFIASLLQIQHIVVCVNKMDLVDYGEERFNEIIEEYKSFASKLKIKDV
RFIPISALNGDNVVDKSAHMPWFSGDSLLGTLENIHISSDHNMVDCRFPVQNVIRPFSDE
FHDYRGYAGRITSGIFKKGDEVMVLPSGFKSKIQSIVLGEEELEEAFPPQSVTINLEDDI
DISRGDMIVREHNQPEPQQDIEAMLCWMNNDAMSPRAKYAIKHTSVEARAMIKQVLYKVD
INTLHRQEEYDTVGMNDIIRVKMRTTKPLLVDEYNQNKGTGSFILIDESTNETVAAGMVI
>KECLDBNJ_01828 Sulfate adenylyltransferase subunit 2
MRKYALSHLQELEAEAIYILRETAAQFENPAILFSGGKDSILVTELARKAFYPAKIPFTF
LHVDTGHNFPETIAFRDELMQKLGANLVVGLVEDSIKSGSVKEETGIDANRNKLQTTTLL
EAIEEHQFDACIGGGRRDEEKARAKERFFSHRDDFGQWNPKNQRPELWNLLNGKLNMGEN
FRVFPISNWTELDVWQYLTLNNIAIPSLYFAHERQVIRRQDTWIPNSEFISLRPKEEVVT
KKIRFRTLGDITITGGSESEADTLELILEEVAIARQTERGNRSDDKRSETAMEDRKKEGY
F
>KECLDBNJ_01829 putative adenylyl-sulfate kinase
MASTNIKKQKYNIDRSARAKRKGHRSLVLWFVGLSGSGKSTVSDALEKFLYEQQIDTYTL
DGDNIRMGLNKDLGFTAEARSENIRRIAEVGKLFADAGTVVLTAFITPMGRDRQRAKDIL
GEDYIEIYVNCPLEVCEARDVKGLYARARTGEIPNFTGISAPFEAPQHPDIEIKTHEDDI
QTCVQQIWDVINDKLTNIL
>KECLDBNJ_01830 hypothetical protein
MLEGFYAFTETYDLYITGISLIWMVFALIRGKRNPSYVFAGIVLLFLICGYIQVESILNA
AITKSVLLIFIVVALSAAINRNMNLDLYLDRVLGGIRSPILFLGVLCMLVALISSVFNNT
PVVIILIPYMMKMAEKYEIAPSKLLIPLSFAAILGGMLTLIGTSTNLVLNGLIAGSGLPE
FGFADFLLPGSLVVIAGVLYLMTLGYYLLPQRAFNFKKKQDAVRKYFVEAKIPAASALSG
LSLSESGLKEYKGVSLIELIRGSRSFEVVASRNMILQEGDRLIFSGSLTDVMQINAEERK
LEFIAEKRLAHENKVEFVEISIPTNSSLDGKRVNETNFRQRYGATILAVHRNSEDLSGRI
GELQLKSGDLLIVVPHINLTDALRADFYILSNVTQEQQPLSQKIKLGLGLVAIITAALIV
QLDLFLTLGLILTLAVVLGFTSIQEIKNEFRLNLFVILVSSLLVGEVFMSTGLANEVSSW
ILNAVLPYGFNGVVLGLMLFTTLLTSFITNVAAVSIAFPLAYSISATTGIPSEALFLAVA
FAASAAFMTPIGYQTNLLIMAPGDYRFKDFFKAGAPLTLIYLGVIWGYLYFIYT
>KECLDBNJ_01831 GDP-L-fucose synthase
MQKDAKIYVAGHRGLVGSAIVKNLKEKGYTNLVYRTSSELDLRDAAQVSAFFQEEQPDYV
FLAAAKVGGIVANNTYRADFIYENLMIQNNVIHQAYVHSVKKLLFLGSTCIYPKNCRQPM
KEEYLLTDTLEYTNEPYAIAKIAGIKMCESYNLQYGTNFISVMPTNLYGPNDNFDLEKSH
VLPALIRKMHLGKALENGDWDSLKADLNKLPIEGVDGNASEATILEILSKYGIQSSSPSG
SGQVRVEIWGSGKPMREFLWSEDMADACVFIMENRNFADVTPSAVEGQPAEIRNTHINIG
TGEDISIKDLAALIKKTVGFEGELYFNTEKPDGTMKKLTDVSKLNALGWRHEVALPQGIE
RMYHWYTQS
>KECLDBNJ_01832 GDP-mannose 4,6-dehydratase
MKVALITGVTGQDGAYLSEFLLKKGYQVHGLKRRASLFNTDRIDHLYQDPHVENRNFILH
YGDMTDSTNLIRLIQEIQPDEIYNLAAMSHVQVSFETPEYTGNADGLGTLRILDAVRLLG
LSEKTRIYQASTSELYGKVQEVPQTEKTPFYPRSPYAVAKMYAYWITVNYREAYGMYACN
GILFNHESPIRGETFVTRKITRAAARIALGLQDKIYLGNLDAKRDWGHAKDYVRMMWMIL
QAEEAEDWVIATNTTTPVRDFVRMAFGHAGIELEFKGEGVDEKAYVKSCVNPEYQLEIGK
EVLAVDPKYFRPTEVDLLIGDATKAKEKLGWVPEYDLEDLVNDMMQSDLKLMKKDQYLKD
GGYRIMNYFE
>KECLDBNJ_01833 dTDP-glucose 4,6-dehydratase
MNTRILVTGGAGFIGSNFIPYYLEAHPKVHIVNLDALTYAGSLDNLKEVEEHPRYDFVHG
TICDRKLLEQLFEQHQFTGVIHFAAESHVDNSINNPGVFIETNVTGTFTLLDVAYRFWME
APFVYKRGFALARFHQISTDEVYGSLGATGSFTEASPYAPNSPYSASKASADMLVRSYHH
TYGLNTVITNCSNNYGPKQHTEKLIPTIIRKALAGEAIPIYGDGKNVRDWLYVLDHCKAV
ALVFKHGNAGETYCIGGDAEWTNTNIAKYICKVLDRIQPKVRGSYVEQIRFVTDRAGHDH
RYAIDPYKIKRELGWEPREDFETGIQKGVQYYLDIFNKK
>KECLDBNJ_01834 dTDP-4-dehydrorhamnose reductase
MNRVWVTGANGQLGRCLQALKKEDPSFCFTTREQLDLRDIAMVAQFVEQNRIQTVINCAA
YTAVDAAEIYAEAAYELNRDVVANLGRICKRFSVRLIHLSTDYVFDGQAYRPYPTTAACG
PINVYGRSKWEGEEALRALALPNSLILRTSWLYSVYGSNFVKTMLRLGQLQEEVQVVADQ
VGRPTCAEDLARFIVTQLLDFESSQTETYHYANAGLCSWYDLAVHIMQNSKSACRVAPIP
ASAYATPAARPYYSVLDTERTQKDFKVRLPYWNSSLTRCISQLQATG
>KECLDBNJ_01835 dTDP-4-dehydrorhamnose 3,5-epimerase
MLTGSIYFNVPQGTSMHFERCPIPEVILCTPKLHTDARGYFMESFRQDALDAFLGFAINF
CQDNESQSRYGVVRGLHYQQAPYAQTKLVRVLHGRILDVAVDLRQEASTFGQHVAVVLDA
QNKQQLLIPKGFAHGFAVLSSTAVVAYKSDAYYAPKAERGVYYGDTQLNINWQLPVDTHQ
LSSKDQAWPSLAEAEVFDSNTSLYR
>KECLDBNJ_01836 Glucose-1-phosphate thymidylyltransferase 2
MKGIILAGGSGTRLYPITKAVSKQLLNVYDKPMIYYPLSVLMLAGIREILIISTPQDVSQ
FERLFGDGSALGLHISYQEQPKPEGLAQAFILGAGFIGADDVCMVLGDNLFYGDGLTEKL
KHARQRLQTQKLATVFGYQVQEASRYGVVAFDANGKVLSIEEKPKHPKSNYAVTGLYFYP
NSVVQYAQQVQPSARGELEITSINELYREANALHVSLLGRGYAWLDTGTHESLLEASNFI
HTIEKRQGLKVACIEEIAYDQGYITKFQLQTLAQGLENNAYGQYLLQRAARN
>KECLDBNJ_01837 UDP-glucose 6-dehydrogenase
MKVKNICCIGAGYVGGPTMAIIAQKSPEITVTVVDINEKRIAAWNDPDVEQIPIYEPGLS
EVVAEARGRNLFFSTDVDAAIDAADMIFISVNTPTKTYGMGKGMAADLKYIELCARQIAR
VAKNDKIIVEKSTLPVRTAEALKRILDNTGNGVNFQILSNPEFLAEGTAVTDLHKPDRVL
IGGDLDSEKGREAIQALVDVYAHWVTPDNILTTNVWSSELSKLTANAFLAQRVSSINAMS
ELCEVTEADVQEVAKAIGMDSRIGPKFLKASVGFGGSCFQKDILNLVYIAKSFGLNEVAD
YWEQVILMNDHQKRRFAAKIVKTLFNTVSGKKIALLGWAFKKDTNDTRESAAIYVADYLL
NEQAEIVVYDPKVTQEQILADLDYLGTRSEEENRKLITVVNTAEAACAEAHAVAVMTEWD
EFKTLDWEAIYTHMLKPAFLFDGRRLLDKEALTDLGFEFYAIGS
>KECLDBNJ_01838 hypothetical protein
MNRFLQKRINSLLLTLTLIGGASVSYGQAQELEGLQLSISGRGLAATGSENPFWMYSNQY
GRLDAETNVLGLAQVAYATRFNENHRLEIGGGLLANDGIYDGVKADELYATYTWKWIEAN
AGLKHRERQLNGISSVDGDIVWSNNARALPGIYIRMLKPLKVFKWLEASATFGHYFLEED
RYVSNAQVHHKSLELALVFSPGDRLSGSMKHYVQFGGTSPVYGEQPTDFKNLINIFFGQG
ASAGSGAFGGDQINSLGNGLGSYELAYEFTRPTFYLKLYHQSLFEDTSGIELSNFPDGVW
GAYLEPEGISWLDALDLEYVQTVSQSGRFGDASNGGSFSGGDSYFWNGIYQSGWNYQNRI
IGLPFIIPGVYGQRNVNDRSYVVHLGATGSFGKLQYRGKLSYVTNLGTYNISYQPREHAL
YSYGELRYATAFGVFTGTLGLDWSDRVQNTLGVGLGYRYNFSL
>KECLDBNJ_01839 Transcription termination/antitermination protein NusG
MLENPLNFVTLKETICMNWYVLYVKPQTEKKVASALEKIGVEVFCPTLEEVRIWSDRKKK
IRVPLFKSYVFVRLNSTDRQQVFAVHGVVRYLFWLGKPAIVRDEEIAAIQNWLSDDAVTE
VRVCAYQPGTEVKIASGHFKGQKGVVQEVGRKKLKMAIKSLGVIVEARLKDLVN
>KECLDBNJ_01840 Thiosulfate sulfurtransferase GlpE
MKNITQEEWEAQIAEDDNAFILDVRTQNEVDEGIIPNSHHIDIYEGQGFIDKVNELDKSK
NYYIYCRSGNRSGQAAQLMDQLGFENTYNLLGGFMEWDGETTYQE
>KECLDBNJ_01841 Thiol-disulfide oxidoreductase ResA
MKSLKVLIVLTLVLVVSALGIAGFNQFKSGYDIGDRASDFRLKDVSGELVSLSDFGEAKG
FIVVFTCNTCPFAIANQERIQALDAAFKPKGYPVIAINPNNPEVKSGESYAEMQKVAKDL
GVTYPYLYDANHEVYATYGATKTPHVYVLQKEEDALIVRYIGAIDDSVRDAASVTHAFVA
DAVEALLNDTSVTPETTKAIGCAIKA
>KECLDBNJ_01842 Thiol-disulfide oxidoreductase ResA
MIRGLLGFWMLCVLMGCASKAASIQAAKPVRIVNAEGYQLPVYDFEAFKPMLDFPEGETV
KVINFWATWCAPCVQELPVFEKLHAAYRKQGVEVTLVSLDFPDQIEARLIPYILKNQLAA
QVLLLDDPHSNVWIPQVSESWSGAIPATLLIAEDAYRFYEQSFDYRSLEREVLALNPNLN
SN
>KECLDBNJ_01843 HTH-type transcriptional regulator MhqR
MKIEEALKIGNGLDLSSKTLINIQYTSRFLEEHFAALLKEFDLSTPQFNVLRILRGQKGK
PASLACIQERMVDRSSNTTRLVDKLIKKALVSRRICPANRRKVEIEITAAGLELLEDLDP
LTAASNAANTATLTTTELETLNTLLDKLRKDE
>KECLDBNJ_01844 Putative NAD(P)H nitroreductase
MSKYIEHLNWRYATKQFDANKKLSEDQLQTLIDAVQLSASSYGLQPYKILVIKDEKIKEQ
LKAAGYNQAQFTDASAIFVFAHQTDFGAELVDSYIDHAARIKEVETGALEDYANLMKNSL
LNLPQEAKAGWTARQAYIALGNLLSAAAAHQIDTCPMEGFDADAFDKILGLADTNLHAVV
VAAAGYRSAEDQTQHAAKVRRPQEELFQIL
>KECLDBNJ_01845 Protein YceI
MSTLNQSLAKLNLATKKAFNQLNRDNRVKSVLILAVGIAAASFTTKTIMEKVSVKSSSIT
WVGKKVTGKHMGTIDLKEGFFEMEDGAVTGGEFMIDMNSIACTDLEGDSKGQLEGHLKSD
DFFGVENYPTAKLVITNAVKNGNTYKVTGDLTIKETTEPITFDLEEAGDNFTTTLTIDRS
KYNVRYGSGSFFDNLGDKTIYDDFTLDINLSI
>KECLDBNJ_01846 Anthranilate synthase component 1
MKYTLKTHRKKILADTITPVSVYLRLRDKFPNSLLLESSDYRANDNTFSYICCKPIASIT
VKNEVITEVFPDGTTTTTAIEVDTDVVGIIEAFAKKFETEDNEQKFIQNGLFGYMSYDAV
RYFEDIEVTKKEAQLDVPDLYYAVYQNIIAINHFNNEAHIFSHTYNEENNLSQIAQLLTV
KSFAEYHFKLEGEQQSQMSDEAFIELVKTCKKHCQRGDVFQIVPSKRFSQGFSGDEFNVY
RSLRSVNPSPYLFFFDYGNFKIFGSSPEAQLIVKEGKAEIHPIAGTFKRTGNDEKDAALA
KKLSEDAKENSEHVMLVDLARNDLSRNGSNVKVETYREVQFFSHVIHLVSKVTGTKHPDT
STMRVVADTFPAGTLSGAPKHNAMKLLEKYEPINRDFYGGAIGFMDFNGNFNHAIIIRSF
LSKNHQLHYQAGAGIVSDSVPEKELEEVYNKLGALTKALKLAEEL
>KECLDBNJ_01847 Aminodeoxychorismate/anthranilate synthase component 2
MKKRVLVIDNYDSFVYNLVHYLEDLDCEVTVKRNDQLQLEEVAAFDKILLSPGPGIPEEA
GLLLEIIKTYAPTKSMFGVCLGQQAIGEVFGGTLINLDQVFHGVATSAKQLVTDEPLFKD
IPTEFEIGRYHSWVVAPENFPEALEITSVDVNGQIMSLRHKEYDVRGVQFHPESVLTPEG
KTMIKNWVNN
>KECLDBNJ_01848 Anthranilate phosphoribosyltransferase
MKTILNRLINHEQLSKEEAREVLVNISEGKYNTSQIAAFITVYMMRSITVEELAGFRDAL
LDLCIAVPFDGYNAIDLCGTGGDGKNTFNISTLSSFVAAGAGINVTKHGNYGVSSVSGSS
NVMESFGIKFTNDADFLKRCLDEAGICVLHAPLFHPAMKNVGPIRRELGVKTFFNMLGPM
VNPAFPENQLVGVFNLELARLYGYLYQDTKKNFTILHSIDGYDEISLTGNTKAIRNNSER
MLTAEDFGVHTIKQEEIYGGDTIESSAAIFKKVISGKGTEAQNNVVCANAGMAIATVKNL
EPKAGFELAKESLLSGKGLERLNKLIALSSK
>KECLDBNJ_01849 Indole-3-glycerol phosphate synthase
MNILDKIIADKYKEVALRKQLIPVKQLEQSVLFERKSPSLAQALSTSASGIIAEHKRRSP
SKATINHNLNVQDVASGYEQAGVCGMSVLTDGKYFGGSLDDLLLARAAAQLPLLRKEFVI
DTYQILEAKAYGADVILLIAAVLTREEIKTLSEFAKSLGLDVLLEVHNLEELQKSVMPSL
DMLGVNNRNLKTFEVSLETSKSLSAEIPDDFVKVSESGISSIEAIKALQPYGYKGFLIGE
NFMKTDDPGASATEFIKQLI
>KECLDBNJ_01850 hypothetical protein
MRSLLLFQNRLYKMGKTAQRPFYKMVFITDEGYGKFLTKGVFFFGSFLLDEQKK
>KECLDBNJ_01851 N-(5'-phosphoribosyl)anthranilate isomerase
MVKTIHNKKYDKLCLKVCGMKHNTLDVAQLKPDYLGFIFFEKSKRNYDQAAIEALPEGIQ
KVGVFVDASIEFVLDKIQQFQFDVIQLHGSETPEYCKTLQNGCLIERSRDTAEATPSKIP
KIWKVFSIKDHFDFSVLEAYEAVVDKFLFDTKGKEKGGNGYTFDWSVLQDYPSQKPFILS
GGIGLEEIPAVNELKKTTLPLAGIDVNSKFEDEPGLKNIDLLKSLIKELNR
>KECLDBNJ_01852 Tryptophan synthase beta chain
MNYNVNEKGYYGDFGGAYIPEMLYPNVEELRQNYLKVMQEPDFQEEFKALLKEYVGRPTP
LYYAKRFSEKYGTKVYLKREDLCHTGAHKVNNTIGQILMAKRLGKNRIIAETGAGQHGVA
TATVCALMGLECIVYMGAIDIKRQAPNVARMKMLGATVVPAESGSKTLKDATNEAIRDWI
NNPTDTHYIIGSVVGPHPYPDMVARFQSVISEEVKKQLLEKEGKENPDYVVACVGGGSNA
AGLFYHYLDTPEVGIIAVEAAGKGIHSGESAATSALGKEGIIHGSKTLLMQTDDGQITEP
YSISAGLDYPGVGPMHAHLFRSGRGEFISITDDDAMQAGLELCKLEGIIPAIESSHALAI
FEERKFKKDDVVVVNLSGRGDKDLNTYIDYFKLA
>KECLDBNJ_01853 hypothetical protein
MDELFYAYILTNKNHTVLYIGVTNDLKRRLKQHKQKSNKGFSGKYNVEKLVYFESSPYVE
NAIKREKQLKKWNRAWKENLINEMNPDWNDLSWMLNE
>KECLDBNJ_01854 Tryptophan synthase alpha chain
MNRINKKLQESQKLLSIYFTAGYPELEDTTTVIEKLVESGVDMIEIGLPFSDPLADGPTI
QESSTAALKNGMTTAKLFDQIKDIRKTVDIPLIVMGYFNPMLQYGVEKFCAICAEIGIDG
LIMPDLPLAEYEEHYQATFEKYGLKMIFLITPQTSDERIRQIDAASDGFIYMVSSASTTG
KTSGFSSVQTDYFERIAALKLKNPQIVGFGIKDEETFKAATQTAKGAIIGSAFIKTLTEK
GLDGIEPFIKSIRP
>KECLDBNJ_01855 hypothetical protein
MDKKFERTVDQKNPTNPTGNRNEKTNKVDIDEKTIKDQQNKH
>KECLDBNJ_01856 Bicarbonate transporter BicA
MKKVFNLFDLTQKVNYKTEILAGLTVAMTMIPESLSFAILAGLPPLMGLYASFIAGLVTA
IFGGRPGMISGGAGATVITLIALMNSHGLEYVLAAVALAGVIQVLIGLFKLGKFIRLVPH
PVMFGFVNGLAIVIFMSQIKQFKTLVNGEVAWLTGTPLLIMAGLAALTVLIVIFLPKLTK
AVPSSLVAIIVVFALVYFFGIDTKTVKDIASVSGGFPPFHIPEIPISYETLKVIAPYSMV
MAAVGLTEGLLTLNLVDEITQTKGNGNRECIAQGSSNLLNGFFFGMGGCPMIAQTLVNLS
AGSRARLSGIIAALTILMIVLFGAPVIEKVPMAALVGVMIMVAVGTFEWATLRIFNKVPK
KDIFLVIIVAAITVILHNLALAVLVGVILSALFFAWESAKRIRARKYVDDEGTKHYEIYG
PLFFASTTNFTEKFDILNDPNKIIIDFKESRVADMSAIEALNVVTSRYHKLGKTVYLRHL
SPDCRRLLKNAEAIIDVNIIEDPTYNLVGSDAN
>KECLDBNJ_01857 hypothetical protein
MKTSLYILAGVLALAGCKNDKSVPESEQEELADNGPVTVETTVGPLELPAPFASESVTKE
SKIVAWPSGTTPTAAEGFKVERFADSLKHPRWTYVAPNNDIFVAESNTKDSANRITLLRD
TNSDGKVDERYIFKEDLNQNFGMLVLDGSFYIANTDGLYRFPYTEGQTKLEGEGEKIVEL
SASGYNNHWTRNIITNEAGDKIYISVGSASNVGEQGMEKEERRANILEVNPDGTGEIIYA
AGLRNPVGMDWNPVTGELWTAVNERDELGNNLVPDYATSVKKGGWYGWPYSYYGQINDPR
WEDDPHQDLVDKAIMPDVALGPHTASLGFTFYTAEQFPQMYRNGAFVGQHGSWNREPFSG
YKVVFIPFENGIPKEPTDFLTGFVPDENGNEVYGRPVATTVAPDGSLLVNDDDGGVIWRV
SAE
>KECLDBNJ_01858 Colicin I receptor
MKNILLGLLLFSGCAFAQEKTAADSVLVRNTLGEITITSTPIHDKLQRIPAAVNVIAAED
FQRGDQLSIANELNKNPGIQMQQGALNTSRISIRGLGARSQYSTNRVKAYIEGIPLTTGE
GETTLEDIDLNLIERMEIIKGPASSSYGAGLGGAINISVIKPERSTIKLNGLAGAYGLFK
SGITAALAEDKTAGFVSFNHLEKDGFRANSNYNRNTLTGFARTQINAASTLTFFGNYTRV
KAFIPSSVNEETLQNSPEDAAFTWGQAQGYESYDKALAGLSYDWNINANHRWQTSVFANY
RDGYEPRPFDILDEDSFAFGIRSTLKSQFSLFNLPAKSSIGVEYFDEHYQAQLFNNLYEE
NNGNGSLQGDRFSNQEQDRKYLNLFAQLSLQLAPKLKADVGLNYNHSRYRLDDYLNEANI
DNSGVYTYPRIFLPQAGLSYEAASDKFIYASVSRGFSLPTVAETLTPEGAINPEIKPETG
MNYELGLKAQWLDKKLYTELALYTVQVTNLLVAERVGDDQYVGRNAGATDHNGIEFFIHY
REKLSTEWSLQPYGSLAVNDYSFDEFVDNDENFNGNDLTGVADQVINLGLDVAFQNRFKI
NINYRHTGSIPLDDANSLYSDAYNLVNLRGDYSFTLFNEIKTQLFAGVNNVFDTNYAAQV
LPNATGFGGAAPRYYYPGEPVNFYAGLNIDLF
>KECLDBNJ_01859 hypothetical protein
MRILILLTGVVILMMGNAYAQNTSGKVYAGDKRVPGVLVQNLTQNKSTTTTDEGDFSLAA
RLEDSLVFSAPFMETQVFVVEQYQLEKVWVVELKENLNELDEVRLTEAPKEKPFDVRVYD
SIFNSRIQNDIKKNRQLYRPPNSTNGVDFMEIGRLFMSLFKKDPSKQKESYAPITYKQYR
VLFATDEYFNREFLVEQLGIDAYYHNLFFEYCDAKQLPGNLLEPENQLDLLDKFIELADS
FEAELNEFGENGMKLPEGN
>KECLDBNJ_01860 hypothetical protein
MLSKLIFAFILLLSTAVYAQQSQGKVYAEDKPLEGVLIINKTQDLMTSTNRWGDFEIAAQ
LGDSLIFSYSFFETQIHQVEAYQLEETWVVELKESRNELDAVTITATNKVKEFRVEEYDK
NFNTWLQKDIQEHPELYSPGPSGSGIDFIAIGKMVWNSIKKDKKEKAEDPNRFRILKLGE
LEAFFKKDAFFNQDLLRNQLAVTQEEEPLFFDYCLEQQVDARLLQDKNEMRFLEYLMKRS
AEFHKLNAAN
>KECLDBNJ_01861 Phosphopantetheine adenylyltransferase
MKRAVFPGSFDPLTLGHYDIIERGLKLFDEIILAIGVNADKKYMFTLEQREGFLKESFKD
EPKIKVMTYQGLTVDFCNATDSGFILRGLRNPADFEFEKAIAHTNRKLAQIETVFLLTSS
GKSYISSSIVRDVIRNGGDYTGLVPDAVRV
>KECLDBNJ_01862 D-alanine--D-alanine ligase
MSKKNIAVVMGGFSSEVNISILSGNTVCKHLDQSIYNVFPIHILKEGWFCKHADHPPIPV
DKADFSINVEGTKITFDCVFNTIHGTPGEDGVLQAYLKLLKIPQTACNYYEAALTFNKRD
CISVLKAYGIKTATNYLLNKGDVINATEILDKVGLPCFVKANKAGSSYGVSKVYGSEELE
GAIEVAFKEDDEIIIESFLEGTEVSVGVINYQGKVMALPVTEIVSDNDFFDYQAKYEGKS
QEITPARITDAQTEAVQREAEKVFKILKLKGLTRAEFIFHNGAPHFLEVNTTPGLSPASI
IPQQAKVAGISLPDLFDNVIEQAMNGEKSQ
>KECLDBNJ_01863 hypothetical protein
MGFFKFIFSKAFLKQLLLALLVLVLLVFGLLYWLRASTNHDQRIAVPDLSKMSLGLVQQE
LENADLNYVVIDSSNYNPDYPTYSVIEQNPAAGKFVKEGRKIYLVLNPSGYRKIEIPQLV
GRTQRQVEPTLLALGFKIGKIDYRDHISSDEVLELRHDGKTLKVGDALRKTSVIDLVVGN
GKGSYRTSGDAAQDVINDAEELDDAGF
>KECLDBNJ_01864 Ribosomal large subunit pseudouridine synthase D
MQDFKTEGPDEQDDELYEHYSFTAGKGQEPLRVDKFLMNFIEKATRNKIQQAAKNGNIQV
NGAVVKQNHKVKANDVVRVLFEHPPYEFLLTPEDIPLDIVYEDDTLLVVNKPAGMVVHPG
HGNYSGTLINALIYHFDNLPENSSGRPGLVHRIDKDTSGLLVVAKTEEAMTHLAKQFFDK
TSEREYIAIVWGNVEEDQGTVEGHIGRHPKNRMQNTVYEDGDQGKEAVTHYKVLERLGYV
TKISCKLETGRTHQIRVHMKHIGHTLFNDERYGGDVILKGTTFTKYKQFVENCFKVLPRQ
ALHAKTLGFEHPKTGEWLRFDSAIPEDMEACIEKWRSYAKHAME
>KECLDBNJ_01865 hypothetical protein
MLDFIPDNLQSILIIVVLAVLFLAVMANNKRNQSKLRDRRKRNFKTDYFNLKKEREDESK
S
>KECLDBNJ_01866 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKTGDKGTTALFGGTRVSKHNIRIESYGTLDELNSYLGLLRDQEIDAHSKATLISI
QEKLFVIGAILATDPEKAVLKNGKERLNIEKVSEADIQHLEQEMDAMDAQLPPMTHFILP
GGHQTVSFCHVSRAVCRRAERLATALYQEVPFEENALKYLNRLSDYLFVLARKLSKDLQA
EEIKWIPEKKG
>KECLDBNJ_01867 hypothetical protein
MYWTLELASHLSDAPWPATKDELIDYAIRTGAPLEVVENLQAMEDEGDSYDSIDEIWPDY
PSEDDYLWNEDEY
>KECLDBNJ_01868 Protein translocase subunit SecA
MGLLDKVLKVFVGDKSKQDVAAIQPIVDKIKSFEAQLEALTHDELRQKTTEFKAKIADAL
SDTNATLLQLEKEADETEDIDRKEEIYAEIDKLKDESYKISEAVLNDILPEAFAVVKETA
KRFVHNPQLKVTASAFDRELSAEKDYVQLDGDDAIWSNSWDAAGKPITWDMIHYDVQLIG
GVAMHQGKIAEMQTGEGKTLVATLPVYLNALTGNGVHLVTVNDYLAKRDSAWMAPLFNFH
GLTVDCIDYHRPNSASRRKAYAADITYGTNNEFGFDYLRDNMAHAPNDLVQRAPNYAIVD
EVDSVLVDDARTPLIISGPVPKGDQHEFDALKPKIDSLVSLQRQQLTGTLAEAKKLISAG
DTKEGAILLLRVYRGLPKNKALIKYLSEEGIRQLLQKTENHYMQDNNREMHVIDSELYFT
IDEKNNQIELTDKGIDHLSGKEDPNFFIMPEMGVEISKIENANLSTEEEAEKKEELFREF
SVKSERIHTMNQLLKAYTLFEKDTEYVVMDNKVKIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEDATQTFATVTLQNYFRMYRKLSGMTGTAVTEAGEFWEIYELDVVEIPTNRPIAR
DDKDDKVYKTKREKYNAVIDEVQLLVQAGRPVLIGTTSVEISEILSRMLSMRKIQHNVLN
AKLHKKEADIVADAGNAGQVTIATNMAGRGTDIKLSKEVKDAGGLAIIGTERHDSRRVDR
QLRGRSGRQGDPGSSQFYVSLEDNLMRLFGSERIAKMMDRMGLQEGEVIQHGMISKSIER
AQKKVEENNFGVRKRLLEYDDVMNAQREVIYKRRYHALFGERLRVDVANMIYDTSEAIAE
TNKMAQDFKNFEFELIRFFSMSSPVDEAQFASSSAKQLAVTVYDAALKHYKEKMERNAAT
AFPIISNVYENPESNYERIVVPFSDGTKELKVVTNLKDAYESQGKQLITDFEKNITLAII
DDAWKTHLRKMDELKQSVQLAVHEQKDPLLIYKFEAFELFKQMIDQVNKDVISFLFKGEL
PVQQQNQIREARQVRQTEQTQTSKEEIPNLDERAAQSRAASGNTQPQRQQVTETITRERP
KIGRNDKVTIKHVMNGENKTMKFKQAIPLLDKGDWVLVDE
>KECLDBNJ_01869 hypothetical protein
MFSKERLHNELIQSTNMSAVELRAWLRTDIAPITVANYKDAPSLDQSNKLLTILMKNTEE
LTRTDCFFIQSILQRIKYLKNNRSKEGYARLDWENSLRSLGYDIKKQLKPAKKSKAYH
>KECLDBNJ_01870 hypothetical protein
MVASNRMKNFRLELKWAVIYTLTLLLWMVFERLMGWHDEHIDMHHIYTMLFYIPAIILYY
FALSDKRNNFYGGIISFKQAFLSGLILSVFIALLAAPAQYITSTYITPQYFDNVIAYAVE
SGKIAPEEAASFFNLKSYMIQSVAGSLAFGLVLSALVAFFVKRK
>KECLDBNJ_01871 Putative phosphatase
MCSDIDGTLLNAKRDIAPETAAAINKLPQDFPIILASSRMPSAMYYLQEKIGRLGSPIIS
YNGGLVLDGKGNKLYSQTVSLDFLETVIQHQQDYDYNISTYCTDTWRTAKSDYWTLREIR
STRVEPVYTPLNEHIAVLKAIDEQPHKIMCMGSPRALDSLIALLREKHGNEAHFYRSKDV
YVEITPKNIDKSSALATLIDKNYGLELSDVIAFGDNFNDTTMIKNVGLGVAVANAAQEVK
DVADYVSEYTNKEHAVAKAIEKFLI
>KECLDBNJ_01872 putative protein kinase UbiB
MKTIDHIPTNKLSRASQLVKTGVKVGGNYAKYYSKKAFDSSITRETLDDENAEDIYDGLK
SLKGSALKVAQMLSMEKNILPKAYVEKFSLSQFSVPPLSAALVRKTFKKYLDKYPEDLYD
TFEKDSVNAASIGQVHQATLDGKKLAVKIQYPGVADSISSDLALVKPIATRMFNLKGKDK
EKYFKEVEEKLLEETDYLLEVKQSQEITKQCSVIDDLRFPKYYPELSSERIITMDWMTGV
HLSEFTQVNTDKEAADKIGQALWDFYMFQMHYLKQVHADPHPGNFLVDKEHNLIAIDFGC
IKKVPQEFYTPYFELAKPENINDPEIFKAKMLELEILKTSDSAEETAFFSALFHEMLSLF
TKPFHLDTFDFSDESFFAQIADLSDKYSKDTQLRKMNGNRGSKHFLYINRTFFGLYNLMH
DLGAKIKVNNYKNYLD
>KECLDBNJ_01873 hypothetical protein
MATTKKATTTKKAPKLTASAVMTMYMEYVLEHGHKPASVFKFCKDHNIEEGAFYNFFGSF
QGIREAVWIAFYDNTIQVLHKNPDYATYPNKEKMLSFFYTFFEVLTANRSYVLFALQEQK
NSLKSLAQLRDLRLKVREFASDLIEQDNENKSSRFTKNPVSIFSEGAWLQTLFLLKYWMD
DNSARFEKTDVAIEKSVNAIFDVFNTTPLESVLDFGKFLFKENFSRTK
>KECLDBNJ_01874 Chaperone protein HtpG
MSTGKINVAVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLTNIGEASVEYGNPV
IDVKIDKDAKTLSITDQGIGMTEEEVQKYINEVAFSGAEEFLDKYKDTAKDSGIIGHFGL
GFYSAFMVARKVEIITKSYKDAPAVKWECDGSPEFTLSPAEKDVRGTEIILHIAEDSEEF
LEENRISELLTKYNKFMPVPIKFGTKEETLPLPEDAPEDAEAETKTVDNIINNPDPAWTN
QPTDLEEKDYKDFYRELYPMQFEEPLFHIHLNVDYPFNLTGILYFPRLGQDMNIQKDRIQ
LYQNQVFVTDNVEGIVPEFLTMLRGVIDSPDIPLNVSRSYLQADGAVKKISSYITRKVAD
KLKSLFNEDREDFEKKWNDIKVVIEYGMLSEDKFFDKADAFALYPTVDNTYYTFAELQEK
IKENQTDKDGKLVVLYASNQDSQHQYIQAAKDKGYEVLLLDSPIVSHLLQKLETSKENLS
FVRVDGDDINNLIKKDEEQISKLSDDEKESLKTLLEETINDKSYTVKLEAMDSNSAPFMI
TQPEFMRRMKEMQATGGGGMFGMGNMPDMYNLVVNTNSELVGEILNTKTKKKQERLITQS
MDLARLSQGLLKGEALTNFVKRSYEMIK
>KECLDBNJ_01875 Nicotinate phosphoribosyltransferase pncB2
MFQFTATYTDLYQLSMAQVYFNKNQNQQAVFDYFFRKLPFNGGYAIFAGLEELISIIEDL
RFSEKDIEYLKQHDFEPEFLAYLKDFRFRGSINAMPEGEIVFPTAPVLQVEANLIEAQII
ETILLNTLNFQTLIATKASRIRNVAGDKTLLDFGLRRAQGPGGYYASRAAMIGGFDGSSN
VITGRDYGFPISGTMAHAFVQSYDDELTAFRDFAEHRPKNCVLLVDTYDTLKSGMPNAIT
VAKEMEQRGQKLLAIRLDSGDLAYLAKRCRKMLDDADLAYVKIAASNQLDEYVIQSLQNQ
NAPIDVYGVGTNLVIGKPNGALDGVYKLSFANGKPRIKISESISKVTLPHKKQVYRISTE
DHTLIGADAIALANENSVSRMYHPVEPFKNLSIEGLKQTPMLQPVMQEGKRLYPEKSVQE
VAAFSKKQLAALPEEFKRFDNPHIYKVGISNQLKEERDRLIAAHKN
>KECLDBNJ_01876 hypothetical protein
MKLFTICLFLVTLTLPANAQETNTKALLTQNDNETWLQEYQQLEDSEEKLKMIKAKILYD
AQFVGPRPGISLTGLNEEQRKALKQRESNKPKVTADCKILFVLQATQSHILDLEKSPHYT
SLVEHLETFSISDTILTGTSASAFYGTRARCGVVLLKTEDSKALDYLENINNQK
>KECLDBNJ_01877 Nicotinamidase
MKALVIIDMQNDFMPGGALAVPGGDQIIPLVNKLQEKFDLVIATQDWHPENHSSFADNHH
DKENFDTTVIDGLEQTLWPVHCVQTTDGADFHPHMNAARIEAIFRKGTDPAIDSYSGFYD
NAHKKATGLTGYLKGKGVTSLYFCGLAAEYCVSFSVLDAIEEGFKVTLYEDATRALDEAA
FEKMKTQIIEKGGRLKLAGELV
>KECLDBNJ_01878 hypothetical protein
MIAGGIDGCKAGWLLIWKDQQGYQYSLLDRIDDLERCVKSAARFFIDIPIGLSSETFHRS
IEAKLRKELKSRSATIFNAPCRAAVYEVDKKKAKELNKRILGKSLSEQTLNIKDKILETD
RYINTSKSTSIQLLESHPEICFKYLNQGQILMSKKSQKEGVEQRLDLLSRLDPEAKILYE
RILAETKRNQVKRDDILDALCLCLANQISLKTQTHFITDENQVDAQGIPVKLAYAKL
>KECLDBNJ_01879 hypothetical protein
MKLLYKKRRLYLNLAIGIVWIILFILKLLYTEPHNIWLLDYYMPVLSVLYLGQFLYQYHY
QYLIVTDTEIIRNHLFFGKKIPLNAVERFYTNNLGDYVIEGAGKKIKINPIIVNQKSLQE
FKGFTRTLSIATEIH
>KECLDBNJ_01880 hypothetical protein
MNKSIFLLLTLAILSCKQNNSEESKDAPEQEQQVTTTSNSFVDKIASAHNKAAFAAQEAI
AFDLQLMFGGNERINATISMLTNSSKIRIDKTDGTQLIYDGSQVYSAPQGAIPDGARYDI
FTWPYFFAFPFKLQDPGVNIQELTNDTEGQFKLTFEGGTGDTPDDWYIGYLNEENRVKAT
AYIVTFGDKTIENAEAAPHAIAYSDYKEIEQVPLATTWKFYNWSEEKGIFGDPIGEAQLS
NIRFFEVEDGFFEKPESSDVVNY
>KECLDBNJ_01881 hypothetical protein
MHYPWHLYLMAVMYIVAGLMHFIKPRAYMRIMPRYLPEHKKLVFLSGFAEILLGIGICIP
LFKNCAIYGIVAMLISFFLVHFYMLSSKKAGMNLPKWLLWARVGLQFLLIYWALFYLKY
>KECLDBNJ_01882 hypothetical protein
MKTTIKTLVFALTLALTLNANAADGIAVTVNENFMVKVEYTNAIEGAQIYLEDVDGERLY
SEYAGSVANDSKTLSLEELPVGKYYLIYEDDYAKSYTTIKKEFKGLDIVKDESKTIFKPN
YRVENDIVMISFTNPKEVKTTTRVYDETGAIIESMSDTNLVVKQALNFEELPAGNYRIGV
SIGKDYFSKQIAIK
>KECLDBNJ_01883 HTH-type transcriptional activator RhaS
MIKSPKPAFEKIEPGFGSSFSYRTYDENHENNSHNFWHYHPELELVYVKGGTGKRQVGSH
ISYYRNGELILIGSNLPHCGFTDSLNNYERETVIQMRPDFLGESFFNIPEMRSIKALFER
AKMGIVFHGELKRIIGSKIETLKSLSNYERLLGLLDILKQLESAEKYTVLNAQGFILETE
LQDNNRINIIFNFVKEEFKRQITLEEISELVSMTVPAFCRYFKKITGKTFTQFVNEYRLV
HAAKLLHEKPISITDVCFESGFNNFSHFNKQFKKFTGKTPSTYRNELKFIVS
>KECLDBNJ_01884 Xylose operon regulatory protein
MIQLNWQDIFIIDRFSTSRWDAVNKGDIYFQILFIEEGSGRITIDHKVTSYKSRDIFVFA
KNEVPDIKTHETTTFIIFKFTDLLFSSKVSLPDKQNWLRRSEFILNHPKRKFQEALKNIE
DRDLIWRILFFIRKENTAKEQYYLQIIANMVSTILSIIARNVTEKNPEHITPKSTKKNER
IDEIYAYIRYNIYDTNLLKISAIAKHFHITSSTLSNYFKKETGNSLHNYILLYKLEIAKD
RLLNSDFTVSQIAIQLGFTDESHLTRIFKKYCDATPKQYKDSHVLADE
>KECLDBNJ_01885 hypothetical protein
MKRRLLAFGIILSLAFNVKAMGSDEDWGSKGHRAVAAIATKYLKPKTRKAIEKLLGAETL
VTVSTYGDEIKSYEEYRKYSSWHYVNIAPGLTYAEADKNEYGDLVQGIRTCKEILLSDET
SEEEKAFYLKMLVHFIGDLHQPLHLGHAEDKGGNDFQVRWFNDGTNLHSLWDTKMIESYG
MSYSELATNFGEVSKTEYKALTSGDVLDWVSEGQDLAEMVYASAEIGEKLSYRYQADNYH
IIQEQLQKGGVRLAAVLNEIFK
>KECLDBNJ_01886 hypothetical protein
MKTFKEIQRFDQWWLRLLLVVILAIAVSPLVLDWDNLKFSKFEIASVILSILVILGLFLG
FWYIFKLETTIDEKGITYRFVPFHIKSRFKAWSEIKSAKIRKYNPIREYGGWGYRISFTK
RKALTTKGRKGLQLVFNDGNELLLGTQYPEKIEALLMHYSKLK
>KECLDBNJ_01887 Esterase EstD
MRLVFIIGLLLAVSTAHSQDPTSSEIRINEFISGTLLQPVKQTDTLAIIIAGSGPTDRNG
NQQMMQNNSLKQLAQQLTKNGFATFRYDKRLFALMRQNALIEEQLNFDNFVSDAASTVNY
FEQDFKTIVLIGHSQGALIAKLAAQQTKVSKLVSLAGAGQAIDLVILDQIKKQAPGLAEN
AQQALTDLKETGNSKNYNPALASIFRPSVQPFMKSWIKYDPAEEISALDIPILIVTGTKD
LQVPLKEGELLKEAQPKAEYAIIESMNHVLKTIEGDDIENSKSYNEASRPINTELIKEIT
RFIRE
>KECLDBNJ_01888 hypothetical protein
MQIRSAILGLVCLLVLASCGKDGDFTLTGKINGLKKGKIYLQRIEDTSLVNIDSVIVDGN
PEFEFITDLKEPQIVYLTLEKVDAYEYDDRIMIFAEPGEMTLNTSLKNFESQAAITGSQN
QQKLDEYSKVIHRFNDKNLDLIKRSFEVRKEGIEDSIIYYDTQLQNLMKRKYLYTVNFAI
TNKEYEIAPYLAVSEIFDANIKYLDTIYTSLKPKVRKSKYGKALKDYIEERKETNANEAT
TTTIDSTVVEE
>KECLDBNJ_01889 hypothetical protein
MASIRDLKKDINFVLGDIIDAVYIWEAINPKEDQKEAEAIVDDAIVTFDELIAKVNNNKV
ENRRKHLKAVNAELEERGKALIDRVNAL
>KECLDBNJ_01890 putative mannose-6-phosphate isomerase GmuF
MSKTVYPMTFQPVLKEKIWGGQKLNKLFNKGNSATAKMGESWEIADLEEGQSTVSNGALQ
GKTLNEAILENPAALLGAKVYDKFGPHFPLLIKFIDAASDLSIQVHPTDETSPTGVGKTE
MWYIMQADKGAKLTVGFNQKITKEEYDKRIDDLSIEEVMDQHIVSEGDSFFINAGRIHAI
GGGVLLAEIQQTSDVTYRVYDYNRKDDEGNLRDLHVKESREVLDFETTQDFKLEYDRSVT
NTPQVVKRHTYFKTEWVKLTKPYSIARTDTFTIIIVVSGSLNFSDGEIEGSLNAGETLLI
PAASDEVTLDAESCEILEVYL
>KECLDBNJ_01891 6-carboxy-5,6,7,8-tetrahydropterin synthase
MKQVTVKRKAHFNAAHRLYRVDWDDAKNLEVFGKCSYPNYHGHNYELIVAVTGPIDPETG
FVIDLKVLKDLIKAEVEEPFDHKNLNLDVPEFSTINPTAENICVVIYDRLKRHLSETFKI
EVTLYETPRNSVTYSGE
>KECLDBNJ_01892 Isopentenyl-diphosphate Delta-isomerase
MKEELVILVDENDRQVGLMPKMEAHEKALLHRAFSVFVFNDQNQLMIQRRAAHKYHSPGL
WTNTCCSHQREGETNVEAGKRRLMEEMGFTTSLTENISFIYKAPFDNGLTEHEYDYILLG
DYNDEPNINPDEVSEWKWMSLEDIEKDMKVHPEQYTEWFKIIFDKFYNQIER
>KECLDBNJ_01893 Outer membrane porin F
MKQLLQVILLLAIAFSFDSVYAQEREIAKGNKKFDQYAFVDSQKIYLRVAEEGYESADLF
SKLGDSFYYNADYKEAVTWYTKLVEKYPEEVTPYQYFRYAQALRAEKQYDKSTEMIALYQ
EAVSSSDDIYSSQSISEIENGSATFEIEKLKVNAAKFSDFAPSFYGEQLLFASTRDTGTF
TKRIHKWNDQPFLDLYVGDIDENNQVATASKLPGSVNTEFHESTALLSTDGNTLYFTRNN
FTNDTYKADSNNTNRLKLYKAQRNGDGFNNVEELPFNDNGFSTAHPALSTDGKTLYFASD
RPGTYGESDLWKIALNEDGTFGEVENLGDKINTPGRETFPFISKEGKLYFSTDGRAGLGG
LDVYVYDFEDESLENIGAPVNSVKDDFTFIINSETGRGFFATNRANNPLDDDIYTFIQSA
CESTLIVNVIDKNTKEPLNGAMVGVRDTENNLVVSGIAEAPDATFAYNDPECDKEYFIRG
EMEGYLTDEKLVKIPSSSSEVSVVLELEPSITQIPPDFDLGKLINPIYFDFDKSYIRPDA
AVELAKVIEILKEYPELRIDVRSHTDSRGNDAYNLALSERRNKSTIDYIVEEGGISRERL
TGRGYGETQLLNECSNGVQCTEEQHQLNRRSEFIVQDY
>KECLDBNJ_01894 hypothetical protein
MSIYNKRLHMVKRNLGKLVLLFVLLISLSGYSQQDPQYTQYMYNPLVINPAYAGNRGVTS
ILLLHRSQWVGLDGAPSTQNLAVHSPIGLGKVGLGFSLVNDVLGPARETYFNTDFSYTID
TGAEGKFSFGLKGSLNLLDVDFSRTNPFNQNDPFLVSIDNKLSPNVGVGIFYHDAKFYGG
LSAPQLLRTDHFDRSGSQGAQTFVSEEEIHYYGLAGYVFDLNRNLKFKPSTLVKMVAGAP
LSVDVNANFLLYDKLTLGASYRWSAALSALAAFQVNDGLLIGFAYDRESTDLGNATYNNG
TYEVFLRFELFKEYNRMLTPRFF
>KECLDBNJ_01895 hypothetical protein
MIIQVLPIEDELDVNEPPVANDDTAITESGVPATGNVLVNDFDPDGDTITVTSNTQPTNG
SVTVNPDGTFTYTPEPDFVGEDSFEYTVCDDGEPRECATGTVTIEVTPDSGNTTVANDDA
YFGLIDAAITGNVLDNDFDPEGQTQLVDITVSPANGPEDGSLIINEDGSFTYTPNDGFIG
TDQFTYQISDNGTPVATDVATVYISVRGSDIVPPVASLSLEKVGIFNDENGDQRPQVGET
ITYTFTVYNTGESTISDIVIEDPLVDVVGGPITLEPGEVDATTFTAIYSITQADIEQLFV
ENQALVSGVDPYGDVIEDLSDDPNNSDDEDVDNDGEPDDVTVTIIPNVLAEEDIVIYNVM
TPNGDGLNDIFMIENIDRFPDNKVQIFNRWGIEVFSTEGYSINNDNVFRGFSDGRATVRR
GERLPTGTYYYMIEYADPDSGQVRRKASFLYIN
>KECLDBNJ_01896 Single-stranded DNA-binding protein
MSTLRNQVQLIGNVGQEPTLTTLESGKKVVRFSLATNEFYKNAKGEKTQDTQWHTIVAWG
KTAELIENYAPKGKELALTGKLKSRSYTDTAGLKRYVTEVEASEIVLLGSKSV
>KECLDBNJ_01897 HTH-type transcriptional activator RhaS
MKNTRSVSEFNTELKLKGFNVFQIESDSNATRIYSRKDFYKICLTTGESKIHYSDRSFNH
KGTVLFFGNPHIPYSWETISTTYTGYTCLFSEAFLATSYRSESLQQSPLFKLDGTPVLKI
SEEQRLFLNTIFKKMIEEQKTDYSLKDDLIRNYINLLIHEALKLEPSQNLHQPVNALTRL
ANVFIELLERQFPIEGMAQPLKMRTAKDFAEALSVHVNYLNKAVREVTGHSTTTHINNRI
ANEAKALLLHTDWNVSDIAYALGFDYPSYFNNFFKKATQTNPGAFRAAHS
>KECLDBNJ_01898 hypothetical protein
MTAKPVFNLAATAVIAALLSVACNDRKPHKDTSQTTTQTEFIFSKGEKVPDQNFTGNAYN
TSLVAPDSTYTTAIGNVYFEPGSRSNWHTHPGGQILIITDGKGYHQIEGQPKQVIQKGDV
VKCSPNTRHWHGATENTGLQQMYIVPNTEKGIVNWMETVTDSVYIK
>KECLDBNJ_01899 hypothetical protein
MKITRNQEIHSAPGPEAYFTGSVRVEMQFSQQPRTKAAAAMVTFEAGARTAWHTHPAGQT
LIITSGMGWIQKEGEAIVEVFPGDVIYFEPEEKHWHGASPQKAMSHLAIQEEVDDKVVDW
LEKVTDDQYKK
>KECLDBNJ_01900 Putative acetyltransferase
MKTIFDRLRANEEVAMNDPDYGLIGASVETTMRLNLKLNNAQDLDEARHYLSEIIGTVVS
KDTTVFTPFYTNFGRHIQLGRNVFINHACSFLDLGGIVIEDDVMIGPRVNITSENHPIAT
STRNTLIPQKVTIKKGAWLGANVTVLPGVTIGEHAVIAAGAVVNKNVEPKSVYAGVPAKK
IKDLE
>KECLDBNJ_01901 hypothetical protein
MKTINLITVLILSVLGIVDNQNRSEHKIAATENELNQEHKRDTMRTEEDYIFELNEEVTR
TSVRFKNRYGITLAGDLYLPKNSTDKQLSALAISGPFGAVKEQASGLYANELAKRGYAVL
TFDPSYTGESGGEPRNTASPDINTEDFSAAVDFLGVQEGINRDKIGIIGICGFGGFALNA
VAADKRVKAVATTSMYDMSRVNAKGYFDSTTSEQRAAQLEQMSLQRWEDAKNGKRAMAPQ
GLPSEINGDEPQFVKDYFDFYKTDRGFHPRSINSNGSWTATNSISFMNMPILTYIEEIAP
RPILIIAGSEAHSRYFSEDAYKAAQEPKELMIIDDAVHTDLYDGGDKDFIPFDKLETFFN
ENL
>KECLDBNJ_01902 putative sugar epimerase YhfK
MKTLIIGAHGKVGQRIAKLMQASTDFEPTAFIRKEEQKPLFEKMNVPTVVESLENTPEAL
EKVINNYDAVVFTAGSGGSTGADKTMEIDLDGAIKTIHAASQTGVKRYVMVGASHSDDRS
FWGKVEGMKPYYIAKHYADKELQRSDLDFTILRPVTLTDDEEAGNVMMSTDPEKVNSKIP
RQAVAETVLEVLNNKNTFGKIIEMSSGEDSIPQALHKFIN
>KECLDBNJ_01903 Sensor histidine kinase TmoS
MCVLSRNSTLVIKWFFLICFYNLSYTQIKYDLRNETLKEQLTFYHLDTQNGLSNNTVKTI
EQDELGFIWIGTSDGLNRYDGNEFKIFRKENSNIRNNYIQNISFENSGELKLATDGGLVT
YNPKNERFYSLNDFNPHLKLSINSYIDISENSYAIGVYGQGIFTFNDTEETTFLNSETSD
LSSNKISCMVKQGSKGAWIGTFDEGLNYFDFQANKITPIPLVIDDEKVEEINTLYLDENQ
ILWIGSSQGLIARSYNGKLYTLKEGSTKQTLTDDQILAIEKDDYGKLWVGTYSGGINRFD
IKAFLSKSPSFSIDTYQPQDDGTSITNASINALKKDRNGYLWIGTNAGIDFVDPKGEPVK
LLKNNLKGGARLIHNRITGLEELKSGLILIATDGGGLDSFNPDTGIYSDADFIDSDKLRT
KHLNCLFEDNQEKLWIGTYQKGLHQYDPRNNTWSYYLNGSKADGNDVRCIAQDSKNQIWV
GTNRGGLFKYDSSKKKFVYVKALDQITERMDIRAIDFDSNGVLWLATYGNGIVKFNPDNN
EVFSYFHGNLDGLTNNVIFSIKVLSDDTIAAGQKYGGLILFKDGDSSGTTYTESQGLSNN
TINSIINYNSQKLFLGTYKGLSEFNLGNKQVKSLNSLYNIQKSEYNVGAALISKKGYLYF
GGNKGVNIFSPEDLKNQNEANTIIIKDLKVHNEDVNVSLDNPKAILDQSIIYKDQIKLQY
NQNNFSLDFTSLNFPFAASLNYSYILEGYYDQYTHLKNSNRINFSNIPPGNYTLKIKAEN
QANSTRFKELSIIILPPFWQTLPAYIFYIVTLIIFIWGGLKYYAERLKLKNSLLFEQKQR
QLEHELNEERIRFYTGISHELKTPLTLILAPLESLIDNVIHKKQQKSLRLIKKNAEHLLQ
FINKLLEFRKSEEGLSTLHLHSYDLNKNLSHWLESYKHLLKKKNINLIFNKPEAPVLVVC
DLEKIHIIINNLITNAIKYSNINSKIYVKLCSNASDVTIEVADIGAGIDETEIHQIFEWY
YQAHSKIRKGGSGIGLALSKRFAQLHNGNLYVRSTPQKGSTFTLSFPLSQPKQSEGSQSQ
PKNTIEDNLANIQATIYEELTVNDVIIGVEKERKLALLIDDNPDILALLDSILATDYDLI
HAQNGQEGISRAIKYIPDIIISDVMMPQKNGIDLCRELKEQRATSHIPIILLSAKSNFDI
IETGYSKGADDYMVKPFNIKVLKARIANLIASRTSLLQKYETHDAINANVDADELKVLDS
EKAFLKEFKEIVHQNIQQDIKTIDTISEQMNMSRSSLYRKIKAITGKNINEYVRNIKVEH
AAYLIEKKNFNITEAAYEVGYLDPKYFRKIFKQRYGKTPSAFKSN
>KECLDBNJ_01904 hypothetical protein
MFTNYIKVFQLIAAVILSASVYGQKNDHSSFFPGKLWPDNDGNHINAHGGGILYHNENYY
WYGEHKGANSLAEVGVRVYKSKDLINWSNEGVALEVSTDPNSEITIGSVIERPKVIFNKK
TKLFVMWFHLELKGQGYAAARTAVATSQSPTGPFKYIQSFRPNQKSWPQNFELSQTQENL
EEQHLEWWTEEWHQALVDGLYVRRDFKKGQMSRDMTVFVDDDDTAYHISSSEENQTLHIS
KLTDDYLGFSKEWVRVKPGGQNEAPAVFKHKETYYMITSGLTGWKPNKARSFKAKSMFGP
WEKLANPAKGKNADVTFFSQSTYVLPINRAEGIYIYMGDRWNPKKHSDGRYIWLPLVVKQ
GQPAMEWQDEWSLDQLKYISDNHKAD
>KECLDBNJ_01905 TonB-dependent receptor SusC
MIQQLIRVKHFLRCLVLLLALGFGAQFKAHSLDELPQQIITGTVYDGSDSNQPLIGVTVV
EKGTQNGTSTDFDGNYSIRVSPGSTLVFSFVGFETKEVLVSDQESINVSLNLSSESLEET
VVIAFGGKQLKESQVSSIATINPAELKGPTNNLTNMIAGRVPGMVSFQRSGEPGADNSDF
FIRGLSTFGSGKRNPLILIDNIESTSTDLARLQPDDIDTFSVLKDAAAASVYGARGANGV
ILITTKSGKAGKAKFSARAASRISTNTRNFEFADNITYMQLANEAALTRDPLAILPYSQI
KIDRTAAGDNPYLYPSNNWIDQILKEYTINQSFNISASGGSERARYYVSGTYNIDNGILD
VNPINNFNSNIKLQNYSLRSKLDIDLTPTTLATVNIYGQFDDYNGPISNGGDIIASTVNA
NPVAFTSIFPSELYPLAEHPLFGNSPLSLASNALYTNPYAEMVKGYRTTKNSTVQAQIAI
DQKLDFITEGLKIGTMNYIRRYNTYSISRSYNPFFYQASRNPLNDGVLLSVINDGTQSSI
GTPGTEFLNLSGENNESNSRIYNQFTLNYDRVFAEKHAVSGFLINVLQSYETTEFSSLQE
SLQYRNHTFSGRFTYAFDKRYIGEFSFGYNGSERFDRSNRYGFFPSFGVSYVISNEDYFS
NLKETISNLKLRFTYGKAGNDEIGNLDEDRFFYLSSVNTNNGGFGATFGQDYNFYRPGIS
IDRYANAAIGWEVSEQYNLGIDIGLWRDLNFTAEIYKQNRSNILQRRTEIGDVIGLTAQP
QVNFAELESKGVDLSLDYNRQINQEWWTQARATLTYATNEVKQTNELNYPDNLSYLSQVG
NNASQMYGYIAERLFTDQEEVNNSPTQFGNYTGGDIKYRDVNGDGVITSLDRVPIGLPTT
PEIIYGFGGTVGYKDFDLSVFFQGSARSSFQISPTDISPFVLGTGNETGQQNGLLRLIAE
SYWSEDNRDSYAFWPRLSPNIVENNVQSSSWWLQNNDFLRLKNLEIGYRASEKLVDALGI
RSLRIYASGINLAVWSSFDLWDPEMGSNGLGYPIQSTYNLGVQFDF
>KECLDBNJ_01906 hypothetical protein
MKTIIFKKLIKQGIGALLLLVLLNSTYSCQDDYLDVVPDGLATVDKVFNLRQEAEKYLFT
CYSYMPRLGDPRRNAGFLAGDEMWVPDNRENGDYFALEIALGRQRVSNPYFNVWQGEYQA
GAPYDGPEIWDGIRHCNIFIENMSDENNVPDITQSERERWIAEAKFLKAYYHFYLTKFYG
AIPVMRENISIDAPTEEFDVTRAPYDEAIAYIVELLDEAAAVLPPVIADINTELGRITSV
TARSLKARVLVTAASPLYNGNEDLAVVVNKDGTPLYNNTYEPNKWQLAADAAKDAIDAAE
ASGLRLFEFNESVTGFDLTDTTVTKLSIRNAITDPESIEIIWPNTQSLTLGEDGLQASAM
APLEVGHNTRVARKVLSPTITMAKLFYTDNGVPITEDRNYDFNDIRELREATPEERFNIE
EGYRTSRLNFDREPRFYADLGFDGSTWYKRDALGDETKWHIEGKFGDYSGSDHPFFFNET
GYYCKKLVNWRMTFSNDGGSFENYAWPEMRLAELYLLYAEALNETQGPSSDVYNYLDLIR
DRAGLDGVVESWANHSVNPNKPLSQDGLRSIIQQERMIELAFEGQRYWDLLRWKRAVEEF
NDDVQGWNVFGDDEASYYQVRTIHLQSFVSPRDYFWPLSETSLIRNTNLVQNPGW
>KECLDBNJ_01907 hypothetical protein
MKTIILKKIAFAFVLALLCSCSEEVEQIPLESNSIAPQQVTNIKVENLPGKARLTYTLPK
DQDLLYIKANYTLPTGREMEVKSSYYSNAMLLEGFTGNDDINVDVVAVNRSEVESDPVSI
TVNPLPSPIFDVYNSLDVGEAFGGIYINAENPERMDLAILVLNKNEDGDYVASPNSIYTS
TNDIKSRIRGLDTIAKDFAFTIRDRWLNYTDTLERTITPLFEEAIPKSNYGDLRLPNDAP
GHNSTPKSGMWDNDILNWPRCYLTQGNFLEDTHITSFDIGKLTKLSRIVIWDYPEYYNGG
REYYYNVCMKEFEIYGSAELEPTGDLDKWTLLGSYEQVKPSGLPYGQSTSEDFEAANSGF
SWDIDPNAEPVRYIRIHMIDNWAGTYSMGISELQVYGNSNF
>KECLDBNJ_01908 hypothetical protein
MKNIYKYILFAFAGILSLYWSCTSEEYDDYKEFTAGGEISYTEKIDSLKTFSGNNRIMIQ
GIINADPKITQF
>KECLDBNJ_01909 hypothetical protein
MIIDGIEENIYNFELRTYDDQGNKSLASNITGVVYGERYQNTLFNRPVVANNLIEDSLSI
EYASMDLTTGVIGTEIIYTNTSDNQVTTFVAIEEDFKSILDYKPQSTYKYRTVFIPEETA
IDTFYTEYISFTPISKPVILNAAIPFKAVSTAGRWGILEDWTTTDPVKIHNGQGGWDEWN
GNIFNIESGWGAPAITNGKIYQSVMVEPASYTLNVLIRDTNHSLDDAGGSFFVVAEGETL
PDVADVLTSDSVLAQKRINSALGTEYTYSLNFTVDEAMTITIGQITTQWGETPGRFCNIR
SWDIIVAE
>KECLDBNJ_01910 hypothetical protein
MTRYNFFFGIFCTCFLLLSCEEKKLFTEIDVQKAGLNFENTLTESDEQNVMTYEYFYNGG
GVAVADFNNDGYADVYLSGNQVKNKLFLNLGQWQFKEVTNSAQLNEEEGWKTGVTAADVN
GDGLMDIYLSYSGNAKGEGHTEPIIKEYKGRSNALFINHGNNAEGIPVFREMAKEYGLDA
SGTFSTQAYFLDYDLDGDLDMFLLNHANKFYNTLLNVKTLRNIRHPYYGNKLFENRGNSF
VEVSEEAGIKGTGINFGLSASISDLNNDGYPDIYVTNDYVEQDFCYINNQDGSFKEVSKS
AFGHLSKFSMGSDIADLNNDQKPDVLVLDMLPEDNYRQKVLKGPDQFNRERTLVDSGYHH
QYMRNTLQLNRSVAADSSLAFSEQAQLSGISNTDWSWAPLLADFDNDGLKDIFITNGYLR
DFSNLDFTNYTVNEAISQAQQNNTNVDIGLLVSKMSSTKVSNYIYQNKGEAHFENKTAAW
GFEKKTVSNAAAYADFDNDGDLDLIVNNLNAPIDLYENTAENRKHHYLKIVLKGTSKNTK
ALGAKILLQLNDTTSIFQEAYYGRGYQASVEPVLTIGLGDIQLIQELKIIWPGGKISGLK
NEKVDQTLVIDEKDARANIDSVSEESKTILKDVTAVSKLSYTHQENSYQDFNSENLILYR
ASMLGGNASVADLNNDGNDDIYFEAAKDQPGVLYLGKPDGTVEIFNDNQPWLDPQAITQE
DLASLFFDADGDGDLDLYVVSGGNEEFNGNDFYQDRLYLNDGDAKFSEAKDALPDMRFSG
GTVKAADFDNDGDLDLFVGGRISGKNYPMSPISMLLENTSDKHMVAFKEKRNYDIENLGM
VTDAVWDDLNEDDLPDLIVVGEWMPVTILLNTNGNLSKSDDYNLNNSTGWWTSIVPFDFD
NDGDTDYLLGNMGLNSQLKASVEEPMRYYIQDIDNNGRIDPILSYYIQHRNYPLAGRDEL
IAQAPGLKKHFPYYEDYAKTTTEELLEVAQIKPRFVLDIKELRSSVLVNTGKGSFDLQPL
PKAAQTSVVQDFIIEDFNNDGIKEVLAAGNFFPFKISLGQMDASFGSLLQFKNGKWFSLE
ETAQLNLRGDIRDLNTLHFASGTKKLLVTRNNDSASLHRFPENN
>KECLDBNJ_01911 Sensor histidine kinase TodS
MRAALLSVLIFLGFQLSVFAQKDAQEYSDLYFYQINSSDGLSNNVINDITQDSLGFLWIA
TYDGLNRYDGTQFLKFRKNIADEKTGVSNNYIQELQLLDNNRLLIATDAGLNIYDLTTET
FKVLTTTDGLLNNSVSALTLNEQKQPIIGTYRGGIQYLSSLAFKTLGLSKDGEALSSNEI
SSIAAQGDSVLWVGTYDKGLNKITRKQGIYTSEVIDIPQLKNATVYQVYIDKAQNLWGAT
NKGLVVITPTGDYKFLNKGNTSTSGLSDSDILSIVDDQHGNLFVGTRYGGLNILNKRSLL
TENIPLDIQWYQPTNDGASVFDRSVTSLFIDKDQGMWIGTPTGLNYTNLKGEFAKTISEN
GSYPYAISDDRVSAIAVKSNTQVWVGTDGEGLDLYDLNTGKLKTFSSSSNSANPLSGNSI
LALLPDGDEHIWVGTYQKGLNYLNHKTGESTYFLQGSQQDGNDVRTLFRSKNGTLWVGTN
RGGLFKYDDSLEDFIYVSDLEKLDIRDIEEQDGYLWLATFGSGLIRYNPSDGSAIYYNSD
NIKNLNTNIFFTLEIVDDSTILLGTRYNGLKIFDPKNETVKSYSENDGLSNNTINSLLLQ
QDQFVWIGTYTGIDRFDLKNNVFKNFTALRNVQNEGVGPIASTTDGKVFVGGLKGLQIID
VSELERLEGDQNIVFKQLNVLNKVITPEENSVLQKAITYQDALEFDYFQNAFSIHFTALK
YPLGNTLSYSYKLENYNDFWIDTQEGIANFTGVPPGDYILKVKTESSSGKEILKTLAITI
HPPFWKTPLAYVIYILALVLIIYLISRYFSERLKLKNRLILEQQQRQLEHELNEERLRFF
TAFSHELKTPLTLILAPLDNLITDANNRSLKKQLNIINRNAKKLSAAINKLLEFRKSEEG
LSRLNLSDHNLSANLKKWVKNYAPLAIDKNITIRTFIEESEQRYLFDIEKLKVIINNLLS
NAIKYCDDDGSIEVHLYINKYTIDISVSDNGAGIAPQELEEIFSWYYRSETATQKSGTGI
GLALSKRFAELHNGSLKVTSTPHVKTTFMVEIPKLIPEAETISTATPKEENSVETKDLHL
ATEIVNAEKDNTKSIASAENRALVMVIDDNPDILNFLDEILKGDYDLVFANNGEEGIKKA
QKFVPDLIISDIMMPKKTGIDLCRALKNDLATSHIPIILLTAKGNLESLKTGYEEGADDY
ISKPFQPQLLKTRISNLLRNREAVQRFLQTKEKKQQPEESNSPALNKEKEFLAKLDAIIH
ANIGSENENVFDIAKELGMSRTSLYRKLKSITGYSINEYTRNLKLEKAADLIENQEYSVS
QAAYEVGFNSPKYFRKIFKEMYGKLPSEFKS
>KECLDBNJ_01912 Glucuronoxylanase XynC
MKLKFVKIVLFVFALGGIIAFASFKLKKSDQATGPIEEAIELHLNPKETFQKIDNFGASD
AWSVQFVGKNWPIHKREQIADLLFSTQMDQEGNPKGIGLSLWRLNLGAGSAEQGKSSGIR
DEWRRAESFLTENGAYDWTKQSGQVWFAKAAKERGVEQLLLFSNSPPVEFTNNGKAYTSN
KKESNLAATNTQAFAKYLVDVTEGFDTMGLEVDYISPVNEPQWDWADGSQEGTPFWNNQI
KDLVVALNQELKSRKLQHTLIDIPETAQLNYLFENGNKTGRADVIQTFFDENSSEYVGDL
EYLSRSVSAHSYFTTSPFESLVKQRKTLFNAVNKIPDLHFWMSEYCILGDNAGEIEGNGR
DLGMTSALYMAKVINTDLVVANASAWHWWTAISPYDYKDGLIYIDKNKNDGEVLESKMLW
TLGNYSRFVRPGYTRIRIEDLETNTLNENFLYSAFRSPEKDKTVLVFVNDSNTNKAIRLS
NYTESYDAKSYVTSAEANLELTPLQTKNGFEIPKKAVVTLVLETKN
>KECLDBNJ_01913 Cytochrome bd-I ubiquinol oxidase subunit 2
METILGIDYPTWWFLVIGGLFSGYAILDGFDFGAGAWHLFFKKELNRRIALNAVGPVWDG
NEVWLVIGGGALFAGFPVMYATLFSSLYIPFMLFLIFIIFRAISIEFRGKEEMLWWRRLW
DVSYSISSIMLAFLLGVVLGNVLQGFAIGENYQYTGSGFFEFLNPYAIMTGVTTLALFMA
HGAIYLLLKTEGAMFDQLTNLLQKGMIFFMVSFAITTLYTLLYIPHLSDDFKSAPILFAV
PVLTFLSIANVPRLASKKNYKLAFFFSSLTISLLLVLVAVELYPNLLFSTVDPKYSLDVY
EAASSERSLGIMLLFVAIGGPLVLGYTFFVYRTFRGKVKLDDHSY
>KECLDBNJ_01914 Cytochrome bd-I ubiquinol oxidase subunit 1
MDVELLARIQFAFTVAFHYIYPPLSIGIGLLMVVFESLYVRTKKEDYHILAKFWTKIFAL
TFGIGVVTGIVMEFEFGTNWATYSRYVGDVFGSALAAEGIFAFALESGFLGVLLFGWNRV
KPWVHLVSTIGVFLGSMFSAIWIVVANSWQQTPAGYHIVGEGMQARAEITDFWAMVFNPS
SVERIWHVWLGAFLAGVFLILSVHAYYILRGRYVSISKKAFKITLIIATITSLAQLVAGH
ASAEVVAEHQPAKLAALEGHYDESAAADMYLFGWVDQEKQEVTGLAIPGGLSFLLDQDFE
APVTGLNAFPADERPSQVNAVFQFYHLMVAIGMFLIALTLYASFLLWKKKLFTKKWLLWV
FVFTALLPQIANQVGWFSAEMGRQPWVVYGLLRTNEAFSQAVTANQVLFSLILFFAVYAL
LFLLFVYLLNKKIKHGPYEEANDEDDDRPLTKEISEVVTG
>KECLDBNJ_01915 hypothetical protein
MEKYLKIIQDSFTGYFNYLIEEITNPGWTNYFYWLLGLSLLVFAFEIIIPWRKKQPIFRK
GFWLDAFYMIFNFFLFSLIGYNALSNVGVELFNDFLGLFGIDNLVAIEVQDFPVWAQLLI
MFIIADFIQWNVHRMLHRVPWLWKFHQVHHSVKEMGFAAQFRFHFVETLVYKSAQYIPLA
MIGFGIEQFFVVHMFSVFIGHLNHANLDWSYGPLGYVLNNPRMHIWHHAKALPPEHKYGM
NFGLSLSIWDYLFGTAYVPKSGKDIEIGFDGDERFPHDFTGQLTYPFKEHSQK
>KECLDBNJ_01916 hypothetical protein
MSQAAALAQRLQEVILDGTWIANTNFKKELNTTSLAQVSIPIRSYNTVEVLAQHIHYYIA
GVKQVFLRGELSISDRFSFDFEPLQSDQEWQNFLALFWKNTEELIALIQPLSDAQLDAIF
VKEAYGTYKRNIEALIEHSYYHLGQIVLLLKTEAST
>KECLDBNJ_01917 hypothetical protein
MKIVKIGIALWLFMTPFLLKAQQDTAYKYEVLAGHDNDFTIFGTRTDWHYTYGIHLGFGW
RPKQTNLITQLFPNKKAFSHYIAAHIQAYTPDYARTYQIVKTRQPYAGWGYLDFANNYGF
ENVFLQLKVDLGILGPAVHAGDIQNFIHQKFSKDIFVDQWEDQIPNQFGFNLRANYAQDI
FTEKWLNLYSLSRISAGNIFTFFEQGLYFRFGQFNAIGRSVARQQSLLGNGETEIFLEAG
FNMNFSAFNATIENANGQGEKVVPQNLVNHRILNGHVGVFFSQKRYAIGLKWNYTEGEIK
GNEPHRFAILAGTYKFN
>KECLDBNJ_01918 putative sulfate transporter
MKKFFPIFDWLPNYKKSYLSGDVSAGITVGIMLIPQGMAYAMIAGLPPVFGLYAALLPQV
IYALMGTSRQIAIGPVAMDSLIIASGLGALSLSGLDEYIAMAIFLALFVGIIQILMGFLK
MGFLVNFLSKPVISGFTSAAALIIGITQLKHLLGISVTSNRTLPIIKQTLGQLDQINPVA
VVVGLTGIGIMLLIKRINSQIPAAIVVVVFGIALAYFTPLTNYGLLLVGKIPQGLPGFDI
PTVPWEDLGQLFTLALAMSLIAFMEVVSIGKALEEKVKSNTIKPNQELIALGTGNIIGSL
FQCYPTTAGFSRTAVNFQAGAKTGVAAFISASLVALTLLFLTPVFYYLPNAILASIIMLA
ITSLIDLKYPKELYKNQKDEFFLLVTTFIITLFVGIQEGIILGVLFSLLLMVYRTSKPHM
AVLGQIKGTTYFKNINRFATDIIDRKDILVVRFDAQLFFGNKDYFYKELKKHIKAKGPDL
KTIIINAEAINYIDSSAIYILKFVILELRQKEITLMIAAATGPTRDILFKTGVTELLGAE
NLFVRVVEAVEFIDGIHPRTEIEDRVSRQKF
>KECLDBNJ_01919 tRNA(Ile)-lysidine synthase
MIKRFNQHIESQFNGLKQTSVLLAISGGLDSVVLAYLLKACDVDFEMAHCNFKLRGSESD
ADAIFVEKLAEALQVKLHLQNFNTEAYAKDQKVSIQMAARELRYHWFEELCQTFGLAYIA
TAHHAKDDLETFLINLSRGSGIDGLTGITAHNEQLIRPLLPFSREEILAYAEANEIKWRE
DSSNASDKYLRNHLRHHAIPAIEEAAPQFLNQFQKSQQHLKEVALLLEDYTAMLFSQIVN
QSFKGYELSIQKLKQTPNTKAVLYQLLKDFEFTAWDDIYDLLDAEPGKYVSAKNHRLIRD
REVLLLTEHKKKHEVVLWNEQDASLVLDNLKIKKEAVDQFSKTTATEAIFDKDQLDFPLK
LRKWEEGDWFYPFGLKGKKKLSKFFKDLKYSTLDKESVWLLCNDQDIIWVVGARTDDRYK
VTPNTSQFLKITAYYD
>KECLDBNJ_01920 Thiol:disulfide interchange protein DsbD
MIKYGFLLVTLLISLTGNAQAFGPSAGAQNPAQWMAQVDKTSESEYTLLLNASIEPEWHV
YSQFTDPGGSLPLELEFLEAGKAYSLEGPTVESETTTAYSEIFEVDETFFSETAQLSQKI
KAEETTEYVKLILKYQVCKEVCINEEKYIVFDLVKENGKVFKDFNDFQEYGNVQEEVEKI
EPVKEVVKKEEKQDLWTIFFVAFASGFLALLTPCVFPMIPMTVSFFTKQSKNLAVGRRNA
ILYGIFIVVIYVLLGSLVTGIFGADALNALSTNVWFNLIFFLLLVVFAVSFFGAFEIMLP
NSWANAVDRKADRGGIIGIFFMALALAIVSFSCTGPIVGTLLVQAASEGGLAPILGMLGF
SLAIAIPFALFALFPGLMNSLPKSGGWLNSVKVVLGFLELALAFKFLSNADLVLQAHILE
REVFLAIWIAIFGAMAFYLFGKIRLSHDSPLTHISSGRLILGLFVLSFTLYLIPGLWGAP
LKLISGFPPPLNYSESPYGVGYSKGSVAGLTEGELPEEAELGPYQLVTFTDYDAGMAYAK
AENKPVLIDFTGKACVNCRKMEERVWGEPQILGKLQNDVVLISLFVDLKEELPEAEQYVS
EVTGKRIQTVGNKWSDFQIEKYQINAQPYYVLLNHNEDELNTPVGYTPDVDEFEAWLEDG
ISKFND
>KECLDBNJ_01921 Cocaine esterase
MKKVKNLVFAVLLLFVSCIQAQTEEYVREHYDKKEVKIKMRDGVLLHTTIYSPKDKSQEY
PILMMRTPYSCAPYGEENYKGRIGPNKFMVEEGNIFVQQDVRGRWNSEGVYDNMRAYIPN
KKGKQVDEASDTYDTIDWLVKNVDNNNGNVGTWGISYPGFYATYSLLSEHPALKAVSPQA
CISDFFFDDFHHNGAFLESYWRAISLFGYMKDQPVTKPWYAFPDLPTQDQYQFFLDAGPL
TNLDAYYKEDNVFWQQIKDHPNYDEFWRSRGIIQHLNDIKPAVMVVGGLFDAEDLYGPFN
TYRKIEETSDNYNILVYGPWSHGDWARSSERQAIGNVYFGDNLSRDFQQNYETVFFNHFL
KNDGKGAIDFPEASMYDSGSREWDSYAEWPPKAAETKSFYLGADQKLTESASADFENAFV
SDPSKPVPYSEDIKMVFTPRKYMTDDQRFAARRPDVLVYETEVLEDDMTITGEILAKLQV
ATTGSDADWVVKLVDVYPAGAEDYPETQDYLKMDNYQMMVRSEVMRGRFRESFSEPKAFE
PNQKTEVDLTLQGVNHTFLKGHKMQIQIQSTWFPLIDRNPQTFVPNIYKADAEDFQKQTH
TVFGDSEIQFKVLK
>KECLDBNJ_01922 Alpha-amylase 2
MIKNILLISLGILLTSCAQNKSNHIKEPMQNTDPKKKVVYHVFTRLFGNTNTTNKPWGTI
EENGVGKFEDFTAKALSEIKELGVTHIWYTGVPHHAVITDYTQFGISNDDPDVVKGRAGS
PYAVKDYYQVDPDMAVNPANRLEEFEALINRTHQADLKVIIDIVPNHVARKYESLNTPEY
TVPFGANDDTSVAYAKNNNFYYIPGTDFIVPQWENGYVPLGEKSASADAQFTESPAKWTG
NGARDAQPAQNDWYETVKINYGVSPEGHKDFDLLPEDAGHWDHQKHFDFWKDKDVPASWK
QFKEIALFWLDKGVDGFRYDMAEMVPVEFWSYMNAAIKMERPDAFLMAEVYNPQLYREYI
FKGKMDYLYDKVELYDTIKHVMQGHGSTDHFAPILKYQEDIEHNMLHFLENHDEQRIASD
AFAGDAAKGKPAMVVSALISTAPTMIYFGQELGEPALEDLGFGDPTRTSIFDYGSVPSVV
RWVNDKNFDGGQSTPEEKELRDFYKRLLNFSLENSAIMGGYADIHWHNRQHTEWYNDRVH
SFVRWSDTDKLIIVTNFDAKDTFGFELQIPQDIIKQWYLNDGTYKATDQLYNEEQAALQV
QNQAGTIRVDIKPLQSFVFKIE
>KECLDBNJ_01923 hypothetical protein
MSKPYTIGIVGVGPRGLAALESLFLVKSNSKSSLDLHVKLFEASPYPGAGQIWTPDQVET
NLSNIHERNLSNDLAGRPSISVDDIFIPEFPGYADWLTDRKDAPANVSKDHFPARSMLGI
YLYERFLTIYDALKGQNKAELFSAEIVQIDANEQSGIIITKDAQQHMVDEIVLTIGHQPT
YDSEQLQLWDTHAKQNNLKLYKDPYPVGALETDAITPETKIALRGFGLSMVDQVRALSIG
FGGSFVPIADSVELNYIPSEEAPRELVAFSLNGLPPVPKPFSGEIDSWFEPSEEEFKLLI
QAVEQAEANASTINDASFLIEAIAQITSSVYKRLGSKAKATDLSADDLTELTLQVIKKPD
TEHTLLVSTKKDTLEAMLLYLHMAYGKTKISLDYCLGQVWRFALGVLYHDYTYMNLGDDA
MVDVVKYIEASKRYSYGPPVKSLQQLIALVKAGVLNLDFVADPEINLVPKGWQLRKDGKT
IVVQVMVNSVIDAPQLAKVSSPLIAHLRTDKRVDAVSYKLGLHTLEDGRIISKGGNTHQN
IALLGRLAKGSVVGVDDLIECFGKPARKWAEGVLNRN
>KECLDBNJ_01924 Competence protein ComM
MLTKVYGSAVFGVEASTITIEVNIDKGIGYHLVGLPDNAIRESNYRIAAALQNNGFKIPG
KKITLNMAPADLRKEGSAYDLTLAIGILAASGQIKAENLEEYIIMGELSLDGSLQPIRGA
LPIAIKAQEEGFKKFLLPSQNAKEAAIVKDLEVYGIDSIAQVIDHFDNDAPLERTIVDTR
NEFFNALEHPEFDFSDVKGQESIKRCMEIAAAGGHNIILIGPPGAGKTMLAKRLPSILPP
MTLREALETTKIHSVSGRMREHVGLMAQRPFRSPHHTISDVALVGGGAYPQPGEISLAHN
GVLFLDELPEFKRTVLEVMRQPLEDREVTISRAKFTVTYPSSFMLVASMNPSPGGYFNDP
SAPVSSTPAEMQRYLSKVSGPLLDRIDIHIEVTPVPFDKLSEERKAESSVAIRKRVTEAR
KLQTSRFAEIETINYNAQMGVKQIRQHCALDETSKNLLKNAMEKLNLSARAYDRILKVSR
TIADLEASEQIQAHHITEAIQYRSLDRDGWLG
>KECLDBNJ_01925 putative zinc protease
MIKTRWTPMALLLSLFVATFISCDDKKAGDNDVAEAKLSIDYEKYELENGLNVVLHQDKS
DPIVSVAIQYGVGSNREKKGRTGFAHLFEHMLFQESENVPQDQFFKTIQDAGGTLNGGTW
QDGTVYYEVVPNNALETVLWLESDRMGFLINTVTESAFANQQEVVQNEKRQRVDNNPYGH
TSWVIDKNLFPDGHPYSWQVIGELEDLQNATVEDVKEFYDKFYGPNNATLVIAGDFEEGK
AKELVEKYFGEIKKRQEVEPLPVQNVTLDETKRFYHEDNFATAPQLNMVWPTVEQYTDDA
YALDFLGEILSDGKKAPLYRVLVEDMELASQPYAWNGSDQIAGKFRISVTANSGVDLDSV
ETGINKAFALFEKEGVKAEDIERIKAGLETDFYNGISSVLGKSFQLAQYDVFTGDPGFIE
DDIENIKAVTAEDVMRVYEKYVKGKPYVMTSFVPKGQMELIAENSEKAEVVEEEITENVE
TEIVDADVEIEKTPSKFDRSVAPAMGETPKLNIPDSWTAELPNEMEVYGIVQDELPLVNF
SLVIEGGHLLDDLNINGVANLMSDILMEGTATKTPLELEEAIDRLGASINMYTTDESIVL
RGNTLARNFDATMALVQEILLEPRWDEKEFARIKTSTINGIKRSDANPNVIANRVYSKRL
YGENHPLAYSTSGTVESVEAITMQDLKDYYNNYFSPSVSRFHVVGDISESQALASLEGLK
ENWAAKEVTIPEFPVENNRDKASLYFVDVPNAKQSVINIGYISMPRTDKDFYPAEVMNYK
LGGSFSGNVNLVLREEKGYTYGARSGFSGSKIPGTFTASSSVRTNTTGESVSIFRDEIQK
YKDGISPEDLEFTKNALIKSNARRFETQGSLLGMLQERSAYDLDPNYIENEEATIKNMTL
EQHKALANKYLDESKMAYLVVGDAATQYQQFKEMGFDEVMLLDKEGNEVKLEEIKK
>KECLDBNJ_01926 Divalent metal cation transporter MntH
MRNPFKNIGPGALVAAAFIGPGTVTVCTLAGIQFGFSLLWAMTLSIIATIILQETASRIG
LVSQKGLSQVLRDELPAGILRKSVLGLVLAAIVVGNAAYEGGNISGGVLGLQALGSTGII
EVAGNTINGYSLLIGAIAFILLYIGNYKVLEKVFLLLVILMSLSFVITAILTGPQLLTVL
KGALIPQFPDGSILMIVALVGTTVVPYNLFLHASLVNQKWKDRSELSAAKKDTIVAVILG
GLVSMSVIIAAAALSGQEVDGASGLALSLEPLYGSAARYCIGLGLFAAGITSAITAPLAA
AYVAQGCLNLGGDLKSRNFRLVWILVLVLGVGVATFGIKPIEIIQFAQVANGILLPVIAG
ILIWLANRSTLLGSYQNSKLKNVISVCILIVTLILGARAILSVFGLI
>KECLDBNJ_01927 hypothetical protein
MRTSIDLNCDLGEGIGNEAALMPLISSCNLACGGHAGDLETIDQVVQLAKQHKVGVGAHP
SFPDREHFGRKEMQLSFKRLKDSVLEQIARVNQACLKHQVPLHHIKAHGALYNLCAQKKE
YAEFLTEVLAEAYPEIPVYVPFDSEMARVATGKLKLLFEAFADRNYEPDGSLVSRQKDHA
VITDENTLINHVLRMVQHNEIKTLDGGILKVKIDTICVHGDTPKAVELLQLLNQKLDDNQ
IKKTTVSCT
>KECLDBNJ_01928 Kinase A inhibitor
MHVKPSINRLGEQAILLQWDFKISPENLKFLLSIKKYIASNIVKHKVEITNTYNSILINY
VISIESVYSDFERLKTLDFHNIPLEAVTSKLYRVPVCYDAEFGLDLELLAKEKSLTIDEV
ISLHTAPEYTLYFIGFLPGFLYLGGMHERLKMPRKSEPRASVLKGAVGIAENQTGIYPNS
SPAGWQIIGNCPVALFDPKSEPPCPFASGDRIQFYSVSKLKYDEIQQEVQAGTYHLTSTH
G
>KECLDBNJ_01929 KipI antagonist
MANIHVVRPGFYTTLQDTGRHGVAQYGVPQSGVMDSFSAGKANLLLNNDPNAAVLEILMT
GPVLEFSSETYIAVCGAQFDILLNDQAISLAKRYRVQKGDVLKFGRLHKGLRAYLAVSGS
FQTELVLGSRSQYPGITMAAKLEKGAFLAITDEVVTTKALSRVNFEDTQLWDPAIEAYPG
PEFALLSTEEQQQLFERLFTLSSKSNRMAIPFKETFDNTLKGITTGPVLPGTVQLTPNGT
LIALMRDCQVSGGYPRVLQLSAFGICQLAQKRPGEAIWFKRKALKS
>KECLDBNJ_01930 hypothetical protein
MNNPPVKCHITDLETTNYPSSYDLAEYIIEYSGRRILFRFHWDHKNSRFVESNKHLLQGL
ILNDKFPKEYGLSDSPVLDNKKLEKIIRESIIPNTPDEKMENLLSYLHSLQDYEGAIIKF
PEKSKDLLAKKLYFKNYQELTFYLFTLKLKGFIEGKARHTMDGSDLGYIHLTYEGLSKVI
DIYESGNKSNRYFIAMSFSDSLNDTREAIKIAVSNAGYLPILIDEIHYDADVTINDALIA
EIKKCKFLVADFTQHKHGVYFEAGYALGLKRPVIYLCEKEDFGDTHFDTNHYPHIIYSDL
DNLKESLVNKIEAWIN
>KECLDBNJ_01931 hypothetical protein
MKNSITILFVLFSLAVFGQDQEYQVSSYLTSGVKAPNTHYIGEAWLNGIIAGDAELGYNI
TKATFKANSTLDWHKHSSPQVLIIVDGEAYYQERGNNAVVLKEGDIIKCEKDIEHWHSST
KNSDVTYLALYGGEQPTTWTEVVTQAYYDKIAEELD
>KECLDBNJ_01932 hypothetical protein
MKKILLLFSLIALNSCDDGDIIVSSFDFSEQDVDYCSTVDDTESETVNYIFYKINSDTNE
AIAFRISTDEPILTELSNETAYTFNLGSSSDTFVSYRIFNNPVTSDYFCNEVPPSQPSVT
EEYISAEGTVTIVTEGEYDDDDDIDAEFEMTLNGETDLDGDGIPNYYDFDDDGDNVPTNQ
EGVVLNEDGSIDMEGSLDTDGDGIPNFMDPDDDGDGVLTINEDVDRDLNPNNDVTDVSIG
PDYLNDNIAIDYNVNAFREHTYNLNNITLTINLTDLVFISQNGEATIRQEELLFGEYSAP
SEKTQVTPEFPE
>KECLDBNJ_01933 Cysteine desulfurase IscS
MSQVYFDNAATTAIRPEVLERMIEVMREVPGNPSSTHAVGRKAKSIIEQARKTIANYLHV
TPGEIVFTSGGTEADNLIINSAVRDLGVRHIITSPIEHHAVIHVVEHLQLAYDIKVSMVR
IKECGSVDLDHLTELLAGSEEKTLVSLMHINNEIGNMLDLEAVAKLAKEHNTLFHSDMVQ
SVGHFDLNLSEIPVDFIAAAAHKFHGPKGVGFAFLRKNSKVKSLIFGGGQERGSRAGTEP
VHNIAGMETALIKAQENLAEERAYIEEIKWYFKEQLETHIPDVHFNGNCHDGTKSTYTLL
NVCLPVPEDKALMLLFQLDLKGIACSKGSACQSGSDQGSHVLNAFLTEDKLKKPSIRFSF
SHENTKEEVDYVVATLKDFIA
>KECLDBNJ_01934 hypothetical protein
MWATAQLLKQPSTENNLLRTTTLFCVLCVLLSVSGMAQQAIVRGVVFNEQQVPQSGVNIT
WSGGGTQTDESGFYTLSIPAEKTIQLNFSHIAYKAIKAQFNLKENEMVEFNPVLNAKVEQ
ISDVVITANTTDQLSGITILTPETVRKIPGANPGVENLLQALPGVSSNNELSTQYAVRGG
NYDENLVYINDIEVYRPFLIRSGQQEGLSIINPDLVRDIDFSAGGFQAKYGDKLSSVLDI
TYKRPVEFAASADVSLLGASISAEGISKNKKFTAIGGARYWDNSLLVDAKQTQTNYRPRF
TDLQTYLTYTFNPKFSIDFLGTVAVNSYNYEPQTRQTNFGTLADPVALVVVYNGQEQDRY
ETYCGALSTTYQPNEQLDLKFTASAYHTQEQEHYDIAAQYALGTPNTTIGSANAGEVDFT
RAIGAQLTHARNNLDALIVNLQHKGQYIKDEHQLDWGLKYAHENIRDRLQEYEIIDSAGF
SKRPPLEEFVNEQPYEPFDAPLSPFTSRRAQNSVSIDRVMGYLQYSKRINWSSAKAWFNA
GIRSQFWTVSGLGIASTSQQVVSPRGQFSLKPNWKSDMLFRLAAGIYHQPPFYRELRNDQ
GQVVPDVEAQRSVHLVLGNDWSFDMWGRPFTLTSEAYFKSLDNVNTYTLENVRIRYRAAN
DAEAYAYGLDFRLSGEFVPGTDSWISLGLLKTEENIQDRGYIARPTDQRFKVAFLFQDYV
PRIPDMKLYLKMVYQTGLPGGSPSYADPYLYQTRLPFYFRSDVGFLYTIINSERSSLRNS
LIKELSTGIEIFNIFDRQNSITNTFVRDAATRQQYAVPNYLTPRVFNIRLSARF
>KECLDBNJ_01935 hypothetical protein
MKKSLLFFFGIAANVMFAQNEFPQDAFIKPLKIPTVFAGTFGELRSNHFHSGLDIKTQHR
TGLEVVASASGYVSRIKVSHYGYGKALYITHPNGYTTVYGHLSKYGPAIDAYVKQKQYEA
ENYEVELFPNPDELVVTQGELVAYSGNTGGSGGPHLHFEIRDKNERPLNAQLFGIQAPDH
QDPILKDLVVYTLSDSSHVNQSQKRQELRFTKQPDGTFLAEKIRAYGQIGFALGTIDQQD
GANNSNGIYSIETSFNGEKYLEVKMDQFSFAETRYLNRMIDYELYEGDRKRVQKLFIERN
NPLSIFTYEKNKGVIDLTQNGNASVYTIKVKDIQGNTSTLVVPITIAKEPILTPKEIKTT
PYFVEADTYKNFEVGDWEVFIPEGAFYDDYYLDITANTDALHLDEDLIPVHKYIRLAYDV
SAFARQNREKLYIGRVNYRGLLRYEGARLEDDHLTASINALGDFKVGIDTKPPKIQSLDF
SDGKWISNLNEINFKITDEDTGIKSYRATINGKFALMEYEYKKNQLTYSFGDGISVSGAN
EFKLTVTDNVGNSTTFEATFYRK
>KECLDBNJ_01936 hypothetical protein
MSELLERVDALQNVMSKLVHRYQKLQRNHELLEAENQKLKLEQQELNEVLANWEAKYSTL
KAANAMLGSNEYKRETKLKINAMMRELDACIAQLAD
>KECLDBNJ_01937 hypothetical protein
MSDYLKIKLSIADRVYPLTIKPQQEEGLRKAAKEIEAMIKKFEQSYAVRDKQDVLAMCAL
QFASKAIQQDMDGAGQHSEAIEQLKNLELLVKSQLS
>KECLDBNJ_01938 Ribonuclease Y
MGNTVLIIVGVILIAGTLGFLLAKLLEKNNASQIVSNAKKEAANIVKEAKNEGESIKKDK
ILQAKEKFIELKSEHEKVILSRDKKINDAEKRTRDKESQVSSELAKNKKLNKEIEAKVKD
YDDRLEYLDKRQADIDKLHASKVQQLEVISGLSADDAKEQLVESLKDQAKSDAMAFIQNA
MEEAKLTAEQDAKKVIINTIQRIGTEEAVENCVSVFNLESDDVKGRIIGREGRNIRAIEA
ATGVEIIVDDTPEAIILSCFDSVRREVARLSLHKLVTDGRIHPARIEEVVKKTTKQIEQE
IVEVGKRTVIDLGIHGLHPELIKAVGRMKYRSSYGQNLLQHSREVAKLCATMAAELGVNP
KLAKRAGLLHDIGKVPETESEMPHALLGMEWAEKYGEKPDVCNAIGAHHDEIEMKTLLAP
IVQVCDAISGARPGARRQVLDSYIQRLKDLEDIAFGFAGVKKAYAIQAGRELRVIVESEK
VNDEKASALSFEISQKIQTDMTYPGQVKITVIRETRAVNIAK
>KECLDBNJ_01939 putative transcriptional regulatory protein
MGRAFEFRKARKMKRWSAMAKAFTRIGKDIVMAVKEGGPDPDSNSRLRAVIQNAKSVNMP
KDNIERAIKRASDKSLGDYKEVLFEGYAPHGIAILIETATDNNNRTVANIRSYFNKCNGN
LGTSGSVEFMFDHTCNFRINAEGVDAEELELELIDYGAEEVFEDEDGIIIYGPFGSFGAL
QAYLEEAGHEILSSGFERIPQVTKTLTPEEAEDVEKLLEKIEEDDDVQNVYHSMDESSSG
SDE
>KECLDBNJ_01940 Putative pterin-4-alpha-carbinolamine dehydratase
MKKLDERSIKERLDKLDGWDYKDNAIHTSFEFENFKEAFATMTRIAFEAELQQHHPEWTN
VYNTLNISLSTHDAGGLTEKDFKLAHTIEALLGN
>KECLDBNJ_01941 Cytosol non-specific dipeptidase
MTNKDIRQLEPQAVWQKFADLNAVPRASKKEARVIAFMQSFGEGLNLETLVDEVGNVIIR
KPATAGLEGRQTVVMQSHLDMVHQKNNATQFDFDTEGIKMKVEGDWVKAEGTTLGADNGL
GVATIMAILESTDIPHPALEALFTIDEETGMTGAMGLKAGVLQGDILLNLDTEEDDEIGV
GCAGGVDITATRTYSEEKVAKGKTAFKLTVDGLQGGHSGMDIIKGLGNANKFMNRFLLDG
FENYGLQITEINGGGLRNAIPRESIAVFCIDEIHTEAFKADIAEFTETLKEEYKTLEPNL
TVTLEAQELPQTVMNLGVQEGLLKALRAAWNGVYRMSPDIEGLVETSNNVARVNVKDGKI
EVLCLTRSSVESSRTDLANTIRSVFELIGCEVELSGEYPGWKPNMDSPILKVLVEKYTNL
NNEAPHVAACHAGLECGILGQNYPEMDMISFGPTIRGAHSPDERASISSVQKFWVFVQEI
LKDIPVKN
>KECLDBNJ_01942 hypothetical protein
MITFKKNIITLALTGALVGGLSTAAKAQQLPAAATAQAQTTISTAELTKFADAFQEVQVE
NQAAQQEMMGIIKTEGLDVQRFTEIQKAQMNPETEVEATDEELKKHAAVVAELKKMQPAL
ETKMAGIIEEHGLTLDRYKAVAMALQQDKELQKKFQGIMMKKQTEG
>KECLDBNJ_01943 putative peptidyl-prolyl cis-trans isomerase
MRKALLFTFLILFALVSCSDEQYPDLDNGLYAEIKTNKGTMVVQLFYDQVPAAVANFVSL
AEGNNPLADSIYKGKPYYDGIKFHRIIKDFMIQGGDPNGTGSGGPGYKFHDEFSPELKHD
TIGVLSMANSGYGTNGSQFFITDAPTPHLDGYDAENNLKNCENPQIGCHTVFGQLVLGFD
VLKAITEVEMKDARRGKPMRPVTMESVRIIRKGKDARHFEAPEVFTEEIDKRAKELAEAA
RAKEQLKEEQRALFEEQRQQADTLESGLAIFISEKGSDEKPKRSQMVKVNYAGYFEDGEL
FDSSMKAYAEKWDMQTRPKEEMYGPTEIPYGPEAQMIAGFKEGVQQLNYGDKATLFIPYY
LGYGERGYRIIPPRTNLVFEIELVDDRETETE
>KECLDBNJ_01944 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MNRSICALLLILFVISCKTPEARRPVSHSSGSYIDASIARNKKLNKAEETAIKELMAQNP
EVEYFASDKGFWYYYNTRDTTALPTAQTGDLVTFDYEINALNGASIVSKAELGTQTYQIE
QSNQELISGLKDGLKLMKEGETVTFLLPSHKAFGYYGFEDRIGSNLPIQTTVTLNDIKPG
NSEN
>KECLDBNJ_01945 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MFGPKIRHLTLSLDEEIVYSPPMKASELAVLKELLATPKKIVIVPHKNPDGDAMGSTLAL
YQYLVKTGHKAHVVSPNDYPKFLKWLPYEDTVVKFDLQNKKAVRLINEADLIFTLDFNAL
SRVAEMEPALQNASAQFVMIDHHQQPDDYAVVTYSDTSVCATCQMVYHTFEMLEVTDLID
ADMATCLYTGIMTDTGSFRFRSTTATTHQVIAALIAKGADNALIHEKIYDANNFSRMQLL
GTALTNLHRLEEYRAAYITLSQEELDAHDFQKGDTEGFVNYGLSLENTVLALIFIENKQE
GIIKISLRSKGDFSVNLMAREHFEGGGHTNAAGGKSDRSLEDTVAYFISILPQYKEALNE
>KECLDBNJ_01946 hypothetical protein
MRLKIKAFFALILCFNLYSALLAQTSTNFKILFGSCNKVDLPNPFWEDMTARNADLFIWG
GDVIYADTEDMDKMKAMYAEQLANTAYRNFIEELPVMGTWDDHDYGINDGGAAYAKKQQS
QQLFLDFIGTAKDAPARRREGVYAARTFVKAGKTIKIIVLDTRYFRTDLAPSINPEKRYR
KIKRGTILGETQWEWFKEELAEPTDFTIIMSSIQLLSAQHGFETWGNLPKEVKRFEKALN
KSKAQAVLVLSGDRHISEFSRKKVKGLDYPLIDFTSSGLTHSYTEYDGEPNRYRVGNVVS
TRSYGMVNIDLESNRIAMKIIGVGGEILGELQQDY
>KECLDBNJ_01947 Nucleoside diphosphate kinase
MATNRTFTMIKPDAVEDGHIGAILEKITASGFRIVALKLTQMTVADAQEFYAVHSERPFY
GELVEFMSRGPIVAAILEKENAVEDFRTLIGATNPADAAEGTIRKMYAKSVGENAVHGSD
SDENAAIEGAFHFSGREMF
>KECLDBNJ_01948 hypothetical protein
MAQRDADPKSIKDVLGAFVETNKLQKGFDKVNVADAWRDVMGPAIAKYTTQIKLDNDRLI
VQLSSSVLREELSYGKEKIMRNLNEELGKEIITKLVLR
>KECLDBNJ_01949 hypothetical protein
MKKIGFFILVILTLISCEKNDPKAQLQHLNGYWEIEKVETPYGEDRGYKFNERVDYIEIE
DSVGFRTKVLPRIDGTFVNSETQEKITVRIIDDSLRLNYSTPFAEWTETVLEANGERLKV
KNDRGMIYSYKKFEKINITD
>KECLDBNJ_01950 DNA replication and repair protein RecF
MILKALSLINYKNFESASFTLDAKINCFVGNNGVGKTNVLDAIYHLSFGKSYFNPITTQN
INHQADFFVIDGIYDKNDRDEKVIVSAKRGQKKVIKRNGKIYERFSDHIGFLPLVIISPA
DRDLIIEGSETRRKFMDGVISQSDKAYLDTLIKYNKTLSQRNALLKYFNANHTFNADTLS
IYNQQMHELGTVLHKKRTKFLEDFTPIFKKRYAAISGDKEAVKLKYKSQLNDAPLSQLFE
ENLKKDRALQYTSVGTHRDDLSFKIESHPIKKFGSQGQQKSYLIALKLAQFDFIKAQSNT
TPILLLDDIFDKLDESRVTQIIDLVNDDNFGQLFISDTHADRTEAIVKEIHQTYKLFKL
>KECLDBNJ_01951 hypothetical protein
MATYQKRGYKPKTKEEVEEHVQEESTTAEVFESLDEGASKTEAWVENNQKPIFIGIAVIV
VAVLGYLAFEKFIQEPKELEASNEMYQAQNYFNEAVEGSVAKDSLFNLALSGGEGKYGFL
DIIDNYGSTKAGNLAHYYAGMAYLNTNKYQEAIDQLDAFESEDAMLAPLAKGAIGDAFMQ
LDQPEEALSYYEEAASKSENNFVAPRFLLKAAKVAISLDENDKAVSFLNRIEEDYSESAE
AGEVPLLLGVAGAE
>KECLDBNJ_01952 6,7-dimethyl-8-ribityllumazine synthase
MATTDLSVYDKATIPNAKDFRFGIVVSEWNDKITEGLFQGAFDTFIDCGVKKENIVRWNV
PGSFELIYGCKKMQQSYDMLDAVIAVGSVIQGQTKHFDFVCEGVTQGIKDLNIQSDIPVI
FCVLTDNTMQQAVDRSGGQHGNKGVEAAVAAIKMAQLRKDARF
>KECLDBNJ_01953 hypothetical protein
MGVLKTRKNKKYSYSPRYYEGEGSPFKLESKFDQYRKATLENKGLKKKFTTALDDFKYNK
DERANKITLIILMVLVFLFLYIIDFDLSIFFG
>KECLDBNJ_01954 DNA mismatch repair protein MutL
MSDIIKLLPDHVANQIAAGEVVQRPASVVKELLENAIDAGATTIKLVVKDAGRTLIQVID
DGKGMSPTDARLSFERHATSKIIAADDLFALSTKGFRGEALASIAAVAHVDLKTKPEDEE
VGTRIEIEGSTIKNQEVCAAPKGTSIAVKNLFFNIPARRNFLKSDAVELRHVIDEFQRVA
LAHEAIAFVLYHNDSELFNLPKTNKRQRIVGVFGPKTNEKLVPVSEETEIVNIDGFIIKP
EFSKKTKGEQFFFVNDRFIKHPYLNHSVSAAFDGLLPDRARASYFIYLKVNPKTIDINIH
PTKTEVKFEDEQAIYTLLRAAVKHSLGQFNIAPILDFNRESNMDTPYSYKNKEAQVPKVE
VDRHFNPFEQEQKVKTSGFSSAPTYEKKSAAGWENLYAGLDRKNDTSNFSHVEIENEPEA
ESLFVEQESKGFSEAKETESDSANTYQLHNKYIVSAIKSGMMLIDQSRAHQRVLYEEFLR
NITVKESVSQQLLFPLRLDFSASEIDILKELKDSLENTGFALSMPEAGVLEVSGIPASIQ
ESEVSIVLEQLLSDVEQEVPDTGFSQTDVLAKSMAKSMAVKTGEKLDELSREHLVNKLFA
CTEPTLSPFLKKTFITLTIDELDRKFNA
>KECLDBNJ_01955 Rhomboid protease GlpG
MGRITETVKVLLIINVIFFLGSQFLIPNAVQLFGLWFPENPNFHFWQPVTHMFMHDQSSI
FHILFNMYALWAFGGPVEQSLGRNKFIFFYFSAGLGAALIHTLVGYYHYQAGYEALINAG
LTPSEISDTVNKAFTSIQQSGQYSYPNINEPDKVRGMIEAFSTSAVGASGAIYGVLVAFG
MLLPNAELFLIFLPIPIKAKFFIPGLILLDLFSGVTGFSIFGANIANFAHIGGAIFGFIM
MWYWKKNSFNDKRWY
>KECLDBNJ_01956 hypothetical protein
MAGPSLSYQYKTANIVVKLIVINVLVWIGFMLLEWMLNSGSIFSQWFSLPTDLSRLLIQP
WSLLTYAFLHAGFWHIFWNMLILYWFGQIVLNLFTEKRFLTIYLLGALAGGVLFVLAYNL
FPVLITSSAYLVGASAAVRAIMIFIAAYTPNTEVRVIFFNVKLWHIGVFVVLTDLIQIPS
SGNAGGLLAHVGGAIFGYVYAQQLSKGNDIGLWWERLADRVVNLFKSKPKSAKKANMKTV
YKNQTNAQKRTYRSGSRVSKNEQQAQIDAILDKISKSGYDSLSKAEKDFLFKAGKDN
>KECLDBNJ_01957 hypothetical protein
MKNLNLWNKFVFLINSVFALLLLVGYLLPYYPPKIFPPIAVLTLIIPVLIAVNLAFAVYW
LLLFKRQMLLSILVLGLWMLHNTTLYKIESGTLPAELESSEHQISLLTYNAHVFRSESFS
RDTIQAGNEALVSQANPDIVCYQEFSNHGAPDLNYPYHYFGVNANTRSSLQAIYSKYKII
NQGSLDFESTFNNAIFVDIVKKQDTLRIYNMHMQSLALTPELGALEQENTKSLVGRLGRA
FKKQEDQVELFLEHQAACPYKKIVAGDFNNTVFSYTYNKINGEKTDAFAEQGSGFGQTFI
FDIIPLRIDFILSDPEFKVRAFENFDVTYSDHFPIMAILEL
>KECLDBNJ_01958 hypothetical protein
MNIVLNPTYFPDIITTAALVQATEVRLEVCDNYQKQSYRNRMYISTSNGTLLLNIPIKHT
KTEGHKKTTDALIENNFLWQRQHWRSIVIAYRTSPFFEFYEDDLYPIFHTPYENLLELNK
ATIACILEMLDIEIDFTTTAEYKKEFNDQTDLRFLANAKRKNRLVIPEYRQVFSEENGFT
PHLTVLDLIFNLGPEALPYLQSLDLKF
>KECLDBNJ_01959 Aerobic respiration control sensor protein ArcB
MKNLHPTFIFVAFLFCFSIVRPAIVAHDVDSTQKLPLQKQLRELRQLNKQHEYDRVIEVA
STLINQASKKGENGFLFHGYNYLSLTYDQLSDTIPALDYAEKALHYAKLSKNDTLISWGL
NNLAASLSYFPDRRSDALKLYKESLVIQRRLNSDQFNDAALNIAEIYRDEENYTMMYPYL
KEAQKSYKSDTLRYDDPKAYLDILWGDYYRGLDFNNKALSYYQSAYDIIERFEMSYLALN
FYNKYAQFLAENNRPEAAYEVHQKYFDYYQNKELTKTKETVQLAQARLEAEELRRERNDA
ELKQEILDQDLKRKKTQSVLLGSIIGLMVLFLAYLFYSEKLRLGLIRNLKVNNKHLKQAK
ESAERSERAKTKFFSNLSHEMRTPLYGVTGIVALLEKSEAFKEYKEEIGSLKFSADHLLE
IINDLLDLSKLEDESFKFIEKPFNLKLLAEELANSFDQNSLKNSDCKIICDVDSSIPNYV
VGDSRRISQILLNILGNAVKFTPKGVIALRLRSNHLANGKHAIYFEVEDNGIGIPAAMHK
SIFDEFSQIDHVNTVNKGTGLGLPIVRKLLLKMGSDIHLVSAPGKGSTFSFTITFKEATL
LEVIGKRKKGEAEEEEVLTDLTNQRILIVDDNKINRMVTRRVLEKQNAQVFEAQNGEEAL
ERVRKHHFDLILMDINMPGMNGYETTKEIRVFDKTIPIIALTAAEANYIKQKAKESGMND
VITKPYNLSQFSKVIAKELKKDSLLGAGL
>KECLDBNJ_01960 hypothetical protein
MRNSTSIHAGSMADIAFLMLIFFLTTTTINTDQGLDQTLPEDCKTEDCATKLLERNIFEI
HLNDQGTCLIQNKISSKEELANQLIDFVGNQSGSTIAPENPAEAVIRLEVSRTNSYKDYV
SIMDEIKAAYLHMRTQYSLEKFSKNFSDLNAIERKLVLKHYPLQLSEATK
>KECLDBNJ_01961 hypothetical protein
MINYRYTKYHIFRGSLLLLLMFLIQPYLGLKVYAQDTQKIVEYKGTVVDAQTGDALPFVN
LEIAGTNIATVTNSEGNFSLKLDEAMPNAKVAITYPGYKKLLVILKDLAKTNNEIALSAQ
RFELDEVSISRPKDAYTLVAKVFSNRNQNYLDTETYMTAFYREAINKRNRSASLAEAVVA
IKKRPYTNAGSDLVGVYKARKSTNYNRLDTLAIKLQGGPLNALYADLIKYPEYFMTPATL
SNYDFSFGEPLINDSKMVYVVNFKQKENILDPLYYGKLYIEAETFALTNAIYNMNVENRK
RASELFVKKKPNRVKVYPSEISYRVDYRNTDGKWYYSYSNVQLEFVVNWKRKLFNNKYRI
KSEMLITDWEEELGAQNITNKTKFKSNTILADEVSGFRDPDFWGSYNVIEPEKSIQQAID
KIQRQIRRE
>KECLDBNJ_01962 hypothetical protein
MSNELRFNTPFRLKYILVGAFVLSFSMVQAQIDSRKGSFKIPAVVDTAGTPTPVPLDSEA
QPDIPLSRGGLSIGPDGKLTERPQLRAPESAEFYMLKREDFADSGQRYTDMMNEREANRK
SDKSDTPAHQSDQDLGTFHSGAQQVKIVCRDYQFVDGDRVAVLMNDEVVVPSIWLTETWS
SFYLPLKRGFNRISFKALNQGSSGPNTASFTVYDDSGNVISSNEWNLLTGVKANIMIVKE
E
>KECLDBNJ_01963 hypothetical protein
MSTKEKSKTDYNADLTKEDLDLLNQKNLHKDGGVDEQLRDREKPVDFTGKDLDIPTGEDR
SNMKDEENKLYSQGGSRNNNLEEQKGEL
>KECLDBNJ_01964 hypothetical protein
MSKKSKKILLKILKILGKIIGVLLLLVILLVLFVRSPWGQGIIVDKAVNYVKDKINTEVR
IDKLFVTFNGNISLDGLYLEDTQGDTLVFSKHLEAEIPLWSVITGGPISVDDVTWEGVRA
NVVRKDSITGYNYQFLIDAFAATDTTSVQPTPTAQDTTALQLNLGTFDFKDIQLNYADQV
TGMQANLNLGALEVQMRETNLDDMLLDIGDVRLANTKVVYKQTKPIAPSADTTEVPLPIL
RIGELVVEDVTFDYASTPDGIAADGTLAVLETHIPQIDLKNKVIEVEDFLLKNSVVNLAL
QTVVKQEAPAETLPETSQELWPPFTVAVGEINLENNAIQYTLDGAQPSAGRFNPNAIVLS
ALNLNLEGINLKDQNLEAHVTRADFKEVSGMNLDELAFDLHVSDTRLDLDNIAFQLNQNA
LAGTLQLDYSSLNAFIEEPGSAALKLNIPQLTLNLNTLFKFSPELRANEYLATLSKRPLR
GSLNLSGKLDAIDLKPTRINWGNQTSLAVQGSIYNASTPENLSYNLPVYTVKSAKQDLGR
FVDEQALGVQFPEKVTLQGSLKGTTTRAATKSVLTTTDGIVRLDGNASFGDTLEFKGDVS
AQQVNLGKLLQNEQLGFVELQLQAEGAGNSINTLDATVNATIDSIQLNNYTFKDLGINGA
FKSGTGDLKTAYKDENLNMTLDARVILDSVASQAAINLDLIGADLQALGLTEQNIKAALT
LQGTFKGDPEDYEIQTQINEGVAVYDDRAYQLGDLDISAYVKPDTTSLAISNRILNLDLE
SNANPQQVITSVQNHFKRYLQKNPVLDSIQDPVLMKITGTVHQAPILGEVFIPNLRELDT
VDISVDFDEYKRTLNADIQLPYINYNGYTIDSLALKMVSNKENMDFGFGLKELIAGPVDM
QDTRIGGRVTNSKMYIDFLSMHDKEKLVHVLYKIALEEDNIKIQIDPDDFILNKKPWEIN
PNNSVTLTKTNTIFEDFEMSYNNQRITAGNNLQGISKEHLGINFENFKLANIMSLLNPDA
ALARGKLSGQFAVEDPYTSPGMVLDLNIKDFEVLETNMGVLTAQGNSISNSGYDFQMAIK
EGVADLDLKGNYTANEMAAQIDLNLDLNRFDVAALEKLSFGELSNAEGTISGAMKLAGTT
AEPRYEGAFQFDNAKFEVTKLNASFLLKNEELNLNNEGVTFNNLRVEDENANPIVVNGSI
GTESFVNPTFDLDLKATNFKAINSTKDDFDLVYGTAVFDADAQITGDLNLPKVTLDLTVN
SNTDVTYVLPPSEVQIESKEGVVLFVNKENPDAILTNNEEDSYTVSGFTIDANFGIEKGA
VFNLVIDEQTGDNFQVSGTGDFEFDMYPNGRMTLSGRYDVTDGHYEMSLYNLVNRRFELA
PDSRITWSGDPFDADLDIKAYYSVETSASGLMASQTSGADISTQMQYRQEVPFQVYININ
GELMQPIISFNLDIPEGSRGAVGGQVYSRVQQLNQQENELNKQVFSLLVLNRFFPTSSSD
GSSGGTAAIARDNLNDAISDQLNMFSDKLLGDTGFNLNFGLDSYTDYQGSAPTDRTTLDI
AAQKSLFNDRVVVSVGSAVDLQGSGNTDSGNAPVVGNVSIEYLLTEDGRYRLRGYRSSQF
ENIIDGQIIVNGISLQFTREFNKFTELWQSMFPAKTEEEEDTNE
>KECLDBNJ_01965 Outer membrane protein assembly factor BamA
MKMNKNLLAVLFLMLVCYGCSVDRYIPEGKYLYTKETVNITPDSVVENLDAIKTDLKAAL
RPEPVGSFLGGYPGLYYHYKAQREKPGFLNKFLNRKFGKEPVYDTDIETYEMEQILLNRL
ENKGFFYSTVSSEIVRDTSSKEAEAIYSLRLTKPYRLKTYQLDTDTLPVYAKIQNSMNET
LLKKDMPFNLSAMKAERERIDTYLKGEGYYNFNGAFLIFETDTNQYKNKRFDQYLRLKKD
VPSKAIIPYQIGKVNIFPNNRVDIDSTTLDTTQFANKNFIQDEVYFKPKRLDPFVLIEEG
ELYSPSKSKATGRRLGSIGAYKFVNIRYQEMDTDAEDSLGLLEANIYLSPLNKRAVRAEV
KGVTKSNGFSGPGLGLTFINRNLFKGGESLNISLDGAYEVQAGGSGSNSGSTSLQLGLSG
KLIFPRMLFPIEISKNYFKYDIPKTKIEMGISYLNRTQLFTLGSVEAKFGYVWQANKYVT
HEINPVAINYVSLANTTDEFEQILDENPFLRTSFDQQFISGLTYSFIYNGMIDTQRQHQI
YLNANFETAGNSLSLIASGEKPQNIFGLDYAQFARVDADFRYHFKLTEKQTIATRLFAGV
GIPYGNSDVVPYTKQYFSGGPYSVRAFRTRSLGPGTYQPEDSETFSYYDQTGNLRLEANL
EYRFPLVSLLQGAFFVDAGNVWNTTDNEALEGDTFGSDFMKQLGIGGGFGMRVDIQNFVI
RLDLAAPFHDPSLAEGSRWSWDLENPILNFAIGYPF
>KECLDBNJ_01966 hypothetical protein
MRQSLYLFILKLRNLLAQKFKQYDAKLPYLITVFIALIIVVLGVNVFIELTDTLESDMLN
EWDSKITTYVISHRNPALTKYFMFVTDVGDLYGYLIVMGLFVGISYFIFKRWKYVAQTAL
VLLLASISNVILKRFIDRARPSIEHLVSVETLSYPSGHAMSAMAFYGFLIYLTTQFKINK
WAKIAAITFLAFILLSIGISRIYLGVHFPSDIAGGFIAGFIWVIFCILLFNVIELFRRDP
RTH
>KECLDBNJ_01967 Inward rectifier potassium channel Kirbac3.1
MLDSSSMAVNKTDAYEKKKYNDFGLGEKATSGHYRVINKDGTFNIKKNNVPLLEKINFFH
ALVSMSWSKFLLLVLATYFCVNLLFASIYILIGIENLTGIYGTTTLEQFIEAFFFSAQTI
TTLGYGQVAPTGILANIVAATESMLGLLGFALATGMVYGRFSKPAAKLKYSKSAVIAPYK
DINGFMFRVVNPHGNQLLELEATVALSMLRENSNLRNFFPLELERSQVVFLPAAWTIVHP
ITETSPFYRLSKEELMIKDAEIIVTLKAFDDTFSQSVYSRTSYKYSEIEWGAKFTYLITH
EGGKISIDVSGIDNTEAAQLNHY
>KECLDBNJ_01968 hypothetical protein
MKKLLRALLAGYGAKKIGGGRCGCIGTIVVFIILYWLLGFVFDVL
>KECLDBNJ_01969 General stress protein 69
MAASRKSQSQIKVPSLVFGGNVFGWTADKKMSFYLLDALLERGLNFIDSANVYSYWGEGN
SGGESEAMIGAWLKERKNRDQVIIATKVGSPIGDESNNLSASYIKEQIDLSLQRLQTDYV
DVYFSHKYDDSVEQRETLAAYKHLIDAGKVREIGASNFPLAVLREALELSKTESLPKYQF
IQPHYNLMEREGFEGAYQEFCIEENLSVTSYFTLASGFLTGKYKTAEEASGKARERFVKK
YFTPKGFEVLNALETLAKRYDCSPAALSIAWTLHQPGVTAPIVSATKENHLTAFDEALKL
QLDEDALALLNQASA
>KECLDBNJ_01970 hypothetical protein
MKLKLYPIATFMLAMLTVNCASTKQKKKNASTATEEKQEKSKSDLKAYDKVITKEAVSDS
GLFTVHKVEDDYFYEIPDSLFNREMLMVTRIAKTATGIGFGGGKANTQVLRWEKKNKKVL
LRVVSHEIFAADSLPIHEAVSNSNFEPVLFSFDVKTINKDSTATVVQVNDLFSDDVQALG
LPGYYRESYKVRNVDKGRGYIESLKSFPLNIESRHVKTYNAGNPPSNESVGSITVEMSNS
MVLLPKVPMERRYFDRRVGWFARGQVDYGLDAQESKTVRYLDRWRLEVKPEDEAKFKAGE
LVEPKKQIVYYIDRATPKKWIPFIKEGIEDWQVAFEAAGFKNAIIAKEAPTKEEDPDWSP
EDVRYSTVRYLASPIPNANGPHVSDPRSGEILESDINWYHNVMTLLRNWYFVQTAAKNPE
ARGVAFKDKIMGRLIRFVSSHEVGHTLGLPHNMGSSVAYPVDSLRSKSFTDNYGTAPSIM
DYARFNYVAQPGDGDVSMMPNIGVYDKYSIKWGYRPILDKEGMEEKPILDQWILEHAGDP
LYRFGAQQWSVVDPSSQTEDLGDDAVKASNYGIENLKRIIPNLISWTSEDGKDYDDLETL
YGQVLTQFNRYMGHVSNNIGGVYQYNKTYDQEGAVFIPVPKERQEESMQFLQDQLFTTPE
WMIDNNILNKIENNGNVERIRGLQVRTLENVLDFGRLGRMIENETLNGKEAYTLTEMMND
LRSGIFSELRSGKKIDTYRRNLQRAYVERLKYLLTEEQSGRRNATSVNVSQSDIRAIARA
ELNTLKRSVRSAIGRTGDALSRYHLQDLMERIDLILDPR
>KECLDBNJ_01971 hypothetical protein
MDINLQKTLLFLLFIGIGILLKVKLKNKSELAGIKVIILNLALPATIFIALIGVNIEASL
LLLPIIALLLNVVLFFATPLVFPLLGIKKGSPNYRTGQLLLSSLAPGLSCFPFILEYLGD
SYLAKAAMADLGNKVFVLLVLYLVAMRWHYKTQEIENTSNRAKFKSLCIAMVSEPVNLFI
IAALILLSFGFHMNNLPFIVSESLSRLSLLMTPLVLLFIGLSVKIKKRQFAQIISMLLLR
AGIVVILGIALITAVQINVAQDRLLLLAFGLSACSFWPFAHIAAVDAQEKRVLNFKKTFN
QNFAINILAVSFPLSVVLILGILSAGTLFASIKTMVLLAGILIASGLIYPAFMLVVKKKT
IAQIQSLDTETGDSYKLKRVSEN
>KECLDBNJ_01972 Putative phenylalanine aminotransferase
MSTSNLHRRDWLKKMALSVGAVAVAPTALWAATVEEAQKNNQKFLYRNTSFDEFTPPRMP
DLSTVKARLVWNENPHGPSKLAAKAFQEAVWDGNHYSWSTLGQLVQKIADKEGVTPDNIM
MGPGSSDLLEKTALVYFREGGNVVSADPSYMSLVSVAKASGGSWKAVKLTEDYQHDLKAM
EAAIDVDTKLVYITNPNNPTATQTDTEDLKDFCRRVSKKVPVFIDEAYLELAPEGMDASM
APLVAEGYNVFVARTFSKIHGMAGLRMGYMLGKKESLEAINDITRGGMGIAGPTIAAASA
SMDDEAYLTDCKDKIKEARDYTTSYLESRGFDYMPSSTNFVIFPIPMEGDAFLEKIYDKK
VVVRAFRFWDQNWCRVSMGAMEEMKYFTDAIEEILV
>KECLDBNJ_01973 hypothetical protein
MNAEKQKLNLELTETLQKLLVKNYDAEKGFIKAMQEIEHTELRGFMQRQAVKRNHFANQL
DKELHALNARPEGDGSLAADLHRIWIDVKSIISKDDISSVLEECMRGEKMSAEEYENALK
EHDFPQHLRTVLNNQLSQIYHTIEDLQQLDDIAKLR
>KECLDBNJ_01974 hypothetical protein
MKLSELQAVLKKVYKIGFELPNGKLLPSHFYWSKVSLKKEHQMLPNGSTKKNEVIEIHLT
ASSQNNHRRNPSDLQGFLDKAKQGLNLSDLPIEIALLDHGTTWFTLQIGDPYFKLIALDN
TSVSNNKTVKNQQTTPLMKAASDPSLPGSSCCI
>KECLDBNJ_01975 Enterobactin exporter EntS
MAKNDPYAALRFREFNVFLMLRFAMVFAWSMQFVVIEWQVYSITKNALSLGIIGLMEVIP
AVSLALFAGHIVDQSEKRGLLFKCLFGFSFVSIGLFLLTWPRVTEHLSTSLTLYAIYFLV
FCGGIVRAFLGPTIFSLFALIVPKKVYPNAATWSSSVWQMGAVVGPAAGGFTIHLIGVHW
SMCVIFGFSLFALICLSQIKKKPIMNPKIGEPVMQSLKEGILFVRNSKAVLGALTLDMIA
VLFGGAVALLPIYAQDILKVGPQGFGILRAAPAVGALITMFTSAYFPLYKKAGIKLLAAV
FGFGVSIIVFGLSTSFWLSVLALFMSGVTDGISMIIRQTILQLKTPDHMRGRVASVNSMF
VGSSNELGAFESGLTAKLMGTVTAVVFGGSMTLITVLATGIISPKFRKLDLRKDLEEHEK
SE
>KECLDBNJ_01976 hypothetical protein
MKLLITSIVIFISCLTSKAQVGINTNTPRDLLDVNGDTRIDGKLFLEDPGNSNQIRGSKL
IIERQDLSIVQYDIDISKYGPINYAELVFENTSNRGVENYNTKISIEDYVVTVQGYYFIE
HDTGNTSVITESYAGNDVVEGFQVHAYKNTDEGTWFIRGFANNGFFRTGNTDITIDLHMN
LIIYRKGFIAKDAPGTYSINMQQFTNATLLKPPGF
>KECLDBNJ_01977 hypothetical protein
MYKKFTFSFVLSIFCVVQLFAQVGVGTTNPESDLHIVGSMAVQKQFELGTLGTVTNTDED
FKLLTRRTDSTALNGEITKLNVDELTVAPINVLKYYFHNLSYDNIVDLNLSFETSRYIVG
LADIRYIGAPVNKRLIDGGDDSIGTFVARTFESNGTWHLEIRNRFLDTTNRRNAVHYECT
FIIYDTSFYRKLPVIRTDLGGNRNGSASAIPDLY
>KECLDBNJ_01978 hypothetical protein
MKHFYPNLQLVAFTIFFLSIVPVLGQTTGVGIGTTNPRVKLEVAGDARVQNTVTISTIND
LKDDDTSTFLIQDGNSKIKSLDVSNPTGAALGYIQIYELYDPQEDWVFDFDTRVDANEFV
LNTLSASYDRELDINSNATIPFYSAFIKDGTWHITADFPAANNLNPNEKGTWTITTLIYS
KDLSKQFGRIPVAMEEASTQSATNPFID
>KECLDBNJ_01979 hypothetical protein
MIAETAIYHQICLTNINLQHQFQGFIDTPQIDLSSEILGVSNFDFKPANLELPEDFEMPQ
SIRLGQRMEYFMQMYLTARGYKVLAQNLQVIANKLTLGELDFIIENQTGLRIHLEMVYKF
YLYRPELEGNWIERLIGPNAKDALTEKVKKLSTHQFPMLQHPETEKMLHALDILPTSLKQ
QLSFKAQVYIPLGLQLQHLEISHQLIAGYYYNLDQLLQLKDEETTFYIPSKNDWVGAPTS
VQRLSFDHFFDSAKIRLTQSRSFKFWIFKSDSVLNAFATWW
>KECLDBNJ_01980 Cysteine synthase B
MNYSIERLIGNTPLVESKVLQKNPKVKLLFKLEGQNPGGSVKDRAAFNMITAAMERGEIT
KESKLIEATSGNTGIALAMIASMYGLDLEIVMPENATKERVQTMRAYGAKVILTSKDIGI
EGARDFAEAKVKEEGYFMFNQFSNPDNWKAHYKTTGPEIWNDTQGKVTHFVSSMGTTGTI
MGTSTYLKEQNSAVQIVGVQPTDDSSIPGIRKWPQEYLPKIFDASKVDQVLEVSEADARA
MAKRLAKEEGIFSGMSSGGATVAALRLCEQLEEGVVVSIICDRGDRYLSSDLFD
>KECLDBNJ_01981 Serine acetyltransferase
MINKENIISQIRAHKQNANLNFKLKTDTHRFTKELFATLFNFPNDLDEDLDRLERLFENL
VELACWEIDKKCSKVWDDYVAQLPEILRKLNLDAEAIFENDPAATSIEEVYLAYPGFHAI
AIYRLSHALHQKGFPIVPRLMTEYAHHITGVDINPGAVIGEYFFMDHATGIVIGETAVIK
DHVKLYQGVTLGALSVAKDLSAVKRHPTIEDNVTIYANATILGGDTVIGANSIIGGNVWL
TKSVPPYSLVSHKPEILIRELEKKE
>KECLDBNJ_01982 tRNA pseudouridine synthase A
MFKKEFFYLFKIQYLGFRYHGWQKQPDLLTVERMMQRTLKYVLGRNNFKFIAAGRTDAKV
SVNATYVELILQDEPLAVNDFFKVFNDNLPQDIRLLEVIEKPKQTNIIQAPKLKEYIYLF
SFGEKNHPFCAPYMVNVKGALDISLMQRGASLMQGTHDYRNYAYKATAETQTLMTIESSV
IEENTLYTASFFPKHSYVFKVVGAGFKRHQVRLMMGALFDLGSGILSWEAFEKSLDGSIS
YKLTHIAQASGLILQEINLEEH
>KECLDBNJ_01983 General stress protein 18
MKKVAILATNGFEESELTSPLEAMKKEGFQVDIVSEKKGTIKAWAETDWGKDYDVDKTLD
EVSAKDYNALVLPGGVINPDQLRRNENALVFIRDFFKQHKPVAAICHAPQLLISADVVEG
RTLTSFSSIKKDLENAGALWVDKEVVVDEALVTSRNPNDLPAFNAKVIEEINEGKHDLQH
A
>KECLDBNJ_01984 Cobalt/magnesium transport protein CorA
MSKRIKIKKPRIPKIPKIKLAHKKIQNDVPGTLTYTGSKEQKHVTVELIDYSPSTHKNIT
VDDVSQAFNKKHPEEISWINVNGLSDIDQIEKLGDHYKLHPLILEDIVDTSQRPKIDEYP
DYLFIVFKMLYYNSEGVFMNEHISLVLGENYLITFQEADGDVFDSLRQRIANAKGRVRNA
GADYLMFAIMDAVVDHYFTLIETMSDRIESLEDILFSNAADQDITQDIQELKREVLRLRK
AVFPFREVVNRLEKIDSQLIDERTITYIRDLYDHVTQVTDSIDIYREMTWGLMDMYMTTI
SNKMNEVMKVLTIMASIFIPLTFMAGIYGMNFEYIPELHLKYGYYYLWAAMILVFLGLLY
YFKRKKWL
>KECLDBNJ_01985 hypothetical protein
MTSSKPNRTFWIITTLAIIWNLMGVFAFMGQTFVSSAALAELPADQAELIQSTPQWLKGI
FAIATITGFIGSLLLLLRRTSAVTLFLISLVGVLIQMGYSFFATPAIEVYGMVQGLLMPL
IVIFIAVYLYFFSKRSLKQGFLKN
>KECLDBNJ_01986 hypothetical protein
MSTKLPAAYFPFLNELKENNHKEWMDAHKDEYKILEKQFKQFCEDTKSQLNNFEEIERAK
VFRINRDIRFSKNKNPYKTNRGAIFSRSGVQRRGSFYFQMAPGASFAGGGFFKPESADLL
RIRKEFEFDADPIRSILNQKEFKSVYGGFNTESQVKTAPKGFSKDDPNIDLIKNKNFFVT
HQYTDAEVLAEDFQQTLLQHFKLLLPFFDYMSEVLTTDLNGESIL
>KECLDBNJ_01987 DNA topoisomerase 4 subunit B
MKCYISGHPFYFMAEETKYTEDNIRSLDWKEHIRMRPGMYIGKLGDGSSADDGIYILLKE
VLDNSIDEFVMGSGKTIEVSIQGTRVIIRDYGRGIPLGKVVDVVSKMNTGGKYDSRAFKK
SVGLNGVGTKAVNALSEYFRVESTRDGQSASAEFERGTLKDQEFLEETSRRKGTKVTFVP
DDTIFKNYKFRNEYVSRMLKNYVYLNPGLTIVFNGEKFYSENGLKDLLGDRIAENDVLYP
IIHLRGDDIEVALTHSRTQYSEEYHSFVNGQNTTQGGTHQAAFREAVVKTIREFYNKNYD
ASDIRKSIVSAISIKVMEPVFESQTKTKLGSTDMGGDLPTVRTYVNDFLKTKLDNYLHKN
PETAEKLQRKILQAERERTELSGIRKLAKERAKKASLHNKKLRDCRVHLTDSKKERNLES
TLFITEGDSASGSITKSRDVNTQAVFSLRGKPLNSYNMSKKIVYENEEFNLLQSALNIEE
SMEDLRYNNIVIATDADVDGMHIRLLLITFFLQFFPELIKEGHLYILETPLFRVRNKKKT
IYCYSEQERRDAIEELSGKPEITRFKGLGEISPDEFKHFIGDSIRLAPIMLDEAMSIEEI
LQFYMGKNTPDRQKFIINNLKVELDPVLEN
>KECLDBNJ_01988 DNA gyrase subunit A
MSENYEDPNLEQPDDENSGETITRVTGMFKDWFLDYASYVILERAVPAIEDGFKPVQRRI
MHSMKDLDDGRYNKVANIVGHTMQYHPHGDASIADAMVQMGQKDLLIDTQGNWGNTLTGD
SAAASRYIEARLSKFALEVLFSPKITDWQASYDGRRKEPINLPVKFPLLLAQGAEGIAVG
LSTKVLPHNFIELIDASVKHLEGKKFKILPDFPSAGEADFSDYKDGKRGGRVRVRAKISQ
QDKNTLVITEIPFTTTTTSLIDSILKANDKGKLKIKRIEDNTSSEVEILVHLPAGLSPDK
TIGALYAFTNCEVSISPLGCVIEDNKPLFVGVSEMLRISTERTKDLLRQELEIQLEELEN
QWHYASLERIFIENRIYRDIEEETTWDGVLHAINEGLKPHIGHLKRPVVEEDLVRLTEIR
IKRISKFDIDKAQQRIEALEDQIAEVKHHLEHLTEFAIAYFKRLKKEYGAGRERKTEIKL
FDDIEASKVVIRNTKLYVNRKEGFVGTSLKKDEYVTDCADIDDIIVFTKEGKMMVSKVDT
KTFVGKDIIHVAVFKKKDKRTIYNMLYRDGKGGATYVKRFNVTSTTRDREYDMTKGKKGS
QVLYFSANPNGEAEVVSVYLRAVGNIKKLKFDLDFSDILIKGRNANGNLATKHAVRTVEL
KEKGVSTLKPRKIWFDDTIQRLNVDGRGELLGEFKGEDRLLIITQDGIAKTITPELTTRF
DDKMIVLEKWIPAKPISAIYWDGNRERYYVKRFLIDNPEKEESFVSDHENTQLELVSTDH
RPVVEMVFYKERNKDQKPNETVDIEDFISIKGINALGNQFYTEKLKQINLLDPLPYEEPV
EAQPEQDVETHSESEETAHSENDQEDHIKGDGSQGSLF
>KECLDBNJ_01989 Large-conductance mechanosensitive channel
MGLIQEFKNFAVKGNMVDIAIGVIIGAAFQSVVDVIVKKIMMPPLSLLTDGVRLANKKIV
LKDAYIAVDGTAVEEIAIGYGELIEVLIDFFIIAIVVFIVVKLMNSLKRQSEDDQNPAVE
TPKNIQLLSRMETLLEEQNQLLRNQQKSKK
>KECLDBNJ_01990 Aerobic respiration control sensor protein ArcB
MAKGIPPKHYFIAFLWFLIPALVCFYVYHSYKVALPQKLSDQVQLTGSLATQDFKRTVRS
NVQALQNLTERIEETDGAYYDYWKQDAKRLLKQNESLDFVEIINADGIIEDVYPRRPNVP
AIGLDISKLAYRFEDWKSKSNQGITNITQWLHLSQGGDSFLIDVPVYINDEFRGTVTGGM
NFNEEFDRLSYYLKDFAIQIFDEEGTQFYNYNNYDLAQKDPYYIFETAMIMDSDLNESWN
FQLTFSNPDFFAEEMLLINIALAVGLILSLAIGLLSFFNRNAQVAARRTFIINKELKKVN
QHLEEQTQRANQASIAKTEFLSNMSHEIRTPLNAIVGITDLIGSGTNTFEEEHYLSLLKQ
SSKTLLNLINDILRLDKIESGFSEVAHIKFCPSDILKNIEQFNLQVLKDKGIAFELKIEA
EEHSFVLGDRAKYEQIINNIISNAIKFTESGSIKVLYKEEVSENKTHLSISVKDTGIGIP
QDKLDKIFERFIQLDTGMRKKHSGGGIGLSIAKHLVELLKGKISVKSQEGKGSEFSIALT
FDTAVENCTTKDTTPKSEIPNLNILAVDDNKLNVIVLSQLLKKLGLDADIAYTGKDAVSK
AQKKKYDLIFMDVHMPDIDGYEATKQIKLANKATVILGLSADSTLSAMDKGIDCGMSDYL
TKPIDKSKLILVLNEHFGIGGSQKIVI
>KECLDBNJ_01991 Sensor histidine kinase YpdA
MSRAIFYTFLCFCLFCFRPSFGQDTNVKNIIDELLQKRFTTFDSLQKYTSRFRRDSLGIT
SFIDRAQKANYDFGEAFGENLYGIFLRDRSYYDESIAHHQRALTLAETINDVELEVSILN
MTGVVYRRIDAVSSALDNHNAALALAESQPKKSNALLKGIAISQNSIGNIYLLLRDYEQA
EKFFKMAINSEINLTSDLGMAINYANLGITYEERELYDKALINYQKSLEYNEKINSDLGR
VICHNSIGQVYLKQGKPQEALALIKPSLPKALKIGDKFYIALTYINLGWANSEVGNLSLG
ENYLLKGKNIAKENDQKQFLSLAYMHLSQLKEKTGDYNAALQYQRKSQEVQEAYLNEANH
KYVSNLIYKYDTEQKKNTISLLQQNNEIAQIQLSQSRKNNIFILLVAFLILIILIILYRQ
TQLRNQKQRLNAEQKLMRSQMNPHFIFNALLSIRIYLQNSNLEDATNYLNQFAKLIRSIL
SSSLEKEITLAEELETMRLYVNIENIRFCNEIDYKETIDDQVDISAIKIPSLILQPFLEN
ALWHGLQAKEGYKRLALDVKKKDEHYITITITDNGIGRKKTMEMPSEKINTQKKSIGINL
TLKRLQNFSKNLRHNYTLNFIDLYDANQKPKGTQVLLNLPIK
>KECLDBNJ_01992 hypothetical protein
MRYFCFSLLAMLLLNSCYNPERNCTDFKTGSFEFETYLDGEVVKTTFTRNDTLEIDYYKG
QADSSSIRWINDCEYIAKKINPQSMMDRKALHFKILTTQGNSYTFEYALVGDSKKQKGTA
VKVK
>KECLDBNJ_01993 hypothetical protein
MVNSELFTKRLQKIMDEYDLNATSFADAIDVGRSSISHIISGRNKPSLEFVMKIIEAFPE
VELYWLLNGKGSFPKSRVTKRAPIVSSQLAANFDDEPVALASNSTDASSTAQPTPDTSPS
TKSDIERIVIFYKDGTFKSFHP
>KECLDBNJ_01994 hypothetical protein
MNYTTLCDWHKLHHEKALFGRYITTSHIQPLIDQLPELFQVKSLGYSVEKRLIQSVTFGT
GPIQILGWSQMHGNESTTTKALFDLFRWFATHQDQTEVKHLLNACTFTMIPLLNPDGAEA
YTRVNANQVDLNRDAQNLTQPESSILKEAYTSIKPDYCLNLHGQRTIFGVGSPAKSAIVS
FLSPSQDELRTVTASRKIGMSVISDLNEMLQQFIPGSVGRYDDGFNLNCVGDTLQQLNIP
TILFEAGHFPGDYEREQTRCFMFLSLIRVFESVLLLKSEEIGDSNSYFAIPENKKCYFDC
IIRNVNIPQIGVTDMAIQYEETLKNGTLYFVPKIAQIADLDDFVGHKELNFHQKEIQIPE
GMQLEVGTNLENLQANSNLPTTFSVKSNNLL
>KECLDBNJ_01995 Regulatory protein AsnC
MAKFKLDEVDHQILDMLIENTRTPFTDIAKKLLISAGTVHVRVKKMEEAGIIVGSSLTLD
YAKLGYSFIAYVGIYINKTSQTTFVLERINQIPYVTVAHVTTGKFNIFCKVRAKNTEHAK
NIIFMLDDIEGVYRTETMISLDESINDKKRLMHSIFQDL
>KECLDBNJ_01996 Phosphoenolpyruvate carboxylase
MSRQPKLERFNNLVKSKYQVYNSLFMTLPFHGITDTGVLLPLFDRICTRGYDKHYNPEKI
VNYFFDKYQRDVSEEERYDLLFRFIQYIERQVVLFDAIEDAAYRTVNNMDGRGTLRNIKE
EAEAQSKTEELKAYLQDFKIRPVLTAHPTQFYPGAVLGIINDLSKAINENNVEMIKKLLS
QLGKTPFFKKEKPTPYDEAVSLIWYLENVFYKASSHIYNYVRQNVFKGEAFDNEVIDLGF
WPGGDRDGNPFVTTEITLKVAARLRNTIIKNYYRDIRSLRRRITFVGTEEPLADLEKRLY
ESIFLPGDEVTVSLEELETTLLRIRKIVVERHESLFLEEIDDILNKVKMFGYHFAVLDIR
QDSRVHMHVMEEIVKQCAKDNLGIFPDNYLELSEEEQIKVLQDVKGSVDPSTLQDDIARK
TLESIYAMQDIQKQNGERSCNRYIISNNQTGLNVMQAFSMIHLTGWEDPTVDIVPLFETV
PDLKIAKEVMRGLYTNPAYAAHLKKRNMKQTIMLGFSDGTKDGGYLMANWSIFKAKEELT
QVSREFGIKVIFFDGRGGPPARGGGKTHQFYASLGDTIEDEEIQVTVQGQTISSNFGTPD
SCQYNLEQLLSSGIFNGVFSQKTKAFPDEDRKTMEELAEISYKAYSDFKAHPKFLGYLER
MSTLKFYAKTNIGSRPSKRGGSDKLDFSDLRAIPFVGSWSQLKQNVPGFFGVGTAIEKLE
ERGEFDRVQSLYNNSMFFRTLLENSMMSLTKSFFALTAYMKDDPEFGAFWELIYEEYERS
KRVLLKVTGYSELMEDEQAGKASIQERERIVLPLLTIQQFALKKIQEMQREENPDEKKLE
MFEKMVTRSLFGNINASRNSA
>KECLDBNJ_01997 hypothetical protein
MAKVIDLDHSEFNAFYKNYVELVKPDQLLLDALIEGKEKNIAFYDDIPEDKWSYAYQYGK
WTILEVLQHVIDTERIFCYRALRIGRGDRTPLPGFEQDDYITPSRANQRQMHELLDEYAL
VRDCTISLFKHFDEEALAFKGTASDATLTTRAAGFIICGHEIHHANVIQSKYLI
>KECLDBNJ_01998 hypothetical protein
MNFKSRKDPLFFSILLVLITLFVLIGVFSDSGSATGWYWYLLGITPTSLLFIWFYFGTSY
SLSASLLKYKSGPLTGSIPLKDIREIIRDKTLWVGRKPATARKGLIIKYNLYDEIYISPQ
NNDDFIKTILSLNADIKII
>KECLDBNJ_01999 hypothetical protein
MTTKLYLPFALLLMVLTACKNNATYNRTDETAESVADSTATQAYLLTYFKDDTHSLHMAF
STDGYSFTDINEGNPIVAGDTIASQKGIRDPHISRGPDGAFYVVMTDLHLFAKDLGYRDT
TWERPIEDYDWGNNRGFVMMKSFDLIHWTHSNFLFNENFEGFDEIGCAWAPQSIYDPDEG
KMMVYYTMRMEHGLTKLYYSYANEDFTALETQPKQLFEYPDASIQVLDADITKMPDGRFC
MMYVAHENPIGIKMAFSDTINSGYIYDPEWIDMEPGSCEAPNVWQRIGTDSFVLMYDIYS
INPHNFGFVETTDFKNFEDIGHFNEGKMKTTNFSSPKHGAVIQLTKTEAQKLAEYYQYDL
KFD
>KECLDBNJ_02000 Inorganic pyrophosphatase
MIIRLTCIVFALVAIFSCKTSTEENLLTDYPAIAEDGSVNAVIEIPAGTEQKWEVNKTSG
IIEWEQVDGTGRIVNYIGYPGNYGFIPQTLLAEKDGGDGDPLDILVLGSPVNRGSVIKCK
IIGVLYLQDRGEQDDKLIAVAKDSPFYQLDSLEDLEATYNGVADIIRLWFSNYKGPSKMV
PKGFGDHDAAQQVLEAAVTGYQNK
>KECLDBNJ_02001 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MSDKSYKEYLRDITTFIFDVDGVMTDGSLIINTEGEMFRTMNVKDGYAIKCALDNGYNIC
IISGGTNEGVRNRLAALGVTDIHLGAHTKMKQFTKYIEEKNIKPENVLYMGDDIPDYPVM
KEVGLPTCPQDAVKEIKEVAKYVSHKKGGKGCVRDVIEQVLKVQDNWMNYFDAGLKQH
>KECLDBNJ_02002 hypothetical protein
MYFWSVISVSIIGTGNVAFHLAKALSTSQSAKLQFIAGRSTTQLTDFKAFAEVSTQVSDT
FHSDLIILAVSDNAIGEIAEKLQYTNGLLVHTSGSTAMDVLAPKTRIGVCYPLQTFSKRK
DLNYRKIPFLLEANHQEDYALLEKLLGSLNAPVHQMNSKDRASIHLAAVFSNNFTNHILT
EAAQLCNQHQVSFELLKPLLEETLEKAFLNGPENSQTGPAKRHDTQTIQKQLEALKTSEQ
QELYSTLTKAIQNYYER
>KECLDBNJ_02003 Cytochrome c biogenesis protein CcsA
MQKRIADFLFSTRLMAVLFIVYAVAMATGTILDAGQETSPTPYTRELVYEAWWFELIHIL
FIVNFVGNIWKFRLWRKEKWSTLVFHAAFILIIFGAAWTRYIGFEGVMPIREGETQNTFL
SEKTYLNVFIDGERDGAPMRRKLEPKRLNLSTRLDNSFDWETDFDGKPVTISFSKFIDGA
EEGLIETTDGKAQLKIVEAGDGQRHEHYLEEGQVASIHNMLFALNQPTEGAINIGYDGEN
YTIDTPFEGSTRVMATQTDYAVAKDSVQELKLRALYQLGGMQFVIPDPVIKGTNGIVEAF
PKQKGQADALFVTVTTPDGQETVGLLGGKGYNNEMVSTDIGDLKFHMAYGSLAQELPFSI
KLNDFIAERYPGTTNVYSSYESEITVINGPQDTFDYDIYMNHVLDHKGYRFFQASFDPDE
LGTVLSVNHDMVGTWITYIGYFLLYLGLMIILFDKGSRFGDLKMRLDKVKSKKAKLSVIA
AVIAFSGTALHAQEQEVVVENGNTKVVEEQPEDFIPGTAAIAEETQHTVPTAQQIDSVLM
ANKVPAEEAAKFGKLVIQDDGGRMMPVNTFSSKLLRKLSRSDKYQGLTADQVFLSMVETP
FFWYNVDLIYLKPANDSLRGIIGVPKDQKYVSALDFIDNMGRNKLDPYITAAYQAEVKNS
FDKDFIDIAERLGLLNRAVSGEILKIFPLVNDENNKWVSYPELNESGFKGMDSLYTKQIL
PLYFSALREGNESGDFSKADTFLKSIKSFQEKYGSAVIPSQNKVDAEVFYNKHDIFTKLY
WMYLLASVVMFVFVIIRIFKDNRFIKTMVRLSGLAVGILFALHTAGLIWRWYISGHAPWS
DAYESILYVGWATMFFGLAFGRKSSLTIASTAFVAGFILWGASMNWLNPAISNLQPVLDS
YWLMIHVAVIVASYGPFTLGMILGIVSLLLMLLTNSKNKKRMELNIKELTIINEMALTVG
LVMLTIGNFLGGQWANESWGRYWGWDPKETWALISIMVYAFVIHMRLVPGLRGRWFFNLM
AVLAYGSILMTYFGVNFWLSGLHSYASGDNILNLNKAICIFAGVIVFALLAYPKYKKFYK
>KECLDBNJ_02004 Fumarate hydratase class II
MDYRIEKDTLGEVKVPADKIWGAQTERSRNNFKIGNPASMPLEIVYGFAYLKKAAAYTNH
ELGVLAEEKRDLIAQVCDEILEGKHDDQFPLVIWQTGSGTQSNMNVNEVIANRAHILAGK
KLGEGDKTLQPNDDVNKSQSSNDTFPTGMHIAAYKKVMEVTLPGVIKLRNTLKKKSDDFR
EVVKIGRTHLMDATPLTLGQEFSGYVSQLDHGIKALEHTLDHLSELALGGTAVGTGLNTP
KGYAKLVADYIAKFTEQPFKTADNKFEALAAHDAIVESHGALKQLAVSLNKIANDIRLLA
SGPRSGIGEIIIPANEPGSSIMPGKVNPTQCEALTMVCAQVVGNDMAIAVGGMQGQYELN
VFKPVMAANFLHSAQLIGDACASFEEHCAAGIEPNHPRIKTMLENSLMLVTALNTKIGYY
KAAEIANTAHENGTTLREEAVNLGYVTPEEFDEWVKPEDMVGEL
>KECLDBNJ_02005 hypothetical protein
MYFKQEYLNLQPDKNHIMFEFDQYLGFLAFLTIATMGFWLMIFLVSILPYWIGGAFVERM
KEIREKKKLERGN
>KECLDBNJ_02006 hypothetical protein
MKNKFLFALMCFCTALGFSQSTNYAITGTVTDKDAGIPLEYATVTVTDANDAQDVEGGIT
DMDGNFRVEVPQGSYTIKIEYISFQPIILNKTINGDLNLGTVQLEFAASDLDEVTVVAET
TTVDIRLDKKIYNIGKDLTTAGGTVSDALNNVPSVSVDVEGSISLRGNENVRILINGKPS
AIAGYGSTDVLRQLPADAIERVEVITSPSARYDAEGTAGILNIILRKEKTLGFNGSINGS
LGNPDLASISANLNLRTEKFNIFNTTGYRYSSSPGNGYFDTRYNTTDEITPTYERIIEDR
DIQRLNRGFNTNLGLEYYLDDQSSITGTVFYRNGNDVDETTNLTQSFNNSSRVLETSRIE
RQKEKDDRYQFSLNYINRFNDEGHQLTADLQYATSDQTQNTLINEDITFDSENTDPIIAE
RLLSIEKQDEYLIQADYVLPFGEGAQFEAGYRGNFENEITDYRVNQEQIANSNNFVQNDT
LTNVFDYTENVNAVYTQLGSKFGDFSVLAGLRLENTQLKGKIGSALTEAELQDIYGFEIN
TDFDNNYLGLFPTLNVTYELNERENITLGYNRRINRPRGWFLNPFPDRSSRNNVFQGNPN
LQPAFANAYDLGYLKRWDKLTLTSSVYFQRETESFEVVEEIIELQGQGSNTNGNTVIRSI
PVNLSSNERIGAELGLLYNPAKWLRLNGSFNFFQFNTEGFFNDVDYSAKNTSYFARFSSK
VSLPWSIDWQTNAFYRGAAQNAQSDTDGILSVDMALSKDLFDEKATISMNVSDLFNGRKR
SQITTNDLFTRDSQFQWRQRQINLSFVYRFNQRKNDRQNNRKSPVNDDDNEGDYQS
>KECLDBNJ_02007 Arsenate reductase
MLKIYHNPRCRKSREGLAILEESGKEFDIVKYLDTPPSYIELAAIIGKLKIEPIALVRKN
EAIWKDQFKGKELTDEEIIQAMVDHPKLIERPIVILDNQAVLGRPPEDIKKLLR
>KECLDBNJ_02008 Peptide chain release factor 2
MITSDQIKDLVQRLDALKIHLGIDQKRVEIQNEEEKTFDPNFWNDPKEAEQFMRTLREKK
NWVKNYEQAIALTEDLEVMLEFHKEGEASEEDVVKQYDKAVKLIEDMEFKNMLSDEGDDL
SAVLQITAGAGGTESCDWASMLMRMYLMWSEKNGFKVKELNYQEGDVAGIKTVTLEIDGA
YAFGWLKSENGVHRLVRISPFDSNAKRHTSFASVYVYPLADDSIEIDINPADISWDFARS
SGAGGQNVNKVETKAILTHHPTGIVIHNSETRSQLENREKAMQMLKSQLYEIELKKRQAA
RDEIEAEKKSIEWGSQIRNYVLHPYKLIKDVRTGEETGNTDAVLDGDIDSFLKAYLMMTG
QKETSNEL
>KECLDBNJ_02009 hypothetical protein
MEYTIKYKAVNTYDAPVDEAFWQFLLRPEENETQRVRLSKFSNSINAAVDASTNTFGFPI
CRVHLKKAVERISFEANYIISKKHSNPFSALDSVVNPVHTQLLNSLDFKIEYERFLGETS
LTTLNREALPFKFSDSHSIFDNLNELNAWIYKNFEFKTRVTDVTITPSEFLAQGAGVCQD
FTHLFLTIARLHQIPARYTSGYLHQGNGYKGDSQMHAWAECYIPEKGWLGFDPANNLIAL
ENHIKVAHGRDYADCAPIKGIIYSNSEKNETNYVVEVQAREESEPDVFMDFEVSEPLPFA
QQLAFQSQWQQQQYQQQQQLRQQQNPLDSSEL
>KECLDBNJ_02010 hypothetical protein
MLARVANNLFWMGRYIERAEHLARYLNVNYFSSLDAPNEKSQSRDHVLHSLLFMANGPVD
EEYELTEQNVFYDIGMSSEQPFSILNSIKYARENANGARDLISTELYESINKFYHFVLSY
DSDYFVTKGLFDFTTQVAESTSIIRAKIRGTLLHDEVYAIIMLGVNIERATQVVRIIQAK
YYDALNAQGGYDKKFSKSYEWTTLLKCIEAYDMMRRHYKKTPTSLSTLEFLILNPECPRS
VMNSLVQVKNHISVLNEDKYPGKDTAAFLIGKTHAQYRYRTVDTIEGNVESFIEEIQDTL
IEIAKKIEKEYFNY
>KECLDBNJ_02011 hypothetical protein
MSTTQQTIFSSYDKDPKFFDEIFDEKGNVKEVYQTLFDLYSGHSSQDFAKLNDKAKASFF
NQGITFQVYTDQEAKEKIFPFDLFPRIIDHKEWETIERGVLQRSKALNHFIWDIYHDKKI
IKQGIIPLDLITSSANYLQQMIGIDPPGGIYNHISGTDLIKHADGKYYVLEDNIRCPSGV
SYVICNRTALKRALFGVFNHYNAHTVTDYAQNLLEIMESVKPRGVDEPNCVVITPGVYNS
AYYEHSYLAKSMGVELVEGRDLFVENDFVYMQTIKGPERVDVIYRRIDDAFLDPLEFRPD
SALGVPGLFSAYKKGNVCLVNAPGTGFADDKAVYTYMPEIIKYYLGEEPILNNVHTYHCS
RPDELKYVLENVDKLVIKPVDEAGGYGISIGNRLTKEEIEKVKKTIQASPRKYIAQPIMS
LSVHATYIEESESFESRHVDLRTFCLLGADKEFVLKGGLTRVALKKGNLIVNSSQGGGSK
DTWVLKK
>KECLDBNJ_02012 hypothetical protein
MTKKITIVLMLVFAVGSAQFLEQKKDLKTTEGFFDFHYNEKEDELYLEVDNVDQEFIYVH
ALKSGLGSNDIGLDRGQLGGTAIVKFIKAGNKLLLVQPNQDYRAITDNAAEKASVEEAFA
KSVLYGFEIKETKGSAYIIDLTPFLLEDAHGVARRLKANREGSYKVDMSRSALALTNTKS
FSKNTEFEALITFTGTPEGRNLGSVAPDASSVSVVQHHSFVALPEDGYQVRAFDPRSGAI
HRSYMDYSAPVQEDMTKRFIIRHRLEKKNPELAVSEAVEPIVYYLDPGTPEPIRSALLEG
ARWWNQAYESIGYKDAFQVKMLPEDADPLDLRYNLIQWVHRSTRGWSYGASVVDPRTGEI
LKGHVSLGSLRIRQDFMIAQALMNAPFESSDDNYEPMLEMALARIRQLSAHEVGHTLGFA
HNFAASVADRASVMDYPHPTIRLKNGNIDFSDAYAVGIGTWDKVTVAYSYGDVPKGMTES
WYLNDILEKAEAQGLRFITDSDARAATGAHPDAHLWDNGANAAQELEDVLALREKAIENF
SLANIKTGEALSTLEDVFVPLYFYHRYQAEAATKSIGGQRYTYAVKGDEQQEIVTPLSAK
EQQQALDAVLKTLDAQYLAIPKDKLAMFPPRAFGYRRTRESFKGNTGITFDPLAAPETAA
DMTVAFLLNPERANRIVAQHAWDDKLPSFESVLDALMEQTLYKKTKDTYAAEVQRTINYR
VLEHLKKLSVTKDAIPQVKAATFAKFLDLSSKLAMSKDANDRFIALELGRFMEDPEEYET
IPAPQIPDGSPIGSFQCLNH
>KECLDBNJ_02013 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MTKEEIVSKLPYADPFLFVDQITEVSQKHIKGHYTFDETSDFYRGHFVNFPVTPGVILLE
CMMQIGLVSLGIYLLRDKSFDLRGNSTVAMVENEARFYKPVFPNEKVTVVSDLEYFRFHK
LKSKVKMLNADNELVCSGIFSGILKPGDE
>KECLDBNJ_02014 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSKQRVVITGLGVCAPNGVGVPAFKEALETGKSGIRFYSELEKLKFSCQIGGMPLISEAV
KTKYFTPLQLRNFNSAGILYGVVAGVEAWQDAQLPTDEEQCDFDSGTVFGVGSLGVDKYR
ESIYKIDEGNTRRLGSTSVQQTMSSGVSAYLGGMLGLGNLVTTNSSACTTGTEAILMAYE
RIKAGKAKRMLAGSTSDGGPYVWGGFDALRILPSKYNDKPTQASRPLAGDAAGFVPGCGA
GALVLESLESAQQRGAKIYAEILGGSSNSGGQRNEGSMTAPNPIAVKRCIEDAVVDAQIS
TAQIEVINGHLTATSKDGLEIKNWSEALKRSGVDFPYINSLKGMTGHCLAASGSIECVAS
VLELKHQFLFPNINLHTVHDEVLEHISESKIPRVKTALKFNYLAKASFGFGDVNCCLIFK
TF
>KECLDBNJ_02015 Acyl carrier protein
MSQDIYPQLKEIIKPYLPEDVNPDAISHESHLVTDLNINSTHLVDIVLDVEDAFDITIED
DELDKMETVKASIALIEQKLAAR
>KECLDBNJ_02016 malonic semialdehyde reductase RutE
MQEITKITPTAFEIMDEIKTRWSPRVFDDVPLSISEVKQLLEAGRWASSSYNQQPWRIIY
GIKGDKVYDQILDCLIPFNQDWAKNAQALLVTAYKKTNFDGDPYFHAPHDLGLFMGNLVI
QANHNGIAAHHMGGIDQEKAHKTFEFTDDFEVATAVALGHYGGNPDRLPEELQEQEVDPK
RERMAINEFAFNGNFKSK
>KECLDBNJ_02017 hypothetical protein
MKQFTVVLAFLLCAVVGQAQVQYLKDKPAYIEKQADSLTQIYSKKLGLTPKQDLLFKTNI
GDYLVLREEVEKKYKGTEKLNELYKVSKKESGSMSEVLTEQQFELYEKIKSSIQPIARL
>KECLDBNJ_02018 hypothetical protein
MLKHFGKLEKIQSLKDAIKKTAIVTSRFFYELNVLSNLA
>KECLDBNJ_02019 hypothetical protein
MKSIARDENQVTLIYSSTTRTGERTYGHISAVKDKELQTIDIAKTPLTGTQWAELADELN
KPIKDLLSFEDVSDDDELKTADYDENDYINIIKNRPELFAHPIIIHKDEVKQVTNPTQAQ
EFLGVDSAGLDKKMMYDEPTISSTTKKEHFIDKPDKGDHN
>KECLDBNJ_02020 hypothetical protein
MNYNFEYHDVAASAALEEFTKEQLDKLANKYDFIVRADIFFKIENTSSDETGKIAGIRLS
APGPRLFADHSSKSFHESVKEATRELNIQLKKRKDKMKSHH
>KECLDBNJ_02021 Inner membrane protein alx
MLVWGIFIAFILVCLALDLGVFNKHDHVIKSKEAGIWTAVWFSIAMAFSGVIYWLFNAEL
IENPTNITANTAVLKYITGYLIELSLSIDNVFVIAVIFSSFKIPPKYQHRVLFWGILGAI
IFRALMIVFGVALINKFEWIIYVFGGFLLITAYRMLKSNDDDDYDPQDSAVYKGVKKLFP
VTTKMEGHDFFIIDQGKKAATPLFLALIVIELTDILFALDSIPAILAITADPFLVFTSNI
LAILGLRSMYFLISRMLQKFRYIHYSLVVILAFVGLKMIFSHIIEIPEWLSLGVIVVSLV
GGILASIYLKGGQDPEANTAKAEELP
>KECLDBNJ_02022 2,3-dimethylmalate dehydratase large subunit
MKPLNVTQKLINDHLIEGKLAPGEEIGLKIDQALLQDATGTLVQLELEAMNLDKAKTEVA
VQYVDHNLLQTDFKNADDHAFLHSAAQKFGLWFSRPGNGVSHPVHMERFGKPGKTLVGSD
SHSCAAGSLGMLAIGTGGLDVAAAIAGQPYFVKMPQVMGVKLTGKLPDWVSAKDVILEML
RRHDVKGGVGKVIEYYGEGLKDLSAMDRHVIANMGAELGATTTVFPSDQETKRFLKSQGR
EEDWTELIADEGCSYDLHDHIELDKLVPLIALPTSPGNVVPVSEVAGKSISQVVIGSSAN
PGLRDFWIAGAIVKGKSVNPDVSFDVNPTSRQIIQNMIDTKAFANLITAGARFHQSGCMG
CIGMGQAPASGTISLRTMPRNFPDRSGTKDDQVHLCSPETAAASALTGKITDPRDIASLY
DMKYPKFEDPELHIINEDMLVAPAEDGSKVTLKKGPNIKSLPHIEALQSDYEVPVLLKMQ
DNISTDEILKAGAEVLPFRSNLPEISKYSYTVIDETFYDRAMATKEKTGGHIVVAGDNYA
QGSSREHAALAPKYLGQVAVIAKSYARIAWQNLVNFGILPLEFENPDDLDKIEQGDTVML
KNLRQLVEQRETIEVLIKKETGEVAIPTKHSLSDRQIRVLLKGGIINDFKEKLSA
>KECLDBNJ_02023 Guanine deaminase
MEQQLHENFLRKAIHWARQGKASKGGGAFGAVIVKDGIIIAEGHNSVGASTDCTQHAELA
MIQQAYVKMRTKSLTGCILYTSCEPCLMCLGATRWAELDAVYYGASATDAKEAGYIYSDL
FYNSHSGKRHQEFKLKQLLRDEAVAVWN
>KECLDBNJ_02024 Inner membrane protein YfdC
MSEEEVKQENIDKELEKSEVSEDSQAKSHGEILKEQICEGKKIYTLSTSSVLVSSLTAGL
ELGFSYMMLCSVFFHFSDSFSDSTLFKLIALVYPLGFILVVLGQSILFTEQTSLLTLPVL
NRKHSLMSLLRIWGLVIFGNLLGGWLIALVLMWIGPQLGIFEVETMVSIGDHVAHYTLPV
ILVSAILAGWMMGLLSWLVTSSKDTVSRIIIIFLITATMAFVGLHHSIIGNIEVFCAYVL
GDEISLGRYVWVQSTALIGNAIGGAFFVALLKYRAFVNNVN
>KECLDBNJ_02025 hypothetical protein
MKNLVVIVLAFGVLGCSGSKIAADSNTELNQWIESGTYAIESQWASPMPTSAFMAVANSN
ILGPGNNANRINLIGNPNHLRVYNDSIDVHLPFFGERFMGGGYNQNGSGIEFKAPIKNYT
VSVAKGYYRVKFSAADRTESYNIVLNLYPNQTANIAVNSSQRAAIQYQGRIEAYDPDKTE
TESEK
>KECLDBNJ_02026 hypothetical protein
MKQRPKIFIITFIIVTAFVFGFYYLDTHNVFNSLKLGAIGGIVIAAMAALLVPFVLKKR
>KECLDBNJ_02027 hypothetical protein
MNYKILLFLKGLLSMILTTEKSEFMKDCTCKKTDLTKGLVLKGSGNRYSVTLPNKDWNPV
IIENGLNAAVFEKDAFKFFGIVEMKNSQPKQTLDEQQQDIERKFDVIESGTTMMFNKKSI
>KECLDBNJ_02028 hypothetical protein
MKSRLKSLLIGGCVGGGVYAAIMAAFDYYDGQEFSLWKFVINFLIFGGFMTLTTWYSLKK
ADKKGQ
>KECLDBNJ_02029 Guanine deaminase
MDHKHYMQEAVTAALKGMQNNEGGPFGCVIVKDGKIIGKGNNKVTSTNDPTAHAEVTAIR
DACKNLGSFQLEGCTIYTSCEPCPMCLGAIYWARPEKVYYGSTKTDAAHIGFDDDFIYEE
LKLPYADRSIPFEQLAPEVAIKPFQEWAVKEDKTEY
>KECLDBNJ_02030 hypothetical protein
MLEKRTQVPQNYDLDPDKFIYCLEGVEDVAVDALTEVQKSLEELALQFGVASIYQTCDTI
EGLETSLNTLIMDDHYFKEYEIIYLVMTGAANSISLNGYNYSFQEIAELFEGKLRGKIVH
FSNAKVLDLDEEEAQYFLDITNARAVSGYGNAFSGVSSANLDKVFFNLFNEDDDIFNVVE
ELHQKHFTACKVLDFRMYY
>KECLDBNJ_02031 hypothetical protein
MSVIWYECKVKYPKLDEVSGTKKLKTEPFLVDAVSYTEAEKRITEEMQLYLSDGEGILIT
NIKVANYAEIHPFENADRWFKAKISLIAFDEESGKERKTNEYLLVQANDVKEAYENTMHA
MKDTMGEFSIPSIAESPIVDVFPYFTGEEENSERLEEFLRLKESVPADNAEDEALAMEDS
LTA
>KECLDBNJ_02032 hypothetical protein
MKSTLILILSFLCTLSIMAQDFCSEVECQYLDNLYQVSDSLYRSEQPSRKGFGELDKLGI
KTVLNFRRLWKDDRKARDTDMELVWMPLRAGELTEEELLTALTAIKNAEKPVLIHCWHGS
DRTGAISAAYRIVFEGWSKARAIEELRIEALGYHEDWYPNVIDLINDLDTQYFRTALDIK
TSELAAGQ
>KECLDBNJ_02033 Zinc-type alcohol dehydrogenase-like protein
MKAIGFKQSLPINEEESFIAFETEIPKPEGRDLLIKVQANSVNPVDYKIRQNAVKDQVLD
SPKIIGWDAVGIVEAVGEEVSLFNVGDAVFYAGDLTRSGSNAEYQLVDERIVGRKPRNLS
IAEATAIPLTSLTAYETIFDRFKYNPATDKGRILLILAGAGGVGSIAIQLAKKLTDLTVI
ATASRKETVEWCKQMGADSVVNHYDLKDELAAKGIEQVDFIFDCVDLKSYWETAAELIKP
QGHIVSITGSSDPLNLNLLKNKSVTFSWELMYTRSMYETADMQRQHNILNHLAELLEEGT
IQSTLTTTFNGFTVANLKEAHKLQESGKSIGKNVILF
>KECLDBNJ_02034 Xylene monooxygenase electron transfer component
MSYTVKINEIHFINHDVLHIETEKPQGFDFTPGQATEVAINKAKWKEKKRPFTFTNLPEE
DVLQFTIKTYPDHNGVTQRLGKLKNGDELIIDEAWGAISYQGTGVFIAGGAGITPFLSIF
KKLEQEGKVNGNKLIFANKKEEDIIYAPELEALLEEDFINILSEQEDTDYAYGHIDKAFL
NKNINSTTLKKFYVCGPPPMMESVIKDLKKMGVTEERIVQEAME
>KECLDBNJ_02035 hypothetical protein
MKTLILSSLFFLCAVSFAQETPCSKGDCQNGYGFYYNKETGDVYHGFYKNGLYNGVGYSQ
NKTSDYYYSNFKEGKPDGFTVYDEGEGRTSGLFEKGIKIGDHIREVRSSQGFSRELISYD
QGQVLSRKTFTPQDIADATCISGDCIDDYGIYFQNNTIISGKFENGRFTYGEMMHIETKT
SDFFMPPLETEQHTPYFKFSITMTDNGANEAAYISVGPKADGQYILVNMKQNNFVGALFK
DNQLVERY
>KECLDBNJ_02036 hypothetical protein
MRILVLLLVFSSSLWAQGPYDINKNQNYTKFTALKKAGNNKEAFNVGFKLLDAFYTNTDL
YFEVGISRAALSQEPIIGAQLIQTAYDMEPIYDRLAQSAIAYAFFAKDLPRAKQLLWEYS
FYPHPPEDFKRSVTYLEGAVNYYKKTFTTSQVQQAQRMLDVYKAEASKNMMVFWEKFNPI
YSASPKDIIQKGPEHYLKVLEPVKQQMDAGNFPVSYYNVALETLALITFWNNWQQAHVLI
PELKLQFSNPKTAPMMKFKLYDILSKINEVNRNYEENITLAVIMRNELPQFTYSNSTLML
ALNNQLFSLVQLERYKEAYKLAEGAQNFMNKVTNPDVKMMGYYNLSRALTYGGDKEKGLQ
YAEAGVNYMKQNGYEEHPQFGKTLLSNLQSLKFYKDNSVAIETNINSTDIIELYDYGLQL
GMKKKYAEAVPFYEKAFKRQKPKVSETTGSQRTAQLDLFTKIGGNLIACLFESNQKEKIF
SVMEELKANGLLASQDEIPTLSLSEIQHGLKADEALVYYVDVMRGNVNEGVYMAAVITKN
DINYRYINTIGALMRVYVDRNTEIGAIEKAMAQRELRQPKYTVYRNLDEAGFNQYKKGDF
VLLAELYRNFLNPNEGGEVREEYTDTAYRDYIANSFFIDMMSRIEPWFKGKKRIYIAADG
VLHFLPFESFKNNKGRYLVEDYEIGYVPAGSTLITLRKRPKTNYEKNVLAFGDAKYQKRA
NPGRDLESAADIKRLELDVEESLQKNEPLDYAFATFSSEAMKYLKGAKDEVLAIKELVPK
TDLRLDTQMTENEFKKMSREGALHHYRSIHLSSHAVTHPFVFDLSGIAFSVFSYPKDGED
GMLTVKEMAQLDIDTDFMFLSACQTGLGKLVPGDGVQGLNQAMLMAGANATLTTLWSVND
YGTSVYTKSLYYKIFQENKDYLTASTEVKREFIKGSYNKYVDLSSPQYWAPFIYTGK
>KECLDBNJ_02037 Peptide methionine sulfoxide reductase MsrA 3
MTNSLEKIAVGGGCHWCTEAVFQALKGVEKVEQGYVASDPPFEEFSEGVIIHFNPQIISL
EILIEIHLHTHKSTSNHSFRSKYRSAVYCFTEEQKREVQHILTQLQNEFEQSLITQILPF
QRFQASRESLHDYYRSNPEKPFCERYIAPKLQFLLKQYSNRLK
>KECLDBNJ_02038 hypothetical protein
MKLKSTISRIPEGYSEGFYNNRKYSITRTDFNEGKSTKIYAKELGGTDFISLNYYETKMG
ELLKPCEMPELKVITFLKEVRIID
>KECLDBNJ_02039 hypothetical protein
MQFNINNLFTEALPADPNFENSRRQVMQGYYSFVSPKETAAPQLLHVSDEMLNALGISEE
EAESKEFLEVFTGNAVLPDTHPYAMLYGGHQFGHWAGQLGDGRAINLFEIDNDNKHWALQ
LKGAGETPYSRSADGLAVLRSSIREYLMSEAMHHLGIPTTRALSLALTGDSVLRDVMYDG
NPAYEKGAVVCRVAPSFLRFGNYQIFTSRNDIAGLQKLVIFTIENYFPELDASSKENYLK
FFAEVSERTLEMIIHWQRVGFVHGVMNTDNMSILGLTIDYGPYGWLEGFEWGWTPNTTDR
QHKRYRYGNQPNIGLWNLYQLANALYPLVEEADGFEEILDRYKEDYAKRSFQMMADKLGL
EAPEESDLQLIADLEECLQATETDMTIFFRKLADFKKDASVDGLTLISEAFYTTEEISEK
IQNQWKQWFQAYSTRLQQDQQSDEARKKAMNATNPKYVLRNYMAQLAIDAADKGDYSLID
ELYQLLKKPYDDQPEYEKWYAKRPEWARDKVGCSMLSCSS
>KECLDBNJ_02040 hypothetical protein
MARTIITLILMVLLGFATMNAQTSMYLKLPDIEGESQQQGHEEEIELTQVSWEVSIPDAA
LSGRTRARTSFSGISIGKNTDLASNTMLDFLARNKTLRNVILTFSTNSSGGINDYLIYEL
DNVRITSFKMEANEKDSKPQEYWTLSFEKINSLYKQFNNNGRLEEEVEFEYALRTGS
>KECLDBNJ_02041 hypothetical protein
MTTRNQNAGIAAALLGLAGGLFAWWRYNNATPEEKARLKNKVNELGTKLKDTYTEVEDTV
SDNVATLKNKLAKEQQNAADQAEKIAS
>KECLDBNJ_02042 Ycf48-like protein
MRYNFTSFLLIFSIAFCAAQDVNTYFKPLKYRSIGPFRGGRSNSVSGVVGDPLTYYMGTT
GGGLWKTADAGQHWENISDGYFKTGSVGAVAVSESNPNIIYVGMGEHAIRGVMTTYGDGV
YKSTDAGKTWTHLDLENTQQIARIVIHPQNPDVVYVAAQGAMQEATPERGVYKSTDGGAS
WEQVLFVDKKTGSTELSMDMNNPNVLYTAMWQHQRTPWKMISGGAGSGLYKSTDAGKTWK
VLKEGLPEEMGKMAIAVSRANPDKVYALIESDSEKDLGGLFVSDNAGASWKMISGDNRLT
QRAWYYTEVFTDPNNEQTVYVLSAPALRSTDGGATWETLSGTHGDYHDLWINPANSKNMV
IGNDGGAAISFNYGASWSSQDIMPTAQFYRISTDNLFPYNIYGGQQDNTSVKIASLSLGS
GSIGRQDWTSSAGGESAFLAFDKDEPRYVYGGSYLGTIEVLDMQTKMSTKVMAAPIQYLG
KAARDMKYLFNWNAPIIYSQHEPNTVFHGAQMVLKTTDQGRTWTEFSPDLTRNIDEKQGK
GGGPYTVEAVGAENYGTLSYIIESQHEKGVFYTGSDDGLVHLTRDNGASWQNITPKGLEE
TLINAIEVSPHDPGTVFIATTRYKFNDYTPALYKSTDYGKTWKSINNGIPYGAYTRVVRE
DQDQEGLLYAGTEQGVYVSWDAGASWESLQLNLPITPITDLKVHQGDLIVATSGRSFWIL
DDLKLLQQYSANADQFQLFEPKNAIYGSWYSALNGSDPDFDGTSTFEGVNPANGSEIYYN
LPKLKDSIAIELTIKTQDGTLINSFSSNADENFSAYAGGPSPTPTLSVDQGLNRFVWDGR
YPELPGVPGVYIEASYAGHKVAPGTYTLTLTYGRESQSTTATILPNPNLDIDATDFEAYH
ELMNVMEQRVTAMHTLVNQLKTAEEEIASLLPKLKAKNATALVEQGEALINDLNAWDSKM
VQRKSKAYDDVENFENKFSANYMFVMNQTDSDIPRVNASNKAEFDRMNQEWESLKVEGLN
LLETRIPNYNAALWKAGIGAIPTAE
>KECLDBNJ_02043 hypothetical protein
MRIYILSGLLFFSIQINFAQDYIDLANLSYSLTPQNQFESSNAQTQVEELEFQFTFPQVL
DEKNTLIANVMLESNALRLDPSLADRTTLASLGLALGFNHRYSEKLAITYLVIPKIASDL
KQITGQGFQLGGLALATLKKNENLNYKFGLYANTEEFGLFLVPYVGFYYLSPSKRFEAYI
TTINGDINYMLTEKINIGGDVNGLTSSYALDDPYFGSSPEYFAKNTTEFFAYVRYPVAKN
LFLKAKAGYSITRTYKVFEQSDKVDLGLSLFFLGDDRNLLNTPLQKGALFKLELLYRFPL
>KECLDBNJ_02044 Thermostable beta-glucosidase B
MNAKIFILIMLLAVFSGVAQEDTQKLIDQLSVDEKIYLSIGTGMDIPGIPAGAEAPQAVV
GSTKSEVAGAAGTSYPISKINLPPIVFADGPAGIRIDTVRPQAPGKTFYATAFPTASSLS
SSWNIELAQQIGQAFGIEGRDYGVDFLLAPALNIHRNPLGGRNFEYYSEDPILAGEITAG
FVNGVQAEGLGATIKHFVANNSETNRTALNTVVSERALREIYLRGFKLAIDKSEPWAIMS
SYNKINGTYASENSELLTDLLRKEWGYEGFVMTDWFAGLDAVAQMRAGNDLLMPGTEVQF
NAIKEAISNGTLEESILDRNLTATLNAYKKTFSCKGYEPSGVTDLEGHKMVARNAALEGM
VLLKNENKVLPLKSDAKIALYGSASYETIAGGTGSGDVNKAYSVSVFEGLKNANVHLDQE
LTSIYEVYMKEERAKIPPKAMFFLKDELVPEKTWTEAELARAAKANDVAIFTLGRTSGEF
QDRIEAGDFELTATELELISDLNKAFAAEGKPLVVLLNVGGVTETNSWKALADAILLIWQ
PGQEAGNAITDLLLGKANPSGKLPVTFPIALDDNPSSKNFPGIPLDPNAEKPANPLQGIP
SEEIYEEGIYVGYRYFDTFEVPVSYPFGYGMSYTTFEYSDLQVESGATISVSFIVKNTGS
VAGKEIAQLYVSAPEGTLEKPSKELKAFAKTALLEPGASETITLEINPESLASYDDKKHA
WILDGGTYTLSIADNIASSKLKATLEIEATTVRETEALLVPQNALNTLSKN
>KECLDBNJ_02045 hypothetical protein
MIDAYLEILDAFSPLQEEARALIESQITIKDIPKGDFILQEGSVCNHIYFLHSGFARQFY
YKNGKEITEWFAASKEFCFSIESYFHQTPSKLMIQTLEDSTVIFLHRDAYMELSKIQSDL
SQLAIKMFAESLVFSQRRMEHVLFESAKDRYVHLLETKPNIIQKVPLAYIASFLGITQET
LSRIRGQL
>KECLDBNJ_02046 hypothetical protein
MNASESTVNREISQEDLQTCLRVLEQFNTDTNLLFELDREDRIAILKASGRLSRPDRDEF
SRRKKDAKKAQKRKQAAKDRAARKVTGIRSAREASVFTAPKLLQAAELEKLETPELQTAR
NCYVCKTEFTKLHHFYDTMCTSCGDFNYAKRFQTADLTGQVAIITGSRLKIGYHITLMLL
RAGATVIATTRFPVDSAYRFSKEEDYHIWANRLKIHGLDLRHIPSVEIFCNYIEQRYERL
DILINNAAQTVRRPAGFYQHLMAKEETALSELPQVVKTLLSDHIGCLDELKSLSTSASGT
KNMPVTWHGPEPGIGIRASAKLSQIPYSFDNSLQAAEVFPEGKLDADLQQVDLRKTNSWR
LKLGEIETTEMLEVQLVNSVAPFVLCNRLSELMKQELTGQKHIINVSAMEGKFHRFFKED
RHPHTNMAKAALNMLTHTAAGSLAKDGIYINAVDTGWVTDEDPVALAQKKVEEHDFQPPL
DIVDGAARVVDPLFDGINTGKHWSGKFLKDYFPIDW
>KECLDBNJ_02047 Trehalose synthase/amylase TreS
MAITPFIDDQQNWYKDAIIYELHIKAFFDSNGDGIGDFEGLLQKLDYLEDLGVTAIWLLP
FYPSPLRDDGYDIADYYSINPSYGEIEDFKRFIEEAHKRGLKVITELVINHTSDQHEWFQ
RARKAPAGSKYRDYYVWTDDVEKYKDARIIFTDTEPSNWTWDAEAGAYYWHRFFSHQPDL
NFDNPDVQQEVFNIMDYWCELGVDGFRLDAVPYLFERDGTNCENLPETHVFLKKLRAHID
SKYDHKLLLAEANMWPEDSAAYFGDGDECHMNYHFPIMPRMFMAVKMEDRYPIMDIIDQT
PDIPESCQWAIFLRNHDELTLEMVTDEERDYMYKVYSKDPKAKINVGIRRRLAPLLDNNR
NKIELMNVLLFSLPGTPVLYYGDEIGMGDNFYLGDRDGVRTPMQWTADRNAGFSMANPQK
LYLPTIIDPQYRSESVNVEAQQMNPSSLLWWMKRVMHMRKSFKAFGRGDIQFLSPSNAKI
LAFTRTYEDETILVLANLSRFSQAVELELEDYIDYIPVEVFSHNKFPRIMNRPYLFTLAP
HGYYWFALTHRASEAQDGPLPQVKTSSWESLFDAKSVKLLERKILPAYFKSKYWFGDANR
IIQSMHVTNMLDLSDSTVLVKNLIVEVNFNEGLPEIYQLPVSFIANSQESLIEAIPHKGI
LAEIQLEDRAGLLVDAVYVAPFRAQLFYGLQEGKTLKFGKEKLTFNRGKITPDEKIKDVN
SRIIESKQSNTSIIYDHRYFLKLYRRLDNTINPDAELAQYLTETVKFANTPDYMGKLVYH
TEKRNEAVLGMMQDLVTNVGTGWVNAKDAAHRYMERIETQAQELQPDYDKTLRTQPLVFE
ALHEPESELIESLFPERISLLGRRSAEMHLALASHKELSGFEHEAFSLHYQRSLYSSLQR
VTREAFENLRRSIPSLPTTIQAEAEAVLQRKNEVLACFKRVFKHKINTVKIRTHGDFQLG
QLLWTGKDFVIINFEGEPSRPFSERRILRSGLRDVAAMIRSFHYAAYSPLMQQNYAEEYR
EEHLEQWAEAWYYYVSRFYLDGYKSTLQDTDLIPDNDRDYSVLLDTFLLEIAVGELNSEL
NHRPLFALVALRGIQAVLDGISTE
>KECLDBNJ_02048 hypothetical protein
MDSKSDMFFKQATKWKEELAYLRSLVLDSELCETFKWRNPCYTYKNTNVLILRSFKDYCA
ISFFKGVLIDDTYNLLEAPGANSQSVRLLQFYSVDEIVKKKQCIQDYVQQAISIEASGQK
VVLKKTEAFDFPDELQQKFKEDLPFEKAFKALTPGRQRGYLLFFGGAKQAKTRIGRIEKY
TSRILSGKGINDCTCGLSKRLPSCDGSHKYL
>KECLDBNJ_02049 hypothetical protein
MKTFYFLLFLAFLISCNTENKPIVPIPSNAPNQAQLKQIARQYGMFIHFSINTFNDIPWS
DGSLPASSYNPTTVDAEQWVKTAKDAGMNYIILISKHHDGFCLWDSAYTDYDVASSGNGT
NVIEEVAKACKKFDIELGLYYSLWDRKENGNAYINGENTVPYTYVKDSVADQKYNRFMIN
QLNELIDITQPYTDVVEFWFDGGWTKEHNRWPLNDIYQTIKSRVPECQIGVNWSIGLPEN
IDYHAVYPEDQKEGYPIRYFPSDFRLGDPMLPANPDPKLFTHKGKTYYMPWESTVCLSER
WFYNTTDSTYKSIAQLTDLYQKATAQNNILILNAPPNREGKIRAKDQEILLELKGQIDSL
EGSL
>KECLDBNJ_02050 Mechanosensitive channel MscK
MVFAQRLSFVLVFFFTLVTSAQTDSTTTVVDSVPAVTTGDDFVKKLAELEKQRFADSIRR
ADLEARLDAVSSTNNRERTQLEAQLKQFETKESELLEKKRLQIESLKKTTRGFPVAGFED
DTLFLIYNRLGSFSAQERANAISSRIKRLTETLEFFSDSLKVNENEATVDVIYGNQTIAS
VTEVDALWFETTPLALATSYKEIIADAVTVYKEEHSLINLLKSIGMALLVIIVMGLIIKY
VLRLFRWTALKIQRQKHKRLKAVTVKNYTLLDTERQVHVLLLINRILKWVTVLLAIYIAL
PLIFGFFPQTEAFAHELLGYIINPIKGIFLAIWNYLPNIFAIVVIIVVFRLLLKFLNFLK
VEIAEGRLTFNGFYPDWANPTYQLVRVLVIAFAFVVIFPYLPGSESPVFQGISVFLGFLF
TFGSAGSLSNVIAGLVLTYMRLFKIGDRVKIGEIVGDVIEKSSLVTRVRTPKNEIISIPN
STVMSSHTINYSSDAPEKGLIIHTTVTIGYDIPWKVMHQTLIDAALRTDLVLKDPQPFVL
QTSLEDFYVAYQINAYVREANKQASIYSNLHQNIQDVCNENGIEILSPHYRAARDGNQST
IPSDYLPKDYVAPSFNVKTQSDSKKSE
>KECLDBNJ_02051 HTH-type transcriptional activator Btr
MHTTVWKQKIQLLESLNKDTELLSENSFGFYFSSDQAFSKLYLKPLNEAFAAEAYEYSEG
ILINFERELIEEDDQEYALDVMQLFNGSRCLHLNQNVWISNQIQHSIVLLKEEYAYDKCS
YIVLKTILKVLMLQLIRFQKTHYAPQELDQKRIYEFLKLMETYYLQETESIYYATKMGIS
EKRLNQILKEKLQRTAKQIIQQRQITEAKRLLIRSEATIQEIGFQLGFNSLSSFSRFFKN
QVGESPSTYKELHS
>KECLDBNJ_02052 hypothetical protein
MHFGFVLLILVFLQEMPVYAYYRLETENTAPRVFE
>KECLDBNJ_02053 Tetracycline resistance protein, class B
MHFCGMNTLSKFCIFTLLFISSLTIMVGSAIAPALSGIIEATDFNFPPSLLITLPALGVL
VFAPIIGKLTNVLGPFKLLALSLIPYAVLGVIGAYLGNQYLLLIDRFLLGAATVAIQVSV
TGLIAQLFSGPTRMKIIAWQGMAIELGGVVFLSIGGILGEWHWQAPFYIYLTALFCLFLL
YTTIPKNTPTEAEQTRETQHKPSAQKTIWAICAASLAAMVLFFVSFVTLPLYLDQGFDFS
ESIIGYYMAFISLMAIATASQMPKVVSKFGDAKTVAIGFLFFCFGYVVFAATHQIAFLIL
AAIFIGIGFGLTVPLLNHMTVEASTPETRGKNLGRYSMGIFGGQFLSTFITFISKDYITI
YWVAAAFGILVCLVLFILFKKVLNT
>KECLDBNJ_02054 hypothetical protein
MENKAIYAVILAALIAGFNGILIKAMPSLSTGAIGWFRAGVPVLFLLPGLLKASQLKVQG
NTRMLLLASVINAVRTYFFLLAFVYTSVGNAIVLFYVYPLFITIIETTVYKAPISKKQVL
FMLLAFGGIAFTYADKEFSFESRDFIGMLAAILAAVGYAFFVSIFKRQTQDCNRNQLLFY
QNLAGAVLFIPFLFGLKDVALTHMGIGVFYGLLIGIVQFGLFFFGLKHLNATTAASLMYL
EVLSAVLLSFFILNEQLSWNTYVGGLLILISSFYISKLNRKAT
>KECLDBNJ_02055 hypothetical protein
MLKQFGGKITPELKKRYAQSPNWKSGSFQNLEETTMDIGLAEMPGMLWKMFFSKGNTIPQ
QNLPIQAFDKTTFLAPDDSLKYIWYGHGVYLLRLAGKTILIDPMLGPDAAPIAPTKSARF
SENTLQLIDDFPQIDLLLLTHDHYDHLDYASFKKLLPKVKKYYVALGCGRHLEAWGAASQ
TITEFDWWDSHTFEDIKITFTPSRHFSGRGIRDRAKSLWGGWVLKTAQTALFHTGDGGYG
AHFKEIGERLGPFDLGFVECGQYNERWRAIHMLPDEAVQAACDAQIKRATPYHWGGFKLA
FHSWTAPAEDFTAAAQLKHLEYTLPKLGQLMHLDQPAQVDPWWKDIT
>KECLDBNJ_02056 hypothetical protein
MTGQHKRKQQAKLLRQFRSVHRAMGALLFVFFFVISISGLLLGIKKNSGDLLLPKTQKGT
TTDLTQWLPLEDLKEQAIQVLHDSVSADLSTKLDRIDVRNEKGIVKFIFDGHYYGIQLDG
ATGNVLHIGKRRSDVIENIHDGSILDNYLGTGGYIKLVYTLVMSIALLLFTITGFWLWYG
PKRMRKGRN
>KECLDBNJ_02057 Ribosomal large subunit pseudouridine synthase E
MASPQHFLIFKPYGYISQLSSNDLRQRRKKKFLAELYDWPEGIMPIGRLDEKSEGLLLMT
TDGVLSDHINRSGIEKEYYALVNGVPTEVQLDQLRNGIEIGLEGKKYTTKPCEVQKLEGI
PALPDRGKKIRDSRHGPTTWLSITITEGKFRQVRKMTSAIDCPTLRLVRVRVGNLKLNTM
QPGEVLAWDGEV
>KECLDBNJ_02058 hypothetical protein
MGKKLTVYMIDGTAYGPRLAEIGNWVGKAIYCPRATVNKIITRPEFNNPGIYCLKGDPTD
EAFDERIYIGEAENIKSRLKQHLSDSTKDFKELIFFISKDELLTKTQIRYLESRLVQLAI
DAKTAQIDNGNSPGIPTLHEADISDMEYFLEQMKLILPVMGFKFLISSTVTENKEEQRSQ
KLEVHQTYTIKTRSFEARMKETDQGFIVTKGSVAKKKLSPSCTETYRNMRKRLLETNVLI
EYEDKLIFAEDTVFNSPSAASNMILGRNSNGLTEWVTEQGETFKQVQEKLNP
>KECLDBNJ_02059 Fructose dehydrogenase large subunit
MKNEDTMNTQYDAIVVGSGISGGYAAMELCKKGYKTLVLERGRDVEHISDYETANDDNWD
LPYNGRVPKKEIDAHYPKQNRLSWWVNQDNKPFINKDDEYPYEELSRFDWIRGHHVGGRS
IMWGRHCYRWSDIDFEANKKEGIAIDWPIRYADIEPWYDQVETFVGVSGQAEGLKQVPDG
KFLKPFELNCAEQDFREKVNAKYPERVVTPGRIANLSEYDPEVHLGTRGQCQTRNRCWRG
CPFGAYFSSQSATLPVAHETGNLTVRPFSIAAEVCYDPKTQKATGVRVIDANTGEETVFT
ARIIFCNASTVGTTALLLNSRSERFPNGMGNDSGELGHNLMDHHYGMGAGGTYPGFEDVY
YQGRKANGFYIPRFRNIDDETKRADYLRGFGYQGNISRGAHVPEETIGVELKETIFKPGP
YNVSVACFGEMLPYHENRMFLDFEKRDQHGMPIITFDAKLRDNEMKLREDGVQCAVEMLE
AAGVENIWSYNDLTAPGACIHEMGTARMGSDPKTSVLNKWNQIHAVPNVFVTDGACMTSS
GTQNPSITYMALTARAVDYADKQIKAGKL
>KECLDBNJ_02060 hypothetical protein
MKRRNTIKLLTLGTGAVFVTPLVSGLLSGCKAEPKAPEFDPEFFNENDLPFLVAVIDTLI
PATDSPSASEVGVPQMLDHMIAGLYSETDQANFSMQFSALKDYLNTIDGQSFVYLDPEEQ
TAHIQELITSREDSTNAARSVLLAIKNQSVNYYLNTETIAKNHLNYLPVPGPFLPCVPLE
ELNGKAWAI
>KECLDBNJ_02061 ATP-dependent RNA helicase RhlE
MASFEDFKINKQLRYAIEDLGFSNPTPIQEQAFSVVKSGRDVVAIAQTGTGKTFAYMLPV
LENLKFSKQINPRVLIIVPTRELVLQVTEQVKAYGKYSSIRVVGVYGGTNINTQKEAVLQ
GCDILVGTPGRLYDLALSRALQLKSVKQLIIDEVDVLLDLGFRFQLVNIFDLLPAKRQNI
MFSATMTDEVDELMDTFFTSPERIQVALSGTPLDAIEQHYYEVPNFYTKANLLSVLLKDK
NEFKKTLVFVSNKKLADRLFKVLEEVFGNEVGVIHANKTQNYRINAIEQFDTGTYRILVT
TDVMARGLDLDEVTHVFNVDVPRFAENYMHRIGRTGRAGTTGKSYLIGTPDELERKEAIE
ALMNKSIAQVDLPEGLEVSKRLIPEEEPNYVEINNPTKRDDTRGASFHEKKEKNKKVNLG
GKYKREIAKKYKKPKTRGDKNYNRRN
>KECLDBNJ_02062 Putative agmatine deiminase
MKNNRRLPAEWEKQQGILLCFPSNGNDWPGKYQAIQFVFIDFIKKIAETETVFLLIGRES
MKEKVITLLEAAHANMSKITFILQKTNRSWMRDSGPIIVKNNGAREALNFNFNGWAKYGN
YRLDKQVPKRMADFLGIPLQQVMYNGEPVILEGGAIDVNGKGTLLTSEECLLDPKIQVRN
PGFTKEDYESIFKQYFGVTNTIWLGNGIAGDDTHGHIDDLCRFVDAKTIVTVIETDKTDP
NYAALQDNLARLELAKLEDGSSPKVVTLPMPKRIDYEDLRLPASYANFLILNKTILMPTF
NDPNDCVALQTLSDLFPTRSVVGICALDLVWGLGTLHCLSQQIPS
>KECLDBNJ_02063 N-carbamoyl-D-amino acid hydrolase
MKARKYTIAVLQLALNNTPQNNLEKCKKWVADAAEKGAEIICLPELYSSHYFCQDEDVDN
FKYAEPLYDVSFIEFSALAKQLGVVIIVPFFEKRMSGIYHNSAYIIDSDGSEAGLYRKMH
IPDDPHFYEKFYFTPGDLGFKTIKTQKANLGTLICWDQWYPEAARLTALQGAEVLFYPTA
IGWHPQEKEEFGVNQHGAWMNVMKGHAVANGVYVAAANRIGLEQYVPDTNGIEFWGQSFI
CGPQGEILAQASADQEEILLAEIDLDLQENVRQNWPFFRDRRIDFYGEITKRALD
>KECLDBNJ_02064 ATP-dependent DNA helicase RecQ
MSASIDQNTLLTTLKTYFGYDSYRNQQSKIIETVLGGDDAIVIMPTGGGKSICYQLPAVL
FDGLTLVISPLIALMKDQVDGLKANGIAADFYNSSQSAEDQQKILDQVANRELKLLYVAP
ESLSGINPILNKTYISCIAIDEAHCISSWGHDFRPSYQQLGFLKKSLPQIPLIALTATAD
KATREDIANQLNISEAQQFISSFDRKNITLEVRAADKRLNQIKSFLEKHQDTSGIIYCLS
RKTTESVSESLKAEGIAATCYHAGLSFEERNKVQEDFIYDKTQVVCATVAFGMGIDKSNV
RWVIHYNMPKNLEGYYQEIGRAGRDGLKSHALLFHSYADVLQLRRFTQGAGNEEVQNAKL
DRMKQYAEATTCRRKILLSYFGEFLAEDCGNCDVCKNPPQFFDGTILAQKALSTIARVKG
SEPIGVIIDILRGAKNAHILDHQLDQVSTYGIGKDISWKDWQHYVLQLINQGYCEIAFHL
RNNLHLTESSKEILFHGKKVRLTSPTEVLQKEPVEAKKPKIKKGNELFEKLRALRAEIAK
EEEIPAYLVFSDKTLKELEKARPVTEMEFLEISGVGQRKLEVYGDAFIKAIIDFQKNKIK
KKGSKSATHQVTYELLKDGLSVEAIAAKRDLKDTTVYSHLAKLAQDGADLDLYNYVSPTE
VAQIKTARQELEHPEGLKPYFEHFEEKIPYYKIRLALTLIGMEG
>KECLDBNJ_02065 hypothetical protein
MPKILLFFSLLLTCFIAHSQVGIGTTDPHPDVMLDVNGGLRIRNYNDGSDNAAKDSLVVL
DGRGVVHRIATSTLLANMDKSLVKANISSSASSLLSITIGESLIKFDNTEFDIKGEYNSS
SGYITIENSGIYRITSQILSSSTISGLVLFGLRLKIRKGGVGSFNTAAETNYTGLSAVPR
TISTILELEAGDQIAFYSYNDLSIGVINLSANAYDNYFTIEQVR
>KECLDBNJ_02066 Phosphoribosyl-AMP cyclohydrolase
MEIKYDENGLVPAIIQDAKTKTVLMLGYMNEEAYLKTNTTKRVTFYSRSKQRLWTKGEES
GNFLNLVAIKNDCDNDSLLVTVNPVGPTCHTGTDNCWGEDNKQTFGFLTELEQTIADRKA
NQDNDDSYVASLFRKGINKIAQKVGEEAVEVVIEAKDDNDDLFLNESADLLFHYLILMKA
KGFGLNDIEQVLLDRKK
>KECLDBNJ_02067 Imidazole glycerol phosphate synthase subunit HisF
MLTKRIIPCLDIKNGRTVKGVNFVDLRDAGDPVELAAKYAETGADELVFLDISATEERRK
TLADLVLRVAEKINIPFTVGGGISSVEDVDVLLQNGADKVSINSSAVKNPQLINDLAAKF
GSQCVVVAIDAKQINGKWTVHLVGGKVPTELDLFEWAKEVETRGAGEILFTSMDHDGTKN
GFADEALAKLSTMLNIPIIASGGAGAMQHFADTFVNGKADAALAASVFHFHEIDIPELKQ
VLKENNIPVRI
>KECLDBNJ_02068 hypothetical protein
MNNASTFREELVKNIFYRLDENLRMIRIAFAQITEEEIWLKPNPTLNSIGNLILHLCGNL
TQYGISSLSGASDDRVRDLEFSTESGLLKQELLDKLETTVNQVKATIIQVSDERLIQIKE
VQGYQFSGIGNTIHLVEHFSYHTGQIAFWVKMLKSKDLGFYSNVDLNKRNKKE
>KECLDBNJ_02069 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIDGKCVRLSKGDYNTKKIYNESPLEVAKEFEAHGIQYLHLVDLDGAKSKHI
VNHKVLEQIASQTSLKIDFGGGLKTDDDLRIAFESGASQITGGSIAVKDPETFKSWLQKF
GANKIILGADAKDEKVAVSGWLEESKEELIPFIQGYQKEGVSYVICTDISKDGMLEGPSF
ELYKRILEETKNLKLIASGGISSFDELPKLAELGCEGTIIGKAIYEGRISMKQLENYILG
HE
>KECLDBNJ_02070 Imidazole glycerol phosphate synthase subunit HisH
MKLVIINYGAGNIQSIKFAFERLGVHAILSDDADEIKAADKVIFPGVGEASSAMAKLKAT
GLDKVIPTLKQPVLGICLGMQLMCNHSTEGDTTGLGIFDVNVVKFSNKVKVPQIGWNEIE
SLKTLLFKDIPEHSFMYLVHSFYAPTCDQKIATTTYGVDYASALQKDNFYGVQFHPEKSG
VVGEQILKNFLAL
>KECLDBNJ_02071 Histidine biosynthesis bifunctional protein HisB
MTTETTSKKQKVLFIDRDGTIIKEPPGYQVDAFEKVTFYPKAFTYLGKIAQELDYKLVMI
TNQDGLGTDIFPEDTFWPVHNFILKSFENEGVVFDDVFIDKTFPEDQADTRKPGTGMLTE
FFSEDYDLANSFVLGDRITDIELAKNLGAQGIFISDHTDLGADEITTKREDLDAYIALET
TDWQKIYEFLKLKERTASISRKTNETDIEIKLNLDGTGKSDINTGLAFFDHMLDQIARHG
SMDLKIHVDGDLEVDEHHTIEDTAIALGEVFSKALSNKLGIERYGFCLPMDDCLAQVAID
FGGRNWLVWEADFKREKIGEMPTEMFYHFFKSFTDGARANLNIKAEGTNEHHKIEAIFKA
FAKAIKVAVKRDPDKMVLPSTKGML
>KECLDBNJ_02072 Histidinol-phosphate aminotransferase
MTATTFNLERLIRANVAQLKPYSSARDEFKDFHEDMVFLDANENPFENGVNRYPDPQQLT
LKQHLSSLKRVPVDQILLGNGSDEVLDLLFRAFCEPKQDNVITLPPTYGMYGVLAATNDI
ANREVLLSEDFQPQVAKILDQADHQTKMLFLCSPNNPTANSFKADAIEVLLQNFKGLVVV
DEAYIDFSPEESWTTKLQQYPNLVVTQTLSKAYGLAGIRLGICYASAAIISILNKIKPPY
NVNELTQKRALERVLDDEKVQGEISTILKERDVLSKVLLQVNFVKKVYPSEANFILAKVD
DANKRYDQLIKKGIVVRNRSTQALCENTLRFTVGTTTENEKLITALKELV
>KECLDBNJ_02073 Histidinol dehydrogenase
MNTIVNPERSQWNEILKRPTQTYKQIEKTVLEVFEAIQNDGDVAIEKYTQKFDGISLNSF
EVTPAEITAAVANLDAHLKEAITLAKANIEAFHKAQRTEKIELETAPGVKCWQEKRPIQK
VGLYIPGGTAPLFSTILMLAVPAKIAGCKEVVLCTPPDKEGNINPAILFTAQLCGIDKIF
KVGGIQAIGAMTFGTPSIPKVYKIFGPGNQFVTVAKQMATQFNVSIDMPAGPSELLVVAD
DTAEAAFVASDLLSQAEHGVDSQVILVSTSKDLIKAVAQEVQEQLQALSRKAIAEKAIAN
SKLIFVETKELALELIDEYGPEHFIVATSDNAFYVENIANAGSVFIGNYTPESAGDYASG
TNHTLPTNGYAKQYSGVNLDSFMKSMTFQEITSEGIQNIGKAIELMAAAEGLQAHKNAVT
LRLTQLANSN
>KECLDBNJ_02074 ATP phosphoribosyltransferase
MNKKIRIAIQKSGRLNEDSLQILKDCGISIDNGRDQLKANAANFPLEVFYLRNGDIPQYL
RDGVVDIAIIGENVLIEKGEDIAIAQKLGFSKCRVSLAIPKGVKYDSVSDFEGKKIATSY
PNTVLNYLSKYNVKADLHIINGSVEIAPNIGLADGICDIVSSGSTLFKNNLKEVEVMLTS
EAVLAVSPKIDEERQTILDKLLFRIKAVLKGRDYKYVLLNAPNDRLDEIIALLPGMKSPT
VLPLAEKGWSSVHSVIDKNKFWEVIDNLKDSGAQGILVSDIEKMVL
>KECLDBNJ_02075 hypothetical protein
MKNFLIAFSVFTCWCVVGLYFLNATGAFNNRKSLFVDASSTVESPNSGTIKKQAPGYVLD
SIYQATEPTEQLANRGIYQDSSLAKTGNYDKLIDDIQKRMERNQRAIDEDEERLRLAKLS
KTATTKATKPNADITFRPVFKMARLVRDENASRFLAEVERRLKIKPQAKIEIIGYTDHIG
DDRDNYVIALEQAQKIRLFLIKSLNLPENQVIALSKGEEFPLYPREQEDKIELNNRYELI
FK
>KECLDBNJ_02076 50S ribosomal protein L21
MLHLVLTQTNNDYVSIPLVYIEVIVLMLGAFSIGYFFAYYYQKSKYVKRISNLRQKLSEQ
AGVAIEDPNLEETLPDEDIQIAAKAKKKRFAQDELDKTRTELDFERIGYASYEDADDLQK
IIGIGPYTEEKLNTIGIYTFDQISKFNTRDIEIVTERIQFFPDRIVNDNWVAKAKLLQET
KQQIKLRRDRNVRMKKA
>KECLDBNJ_02077 hypothetical protein
MDRLPKIGIPVIIGVIIVIVLIAKSAVTIDSGEAGVLYKPFGGGVVTDEPPLGEGFQIVA
PWNKVYIYEVRRQELKEIMNVLSSNGLDIKLEASVWYKPQAENLGKLHQEIGEDYLNRIL
LPTIRSAARSVVGRYTPEQLYSSKRDAIQAEIYDETKKIVKDQYIVLDEVLVRDVTLPAT
IKQAIERKLRQEQESLEYEFRLISAQKEAERQVIEAQGKADANKILSQSLNDQILKDKGI
EATLKLSESNNSKVIVIGSGDSGLPIILGNN
>KECLDBNJ_02078 hypothetical protein
MAISTVLYIILLGIMALGIAIFFYFHKPERSKRLRLLLSALRFISIFAVLILLLNPSVKQ
TSYKTIKPKLAVVLDNSESMSFLADSVAIREVFQAILQNEALSERFDLDAYTFGSELNQQ
ERVDFSETQTDIAKSIQALDRIYKDQKYSSLLITDGNTNLGANYRYVATEAREIARHFIV
VGDTSAYEDLRIDQVNVNRYAYIDNQFPVEITASYSGKKEVSAKLSVTHSGTIVHTETLN
LSSQNSSFRSNFYLNADQIGTQRYTVRLDASIDETNLENNTKQFAIEVIDQRSEVLIIYG
VLHPDLGTLKKSIESNQLRSVSLRAINDVKVAELNEADLVLLFEPNARFATVYQELNKLN
KNRFTIIGLQSNLSFLNQNQEAFTLPLRRQSEAVQAIKNESFSAFQISEINFANYPPLEA
IFGEITVAGSSDVLFYQRITGVTTGNPLLGLTELSGRREVFLFGTGIFQWRSQSFLDTGS
FETFDTFIDHLVQYAASNQKRQRLELDYDRFYYGGNAIILNAQYFDKNYVFDPGAQLQVK
IFSENEVLYESPLVYNGTNYSTQLADLEPGTYSFEITVADENLKAKGSFTVIPYTIEHQI
KNADWTTMETVAKETNGSIAPLDRYSELIDSLLDNQEFTPVQRAIEKNVPLIAFSWLLFL
IIASLAAEWFIRKYNGLI
>KECLDBNJ_02079 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKNTIITGASRGIGNGIAKVFAQNGANVAFTYSSSAGPAEELEQELLAMGVKAKA
YKSNAASFEDCQELVKQISADFESIDVLVNNAGITKDNLLMRMGEEDFDQVIEVNLKSIF
NMTKAVQRTMLKQRYGSIINMSSVVGIKGNAGQANYAASKAGIIGFSKSMALELGSRNIR
TNVVAPGFIETEMTAKLDEKVVAGWRDAIPLKRGGTPEDIANACVFLGSDMSAYVTGQVL
QVDGGMLT
>KECLDBNJ_02080 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKDSKIIVQGFTGSEGTFHAGQMIEYGTNVVGGVTPGKGGQTHLDKPVFNTVEDA
VKETGADVSIIFVPPAFAADAIMESADAGIKVIIAITEGIPVADMIKAADYIKDKDCRLI
GPNCPGVITPGEAKVGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVKQGLGITTAIGIGG
DPIIGTTTKEAVELLINDPETEAVVMIGEIGGQLEADAAKWIKASGTKKPVIGFIAGETA
PAGRTMGHAGAIVSGEGESAADKKKILRENGVHVVDSPAEIGKKVAELIG
>KECLDBNJ_02081 hypothetical protein
MSQSAKDLVRGLYESDFFNDSTVLKKFLHQDAELYWNASTGFSKMTYSDIADMSSEMGKS
FISLRSSISHLISEGDKVSARLTYYIQTVENPEEEVGIIHFMAIWELKDGLLYRGYQISQ
PSDDDPQNNDAHIRIKS
>KECLDBNJ_02082 UDP-3-O-acylglucosamine N-acyltransferase
MKFPQKHSLEQIATILGVEYVGAADFPVLGMNEIHVVEPGDIVFVDHPKYYDKALASAAT
VVLINKKVACPAGKALLISEDPFSDFNKLTKFFKPFEKATSSIATTATIGEGTIIQPNCF
IGHNVKIGRDCLIHANVTIYDNAIIGDGVTIHSGTVLGADAFYYKKRETGFDKLLSGGRV
VIEDHVDLGALCTIDKGVTGDTTIGQGSKLDNQVHVGHDTQIGKRVLIAAQSGIAGCVVI
EDDVVIWGQVGIASGITIKEKAVIFAQSGVGRTLEGGKSYLGTPAEDSKKKFRELASIRQ
IPYILEQIKK
>KECLDBNJ_02083 Elongation factor P
MATTSDIRNGMCIHYNHDIYKIVEFLHVKPGKGPAFVRTKLKSVTNGKVLDNTFSAGHKI
EEVRVETKGYQFLYNDGEWYHFMNTDDYTQIRLLESALDQPGLLKEGEVVSIAINTEDGM
PLSVDMPAHVILEVTATEPGVKGNTATNATKPATVETGAEVNVPLFINEGDKIKVETEKG
TYKERIKE
>KECLDBNJ_02084 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTINNNVVIGEGSWIGSNVTIMEGARIGKNVNIFPGA
VISAIPQDKKFDDEDTVTIIGDNTTIRECVTINRGTTDKMKTQIGHDCWIMAYSHIAHDC
IVGDHCIFSNNSTLAGHIVVGDHVVLAGMAAVQQFCTIGSHAFVTGGSLVRKDVPPYVKA
GREPLSYVGINSIGLRRRGFTTEKIREIQDIYRILYQKNYNNTQAVNIIEAEMEATPERD
EILQFIRNSQRGIMKGYFTAN
>KECLDBNJ_02085 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MISKAEGKQKTIAGEVSLTGVGLHTGKNVTLTFKPADENTGMFFKRVDLEGQPIIEANAD
YVVNTQRGTNLEKMGVHIQTSEHVLAACVGLGIDNICIELNASEPPIMDGSSKFFVEAIE
KVGIQEQEASREEYVVTEVISYVDDKSGSEIMLMPADEYQLTTMVDFGTKILGTQNASIK
SISEFKDEISDSRTFSFLHEIEMLLEHGLIKGGDLNNAIVYVDKELSPETMEKLRKAFNK
DNISVKSNGILDNLTLHHPNEAARHKLLDVIGDLALVGMPIKGKVIANKPGHFVNTQFAK
KLKKIIKLEKRNNVPNFDLSKPPVKDIHQIMAMLPHRPPFLLVDKILEITDTGVVGLKNV
TMNEPFFVGHFPGAPVMPGVLQVEAMAQTGGILVLSTVPDPENYLTYFMKIDNVRFKQQV
LPGDTLIFKLDLLSPIRRGICHMQGSAYVNGKLVSEAELMAQIVKVKKD
>KECLDBNJ_02086 UDP-3-O-acylglucosamine N-acyltransferase
MKFTAEQIAGILEGSVDGNPEAEVSKLSKIEDGTTGSLTFLANPKYTPYIYKTKASIAIV
DKNFKPEHDLDVTLIRVDDAYKSFSKLLEYYNQVKLSKSGIEQPVYISESASYGDDIYLG
AFAYLGNNVSIGNNVKIYPNVYIGDNCKIGDNCVIFQGAKIYSDCVLGETVYVHSGAIIG
ADGFGFAPDENGEYSRIPQTGNVIIEDNVDIGAGTTIDRATLGSTIIRKGVKLDNQIQIA
HNVEIGEHTAIAAQTGIAGSTKIGKNCMIGGQVGIVGHLTIGDRVRIQAQSGITRNIKND
EAVQGSPALSYNDFNKSYVHFKNLPSLAEQLNNLEKQKSNDK
>KECLDBNJ_02087 hypothetical protein
MKTPNKLTIINDPIYGFITIPNGLIFNLIEHKYFQRLRRISQMGLSYLVYPGAHHTRFHH
AIGCVHIMQKAMEKLEQKGVEISAEEKEATLVAILLHDIGHGPFSHAMENSIAEGVHHEQ
ISLQFIEYLNSEFNGSLTLALKIFKGTYHRPFLHQLVSGQLDMDRTDYLKRDSFYTGMAE
GNINTDRILAMLNVKDDELMVEEKGIYTIEKFLVARRLMYWQVYLHKTSLVAEQVLVKVL
KRAKALTEAGYKLPASTALGYFLKKKNAEGIFDQEALEVFSKLDDYDIISAMKAWCEEDD
FVLRTLCKTIIDRKLPRIKIKKKPFKTDFIQTERSRVKAHYNISDEEVDYFVFTGTLTNQ
AYTLKKEAINILTKKGKVIDVISASDQLSLKALSKVITKNYICYPKHLN
>KECLDBNJ_02088 Transcriptional regulatory protein SrrA
MSTIKILWVDDEIDLLKPHILFLEKKNYEVTTCQSGTEAIELVEEQNFDVVFLDENMPGL
TGLETLSEIKAKRDTLPVIMITKSEEEYIMEEAIGSKIADYLIKPVNPNQILLSLKKNLD
TSRLVSEKTTLNYQQEFRKIAMDMAQVNSYEEWVELYQKLIYWELELENIEDQSMQEILE
SQKTEANSQFFKFIERNYKDWFSDEDRPTMSHTLFKDKIVPQIKKDDAPVMLIVIDNLRY
DQWKSFEPIISNYYKKESESAYYSILPTATQYARNAIFSGLMPSEMEKQHPDLWLNDTDD
GGKNLNEDKFLEAQLKRLGLSNLNWEYHKITNLKSGKKLVENFNSLKKNDLTVLVYNFVD
MLSHSKTEMEVIKELASNDKSYRSLTESWFKNSPLLEMIQKSQQLGFKIILTTDHGTINV
KNPSKVIGDKNTSLNLRYKTGRSLTYEQKDVLEAKEPKSIHLPTINMSSSFIFAKGDLFF
AYPNNYNHYVSYFRNTYQHGGVSLEEVIIPFIVLNPR
>KECLDBNJ_02089 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MEYTYALDQIDEVAEALIKNLKFSTILFYGDLGAGKTTLIKALVKRLGSADNVSSPTFSL
INEYKTDAGASIFHLDLYRLKDENEAYDLGIEELLETDSLKLIEWPQKINSLLDDEVHSA
RIFSTKDNVRTLEFL
>KECLDBNJ_02090 hypothetical protein
MKLKALLLGLLIAGATAVTYTAQDTNADYAAKKVDPTKIRVPSNG
>KECLDBNJ_02091 hypothetical protein
MQRKKLTQLRSESLLTGSILAAFIAGTPYFFYLYEGFPDVKIWETSFFGFDIRYESGFYQ
SVNVAGWLFFSKLIPLLLLLIWFFTCKHWWYHSLIIPICMYIFQIYSLFNEDIFYKDSVE
IYYLAPLILFAFIFLYTVRMKIFDRIHNIDLSELERVSFKGKIRDEDELTNQYPSFSKED
EQEDDDDDEPLFMG
>KECLDBNJ_02092 Alanine dehydrogenase 2
MIQNSPFTREQLIPQEEKLEIEQRKGSLFIGIPKENHFQEKRVCLTPDAVGALVAHGHRV
LIESQAGENARFTDHDYSENGAEITSDRAKVFGCPMVLKVEPPSLEELEMVNPQTVIISA
LQLKTQKKEYFKILATKRITALAFEFIKDADGTYPAVRALSEIAGTASVLIASELMSRQD
GGNGLMFGNISGVPPVEVVIIGAGTVGEFATRSALGLGANVKVFDNSLTKLRCLQVSVGQ
PLYTSTIQPKNLLKALRRCDVAIGAVRGKDRSPVIVTETMLEYMKPGSIIIDVSIDMGGS
FETSEVTSHDKPTFVKHDVVHYCVPNIPSRYARTSSLSISNIFTPYLLEIGEHGGLENSL
RINKGLKNGLYFYRGILTSKSVADWFDLPFRDINLLFF
>KECLDBNJ_02093 hypothetical protein
MKILYRLGFYLGGFAIGLILLAFFVKGSGVELPSCDYMPNARVLKTIRNNGYTLSEQAEK
QLQELKLDTSDLNTVFLEGEVDFDKSDTRKEPCGFYMIHSQETMPTPITTTLELCDETFE
VLSVIKH
>KECLDBNJ_02094 Proline dehydrogenase 2
MLEQKIFDDTKTAFSLKSDSELERAYFLFKMISLQPLVKIGTAVTRFALNASLPVEGLVR
ATVFDHFCGGVSEKDCVSTIDAMYSKNVHSVLDFSVEGKETESLFDSALERVMSLIDFAK
DRPGMPFSVFKPTGFGRFEVWRKVTENETLSDKEQQEWKRIQERFHKVCKKAKACDIKLL
IDAEESWMQGAVDDLVLEMMQTYNQEKPIVFTTLQCYRWDRLAYLKDLHQDGIEKGYHLG
IKIVRGAYMEKERARAEEKGYDSPICKDKPETDAHFNAMLVYIFDNLEDIWAFIGTHNEE
SNYLAIEIMAQKEIAPDDGRVWFGQLYGMSDHISYNLAKEGYNVTKYVPFGPVKDVMPYL
IRRAEENTSVAGQTNRELSLIQEERRRRKLN
>KECLDBNJ_02095 3-dehydroquinate synthase
MEAIQAKDYQVVFGENGYSNLNAILKEKNYSILFVLVDSNTHEHCLAPFLQNIVTQTTIE
IIEIDPGEEFKNLETCEGVWNVLSELNADRNSALINLGGGVVTDLGGFVACCFKRGIDFI
NIPTTLLAMVDASVGGKTGVDLGPLKNQIGIISNPELVLVDTHFLGTLSVEELRSGYAEM
LKHGLISSEAYWNTVKQAKYTDFESLAELIRQSIAIKNEVVLEDPFEKNRRKSLNYGHTL
GHAIESYFMESDQKERLLHGEAIAIGMILANYLSSELCSLPKSECDVISEAILAFYPSVE
FTEKDIESIITLLKYDKKNSHGKVLFVLLNRIGEVVLNQEASNELIYNAFEYYKKLKKN
>KECLDBNJ_02096 hypothetical protein
MRRVIVDFKKLTPEILALLVDKYPYGYDDDHIISFKNAQNETIECVEVRTADTIYLVKVS
KKLETSMENYDVEDYDDDDLNEPISEIPEKMDEEDEEMVDDESEEDED
>KECLDBNJ_02097 Thioredoxin reductase
MAVERIKCLIIGSGPAGYTAAIYASRADLKPVVYTGMEPGGQLTTTTEVDNFPGYPEGID
GPTMMVQLQQQAERFGTEVRIGMITNVEFSSEEGGIHKATVDNTTEIEAESVIISTGATA
RYLGLPSEQRLRGGGVSACAVCDGFFYKNQRVAIVGGGDTAAEEATYLANICEHVTMLVR
KDEMRASKAMQHRVNSRKNITVLYNTEVEEVVGEQVVEGLKMINNQTKEVSEIEITGLFI
AIGHKPNTDIFKGQLEMDETGYILTEGKSTKTGKPGVFASGDVQDKEYRQAITAAGTGCM
AALDAERYLASVEEKVEA
>KECLDBNJ_02098 Aldose sugar dehydrogenase YliI
MKNFSILLLSVLTTVIACAQNPKEVKDNDVPITVSEAYEYEVIVPDLINPWGMAFLPDGS
LLITEKSGELIHFVNGEKITIDGVPEVYNRGQGGLLDIQLSPNYESDGFIYFTYSSTEGE
AKGGNTALMRAQLSGNSLSNQEVLYKATPNTTKGQHWGSRIVFDDAGHVFFTAGERGERD
INPQDITRDNGKVYRLNLDGSIPTDNPFVGTENAKEAIWSYGHRNPQGMLINPETNEIWV
HEHGPRGGDEINVIKKGANYGWPVITYGINYSGTDITDITKKEGMEQPLYYWVPSIAPSG
MAMVTSDAYPELKGNLLVGSLKFVYLEALYLDENNSVIKREKLLDGVGRVRNVIQGPDGF
VYVGVEGVGIVKLVQN
>KECLDBNJ_02099 Cytochrome c-552
MKTALITLASFAIIIIFSASKGDQSFGTSASVYIPIQKDTSLQNSIKRGKTVYEDFCMQC
HMATGEGIPGAFPPLAKADYLLNNRTKAIHAVKYGLQGPITVNGTDYNSIMAPLGLYDDE
VADVMNYILNSWGNSSDKPVTEKEVAAIEK
>KECLDBNJ_02100 hypothetical protein
MKLSLITLIFLISTVYSTNQTEIKQDNDVLIRGTWELRDFYHYDENEVVDTVATTDGYRQ
IKMYTKDRVMWTRYVPKDSVEWFGYGSYVASDDQLKETLEYGSESMMNVIDTLRIFTFEL
QISENEYSQITVDEEGNRIFSENYKRIE
>KECLDBNJ_02102 hypothetical protein
MKNITITLLFFCMFQMGAQEFTVDADLRQRFEYRHGFTTLFPDNAEPAAFVRQRARLNFN
YSAEKLKLFIAVQDVSTWGDTRQILPADGNDSFMLFQAWAELQLGTHWSTKLGRQVISYD
DQRIFGGLDWAMQGRFHDAALLKYKKERTQLDLGFAFSQQGESILGTTYNIPGFFTYKSM
QYVYFKQSWEQSSFSLLGLNTGFQRFAQEDMTQADGVYYTHTVGSYFTFPVAKLKLSGSA
YYQFGEAYPVDESLSAYQLALNATYKVGSTLLGVGAELLSGSDQGSSDRKSFFPLYGTNH
KFNGFMDYFYVGNHANNVGLNDFHAKAVFKTGERATLLTALHYFTSNGSLAETTDKYLGT
ELDLVYTQPLIKNIKLQLGYSHMFASSNMSLIKNGVTSENTNNWGWALLVINPKLFNHNF
D
>KECLDBNJ_02103 Uroporphyrinogen-III C-methyltransferase
MNTGKLILLGAGPGDPELLTLKGLKALKSADIVLYDALVNPEVLKHCKPETELIFVGKRK
GCYAYHQDQINDLIVDRAQNNAIVVRLKGGDPFIFGRGAEEMLYAAQRGISASVIPGISS
CNAVPALQNIPLTKRGVSESFWVITGTTKAHTLSKDVELAAQSNATVVILMGTSKLNEIL
DLFKAQNKYELPVAIIQNGSLSNEKIAIGTVNTIAQIYKEKQLSNPAIIVLGHVVNHRDQ
MLQIAQQVETQPSAY
>KECLDBNJ_02104 Rubredoxin
MRQQFSRVIVKGGVVSPGELKIILDQAERLDLDTIAFGSRQDILFLTQNKIVDNSSSLRL
VTPDGDRVENIMSSYVTSDLFASTHWLTGDRYLYILEQFQNTPKLKINIVDPKQRVVPLF
TGHLNFIASEQEDYWYLYMRLPHWEKTQMYPVLIYSWDLAQIAEAVERILKEEPQNVEMV
FDLVIDATDLNNKTVSSPLAMDFQPFPYCEGMNRMQSGKYWLGLYWRNNKYDIKFLKGLC
DLCVTSKIGKIALTPFKSFIVKGIPSEDKLAWEKFLGLSGINVRHSMLELNWHLPVANEM
ALNLKQFLVDSFNKQDISTYGLTFGIADFYRSGSYFTSIVIERNKPDVLPVEFEARASFN
IVYARDFDPNTQDYIVHVQDVDQSELPALLMELSQMYFKNLGDKKPAKEVSAPKLQTIKV
AVYQCNSCQTIYDYRFGDQTQNIQPGVLFEKLPNEYCCSLCEGPKENFSKISFMAELNQ
>KECLDBNJ_02105 Nitrate reductase
MQDNSIKSTCSYCGVGCGLLIKKDSKNKVSVEGDPDHPVNKGMLCSKGRNLHYVVNDTSD
RLLYPQMRWSKSHPNLDRVDWDTALERAAHVFKSIIKQHGPDSVGFYVSGQCLTEEYYIA
NKLVKGFLGTNNIDTNSRLCMSSAVVGYKKTFGEDSVPIAYADIELADCFLITGANPAYC
HPILFRRIEAHKEKNPDVKTIAVDPRRTDTAAYADLHLQLLPGTDIILYNAIGRRLLEQG
LVDKDFIDNHTEGFAQYRAQVMQLSLKEAAKQCGVPVADIKKAADIIGISKGFISMWAMG
LNQSVVGTNKNFALLNLSLITGQVGKPGSGPFSLTGQPNAMGGREVGGMANLLAVHKDLM
NENHRREVAHFWGVNEISGKPGYTATQMFEALETGRLKAVWIICTNPSVSLPDVRKVDKA
LQNAKFVVVQDISKRSDTLQYADLILPAAGWLEKEGTMTNSERRISHLPKVVEAPGEARP
DVEILCDFAQKMGFRGFDYYNTSEIYQEYAAMTKGTNIDISYLNYDRLKNEGTFQWPVNT
YRHTGTPRLFEDKKFYTPSKKAVFNIPSTLYNRSIKPDAEYPFVLTTGRVRDQWHTMTKT
GKVSRLKTHYPTPVLEIHPVDAVKLKIREGTICEVASENGNVRVKAKLTDTIRQGVVFLP
MHWGKKLASDLNRTNNLTQNMVDPQSKEPDFKFTAVRVEKYTKKREKIVVIGSGAAAFRF
IQNYRERNTQDIICVFSKEAHPFYNRVLLPEYITEELSWEQLLKIKEQHLSTLDIRLFKN
NSIVDIDKKSRTLKDSQGIYHAYDKLIIATGSRAFVPTDVRLDLPGRFTMRDKLDADRFK
KYLMQSGIPNDQQHVVIVGGGLLGLELAAALRHKSVKITIIQRSSYLMERQLDSIASNML
ANNVQQRGIQIYFDNEVSTVFDAEESHSLEVTLKSGKVLEANAIVYAVGTRPNIEIARKA
GLKMGKGLRVNEYMQTSEASIFALGEIAEFRNQTFGITAAAEEQANILANYLAGDISNPY
KGSVLMNILKFEDLDLCSIGQVSVPKNDPSYEEVIFMDVSKQYYKKCIIKDDLLVGAILM
GDKQEFAEFKNLIDSRIELAEKRELLLRGATKQEPVKGKLICSCSQVGSGNIEEAIRQGC
TDFTALCDQTGAGLGCGSCKTEVREILTEATVKL
>KECLDBNJ_02106 putative nitrate transporter NarT
MKTTITSAKATRLNFRDFTSVPMRTFWITSIAFFLCFFAWFGIVPFMPDVVRDLGLTPAQ
KWNSVILAVSGTVFARLLIGKLCDKYGPRLCYTWLLLLGAIPVILCGLVQTPLQFLICRL
FIGFIGASFVITQVHTSLMFASNIVGTANATSAGWGNMGGGANRLIMPLIAAAIIGLGVA
EADAWRYSLVIAGVICFLMGIVYFFFTKDTPEGNFKEIKAAGKKIKGKKKDEVGFLEALK
DYRVWILFVVYAACFGIELTVYGTMDDYLQNTFNLERITAGNIVLSFALMNLFARTLGGY
FGDRFGKLKGLRGRVLFLVAILAVEGVMLVTFSTITSLLLGIIFLVAFSLSVQMAEGATF
SVVPFINKKAIGSISGIVGAGGNVGAFLAAMLLKSKAAVAEQAAINANSGASEEVIRLAQ
SEAAATAVSSGYFIIGIMVFVIGLLAYAIKFSTADEKNAIEELKLSGQENFIPSNA
>KECLDBNJ_02107 Oxygen regulatory protein NreC
MDTETLKVILADDHVLVRDGIKALLEEEHEIMVIDEASNGKEALQVIKETTPDLLIVDIR
MPEMNGIEVVQAIKNEAIPVKTLVLSMHDSEEYVLQSIQAGADGYLLKGSSKEEFIKALN
TIKNGEKYFAGELSSIIINNFVNGNVSSVPKQETKKESVADAFSLTKREQQILNLVLEGK
SNKEIGEELNISKRTCEVHRFNLMKKLEVKNLMELANKVSAFNIS
>KECLDBNJ_02108 Signal transduction histidine-protein kinase/phosphatase DegS
MASLDQKTFVKLRRLYIIALSLIAVSVFVSQFLVQNFLDDQATDSRVINIAGRQRMLSQK
LTKEAIQLKYPDSKFALRALQDSLAQTRNLWYVSHKALQQGSDSLQIPHIASDTIAKLYE
KINPFFNQILDASSTLIRPSQNTSQSNAEMDSAIQTIQKNEGAFLKLMDQIVDQYELEAA
AKIDRLRTLETLLACLTLLILLGEFIFIFWPTAKVVRNGMLELINAERKALKMAKDADAL
TESKEKLLWESRALNQAMDKTLLFVRTDTSGVLLQAGEQFKKMFKLNSVQENTKFASVIS
NVELEQQNLEKILTEHKKTGWQGEVKGRSPEGDELYLEMSLLPFQKEKSSNELLIILLDI
TKRKEAHEEIERLTKANFEERISRQKNVSRQIIENQEQEQNRIAQDLHDGIGQMLTGLKF
TLESINLKDRDKAQTKIDHLKVLSLDIIKGIRTATFNLTPPELTDHGLVPALIKLAKELT
GLTGKQITLNNTTGFYQRLDSLVEINTYRITQEAVNNAIKYANSTSILVRIRHTEHLLSL
TIEDDGDGFDIEQAQQTKRGDGGMGMTFMRERMNYINGRLFVNSEVGKGTRITLNIPID
>KECLDBNJ_02109 hypothetical protein
MTKLEQAIQKIDALNAQDPNLEKDGDQEVPKELLYSQRMTQHLFAFEPDASEPLQVAARA
QHICRWKSPREDYPMTRVGYLKWREELKKMHAQVTGDLLESLDFEKEFIDRVQFLIKKKR
IKKDQESQTLEDVICLVFLSYYFEDFAAKHETDKVIDIVQKTWAKMSEKGQQAALKLPLS
ATTLDLVGKALA
>KECLDBNJ_02110 Nitrite reductase (NADH) small subunit
MEELLNTYKSVTLEGARTWVQVGHQSDFPQNGGACIKHKNKQIAVYNFSLTQSWYACQNL
CPHKMEMVLSRGMIGDLDGIPKVACPLHKKTFSLENGSNLNGENFKIAVYPVKIQNEMVY
IGFED
>KECLDBNJ_02111 Nitrite reductase [NAD(P)H]
MKKIIVVGNGMVGYKFCEKLSQHPDFEAYEVTVFGEESRPAYDRVHLSEYFSDKSADELL
LAPSGWYASKNINLRTSELVIAIDIDAQTITTHKESQYAYDYLVLATGSSPFVPPIKGAD
KQGVFVYRTIEDLDAMKAYATKLKAAGKKNAAVLGGGLLGLEAANAAKELGLNAHVVEFA
PRLMPRQLDQQASDMLQAKIESLGIGIHLSKATDLIAGEDCISRMDFTDDTHLDVDMLII
SAGIRPRDELARNSGIQVGARGGIYVNEKMQTSVETVYAIGEVALYNEGIYGLVAPGYEM
ADVAVQQITGGDKCMVASIDMSTQLKLIGTEVASFGDPFVENDEIVAITYENKHSGIYKR
INVARDGSRLYGGILVGDSSDYNSLFQIYYNVMKIPENPEDLILGSRGGDNILGSVLDLP
DSAQICSCESVSKGAICKSLEDGSCSGYKDIVSCTKATTGCGGCKPMVTDLVNETLKSLG
KEIKDTVCEHFEFSRQELYDLVKVKKITTFEEALQKIGKGCGCEICKPVLASVFSSIYME
TANKQPAIQDSNDRFLANIQRNGTYSVVPRVPGGEITPEKLIVLGEIAKQYDLYTKITGG
QRIDLFGAQLHELPLIWKALIDAGFESGHAYGKSLRTVKSCVGSTWCRYGMHESVSFAIE
IENRYRGLRSPHKLKGGVSGCIRECAEARGKDFGLIAVDGGWNLYVCGNGGATPKHAILL
AEKLDDATCVKYLDRFLMYYIRTAGPLVRTAPWLEKLDGGIEYLKKVIIEDSLGIADDLE
QEMQGLVNRYECEWKQAIENPEMASRFKHFVNSDDTDDNIEFVALRDQKMPKPWAS
>KECLDBNJ_02112 4-hydroxy-tetrahydrodipicolinate reductase
MIKVFIAGGTGWAGAALCKGVFNHPNMQLVGALSRTHKGEDLAQILQIDSEPIPIYENIE
IALDKVDFDIFVEYTKPNSAKNNILKATEKGKNVIVGTSGLTDADYADIEKAANRFNTSV
LAVGNFALTVVLLQKFSEMAAKYIPNFEIIDYTHEDKIDAPSGTARELAYRLSNVQKPNK
YVTEDELMGDQASRGANLNDVQVHSVRLPGHVISIETIFGLKDEKLSIRHDSGASAEPYV
KGGLLAIEKVGTFKGLKRGLDSIMEF
>KECLDBNJ_02113 putative oxidoreductase
MSKPVNRGVSITGIEEFTNIKLGDPVRDAAGMLGVKEALKHGFKEMGVLRSMGALLKMNQ
KDGFDCPSCAWPDPENRSPVAEYCENGAKALADEATLAKADTNLFKKWSVGELSQLSDYE
LNKFGRLTEPMVLKPDSTHYEPITWEEAYQLIATHLKELHSPDEAIFYTSGRSSNEAAFL
YGTFARAFGTNNLPDCSNMCHESSGVALGETLGIGKGSTVLEDLYEAEVILIAGQNPGTN
HPRMMSALEKCKNNGGKVISINPLEESGLVNFKNPQHLSGTIGSGVQMADLHLPVQINQD
IPLMKLILKKLAVLDGIDHLVFDHAFIEKYTLGYKALMLDLDQYDEQDLLNRCGVSEASI
NKAVAMLRNAKKIIVCWAMGLTQHKNGVENIREFVNLLLLKGALGKPGAGTCPVRGHSNV
QGDRSVGIQHFVDEAMNERIRKHMAFEPPTEKGWDVVESIQAMHEGKAKAFFCLGGNFLM
AASDTKYTAEAIEQCDLTVQISTKLNRSHLVTGKTALILPTLGRSEKDMNGDTKRYFTVE
NSMGKVSQSKGVLKPVAGNLRSEPQIIAELADAYFDSHPLDWKRLSQDYDLIREYIDKVA
KGFEETSKRSEGHGYYLPNNVRNLDFSMLPEGKAQLTVNKLPEHQLDNDELMLMTIRSHD
QFNTTIYGLDDRYRGVYNERRVVFINKEDMKAQGLQKLDVVDLTSSYDGVVRTAHKFLVI
PYEIPKGNVAAYFPETNVLVPYNHYADRSNTPISKSVKVRIVKRIDLSN
>KECLDBNJ_02114 Molybdopterin molybdenumtransferase
MISVAQAQKIVIEKASLLPRTLVPVSKSRQRYLTEAISAPISLPPFRQSAMDGYAFIYEE
GITSLTLAGKVQAGATKVPQLKKGEAIRIFTGAPVPDAANTVIIQEHTQFEDQILHLQKL
PAKGANIRPVGEQVTEGVKVLEQGHAINEASIGFLAGLGITEVSVYSLPKVAVLMTGDEL
QEPGTPLEPNQIYESNGIMLKNALARLGIIEVTLVKAKDTFEETKNSIAQALETHDVLLV
SGGISVGDYDFVQEALKANSVTEHFYKVNQKPGKPLWFGTKDSKSVFGLPGNPASSLTAF
YVYVLPHLRARMGSLSPFLPTRKARLTEAVKNPIGKTLFLKAGVTDDTITPYTGQASSML
NTYALSNALLVVEEDQEMLEKGQQVGYIDLNF
>KECLDBNJ_02115 Molybdenum-pterin-binding protein MopA
MQIKSRVWIEDEGSVFLGYGRIELLKKVQETQSISAAARAMKMSYKKAWGLINAMNSTAK
HPLVVTNTGGKSGGGTYLTDYGKEMIVEFEQLNAACEEFLNEKFKEVNYLGASL
>KECLDBNJ_02116 putative molybdenum cofactor guanylyltransferase
MTESSAHNIPVYILCGGKSSRMGRDKGLAMLQEKHFIDHIISGINEVSKEIVFVTQNSEY
SRFGLPIVNDHYIDKGPLGGIHAALKHTNQERILILSCDIPLLDASVLKRLIAEKKTADI
IFAETATNWHPLIGIYSKRILKNLEAHLEKDQLRLFDFIKTNNYRALNFTAERAFTNINT
PEVLARVEQELN
>KECLDBNJ_02117 hypothetical protein
MEVTLKYFGQLVDVLGTHEETRGIEQHTSAALLDHLKKNNAIGHIPFQLAINQKLIDQDE
NVTLKEGDVIALLPPYAGG
>KECLDBNJ_02118 putative adenylyltransferase/sulfurtransferase MoeZ
MNHYQRQIILPQVGEQGQQKIAEARVLVIGAGGLGCALLPYLAAAGVGHLGIVDGDRIEE
SNLHRQILYTPEHLGAFKVEQAKQVLQKQQPQCTITSYPEYLSGKNALELFDHYNIIVDA
TDRIDVRYLINDAAILTSKPVVYGSIHRFEGQVSVFNYNDGPTYRCLFPKAVEVPSCAEA
GVLGTSVGIIGMLQAAEVMKIILQTGSILSGELLVYNTLTAHQEKFKFSKKESIEITQDF
FDENHNKSENIQVNFKQEFLERAVLLDVRNLEEQPRIKHPSVLEIPLSELSQNKASFKPE
QNYYVFCQSGRRALQAVNYLKENHINNTKPLAENATQLKNLVTSVTIIK
>KECLDBNJ_02119 Molybdopterin synthase catalytic subunit
MKKVFIEGPISSEFIGDAIAKHQSKTSIGAHNIFLGQVRADAVDGKNVAAIEYTCYEELA
NTKLHEIREAAFEKFDLICMHIYHSLGTIKAGEICFFVFVSAVRRKEVYAATEWLVNQVK
EHTPIFGKEIFEDETHQWKVNS
>KECLDBNJ_02120 Cyclic pyranopterin monophosphate synthase
MVDITHKINTLRSATAQATVCVSKQETIDALQRNAVPKGNVFEMAKTAGLFAVKNTHTSI
PDCHPLPVEYTAVDYRIEGLQVFIVITVKTVYKTGVEVEAMHGASVIALTMYDMLKPIDK
GIEINNVKLLHKKGGKSSFKDQNPSRLSAHVIVCSDSISEGKKEDRAGKAIMEKLQASDV
QIQGYEIIPDDLQTIRNKALELSEVVNLLIYTGGTGLSIRDVTPEALEPILERRIPGVEE
AIRKYGQDRMPYAMLSRSVVGTLGNCLVLALPGSTNGAKESMDAVFPHLLHVFKILRGAQ
HQANE
>KECLDBNJ_02121 GTP 3',8-cyclase
MNSTTSILTDTHGRKHSYLRISLSEKCNLRCTYCMPHDGIPLSPRSHLMTADEIETFAKV
FVDHGVTKIRLTGGEPLVRKDFTAILARLAKLPVKLSITTNALLTHRFIEDFKRYGLHDI
NVSLDSLDAEKFKFITRRDQYKKAFENIEQLIQEGFNVKINAVLMKNFNEDEIVDFINLT
RARAINVRFIEFMPFDGNAWNKEKLVSQAEVINRVTDHFGVEALQPLPNEKNFTSRNFKI
EGFQGTFGIISSVTNPFCDSCNRIRLTADGKLKNCLFSNEETNLLKPFREGEKLEALIDA
ALNAKKAVRAGMTDFDQLTNPDLHSNNRSMIAIGG
>KECLDBNJ_02122 Glycogen synthase
MKNFLFVCAENDALAHCKAGGMADVVRDVPRQIAASGDQVHVVVPAYNRLHKNGRLITEL
KFNIRGEATLASIYEVEPKKQIPGITHYVIDHPEIVEGNIAHIYNDDPEEPFFTDAVKYF
IFNTAVAQAVKQNLFDHIDVVHLHDWHTALLLFHRAFHQDFTILKDSKFVYSIHNLSLQG
IRPLNNNFASINNFFPELGYEYDKVKDPRYNDCINLMAVGIRLADKVHTVSPSYMQDIMR
PSHKPEFIGGEGLEEDLRIAFAEGRLHGILNGVNYKNMRVAKKGNLYANILVQIFKWIQE
ESKKYKSDILANTGEKVVHLLLNPPSFVASSVARMTEQKFYFFKRNPEALKAILTHLESQ
NGIFILLGTGEPEYERLMRDISYEHSNFIFINGQSEDIIDSIYLESNLYFMPSLFEPCGI
SQMLAMRNGVLCLVHHTGGLIDTVRDGVDGFAFYGSHIDETVTNMVKAFAHCIEVFQNDR
KRWGIMRRKAKAVRFSWEDSVKKYYDKLYTY
>KECLDBNJ_02123 Small-conductance mechanosensitive channel
MKANHILLLFILLLNFKGFAQDSTNAKSGANLPDSEATVPEDGAFLPNAIQEYNEAYYVI
NRLNMPNGLPPNKLNFQSPQATLEHFISSARNNNFKEASYALNFNLLPNNLTQEEASTLA
EKLYFVLNQRVKIDWGGLSDRPDGQIDISTTTNQAIAGKPMRSIVFGEIDLEGKDVVLRL
QRVKYKEFGAFWLISSNTVENIDGLYETYGPRELDRMMPDWARVRFLNMPVWKVVGTFIL
IVLSYFLGKVSLIFFRRLFRKSEKAWVNTIAKRLATPAGWAIGVIFFYIALNKLISFGGT
FASTLYAILLIAVILSITWFIMRFIDSFMVYVAETKIGDANPEENNEARMMMTYISVARR
VITFVVIIVGISVILSQFRSLEKLGISLIASAGLATVILGVAAQSTLGNIIAGIQIAITR
PARIGDTVIIEDDWGYVEDIRFTYMVVRTWDLRRLVVPLKNIISNTFENWSMTSAHQVRP
IILYADYEIDVDLVRNKFEELLEAEEDWDRDTPPTVQVVGVTENALELRALCSSKDASTT
WDLHCRLREKLIKYICSLENGKHLSKSRIQFENKLPIEKSKTTKESDKEK
>KECLDBNJ_02124 putative transcriptional regulatory protein YebC
MAGHSKWANIKHRKGAQDKKRAKQFTRAIKEITVAIKENNQNGDPDSNPALRNAIQNAKG
VNMPKDTIDRAIKKASGADADSYEQMTFEGYGPHGIAFFIECTTDNTNRTIASVRSIFSK
NGGSLGTNGSLEFLFDRKGVFTLDKNSIERDWELLQLELIEGGAESFENHDDVFVIYTAF
TDFGKMAQHLEELNIETKNAELQRIPLNTIELPLKEAKQILNLAEKFEDEDDVQNVFHTL
EFSEELELALDEEE
>KECLDBNJ_02125 Global nitrogen regulator
MRALLEQHYAHIFEPKLLDEIAKAGILKEVSEGEKLMEIGQYITAMPLLVSGAIKILRED
TQGDELLLYFLEKGDTCALTLSFNRGQRKSEIRAIAELDTVLIMIPIQKMEEWSSNYKSW
RNFIFDSYQNRLMEMLDTIDSIAFMRMDERLLRYLRDKQKLMQSNFLSSTHQDIAYEMHT
SRVVISRLLKKLELEGRIKIQRNKIELIALD
>KECLDBNJ_02126 Aminodeoxychorismate synthase component 1
MRKEKSVEIPQDLPLLQQLVCWANQELVSCLLLSNNQVDAYGAYDYVFAAGAHESLQVST
GTAFEALKAFRKRTQDFLLGYFSYDLKNELEDVKSENLDGLDFPDLFFFQPKKLWLVKKN
EITCLYLPEYANELDADLDKVFSQAFQIENTDASEKPHIQVRFNRDAYCAQVSKMLDHIK
RGDIYEANFCQEFYSEAAIDPVASFLHLNEISEAPFAVFFKNETQYALCSSPERFLAKRG
TQLISQPIKGTAPRSLNATEDAFLARQLAADAKERTENIMITDLVRNDLSKKALKGSVRV
EELCKVYSFKQVHQMISTISAQVDADEDPVALIKMTFPMGSMTGAPKVSAMHIIEQLENH
KRGLYSGSIGYFEPNGDFDFNVMIRSILYNAAKPYVSFSVGSAITAQALPEKEYQECLLK
AKAMREALEL
>KECLDBNJ_02127 hypothetical protein
MNSDQLEGKWKQVKGKFKEEYGDVTEDDTKHAEGKFEQMLGKLQEKTGKTKEEIKDWIDK
Q
>KECLDBNJ_02128 Phosphoserine phosphatase 1
MKKTILLCTLLLAIISCKDTPKATAQAAPVSLDATYYLIRHADKMRGPDAGSDPELNDAG
KQRAQFWAEELSDVDFDAVYSTDYKRTLATAQPTADAQALQVNLYDPTHLYDAEFQQETA
GKTVLVVGHSNTTPAFVNAILGENKYDEIDDALYGYLYVVTVKNGSAQVELKDFNDWSAE
>KECLDBNJ_02129 hypothetical protein
MRTLLLGAIALFIVSCGETAEDLNAESIIAKAIETSGGATIDTSLIAFQFRDKFYRADRN
NGRFKLERCTDAACKDTLDQLTNADFKRFVDQQEVTLSDSLVASLSGGVNSVHYFSVLPY
GLDAKAVKPELVGEATIRGKHYYEVQVTFSEEGGGEDFEDTYMYWINKTDFTVDYLAYNY
HVNEGGTRFREAYNIREVEGIRFADYNNYEPAEKFPPLQSLDSLYTSGSLSLLSKIELED
VTVE
>KECLDBNJ_02130 SsrA-binding protein
MKQANTINIKNKKARFEYEILDKYTAGIKLAGTEIKSIREGKASIAESFCEFQEDELFVI
NMTIQEYSHATYFNHNPKSSRKLLLNRRELNKLHKEVRNSGLTIVPLRLFINDRGLAKMQ
IALAKGKKLYDKRETIKERDTKKRLGQIKKAFNN
>KECLDBNJ_02131 TonB-dependent receptor SusC
MFPKSGLGFYPKNYLLETSFMKQKLLLFLLTLSTFTGTSQITGLVSNTEGEPLPYVNIYQ
KNAATGTTSNGDGNYELAITKPGNYTVVFQFLGFQTKEVEVSVTSFPFELNVTLQEETTS
LDEVFVDATGNPANRIIQAVLEQKPVILDKQKAYTADFYSRGLWRVENAPEKFLGQEIGD
LGGGLDSTRTGIVYLSETISKIAYQAPDDFDETITASKVSGNDNGFSFNSAQEADYSFYE
NTLEINAQLISPLADNAFNYYNYKLLGAFKEGNKLINKIAVTPKRENDRVFSGVIYIVED
DWQLYGAELTTTGKAIQVPFVESLVFKHNFKYDSQTDLWVKISQNIEFSFKLLGFGGNGR
FTAVYSNYDFEPQFERSSFSNEVLRFEPEANKKDSLFWQQIRPVPLTLEERADYQLKDSI
QEKRNSKPYKDSVDAVSNTFGIFDPLLGYSFTNSFERWRISYSGVASTLNFNTVQGFNAT
AGLFYNTWTEEYNQATYASLDANYGLDDDRLRFTGNIAKRFNKINKRTLGITGGTKVQQF
NAQEPISKLVNSISTLFWERNYMKLYELDFARVYYSEELFNGFQFYANAAYEKRSPLFNT
TDQVWIKNSVDYTSNNPLAPLNFDTAAIVPHELAKFNARAVIHFDQKYMSYPDGKFNVSE
SKYPTLTLHFEQAFAASDSGFNFTQIAAQLKQELDIGNKGNLGYTLRGGTFLNGDDISFV
DYQHFQGNQTRIQMQGRHLDGFNLLPYYGFSTNNSYFEGHAEHNFKGFILGKIPGIRSLN
ANLILGAHSLITQEQKPYYEFSAGIGNLGFGKFKFLRVDYVRSINGPNQDGAFVFGLSF
>KECLDBNJ_02132 hypothetical protein
MSKGLLLFFSTMLLVSCVKDKSIAVTQIEGFAPDIMGCSCYYAVDEAHFQKQQFIYIDSY
ETTPAYISINDSLIAVDPKNVQKSEYTLDVEIEEEIQLDQERYHREGTLIITDKNGAVYS
TSIYGECGC
>KECLDBNJ_02133 hypothetical protein
MAEKLQQPEVWLRGPLEDLPVLLQPAAFALMQTNEELPFWLKNFPKEKLWVKPAGRASVG
FHLKHLSGVLDRMLTYAKEEPLSSEQFAYLKAEEAIETNLSVEQLINVFTAKVEEALTYF
KTLEEHQLTESRSVGRKKLPSTLIGLLFHAAEHSQRHLGQLIATASFVKML
>KECLDBNJ_02134 Transcriptional regulatory protein DegU
MKNHVVGVVDDHVLFAQSLQGLINSFNGFEVAFMARNGNDLINKLSTCDKEPDILLLDIN
MPIMNGFETISWLNEHKPEIKTITLSMDDDEETIIKMLKAGSKGYLLKDIHPETLNLALN
QVIERGHYYTDNVTTALLKGVSKKEQDTLLENFSSRELEFMELACSDKTYKEIASEMCLS
PKTIDNYRDTLFKKLEVRSRIGLVLYALKNKIVSNGN
>KECLDBNJ_02135 Sensor protein VraS
MSFDDNILGSFELLIIVCSLVLLAFLMIIIILFSVFQKRKIKFINQRNEAILRYQEEVAR
TQVEIQEETLKNVGRELHDNIGQLISVANLELKIFGANNHLEKEPELIEITNLLGKSLSE
IRALSKNLNNDIITHIGLQESIKNELNRLERLKFLNTAFTIQGAPFSIPKDDTIILFRIV
QEFLSNVIKHAKASSLEVMMLFKDDFLEILAQDDGIGFDQSVTSQGSGLLNMHTRAQMIR
AEFELNSTKNKGTRLKIKYIKV
>KECLDBNJ_02136 hypothetical protein
MEDLSSYSQYLELIALIIGVIKYKEFKDFYFKYVFYFLIYVVANEFLAGISYEVLNIPNT
FLYNIYILIHFSFFLAWFHSLIVSTVKARILKFFFLLYIVFWFGEALTIGTITDNYLSIT
FSLGTLLLIIAVAFYFIEMLTREVVLNITQSPYFWVSFGILTYCVTYLPFYITLMFFLQE
NPVILSVVLFLINCIQYCCIAIAFIKSDRYQMEHPIAKKS
>KECLDBNJ_02137 hypothetical protein
MRCFKVFICGFVTVLFLGCTEQYNTAKPPKGVISIEEAKILDRTFTETRADAINKAIGMP
DSRSSWWSVDDLEAYIAYAKSVAKEKGYNVNGLRVYYGAYPKDYHNAEVSGYSTLFIVPT
GYKAASNEAAVFSINFQEEEEDLEVPPLNMGHLRKPPPGTYQ
>KECLDBNJ_02138 hypothetical protein
MLYESLEILREQVEIYLEEMDLGTNLVTLDSIAHFIDKPNRDNQPLDNKIVVSLLNLQEE
VTLKNQRNYTVQSGKPVYKNTPVFVNAYILFTCNRLEYAFSLRSLAAILQFFQGKNSFNH
KNTLFSRNTQVMQAVKEFQFTIELYTPSFEELNYIWSMNGGKAYPAAIYKLNILSLEREH
VLDEGALLTQVNTNFKHLTS
>KECLDBNJ_02139 hypothetical protein
MSTITTYRPLFQLDIFHKFFLDDGITPFDINETVLEKQLQKYNWNSFGKIVPTAETKVNL
QNHRMLLKPSPLGFVVLIEAELLNDTAPNYTPLIALDQDLKLEFYIQLLDPQFYNYTDLD
PAFDRPLFLSNYATLYNAAAPVYLARHNEESNAKNHSVSEAFKDFLIKKYGDLRTEKPFI
ISLKMRDAGSGLNLILLNGTLPQHTPHFKIVFHNRKTIWRYYSVATKVLIYTTEPEEKPL
VQHGIVPISNAGTDYPTPTPSRIYQDRDTDGSLIKTYSNIYIN
>KECLDBNJ_02140 hypothetical protein
MASSYKTPGVYVEEISVFPPSVAQVETAIPAFIGYTNKVSHKTEQDLLLTPKKIGSMLEF
VSLYGGAPEANINDIQLTASKSVASFTIQDTYYLYDALRLFYANGGGDCYIVSVGKCGED
SIALTALENGLAKIAKVDEPTILVSPDACLLDQADLDSFNQGLLKQCGKLGDRFALLGIK
NDNEDLEVDINAFRNGVGMNSLKYGAAYTPWLKANLPRTVHYKSLKGKISFGGVSVTLAE
LIQDEDAKSLANQLDELIDDSALVSDKLSDLADSSSSVDNQYQELLTTVTTSSSIGNLVS
LLQFYADAIDFIRDIVEVGTDNYKLKHTSATPPDQALQPHLNSVFNTSLTSGSIQTITET
MGDILKSFNDAFTASNVINSTTGVDYVPSSSSTTYFVDTESQSSQIAALLPTVSSFYTEI
KSALDYISSTTANYLSTYETAATEMIPALKSIKNAIAGEYIVLPPSAAIAGVYARTDANR
GVWKAPANTSLNSVVGVTHLIDHDDQQGLNVDTVAGKSINAIRPFTGKGIMVWGARTLAG
NDNEWRYVPVRRFFNMVEESVKKATEQFVFESNDANTWVKVRAMIENFLNLQWRAGALAG
AKPNEAFYVRVGLGETMTAEDILNGIMAIEIGMAVVRPAEFIILKFSHKMQES
>KECLDBNJ_02141 hypothetical protein
MAAIYPLAKFHFLVDWGGTNVGFTEVSGLDVEIEPIEYRHGASPEYSKTKMPGMQKYSNI
TMKRGTFLADNEYFAWWNSVKLNTIERRDITISLLNEEHAPVVVWKVKNAFPIKVQSTDL
KSDANEVAIESIEIVHEGLEIQNGA
>KECLDBNJ_02142 hypothetical protein
MADYYPPVGFHFKVEFGAVSPEIDHQFQSVSGLSVDIETEEYAEGGENRFKHKLPVRTKF
PNLVLKRGLVSDSKLIKWCKDAVENFDFSPTDVTIKLLNNEHEPLVTWNVVHAYPVKWSV
SDFNAEQNSIAIETIELAYNYFKS
>KECLDBNJ_02143 hypothetical protein
MPIEIKELHIKINVSDNANSTAATSTTSSAKKEKLIEACIEQVMRIQERKNER
>KECLDBNJ_02144 hypothetical protein
MALGELFKLKITAFRDIKYSEKVADGVFTSLLNPEKYTLAYKIEYNDDQAAGSSGNDPRF
EKMPPKNLDLEFLFDRTGIIAHNQNHDKDVGVVDDIQQFKEVAFEYSGDEHRPYYLEIRW
GSLLFKGILIEMNIEYKLFNPQGTPLRAVIKARFKETVDPELRLADENRNSPDLTHIRIV
ESGDTLPLMAFRIYGDSKYYLKVAQANGITNFRTLKPGQKIFFPPIIEKTI
>KECLDBNJ_02145 hypothetical protein
MNTATALNTGIVSYKLLINGTDKSASFSIKSMVIHHEVNRIPYASIILVDGDVSTGTFAV
SSSEDLIPGSELEILAGYENDNVSLFTGIVVRHSIKIRESVSMLVVECKHEAVKLTVGPK
SNYFYDSSDSDIIESILGNAGINASVEQSNYTHPQLIQYQTTDWDFIVLRAQINGFLCFL
EGNTIEFKKPDLSTEPIITLEYGLNIYDFDGEIDARNALKTITSYTWNSGDQEVSEKEAS
TSNALELGNLTQMDLAEIVDLENFKLNHGGNLTEEVLQDWADAKLQLHLLSLNRGRIKIQ
GNASVKPGMNVILKGLGDRFNGKAYITAVHHEIANGNWFTNLQYGLSPQWFSETFEVNAQ
PASGIIPAISGLQIGKVTQLQDDPEGAERVLVKIPIINNAEEGIWARIALLDAGLDRGSL
FRPEIDDEVILGFINDDPNDAVILGALHSSINTAPIEAADENNEKGFFTRSGIQFLFNDE
KKSVSITTPGGRSIIINDDDEEIHVDDNGTSSVSLTSDGIALDSSGAITIQAKGDLNLEG
QNISIKAQQDLKAEGAAGAELSTSAIAVLKGSLVQIN
>KECLDBNJ_02146 putative deoxyribonuclease RhsA
MPLAARLNDMHTCPMQTPGTPTVPHVGGPIIGPGEPTVLIEGMPAARVGDNAVCVGPPDV
IASGSTSVLIGGMPAARMGDSTAHGGTISIGAPTVDIGG
>KECLDBNJ_02147 hypothetical protein
MKIEESFLGIGWSFPPEFNKETKNIQMVSAIEDINQSLHILLNTKLGERIMLPNYGSSLS
DFVFEGLNMSTRTYIVDRVKMAILYNERRIELDKIDFDQSRILEGEVLMIVHYTVRLTNS
RGNMVYPFYINEGTELK
>KECLDBNJ_02148 hypothetical protein
MSTNCINSFLNALSGTSQEDRTAAAPNPASVQLNDLSWEDYMQLAYNFAKEVKYFGTRNP
EQAIGDWQTFFISGDAKTLQNYLEQGEKEHTITPHLALFISFLRLLEHSKNRFNTITTRH
LDFYYSEVLKIAKKPAQNDQVHLLFELAKNIESYALPEATQAVAGKDEHNKPLLYATEQT
TVINKAQLANIRSNYKDPITKVLKATQKTNTLDGIDQELKEEQFWMPFGYPKTFKNRPEL
PNATLGFAVAATVLNLESGLRQVRISTFYKENKKIDSEEFINLLEVFVTGEKGWIGPIRL
QEKGSYPGFETSSESGIINFAFSLEASEKAIVGFDEAIHTGNFKNGIPVVKLQLSINSTE
SYDLAQSLSELILDDVEIAVAVDGLTTLDLSNDIGNLSASKPFYPFGPRPFEKSRFKIKC
SELTTKNWLQINLRLNWLNLPQSFRDHYLGYRSGTINSTRAFVESIYKIGSKTEVTELAK
LPKTWNSDLDNLIVESNDHFSAQITIADENRLFSTSQSKDTHPLFTEGASQTNINIKSLS
ENGIQSGEHPIELTLNTSFYHTLYPKLYALALAAQDPEVIIPNEPYTPLLESLELSYYAT
QRLDLTSDKQAEETDQQLNFYQIHPYGVSMGTTVFPQYEEGGYLYLALENAQPGAQVSFL
FQLQEGTENPLKESFAEQEKIEWSVLTASGWQALTDQEILREETDNFLKTGIITLALPES
ASTESLLMPKGFIWLRAHTSRAFDVVCRFINIHTQVVKAHLASASFQHLKNGLPAESISK
LNTRVASIKKVMQPYSSFNGRTQESQADYYRRVSERLRHKDRALNLWDYEHLVLQNFPEI
YKVKCLNHTCKTKFKAAGKVTLVVIPNTVNKPVFDLFEPRSSTAKLNEIQEFLIERTSYF
ITPQIINPQYEPVSVALKVKFHKGYDEHHYKNELQEAVKKWLSPWAYEEVSLLTFGVSIN
KSMLISHLEQLSYVDYLSDVVLMHQATPKNEIVPSSPKAILVSAKTHTIDLAKSTCKSNE
NTVLVSC
>KECLDBNJ_02149 hypothetical protein
MLGLQEHISLSKNTSTQDDLDFEFLRKSGIAYIESLSSKLWTDYNSHDPGITILEVLCYA
LTDLGQRMSLPIETLIAHKQEDNLDQFHKASDILSCKPVTHLDYRKLFIDVPGVRNAWLI
KHNKKLYINTKDAKLSYRSFLKNTSYSYLKPQDEHTTILNGLYDLIVDLDGTRSINSLRP
ELMKRYQTNRNLCEDLIHITEVGEHPIKICAQLELEPEADENLVKATVLQKIDQYLTPSI
RPKTLAQLLELGLETQEIFNGPVLENGFLDSNEVKAAQLRTEVRQSDLIAILTKIDGIKY
VKAISIGACSDQTPPPDNWGICIENGKKPVLCDKSSWSFFKGFIPLVPDENKVKAYQTAF
EEQELLVSTQIKSASQDLDIPKGIFTNLAETSSIQNDLPEVYGIGPYGLKSNASKADKVK
AKQLKAYLLFFDQLLANYFKHLSTVGNLLSVAGDKSQNFFAQPLTDIKGLEELLREPQNY
NDEEKLSDLFYSDYTARNSEKRHEIVDHLLSRFAEDFGNYAFLTQKIYGDLANDAVLDTK
ERLLKQYAESSYARGAAFNWYQQPEAQLWETDNISALQKRLYLLLGITDINRRNLSEDYV
EIYEEKDADNKLEYRWRIKDGSKTILSSATKNYASLEALHQELILVKRYATDPSNYKFRK
IKKKNPEDQVKWYFVLVNPTITNTKSEDYIIARRIAQFNSRANARKASRAVLNLVKSFAG
NEGMYLIEHILLRPDITKNTAPEHTFLPICKEQIEEACEPLDPYSFRVSIVLPGWTERFG
NIDFRRYVEDLICRELPSHILPKICWIGYPKNYTEPDGNPPKENEMVLLEAAYKNWLLSK
TNAGQKQDETALTSLNKVLSSLHTIYHQGRLYSCTPSPSNTYEQKTNQKVILGRTHLGKL
>KECLDBNJ_02150 hypothetical protein
MRPILHQITPDYRAFVDDQVLTSGQLNEFLDYFEDQQRLTRICLNGVGIACGFEVSLNAA
TKTIAITPGCGITTDGDLIKLLVDTKKTPTDESTQNLIYKTLAKEAIHYTHFRSFEDDFA
QYEAFRTTSLNSDTYTTIPLYELVPKGSSKTTDKALTTLDLTDKIVVLYLESYAKTPDIC
TETNCDNLGEQHVQKLKVLLVEEKDIEYLLANDSIYRKYDILDVYKKLPPIKMPRVLLNS
GAKEIETPLKVDLSDLFDLTNIRKNLVISNNALSPLKNSFSSVKTPALDIGYNSLSASNT
AIKNFTPVLNSNTKTTVNTKTYSALVSAYAEKINTVVPQLQSALKTITDHFSQLLGLNIS
EDFEQSIKALENHLEQNNGDIQYLYDHLCDLVKIYNELRDLLLDIQSDCCPNIDAFPKHL
ILGRPNDTSRSIAYRHHFYPATTEITGKLPVKKAHFLVRKMLLLLKAFNPETQLGADITP
STSISTENAACAIPFYYNPSEDLVFQWDFKLTQRFNEAFQLSYFKKYLSPINAVQEPLKY
DLSNYDFLRIEGIHGMPYDEALKEVSKLKNDYGLNFDIKAINIDQQIEDIDMDAYACHFN
YLDTDLKTWRQEQNCINKDITEFFSGFNMDDLGSHNYAFEQFDRDDLLDKEVLIDPDKIK
KPTDLLFSNNQLSLLGKLNINANLLAARDKTDREPLITLLDKAQEKISTGASIEDMVSEY
QSSFVVLGEKLEVLNSIEPKSYSKLSTEKNTVQPVLLKASKTVEPVSPVVLNTGVKAYTP
FITETKVNATVTDNLKTKTSDLGFIMNTVLDKNFIGSATEIEKAIDLKRKELYPKIDPEQ
QNLLKVGFTIPNGILARLQIVSSYIPESLDQVNADTKEKYAAAMDDLCAYTKKSRAIINE
IFYNPKAEYTHIGYETLYTFMLDRLEANCCAASSLDIILSEIQTKKEEILDKLIFSNFAR
KHPGLEHKAGVPIGGTFVMVYTGAISNESDKEIPRNTVVADFALPYLCCSDCSPIGFIIQ
EAATSSSLILNQNEVCIDTNAETEIKIGFTKSPTDGVLALLNKNIEGISFSETELIITPY
QLNAFDTPIQFTVNGQLTTANLTATKKPQARITTNPERVSGLPGSTLPPVQFSIENLNNF
NTDLFSFNWTINGTSYTNERPTVNLPIPQHIDSKILEIPVTLTLSNDLCDSTTIEYTLEV
AIDAPKEIQVILKDEPFCSNDQEKYPFTITPEGSEIKLLNDDVKGIYGEGDSWYFIPAEA
GPGKHNITFAEVDPITIEVFKAPETVHFEAELHNKVMVLRITEDIQAEAFSWFNDAKLIA
TTLEPVLEIPQEQKEQLFKIQVVVKTSACGTLESEHKEVRIPALETDSPDPDPTPDPTPE
PDPETDTCTDEVLEKLNTNKKEIETALKQIDDQQVKDAGQKIIAIYDTLINKPDLFKGEY
DAAFAKKLETAFTELSELLFKNKPEQRQPYFSLYLKQQELFYLSIYCRDKQFLDNDLIFS
ILNLIENHFNPQFDIAISLLEGINYKNWYALLNDYSSHFKVDRYQNHFDQLLQWTS
>KECLDBNJ_02151 hypothetical protein
MITQPTHIINKVFVEVDCNSMEEALRLKQNLGQFIIEKLSTHLSKAFDELGTSDEFYTID
KVAVSFEKDFLKESNLSEITNKIHTITTETLSLSRNDLSNKNQIINDQKERNYKAFIYFL
EKGRYPWFFAEKETLNLKELTSFLKEAQPHSLTECLSKTEAQKRLVYQFGEHPKFMLTVW
RTYAELKKLPKSRVNGLVALVSKVEEKNIFEELGSSLFQYDRLSIPEHERRLIKHFEFYK
SKSGLSLDTLQSLSNFFNLKIGISFSPKVLIASFQSLEKATLVFQPSEKISFPKSNSLSK
KEIEERLKSIPVKFQNQRALLDSDDIIEEQQLIEHNPVETDESQGLILPNCGLILLHPFL
SILFEELGVLSSQKQIAEEHYDLVVQLLHFIATGEENISEQQLGAAKQLCGVFSSYPIKK
ENVLQEKHKKEALNLIQTVLNYWSALKNTTASGLRGQFLTRSGKWVTTDEKIELFIERQT
ADILLDQLPWGLSMVKLPWLKKMIYVTW
>KECLDBNJ_02152 hypothetical protein
MKTLKLLSSSLLICFLLSSCGTSFYDQYSFTETLETKANALSLVEVSDQEYQQRKAAAQA
LINKIDMMVSYEKAKSKNEITIQMWQYLQSDASSIQQFLNLWETQGTLSPAFKAEFKPQV
AKIFDLMANYKN
>KECLDBNJ_02153 hypothetical protein
MDFKELYKSIKAGILDLVKERFDEESSLIKNDIDLFLEQSKDKLERWMLLLNQGAITPAE
FELLLQSQKDLLIIQTLEKAGVSKIKIGLFKNAAIKLIVSKAVTLIL
>KECLDBNJ_02154 hypothetical protein
MPAFAKNRTPSTDIKKPSKAAFFKVQAKLKMGHSGDKYEQEADTVAQQVVENTHGNSATK
VQQKPLAQTIKPGIQLKALEEDQIQKKSEEEETVQAKEEEETVQAKTEENEEETLQAKLQ
ATATPSTSIQERLKNNKHNGEPMAPATQTRMEQNFGTNLSDVRIHTDANAQKMSADLGAQ
AFTSGRDIYFNEGKYAPGSPEGDGLLAHELTHTIQQGAIAANKSLTTNPSKPKKTTVSSS
ETAVPKQDSVSEPVKQNSEETKKEQFQSQENSAQTETQDPSYPASAQENEAFQELTESIT
NRSRAAQTTPDAEVSAQAGSAAAPRAANEQMGGAQANQVEVMNAQEPGVFNALSFKSRLM
ERIEAMQLPANEEEADDFESNNNIDSVTQAGVGMANAESQQASGAIDQATSTAPDPNSVA
QREVANIPEAPVGQRPAPVNANAAAPPPRPDSLVQAPLQQNVNEIDQQLEANQVTEDMLH
NSNEPTFDNALNATNEARDHANQAPVAFGASEQASLTSAQNSAQQNSSAQLNAMYNSRAS
SLGNAQLDQQNTATANSAARERIASEINTLFESTKNAVETILSELEEQVASKFTTAAEKA
KKVFEDYVARKMDAYKAERYSGLGGAVTWVGDAFTGLPEEVNAFFEEGREKYIEAMDSEL
TSIAEYIAHKLTEAKTKITEGKQQIADYVGSQPQELQDIAEEAAGTIQSRFDDLEHAVNS
KQDELIESLAQQYQESLAEVDARIEEMQAENRGLIDMAMGAVMGVIQTIINIKNMLTNLL
SAALDAIGAIISDPIGFLMNLIRGVKEGFLNFGTNIMTHLMNGLVTWLTGALGPMGITIP
EDIFSLKGIFSLVMQVLGLTWDYMRQKAVKLLGEPVVQALEFGFELFQIIRTEGIAGIWE
YIKEQFTDLKETVIEGIQDMIITTVVDAGIKWVLGLMSPAGAFVKAAMMIIDIVKFFIER
GSQIMALVNAFIEGVKAVASGNVGAIASKIEEALGRAVPVIIGFLASLLGISGLACKVQN
LIQRIRQRIDKAIDKLILKAKKAFKKLGNKVKSGVQKFIEWWRVKKKFRGQDDKTHTLYF
EGDESNPVLTVASNPTPFTTFISSVVIGEDPKGEKQKAKNEAVQIATEIDTTKRAPLKGT
TEEAKNKSRLDKKEKLEALLSDLSKRAEKLFGLDVSELPTTKIFKQDATTKGDDTVGTEM
IAEPLTQKGSGGSIPTSRKHKLFDKLLKRRLGGSSYYIRGHLLNHNTHGPGKWTNMTPLS
KEGNKNHESLVESLVKAAVSSGAIVKYSVKPDYSRNELATPSSASADIQEIREAEQHVPT
KLVCEAIIIRKKENSFEKTQEIVKKNVDNPIDTTITNYQLDSEKKQPVKLKTDTKDHIAA
NTSGISRVSINRIKDAVDIIDNLKYYDQIIAILNSPAAEAGVEKLRAMNNVTLN
>KECLDBNJ_02155 hypothetical protein
MKTLRYRSRDQEVYFLEELLQKMGYEIYVSTYFGVDTDKAVKDFQQKNDLVVDGIVGLKT
WSKLLAQENQIFDSNSKLLSEQDLIDFAQRYDLELAAVKAVNEIESNGKGFLVGDKPRIL
FEGHIFWRQLEAKGIDPKNYVSEESANVLYKKWTRKYYVGGIGEYDRMNKAAALDDHPDF
KAATKASASWGMFQIMGYHFKSLGYASVDAFVEKMFEHEREHLAAFGKFLEVNKLLKHLR
SKNWAAFARGYNGPGYAANKYDIKLAKAYAKYS
>KECLDBNJ_02156 ATP-dependent zinc metalloprotease FtsH
MSTTQCLGFDTIMQHLQELIIWRLKNPDLSFDEAPQLDRKALPDSLLKQLIIVLELDAAE
IAILLLVLAPNLSPELLKFCVNQVYPDGGELPELGGIQGKNHRGILPTAETALFILTGTN
IEARVRCWQYFDKHSKLIANKVIQLEKPEKNEPKMSGALILDAEYTALLITGNIPEPELS
IEFPASKIETQLTWDDLVLNDETRQEIRDLEIWLKHNETLQQKHHTTNRFKQGYRVLFHG
PPGTGKTLTASLLGKYTDREVYRIDLSTVVSKYIGETEKNLAKLFDKAHYKNWILFFDEA
DAIFGKRTQVRDAHDKYANQEVSYLLQRLEEHPGLVILASNFKNNVDAAFTRRFQALVYF
APPGYQERLELWKKTLPKKFKYAQEIDLKTIAKTYDITGAHITNVIHYCCLQALNQDSLT
ITSKNLIAGLKREYKKEEKMF
>KECLDBNJ_02157 hypothetical protein
MAFSGVYPHYITKAEKKGRTKEEVDQIIIWLTGYDQTALNRILAEKTNFETFFEEAPQLN
PNVSKITGVICGHRIENIEDPLMKKVRYLDKLIDELAKGKTMERILRK
>KECLDBNJ_02158 hypothetical protein
MEEYKTIASTFLKEVAFGNIDLAFKKYVAEDFMHHNQYFEGSRDALMQAMKEDHKTNPNL
DFEIKKVYADGNTVITHSLVSKQTMQIAVVHISRFENNRIVELWDLGQIIEKDSPNKYGL
F
>KECLDBNJ_02159 hypothetical protein
MVKFYYSFIIILLLSVVNTSIAQTVDRPRVLVTTDGEADDRASMVRFLLTSNEFEVEGIV
NSSSQFHWEGGQGWNAFHPVTWVKEYIDLYAQVYPNLQTHDTLFPHPDYLQSIWKVGNIT
EIGEFQKRTEGVKFIAETLLDTNDHRPIWVQAWGGTNTIARALKIIEEDHPEKMKYVARK
LRLFMIWEQDQSYQEYIRPHWEHLNITTIISDQFDCIAYIWPKVLPKTIQTYFKKYWMTT
NIIEGHGALCNAYENNQGAFNAEGDTPAFLHTILNGLRSMESPDYGGWGGRYIKVRNNVW
MDPLPDSSFTRPKKQWGFENSWSKLMENRTSPEAIRTRTQYFKSTWRWLPEVQNDFAARA
DWCVKPFDAANHHPIVKLKKSALSVRTKAGATLKFDASQSIDPDGDQLHFTWWHYNEADT
YSGKTITGSKTSKFIFKIPYDVEIGDTLHIICEVKDSGTPALTRYKRILITISE
>KECLDBNJ_02160 Glucan 1,4-alpha-glucosidase SusB
MHKLSYTFVIFAMLFMSSCEEQKSKENYSLSSPDEKNTVTFSLTEAGKPTYTIAHDGVVV
VDTSAMGFDLKDLDALSEDFEIIKTETSTADETWQMPWGEQLEVRNHYNELIIYLQETSE
NKRKLNIHFKAYNDGIGFRYEFPEQENLNEFIIADENTDFNLTGDHKTWWIPGDWDIYEH
LYSETKFSEIDALAKANNPDLNASYIPENAVNTPVTMKTADGLYLSFHEADLTDYAGMTL
KVNPSQHKMISELVGSERLGGKAQIKAPFNTPWRTIQIADRAGDLIESKMILNLNDPNEL
GDVDYFTPMKYVGIWWEMHIGKSTWDMEGTQDMNTFTVGEKGSSQHGATTANAKKYIDFA
SENGIKGLLVEGWNTGWDKWINTDDREGVFDFITPYPDYDFDEVMAYAKDKGVEVIMHHE
TSAAPLTYVKQMDAAYDFMKANGINSVKTGYVGKIIPKGEYHHGQWMVKHYQKVLDETAK
KKIAVNAHEPIKATGKRRTYPNAIAREGLRGQEFNAWASDGGNPPAHLPTVAFTRMLSGP
IDFTPGVFNIKFDDYKKENRVNTTLAHQLGLYVVIYSPIQMACDLPEHYMVNGKVHPAFQ
FISDVGVDWQQSKVLDGEVGDFVVIARQERETNNWFIGGITDENQRDFTIDFDFLEAGKT
YEAKLYKDGPEADWENNPQDYAIETLQIDSTTSLDIAMASGGGFAMSLISQN
>KECLDBNJ_02161 hypothetical protein
MNWIYDPWPWYVSGPLIALTMFILLFVGKQFGMSSNLRTLCSAAGAGRKSDFFKFNWKEE
RWNLTVMLGAFLGGFIASQYLSDNTVTIAEDVVAKLQSYGIQSAGNEYLPSELFSLENLS
DPKILLILIIGGFLVGFGARYAGGCTSGHAISGLSNLQLPSLIAVIGFFAGGLIMIHLIF
PLIFA
>KECLDBNJ_02162 hypothetical protein
MKTIVYLLIGTFFGILMYKSEAASWFRIFEMFEFGAFHMYGIIGSALVLGVIGVQIIKKF
NLKALGGQEMRLKPKDKSVARYAIGGVLFGLGWALAGACPGPMYVLTGAGYVSIMIVILG
ALLGTFVYGLIKHKLPH
>KECLDBNJ_02163 Uridine kinase
MLIIGIAGGTGSGKTTVVNQIVQELPEGEVTVISQDSYYRDNSHLSYDERIKINFDHPKS
IDFELLCKHLEQLKKGETIEQPVYSFVKHNRTSDKVITHPRKVVIVEGILILTHPEIRQL
FDIKIFVHADSDERLIRRLKRDIAERGRDLDEVLTRYQTTLKPMHQQFIEPTKEYADIII
PYNRYNNVAIDIVRSIINQRLV
>KECLDBNJ_02164 Cell division protein FtsL
MSLLKKLRQKRWFRILGNKYVLILVIFTIWMVFFDTNSWFIHKELNDEIDKLEGNRAYFK
QEIKSDRDQINKLKDSEELERFAREEYYMKKENEELFIIEYEDSLKTKDDE
>KECLDBNJ_02165 Methylmalonyl-CoA mutase
MSKPLFSEFPPVSAKAFKQKIQYDLDGAEYNETLVWNAPEGISVKPFYHREETQVLPIPG
QPENWSCVEEIFILKPQTAAATASRALTKGAEAIYFKADNTFDSAQLLEHLPQESLVLYF
NFSFLDVSFCETLIDQAAAKGFTVYLNLDIFGNLARSGNWYASQKKDHQALEKLFLNGKN
DNVIGVDVSLYHNAGATVIQELAYVLSHLNEYFNHFGETLKNQKVTFKVALSSNYFFEIA
KLRALRLLVATLAREYGLQENCHILAIPGKRNKTLYDYNTNLLRTTTEVMSGILGGANAI
CNTAYDAVYHKTNDFGQRIARNQLLILKNESHFDNTTNPADGTYYVENLTKQFAEKALVL
FKEIEAGGGFVTQLIEGKIQKKIKEAAAKEQKAFDDQQKILVGTNAYVNSADKMNDELEL
YPFVKINLRKTLLEPIIPKRLAEQLEQKRLKDE
>KECLDBNJ_02166 Methylmalonyl-CoA mutase large subunit
MSRKNLQHLSISHTFKAESVKNIRPEHKAPEHLDFAAGIPPYLRGPYSTMYVRKPWTIRQ
YAGFSTAEESNAFYRRNLKAGQKGLSVAFDLATHRGYDSDHERVEGDVGKAGVAIDTVED
MKLLFDQIPLDKMSVSMTMNGAVLPILAFYIVAAEEQGVSTEQLQGTIQNDILKEFMVRN
TYVYPPAPSMRIISDIFKYTSANMPKFNSISISGYHMQEAGATPEIELAYTLADGLEYIR
TGIDAGLKIDDFAPRLSFFWGIGMQHFEEIAKMRAARMLWAKIVKQFNPKNPKSLSLRTH
CQTSGWSLTEQDPFNNVARTTIEAAAAVFGGTQSLHTNALDEAIALPTDFSARIARNTQL
YLQKETAITRTVDPWAGSYYVEELTEKIAHKAWDLIQEVEALGGMTKAIEKGIPKLRIEE
AAARKQARIDSEKDVIIGVNKFALDQEDELITLEVDNAAVKENQLQRLASVKSSRDTKAV
TQALQALTDCAKSEQGNLLTLAVEAARKRATLGEISAALEAVFGRYKAQTKSFSGVYSKE
IKNDEAFKKAQQLADEFAVLEGRRPRIMIAKMGQDGHDRGAKVVATSYADVGFDVDIAPL
FQTPKEVAKQAVENDVHILGVSSLAGGHKTLVPQVIKELQQLNREDIMVIVGGVIPRKDY
EFLFQSGAVAVFGPGSKISEAAISILEILLKTFED
>KECLDBNJ_02167 putative 2,4-dienoyl-CoA reductase
MNFKNKMLRDDALKGKTIVVTGGGSGLGKAMTKYFLELGAQVAITSRNLEKLQTTAEALE
SETGGTCFPVQCDVRDYEQVVAMRDAVLDRFGSIDVLLNNAAGNFISPTERLSANAFDVV
IDIVLKGSKNCTLAFGKHWIDKKEENKTILNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGIRSNAIAPGPFPTRGAWDRLLPGDLAEKFDLSKKVPLRRVGDHQELANLAA
YLVSDFSAYVNGEVITIDGGEWLEGAGQFNLLQDIPEELWDQLEAMVIAKRNKS
>KECLDBNJ_02168 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANATSGLGIDVETIEMGT
YQLLEHSSKAEETIMKTESPNLDLIPAHIDLVAIEIELVDMDQREYMLARAIRHLKDTYD
YILIDCAPSLGLLTLNALTASDSVIIPIQCEYFALEGLGKLLNTIKSVQKIHNSSLDIEG
LLLTMFDSRLRLSNQVVEEVQKHFDEMVFDTIIQRNVRLSEAPSYGESIINYDAGSKGAA
NYLSLAQEIITKNDA
>KECLDBNJ_02169 putative chromosome-partitioning protein ParB
MAKAVKKQALGRGLSALLKDPENDIKAAGDKGADKVVGNIVELELANIEVNPFQPRSSFN
EDALKELASSIRELGVIQPITVRKIEFGKYQLVSGERRFRASKLVGLETVPAYIRIANDQ
ESLEMALVENIQREDLDPIEIALSYERLIEEINLTQEQMSERVGKNRSTIANYLRLLKLD
PIIQTGMRDGFLSMGHGRALINIENTSDQLDIYEKIIQDSLSVRATEALVKNYKEGKKSG
KATPIKTKVPEFIQEGKKEFASYFGAKVDIKVASKGNGKLIISFSSEEDFKRLKKLISGA
E
>KECLDBNJ_02170 hypothetical protein
MPNKLIILAALLIFSFSFSQETPEEEPQIEAEEIDAAFQEYDALKPAKAAFYAAVLPGLG
QAYNKDYWKIPIVYGALGTGVGIAVYNHDLFKQYRSAYKDRIAGRIDEFTIVDEDGNTTE
LFTEDQLLRAQDFYRRNKELAILISAGLYVLQILEANVDAHLSQYEVEDRLSFAPFMERN
EFDFSNTFGMRITYTF
>KECLDBNJ_02171 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGRMGKTIEKLAQERGHEIVKTIDANDDYDFNGAEVAIDFSVPTAAVANISAC
LNANVPVVSGTTGWLDHYDEMVALCKKNNGGFIYASNFSVGVNIFFELNKQLAKMMQGLK
DYNVSMTEVHHIHKLDAPSGTAITLAEGILEHSDKTDWVLDAEENDKISIKAEREGEVPG
THIINYGSQVDEITIEHRAHNRNGFALGAIIAAEWLKDKTGVYSMKDVLNLS
>KECLDBNJ_02172 Signal peptidase I
MTMMQWFLFFLLVQVIHFLGTWKLYKKAGRQAWEAIVPVYNAIVLMQIIGRPKWWTILLF
IPIVNLIMFPVIWVETARSFGKNSTTDTLLVIVTLGFYLYYLNYAAPVTYKTERSLVAKS
AFGEWVSSILFAVVAATIVHTYVMQPFTIPTGSLERTLLIGDFLFVSKFHYGARTPMTTV
SFPMVHDTIPGLGIKSYLDKPHLPYFRLPGFQDIERSDIVVFSWPVDTVNRFYGLDDGKY
YHKPIDKKSNYVKRAVGLPGDSLKVVDGKVYVNNNPLELPGRAQLQYSYQGTAKGGGFNA
KNLYDQYKISNLKFYNSTQFFTQALTAENAERFRNHPNVASLEKLIAGTDQKDPSIFPKG
NASLGNRDQIASVYIPKKGTTTPISVENLPLYKRLIEVYEGEEMGEVREISVEVNQVLLN
GEPLSEYTFQQDYYWMMGDNRHNSEDSRFWGFVPENHIVGKPVFIWFSWDSNGTGIMEKI
RWERLFTTVGGDGKPVSYFIYFIIALVAYFVISKVIKIRKAKS
>KECLDBNJ_02173 FKBP-type peptidyl-prolyl cis-trans isomerase SlyD
MPPLFYSFRTMETQEKNTQRSVKNNDTVQVHYTGKLTNGQIFDSSVDKQPLEFQLGQGQI
IPGFEKGLIDMTVSEKKTITIPEAEAYGEVRKDLFQEVPKADLPQEIDPQVGMGLVAKNP
DGTERQLRVAEVRNESIVIDANHPLAGQDLIFELEVVDIK
>KECLDBNJ_02174 Outer membrane porin F
MNTVALVGATILTVSCVSKKKYTELETKYDNTRVSLTKTQVEKEELEAKYSAIENRVADY
NSKINSLRDDNYQKLDLVENLAVMSESTKDKMRQTLRNVDQNELSQAKSLEDSMNLAISY
NLKKNLDNSVGEDEDIQVDIDETVVMINVSDKLLFNSGSYRVSNKADGLLQRLADVINSE
PAIEVMVEGHTDDQTVKPGAYIKDNWELSVERSTAIIRELQDKYDVDPSKLIAAGRSSYL
PLVDNATKEDRAKNRRTRIVILPNLDKFLSMVSSTD
>KECLDBNJ_02175 hypothetical protein
MRVEDSPLIDFIREEHRFSFGTFYFFDNFIISEINEGELFDWNKASEVIRVGQEFYGEEG
QINYISNRIHDYAIKPQDWLRFLYERQLFKTFAVVTYRKTAIYNLVIERFFYKGDIFSFD
SLLEAVNFIREQNALEPANDFDKLTQLYNDNSL
>KECLDBNJ_02176 hypothetical protein
MIILYELALICAGILLAINTLDKWDGSTQLFAKIADALKPFAAVIGGIALILGIWFLFRP
FCTFRDIVAVLAGLALLGGTFENHPSLQNFFNKAASVLNPYRVIIGLVALILGLLGLFNI
AFIC
>KECLDBNJ_02177 putative oxidoreductase
MSLENKNIIVTGASSGIGEATAKKLAAAGANVVITARRTERLNELKDEIEKDGGKALAIT
GDVTSKEDWKSIVEQTHNNFGKVDVLVNNAGLMPLSFVENLKTDEWDKMVDVNIKGVLNG
VASVVPDMKETKAGHIINISSVAGRKIMPAGAVYCATKYAVRALSEGIRLEMGPKYNTKV
TSIEPGFVATELTNTITDDDVKDMMSQFEDLTPLQASDIADSIYYALTQPEHSSVNEILI
RPTNQDL
>KECLDBNJ_02178 Anaerobic regulatory protein
MYKVLRKHLERVIEISDQEFDEFCSLLVLRKLRRKELLIRPGDRVTSEFYVISGCLQAFH
TSENGDQSILQFGIEDWWVSDFEAFFNDTPARLSVSCIEDSTVLELNKEMLEELYKRIPK
FERFFRIKLTKAFVALYSRIQNGLEKNSTTRYLEFCETYPHIEQRVPNYKIASYLGIKPE
SLSRIRKELAEREASINKA
>KECLDBNJ_02179 hypothetical protein
MDLAIIEVFIILGITIFLFVTELFPVDKIAIFIIIALMLTGLVTPEEGISGFSNTATITV
LALMIIAVALEDNGVIAWFTRGLQRLSIIPLILLIPTFMIITASISSFISTTAVVIVFIK
IIFQLSERYGVAAGKLLLPVSFAGILGGSCTLMGTSTNLIVNSVAQNRGVEKLGFFEFAW
FGVIFLLIGVVVVTIGSKFLPKKNVSEGLETDYEIDNLITTLTINGDSPLIGKAIQDTFL
FKDTDVTLLKLIRDRVVTNAPGKYITLAENDRLVVMADLENIERISAEEHLTQRTLRSKK
EQTEDIKVTDKDKSNTKRDKQEIQLVEVLVLPGSAFIGNTLNNLKRLKLEGALPIAIKKR
KNIRNTTERLIRKDLNQIRIKPGDRILLEITQTELNTLERLEGIVILKMHESSNTKNPKR
MYITAAILVAVVTMAASGLLSILASSLTGIGLLLATNSLEMNKIYHKVDWQIFFLLAGMI
PLGVAMTNSGADLWLSEQLLNLFDGKNNLFILAALFMITMILSGSISNNATAVIMAPIAI
SVAAGLDLPAKPFILAVMFAANFSFFTPVGYQTNTLIYNLGIYRFKHFFIIGGILSIILC
VAATLLLSTLL
>KECLDBNJ_02180 Penicillin-binding protein 1A
MKNPLGNSNLTELKSKALKFFVKTLKYIEIGFRFATLKFNSAIKKKWVRYPLLGLGSLFF
LFSLFFFSIYVGVWGSLPSKYELSHLEQSLASQLVDRNGKVIGKYYIFDRRPIGFDEIPS
HLKNALIATEDARFYKHDGVDKVSLMRVFFKTLLMQDDSSGGGSTITQQLVKNIYGRRGS
GAFNLVISKFKEFIIAQRVEDVYTKDEIINLYLNTVPFPDNTYGIESASQKFFNKDTENL
TLNEAAILVGTLKANNSYNPRVYPDRAKKRRDVVINQMLRYNYLQPRDTVGMERDTIVLS
YQKRTDLGVAPYFRELIRREAQDLLKNYKKEDGSSYDLYQDGLTIHTTLDKTMQQYAEAG
MREHMAALQAQYEKAYGNYAPWKRASVLEPSLKKLPYYQRLVKDSISPEALEDSLNLKQK
RKIFDWNTDETTQDISVKDSLAHYLSLLNCGFVALDPQTGGVLAYIGGIDFENFKYDHVS
QSERMVGSTFKPFVYTTALEQEMDPCTYYDSAQEIYYFNNKEWSPANAGGEGEDLSYSLK
GALSNSINTVAVKVIIDVGIRKVINQARRMGISSNLPQVPSLALGTAQIKMRDLASAYTS
FVNGGRPMKPYYITKIVDRAGKTIAQFEPEVPEKAVMRNFTRQAMIEMMRGTVSEGTATR
LRYTYKLKNDIAGKTGTTQDNKDGWFVGLTPYMVAVSWVGNDDYRIGFSSTGLGAGANSA
LPIYAKFMQQLNQDTTYAELTKQRFKAPSAEVREALSCAPIVKDSTSRVTKFFESIFNGQ
EQKFIKKVYLDDNGAIIRTEEEPVISDEAIEETEEVEEENTSGGFFSFLKRKKKNDEEN
>KECLDBNJ_02181 RNA polymerase sigma factor SigA
MRQLKITKQVTNRESKSLNTYLQDVSKLDMITADEEVELAQRIREGDQVALERLTKANLR
FVVSVAKQYQNQGLKLPDLINEGNVGLVKAAKRFDETRGFKFISYAVWWIRQSILQAISE
HSRTVRLPLNKIGTISKINKAFSYLEQSLERPPSAEEIAKELDMTVAKVKLAMKNSGRNL
SMDAPFKEGENDSNLYDVLKSGESPNPDADLMQESLGTEIERALETLSPRESDVIKLNYG
LGGEQPHTLQEIGEMFDLSRERVRQIREKGIRRLRHTSRSKVLKTYLG
>KECLDBNJ_02182 hypothetical protein
MKATKLFALALVAVIGLNSCSSDDDNTPEEINEEEVITTITVTLAPQTGETVTLTSRDLD
GDGPDAPVISISGALQAGMLYNGSVLLENETETPAEVINEEIQEEADEHQFFFQASSDLN
ADFTYTDSENTYLNNGVSNPVGLTFNLQAGTASSGTFTITLRHEPSKDAEGVSEGDITNA
AGETDVQESFDVVIE
>KECLDBNJ_02183 Vitamin B12 transporter BtuB
MNVFRLVILLIFTVQLQAQTCDYSITGVVRDFHDGSVLANSTLSVNGYDIYALSDFDGRY
TLDGLCAGTYVITITHPECEVAEFTVEVQRDLQRDFKLEHHTEELNAVTVQGENLNQGTI
SGSQEVLKSEVLEQYSNASLGDALREVPGVSSLNTGSTVVKPVINGLHSSRVLIINNGTR
MEDQEWGVEHAPNLDINAAENVTVIKGASALRYGGDAVGGVIVTNAPKAPVKDTLYGKTI
LSGASNGRSVGLTTSLLKAYKSGFYVQGQGTAKYAGDLRAPDYVLSNTGLRERDFSVGFG
LNKFTYGFDAYYSFYNSEIGILRASHIGNLSDLIRAINSGAPDYVQDFTYDINAPKQDVS
HHLAKLSFYKRFENAGKLNLDYSFQQNNRKEFDIRRGDDSDKPSLDLRLTTHTLSSNFLY
DAMAGVKANFGAEVSYQENFPDPNTGIRRLIPDYEMYTAGVYATADIDLSPDWRLDGGIR
YDFMQVDAQKYYLNSSWESRGYEEEFGDLVVSRSDSQLLVNPVFDYHNFSGTVGARYRIK
PNWDLKFNLSSASRAPNPAELFSDGLHHSAAIIELGDLRLNQEQSYKASVEFTGQIEGLS
FGINPYYNHIDDFIIMEPSGLQYTNRGAFPVYQYGQVDARLLGVDLRAAYAFNENFDLQT
VFAYVNGQDLERNRPLIDMPAPNINTTLGFQKPEWNNLKLGLRNQSVLKQTRFPDNDFEV
TYINDAGEQTTERVEVSRTPEAYSLFHLTSSVDFDVFKQSTLTVGFYVDNILNTAYRDYL
NRQRYFADDLGRNFRIQLKLNY
>KECLDBNJ_02184 hypothetical protein
MILKSKTSKAGISLLLILALFAFKIVDLHNYTAKKDRDSGHSYHELCLMGDNHKQHLDFV
LPPVFEIEQDEIFVYLKKPQTLSNTKRFFLYIEKNHLNKAPPALIS
>KECLDBNJ_02185 hypothetical protein
MHRKTRSFYLTFLLVTTSFLLSSESNAQRGNHELGGWYMYFFETDFGQSNFGIMGDVQHR
SFNVAHDFQQFILRAGLSYKFKNSSFRAVAGYSFFNSGTFGPSNAQLIENRLYQDLIWTN
ALFEGRIALLHRIRIEERFIENQDFRSRYRYFLNAKLPLNAKAMGPKTFFAWTAAEIFVN
GEKNIGNGQSVNLYDRTWLFGGLGYQFSKSLRSELSYMREITENQTKGQLILSFFHTF
>KECLDBNJ_02186 Putative DNA repair helicase RadD
MSEKASAQDNGNGKELYNYQLNDLDKIFNCMEEESDDFNLLYQLPTGGGKTVIFSEIVRR
YIKEKQKKVVILTHRIELSSQTSKMLKSFDVPNMVINSKVKTLEGNEDYMCYVAMVETLN
NRLQDEQIDINDIGLVIIDEAHYNSFRKLFSYFKDAFILGVTATPLSSNVKLPMKDNYRK
LIIGESIGSLIEKGFLAKANMHTYDVGLKTLQVGINGDYTVKSSEILYTNHSMQEKLLAA
YEERAKGTKTLIFNNGINTSRYVYETFREAGYDVKHLDNTHTNKERKEILKWFKNTPDAI
LTSVSILTTGFDEPSVETIILNRATRSLTLYFQMIGRGSRVLPDKKTFEVIDLGNNMARF
GLWDAPMDWNDIFLYPDFYLENLVSDEEIERNFEYVMPPELRAQFSNSESIEFDIKKEYE
DVFAKGLKSKEALERSIDQHARIIFENTEDVFDARILARELKEEIQYRIRLYSYCIMKNT
KNYKDWLEEDYMRKLRLKLSQMYANIPAQ
>KECLDBNJ_02187 hypothetical protein
MKNPKAIKLINKLIGDVEQNGIIINTVVEDLQNLRPYAVEEKRPLLAKTIRLVFEHIEAY
QTFDIAIPDEEPVEGYEDEFEETEVSSSPAESLLYLLNLLAEPENKVNRLDLRAYVEAMQ
EYAEEH
>KECLDBNJ_02188 Sepiapterin reductase
MEKFKNKVALITGGTKGIGKGVAEALLELGMNVAITSRTLTAAEKAAEELNKSGKGKALG
VKADVRSMESQVQAVDAVLKEFGQIDVLVANAGLGHFASITDLTAGEWQETIDTNLTGVF
YSVKACLNELKRSKGYIFTISSLAGTNFFANGSAYNASKFGLTGFTQAIMLDLRQDDVKV
STIMPGSVATHFNGNEPSKKDAWKIQSEDIGELVVDLLKMNPRTLPSKIEVRPSKPPKK
>KECLDBNJ_02189 hypothetical protein
MLKIRLIQPNTHAAFFKILLNLGIYKNISRNNFSTGFSSGIFAKKLMAQESKTKKKSRIR
LLHQYYKFTGFYSFIGGSLKKALTPVIIFVAALLAIHYFVIDINALLVKMTDTFPPFWVL
TVFFISESILGLIPPEIFIAWSDKMPDPILYLSLIAILSYAGGIISYFMGRASTRIPAVH
DYLEVKMAKHLKNARKWGGFLIIVGAVLPVPFAISSMAAGMIKYPFINYLLFGLLRFVRF
AVYGAAIFNLV
>KECLDBNJ_02190 hypothetical protein
MIKAFQILSILEGVSLLLILFVTMPLKYIFDQTGPNQIIGMAHGILFLLYVVMAILVKFE
LKWNFKTLFIVLICSVIPFGTFWMERKYLKNQA
>KECLDBNJ_02191 D-alanyl-D-alanine dipeptidase
MVKSYLALVIFLLGNFAFAQQAEVPLIKIDTLADGFTYDIRYATDNNFLKEAFYDCASCY
LRPEVAAALKEANHYFCEKGYRIVLYDCYRPVSAQKKMWAVYPNAQYVANPYTSGSVHNR
GAAVDLSLEKLDGTPLNMGTDFDFFGRKAHIDNTSLPREVLDNRKLLQEGMTRFGFQTIR
TEWWHFNYKKNYGFEIIDFDFGCD
>KECLDBNJ_02192 hypothetical protein
MKKKKSIEVKTQTVGRNRRNFLKVSGLALAGSSLLLAACSDDDDNGNMMGGGTFDLGTGD
VGVLNYAYALEQLEAAFYTNVVNGSFYASASADEKAILLDLYNHEVNHREFFKAAIGANV
PMEQQLTADLEFDFSSVDFGNRDSVLTTARILEDTGVSAYNGAGQYIQTAVYLTLAGKIV
SVEARHAAAIRSIINGSADYTAFAGDDIIDSNGLDLAASPEEVISAAGGFFVTPFTYNNP
GA
>KECLDBNJ_02193 hypothetical protein
MNLIKFLDEFTTDKMQEPMTCRRAMFGQLGSIGKKAALAAVPFGLATASNKAMAQSSGDV
VGVLNLALTLEYLEDEFYAMALDSGVLSSNAKAEAIYQQISKHESQHVDFLTAAIEGAGA
DPVAKPSFDFTVGGAFDPFNENGAGQATAYAQLLALAQAFEDTGVRAYKGQAANLMGSAG
VLTAALQIHSVEARHASEIRRLRGLEGWITGNQRGAGMPEATQAVYNGEDNISQGGVDVT
TLGSGSPFTMDAATQAYDEILTRDEAVTIASLFIES
>KECLDBNJ_02194 hypothetical protein
MIAVVYLFMIRPQMKRQKEEKKFAEELKRGDRVITKSGLHGKILDLNDTTVILESGAGKM
KFERTALSLELTKKLNEPAKVEKKK
>KECLDBNJ_02195 hypothetical protein
MKKVFLAVGLVAAVAFTSCKDNASDKVKGENVEMAATRDADATVFPTMEFEESAYDFGNI
ARGTAVEHVFKFKNTGKAPLVIVDATSTCGCTVPSYPKEPIQPGETGELLVKYNGSGLNA
VTKIVTVKSNTEKGSETVKITAFVQSAEGPAVNG
>KECLDBNJ_02196 N utilization substance protein B 
MLNRRHIRVKVMQALYALHQSEQPDLLKEEKFLNASTAQMYELYLTIVDLLVEIHAHAKD
ILERSQQKMLATESEKNPNLKFVNNPVLVKLSENELLQKELKKAKLNNWRLDNEYVVLLY
NELIASDFYAEYMASETSDFKTDRDFVIDFFTEFVAPNDKLYDYLEDYRLTWVDDLPVVN
TTIVKRLGKIKPNSPESTILPKLYKDEEDRQFAKDLLLRTARNDEEYEAEILGNTPNWDQ
DRIATLDKILIKMALCEFLRFSSIPVKVTINEYLELSKEYSTPKSSIFVNGVLDRLVKKY
KKDNRLNKAGRGLIE
>KECLDBNJ_02197 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKELQHLNKYFKKYKWKLILGFFIVLVARIFAILTPKFSGDMIKYVENYIGDGGDLSELK
QQLLMTLFLLLGAALLSAFFTFLMRQMFIVVSRYMEADLKNEVYDQYQNLSLSFYKKNRT
GDLMNRISEDVSKVRMYLGPAIMYGVTTVILFATVIPYMFYTAPELTLYVLIPLPILSVA
IYQLSRLIHKRSTIVQQYLSHLSTFTQESFSGIGVIKAYGIEPQTYENFEKLSETNKEKN
LDLVKVQAFFFPLMIALIGVSNLLVIYIGGKKYIDGSIPDLGVIVEFLIYVNMLTWPVAS
VGWITSLVQQAEASQKRINEFLKEKPEIVNKTEAHTPVNGSIKFDNVTFTYEDTNITALK
EVSFEVNQGETLAIIGKTGSGKSTILELIGRLYDTTSGVITVDDTPIDQLNLKDLRTSIG
YVPQEAFLFSDSINENIKFGNNNATDAQVIQAAKDAVVHNNIVDFSKGYDTILGERGITL
SGGQKQRVSIARAIIKDPQILLFDDSLSAVDTETEEEILSNLKKVAATKTTILVSHRISS
AKNADKIIILEEGEIIQRGTHADLIAEEGYYQELYRKQLDEKEME
>KECLDBNJ_02198 hypothetical protein
MSNNEMKGNDEIFSKVLRAGRRTYFFDVRSTRAGDYYLTITESKKFTNDDGSFHYKKHKI
YLYKEDFEGFSEILNEMTAYILDEKGEEVISERHQSDYVKEEDKEPVLEGKSAKAFTDVS
FDDI
>KECLDBNJ_02199 hypothetical protein
MKQLLLHLFLIFTIFQSTAQVMHPSLDYYLPDDVTYDPEIPKPQEILGYVPGEWHVSHDA
LVGYMRTMAAASDRITIENRGTTYEGRPLLLLTITSPENHANLAQIKTEHHALTESGAAN
LDTETMPIVTYQGMSIHGNEPSGSNAGLLAVYYLAAAQGAKIDAMLQDVVILFDPSFNPD
GLQRFSYWANTNKNQNLTTDPQDREYSEIWPGGRTNHYWFDLNRDWLPAELPESQVRIKT
FHEWYPNILTDHHEMGSNSSFFFQPGIQSRTHPLTPKLNQELTAEIGKYHAAAFDKIGSF
YYTEEDYDDFYYGKGSTFPDINGSVGILFEQASSRGHVQETDNGLLTFPFTIRNQFTAFL
STIAAAQGMRKKMLDYQRDFYANSRNEAGKDAYIFGSKNDPARAAHLAQLLQRHKIAVYK
PSENYTTKDLSFDTESSYVVPKTQKHSRLLKGMFEKRTTFEDSLFYDISAWSFPLAFNLD
FSDSAPASIAGTKIDSVALQTPLSLSRSDYAYILPWGNYYAPKALNAILNKGIRAKVALQ
PFSVGGIDYDYGSVMIPVQNQSLNAADLQAFLDDVAKASHLSIDPVKTGLTEGIDLGSRK
FEALKPQKIALLVGDGIRSYDAGEIWHLLDTRFDISITKLDTRNFSRTDLSQYTTIIMPT
SGWGGGLDELAGNKIAAWVRNGGTLIGFKNAARWIKRQGLVDFREVETENPAKEVTFEQR
SDFNGAQVIGGAIFSAKLDRSHPIAFGYDNAAISLFRDTTLFIEADETSYKNPILYTEEP
LAAGYISPINYEAIKGTRPFVHQSSGRGEVLIFTDNTNFRAFWYGTSKLLMNGIFFSNQM
>KECLDBNJ_02200 Bicyclomycin resistance protein
MSEVKTRKSPGLILILGLLTALGPIATDIYLPAFEDIAVKLNTHISTISYTLSSFFIGLS
IGQLIYGPMLERFGRKKPIYVGLVIYFLASLGCALSADIYILIGLRFFQAVGACAGMVAA
RALVRDLFEDKEVAQVFSLLMVVVAVSPIIAPTLGGLITIQLGWRWVFASLSILTLLVFI
GSYFKLPHGKPANPKHSLRLKPVLKNYREVLLDKQFAVYAISGSIAYAGIYSYLSGSPHI
YLELFAVSKTEYSIIFAIIAAGLIGSSQINNLILKKKETAQVVPVAQVFQCLLSVALVAI
SYFEMGGLYLTTVLIFLYMCCLGFIFPNASALSLVRLGHTAGNASAMLGAMQMVMGAIGS
ALVSYFQARTDLAMYLVMCSVAFLAFALLISGTKSLKSAYHLAEK
>KECLDBNJ_02201 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MRSIYTLPLALLLLIVSSCKESQETTEAETLSEEKTTCTEMPYNNPIVGQRADPWVYKDS
DGTYYFIATAPEYDRIEIRKANTINALGTAEPQVIWTKHETGRMGHHIWAPELHKIDDKW
YVYFAAGEAENVWNIRMFALSTDAADPTQGDWVEEGQIATKRDSFSLDATTFEHKGTRYL
IWAQNVREGENTSLVMSAMENPTTLTGPEIIITDPEYDWERIGYKVNEGPAVLKRNGKIF
VTYSASATDANYAVGLLWADEDADLMDEASWNKSETPVFTTNAEARRFGPGHNSFTKAED
DTTDVMIYHARVYEQIRGNSLYDFNRHTRARVLKWDEKGFPDFRQDQRD
>KECLDBNJ_02202 Serine/threonine-protein kinase pkn1
MKDLRVRACIAMTIAVLVVSCKERASDKINAATTSKEVTQKPHELLVAQPDSIKTPEGMV
WVSGVEFTQGAGAGDALALPREKPAHPVAVDGFFIDQTEVTNAQFEKFVDETGYVTLAER
PVDWEAMKKTLPPGTPKPADSLLQPGSLIFDRSVQQVTDLNNYTQWWEWKIGANWKHPQG
PESTIEGKANYPVVHISYEDALAYCKWANRRLPTETEWEAAAYGKLPGGIYTWGDDATAL
PEKANTWQGTFPTRNSDEDGFAYAAPVGSYAPNSLGIYDLSGNVWELTQDWFSTRYYQEV
AGSKSINPQGAVESYNPENPYQPEKVIKGGSFLCDDSYCASYRISARMGQALESSSDHSG
FRTVADVKMLQAD
>KECLDBNJ_02203 Trehalase
MKEHSGYPGIESYGVIGNCQTCALIQREGSIDFMSFPEYDSHSVFAALLDQRKGGSFNTP
PQAPYAKCFQEYILDTSVLTTRFLSDDYNVEFTDFMPIQADGSAEVNQLVRKISLIRGNL
DFDLILDVLINYGKLTTHVEVIDEYTLIFKNQEHADALKVRATLPITAQGSIKKSFSLSE
GQDAYFIIESADAPALDHTIEEEIACLENKLPATLKFWHQWIKTCNYHGDFAEHMKRSAI
TLKLLTSAKYGSTVAAPTYALPEEIGGGKNWDYRYAWVRDAAFTMYAFMRLGFLEEASQF
MKWIYDRIDIDINGGVELQIMYRIDGSRDLEEEELDLEGYKGSKPVRIGNAATSQIQLDV
FGELMDTIYLFDKYGQNVMYSFWQNVEKLIDYVCKNWQNADHGIWEVREVKRHYLFSRLM
CWVALDRAIRLVRKRSLPTDVSTWEKNRNLIFQDIYDNFWDEELQSYVHFKGAKTVDSSL
LMMPLMKFISPYDKRWVKTLKVIEEQLIVDDVLVYRNLHDSIPHKGDSAEGSFTIGSFWY
IECLSRGGEIARAERYFQKLMSYGNHLKLFSEELSPSGAQLGNFPQGFSHLGLISTLFSI
DRQKGQNTFVLKQ
>KECLDBNJ_02204 putative xanthine dehydrogenase subunit A
MTHEFRTLIQTAYTYFQTNTACVMASVVALDGSSYRKPGVRMLIAENGTMTGAVSGGCVE
KEVLFQAQEVFETGKAKMMTYDGRYRLGCEGILYILIEPLQINESIYNKLTIILTQRKDL
QLTSYFVKDTEAVEQPLGTVVKANEETLALFYIEEALQSTAKVQTFTQVLPAVFQLFLFG
AEHDAVQLGTLGAQMGWDVRVIASPKDPKTKANFPGVHEVLHLLPEQASGLQIDAESAVV
LMNHNYATDLNFLVHILDKQPQYIGILGSSKRREKLFNELIDYKPDLDATVLDRIYGPAG
IDIGAITPQEIALSVLAEILAVKRKREVSSLRDKIGSIHKEV
>KECLDBNJ_02205 Putative xanthine dehydrogenase YagR molybdenum-binding subunit
MNLNTSKGTGNPIDRVEGKLKVTGMAKYASEFKVKNLVYAQGINSTIAKGRITAIDTAEA
EAQPGVLAVITYKNAERLAQYDKDLHPLSTTSIQPVLQSDQVHYYGEYVGLVVAETFEQA
QYAARLVKYTYAQETPDIDFEASKGKAYTPTEQSDYSRGNVAEGLAEADVTLDETYVTPI
EHHHPMELHAIIGSWNGGNVQAYASQQMIDNAATTIADTFQIDKKNVRVMSPYVGGGFGS
KLAAKQHVILALMASKAINRPVQLTVSRNQMFTNTNLRQRNEQRIKIGAKSDGTLTALSH
DTLSHTSTYEQYQEACGTVTKMLYKTPNNSVTHRLMPMNLQSPFAMRAPGEATGSFALES
AMDEMAFKLNMDPIAFRIKNDTQVDPSNGKPFSSRLLNECLRLGAKEFGWENRPQKPASK
SEGNWLVGYGVSAASRRAPYMKTSAKVILELKNDAVWATLQMDATDIGTGSYTILAQTVS
EYLDIPVEQVDVELGDSEYPVTPGSGGSWGAASFANGARAACEQALKDLKDKAGETAATT
TVALMKAAQLSTLEAEGTAEPDEEYKAHSVFSFGANFTEVWVDKDTGVFRIKRMLNVASC
GKILNPKTAFGQIIGGCVMGAGMAIAERTEVEPNFGNFITRSFADYHVPVNLDMANIDVV
YLPEEDKIANKMGIKGIGELGITSVAASIANAVFNATGKRMRDLPLTPEKIFVKKEEAA
>KECLDBNJ_02206 Putative xanthine dehydrogenase YagS FAD-binding subunit
MRPFNYIEAKTKQQALAAVQEQEHAKYLGGGTNLVDLMKEDVERPEALIKVADLDNDTIT
SNAVGGLTLGAARSNAATANHPEVRKQYPLLSMAMLSAATAQIRNMATNGGNLLQRTRCP
YFFETSMPCNKREPGSGCGALDGANAQHAIFGWSKSCVATHPSDMCVALAALEATVTVQT
PDGSERTIDFSDFHRLPGKQPELDNTLEPGELITAIELPKPQFTQHYHYLKIRERSSYAF
AILSVAAGLKVRGGVVTDVGLAMGGVAHKPWKLTAAEDYLIGKEPTTKNFEEAAQLALAD
ARTLEHNAYKVPMGIKAIVRTLEQAYSKEA
>KECLDBNJ_02207 Putative xanthine dehydrogenase YagT iron-sulfur-binding subunit
MKKQKAHQPLKEAQLTDDEVEILDQLGIFGDSRRKFLGQISAASMSVMATPYFSSELLAQ
TQAGTSKDDLDALLNKVEVNLHVNGKQNPLTLDSRTTLLDALREHLQLTGTKKGCDHGQC
GACTVMIDGKRKLSCLTLAATCKDKKIKTVEGLANTAGLHPMQKAFLKHDGFQCGYCTPG
QLCSSVALLDEAKQGEASYVTRDFTKVTTNLDLSEEEIRERMSGNICRCGAYNNIVQAVK
EVQSGVEEQPKWRFASLAELKEAGEQ
>KECLDBNJ_02208 hypothetical protein
MSFNTEILNLNRKPMRCCFFLSLLVVLLATFVLTAQETHKYTNQLIEETSPYLLQHAHNP
VDWQPWSDAAFAQAKEENKLVVVSIGYSSCHWCHVMEEETFSQEDVAQVMNENFINIKVD
REERPDVDQVYMKAVQLITGKGGWPLNVIVLPDGKPLYGGTYHKKDEWLQLLNSLSKTYA
EKPEQAAAFAQRLTTGIQEEQQQAAANTSVQYRPELIETLFNTYQQEWDMKNGGRKGFEK
FMLPAHLNLLLDYVSLTQDAKSKTFLEQTLDAIAMRGVYDHVSGGFFRYSVDPLWKIPHF
EKMLSDNAQLISVYARAYTLFDKPIYRQRAEETITFLNNQFKTKEGSFIAALDADSDGKE
GGYYLYNTNQLETAITTEKELFDAYYTQEPLSRFETDILHLYPTQTDAAFAASYKLSAEQ
VAQLITQWKSELQQVRSTRSLPRADDKIIVPWNAMMISGLVAAAHSFEQPDYLKQAKALY
SVLMQNAYKDGTLMHSYKAHSDTAPAFLDDYVFMSQATLDLYSSTTNTEYLETLNQLITD
TQTHFKDANSPFYTFNTGDELITNIITTNDGVQPSANALLAQLLFKLGHLNYNTAYLEQS
KAMLLAMHDNLKEQPWSYTQWLALAIQHSYPFYEIAVVGPDAVQRIDDFSRQPVANRLLI
GTTVDSELPLFESRFVPEKTYIYVCEGRACKLPVTTVAQALKQLEAVEGFGF
>KECLDBNJ_02209 hypothetical protein
MSEHYSSDKPVEIENQDRFQRYGFSKRIAETIVQRENEEGIVIGIYGAWGEGKTSVLNFI
KSELDLKENILTLTLNPWRYNDEESLIKNFLNKVAEVLGKELDTNKEKLGSFIEKYGTFG
SIIGKDVSEIGKNLSNVDLETLKNRIDEFLKESESKLVIFVDDIDRLDKQEIYSLFRLVK
LTADFTNTTYVLSFDEKMVASAIGERFGKGNIDSGHNFLEKIIQVPLQIPQAQPDALKKY
CFELVDNAINKSTLELTKEEVQRFVSAFSHNILLRLKTPRLAIRYGNSLSFAIPLLKGEV
NHVDLMLIEAIKVFYPKHYLFIKSFPHYFTSSYSSRSTYGDGQSVKEKKEELKKHLDKLA
SDLTKNEKDAIFQLLKTLFPRLNEAFHNTFQHEGHKQWLKEKRIVSTSYFKRYFSYAVIE
GELSDVMFEEFMQSLEAIEIKDIAKGMKDIINESSPENFLFKVRTYEDSLSWKASQNLIL
TIAVMSELFPKGDSFFSFGMGGAQSQASIFIYNLLKNHKDNDEVFELSKTLMGKEIPYDF
AYQINNWLRSGEGEEKIFKQEQYVELATVLRKRALEECGELPIFVKFPDNIFYIFSTWYE
NNPEDLESYLKGYIDEEPKYLKQLFLALTPTATSSNHPEPYKSNFDKEGYDYITNILNKD
YLHAKINEYFSDELHQEGVKFQRFDHNQSEINILRQFEHWYSKDDGIEEAEIVE
>KECLDBNJ_02210 hypothetical protein
MGTWGPALFSDDLALEVKSAFKDKIALALSKIELYNTKNL
>KECLDBNJ_02211 hypothetical protein
MKLKLTLAFLIICWSKMLACSCAYEPDFQTKEDLEEYRFIAHVKVQGVEAAEGIDSEWPI
HQMNFELLELYKGAPTKEILVSGSHPSLDGWTSCDLAERADEEWIIFGYYDSHKEKLITG
YCTRSKRIKRANGFEDLKYPNQLTLKKKLQQVFDKKTNQPTYEGARIVYYPNGTKQLEEH
YENGVLNGKRLLYYPNETLQSIQQYSNGAKTGKFKWYSDKEQLTKTETFKNNFPVDTTLI
WHEIDTSYMSLKIYSGLNNVAMEEAKSILAKPSLCIQRIFNEQGELLSNITYYQNGIKND
EHLYFPDQKKEHIRYYYKNGTLRSELYKENGLNTGVYKDWDEQGKLLRSWEYDEKGEVIE
GSRKDY
>KECLDBNJ_02212 hypothetical protein
MLGILLLYWIGKYYYKLAEAHGKSKWGYAILGIVTYYACAVVSGFLMGIFIELIWPGAVD
TINEFLFGLMLLPFGIAGTYLLYYYFKRNWESKAPQLGVEELGAGEPTETTL
>KECLDBNJ_02213 hypothetical protein
MQQKFNHQPHIGRRILAALIDYGLIYTFIYVFLMSFGTPTTMGGYSITGLPILIPIAFWL
LMTIGLESGLGGTLGNSIVGLKAIPQNGRNRKLSFSESFKRHFLDLVDMSFLGLPAILLL
KRTEKCQRFGDLWAKTIVVKMSSLETPATSRS
>KECLDBNJ_02214 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MKKIVKRILVFIGINLCLYLIAVVVLINWPIPQKVPAKNYDYTSIDTIAVKTYPHQEEWI
SMRDGAALFSRRYAANCKTVLLLLHGSGSESRYLQSLAGRLAQEDLATVLTPDLRGHGRN
LLLHSDIDHIGQLEEDLEDFLFYAQHELQAEKIVLAGHSSGGGLVLRYLASAKHPQVDQA
ILLAPYLGHDAPTVKQNSGGWVSVGVKRWVGLAMLNGIGVTAYNDKPVLFFNRPKAYEDP
LQAPSYSYRMAVNFAPTHYQHDIIKLKTPTLVLVGNADESFYPERFQEVFEPAAAFTRVQ
RIPKANHLNIIKNEEVLTQIRELLLEE
>KECLDBNJ_02215 Amino-acid carrier protein AlsT
MDVLNQWIAETASFVWGLPLLFLLIGGGLFLLVYSRFLPFKYFGHAIQVLRGKYDNPDDP
GEISHFQALMTALSSTVGMGNIAGVAVAIAVGGPGAVFWMWISALVGMSTKFFTCTLAIL
FRGKDDSGTLQGGPMYFITEGLGKSWKPLAVFFSIAGLVGALPVFNVNQLTQAVNDILLV
PNGIEKGFATDLSIGIVLAVITGIVILGGLNRISKTASKMVPAMVVLYFIAVLAILFINA
AEVPRYLQLIFTDAFAANNYTGDPMFGGMLGALIVLGIRRGAFSNEAGIGTAPMAHGAAK
TEEPIREGLVAMLGPFIDTVIVCTLTALCILVTGVWQTSEANGVTLTAKAFSDSIPGYGP
YVLLVCIAVFSISSLFSYSYYGSKCLAFIFGTRHKHWYNYFYIASILIGATTSLDLMINL
IDTFFALMAIPTMLATLILAPKVMQRARQYFTSLNKV
>KECLDBNJ_02216 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MSNKTITDTNYTFPGQTNVYKGKVREVYSLDNDLLVMIATDRLSAFDVVMPKGIPYKGQI
LNQIATKMMRNTEDLVPNWLAATPDPNVAVGKKCEPFKVEMVIRGYMSGHAAREYKAGKR
MLCGVPLPEGMKENDKFPQPIITPATKAEMGDHDEDISKEDILKRGIVSAEDYAVLEDYT
HKLFQRGTEIAAERGLILVDTKYEFGKTAEGEIVLIDEIHTPDSSRYFYADGYAERQEKG
EAQKQLSKEFVRQWLISNGFQGLEGQTLPEMTDAYIETVSERYIELYENITGETFVKADL
SDIDKRIETNVLNYLNA
>KECLDBNJ_02217 PhoH-like protein
MNELIIELSEITPREFFGQNNANIELLKKYFPKLKLVARGNHIKAYGDEDLLEEFDKRIT
MLLEHFAKYNKLDENMIERVLTSDSREDYETSPQSGEILVHGVGGKLIKAQTANQRKLVD
MARKNDMVFAIGPAGTGKTYTGVALAVKALKEKQVKRIILTRPAVEAGENLGFLPGDLKE
KLDPYMQPLYDALRDMIPHEKLESFIEKGVIQIAPMAFMRGRTLDNAFVILDEAQNTTHA
QMKMFLTRMGKHAKFLITGDPGQIDLPRRVISGLKEALLVLKDVDGVGMIYLDDKDVIRH
RLVKKVIAAYKAIENRD
>KECLDBNJ_02218 5'-fluoro-5'-deoxy-adenosine synthase
MPILTLTTDFGLKDHFAGAVKGAIYSEMADARIVDISHNVSPFHITEAAYIIQNAYKNFP
PGTIHIIGIDSEQNPENKHIAVKLEGQYFICANNGIMSMITKTINPEEVVEINIHDRIKT
NFTELDVFVQVACHIARGGTLGVIGKPIKEIKEITGIMPVINSDQKGIIGNVIYVDNYGN
VITNITKRLFEDVGKGRKFTIQARRAMFKKIHQHYSDAINFEIEKSKREEDGKKIALFNS
SGYLELAIYKSNPSTVGSASTLFGLDYRDAVSITFE
>KECLDBNJ_02219 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNIAVIGAGTMGNGIAHTFAQHGFKVSLIDISETALKNGIANVTKNLDRQVAKEVLTEA
QKNETLLNIALLTDLKEGVAKADLVVEAASENLNIKLDIFKKLEELCKPNTILASNTSSI
SITQIAAATKRADKVIGMHFMNPVPVMKLVEIISGYNTSPETLATVTKLAEQLGKTPVPV
NDYPGFVANRILMPMLNEAIETLYNGVAGVQEIDTVMKLGMAHPMGPLQLADFIGLDVCL
SILEVMYDGFKNPKYAPCPLLVNMVRAGKLGVKSGEGFYDYSESRKAETVSAQFQ
>KECLDBNJ_02220 hypothetical protein
MVKSKIAWLGVFCFVTIIYLMAVCILVLIEQFQTLSTFSLYTMFGLFFFCLLFLLTEFRK
RADVFILSKNQIEKRSFFGIGYAQHFDLKELDGFTEMENYSKKYIHLIKNGKRVACCCNF
HMRNYDEVKKALGDNLVFLGEEHYSIKAEAVYLLKL
>KECLDBNJ_02221 hypothetical protein
MPKIIPFRAVRPTRDKVSLIASRSYDTYTKAERKARLDNNPYSFLHIVNPGYKYHKELSG
QERFQLVRNRYLEFKEEGIFIKEEQPVFYVYKIVNRDAESFIGIIGAASVADYKNNQIKR
HENTIKAREEVFKEYLKTTGFNAEAVLLTHPDYIPLNAIFEEVMRARAEYEFTTTYRDTH
YLWPVTQEHLIEKIKTIYADMPELYIADGHHRSSSSALLADDLNGSDLAGDAHNYFMTYI
IPESHLRIHAFSRMITDLCGMDKDRFLIKLDSIFKIENRGDEYIQPSKVHHFSMYLDGDF
YTLELRKHYRNFKDALEGLDAQILYDLVLNPILKIQDPRQDARLAYGKGKNDMLGAKEKV
DRDKYAVAFGLFPATVQQIKDISDEGLTMPPKSTFIQPKLRSGVTIYEFL
>KECLDBNJ_02222 hypothetical protein
MADITQNLKQFKSELPKEVTLVAVSKTKPNEDLQEAYDAGQRIFGENKIQEMTDKWEALP
KDIQWHMIGHVQTNKVKYMAPYVNLIHSADRLKLFKEINKEAKKNERVIDVLLQVKIAEE
DSKFGMPPEEAKAFLEENKAAQYPNVNIVGLMGMASFVDDEVQIKREFAQLEKIYNTFKE
QYAFSVLSMGMSGDYKLALEHGSTMVRVGSAIFGARNYN
>KECLDBNJ_02223 putative ATP-dependent helicase DinG 
MYAILDLETTGGKYNEEGVTEVAIYKFDGHKVVDQFISLVNPERPIQAFVVGLTGINNAM
LRNAPKFYEVAKRIIEITQDCIIVAHNAQFDYRILQLEFDRLGYDYQRKSLCTVELAQEL
LPGQESYSLGKLVRNLGIPITDRHRANGDALATVKLFKLLLAKDSKKTIIQEAIKLNPKK
QIDTKLRDIIADLPSSTGVYYMHNANGSVIYIGKSRNIKKRVNQHFTSDNRKSKKIQEEV
EAVSYEETGSELVALLKENEEIKSIKPKHNRALRRTKFKSQLVHFRDEAGYINLRLEKAD
PRKEHITTFATSHSAKQYLEKMLVEYNLCQSKMGLHTTDSNCFNYTIKACDGACVGEESA
ADYNARVTEFISKHSFENKNFLIIDRGRSVDERSVVLIEEGKFKGYGFYNLNFQINNLDI
LERIITPMQDNRDARHLIQSYLRTRKVIKIMELTELEN
>KECLDBNJ_02224 hypothetical protein
MIKSLLLFSVILLFGSCSVQDNDLDYHTDTQQIKLICQVSVSTEKTDPLYALLLEGKYYK
IDDFFKDIPISALAKVSILKGKKATAKYGASASYGAIELEYKPAFRKQLLAKNLEELTVT
L
>KECLDBNJ_02225 Cyclic nucleotide-gated potassium channel
MTQPQKHTWKTRLHEVIYEADTPAGKTFDVVLLILIFVSIILVMLESVAPMQAQYGDYFY
LGEWIITIFFTIEYILRVISIKKPSSYIFSFYGLIDLISTIPLYLSFFIVGTNALLTIRA
LRLLRVFRILKVTRYIGEGNKLARALRDSRPKILVFLFAVMILSIIAGTLMYIVEGPEHG
FKSIPVSIYWCIVTLTTVGFGDIAPVTALGQFIATVIMVVGYGIIAVPTGIVSAEMAKGE
RKEPEPQKLHMNTQVCHHCGARKHQDSAKYCHNCGNSLHYE
>KECLDBNJ_02226 tRNA dimethylallyltransferase
MNKLLIAVVGPTAIGKTALGIKLANHFNTEIISADSRQFFKEMYIGTAVPDEDELAAAKH
HFIQHISVEEEYNVGLFEQEALAKIEALFTEHDVVIMVGGSGLYVDAVINGLDKFPDVDP
EIRNTLTQRLESEGIESLQDQLQILDPNHYQRIDLHNKQRLIRALEICLGTGKPYSSFLA
RNTVQRPFNTLKIGLNAGRQLIYDRINKRVDVMIEKGLIEEAKGLYAKRELNALQTVGYR
ELFGYFAEEFDLDTAIEEIKKNTRRFAKRQLTWYRKDETIVWFDYKTPFEEIVQRIKEKV
PL
>KECLDBNJ_02227 Transcriptional regulatory protein WalR
METENKKILLVEDDPNFGTVLKDYLSMNDYDVTHAKNGMEGFEKFKKDDFDLCILDVMMP
YKDGFTLAKEIREKNEDVPIIFLTAKAMKEDVLKGYKVGADDYLNKPFDSEVLLMKIKAI
MLRKATDSVADSKQFEFQIGNFFLNSKLRFLTYKDEEPNKLSPKENELLRLLALHENDLM
PRELALTKIWRDDNYFTSRSMDVYIAKLRKYLKRDDTVEILNIHGEGFRLVVKTEEEK
>KECLDBNJ_02228 Sensor protein kinase WalK
MLKSYIWAMNKNLFVLLVVLMSLSLIGIIFVQGYWISNSIEAKRGQFAFSAKQVLKEVAR
DIQMKEVNTWYNPVLRMRDSLGVPDDVSLYDLIYKQDDSLSNESYIFRNSIVEQDYKLSA
PVLDYEVDSIKFKRYLQRQYTQIIDKNDLDRSEVDRTTVLTRMSDLSEIERYNIEQAVMY
ITRKIPIHKRVEEADLQRLLTMELAERDMDTNFEYAVYSNNLVTSVRSKDFDLQSPEQNF
SVPLFTDVEGNSDYQLVANFPGEKKFVVSSVIGMGGLSILFTLIIVIAYSSALQQLVKQR
QISEIKTDFINNMTHEFKTPIATINLALDAIKNPKISSNPEALTRYMGMIREENKRMHAQ
VENVLRISKLEKNELDIKKERLNLHDIIEDAITHIELIVEDRQGYINTHLGAVKTSVLAN
ESHFTNVLVNILDNAVKYSTDVPKIDVYTENLKTFILIKIKDQGDGMTKQVQKKIFDKFY
REHTGDIHNVKGHGLGLAYAKRIVEDHAGEIWVQSDKGKGSTFIIKLPLIS
>KECLDBNJ_02229 Dephospho-CoA kinase
MKTVGITGGIGSGKSTIASFFNSEFNIPVYYADAEAKALMHTEALKEKIISLFGAEAYQG
QKLNRKFISALVFKDEHLLEQLNKIVHPAVGEHFKQWKEVQHAPYVLKEAAILFENGTAQ
SCDAIILITAPEEVRIQRVLKRDETSIAAIKDRINKQWPDAKKIPLADFLIENMDLEESK
KQARKIHLQLLGDRVNT
>KECLDBNJ_02230 hypothetical protein
MSDKKKKNKNSNLRVFLTILLVVATISVMIKLNRNFSFSVKVPLTFQNLSEDQILKSASA
NEVKVTGKASGYDYFKYRFFSQQFPIDLSQLQKAKGKAFYVFNPEDDALQGSLTGSDITA
FQPDTVFFDLDRNYEKQVAVIPDYQVDFAAGYGSLEGFKIKPDTVTIRGPQSEVDTITRV
YTDAVRFEEVRNSVADSLNLRFASNIPMVEIQPKKVLYSLSVDKFTEGSVSVPLQLINVP
ANVTAKVFPKRINVIFNVNLSNYELVKSSDFKVVVDFDQVDDSSTSLTPEVKEAPVYVRD
IRLSESTVQYLLVK
>KECLDBNJ_02231 Putative glycosyltransferase EpsH
MNVHFSIIVPVYNRSQEVYELLESLKHQEYNKPYEIVIVEDGSTETSEAIVKQFPELNCS
YFFKENSGPGASRNYGMQRAQGNYFLILDSDCVLPPEYLKAVETGLKAKFTDFFGGPDAA
HRDFTTLQKAINYAMTSLLTTGGIRGRKEASKKFEPRSFNMGISKKAFEASQGFGTIHPG
EDPDLTLRLWKLGFESQLLSDAYVYHKRRISWSKFYTQVKKFGTVRPILTRWHPESARVT
FWFPSFFVLGLVVAILFALADIGLPILMYAFYFAAIAIHASIVNKSILIGLLSVWAVMVQ
FTGYGKAFLVSKIKIGWFKKDPRAEYPHLFFE
>KECLDBNJ_02232 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSYNLLKGKRGIIFGALDENSIAWKTAERVHEEGGTFVLTNAPIAMRMGSINKLAEKTGS
KIIPADATSVEDLENLIAGAVEELGGKIDFVLHSIGMSINVRKGRHYTDQKYDWTQKGTD
VSAMSFHKTMQVLYQKDAMNEWGSIVALTYMAAQRVFPDYNDMADNKAYLESIARSFGYF
FGRDKKVRVNTISQSPTPTTAGQGVKGFDGFIAYADKMSPLGNATAQDCADYTVSLFSDL
TKKVTLQNLFHDGGFSNMGVSDAVMEAFVEKEEQ
>KECLDBNJ_02233 DNA repair protein RecN
MLTHLQIKNYALIEAVSLNFNDGFTVITGETGAGKSILLGALGLILGKRADISSIGNPDE
KCVIEATFDIHNYQLQSLFIAEDLDYESQTIIRREILASGKSRAFVNDTPVTLSQLSALG
ARLVDIHSQHQTLEVTDVDFQFQVLDAFAENTATLQSYTQLYKDFRGKENQLKKLIKQKD
EAQKEEEYKNFLLEELLAANLKPGEQEQHESAHDALNNVEQITEGLAEAYQILSREEVGV
NEMLLSAKLRLSKLSGFGPKLNELSERLDAVTIELDDISEAINDLASETEGDPEELTRLE
NRLKLLFDLQKKHQVDSVDALIAIRDGLDDEVQSLNNLDESIARLKLEIADAQKQLDILA
GKLSKERSKAIKPLTSKLEAILSNLGMPNARFEVSLESSTTFLDNGKDVLHFLFTANKGM
RAQELKKAASGGELSRIMLAIKSVLSDYAQLPTLIFDEIDTGVSGEVALKMGHIMQAMGN
RMQLISITHLPQIAGKGAQHFKVYKEDVAQKTTTGIRVLPKEERIAELAEMLGGKASSDA
AFDHARQLLNE
>KECLDBNJ_02234 hypothetical protein
MIRSLVVFCACLLAVAVQGQELNCSVVINAEQTGQSNRQVFRTLKTELTEFMNNTTWTDL
NVKQQEKIDCSLVIIVSNIDSDYFTASLQVQSSRPVFNSTYTTPILNFNDKQFNFRYTEF
QPLNYNPNVFDSNLISVLAFYAYTIIGLDAASYQLNGGEPYFQEATRIVNTAQQQVTEGW
SPQSGTQTRFRLNNDLLSPNFRTFSDIMYAYHRNGLDYMADNPREAKQGIAATLELFNQM
YASRPNNFLTRVFFDTKAEEVSKMFSSGPQVNVSNLISVLNKVAPTKSTFWQQIKL
>KECLDBNJ_02235 Coenzyme A biosynthesis bifunctional protein CoaBC
MSILSGKKVLLGVTAGIAAYKAAFLVRGFIKAGAEVRVVMTPEAKEFVTPLTLSTLSKNE
VLSTFTQEENENAVWNNHVELGLWADFFVIAPATANTLSKMASGTSDNLLLATYLSAKCP
VYFAPAMDLDMYKHPSTHNSFEKLQSFGNIMIPATSGELASGLEGQGRMAEPEDIVAFIE
ADILSRLPLKDKKVLITAGPTYEAIDPVRFIGNHSSGKMGYALAEAAANLGAQVTLISGP
THLQLKHNLINRINVTSAAEMFEEVKKHYKTVDIAIASAAVADYRPALVADQKIKKKEAA
LKIDLEPTADILAYIGAEKKKQLLVGFALETENEVANAQGKLQRKNLDLIVLNSLNDKGA
GFKTETNKVTFITKYGAVLPQELKPKAEVAQDVFELIQQLLHD
>KECLDBNJ_02236 hypothetical protein
MDVKNLDAPVNTITHNRSEIDAPTGNIYEAISIIAKRATQINTEIKRELLEKLDEFATYS
DSLEEIFENKEQIEVSKFYERLPKPHAMAVQEWLEDKIYFRDTTTKE
>KECLDBNJ_02237 Outer membrane protein assembly factor BamD
MFLSLMKKTILVVLAVITLASCSEYQEALKSEDMGLKYAFADSLYDVGKYRKSLKLWEQI
VPAYRGKPQAERVMYLYADAHFQVEDYYLAGYQFDRFVSAYPDSDKAEEAQYKAAVSYAE
LSPNYQLDQSETEKGLDYLQQFITAYPDSEYAADANERIKDLSVKLQKKSYEVAKGWHKI
MEYPAAIASFDDFLSDYPGSPFREAAFFYKLDSQYQYGSKSINVLVKPRLEEAIEMYETL
IRYFPEGEYRTEADAIKADIDQILENYS
>KECLDBNJ_02238 4-hydroxy-tetrahydrodipicolinate synthase
MQELKGTGVALATPFKSDLSVDFDGLAKLVEYNINGGIDYLVVMGTTAENATLTAEEKDA
VIAKVIEVNAGRLPLVLGVGGNNTSAIVAELKARDLSAFKAILSVSPYYNKPTQAGIYAH
YEAVAAASEVPVILYNVPGRTGSNMLPETVLKLANQVENIIGIKEAAGDMAQMMRIIKDR
PEGFLVISGDDLLALPTVTAGGDGVISVLAQGIPNLFSLMIKEGLHDNYTEAYKKHYTLM
PATDLIFAEGNPAGIKALLALKGICSPEVRLPLMQATETLQQNIATYLSETGL
>KECLDBNJ_02239 hypothetical protein
MFLDGLKHNLVKTKVNNWLAQPTTHKEVGHITNVVILVEARFVNEGKNLLKRLDKLTQSS
ENKLVVFAEKRADQSAEDLLYLSKKDFSLFGNLKNEAVKNLIEQPFGLLISYYTSENVFL
NFVATQSKAAFKVGIDHKNTAINALTIQVEPTDVAAFETELVKYLKLLKRIE
>KECLDBNJ_02240 Mannosylglucosyl-3-phosphoglycerate phosphatase
MLRNFILLFLALHVFSCKDSQATLTHIDGKQIPITDSIKSDPAIVEYVAPFKARIDAEMS
AVLAYAPQSLSKNDGPFNTALGNMMADAVLELSNPVFEKRTGNTIDAVLLNHGGIRSTLN
AGDVTMRTAFDLMPFENSVVVVELTSDKVNEMFEYLKSGKAHPIAGMQISIDDDNNLVKA
TINGEPVKDGQTYFIATNDYLQQGGDGMTFFSDPVSMEVLDYKIRSILVDYFKTQDTIAP
VRDNRFTKE
>KECLDBNJ_02241 Trifunctional nucleotide phosphoesterase protein YfkN
MERRKFIKQTGIATAAVAGMPSLDLFGASAKSKKITILHTNDVHSHIDPFSPEDASFPNQ
GGVARRLTLIEAIRKENPNTLLLDAGDIFQGTPYFNFYGGELEFKLMSLLKYDAATIGNH
DFDNGVGGLAAQMPNATFKMLSANYDFTNTAMEGLTKPYEVFIKDGIRIGVFGVGIQLEG
LVTKALSKETQYLDPVEAAQDMSRILREEEACDLVICLSHLGYEYRYDKISDLKLAEKTS
GIDLIIGGHTHTFLDKPVVVSNAKDEDVLVNQVGWAGINLGRIDFEFDTSGTVKTTSKTI
TV
>KECLDBNJ_02242 hypothetical protein
MELQPLKSNTVLVSSGLACVLFILLSSVTSKVGYYIQPLFYIGFYLYYFLSLRRHNYVFA
IFLISAYIGEAFLITDVHRYFIEIVSMFIIAAAALLYTFWPILKLKPRKITKAMLVEPGI
GTLFCIYTIIYLMTMYYDLIPNKFLFVSGTILLLVFTIVCFLIPLRNRHPSNMYLYLIGG
GLLIEAILAFVFTYSISIPIIAIGAKIAICVHKACVTLYCVSIDHVRTDMSYDEY
>KECLDBNJ_02243 hypothetical protein
MKYKYLLLAYLLLGFLEVFLPDHFFNLAVSLRPINVAIIYCFYVGNTKQHNYLLLFYLVC
ELLNEIFFLIDFTKYFTLVLSCYSIATFTMIYHLWPVLKSAANKADAVDWLRPSLGLLAI
FYMFWKLSLMVFDELPNNSIFFVGVLALVCWSVFCFLVPVKNKHPDNFALYFMGGAMAVM
APSMFIYEFIWTFEVILYFSLLSMLLFKIFLVWYLIHFKYILRSQEEYF
>KECLDBNJ_02244 DNA ligase
MTTQDKIEALRAELRQHNYNYYVLDQPQIDDYTFDQKLKELQELESKHPEYHDPNSPTLR
VGGQVTKNFATVKHQYRMYSLDNSYSQEDLEDWEQRIKKLVDGKVEYVCELKYDGASISL
TYENGALVRAVTRGDGTQGDDVTNNVKTIRSVPLKLKGDYPDKFDIRGEIVLPLAGFAAM
NAERVEAGDEPYSNPRNTASGSLKLQDSAEVAKRPLECLLYSIVGENLNFDSQFESLEKA
RSWGFKVPDVAKKTASTSETFEFLNYWDEHRHDLPYETDGVVIKVNSFRQQEELGFTAKA
PRWAMAYKFKTEQAETVLEKITYQVGRTGAITPVANLVPVQLAGTIVKRASLHNADQIEK
LDVREGDSVYVEKGGEIIPKIVGVDFEKRDPDSAPTTYIDTCPECETPLVRQEGEAQHYC
PNDMGCPPQIIGRIQHFISRKAMDIEGLGGETVALLVNEGLIKNYADLYTLKKEQILPLE
RMAEKSADNLIKGIEASKQVPFERVLFGLGIRYVGETVARKLAKQFKNIDALAAATEETL
IAVDEIGNRIAQSVVAFFSDAYAQELIGRLKAYGLQLELDAAVLENQTEKLKGQTFVISG
VFSKVSRTELKKMIEDNGGKASGSISSKTNYLVAGENMGPSKLQKAESLNVPIISEDDFL
EMLEQ
>KECLDBNJ_02245 hypothetical protein
MIRVFGMVLLLMLTSCLTRDERISEFQEKLGLEKAQVLNDMVDHFENRLQVLYPKLELKD
AYLQLLEDLEHQALDNTEMQFQWPEALLLKDINSGLQDDFYMQKFNSKTLNQEGVFFKAM
RSQSYYDELIAEYFWVLEQTGRITPSQFASGMLRFDFDPNNFFHKRILVFQFSP
>KECLDBNJ_02246 LOG family protein YvdD
MNTLKSICVFCGSSEGNDPAILEQAKVLGTQLAANNITLVYGGSQLGIMGAVAKASLTQG
GKGIGIIPEFLKTKEIVYTELDEVITTQNMHERKLKMQEVSDGFITLPGGFGTFEELFEI
ITWSQLGLHHKPIGLLNINGFYDHLIAMLDEMVNRGFLSAKNRQLLIVDDEVDGLLDKMK
HFIPDFTSKFLKPENT
>KECLDBNJ_02247 Release factor glutamine methyltransferase
MVLKEYRQKFYNALDVLYPQEESETFFKILSQEYLKLAAFEIPLNFQLELTEAQQIRFDQ
ALNRLKKFEPLQYIVGTTEFYGFPFVLSPDVLIPRPETEELVEWIYTDFKDKECRVLDIG
TGSGAIAVSLARILPKASITALDVSAKALKIAAENATANAVKVRFIEQDILACETLEESY
DVIVSNPPYVRDLEKAEIKPNVINYEPHLALFVPDDNALLFYRKIAELALKALQPNGILY
FEINQYLGEQTVSLLKNIGFSKVELRSDFAGNPRMIKAQR
>KECLDBNJ_02248 N-alpha-acetyltransferase RimI
MLQIRAVEAADNKELASLLRSILIEMGVPKVGTAYADTTLDCMYETYDVDQAEYFVIEED
GTLLGGAGIAPLANYEGPVCELQKMYISASLRGKGVGQRLMNTCLEFAKNQGFEQVYIET
IPYMEAAQKLYKKSGFEYIDGPMGCTGHSACPVHMLKTF
>KECLDBNJ_02249 Riboflavin biosynthesis protein RibD
MARCLQLAKNGLGNTYPNPMVGSVIVYNDRIIGEGWHHQAGQPHAEVNAVNSVKDTSLLE
KATIYVSLEPCSHFGKTPPCSDMIIAKGIKKVVIGTVDPFIEVAGRGIKKLMDAGCEVLV
GVLEQECIDLNKRFFIFHQQKRPYIILKWAESLDGFIAPDAESRSTQAPVWITNKYSKQL
VHKWRAEEQSILVGRRTVEADNPSLTTRDWSGASPTRIVLDRELKIDLESTIFDHTVPTL
VFTEKEQSNSDNLKYITIDFTKNTIQQILDSLYKEGLQSVIIEGGSATLQQFIDAEAWDE
ARVFKGTTSFTSGIHAPKLKRAKTLKTEKLTGDLLVHYTHAND
>KECLDBNJ_02250 D-ribitol-5-phosphate phosphatase
MIKNLVFDFGDVFINLDKKAPEQALAKMGIRQIDDEMVNWHNTYEKGLMSSEALTEQYLK
KFPALTALSFKQAWNSIILDFPQHRLDWIIQLAKSKKYRLFLLSNTNDMHIEQVIKNMDA
MRYSQFQNCFERFYLSQQIHMRKPDLEIYDFVLQQDQLIAQETLFIDDTILNTAAASSMG
IHTWHLEPGKEDITQLFKIKKQLF
>KECLDBNJ_02251 hypothetical protein
MIYLLLSIASSSIIFLVFKLYDTFKVNTFQAIVVNYLIATTCGFMAYGKSVNLTIIPSYD
WFPGTLFLGVLFIVIFNLMAITTQRNGLSVVSVATKMSVVLPILFGLIYYKESSGALKIL
GIVLALIAVYLVSLKNSSEISKVKNNGLLLPILVFLGSGIIDTSIKFLEDSFVAEQDVPL
FSAMIFLTAFVLGIAVLFYQIIQKKQHLAFKNIIGGIALGIPNYYSIYFLVQALRHPTLE
SSTVFTLNNVGIVMVATLIGILFFKEKLSTKNWIGIAIAVVSIILIAVVKS
>KECLDBNJ_02252 IMPACT family member YigZ
MQEESHRDTYKTITKTSAESLFKDRGSKFIGQAHPVRTEEEIEEILTSLHQQHNKASHIC
YAWQLGKNYEHYRANDDGEPGNSAGPPIYGQLQSFEVTNTLVTVIRYYGGTNLGVGGLIQ
AYKTAAQLALETAKIVVKTITEELQLKFEYALLHTVMRIIKEEQLTIANQEMELSCSVTV
SVRKNDLERIQERFDAVFGIETIIL
>KECLDBNJ_02253 Putative esterase
MKTHNSSVKVRYGETDQMGVVYHGNYAQYLEVARIEWLSDLGVSYKKMEENGVMLPVYDM
RYSFLKPAFFDDLLTVKTTLRKIPRASIVFDYEIYNQNQELLTRAETTLVFVDMKTNRPT
RCPQYILDLLLDQDAKE
>KECLDBNJ_02254 Chromosomal replication initiator protein DnaA
MSMTAQTVWDNCLSFIQDNITPQAYKTWFEPIRAVKLTDNALSIQVPSKFFYEWLEEHYV
KLLKVSLTKELGEQAKLVYVIRMENTYGNKQPFTEKIPSTNRPNTMKSQEVDAPLKNKNP
ELKNPFVIPGIRNLEIESQLNPNYNFDNFLEGDSNRLARSAGMAVANKPGGTSFNPLLIF
GGVGLGKTHLAHAIGVQIKDRYPDKTVLYISAEKFTQQYIESVKKNNRNDFIHFYQVIDV
LIVDDIQLLSGKAGTQDVFFHIFNHLHQNGKQVVLTSDKAPVDMQDIEQRLLSRFKWGLS
AELQSPGFETRVSIIRNKLYQDGVEMPEDIVEFLANNIKTNIRELEGAIISLIAHSSFNR
KEINLELAKKIVDNYVKHTKREVSIDYIQKVVSDYFQMDVDTLQSKTRKRHIVQARQLAM
FFAKKLTKASLASIGSQIGKRDHATVLHACKTVDNLSATDKQFRKYVEDLNKKLTM
>KECLDBNJ_02255 Low molecular weight protein-tyrosine-phosphatase Etp
MVCLGNICRSPLAEGLLKSKLDAEKFQVDSAGTGHWHVGNLPDSRSIAVAQKNGLDITDQ
RGMQFKPAFFERYDYIFVMDNYNYEDVVAQAPKEEDKAKVQLILDEIFPGERVDVPDPYN
DSQRGFDRVYEMLDEATTKIAERLS
>KECLDBNJ_02256 Ribosomal RNA small subunit methyltransferase I
MHIKSEFGKLYLIPVTLGDTPPLEVMPGMIQNIIETIDQYVVENEKTARRFIKQICPKKP
QPLLKLHALNKHTDPTEIPNFLDACLSGTSMGLMSEAGVPGVADPGAEVVRIAHEKGIQV
VPLVGPSSILMAMMSSGMNGQNFAFTGYLPIDQKEKRNELKRLERLSKDYNQAQLFIETP
YRNNKMLDELCNTLNRNTRLCIACDITLSTEFIVTKPISVWKSNKPDLHKRPALFIIQH
>KECLDBNJ_02257 hypothetical protein
MTKNIVKLAALPSVFGLVALSMSVKDADKPRENSTEGLELFYTVPQFDEADASVLDNTSN
LNLATTGKSFTGFKEALGFKESQNDYKRINQLGYLGKYQFGRSTLLLLGITDTDEFLNNP
VWQEKAFVANASRNKWVLRKDIKRFNGKMINGVKVTESGILAAAHLAGPGSVKSYLRSGG
VEGFRDAFGTSIRSYMKKFGGYDVSFIEPNRTAKVKLNS
>KECLDBNJ_02258 Endolytic murein transglycosylase
MYIKKIIAATAVIGMIVGGIFAYTIYGKFFSPNTAFNNEEAHLYVKTDATYSDVRADLEP
LIDDIESFDQVAERKGYVSNIKPGHFIIEKGSNNNEIVNAIRSGNIPVKISFNNQERLEN
LAGRISQQIEADSTALLEAFTDAEFLKANGFSEETALTMYLPNTYELYWNTTAEEYRKRM
LTEYDRFWTDARKAKAEAQGLTPKEVYVLASIVQKETAKNDERPRVAGVYLNRLHNGWKL
DADPSVIYAVKKQQGDFDQVIKRVLYKDLETDSPYNTYKYGGLPPGPIFMPDLSAINAVL
NPESHQYYFFVADVSNPGYHLFAKTVAQHNANRKQYIDWINKQGINR
>KECLDBNJ_02259 Acetyltransferase
MDGLTLKGELVYLRALEPEDLDLIFKIENDEDLWELSTTLTPFSKFLLKHYLKNAHKDIY
EAKQLRLVVCKAANDEALGMIDLFDFDPRNHRAGLGILIFSKVERGRGYGAEALKLITKY
AFKRLELHQLYANILEENAPSIKLFEKQGFERVGLKKDWTRVGGSFKNEYLYQLIHNDVH
>KECLDBNJ_02260 Diaminopimelate epimerase
MSIPFYKYQGTGNDFVIIDNRQNIFSKNDTKLVKKLCDRKFGIGADGLILLENHDTLDFT
MVYFNADGNPSSMCGNGGRCIVAFANELGVINNTTTFEAVDGLHEAHIENGQVHLKMQDV
AEIKEFDTHLFLNTGSPHHVQWVSQIEDFDVKTEGATLRYSELYGKAGSNINFVEATTDG
FRLRTYERGVEDETLSCGTGATAVALAIHKQGKVNQTSVPLQVEGGKLTISFEPEGEGYK
NIFLIGPAQKVFQGVWTD
>KECLDBNJ_02261 Periplasmic serine endoprotease DegP
MKKFASLLFVAIVGGGVTLGAYKLLEDESKTEVSNLTTSPNFNTVAYEGRPISSTNADFT
EAADRTVHAVVHVKNVQTSRQPRNLQEFFYGGGETRKGLVGAGSGVIISADGYIVTNNHV
IDGATELDVSLNDNRTFKAEVIGTDPQADIALIKIDADEDLPYLPFGDSDNVRLGEWALA
VGNPFNLTSTVTAGIISAKARDINEYDSNPQSFIQTDAAINPGNSGGALVNINGELIGIN
TAITSQTGSYVGYAFAVPSNNARKIVEDILEYGDVQRGILGVSGTSLNPSIASQLDVDAV
EGVYVADVEFESGAKKAGLEEGDIITQIDNVKVSKFSDLSGYLGAKRPNDVVQVTYTRDG
ESITVPVTLLKYEAYVIDKPGLEVREASSELLKEYGVKNGVVIAQATNDKLKRYGLNGIV
ITEIDEEPVKSVADVKRIMNAKNPNEPVSLSFVGKGGEKKQIIFQ
>KECLDBNJ_02262 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MTTSSTYEKELAFQADRRRATIEFIKIISDLWYDNNIELVLFRNQLIDRNVSEILNLHAY
AGAFVQKPISIFDSVELAKAIQQVHLPPAKLDIGKLTYEYHIEDNEYADATAFIHHKLKE
AHSAETITPKDVVLYGFGRIGRLVARELMTRTGSGNQLRLRAIVVRGPINEAVLQKRASL
LKSDSIHGDFPGTIDVNIEREALIINGTTVRLISANTPEEIDYTQYGIDEALVIDNTGAF
RDQEQLSRHLIAKGVAKVLLTAPGKGIPNIVHGVNHNQVNPDETAIVSAASCTTNAITPV
LKVIEESFGIVTGHLETIHAYTNDQNLVDNMHSKYRRGRAAALNMVITETGAGKAVAKAL
PELEGKLTSNAIRVPVPNGSLAILNLKLNHKTTVETINATLKKYALEGDLVEQIKYSINN
ELVSSDIVGSSAPSIYDSQATLVSSDSENVVLYIWYDNEYGYSHQVIRLAKYISKVRRFT
YY
>KECLDBNJ_02263 hypothetical protein
MNTIKINFLLLFFVITAVSAQEKQTTEQPAEPKVNTISQQFEDLLENSNNYQEYKVVKQN
ALAKLKSNAADSINDLKGQIVNLQNEIQTQDSKISELNKSLEDTQSTLDKTREEKDSIFF
LGIPMSKGGYMGMMWGIVAVLALALVFFIFKFKGSNAHTQEARQKLADTEHEYEEYRKKA
LEKEQKMGRLLQDERNKAVKNNKK
>KECLDBNJ_02264 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITVVPELLKSPFEASIMQRSIAKGLVEVHFHNLRDYTTNAYKQVDDYQYGGGAGM
VMMIEPIDKCISELKAARDYDEVIYMTPDGETLNQGIANTISLQKNIIILCGHYKGVDQR
VRDQFITREISIGDYVLSGGELGALILCDAVIRLIPGVLGNETSALTDSFQDDLLAPPVY
TRPADYKGWKVPEILTSGNTPKIEAWREEQAYKHTKNRRPDLLNE
>KECLDBNJ_02265 50S ribosomal protein L19
MEDLISFVQNEFVEKKEFPEFSAGDTITVYYEIREGEKVRTQFFRGVVIQVRGTGVTRTF
TIRKMSGTVGVERIFPINMPALQKIEINKRGKVRRSRIYYFRGLTGKKARIKEVRK
>KECLDBNJ_02266 hypothetical protein
MKLTPNFTGFKKNLSVKIYPKILYLQSTKLFLKLFLLKEFTPFLMTELKSRLIKRTHFYV
NQNI
>KECLDBNJ_02267 Isocitrate dehydrogenase [NADP]
MSTKTSKIAYTKTDEAPALATHSFLPIISKFAKPANIEFEVKDISLAARLLANFSDFLKE
DQKVSDALAELGELAKSPEANIIKLPNISASVPQLTAVIKELQAKGFAVPNYPEEAKTDE
EKAIKQRYAKVLGSAVNPVLREGNSDRRAPKPVKEYARKNPHSMGAWSKDSKSHVATMAS
GDFRSNEKSVTLPEATSVDIIHVDNNGTKKTLKEKLVLKEGEIIDATLMSKAALLKFLSE
QIEDAKAQGILFSIHMKATMMKVSDPIIFGHAVKVYFKEVFEKYGEDLKSIGVDTRNGLG
DLLNDINKLPEAKKNEVEKAILDTLETRADLAMVNSDKGITNLHVPSDVIIDASMPAMIR
NSGQMWNAEGKSQDTKAVIPDSSYAGIYQETIDFCKEHGAFDPTTMGTVPNVGLMAQKAE
EYGSHDKTFEIATAGKVQVIDASGKVLIEHSVEEGDIWRMCQTKDAPVQDWVKLAVNRAK
ATGVPAIFWLDKNRAHDAELIKKVNVYLKDHDTAGLDIQIMSPVEATRFSLKRMKEGKDT
ISVTGNVLRDYNTDLFPILEVGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQFVEEGH
LRWDSLGEFLALAVSLEHEGTTNDNPKALVLAETLDEATIKFLDNKKSPSRAVNELDNRG
SHFYLALYWAQALAAQDKDKELQVHFAEISSEMETNEEKILQELLDAQGSEVELGGYYFP
DEDKSSSAMRPSATLNAIINS
>KECLDBNJ_02268 TonB-dependent receptor SusC
MGYLTVTHFYFHKVVLQCTKSLIFEKKSLRKTYFLVFFLLMCHLVSGQKNHTLSGVITSA
ESNETLIGVNVIIPELNKGAVTNEYGFYSITLPEGTYALQISFLGFESISQPLVLDANQK
LNFSLNASTETLDEVVIEEDVEQLSIRKPQMSVNTLTAQTIKQIPVVLGEADVIKSILLL
PGVTSAGEGASGFNVRGGAVDQNLILLDEAIIFNSSHLFGFFSVFNPDAIKDLKLYKGGI
PARYGGRVSSVLDIYQKEGNSKEFHANGGIGAVASRLLVEGPIVKNKSAFLIGGRASYAH
LFLPLFDIDNKAYFYDLNAKLNYNLDEKNSLFLSGYFGRDLFGVSESFVNTYGNSTLNLR
WNHIFSDKIFSNLSLIYSDYYYGLLLDFVGFQYDSGIRNFNLKYDFQHYLNSEIKLSYGV
NNIYYRFNPATITPNRPDSGIIPSQLTHKYANEFSAYIEAEQDLSDKLIVKYGARLSHFT
RLGQDSFAVYQNDQPLTYNASLSIYQPAEPVEIQSNTGRLADFTNIEPRASLSYLLNDNS
SVKASYNRMAQYLHLISNTNAPTPLDVYAPSGPYLKPQILDQYALGYFRKIKNNEFSIET
EVFYKDVQNRLDYRNGAQLIANENIETEVLAGKGRAYGLEFLAKKNKGQFTGWLAYTLSR
SEQQTPGRTPQETGINDGNWYPSAYDKTHDISAYLSYEANKKWTFNANFIFQTGQPTNFP
VSQSQFQGLNITNYDGRNQQRLPAYHRLDLSATLTPKNQNKKFKGSWVFSIYNAYNRMNA
ASITFRTNDDTGANEAVRTTIFGILPSVTYNFKF
>KECLDBNJ_02269 hypothetical protein
MKRLKNCYIVLLLMTLLVSCQDTIEVDLPPTQERLVIDAVMRIPDTDTFIVEAYLKLSKT
TDYYADSIPKVNDALVSLTTSNQTYTLQAEENGFYSTVLPREELTQGPVSLAIEYEEEFY
SATTQFVNAVPIDQVEQGDGSLFAGDETEVIITYTDAPNQTNYYLFDLDKGQYLTSEDTF
YQNQQFSFSFFYEDLKPNDTLNIELLGVNKAFSDFMTVTINQSGQASGNPFVPAPSVIRG
NIVNETNDAHYPIGYFSISQVYTASIIIE
>KECLDBNJ_02270 N-acetylmuramic acid 6-phosphate etherase
MSFTKTTEQDSKYSDLEKMSVTTLLHSINTEDKTVPQAVEKAIPQIELLVNQLVAQMKEG
GRLFYMGAGTSGRLGVVDASECPPTFGVSHDLVIGLIAGGETAIRKAVENAEDSTTQGWE
DLKAHNISEQDVVIGIAASGTTPYVLHALKACNKNNITTGSITCNKGCPIAIESKYPVEI
VVGPEFVTGSSRMKAGTAQKLALNMISTTAMIQLGKVKGNKMVDMQLSNDKLVDRGIRMI
QSEIPVNAEEAAQLLKENGSVRAAVNTYLNGNQ
>KECLDBNJ_02271 hypothetical protein
MATNKEALARGVRTMATSLLFMFLGPGIIYQAFKNSEHPLYIPVLILGFVAAALAIYFGF
KGINRIMNALFDKN
>KECLDBNJ_02272 50S ribosomal protein L31 type B
MKKEIHPENYRVVAFKDMSNDEVFLTKSTANTKETIEVDGETYPLVKLEISRTSHPFYTG
KSKLVDTAGRIDKFKNKYKKFAK
>KECLDBNJ_02273 hypothetical protein
MEDQKLTTGKVALTYGGLLGLLTIILAVVLYVTNNLLEQSWITAVVSFLIMIGCISYGQK
VFRNGNGGYMDLKDALKVGVGIALIGAIIGALYNYTFLTVIEPGFTELIIEKQREAMITT
QPNMTEAQIDQAVEFAGKFAQPWVQSSFQIVAGIFFGFIISLISGLILKRNNPHQ
>KECLDBNJ_02274 Dodecaprenyl-phosphate galacturonate synthase
MQLSVVIPLLNEKESLQELYDWLIRVISKEGYTYELLFVDDGSTDGSWQKIEVLALHNPN
VKGICFNRNYGKSQALNAGFLAVEGDVVITMDADLQDSPDEIPELYRLISEEGYDIVSGW
KKKRYDAVLTKNLPSKLFNAAARKTSGLQLHDFNCGLKAYRNEVVKNIDVYGDMHRYIPL
LAKNAGFINITEKPVQHQARKYGQTKFGADRFIKGFLDLLTIWFTTHFAKRPMHLFGTLG
AIMFIIGFGLAAYLGIDKLFINPTARLLTQRPQFYLALTSMIIGMQLFIAGFLGELVQRT
KHERPRYLIKDKKGFN
>KECLDBNJ_02275 Phosphoglucomutase
MNSEIIAKAKSWLSSTFDTTTQEKVQQLIDANGDELNESFYKNLEFGTGGMRGIMGVGTN
RINKYTLGKNTQGLSHYLKATFKGETPKVAIAYDCRNNSKELAQVVADVFSANDIQVYLF
SDLRPTPELSFAVKHLECHCGIVLTASHNPPEYNGYKVYWQDGGQLVPPQDSEIVAEIES
LDYDAVNFSAKKEHITYIDKDVDQAFIEASLKNGSFTELDKHRDDVNIVFTPLHGTSVTI
IPDVLKDAGYKNVHVVEEQRTPNGNFPTVKSPNPEEPEALKMALELAEEKNADIVIGTDP
DCDRLGIAVRNNEGKLQLLNGNQTMVVMTDFLLDLYFSKNKAKGNEFIGSTIVSTPMMDV
LAESYNVECKLGLTGFKWIAKMIKDHPNQNFIGGGEESFGYMVGDFVRDKDAVTATLLAC
EIVTKAKSEGSSFFKKLQELYVKHGFYKEDLTSLVKKGISGAEEIKQTMIDLRENPLTTI
NGEQVVQIDDYASSKSLKTTTGKSVDITIPKSNVLIYHTKEGSRIAARPSGTEPKIKFYI
SVNESVESLDALDKTEEKLDAKIAGIRKELGL
>KECLDBNJ_02276 Lipid A export ATP-binding/permease protein MsbA
MNYFKQIMQFARPYKKYAVLNIVCNILYAIFSTLSFLALIPVIDILFDKNKRINELPVWE
GWSGVKDYVFNSFYYYVSQQVADNELSALVFICAIVVVLFFLKNIFGYLATFFITFLRNG
VMRDVRDAIYDKLLELPVAYFSEKRKGDTISRITADVQEVEVSFLSILEMVVREPLTIIF
TILAMVVISGKLTLFVFVFLPISGIIISRIGKSLKKQSNQAQEENGAFLSIVEETLSSLK
IIKGFNGEDQFRAKFRASTTRLNGILNSLVNRQNLASPTSEFLGIFVIVVILWFGGQMVL
VEGSLEASQFIAFLGLSYQILTPAKQISKASYSVKKGNAAAERILSVLNTETTIKDAPDA
QTAQEFKDAVHIENVSFKYEDENVLTNFNAVVPKGKTIALVGQSGSGKSTIANLVTRFYD
VNEGAIKLDGKNIKELTKASVRAQMGLVTQDSILFNDTVRNNILLGKPDASDDEVIAALK
VANAWEFVSELPLQLDTNIGDSGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDTES
ERLVQKALENMMMNRTSIVIAHRLSTIQNADQIIVMQKGKIVEQGKHQELLALNGTYKKL
VEMQSFE
>KECLDBNJ_02277 hypothetical protein
MVLQLMTVSIHKVTKLKKSASSDADFFIAVNAFVGFFKRSLKSTLILGAKKDFNVLGLYN
NFN
>KECLDBNJ_02278 ECF RNA polymerase sigma factor SigW
MNNLEIHTIESLKFEDLVSEYKERLYWHIRRMVISHDDADDVLQNTFIKVYKNLHNFNGE
SQVYTWLYRIATNESLTFIKKRKRTTHISNEEVQESLVTNLTSDPYFNGDDAQLKLQQAI
DTLPTKQKQVFVMKYFDELQYNEISEILGTSEGALKASYHHAVKKITEYVTAH
>KECLDBNJ_02279 hypothetical protein
MKSKKENNKQQFNIPLGYFESFENRLLTELKFQELFPNKNDGFSVPAQYFEKVEQVILNQ
NKPKGKLVEYNFKTIAATVAAIAAVLLVLFNVVNPIEKEMQFDSLSITSLENYFEEEERV
QDYLSAEELSTIENSTSIFDNETVSEELIYEYVDQDIVQSSLLDQ
>KECLDBNJ_02280 hypothetical protein
MKNLIIIFVLCLGLSGQAQKKDRHEQIKALRVPFLTEELNLTPAEAEKFWPIYNTYDCKM
VDLRSRERALFEEKFFESGSKKNLTEKEANKLMAEYNDIQRSKYEIESQLMTDLTQKLPA
SKMVFLPEAEHKFGRKLWEEYKKRKGKD
>KECLDBNJ_02281 Ycf48-like protein
MRYLLGVALSLAVFGCKNTPEPKELTAIQTVEIERIYEDSVSLRALEILDDGSVAFAGSN
GKYGLYNPTTKVWNTAVMKRDSVTPSFRAVAHTAEDFFMLSIESPALLYKTGDSGAMELV
YEENDPKAFYDSMTFWNDQEGIAMGDPTENCISIIITRDGGNTWTKVSCDALPEAAAGEA
AFAASNSNIAVYGNNAWIITGGMKSRVLHTGDKGKTWEVFDTPLKQGTSSTGGYSIDFYD
ENTGVVIGGDYTHAEGNEANKAITHDGGKTWALLADKAAPGYRSCIQFIPNTKGKELLAI
GFEGIDYSSDQGATWKNLSSEGFFTVRFLNDSTAYAAGSNRIAKLKFKR
>KECLDBNJ_02282 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVFAVIDGLIEIFNEGGYADKVIAKQLKRDKRWGSRDRSFIAETTYDIVRWKRL
YAEIADVKEPFERKDLWRLFAVWCTLRGIKLPDWHQFEETPTRRIKGRFDELSNTRKFRE
SIPDWLDALGEKELSDKWDAEIAALNKQAPVVLRVNRLKSDIGALQTALAEEGHETENIK
PYKDALQLQERGNVFTTEAFKNGLFEVQDASSQLVAPYLDVEPGMRVVDTCAGAGGKTLH
LAAQMDNKGQLIALDIYGNKLKELKRRARRAGAFNIETRVIDSTKVIKKLHNSADRVLID
APCTGLGVLSRNPDAKWKLQPDFVEKIQATQQSILKDYSKIVKPGGKMVYATCSILPSEN
QEQIKKFLKTEEGSDFSIEKQKTVLSSESGYDGFYMCLMVKKDKA
>KECLDBNJ_02283 Phosphoribosylformylglycinamidine synthase
MIHFFGSQDTKIYAVQAKAELSEETTNKLIWLFGNQPKIEASAIDAFFIGPRATMITPWS
TNAVEITQNMGIEGIIRIEEFVAGKAEFDPMLSQEYSKLDQKIYTIDIEPEDIKAIEDIQ
AYNEQEGLALSEEEVAYLESVAERIGRPLTDSEVFGFSQVNSEHCRHKIFNGTFVIDGKT
MPSSLFKMIRKTSEANPNEIVSAYKDNVAFVKGPKATQFAPATADKPDFYTEKEFDSVLS
LKAETHNFPTTVEPFNGAATGAGGEIRDRLAGGQGSLPLAGTAVYMTAYSRLKEERPWED
AMPARKWLYQTPIDILIKASNGASDFGNKFGQPLIAGSVLTFEHDEAGRKLGFDKVIMQA
GGIGYGKKQQALKEKPETGDKIVILGGDNYRIGMGGAAVSSADTGAFSSGIELNAIQRSN
PEMQKRAANAIRGMVESDENTIVSIHDHGAGGHLNCLSELVEETGGLIDLDKLPVGDPTL
SAKEIIGNESQERMGLVIGAEQIKTLKTIADRERSPMYEVGDVTGDHRFTFKSATTGAAP
MDLAMNDMFGSSPKTVMVDTKIHRIYSDVSYSLENFHEYLENVLQLEAVACKDWLTNKVD
RCVGGRVAKQQCVGSLQLPLNNVGVMALDFKSSNGIATSIGHSPVSGLIDPVAGSKNSIA
EALTNIVWAPLEKGLKSVSLSANWMWSCNNAGEDARLYEAVEAVSEFAIALGINVPTGKD
SLSMKQKYPEGDVLAPGTVIISAAGSCDDINRVVEPVLDAEAGSIYYLNLSQDSFKLGGS
SFAQIQNKVGMEAPSIKDDTAFATAFNTLQSLIRQDLVAAGHDVASGGLITTLLELCFAE
NKLGASVDFSAFTEQDIIKILFAENAGVVVQASDDAAFEAALAENNVEFFKIGSTNTSDE
LLIKKDSVEIGLNIPSLRRKWFETSYLLDQKQTANGLAEDRYNNFDQQDLKFEFPKHFTG
IKPTIDASKPRPKAAILREKGSNSEREMANAMYLAGFDVKDVHMTDLITGRETLEDIQFI
GAVGGFSNSDVLGSAKGWAGAFLYNEKANKALKDFFARPDTLSVGICNGCQLFVELDLIN
PEHDQKPKMLHNDSHKHESGFTSVKIQKNDSVMLSTLEGATLGVWISHGEGKFELPLSEK
EYNIVAKYGYDAYPANPNGSSYNTAMMTDKTGRHLVTMPHIERSIFQWNWANYPKGCKDE
VSPWIEAFENARKWIEKH
>KECLDBNJ_02284 hypothetical protein
MTGLSRKHTGIRIFWGLIALYMLNICVDSPDLFPNRAENLNYNDQESVIELVVEQVLDLG
DVIPEYDDNDAEEHTSSETSVNLDHFIVDQSAIAFQQNFSLLKKQNTLFALANFCTLSLE
VDAPPPRY
>KECLDBNJ_02285 hypothetical protein
MKHLPLVLLMAVLTQYTYAQETEPNAIKDSLYIAEVEGSQEPLKILHAEPLYIDLIRDLG
ARKGEKEWNIGLGLTDRDRYDEYLALVEYEWAPADRLGLEIELPFSLHYPIGENGDAPGN
RLNSIKIAGQYTFWVSEKHKTSLAFGYIQEFELTNFNNYGAGKLFTGNVYNPFFIAAKRL
GSNFHSLIYTGPAIAHHFSDGALHTSWQINSNIHYMISGTRNFIGLEFNKEFNQGDFDMT
IRPQLRLDVAENLLIGIVTGIPINRETERFSSFLRLIYEPGH
>KECLDBNJ_02286 hypothetical protein
MKNRLKYILVVLLTIPILSCQEDFLERTPTDAISSADALASEENMQLVLNGIHRGLYSQS
QTVFPGGNTARANNHYWVPMGDNLTGDLIHSANANNLSWRSVMQWNEHTQETSLTSSLLW
YHRYNIILHANLLINEIEGGALTETARLRNILGQAYTYRAYAYLSLVQHYAKGYLIGNPA
SDPGVPLLFSSESPFTSEPRSTVQEIYDQIESDLDAAITAFQDSEAPSVGGAAAKAQLSI
NAAYGLLARCALSKGDWQTAADAAVAARDGFPLLSEDEWKSGFNTNTLSEVIWGSNVIAT
ETTFFRSYFYLASNTFNGSQIRNNPKIADRRMVDAIPETDYRKDVFLPDAPNTNTSAANG
NGGFSNNTNPLYPTEEEFDAAVDSIKAVYGLVAGHNLHPYMQFKLKQANPGTIDPDDVIY
MRSSEMYLIEAEAELMMNNLTDAREALQPLAEARDSSWEATDYPTAESFLDHLKFQWKLE
MWGEGFGYTNHIRWDDGIDHAADGGSGASEVLYQQSYQIERPSLNDDWIFKIPQAEIDAN
PNLGSGDQN
>KECLDBNJ_02287 TonB-dependent receptor SusC
MNEKKLLTVFLVLCFGIQFSFAQQKTVQGTVVTAEDGLPLPGASVLVAGTSRGTQTDFDG
KFSIAVAPDETLTVSYVGFKTINKVVGNASEIMFSLEADSESLDEVIVTAYGTSTKEAFT
GSANVVGQAELQQRNVTSPIAAIEGNATGVQFTSAAGPGASPNIVIRGVGTLNGDTDPLY
IVDGIQYEGALNTINQEDIESLTILKDAASTSLYGSRAANGVVIITTKRGKKGALRVTAS
AQSGFVTNSIGQYDQLSPGQYYESMWEAFKNSSAGGGDPQFASDNIYNQLGYNPFNVPND
QIVNTNGQLNPNAQVIYKSLDWFEELQQTGYRTNYNVYISGGGDDHTVFFSASYLDEESY
VVTSGFDRLTARLNADFDVSDNIKIGGSANITLSEARGPSSAGSGSIVNPFSFARGIGSI
YPVYVNDLNGDIVLDDFGNPVFDNGEGYAEFNIGSRPVNQGRHALQELLLNNESDRDNTY
GFRFYGEWEIFDGLSFKLNYGRDINELFEREYENAIIGDAQPDGRLSEDRARREIENFNQ
LLTYQKSFGDHNVDITAGHESYDRSISSLNGLATVQAANGIYEFANFSNIVDLGGATFDK
GIEGYFLRTNYNYKNKYYLSASARRDGSSVFQTDSRWGTFYSVGGSWRIDQENFMQDVSF
INKLKVRASYGEVGNDDLFDSYLSQARFSITSNAGAPALLFTDIGNAALQWETIENFDVA
LEFGLFNNFLDGSIEYYKKNSSDLLYNLPISPSNGLNQVPVNLGDMYNSGFEFALTGHLV
NRNDFRWDMTLQASTFKNEITSLPDPFINGSKRWVEGRSRFDFFLLRTAGVDPETGDQLF
LLYEQNEDGESVPVIDETTGEIATTNDWEETERAYTGDSSIPDLLGSVSNSFSYKGFNLN
FLITYGIGGKVLDNGYSSMMHSGTYGRSFHPDILNAWRAPGDVTSVPRLENGNVDLVRTQ
SERFLTDASFWALRNVSFSYNFGDSVTNTLGLDALRVSITGENLYLKSKRKGLDPQYNLA
GTPSANDFSPSRIVSLGLNLSF
>KECLDBNJ_02288 Long-chain-fatty-acid--CoA ligase FadD15
METKRLFDFPYHQLEQYNLKEALVTKYDGKWVATTTQSYLDQANAISRGLLKLGVKPNDK
IAVISSTNRTEWNIMDIGILQLGAQNVPIYPTISEEEYEYVLNHSESIFCFVSDEEVLTK
LNAIKANVPTLKEVYSFDAINGCKSWEEVKEEDDSLQPEVEKLKAAVKEDDLATLIYTSG
TTGRPKGVMLSHKNVVSNALNSASRFPIVPGQSKALSFLPVCHIYERMLMYLYQYTGVSI
YFAESLDTISENLKEVQPEVMTAVPRLLEKVYDKIIAKGADLTGIKKKLFFWAVETGLDY
EPYGQNGWWYEKKLGIARKLIFSKWQEALGGNLKVIASGSAALQPRLARVFNAADIGVME
GYGLTETSPVISVNDMRDKGFKIGTVGKPIPQTEVKIAEDGEILIKGPQVMIGYYKDKEK
TDEVLENGYFHTGDIGEIDSEGFLKITDRKKEMFKTSGGKYVAPQIIENMMKQSRFIEHI
MVVGEGEKMPAALIQPNFEFVTEWAKLKNINVGTTPKEIASNEEVKKRIQEDVDIHNEKF
GKWERVKKFELTPDEWSIEAGHLTPTMKLKRRIVKEKYLDLYNKIYERE
>KECLDBNJ_02289 Organic hydroperoxide resistance transcriptional regulator
MSKKDITIDHALRATWQAVIKMYNEQAAKLDSTMATGFALLSIDPEEGTPSTALGPRMGM
EATSLSRTLKSMEERGLIERKPNPADGRGVLIFLTEFGKENRDFSKDRVLKFNEAVRANI
DAEKVDHFFEVIHVINDLIQNKKIYNTSETTIKQ
>KECLDBNJ_02290 putative 3-hydroxyacyl-CoA dehydrogenase
MSKRRINKVAVIGSGIMGSGIACHFANIGVEVLLLDIVPRELNDKEKAKGLTLEDKAVRN
RLVNDHLQNALKSKPSPIYHKDFANRITTGNMEDDIAKVKDYDWIIEVVIERLDIKKQVF
EKLDKHRTPGTLITSNTSGIPIKFMSEGRSDDFQKHFCGTHFFNPARYLDLFEIIPGPKT
DKEVLEFLNAYGEKFLGKTSVVAKDTPAFIGNRVGTYSIMSLFHTVEELGMTVEEVDKLT
GPVIGRPKSATFRTVDVVGLDTLVHVANGIRENVENDERAELFSLPNYINTMHENKWLGS
KTGQGFYKKIKKEDGSSEILTLDLNSMEYRANKRASFSTLEMTKSIDNVADRFPVLIKGK
DKAGEFFRKNFAGLFAYVQNRIPEITDELYKIDDAMRAGYGWEHGPFQIWDAVGLEKGIE
LMKAEGYEVADWVAAMLSSGKDSFYTVKEGNTFYYDIPKKEYLKKPGQDGFIILDNIRQS
KEVFKNSGVVVEDLGDGILNVEFRSKMNSIGGDVLSGLNKAIDLAEKDFAGLVVANQGKN
FSVGANIGMIFMMAVEQEYDELNAAVKYFQDTCMRLRYSSIPTVVAPQAMTLGGGCEMTL
HADRVVAAAESYIGLVEFGVGVIPGGGGSKEMTLRASETYKKDDVELNRLREYFLTIGMA
KVSTSAYEAYDLGILKPGKDIVVVNKDRQIAAAKEVAKFMADQGYTKPIERSDIKVLGKQ
ALGAFLVGTDQMNAGKYISDHDKKIANKLAYVMAGGDLSEASYVSERYLLDLEREAFLSL
CGERKTLERLEHMIKKGKPLRN
>KECLDBNJ_02291 3-ketoacyl-CoA thiolase
MKTAYIVKAYRTAVGKAPRGLFRFKRPDELAAETIDYMMKELPDFDKKRIDDVMVGNAMP
EAEQGLNVGRLISLMGLKIEDVPGVTVNRYCASGIETIAMASAKIQAGMADCIIAGGAES
MSYIPMGGYKPVPDYKVAKAGNEDYYWGMGLTAEAVANQFNVSREDQDEFAYNSHQKALK
AQEEDRFKEQIVPIDVEHTFVNGAGKKETKTYTVSKDEGPRADTKLEILAKLRPVFAEGG
SVTAGNSSQMSDGAAFVLVMSEEMVKELNLEPIARLVNFAAVGVEPRIMGIGPVKAIPKA
LKQAGLQQKDIDLIELNEAFASQSLAVIRELDLNPDIVNVNGGAIALGHPLGCTGAKLSV
QLFDEMRKREMKSKYGVVTMCVGTGQGAAGVYEFLN
>KECLDBNJ_02292 hypothetical protein
MSKRRHNYKNLKIWSLGLEIACDISDVIESFPKDERFDLASQMSRASTSIPSNISEGSSR
TDKAFSTFIDYALGSSFELGTQLLIARHKNYIDDKKIVELETKIQEWQKMTMGFQNGL
>KECLDBNJ_02293 putative acyl-CoA dehydrogenase
MAETADKKEILRGGQFLVKETACEDVFTPEDFNEEQKMMKETVKEFVDREIVPNKERFEH
KDYALTEEVMRKAGELGLLGIAVPEEYDGLGMGFVSTMLVCDYISGATGSIATAFGAHTG
IGTMPITLYGTEEQKKKYVPKLATGEWFGAYCLTEPGAGSDANSGKTKAELSPDGKSYKI
NGQKMWISNAGFCNLFIVFARIEDDKNITGFIVENDPSNGISLGEEEKKLGIHSSSTRQV
FFNDTVVPVENMLAGRGEGFKIAMNALNVGRIKLAAACLDAQRRIIDMGVKYANERVQFK
TPIAKFGAIKYKLAEMATNAYVCESASYRAAKNIEDRIAIRMADGNSHQEAELKGVEEYA
IECSILKVAASEDMQNCADEGIQIYGGMGFSADAPMEAAWRDARISRIYEGTNEINRMLA
VGMLVKKAMKGHVDLLNPAMAVADELTGIPSFDTPDYSEVLSEEKAMIAKLKKVFLMVAG
SAIQKYGPALEEHQQLLMAASDILIEIYMAESAILRTEKNVKRFGEDAQKEQIAMAQLYL
YHAVDTINQKAKEGIVSFAEGDEQRMMLMGLKRFTKYQNQPNVVALRNIIAEKVTEENTY
PF
>KECLDBNJ_02294 hypothetical protein
MQKIGFILLAFVMSFSLQAQENTEVFLFEIKTTPTTIEIVNGKNISQNAGYDNQPSFYDE
STLLYSRTQDSLTTIGVYDISTSKTSVFTNEPNSGFFSAQRIPNTETIVAVRQDPEGRQR
LAQYDFQTKAFKKLLDSSQVGYFSFYDQQTFIASVLQPNQMDLFLINIEKGTSESIITNS
GRSVQKIPNSNSMSYTVENETKNMDLYTLDFSGDEPTSYFVCEMPIGRQDYTWLDENRIL
VGSGDSLFVYDLFGEPAWTFAASLNSYGIKNITRMTVSPDGKYLAVAAEPVEN
>KECLDBNJ_02295 hypothetical protein
MPKQTKIIILIVLAQFLGTSLWFVGNIVVPQLPVARLGNPDLLGDLLAAVQLGFILGTLV
FAVLAIADRFSPSKVFAVSAILGAVANLALLLPQAESGTLLISRLSTGFFLAGIYPVGMK
IAADYFEKGLGKVLGFLVGALVLGTAIPHALNSFEVSVDYKIITLVTSGLAAVGGLLIGV
FVADGPYRKAQQKLSIKAIPFIFQTKKFRRAAFGYWGHMWELYAFWGFLPVFINYYQAEH
QVYLNTSLWSFFAIAIGAISCAFGGVLTQKISSKKVAYYALVISGMCCLVSAFSIEFPPV
IFGFFLLIWGAAVVADSPQFSTLVAQNAPPEYRGTALTLVNCIGFAITVVSIQLLNYWVI
HFDIDYLFLVLSLGPIFGILSLYRSKL
>KECLDBNJ_02296 hypothetical protein
MRILYCFFFLIFIACGKNEGPPPLFQKSENTFTPVQKAIIAPRVDGKPHDPAWQHLEWTQ
MNNIWSGKASANSTIQYKLTWTPDALYVLLRLENITIQSTFGNPMEHFNSEDHLSVYVDE
DNSAGSYESSYNAFNYQISPSNTSVFLDQNKKPRTANHAVYSAVKNYGIISYWELRITYF
DSTFNPNAPHEAVSLKPEKLMGFALAFEHADAKATNTVLGSVAIPQDYEGRIDLDAGLFE
TLKLIQ
>KECLDBNJ_02297 Oxidoreductase YdhF
MENRIALNDNLSLSRIVHGYWRLRDWNLSDDHLLKLIEQVLELGITSFDHADIYGNHTCE
AYFGRALAKRPELREKMELISKCGIKMATDYNPELDIKIYDYSTEYIIKQAETSLKNLGT
DRLDLLLLHRPAPFFNPEEVAKAFDQLRSSGKVLNFGVSNFSPAQFDTLQSYLDMPLATN
QVEISVSCLEHFENDNTEYFLKHKIKPMAWSPLAGGAIFNPKTEKDQRLTAELKSIAAEL
NTDIDQVMYAWLLKHPTGIMPIVGSQHINRIKSAVDALEIELSLEQWYKIYIASKGEDLP
>KECLDBNJ_02298 Beta-galactosidase
MRILSLSFLLGLVFLCSPILNAQELPEWQNLSVVTQNTEAPGSTFYVYDSEEEAVENAYY
NSKNLLLLNGTWKFNLADTPEQRPKDFYLPEFKTNDWDDINVPGDWQMQGYDFPLYVSAG
YTHAINPPFVDTIYNPVGSYKREFIIPKDWKNKQIKLYFGGVTSAFYVWINGQKVGYDED
AKTPSEFDITSFIKPGNNEIAVEVYRWSDGTYLEDQDFWRLSGIERDVYAYAQPKVHIQD
FFFKTGLDSKYIDGIFDGKIAIKNDGATTESLQLDLKISDANEELYSATQSLRLASAKSD
TLQFQETFETIEPWSAEHSKLYQVVLSLRKGDELLMSTSAKIGFRTSEIKNGNLLVNGKP
ILLKGVNRHEHDQRTGHVISKESMLEDIRLFKENNINAVRNSHYPNDPLWYSLCDEYGIY
MVDEANIETHGFGYDEDKTPANKPEFALMHQDRLEAMVETNKNHPSIIIWSMGNEAGDGP
AFIDGYHWIKNRDNTRPVQYERAERGKSFQEPHTDVIPWMYARMNYIEEHYLGKYPDRPF
IWCEYAHSMGNSTGNLSDLWDFVYKHDQLQGGFIWDWVDQGFVKKDSTGTEYWTYGGDYG
PDRYRNDGNFVLNGLVNPDRSPHPALAEVKHVYQNVKISLVDTLKRKFKLENRFFFTNLN
NYTISYEVLKDGKIIAEDNLPAFDVAPQQSVDFSIKTLELPEDGSEYFINFSIKTKDASA
MLPAGFVIAQDQILLQKAAPLVFTPDLEKRKLKTIDTRNALEVSGEDFSLYFDKTTGSLA
KWTYKDQDYLLEAPRANFWRAPTDNDFGNNYQKRGKLWKDASKNQKLISFETLAKTKDSV
ILESTLALDTLQAKTKIRYTLYKDGSLKINEKLEYSGAEDIAELPRFGMNLILPKEFDQV
KWYGRGPFENYQDRKEAAFVGIYEASVADLYYPYIRPQENGYRTENRWLQLTDDQGSGFK
ILGLPEFSFSAHHNYTADFDPGTRKAQRHTTDIKPRDLISLHIDYKQTGVGGDNSWGAKP
LEKYQLKPQDYEFSFIIKPLE
>KECLDBNJ_02299 hypothetical protein
MILVKQIRYITGFCVVLFTMASMEAQEIKPAKQVDGEMPLFEVEAPDYKLSPMTGMTRKH
WEDAARYLLEGAFSYIDDLDDPMKFPKLPGKSYPHDISRVPTEKLEGLVRTLFVAAPLLK
KEPGLTLNGIKVAEYYQHQIPKLANPESEAFIKPRGNGGPSQNLVEYGALAISLFISPET
LWEPLSQEDKDALAASMLSYGDGPTVDSNWKFFNIFVLSFFDAQGYEVNKPLLEEYLNKS
LADYRGQGWYNDHPAYDYYSMWAFQVYGPMWASVYGNTHYPEIAKAFKTNFQDLVYHYPY
MFSEDGKMIMFGRSISYRIASMSPFPFAGTLDDDTINLGWLRRISSGVLLQFLKNPEFLK
DRIPTLGFYDHFEPAVQNYSTRGSVFWMGKAFLGLLLPEDNAFWTATENEGPWASRFEDD
AVYNKFQAASNVLLTDYPGIGASEIRAWCHERKADDWQGFRSSENYNKLSYNSEFPWQAD
DPDGTISMNYVFKNAKEEWEPWRLYTFKKYEDGKYYRDAVLETNDQVHMQLVDIPLANGI
LRVDKQTSEVPVAMRLGHYSLPEIDGKTIEQSTQKVGDYTATIIDNGQYQLAMVPLSGWE
DVDVIEKTDLHPVADDSAVINVSAEFSPEDKNKIYATLMLWKNSGEAWSAEDLLPVKDLK
TEENEVEVEMISGELHSINFD
>KECLDBNJ_02300 Unsaturated rhamnogalacturonyl hydrolase YteR
MNNHFKTLLFSAVLGVVLSSCKSNGDSTSNTQDAEVEVTGIPQEKDSVLAIIEKVNKHWQ
ETHPKPGFAFWHPAAYHTGNIEAYKVTGNKDFLDYSKAWAEYNQWMGAKSQDKSKWKYNY
GETDEHVLFGDWQIAFQTYIDLYTLEGSKDPTKIARAKEVMEYEMSTPNNDYWWWADGLY
MVMPVMTKLYKVTGNEQYLEKLNEYLAYADSIMLDEETGLYFRDAKYVYPKHKSLNGKKD
FWARGDGWVFAGLAKVLQDLPQDAQYRQAYIDRFKKMAKTLKEAQQPEGYWTRSILDSEH
APGPETSGTAFFTYGYLWGINNDILEEETYLPVVEKSWEYLTEVALQDDGSVGYVQPIGE
KAIPGQVVDVNSTADFGVGAYLLAASEMARFVDSE
>KECLDBNJ_02301 hypothetical protein
MVKFKGLFIFSFIAVNLFSFKILAQKEEREYMVETLLKIADPVLTNLAEEKLKKNMPVER
SPGAWDDRTHVTYLEAFGRLYSGMAPWLELGPDDTSEGKLRKKYIDLVIRCLDNATNPES
DDFMNFNKDAQPLVDAAFLAQGLLRSPTQIWEKLDKEVQERIIEALKSTRVIKPYYSNWL
LFSGMVEAALEKFDNSGDLLRIEYGLNKHREWYLGDGMYGDGPEFHWDYYNSFVIQPFLL
DIYQTLQETDNGRKKDFDNVKYRAQRYASIQERLIGPEGTYPPIGRSLAYRFGAFQLLSH
IALRQELPEEVEPAQVREALYVMIKRQIEAPGTFDDNGWLKVGLFGAQNNIGEGYISTGS
LYLCSEAFLILGLPETAPLWSDPYASWTQKKIWSGENISIDHAH
>KECLDBNJ_02302 Beta-glucanase
MKLSILHTARLTRVLFTLVSIVLVSSCKSSSEKSTEDSIQAPRGYELIWHDEFDSGDKPN
AASWSYEEGFVRNEELQWYQKDNASVAQGNLVITGRKEKIPNPNFKADATNWKQNRQQAE
YTSSSINTRGKFQFKYGILEVRAKIDTASGMWPAIWTLGVEKGWPSNGEIDVMEFYQIGG
KPHILANAAWGPDWRNVSWDSAKIPFSEFIAKDPQWAEKFHIWKMDWTSEFIKLYLDDEL
LNEIDLADAINPDGSNGFQQPHYILLNLAIGSNGGDPSKTEFPKEYLVDYVRVYQKTDQN
Q
>KECLDBNJ_02303 Retaining alpha-galactosidase
MQKFRIASLVSLFFILTGQTAWCQLPVKVSSPDKHIGVEVGLQDEKPVYSIHVDDVLFME
DSPLGLKTSIGDFSEGLSYAAQGSSAIKEAYDLKKAKVSHVEYHANELIVKFVNANEDTL
AVQFRVSNSDVAFAYKLTAKERNTKVKILEEATGFNLPDDATSFITPQALPMTGWEQTKP
SYEEEYTFDEALGTQSQYGVGYTFPALFKNAEKGWILISETNVDGSYPGARLGESDKNGL
FPIAFPQEGENNGLGDAFAAMAMPAQTPWRTITLGKTLKPIVETTASFDLVEQRYEASQD
YTMGRATWSWIVWQDNSINYEDQVKFIDLAEALNFEYVLIDNWWDANIGREKMEELVAYA
NSKNVDVVLWYNSNGFWNNAPQTPQDFMNTAYKRQQEMAWLQEIGVKGLKIDFFGGDKQM
TMQLYEDILNDGNDYGLAITFHGCTLPRGWEKMYPNYVTSEAVRASENLIFTQYALDKHA
YYSTILPFTRNPVGAMDFAPVFLNKRLSKDQKGGTVRKTTDAFELATAVLYFSPIQHFGL
TPNNLDEQPEFVLDFLRAVPTVWDETVYVGGEPGDYVAIARRKGDTWYLAVTNGEQEKKT
LELDLPMFKNAEATFIYDAKDKTAAQKTVKVKSSGKLKIDVLGEGGALLISK
>KECLDBNJ_02304 Beta-galactosidase
MKKTVLSLLSILCLWGATAQQAQNEWENPEIIDRNKEEGRSAFVLYESTQKAKTREATAS
QLYKSLNGTWKFDIVKTPAERPTDFYEVDLDDSAWSNIQVPSNWETEGFDIPIYTNVSYP
FPKNPPFIDDAYNPVGSYRTTFRVPENWEDKEVLLSFGSISGYARIFVNGEEVGMTKASK
TPAEFNITEFLEEGKNLLAVQVFRWHDGSYLEDQDFWRLSGIERDVFLQAMPKTTIWDYK
VVSDLTSDYKSGKFSAEVDLRTFEKSKIKKARVEVALFDAEDNLVFAEKKEVPKDRGTLS
FEKSLPNIQLWSGETPTLYTYTLAIEDKKGNPLAATSGRTGFRKVELKNAQLLVNGKAVT
VHGVNLHEHHPDKGHVPDLEITRKDFELMARNNINAVRMSHYPHGQQVYDLADEFGFYIV
DEANIETHAMGAEWQGNFDKSKHPAYSEEWAAAHLDRIKRMYEMDKNHISIILWSMGNEC
GNGPVFYDAYDWLKETDPTRLVTFEQAGQNRNTDVVAPMYPGIKHMKEYAARTDVTRPFI
MCEYSHAMGNSSGNFREYWDIIDSSPHMQGGFIWDWVDQGLRAETEDGREFWAYGGDLGG
EDLQNDENFNANGLITADREAHPSLAEVKKVYQNIDFTLAGSNLRVENKYNYTNLEAFDF
KWELLENGNVVKTGTFDAAVAPNSYKLINLNLPQTADAEYLLNVYATTKAATALVPAGFE
LAKEQFKLGETDYFAEETISSTETPLSFKKDGDQLRFTASEVSGVFDLKKGKLSKYQLAD
GSAVIAQFPQPYFWRAPTDNDFGNGMPGRLKAWKDATANAVVTKSQVGVQTKEGLPVLVT
YQLPEIDAVYTVEYFIENSGDIKVTASIKINDEKTPEIPRFGMRMVLNEDYDQLQYYGRG
PWENYSDRKESAFLGVYQDDVKNQFTWTYIRPQESGYHTDTRWLSLSDGNGNGLKVTGAQ
PLGFSALHISTEDLDPGATKDQKHPTDLTVEDEVYLHIDLKQRGLGGLNSWGQYPFEQYR
LEDQEYTYSYTLSLLNN
>KECLDBNJ_02305 hypothetical protein
MKKQRFLIVLVLASALALNGCNAIKPSTTLQEKEIGLGWSANSVNTVIFRQNAVTTFNTT
QFTAYYDQDAHVVLAKRSLPDGDWELNKTEYTGKTTDAHNAISLAVDGEGYLHVSWDHHD
NSLRYAKSVAPLSLELGEKHEMTGIEEEKVSYPQFYNLPDGDVLFMYRSGQSGRGTLILN
RYDTAHKTWRQLHKNLIDGEELRNAYWQAYVDVQGAVHLSWVWRETWDVSTNHDIAYARS
LDGGETWERTTGQVYDGPITESTAEYAYRIPQNSSLINQTSMTTDKTGNPFIANYWNEEG
KTQYQIVYLEDGIWKKENTAFRNSGFELGGGGTKKIPISRPELFIYENQGKKILGLIFRD
DLRGSKISLAYKDLKTDTQWQVKDLSDENIGDWEPNFDKELYKHTKALHLFKQKVTQIDG
EGLSKAPATPVSILEINLQNILTNPK
>KECLDBNJ_02306 Sensor histidine kinase TmoS
MFKKISLFILLFTQVCIGQYDNHDRQLTFYKLDTEDGLSNNLVRVIEQDTLGFIWIGTAD
GINRYDGNDFTVFRKENSALANNYLQNIVHHTNTGNLLIGSDGGFDLFNLKTNSFEHYNA
ANTILSNSVNSFAFTKSGTIYAGDFGIGIRVFKDQSQQKVFKHEAQNFRSLSSNEIISLH
VQNDSILWVGTRHDGLNKINLKTQEVSRIPIQGRTNFRVNALFIDRDDHLWLGTNEGIKI
LTQTTALNPTVVEGLVGSDITSFEEDAYGRIWVGTYDEGLKIISKSKPLRGFNDLSITNY
LPKDDGTSVFNATVFSIKKDRSGNMWLGTYAGINYVNPRGEPVKLITNSLNGTERITHNR
INAIAEDASGKLFIGTDGGGVDQYDPKTNTYAYAVFNEANALKSNHVLSLLQDTDNQLWI
GTYLGGLSRYNKTTKLWQHYLQGEQKDGNDVRVLYQAKNELIWVGTNRGGLFVYDNARDA
FKYIAELGKVDVRDIAEDSRGNLWLATYGNGIIHYNLESERSTHYNSENLEGLTTNVVFS
IVVTEDDAIIAGTKHGGLVHFNPESKKALNLREDDGLSNNTINSIIAHDSNSIWLGTFKG
ISKYDPISHKIENLTRFNNIHKSEYNPGAALKAINGALYFGSNKGLNQFRPENLKNYTTS
EALVIKDLLVFNESVAIEPTNKKAILNQAMPFQESIQLNAENTVFSIDFTSLDFPIANNT
QYSYILEGYNDHWIDLKNSNRINFSNISPGYYTLKVKAETLASTPLYKELALTILPPFWQ
TWPAYLFYIVTLIILIYSGLRYYSERVYLKNSLHFEQKQRRLEHELNEERVRFYTGFSHE
LKTPLTLILAPLENLLDEIVHKQHRKSLKLIKRNAHNLHQFINKLLEFRKSEEGLSQLTL
NNYNLTKNLSNWLGVYEPLLKKKNLDLVIQMSQTPIYIYCDLEKIQVIVNNLISNAINYS
PENSTINIELSQDEEAVFLKVIDHGSGINRQDLEHIFEWYYQANTTLKKDGSGIGLALSR
RFALLHNGTLAVESKLGAGSTFTLKLPKDDSLVDAYLEGDKHATENKKFIEASIQSATEN
GIETQTTQAMRIKPESQRALILVIDDNPDILDFLDTSLSQDYDLIQAENGEEGIAQACKH
VPDLIISDVMMPIKNGIDLCNYIKNRKETSHIPIILLSAKSNTEMIATGYTEGADDYILK
PFNLQLLKARIENLIDSRKRLLKAYSENENTLETIDDDQKRLLDVEKKFLVEFHQIVEEQ
MQQGIKTVEVVAQEIGMSRSSLYRKIKAITGKNINEYIRNIKLDKAAQLIEKEQFTISQA
AYEVGFGDAKYFRKIFKERFGKTPSAFKPN
>KECLDBNJ_02307 Arabinoxylan arabinofuranohydrolase
MFKFRLVFILALLVSSQVFYSCDTTKTADDYTAYLFVYFTGNRAGEEAVHYALSRNGFDY
YALNDDKPIVSTDSISTTGGVRDPHILRGEDGNFYMVLTDLKTDNGWSNTEIILAKSKDL
LDWETSQINLAEEFSEFSDISRAWAPQTIYDAEAGKYMVYFSMLQPGGYDIIYYAYANED
FTALESTPKQLFYSPDEKSCIDADIIKKDDKYYMFYKTEGTATKGIRVAVSDSLTSGYVP
EEGYKDQTDRAVEGSSVFKMIDSDKYILMYDMYVDGKYQFAESTDLLNFKALGADKVSMN
FHPRHGTIIPVTEAEATQLLKAFPSENLPLVVGSKSGAVRTQNMVTNAENASVYLPVYTD
SSVAALDPQLITFPGVKLIDSGAKDFSSAAQSYTLELPDGTQKTYSVEAAVANNPVLDGY
YADPEIIYSSKDQKFYLYPTSDGFDGWSGTYFKTFSSKDLVHWEDEGVIVDLLEDVSWAN
RNAWAPCIAEKEIDGELKYFYYFSAAQNIGLATADDPAGPFTDSGKAFVGEKPEAIKRGG
GQIIDPDVFVDPNDGKAYFYWGNGYMAGAELNDDMMSYKEETLKEMTPDGTFREGTEVFF
RKGKYYFLWSEDDTRSPNYRVRYATGDTPLGPLNIPEENLVIKKDEENEIYGTGHNSVIN
VPGTDDWYIVYHRFTRPRGITMGGPAGFHREVCIDKLTFAEDGSILEVTPTVEGINPVTI
PAQ
>KECLDBNJ_02308 TonB-dependent receptor SusC
MLQLKSIAICSLVMLLLGFSFDVKATTISQPQQTVSGTVTTAADGMPLPGVTVVVKGTSN
GTTTDFDGNYELEVAADAVLSFSYVGMKTIDIPVNGQSTINAQLEEDLGVLDEIVVVGYG
SQKKSDVTGSVASVPEERLENLPVTNVTQAIQGTTAGLNISQGSSVPGSTGSIQVRGINS
ITGSTSPFIVLDGVPFTGTLNDINTRDIQSIQILKDASAVAIYGTRGSNGVILIQTKRGT
SGDPVINYSTYGAIEEFANVLEPLGPDAYVQKYADFFSQNNPGAEQDRILENQSEIDNYN
AGITTDWFDIATRSGVIQEHNLSIRGGSEKTKYFVSGSYLDQKGVIEGYDYQKFTLRSNI
DVQLTDYLKVGLNAFFANNNFDGGRANLLLATAMSPYSVPYDENGELIINPMLPELLYEN
PLLGLTTDRVQRERTLSGNVFAEVTPAFAEGLSYRINASYTFNPYLYRNYTGRAANNNRG
TANVGGDEEKVWIIENILKYSKSFGKHNFDLTALYSAQANEFFQESLTGTGFVNDQLSYN
NISAAENITGDTYSTRSTLLSQMGRLNYNYDSRYLLTFTVRRDGYSAFGSNTSKYGVFPS
AALGWNIHKEAFMENADVINNLKLRFSIGETGNRGVGINQTQTRAGTLLYPFGGQSYTGT
YIAGLGNPNLKWETTVSGNLGVDFGLLNNRINGSFEVYKSKTEDLLLNRSIPALTGTTSI
IENIGAVENRGFEFTVNSTNIDTGDFRWESNINFSTYKNEILDLYGDGEDDIPSRWFIGK
SLGAIYDYKMVGVWQEGEDTGSFNANPGDLKFEDINGDGVIEPENDRVYLGSSLPKWTGG
LTNTFSYKNFDLSFFIQTVQGVLKGNPDINYGDELSRRNTPSNVGYWTPENQSNEFPSLV
YRNTLGYGYPRDASYVRLKDARLSYRFPIEKIERFGLDNLMIYVAGRNLYTWTDWIGWDP
ESSQSYRGSGDWTNNYPVVRTYSIGLNVSL
>KECLDBNJ_02309 SusD-like protein
MKNISKLTLILLSLNIFIFSSCGDDFLEEEIRSDFTPETLNDELGYQAQLVGLYQMLSTF
YTRSGQQGWLSVWQAGTDIVWPTAPQGVEVPYYKYNQLTTDDSAAYQSWELWYNMVENTN
SIIASIEANTSEELSQEEKDAINAEARFFRAYAYNNLATLFGGVPLITEPVTEARFDYTR
NSLEEINAQIETDLQYATANLADPTNAPQFEARVHKYVAHQLFAEFYLRSGQPDLAEDQA
DIIINSNAFQLVTERYGVKAGEEGDPFSDMFFKGNQRRSQGNTEAIWVLENENPADVRGG
SSGSPQQRRIWGAGYHNVNGMIPADSLGGRGIARIRLNNWVIYDLYDEGDMRNSKHNIHK
RFRYNNPDPNFSDIYGELVPYEGIDTLARIQPYSLKWGHFDPADVFGFGMWKDFMIMRLG
ETYLLKAEAQVAQNNPGGAATTINILRTRANAPQVTAGEMSLDFILDERVRELLAEENRR
MTLMRTKMLVERATRLNIQDESIPLPQTMRIEGLQEFHELFPIPLREIQLNKEAELTQNP
GYTGS
>KECLDBNJ_02310 Miniconductance mechanosensitive channel MscM
MLDYFDSQTSKFLLITILAGMVFFGLIFYFLKKLGKSPKNILPVNFAGKMRLPLALFMLA
LVLKIIKTNDRILEFIEENFLSHVSTLLFILSITWILIVILKAFKRNILLKYDMSASDNV
HARKVYTQFTVLERVLMFLIILFAVSIALMSFDSIRSIGVSMLTSAGIAGIIIGFAAQKA
LGTLMAGIQIAFTQPIRLDDVVVVEGEWGRIEEIYLTYVVVKIWDKRRLVLPTTYFIEQP
FQNWTRNSSDILGTVFIYTDYNVPFDALRKELTRILKNTDLWDGEVNVLQVTDTNNEMVE
TRALMSAIDSPTAWDLRVHVREKLVIFIQENYPHSLPRTRVEMQSRKDSDKVEKATKEPD
KSDLLRDK
>KECLDBNJ_02311 Ferrous-iron efflux pump FieF
MSKTESAVSATYFSIVGNTVLAIAKALAGIFGNSYALIADAIESTADIFASLLVLFGLKY
AERPADDNHPYGHGKIEPLITFMVVAFLVTSATVIAYESVQNILLVTPQKPPKLWTLIVL
AVIIIWKEISFRIVLKRSKETNSSSLKADAWHHRSDAITSVMAFIGISVALIFGEGFETA
DDWAALFASGIILYNAYLIFRPALGEIMDENRYDDIIELVRIKALEVPGVLDTEKAFIRK
AGMSYHLDLHAIVDGSISVAKGHEIAHRLQDYLKEEIPNLNFILIHVEPGNP
>KECLDBNJ_02312 6-phosphogluconolactonase
MDLHIKETKQLVAEEFSEFFKEKCTTGEDVHIALSGGSTPKIVFDHLAKEYGADIDWSKV
FLYWGDERCVPPSDDESNYKMTVEHLISKIDIPEENIFRIKGEDDPEEEAKRYSKVLDEQ
LPKANGIPYFDVVMLGMGDDGHTVSIFPYNIELWDMPENCRVAKHPDSGQKRVTFTGKIV
NNAKTIAFLVTGAGKKEKVTAIHKKHDGYKEFPASLVAPKQGELHWFLDQDAAAGL
>KECLDBNJ_02313 Glucose-6-phosphate 1-dehydrogenase
MNKTSNQLLVIFGASGDLTARKLIPALYNLYEGGHFPENFAVLGASRSDMSDEEFRKRVV
YESPFLKDKLKKKDDEFIKKFADMMFYSDLGDDYDSEYSKLNKRITSLNEEHGLDGNYSF
YLSTPPSLFEPISKNLSDQGLTKGSGTDKGFRRIIVEKPFGYSLETAKELNAGLQKYFKE
KQIYRIDHYLGKETVQNLMVTRFSNSIFEPLWNRNYIHHVEITNAETVGVEKRGGYYDKS
GALRDMFQSHLLQIVSLIVMEPPISADADEIHNEKVKALKSIRRMTDTQTLFDHTMKGQY
VASSIDGKRVKGYREEEGVDPDSKTETYAAIKFFVDNWRWKDVPFYVRTAKRMPTKVTEV
VIHFKTPHHQVFKEQDINNKDNKLVIRIQPDEGILIKFGVKVPGQGFKVERANMDFYYSS
LADKNIMDAYERLLLDAMQGDTTLYARADEVEAAWAFVDPILEYWANDKDVPTYGYPAGT
WGPKNSDDLIEDSNGWRNPGELLTDETGFCII
>KECLDBNJ_02314 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MEHKNYDFGLVGLGVMGRNFILNVADNGFKAFGYDLDQEKVDALKKEGGDLNKVDASTEI
ETFVEALAAPRKIMLLVPAGKIVDQVIETLLPHLDQGDIIIDGGNSFFTDTDRREAYLKE
KGINFFGAGVSGGAEGARKGPSIMPGGNAEAYTHIKPIFEAVSAKFNGEPCVAHLGPKSA
GNYVKMVHNGIEYGLMQLTSEIYDLLKKSVGLDNDELHQVYDLWNKGRLQSFLVEITAEI
FKQEDDLGDGRLVDMILDKAKQKGTGKWTSQNAMDLGIPVPTIDVAVSMREISALKEERI
VADKLYSRPEPKPIDKDKIIAMAEESLYFSFIIAYAQGLHQLADASKEYEYDLDMSVIAK
IWRAGCIIRAGLLEDISQAYTADKELPNLLLAPSFVEKVQGTLESVRETVAYAAQSGIPV
PGLSSALNYFEAYTSSRLPLNVIQAQRDNFGSHTYERIDRSGIFHTEWGK
>KECLDBNJ_02315 Adenine deaminase
MSVSTVQVFSIQNGENNQRAINPLAVPIKLKRAFNEALFLFLFLKHHNTLFMKRALLPLL
ILITLLNSCGNPPPQFDIAIHNVNIINLQNGKVAQDQSVFIAGDTIHSIVNSRDLMTSAA
KQQIDGSGKYLMTGLWDNHVHFRGGADLIEENKDLLKLFIANGITTVRDAGGDLTTAVQK
WQKEIAANTLVGPTIYTSGPKIDGPGATWAGSLEVENDQDIEQALDSLQELNVDFVKIYD
SNISGENYLKVISEAEKRNMITSGHMPYSVTVDETTSAGIDAIEHLYYVLKGCSSDELAI
TEAVKNNEAGFWTSLDRVMQTYSDSVATQTFNKLKERNVFVVPTLHIGHTLSYLDEVDHT
QDEYLNYIGNGIQKTYAGRINSAKNASPEFVVMRKNLDSAFVKLAGTLADNGVGLLAGSD
SGAFNSYTYPGISLHKELQALVDAGLSPLEALQTSSQNGAVFLKKQLPQINAGAQADLLL
LNANPLKNIENTQDIFMVVKNGKTFDSNQLSELLNSTVKN
>KECLDBNJ_02316 hypothetical protein
MNLKTTLSALALLVCFASALRAQQVKAPVDTTITSTHSVTIKGQNIPYKAELGFQPVWDN
SGNPVATLNYTYYTRTDVKDNQTRPLLISFNGGPGSASVWMHIAYTGPRILKITDEGYPV
QPYGIKDNPNSVLDVADIVYVNPVNTGYSRMVPNAAGEMPKRDQFFGVNADISYLADWVN
TFVTRHNRWRSPKFIIGESYGTTRVSGLAKALQQGNWMYLNGVILVSPTEIGFDFAGPVE
IANRLPYFAAAAWYHNALPPALQNKDLTEMLPEVEKYAVEELLPVLAKGGYASEAEKQQA
IEKTAYYSGLSERTVSQNNLAVPFNYFWKDLLRDKEGYTIGRLDSRYKGLDIADAGERPD
YNSELTSWLHSFTPAINYYMSEELGFKTDLTYDMFGNVHPWDRSNNHTGADLRDAMGMNA
NLHLMVQSGYYDGACTYFNAKYIMSQININGKFSDRMDFKGYRSGHMMYLRAEDLKNANQ
DLRDFIEKASEGIDQGAMYK
>KECLDBNJ_02317 Sugar phosphatase YbiV
MDLTQVKLVVSDMDGTLLNDEGKVSPKFFDLFKQLQKHDVQFIAASGRQYYSIIHKLDAI
KDEIIVVAENGGITIKKTEVLDTCTVDTETVHNLIKQMREIEDAHIVLCGKEQAYVESDH
EPFIEIFQEYYTKFKRVPDLTEINDDHFFKIAVYSFGGSEETTYPIAKALEKEVKVKVSG
EYWLDISHLDTDKGRALKILQDQLKVSKAETMVFGDYNNDLEMIEQADYSFAMQNAHPNV
TKAANYTTKSNNEGGVEHILEQLIAAKEALLTK
>KECLDBNJ_02318 hypothetical protein
MRFYQKEIRLQSRSRGFHLITQEIERNLDDLKNIKVGQLQVFIKHTSASLTINENADPTV
RQDFESHMNKMVPENAPYYIHTYEGPDDMPAHIKASLMGASVTIPVTNGRLNLGTWQGIY
LCEHRNHGGARKVVLTLFGE
>KECLDBNJ_02319 Quercetin 2,3-dioxygenase
MAAIQKITQLHAQWDTQDPFLFCAFHNDKYPKGNGQLGPATSLAGRNLGQDFVQKDGWAM
YHGSKVPGFPGHPHVGFETVTIAEEGFVDHSDSLGAAGRFGQGDVQWMTAGKGVQHSEMF
PLINTEEENPLLLFQIWLNLPAASKNVEPYFGMMWNEKIPVVSTQDNEGKHIQIKLIAGN
YKDTKALAPAPDSWAANPENGINIWLISLEPEATFTLPKGAAGANRSLYFYEGEMLYAEE
FEIPPMHQIKADPTEELVVKNGNQKAQLLLLEGKPINEPVVKHGPFVGNTRKDIETAFMN
YQQTQFGGWPWDSHEHTHAADRGRFALFPDGNLQKP
>KECLDBNJ_02320 hypothetical protein
MHKTITFLGKIACLFFLLFNAGISSKSYGQCAGEDASLTSCDKETNQFIDLYAALGGTPV
PGGTWTDEDNSGGLNTATGQLNTWLINRGGTFTYTYTVEGEAGCTDTDAIVTVTLAGYAG
RDNNNAVACEDETNVNLFQFIGSGPNPTLFGTWVITSGPAGALNGPTFNAQIAGPGSYTF
TYTVDAQGSCPATMSTVNLDVVEAPEAGTVDPAVTTIFCETDDLSSLTNFNLRDAIVGED
TNGVWSEGFLTNEITAFNDSFINIENIRDTYGPGSYPFTYTVQPTNPLCTLSQVTVTIII
EEVIDFSNATFELTFPTEEEDIICEDILPIEAIATITGELDDIPNGDYALTYEVSPAPNT
GTETLTITMTDGIGSFPINPDFFTGAGVAEVRVLQIIDPTTQNVCDAQLGDLSDTLTIVA
LPDVTDTELSVVQPLCFEENGVLTFSDAATTPEIELVDGDYTITYTLSNTNTSQEYTELI
TVAAGTATLNLLAENLPTADDYTFSLSSITNTNGCTTAVELSTTFTVSPKPDAQTLGVTI
ADTCEDEIVSVTLTDSSETPNLADGSYEIIYDISGAISVTDQTATVVITDGTGSFDLPQA
LLANGSSTLTLTSLLNSISSCEAENFTMPTATFNIVATPDATNLVGTVTDSCEDRSATVN
LTTDATFIQDGDYVITYTLSGANTLAETTTNVTFTAGVAEFELAAETLAEAGTTSLTIEE
LTTASQSCDATGLPITIDFEVLPVPTLENTTISVDSVCLGEDALISFTNSDLADGSYIIT
YQVGEGTLAPSENVTFAGGEASITIDSELLITPGSVTVSIISIANPASLCFNDTATTVSF
DVNPIPDLMDGDLSASDICLAEDGLVTITSSDLADGEYTIDYELAGANTALAQSATALVS
NGVGSFTIPATTLAATGTTSITATLISSASGCTSLPIAVSTSFEVNPLPNATGVTVTATD
VCFGEQVIVTLSGASALQNNTYLISYQITGATTSEVTSENVDITNGAASIVLDANVFTAG
GITTFSLLDIQNETSGCSATNLGAAFTDFSVEDPAMPSLATNGGVFCINDNPTVADLETN
VSSSFNIITYDAASGGSVVSPTTPLMENTTYYIAAQNTATGCEGSQRLAVTADLSGCDSV
FIPDGFSPNGDGINDVFEMQNINIVYPNYTIEIFNRNGAVVFKGNASTGFWNGQANRSRL
GGNTLPNGVYFYIINYNDGQTSPKQGKVYLNR
>KECLDBNJ_02321 hypothetical protein
MARLAQNKVKFTLTDKRIIPMKNSTSKLTFFAAFVLFCGSIFGQQDPEYTQYMYNMSVIN
PAYSTVNQAKLGGLYRAQWVGIDGAPTTATFFGHLPMSERVEIGVNLVHDEIGDVVQETN
LNADFAYKLPVQENATLALGLKAGASFFSTDFSRLQLGSGGPATDPSFAQNINQTYPTIG
IGAYYFSESYYIGLSAPNLVASRHIEDEDGVQRLGSENTHYFLTGGYVFEPSADFQIKPS
FMARWVNGAPVSLDLNANVRFYQRFEAGIGYRLDDAVTGMVNFEVTPGVRVGYAYDYTTS
NLGEYNNGSHEVMVLFDFDLLGKLPSYRKSPRFF
>KECLDBNJ_02322 Outer membrane lipoprotein Omp16
MKNYTLLIILLAVCQVGFTQNQSIEKANKLFASQAYAEAIALYSAADQLDSDAALNLADA
LYYNANAEEAVKAYAKAWELNPGRSMDAHFRYADALKRSNAYDKANEILTTYSGTSIDIL
KAMEKNDMEVSQFFMPEVMDAASAYADFAPAYYDRQLVFASDRNAARPTYPWTGKPFLDL
YYAQPVADTLSEYQTFSRSINTDTHESNAVFFANGTKMYFTRTSNKFKKIDGAKVAPLQL
YSAELVNGKWGNIELLSISSDSYSVAHPALSADEQTLYFSSDMPGGYGSFDIYKVSINGN
NTFGTPVNLGENVNSDKLEQFPYVSENGNLYFASNRVEGLGGLDLYSSDASGDAFAEAYN
LGSSINSNADDFSLIIKERQASGYMSSNRTGKDKIYQFTTFPNLDYQIIGNVDDKKTLEP
IEGAEVTLYRPETGSTQKMTTLADGSFKFEVHPNSTYKVKASKALYAPVEKEIKIEYAQN
TKTLIKLQMSAYADSEEIVTVNDRNQLTQVNLEKIYFDFDKANIRPDAAVTLDKLVQLMK
KYPEMDIEVASHTDQRGSDSYNLALSQRRAQSTVDYVVSKGIDRNRLKAKGYGETDPIHA
CPSGDCTEAQFDENRRSEFTLLK
>KECLDBNJ_02323 hypothetical protein
MSKPAIKTLGELKKTDYKSRSIKEELRSNLVKNIKEGKNSFEGIHGYEYTVIPELERAIL
SKHNINLLGLRGQAKTRLARLMVQLLDEWIPVVEGSELNDDPLKPLSRYAQQLIAEKGDE
TPIDWMHREERFAEKLATPDVTVADLIGDVDPIKAANLKLSYADDRVIHFGMIPRANRCI
FVINELPDLQARIQVALFNILQEGDIQIRGFKLRLPLDLQFVFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPENIQIARTITEQEAKRDERNEEQVYVPSLAKDLLEQISFEARESEYI
DVKSGVSARMSITAFENLLSTAERRALMAGDEKTTVRLGDFMGMIPAITGKVELVYEGEQ
EGAATVAHTLIGDAIQTLFITYFPEIKKLEKQNEKSPYDEVVTWFFDQSDFQLLDDLNEE
EYKKMLDSVTPLQNLINTHQPDLPKSDQYFMKEFILWALVEFKKLSKYRMTDGIRFKDLY
GSYISGL
>KECLDBNJ_02324 hypothetical protein
MKKETLRKGFVFKSYEAPQQSLFDRLFEIFKELITHTSGDFDEAMDWLKELDKEYNLTTE
DYTLDDFVQELKDKGYIREEIEPDGNGGMAITAKTERAIRQRALDQIFGKLKRGGAGNHK
TNRIGRGDEHTGEYREYRFGDALERVSMTESLKNAQINNGIGNFDLTEKDLVVEETQFKA
QMSTVLMIDISHSMILYGEDRITPAKKVAMALAELITTRYPKDTLDIIVFGNDSWPIAIK
DLPYLQVGPYHTNTVAGLQLAMDILRRKRNTNKQIFMITDGKPSCVREPDGFYYKNSVGL
DDYIVNKCYSMASQARKVKIPITTFMIAQDPYLMKFVRQFTQANQGKAFYTGLQGLGEMI
FEDYETNRKKRIR
>KECLDBNJ_02325 Immunogenic protein MPB70
MKKLVLSMAVLASIAFTSCKDSEKSESEEPMAQEEMAMETTETSAEATMPEEQTIAEIAM
AIEDFSTLVTAVKAAGLAETLNSEGPYTVFAPTNAAFDKLPEGTVESLVEPANKEKLAGI
LTYHVLEGEYKAADIVKAIKDNNGSFTVVTVEGESLIAMLDGENVVLTDAAGNESTVVMT
DVEASNGVIHAIDAVVMPKS
>KECLDBNJ_02326 Ycf48-like protein
MKNILLLCLLGISLIGNAQQLNLDLVKDMKPRNVGPAGMSGRITAIDAVTDNPDIIYAGS
ASGGLWKSTSGGVTWTPVFEDEATSSIGAVAIQQSNPSVVWVGTGEGNPRNSLNGGFGIY
KSLDGGKTWKCMGLENTRHIYRVRINPSNPDIVYAAAIGSPWGEYEDRGVYRTKDGGKTW
EKILYVNEKTGPAELVMDPTNPNKLIVAMWEHKRDPWFFTSGGKGSGMYITYDGGDSWKE
ITSENGLPKGDLGRMGLAIAPSKPNIVYAYVEAKKNGLYRSEDGGQNWKLVNDDMNEIGN
RPFYYAEIYVAPDNENRVYSVFTYVNVSEDGGKSFEELMPAYGADNGVHPDHHAMYIHPK
NPDFMIDGNDGGLYLSRDGGETWRFAENIPVGQFYHIAIDNEFPYNVYGGMQDNGSWRGP
AYVWKAQGIRNSYWQEISFGDGFDVVPDRDDSQYGWTMSQQGYVSRYDWVTGANYLVRPT
HPDPEVDLRFNWNSAINIDPFDNSTIYFGSQYVHKSTDKGLTWEVISPDLTTNDPEKQKQ
SESGGLTMDATGAENHTTILVIEPSPAQKNMIWTGSDDGKVFYTRNGGEDWTDVSKNIKG
LPEGSWIAQIKASATNQGEALLVANNYRRFDYKPYVYRTTDYGKTWKSIVDSEDVGSYAL
AILEDKEEPNLMFLGTDDGLYVSIDAGTNWQKWTNGFPTVPVKDLIIHPREDDLAIATFG
RSIWVLDDIKPLRALAANADLGMNLSMKKGMVLEVIPPVVAYQNASQQPTGGRFGADATY
GGANRDRGAFIKYMLNPKEAEKQTEDETNETNTESDENAPKWDSIALTIYDGDRLIRTLK
TKAPDSAGMYHFRWFLDEKGVDRPSRRVRDRNYEPGGATVKPGTYKVVLNYGTLEDTETI
TVKSDPRLDISTAATNEIYEAEKEIERMTQVAADAVKQLVESKTIAEDFLADFKKKDKDA
YEVQIDSSKAIVKKLDAHIATFLGKEDDRQGITRNAEVTVLNRIYLASSYVNSRPNGLTA
TENQLLAHAEEELKTALKNVNTFFTEDWAAYETQMKQVELSPFKEIKSFQLE
>KECLDBNJ_02327 hypothetical protein
MKLDLQLYRGYANDEELVVFGHLFKSWAPDKFQTDRKGFKHAFSVLHMFRISPLKNVEVR
LRFKDIDVTTRTMDDGFFRFNVPYENTLESGWHTYEITCKPKEVDYGIIEKAEFLKPFES
KLSIISDIDDTFLISHSGNIFKKLYVMLARNVNHRKTFEDVVRHYQSLSTSGHDEEGKRN
SFFYVSSSEWNLYDFIVQFTKLQELPKAVLKLKSIKTGISDFLRTGGGNHDHKFIKIKDI
IAFYPQQHYVLLGDDSQQDAFIYERICKMFPVNISAVYLRQTQKHQHKKISKVLENIEEM
GVATCYFKKSSEAIKHSKEHGIIKAE
>KECLDBNJ_02328 putative lipid kinase YegS
MKTQNTILLVINPIAGGTDKQPIINAFEKHVSQDGNQSFIYETTGDRDKEAIQELIKEQN
PDRIVVSGGDGTIREVADAIKGASVKVGLLPSGSANGLATNFDIPDSLEEQLDIALGNHF
IAMDLIEINGYTCLHIADLGINAQLIKNYEKSEIRGKLGYLIQSFPTLLSSDFPFEVEIQ
CDDQTISEEGILVAIANANKFGTGAQINPTGKMDDGIFEVLVFKNFSIKGILETFYDDAE
LDPDFVKVIPCKDVNIVSKKSIAFQIDGEFIGDEQRIEAKMTPHKLNLAIPKSFRR
>KECLDBNJ_02329 Superoxide dismutase-like protein YojM
MKNYALLFSLALTLGFTSCKNENKDKETDETMTTDATEVQEEAPVSKKLTISLDSKSGST
ATGNVVFTEEDGEVSMTAVFEGLEPGMHAIHIHENADCSADDGTSAGGHWNPTKEQHGKW
GDAEGYHKGDIGNFEADDNGNGTITMATDEWCIDCEDATKNIVGKGVIVHQGADDFTSQP
SGAAGARVSCGGIIQ
>KECLDBNJ_02330 ECF RNA polymerase sigma factor SigK
MQPDDLILRLQQKDEKAFEQLYSMYSESIFGVINSVLHNTEASEEVLQDVFIKVWDNCAS
YSSNKGRFFTWLLNIARNAAIDKTRSKSFKNQKKNLTQEYFVDILENKTSFSSKVDAIGI
KKYIKKLGEDCKNVIHLLFFKGYTQKEASEELDIPLGTIKTRNRLCINKLRAILVN
>KECLDBNJ_02331 hypothetical protein
MDIQEYIESGILELYVYGALTPQESEEVSKVLKQYPEVQQEVEQIEAALQQLATAAAPYN
PEEMLAAIKAKLLNSKGVVQLQPAAANKRTRLLSFISVAASVIFLIGIFILLNRTNNLRD
ELKVVQIENTKLESKLQYSEEALTESKEILAVIRDPQVTKVPLAGQQVAPDAYVTVFWNK
ENNKAYIDALGLPEPPEGMVYQVWSLTLDPLTPTSMGLLDNFSEDENKIFTLENPNESQA
FGITLEPAGGSATPTMEQLYTLGVIENNA
>KECLDBNJ_02332 hypothetical protein
MNPSSTGWIAKHQPVVNQLITQQHLQSQELYDRILKTGFFYGVSVTTMSYGAKEPLRWTE
IERTKLNFFDCLYFVYYQQYQAETGFFDKITSFYSELNPRAHRYFSGFSKPKPTAASLEK
IIQERIQTNEATLQKNFSNLITNALLFLDVLCFEHFLKDPEDLNAYAIQLEATLMNVIWM
ALLQKEEKEHYDKLLLKLFEKSLRYNRNLKQEAQTLQELPFEHFNTLFAKRYALDLAALA
IWDDAKLDKTEFLFLNSFGTILELPKHIIDQSTTYVHDFIQDNRHRISYLNYSNPVKHFY
NQTSQTVKVLILRNKKRLLQELAESKDLVVLLGQSTVRDLSKAEKKRVKTQLLDICKSVP
SLAIFMLPGGGVLLPLLIKFIPELLPSAFNDNRIDLTADKDHDTL
>KECLDBNJ_02333 hypothetical protein
MLKLITKFKLFIANLTGKIGFYPSLFAFGGLLFGFAMLYAEDQGVSSFLIENAPQLVIND
ADTARTLLSTFIGGIISLMVFSFSMVMILLNQASNNYSPRILPGLISNKKHQNVLGFYIA
TLIYCILILLSIKPTDNKYQLPGFAVLVGIVLSMLVLALFIYFIHSISEAIQINKIIESI
YQKAKTRLEQLIKQTDEDSMQSNFPDTENWHAVEVNRTGYFQTIAVDALLELCENLDCKI
EISVPKGTFILKGIPIAKCSIELNEEHQEQLLTCFGFSRSEIVTHNYILGFKQLTEIAVK
AMSPGINDPGTAITCIDYLSELFALRLKKKDFSFIANQDNEAVIKLRTIDFKELIYFVFA
PLRAYCKHDVVMLHKMLTALYFLLQSDSVLDDAETILINEANLILEDAKTAIENKDDLKG
IFSIRSKMQAINGTQNALIELAD
>KECLDBNJ_02334 Sensory transduction protein LytR
MNVLVIEDEKPAARRLSRMLEALELNVLAQLNSVEEAVEWFQKNEHPDLIFLDIQLSDGL
SFEIFDAVEVTSAIIFTTAYDEYALQAFKLNSIDYLLKPIDDEELEAAVKKFKKQQPQKQ
DVKLNFDDIRQLLGVNPVEREYKKRFTVKIGQHIKMINIEDVCCIYSENKGTYARTLDKR
DYLLDTTLETLEEELAPDVFFRVSRKYYVNVNAIQDIISYTNSRLQLKLKAAEDQEIIVS
RERVKDFKLWIS
>KECLDBNJ_02335 hypothetical protein
MEIMENQKSSFERAQKRVKDIKAWYSHLSVYLTINGVYLLFYFGLFDRGAVSGYIPWWSP
VSMLVGWGIGLMIHYIMVHKGNFINRSYKNWEERKIKEYLDREEAQRADLNKWE
>KECLDBNJ_02336 hypothetical protein
MENFDKENRYLQAKEKVGEIRKFYGGIISYIIVIGALAGLNYWIDGLRHPWFLWAALGWG
IGLIFQAAKAFDWNPFMSRDWEERKIKEFMERDKKSQSNMGRWE
>KECLDBNJ_02337 Sensor histidine kinase YpdA
MNNLLSEFLKAVTVGIAIYIVFLLIHLMGGNTIQFNSDLALDFAISMLYSVVLYMLNMQV
FKFFFKKYKHHLYSFKHLVKAIPASVFITVIGVFFIRLFIITVLYGKTLQFFFSQEEVID
YSIPLVVALVCNAIFYFFFYYRYKKERQVKEQKIIAGTASAQFDALKNQLDPHFLFNSLN
VLTSLIEENPLQAQKFTTSLSKVYRYVLEQKNKELISLSEELAFAKTYMTLLKMRYEDSI
VFKLPEAVADPDAKVVPLALQLLLENAVKHNVVSGNHKLYISIEEEAGYLVVRNNLQPKK
VMAKSSGVGLINIKQRYGLLTSREVLIQQTESEFIIKIPKLKHQLKSTVMNTEQYLSDKK
YTMAKKHVEELKGFYINLSLYCIIIPGLALLNYYTTSFPWAIFPALGWGLGVFFHGMEVF
GWNPFLGKDWEDRKIRELMKKDQDR
>KECLDBNJ_02338 hypothetical protein
MVKVILLILEWALASTGAQANSELQSIKNSISQEVTVVVYEDCDTFKSESTIAPSIFLIA
TDE
>KECLDBNJ_02339 hypothetical protein
MFIRRIVYCFSILLALSLLHSCASKRTQFRDPKNTIINTATDTSTYRSVFLLGNLGSGKT
GPNETLLQAFNAHQKQMAKKDDYLLILGDNVYANKLNEGQNKQQLERIVSLTEAFKGETL
IIPGENDWNDHGVEGLEKIEDYIEKQMGKDNHYQPENGCPIETITVDAQTEIIIVDSQWY
IEDWSKHPGFNDKCAIKTRAQFLTLLKDEARKARHKNVLLVMHHPLFSNGIYGGEMSTRA
FYRPTAENAYVPFAGFLWAFARTQGGISKQDQFNPLMNDLMSEIKKMAIDLPRLFVLSAH
EHSMQYIENQNIRQMISGTGSKTEYVRLGKDGKFASVQPGFAELRLYKNGASSVHYYEIN
PENQLEERFSKLAYDKPEAFPIDSLPQQFNATQKASIYAKEEVEVTERYEKFWGKHYRDL
YGLEIDAQVATIDTLHGGLQVERAGGGHQTQSLRLVDEDDREYNMRALAKDPFAFLKSSG
YDNLDAESYFSGTIPARIIEDFYTASHPYGAFAIPRLAGAADLNHTHPKVFYIPQHKELG
DFNKTHGNRLYMLVEKPDDDFNGTHMFGFNEDVESTADLFEAIREDEKNRVVEKDYIRAR
VFDMLVGDWDRHEDQWRWAEQEDENEVRNYIAIPRDRDQVFSKFDGKMIAFLQKFMPGTR
ELGNYGPDIKYVEKFSESAISLDRALLQKSNKEDWFEAVAYIQQNITPEVVTKAFKEMPV
EVQDDNWLQLQEDLLARKANLQDIVSRYYDYFIRFQTLKGTDKDDHFYITRNADGSTGVK
AYRIKDGEDGYELFDRKFTPNETEEIWIYGLDDDDIFTATGSGPGNIKIVIAGGQNDDVY
DLKNGKGITIFDQPDGNTIENLGGARKRFSSVYENHIYDSERRPEKAKKINIELPYNPDW
GVAPHLKFASQNLGFERHPFTSQFVLDAQYFSLTQAAIFKTAYHTANFFPQWNLKIGGLA
TTHNYTRNFFGFGNETVNSANNLDENRIFLQQFEAETGVYYIGEYGSSFEASIAYQNFTP
EQSLYINTFNSLNNNNYITLKSIYSYKSKDDLNFPTRGMHFEASGYYSDNLENRETVVAA
DPKITFWNAIDTSRNLVLKSEVAGQLRFGNEIPFYQSASLGGNSGLRSYRLNRFSGDQAL
RGSADLLYKIKPIKTAIFPLQSHLFLGYDLGRVWYNQESSEVWHDSFGGGFNLSMGGFLN
SSFGYFTGSEGGRFQFSIVLGAR
>KECLDBNJ_02340 putative metallo-hydrolase
MKIEQIYTGCLAQGAYYIESNGEVAIIDPLREVKPYLDKAEAADAKIKYIFETHFHADFV
SGHVTLAKETGAKIIYGPNANPAFDALIAKDNQEFSLGEVTIKVLHTPGHTMESTTYLLK
DKEGKDHAIFSGDTLFLGDVGRPDLAQKAKELTQEDLAGYLYDSLRNKIMPLADEVIVYP
AHGAGSACGKNMSKETVDTLGNQKKTNYALRADMSKDEFIAEVTDGLLPPPSYFPLNVKM
NKEGYDHIDEVLERGTQQLTPEAFEAAANETGAVILDVRKAADFAKGHIPRSIFIGIDGS
FAPWVGALIADTAQPILLVAPEGREEETVTRLSRVGFDQTLGYLNGGFEAWKTSGKEIDT
VTSVEASNLEKTVQSDATTPVFDVRKPGEFESEHLEVALSTPLDFLNKHLTEFPSDKVFY
VHCAGGYRSMIAASILKSRGIHNLIDVKGGYKAIKETELKRTNYVCPSTLK
>KECLDBNJ_02341 Thiosulfate sulfurtransferase PspE
MRTILFLSMFLMSLGVFAQESNHVILSKELFEASIQTNSENLKRDIQLVDVRRPEEFEAG
KIEGAVNMNVLEPETFKEQIETLDKSKPVYIYCRSGNRSGKAAMLMQELGFKAIYDLEGG
YLNWTSSSETKATEKNHQ
>KECLDBNJ_02342 putative HTH-type transcriptional regulator YybR
MSEKSLNFFGDAENCPVRNVMDRFGDKWSTLVLLLLEDQGVMRFNELHKTIKSVSQKMLS
VTLKSLEADGLILRKQYPEIPPRVEYRLSERGQSLIPHIQSLVAWANQHMPEIKKSRASY
SS
>KECLDBNJ_02343 Quinone oxidoreductase 2
MSTFLITGATGGLGSSVIKVLSKDVNPNEIAVLVRDAQSEKAQEYKAQGFDLRIANYNDA
DALTKAFQGIEVLYFVSANDIFSRDAQHKNVIEAAEEANIKHVIYTSAGRKDESQESPVA
AVMDAHIKTEKWLQESEMIYTILRHNLYAEVVPMFLGDKEALLNSKTVFLPTGEGKTAFA
SRNDLAEAGAFVLKNHKAHQNKIYTLDGLEAVDFTKIAAILSKITREEISYVSPDLETFK
TTMTTYGVPEDAIGMMLSFSLGIAQGEFDSERKDLEKLLGRKPQTLKSFLSEVYA
>KECLDBNJ_02344 Ribose-5-phosphate isomerase A
MTADQEKKQAALEAVKYIKDNMVVGLGTGSTAKHMIEAVGKLVADGMNLTCVPSSDATEK
LAKQLGIKIVALDEIKKIDITIDGADEFDGDFQLIKGGGGALLREKILAWNTKYNIIIAD
SSKDVKKLGAFKLPVEVIPFATKQIVSFLEDEGLQPVQRMKGNDPYRTDENNNIIDIDIL
EVDDLKALEIKLLKVPGIVETGLFLDTTSLIIVGKEGGPETKER
>KECLDBNJ_02345 Purine catabolism protein PucB
MNIAILILAAGAASRMGTVKQNLEFNGTTLLGNAIDQALATGMQNVYCVLGAHFETVGNS
IQDKAVTVIENKNWKNGLGSSIACGIKNIEVNNLDAVLVMLADQPLIDAEYLKQLIQTAT
EHPHSCVASDYGKKNGVPAVFPKQYFKELERLSGDQGAKELLNSPAASVIKLDARDRVWD
IDTPEEYARLLKK
>KECLDBNJ_02346 Non-canonical purine NTP pyrophosphatase
MTLVFATHNANKLQEIQALMPSEIQLKSLTDIGCTEDIIEDAATIEGNAQIKARYVKKHY
GFDCFADDTGLEVDALDGAPGVYSARYAGPQKNADDNIDKLLEALTDAPARKAHFKTVIT
LILNGEEHNFEGICKGEITQQRTGIGGFGYDPVFKPEGYEQTFAQMPLSEKNKIGHRGKA
TQLLLNFLKN
>KECLDBNJ_02347 DEAD-box ATP-dependent RNA helicase CshA
MSTFKALGLNDAILQAVTDMGFTAPSEVQEKAIPVLLREETDVVALAQTGTGKTAAFGFP
LIQRIDVNNRNTQGLILSPTRELCLQITNELKNYSKFVKGLNTVAVYGGANIQEQARQIG
RGAQIIVATPGRMQDMMRRNMVDITGIDYCVLDEADEMLNMGFYEDITTILADTPKDKKT
WLFSATMPKEVAAIAKQFMKKPIEITVGTKNMGAENVSHEYYMVNARDRYQALKRLADAN
PEIFSVIFCRTKRDTQKVAENLIEDGYNASALHGDLSQNQRDLVMKSFRNRQIQMLVATD
VAARGIDVDDVTHVINYQLPDEIETYTHRSGRTGRAGKTGISMVIVSKSEMRKIRTLEKI
INKKFTQKEIPTGMEICEVQLMHLANDIRSTKINEEINPYLYSINEVLEGLSREEVIKKV
FSVEFTRFFNYYQKAKDLNVAVQADLKEESGESTRYFINVGAKDGFDWMNLKDFLKETTG
LGDGIYKVDCKDSFSFFNTDTEHKDTILALFEDFKLQGRQIHVEITKDTRGGGGGGKRKR
GGKGKGRRNDDGFSGGRSKKGDSNNGFRGKSKSSGERRGKSKPNKKENKSPFSGKRRRRD
R
>KECLDBNJ_02348 hypothetical protein
MKKILFLLLLIAAPVYIFAQETTPTSAQQEEASFIEGTVLNSSTEEPLEGVNIINLNTVK
GTITKPDGTFRIKATSTDTLYFSFLGFKSLQVRVTNDWKRFGDVKVKMTETGIALEEVVV
KDVELTGYLEIDAKNVPVYKNVRYSISGLESAYEAGNSQPGAFDKVMSAIFNPADFLNKV
FSNKGSQMRKLRQMKEDDNIRDLLVTKFDRETLSALLQIPREDIEAILGRCDYSESFVKT
ANDLQILDALSSCYEEYKVLNRDR
>KECLDBNJ_02349 hypothetical protein
MNLVDWLGAIGVFQILLAYILNVTGKITPESWSFILLNFIGATIACTASVLLDYLPFVIL
EGVWALTSLITLIKKIISPRNTNLEV
>KECLDBNJ_02350 tRNA (guanosine(18)-2'-O)-methyltransferase
MSEDLINYLETFLTPRRQDLFQQVLKERTRFLTVAIEDVGHLHNTSAVMRSCDAFGIQDV
HVIEELKGKRIDREIAMGAQKWTSVKRYDATKEALAQLKRLGYRIVATTPHHTAHKLEDF
KLDQPTALFFGSEKDGLTETVIEAADEYIYIPTYGFTQSLNISVCAAILLQELTHRMRNS
TLDWQLKPEDIKEIKTLWLQRNLKDYEALVKNYKAEKE
>KECLDBNJ_02351 hypothetical protein
MKKFYFLLFVALIAASCDNDDDSLDVIPGESTGNTTTYDLSAVADPDVSGTVTFSEKTDG
STDISILLSTPTEGSHPAHIHLNTAAEGGEIAIDLEAVDGPTRRSLTNVTQTNAGTAVSY
DDLIDFDGYINVHASADDLGTLLAQGDIGQNDLTGTTKSYDLVTKDVEGISGTATFSERI
NGEALLEVMLDGTPDGGMHPGHIHNNSAAESGDIALTLTTLNGTTGMSKTNISALNDGTQ
IGYAGILDYDGYINFHLSADELATLVAQGDIGENELTGDTKEYELMTKDVDGISGTATFA
ARKSGAALVTVMLDGTPDGGMHPGHIHLNSAAESGGIAKTLTTLDGTTGMSVTHIEALND
GTEIGYDGLLNFDGYINFHLSADDLATLVAQGDIGANELTGDTKEYELMTKDVPGISGTA
TFAARKSGAALVTVMLNGTPDGGMHPGHIHLNSAAEGGGIAKTLTTLDGTTGMSVTHIEA
LNDGTEIGYEGLLDFDGYINFHLSADDLATLVAQGDIGANELTGETKEYDLVTKDVPGIS
GTATFAARKSGAALVTVMLDGTPDGGMHPGHIHFNSAAETGGIAKTLTTLDGTTGMSVTH
IEALNDGTEIGYEGLLDFDGYINFHLSADNLATLVAQGDIGQNELTGESMSYDLGTKDVP
GISGTATFEERLSGETLVTLDIEGTPVDGMHPAHIHAGAVADAPGDILITLATVDGSLGM
SQTHVAAYNAADGTANGGAAITYDELIGIDGYINVHLSATELATIVAQGNVGANAQ
>KECLDBNJ_02352 NAD-dependent protein deacylase
MKKIVVLTGAGISAESGLRTFRDANGLWEGHDVMEVASPEGWHKNRTLVLDFYNQRRRQL
KEVQPNAAHDALVKLEHAFKVDIITQNVDDLHERAGSSSVIHLHGELLKARSTQDEHLVL
DWHEDIKEGDLCPKKSQLRPHIVWFGEMVPLLDTAAALTAQVDYILIVGTSMQVYPAASL
INYAKPDAQIFFIDPKPNIHSQSNLKVYAEKASTGVPTVVTQLLNN
>KECLDBNJ_02353 hypothetical protein
MPLESYTLIHTEALLDTAQTEVLLNWATTARLNYLGAALPQ
>KECLDBNJ_02354 hypothetical protein
MIWIRHLLVFALVALVLIQFIPIDKNEGGYESLEPFLKETKPTTEVAVLLKSACYDCHSD
QTAYPWYAHVAPASFYLDEHIQNAKQQLNFSEWEQYSAKRKNRKLNQII
>KECLDBNJ_02355 hypothetical protein
MTETQWKDEVALISARLKEREALGNKILNNPSYIEFSLKLIQQQDPLIATNAAYGLDIAL
RKDITLLKPYLKEFLEVLDRNTIATVSRILAKSCELLTTAHTKNNSIALNKKEQQQLITR
CFDWLINDEKVAVKVFAMQSIYNLVDIEPWIKPELNAQLTLQFENSTAAFKSRASKILAL
L
>KECLDBNJ_02356 Adenylosuccinate lyase
MSLSLEAVSPIDGRYASKTEALSAYFSEKALIKYRIKVEIEYFIALCEISLPQLSEFPKE
TYPKLRAIYEDFTTEDALKVKEIEGVTNHDVKAVEYFIKEKFDALGLNESKEFIHFGLTS
QDINNTAIPLSLKDATNHVYLPQLLEVVDHLKQLADEWDGISMLARTHGQPASPTRLGKE
IQVFIVRLEEQIKLLKAVPSAAKFGGATGNYNAHHVAYPQIDWKAFGHSFVNGTLKLHHS
FPTTQIEHYDHMAALFDSVKRINTILIDLNRDFWQYISMEYFKQKIKKGEVGSSAMPHKV
NPIDFENSEGNLGIANAILEHLSAKLPISRLQRDLTDSTVLRNIGVPYGHTLIGLQSTLK
GLNKLLLNESKFAEDLEDNWAVVAEAIQTILRREGYANPYEALKGLTRTNEAITQNSMHA
FIETLEVSSAIKDELKAITPANYTGI
>KECLDBNJ_02357 hypothetical protein
MQYKFSLNLVLVVLLYAGILIAGLTGILTKTPVLIVLALIFLILIINLIKTRRK
>KECLDBNJ_02358 Acetate kinase
MNILVINSGSSSIKFQLIQMPETHVLASGVVERIGIENGSISYKTKTADFSEKVDIKDHA
EGLQKVASLLMSAEIGVIKSADEVDAVGHRVVHGGKQFTKTIKVNDEVKANIKRLFSLAP
LHNPANLTGIEVAEHLFSKAPQVCVFDTAFFESIPQKAYQYAIPQHLMEESRIRAYGFHG
TSHKYVSNRALEYLDNPYAKLITIHLGNGCSMTAIKDGKAIDTSLGFGPANGLIMGTRAG
DIDQSVVFFMQEHLGYSVKEVSDLLNKKSGMLGLTGHSDLRDIEAAAASGDRTCALALDM
NAYRIKKYIGAYAAALNSLDAIVFTAGIGENSSTIRSKACKEMDYLGIALDESLNGQRSK
NLREIQAEASKVKVLVIPTNEELEIANQVYDLI
>KECLDBNJ_02359 Phosphate acetyltransferase
MNKGIYIATLEPNSGKSIISLGLMRTLLGKTAKVGYFRPIIDDSKSTGKDNHISTVLSFF
DIKLDYEDAYAFTSSQLIKKRNKGKSGEILDTIITKYKNLEDRFDFVLVEGSDFTGEGSV
FEFDTNVLIAKNLGLPVILVGSGVNKTEDELMGSLQIAYTSFLERDVSVLAVVANKVQEE
NLMVAKNGLSNFLPDSVEVFAIPYTEKLAHPTIKEIVEELDGEVLFGAEFLDNQTGNFGV
GAMQLRNYLTHLKQDSLVITPGDRADIILGALQANISTNYPRISGIILTGGLKPEEPILQ
LIQGLSQIVPIVSVNDGTFSVTNRVGNIKSKIYASSKPKIETSLTVFSKEVSFDKLIERL
INLKPKGITPRMFQYGLMKRARTAKKHIVMPEGTDDRILTAAIQLVELDIVQITLLGEIE
KVKEKAVQLGLVLDLEKITVINPVQSEHFDDYVETFYELRKHKNVNRDIARDWMADVSYY
GTMMIYKGHADGMVSGAAHTTQHTIRPALQFIKTKPGVSVVSSVFFMCLEDRVSVFGDCA
INPNPSATELAEIAISSAESSLAFGIEPKIAMLSYSSGTSGKGADVDRVREATEIVKKER
PDLKIEGPIQYDAAVDAAIGKSKLPDSEVAGQASVLIFPDLNTGNNTYKAVQRETGALAI
GPMLQGLNKPVNDLSRGCTIEDVFNTVIITAIQAQGFN
>KECLDBNJ_02360 hypothetical protein
MKLFKFSLLFVVVATLMSCNNQQSLQEYYIDSKENDDFIMVDLPTSLISPKSETLSPEQK
KVIASVKKINLLAYSLKDTAFYTSETGKVKAILKGDHYDELMKLGSTEQRMRIFIKGDED
AIDEVVVFAQDNNKGFVLARVLGDDMNVADMVRFAETMDTSSAGLNTGQFEGIMDVFN
>KECLDBNJ_02361 hypothetical protein
MNKLVITLMLVGLSFSTYAQKSFDRFEDMKDVTSLVMNQKMFKLLGKMDLDSNDPEMKNY
IDMVNSLEDIKLFSTKNTNAAKAMKAEFSSYKASEKLEQLMSVKDDGKNVNFYYKPGKSD
DFVSEFLMFIDGETNDDDTVLIKITGNIDLKEIGKIANSINFKGSDELKNVKVN
>KECLDBNJ_02362 hypothetical protein
MELNKIEQLLELYFEGETTLEQEAQLQEYFTSDKVAPHLAEYVPIFGAFAKAKEEGFNRT
IVLPETKRSWRWVPVAASIILCVGLFLTFNQRQASEHDLGTYKDPDVAALKTKQALFMMG
NFMNKSTGQLDKLDTFEETANEIKK
>KECLDBNJ_02363 ECF RNA polymerase sigma factor SigE
MNQKEFLAQVTPIQDRLYRLAKRLLVSEDEAQDATQEILIKLWSNRMKIKKLRSIEAFAV
TMTKNYCYDKLKAKSSSNLQLVHSNYEDQHYNTVKTSENNDSVNWVLELMKELPEQQRLI
LHMRDVEQYSNSEIAKELDLNETAVRVTLSRARKTIREQLLKKHNYGIK
>KECLDBNJ_02364 hypothetical protein
MKKITLSLTLLTLLILTSCSKDRDDELAPLAELEIENFIYNGMQLYYLYKPEIPQLGNTF
FESTADLNTYLSGFAGPEDLFYNGLVADVDRFSFLSDDYRDLENSFAGVTKTSGIDYGLA
LDRNDPNFAFAYVRYVMPNTSASQNGVTRGMLFNTINAERLTTTANGDGTYSLSARSREL
LNLDSYTIALAEFDSNEDLQPTGVSIDLVQEEYTENPVFIAKTLDINGSKIGYLMYNAYR
RNFDSDLNAAFAQFQADGVTDLVLDLRYNGGGSVETAIDLTSMITGQFNGEIITQQQWNP
EIQAAFEADDPESLIDRFDNTISDGSAINSLNLSRLFVIGTGSTASASELTIIGLQPYID
VQTVGTTTVGKFQASITLYDSETFRRNDETLNPRHFYAIQPLVYTYANANGVVGPPAGIT
PDFELREDISNLGTLGEADEPLLSLALDQILGRSYASKNKSGTVFETFGERKNQTATYQR
MYIEALPNYVK
>KECLDBNJ_02365 putative CtpA-like serine protease
MKKNFLVFLLSVLIISACSNDDDVAEVVEEPETEEPTPEEPEQEEETLDRADYPIQDFMY
LAMNLYYLYKADIPELADDYFTDVDTYVEYLAENTVPEDFYYDDLVTEQDRFSFMTDDYV
ALENSFSGVSKSNGLKYSLVRFSNSNDIFGYVRYVAPNSNASATAIKRGDLFLTIDGTQM
NLSNYQTLLAQDSYTLGLATIANNTVSATGTSVTLTKEEGFSENPILIAKTLDIDGQKIG
YLMYNSYVGDYDDELNAAFADFKADGITDLVLDLRYNGGGSVASAIDLTSMITGQFEGEV
ITKQQWNAEAQAYFESESPESLIDRFDGQIRTGEAINSLNLTRLYVIGTESTASASELTI
IGLRPYIDVKTIGTTTVGKFQASVTLYDGDNFTKQNVNPDHNYAIQPLIYTYANANGTVG
PPTGIVPDFELEEDLANLGTLGEESEPLLSLALDQILGRSHTSSKRKAGPAYELVGETDM
NQPTFQRMYANEVPQIKK
>KECLDBNJ_02366 hypothetical protein
MKINKLALFALLGVFVLNSCSNDDDASEPLPEGDYTDGFFVLNEGGIGTVTYISDDLSTV
EQDIFASVNPNAADLGAYTQSIFFDDNDRAYIISNGSNLITVVDRYTFELIDVIDEGLTV
PKYGVVYNGKAYVTNNNTFNDYTYDNDNPPASYDDFIAVINLETLSVESTIETDSYTEQI
EEEDGLIYVNGSSFGYGNTINVINPSSNAVERTITTAFGVNSFDIEDGSIYALSSNSYEV
FNKDNGEQLSVLEFADLSGASNLVLEDDQAYFTIDRSVYVMEQNSITEPATALLTYSSTS
EYGAMYGFAVEDGRIYIADGGDFSSDSFVEIYSTSGSLLKNITVGLGPNGFYFN
>KECLDBNJ_02367 Vitamin B12 transporter BtuB
MNIRVFYFFLALGLCVSFTYGQNTAFTALDSVYITDLKLKHYSTGRAVLQLSDSTTRLNR
PLLTNTLNFNSPIYFKENGLGMVSSPSFRGTTASQTAVIWNGININSQFNGQLDFNTVNS
GAYDEIAVRGGGGSVVYGTGAIGGSVHLNTKLEFIKQQEHNLFLQYGSFNTRDARYQFKL
GTQAYSLSIALAHNSSDNDYDYPDGGTNLNGDFQNAALNVGLGFKLSRQHSLRFFSEVFD
GERHFSLIRASETRTKYDDLNTKNLLEWEYDFSNFTSIARLAYLEEYYKYFGNLDSDNFS
FGKAKTTIAKYDLTYAFYEGLSINSVLTNTYTSGEGSSLGDNDRNIFSAAVLMKHQLKNE
LDYELGFRKEITNNYESPFLFSVAASKAFSKHFSLNLSGSRNFRIPTYNDLYWSGAGNAE
LLPEKSLQGQLGASLTIANFNLDLTGYYNSVTDMIRWLPGSDGVWRPQNEEEVSIYGIES
ILNWSPKLGRKQHLELYGTYAYTVSENAQTGYQLIYVPFHKATAGINYDYKRFNGTVQAI
YVGEVFTRSDNNSRYNLDAYAVANFSLGYSLGKEKNYELGTRVNNVFNAEYQSVVNRWMP
GRNFNMYLNLKL
>KECLDBNJ_02368 hypothetical protein
MIKNLLSIFICIAFLNVVSCKKNTEKSVETLQTASQNTIEYAQGFTLKTYNTYTILSVTN
AWPESDKTFNYLLLKEGQTAPDSIQADAVIHVPIRSIVVTSTTHIPALELLGVEQSLVGF
PNLDYISSEKTRALINSGAITELGQNESINTEKAIDLDPDVVVSFGVEGENKTLSSLQRA
RIPVLYNGDWTEHQPLGQAEWIKFFAALYGKEKEADSIFKHIETRYTDLKEKALVAKNKP
TVLSGAMFKDVWYLPKGDSWAAQLVADANAAYLYADSEGTGSAALSVESVLDKSQTAAFW
IAPNAFASYEALAEANEVYTQFDAYKNKTIYSFAKAKGATGGMLYYELAPSRPDWVLEDL
IGIFHPELKQVGKPHFFFPLD
>KECLDBNJ_02369 Hemin transport system permease protein HmuU
MVLLLFLANIALGSVKIPIEAIFDIFFDPANVKEAWKYIILDYRIPKALAAVMTGSGLAV
AGLMMQTLFKNPLAGPFVLGISSGASLGVAFFILGGSALGLTAMLAPNGWGTILAASLGS
FAVLSIVILVAARVRDAMALLIIGLMFGSLTSAVVSILAYFSPAEDLQRYMFWSFGSLGD
ISWPALGILSVCYVIGILLALSITKSLNSLLLGDHYAQTLGVSLKKSRFIILIATSILAG
SLTAFVGPIAFVGLAVPHLIRQWFTASNHWVLMPACILGGAVLMLFCDIIAQMPWFEFTL
PINAITSLIGAPIVIWLLVRKKKLLF
>KECLDBNJ_02370 putative siderophore transport system ATP-binding protein YusV
MEQAKSVLLKCEALSVGYTSSSLEKPIVKEANLQLKPGMFTTLVGINGSGKSTLLRSLAG
LQKPFSGSVILNDIPLNKLSPDARSKCISVVLTGQQISKNLSVLELVALGRQPYTNWLGK
LSAHDKTHIDQAIASTQLEALQHTPCYALSDGQFQRALIARALAQDTPIIMLDEPTTHLD
LHHKASIFTLLSEIAHKHHKTVLCTTHDIELVLSLCDEMIVIQNEKAQQNTPQQLIADGV
FNQLFPSNSIGFDQNSRRFFIK
>KECLDBNJ_02371 hypothetical protein
MTESFLFLIIAFVALLGGTVLGYFIASLKQKTNTAILQERINLLQDQRNTFDQTRTDLLK
KQDQLQEDKEFFQNELTARNVAFESLQHQFKEKTSELERLQEKFTKDFEIIANKILDEKS
SKFTLQNKENLDTLLKPLQERISSFEKKVEETNKESLGRHSELRQQIKGLAELNLQMSKD
ADNLTKALKGDAKMQGNWGELILTRILEKSGLEKNREYTIQDSHLDEQGKRLQTDVLIHL
PDGKKMIIDSKVSLTAFERYVSETEETQKAVYLKQHIASVKQHVATLSAKNYQQLLEESP
DTVFMFIPIEPAFALASAHHPQLYEEAFNKNVIIVTPSTLLAALRLVENLWQNDRQKKNA
IEIATHAGRLYDSFTLLTEELTKIGLQLDTVRNTYDRSMVKLTGKGNLINRVEKLRKLGA
ITSKQLDQKLLKSAEEDDATAKAND
>KECLDBNJ_02372 hypothetical protein
MKKLLGFVLGGIVLLAILYYSFIYFVPYSEGTRAGELIKFSRKGVLSKTWEGQISQGISG
AQIFDFSVMDGEEEVIQKLKDYQGNYVKLTYVERYATFIFWGDTKYFVTDVTKENSPHFN
RN
>KECLDBNJ_02373 putative acyl-CoA thioester hydrolase
MDQFKTIEASQVTISELMLPSHTNFSGKIHGGYILSLMDQIAFACASKHSGNYCVTASVD
TVDFLRPIEVGELVVMKASVNFVGRTSMVVGIRVEAEDIHSGTIKHCNSSYFTMVAKDDS
GKSVPVPGLILKTEKQVRRFLKSLNRQEMKKNHRNETSKKTELRIEDLEILRNSHKVQLE
Y
>KECLDBNJ_02374 hypothetical protein
MKFTWFYIFIFIIGTTICAQETHVIQWASGSQALQSTLEVEVGDKVKWVFDEPIPQNLLN
TSLKASSDFGTRELLGKGSVYEYIFSDKGIYTFQSGINKELKGTIRVTDNASILSQTKDG
FKIYPNPVKDRIYFKNPDLSNSVEITFYDVLGKMVKRDAINSGMIQGGMDVSRLKRGVYL
VQIDNGERSFTQKLIKD
>KECLDBNJ_02375 Carbamoyl-phosphate synthase large chain
MPKNENLKSILIIGSGPIVIGQACEFDYSGSQALRSLREDGIETILINSNPATIMTDPVM
ADHVYLLPLTTKSLVKILKEHPQIDAVLPTMGGQTALNLCIEADEKGIWEDFGVKIIGVD
IDAINITEDREKFRELMLKIGVGMAPQATATSFLKGKEIAQEFGFPLVIRASYTLGGAGA
SIVYKPEDFDRQLSHGLEISPIHEVMIDKALMGWKEYELELLRDKNDNVVIICTIENMDP
MGIHTGDSITVAPAMTLSDSTFQRMRDMAIHMMRSIGDFAGGCNVQFAVSPDEKEDIIAI
EINPRVSRSSALASKATGYPIAKIASKLAIGYTLDELDNQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGSDRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKGYTNY
DKIIEKLTNASWDRVFTIYDAIQMGIPLSRIHEITKIDMWFLKQFEELDALEKEISKYKI
DTLTRDLLLEAKQKGFADRQIAHMLDCLESDVYNKRDELKINRVYKLVDTCAAEFVAQTP
YFYSTFESDMELASGERFSQNESKVTDKKKVVVLGSGPNRIGQGIEFDYCCVHGVLAAAE
CGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLDRYGIKIIGTSYQALDLAEDRGSFSRLLKENNIPYPEFDTAETAEEALAVADRLDFP
ILVRPSYVLGGQGMKIVINKDELEETVVDLLRKIPNNKLLLDHYLDGAIEAEADAICDGE
NVYIIGIMEHIEPCGIHSGDSNATLPPFNLGDLVIQQIKDHTHKIALALNTVGLINIQFA
IKDDKVYIIEANPRASRTVPFIAKAYGEPYVNYATKVMLGEKKVTDFDFKPKLNGYAIKQ
PVFSFNKFPNVNKALGPEMKSTGESILFIDSLKDDEFYDLYARRKMYLSK
>KECLDBNJ_02376 hypothetical protein
MFNKNIKLVLAVLVFGLAVWQIIDRSIGNGIMLILLSAIFVLLYFKNEILILAFLRLRKQ
DFAGAQKWLDKIKNPEAALVRKQNGYYNYLNGLMLSQTNMIQSEKYFKKAVQLGLSMDAD
LAMAKINLAGIAMTKNRRREADKLLAEAKKLDKHNMLDEQIKMMKKQMKQAANMPRQQYG
RGGRR
>KECLDBNJ_02377 hypothetical protein
MPRTLLILLFISLWNLNAQENEKILFSEALNSTINTYNSRVDAALASGEFDYAKSLFDSL
VKDHLQGSYIDALEFERFNSGIASTEEFDKPTILLTYASWCIPSEGEIPVLNKMVERYSD
LVDFVVLFWDSKDTVRKLAKSFDKNIHIVYVDETKNKHMQTVNLLKHALGLSLSFVMGAD
GEILDINRRPPNKMNLSESQLFNQNITFLSRQIAAINIDHNININELPESLATF
>KECLDBNJ_02378 Membrane-bound lytic murein transglycosylase D
MINIKNILAGVGLVATTAVCVQAVQQDNTTTNTDPEIKKTDKLVNDYNVYAIPLPDQLEF
AGEAVPLDNPDIRERLDRELLVNTYWQSNGLLLIKRAAKYFPIIEPILEEEGLPDDFKYL
AVIESGLTQAVSPARATGFWQILSSTGKELGLEVNDNVDERYNVELSTRAACKYLKKSKA
SLGSWTLAAAGYNAGNAGMSRRLNQQDVNGYYDLLLGEETGRYVFRILALKQILSDPERY
GFNYTQEDLYKDVPSYKVKVDTVVTDFVKFAQQFGINYKILKLHNPWLREDHLNNASRKE
YHIEIPKEGYYNANIGQ
>KECLDBNJ_02379 hypothetical protein
MIHVYLMPGMAANPSIFEHIKLPEKNYTLHALSWKIPQPSETLEDYAKRMLEEVKEANPV
LLGVSFGGVLVQEMAKFITYRKLIIVSSVKSKLELPKRMRFCRALGLYRIAPVSLARNVD
TLANYAIGDRLKHKVELYQKYLSITDPVYLTWALEQMLCWDQVKCKEDLVHIHGTSDPVF
PYRYINNCIPIPGGTHAMIITKCKWFNKNLPKIIEN
>KECLDBNJ_02380 hypothetical protein
MDVMTAIELTDNEFLRQFETTFDEKLAKIEYSLQDRKIFLTKIHMPEGTEDRMNDFIVAV
FKEVEDRNIRLVPTSPEIAKFMRSNRRKYKNLLPVGINI
>KECLDBNJ_02381 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MNEAGKKVAFYTLGCKLNFSETATISRSFKNEGFDRVDFSESADIYVINTCSVTENADKR
FKTIVKQAQKVNPDAFVAAVGCYAQLKPEELADVDGVDLVLGATEKFKITDYLNDLSKND
MGEVHSCEIEDADFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDTLENVL
NNAREISAKGIREIVLTGVNIGDYGKGEFGNKKHEHTFLDLVKALDQVEGIERLRISSIE
PNLLKNETIEVVANSRAFVPHFHIPLQSGNNEMLGKMRRRYQRELYVDRVAQIKKLMPDA
CIGVDVIVGFPGETDEHFLDTYNFLNALDISYLHVFTYSERDNTLAAEMDGVVPLKVRKK
RSKMLRGLSAKKRRAFYESQIGTQRTVLFEGENKKGYIHGFTENYVKVKAPWDPALVNTT
HSIELKEIDDDGMVRFEYCTETTEVLA
>KECLDBNJ_02382 Periplasmic dipeptide transport protein
MTLTFMKLNSFLKSLAHTHSFIIGTLFLCLVSCNSKAEAENDLNVFRYNEHYNVATLDPA
FARNPPIIWPTNQLFNGLVQQDDSLNIVADIAKSWMVSEDAKTYTFILRDDVYFHKHEQF
KTKDSTRSVVAGDFVYSFNRLKNATVASPGSWVLNNVEQYRAVNDTTFSITLQKEFPAFL
GLLTMRYCSVVPKEIVAFYGNEFRRNPVGTGPFKFKRWEEGVKLVLRKNELYFEHDADGN
QLPYLEAVAITFLPDKQSEFLQFAQGNLDMLNSLDPSYKDELLTATGKLKDNYKDRVKTI
TGPFLNTEYLGFFLDSKSEEVRSKLLRQAVNYGFDRVKMIKYLRNGIGTPANAGFIPKGL
PGYGTSGFEYDPAKARDLINQYIKETGNGTPSITIGTNSQYLDICEYIQRELGKLGLNII
IDVMPPSTLRQLKSTGKLDAFRASWIADYPDAENYLSLYYSKNFTPNGPNYTHFKNQTFD
SLYEASFKFSDIEKRKVLYEKMDSIILENAPFVTLYYDQVIKFVHKNVTGLKANPQDFLV
LKRVRKSAKMQ
>KECLDBNJ_02383 hypothetical protein
MGFGGSVAAMLATLNNNKRERTSRFDSKHRTNTTSQNASSKLVFKKLNDKDLYEVKKQIQ
QKASAHNKKVAVLTIISLVLLAALILWLFLDSGTPLV
>KECLDBNJ_02384 putative HTH-type transcriptional regulator YttP
MELNDKQKEIVQVAEKLFAEYGFDGTSVRLIAKEAGINIAMISYYFGSKEKLLEHMVVHR
MSGFKVNLDEIIAQDDRSYHDRLNEIVALYVKRIHKNNRIYKIVHNELTNNARSLTFEHY
LSQKKKNLDSVTKFIEAGQKAHVFKKHIEIPLLIPSILGTYFHFHYNQRFYEESYGLNTP
ESKELFIETTLTKHIQKMLNALITYED
>KECLDBNJ_02385 Outer membrane efflux protein BepC
MKTRFIITAIPLFFSLFVSQAQKIQNLSLDDVVQMALTTSDASKINAAQVTQAQQALKVS
KNNQYPDVDISGQYRYLTNADVKLQIPVSATSAGNSEEQATASPDVNGLWLGSANVSMPL
FSGFKLKNSISASENKLQAAIYNAANDQEELALRAIQTYLNLYKANATIGLFEDNLKSAN
QRVTDFSNMEANGLLARNDLLKAQLQQANVELSLAEAKKNAKILNYRLNALLKLPEETQI
STEVNAVTPVANGLPSTENRNDLKALDFQEEALQDQIKVAKADYYPSLALVGGYIALDLN
NALTVTNAMNVGVGVSYNLASLFKSKANVKLAESQAQQLRYQIDEATAQAKVNAQNAFAE
YNLALNTFEVYEVSKEQAEENYRIVKDKYDNGLSDTNDLLEADVQQLQANINLTYAKADI
TQTYYQLLSAEGVLTKQFSQN
>KECLDBNJ_02386 Multidrug export protein EmrA
MEQKKKTNKKFIIITAVLVLIGATYGTIKFIHSLSHEETDDAQVEANMSAIIPHVGGYVD
QIFVEDNAIVKAGDTLFTIDQRDYLVQLEQAKASLAAAESQLAVAQSSIGSSKANASASY
AQVSSTYGNIESAKIQLRRASDDYTRYKNLYDNKSITTQQYEQALAAKQEAEARLSVLEN
QQKAMQSQSRAATSQNEVTEKQVAVAEANIKSAQAQVDAAQLNLDYTVVIAPIDGQLSSI
EIQEGQFVQPGQSLFYLVNTQDKWIVANFKETQLNDMKVGQKVGIAIDAYPDEEFEGVIA
NFSPATGARFSLLPPDNATGNFVKTVQRLPVKINFTDANSKERLALLRAGMNAEIDVHLN
>KECLDBNJ_02387 Multidrug export protein EmrB
MAEAIEAEDSLVEYGFRRVIITITAILCALLEIVDTTIVNVALNDMRGSLGATLTDVAWV
ITAYAIANVIIIPMTSWLSKQFGRRNYFAVSIVIFTCSSFLCGNATNIWELVAFRFVQGL
GGGALLVTAQTIITESYPVAKRGMAQAIYGMGVIVGPTLGPPLGGYLVDNFSWPYIFYIN
IPIGIIATFLTILFVRSPKYGEKLSANQVDWWGIVFLASFIGSLQFVLEHGQQDDWFEDH
MIVILSVVSLFGLVAFIWRELVYEFPIVNLRVLRNTNLWTGTIMTFILGFGLYGSTFVIP
IYTQSILGWTATDAGLLLIPSSITTGLMMPIIGKLLERGIPAKYLVALGFIGFFLYSLWM
HNLLTPDTSSEAMFWPLVLRGMGLGLLFVPITTLALSTLKGAEIGEGAAFTGMMRQLGGS
FGIAIITTMISRLNQQHRVDLIPNLSSIDPQTQQRVNGLQQMFIGKGFSFNEALDRAYQV
LEGSISLQGTVLTYMDVFLYLGILFLVCVPFVLMMKNGSGKPASGAH
>KECLDBNJ_02388 Bifunctional protein GlmU
MNYILFDGPARKKLLPFTYTRPVADLRIGILTIREKWEKHLGSTTSTITEEYLSEKFPMV
EFEENVMINASYIPTEVLVEQVLDLQENQALFDGDDIVAFYTKDTQEEIDFDTYEQLEVT
VEGIFKIENNWDIFSKNHEAIQLDYDLITEGRISAEIPKGVQTLHAENIFIEEGAKINFC
TLNASDGPIYIGKDAEIMEGALIRGPFALCEHAAVKMGAKIYTGTTIGPYCKVGGEVTNS
VLMAYSNKGHDGYLGNSVLGEWCNIGADSNNSNLKNNYEEVRLWDYETEGFAKTGLQFCG
LMMGDHSKCGINTMFNTGTVIGVSVNIFGTGFPRNFVPSFSWGGASGFTTYKTNKAFETA
KLVMERRNIPFDEQEAAILEHIFEESAKYRRY
>KECLDBNJ_02389 30S ribosomal protein S1
MAEENKKPEAQEEVELKTNVAAAEELATPDAIKEPKGYESAAQANPEKFLKEFNWHNYEE
GIDPIDDDKLDEFEKLVAENFVDTLDDEVVEGKVINITDRDAIIDINAKSEGVISLNEFR
YNPDLKVGDTVEVLIDVREDATGQLVLSHRKARVIKAWERVNKAHEDGTIVTGFVKARTK
GGMIVDVFGIEAFLPGSQIDVKPIRDYDAYVNKTMEFKVVKINQEFKNVVVSHKALIEAD
IEEQKKEIIGQLEKGQVLEGTVKNITSYGVFVDLGGVDGLVHITDLSWSRINHPNEIVDL
DQKLNVVILDFDEDKTRIQLGLKQLKKHPWDALSETLSVGDKVKGKVVVIADYGAFVEVE
EGVEGLIHVSEMSWSTHLRSAQDFVNVGDEVEAQILTMDREDRKMSLGIKQLTQDPWTDI
TSKYPVGSRHTGIVRNFTNFGVFVELEEGIDGLIYISDLSWTKKIKHPSEFTNIGDKLEV
VVLELDVEGRKLSLGHKQIEDNPWDKYEADFAVGTKHTGTIGEIVDKGATVEFNEDIVAF
IPGRHLEKEDGSKLGKGDEAEFQIIEFNKDFKRVVASHTALFKEEEAKIVKQAAKKAADS
AAASAPTLGDANDALAALKKQMEKGGN
>KECLDBNJ_02390 Monoacylglycerol lipase
MLAEKSNTTFTGQTTRHELFGKVWKAPDQKAVVCIIHGFGEHLGRYTHVAEYFNTKNITC
YAIDLPGHGNSSGERGVVRSLQDFILAVDFLYEKAIQENPETPVFLYGHSMGGGIVLRYL
LMTADPPAGALVTSPWLKLVNNPGALQIILGRMALTFALNPVKETKLNPEDLSRDAEVGK
AYQNDPLVHGKASIKLFFGLNDNGVYLMDKTFDFRTKLLLAHGTEDNITKYQASKTLASR
HPDQMDFKSWEGLRHETHNELNKEEVLEFYSNWILDQANS
>KECLDBNJ_02391 TonB-dependent receptor SusC
MRIGVLWFLTLLSVSFGLFAQSTQEVTGYVTSLGTPVVSAKVTVVGTEVMTATDSRGYYT
IDVAPRQELQFSYVGLETVTIIIEDVTRTLNVKMLPEVNDLDEVTVTTKNKNQSDFQEEF
GPNGKPRKMPTAMGYISTGGSSAYVKGASLNQAAVDLARAIDGRAAGLEVNSEGEIYIRA
GNSINNNIPAIWDIDGTIYTEPPFIDIANVQDILILKSLSQTNRYGSLASGGVIVVRTKG
AYFSQRKEKVNKTYGNQRIYSDDAIAMESLITVTPEYQKDLESSNTLEEAFSIYEKSLVN
NARDVAFYADVAQYFYDKNATDKAHSVLSEMETAFETNAEALKVLAYTYEANADREKALS
VYKKIFRLRPQYAQSYRDLGNSFAAAENYQKAWLMYMGYMNNTDSLSGTGIDAIVYREME
ALYFQHKDKIDADAKFSLPENKSELAYDVRLVFEWNTSEAEFDLEFVNPQNQPYVVNHSL
EQSPERIRDEKLKGYTSEEFLIDDLGSGDWLVNLKYYGNKQFQPTFLKVTTYYNWQQPNQ
REMVEVFKLTRQNIKMQLLKLYNRNFRY
>KECLDBNJ_02392 p-aminobenzoyl-glutamate hydrolase subunit B
MNTKITLLFLLIGLVAFGQKIPKDKKQLIASVENHKEELISISDQIWANAEIAFQETESS
KLLADYAEANGFTVERGVADIPTAFIATYGEGKPVISVLGEFDALPGISQKAQPTKEPLE
AGAAGHGCGHNLFGTASLGAAIAVKEMIEAGKIKGTVKFIGTPAEEKFFGKLWMLEAGVW
DDVDVNVSWHPSADTKADVQSSLAMVDFIVEFNGQAAHAAADPWNGRSASDALELYTTGI
NYYREHIKPTVRIHYHIQDGGQVVNVVPDYSKLWVRVRNTDTKGMLPVFEQVKKMAEGAA
IMANVDYKYSLVSGIRETLVNRTGGAVMQENLELLGPLEYTEEEIAFGKKIQEMTDKPQV
GMDSKIYPFEETRENPGGGSTDVGDVSWNVPNINLGVTVAPKDTPWHSWAVVACGRMSIG
HKGMVMASKAMSMTMYDLFEDAKLVEEVKTEFKERKGDDVYKAMIPDGPPPIGN
>KECLDBNJ_02393 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MSTDILDKPNATQKATSKDTIQTINPSTGKPLDRYKMMTDQEASDAVQATHNAFLEWKTF
PLEKRAAFIQKIGKSLAKHKEQLVKLMTEEMGKLISQGEQEVDLCVGICEYTAQNGPKAL
QDEKRTLPQGGKGVITYSPLGVIYGIQPWNFPTYQVMRYTIANLMAGNGVLLKHAENVTG
SALLIEKIISEAGLPENIFTVLRISHNQSDAIIENDLVRGVTLTGSGAAGKVVGEKAGKA
LKKTVLELGSNDAYLVLDDADVDTAVEWSIKGRIYNNGETCVAAKRFVVTEKVYDEFKQK
FVAGMEKIKFGDPTDDTVDIGPMARKDLREKLHDQVQESIANGAEVLCGGNLPKGEGYFY
PATVLGNVKPGQPAYDDELFGPVASLIKAKDNEDAMRIANDSRFGLGGGIFSKDEKAAFE
LAKNHFDTGMVFINSFGLAQPNMPFGGVKASGYGREHGGFGIKEFVNEKAIMSLDS
>KECLDBNJ_02394 putative transporter
MKATQLDRGLLYLMAAGAGLVVANNYYNQPLLNLMAKTFSVTEAQVSNIPLATQLGYAFG
LLFIIPLGDKFSRRTIILIDFVAIIGSLLVTAMAPSLTVLTISSFCVGFSSVVPQLFVPM
AAQLASEENRGKAIGIVMSGLLIGILGSRFLSGLVGEYFGWRFMYYVAAVIMLVYAALLY
FKLPDVATNFKGTYSQLMQSLWKLFKTKPEVRIAGLRGALGFAGFSAFWTTLVFLMETNF
GYGSGAAGLFGVLGMIGALGATISGKLNDKYPPKKLIYIFTAILIVSWIVFQFSGNSIFG
LVIGVLSVDFGLQCLHVTNQNIIFNQNPEARNRVNTIYMVLYFIGGALGTVTGAYAWQHY
QWAGVATLGLVYSILIIILQLLFQWKHKH
>KECLDBNJ_02395 Cytidylate kinase
MKKITIAIDGYSSTGKSTVAKMLAKELGYVYVDTGAMYRAVTLYAMRKLFIKAGHFDKEA
LIRHLFMVSVKFQMNAETGIADVYLNGENVEREIRTLEVSNFVSQIAAIPEVRKLLVQKQ
HEMGKEKGIVMDGRDIGTVVFPDAELKVFMTASADERARRRFEELKAKGDAVSYEAVLEN
VQKRDKLDTSRADSPLVQAEDAILLDNTHTNIEDQFHILLQLAKDRIFGRC
>KECLDBNJ_02396 hypothetical protein
MIKKLLLILALLTSFSFWAQLGGRATYQFLNLVSSPKQAALGGKLLTDYSYDPTSGLFNP
ATINPEMHNQLSLNYVNYLADVNYGTVGYAYEYDRRSGVFHAGVTYVNYGTFEGYDERGN
ATADFSGGEVAFSAGYAYNIPRTDFFVGANVKLISSKLEQYTSLGGAVDLGFIYVNDKLE
LNIAGVVRNIGTQFTAYDFTYERLPLEVDLGISQKLEYVPVRWHLTLENLQNWNLAFANP
ARATSDLNGNSIPENVNFFDEALRHMIFAAELFPDKGFNIRLGYSVRRAEELRIVDQRSF
AGLSAGFSVKFNKLRLSYSYARYNTAASSGFFGLNIDLN
>KECLDBNJ_02397 Lon protease 2
MARTKFTNLDNLSLQDFEGDAELIPLMTPEDEDEINREELPETLPILPLRNTVLFPGVVI
PITAGRDMSIDLINEANKGSKIIGVVSQKDGDVENPSADDINTTGVVARILRVLKMPDGN
VTVIIQGKKRFNIAEVITEKPYLVATVREVAETKPEKDSAEFKAIIESIKEQALQIIKQS
PNIPSEAGFAIKNIESESFLINFVSSNMNLSVDEKQGLLEINDLQERALQTLRYMNTEMQ
KLELKNDIQSRVHNDMSQQQREYFLHQQMKTIQEELGGVSQEDEIEEMRQRAKKKKWDEK
VGKQFKKELAKMQRMNPQVAEYSIQRNYLDLFLDLPWNKFSKDKFDLKRAKKILDRDHYG
LDDVKKRIIEYLAVLKLRNDMKSPILCLYGPPGVGKTSLGKSVAEALGREYVRMSLGGLR
DEAEIRGHRKTYIGAMPGRILQNLKKAGTSNPVFVLDEIDKLSNSNQGDPSSALLEVLDP
EQNAEFHDNFLELGFDLSKVMFIATANNLGSIQPALRDRMEIINVTGYTIEEKVEIGKRH
LLPKQLKEHGVTADQLKIAKPQLEKIVEGYTRESGVRGLEKQIAKMVRYAAKNIAMEENY
KIKIDNQTVIDVLGSPKLERNKYENNEVAGVVTGLAWTQVGGDILFIESILSKGKGNLSV
TGNLGKVMKESATLAMEYIKSNAEYLELDPSVFEKYNVHIHVPEGATPKDGPSAGITMLT
SLVSLFTQRKVKQSIAMTGEITLRGKVLPVGGIKEKILAAKRAHIKEIIMCAENERDVKE
INEDYLKGLTFHYVYDMSEVLDIALTNEKVKRAKQL
>KECLDBNJ_02398 ECF RNA polymerase sigma factor SigR
MYNTSLRIVRDSAEAEDVMQESFLSAFTKLDSYSGEATFGSWLKRIVVNNSISSYNKRNR
LKEDDLDDTLYKLEEDQGITECDTNHLEVQRVLQTMNHLKENYRMALTLNLIEGYDYEEM
SDILGISYANCRTTVSRAKESLRKKLSELITE
>KECLDBNJ_02399 hypothetical protein
MKPNLENWFEEQRDCFDIAEPGDGHELRFLNKLKETQVEEKTVKKLDWWKPLASAAAIVL
IVFAGYATLKPANSGAELAAVSPEMAKTQDFFTKAIEEELYNINEARTPETQELVEDALV
QLEALEKDYQELTEDLATSGEDKRVIYAMIANFQSRIDLLNTVLEEIESIKKIKNDVYED
QLL
>KECLDBNJ_02400 hypothetical protein
MKTNYYKYLFLFLVTSAVTFANGNDPDRFKGRYTKEKKINKQYNVNANALLKINNSYGNV
DVISWDQNQVVIEVHIKTNGNDEDKVIKKLNQIEVSFEASADMVAARTEIESTSSSWWSS
WTSGGNNVNMEINYKIKVPVTNKVDLSNDYGGISIDKIKGQAKISCDYGHLDLGELLADN
NLLSFDYTNNSNIAYMKSGKIRADYSAFTLEKGGNIELNADYTKSTFGSIKNLQYSCDYG
GLNLDAAEAIKGSSDYLSVKLGKISGPVDLNMDYGSIRIDELTASAGNVRINSEYAGVKI
GYNAAYQFNFIIKLDYAGLNGEEDFEITKRQIESSDKYYEGYYGSASAKNNVNINSEYGG
VSFYKVN
>KECLDBNJ_02401 hypothetical protein
MKKIILILGIALVSSTVNAQWWGGKKITGNGNTTTDTRNLSDYDEVGVSGSFDVILVAGA
EGKITVEAEENLQEYIITEVKGDKLKIYTEDGVSLRTSRNKDIIITVPFKDLEAVNLAGS
GDVTSKDVINAKNFKCSVSGSGDMILEVNVQDVTASVAGSGDLSLSGSTQKSHLKVAGSG
DLHASDLKSNDAEASIAGSGDISLNCNGGTLKAAVAGSGDIVYTGKPDKVDSKVVGSGSV
SN
>KECLDBNJ_02402 hypothetical protein
MEALPKGSKKLLNAWAFYDWANSVYSLVIASAVFPIFYGALTLVKDEEGKILDDSVNFLG
YDFNNDTLISYVTAAAFLVVSFLSPFLSGIADYVGNKKSFMKFFCYLGALSCIGLFWFNM
NYLWFGLLCYFLALIGFWASLVFYNSYLPDIAFPHQQDKISAKGYSLGYIGSVILLIVCL
AMILMYETFGFEDEGLPTRLSFVLTGLWWIGFSQYTYYYLPKGNKKEKLTKNVMFNGFKE
LRKIWKKLKEDKPMRTYLMAFFVYSMAVQTIMLIATYFGIEELDWGTTDSTTGLIVSILL
IQLVAVLGAWLTSKASAKFGNIQTLIVINCIWIAICIYAYTITTPFQFYFTAAFVGLVMG
GIQSLSRSTYSKLIPEGEKDTASYFSFYDVSEKIGIVIGMSTYGFIADQYNIRNAILFFI
VFFIVGVILLFFVPRKRIVEQVE
>KECLDBNJ_02403 Beta-barrel assembly-enhancing protease
MKTKKILVALATIFLIISCKTSPFTGKKTLNAYSNETIFPMAFQQYNEFLAQNTVVKGTA
EAQMVQRVGNKIAKAAERYMTALGYPNYLDEYKWEYNLVQDEAINAFCMPGGKIVVYTGI
LPVAQDETGLAMILGHELAHALANHGAQRMTAQQGQSIVGAVGGVALGDSRAGQLFNQYY
GTASTVGAILPFSRSHESEADEIGTIIAAIAGYDPYEAPKLWERMKAQGSSGTPEILSTH
PSPDTRIAALTQIAPRAEAEAKKFGVTTFK
>KECLDBNJ_02404 Oligosaccharide 4-alpha-D-glucosyltransferase
MIINTELEQKGNQFPNEIKSVRQEVDTLYFTTQNNVILELTVLRDSVIRFRYGTRGILED
DFSYAIDSENHIGYNHLELSENKNFYIVTTSKLIIKIEKISLQSKILDREGNLINEDEIG
FHYEESFTLGGNIVKMSKRSHPGEAFYGMGDKPVHLNLRGKRVSNWATDSYAFGKDTDPI
YKSVPFYIGLKDKQAYGIFFDNTFKSSFDFCHERLDVTSFWAPGGEMNYYFLYGPGMNEV
VENYTHLTGKPELPPLWTLGFQQCKWSYYPESTVKGIAKKFRDLKIPCDGIYLDIDYMDG
FRCFTWNKEYFPDPKRMVKELLDDGFKTIVIIDPGIKIDPEYWVYKEALENDYFCKRADG
PDMVGKVWPGECAFPDFTNPEVREWWADLFKELVHDIGVRGVWNDMNEPAVMEVPGKTFP
DDVRHDYDGHPCSHRKAHNIYGTQMARATYEGVKRYVYPKRPLVITRSAYSGAQRYTSSW
TGDNVATWEHLWIANNQVQRMCLSGMSFTGTDIGGFAEQPTGELFVRWIQLGVFHPFCRV
HSSGHHGDQEPWSFDDEVTNVTRKFIELRYTLLPYLYTAFYEYATEGVPMLKPLVYCDQD
DVHTHYRTDEFIFGNHILVCPILEPNSKGRRMYLARGRWYDFWNNEVVEGGRELWVDADF
DTIPIFVKEGAIIPRYPVQQYVGEKKIEELKLDVYYAEDTVESRVYEDARDGYDYKKGRY
SLRNFKLTGKAKDLSIQQFKTGTFETEYEYIKLNLIGLPFSIKKITVDNVAYDLNNLDKR
EKYLKLPKEFSVVHMIG
>KECLDBNJ_02405 1,4-alpha-glucan branching enzyme GlgB
MSSVYVHSLFSEFDIDLFKAGKHFRLYEKLGSHPMTLEGEKGTYFAVWAPSAKSVSVVGD
FNYWLEGDHKLNVRWDGSGIWEGFIPGVMPGAIYKYKIQSNHNDVKTEKADPFARRAEHP
PKTASVVYAADYKWKDKKWMSSRAKYNALDTPFSVYEMHLGSWRKTGEENRSLSYTELAD
ELVAYVKKMEFTHVEFMPIMEYPYDPSWGYQLTGYFAPTSRFGYPEEFMLLVDKLHQAGI
GVILDWVPSHFPEDAHGLGNFDGSHLYEHPDPRKGWHPDWKSLIFNYGRNEVRAFLISNA
LFWLDQYHIDGLRVDAVASMLYLDYSREDGEWEPNQFGGRENLDAISFLEELNKTVYKNY
PDVQTIAEESTSYTGVSKPVFLGGLGFGMKWMMGWMHDTLEYFKKEPVHRKYHQNDITFS
LTYAFSENFMLPLSHDEVVYGKRSLFDRMPGPEWERFANLRLMFGYMFTHPGTKLIFQGG
EFGQSAEWNFQESLDWHLLQYDFHTGIQKCVKDLNKLYKSQPALYERQFRPEGFEWIEWA
DGENSVLSYLRKGYDAENAVLVICNFTPVPRENYKVGVPEAFTKAGSKVKELFNSNEKKY
GGSGDFISKKVKVEATPWNGREHSITLDLAPLAVMVFGLK
>KECLDBNJ_02406 Maltokinase
MNQEQEIDGRIVFKYDTGWKELLESDRFKKELCEDILEPYILNQRWYGGKASALKYIEVI
DSFPIEDEVDTFYGIVLEVNFREAFVHNYFLPIAFVTDQEVVGDKFIAHLKLNGTSGFLV
DALLLESFRKQIFEKILEGEKYRYKEVAYRRGRSNQSQGYKSSRLMGVEQSNTSIIYNDK
YILKIFRRVYVDENPDYEISKYLTAKALFNNTPKYLGSITLKFSDKNVITLGLMQELVPN
QGDAWEYFVHNLKLTFEELSRQQPKLETLRATKYLEQISITDVPASILAWCPIEFFEDVS
QLALRTAQMHIALGQERINTAFTPQAFSNDYSVWLKNRLIYQFENRINLVENNLHKLDGL
QLELANELLSKKKIIRKQFLDFDETMLKSERLRIHGDYHLGQVLVQDRDFFIIDFEGEPE
STIRDRKVKQPPIKDIAGIFRSFNYAIYATVFNNHESYDFELEELFEVADVLYSHIIGVF
LKTYINEVQTANLNIGYIKEIEFLLQYCLLEKAVYELGYELNARPRWAIIPLKGISNILN
QQHYE
>KECLDBNJ_02407 Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase 1
MTRERIVIENVEPQLQGGDFFIKRVVGELVTVTADVLGDGHDVIDAEVCYKSEHDKMWKT
VRLEPQGNDHFAATFRVDQQGFYEYKVRGWVDHALNWQHGTEAKLKDGQYIKSELLDGVQ
YLEAVEKKLDNDGKQYVNTLKKLFQDEKRYDEACAYAVSHDLHRIFKDHPERKFAHESKT
LQVYVDREKARFSTWYEFFPRSASEQPGQHGTFKDCERLLPRVASMGFDTLYFPPIHPIG
EVNRKGKNNATNAEEGDSGVPWGIGSRFGGHKSIHPELGTEEDFKNLIKHAESLGIEVAM
DLAFQAAPDHPYLKEHPEWFRKRPDGTMQYAENPPKKYQDIVNFHWESEDYKKLWEELLS
VAFHWIDFGVKVFRVDNPHTKPYYFWNWFIAEIKKKHPDVLFLAEAFSRPKVMQQLAKQG
YTQSYTYFTWRTSKHELVEYMIELTQTKMREYFRPNFWPNTPDINPYHLQGANEAQHIIR
YALAATLSSNMGLYGPVYEFMVSDAVPGKEEYFNSEKYQISHWDWKHENKLSRLITKMNM
IRKQQPALQQTNNIEFCELHHDALMAYYKWDQDRNNELLIVVSLDPYYKQSGHLRLPYEK
MNLAPGSQVVVKDLITDSTYTWNQEWNYVELHPALPVHIFQIYK
>KECLDBNJ_02408 Peptide methionine sulfoxide reductase MsrB
MKKLLLLGLLVSLYACKGTAQNEKKEQFPVSKTEAEWKAELTDAEFQVLRKEGTERAFTS
ELLNIKEEGTYVCAACQNPVFKSKTKFDSGTGWPSFYDYIEGNVAFSSDNKLGYTRTEEH
CANCGGHLGHVFNDGPKPTGKRHCINGVALNFVPTKG
>KECLDBNJ_02409 Peptide methionine sulfoxide reductase MsrB
MKEYPIQKTEAQWKEELGPERYHILRGKGTERPHTGKYNLHFEKDGTYHCGACDAKLFEA
NSKFESGCGWPSFDESIPGAVEYIRDTTFGMIRTEILCANCGSHLGHVFDDGPTETGQRY
CVNSASIDYDKN
>KECLDBNJ_02410 hypothetical protein
MKKLFTILSIVALGFTACEGDPGPQGPPGLDGLDAEYSKVVEVETTLSYNSDSGIWESPI
IEFPSNVEVLDGDAVIAYRLEYIDNGLDVWTQLPHNFFFSEGTMQYVFTHTIGDVQFLID
GNYDLSNISTDYTDNQIFRYVLIPTEFAEQFNGDFSNYNEVMSALELNETDVQTLQ
>KECLDBNJ_02411 hypothetical protein
MKGLLTEIRHCSVCKPFLPLGANPIISASPKSKIVLASQAPGKIAHEKSIAWDDPSGRRL
RDWLGVDEDTFYDSDNFAILPLGFCFPGKGKIGDLPPRPECAPLWHKKVTDHFEADPLYI
LIGNHSQRYYLNDNLTLTARIKAFESYLPQHFVLPHPSPVNRFWMAKNKWFETDVLPVLK
RVVQQRLA
>KECLDBNJ_02412 Dihydrolipoyl dehydrogenase
MSKYDIIILGSGPGGYVTAIRASQLGFKTAIVEKESLGGVCLNWGCIPTKALLKSAQVFE
YLKHAEDYGLKVEGADKDFDAVVKRSRGVAEGMSKGVQFLMKKNKIDVIEGFGKLKPGKK
VDVDGTEYSADNIIIATGARSRELPSLPQDGKKIIGYREAMTLKEQPKKMIVVGSGAIGC
EFGSFYNAMGTEVTIVEYMPNIVPVEDEEVSKQFERSLKKAGINIMTGSSVESVDTSGEG
VVATVKTKKGEEKLEADIVLSAVGIKTNIEGIGLEDVGIITDKDKVIVNDWYQTNMPGYY
AIGDVTPGPALAHVASAEGIICVEKLAGMHVEKLDYGNIPGCTYASPEIASVGMTEKQAK
EAGYELKIGKFPFSASGKASAAGNKDGFVKVIFDAKYGEWLGCHMIGAGVTDMIAEAVLG
RKLETTGHEVLKAVHPHPTMSEAVMEAVAAAYDEVIHL
>KECLDBNJ_02413 hypothetical protein
MQKAYFNWSSGKDSALALYRILAEKEFEVTKLVTTINSDVERVSMHGLRETLLDRQAEAL
GFPLEKILLHGAISMTEYSDVLGAAAQKAVDEGNTHSIFGDIFLEDLKAYRDEQLTKVRL
KGVYPLWKKDTKRLITEFIDLGFKAITVCVNGKHLDKSFAGRIIDHQFIADLPPAVDPCG
ENGEFHTFVFDGPIFSKPILFEVGEIVKRSYKPKADQEDNCFSEDQKSWDTEFYFCDLIP
V
>KECLDBNJ_02414 3-dehydroquinate dehydratase
MAQELKILIINGPNLNLLGKREPDVYGNQSFEDYFSKLQFQFKETELSYFQSNSEGDLIT
KIQEADAIFDGIVLNAAAYTHTSVGIGDAIAAVSVPVIEVHISNTFAREAFRHQSYISKH
AKGIIVGFGLQSYDLAIQSFL
>KECLDBNJ_02415 hypothetical protein
MKKLFLIASFMVLGGAAAQAQDAFHFGAKGGVNFANIAGDDAADQESRTSFYAGLVAELP
ISEMFSIQPEVIYSAQGSTIAAIDEDNTFDVDDNVEYQLDYIQVPLMAKIYLADGFSLQA
GPSLNFLVSEEIDFQPTSASGDIDIEDGANNFEFGTAAGLEYQFDNGLFIQGRYTRGFTK
IYDDVSAYNYAIQAGVGFVF
>KECLDBNJ_02416 hypothetical protein
MKKLFLAAILVFGGTSLMQAQSELAFGIKGGVNFSNLTGDGFDEFDDDSARTSFNLGALV
EIPVTEKFAIQPEVFYSGQGFDLVQRDDAEDTEFQLDYINVPVLAKFYLVQGLYVEAGPQ
LGFLVDSEIEGPNATLGLNEDNFNDIDFAGAVGVGYKFNGGLYLNARYTQGFTDIYDGET
GDNATKNGVFAGSVGFIFN
>KECLDBNJ_02417 Tyrosine recombinase XerD
MNWQQSLKDYKLFLKIERGLSENTIINYGLDIAKLISYLDLNAVEASPISITKEQLQEFI
YTYAKELTASSQARLISGLKGYFEYLVFEELRTDNPTELIEAPKIGRKLPDTLSEEEVNQ
IIDAIDLSTPQGERNRAIFETLYGCGLRVSEVLNLKLSDLFFDEGYILVTGKGNKQRFVP
IAPVTQKYIEIYRDEIRIHESPKPEFKNILFLNRRGAQLTRAMIFTLVKQHTKKAGIKKK
ISPHTFRHSFATHLLQNGADLRAIQQMLGHESITTTEVYMHVDRSHLAEVLNTYLPRK
>KECLDBNJ_02418 18 kDa heat shock protein
MSLVKRTNENWLPSIFDDMFKTDWLGGTTNVNSIGVSIPAVNIIEKDSGFEVAVAAPGKT
KEDFNIELDNDVLTISAQEQKESETKEEGRFTRREFSYSTFKRAFSLPDTVNSAKIEASY
ENGVLNIVIPKKEEAQVQAKRLIEIS
>KECLDBNJ_02419 hypothetical protein
MKTFKTMLLAVAISCGTALSANTTEPTEPTAKTTSEVVKRAMNKEIANLLAEPNFNVEQT
TSVKVSFTVNKDNEVVVLNVESKDVSIEKYIQGRLNYQKLDSKALVGQTYHVPVKLESTL
>KECLDBNJ_02420 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILSSFGVRIQRGKVATTAAEAVEAAKKLTEETGTGWHVIKAQVHAGGRGK
GGGVKLAKNLQEVEQIAGEIIGMNLVTPQTSAEGKKVHQVLVAEDVYYPGDSEPEEYYMS
VLLNRATGKNMIMYSTEGGMDIEEVAEKTPHLIFTEEINPATGLLPFQARRIAFNLGLSG
TAFKEMTKFVAALYKAYSASDSSLFEINPVLKTSDDKIMAVDAKVSLDDNALYRHKDYAA
MRDKREENPVEVEAKEVGLNYVDLDGNVGCMVNGAGLAMATMDLIKQAGGEPANFLDVGG
TADAERVETAFNLILKDPNVKAILVNIFGGIVRCDRVAQGIVDAYKNMGTINVPIIVRLQ
GTNADIAKELIDNSGLDVQSAIQFKEAADKVQQVLA
>KECLDBNJ_02421 Diaminopimelate decarboxylase
MTHQNLLSIAKEHGSPVYVYDAEKIESQYKRLTGAFKKVKNLRINYAVKALSNLAVLQLI
HGFGAGMDTVSIQEVRLALAAGIDPSKIMFTPNGVSLDELEEVAKMGVQINIDNLSILEQ
FGTKHPKTPVCVRINPHVMAGGNTNISVGHIDSKFGISIHQIPHLLRIVKNTGMNINGIH
MHTGSDILDIDVFLHAAEILFDTAKDFKDLEFLDFGSGFKVPYKEGDIETNIEELGDKLS
KRFNAFEKDYGKSLTLVFEPGKFLVSEAGKFLVQVNVIKQTTSTVFAQVDSGFNHLIRPM
FYGSRHEITNISNPKGRERFYSVVGYICETDTFATNRRIAEIAEGDILAFSNAGAYCFSM
ASNYNSRYRPAEVLFLNGKAHLIRKRETFDDLIKNQIPLKETVKA
>KECLDBNJ_02422 Bleomycin resistance protein
MSASNTDYLAQIIPILPVKDVLEALEFYIKKLGFELVFIDEERQPRYAGIRRNNIALHLQ
WHEASEWEQDKNRPMLRIQVQGIENLYKKYQLMGVFHNHTSLEEKPWGTLEFAFYDPFKN
GLIFYAEA
>KECLDBNJ_02423 hypothetical protein
MQYEGGGDWYANPTSLPNLAQFCNTSIHTAIDPNIATIKATDPAIMQYPFVHMTGHGNVY
FSEDALRNLRDYLNSGGFLHIDDNYGIDEYLRPQLKKLYPQEELIELPADHPVFSSAFAF
PQGLPKIHEHDGLRPQAFGLFKEGRLIILYTKESDLGDGWESPAVHNDPPEVREKALKMG
ANIIKYAFEN
>KECLDBNJ_02424 tRNA (guanosine(18)-2'-O)-methyltransferase
MKTKQLNHEETQLAPQPLPFVLVCDRVNSPANAGSLFRLADALGIEHIYFCQASLNFEST
RLKRTARSSEKQVAYTAVEDVETLLLQLKNEGFSCIGLELTTQSIPLETFKHQAFEKIAL
VLGNERHGIDQRILEQLDYLTYIPMHGKNSSMNVSQAAAIAAYQLLNAPKHER
>KECLDBNJ_02425 hypothetical protein
MKDKSKVIAYGILRALGIIAGIVFILWFLYKIQAVLVFICIAAVISLIGRPVVNFLKNKC
RFSAVAAAIATLIMVLIVISGILALFIPILIDQSEHISKINFEEVKHNINRLNVEFSRAM
GVDQVTLIEGLKQSDFIKNFDISVIPTFINSILGNFSSLIVGLLSVIFISFFLLKDSHLL
LDSFLVFANTGEEKRFRRVFHKTKQLLSRYFLGILLQLMILFSIYAILLVSFQIPNAFAI
ALFCAMLNVVPYIGPVVGGVVMMLLVISGNFTADFQTVILPKMIYVFIGYCIAQLIDNFI
NQPLIFGSSVKSHPLEIFLVIVIAGLIFGIFGMVVAIPAYTAIKVIAKEFLSEYKIVQKL
TKNLYEP
>KECLDBNJ_02426 hypothetical protein
MSLNKNLLQLEVQAYLRAHYKTDVSKVLLSSSPFEAISSPELAQQLNGLQKAEGKLPTWF
KHLEILYPPKLNLEQTSSEETAAYKANLFSGKKALDLTGGFGIDDYYFSQQFDEVIHCEL
NPKLSALAQHNFEVLGAKNIQTLNQNSIDLLKGTSSHFDLIFTDPSRRNEVKGKVFMLKD
CEPDIPEHLDLLLDKTDILMVKTSPLLDITAGLRELKHVLQIHSIAVKNEVKELLWILSK
KDDTKALSLFAVNLSSDFDAPVTLDFDALQFAEATFDEPQTYLYEPNAALLKLGAFNWIS
EHYALDKLAVNTQLYTSEKLIEFPGRRFRIKDSIPYSKKTISRLLKGKQAHITTRNFKAS
VADLRKKFKIKSGGDRYIFFTTLENGKSLMLDCEKI
>KECLDBNJ_02427 Heme oxygenase
MILKHLKTQTATLHQKTEEDNLAKFILDHSIDVATYTQLLQQNYLAYARIDRILEANSAS
LDENLKMYADAVKSKALAEDLTDLGAEIPQVESTEEQFSSAYLLGLIYVVEGSMMGGLLI
RKNLESCEHLKDKTKHHFFGKSAPEVMQRWKNFTGAVEEKTYSEQEHQDAVDGAHAAFMI
FKDSYSYA
>KECLDBNJ_02428 Regulator of RpoS
MITEELKILMVEDNPADVTLMRREIFKVAENAEVIVCNNLTDFRLNLVNNPPDLIISDYN
LPTCSGLEILEVAQKLTPSVTFLFITGTINDEELAADTILSGASGYMLKKNISKLHIRLE
PYLNAISKNGPMMHPVRKKIVESKKLVRDIEVFLENFSRENMSHREGMLKIQEDLKRLKS
GYDFKTLKDPNSNFTPED
>KECLDBNJ_02429 Response regulator rcp1
MAEDYILSIEDNNTDIALMNRIFQKNIPHYGIKHISDGQEAVAFLESEAFRLQQPKLVLL
DIKVPRLNGLQILKKFRKIEAYLGIPVVMMSSSDRKDEIIKAYKLGANSFIEKPRNYPEL
SKALPALINYWIVYNK
>KECLDBNJ_02430 Phytochrome-like protein cph1
MAHGPTSLYPKEVTLTNCDREPIHILGKIQKHGYLIACDAISHIVNYCSDNIAQILAKGP
EALLGQPLNAVFDEVQMKQLLETKVAEKATPIHTTIEGQHYAMLAHLNEGNLVVEFEPLE
VDANAFEYQNQLAEIVSKLNGAGEEQHMCDVTADLIKEFFGYDRVMIYRFDEHWDGIVVS
EARESHLESWLGLRYPASDIPQQARKLFLKQGVRIIADVTSTPVHIQALGGKEQENPIDL
SLSETRASSPIHIEYLENMNVGASLTAAIISEGALWGLIACHHYSPKFVDFYKRQSCKFL
TQIFSSQLVLLSSNILLQKLNEASKTRSLLMEKITKNWNVHKGLTKGSHTMLDLTQAQGA
AVFLDGKLKRVGITPDKEQILALINRLKPLEQDEVITTQLTKDLPELQDIKAKASGVMCL
FLSNLKKDAILWFKSEKIETVNWAGNPDKLSTLDSNERLTPRKSFEAWSIQEEGKSAPWE
DYEIVAARALKQDISQIILEKYDEIKGLHNLLQIAYEDLETFSYSVAHDLRAPLRGIDGF
AHIIKEDYFEQLDEFGKSSIDTIIGSATKMNQLIDDILAFSMVSQSEMNKDKFSMNKLVD
DVLGILPISQDYPSVSITVAPQMPQAYGDRKMIAQVLQNLFTNALKYTRAVEQPQITIGF
KEHQNKGFYFVQDNGIGFDQSHEKRIFRLFNRLVGDEYEGSGIGLTIAKRIIKKHKGAIA
VISKPGEGSTFLFNLG
>KECLDBNJ_02431 Phytochrome-like protein cph1
MNTNTKTNKATHVIVGIGASAGGLQALNDFFDNVPTASLYSYIVVQHLSPDHKSLMAELL
GKNTKIPIEVIEDEGEIKANCIYLIPPTNNLVIKDGKFRLLEKPKDKSLNLPIDLFFESL
ANHSKEHCAGIILSGTGSDGSRGIRAIKEKGGVVMVQQPEQAKFDGMPRNAIKTGLADFI
VPVERISDELSNYFEAQSSIDFDAELYQYDERLLKEILKVLKTHTALDFSLYKRPTLLRR
IGRRVRVLKLDSLEGYFEYLKTHKEEVQTLYKEFLIGVTKFFRDYKVWELLAEGIIPELV
ASKDDGDVIKVWDVGCSTGEEPFSLGILFLEEIEKQDKDVSLKIFATDISQDHLDIASRG
SYSENVLSDLSKDRLKKYFRKHGDDFVVKDNLRKCIIFSNHDITNDPPFKNMDVVMCRNL
LIYLQNDVQTKVIHLLHYALKQDGILTLGSSESLGVHKDNFEEINRKWNIYRNIESSERL
KTEILNSTAERQTFKRHENGMKNGNVQNYSNTQRLKEEISKAIIQQYGAASVYIDENFQI
LEAMGAFKKYAQLPEEGFTTNLIDMLPEELAGPIKNTVNKAKRKRSQILYKDVEVYGDDE
ELQTRLDVLVKPIKNGVAEGDFHFIITLIEQDREHNKAIIVERADIHKSSQERIRDLEEE
LKETQYELSNALEEAETSNEELQASNEELLASNEELQSTNEELQSVNEELHTVNAEHIEK
MEDLAMLNADMDNLLDSTRIGTVFLDKNLIIRKFTPAIREHFHLVKQDIGRSIENFVANF
GIRRRKTIVDNIKSVMETGQVFEKRIKSKSGRYFLQRISPFVTGQDKIDGVVITFIDIHK
VEQSQERLRKSEEKFKAFYEDDPVMHVTINSHTGLISECNKLFVETLGFKEKNEIIGKSI
FEFYPKRTKVKAIALLDELEKSGSIANEELMLECVDGDKVDVLFNAELMTTTSAKDTTQW
RCTLMEITDLKNAQQELQKQKEDLERINTDLEQFVSICSHDLQEPLSTIRFSSDFLSKKF
SSELSEKGKEYLGYIHEASGRMAEQIKALLEHSRIGEDLKKTKVDVAELLEVVKYDLNRS
IREANATVTVGKMPQMMAYETELRLLFQNLISNALKYRKKDTNPSIRISTFSDDEYQTFA
IADNGIGIKEDDLEAIFKIFGRVPTEEKYDGTGVGLAHCKKIVKLHEGKIWVDSEFGQGS
TFYFKIKK
>KECLDBNJ_02432 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTTYSVITGTGIYLPKKKVSNEDFLNFAFYEANGTPIAKDNRYVVDKFKEITTIEERRYV
ADDLVASDIAYFAAKDAIKDAQLDPETLDYIIVAHNFGDVKHGSNRSDMVPALAARVKHK
LKIKNPECVAYDVPFGCPGWLQGIIQADYYIKSGDAKKILVIGTETLSRVIDLHDRDSMI
YADGAGATILESREADQRTGILAHKTRSDTYRYAEMLTMGCSYNITEENKQDLYLKMNGR
RLYQYALETVPLSIKACLDKAEVPIEKVKKVLIHQANGKMDDAIIDRLYKLYGYEEAPES
IMPMIISWLGNSSVATVPTLLDLILKNKVEGHSIEAGDLVVFASVGAGMNINAAVYQF
>KECLDBNJ_02433 Cobalt-zinc-cadmium resistance protein CzcB
MKKIVAFSLTTLVLGLALGYLLFNTSEEVKEVPMHEHSEDTALWTCSMHPQILRNEPGDC
PICGMDLIPAQQENAGLAVNQFRMTERAIALADIQTTVVGNSGEATSELKLSGTIAINDD
QVATQPAHFDGRVERLMVTSVGQQVRRGQQVATIYSPELVAAQQELVTAAKLKNKQPKLY
KAVRNKFKNWMISDALLDEIETTGNTVTRFPIYAHVAGVVRELMVSEGAHIMDGNPIFKV
ANLNTIWAEFDAYEHQINQLKMGQDLEITTNAYPDQRFNAKISYIDPVLNTATRTVTVRA
TLTNPQEVLKPGMFIETKLMGSTSEASTITVPASAVLWTGDRSLVYVKPKSDQSVFEMRE
VTLGTKSGDYYEVLNGLSPGTEIVTNGTFTVDAAAQLSGKKSMMHQGTGSELQETAPNFQ
LSEAFQKNLNAVLPSYFALKDAFVASDAQEVQKASETFREDIEVLKVDGMQTEVQKLLAT
VLEQAAKISNSSALAEQRENFISLNVHFTPLVQNSTAIKPYLFVQRCPMANNSQGAIWLS
NSDEIKNPYYGEAMLTCGSTIDTLGD
>KECLDBNJ_02434 hypothetical protein
MTHTYKITGMTCEGCRSGVEAKLNAVPDVAHAEVDLNNGEAQITMHKHIATQTLQQALPS
KYKILETGNHAQPKSNVFETSTAETSQSKIQQLKPLFLIFAFLIAAAILLHKDTWDWQAM
MLDFMGLFYIVFSFFKLLDLKGFPDSFSMYDPLAKAIPAYGWVYPFIELALGLCFLMRFQ
IAVALILTLVILGITTIGVTRTLLDKKAITCACLGTALKLPMTEATFIENALMIIMALVM
LFI
>KECLDBNJ_02435 Putative permease
MTDFLKQWGEAAYTTAGFFWMALWAFALGYLISSMIQIFVTEKRMQKTMGGNETKGVLLG
TFFGFISSSCSFAALASTKSLFKKGASFVASIAFLLASTNLVIELGIIISIFLGWQFVVG
EYVGGVLLILLSWILIRLINPKKLIENARKNLGEKEDDTDTDSKSWKQKMKSEESWAKVA
KQYGMEWKMVWKDVTVGFTIAGIVAAFVPDAWFQTLFIGSGDGNTDFSFLEILEHIIVGP
VAAFITFIGSMGNIPLAALLFGKGVSFAGVMAFIFSDLVVFPILRINAKYYGWKMSLFIL
FLLFTSLVGASLLLHYGFEAFQLLPDPSQVTVQDTSYFKLNYTFFLNLAFLAGSGYLLYL
GFFKHKNMMHMKEMAPKSKTLERTLKYAALGCYVWLTAGLLIKFFN
>KECLDBNJ_02436 hypothetical protein
MKKTLNFISIAVVALSLVACGNDKKSSSETDVKLEDHQEQPMQMEEVDEMGEKNKASAEA
PENKVDNAPLAFADNNANAVWEAYAKVQQALVASDSEKAKQEAAQLAMIFDERNAKLKTL
AEGIATTDELPAQRKAFAAFATGAKAYFKSTIKAGTLYVQHCPMAFDGKGADWLAKDTAV
TNPYFGAKMLNCGSVTATITQ
>KECLDBNJ_02437 hypothetical protein
MKNKIIIASIILLGTTVVAPAQDLSAYIAQAEAQNPALQAYALRYDLAQEQVNEVNSLPD
TEFGVGYFVETPETRVGAQRARFSVKQMLPWFGTIAKRQGYQNALADNEYLEYVIAKRKL
SLEVAQSYYQLYGIHAEEQVVQQNLDLLDRFKELALNAVEVAEASVVDVLKLEMRQNELN
AQLAILDERKRAVAVQFKNILNVAQDTPIQLVDSLTIPQLETSDSTEALETNPELLKYDA
LYKSITQAELLNQQESAPKWGVGLDYIPVSERTDLFPADNGKDIVMPMVSVSVPIFNSKY
KSVTRQNELRQQRITAEKEQRLKYLENLLAEAKQYRNAARINFNAQQQNIAQAQDAEAIL
LKSYETGTIDFSDVLDIQELQLSFQRKQIQAVQDFYEQTALINYLTNN
>KECLDBNJ_02438 Cation efflux system protein CusA
MLNKSIKFFVENKLVAFLLLALFLGWGIATAPFNWDGVSEIAGIPRAPVAVDAIPDLGEN
QQIVFTKWQGRSPQDIEDQITYPLTSALLGIPGVKTIRSSSMFGFSSIYLIFEEDIEFYW
SRSRILEKLNSLPANLLPEGVNPSLGPDATGLGQIFWYTLEGRDADGNVTGGWDLQELRS
IQDYYVKYSLASAGGVAEVASIGGYVQEYQIDVNPELLKQYNISLDALVKAVKSSNEEIG
AQTLEINKAEYLVRGLGYIKSLEDIENAVVTSEAYTSIRIKDVARVHMGPAPRRGILDKE
GAEVVGGVVVARYGANPMEVITNVKAQIKELSAGLPSKTLADGRISQLTIVPFYDRTQLI
HETLGTLDEALTMEILITILVIVVMLFNLRASLLISGLLPVAVFMVFIAMKLFEVDANIV
ALSGIAIAIGTMVDVGVILTENMIRHLEEADKNDSKLSYNTLIYNATAEVSGAIVTAVLT
TIISFIPVFTLMGAEGKLFRPLAFTKTAALTASLIIALFLIPPFAALIFRKRKFKSTTQN
LVYALLMLTGSAAVFYGVWLGLVLIAFGTLYFLRKAKELPFQNLKHAEIIITVVAIVFLL
ATYWRPLGFNRSIFINLVFVTLICTSFFGLFWVLRRFYDRILRWALANRLLFLTLPATLL
ISGAWIYSKMGKEFMPALNEGTFLLMPTSLPHAGVEENKRVLQQLDMAVASIPEIETVVG
KAGRAESALDPAPLSMYENIIQYKPEYMLNAAGSKQRYKVDEQGYFLLHDGSKAYNPNMQ
TGAVAPEMSMKFPVTAEDLIEDEAGAYYRNWRPEIQSPDAIWKEIARVTQLPGVTSAPKL
QPIETRLVMLQTGMRAPMGIKIKGQNLQQIEAFGFQLEKHLKQVEGVKAEAVFADRIVGK
PYLLIDIKRDRLARYGISIADVQQVLEVAVGGMPITQTVEGRERYSVRVRYPRALREHPE
DLKNIYVPVATGNPVPLNELVEIRYEQGPQVIKSEDTFLVGYVLFDKLDAYAEVDVVEQA
QAVLQSKIDSGELVVPQGINYQFTGTYENQLRAEKTLTVVVPMALLIIFLILYFQFKSVS
TSFMVFTGIAVAFAGGFIMLWLYGQAWFLNFEIFGANLRDLFHMKTINLSVAVWVGFIAL
FGIATDDGVVMATYLTQTFSKANPSDREGIRQATLRAANKRIRPCLMTTVTTILALLPVL
TSTGRGSDIMIPMAIPIFGGMIIDVTSYFIVPVLYSWKKEIALNS
>KECLDBNJ_02439 hypothetical protein
MALVLAFVVVCTTMSFTINMHYCGETLVDYTVINKASSCGMDQMASSLGNTDCEQQVIQK
SCCQDKTFSAAGQNELKPSFSSFSLEQQLFVTTFCYAYAALLAPQTTASTDFFAYTPPQL
VRDIQTLDEVYLI
>KECLDBNJ_02440 Phosphate regulon transcriptional regulatory protein PhoB
MRKRILIVEDNQQVAEAIVLSLEQAGYTTCVCADGTTAIEQLKSNTFHLVIIDLLLPFTS
GMNVIKWSKTEFPTLPIIVLSSIIEENIVTHTFLMGAFDYISKPFKPSDLLQSINKALQQ
KN
>KECLDBNJ_02441 hypothetical protein
MNTTKKRVILVEADLNAQLQFKAQFAKSEVEVTAFTSGMGAIQYIKQNGIPELLVLEEAA
KPLGAVQTLNYLKDQIGFSAPVIVVANHIHSGLDKLRVQKIITRPYRNADIQFIKELLML
DAIIKNPSSQAYNLDYLMELADGDDTFIQESLKIFLTSVPAQVHALVESFEENRLEAVCQ
YAHAIKPSYEMLQSKRAANLCDTIAHYAQPQELPSLVKALKKEHETIEYALLQDFPELLN
GKKCNN
>KECLDBNJ_02442 Signal transduction histidine-protein kinase BarA
MITNTALAQKFHKLCSESYELSEWLHSQPSLGFFYSELHTQADYFVSPSFWAAMGYTSST
VHAPIDLWEYVIPQESLQLLTTIRQTSVDQANHDFYFRNSKGAKQRITGQHLRHTDSNGQ
RHLLIRFFNEEEGRKAPKLDCDKIRELQKFNEIYEETNRLALVGGWEVDIASKTVKWTNV
TKAIHDVPTDYFPQLETAIAFYKEGWSRDRIMEAFDKCVEQGISNDGEYIIITATGQEKW
VRAFMKAEFKNDTCVRVYGAFQDITQQKQQEQSIITTEQRFQKVFENSALGIILIDGSNT
IQQTNAVAKEIFGLTKLTAEEVKSYTIKNVIKKEYLAKALLERDRLLTGEIDSYNFEAEF
WHTSGRSLWCNITCSLVKEINSENSLIITQVEDITKKKKLERNALEHAYRFKRIFEYSPN
GMALVDLEGNWKNINKNLAEIIGYTKEEFLQLTFADFTHPEDLFKDQELLKKLVAKDIST
YQVDKRYIHKNGSIVECVLTVSALYDREGNIYSIIGQVVDLTESKADKRALEESLLDHQA
LLEATSQIIIVETDRNHRIKRFNKGAENLLGYKADEVIGHKYHELFFLQQELLTYTALLS
EEYGEEISAEEVFTFKLNKGIITSEEWNLLKKNTKLLPVQLIVTPVKNEDGAVKGYLKIA
TDISALKRMEQSLITAKERAETANKFKSEFLANMSHEIRTPLNGVIGFADILLKSQLSES
QAKYLETIYSSAISLLDLINDILDFSKIEAGKLSLNQERINIAELCARSVEMIKNQAHQK
GLEVLLNLPNAINQYIIGDGLRLRQILINLLSNAVKFTHRGEIELKVEAHNSLQKDDEVV
YTFSLRDTGIGIAPHNIEHIFSAFDQGDRSTTRKYGGTGLGLTISNRLLALMNSSLQVDS
ELGVGTTFSFTVTFAKGAGIKKASLQLVSVHNVLIVDDNKNNRLILTEMLESRDMKVFQA
ANGIDAIEVLEQGPNFDLALIDFNMPYLNGLDLIKHVRQDLHISQKELPIILLHSSAEDS
KINKQIRLLEISGHLVKPVIRNTLYETIDNLTQNKPTVYNDALQLQAIKSAALNILIAED
NPVNKFLARTILNKLLDKAQLIEVENGEQAVAAFKKNHIDIIFMDIQMPVLSGYEATQQI
RALESKEERVPIIALTARALKGERERCLAYGMDDYISKPLVMDDVQSVLKGLVKKKSIHL
I
>KECLDBNJ_02443 putative ABC transporter ATP-binding protein YlmA
MPHTNKQTHYAIDTSNAPLSKQQLKELKDQAWLKEEAGPFGLVFSNHTLDAYLDEEYRHG
NSILTKDGDLLKTKSSGERKRLLLAYQLAQNPDFLILDNPFDALDIQRVASLKKELQELA
KSTVLLQLFRRSDEVLPCCTVGLTYQEGQFVKVDLITEQHTSVSINHEQKLPEPLEAFKN
VPDELISFRNVSVSFDEKPVLKDITWTVKRGSSWHLKGPNGAGKTTLLSMVTGDSTKGYG
KELYLFGRKKGSGETVWEIKQKIGYFTSAMTERFDGMHDVQSMIISGLYDSVGLYQKPTT
LEQARAEEWLVLLGLKQLSGARFRTLNEVQKRLILIARAMIKHPPLLILDEPTAALNETG
AALIVSLINKIAASGSTSVLYVSHKEEVGLELFNELLLVQDDCDFAGYTAKIRSS
>KECLDBNJ_02444 Quinone oxidoreductase 1
MKAIYITQAGGPDVLQLQDLELPVLEPNEVRIAVKASGVNRSDILTRQNPDAYGGDTPKA
QIPGLEVSGTITAVGASVENFKIGDAVCALVAGGGYATHIHVDARLCLPIPKGLSFVEAA
ALPEVIFTVWFNVFQQAKAVKGEGLLIHGGTSGIGVMGLQIAKALGLQTYTTVGTQEKVH
FIEKHALAKVINYKETDFEQAFSEEKIDVILDMVGGDYTQKNLNILQKNGRLVHINGMKS
LTPTINLWTVMSKQLIITGSLLKPQSISVKKQIAEEVAQTVWPLLASGEIKPEVYRVYPL
EEAAQAHQLMEDSDHIGKIILEPQH
>KECLDBNJ_02445 Dihydrolipoyl dehydrogenase 3
MSTYDVAVIGSGPGGYVAAIRCAQLGLKTAIIEKYATMGGTCLNVGCIPSKALLDSSHHY
EDAVKHFEEHGIEIPGEVKINLEKMMGRKASVVEQTTKGIEFLMSKNKIDTYQGVGSFKD
KTHIHIAVAEGDDVEIEAKYTIIATGSKPASLPFIEIDKERIITSTEALKLKEIPKHLIV
IGGGVIGLELGQVYKRLGSEVTVVEYLDRIIPTMDGAQSKELTKVLKKSKMTINTSHKVS
AVERNGDEVIVKATDKKDKEVEFKGDYVLVSVGRKAYTDGLNLDAVGLKTDDRGRVEVNE
HLQTSVANIYAIGDVVRGAMLAHKAEEEGVFVAETLAGQKPHIDYNLIPGVVYTWPEVAS
VGKTEEQLKETGTAYKSGQFPMRALGRSRASGDIDGFVKILADKETDEVLGVHMVGARVA
DLIAEGVTAMEFRASAEDIAIMSHAHPTYAEAVKEAALAATEDRALHI
>KECLDBNJ_02446 hypothetical protein
MQVLLTSTFARPQLYDMKQQILALSFLILSFSIHAQIGIGTTSPEATLDVRATNHLGAAT
ATDGILIPRINDLSVSGSEDGQLVYLIAAYGSYGKGFHYWDQDASAWVPINSTVEPWYDA
ADQQPATSNTATIYTLGQVGIGTNNPLGALHVSTENSRDVLFLRFIDGLDDDLDLDLFRA
LGTLESPALLPDNTRIGGLRGQGLINASTYAFKPSAEIYFQADGATSSSSSAGKIKFATT
PSGATSTVDRMVIRNDGKVGIGTNDPIEHIEIKRAGDNDMQFTSASNNPPNLIFYNTGGS
LEAPGPTGTNQEIGSMIFKTHDGVAVREIGGMRLYIDGTPTNGSTPSKFVITTTPSGTTN
QAEVVTIDNQGYMGVGVSDPQARLDISGNVKIVDGTQGNGRVLTSDANGNAGWQTPPSSQ
AMLRNNIIYTSSGSDFLINYSNELFSAIPGASYNGTTLTLPQGIYEIESNIFLTDNGMVE
WNMRVNGSVSSQSIGGLAAPVTYSANVSPHKQEAIIRVSDTTAAIDFIITSYTGSINADP
AQCWMKIKRLQ
>KECLDBNJ_02447 hypothetical protein
MAYLDSKLGIVGRVGPLVFRNVNGKTIVQAKPEKTGKFPAGRSRQTATDFGKASQTTSAL
VRGLRPFIGTHYDPQFFNRFRKAVYQGMKMNDSLPQGRLDLWQGEPTVLEGLETDLKHQF
PQYVQLPGLQLSLEAGTLNINIPEFKANNNLLYWPSTAAEAELCYWVSVYDSKTYRLLSY
ELFQVPIPHKSRSIPASRFTATALPPEALVLVTTGVLYYTAAMRLGKVGMNSKAFNPMQV
LKVFKT
>KECLDBNJ_02448 hypothetical protein
MTYHQDIANSLKSYVCNIENIGEEGVRPQNVNTYLDKANTILHIIDRQRPEDYRQLIEWL
NQQGRNFGWSFPKNSDEDTFETEFWRLKDSIKRITQGMTLNERLYFFGYLDEYEKLRPIE
RSAREEIELKLFMK
>KECLDBNJ_02449 hypothetical protein
MNLRKLFEIKPKEQKPYEFANVLHMWEDDYLMIELLPKDNLEFINKESHRINEFGKEHFD
GYGFTDITVIGEIPIKTIDKKIDFKSVAEIFEKNGMQRIKEVVYQNVGHLTGEKVPFGFG
SNKFAILLDEAHGKLKYIWTTGRIENEELESKFKKGLSEFVETYNFLAIDWYKCQSFDLH
SENGIEEFIKYSC
>KECLDBNJ_02450 hypothetical protein
MGVEKDQIKEILPIGDQLRAMISQSFLTGKHLRDLLSSKGIFIDENDKNKSVPLLMNSIL
SPKEFLRLVENQKTKEEKFKVNTLTLPCQTDKPLLDIIPPNFSINKIIKENIVYKPNYKV
KANPQFTYSSKDKKSIQLEYEIERENRTKDWVNTKTTHKAVITIEKKANNEISLVLTKSY
TSKETNDINEMVLRNLKGHFKNVNIVKEEVDFVRILFKDFTNQNRIQFLYSFTSPALSRH
LEFVEITDLNVHIDPDIDTPQEIKEFISGIDKLKINGKELQEHIFITKNDYHEKIIFSSI
SLKYKFIFNGIEGNCIIEYSFPAYLLKQNTNAEFQFDIVINVDRKVKEFANISELHKNIS
KIIENQKLEQFEKYKK
>KECLDBNJ_02451 hypothetical protein
MGEWSKKIGEQGENIVKYFFEELIGFKDIYRTGIEIPCSFSEQHKKEQAKKRLTHGIDGL
VSYTCPLVEELLEIELVSVKYTADKYPTNLKDKFKDWFIELAYTMKCFSNSEVYQSINSS
ISDVSDTSVSGLLFWLSNNDEHKEYNILPEIANSTFSGNELVYDKIIVVDNARMNFLFNL
IQPIKNIFGEDNFDFVYHKTGMNNAITQNLSFGKKMPLQYICSDIIPIRLTKSDDVILVI
GSRDNFEKNDLLRLIALSKEFNHLEATSKTLISFPDYNKLEHQDIVTSVLAQIENLSYKN
QIEVVRHDFDFRNL
>KECLDBNJ_02452 hypothetical protein
MAEIENIKYFAILEEFETSDKLIKLGLGELQNINLDNDFYFLPFQLLSQGFERFMKAYIC
LGHFHKHGKLPNFKYLKNLGHDLEKLLNEIVENYYIDFNRPQFDLDNDFIQNDSDLKRLL
YILSEFGKLSRYHNFDLITDNKKIGVNTKKLWQEFENTILNKNDYDKLMDFNLSQEVYQK
ITNHIIVVFEKFVSALSRQFIFKCLGQKGIQLSAITAFDFGMLYDKDFGKKDYRSQTTRY
KETPKKVHKRTVIDEVQRKVNPDYKSKKIRKKEYEGDWPFYAEEIIIESRQKHWCTVTID
GFDYALNGSAKGRYKLENPHDAGMAILGKSLADFIKMALDLNKDKKH
>KECLDBNJ_02453 hypothetical protein
MTTTKPNHIGRKIARIRELRGMKQEALAHELGISQQSVSHMEQSESLEDSKLEEVAKVLG
VTKEGIENFSEEAIFNIISNTYHNTSNDNSSLIASSLNYQPTFNTVEKIVELYERLVQAE
KDKVSYLEELLKKK
>KECLDBNJ_02454 hypothetical protein
MNTAFTPDSKLHDLIRLLCSLSRVHTVYLMRQVSTNRTQTYTGGLSISIKPETREVLSLL
VISHEEVADPMHIQHSLLNKTQGRYEVFSIHLTLREANSRIHWGSAFLNRVLRECLLLYR
EDQRLELPSGYLQHPQVYIRIANHWNTRLQRARYFETKAVDCEDPQSNYGKYLLLQQAVQ
QACLGLIYVFWEYQPSCFALPYLLHLCEHFCDLPQILYPKRSFRSHQVYTLLCHASYNLH
EKTGRDTIDTDAYKAEQLTYRFIKAARQRAEEKLRELKKLHHTPSKTSSYEKETDTGTAE
CT
>KECLDBNJ_02455 hypothetical protein
MKKKQIRERLNALRAQKLVHLTPKTGRTGRYYEGTYRVSSYSDLMFLVTNLIKVSVLALE
KNEGVAAQELPDPQYNVLQVLLHALQLIPVEELELIDDLAQLLEEVNGDEL
>KECLDBNJ_02456 Malate-2H(+)/Na(+)-lactate antiporter
MSNQDQDPKNQEILENRELSIWEALIPIIALVGMLAYNVFVFGDDALSGSNQFILLLGAA
VAALVGIFNKTSFDTMMEEVAQNIKSTAGAILILLMVGALAGTWLISGIIPTMIYYGLQI
LNPSIFLAACVVICAIISVATGSSWTTSATVGIALIGIANALGISLGMTAGAILSGAYFG
DKLSPLSDTTNLAPAMAGTDLFTHIQYMLYTTVPTVTITLIVFIIIGFNIETSGDADTSV
ILTAIDDAFTISPWLFLVPAIVIFMIVKKTAPLIALLIGTLLGGIAALIFQPEIVATLGG
SETLSLESGYKGIMNAITVDTAIETTNENLNDLFAASGMAGMLGTIWLIICAMTFGGVMD
AIGALARISKFMLNLFESTFGLFASTVATCIGLNATASDQYLAIVVPGKMYAKAYRDKGL
APENLSRALEDSGTVTSVLVPYNTCGAYQSGVLGVSVADYFVYAIFNWLSPFMTLIFAAF
RIKIRSLKEAKAS
>KECLDBNJ_02457 putative peroxiredoxin
MTLVGKEFPNLAVDAMNEMGDTFKVNILEEAKSKNKKVLLFWYPKDFTFVCPTELHAFQA
AMDEFEKRNTIVIGASCDTPEVHFAWLNTPKDNGGIEGVTYPILADTNRNLANRLGILDV
TNERYDEESGVLTVDGDNVTYRATYLIDEEGTVFHEGVNHMPVGRNVKEFLRLIDAYAHV
QKNGEVCPANWEEGKDAMNANRDGVASYLASN
>KECLDBNJ_02458 Putative thioredoxin 2
MIQELDQDNLSELVSDNETVVVQYMASWCGNCRLMKPKFKKLASENENAKFYLVDAEKYP
ESRKLATVDNLPTFATFKNGTFVNQVQTNKFENLKELVDEVTSN
>KECLDBNJ_02459 hypothetical protein
MKLPVIKHLQKNNSAEALQNTIDVLESFTEHRSCTDNDMDVVGELITNLCGAVEMHQMIA
DGMSERDAANGFAQKVLGSIDR
>KECLDBNJ_02460 putative thiol peroxidase
MATITLGGNTTHTSGELPKVGTAAPDFKLASKDLAQVSLEHYKGKRIVMNIFPSVDTGVC
AASVRHFNKDAAALDDTAVLCISRDLPFAQARFCGAEGLDNVETLSDFKDGSFGKDYGLE
IADGAFAGLHSRVVLVLDADHNIIYEEQVPEIGQEPDYEAALSVLN
>KECLDBNJ_02461 Undecaprenol kinase
MTDPETKEHFVVNRIKAFKYAFKGAWLLLKNEPSIQVQSLCALVVTVLGFVYEISSVEWC
IQLLAIGLVLAVEGLNTAIEKIADFIHPDYHKKIGVIKDVSAGAVTFAAVIAAIIGGIIY
IPKLF
>KECLDBNJ_02462 DNA translocase SpoIIIE
MARKKTKTKAKSKTTKQSKKISFVLSKQQKIVLGSFLFLLGLALLFSFISYFFSWQADQS
TLNDLSDRSLQSQNWLNKFGAALGDFFIYQGFGLAAFTIAVLVTLTGFYYFFDKPKKRLQ
SFWFWGIIVMLWFATFLGFFSETSPLLGGMVGFELNDFLQDFIGLIGTILVLAFVAIVYF
AVRLKLTPEHIAHFFAKRKQAFASEFNSQDDEDNEFVDTAFDKDNIELPKEAPEEELEEP
QLKTTPAQPAPAPTPVKEKETPKDADEDFEIEIEETVEEEEVVENLSTKLVQDFGEFDPT
LELSNYRFPTIELLKDYTKGQSITVDQEELEENKNRIVDTLKNYKIDIAHIKATVGPTVT
LYEIVPEAGIRISKIKNLEDDIALSLAALGIRIIAPIPGKGTIGIEVPNKNARIVSMRSA
IASPKFQNAEMELPLTLGKTISNETFVVDLAKMPHLLMAGATGQGKSVGLNAILTSLLYK
KHPAEVKFVLVDPKKVELTLFNKIERHYLAKLPDSEDAIITDNTKVINTLNSLCIEMDKR
YDLLKDAMARNIKEYNAKFKRRKLNPNDGHKFLPYIVLVIDEFADLIMTAGKEVETPIAR
LAQLARAIGIHLIVATQRPSVNVITGIIKANFPARIAFRVTSKIDSRTILDSQGADQLIG
RGDMLFTQGNSLIRVQCAFVDTPEVEKITDFIGSQKAYPEAHQLPEYVGEEGGTSLDIDA
SDRDALFMEAAEVIVTAQQGSASLLQRKLKLGYNRAGRIIDQLEAAGIVGPFEGSKARQV
LVSDMNALHQQLNNE
>KECLDBNJ_02463 Outer-membrane lipoprotein carrier protein
MNNMNFSKIKIFTLALIALVSVSSASAQDAKAKKLLDQVSAKVKTYDNMFIDFKYGLSND
AAGINQETRGDVTLDGDKYKLNLMGTTQMYDGKKLYTIVPEDEEITISTQDPGDDDAITP
SKMLTFFNEGYTYKWDIEQNVNGRKIQYVKLTPMDSNSELKSALLGVDAQTKHIYRLIMT
QNNGSKITITVNSFKTDQPLPGNLFTFDASKYGDYYINNLD
>KECLDBNJ_02464 hypothetical protein
MFIFVLQTVWLYIKELAGKDLDLVIIVKFLLYFSPRLVTLVLPLTVLLTSIMTFGNFAEN
YEFAAMKSTGISLQRAMRSLTIFILALAGISFLFANYVIPAAEFESLNLRRNIAQVKPAM
AITKGQYTTIGEDYVMKVADKQGDKGQFLKDVIIYQKDPSRVGNYTVIKAREGELISAEG
DNVLSLKLIDGNYYDEVEQKDFRKQKREPFVKSYFETYTINIDLSEIDNVDMDEKSIDNA
YTMLTVRQLNDTLVDISKNYNTYLASLGKAQVREMQLRKLDTSYLKNIPRDTTRTLNLDL
IENFEFSEQIQVLDYAKTTVKNTITSIKNRKTDNSVKVKTLSKYEIALHEKFVLAFGCVI
LFFVGAPLGAIIRKGGLGLPIVVGVVLFLTYHFIGIFAKNSAEDGSVAAWLASWLSTLIL
FPLGVYLTYRATTDQGLFDLDGFLDPVKKLFQKKKDQKVDPEQPLADFNLSNSEKAILKT
KTKRELEDIIANYKAYGYSSTFKEAAETLHKNI
>KECLDBNJ_02465 Riboflavin biosynthesis protein RibBA
MAAQTLTKEIQLNTIPEAIEDIKKGKVIIVVDDEDRENEGDFLAASEMVTAETINFMATH
GRGLICAPITEERCKELKLEMMVGTNSDPMETAFTVSVDLKGHGVTTGISALDRAKAVKA
FTNPEMKPWDFTKPGHIFPLKAKEGGVLRRTGHTEAAIDFARLAGFAPAGVIVEVMNEDG
TMARLPQLAEIAKKFDLKIVSIADLVAYRMQHDSLIVKKEDFTIQTHYGEFRLRAYQQTT
NDQIHIALTKGTWVNDEPVLVRVNSTFVNNDILSTLTEQPDTKLDQIFEVINKEGKGAVV
FINQENFASKLLYRLADLKERQESGRQPNPHPKMDLKDFGIGAQILHDLGISKIKLLSNS
EEHKRVGMIGYGLEIADRVHY
>KECLDBNJ_02466 hypothetical protein
MSTQRYASVLLIFGFGSLMQAQIASQMHLTEPDSLVTNQPLNLNEQDFSISDLNDFEDRF
ETFEFLQQKPNGFKPLMPILKPDDSFEYKMRYLDHEDPYQYNMPILEPIMINRFYQS
>KECLDBNJ_02467 Oxygen-insensitive NAD(P)H nitroreductase
MNVISSLKWRYATKKFNDSKILSEDKLDILKEAFNLTATSYGLQPVRLVVISNKTLQQRL
KEAAMNQSQVLDASHVLVICVERKVEAPFVTNYFDRVKEVRETPDAILKPFREMLEQKFD
KQPKADTREWAIRQAYLTLGNLLTVCALEKIDACPMEGFEPEKFDEILELKKHNLASALV
LPVGYRATDDMFADFKKVRRPQKETIIHL
>KECLDBNJ_02468 hypothetical protein
MPIKKLLALRVLRYLVLFGLLILLLTSFLAYHINDETEAYIYDSVDALPETYTGLVLGAS
VRRNGELSTMLRDRVESALLLYKRGKIKRFLVSGDNRTTNYNEPVAMKNYLLDRGVPEED
IFMDFAGFDTYDSVYRASYIFEVDNAIVVSQRFHLPRAVYIARRMGLNFYGYNGDRREYE
LESRNRFREVAANVKAWLELLINKEPHFKGDKIPITGKNN
>KECLDBNJ_02470 hypothetical protein
MMKLLDKHILEEPTTGVVTIQSMLKDKRYNA
>KECLDBNJ_02471 Cellulose synthase catalytic subunit [UDP-forming]
MTLRYFKLLILISLLIGIIILMLFSVVYLYIFAILNFVFIALLAFIKTRNKRSNSSLEQK
KVVEDDLFISIHIPIYKEPVSTVLKTIQAAINQNYSNFEVLVIYNNTPDINYWKPVQNFC
EQFSEQVKFLNFLNVKDYKAGALNKALPYIQPQTDLILTVDADYELSRNALKFVNSDFIH
NKHNLIQYPQHYNNLDTDCPVNAEFNHYFEFYSKFAANESLSLPTGTLSAIDKKSLEKLG
GWPTVSITEDAQLGIQLFENNFSAIYIDRVIGAGTAPNAPAEFIKQRERWIYGNFQNLIY
LLKSKKLPLAIKAKLIPQLTCWFNFNFFSYLILLTSAISISFNLVTAASVLYIVPITIVS
LLTSHLSKFYSFLQSTATFYLAVKAFLLHQGLAFQSSIYWLTYFIDTRLPFRRTSKVQSR
FKPVYDSLYLIIPIQCIALIFIDHQLQLLGLSILCYSLLLTYGMYFFNIKLYKNSYNQLA
NTISINL
>KECLDBNJ_02472 Glycogen synthase
MKIAIIAHAKFPIAEPYAGGLEMITHLLVDALVDRGHQVDLYAHHKSQTKANLIAIDHFK
GDVIEDLNSEDYPIFNNLQLGHLINYSRVFNQIKSKEYDIVHNHSLNIQALLLGNMLPQQ
VITSLHTPPLTDLKVANLILKDLHNQYYTSVSNSLCKQWKKFIPSCTTIRNGIDVSRWEY
VTQKSSSFVFWYGRICKEKAPHLAIEAALLKNKEIRIAGPIDQEAQEYYDTYIKKYINNP
LVTFLGHLSQSELNKELLKSECCLFTSLWDEPYGLVLAETLATGTPLIAFDTGAVNEILS
EKVAVIVEKGNVNQLAKALDKVKDIDPSICRAYAEGHMSYERMVDDYIALYDHILEISQF
LYDTQNSVLRT
>KECLDBNJ_02473 hypothetical protein
MTHRIAYYAHSHGSGHSRYASRFADGYGSNCLILTDSDYNFPDHAEVQQLPNEDLDGTEL
MPNSYNKPSYLHHSPVGLSKILKRNMYILQALQKFSIDFLIVDVSVEIAALARVSSVPYV
YRRMPGNRSDLAHVEAYRGALFLLAYYPRDFESIDTPAWIVAKTCYLGFINKPGIQSIQA
VKPYYDITIVTGFGGTTITNLLPVLLNQYPDYSVQVLGPVENSIQNENVTYQGVVDRVED
FIHEKTIVIASCGTNMVLKMISLGKRFLAFPEERPYLEQKTTAGILEKLNIAQKVDVHNL
NHLIKVAKTFQPYKTPEHYFTTVNKLTGQVEVFFKTVINASKEKEYETNSRM
>KECLDBNJ_02474 hypothetical protein
MLQKKKNMKPIAECSIITIHYGRQEHLNNLILGIERNSIHPKELIIINMDPKLKLDYNGP
LTINLNNILSDRANLLPIANARNLGAELAETNHLLFLDVDCIPEDNYIQNLNDQLDIYKG
LIMATPRYLKKPVTRVETIDLIDKSTLHPRRPAYSKVTLIDHYELFWSLCFAMTKQDFKA
LQGFDEEYKGYGAEDTDFAFKAKAAGMKFCLSPAIAFHQQHSFVRPPLDKIEGIVNNANY
FHKKWDIWPMEKALKAFDNAGFITFDTSTNTYSITHLPDDHSIEKYRVTNEPFA
>KECLDBNJ_02475 hypothetical protein
MDNLVSGARVYPKCIKVDNGSEFISKVLDKWAYESNVELYFSRPEKPTDNPFIESFNGSF
RDECLNTNWFFSLEDAQEKFDIWREDYNGFRPHNSLGDMSPNEYIKINENSPDSLVMTST
>KECLDBNJ_02476 hypothetical protein
MLPRNKTENLLPYDGCVAFDPSFIDVTMQAYYMDVFSNTIPWQSDRIVIFGKTIYTQRKT
ALFGDSDLTYTYSGTKRQCEIWNQDLLNLKAKLEDQLHETFNSCLLNYYPDGATAMGWHS
DDERDLVAKGTIATLSFGATRKFNLKHNETKNKVSIELHAGSLLVMKDETQQFWKHNISK
TKKVTTPRISLTFRQLIKQ
>KECLDBNJ_02477 hypothetical protein
MENWLVVSETTIIKVVLSVISIFTVMIVITRINGLRTFAKMSSFDFAATIAIGSVLASIV
LNTNQSLVKGTIALACIVAFQSIFSWIRRKSKAMQHLISNDPVVLMYQGEIFYENLKKTN
VGEDDLIAKLREANALNFKEVYAVILETTGDMSVLHGPDHQSIDKKILKGIKGWPTSSSD
DTVAKPNKNSNL
>KECLDBNJ_02478 putative siderophore biosynthesis protein SbnA
MYTQLPTPPLRRIEKSSVLDTIGNTPLIHLKRLSSITGREVYAKMEMANPGGSIKDRTSL
AIVEEGIRKGHFTKDTTLIESSSGNMAVGLAQVCCYYNIPLIIVVDPKANPHTLKILNAY
GAKINNVQKPIANGGYLGARLARIQELLLEIPNSVWTNQYQNESNPKAHHRTMREIYQEL
PEVDYVFAATSTCGTLMGCANYIQAHGLNTKMIAVDAVGSVLFGHKPQERHIPGHGAGLP
SHFLRREAIESACHISDMECVEGCHKLLDTEGILAGGSSGAVLSAFLKLQQQLPENSKSV
LILCDRGERYLDTLYNQNWVQSHLK
>KECLDBNJ_02479 hypothetical protein
MEFADFHIGIIGLGPKGFYGFERLVAELDRCDNCSAITIHMFNETENFASGWIYDPNQPE
YLLMNYPNKYISCSPSNALQPLIPIQSFSDWLSSTYNLPKEQVDSQVAPRAVVGRYLQYY
FERILSAARIKINIQLHTTCVTDILKETEGYKLLTENTCCRDIHFQSLLITTGHSPAIQS
CKQQKKESQCYIPFVYPLCENLNPIPPQSTVLCKGMGLTAIDAILELTEGRRGVFKKNTS
GAFDYLKSGHEPALIIAYSRSGIPIVPRGDQADMLNSTSHFLKNKIDSILNSHTRVDFER
DILPWIKLDIESAYYQMLFKMYGFEYTPSDVAHFNTAKTDFHRLNLAIAPFKADELLYPD
AHTNLDYANSPENYWNFWIEELNHAQSPWVAAASAWRSLSKEFNRLYQTALLTSKSRKRF
QDTYFGLFNRIAYGPPIENIKKMLALHQAGILNFSFARHPSTVFTKRGWTVILNDRKQDA
DFMIDARIPRKFSKSSAILFNGNSTTSLFSSPQEQDWINLHCTIEGHPISSTGAIEKNIV
LYGTPTEHILFDNDSLSRAHNDTSSAWARNTVKNVQEIKNYNLTYES
>KECLDBNJ_02480 Diaminopimelate decarboxylase
MNPNLPALTPITSQWMHQLIGNFDLLEHLLEAYGSPINLHHLKAFQENIEEYQKILDTYQ
IKYQLFFARKANKFKNLIPAAAQMNIGIDTASYPELQQCLDLNISSDKLISTAAIKNKKL
LQTAIEQEVLLIIDNQDEFDQVLALSTQFNKKVKIGIRISGFDFQGSQLKSRFGFDITAV
TQFIERYFKDATVLSKIRLEGFHFHLDGYSTAQRGTALHQTLDLIEILKPLELPISFIDI
GGGILMNYLQSQQEWDSFQHVLKQAVLEQHPSITYNNDGLGFTMRNGELEGHLQTYPYYN
ENTKANFLKEILETPNQNNKTVVQRLQANSIELRLEPGRSLLDQVGITVARVAHRKIDAE
GNHLIGLEMNMSQLKSSSADFLLDPFVSYKHQKSNAEPVPVYFTGAYCLERDILLKRKIM
LPQLPEIGDAVLFVNTAGYMMHFFETEAHLFERAQNLSIAEYQEDYQFENFDQEY
>KECLDBNJ_02481 Sugar transporter SemiSWEET
MDMETIVGTTASIFTTIAVLPQVYKVLRTKSAKDISLPMFMCLLIGVGSWTIYGILKEDW
PIIITNGLSFLFNGMMVYTKLKYDKSYTR
>KECLDBNJ_02482 hypothetical protein
MGGLITFVFLLVAVFVLGNISGYEGKVLIEASLSGINMLCNTIVLGSATILTLLLTLLGI
STSSRSTLKKAHYKQVANIAKLDTVLFIFALVLFQIFNIPITESEQVPTFWFKYIYWATL
FSSSLLSGMMVTVVLLLYTTVTNIITIVGLGKDHYLISEEEIEEEEKQT
>KECLDBNJ_02483 hypothetical protein
MNIVSLFLITLASTTVMTLFSYGFSCLVHQNLVEPYWLNRLLFKREGWRSPYGWITHYIT
GIGFLYLIDLLRNYFSFPQYLEILIFGGLEGGLGILMWILLFWFSKPSETFDRQRYYLNL
LIAHIFFAATALALL
>KECLDBNJ_02484 Catalase HPII
MSKKQTSEFKSKKIDQLEQSTKDYQDQVMTTNQGLKVNDTNNSLKAGERGPTLLEDFLLR
EKITSFDHERIPERIVHARGSGAHGYFELYKSIEKYTKAGLFTDTKRKTPVFVRFSTVAG
SKGSPDLARDVRGFAVKFYTDEGTWDLVGNNMPIFFIQDAMKFPDLIHSVKPEPNNEIPQ
AASAHDTFYDFVSRATETLHNHIWVMSDRAIPRSYRMMEGFGIHTFRFINKDGKSHFVKF
HWKPVLGVHSVTWDEAVKINGADSDFHRRDLWEAIEAGQYPEWEFGIQVVPEEDEHKYDF
DLLDPTKLIPEELVPVEIIGKMTLNKNPENFFAETEQVAFLPGHIIPGIDFTNDPLLQGR
LFSYRDTQLSRLGSPNFHQIPINRSVAPHHNNQRDGHMQTEIPKGQTAYFPNSLSMGCPH
LAKMAEGGYTHHQERIDAHKIRGRSASFSDHYSQPALFYRSLSSWEQQHVADAYTFELGK
CNHKHIQERMLWIINQIDQELAKKVADGLGLTVPKKIDEPVNQAIGADAEIEKFQPNSKK
QYVDKDSSLSQANTKFDSIATRQIAFLAADQFDMKRFEPYKTALEQAGAMVKIIAPHGGS
ITCDQGMKHEVDAAILTTESVLFDAVLIAGGQKAVKSLQAKAKFQKFVNEALKHCKAVAA
LGEGEALLKHSAYKHYEKDKAVFIDAKPKAFIDAIAQHRNWERKDKVEGIAV
>KECLDBNJ_02485 General stress protein 39
MTKPNQFPEQSQELPGSEAQMNPQPEIVRESYKGSEKLVNKIALITGGDSGIGRSVAVHF
AKEGADVAIVYKSETEDARYTQELVEKEGRTCLLLEGDVRSQKFCEQVVDRVARELGPIN
ILVNNAAVQFPKDHISEIDQDQLAETFETNIYPYFYFAKYLENKLVKGDCIINSTSVTAY
RGSSHLIDYSSTKGAITTFTRSLSKAWAEKGIRVNGVAPGPIWTPLIPATFDEVAQFGQD
VPLGRAGQPSEVAPAYVFLASQDASYITGQIIHVNGGEVVGA
>KECLDBNJ_02486 hypothetical protein
MSDKSKNDKKEDKKDIDKGPIKDDHKNQYGSTKDRKKKRRA
>KECLDBNJ_02487 hypothetical protein
MKGNHQHITNYKTVLWVYRLDIAEYYALALSATDCYHKHIYKRLGALKTAVIASICHQEK
DISSTNEHSDVNLKNQLYFPKPTTTNHLRSFEAKQFNKVIQLLEGCSKASRDTSPQLRSN
MQRLQGFLNAMN
>KECLDBNJ_02488 hypothetical protein
MKTSPNSHFANLIATILKRYRCTESEKQWLSTLSIDQIIQISQTEFGGFDKVTGQFNPEI
KSGTYKVKIDYNDMNEGRCKREYLVSNQIN
>KECLDBNJ_02489 hypothetical protein
MLKLEPVLNIKSYDSIEDLNPTADCHYCTINNVLHNANLLWSLKFLKKLNQCLNTKMT
>KECLDBNJ_02490 hypothetical protein
MKKATLFSTLFLAAILFSAQAQRADVTSFSTTANDYDSNVEVLNVEMVVPEVIVIDLEDG
TGQEINQLQFDFRKMTAELEAGQINFDEIVSDPIYLQYTSIVTDNTSDRNKIDVSFAGNI
PAGVDLVLNVDPSFQNAPSNNGTPGTIRLSSMAFNATNTTATLVDDIASVFTGSGAQNGI
LMNYSLQQNGSFTDFEAGTYNSTITYTMTNM
>KECLDBNJ_02491 hypothetical protein
MRLKIFIIILLALAFVQSSAAGVIVLNGLTHRYSGNQGETIQGEIILYNPTDAKQLIKFE
LQDVHYSCESSRYFTQNTTHPRSSKTWFNGNLTDYELAPKEKFVYQFEIVIPRNQTIKGS
YWNILMIEIDKPMRQNKLASTLGVDSKIRYGIGLITQIGQAEQVAIDFEKAVLDTKKEQT
KLNLALINTSFFLEEPNVALEIYDMEGKLMLSKNSSRQKLFPESCSKYLFDISNLPNGKY
ECLIIAESRNEYVGTQMSLTIE
>KECLDBNJ_02492 hypothetical protein
MQHSNYKILICIILLSQTLSFAKETSLGAFIESSSTLVSNVERYYSSLSLLNLHQQSLNT
EPEAELVLTLKTTQKSFDPNSRHTLVFEVYNQSKASKQIKVLPILPTSWQLLSVSAINHL
APAEKKLVLVQFFIPSYQAAGQAPITVNLNTQNELIRSENYTINVATHQDIRVEPLPAAP
NLEGGTLFKSSFEIKNMGNQTAALKINSSTFIDGFKEIQLKSDADTIIVVQQSTPKLVHA
PLKVINDLEVENVNTQVKKYAYNSTTIYPSKIKQKDPFFRYMIDASVYYNSFTNSNDHFS
IMTAEVKGNGFLDIPKEHFLSFIVRGPQKINVRRFGITDQYSLIYRYKDATTVKAGDHGY
QLNRLGFGSRFGIGFSLDHSINSRLTFSALYVKPRLYTSNNSSFYGVKAQYLLSPSFGAG
ISISQSKESVYRSFSQKKTNNNDFGQIATINFDYQNARHFLYSETSLSNFKGDIQYTQML
NAGTRLGNFRFNGNFTVAAKNYFGTVSNGLQLNTNITYAKNKWNLSLGQSLSKIIQNIDP
RFSSATPYFKNYFARLGFKIDQASLLSIRLDHRLREDRLMPRNYFYKEMGMDYQYSLNLP
RLNLNFNGRIAKTKNMLLTQSYYLNNYFHGVNINYNLLKAFSVRGGFNHSYTSRYSLDGK
TSHNYRYSLGLSTSINALRFNLLYTSGFTPEYFHLKRDYLNASIFYSINNHHHFEIRANY
YENPGFQNAKEVLASAKYTYRFGIPLKRTISAGGIKGYIQVPKNYQLKEGIQLSINGKTV
IADKNGYFEINNVSVGKQFLFIDQSKLPKHLILGIKNPIELDIVKNQSQDIIIPLVEAAS
LRGNLNKAPKDSIVPKILIHLKNEKNAYTLRSNPDGTFHFKEIIPGSYDLNFQFLGTNMD
YKAIPSKQITLNATSTKSITIDIEKKVRQVIFKSKKLYISN
>KECLDBNJ_02493 hypothetical protein
MKKLSLYIVIFCLVSSGLTAQAEADFEPTTINAYDPNSYAAESTTSLGLTTVLKPEGDQR
SIPIQIGILPINLVDIEGDQTAQTIDLSALEAGASLQTAASTIFDDELWLNFTFRSVDYS
NGNLYVYSNLPLPDGMQVTVNIVSSNLADGSYNTASFYSSVNVTNQGSNPASRLLYDFQN
GYTGDGFGKGYHIKFDVQNPSSLPDGFEIYFEIL
>KECLDBNJ_02494 hypothetical protein
MERIYHIFTLMLFVFGFNCFSQSNMFPGTLTIENSLNFNQTIGDVVQEAGGDDASKGFII
YEGNILSYTTVNCEANIYRYGVYAYVIGLPQGVTLEARLNNRGIGIPSSMITDLSGAVIP
RDAYSRPGGNDGFHALPNDGSQANLLYEFVGCRQDMSLDIRIKASSATYIPALSTNNIEI
IYTVRGKRIQ
>KECLDBNJ_02495 hypothetical protein
MVSIASYRRIEINETIDCINVSEMQRKIEFELNEYKTIIISLKKLKRIDLSGLYMIYLLK
QKSPANTIILEGLENSAFLKAIEKTGTAHLLYKIRA
>KECLDBNJ_02496 hypothetical protein
MHYTLFFLLLCTGLCFGQKAYTFDYRLEYQQTFFKDSIPIKNRAFYTQDSIATVTYLTNS
KDNSYHTVLTAPDSLHYLLNFKDENGLQFVVSFLKAEFDQAIAIKIPCKFVRSYRNAYTY
QTKHYDFSRAKDTLIDGLQYQYYTLAANNPRRAKKKKTGTLLYIIAPKTSFHLPLLTQAT
AFEEWKATQNLPNRIFYRKYFIDYYDRKDTQWQLLNYQNINLKLSIEAACDYTEGLR
>KECLDBNJ_02497 Transcriptional regulatory protein YpdB
MNCIIIDDEALARSIIRNHCDKTADVEVVAQFENAISAIKYLNQNEVDLIFLDIHMPDFT
GFDFIQTLKNPPRIVLTSSDRNFAIEAFEYECIVDYLVKPVALPRFLKAVQKAQQFVAST
EPIQDTSVQSQPQQETENDLYINIDRRLIKLNFDSILIIEAKGDYILIKTEGKNYTVHST
LKKIEEKLPESKFLKIHRSYVINYHKIIDIEDNSVLIAKDVIPISRSNRPILMKRLNLL
>KECLDBNJ_02498 hypothetical protein
MTKPNLDKIKEIAGGTASFEQEMISIIKEELPAELEQYQFHLEQNNFKQTAESVHKLKHK
ISILNMEEAYATAAAYENELRAENPTSAPAFKKIIDELNAFVKKL
>KECLDBNJ_02499 Phytochrome-like protein cph1
MNRLLQRQIRKHLLEKGVELDEQLQVFLDAVSSSYTNYEEQLTMVQRAMSLSSDELFEAN
KNLQKETSQQKNIIESLTQTIAALYKYNNQLETPKKDSINLDALELARVIDNQTREIIAT
NKHRDELLAQLEKQNEELNDYAHIVSHDLKSPLNNINALTNFIIEDDRLSEESIENLDLI
LEHVEHMHNLIQGILEYSAIDKAVDDKHAIDLNRLVTDLLATMHTPKHIEISVLKHLPKV
YGNSFRFQQLFQNLIQNAINYNDKAQGVVRVTFEERDECYEFSIADNGRGIDPAYHDKIF
QVFQTLEQDAKHKGIGLSIVLKIIKFYGGKIWLSSKPKEGTTFYFTLPKH
>KECLDBNJ_02500 hypothetical protein
MKIQQGTRDASGKWQHTDVASSLKAPLVLVFSNRFLLEDESIFTQLRAQFPDGHLVLGST
AGEITGTNVLSDGLAYTAIEFEKSAFEIVSASILEQNKESFATGKVLAERINKNGLKHVF
VLSEGSFVNGSELINGLSSVLDTDIAITGGLCGDDARFEKTLCGYNQPAKEGEVVLIGLY
GDSLEISFANYGGWFSFGPERLITKSSGNVLYELDHRPALDLYKKYLGDKASELPQAALL
YPLSVQFEHKKNPLVRTILNIDEDTNAMVLAGDAPEGSRVNLMMATVDGIVDGASEAAKR
AVEHRNSPPELAILVSCVGRKLVMHQRVEEELEEVCEVLGKNTTLTGFYSYGELAPFADD
RICELHNQTMTLTLISE
>KECLDBNJ_02501 Phytochrome-like protein cph1
METENVALYKRLIARERSARKAAEAILEQKSTELYALSEELKKSNDQLQSLIYQKNSELQ
GVFENLADAYVVIDIDGRVLKMNDAAVTLMGYDATKEPVFLPYLVLEEEQKSVETAFKKL
LKQGSITDFKVSIRTKSGEIRRVHINASTILDENNKAIVAQGIVRDITLEESKATIIEEQ
KQQLEFIVNNSPLGIALAIDGKIQKCNTSFKNILAFTEDQILGKDLKALTFAAEKSDYKE
QLEALQEGAVNAFVSTQKYITKSGQIITTKINGTAIKNPENGMQIQEVITVEDVTKELLA
REQLVESENRLSALISRLQNGILLEDEQRDIVLTNQMFCDMFGISAKPEALKGLSCINAA
EENKPLFKDPEAFVARIKEIISARELVTGDELELKDGRILERDFVPIFTNGNYKGHLWSY
TDVTLQRRYKNDLQQQKEKYSSIIANMNLGLLEVDNEDRILLANQSFCEISGFSKEELIG
KKAAALFMKPKSQEIIHSKTKVRAQGVSDSYEVEVLNKTGQKRNWLISGAPNFDINGKLV
GSIGIHLDITEIKNLEAQKDLLFANLEKSNRELQEYAHVVSHDLKSPLRSINALANWIKE
DNLQHLDDQSLENFENLENTLEKMEALITGILNYSSIQRDHTQDDATDIGSVIDGVTELI
HIPDHIKIKKGPMPVIPIDRIRIQQVFQNLISNAVRYCDKAEGWVEIRYTEEAHRHVFAV
EDNGMGIEPAYHNKIFKIFQSLTDHEDSTGIGLSIVKKIIDLYHGDIWLESTPGDGTTFY
FSLKK
>KECLDBNJ_02502 hypothetical protein
MKGVVFTEFLELVEDKFGLEMVDAIIQASDLESGGAYTAVGTYKFVEMVSLLTALSERTQ
LSIDELLYVYAQHFFKVIETSYAALLNSYTDPLELLASIEDHIHVEVRKIYPDSQLPTFK
TINKTNQSLILDYHSSRAMYSFGLCLMHETFTYFGFDSKVRFQKLKSDGTHVRFFIEKGH
GNRKRSAI
>KECLDBNJ_02503 Response regulator rcp1
MKGRVLTILLIEDDRIEIMKLKRVLAQSALKHHLIEAKNGEEALHILEDKSALPDIILLD
LNMPKINGIEFLKILKADAMLKYIPTIILTTSSNHNDVKQCYEIGIAGYVLKPLKYEDYV
SKITNLLNYWSLNELIHT
>KECLDBNJ_02504 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MKKQNLILVPALALILSLTSFDIIKERIDPPKKGVPVFSNVVYEGNDAVYNENPLEANEF
YNPILQGCYPDPAITRKGDDYYLVVSSFAMFPGVPIFHSKDLVNWKQIGHVLDRVSQLDV
HDTGISQGVYAPGITYNENNDTFYMITTAFAGGLGNIVVKTKDPMQGWSEPIKLDFQGID
PSIFFDDDGKAYVVHNDAPNEGEELYQGHRVIKVWEYDVEKDQIIKGTDKIIVNGGVDLA
DNPIWIEAPHLYKKDGKYFLMCAEGGTGDWHSEVIFMSDNPKGPFVPAPSNPILTQRYFP
KDRENNVDWAGHADIIEGPNGQWYGVFLGIRPNAAGQVNTGRETFILPVDWSGTYPVFEN
GLVPIEPTLELPEGVMNKTGEDGNFPNGNFTFKEDFSADKLDYRWIGLRGPREAFIKHTK
KGLEIEPFETEITELKPTSTLFHRQMHRTFSFKTDLTYTPKSDEDFAGITVLQNERFNYA
FGVTKKGKEYYVVLQRTEKGKSTIIASEKIDLDVKLSLKVEGDSADYKFSYATDGNNYKI
LGGTVSGDILSTNVAGGFTGALIGLYATSNNSIEP
>KECLDBNJ_02505 Xylosidase/arabinosidase
MKNFQSICSYTLSFFLILFLINEVQAQDSVSDIGVSNNSISYKAMGNPYLPLWEHLPDGE
PRVFEDPDNPGKYRAYIIGSHDVRYTSYCGPDIRIWSAPVENLSEWKDEGPVFTYQVDGK
WDVMYAPDLVEVKDKEGTKTYYLYPHSRGSNREAMVAKGSRPDGPFTPINLSEDGKKTVP
GSILGFDPAIYIEYIDDPTDPDYEIGYRAYGYWGFQKSSAAQLDQNTMYSLRPGTEVIER
LLPASRRYGVIRDPEGTIFPKIYEGEDLGSFNFFEASSIRKVGNKYVTVFSGYSGPDYGV
GSSNSTLRYAVADSPLGPWRSGGVLVDSRAPVLNENGTAIETTYSGHNTHGSIEEINNQW
YVFYHRPPRGFGFARQAMVAPITVSWDEKSVEDGGSVYLRGYDPYASDEIWTAKASNGLE
YNGAEVTSEGFHIYGLDPYQYYSAGYACYLSDIGIQQDAWDIWNNHMPISDLKNGHIIGY
KYFGFGGVSEDQKGVTAFEGTKEGNETKFNLFLKPQSQESFKVQVWLDGPWDNATWNGKR
IGDITVPAQAKNEITQFTLDVSEFVDKLDKKHAIFLKIVGAEVESLGELVGLGFSSKDKP
INRPVVPEIFISANGKALDLPETPVRSTDENGITGYAIYETTYNVEDAASVPVLTAKSDN
PDVNVNITQASSPSEEAIVEFDYKGKVKTYHVAFK
>KECLDBNJ_02506 Beta-galactosidase BoGH2A
MKNVFLNNYIFISALLLLMYSCKIPSVNIDDDISARQSTSIDSGWKFYKYEKLQDADSLI
YDTRPDYVDTKQVVPADAKPTEAVLKKNNSNALKPWIMPTGNDFISNPKKRFKRPKGNPG
NDFAFVQKDFKDSAWTTVSLPHDWAISEPFLEGWDANVGGGMGRLPSPGIAWYRKKIFIP
KSDQDKSIFLDIDGIMSYAMVWVNGNLAGGWPYGYTSWRLDITPYISPGEYMQLAIRVDN
PPNSSRWYPGGGIYRSIKLTKTNSVHVAHWGTFINTPEVSTKNAKISFELTLQNDLKEKA
RVKVKTQIFELDARGNMQGTSLAEMVSDQLILPAGSKMTWKDTTHLTNPKLWGPPPAQVP
NRYMAVSKVYSDETIIDIYKTPFGIRSLNFDPEHGLLVNDKKVYLKGVNQHHDLGALGAA
FNLSAAKRQLEVLKELGANAIRMAHNPPDPKLLELTDEMGFLVIDELYDSWERKKNPLDF
HLIFSDWSEQDIRAMVRRDRNHPSIIMWSTGNEVGEQYTGEDGAAIAKRLRKYVLDEDPT
RPITASMNYAKPNMPLPKTMEVLSLNYQGEGIRNSPGYSHLPGINTPPLYPDFHKAFPDK
MIISSENAAALSTRGTYIFPVTKEISAPVSDTTGGDSRSNYVSSYELYTAPFGSSADKVF
ESLDKHPYVAGSFVWSGWDYLGEPTPYYLARSSYFGLIDLAGFKKDRFYLYQSRWRPNLP
MAHILPHWNWKDRLGKITPVHVFTSGDEAELFLNGKSLGKKSKKDFQYRLRWDDVLYTPG
ELKVVTYKNGQFWAENIVETTGEPYKLELIPEQKSIKADGKQLAFVQVKIVDSNGRTVPN
ANNLLHFKLNGSAQIVATDNGDPTDMTSFVSHSRNAFNGSALVILKSRNEGNFKLTVSSQ
GLQEGSMLLVAKN
>KECLDBNJ_02507 Carbohydrate acetyl esterase/feruloyl esterase
MKKHLLLFGLLILSCSTGWSQDENFHIYLAFGQSNMEGHARFEPRDTIVDERFKLMQAVD
CPDLGREKGNWYTAKPPLCRCKTGLTPTDYFGRELLENLPQKVNVGVINVSVGGCKIELF
DKDNFESYVETSPDWLKNMVKEYDGNPYARLVEMAKLAQKDGVIKGILLHQGESNTGDSL
WPQKVKGVYDNLIKDLQLDPKKVPLIAGELVSEEQGGACASMNPIIRTLPDVIPNSYVVS
SEDCEAIADHLHFSAAGYRKLGRRYGEQMLEHLGYPKLVKEAPKGFDVRQSEIKHGTIDT
IQYPSKTVGTNRKALVYTPPGYAKGKKFPVLYLLHGIGGDHLEWLKGGHPEVILDNLYAN
GEAEPMIVVMPNGRAMKDDRAVGNIMAPDKVEAFAIFEQDLLNDLIPYIEKNYPVKIDRE
HRAIAGLSMGGGQSLNFGLGNLDTFSYVGGFSSAPNTKAPEVLVPDPKAAREKLNLLWIS
CGDADRLLRFSERTHEYLVENDVPHVYYIEPGDHNFKVWKNGLYMFAKLIFKPVDESLIT
KYSLLGTPASTNMRNAKYPQLMPDGSAIFRLKAPDAKRVQLDLAKKYDMDKNTEGVWEVR
TDSLTEGLHYYSLLIDGVAVADPASKTFYGMGRMASGIEVPFKGDDYYALKDVPHGDIRI
KQYYSPVLNSWRQFYMYTPPGYESSDEKYPVLYIMHGGGEDESGWAMQGKTNLIFDNLIA
EGKAKSMIVIMPDGNMPASAFTEMGLQMFTNELKDGLIPFVEKNYRIKEGSENRALAGLS
MGGIQTLFTGVQNTDLFDYLGVFSSGWFANDDSISGKQYEFMQENVDQINENLKEFWVAM
GGQEDIAYTNCKVMLQKFDEMGIEYTYSEYPGGHTWPVWRNNLYTFAPLLFR
>KECLDBNJ_02508 Carbohydrate acetyl esterase/feruloyl esterase
MKTLQHITCLFWLAGLSLVQAQDYKPSTSNQAGKAFPQVNAEGQVRAQISAPEATSVKLD
IGGVKYEMTKDAEGVWTGESAPQDVGFHYYQLNIDGASVPDPGTKYFYGAGRWGSGIEIP
AQDDAIFALRKVPHGKVVENLYFSEITQQWRRNFIYLPPGYTTSDKSYPVLYLQHGSYED
ETGWSSQGHANLILDNLIADGEAEPMIIVMDNGYAYKPDAPKEGRPESFFEEVMLKEIIP
MTDAEFRTLADREHRAIAGLSMGANQTMRIIMNNLDTFSYYGGFSGTANFGMEGAIDVDT
FLNAAFSDGTQVDEQLNLLWLGLGTKEPERFPKTINAFVDMLKAQKITYTLYESPETAHE
WHTWRRCLHQFAQQLFKD
>KECLDBNJ_02509 Endo-1,4-beta-xylanase/feruloyl esterase
MKKLAVLFLCLNFLWSFGQEDVKEDFKPSTLNQPGQEYPMVNSQGYVRFKIKAPAADSVS
VSLGLGGRGGTKLTKNEEGFWTGTTEGPMDEGFHYYHLTVDGGTFNDPGAKNYYGSVRWE
SGIEIPAHDEEFYALKDVPHGAVQQILFPSPSTKTSRRAFVYTPPDYHLNTATEYPVLYL
QHGWGENETAWMNQGRANLIMDNLIAEGKIEPFIIVNTYGMTNEIKWGGIRDFDIKYFQT
VLTEELIPYIDSHFRTLDNPKNRAMAGLSMGGMETRMITMNKPGLFQYYGLLSGGTYSPE
DLKEHEDLKLVFLSAGSKENPDRVKQAAKALNDAGIKAVSYVSEGTAHEFLTWRRSLYQM
APLLFNE
>KECLDBNJ_02510 Xylan 1,4-beta-xylosidase
MKNFKSQTRIKQGLSFVLFHLVFAFISAQDHPYQNPALSPEERAADLVNRLTIEEKATLM
CDVSEAIPRLGIKKFNWWSEALHGFANTNDVTVFPEPVGMAASFDDELVYKIFDATSDEV
RAKYHQAMRNGEENRRFMSLSVWTPNVNIFRDPRWGRGQETYGEDPYLTSRMGIQVVKGL
QGPEDAKYRKLLACAKHYAVHSGPEWSRHELNLNTISQRDLWETYLPAFKSLVQDADVRQ
VMCAYQRLDDEPCCGSDRLLQQILRDQWGFEHLVVSDCGAIQDFFTSHGVSSDAVHAAAK
GVLAGTDVECQWNNHNYKLLPEAVKRGLVQEEEIDIRVKRVLKGRFELGEMDPDSIVPWA
QIPASVINSEKHRQLALEMARKSMTLLQNKKKVLPLNKTLDKIAVLGPNADDEPMLWGNY
NGTPVRTITILDGIKSKVGEERIVYDQACDLVEDKVTESYFSKIGIDGKKGFKATYWNTP
DYSGPVIAETYITNPLKLTTAGQHEFASGVNLEGFSASYATEYSADKDEELAFKFGATGH
FELFVNGKSLRQTNNWRTLPSTLPFPVEKGKTYNIEIKYAQLNNWEANLEFNFGKEIPVD
FTGLIAKLEGIKTVIFVGGLSTLLEGEEMPVNYPGFKGGDRTDIELPAVQRNCLKALKEA
GKTVVFVNNSGSAIGLVPETQTCDAILQSWYGGESGGQAVADVLFGDYNPSGKLPVTFYR
DTTQLTDFEDYAMDGRTYRYMKEDPLFKFGFGLSYTTFEIGEAAIPKTEITKSQSLKFTV
PVKNTGDRSGTEILQVYLRKVDDADGPIKTLKQFKRVELKPGEQQQVALEIVPESFQFYS
EEKLEMAAEPGEYQIFYGNSSDEANLKTFIINLKPQI
>KECLDBNJ_02511 hypothetical protein
MNIKSSILLIFLSLSAFAQQPDMTLRYDEPAKLWVEALPVGNGRLGAMIYGDPEHEILQL
NENTLWAGQPHRNDNPNAKEALPQVRQLIFDGNYAEAQDLVNQKFFSGKSGMPYQTFGKL
HLDFKNTGVVTDYERTLDLETAVATTQWSRDGVAYTMEVFSSFPDQVIVVQLTASESGKL
NFAASITREERATSFVDDEHILRLQGTSSDHEGIAGAVKFEAQVKAKTSGGSLSQSENQL
EITNADAATLYISMATNFKSYNDIGGDAAAKARTFLDAASQKKFDGLKRAHIADYQSYFN
RVQFSLEETNSNSETTDVRVANFKDGNDLDLVPLYFQFGRYLLISSSRPGTQPANLQGIW
AEGLKPAWDSKYTININTEMNYWPSESTNLSELHEPLIQMIRELSETGKQTARDMYGASG
WVAHHNTDIWRITGPVDGAFWGMWPMGGAWLSQHLFDKYEYTGDTQFLDSVYPILEGSAR
FLNDFLVEEPKHNWLVIAPSISPENAPYSDHPESVAAGATMDNQLVYDVFTKTLKAAKIL
NKESELLTQIEASLERLPPMQIGKWGQLQEWMYDWDNPKDNHRHVSHLYGLYPSNQISPY
RTPQLFEAAKTSLVARGDESTGWSMGWKVNLWARLLDGNHAYKLIQDQLTPSIQPDGKQR
GGTYPNLFDAHPPFQIDGNFGCTAGIAEMLVQSHDGAIHILPALPDAWETGSITGLKTRG
GFEVDIEWERNKAKTINITSELGGLCRIRSYEPLKGEGLSEFKGEVENGFFQTPEIPEPL
NANPQELTKSELKPVFEYELNTQPGKTYTLTAR
>KECLDBNJ_02512 Arabinoxylan arabinofuranohydrolase
MNQKNLFQLFGLLVFSTVFAQNPIIQTNYTADPAPMVYNGKVYLYTSHDEDDSTWFTMDD
WRLYTTEDMVNWTDHGTVLSYKDFDWAQRNAWAPVATERDGKFYMYVPITDRNGQNGIGV
AVSDSPYGPFIDPLGKPLVQESQADIDPAVFVDDDGQAYLFWGNPVCYYAKLNEDMITLG
SEIQQIPNTIEAFGKREGEPNERRPTTYEEGPWVYKRNGLYYLIFAAGPLPEHLSYSTSK
NITGPYTYQGKVMPRQGGAFTNHPGVIDYKGKTYLFYHNAALPGGSGFTRSVAVEELKFD
KDGNIPELQMTEGIEKSLQVLNPFIKTEAETIAWSEGVKAHENDNVGVFVTAMKNDAYIK
VKDVDFRAEGATRFTARVGTTHNSDVSMEVHLDSKEGPLVTAFKVPMTGGNDRWALVSKE
IEKVSGVHDLYFVFKGKAATKIMFFDYWMFSEN
>KECLDBNJ_02513 Retaining alpha-galactosidase
MKSLIYVSVFLLVFIARAQNKTIASPNGNLKVIIDVIDGGVIYTVKFDNTIIIENAPLGF
RTKKADFTKNLTFVNAESRKVSKTYEQDKIKQSQITYNANTLRYTVKDSKDRQFSVLVQV
SDNDIAFRYEIDKWGETRAIVVEKELTGFSFPQETSSFLSNAMRPMTGFARTAPSYESAY
TADKPIAEQTAGGGYVFPALYKVKDEYWVLLSETGVRSLYPASHLSAYQDGTFYIEYPNE
KENNGFGSSGAQLGLPGVTPWRTITIGKSLKPVVETTIPWDVVEPLYEPSQEYEYGKGSW
SWIIWQDASMNYKDQKAYIDLAATMDFKYILIDAWWDERIGYDRMKVLIDYAASKDVGVF
LWYNSNGIVNDAFQTPLNKMNTSIERKKEMKWLQEAGVKGLKVDFFGGDKQETIRLYEDI
LSDANDYGLMIIFHGTTLPRGWERMYPNFVGSEAVVASEMLVFVEDVRKKEAYNATLHPF
IRNAVASMEFGGVVLNDYLNRGNKSGQRRLTTDAFQLATGVLFQNPVQMFALTPNNLDDA
PKFELDFLKELPTTWDETRFIDGYPGKFSVLARRNGNIWYVAGVSAESEPKKLELDLSFL
GGRIATLINDDKNAETFTKEIKIPKNGKLNLTIQSGGGFVIVNE
>KECLDBNJ_02514 Sensor histidine kinase TmoS
MIDYLKYGSFIIAVLASISLKAQPSTSDYRFTEVKDVPVKRAITAITQDNYGFLWFSTYG
SGLYKYDGSTFSTYKESWSNKHSLNSSLVHVIYKDQDGTIWIGTEKGLNRYRPETDDFEN
INLSSSDNFKPLAIHSIARLDDSTLILGSHNNGVYKLNTTTNRLSTIPFDHSLDRDWLRF
NSMSVVDDKLYIGTSSGLFELNKNGAIINRSKFLVNNKEFTIKAHVSKLFTVSKGTLWIG
TYSDGLIRLNVRNHQADSRALHITDKRILSIAEIEHNKLLIGTENDGLFILDSAGKTLAN
YTYNKFGDNRIQSNSIWSLYVDSEQRIWIGYYSDGISFYDANYDKFRDIESIPYKNESLQ
NSSVTGILEDPESNLWISMDGGGIDVLNPKNQEYTHLIDPNNSVASGLTSSDIQNIFFDS
KNNLWASSWNSGIFYLEKGASKFINYTSNDGLASRSTICFAEDSQGTIYIGTFNAGLQSY
NPKTSKFTRLDSEVFRNAGIANCDVRKILIDKNDVLWVGTTKGLFTVKKRGDVYEVKSKN
KAMYATRQSNSLLYYILSLYMDAQNNLWIGTDGGGLCKYDVSSNTYQWFEEKISKQTISS
IISDSEGILWLAGNNGITKFNPKNNEVINYTVNDGLLANDFHNNAVLNSGDNLLYFGSYN
GINFFDPTSLNLNLQQPLLYFSELRLFNEKVLPKKENSPLKEILFSTDELTLKSDQSVFT
IEYAAIDFTRPSDINYAYLLEGFDNSWNYVGTSKSATYTNIPPGKYTFKVRAANNEGVWT
QSPISLKINILYPWYKQGWAIVIYVVLGLILTFITYKITQKRLAEKRLIQYERDKRQQEE
ELNNRKLQFFTNISHEFRTPLTLIKNPIEDLITNKAFSFPQAIEEKHKSIFRNTERLIRL
INELMDFRKLQFNKTRLKVEKIAINAFCEQIVSHFEEEAHQRNITLNVTAEREDFYVYAD
PGMLEKIIFNLLSNAFKATPDEGIVSIYLKTTEVPIILPEISTQTPVNAVEIQVQDSGIG
IPKTEINKVFDPFYQVEGMNKQYYGGTGIGLEVVRSFLIMNKGKIEVESEVNLGTTFKIY
LALGNSHFTAEELADTVTILPKLEKPEHQRSFTSMGKEQNKLSSDSSAHNFTLLIVEDNF
ELRKYLKEELKDQYRIIEAVNGQEGLDLASKTIPDVILTDVLMPAMDGVTFCKKLKNDLK
TSHIPVLMLTAKAQTDDWLAGLDAGADVYINKPFNIKIVRSQLKQLIESRQKLFNKYFNE
LSNTKFKSNSTSVDKRFISRVITYIYDNIDDPKLNVENLADELHLSRSQLYRKIKALTGQ
TANEFIRKIRLEKAKELLEQGVASVSEVGYKVGFSTPSYFTRCFKAEFGKLPTEVK
>KECLDBNJ_02515 Endo-1,4-beta-xylanase B
MQNTIQMIKTLLFLILALLTGCVSKPLDDKGLKEIASFPIGGAIEISQVTKDSALRNIII
RNFNSITATSDMKMYAIAPTDSVYNWEKADSLVDFSQRNDLRLFGHTLVWHSGTPRWVFQ
KASQDSVWLSNFLKIYIQDYVGRYKGKVAAWDVVNEGLETQGGAYRETLWYNKLGKEYIA
NAFRYAHEADPDADLFYNDFNLERDTAKLNGVLRMIEELKADEVPITGLGVQMHLRMDIP
EKLIRESVRKMAATGLKIHFSELDIIFNTHDDSRGGGEQIYSVVTSEMLEQQAQKYEIVA
KIYREEVPKEQQFGITFWDFTDRDTWINPFFGLNDWPTIFNKELKPKPAYYGFQKGLAE
>KECLDBNJ_02516 hypothetical protein
MLVLLVYSVPFYAQEYVPVMKVEDRLEAIKDQNVAYQWSEMAILGTANDTDRIAPRPTVT
SRFLALVFVAVFDAWSAFNDAAIPVYMEAYDKFPGDKQTRANKEKAISYAAYHTLREYYP
YDSLQFKKFMLHLGYDPNDDSLDSTTPAGIGNLAAQATIKARYNDGSNQYGEVEGFSKPY
SDYTNYKPVNTVDQLNDYDRWQPKYFTSDTGEKFAPACLTPYWQLVKPIALSSADQFRPG
PPPKVGSKRLQKEVEEVVELQANLTDEQRALIEFMRDGPQSVQQAGHWLKFAQQVSQRDN
HILDEDVKMFFANQVTAMDAFIASWDSKMFYDSARPFALVHHYFKDKEIKGWKGPGLGTG
TINGEDWRPYSPSAFLCPPFPSYTSGHSTISGACAELLKLWTGNDYLDVQVEIMPGALTE
PQALGEPIVLDFPTFTQAAEMAGISRVMGGYHIQSDNIAGLELGRNVAHKVWDFYNYHIG
KNN
>KECLDBNJ_02517 hypothetical protein
MIIRIQIISKILIIGLVAQFICSCAETEKNQTPEFDTDFKVFESLSAETTGISFINALTE
NDSLNYFTYNYIYMGGGVAAGDINNDGLIDLYFTGNQVQNKLYLNKGNLHFEDITIPAGI
AGDERWYTGVTMADVNGDGYLDIYCSVSGKFEPRTNQLFINNQDNTFTESAAEYGLADKG
SSIQATFFDYDKDGDLDMYQANYPPTKFSSPTWVYEQYMRDPSDLQTDHLYENTTNGFVD
VTDKAGLRSYSLSLSATIGDLNNDGWPDIYVSSDFNSPDMMFLNKGDGTFTEVIKEATAQ
TAFYGMGVDIADFNNDGLLDFFQADMDAKINRRKKANMASMNIDLFWSVVDAGFHYQYMH
NCMQMNNGVFNAEGIPDFSNISRITGTSSTDWSWGPLFADFDNDGLKDLFITNGTRREIN
DNDYFNRIEEQGGIAQDSLLFWSQNIPEEKLDNFMFKNKGDYAFEKANDSWNISFNGFSN
GGIYADLDNDGDLELVTNNIDDPASIFKNKSSERSNHLRIKFKGETANAMGIGNRVYLKT
GDLTQMQELTLTRGFQSSVAPVLYFGLDNTETIDEIRVIWTGGKEEVLQNVAVNQELIFD
EKNASESDTSTQKSNENRLFAQADGELFPIYLHTENSYDDFKNQVLLPHKMSEFGPALAV
GDVNNDGLQDYFVGAAKDQTASLFIQNSQGISQKNLAAFTEDKSYEDIDATFFDADGDGD
QDLYVVSGGYEFFKNSNLLNDRLYLNDGKGNFTVAGNALPDLQISGAKVYAEDFDGDGKQ
DLLVLGRQTPGKYPLPASSFLLKNNGTPGNPKFEVAKDLQPKEFKDLGMATAAAVSDFNG
DNRPDIIVVGEWMPIRFFENTTKGFVEVTQMILSNQDTTGWWWSIASGDFDGDGDTDYML
GNNGLNYKYKASEDEPFDMYAGDFDDNENEDIVLGYYNDGKQYPLRGRQCSSQQIPGIKQ
KFKDYASFSEATLGEVYSEKLLNSSLHYQVKSFASIYLENRNGKMVIHELPRAAQLSSVN
GIVVNDFNNDGFLDAVFAGNLYQSEIETPRNDASRGIFLAGDGKGNFKALSAAKSGVFIP
GDVKNLRTFQFGKTSYILAAKNSDYLQVLKLNEADQKN
>KECLDBNJ_02518 SusD-like protein
MKNYKIYALFALVFVMTQSCDESNLELVNPNALSPETFFTNEEQLRSAVNASYAQNQTNA
LYSRLLFYMYDNMGQDNSPNPQQEANKLTYSRFTFDSSNTEIADFWDSCFKGINKANFVI
SNIERINEIPESIMSERLKNKYIAEARFLRGHYYYLLATRFGGVPLFSGLPESSEGIPRA
TRDEVFAQIIEDFRFAAENLFERGEELNGRATKGAALAYLGKALLFQKQYDLAYDAFDDI
VGYDLEDNYFDNFKEETEHGIESLFEIEFDRAIGTANKWDSNVSAQGFNESTFRGQDYGV
LDWFNVYPSLDLLEEYEEGDIRLEENFYFEGDTYNNGEGVIVASDLSTTAGIRPAGWRKY
QNYYRRTAEEQESGINFKVIRYADVLLMKAEAANETSRTPEAITLINRVRERAELNPIAD
NLSQQQVFDAIVHERKVELAGEQVRFDDIIRWGIASTELAGTGFQQGKHELWPIPDREIS
ANDAINQEDQNPGY
>KECLDBNJ_02519 TonB-dependent receptor SusC
MNKIRFIYLTLLILFVGYSGYSQTMTVTGVVKDPTGLPLPGASVAVIGTTKGASTDFDGQ
FAIDGVSASDVLLISYVGFEEQQITVGSQTTFNITLQESAQALEDVVVVAYGSQSRTKVT
GAISTVGSEAVEALPVTNAEQALQGRAPGVTVTNAGAPGTTPNVRIRGLGTFGNNDPLYV
VDGVIVGNLSGISPSDIESYSILKDASTTALYGSLGSNGVVLVTTKKGKSGRGTLSVSAY
SGFQTIYKRYNTLNTEQYLQFANEIGTTIDRPADFLNNYTDFQDAIFESGLIQNYNVAYA
GGNEHGTYRFSANYQDQEGAVINSGFERLAFRANSEYKAGKFKIGETMSVAFSKTKPILE
SGGRSLIEHAIKVAPYLNIYNPNNLGGFQGPNSAADGQDAENPVRVQTLSDFETRNVSVI
GNIYAEYEILDGLSFRSQVGLDFFDGLTNQFTPAYNDDNIGATHFQNFAFALRGSTRGQA
ITFDNSITYNKTFDDVHNLEVLALAERYTSKTENFSAEARNTISNDIKELGSEQQSAGSS
TFENNRLSYLARVNYDYDNRYILSASFRRDASSRFGANNRWGNFPAFSAGWNIAGEEFMS
DSEIGTLKLRGSYGITGSDRIADYRYSTTLFSDFVYPIDGQAAIGTTPNGLANPDLKWEE
TSMLNVGLDFGAFNNQFTASLEYYKNRSDELLVDIQLPLSFGYSSSTFASNAGSVETQGV
ELALGYNDYEGDFTWSVNLNLGTSSNKVLNLGGSSEQFFFDGFEGERIIRAEPGEPLFHF
YGLVTDGIYQNQAEVDAVFTANPEQNVVQPGDIRYIDTNNDGTINSADRQIIGNPYPDLT
YGLNFDARYKNFDFNLFINGVTGNDIYNTNIYDLQGMTRLFNAGVEVLDRWTPTNPSNSI
PRYDGAPQNVVASDRFVEDGSFMRLKNISVGYTFEEGTIDFIQRLRVYLSGQNLITLTNY
SGLDPEVVSRAGEVGFDRGDYPQPVSMLLGLDVSF
>KECLDBNJ_02520 hypothetical protein
MIPFLKSFVFYFFSLLLFGGCIDHAQQTKTFKHTNSLVGETSPYLLKHAHNPVDWQPWND
SIFDQAKLENKLIIISIGYSSCHWCSVMEEETFSDDSIADFMNANFVNVKVDREERPDID
QLYMTALQLMNGSGGWPLNIIVLPNGQPLYGGTYHTKENWLSSLKLIDSLYKKDPINANN
YARQVTARIKELNQYAIRNTLTSNYSPEVFNELISKWQVKWDFYNGGIQGSQKFMLPVNL
NFLLDHGILTKDQNILDFVELTLDQIMSKGVNDHIDGGFYRYSTDKHWITPHFEKMLYDN
AQMVSVYAKAYQYFRKPQYKDVLEQTLNFLTTKLKTQEDVFQSSIDAETDGIEGLYYTIT
DDQIKKYVTVRPDLFMDYFQINNQKRNGSIRFHLYQDQPDSLFIVSHKMELRKLTELKDQ
WRQNILKLRAQNEQPAKDDKIIISWNALTIEAFVDAYLASKNQHYLQQAESTFKTLMRTA
YFNEDLIHSYKKNSSKIRGFLDDYSFMIAACLKLYKATGSQEYAVQALHLTNRVNEIFSS
ADSPFFKYSSSDELIAPIIKTNDDVLPSGNSVMAHNLFILSHLFYQDEFEHQAKKMLEGM
NEHIISEPGSYPLWLSLYQNHVYPYYDIAISGENSENLSFEMINLNIPNSLIVFNNTQNE
VPIFEDRWQPKETLIYICEQRSCKFPVKTISEAKSLMNF
>KECLDBNJ_02521 hypothetical protein
MTTEQQKTKQLYVILIFFFIVTLQGLEANIRLPKLISDGMILQRNTNVAIWGYSDTNTLI
SITFLNSTKTVTTGDKGIWIANFNTPNDPGPYQISITSKDEQIIIKDILLGDVYLCSGQS
NMELPMRRVAPLYQDEIQNANYPNIRYFEVPKEYEFSAPRDTLSGGQWLKLDENSIDEIA
AVSYFFSKEIHQDQNVPVGIINSSLGGSPIESWLSLDDLAPYPLAFEEAKNYQNQEFRDS
IIQSDQNRIQNWYADLNQKDLGIKQNWKLGNIDSTQWNTINIPDYWSNTSLGNKNGVVWF
HKRFKLDNNHKGQKATLNLGRIVDADSVFVNGRFIGNTTYQYPPRIYTIPEDVLESTNTI
IIKVINERGQGGFVDDKQYNLQFADGNEVDLVGAWRYKLGAELHPLRPQTFIRWKASGLY
NAMIHPLIRYRFSGVLWYQGESNVDNADEYDTLIKTLIAKWREDWNDDNLPFFVVQLANY
LQSNDEPTESDWAVMREAQQSVLDLDHTAIAVTIDIGEWNDIHPLNKKDVGHRLALAAKN
IVYKEDVIYQSPRIDSVIVEKDQIQVHFNTFGSNLVIQGEHPRGFAIAGKDRKFYWAKAE
LVKDCVILKSPKVIHPQFIRYAWADNPDTANIFNEEGLPAAPFRNDSD
>KECLDBNJ_02522 Extracellular xylan exo-alpha-(1->2)-glucuronosidase
MTELKQFAENIIIKTKSLSLVTHLILKPMPKFSFLLLLLLFNLGNAQNTRNLWLQYDLVT
DPVVLRTYKEQLNAVDIRSAALNKQVIQDELQTGILSMLGKHLSFTSSNAEVVIAKLKDL
DANEKQQVSKTPKLESDGYIIKTIPKGSKDVILISGLSDNSLLYGTFHFLRLLQLHESLS
DLDLVENPKLSIRILNHWDNLDRTVERGYAGFSIWDWHHLPGLIKKEYIEYARANASIGL
NGTVLNNVNASAYILQDEYLDKVKALADVFRPYGIKVYLTARFSAPIEIGGLDTADPLSS
EVQRWWKDKADEIYNLIPDFGGFLVKANSEGQPGPNNYGRSHVEGANMLADALAPHQGVV
MWRAFVYSDEKPEDRAKQAYTEFIPFDGEFKDNVLLQVKNGPIDFQPREPFHPLFSGMQK
TPLMMEFQITQEYLGGMSHLVFLPQLFEETLQSDTFIKGKNSTVSKVLVGDLSGQKVTGI
AGVSNIGTARNWTGHPFAQANWFGFGRLAWNPDLSAKAIAEEWLKMTFSTDPDFVEPMST
LLLNSREAVVNYMTPLGLHHIMAEGHHQGPGPWVDGLAREDWTSVYYHKADSLGLGFDRT
ASGSDALSQYGTEIEKAYSKIETTPEKYLLWFHHVPWDYKLKNGHSLWYNLARHYQDGVL
KVEDMISTWEQMQPYVDEYVFRQTQMLLNIQLKESKWWRDACLLYFQQFSNMEMPAFIPH
AKHALDYYKSIQRPYAPGIKPSWD
>KECLDBNJ_02523 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MLLALNLRGTNMRKKIALITGGNSGLGFATAKKFCDENIITYIIGRTYDKTEKAQTQLGP
NARSYILDLSELEKIPSAVKQIAEEAGGIDILVNNAGINMKKNFLEVEDQEFQSIIHTNL
TSVFVITREVTKVMKEQNSGSIINISSMAAKYGIPKVVAYTASKAAIEGMTRSMAVDLAP
YGIRVNCVAPGFIKTKMSSKALDSDPERKNKVLNRTPMAKLGDPEDIADTVFYYASNMSK
FTTGTILCVDGGNSIGF
>KECLDBNJ_02524 Mannonate dehydratase
MESFIIKTMRWYGERDLLSLADLKQAGITGIVTALHHIPVGDIWTSEAIKETKDRIEGAG
LVWEVVESLPVHENIKKRTGNFQELIENYKLSIENLAKQGIHTITFNFMPILDWVRTDHR
HLTNTGASVLKFDPIKLRIFDLYILKRPNAELDYSVLQITQAKQSFENYTDKEIVQLKKN
VLLGLPGSTEDFTTQELLMQLEDYKTIDKTKLREHLISFLKAITPTADDVGSKLAIHPDD
PPFSVLGLPRIVSNLTDLEFIFSSIESMACGLCYCTGSLGSHSENQLIEIYDKFKERIHF
LHLRNVKKFEDGTFLEADHLEGDVPMKSIMQCIIDYTSHTGIKIPMRPDHGYLHSLEEHK
NYYAGYSFIGRLKGLAELTGLELGLHDF
>KECLDBNJ_02525 hypothetical protein
MRNTSISFKLNLCFFIIILLSNTIALRGQNIAVYKKFKNQAFRLVDNTNVAKFIIDNQDY
EGVHIAAENLRNDIERVSAVKPEYDQVIKNGGNVIIGTLGKSKYLEELIIADKINLDSIE
NKWEAYTIQQIDGNLVIAGSDKRGTIYGIYTLSELIGVSPWYWWADVPVEQSNKLYITAN
NVINPGPKVQYRGIFINDEAPALSGWVGEKFGSFNHQFYEHVFELILRLKGNYLWPAMWG
RAFYDDDPLNPKLADTYGVVIGTSHHEPLMRAHSEWGKYGNGPWNYTTNAKTLRKFWGEG
IKRMGTNESIVTIGMRGDGDEPMTEGTAIELLETVVKDQRKIIQDITRKPAEETPQIWAL
YKEVQDYYDQGMRVPDDVTLLLADDNWGNIRKLPDPKDFTRTGGYGIYYHFDYVGGPRNY
KWLNTTQIARVYEQMSLAYAYNAKKIWIVNVGDIKPMEFPISFFLDYAWDPENFNLSNLE
SYTINWVKKQFGNAHAVEVAALMQSYSTMVSRRKPELLGPETWSLNHFNEANRVLKEYKN
LELQATAIEKKLSKSYKSAFYQLVLYPIKALANLNRLYIATAKNRQFANQGRNTTNDYAN
KVSELFEMDQTLTDTYHSLNNSKWNHFMDQTHIGYTSWQEPKKNIQPLTEKIEIPQKGNL
GIAIEGTDDYFPKVSTLKLLPFDDNHQTQKVELFNTGLDQREFRIENLPDWLLVDTSRGS
FNQEHTIEIKLNPIKLPLESTSAMFKIGSNGKAAKIEVNYILKDDQLFSNREYNGIIAIP
SDNFQENVGWEEIAHLGRQNSALRPEHKFSEHINYDNTKLVYQMYTGQELQGTITFYVSP
TLDFKNQGGLVFKYQIDNGPIKHVNIHKDTKDDWGTSVSNNATRVQASIHLSQGAHSLKI
IGEDPGIVLQQILIQSNENLQESYLVPNAANLIEE
>KECLDBNJ_02526 Sensor histidine kinase TodS
MVNYIKTFILFQLIFTSLSYGQNGKIFSADSELSSSLINAIFQDQKGYVWIATEDGLNKY
DGAKFVTYKHSEKDSTSILNNYVKSIYEDKEHNLYFGFFNGLQIYDHGRDSFQQIHLSID
ESYTYDAHVTKIIQRNSGEILIGTSGRGVFSLKRKSQSFYTEHLPDFVPTAFINDIYQDK
NGHLWVLTPESGLYRINAKNKASAFFQNAELRSTLSAVVQDDEGTIYVGSYTKGLFKYDT
QTSTFRSIPNTQKYVIHSLFINSRGELLVGTDGDGLYIYNPKEEVLAPYQITIARFDASK
SKVHEIIEDNSHNIWLGLYQKGVVIIPEKKNNFNYIGYESNTLDIIGSNCVMSVFKDSEG
ILWVGTDGDGLYSIGPDQTVLKHYKNEKSSGKQLNTVVSIFEDSNHNLWIGTYLNGLAKI
DRKSLKMSFLNKLVDEQNNPVKSIYSIVEDSNKNLWLGSMGSGLFKLHLPSENIKSCNIQ
ISDAPKGPTFFNNKWINKLLLDASEEWLYVASYDGISRYNLKQEKFQSFPQGIRHFGGEI
VYTIHSDNDDHLWMGTANGLIKIDTDFKQLAKYTINNGLPSNTIYSIEETPRRQLWIATN
HGLSEFIPESESFLNYYFNDGLQGNEFSKNASFLYAGNELYFGGMNGITYFNPSEIIDDD
TKPKILITDVYLQNTPIRQGMVSGNYNILNKPIIEADSINLSYQDNSFSLEFSSLEYRNP
KRISYSYAVNEGPWIDLSPGVNSIAFENLEAGTYNFELRSKDYDKYSSIKAFTVIIHPLW
YLSKIAKIIYILLILFFILLISYHLRQRHNNQKRLQEYSKVRLINEAKLQFLTNISHDIR
TPLTLIINPLKKLLSTDTNPLRSKSYQIMMRNTDRILHLTNQLLDVRKIDKGQLELKFEE
IELISYIESICALFEDQIEAKEIKFNFKHSNDVLHAWVDPNYFDKIIQNLVANSLKFVPK
GGAVTLVLEQLDPQTQAYDRPYFQISVIDNGIGIEPGMEQLIFERFYQDKSTPYHIEGTG
IGLNLTRSIAELHHGTIYAQNNANGKGCTFIIRIPLGCEHLTAQDLNIASHDETSLSHNS
GKNQIENRANEIDLSSSGRQILVVDDDLEIRNYIKKEFSPKFNVTLAGNGREALELILKK
NFNLVISDIMMPEMDGLELCRRIKKNININHIPIILLTAKSTPERNMESLNLGADAYIPK
PFDITILQKTALNLIQNRKLLKNTFDGSQLQKDKVKQVALESSDEILLKKIISFINENLS
NSDLNVEMIANAVGISRVHLYRKLKDLTNQSASDLIKNIRLQQAADLLKSKQISVSEVAY
AVGFSNLSTFSTNFKNLHGESPKKFQDKHLK
>KECLDBNJ_02527 Multidomain esterase
MQYFNNLIATLILIILFPFCLLAQDKAVVRDSINTYSNLDFKHMKAQLGITTENRPGPSG
NPKDPNAANTDELKVHNYNLPELLLSSSGQRILTEKQWEQERRMELLQSIETEMYGTIPK
HIPKVSWSILTSKDTLIGNILVEEQHLLGVVDNAQYPELSVEIEVLLGIPKTQDTIATPV
VIQLGFIHSPFYRIQEPKSYFISPFEPLFKQQLTTQGWGYAVVDVNSIQADHGAGLLSGI
IGLINRGKRRSSTDWGVLRAWGWGVSSLIDYFETRSAVDHNRIAVEGTSRYGKAALVAMA
FDTRISLGFIGSAGAGGSSILRRNFGETLENLASPGEYHWFSGNFLKYASIMTVNDLPFD
AHSVIALCAPRPVFISAGSSNIEGHWVDAKGMFLGGKFASPVYELYGLQGYANEEFPVMG
KAITDGEIAFRQHSGGHSTGPNWSTWIAWARKYWDK
>KECLDBNJ_02528 Xylosidase/arabinosidase
MKEPRYLVDHAYMADPSAHVFNDKIYIYPSHDVESGIPENDNGDHFDMRDYHVFSMDSID
GEVTDHGEVLHVKDIPWAGRQLWDCDIACKDGKYYLYFPLKDQTDIFRIGVAIGDKPEGP
FKPLEAPMKGSFSIDPCLFKDDDNTHYMYFGGLWGGQLQRYRDGKAIECGAEPEDQEPAL
PPRIAKLSDNMLEFAEVSKSIMILDDDGKPLTAGDHDRRFFEASWMHKYNNTYYFSYSTG
NTHKLCYATGDNPYGPFTYRGVILTPVVGWTTHHSIIEFKNKWYIFYHDSVPSGGKTWLR
SMKVIEFSYNSDGSITTLQGTK
>KECLDBNJ_02529 Xylosidase/arabinosidase
MIITYTKTCGFLPEMKCNLAFLGALIWGFQAIWAQNPLIRDQYTADPTARVFNNKLYVYP
SHDIMCTEDKGEPGWFCMEDYHVFSSKDLTIWKDHGEILHQKDVPWAYDEGYSMWAPDCV
EKDGKYYFYFPTKHKDTEGFTIGVAVGNHPEGPFTPQKKPIANVNGIDPNVFIDHDGQAY
IYWSGRDIWVAKLKPNMLELASEPSIIANLPKEGHLEGPFMFERSGKYYLTYPHVENKTE
RLEYAIGDSPMGPFKVTGVIMDESPTGCWTNHHSIVDYNDQWYLFYHHNDLSPDFDKNRS
IRADSLSFNTDGLINKVIPTLRGIGVNKASEELQFDRYSAKSADAELHFNNSQNTFQGWN
IALKQNDWVQYNSVEFDETYASLTIRVNASLKSQLEIVDASKNTILAAIEIPANTGWLEY
KAALPQIANAVYDLRLVLKAGQASIDWIRFMD
>KECLDBNJ_02530 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MDISNNTYHIKIWLLGICLCALQGVAQNTASNPLIYADVPDMAIIRVDSTYYMSSTTMHM
SPGVPIMKSNNLTNWKLIGYAYDRLVDNDAMNLENGQQTYGKGSWASSLRFHKGTYYLST
FSATSGKTHIYTTRDIENGPWEKHEFAPSYHDHTLFFEDGKIYMIWGAGEISIVELEDDL
SGVKEDTQQVLIENATKPIGASVLLPAEGSQLFKHKGKFYLFNIAWPRNGMRTVIIHRAD
RITGPYEGRIALQDKGVAQGGLIDTPSGDWYAYLFQDSGAVGRIPYLVPVKWVNDWPVLG
KNGKVPKELNLPKNESLIPGIVNSDQFERKSGDAMLPLVWQFNHNPNNNLWSVSERPGYL
RLKTGRIDTLFTQAKNTLTQRTIGPESSGTIKVDVANMRSGDFAGLAILQQKFGQIGVSF
EGSKKYIFIRKNEGDGTFISKIELKQDVVYFKIRCDFKKRTDKAYFYYSLDGKNWQSIGG
VLQMQYTLPHFMGYRFGLFNYATENVGGYVDFDYFKISDKPSY
>KECLDBNJ_02531 Endo-1,4-beta-xylanase A
MNYLSSLILIAILLVNCKSDKSEDVAQLNEKPLKLKEALADKFLIGTALNARQIAGYHPE
ELAVVRENFNSIVAENCMKSERLVANQDVYDFTTSDKFVNFGIENNMVVHGHTLIWHSQT
PKWFFKDSLDQEITREELIQRMKNHIHTVVTRYKGKIKTWDVVNEAVLDDGTLRKSKFYN
LLGEDFIKMAFEFAHEADPEAELYYNDYSTAVPEKREGIVRMVKKLQEQGVPIHGIGMQG
HVGMDYPELEEFEKSITAFANLGLKVSITEFDITVLPSPWKNQGAEVSANFQYKEAMNPY
PEKLPDTVSNALNQRYLEFFKLFLKHHKKIDKVTLWGVNDGNSWRNDWPVAGRTDYPLLF
DRDNKPKSVVDSIIAIAKK
>KECLDBNJ_02532 Inner membrane symporter YicJ
MKPNHNTISIVEKIGYSLGDLAANLIFQTLMTFLAFFYTDVYKIPPSKASFIIFTGGMIG
AFFNPVMGIIADRTKTRWGKFRPWILFTSIPFGIVAILAFSTPDFDLTGKVTYALITYIL
LVIIYSANNLPYASLSGVMTGNMSERNSISSYRFVAVMIAQFVVQVLLLPLVLILGDGDK
VEGFKQTIWLFAIVGVIFFIITFLTTRERVLPKAERDSSIKQDVKDLLKNKPWRAVLLIT
IFVFVTLSLKGGMYVYYFNDFVDNASLSTFLENIGFNGFILNLNKWLINMGFVGFTWPDD
PATSGFSLFNAGGIVMMMIGIGFSKTLADKFGKRDVFGLSLFLSAICLVAFFFYAEDAIA
LIFITQLTHGFFYGISTPLLWAMIADVADYSELINFRRATAIIFSAMIFGLKAGLSIGGA
LVAGLLAWYGYNEQAELQDALTISGIKLSVSIYPALFFFISVTCLIFYKINKAKELEIQE
ELSNRREPSPKRL
>KECLDBNJ_02533 Endo-beta-1,4-xylanase Xyn10C
METFYLKRLLLIVPILSVFSCVDLDPLEYQVEKPLSIEQQEELDQLEPLKEYIGESSLKL
GAGVSISSYNSQGTVFSLSNSNFQELTAGYGMKHGAVVNDNGELNLDEVSQFVNHAKEAG
LSIYGHTLAWHSNQNATFLNSTIAPTILPAQSNPEWETILSIDFESDDQSGYQSNGPNAA
LAFTSDGAGFNGEGRALTITNAEVRPNEWDSQLFVTFPEATEVGQVFRLEMDIKSDVDTS
INTQAHTAPGSYKHYDFFGTLTANPTWKHISIDVTINENTSGCNTIAFNLGTTAATYQFD
NIEVSKYNENGNGPDWEDLLDQPFETDAQNGYQSNGPNAVLSFTAMGEGAEDSGRALEIT
NAEVRPNEWESQLFVTFPKVTEVGQKFKLEMDVRADAVAAINTQAQTAPGAYKHYNFFGT
INATTQWKHINTEVTINESTAGCNTIAFNLGLTATTYYFDNLKVSWFNEEAGQDIIIEMS
EEEKKDTLSFHLDKWISGIMEVSKSNTFAWDVVNEPMDDGNPYELKSGIGKSEMAADEFY
WQDYLGKDYAVEAFNLAAKYGNADDILFINDYNLEYNIDKCKGIIAYVNYIEEQGARVDG
IGTQMHINIDSDRSKIIEMFKLLAATGKQIKISELDIGIGVQTKDATEELYLAQADMYHF
VISEYFKLIPQNQQYGITIWSPTDSPSNSSWRAGEPIGLWTESFTRKLAYKGVVEALQSK
EIN
>KECLDBNJ_02534 hypothetical protein
MQTYKHTIMRIYFNLLLILLICCYSSCENGEWEFPDYEYQAVYFAYQYPVRTITLGEDIF
DTTLDNQGKCEIRATVGGVYENQNDIAIGFQVDNSLVEGFLFGEGENPILPLPTTHYSLA
TDKIVIPAGELSGGVEVQLTDSFFNDPKALERNYVIPIRMLSATPVDSILSGEAQVTDPR
RGNALDWAVQPKDFIFYAIKYINPWEGYYLRRGQDIITGRNGNSEADQTIIRRESNVIDD
EVVMLDSKSRYQISFDTGIQNKEGVDLGISLLVTLQDDGTATISSPNPTEYSISGSGSFI
KDGEKNSWGSQDRDALYLTYEVETEELSVSTKDTLVMRNRGVSLETFSPILQ
>KECLDBNJ_02535 hypothetical protein
MNTKILLLLIVACIATSCDDLFEPAIENNRGLEDAYGEATYAEGLLLNGYIRIPTMNWSF
NDVATDDAVSNDITNDFRQAATGQWASNFNPFTQWQGSRSAIQYLNIFLSEADNVEWSTD
NDINVLYNRRLKGEAYGLRGLHMYYLLQAHAGLAEGELLGVPIILDPEDPESDFNIPRST
FRNCMIQLLSDLERADEMLALDFEDINDPSLLPSGIDNINDYNRVFGERGRQRMSGRIVK
ALKAQAALLAASPAFGAYSGISWEQAANYAGEVVSLNGGISGIAPNGHTWYTNASQINQL
GGGSNPPEILWRGDVGQSNNLEMDHFPPSLNGAGRLNPTQNLVDAFPDSNGYPISNPLSN
FDPNAPYENRDPRLRTYILVNQGTAGVNNATITTAADGNSIDAINREATSTRTGYYMKKL
LRQDVNLDPVTTNTQLHYKPRIRYTELYLIYAEAANEAWGPRGTGTQDFSAYDVIAELRQ
RAGISQPDLYLESIGSDKVAMRELIRNERRLELCFEGFRFWDLRRWNLNLSQTAMGVSIE
DNNFDYINVENRAYQDYMQYGPVPYSELLKFEALQQNEGW
>KECLDBNJ_02536 TonB-dependent receptor SusC
MKYAQSNIVLLALAILSCLTLTAQSTNSVLVEARVLNDQGTPIQDALVEVDDTELFSVTD
EEGRFSIQMNDTSVLEISATGYQEVTLSGLEDQEDVILISNLDSKVQVAYREVDKDELIA
GGISHINLEQLIEKNYTTYSLENLNGFIGGFNGGNIWGMSNYLVLVDGVPRSANSALPIE
IEQISFLKGVSAVSLYGSRAAQGVINITTKRGQIGKQRIDVRVNAGLFVPKRYPKYLGSA
EYMTLYNEARANDGLAQLYSDETIYNYGSNTNSYRYPNVNYYSDAYLKKVNQRYDATLQI
SGGNESAKYYTDIGFLRIGDFVNFGQARQNKTERFNVRGNVDLKINDWIKASLGANAIYY
SGRGVNANYWESAATVRPNRFAPLIPVDRIPADNQAAQLLVDNSSNLIDGRFLLGGTQLD
QTNAFASIYAGGYNTYTSREFQFNTAIDADLNRALKGLTFRTMFGVDYATSYNQSYNNQY
AVYQASWNTMNGVDEIGGLTKYGQDATDGIQNINNSAYQQTIAFSSQLNYSADIDQNQHF
SAMLVAGGWQQTQSGAYHRISNVNLGLQLAYDYKNKYYLLFNEAAIHSARLAKGNRTGYS
PTATLAWKIDKEPFLENSTLIDDLQLSVTAGIVSTDLGINDYYLYENVYTQTDGAWYSWR
DGALTRTTDSRQGGNKGLTFAKRKEFNVELKGSLFEKSFDFQTAFFRNRMKGNIIQASIL
YPNYFQNFYPNSSFIPYINYENDDRVGFDFDFTYHHRSGSVNWSLGVAGIYYDTQASKRA
EMFEDAYQYREGLPLDGLWGLRSDGLFDNEEEIANAPSQDALGNVAPGDIKYIDQNNDGV
INAQDEVYLGKAGWNGAPLSAGIHLSATWKNLTLFALATGQTGAYAMKNSSYFWIDGEDK
YSIITRDRWTPETADTATFPRLTTQNSANNYRSSDYWIYKTDRIDLAKIQLSYELPQNVL
GDSLFKNLNIYISGANLLTISPERELLELNIGGAPQTRFYNLGLKALF
>KECLDBNJ_02537 hypothetical protein
MNINTHGIMRILIMIVAVLSLCSCEDYLDKEPASIISEEEAFKNFTNFQGFTEELYHCIP
DFSNAYWTNSWNWGDDEITSADMNFHVIHKFDNGNFWGWQTEYDGWGASWMNQADASRND
DRFQKDLWKNAWYGLRKVNLGLENLELMTDATSQERDFIKGQLLFFRGWFHFQLIQYFGG
MPYIDYVLPSDEPLELPRLSYHECADKVGADLREAANLLPIDWDDTQAGAATREKNDLRI
NKIMALGYLGKNYLWASSPLMNLESTGSKSYNADYAKKAAAAFGELLDLCESGAAPYELV
AFENYSVNFYTTGQGWRIPGGSEAIFRGPYYGANGSNWGTSKQYQPAIIQDGSNFMPTAN
YVSYYGMANGLPIADITKPDPISGYDPEYPWKDRDPRFYHDIIFDGVKVVQGAMPDDVEQ
HRFANLYTGGSYRDVSTGSRSGFLNYKFIPITANRYDDGFNYGNNLNLHLPWMRLADVYL
MYAEAVVQGYGSPNAKSNNFSKTAVDAVNTIRNRAGAGELSESEGGYISSIDGFMSELRR
ERAVELSFEGHRFNDLRRWMLLIEKPYTLKTSLEFDRSGTLNTEDPTENRVLNLREELIL
ERNYSSKHYWLPLKNADTNMYVEFPQNPGW
>KECLDBNJ_02538 TonB-dependent receptor SusC
MKIKFSKSDYAFKSALFGVISQIIISGPLLGKESTLLNPLEYSIQQQTTISGTVLSETDG
LPIPGVNVLVKGVSGMGTVTDFDGNFTLNVPSSESVLVFSFVGFQTIERRVGTNTSFTIQ
LKTDETSLEEVVVIGYGQQKKESVVAAIAQASGEDLERAGNVPNVGSALAGNVPGVITTA
STGLPGAEDPRIYIRGQSTWNDSSPLVLVDGIERPMNTVAISSVESISVLKDASATAVYG
VRGANGVILITTKRGKSGKAVIRARLNSSVKTASKLPGKKDAYDTFLVRNQAIENELSLR
PESWGFYQPQNIIDKYRFPANLEESERYPNVDWDKALFRDFAPSYNANLNISGGSDFVKY
FAGADFQYEGDLIREYDNGRGYQPGFGFNRLNVRTNLDFQLTNTTTLKVGLSGSYGVRKT
PWNFGGGDYVYWIAAYTTPPDIYLPQYSDGSWGYNAPSGGGQGNAIRNLAISGVQYLTNT
QLQTNFTLEQDLDMLIDGLSFNGTIALDNTFVEANRGINDLYNDPQEKYIDPDTGIVTYR
QTYDANTGFDYQQGVKWSAQDGAVNNGAAYRRLFYQTQLNYTKNIAQKHDITAMGLFNRN
EFATGSVLPFYREDWVFRATYGYDNRYLLEYNGAYNGSERFAAGNRFAFFQSGGLGWNIS
NEAFMEDINFVNNLKLRASYGEIGDDNINGRYLYLTQWSYGGQSRLGVTGEQAEASPYVW
YVESAVGNPEISWEKVKKSNIGLDFGFLNGKISGSFDLFRDQRVDVLISGDQRAIPEYYG
TTAPVANLGEVENKGYEIVLNLKQDFGTDWRLWAELNMTHAENKVIEGDNPQLLPEYQKN
NNKAIGQAYSYVDNGFYNTWDELYATTQFNTDDAQKLPGGYQIIDFNADGVIDGFDNIPY
GFSGAPQNTYNATVGFQWKGLSGFVQFFGVNNVTRQVVFNSFGNQNNIVYDEGSYWNLNN
TNADAPVPRYVSTPNGASDGSRFFYDGSYVRLKNAEIAYTLDENSKLLKGLGFESLRLFV
NGNNLYVWTKMPDDRESNFAGTGWASQGAYPTLKRFNLGLNITF
>KECLDBNJ_02539 Xylose isomerase
MSTYFKNIDPIKFEGKESDNPLAFKYYDENKVVAGKTLKEHMRFAMAYWHTLNNKGGDPF
GAPTETFAWDANPDPIVRAKDKMDAAFEFMTKLGLPYYCFHDVDLVDEAPSLGEFEKRIA
AIVDYAKTKQQESGIKLLWGTSNLFSNPRYMNGAATNPNFDVVAYAGAQLKIAIDATLAL
GGENYVFWGGREGYMSLLNTDMKREQDHLAQFLTIARDYARKQGFKGNFLIEPKPMEPTK
HQYDFDAATSLGFINKYGLQDDFKLNLEVNHATLASHTFEHELQVAVDAGMLGSIDANRG
DYQNGWDTDQFPIDVYEATQAMLVILEGSGIQGGGINFDAKVRRNSTDLEDKFIAHIAGM
DTFARGLIAADHVLQHTSYKELRKNRYASFDQGNGAKFESGALSLEALSTLGHQTGEPKP
YSGKQELFEQLIANAF
>KECLDBNJ_02540 Xylulose kinase
MYFLGIDLGSSSIKLAVLDANTGKSVVGCTVPEHEMIMDTPQSGWAEQEPEQWWNYTCRG
IQEIERKGFDLKQIKAIGISYQMHGLVLTDKDLNVLRPSIIWCDSRAAPIGEQYYQEKGA
AFFQDRVLQSPGNFTAAKLKWVQQHEPELFDQVAHMMLPGDYLAAKFSGVAQTSKSGLSE
AALWDFKKNNLAEEVLNALDLPRAVIPEVVANFSHQATIAPQIAECLGLSKDVAITYRAG
DQPNNALALNVNQPGEIATTAGTSAVIYSVTDQDAFDTENRINTFLHVNNTETQKRNGVL
LCINGSGILYQWLRKILSTGKDELLSYDFLNAQAAQAGPGSAGLNFYPFGNGVERIFNNK
KSFSGLQNLDFNRHGATHMVRAACEGIVYAMNYGFEVMQHIGADGHSVKATKANLFLSPV
FREIFVNTTQTTLALYKTNGAEGAARGAAHGYGFYTSLDEAAHGLELLSTQEPQPELKQQ
YTDLYQTWKNNIQIIE
>KECLDBNJ_02541 hypothetical protein
MTTTEASKTTSHSAPILDSITIDCVIFGFNQGSLEVLLVKHADGISKDKWGLPGGWIYTD
ESTDDAANRLLLALTGIKDIYLEQLRAFSAPDRFPVSRVITIGYYALLKREDWVGLKPGA
TASEVAWFKVSEVETLIYDHLHILEIGLKRLRRRIKQEPIGFNMLPEKFTLLQLMHLYEE
ILGYEMDKPNFRRKILRMNLLTALDEKQKDVSHRAAKLYRFNPEVYQKLQQKGFNFEF
>KECLDBNJ_02542 hypothetical protein
MYLCNYVGHNKIKKKMFDKNDIVKNLTLINSLKNLIYEKNINATYENNFTGRHFELNIFR
LGTSN
>KECLDBNJ_02543 TonB-dependent receptor SusC
MKTLLQLRMLKQITLVVLALLGTTTIMASPALGEVFDNYDQKTISGVVYDTESGETLPGV
SVSIKGTTTGTITDFDGSFQLQVEPGAVLVFSYVGYMKQEVPVGDQTSLTVNMETDVQSL
EEVAIIGYGKVKRSNLTGSVSTVSSEVLEQTNKVDAVSSIQGQVAGVTVQRTDNKPGAGG
FNIRVRGANTINTGAGNGGYSPGQNPLFVVDGIFVDDISFLNPADIERMDVLKDAASAAI
YGSRGTNGVVIIQTKKGKEGKMTVRYNNYIGFKEIYNLPPVFNGQTYIPFLRDVVVGNQF
ASNTDGNFSQYSAEAVNINDYLSEEERENIANGVSTDWVDLITRNGFQQNHTLDISGGND
KTVYAAGLGYTEDQGTIYGEDFNRYTLKGNIQSDLTDWLTFGYDNYVTLATTNEGSLEAF
RSAYRLKPIGRAYDDNGDLLFLPTQKETQVSNPIFDTQNWKLENKYINFIGNISLSVKPV
EGLSITTKFAPNVKYTRVGEYRGLLTKSTIGNQSNTRAEVNNFLDYSYTWDNIVDYSLDI
NKDNSLAATLVYSRFLQDNESYGIQVRNFTSDNFLFYNLGAGSNVNSYGSGFSRQTLESY
TARLNYNLMDRYILTLTGRYDGASVLSDDNKWAFFPSASFAYRVIREDFMRNQKVFSDLK
LRLSYGQTGNNGIGGGLNPLGTLSLLESSYTNIGDASVPTLYVNGLANQDLSWERTSEVN
FGLDFGFLNNRLTGSVDIYNRDIKDIIFYRPLPNVTGFGGTFDNIGESRNRGIEVGLNAK
IFDGENFKWSTNLNFASNRNEIVNLYGNSDEIIFGAQGGTFIHRVGEPTGSLYGFKFDGI
WQLDEAAEAATYGQKPGQVRVVDVNGDGQITEQGDRVILGNPLPKWTGGFTSTMNYKNFD
FSFFVYTSQGVTISSNFHNARAFSYDGEPARLWNGYDTDYWTPTNPTNNWFQPGNGGPYQ
QAIKNMDVSFVKVGFMTLGYALPQETIRKFGIQKLRLYTTVQNPFTFSEYDGWDPENAGR
NTYGASFMARTYMAGINFTF
>KECLDBNJ_02544 SusD-like protein
MKKSIYTSALALLLTGTLVTGCDDFLEETNRQAISIPSSRENSESFVQLVNYIYEITREN
TTHYQPDMLYVLEDLGTDIVTRASPLTGTDAINDYVDLNASNYVLQVYWSNQYKQIAAAN
TLLANADLIEGVEESLKNRGVGEAKFFRAWSYFNLVENYGGVPIVTEPITTAQSDFLRDE
EQEVYELIVSDLNDAINAVDENPEEFGRVSKDAARHLLSKVLLTRGYKSFAASDDYTRAI
ALAETVIDNHPLEPTFADVVDIENQRNDEVVFSFLFGTETSSLGWGNTKHLLYKFEYFNY
PGLARGSLYQNGIARMPTPFFFNMFDEEDTRNDETLRYVIYADVAEDGIEVGDTAIYFPK
TAWSQERIDSKPYAVINADQYLVNDGVTNTHWPMFKKFDDPGAPFTYANERAFGDRDMVI
MRGAEAYLIAAEAALQNNNPGAAATYLNAVRSRAGITTPLTAGDVDLALILNERARELIG
EVNRWMDLKRTGTLISRVLEYNPHAALNNAIAEKHLLRPIPQSEIDASGQTISQNPGY
>KECLDBNJ_02545 HTH-type transcriptional regulator LutR
MNVLSFQCFYQKFATNYHIAMSSKIKPIKSVSLVEQVEQRILEFLKENRFKSGDSLPGEI
ELAENLGVSRNIVRESLSRLRMLGVVESKKRKGMFIAEPDILSGIERIMDPDLLGEEAMQ
HIFELRLVLEVGMSELLFIRKNDSDVDNLQEIVDREANDPLCKTDLQTRLAHEIEFHSYL
YKMSGNGTLNRFQSMLLPVFHYMMQQESKSAAQPKRGSISHNDLVETLRSGTAYEFRENM
RNHLTPHFSKLS
>KECLDBNJ_02546 Polygalacturonase
MNITNIHEFGAVNDNFTNNAVSIQKAIDSCAANGGGKVVIPAGKPFLSGPFELKSNIELH
LEQGAVLKAFPDESVYVKSAFRQNLGEGTIWIGGENLSQISITGGGTIDGNGIFFMGDEL
HDSYELKPFETIDPRPHILTLVSCKNVKMHGITVSNAAYWALHFLGCYDVSIANISIYND
LKVRNSDGIDLDHCQNVRISNCHIESGDDCICLKNRREYEELGPCKNIVISNCTLISTSC
AIKIGSENMDAISHVTFNNCIITGSCRGIGIQNRDEGTVSDIIFSNIMVECKQFSDVWWG
MAEPIYITAYPRASHDHKDAGWRLKPGAAEAGIGKVSNITFANIRCKSENGIFLGAASPD
LLDNIRFNDIDLEISKTTEYPGGYYDCRPCKDADFIGDQTAGFYMVNASNVYISNTTVNW
GTQIPDYYGNAVYAENITPLVLDNFNGSAAFDHLESIVKQGQTQLEKISN
>KECLDBNJ_02547 Osmoregulated proline transporter OpuE
MILGLSYLDIIVLALYFGVIVYIGIRSSLKIKKEEDYFLGGRKFGKLFSTFASFGQATSA
DGPAGVATTSFKNGASGIWSSLLMLFATPLFWITAPWLRRLRITTMGDFYEERYASRKMA
ATYALVGTIGMMGLLSVGYKAVTTTALAMTGKPETALTPTEKIEKEKADRLFELSNENFT
YLSQAEKQELTELRQENPRALFSYFSEDLLIWTICFIVLFYTALGGLEAAFYTDLLQGIF
IILLSIILIPFAWQAINQQFGGSGMMQALTNLHEQLPESTFEVFGSPATLDFTWYFIIMA
ALVSGMTVVAQPNQLVTAGAAKSEDAARTGFVTGTFMKRIVTILWGMVGLCAILLYGGKI
MNSDFVWGHATTQLLAPLGLGLVGLMLASLMAALMSTADCLMITVSGLIVNNFYKYFYPE
RSARHYIWAGRISGAIFLIGAAVITTQFDTILQILKFIWEFFVVFVAAFWLGLKWRRANR
IAAWCSILLTLLLFYLIPMILPVVFPAMRTDESLAKLTESLIVTRNYDVKEVDLENRKHD
IAQWEKLPQSEKEQIKKPEALTLGGTNAVDYAMPQQAIFWSKGVSVNRADERYGRGYIYL
ELYLLDRLGWDLSRNPYALNETIRLGIRLLFPFLALIFIALATKPDPDEHLMFFYQKMRT
RAIDNSTLKNQPVTERLLFPNSNWELYTWNRKDSAGFLLACLVVILIIGLLYLMVSLGS
>KECLDBNJ_02548 hypothetical protein
MKDSNQNAQPLGSLDEWEDDVVRRYPEEAHKAKEEFRNYEAPARDTVKEFYRINHINQTY
DFVLEKKNDFLKFNRREMSLWDAVEFLNTLVDDSDPDIDLDQTQHLLQTSEAIRADGHPD
WFVLTGFLHDLGKVLCLFGEPQWAVVGDTFPVGCAYSDKIVYPEFFKQNPDYTNERLNTK
YGVYKPNCGLDNVHMSWGHDEYLYHIMKDYLPEPALYMIRYHSFYSQHREGAYDHLMSKH
DHEMFKWVEKFNPYDLYSKAPTPPNVKELRPYYEDLAAKFLPDTLKF
>KECLDBNJ_02549 hypothetical protein
MILKPKYKSVLKLACCLFLIAGLNSCKKEKEPEIQTQEGTPYTSLLKRVVPEYADQFSID
SLPGAGDQTFEIAAQDGKISLRGNNGVAIASALYYYIKEYAHGQITWNGTNLNFPDTLPL
PEQSVRKESPYEYRYYLNYCTFNYSMSWWDWERWEKEIDWMALHGINMPLAITGEEYIWD
EVYKSYGFTDEDLNDFFSGPSYFSWFWMGNLDGWGGPLPQSWKESHRDLQKKILQRSREL
GMKPVLPAFTGHVPASFKKFFPDANLKKTNWGNDFGDTYILDAGDPLFAEIGKRFLEKQE
EVFGTDHLYTADTFNENEPPSDDPQYLGELSEKIFEGMKAADPEATWVMQGWLFYSHKDF
WKTPQIKGLLSTVPDDRMIILDLATEIEPVWKQTEAFYGKQWIWNMLHNFGGNISMFGRI
ETVAQEPAKALSDSTSGNLKGIGLTMEAIEQNPVLYELMTDNTWRDTPIELKPWLKHYTR
NRYGAVNDSITKAWDILVETAYNGTTIRDGAESIIAARPTFEGYRRWARTKMNYDPLDLL
PAWDLFVGASDTFKNADGFEYDLVDLTRQVLANYGLPVQQQMAIAYRNNDQEAFKKHSEE
LLTLISDLDQLLATRKDFLLGPWIADARSWGTTPEEKALYERNARDLITLWGGPDNPLHE
YSCRQWSGVLNDFYKPRWQQFITDVQADWGNFDQEAFDEKIKQWEWEWVNKEESYPTEPS
GDAYQIAKALYTKYRSKITPITKIMPPIDYNY
>KECLDBNJ_02550 hypothetical protein
MTVKTSERFLSLDVFRGLTIALMILVNTPGTGAEMYPYLVHAQWFGFTLADLVFPSFLFA
VGNAMSFSMRRFQEASPADFWKKVLKRTAIIFLLGFLMYWFPFFEYNDGQLQLSPFSETR
VMGVLQRIALCYFFGAVMVRYFSVKAIFIACIAMLLAYWGILYAFGEPGAELEMATNAAA
KFDFAILGEGHIYKKDAIPFDPEGILSTLPSIVNVLAGYLAGVFIRRKGKTYETIAKLML
AGFIIFALAEWWGLIFPISKKLWTSPFAMLTIGLNLSMLAALIFAVELKNIKFGSDFFNT
FGKNPLVIYLFSELFYITLRLIPVNENQDAFERVSEEIFQRIFPGSFGALMTAIVFMLLC
WALGYWMDKKKIYVKI
>KECLDBNJ_02551 Beta-galactosidase
MKVIASLYFILLFCLTGLAQEVNEWENPLVYERNKLEPHTDFIAYSNKTDARADVFSTSP
FYQSLNGIWKFHFVKKPEDRPLDFYKTDFDDSDWDSIPVPSNWELEGFGIPIYTNIDYPF
PKNPPFVDNSYNPVGTYRRSFTIPETWDDQEVILNLSSVSGYARVFVNGKEAGMTKVAKS
PSEFDITPFLQEGSNQLAIQVCRWHDGSYLEDQDFWRLSGLEQDVFLYALPKTSIWDFFL
KADLKNNYKDGVFNASVNLKNFDNAAQSGSLQLEIIPAYASKAVYSATKKFTTTKTPVNF
HTTIKNVQTWSAETPNLYDVVLTLKDASGKTLMLTSEQIGFRAIELKNAQLLVNGMPVLI
KGVNLHIHDDVKGHVPSREVMLKDLKLMKQNNINAVRTSHYPQNPLWFKLCDQYGMYLVD
EANIESHGMGANVHAVKNKDQHPAYQPEWFPSQMDRIQRLVERDKNHPSVIVWSLGNECG
NGIFFPQAYDWVKERDDSRLVQFEQANEERNTDVVCPMYPSIDHMKEYAAATDKYRPYIM
CEYAHAMGNSSGNFKEYWDIIRSSDQMQGGFIWDWVDQGIKTEDDMGTYWAYGGDLGGLD
FQNDENFCANGLVSSNRTPHPALEEVKMVYQNVQFDFDEESKKLSVFNEFDFTNLKEYQF
QWALVENGKVIEVEDFSLAIAPQTLGTAKIKLPKRQADAEYLLNVYAFTKTATALVPAGH
EIAKAQFSLNPPVFISASTAGKLEVKQTENQLIFETSETRGTFDLKKGVFTSYSSDSVTL
DALPQPYFWRAPTDNDFGNKMPEELNIWRSAHSNVTLQDVKVEKQTEEGLPIQVIYHLND
INLPYTLAYVIQNVGSIRVTARLDLKAKKLPELPRFGMRMQLPAGFDNLEYYGRGPEENY
ADRNSAAFIGIYKAQVDSLKMPYIRPQEYGYHTDTRWLKLTDASGNGIEVEGLQPLSFSA
LPIKTEALDPGETKKNQHPTNLRYRDETTLHIDLAQRGLGGDNSWGEYPHSEYRLTNDDY
SYSYILKLINPEP
>KECLDBNJ_02552 hypothetical protein
MRNTIFRSSYLALLILLIISSCKKEETQNPELAKSEIPELWYDAPAREWVEALPLGNGKI
GAMVFGRVSDELIQLNESSLYSGGPVPQSINPDTSKYLEPLREAIFAKDYEQATLLAKKM
QGYYTQSYMPMGDLLLHQDLKNDSVQNYKRTLNLADAITTTVFEADGVKYNRELFTSAPD
NVLVIKLTADAAKALSLNFSAQSQLRSEVSVTEDQVLVVSGKAPANVNPNYYNPEGVEPI
TYEDPEGCDGMRFQYRIKVLNTDGTLRVENNSLAIADASEVVVLLTEATSFNGFDKCPDK
DGLDEAKLATESMQAASAKTYDQLKADHIADFSAYMQRVTLDLGTTQEDQLNKPTDARLK
AYSEGANDPELEALYFQYGRYLLVSSSRPGGTAANLQGIWNKEMRPPWSSNYTTNINAEM
NYWPAETTNLSEMHQPLLAYIQNASVTGSRVAKEFYDADGWVLHHNSDIWATANPVGDLG
DGDPLWANWYMGGNWLTLHLWEHYAFTQDEGYLAKVYPVMKEAALFTLDWLVERDGQLTT
APSTSPENLFLVDGKGYAVTEGATMDIAIIRELFSNTIKASEVLGTDTEFREKLVAAQER
LIPYQIGGKGQLQEWNLDFEEEDPHHRHVSHLFGLHPGTSISPLTTPELAAATEKTFELR
GDEGTGWSKAWKINFAARLLDGDHAYKMIRELMQYVDPYSKEHKGGTYPNLFDAHPPFQI
DGNFGATAGIAEMLLQSHLDELHLLPALPGAWPNGEVNGLKARGNFDVDIKWSQGRLRSA
KIKANNTGKITLRTQIPVDVNIKIFDLKADGDYFLTTFSVEADQTYQITTKNN
>KECLDBNJ_02553 hypothetical protein
MPSLSIIDGVTLVLPNEFPFKVSLLYTEAVLPPSKPSTGIAVKSSSTASIVAAPTATVIG
AEPQLPGFKFSQIVYTMV
>KECLDBNJ_02554 hypothetical protein
MSYVPAGVLAGMITVPFVSIEAPVSPSKSSIAIAISPSSTATPLSVSFSVTSPAFPPVNP
LTGVALKSSSLARSAAGFTTTVAVAVSQFPGFKFSQI
>KECLDBNJ_02555 hypothetical protein
MVPAIIPQNPKDYIFILQMTSMKICTLELTRTLEELMAILMLPHKFIIVLKIQMGQLLQV
HLLFRGPMVLQDLLIHIKEQ
>KECLDBNJ_02556 Branched-chain amino acid transport system 2 carrier protein
MRFNKEVLVTGFAIFSLFFGAGNLILPPYLGYLSGTHWLLVTLGFFISAVFIPILGVIAH
ARLQGTMLDFATKIHPVFSTVFCILVYLVSVTLPGPRTASVTYEMAIEPYFEINSLTSSA
IYFGLVLLSALNRSKLLDLLGKYLTPLLLLILVTIIAILCLAEIPIANDKHITNVVSTGI
LEGYQTYDAIGAIVIGALAIISLKIKFKGSSVTEKRKVLFKAAFIAGIGLLLIYTGLIYA
GSLFSNLTEEPSRTDLLTLLSYESLGSSGNIVLSILVALACFTTAVGVVTGTADFFQGLN
RSNKTIYPLTVTLACIAGIIIGQTGVSYIITIGVPILAFIYPLVITLILLNALPERYAST
LVFRVTVLGCILFSIPEFLQSINIETLTPLQQLLPLSDYGVAWFIPTIVFYALGSVAQLA
MKPS
>KECLDBNJ_02557 3-oxoadipate enol-lactonase 2
MPNIIENTLFYEEFGNGPAMLLLHGFLENRKMWMPFVPELSKKHRLVLIDLPGHGKSDVL
KGAQNLVLMAAEIKKLVDHLQLKDLKFVGHSMGGYVALAYAERFPEDISGICLLNSTPKA
DTAERVALREHGITVAQKNYHALVSMSVANLFSQHLRSRLTEVIQITKQEALQTPLEGYI
NSQKAMAIRDDSTEFWKNGSFKKMMILGAHDTLIRAEDLKCEFTEYDVQIDVLEGGHMLA
IENFEGVLAILKQF
>KECLDBNJ_02558 hypothetical protein
MNLQSPTRNPLKRLRCKLFGHNYNLLRQYQTNKKEYECSCCKQQFTEDEHGYLAPLTPKL
RRINEVMEKFYLFKHARRQSA
>KECLDBNJ_02559 Thiamine-monophosphate kinase
MFENKDESRTSLSDLGEFGLINHLTQTFKIKQSSTVTGIGDDAAVINPKENQLVVTTDLL
VEGVHFDLSFMPLKHLGYKAVMVNLSDVYAMNAEATQITVSIAVSNRFPLEALEELYAGI
ELACSIYNVDLIGGDTTSSTTGLLISVTALGQAEPKQLVKRSGAKDGDLLVVSGDLGASY
MGLQVLEREKQVYKVNPNAQPDLEPYAYLVERQLKPEARKDIVELLKKIKVQPTSMIDIS
DGLSSEIIHLCKSSKTGIRLYEEKIPLDPQLIQTCEEFELDSTTVALSGGEDYELLFTIN
QEDYDKIKGNPHLTVIGHVTPEHDGMNLITRANTSIPIVARGWNALKNEE
>KECLDBNJ_02560 Iron-sulfur cluster insertion protein ErpA
MIKVSESAKKKIAVLMTEDGYDPSTDYVRVGVKSGGCSGLSYDLKFDKSKAEEDKLFEDN
NIKLIVDKRSFLYLIGTTLEYSGGLNGKGFVFNNPNAQRTCGCGESFSL
>KECLDBNJ_02561 FeS cluster assembly protein SufB
MAYTEDDLEKELATKEYKYGFYTDIESETFPVGLNEDIVRAISKKKEEPEWMTEWRIEAF
RYWQTLEEPEWANVHYEKPDFQNISYYSAPSKKPKYDSLDEVDPELLDTFKRLGISIDEQ
KKLAGVAVDVVMDSVSVTTTFKKTLAEKGIIFCSISEAIKEHPELVKKYIGTVVPKKDNF
YAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVVADEGSYVSYLEGC
TAPSRDENQLHAAVVELIALDDAEIKYSTVQNWYPGNDEGKGGVYNFVTKRGLCEKNAKI
SWTQVETGSAVTWKYPSCVLKGDNSIGEFYSIAVTNNFQQADTGTKMIHLGKNTKSTIIS
KGISAGQSQNSYRGLVQINSRAENARNFSQCDSLLMGNKCGAHTFPYIEAKNKSAKVEHE
ATTSKIGEDQIFYCNQRGIDTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGSV
G
>KECLDBNJ_02562 putative ATP-dependent transporter SufC
MLEIKNLNAGIEDKDILKGIDLKVNAGEVHAIMGPNGSGKSTLSSVIAGKEEYEVNGGDI
IFEGESMLELDAEERAHKGVFLSFQYPVEIPGVSVTNFIKTAINETRKAKGLEDMPASDM
LKMIREKSELLEIDRKFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVSNGVNKLRSKDNAVVVITHYQRLLEYIVPDFVHVLVDGKIVKSGGKELALELEEKG
YDWVKAELTA
>KECLDBNJ_02563 FeS cluster assembly protein SufD
MSLKDKLLSSYLTFQENTSFDNSILDIKDQAIKVFETEGFPSKKDENWKYTSLNSVTKPD
YSLAATGDDAIEFKDVKQYFLNDIDTFKIVFIDGVYSSYLSETTHDGVDVCLLSSALTKP
KFKQVIDVYFNKIAKNESLTALNTAFAKEGAYIYVPKSMAVNKPIQIVHLSTGNEANLML
QPRNLIVAEENAEVQVIERHQSLSSNAVFTNSVTEIYAGKHARVDYYKIQNDKENASLID
NSHIDQQESSEVSVHTFSFGGKLTRNNLNYYQNGEHINSILKGVTIIEDKQHVDHNTLVH
HKQPNCESHQDYKGIFDDKSTGVFNGKVVVDAIAQKINAYQSNNNILVSDKASINSKPQL
EIFADDVRCSHGCTIGQLDEDALFYMRTRGIGKKEGRALLMYAFANNVLESVKIPQLKAR
ITNLIAEKLGVNIGFDL
>KECLDBNJ_02564 Cysteine desulfurase SufS
MATASTTSTLDVLRIRKDFPILNRKVNGQPLVYFDNAATSQTPQQVIDVIVDYYSNYNAN
IHRGVHALSQEATDAYEQARIKLQKHFNIPNAYQTLFTSGTTHGINIVASGFAEILKAGD
EIIVSALEHHSNIVPWQMLCEKTGATLKVIPMTTSGELDMEGFDAILSEKTKLVFVNHVS
NALGTVNPIEEIITKTHQVGGAVLVDGAQASPHIKANVQALDVDFYVVSGHKMCGPTGIG
MLYGKEKWLEKLPPYQGGGEMIDQVTFEKTTYAGLPHKFEAGTPNICGGIAFGAAIDYMN
AIGFEHIAAYEHELLTYATQKLQEIEGLRIYGESKHKTAVISFNIGDIHPYDIGTILDKL
GVAVRTGHHCAQPIMDFYKIPGTVRASFSFYNTKEEIDIFVNAVRKAKSMLG
>KECLDBNJ_02565 hypothetical protein
MKTFAVMLLLVFVSFNACKSTDKKIKGPKGEYIVASIKKDTVAGKEIQLIFDEEKGQVSG
KAVCNSYSATYVVSGNNIKFSPAVSTKMMCPEGTSIEYNFFQALLNAKTFSLKSNKLSLL
DAEEQPILIAK
>KECLDBNJ_02566 Cysteine desulfuration protein SufE
MSSIQDIQQEIIEEFEMFDDWMQRYEYMIELGKSLPLIDEKYKTEEYIIKGCQSKVWVHA
DLKDDKIEFTADSDAIITKGIIAILIRSFSGQPPQAILDADTSFIDKIGLKEHLSPTRAN
GLVSMIKQIKLYAVAYQAKAES
>KECLDBNJ_02567 hypothetical protein
MHWENALTLTGGICGLVFVVVGILMYRFPPKKINHFYGYRTSKSMKSQDRWDFAQKFSSV
KMIKAGVALLILAVLGAFVNLDFNPKVQMFLILLLIIGSVIYLLLGTEKALDKRFKE
>KECLDBNJ_02568 hypothetical protein
MSDTNEIDTQELGEKVVRVLKTIYDPEIPVDIYELGLIYDVFVNEDYETKILMTLTTPNC
PVAETLPVEVEEKVKTIDMVKDCEVEITFDPPWSQDLMSDEAKLELGLL
>KECLDBNJ_02569 hypothetical protein
MEEIINRVANSKLKTFDLEDLYPSGRRATLDISQWLLEGFILKEKEFRASLKDYDWSAYE
HAFVALHCNTDAIVPAWAYMLVTTYLQPVAKKVIVGTLEDLESLLYTEIIAELDVAPYEN
QLVIVKGCSNKPVPQNAYILLTQKLQKVAKSLMFGEACSSVPLYKAK
>KECLDBNJ_02570 hypothetical protein
MRKLLFLFFLACSVSGVVAQEKTEQELKEEIAPKKAEIAKLQKEVNALQSQIDNLPGWKF
GAFGTIGANFSWFNSWYSQGNPNVSSATIGATVNAFANKKDEKYFWRNAMNLNLGWVKFD
DRDDPDDDDSFRNATDVFNISSLYGYKLSEKLAVSGLGEYRTTILDNFNDPGYLDLGVGM
TWTPITNLTVVVHPINYNFVFSDEDTIFESSLGAKIVADYTRQIGKIAFKSNLSAFQSYK
SSNYSNFTWINSFNYKLFGKVGVGFEFGLRGNKQENLDYALGEYVDNGSTGTEPTFDNLD
SQLQSYYLLGLTYAF
>KECLDBNJ_02571 GTPase HflX
MIEETKIEYEKTVLIGLITQFQDEEKATEYLDELEFLAYTAGGEVLKRFTQKMDTPNPKT
FIGTGKMEEVRAYVDQYEIGTAIFDDELSPAQQKNIEKILKCKVIDRTNLILDIFAQRAQ
TSYARTQVELAQYEYLLPRLAGMWTHLERQRGGIGMRGPGETEIETDRRIVRDRISLLKK
KLEKIDKQQAIQRGNRGALVRVALVGYTNVGKSTLMNTISKSEVFAENKLFATLDTTVRK
VVIRNLPFLLSDTVGFIRKLPTQLVESFKSTLDEVREADLLLHVVDISHPQFEDHIASVN
QIMDEIGGSDKPMLMVFNKIDQYTHKTIDEDDLVTERTEEHFTLEEWERTWMSRVDGDAI
FISALNKDNMEAFRKKVYDRVREIHITRFPYNNFLYPEYDAYGEEE
>KECLDBNJ_02572 hypothetical protein
MPQTKLTLAFYNLENLFDTLNDPNILDDDFTPQGDLKWNQERYTQKLNGLAKTIAEVGKA
ETGQAPAFIGVAEVENKKVLNDLLQTEALHVLNYDFIHHNSPDERGIDTALVYDKNRFEV
IESRSYSLHLQTAQGVRDFTRDILYVEGKLAGVSVFVLVNHWPSRREGVTISEPKRVAAA
ERNREIIRDIQSRDPEARIIIMGDFNDDPQSIAVRDHLVSTDFYNPMVFLLTRYAGSLTH
RGDWYLFDQIILSPNWMKAYDNPLEYEKSAIYNPEYLKEQEGKYRGNPLRTYAGDKYLGG
FSDHFPVYTIFKVED
>KECLDBNJ_02573 hypothetical protein
MALSNNDIFKKLRVALKLRDDDIVKICALVDFAVTKSELGAIFRNENHPKYVECGDQFLR
NFLNGLVIHMRGPMPEKKTGKPALKKDGNKKKNTKQKDSPKKPD
>KECLDBNJ_02574 Oxygen regulatory protein NreC
MIRIAIGEDHQSLIDGIALLIRDEAHIQLVCSATNGLELVQAVRKYQPDVIITDIRMPKM
DGIQATEIIKKEFPEIAVIAFTMFDQQDAVQQMLDAGASGYILKNSSLQTLKKAIETVAE
GTPFFDSQIELNNFEDDHTATSKNGLLTKRQLEILRLIAHGKTSREIADELFIGVHTVDT
HRKNMMRILELKGKGELLRYALDRKYDF
>KECLDBNJ_02575 Sensor histidine kinase ComP
MRWVLWHVIGFLSFSLAFGQENDLSKFDTYFQALKTLEHQEALTQLSTIEDTLYSQPLNT
FAQLTYQGFSGSPENFKAECVLRTSDDPFLNAVYRLNTGYYKFYFLQDRTAAYPHFYKAL
KSANQLAYAPLQRRVLRAILQYFHHEIARNNNNYQIFLDQYQDLILDSNDQVYFQIYEVI
FHSSEIDIKSVYYTKAPLLEGLISQLAPDSKLLPKLYLEIALYHELIKEYDRAAYYYQKV
FDEGKDIPYYNDSRFSAITKLAYLQHLKGNSQEALKKLEEVSCCFNPQDSLKNTFFVEYY
TSLFYEGLGADSLALAHYKTYVEAGHNINFRDNSLEISRLQVELETEKKANDLLLEKQEK
KRILVLTVGLLVALVILLLIAYLILNNSRKRRKLAEQERELEKERVANLLKDQELASIDA
MIAGQEKERSRIAGELHDDLGALMTNVRMHFESLKSSQAPELFDKTDALLHEAYQKVRSI
AHAKNSGVIANQGLLKAVKDLAKKVSQLNALEIQVVHHGMTNRLENSLELSIFRIIQELI
ANIIKHAQATTATIHVINHGDSLNIMVEDDGLGFDPKHISLRSQGMGISSIDKRVNHLDG
SLTIESAPGEGATIIIDIPL
>KECLDBNJ_02576 hypothetical protein
MSLEHKGIEGLIYLGSKAEDYEQLVYASSLYGTFFTVYGTFVVEQKGANKIHIKSATFRL
KNYKGILDLGLRKVTFDSDLQEFKLKIKALKKNKEKSISCIDIDPTRQLKFIRKLDQIGT
KKSRKYLHDDEFYYRDGNFKMKRPPYDLLNNTNCDAIQRCIETKVPFELDSIEKADLAPG
GRCMMSELKILT
>KECLDBNJ_02577 Peptide deformylase
MAADSVTPMRVFKITNKQDSLLLRTPSEHVNVDPKDTVLMNLINRMYATVRDSLSLGAGI
AAPQVGILKNIAWVQRFDKEGFPFEVIINPVIRQYSKKKQDCPEGCLSIPGRRDTLSSRA
YAILVEYDTPDASHEIEMVEDFTAVVFQHEIDHLNGILYLDHLKQEVKDAEGLMTLDTLS
N
>KECLDBNJ_02578 hypothetical protein
MKLPCIYLITSFLLLGCVTSEFEIPETESASVTPEGTEISITAVLNSLRQSSESIISFDA
TDTYFTGYVISSDVAGNFYHELIVQDAAENPTAGITLQLNANALYTQYEPGRKIYVYLDG
LALTTENGVLQLGIRDGNGITEIPNSVIGNHILRDAEVAQLVPLPIAISEFSEAYENILI
QLDRAQFNRNEVLGSSIKTYAGEPTDEYDGIRLLETCEPRGRTLVSTSTFSKFKSVALPT
GSGTISGILSRDFYDDFYILRINTTEAVAFEDTSRCDPELYRCGLAEAEGTTVLFADDFS
EQSRNNPIEGNGWTNYVEYGVQAWEAYTATGTNASQGISARIDSYQSGDALSVCWLITPA
IDLATTTNVRLRFETSSSFADGSDLEVLFSSDWDGDPTTITLASWAILDEAFVIRDLDFF
GDWYSSGIVNLSCSPANNGYIAFKYTGSTQEAFDGTYQLDNISITAD
>KECLDBNJ_02579 hypothetical protein
MLFLYSASAIAQYARIRGTVKDAATSSALPEVEVFVQKTNYTTQTDADGNFDFTPQVPPG
SYTLVLRKSGYLSLTIPVNLIPDQELVLEYLPLEIDLAEANEQITLISLSDVQLNDDNEQ
RDNAVSGLLGATNDVFSNAAAFDFSSTFFRPRGLDSKYSRVIINGLVLNKFNTGRPQWSN
WGGLNDVMRNREFSMGLTASDYSFGAPAGTLHFNMHASSYRPGGRISYATANRTYTGRVM
ASYNSGVTADNWAYSVLVSRRFGQEGAIDGTFYDANSLFFAAEKILSETHRINLSFLYTP
NRRGRSTALTQEVIDLKGYTYNPNWGFQNNEARNARVRAIEEPLVLLSHHWQLGKQASLH
TNLGYQWGTTKNSRIDYTGSTLISNPNEQEHFVGGARNPAPNYYQNLPSYFLRYPNPSAV
QYQQAYLAEQEFRNDGQLEWQALYEANETAVRSGLNTIYAIQQDVNQDQLFTGNIRYKAQ
MSEHFDVNFGIYGSALQSEQYAELDDLLGGNVWLDIDSFAEDDNTTGGDLAQSDLQNRNR
LVQPGDRYKYNYGIAARQIGTFAQLEATYNHLDFYAALNAEQTSYQREGYYENGYYPGAL
SLGKSEPVRFTSLGAKAGITYKFNSKHFALLNAGFLEQPPGFNTVFTNARQHNAILENPQ
SERLIDLDASYIYRGSDLKLRLTGYLLNFTQGSEVSYFYTQSMQTPLIDQGNALVQESTT
HIARQNLGLEFGASYSILPTLTLKAAAAFGQNMYTQDAQVYYTTTLAETPIRFGDGSAKL
KNYHVAGGPERAYQLGFDYRDPDFWWLGASVNRFSNAYVDVSYLRRSGAFSSDYDGQAFN
DYTAKVAQELLKQEQLDAYYLVNIVGGKSWRVKSYTLGFFGLLNNALNTRYKTGGFEDSR
IGDYRSLLEERARDTPLFGNRYFLGYGATFYLNFYVRF
>KECLDBNJ_02580 hypothetical protein
MRNIRLSVLVVCFFIPFLCVFGQEVQQYQMLTLAFYNLENLFDTENDPITYDDDRTPDGK
DRWTQEIYTDKLAKMAEVIAQIGPEEAQGPPAILGVAEIENLKVLQELTGQEVLRSAHYG
IVHYDSPDRRGIDVGLLYNTQVFQVINSKVFELELYDTEREDKRIYTRDQLLVTGNLAGE
RMHVIVNHWPSRSGGEARTRPRRMAAAALNKKIMDSILSQEPYAKIVSMGDLNDDPKDKS
LKKVLKTKARVEAVGLREIYNPMERMAKRGQGTLAYRDSWNLFDQILLSAAWLSKDYETF
QFYKAGIFNKRFLQTPEGPYKGYPFRSFANGNYTGGYSDHFPVYIALIRKTD
>KECLDBNJ_02581 hypothetical protein
MNKPKNPILRQGFTLFQFLKKTYVAWDRNDPFAKSAIIAYYTLFSLPSLLMIVTSIASAF
VGPEAVQGRIHDEISRFISPEVAIAIEQMIGKVTLQNDNWITLIISIGALIYGATGVFFQ
MKKTMNTIWNVTEKNDNFKRMLINRAIAFGMVLVLGFMLLVAFVITVLLNLLTDYLSQFA
PTITVVFADALRFLISFAFIAGLFAAIFKILPDVKMGYKTTVLGASITAILFLVGESILG
YYFASSNPASVYGGAASIVLILLWVNYTCLILFFGAEITVQYALVKKHKIVPSSHAKLAH
SEEMAALREKEKQIEADKKKAIELATNPEEPPKT
>KECLDBNJ_02582 hypothetical protein
MRRFLYVFTAALGLLVVVACGATPGITTTKKQLPNAPLYTYIDTKGNVYSISSKKLIYEP
VSADNTIDGLDDEGRYLELNIELNDYTKMAAECERQLNTTQKELPANYTGYAIPTLTRKD
SLETQSIDLSIEAVDELDYVIKPFLNDE
>KECLDBNJ_02583 hypothetical protein
MSDFWFYFKIGLDHVLDYTAYDHVLFLIVLSVPYVFKDWRRVLLMVTLFTLGHTTSLLLA
VYDVVRINRGLIEFLIPVTIFIAALYNVFTAGRGAHKDKLGVLLITALFFGLIHGLGFSG
FFEQLTAHLSNKLLPLAEFALGIEAAQIIITLIVLIIGFICQTIFRFSRRDWVMFISAVV
IGMVIPMLIANYPW
>KECLDBNJ_02584 tRNA-specific adenosine deaminase
MSSITSDKQLTYDIAYLRMAQEWAKLSYCKRKQVGALIVKDKMIISDGYNGTPTGFENIC
EDDEGYTKWYVLHAEANAILKVASSTQSCEGATLYITLSPCTECSKLIHQAGIKRVVFHK
AYKDPSGIEFLRRAGVQVDCIENIEE
>KECLDBNJ_02585 Carboxy-terminal processing protease CtpB
MGGYQKKYLPIFFCVAVALGIFIGSQLNYSSNPTNILGGNAKKEKLNRLIDYIDYEYVDP
INTDSIVEVTVNGILENLDPHSVYIPPSELQEVSESMKGDFVGIGISFYNFRDTIAVIQA
IPGGPSEKAGIRGGDRIVAADNQSLTGAVVRDDTITNQLKGQINTKVALKVKRPGVEGLL
DFKVTRAVVPLKSVDASYMATDTLGYIKINRFAESTPQEFEKALVALKRKGATQLILDLR
GNPGGYISAAEQIADQFLKEDKLILFTKNKTGKIENAYATDEGAFEDGMVYVLINENSAS
ASEIVAGAIQDNDRGVIVGRRSFGKGLVQREMQLGDGSAVRLTIARYYTPTGRSIQRPYD
SGNKAYYEDYLSRYKNGEMQSADSITVADSLRYVTPGGKVVYGGGGIIPDVFIPKDTNYE
KEAITYALRSGFMSRFIFEIIEQRRPYYNSLSFEEFSKTVSISDKTITDFVNYMSKRSLK
IRVRDYKDDLKRYLKAVMAQQLFGNTVFEKLINEEDPAIIKIKELSRE
>KECLDBNJ_02586 hypothetical protein
MVIIASIFVFCVAAVFRLLDNSAGLLISNGISVSPFYLKAAEIKEQMSRIENDELRKKLK
RTLVYQKLHKVFLILAVLTFIAGIVYEFINPSLVALL
>KECLDBNJ_02587 hypothetical protein
MKVALYIILALASALLIFNLTKVDYSAPLNGDSTVAVISVVACLCAMLLVVILLISRKIA
EKSKAAQKTKTTKTQL
>KECLDBNJ_02588 hypothetical protein
MAFNIKEIITATMILFAIIDIIGNIPIIIGLREKVGHIQSEKASIVAAMLMVVFLFVGKE
ILNLIGIDVNSFAVAGAFILFFLALEMILGISLYKDDAPETASVVPLAFPLIAGAGTMTS
LLSLRAEYAVENIIVAIFINIVIVYAVLKASGRIGKILGKQGINIIRKIFGVILLAMAVK
LFTTNIQGLF
>KECLDBNJ_02589 hypothetical protein
MFQIDQTIVSEDVINKDFVCNLAACKGECCIAGEAGAPVEPQEVEILKEIYPKVKPFLRP
EGIAAIEAQGTHIKTDLDQLETPLVNGAECAYVTFTKEGVASCGIEDAYNAGEVDFRKPI
SCHLYPVRLQKYSKFTAVNYERWPICDDACTLGKELQVPVYKFTKDALIRKFGAPWYEEL
EAVVELLKQEDAK
>KECLDBNJ_02590 Methionine aminotransferase
MRSKLPQNKLSIFAVMSKMAAQYNAINLSQGFPDFNTDPELIRLVTQAMQNGANQYAPLA
GYLPLRENIAAMVQELRGATYDPEHEICITVGASEALYVAITAFVHRDDEVIVLKPAYDT
YEPTIALQGGIPVPVQLDAPYTTVDWDAVAAAITPKTRMLVLNNPHNPSGMVLKDTDLKR
LEELVKDTDILILSDEVYEHIVFDEKQHRSVASYPGLKERALVTASFGKTFHTTGWKMGY
CLAPKALMAEFNKVHQNTVFCVHHPTQVALAEYLNEPEHYLNLGSFYQRKRDVFLNAIQG
SRFRFTSSEGTYFQMLDYTGISDLNDVAFAEYLTKEKGLASIPVSVFNKEQRDDHLLRFC
FAKEEDTLLKAAAILNAI
>KECLDBNJ_02591 hypothetical protein
MTTLKLSSSSSKGDFKVLDGAKELCEVVYKNWFSSTAITNLNKSVIEIKPKNIWTSKVDL
FKNDRNVGDITFNLKGQMVIRYINPDRTEVNYILKNVSGIKLKFEVYNAEKQLQFRLICT
SKWHQLSYNYDVEPEAFDKQTDLEELLVYCGYAANLYISIISAAAL
>KECLDBNJ_02592 Inner membrane protein YccS
MNFRQYHTQTTRFFNSTDFAKALLITFGVVAPMLTGYLLGALNIGLALGTGVLLSSPSTV
TGSLKNKRIGILLSALLGGVISLIGAYIPPTLWVQLPYLGITVFALSMLSVYGFRASLIG
FAGLFAVVLSFANLSASGLLPYERSSLIVLGGIWYLALTLLYDLLAPKKQIEELFETALN
LSASYIEARGEFLKQATDRDSGLQRLFVIQSEFNEHLEKLREILLQARHASGTSSYYRKR
FLVLTELVDLSELSLTSPIPPQQMHEVLKKYPEQLEAFIQLNRAQSESLKRIVTTNLQKH
DLNLNSLEQRLKNAKSVLLLLKQQPVTTDYIVLHNLYELQEKQAQRIFGIADLLDRRKNI
KDTNTDSPKELEGFITKQDYSFQLLLENLNRDSPIFRHALRIAVTAIAGITLGNLFSVQN
PYWILLTIVVIMRPGYGLTKQRSKQRILGTLLGAVVAAGIVYFFENDKMLFRVLAILSFV
GAQASLQKNYRTGALFITLSIIFAYALLRPDVLAVIQFRVIDTAVGAALAALANAFLWPT
REAKTLKQNLADSLRAHRNYLAAIEQHYDTKEELALAYKLARKKAFIATAGLNSGVQRLL
QEPKSKGKLTGKLYELAVLNHAFLGALASIGAYLRTHNVTRRSEAFHKVTAPVFKNIDHA
LLLLEAQNTQADWEEEDLIPFETQLTQEPDEALLETHILSEQLASLKRLSEQVNKQLKNL
HT
>KECLDBNJ_02593 hypothetical protein
MSTTLEAWLEKDTFTSNVSRGLISGVLGGLAGTLVKTAIEKVLPVRKPNTRSAQIKMVDD
LSMKLTGERISESNHELAEQLVNVPFGASLGATYGYAKRDKLDTNIFDGAAYGATTWIGT
HETSLPLLGLKDNPTEIPAKIQVNELLAHLAFGITTELVRGYVAKKLRE
>KECLDBNJ_02594 hypothetical protein
MKEKRINITENPKLLLFAEVNGVCPTCPNQLIYEKSKRKYKRFEIAHIYPLNPTKPELEL
LINEEKLDSDPNSLNNLICLCVDCHTKFDKPRTVEEYRNLVDIKKKLIIRNKEKEIWNNT
KVEKEIYDIIDLLSGKDFKVDAKDILNYNPKTIDNKTDESITFLTKRNIHRNVQDYYSKI
NKKFSELDKIEPLTTETISSQIRTHYLTLAKLNKEINQKDIFDGMVNWLSKQTNQHSNEA
SEIIISYFIQNCEVFE
>KECLDBNJ_02595 hypothetical protein
MIYPNKHITFEESIIFKMISILENASDYEVDIHELFSRTKNKFKNADEFIYSMDVLYVLD
MIEVDFYNETVKYVKRN
>KECLDBNJ_02596 hypothetical protein
MLKEINCKEFIKTPLVFDKGLNSVLGDDYSTNSIGKSTLLMIIDFVFGGNSYIENNSGAV
KELGNHSFDFKFIIKNQSHYYCRNTENPMFIAVCDDNYNQISNISARAFTEELKGLYDIK
NSSSFRSMVNPYSRIWKKGNYNVDKPIHNHVQNKESEAIDNLIKLFNLFDSISETKNKIK
QQQESKKVLNGLHKKKYIQKITKRQFEQNQLEIERIQNEIETIQNNLLKFTLNIEELTNK
ELIDLKTKKKRLLDSQALVLNKITRLNLSLGKKKTKSKYFTRLSEFFENPNEEKIEEIET
FHSKISSILARELGATKKLLEEENQYFEEEIKAIDIKIDGLLQNVKSPKYIVDKIYDLTV
ESNKLSNINKFYKEKEEVVTDIKSLTDKLEETIVGILKEIEEKINTELVRINKEIHTEKK
KIPSIKITRNSYSFDHSSNTGTGKSFADLIEFDLSILKLTELPFIIHDSVLFKNIEDFAV
DKIIEQYTKFDKQIFIALDGINKYSSESKKILKENKIIELTESNKLFNRDWR
>KECLDBNJ_02597 hypothetical protein
MKSIIALLLLVSVLTIGCRSSTNDKGLSYADFEPEEFYEVEGRVLSNLLSFSLPRNRVLN
YEYFLDQETPLVGYELNIHRTLKPGERFIVLVHKQDSTISFFGYVNPMLLDRSIHKLRQR
R
>KECLDBNJ_02598 hypothetical protein
MKKHSARLFSLFGILFLTIKTLSAQEYYFPEYQAEWKTASATSGAFTEASLQAAVDFAME
HEYTGSRDLRQAILKGFEREPYHHIAGPTKKRGGPAGMILKNGYLVTSWGDTQRVDMTFS
VTKSFLSTTAGLAVDAGIITNVNDLVGDYIWDGTFDGDHNSQVTWKHLLEQNSDWSGELW
GGKDWADRPPRDGGIDAWKNRELRTPGTFFEYNDVRVNVLAYALTHTWRKPLPQVLKEQL
MDPIGASTSWRWFGYDNAWSTIDGLQMQSVTGGGHSGGGMFINAEDMARFGLLFLNNGVW
DGKRLLSEAWVKAVQQPSTPNPNYGYMWWLNQQGPRHWKNLPEHLYYAAGFGGNFIVIDQ
ENDLVIVLRWLEPSQIEAFLELVYEAS
>KECLDBNJ_02599 Catalase
MAEQKKMTTSAGAPVSNNQKSQTAGDRGPVVMQDYKLFEKLAHQNRERIPERTVHAKGWG
AQGTFTVTHDITKYTCAKLFSEVGKQTPILSRFSTVAGEAGAADTERDVRGFSLKFYTEE
GNWDMVGNNTPVFFIRDGYKFPDFIHTQKRHPKTNLRSPEAMWDYWSLSPESLHQVTILM
SDRGIPKTPMHMNGYGSHTFSFWNKDGERFWVKFHFKTQQGIENYTNEEAADIIGQTREK
YQEELFKAIDEGNYPKWTLKIQVMPEAEAENLPFNPFDLTKVWPHDDYPLIEVGELELNE
NPENYFQFIENAAYSPSNVVPGIGFSPDKVLQARIFSYADAHRYRLGTHYEALPANAPKN
AMVNHYHKDGPMRFFTNDFGNPDAYYEPNSKGGAVEVPEVEEPPMRISGDVKRYEENDEF
GVYKQPGDLFRLMPQDEKERMFVTIATALDGVSEPIVQRQLGHFYKADPAYGKGVEDAIK
AMKTGVDPNSNVLPQDV
>KECLDBNJ_02600 Actin-binding protein
MKSESLFNAIRSEDEQTVAALLTEHPELINEKDQRGSTPLLLATYYGHKGIAETIIDKGA
AIDAKDASGNTALMGVCFKGYTEVAKLLIDKGADVNVQNFNGATALIYAATFNQKELVEL
LLERGANPELRDSRDLKAEDHARMQGLDQIENLLKHATP
>KECLDBNJ_02601 hypothetical protein
MLHPKVVQDLHSIRFRNVGFKRKPVLYPQAERQFNRFLINAIGHNVFVISTGLGLDVYYS
STQDYSQFIKKKLWLFKPANDVVAEKHFVATLHGPEVLDYFNTVVDSLITHPQLFLSCCK
KFMQYYKDAGVKTRLLQLLYSTFEAHLQELISQERSPYTGRIKKMLNESEISEFKYFDEV
DRLAYQSKNARNFN
>KECLDBNJ_02602 DNA polymerase III PolC-type
MRIPFFSKTLEPPEFYKNYAAQFSGKSLPEFEQARFIVFDTETTGTNAREDRMLSIGALE
LKGNTISLSSSFELYVEQDVFNEEAVAIHGILRENRKYKKVTEEEAVKAFLEFIGDAILV
GHHVGFDIGIINYALKRLGAPKLKNKFTDTGVLYKRTVHLVNITDPNKVYTLDDLCEELN
IARTDRHKAMGDAYITALAFLKILSKLKTNKKFKLKQILLN
>KECLDBNJ_02603 Inosine-5'-monophosphate dehydrogenase
MKNTIAERVADFLKRYPPFQFLAADSLLKIAAQIEVLYFEKDKPIFKEHDTNHAMFYVVK
DGAVRVFRTVDNQPKIVDICDEGDIFGLRPLITKEDYELSASANEESIIYGIPIDLFLPI
ALEHKEVSNFLIASFASNVSDPYSLEESGKLFTEYSVERNSEIFDLQKARYSKNILTCTP
DTTIKVAAKKMSHRDVGSIVVTHDEKPVGIITNRDLRDRIATGDFNISDTVDKIMSHPVK
CFQKDPTVAQAQLIMLKNEVNHLCITEDGTPDTKLLGLITEHDIVVSFANNPVVLLKEVK
LAKRTKRLRDVRLKVSRLLKKYLDQNLPLSQILNILNEINYAIAVRALELSLLKMETPPP
CKFAWLALGSQGRKEQLLFTDQDNAIVFDNVPEEEYEATQAYFIKLARITTRAMHKVGYA
YCPADMMASNPRWCQSLSEWKKQYHTWITDPTPETQLLSAIFFDYSYVFGDTQLVTKLSD
SILDTLDTNPMFYRVMAKDAIRSPSPLGFFRQFLVEEGGDHKDFFDIKTRALMPLIDAAR
VLSLNHKLRNINNTAGRFERLAELEQNNKEIYENCSYAFKALLKFRTKQGILHDDSGRFI
ELATLSKAEKLKLKRCFKSIHDIQELLTLRYNLK
>KECLDBNJ_02604 tRNA-specific adenosine deaminase
MALIEPFDDHYFMKKALQEAETAFDLGEIPVGAVVTVNNRIIARAHNLTERLHDVTAHAE
MQAITAAANFLGGKYLTDCTLYVTLEPCQMCAGALYWSQISRIVFGAADTNRGYQKMGTH
LHPKTQVTSGVLETEAAQLLKRFFIERRNLN
>KECLDBNJ_02605 1-deoxy-D-xylulose-5-phosphate synthase
MSYPLLETINDPQDLRKLPVAQLNELAAELRRFIIDIVATKEGHLGASLGVVELTLALHY
AFNTPEDQLIWDVGHQAYGHKILTGRRDNFDTNRQLGGLSGFPKREESVYDAFGTGHSST
SISAALGMAIAAKIQGNTQRQHIAVIGDASIASGMAFEALNHAGDCDANLLVILNDNAIG
IDPSVGALKNYLTNVKTGSQRQENIFEALNFKYFGPVDGHDIDKLLEIIKTLKKIKGPKF
LHVITTKGKGLKQAEKEQVVYHAPGKFDAVTGELNPKSTTPQPPKYQDVFGLTLVELAKK
NKKIVGITPAMPTGSSLKYMMQEFPERAFDVGIAEQHAVTLCAGIAAAGGVVFCAIYSTF
LQRAYDQLIHDVALQKLPVIFCVDRAGLVGADGATHHGVFDLAYLRCIPNLIIFAPRNEE
SLRNIMFTAQLGLEQPVAIRYPRGRGTTINWKTPFQKIGIGKAEKLTEGDNIALLVTGTM
TETALQLADTFKNEVAVYYFGFVKPLDLAALQEIFSTYTNVITLEDGVASGGFGSAVAEE
ATRQNYKGKLQVLGIPDTFIEQGTTEELRASVGLDFESLKAHVAHCLTLI
>KECLDBNJ_02606 Deoxyguanosinetriphosphate triphosphohydrolase
MMNWEHLLSLKRQGDTAKRLRIEQDDTRLGFEVDYDRIIFSAAFRSLQDKTQVIPLSKTD
FVHTRLTHSMEVSVVGRSLGRMVGKKLLEKYPHLEQVYGYKFNDFGAIVAAAALAHDIGN
PPFGHSGEKAIGEFFKTGYGKRYKDSLTAKEYQDLIKFEGNANGFKVLSQSKPGAPGGLR
LSYATLGAFMKYPKESLPHRPTDHIADKKYGFFQSEKELFEDVAQELGLLNRSTTDDLSW
SRHPLAYLVEAADDICYTIIDFEDGINLGLIPEEYALEYMVKLVGQTIDRNKYNALQETS
DRVSYLRALAIGTLINESVETFMTYEEEILAGTFDQSLIDKSSYQAQITDIINLSIDRIY
NSREVIEKEIAGYEILSTLLEARCRALDNNDTHYNQLIQQLLAPADQSEKSLYQNLIQIC
AEVSTMTDGKALRNYKKIKGLDIK
>KECLDBNJ_02607 TonB-dependent receptor SusC
MKQILGLLMLMFSAVALGQTGTIEGTLSDKETNNEPLPFANVIIKGTTKGATTDFDGKYI
IENVPVGTYEVEFSFVGYEPVTVPNVVVQAGKFTNVSTALGASAAALDEVVIQVQTSRER
ESALLLEQKKAVEIKESIGAVQLAKQGVTDAATATTKISGVTASQASGDIYVRGLGDRYL
YTTMNGLPIPSDDVEKKNFDLGLFTTRVIQNVGISKTYGVSNSADQASGTIDVATKELSG
TKELGVGIRVGANTNATQSGVSDNFKLTGNKGDYTLGFLKNQGFNETTQASSPGYSAYPR
MTQQTWNTSTANFPMNYRYAITAGKKFGEKFKVLFTASQSGDFTYRNGVFRQYRENNIDD
SITDATYYNRRVTTTGLLNTEYKINDKNDVRWVSLFVNSLSDQVFEGGRNGEATIFEEES
RDDVFQFIRDQNTKQTRLWVNQFFGNHELSEKNTLDWGVGINLLSADEPNRVRNEVNITP
DADFVQLGVTGGFQQRKSFQLIDDEELAGFIKDTYVLNEDFDTGSKSEISGGLNVRMKSR
NFKSQFLGATESNAGADFGSVSIDNLDVIFTDENFRSGDLNFQFLPTDRYIADLESQSAF
AAYTLQKEKFNLNVGMRFQCDAIDVLFDVNNFPGRRGATNKEYTNLYPSVNFKYNLTEDQ
GVRFAGSRTITLPEFKEIAPFEYVSPVGQVTKGNPDLEASINYNFDLKYEWFPSSDELLS
VAAFYKMINDPINKVQQRGSAGIFSYFNAGDQANIFGLELEGRVNIVKPVEDSGNIGVRL
SGNITRMFHEQDLKEIYDENGTLLRTFKYNGKSDEGLQGASDWIVNGTLGFSTAEENPWE
LNVVGNYASSKIFALGAPRNQQEPDVFFNESIVEQGFVVLDAVLSKQVTDGFAVKLTGRN
LLDPAIEQTQIQRPTNGDPVFNATVQSYTLGRTFLLGLTYDF
>KECLDBNJ_02608 hypothetical protein
MNNQYLRIFALGLAMAVSSCSNNDDLGFGEETPTEDANLTGNLTEDRQLDPLVEYKLTGS
FIVKSGATLTIPAGTRIVSETGTDKYIAVEQGGDIIVDGSASNPVVMTSANEQGGDWGGL
VICGEAVTTEGVDATAEVGGLIYGGTDNNDDSGSIDYLIINYAGAQINSDSQYNGLTLYA
VGAQTEITNVAILNGEDDGVEFFGGTASVTNLYLENNQDDSVDWTEGWSGSITNTYVVLD
RDDFSTAIEADGDNANPTITDFTAVSETGGIALQFKKESGATITGLSLQGFDTSFDYRDG
GAVSNVQVEGEDSNPALSYVATATVDIADFSWVQSGLEARAYVSLNGDLTTDMTLDADTR
YLLDDVFTVKSGNTLTIPAGTKITALDGGASIYIAVEKGATINVNGTEDNPVVMGSLNGN
RGDWGGLVVCGDATTTEGIDATAEVGGLVYGGSTDNDDSGDITNLVIIGAGAQINADSQF
NGLTLYAVGSETTVENIAIINGDDDGVEFFGGTVSVNNIYLDNNQDDAVDWTEGWNGTVT
NTYITHTDADFSTAFEADGVNNNPTFINVTAISTVGGTALQFKKESGATITNLYLEGYDT
NLDFRDDGALTNVMIDGAAAVLTEAYNTGSQVDISTWTWIEARL
>KECLDBNJ_02609 Aspartate--tRNA ligase
MYRTHNNGALRAENINETVTLAGWVQKSRDKGFMIWVDLRDRYGITQLIFDEERTPKAVM
DLAKTMGREFVIQVTGKVIERESKNPKMPTGDVELLVEKLEILNEAKTPPFTIEDATDGG
EDLRMKYRYLDIRRNPVKEKLIFRHKVSIAVRNYLSEQGFIEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNIFEGLTKHLLKEVVGFEIESFPRMTYDEAMAKYGNDKPDIRFGMEFGELNA
VAQHKDFNVFNSAELVVGIAVPGGASYTRKEIDKLIDWVKRPQVGALGMVYVKCNEDGSF
KSSVDKFYDQEDLAKWAEATGAQPGDLICVLSGETSKTRAQLSALRMELATQLGLRKSDE
FAPLWVVDFPLLEWDEETERYHAMHHPFTSPKPGQMELLDTKPGEVKANAYDLVLNGNEI
GGGSIRIHDKEIQSKMFDYLGFTKEEAQAQFGFLMDAFQYGAPPHGGLAFGLDRLVAILG
GQETIRDFIAFPKNNAGRDVMIDAPAKIDAAQLEELNLKITL
>KECLDBNJ_02610 Multidrug resistance protein MdtC
MAKNTYKEFSISSWAIDNKMTVYVITAIILLSGLAAYYSMPREAFPEIIETKIYVSSVNP
GNAAEDVEKFITEPLEEEFNDIAGIKEITSTTLQDYSIIIVEFEEDVDVNVAKTKVKDKV
DLVKAETTWPTLDNGAKVEPNIFDLNISEEQPILNINLTGDFQVQQLKDYAEYLQDKIEL
LPQIKEATVRGAEEQEVEVAVDIYKMTASKVSFDNIINAIRSENNTISAGNVISDGLRKN
IRVLGEIQDPKELNNIVVKRDGGNIFLKDIATVRFKEKDATTYAREYGQPVVMLDVKKRA
GKNMIEAVESIKKIVAEEEANYYPESLHISLTNDQSIKTENQVDDLVNNIIFGVILVVVV
LMFFLGFRNALFVGFAIPLSMFMSLTILSSLGFTLNTMVLFGLVMGLGMLVDNGIVVVEN
VYSLMDQGMPRLKAAKQGLGEIAWPIIASTATTLAAFFPLGLWPGTIGKFMIYFPITLSV
VLSSSLFVALIINSMLTSRFMKTEEEDMSKKSLVRNSLILTAVGAIFLIVGFVIDSGGFR
GIGNLLLLIAILLWAYKYFLAGAVRYFQFESLRKLENFYERFLKYALRGRKAYVFFFGTV
IMLFLSFVLVGIAQPNVLFFPENEPNQIITYIEYPEGTAIEKTNQLTKQIEERIFDAIKK
YEDADGYNYMVESAISQVGQGAGNPQTDGGQSNEMPHKGKVTLSMRDFKLRRGVSSSTVL
SEVRDAVKGFPGASVIVEKDANGPPVGYPINIEISGEDYEEMLLAAENMRTYIEDLGIGG
IEELKLDVNKSKAELGVTVSREKAGQLGISTAQVGQTLRRSVYGEEASTYKEGDDDYEIN
VRFNEDYRYDENALFNQPVTFRNNQGQIIQVPISALVDKKSSAAFSAIKRKDLKRVITLY
SNVLTEQGFNATQIVEQLKQDLAGYETPNGIEYSFTGEQEEQADNMSFLLMALGIAMGSI
LLILVAQFNSLSKPVIILMAVVLSLVGVFLGLIIFQMDFVILMTMMGIISLAGIVVNNAI
VLIDYTQILIDRKKEELGIEDDEYLTREEYFRITVAGGKSRLRPVLLTAITTVLGLIPLA
VGLNIDFFGLFTDYDAGIYIGGDNVIFWGPLAWTVIFGLVFATFLTLVIVPVMFYLTNRA
KVKFSEKRKVREEQKQQAKLAAASEDSES
>KECLDBNJ_02611 Cobalt-zinc-cadmium resistance protein CzcB
MKNILSLAFVSLLLISCGGKEESVEQIIENGDITAMRAKKTELVNEQNAIKANIDSLNAA
IDKLDVKKKAALVTAVTLQDTLFKHYFEVQGNVDTDQNIVLYAEYTGVLTQLYVKEGQRV
AKGQRLAKIDDGGLGSELARQEAQTALAKTTFERQKRLWDQKIGSEITYLEAKTNYEAMQ
AATDQLRSRVAKTVITAPFSGIVDNTMADQGQVVNAGQTGVLRLVNLSDMYVEASIPEAF
LGKVNQGTEVKIRLASIGKTYDGKIRQVGNFVSPDNRTFDVKISIPNPDSAIKPNLIATV
MVNDYTAENAIVVPENVVQQNAMGNSITYVYEEQADGTAIAKQVQIEEGYSDDQRVEITS
GLEAGDRLIVEGVRSLRDGQAVELKDQSSNNQ
>KECLDBNJ_02612 Outer membrane protein TolC
MQKPMFLFLCLLGYLNPSLAQDTTEVESYALSLQEAITYGLENSYDAKNALTDVEIALKQ
KWEVIAQGLPQISGEVTYQNQFIQPTSFIPAVVFDPSADPGDFIPVQFSQKQNASAVATW
NQLIFDGSYIVGVQSAKTLLQISENAKVKTDLEVKQAIIEAYGNVLLAQESVAILQKNIE
TVNKNLNDTQKIFENGLGEEEDVEQLQITALGLETQLNNTVRQLAIAYDMLKLTLGIPID
SKLMVTDELEDLTMQYYDLNLLTQDINPEQNIDYRIAQDQTNLAETEVKLEKSKALPRLS
AYLNYGAAGASNSFTFLSDEQRYFEQSILGVSLTVPIFSSGMRAAKTAQKELAYQQSLED
LERARNQVKLQIATARNDYQFALDNFATQEKNLDLAERIENKNSIKFFEGIASSFELSEA
QTQLYQAQQDYLQAMYDVIANKAALEKVLDTTVYQPKED
>KECLDBNJ_02613 HTH-type transcriptional repressor KstR2
MKTEILENATQLFLNHGFKSVTMDDIAAHMGISKKTIYANYAHKTELVEAVGHHLLTSVQ
CVVKDMVDEHMNPIEELYEIKKYVIQHLQGEKTSSIQQMMKYYPKIFTKLRESQNAFMRG
CMEQNIARGIELGLFRNNLDIEFVSRMYQIGITNIKDETIFPSDKFPHIPLYETYLEYHL
RGIVTPEGRKILNQIIHSNQD
>KECLDBNJ_02614 (2E,6E)-farnesyl diphosphate synthase
MLRIDQYTEVFVEYLNAKVKVKEPVNLYEPIDYILQLGGKRLRPVLTLMATDIFGSDHKK
ALDAALAVEVFHNFSLVHDDIMDDAPLRRGQETVHEKWDINTGILSGDAMLINAYQLFEN
YEGETFRELAKLFSKTAIEVCEGQQYDVDFETRDDVTIPEYLKMIEYKTAVLVGAALKMG
ALVAEASSENAQRIYDYGRDLGIAFQLQDDYLDAFGDPKTFGKQVGGDIIENKKTFLYLT
ALQKLDPTHSKQLQHLFSINPQDPSEKIETVKQLFIDSGAAEATQQEIENYTQKALNVLE
TLEVPQENKSILEDFARLLMRRKV
>KECLDBNJ_02615 hypothetical protein
MNSGSNLLDQVRKEKLFYALVFQLNKDFERAGLEAEFDTAFENQQLLRNLQAALYNLVVS
DFESYLTLLYAIDVSEAKIKALPDCEVHQLAEFVSVLILEREFKKVQFKNRTL
>KECLDBNJ_02616 hypothetical protein
MKSISKLYIILLFIAFGIASSQAQFRSDSFWDRVNFGGGFGLNFGNDYFAANLAPSAIYN
FNPYFAAGPGLSYSYVKNGSLKSSIVGGSIIALANPLPIIQLSAEFEELYVSQRANWDGG
TFSDDFWNSALFLGAGYRSGPVTIGARYNILYNDDDAIYTSAIMPFIRFYF
>KECLDBNJ_02617 2-oxoglutarate dehydrogenase E1 component
MVRAIYCIFDKLLLKKSTDLIYKMDRFSFLNAANTAYFADLYDKYLQHPDSVEPSWRAFF
QGFDFGIEESGIAADVSELSANTSSDNAVPDKLQKEFQVVKLIDGYRTRGHLFTKTNPVR
ERRKYEPTLALENFGLSEKDLDTVFNAGEILGIGSNTLRDIITHLENIYCDSIGVEYMFI
RKPEEIKWIQNKLNVNDNHPDFSADTKKKILKKLNEAVSFETFLHTKYVGQKRFSLEGGE
SFIPAVDAIIEAAADRGVKDFVMGMAHRGRLNTLTNIFGKNAKDIFSEFDGKDYDQEVFD
GDVKYHLGWTSSRLTDSGKEININIAPNPSHLETVGAVVEGISRAKQDRHYFDNPQEVLP
IVVHGDAAIAGQGVVYEVIQMAQLDGYTTKGTIHIVINNQIGFTTNYLDARSSTYCTDVA
KTTLSPVLHVNADDAEAVVHAALFALDFRMTFGRDVFIDLLGYRKYGHNEGDEPRFTQPK
LYKAIAKHDNARDIYAKKLIEQGVIDENHVKQLEDEYKEKLEEKLEKSREEETTRITAIM
QDEWEGFEPATEDEMMQPVDTTFDLDALTEIAEAITKLPEGKKFLRKINKIIEGRRAMYF
DDNKIDWGLAELLAYGSLLKEGFDVRMTGQDVERGTFSHRHAVTKVEESEEEIVLLNNLK
GEQGHMYIFNSLLSEYGVVGFDYGYAMASPKTLPIWEAQFGDFSNGAQIMLDQYISAAED
KWKLQNGLVMLLPHGYEGQGAEHSSARMERYLQLCAVDNMYVADCTTPANFYHLLRRQLK
TNFRKPLIVFTPKSLLRHPKVMSTKEELANGSFQMTIDDDSVKADQVKTLVFVTGKFYYD
LLAQREELERDDVALVRVEQLFPLPKKEIRAALEKYKNADDVVWAQEEPRNMGAYGHLLM
HLPEAQKFRVCSRKFYGAPAAGSSVRFKRRHQRVIDDVFDKNSNNQ
>KECLDBNJ_02618 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MALEMKVPSPGESITEVEIAQWLVEDGDYVEKDQAIAEVDSDKATLELPAEASGIITLKA
EEGDAVAVGEVVCLIDTDAAKPEGDSGSDKEEQKEEKAEPKKEEPSKSSTPEQTQDKKTY
ASGSPSPAAKKTLDEKGIDAKDVKGTGRDGRITKEDAVNAQPSMGTPGTGSRGESRSKMS
MLRRKVAERLVSVKNETAMLTTFNEVDMTPIFELRNKYKEDFKAKHGVSLGFMSFFTLAC
VRALEMYPAVNSMIDGKEMVSFDFKDISIAVSGPKGLMVPVIRNAENLSFRGVESEVKRL
ALRARDGQITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSAILGMHNIVERPIVRDGGI
AIAPIMYVALSYDHRIIDGKESVGFLVAVKEALENPEELLMDNNVLKALEL
>KECLDBNJ_02619 hypothetical protein
MSIPQSYTEFEATLEKSSPPSSWPEALQALWHQAKGDWEASHNIAQDMHTAMGSLIHAHL
HRDEGDDWNAKYWYRQAGRPFPTVSLEEELTQLVNEVIA
>KECLDBNJ_02620 DNA polymerase I
MAVQKRLFLLDAYALIFRGYYALIKNPRVNSKGQDTSAIMGFVNSLFDVIKREKPDHLAV
AFDKGGSSERVEMYEEYKANRDETPEAIRIAVPIIQEILKAMHVPCIEIEGVEADDLIGT
LAKQAEKEDYQVFMVTPDKDYAQLVSENIFMYKPARMGNGIEIWGIPEVQKRFEVERPEQ
VIDYLGMMGDASDNIPGLPGVGDKTAKKFIKQYGGLEGLLENTDQLKGKMKEKVIENAEL
GRLSRKLATIMTDCDVKFDAEQYELSQPDADKVQEIFDELEFRRLKDQFIKIFSGEADSD
TGAAVSGTETAKKLVSSAEKAANAGAGQYNLFGGDEPAIEERNTRKTIKDTEHFYQSVAP
GMAMNLFIKNLMKQTSVCFDTETTDLDPLQAELVGIAFSWEKTKGFYIPFPSEKEEVQKL
IEALRPFFEAEEIEKIGQNLKYDIKVLAKYDVEVKGKLFDTMIAHYLINPDMRHNMDVLA
ETYLNYTPVSIEELIGKKGKNQKSMADVPVDQQTEYAVEDADVTLQLKEHFQKELGEANT
QKLFDDIEIPLVQVLADMELEGINLDQEFLGSLSEALNNDITSLEKSIYEEAGEEFNIGS
PKQLGEILFDKLKLVDKPKKTRTGQYSTAEDVLSYLAPDHEIVQHVLDYRGLSKLKSTYV
DALPAQVNSKTGRVHTDYMQTVAATGRLSSNNPNLQNIPIRTERGRQVRKAFVPRNEDYV
LLAADYSQIELRIIAALSQEETMMKAFQEGEDIHASTAAKVFNVPIDEVTREQRSNAKTV
NFGIIYGVSAFGLSNQTDLTRSESKELIDTYYKTYPKLRNYMSEQVDFARENGYVSTVLG
RRRYLKDINSSNAVVRGAAERNAVNAPIQGSAADIIKIAMIKIHQKLKDKGLKTKMLLQV
HDELVFDVYKSELDEVQELIKSEMENAFKLDVPLDVEVGLGDNWLDAH
>KECLDBNJ_02621 TonB-dependent receptor SusC
MKQQLRLIWSLVFLMTLNFAFSQTKTVSGTVTDQTGMPLPGVNVTVKNTTGRGTQTDFDG
NFTIAASADETLVFSYMGFKPYEQLVGASATFSITLSEDTQSLDEVLVVAYGTAKKEDFT
GSAVQVNGESLEQRPITNAISALDGAAAGVNVSAANGQPGSAPSIRIRGTGSYSASNTPL
YIVDGVQFNGELSSINSNDIESLTVLKDAASTSLYGSRAANGVVLITTKSGRSGKPQVSL
KMSQGITSRGIPEYDRVSASEYYPLMWEALRNSLSMSSDTPVAEANAIASSTIYDELGQN
PFNVANDQIVLEDGTLNPNASLLYAEDLDWLEPLVRTGVRTNLDFSYSGGTEKSDYYASV
SYLKEDGYIINSNFKRLTARLNANTQVTDWIKTGLNISAADSDSNQAADAGSSSYVNPFR
TTRYIGPIYSVHEHDPETGEYILDSDGNWIYDLGDNRVGGGGSGRNVIQETLLNVDRDKI
FSFTSRAYAEFTFLQDFTFTVNGGIDKRFYSNESFDNPIVGDGAPDGRAGRTTSTRTTVN
YNQLLNYSKTFGKHSVSALVGHESFDTEYEYLNGFRQNQIVEGNTELINFTTTNDLISYT
SNQTTEGYFSRVNYDYDSRYYISGSYRRDGSSRFSKDARWGDFFSVGGAWRIDQEAFMET
ADWANLLKLRASYGEVGNDNLGGYYVSQSLFALDYNNASEGGILVDSPGNPRLQWETNIQ
TDAAIEFGLFNNRVAGTFEYYNRKSEDLLFDVPLPVSSGLDDYPDNIGSWVNSGFEFDVT
VGIVRNSQFKWDFSINASTLKNEIKELSQEEIINGSKKLVVGGDIYDYWLREWYGVDPAD
GMALYIASPEAIEAGGSDLREIDGTTVTTNQNNANYNFVGKATPDVYGAFRNNFEYKGFQ
LGITFTYQLGGETYDSNYSGLMHSGTYGTALSTDILDRWQEPGDITNVPRLDAAQTAAFG
AGSSRWLEKSDFLALRQVNLGYAFDAELVQKLGLTGANVYVSGENLFKLTARKGMDVGES
FNGTTSNRFTPARVLSVGLNITL
>KECLDBNJ_02622 hypothetical protein
MKNNYITKFTLLFVVLGLALSSCSEEFLEEVPTESVSDVTATSTTGNLFLVINGIHRSLY
IRYGAQGRSGIGSLMIQNDVLGEDFVMTSRGNGWFVSAAGWLDHTNADDSDNLFPYRTYY
RIIRNANVVINGAENAEGDAAERQAALGQATLYRAWAHFQMVQLYGIRYSAGAENTQPGI
PIRLTADNDPLPRASVEEVYTQINTDLDAAIELLDGYVRPNKSHLDQSVALGLKARVALV
QQNYQVAADYAAQARANYNLMSNDDYYANFNTYTNGEWMWGSYIQEDQTDYYGNFGAYVS
RNYSSTNIRTNPKAINNLLYDQISETDIRAVLFDPTGQHDSLPPGYSIASNFSLFPYTSQ
KFLAAGTGDSRMDVPYMRAGEMYLIEAEALSYIDEGAARSVLFDFASNRDPEYTLSTNTG
QALKEEIYIQRRIELWGEGFRFYDLKRLNQPLDRTGANHVQTVINNVYEVPAGDNRWQWL
IPLDALNANPLLKQNPI
>KECLDBNJ_02623 hypothetical protein
MKFSRAVKPLLLVLGLSVFYSCHEENVLELEPFNQISEDAAFSTADLVELSVTGMYNAAQ
IGVYTGTGRGYPFGAAFVQQGDNRGEDVVNVATFYQLTYTGTYDPTTANNVYYWSDTYRL
INRANIVLEGVQTALDNGIITQEQADDYEGQAKFLRAAAHLELLFHFAKPYNDTPDASHL
GVPYRDYPINTAESIATALEQGRNTVADCYARILADFDDAESLLLSKAERGGTDGIIRAT
SEAAIAFKTRAYLHMRNWPMVIQEGTKLNGTYTLTASPNEPFASGYANTESIFSIENTAL
NNPGVNAALASQYNRRGLVVISPIIWRNPSWLEDDLRRGEGTLVTTRSGVKYTNKYKDAT
NYTDPAPVIRYAEVLLNMAEAYARTNAAGSALTNLNLVRNRSLAAPATQAYVSTSFATPA
ALVNAIITERRIEFVMEGRRWPDIHRLQLDDLAPVSGVPQKVANGTPTAESYTLGTAYSG
PYGVDAIPYSATAFLWPIPQQEINNNPTLAAQQNPGW
>KECLDBNJ_02624 TonB-dependent receptor SusC
MIKKLLFSFLMCLLSLSAFAQQKTVTGTVIGADGTPLPGVNVVIKGATGRGTQTDFDGAY
TIDASSNETLVFSFVGFETQEQLVGAKTTLNVTLAENTESLDEVVVVGYGVQRKRDLTAS
VSQVKGDDIANLVTPSFESQLAGRAAGVQVTTQTGIIGETPRFRIRGIASIDSGTYPLVV
VDGIPIYTGDLGGYASNNALGDVNPADIESVEILKDGSATAIYGSRAANGVVLITTKKGR
EGKMTINYNMSAGFARPVNTFNLLGASDFVTISNEKRSNRGQSDWAAGTEFNTDWQDLVL
NDNAFQQDHSVSFSGGTQYTKYYLSLGYTEQESIARPNDFVRYTFRSNIEQKIKSWLSMG
VNAGLTRSEYNGLNTGTNSLSGNIFNASRQHPNVSPYDANDPTGYNLDDTFPDRMGRGTN
LETVGDNIPNIMFAIENNSYYSKVNRVIGNVYADIKPVSTINFRTQVSIDQTNTTGFLFW
SPIHGDGYGSNGRVQNSNTDLTRWNWQNVLSYNETYGEDHNVSLTLINEYQKSRDQSFFG
TGTDLSNEFFNQNLISNSYGVQGSGGSLSENGLISYAGRLNYNYKQKYFLQGTLRRDGLS
SLPFENRYGTFPGASFGWTVSEESFMQGIKETLSDFKIRGSYGKVGNTDIGNYPYLGLYG
AAKYGDTNGIGYVQFGNDQLRWETSIKYDLGVDLAFLRNRITISADYFKNDTDDLILDLE
TPMSFGVPNNSYRANIGKIQNTGYEFAVDARILDKEFRWNVSANISFIDNEVIALVNGQD
RIGTNTITREGESINSIYGVRYYGTNPENGNPVYYKADGSLVQGNLPGSSYSVFDPANPA
DVSQAASLSAADDRVILGQSLPKYFGGLNSSMNYKNFDLGFLFRFSGGNKIFNATRRDLL
NQNFTNNSTEILGRWQSVENPGDGWTPRLYASTNTTTNLTSIATSRFLEDGDFIKLDNIT
LGYSLPADTATQLGITKLRLYLQAQNVWTITDYSGLDPEMESAGVDLNGTPRASIFSFGL
NLSL
>KECLDBNJ_02625 hypothetical protein
MKNFSPLVLTLLLFSQALFAQIGIGTTAPEASLDVQSVANGGMLIPRVALTSTTDNTTVV
NTDSGALAESTLVYNDGTGGLTPAGFYYWKGTLWEKLADNTDSRTYTGKLRITSTGSINI
NTLPFSPTAITFTAYANVENYTLDSDNAASNNNSGIANSFGYMTGFANNHSGSIAQQVIC
GGGSGNSINDISRYASPNHCIGIRYANQNGDKLGITSASLTSFDNNGFTLNVDSYADGLV
IIYTAYR
>KECLDBNJ_02626 50S ribosomal protein L13
MDTLSYKTVSANKNTVNKEWVVVDAEGQTLGRMSSVVAKLLRGKYKTNYTPHVDCGDNVV
VINASKINLTGKKWDAKSYIRHTGYPGGQRSLTAKELYGKDPARLIENAVKGMLPKNKLG
SAIYRNLKVYAGAEHGQEAQKPKAININELK
>KECLDBNJ_02627 30S ribosomal protein S9
MEVIHKIGRRKTAVARVYLAPGSGNITINKRDLKEYFTTGTLQYKVNQPLVMTENDKNFD
VKVNVYGGGITGQAEAVRLALSRAMCEVDAENRGILKPEGLLTRDPRMVERKKFGQKKAR
KKFQFSKR
>KECLDBNJ_02628 30S ribosomal protein S2
MAKTENVKDLLDAGVHFGHLTRRWDPNMAPYIYMERNGIHIINLYKTAAKLSEASEALSK
IAASGRKILFVATKKQAKEIVAEQATRAKMPYITERWPGGMLTNFVTIRKAVKKMQTVDR
MKQDGRFDSLSKKEQLQMNRMREKLEKNLGSIEDMTRLPGALFVVDIKREHIAIKEAQKL
NIPIFAMVDTNSDPRQVDYAIPSNDDASKSIEKIISNVADAIVEGLSERKAGKEKSGEGK
KDKAAKPAKAKAKAVANDEEE
>KECLDBNJ_02629 Elongation factor Ts
MAKITAAEVNKLRKATGAGMMDCKNALVEADGDFDEAIAVLRKKGQKVAEKRADRDSSEG
VVVAKINDANNRGVVFSLNCETDFVAKNDSYVELANELGDIAINFDTKEAFLAADFKGMT
VEEKLIEQTGVIGEKLEIGGFELLEAPFVGSYVHGNKIGALTGLSQASDNAEEVAKTVSM
QVASMGATTLSYKDFDPEFVASETEARIAAIEKENIELGRLGKTLKNVPQYISMSQLTPE
VMAQAEADIKEELKAEGKPEKIWDRIVPGKIERFVSDNTTLDNEKALLDQVFIMDESINV
AKYVASKGDAEVVGFKRVSLA
>KECLDBNJ_02630 Uridylate kinase
MQYKRILLKLSGEALMGKRQYGIDPDRLAEYAEEIKKVLDQGVEVAIVIGGGNIFRGVAG
ASRGMDRVQGDHMGMLATVINGLALQSALEEAGIQTRLQSAVKINEVAEPFIRRRAIRHL
EKGRVVIFGGGTGNPYFTTDSAAVLRAIEIHADVILKGTRVDGIYTSDPEKDEKAVKFDF
ISFEDVLQKGLKVMDTTAFTLSQENELPIIVFDMNKQGNLLKVVEGENIGTTVNL
>KECLDBNJ_02631 Ribosome-recycling factor
MNEDIQFILDGTEEGMQNAINHLKKQFANIRAGKASPSMLGSVMVDYYGSQTPLAQVANV
NTPDGRTISIQPWEKAMIQEIEKAIMNANLGFNPMNNGESVIINVPPLTEERRRDLVKQA
KAEAEDAKVGVRNDRKSANNDIKKLEKDGLAEDLCRNAEVDVQDLTDKYIKKIDELLAVK
EKEILTV
>KECLDBNJ_02632 hypothetical protein
MFKQLIFCLFLLLLLQKSAFAQQKSIAVDSLMQRAILAAEQNNPQEALPHYSYTTYEKTI
ITDSLERETNAHSFFTEKVSKNEFDAYSGFKEEVLGLNMAGFKEPRYEVLGITLQSRSFY
DEDFVIFNYRYAGPLSSRGLKNYDYQFVADTTILERTSYAVAFQPKRPQTIPGLEGILYL
DQESLAIQRVHIAINDELVARIEQHYTYLEDKAVYLPKSSKLYIEKGETSKRLSLFRGKV
SVGTIERNPVKEAIEGRYLLSTSYNANFNLSEDEEIEHPNLAVEVMEGAESKPESFWKKY
RSQALTQRDLNSFDYLNNIVETQNIERRLAVINNFGIGYYTVDFFDFDLTYPVKYNNYEG
LRLGLGGVTNASFSQKFRLEGYTAYGFKDKALKYGIGGGIMLNESHGAWLSLTYNDDLQE
VGSFNYLTDRRVYSLFEPRLVNITQFFDYKTLRLNQEYQITPKILSELQFAKTNIIQTQD
YTFVLGDQSYREYDITEATFGVRWSPSSKFMRSEKGTVEIYDGYPKVTAQVSKGISGLFD
GDFDFTRVGAKFYYQVERLNKSTTEFLIEGKMAFGEVPLTHLFHAYPNAPTKETIMQRFS
VAGVNSFETMYFGEFFSDRIATLQVKHHLRPFNLGEKFKPEMVFITRYAIGDISNIERHQ
DVSFGTLDKGYTETGFEINKILFGFGTSLTYRYGAYSLPSFADNIAFKFTFNLQL
>KECLDBNJ_02633 Multidrug resistance protein MexB
MTKLLGYGFWNGVARLILRNRLFILFLVAAFTVFLGTQWKYMRFTYTEANLLPDDHEVNL
EYNKFLDQFGEEGNLIVFGIKDSTLFTPETLNKWNALSDTINDFNEVALSVSLKDLKLLQ
KQEEPKRFEMIPFVDGSVNTKVQAEALKKKLFKDLPFYEGLIYNKETGTVRSAVYLKKDI
VNTAARKDFIVDDLIPLIDQFEEETGITVHTSGMPYIRTLNSATIISEIGWFVGGALLVT
SLIFFFFFRSYRATFISMITVVIGVMWAFGFLGLLGYEITVLTALIPPLIIVIGIPNCIF
LINKYQQEYKNHGNKIKALQRVITKVGNATLMTNITTASGFATFILTQSSLLKEFGIVAS
INILAIFLLSLLIIPIIYSYMSPPKERHLKHLGKTWIEGFVNWIERMVRDRRITIYISTV
ILLIVSMIGIYQIKVSGSLIEDMPKNTTFYKDIKFFESEFDGIMPLEVLIDTKRPKGVMK
LPTLKRMDELATTISETPELSKPISIVNLVKYGKQAFYNGDPQYYQLPTSNERNFILPYA
QSFSSEAGLLDSYVDSTGQYARMTTFMQDIGTDRMEIVEDNLYNKISILFPEDKFDVTLT
GKALVFQKGTNYLINNLIISLSLAILLISIFMAFMFRSFKMILVSLIPNLLPLLITAGLM
GFLGVPIKPSTILVFSIAFGISVDDTIHFLAKYRQELKSSGWKIKRSVYASVKEAGVSMF
YTSIVLFFGFSVFMISSFGGTVALGGLVSVTLIFAMLSNLLLLPSLLLSLERNIANKEDF
KKPAIHILDEVEDEEVLEELEKE
>KECLDBNJ_02634 Asparagine--tRNA ligase
MRKTIVHILKEEPKGHELTVKGWVRSFRANRFIALNDGSTLNNLQCVVDFENTDPELLKR
ITVGAAIAVTGNLIESQGGGQAVEVEAKEIKILGDADPEEVKKTILSPKRHTLEKLREQA
HLRVRTNTFGAVMRLRSQLSFAVHQYFQKEGFYYVNTPIVTGSDAEGAGEMFKVTALDMK
NPPKDENGNIDYKKDFFGKETNLTVSGQLEGETYALGLGQIYTFGPTFRAENSNTSRHLA
EFWMIEPEVAFCDLDMNMDLAEDFIKYVIQFVMDNCQDDLEFLENRLIQEDKSKPEAERA
PMPLREKLKFVLENNFKRVSYTEAIEILKNSKPNKKKKFKYPIETWGADLQSEHERFLVE
KHFKCPVILFDYPANIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERLEVLQEKM
AALDIPEEELWWYLDTRRFGSCVHSGFGLGFERLVLFATGMTNIRDVIPYPRFPQNAEF
>KECLDBNJ_02635 hypothetical protein
MLRGKTPFLKVFFPSEKKDVYFTPDYFKIQQMKKTTLIAAVLTAAFLITSCEKPCECEEA
ETPILGAPANIIPLAQADSLYKNYGNSRVELIELAENITEEGDTIPKEDANYKQATRLVS
FSFAEMKKYMAYIEEQADSAGVEVLELRVYFGKYGKKPIKKTKANKGTVFFNPAAEFVFA
DGTKDTVSFAILNNADGSKSAVTVGSVLNGSALTSGLGAEDVNSLAENFGQEMPPPPISD
EDF
>KECLDBNJ_02636 hypothetical protein
MISDFAELLSFVFGLIYWNNFKQTPIRWFILFLGYNFFNEMAALAYYVSGLSNNNTIFYN
VHQVIYFSVHFYIFYKYLLRKRLKLAVVLFYSVWLISFTYQLFTKNLVLEYALFSTVLGD
FLKMISVLFVFIEVINASTISKLQDNMIIYLGLGLLVYLVISIPTSVTSFVRWEKIGKDT
GPRMEFYQILRNVGTFAGALMYFIFAYGFYRAKAPSMSLTR
>KECLDBNJ_02637 hypothetical protein
MDLEISQERLEFILSNPSTMTMTALELLSFIVGLCYWKKFSKTPIVIFILFLGYNFLNEV
AAAFVVVANLADRNTAFYNLRYLIYFSALFWMYFKYLNKRSFKNTVVAFYALWLLTYIYF
VATSYFLYQKPLFSAVTGDMLLLVVVLLYLVETINSADLSKIQDLVLIYISIGLVISTVI
QLPVSVAIYVGWYKITDASDSLNAFYNIIRDASFWAYCVSYLIFVYGFYRAKAPRTSNLN
>KECLDBNJ_02638 hypothetical protein
MQTSIITFEFSYERLGYLTGNPSLVIMYFFELAAFVTGLYYWKKFESTSIIWFILFLGYN
FLNEVTASTIYIFGWADHTSIFYNVRYPIYFGVYFYLFYQYAVSDRFRQIILMMFGLWCL
SYLYFVFTHGIVEGVALFSRVFGGFLLLIVILFFLIEVINNNLTTTLKDVFLVYISIALI
LNLVVQLPVLTMTYVGWPRVMELNDERRQFFNIIRNASFWVASAMYLIFIYGFYRAKSSN
YLMQ
>KECLDBNJ_02639 Sensor histidine kinase LiaS
MDQDTQLLVILVVLLVLFLLAVIIFVLFSVFMKRKNSLLREQIEAEKRYERAIAETQIEI
REETLRNISWELHDNIGQLLTLAKIKAQNIEDGEDMLEVAETIGTGLNELRALSKSINPE
AINGQSLLKSLENEVARFNRLKFLSATYDLIGDPVQLNPKAEIILFRIVQEFMSNTMKHS
KASKLQIRVQFKADALEITALDDGVGFDAEKLLERGIGLSNIDKRAQLIGAQARISSIPG
AGTQLKLYYPLD
>KECLDBNJ_02640 Transcriptional regulatory protein DegU
MYKVALVDDHTLLSEAIAGLVRRFENFEVVNVSVNGRELVDFIEANPHMQPDVVLMDVKM
PVMGGVETTQYLTKYYPEIKVLALSVEEEEGVVMQMIRAGAKGYLLKDTRKSILEQALNE
VLEHGYYYTNTVERIVKKTERLKDQEIVLKEREIEFIKHACTEMTYKEIAEKMFLSPKTI
EGYRESVFQKLGLKNRTGLVIYAIKNNIFVP
>KECLDBNJ_02641 hypothetical protein
MHQPMHQNVLLTKNTPKINFTLLAPLREHRIKNFSYSVNLNWATPLATRTN
>KECLDBNJ_02642 RNA polymerase sigma-54 factor
MLKQQLKFKLSQKLSPQQIQLMKLIQLPTQAFEQRVKQELEENPALDSGKEDARDEYEEF
DNSADEEYDSEKIETEIDVDDYLSDDEIPSYRLNSNNYSADDEERQVPYASGTSFTQHLM
GQLHTYRLSDEQMEIAEFLIGSVDESGYLRRELVDLMDDLAFTQNIYTSEDELEKILRIV
QNLDPAGVGARSLEECLLIQLKRKEETEAVALAIAILTDAFDHFSKKHYSRLLSKFDITE
DQLRDAIDEIEHLNPKPGGSYSGNTKVVEHVIPDFTINIRDGELELTLNGRNAPEMHVSR
EYTNMLKGYKAAKEKSKSQKDAVLFIKQKLDAAKWFIEAIKQRQQTLFVTMSAIMEYQKE
YFLTGDERNLRPMILKDIADEIEMDVSTVSRVANSKYVDTPYGTKLIKEFFSESMTNDQG
EEVSTREIKKILEITIQEEDKRKPLTDDKLAKILKEKGYPIARRTVAKYREQLDVPVARL
RKEI
>KECLDBNJ_02643 hypothetical protein
MKYFLRFFSVLMHPLFMPLLGVGIYFSVTPKFVPQSFMYAKLFAVSILTIVVPVLFYFLL
ESVKLVSSVHLREVKERRIPLLVQVGLILLIIRIIINGYEFPELYIFFLGILITAATSFI
LSLLNFKTSLHMVGVSGVLCFVIALSMIYNANYLVIIGLLILGLGFTAASRLELKAHTMT
ELLVGLFVGGIPQFLMFYFYKM
>KECLDBNJ_02644 hypothetical protein
MKRLSLLIFLSFTAINFAQDSLVTTIDTASVYQKYREDQFYLGLTFNLLTNKPEAMEQNG
FSGGLQFGFIRDMPINKQRNWAIGVGAGISMNTYNQNLFVGETTSEESIFQIIDDQTDYN
KNWFTTYLVEAPIQLRWRTSTATDYKFWRIYTGLQLGYVYAYKFYFEQQGNAVTQTDVPE
FDRYRMGLTFTFGYDTFNFYFYYNLNPIFKDSAQIDGSPIELNSLKLGLMFYIL
>KECLDBNJ_02645 hypothetical protein
MSKFNKKKSGDLPAISTASLPDIVFMLLFFFMVATVMRENTLMVKNDLPTANQIEKLDKK
DLVMYIYAGEPVDRFKGVYGSSAKIQLNDKISDVSQIQDFIYEERASKREELVPFLTTAL
KVDGDSNMGLISDIKQELRKANALKINYVTKSGDAVEAND
>KECLDBNJ_02646 hypothetical protein
MAKRSAPEVNAGSMADIAFLLLIFFLVTTTIETDSGISRKLPPELDENMPPPPVIKERNL
FTVIVNSNDELLVEDKVMELKDLRAAAVEFLDNGAEDCSYCQGAKDPNSSVNPTKAIISL
VNNRGTSYKRYIAVQNELVAAYNQLRDRVAQERYGESFIAMEARYNDPRTSDANKDKLKP
KLELIRELYPEKLSEAEPKKS
>KECLDBNJ_02647 hypothetical protein
MLHKILKIIALILSVLGAIWLVRIILAGDTAITDSADLQDSLVTPFILIAYATIAIAIVF
VLVFVLKNLFSSGSSLKSTLIGLGAFLAVVVISYVLASGEEVQLRDGEVLSASASRWVEA
GIYAFYILAIVAIGAMVFSGVKKLAK
>KECLDBNJ_02648 hypothetical protein
MKRVFSILVITAVIALGNLTAQANTAPLMTVNTTAIVAAVQDEAADEAAADETESLSFTQ
ELKKRFIEGGPGFMGIVLLCLILGLAIAIERIIYLNLATTNTSKLAQDVEDALNSGGIEA
AKEVCRNTRGPVASIYYQGLDRVDEGVDAAEKAVVAYGGVQMGLLEKNVSWVSLFIALAP
MLGFMGTVIGMIQAFDKIEAAGDMQPSLVAGGIKVALLTTVFGLIVAIILQIFYNYIIAK
IDSIVNDMEDASITLIDMLVRYKK
>KECLDBNJ_02650 L-asparaginase 1
MSKQPKILLIYTGGTIGMIKDFETGALKAFDFKDLLEKIPELRLLDCEIETTGFATPIDS
SNMNPDLWIELCDIIETHYDTCDGFVILHGSDTMSYTASALSFMLENLAKPVIFTGSQLP
IGDLRTDAKENLITAIQIAALRKRNRPYITEVGLYFEYKLYRGNRSSKISAEHFEAFKSP
NYPPLATSGVHLNIEDEKLLPYSRKKLLVHRSLARDILVVHLYPGIDQKLLTSIFENATF
SGVILLTFGSGNSTTSLWFTQLLKKIIHKNIPIVNITQCTWGSVQMGSYETSTGLKNIGV
ISGKDLTIEAAITKMMYLNSQNLSPKVFKTIFETSLRGEMS
>KECLDBNJ_02651 hypothetical protein
MSKFDSIRPYHDSEVHEVLQSFHRHPMIQALLQFTFPEKSSEEIKATIDECHSIFDFQSK
VIYKSVHKIMEKSTDGFSTSGFDDLERNQPYFYLSNHRDIILDTSFINVALYDHELIMTA
SAIGDNLVKKSFLMALAKLNRSFLVERSLTPREMLLSSKKLSEYLQFLLSENQSIWMAQR
EGRTKDGSDKTQQGVLKMAAMARGEQTALNYLKSLNIRPVAISYEFDPTDILKVPELIAK
SEDTTYVKSNNEDFNSILRGALGSKKRIHIAAGKLSATTFDEIEALDLSENDKLQELAKR
IDREIYRIYKLWPSNYVAYDLYYQTDRFAHTYTERDKRSFERRFERRVDPSSEIARESFL
LMYANPVINKLKSIEQTT
>KECLDBNJ_02652 putative metal-dependent hydrolase YcfH
MFIDTHTHLYSESFKEDRDEVIKRALDQSINQFVLPAIDSTYTKAMWDLKEQHPNLMHIM
AGLHPTHVDPLSVSEELDHVKQQLEQENVCAIGEIGVDLYWDSSTKDLQQKAFAQQIRWA
KEYDLPIAIHCRDAFDEVFEVLEQENNDKLRGVFHCFTGNLDHAKQAIAFNLKLGIGGVA
TFKNGKIDQFLKEIDLEHIVLETDAPYLAPKPFRGKRNESSYLIHIAEKLADIYQVPLSK
IEEITTENAKKLFKLD
>KECLDBNJ_02653 hypothetical protein
MASLRQHLTRKGYKRIKLTPVGTGHLKFAATINGVLGEFILDTGASNTCIGFEDLERFKL
FAEDSEVKAAGAGAIDMLTQISQDNLIEIETWSTRSVSIVLFDLSHVNQALINHEASPVS
GIIGADILKKGKAVIDYQYDCLYLK
>KECLDBNJ_02654 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MKRRNFITKTSINTLAFGLGIHSLAQAGTAKNSAEKLKKKNTTATTPVAICTWQFTEANA
TAGALLDQGIPALDAVIKGVAVEEENIKNTTVGKGGSPDREGNVTLDACVMDHTGNCGSV
MCVENITNVAALAKKVMEDTPHVILAGKGAEEFAVKNGFTAENLLTEESEKAYKEWLKTS
KYKPIINIENHDTIGMLGLDKNGNISGACTTSGLAYKMKGRVGDSPVIGSGLFIDNAIGG
AAATGMGEEVIKTVGSFLIVELMRNGMSPQEACEEAVRRIVTTNPNHTNFQVAYIAINKQ
GETGCYCIHPGFKMMKYANGKNMPVVSGSHLK
>KECLDBNJ_02655 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MRWFLFILFYILIDIYAFQAFRTFSKSVWLNSSYILVSLGVLAFLVYTLSTLDRSKGITT
DEMYVFGWFLVFFVPKLLLVLFMFGEDLIRLIVGAFTALSGKESFHMPSRRKFVSAIALG
VAAIPFASLIYGMYKGKYRYRVLSYQLEFDDLPEAFDGYTITQISDVHSGSFDNADKIAY
GIDLINKQESDVILFTGDLVNNFASEMKNWTQHFSKLKAKDGVYSVLGNHDYGDYADWET
QQAKAQNLEDLKTLQAQMGWKLLLNEHRWLEKDGERIALVGVENWGAGFKQAGDIDKAAA
GLSANDFKVLMSHDPSYWSERLKTDPKHFQLTLSGHTHGMQFGIEIPGFIRWSPVQYRYE
NWAGIYKEGNRVLNVNRGFGYLGYPGRVGIWPEVTVIELKRKKLG
>KECLDBNJ_02656 hypothetical protein
MLVKKLLYFVVLFASLTLSAQVGIGTTNPDTSSLFEVQSTTKGLLTPRMTTAQRTAISSP
ANGLLVYDTDESAFYYYESAAWSRLKGAEKRDNYVLVKSQADLPAPSGSVITLDENTFYE
INGTIALTASINLNGAYVSGLDATEDVLSYTGGTVFSGSTGGSIRNITITGARAFNISAS
VSESLLVQNTIVANTTTSVGTIANLGLFFGNIVQFLNNADGVTYTNIGNLLLNNQAWLSS
NSGTYERLSGTFGLVQKVSGFSTVSGSARAFDVSSNPTVGNGVLLSTVFSGTSSNPYINR
YTAGSYTGYNFTNNWTVNCPGIPVESDNVATGNIYFNGTITTGFLQTVPNQNALNLQGNS
NSNNTSAVNLFRMSSPQNNRLTYLGNKTRTFQVNAALSVRGNDNTGSFYAFFIRKNGTIT
LTETNTIMRVNNTSDVVSNSIMGTVELAPNDYIEIWVQRLVTGTGNASTNTNIVVFSLNV
NIK
>KECLDBNJ_02657 Thioredoxin C-2
MSKFGALIDLEIPVLIDFFSEKDQASVAMNPVLREVAAALGDQIKVIKIDIEKNQDLAEA
LRIKGLPTLVIYKSGEMKWRQSGAQTTNALTSVLQKFI
>KECLDBNJ_02658 Peptidoglycan-N-acetylglucosamine deacetylase
MKLKFDLPVKTPKLLKRLYSGYVWDKYATSATEKTLYLTFDDGPIPDVTPWVLELLKAYN
AEATFFCIGNNISKNPEIFQQLVSSSHSIGNHTYNHLKGWKTTTETYLANAFKTEEIISR
FTTPQNLFRPPYGKIKRSQAKALKKRGYHIIMYDAIAYDWDQKLDGKTCADYIINNAQPG
SIVVFHDSLKAEKNMKIALPMVLQHFTEAGYTFKPL
>KECLDBNJ_02659 hypothetical protein
MTMTNFNFPKYNKIVGWLAFAIALITYSLTVEPTASFWDAGEYISTSSKLEIGHPPGAPL
YQMLGAFFSIFAPDSSYVALCVNFMSCLASAFTILFMCWSLSLLLRKLLKRNKTELTSSD
QIAVLAASFIGSTAFAFTDSFWFNAVEAEVYAMAMFMLSSLFYVALLWERDMFKPRGNRW
LMLICFIIGLSFGVHFMALLTIPAIGFLYFFKNYKTITVKNFIVANIIVVAVLMFIFKFL
LPYTLSFFGYAEVFFVNTFGLPFNSGTIIAGLVFIAIFYYILSYTRKKSYYQLNTLALSI
LFIFIGFSSWLMLPIRANAGTTINENNPNNARELLAYYNREQYPETHLFYGPQFTEIFGG
LDAQNPYVDGKPNYEKDEESGKYVIVNEWKNSVQNSEDRHKVFLPRMWSTDHIANYMQFT
GPLEFQVKPEYADNQELQQAVAQFKSDYAQGRMDNEGFQSTLMRLRQYIDVNPPSFADNL
AYMFDFQFGYMYWRYFMWNFTGRQDDIQGKYDNIHGNWLSGISFIDEARLGPQDNLPSDA
LKNKARNTYFFLPLILGLLGLVFQASRDKKSFWVLLVLFLFTGIALKIYLNERAFEPRER
DYALVGSFYVFAMWIGFGVYALYDLLKEKISAKVVLPVVTVVCLLAAPVILAAQNWDDHD
RSGRKTALAMAKMYLDSCDENAILFTIGDNDTFALWYAQEIEGYRRDVRIVNTSLFQTAW
YIDDMKRKAYESDPIPSQLSHDKYVAGNRDAIFYNELRPDDTLDIKTWMNWIASDDPRTM
EELQSGTMVHSFPTQHVSIPVDKQTVLANGTVAQKDADEVVSEIVVNIKESVIYKNRLLM
LDVIANNNWERPIYFTGGSFGDDDYLWMKDYLQLDGVCYKLVPIKTPIDPQAPYDMGRID
SDKFYDIATNWYWGNSGDPDIYHDTETRRNGITYRGNLARLTEKLIQEEKFDKAKNILDL
AMEKMPVDIFEYYTLLEPYISGYYQVGEQEKARELWEQVAKKYQEKLDYWSSLNLEQQYN
YAQDIITDIERYRSLVDLLIINQDQEIIPEKAREFNSYLRKFNQFYGEDETEPETVLPTE
PTQDSSIAIPADTLE
>KECLDBNJ_02661 hypothetical protein
MQTESQTSIHALYRLIDEECQLAQHSARAEQLQKAILKKFFKASDVVIRQTEREVHITMS
PLLSDARSAEINLEIPKARFSTFLQNCIKNDSGSKVFYTNMMRYFITNTIA
>KECLDBNJ_02662 Putative universal stress protein
MIKKLLLPTDFSEQATYAFEVACQLAKQYDAQLHLIHMVELPYSLIDVIDGNHNAQLPEA
LFFMKLAQQNFEKLRAEKYASDIELFEHVKFNSIQSGILDYAEEHEIDIIIMGSHGSSGF
EELFIGSNTEKIVRHSKIPVFVIKKRHVNFKINSLIFATDLENDNLKPVIQALEFAQTQK
AEFKMVYVNTPDRFETTEKIQALFKEFVQKLQIETPHFEIFNDLKVERGIMNYAKSQKAD
LIAIGTHGRKGLAHFFNGSLSEGLVNHAKRPVLTFKI
>KECLDBNJ_02663 Ribosome maturation factor RimP
MLKEKVTALLQEAFEEYENLFLIDLKIKGNNEIVVVIDGDQGVTVQDCINVSRKVEHNLD
REEEDFSLEVMSAGATEPLINIRQYKKNEGRDLEVVLQDGSKITGNLIQVHDEGIVLFWK
ERVPKEVGKGKMTVEKEEVIAFEAIKQAKVKIKF
>KECLDBNJ_02664 Transcription termination/antitermination protein NusA
MENIALIESFSEFKDDKLIDRVMLMAILEEVFRSTLKKRFGSDDNFDIIINPDKGDLEIW
RNRVVVADGEVEDENSEISLTEARRIEPDFEVGEDVSEEVKLIDLGRRSILALRQNLISK
IHEHDNTNIYKQFKDLEGELYNAEVHHIRHRAIILLDDEGNEIILPKDKQIPSDFFRKGE
NVRGVIESVELKGNKPAIIMSRTSPLFLEKLFESEIPEVFDGLITVKKVVRIPGEKAKVA
VDSYDDRIDPVGACVGMKGSRIHGIVRELGNENIDVINFTNNLQLYITRALSPAKITSIK
IDDENKSAEVMLKPEEVSKAIGRGGHNIRLAGQLTGYEIDVYREGVEEDVELTEFSDEIE
DWIIAEFSKIGLDTAKSILEQDVEDLVRRTDLEEETIADVMRILREEFE
>KECLDBNJ_02665 Translation initiation factor IF-2
MAEIKNMRLNKVLRELNISLDRAVDFLKEKGHEIEARPTTKISAEIYEVLSDQFQTDASK
KVASKEVAQEKQKEKEAIRQAREEEIEEKRQEQDSDKEVIRAKSNLQGPKQVGKIDLDKS
GKPKAAAPEKPKEEPKPVQKEEPVIEQKVEAPKVEEKKVEAEKPKEEEKPKVESKPVEKE
VAKPKAEAPKKAETKTEEPKLGDDVLKTDYKKLDGPNFTGQKIDLSQFKKPEKKKKPAAN
KDDKKRKRKRISKATGANPNSGGNNNNRGRNQRGGGRRNAPVVKEEPSEEEVQKQVRETL
EKLQGKSNKGKGAKYRRDKRDQHRQKSESEQAQQEAENKVLKVTEFVTVSEVATMMDVSV
TQIISACMSLGMMVTMNQRLDAETLSIVADEFGYEVDFVNADIEESVAVEVDAEEDLKPR
APIVTVMGHVDHGKTSLLDYIREENVIAGESGGITQHIGAYGVTLKDGQKIAFLDTPGHE
AFTAMRARGAQVTDIAIIVIAADDDVMPQTKEAISHAQAAGVPIVFAINKVDKPTANPDK
IKEQLANMNLLVEDWGGKIQSHDISAKTGVGVAELLEKVLLEAEILELKANPDKRANGTV
VEAFLDKGRGYVSTVLVEGGTLKIGDYVLAGTNSGKVKAMHDERGKEIKEAGPSTPVSIL
GLDGAPQAGDKFNVMEDEREAKDIANKRTQLQREQSVRTQKHITLDEIGRRIALGDFKEL
NIILKGDVDGSVEALTDSFGKLSTEEIVVNIIHKGVGAITESDVLLASASDAIIIGFNVR
PAGNARQVADKEEIDIRTYSIIYDAINDLKDAMEGMLSPVMKEEVTGNAEIRETFKISKI
GTIAGCMVTSGKIYRNSGVRLIRDGVVVYTGELASLKRFKDDVKEVSKGYDCGMQIKNYN
DIKEGDIVEAYQEVAVKKKLK
>KECLDBNJ_02666 hypothetical protein
MKRNLKKPLLYLIFSGIFSTATYAQTAKSNVIQDNKLPELLKLKSEMTVNNELADRYKIQ
LFYGQITEANKVQKDYNSSFSEWEPKIVYESPNYKVWVGNFRDRLDADRALLKIKEKFPS
AFVMKPER
>KECLDBNJ_02667 Menaquinone reductase, multiheme cytochrome c subunit
MKQGNYLNSASRFSIITLALLLSFSSFVFAQDAEPAEGAAQSETTPAVQGGDAAAGKALF
NANCAACHKLYSRATGPALYNVTERRDREWLYQWIKNNRALIDSGDPEAIAIYEEYNQTA
MNLFPQLSNADIDDILAYTDTPKPEPKAPAAAAGAAGQGGGGVSSTVILAILAVVLVMLV
AVLFLVNNTLRKFAVAQGVALPVKEARKPIWKSFVENQFLVLVSVIVLLLGGAYFAYGWM
MQVGVDQGYQPIQPIHYSHRIHAGDNQIECKYCHSSARTSKTSGIPSLNVCMNCHKSISE
VADETSEFSSVTEDYSKEFYDKEIQKLYKATGWDPATQSYTGETQAVEWVRIHNLPDFAY
FNHSQHVSVAGVQCQTCHGPVEEMEIMYQNAPLTMGWCINCHRETNVKMDGNPYYEKIHE
ELSKKYGVEQLTAAQMGGLECGKCHY
>KECLDBNJ_02668 Menaquinone reductase, iron-sulfur cluster-binding subunit
MSSNKKYWKSVEELNENSSIVEALKQNEFAQEIPMDEFLGDKDSLDASSTTRRDFLKYVG
FSTAAATLAACEGPVNKSIPYVVAPERITAGKADYYATTMADGFDFASVLVKTREGRPIK
IENNKLAASLGGNNARVHASVLSMYDTKRLQGPKIDGADVSWSELDGQLGDKLKNLGGKS
IVLLTQTFASPSTSKLISEFSAAYPNVKHVTYDAIGEQAALDAFESKYGERALADYDFSE
AEVIISVGADILGDWQGGGFGPTYAKSRVPKNGKMSRHVQFEANMTLSGANADKRVPMTP
AQQKKAVAAIQSIVSGGSANTGLPAELDEAVKSAAAQLRKAGSKGVFVTGVQDANAQMVA
LSINETLGSRIIDVQAPKMTRQGNAEEVQQLIADMNSGAVGALLVAGVNPAYSLPNADEF
VAGLENVDVKVSFNMKEDETGLLCNYLAPAPHYLESWGDVEIKKGQICLTQPTIRPLFNT
RQFQDSLLAWTGQGVTYYEYLKNNWSNASTSWNQALHDGFVAGSIPAAEETTEMSSATSN
GAITLSSAVAALAQEEASTSGYELTLYSSTGIGNGEQANNPWLQEFPDPITRTSWDNYLT
MSKADADKLGIENEITSKGALNGNYVNITLDGKTIENVPVYVQPGQAPGSVGLALGYGKK
AAVQEEMQVGVNAYPLYKDFSATQSVQIEKVGGVHEFACVQMQNTMAGRADDIIRETTLE
IFNTKDVHAWNPVGEVDYNHSEISVRDKNADIWESFDDTMGPHFNLSIDLNACTGCGACV
IACHSENNVPVVGKQEVRNFRDMHWLRIDRYYSSADTFEEETKTLEELPAFDSYSVVEKQ
SYDNPEVAFQPVMCQHCNHAPCETVCPVAAIGHGRQGQNQMTYNRCVGTRYCANNCPYKV
RRFNWFLYAENDEFDYNMNNDLGRMVLNPDVTVRSRGVMEKCSFCIQMTQKTILDAKREG
RAVEDGEFATACSNACDNGAIKFGDVNMPDSEIVELKNDKRKYYLLEDIGVKPNVFYQVK
VKNTAEA
>KECLDBNJ_02669 50S ribosomal protein L21
MSSHYEAPIREPLILGEKSYHDISVDVGAPILGKANKSWWICFSIALIAFLWGLGCIVYT
VSTGIGVWGLNKTIGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTI
FAVVQAGLFPIIHMGRPWLAYWVVPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMIRDRTKSPFQQKIYGILSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSFDFATSVVPGWHSTIFPPYFVAGAIFSGFAMVQTLLLVMRKVVNLENYITIVHIEFM
NKVILLTGGIVTVAYLTEYFIGWYSGVPYENYTYLSFGAATGPYWWAFWALIICNLIVPL
TLWVKKWRRNILWTFIVALVINIGMWFERFDIIVICLSKDRLASTWTMFSPTFVDIGVFV
GTIGFFFVLFLLYARTFPVIAQAEVKSILKSSGERYKRIRESGEDLAGTATDERTSNYAT
RPESLAAASNAKSTYHQSTVNADALVDTETKKAEIDLMLAKIGTYDPATQSADDLQKISG
VGPVLEQKLHQLGIYTYDQVSKMTKTEYDLLDEIIDAFPGRAERDDWAGQAQNLKQ
>KECLDBNJ_02670 hypothetical protein
MASGNVLHVLYNDDDILMKAVKALRSKHYRIIEVYTPFPVHGLDKAMGLPYTRIAICSFI
YGLIGLSVATLMMNFIMIEDWPRNIGGKPSFSYLQNMPAFVPIMFELTVFFAAHLMVITF
YMRSKIWPFKKAENPDVRTTDDHFLIEVDAANHDLDELSKFLYDTGATEISLIHNEEHA
>KECLDBNJ_02671 hypothetical protein
MKNNIQILGSLVMMLVFMASCQDKDHPNYQYMPNMYEDVGYETYGNYEVFPNGMEAMQPA
EGTVSRGWMPYGYENSTEGYEAAKASLKNPVPYTEDNLNEGKALYTIYCAICHGDKGDGK
GTLAKREKILGVPAYNDQGRAITEGSVYHVTYYGLNTMGSYASQTTERELWLINHYVLDL
KDALDGKPKRAFIDEASSEDVASVEETAGEEETTEAQTEE
>KECLDBNJ_02672 hypothetical protein
MYTLSSKLRLFAIISMVLGLVGVVYGFLSVPATVEEASEVLAAHEAHHGEEASHEEANFV
DEARQEHGYSEKAMAHDKDMGHEAHGQGEHMEHVLHQMQTKPWSAVFVAAFFFMMIALGT
LVFYAIQNAAQAGWSPVLFRVMEGITNYLLPGSVIVLLIVIFAGEHFFPWQNHELVAEDT
ILQEKSVYLNFPFWLIRGIIYVIGWNLYRHFARKNSLAMDDAEGDRPYKNLFKYSVYFLA
FFIVTESTMAWDWFMSMTPHWYSTLFAWYIFASMIVSAVTVIAIVTVSLKTIGKLEFVND
SHLHDLAKFMFGFSVFWTYLWFGQFMLIWYANIPEEVTYFILRIQEYNPIFFGMIIINFV
FPIVILMNSDFKRVSWFVVIAGVFILVGHYIDIFLLVMPSTVGPHWSFGITEFAALLFFL
GLFILMVGLGLAKVSLRPKNNPFLVESEHFHY
>KECLDBNJ_02673 Alternative cytochrome c oxidase subunit 2
MTVFLVLIVIILFAVAIWQMSKIYALSKGSSAEDTQDVANGKDNRINAKLMVMFMVFLYF
LMFYCFWHYSKFYLPEASSAHGGKYDNLMFISIALIMVVQVITQFLLHFFAYKYKGEKGK
RALFYADNDKLEFIWTIIPVIVLAGLIIYGLFTWSDIMNFEEDEDALVVELYAQRFNWKA
RYAGEDNILGDANVRFIEGVNQLGIDPSDADGKDDVVTQELHLPVGRQVIFKLRSQDVLH
SAYMPHFRAQMNVVPGMITQFSFTPTVTTEEIRETEYMQDKMRTIQEIRKEKSKELVAAG
EPALDSYDEFDYYLLCNKICGASHYNMQMKIIVESQEDYEAWLETQKTFEASIAQQ
>KECLDBNJ_02674 Alternative cytochrome c oxidase subunit 1
MSANATAFEHAHDDHAHHDDHAHHDHHQTFISKYIFSTDHKMISKQYLITGLFMGIIGIA
MSILFRIQLAWPEESFTIFEIFLGKWAPEGVMDSSIYLSLVTIHGTIMVFFVLTAGLSGT
FSNLLIPLQIGARDMASGFLNMVSYWLFFLSAVIMCSSLFVEAGPAAAGWTIYPPLSALP
ESISAAGTGMTLWLVSMAVFIASSLLGSLNYVVTVINMRTKGMSMTRLPLTIWAFFVTAI
IGIISFPVLLSAALLLIMDRSFGTSFFLSDIYIGGEVLHNSGGSPVLFEHLFWFLGHPEV
YIVLLPALGISSEVIATNARKPIFGYRAMIASILAIAFLSTIVWGHHMFVSGMNPFLGSV
FTFTTLLIAIPSAVKAFNYITTLWKGNLQMNPAMLFSIGLVSTFITGGLTGIILGDSTLD
INVHDTYFVVAHFHLVMGISALYGLFAGVYHWFPKMFEGRMLNKNLGYVHFWVTAIGSYA
VFFPMHFIGMAGLPRRYYSNTAFPYFDDLADVNVMITIAAIVTASVQLVFLYNFFSSIFY
GKKGPKNPWKSNTLEWTTELKHIHGNWEGEIPSVYRWSYDYSKLNEDETDYVIPGQDFVP
QNVPLQPNEEEMNH
>KECLDBNJ_02675 Holliday junction ATP-dependent DNA helicase RuvB
MNEHLDPTGEGFSHEEYDIERALRPLSFDDFTGQEQVIENLEVFVQAANGRGEALDHTLF
HGPPGLGKTTLANILANELGVNIKVTSGPVLDKPGDLAGLLTNLEERDVLFIDEIHRLSP
IVEEYLYSAMEDFKIDIMIESGPNARTVQITLNPFTLIGATTRSGLLTAPMRARFGISSR
LQYYNTELLTTIVQRSAEILRVPIDMEAAIEIAGRSRGTPRIANALLRRVRDFAQIKGNG
TIDIEIARFGLKALNVDAHGLDEMDNKILATIIDKFKGGPVGITTLATAVSESAETIEEV
YEPFLIQQGFIVRTPRGREVTEAAYTHLNRVKGPIQGGLF
>KECLDBNJ_02676 Putative cytochrome P450 120
MAKPFPKVSMIQFLRSALSILKNPLPFHKRNFEAKGDTFRLKIGFSRSVLFSRDARFAQH
ALQKNQKNYQKSPIQTKDLAKYVGRGLLTANGEHWAKQRKLIQPAFHKKTIHGLLHKIDE
VIQKELSKIESDKTFDIFPIFNDLAFNTVVQALFSNVIDQQDINRLQNITERNQRMMVKE
LRQPYLNWWFQLSGALKKALNESLEARQILSKLIDARIASETRHDDLLDMLLDARYEDDT
PMSREQLIDEILILFIAGHETTSNALTFTAALLARDPKIQEKLYVEALQAQQESDLLDKI
KKLTYTNQVINEAMRLYPPAYFIDRISIENDQFEEFEIEAGTNILFSIFEIHRHTDFWER
PDTFNPDRFADDSLKYSPYYYPFGAGPRMCIGNHFAMYEMVLTVSQLMCKFKIQEEASPI
AINPLITLKPKDVLLTFIPRDRE
>KECLDBNJ_02677 Epoxyqueuosine reductase
MNNTKAKHTAWIKAKAKELGFMSCGVSKAGFLEQEAPRLEDWLNKNRNGEMHYMENHFDK
RLDPTLLVPGAKSVVSLLLNYYPEETQREDSYKISKYAYGTDYHFVIKDKLKEFLEAIRA
HIGEVDGRAFVDSAPVMDKAWAAKSGLGWVGKNSNLLTKQVGSFFFIAELIIDLELEYDT
PVTDHCGSCTACIDACPTQAIVDPYVVDGSKCISYFTIELKNEIPDYAKGKMDDWMFGCD
VCQDVCPWNRFSKPHNEPLFNPKPELLQYSKKEWKELTQEVFSEIFKKSPVKRTKFSGLK
RNIDFLEDIKDPE
>KECLDBNJ_02678 hypothetical protein
MNKVLYTLKKPNLSFWQIWNMNVGFFGIQFSFGLQQTAINPIFSFLGADHADLPLLNLAG
PVTGLLIQPIIGAISDKTWLPKWGGRRKPFFLIGAILGSLCLFAFPYSPELWFAVGLLWI
LDVGNNTAMEPYRAFVGDKLNDDQLTFGYQMQSLFVGAGITIANFSLFLFQDWFGSSAEQ
SAALCSTATETVSNIPTWVYYSFFLGAIASVLTISWSVWKTTEIPPSDEALAALKKEKRD
STFLQRIQEPFAEIIGAIGNMPSMLKKLAAVYFFQWYALFVYWQFVTPMLRNSIYGLTNE
DNQRFEAIMEACKSGGTVGTGDTAFAQNFQMVSEQALAQTGLMNGTYNFVTMIVALALVP
FAKKYGSRNVYVLSLVFTGIALLSMPFITNEYALLIPMVLFGIGWAAMMGIPYAMVSKVI
PEEKRGVYMGIVNMMIVIPMLIQTVTFGPIIKNLLGDNAVNAILFGGVFFIIAALLALRL
KKSYSSDEIKLR
>KECLDBNJ_02679 NADP-dependent malic enzyme
MSKESKRREALVYHAKPKPGKIAVVPTKKYSSQRDLSLAYSPGVAEPCLEIEKDKENAYK
YTAKGNLVAVISNGTAVLGLGDIGPEASKPVMEGKGLLFKIFAGIDVFDIEVDTKDVDAF
IETVKNIAPTFGGINLEDIKAPEAFEIERRLKEELDIPVMHDDQHGTAIISAAALLNAVE
LTNRKMEDIRIVVSGAGAAAVSCTRLYKAFGAKAENIVMLDSKGVIRSDRANLTVEKAEF
ASDRKIDTLSEAMVDADVFIGLSIADIVSPEMLQSMAPNAIVFAMANPNPEIDYNLAMDT
RDDIIMATGRSDHPNQVNNVLGFPFIFRGALDVRATKINEEMKMAAVKALAELAKESVPE
QVNIAYGETRLNFGSDYIIPKPFDPRLIAKVPPAVAKAAMDSGVAREPITDWVKYEDELH
ERMGSDNKIVRLILNRAKTEPKRIVYAEADQLDVLKAAQIIHDEGIGVPVLLGNRETIIE
LMEELDFDADVQIIDPKTPEEKPKLNEYAQIYWQERKRKGVTLYDAQRLLRQRNYYASMM
VKQGDVDAMITGYSSSYPSAVKPVLEVIGSAPNVQKVAAANLMNTSRGPLFLADTSINIE
PTAKELAKIALMTARTVRLFGMEPVIAMISYSNFGSSKNPQADKVREAVSYLHKYYPDLA
VDGEVQADFALNAEMLKSKFPFSKLAGKKVNTFVFSNIDSANIMYKMVKELNNADNIGPI
MMGMNKPVHVLQLGASVDEIVNMSAVAVIDAQQKGKKLQEELLGEANKA
>KECLDBNJ_02680 Holliday junction ATP-dependent DNA helicase RuvA
MITFLRGKLVEKNHTDVVIECNGIGYFVNISLHTFSLLPDGESIMLYTYLHIKEDAHTLY
GFAHKSEREIFKLLISVSGVGTSIARTMLSSLEPSQVKQAIATGDVKTIQGVKGIGAKTA
QRVILDLKDKILKVYDINEVSPIADNTNKEEALSALETLGFARKQAEKVCTAIVRDEPQA
SVETIIKLALKKL
>KECLDBNJ_02681 hypothetical protein
MGTKLRWFSLQMLFISGTLLCSMPVFAQEEEQDSTQTGVSLGKLSLKNPNSIVAKYTYDP
LTDKYIYTETLGQYNINYPRILTPDEFKELVKKERMKTYFQQKIAAVDGRTEEGKESQNG
LLPIYYVESDFFESIFGGNTIEFTPQGSVEMDIGGLFTKQDNPSFSPRNRSNFSFDFDQR
ISLSLLGKVGSRLQVNAVYDTESTFNFQNQIKLEYTPNEDDIVQKIEVGNVSMPLNSALI
QGSQSLFGVKTQLQFGKTTITGVFSEQQSQTNQVVAQGDGTIQDFDIYALEYDENRHYFL
AQYFRDNYDRALANYPFINSNVQITRIEVWVTNRTQRFENTRNIVAIQDIGESDPAKIGL
PTIPGGFVNLPAGAYPRNSSNDFNPFGIDGTGQSVLTSAIRDVATVQQGFGGVQVADGSD
YVSLENARQLTAAEYTLNTQLGYISLNQRLNNDEVLAVAFQYTVNGEVYQVGEFANDGVD
ATSGAYADADGDGVPDIVDVDPDGDGVNNNGQDTDGDQIADAADADQTNGSDINNDGILD
SFITPGQGGTSQALVVKLLKSNITDVEEPIWDLMMKNIYGLGVGQLEADGFRMNIVYNAP
SPINYITAAEGGPALPDDVANTPLLNVFNLDRLTQYGDPQVGGDGFFDFQEGITVNVQNG
SIIFTSVEPFGEYLFDKLRATAGENYENSDTYNANQRKYVYTSLYESTKTIAQDNADKNL
FQLQGTFKSTQEEGIPIGAFNIPQGSVTVTAGGRVLQEGLDYSVDYARGRVIILDQALKG
SGVPIQVSTENNALFGQQTKRFTGLNVEHQFNENFMIGGTLLNLNERPLTQKATYSFEPI
NNTIFGFNANYSTEVPFLTRLVNKLPNIDTDVPSNISVRGEVAYLIPGQPKATEFGGEAA
SYIDDFEGTQTSLDISSPLQWFLSSAPIDFGGELSNGDLRTGYKRAKLAWYTIDPIFYTS
QRPDGITDADVSTYATRRVFRDEIFPEQDIIAGTTQALFTLDLAFYPGERGPYNYSLDAQ
DGILENPVENFGGIMRQFASTDFEQQNVEFIEFWVMDPFIYAENATNTGGRLTIDLGNIS
EDVLKDGRKQYENGLPQDGSASNTVATSWGKVPTNQALIYAFDTEGEQRTNQDVGYDGLS
DDQEAVNFPEFAGFEDPSADNYQYFVAANGSVLNRYKNYNGLEGNSPVDVSQTDRGSTTV
PDVEDFNRDFSMNTVDSYYEYQMEITPQSLDISNEFIVDQRDIEVTLQNGNTMPVTWYQF
KIPISEPTGSKGGINDFRSIRFMRMYMSGWEDPTVLRFGAFDLVRGDYRRYLYTLDPDES
DPSTENTRFEVTSVNIEENNNRNPIPYVLPPGVYREELINNNNNIRQNEQSLSLTVCDLE
TQDSRAVYKNFRLDMRQYENLEMFIHLESLINEVAIQENEMVAIIRMGTDLTSNFYQIEL
PLTPTAFGTTSPDLIWPEANQLKVPLDVLQTVKATFFNGNYNTLLDEITYFDEEGNPIAD
PAGTPYETGKVRVGIQGNPSFGDVRVLMLGLKNGNDEGRSTVCAEAWFNELRLSGLQNEG
GWAGIVNMDANLADFATFSGTARQSTTGFGSIDAGPNQRAREDVKSYDVVTNVNLGQLLP
QKWGIKVPFNYAKGVETITPQYDPLYTDLELDDRLASASSEAERERIKEIAIERTKRESI
NFIGVRKERTGDKKPMPWDIENFTFAYSHNQEEHKDFEIEQSVNKNVRAGATYTMAFQPK
TVEPFKKNDSLFANKYWKLLKDFNFNYLPASVNISSNITRQFSQQRFRDILATEGSIPIP
EYLQRNYQFDRNFTINFPVTKSLRINLDQYQNRVVRNYLNPDSSIDENAGGVYSQFFDVG
TPDRHNQTMQLNYDLPVNKLPFLDFVKSTYSYSADFQWTRGSYQFQTLEGIPDLGNSVQN
ANTHALQTTLDMKTLYDAIGLSKKSAGPSSRSDRSRAVPTLGTPTQPKQQQEENALSAGE
KATNTLIGIATGIKRIQVNYEQNNGTYLPGYLPGVGFLGTVRPTTAFVFGSQAEVRDYAA
RQGWLTLYQEYNEQYSEVENRNLDIQAQTSFLEDLTIDINMNRIYQETYNENYRVNPTTL
EYNSLTGNTLGNYSISTLMIGTAFNSSSLESSANFNRFRSNRLVIAERLAEDFYGNDQYP
RDENGYPVGFGRTSQRVLLPAFLSAYTPGNASNVSLGAFRSFPLPNWNLKYTGLMKLDWF
KKRFKRFSINHGYQAGYTINQFRTNLNYDRDLNNDPSDAQTNQAGDFLNPTLYSNINLTE
LFSPLVRLDFEMNNSVKILAELRKDRTLSLSFDNNLLTEIHGNEYIIGLGYRLKDIRFAT
RIAGRQTVLKSDLNFRADLSLRQNETIVRYLDLENSQITAGQDIYGLTFKADYALSKNLT
AIFYYDHAFATYAISTAYPQTTIRSGITLRYNFGN
>KECLDBNJ_02682 Glycine cleavage system H protein
MSLPADLKYTKDHEWVRIEGDVATVGITDFAQGELGDIVYVEVETEGETLDREEVFGTVE
AVKTVSDLFLPLTGEIIDFNADLESEPEAVNEDPYGKGWMIKIKFSDESELETLLDASAY
QEIIGG
>KECLDBNJ_02683 hypothetical protein
MDNLLKIAVYIYTAFIAFVCLMPMPHISDAPKDSDKIVHLLAYTFFVGLWFLFFYCLKQK
KDNFLPALIKSCILAFIYGIIIEILQGELTTSRSADFNDVLANSIGIVIGILLVFLAKTQ
FIKLKSKL
>KECLDBNJ_02684 hypothetical protein
MEPKKNPKADLSKRSVLFFQLGLILILGLSYLAIEWKTYEKEAIDIGQLQMDDMLEEDVP
ITELNTPPPPPPPPPPPPAPEQIEVVEDDVEIEETVIESTETSQEEEIVEVEEVSFEEEE
VIEDVPFAVIENVPVYPGCEGEKGNDAKKKCMSEKISQFVNRKFNTELGSELGLSGINRI
YVRFKIDQKGNIVDIGSRGPHPRLEQEAARVIKLLPQMTPGMQRGKAVGVLYSLPIVFQV
QD
>KECLDBNJ_02685 hypothetical protein
MKNSQESSKVARQSDNRATSKHDVNLRKNNVVHFQVGLILALILAIIVIELKSPLLAQEP
PKMNDVAVVSFNDDWNEPIRREVKKPEAPKPVVVSLDVPPIVDEELPETLELEVETPEPT
SEAPDVTDIEPVPDDEPVVWVPFMAVETVPVFPGCEGLKSNAERKACMQEKMNAHISKNF
DTSLGDKFGLKGMNKVDVQFTIDEYGEIIDLRTRAPHPALEKEAIRVMEKLPSMEPGKQR
DRKVRVIYSQPIWFKVQN
>KECLDBNJ_02686 hypothetical protein
MSLKTFAFGCVLLISTTGIAQLISGNFEKYPVFSSCETVAAADSKDCFNQTLIAKIKTEF
KIPQDILDTNYKGDMVVLFEVTKEGVFKVINITAVSEALREELKRVFDELPKVKPATYNG
RPTYMQFSMPIPVPEGLRSASDSLEVNDKSFGVTPVQDLESEYDAIKTFPFKNREYNSEL
YIPFSHQTYSRFDQEMNAVGTNAHTAGKPFIYSEVNKYYDLKEKREILYKDKESWFGRKL
WNEHMVTLQGEDYWFTLDPAADLQFGFETADNEDQSFTYNNTRALIFQGGLGEKLNFYTV
FYESQGTFAGYFNRYARSIAPDGGNPAIVPGRGVAAEAADGNFDYPVAEAYLSYSPSKYF
NFQFGHGKNFIGDGYRSLLLSDNASPYPFFKMSTSFWKFKYTNTWMSLRDVRSDVVENGS
FKTKFMANHYLSFNATKRLNIGLFENVIWTNDNDRGFDLNYLNPIIFYRAIEFSTGSRGG
NALIGLSAKYKFSNQFNAYAQVIIDEFSTGAVFSSTKSFQNKQGVQLGVKYYDAFNVDNL
QLQLEFNQVRPYVYSNNEIILNYGHNNQSMAHLWGANFRELIAIARYQNDRWYGTAKAIY
GKRGFEIGDIDDVYYGGSIYGNDENIPSEFGIEIGQGNAATTLIGNVELGYIVNPSTNFK
CYANVLYRNHTIDQFDPVNLEESTLWVNFGIRTDIFNWYFDY
>KECLDBNJ_02687 hypothetical protein
MKAALLGLLIMLSTLATSCKNETTPMKEFDTNFAHVVYFWLKNPESQEDRSAFEASLKKF
LSTSDYAQTQFIGTPANTPREVVDNSWTYSIILTFPSKEIQNKYQQEPVHLKFIEESEDL
WERVQVYDAVGLE
>KECLDBNJ_02688 Protoheme IX farnesyltransferase 1
MRLAISVVFSSMAGYLLGAYTLDWVTIVMLAVGGYLMVGASNAYNQILEKDLDALMDRTK
NRPVPSGRMSVRTAFVIACVFTILGLVTLYYINPITAVFGGISIFLYVCVYTPLKTKTPL
SVFVGAFPGAIPFMMGWVAATGDFGIEAGTLFMLQFFWQFPHFWAIGWFLYEDYKKGGFF
MLPTGRQDRGTAVQVVLYTIWTILVSLIPVFGVTGRLYLTPVSAVLVGILGLVLLYYAIR
LFRFKNNVTAKRLMLSSVSYITLIQIIYVADKFLR
>KECLDBNJ_02689 Cytochrome bo(3) ubiquinol oxidase subunit 3
MDYTSQSEQTKIARSKKMMLWFGIISLSMMFAGLTSAYIVSSERRDWLRDFELPQAFYIS
TFIIILSSLTMLVAKQAVKTSKKSLATIMLLLTLGLGIAFVAYQFIGFDQIIANGYFFTG
SESTVTTSFIYAFVISHIVHVAAGLIVLLVVIVQQLRGKYTKDQMLGLSLGATFWHFVDI
LWVYLFLFFIFADDLIH
>KECLDBNJ_02690 Cytochrome bo(3) ubiquinol oxidase subunit 3
MDATAVKTGTEGKIWGGGEAQPLKASYGKMMMWFFILSDALTFSGFLAAYGFSRFKFVNQ
WPIADEVFTHFPFLHGVDAPMYYVALMTFILIFSSVTMVLAVDAGHHMKKNKVIWYMFFT
ILGGFIFVGSQAWEWANFISGEYGAIETKGGKILQVVNAEGEQVALESFAVELPSARTQL
TKSEALWYESESSMPDFDLAEVVEGFKANPDLLIRTQLLTEAGEKTILSREESLAKLEND
AMGVVQGANLIHNEYGPPLFADFFFFITGFHGFHVFSGVIINIIIFINVILGTYERRGSY
EMVEKVGLYWHFVDLVWVFVFTFFYLV
>KECLDBNJ_02691 hypothetical protein
MAHDATNHGSATKRIWTVFAILSVVTIVEVILGIIRPAFLVETHLLRMHLLNWVFIILTI
YKAYYITWAFMHMEHETKGLRRSIVWTAIFLICYLIFILLTEGDYIFDVYDEGYISWDF
>KECLDBNJ_02692 hypothetical protein
MKKFIVLGVLFILPIVAYLFFASGVHNFAKLPVLEEQLPELPFDQKVKLQDKITVLGFLG
STIEREGGDLFNLNQKIFKPFAAFDDFQFVYLVPEEIDDAALEKVTYELGQLVDLSNWYF
IKTSQERIHTVFNNLNTPYSLEADGGSPYIFIIDKDRNLRGRDDDEDYGVLYGYDSTDIA
ELADKMKDDVKIILAEYRLALKKNNADRKK
>KECLDBNJ_02693 SCO1 protein 
MNRKKTYIGIAVIVLIFGIIVIPKIIDRSMRGEVVDNDRLNVGQLDTQENDGELAYININ
GADRKVPHFEFIDQNRDTITEETYKGKVFLVEFFFTSCPTICIPMNKNLVLIQNKFQDNP
DFGIASFSIDPEHDTPEVLKEYTESYGITDPDWHLMTGDRKEIYELANVGFNLLAQENPN
IEGNFQHSGLFALVDQNGFIRSRRDEFGNPLIYYRGFIPYGAPEVEGEETSQIDILIEDI
NKLLNKNKK
>KECLDBNJ_02694 hypothetical protein
MENLAQKEKVYNRWIIALSIAIPVAVAFLFTIRIPNVPRLGFLPPTYAAINALTAILLFS
AVIQIKKGNRKLHERYIKICIVLSVIFLVLYVLYHATSDSTKFGDANLDGIVSEAESAAV
GIYKYIYYFILISHILLSIGVIPFVLVTYVRAMLGKFALHRKIARITFPIWLYVAVTGVI
VYFMIFPYYPA
>KECLDBNJ_02695 hypothetical protein
MKRFLLTVLFIVVSFVANAQCAMCRAVLESETDNSMAEGVNNGIIYLAAIPYLLMGGLIW
FIYKSRKKANKGA
>KECLDBNJ_02696 putative ABC transporter ATP-binding protein YknY
MITIKDLHKSYTMGTNSLHVLKGINFSVQEGELVSIMGSSGSGKSTLLNILGMLDEADQG
SYTLDGVPIKNLNEKIAAQYRNKFLGFIFQSFNLINYKSALDNVGMPLYYQGMKRKERTE
KAMAYLEKVGLANWAHHMPNELSGGQKQRVAIARALASDPKVLLADEPTGALDTKTSYEV
MDLIQGINDEGKTILIVTHEDDIAHMTKRIVNLKDGLIIDDAPVNQIRAASHV
>KECLDBNJ_02697 Macrolide export ATP-binding/permease protein MacB
MFSLERWQEILETISKNKLRTFLTGLSVASGIFILVILLGFGQGMQNGISAEFQRDAANR
ISVYSGVTSMGYKGLNPGRFIEMTNDDYNYLITKYEDDIEFKSSVYRIWSGTLNYGNESG
SYRVEGVYPDYQFLENENLVAGRYINYDDQRLKSKIMVIGNKVQQDLFAGKSAVGEYVQI
NGINFKVVGVYSDPGGEREETRVFVPLSTSQRVFGGADKVRNLGFTLKPQENFEDALAQS
LQFSAEIEEFLKERHLVAPEDTSAINVNNTLESAKRFYDLIGMIKTFFWVVGICTIIAGV
VGVSNIMLIIVKERTKEIGIRKALGAQPLSIIGMVLHESIFVTAIAGFTGLILSMALLEV
LGPNMQMDYIKNPSVNFNVAITTVFILVFAGALAGFVPAWRAARIKPITALREE
>KECLDBNJ_02698 Macrolide export ATP-binding/permease protein MacB
MFSKDRWDEIIEALSQNWFRTALTAFGVLWGIFILVVLLAAGKGLENGVKKDFGGIATNT
MFMWTQTISKPYKGLPKGRRFNYDLDDVAALKQNIPQLRFVSPRNQLGGFGGANNVVRGL
NSGAFNVYGDYPEYIEQQPMNITSGRFMNYGDIQQKRKVAIIGEGVKNALYDKGEEPIGT
YIKINGVNFMVVGTYAKVASEGDSEENQKEIYVPFTAFSQAFNMGNRVGWMAVTAKDGFS
ITALKPKVFDVIKSRHSIHPEDERAIGNFDLYEQYQKVDGLFIALKIVAYFVGILVLLSG
IIGISNIMLIVVKERTKEIGIRRALGASPWSIRGQILMESVFLTIISGMVGISLGAALIY
VLNKILDANGPVEMFANPSVDLGTVITALFILIFSGLLAGFIPAQNAIKVKPIDALRTE
>KECLDBNJ_02699 Macrolide export protein MacA
MKKSVTIVVLAVIAVIFIGSLYYLYQKNQEDPVVYTTESPSTQTIVKKTVATGSIVPREE
VLIKPNISGIIKEILVEAGQFVEAGDLLAQIEVVPNASSLVSSRNTIQTAKTNLETAKLT
LENQESIYQRQKTLFDKGVVSANDFDNSQREYNQAVQNYKQQQVSLASAQQNYDIVKTGT
TTGLGNNATTSVRATITGMVLEVPVKEGNQVIESNNFNDGTTIASLANVNDMIFEGKVDE
SEVGKIKEDLPLEITVGAIENKKFDATLDYIAPKGVAENGAIQFEIKGTLAKKDSTFIRA
GLSANASIILERADEVLAIKEALVQYDSKTQEPFVEVEVGEQEFEKRDIKLGVSDGIYVE
ILDGVSADDKIKVWNAVKPAQSF
>KECLDBNJ_02700 Outer membrane protein TolC
MRNAILFFILVFSVASGFSQKKWTLQECIQRALDENIQIRQAQLDVEAAALDKSDADGSF
LPTLNANASVSENTGLNFDPTSNLATTTQFLSASGGINTSYNLFDGLRNFKQVQRAKLSA
LAAQYGYEKLEDDIALNVANGYLQVILNKENLKVLRSQNEVTQQQLQQTTDLVEGGVAPR
GDLLEVQAQNANEVQNIVAAENAVQISLISLAQTLLIRDYKNFDIADGDYQIYGEDVLLK
TPAEITDAAKEERYEVKIAENNLELAEKDVEIAKGAAWPTLSAFFGYSTRYSEQDVLNSF
QEQLYLNDGVSYGLRLNVPILNGFQTRNNVRRSKIAADRAAINLEQAQLDLESTVYQAYL
DAKGALKTFEAAQTAVESQELAFSYSQDRYEVGLINAFDFSQSKQRFDNAQIDLNRAKYD
YIFKLKVLELYFGVPVEELKF
>KECLDBNJ_02701 Macrolide export protein MacA
MNRKTLIIILVVAVVLIAALIGGKKAGLFGKTGEFKPVETQEIALASVVETVAATGKIQP
ETEVKISSEVSGEIIELPVVEGQQVEKGDLLVRINPDLIQSALTQAQASLQNVKANQAQS
EAALKVAKANYERNQKLFEKGVISRSEWDQSISDYEIAQANVKSAFYNVQSAAANVNQSR
DNLSRTSIYAPISGTISKLDVELGERVVGTQQMAGTEMMRVADLGNMEVEVDVNENDIVK
INIGDSTRVEVDAYLKKRFKGEVTEIANSAESNLTADQVTNFKVKVRILEESYKDLVEGK
PEAYSPFRPGMTATVDIITNRVDDAISVPISAIVIKNDTIATTGFGTSQYEAVFVKNGDK
ASLKRIKTGIQDDSNIVVSEGLETGDEVITGPYNTVTKLLKDGDMVEVKKDAKFGASEED
>KECLDBNJ_02702 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MALILCLETTTTNCSVALSRDGNVIALKEDMGLNYSHAERLHQYIDAVLAEASLNKQDLD
AVAVSKGPGSYTGLRIGVSSAKGLCFALDIPLIATNTLKALAMQADTTDVQTIIPVLDAR
RMEVYSAIFDAEFKELRGIEAQIIEEDSFQEQLTNGKCLFIGNGSEKLKDILNHTNAHFA
TEALPSAREMAHLAEAKYKISDTEDVAYFEPFYLKDFLVTKSKK
>KECLDBNJ_02703 Small-conductance mechanosensitive channel
MDFDITQWEDYASRFGAKIIDFIPSLIGAVLTLFIGLWIIKMINRLVKKFFAKKDYDATL
EKFIADLINWTLKILLFVLVVTQLGVESASLVAVIGAAGLAIGLALQGSLANFAGGVLIL
LLRPFKVGDWISAQGVDGSVKEISIFNTRLVTFGNQEAVIPNGKLSNDNIINYSSLGIRR
NAQTWGISYDSDIKLAKDILLELVNEQETVLHDPHPEPMIVVTELADSSVNMSLRFWATN
DDYWALHWYILEEGKRRLEDKGIVIPFPQRDVHVFNESGATFSSKE
>KECLDBNJ_02704 Calcium dodecin
MAVLKVIEVLASSNKSWEQATANAVKEASKTVKNIRSVYVNEQSAVVTGDTVSEFRVNVK
ITFEVK
>KECLDBNJ_02705 Fe/S biogenesis protein NfuA
MSTFNITIEPTSNPAIKKFQANSFLVDHNSYEFKNIDEAKNSPLAQQLFYLPFVKTVYIA
QNFIAIEKFNIVEWIDIQDELSGQIENFLNDNGVVIIEDASTAKKIPVTVYAESTPNPAV
LKFVTNKKIVTETLEFKNIDEAKNAPLALALFHFPFVKEVFMDSNYVSVQKYEVAEWDDV
FQEVREFIKNYIEEGKEIVSENFKKTPQAVEQQKEVEFEALDDTSKEIANIIEEYVKPAV
ASDGGNILFKHYDPESKNVKVILQGACSGCPSSTFTLKNGIETMLKEMLRGKINSVEAIN
G
>KECLDBNJ_02706 hypothetical protein
MRKVLLLICLVCGFYAKGQEGIPVYWDYLTENLYLLHPSMAGAANANQIRLTGRQQWFDV
EDAPNLYTAAVNGRVGEKVGLGMQLFSDENGNFSQRGVYGTFAYHLLLSRNYVDLNQLSF
GVSVGLMQNTLDESSFDLTDFDPIISGGSQTDNYFNVDIGMSYYFLDFWAHATVKNVLPR
NRAMFTALESTNQRRYLASAGYVFGKLNSPWSYEPSVMFQATDETQEVSVDINGKVYRKF
DWGKLWGGLSYRRNLDGAQYLNSDGDVESQKSQYLTPFLGVNYKRFLVGYTYTYQQNDIV
LSNGFHQITLGYDFGERREPYECNCPAVN
>KECLDBNJ_02707 Glutamate racemase
MQHKQPIGVFDSGVGGTSIWKEIVHKLPQEDTIYLADIKNAPYGERSKEVILALSIKNTE
YLISQGCKIIVVACNTATTNAIDVLRANYAIPFIGIEPAIKPAALASKTKAIGILATKGT
LSSALFARTSSLYTTDLNVIEVIGTGLVELIEGGKLHSEELFKLLKSYVQPMMDQNIDYL
VLGCSHYPYLIPVLKKILPEHVQIIDSGQAVAKQTERILSENKLLFEGEKEGKHTLFSNA
SIEVLQALTEDVPVNRSVSFLDF
>KECLDBNJ_02708 hypothetical protein
MKHVKTLVVALALILGTTGFVQAQDSKVAHIATQELLTSMPEYKKAQADLEKLQNSYDAE
MNTMANELKKTMERYGNEAQSQTDETNLQRQAEVEQTRNKIMEYRQNALRDLQKKESEAL
QPIVEKARTAIQKVARAKGYKYVLDSTTGTGLILADGYDLMADVKKELGI
>KECLDBNJ_02709 hypothetical protein
MKNNVIFLSIALIFLGLTAEAQRSIRIGYVDMNYILENVPEYQEAQAQLDKRVADWKKEI
EKRTKEIDQMKKALENERVLLTQELIKEREDEIKFVENEVLQYQQKRFGPEGDLMKQRSI
LVEPIQDQVFNAVQEIAEARQYDFVLDKSSDLVMLYANKRHDISDQILLSIKRSSKRTQV
NSRADKEELKRDEALTLDQVNEREEREAEAQAQQTEREQIIAERKATRDSIQAARKAEYE
ARRQKLLEERQRRRDSILEARKKVKDSIN
>KECLDBNJ_02710 Outer membrane protein assembly factor BamA
MPKQAGLFLAFLLNCLTFTTAIAQEDLPVSNGKQYTIGEISVVGAKQYNEQTVIAFTRLR
AGEQVYLPGDRISNVIKRLWDLDLFSDINLYATINGDVVDLKFEIEEVPELNKVTINGIK
EKKAKDIIKDNDLKKGTKVTENLITKTKFYIENKYKEQGYLNSKVNIITRPATDTAETQK
VDMLVNVNLSDRVKIEDIEFIGNEQLSDAKLRKAMKNTKEKRLLRFWKRSKYIPENFAED
KVSVVDKYKERGFRDARIVSDTLIHSGEDLITLKLSVEEGDKYYIGDIDFLGNTVYSDRE
LARQLGLEKGDVYNGVLLKERISKDGDPNADDLSNLYKNSGYLFSSINPVETNVENDTID
FEIRITEGKLAYFDRITISGNDKTKDRVIYRNLRTKPGQRYSQAAVLQTTRELGQTGFFN
PETLNPQFLNANPYDGTIDINYALEEQGASQIELQGGYGGGGFVGTLGLSFNNFSIQNLF
NKDAYQPLPMGDGQKFSLRAQASTFYQTYSASLTEPWLGGKKPVQLQMSFSHSVQYLYNY
GTSGANVDRDRRFLITGGSLGLAKRLEVPDNYFTISHAISFQHFDLKNYNVGLFTFGNGS
SENLAYTIGISRNEGDVNPIFPRTGSRFSLTAKLTPPYSLWNGTDYKELADDRAAAVENG
NNDRVAEIDQERFNWLEYYKVKFEGQWFTSLVGKLVLSSKVDFGFLGAYNNDRGIPPFDR
FFLGGDGLGGYALDGREVIRLRGYPNQSVVPLDRDEASTLNGNTGATIFNKFEFELRYPI
TLKPSASIYALMFAEAGSSFDNFRDYNPFLMNRSAGAGVRIYMPAFGLLGIDFGYGFDPI
PGTVGGPNGWETHFIIGQQF
>KECLDBNJ_02711 Isoprenyl transferase
MDFLDEIDQHKLPKHIAVIMDGNGRWAKNQGLLRVKGHKKGTKAVRETIEACAELGVAFV
TLYAFSTENWNRPKLEVDTLMNLLVSSLKKEIKTLQDNNISLSAIGSLNNLPEKAQRELK
EVIEKTKNNTRLKLTLALSYGSREELVKTIQDISHKVKKNLISPHSINESVIKEHLYTHD
MPDVDLLIRTSGEQRISNFLLWQIAYAELYFTPVLWPDFTRKHLYEAIYNYQKRERRFGK
TSEQIN
>KECLDBNJ_02712 hypothetical protein
MRYLLVFTLVLFAVGSTQSQTYEVGVLAGGSNFIGDVGRTNYISPNNIVFGGIAKWNRSA
RHAFRASILFTNLEASDTDSNDARRQNRGYSFTNTVIEGSVGIEYNFWDFDMHQSFDKPH
TPYLYTGFTYFYHDSFALDPVEDALVNTSSEWDLAIPMVIGYKAYIGGSIVLAAELGARY
TFTDNLDGNFPGTEEYNYASFGNINNKDWYMFSGITVTYTFGRQPCYCGF
>KECLDBNJ_02713 NAD kinase
MKVGIYGQFYHKNSGHYVQQLLDLLNQKDVEVIIEENFLKLIHENEEIDKTYSHFSTFEE
LDNTYDLFFSIGGDGTILQTVTYVRDLDIPIVGINTGRLGFLATVNKEKLVSSVDEILKN
NYSITERSLISIKTSKGEETFGGLNFALNEVTVSRKNSTSMISVDTSLNGERLTNYWADG
LIISTPTGSTGYSLSCGGPVIMPKTSSFILTPIAPHNLNARPIVVPDSTEIKLKVSGREE
EHLVSLDSRIATLPVETEITLTKAPFNIKLVLLEEDTFLTTLRKKLLWGEDKRN
>KECLDBNJ_02714 hypothetical protein
MKITDYIIKDIDPLDEHVLMGEAQELFTQTTYSHVPILREGVYVGCLNENDVHCLDAKEV
IAENNHMYEVFFVRTDTNWLNVLEAFAQNNANLMPVLDEENASYLGYYELADVMTYFNST
PFLSKNGSIIVIEHGIYDYSFSEISQIIESNDGKVLGAFISQVKNEVAQISIKIGSDTSF
NTILQAFRRYGYVVVSEHQEDAFIKDLRDRSQYLDKYLNI
>KECLDBNJ_02715 Pyridoxine 5'-phosphate synthase
MTKLSVNVNKIATLRNARGGNVPDLIKTVKDIESFGAQGITIHPRPDERHIRYQDARDLK
TVVKTELNIEGNPVEKFINLVLEVQPDQVTLVPDSVDAITSNAGWDTLKNKVFLKEVIAE
FKSHGIRTSIFVDPVAEMIEGAKETGTDRIELYTEAFAVGFKEGHPNAVKPYVDAALLAQ
DLDLGLNAGHDLSLENIKFFADSIPGLLEVSIGHALIAEALYDGLEKTIKSYLDALI
>KECLDBNJ_02716 Esterase YbfF
MILHSSITGSGKPFVILHGFLGMGDNWKTLANQFAEAGYQMHLVDQRNHGRSFHSDTFNY
EVLAEDLKNYCQEHGLKDIVLLGHSMGGKTAMLFAMRYPEYINKLIIADIAPKYYAPHHQ
QILKGLTALSENHEARTSRGNADDFLKEYISDWGTRQFLLKNLYWQKDKTLALRVNLPVL
KREVEAIGEGLPTQTVYEGATLFLNGLKSDYITEDDKPLIKAHFPAAKIIGIEKAGHWLH
AENPKDFYAEVMKFLE
>KECLDBNJ_02717 Putative outer membrane protein
MKRVLATSLFLLASAITFAGGYRVGLQGQRALAMGHTGVAYVNSAELAFFNPAGLVYLEN
KINASAGGFGVFSSVAWQNESTGQFANTDSPMGTPFYLYGSYALNEQLSLGLAVYTPYGS
TVEWPTDWAGSHLVNNIELAAVFIQPLISFKISDKFSVGGGPIFVTGNVNFNRNANRFLT
DQEGNRSNVTIDDSGVTNWGWSVGGMFRATENLTFGANYRSEIILESEDGAATFANFPND
SGQPVVVGGTAIPSNGTQGFNASLPLPAELTVGASYSKDKWVVNVDYTRTYWDVYEDLDI
VFADGSESINPRNYKNSSIYKFGVGYAASEKFMLRAGYYFDESPVQSGYFAPETPRNDSN
GFSAGLSYAISSSFAIDASFLYVRFKEINESYDYVDDGSSFGGTYKSSAFVPGIGLTYKL
>KECLDBNJ_02718 hypothetical protein
MKNYIKYMALSAVLLTACEAELDNPIEDGGFYSSGSADFSNYVAVGNSLTSGYADGALYI
SGQQNSFPNILAGQFALAGGGLFSQPLVDDNTGGLLANGTQIQPNRFVLTLDADGNPGPT
PLQGTPTTDIANVLEGPFNNMGVPGAKSFHLVAPGYGNIAGVAAGAANPYFVRFASSTDA
TIIGDAAAQSPSFFSLWIGNNDILSYATSGGTGVDQTGNLDPTTYGANDITDPNVFASVY
NQEVQALTASASGGVVFNIPDVTSIPFFTTVPYNAIPLDEATAAGVNQAYVQYNGALAQY
AALGVITTEERDARTINFTAGQNAIVIEDENLTTLLNPTNGQEIPKIRQATPDDLFVLTS
SSIIGTLADPSNPNSVIGVGVPVGDQYVLIPEEQAMIATAQASYNATIQGLAQANGLAFV
DARAILNQLAESGIAFDAGTLTSTFATGGAFSLDGVHPTPRGYAYLANQAIAAINETYGS
TLPMVNVGDYGTVNISN
>KECLDBNJ_02719 hypothetical protein
MKTLIKLLLTALAVIILGYLLPGVGVTSFFTAFIVAVVIALLRLIVKPILVILTLPITIV
TFGIFLLFINAIIILIADYFVGGFAVDGIWWALIFSLLLSLFQSLLFALIKED
>KECLDBNJ_02720 Trigger factor
MNITRENIDDLNAVLKVDIAKDDYNDKVQKVLKDYRKSANIPGFRKGHVPMGLVQKQYGK
AVLVDEVNKLLQDSLQKYLTEEKLDVLGNPLPKDQEDLNWDAGDYTFEFELGLAPKFEID
LQPKKAITSYTIVVDDKMVDNQITTIQKQYGKITSKQEVEKDDEVSGSFVNEEAEFEKKT
MFEVNKLKGKANTSAFVGAKVGDTVTVSTKGLFKEAGDYRSFLGLSEEEAKEKNLEVSFT
IEEVNHREPADLDQDLFDKLYGPGVITSVTELKEKIKEEGENQFKQQSDQQLLNDVTERL
IENTEFDLPAEFLKKWIQRSGEKELTFEEAVEEYERSEKGLRYQLIEGKIIADNELQITF
EEIKAYAKEMIKAQMAQFGQNDPKDEELEGIAARILSNQDEVKRLSEQLMNKKLLDFFKE
NVKLKEKEVTFDEFVKEVYN
>KECLDBNJ_02721 ATP-dependent Clp protease proteolytic subunit
MNYADEFKKYAIKDQGVNSMYYDKIMSSMYPVGLTPNIIEERQMNAVAMDVFSRLMMDRI
IFLGTGINDQVANIVQAQLLFLESTDASKDIQIYINSPGGSVYAGLGIYDTMQFIKPDVA
TICTGMAASMGAVLLCAGAQGKRSGLTHSRVMIHQPLGGAQGQASDIEITAREILTLKEE
LYKIIAKHSGQPYDKVYEDSDRDYWMKADKALEYGMIDEILARE
>KECLDBNJ_02722 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKEELECSFCGRKKSETNLLIAGLDAHICDRCIEQAHGIVLEEAKDVNKNGLDGELTLK
KPKEIKDFLDEYIIGQDFTKKVMAVAVYNHYKRLLQPETEDEIEIQKSNIVMVGQTGTGK
TLMAKTIARMLNVPLAIVDATVLTEAGYVGEDVESILTRLLQAADYNLEKAQRGIVFIDE
IDKIARKSDNPSITRDVSGEGVQQALLKLLEGTTVNVPPKGGRKHPDQKFIEVNTEHILF
IAGGAFDGIERVISKRLNMQAVGFSASMSDEVIDRENLLKYIIPKDLKDFGLIPEIIGRL
PVLTHMDPLDAKTLRAILTEPKNAIIKQYEKLFEMDDIEFEITAPALDYIVDKAIEYKLG
ARGLRSLCEAIFTDAMFDLPSSDLTTFKVDKEYAQFKLEKSTIKKLKAVS
>KECLDBNJ_02723 hypothetical protein
MFEDKLVVVSNRKITSRSGSSTVLDQSEYKLLGFSKFKNNWRNPHLLAGVFTGKTNHGGL
TFNKTQTQVFYTKTEAGSTNYQLYVATRNPKNPAQWFAPKRLTLAPKGYSVENPWLSRNG
KTLYFSSDMPGGYGGYDLYSVEILPNGRFTTPKNLGKNINTSANEKYPSLSVENHILYFA
SDRPGAYGGYDLYRAYTDAELYSSAQTLGSAINSAADEVGFVPVTTTKGYFSSNKNSLSQ
KMNVYQYEHTASVAGF
>KECLDBNJ_02724 hypothetical protein
MPIPLVNSIASWFLKKRIHQMELFLKYPHEVQNELLLKLVHKAKNTEIGKKYGFKDIRSY
NDFAQQVPITNYEASHEMIERARRGESNIFWPSPVKLFAQSSGTTNAKSKYIPVSPEALE
DCHYAASKDLLCVYLNNNPDSQLFTGKSLRLGGSKRLYESNGTSYGDLSAILIDNMPFWA
EFSSTPGNEVSLMSDWEVKMQAIVQETIQEKVTSLAGVPSWMLVLINNILATTGKQSLFE
VWPNLEVYFHGGVSFEPYRDQYRKVLPRHDFKYYEIYNASEGFFALQDKNERSDLLLMLD
YGIFYEFIPMDCYGQPGQKIIPLSEVEKGKNYAIVITTNSGLWRYRVGDTVRFTSINPYR
IRVSGRTKHHINAFGEELIIENAEEALKKATALTQSEIVDYTAAPIFMDGKEKGAHEWFI
EFKVAPKDPEHFNQLFDKALQEINSDYEAKRKNNMTLNPPTIHYARTDLFYDWLKSKNKL
GGQHKVPRLSNSRELVEELLVLNAACTQG
>KECLDBNJ_02725 hypothetical protein
MQYQGVLTKMQTELQNPVQYYLVFEDDFIHVNQLLDKEIRIEFLKYQCLACGLNKKIYRQ
GYCYEDFYKVPQAADWIMKPELSKAHLDQEDRDLEYEKKVQLQPHIVYLANSSNIKVGVT
RKTQVPTRWIDQGAHEAIEIVEVPNRYLAGITEVALKEHIADKTNWRKMLKNEIEDENLV
EQRDALKQYIPEEALEYYIASNQETNIEFPVLQYPKKLKSLNLEKTPEYQGVLKGIKGQY
LLFEDGTVFNVRNWEGYVVSLSVSA
>KECLDBNJ_02726 Methicillin resistance regulatory protein MecI
MKQLTKAEEEVMQILWDLGEANVAAMLEVMPEPKPAYNTVSTIVRILETKEFVGYKKEGR
GHIYFPLVKKSDYSSASMSKMVNDYFNGSFKSMVSFFVKKKEMSASELESILKEINKDD
>KECLDBNJ_02727 hypothetical protein
MVRYILEVIVFQALFLAVYQLWFRKETFFNINRIYLISTALLAFVLPFMQFELFENQIPL
RENIFFLPEVVVTAEASEVAHAPEPQETDWSIYLLLYAAGVFFSTGMLFRKYQEIQRYFR
FKRKNDTTPKIITIPNSDAAFTFMGTIFIGENINAEAKAHIMAHEEVHLKHWHGLDLMLF
ELMRVVFWFNPLVYIYQNKLAEIHEFIADAQAMRKTEMKAYYNQLLNTAFGTQHISFINT
FFNHSLIKKRIVMLQKQSKQRAGLKYLVLIPVIAGILTYVGCTDDNGLAENKAALTLEEQ
VADLEATLDAKEEISTEERELVSNLLNKANQKALPPPPPSPNEDAVIEVVETQSQKEIND
VPFAVVEEVPVFPGCESLQTNAERKKCMSEQVSQLINANFNTKVGEELQLKGVQRIYTRF
RINENGDIVDIESRASVPELEKEAERVVSLLPKITPGKHKGKNVGVLYSLPIVFQTK
>KECLDBNJ_02728 hypothetical protein
MKKIVYLSIGIAVFALTSCSSEKENRDVAQLSFKDRVANLDAALEAKAELNETEREQIAS
LNQMVLNKSQKPFITTAPPNKSFNFDDLGADRVEFNAITQPPYYSSCEDANMEVQRVCVE
EAIATYVSSHFNAEVYKASKVRGRYEMTASFLIDTEGKIQDVKIRNDYDKALSAEAKRVI
KDLPQMQPGKHKGKPMAALFTLPIVYDLKP
>KECLDBNJ_02729 Lipopolysaccharide assembly protein B
MRSFYLFIFLVLASRAEAQEVSALAIGDSLYAVGNYSKAIESYEQIKAKNERVYLKLARA
HQAKGTLDDALVNYKLAATGTDEVIAMNEYGKLLITKRQFKEADSVFSALISVYDTNPDF
YYQRGRANENRPRDISGKESDSVLVEKLAKVHDPLEDYERAIALDSTHQKALAEVATSYL
KQKDFAMVEKLAFKALESYPTNVEIISTLAQSYYYKGWNEEGIQWFEKLLALGQDTQFIR
EKLGNLYYKKRQYEDAIEQYLGALKFAPEDAYDHATLAKLYNFTADLDAAEMHGLFAVLY
KDQPLFEEYYTLSRTYEMKKEWASAMKYVNRSLDENPRNKSAEYTKAIIADNYYEDRRAV
LKLYEDFIKKYEDGKYAKFDHTLKLAKERRDKLNREIFMAEGEEE
>KECLDBNJ_02730 hypothetical protein
MKNYLLLSFSFIFFLSCNSEKGLNCFQAEGERIEQEIPVEAFSKIIVEERLQLIVKQGET
QKVVLATGENLVNDIEVSVTDGILTLFNDNGCNLVRDYNISKVYVTTPELTEIRNASGYE
VQSDGVLSFDSLTLTSEDVEEEDFYHKDGDFRLELDVNTLNITANGLSNFFISGAAETAT
IEFLEGDIRFEGENFAIQNANIYHRGTNKVIVNPIQSLRGSVLSTGDLISVNRPPIVEVE
ETYTGRLIFQ
>KECLDBNJ_02731 GTPase Era
MEAQNNNPLQSEAENKSHKAGFVNIIGNPNVGKSTLMNAIVGERLSIITSKAQTTRHRIL
GIVNGDDFQAIFSDTPGIIKPAYELQASMMDFVKSAFEDADVLIYMVELGEKELKDEDFF
NKIRNTDIPVLLLINKIDKGNEELLEASRMHWQEKVPNAEIFAISALENFGVSQVFDRIL
DALPVSPPFYPKDALTDKPERFFVNEIIREKILMHYKKEVPYSVEIDTEEFFEEENIIRM
RSIIMVERDSQKGIIIGHKGSALKRIGVEARKDLEIFFGKQVHLELYVKVNKDWRSSERE
LRRFGYNGK
>KECLDBNJ_02732 hypothetical protein
MKVVFIIILVFSYSFNVLACSCDIPKPAIEFYASDYVFEGEVISKIYAKDSLTYTVKFKV
LKHYKFGDEPEFISYTFPAEGEFPGHFTSCDWSVDFGERWLVYSNLYNGKQSFSFYCSNS
KPINEHYGIRKSEQKVLDNGNKLELENYRFINHEAKPITDVDSILSAYNSKDLNLESKTF
APFWIDVDKEGNLTSVNLSPRENREMEVVDTIYGLNIRKNQYSKPRNEFESVALEIAKKV
KKWDTYVFHGKQVRYRTFLTFILDENSKIVLYN
>KECLDBNJ_02733 putative methyltransferase YcgJ
MSYLETTKNVYRDAALTPDVGLCCTTNPIWELPGLKIPKIMQEMNYGCGSTVNACDLTND
PRVLYVGVGGGMELLQFAYFSRQKSGVVGVDVVDEMLEASRKNFEEAEELNPWFKSEFVD
LKKGDALHLPVEDNSIDVAAQNCLFNIFKAEELKKAIEEMYRVLKPHGRLVMSDPTCEQE
INETLRNDERLRALCLSGSLPIKEYVKALTDAGFGTIEIRARKPYRILDPKNYPTDELIY
IESIEVAAIKDPMPEDGPCIFTGKAAIYYGAEDYFDDKKGHVLLKNQPLAVCDKTAGALA
ALGRDDIFISESTFHYDGGGCC
>KECLDBNJ_02734 hypothetical protein
MLFNFIYDTGMDKTVVDLGNLDGKVLLFGGVYSNLQALEALKRIAEAQHIAPQNCLCTGD
IVGYCAQPEEVVQLFKIWGAQSVLGNVEIQLRDGAEDCGCDFRKGSRCDGFSQMWFPYAQ
SKLSKSSLDFIATLPDHIQFRFVDKKFVMVHGDFFNVSEFVYKSTDWSLKQKNFDATGAD
VIIAGHCGLPFNHSQNEKLWLNPGVIGMPANDGSPHVWYAILEEQDGQLKFTHHTMDYNY
KLANQHMQTDFLPQEYARTLITGIWDNTEILPAYESGLQGFGIQL
>KECLDBNJ_02735 hypothetical protein
MDIAIWQWILIIASSVTLFFLSPLAKTTDDFFKATHRRKAPNAFMLTGSLIISWIFAKSI
TNAANLGLEFGIVGGVAYAAYYLSFVMAGILIYSLRTQGGFTSLHQFLTSRFGKNAMRVF
SVLIAIRLFNEVWSNTMVIGSYFGDIGSTPYYASIIVFTLLTLAYSLKGGLSSSIFTDVL
QMGLFGILLFVILASIYSTTNFTVAETLQSGVWGFDTGLNLLFAALIQSLSYPFHDPVLT
DRGFLSSPKVTLRSFLWAGILGAICIVLFSVIGVYAKAMGMQGQAAVEVGKAFGSVILLI
INFIMITSAASTLDSTFSSFSKLAAVDLKLGESISFGRLAMCVLVVLGTIPIFLDAEILS
ATTISGTMVIGLTPIFFFWKLPAPKLSFYLSVFCGIGFGLLLVFNLIPECWILTQGRYAD
LLWANIWAAGCCLILYMIPAWIKLW
>KECLDBNJ_02736 hypothetical protein
MKNTIYTILILSLSFFTACTTDFEEKNTNPNAPVSVQPGLLLRQVIYDFGEQMSYEGFAA
GDLLSQHRTALDFNLFDRHALKSPQLGGNPWPIFYTNLRDNELLLKQAQEVETFKVYEGP
ALILKAYMAQGLTDLFGDVPYFEAFNGIDGTVTAPYDAQENIYLAEGGILDNLDQGIAAI
NAYSGAVALEGDLFFDGDLSKWIQFANSLKLKALMRISSQENVAAAIASIYAEGNFITTN
ADNAVFDFTSSAPNSFRFAQLRAGDFNNFVLSETMEDILTDLDDDRISVFFRPFANSTSG
EFNGLINGIDASQTSIEPANYSLAGTLFRENTAQLDANFMTAWETHFILAEAAEKGFISA
DAESLYNQGVQLAFDYWLTDLPAEYLTGPAAYYAAGTTPVQQIITQKWIANLINGYEGWI
EWRRTGFPEFRAVAASLNDGIIPVRMPYPAEEQALNADNYQAAAAATNDNSLNSPVWWDN
>KECLDBNJ_02737 TonB-dependent receptor SusC
MKHLYFGLMLLLCAVANSQTTISGTVTTSSDGTTVPFVNVIAVNTDAATITDENGMFSLE
VPAAANELRFSAIGFITQTASINGRTTINITLQESTTDLDEVVITALGLERETKELGYVV
QTIEAEEVSAVKAPNFLDNLAGKLAGVTVSQGATGVGSSSKITIRGEASFSNNNPLFIVD
GTPINNNTVFNESNEAAAGFQEIDFGNGAMEVNPDDIASVSVLKGPSAAALYGTRASNGV
IIIETKNGSQSKGLGISINTSVFVDTPFKLPEFQNQYGQGNSGQFEFVDGLGGGVNDLIS
YSWGPRLDQGTLIAQFDSPVTLPDGTVVRGGDTSLYNGIGITPTAFNSHPDNLKDFYETG
VTTINNVAIGSGFDKGNYRISFTDLRSESIIPGVNLDRQTVATKLNFKPTDKTTFNASIS
YVNSGSDNRPSNGYGSENVNYALVAWGPRSLDINSLRQYWQPGLEGVQHYSFNYTYFDNP
FFTMYENRNSFNRDRVFGNISIKQQITENLSLSLRSGMDYSSETRQLRRAFSSNRFQNGG
YAEHDVFYREINTDFLLNYNNIFGDFSLDVSLGGNRLDQKASTKQSQTVNLAQPGIFNLN
NAASPIDVFQFESNKRINSLYGIAKLGYRDFLFLDLTGRNDWSSALATPFSVDGTSFFYP
SASASFILSEVAELPKAFSYAQLRASVAQVGNDTQPYQTSDAFISQTAYNGQPTFSNQNF
IPNANLKPEQTTSYEVGADIRFLKDRIRLDATYYNALTKDQIISLPIAISSGYNQQVVNG
GEVRTQGVELIADLTPILTANFKWNTTFNFSSNTSRVESLPQSDGRLTLAYSRIYDSANQ
TVWFQVEEGGKIGDIYGTGYQKTEDGQFILTPSGSYIADNNLKKIGNYTPDFMLGWNNSF
SYKNWSLSFLFDWRQGGELVSRTRALGTVGGQLAETANRPEEGIVPQGVVNTGTAENPQY
VQNTTAVSAETYYRQFYDRNHEENNIYDASYLKLRQFSVGYTFNLKDGFLGLSSGMDIDL
ALVGRNLFAFSEIPHFDPEQLAVQGTGFVSGVEDMSYATTRSIGLKAGFNF
>KECLDBNJ_02738 hypothetical protein
MNTKTAILIFARSAEEDARHKSMHNGVQLFEALNKQTLKTVKQSGLPFYIYSEKNQKGAT
FAERYTQAFTEIYELGYDNVISIGNDSPHLTKQHLLTAANELQNCPMVIGPSVDGGFYLM
GLNKTHFNAQALLELPWQTSKLTQIILRKVREQKIQATILEVLHDLDSVFDVAALLDRGQ
LPYLIKKLLLRIHFGGTQPITNQKFVFDAFQYQNYFNKGSPVSLSI
>KECLDBNJ_02739 hypothetical protein
MPATQTKKSLHKRHDDLAQANKQLEVLSGGIFADGELPTFAKKIKETNQFPLRPKKLEIL
QINVGYMCNQVCEHCHVDAGPDRKEIMTWETMEQCLEVIKNTGAHTLDLTGGAPEMNPNF
RRFVEEASKAGIKDFIVRSNLTIIRANKKYYDLPEFFKKHNVHVVSSMPHWTRGKTDKQR
GEGVFDKSIKALQELNAVGYGMPDSDLRLDLVYNPNGAYLPSDQAGMEKDFKKALMEDFG
IQFHNLFAITNLPIARFLDYLIASENYEDYMYQLVEAYNPAAVANVMCTNTISISWDGWL
YDCDFNQMLDLKVNSKVKHISEYNEDVLNDRNIIISQHCYGCTAGAGSSCQGTVA
>KECLDBNJ_02740 Alkyl hydroperoxide reductase AhpD
MANNNYYDPADLRKFGKITEWSEELGTKFFDYYGKVFEEGALTAREKALIALAVAHTEQC
PYCIDAYTKDTLQRGVTKEQMMEAIHVGAAIKSGATLVHGTMMMNKVNKLEM
>KECLDBNJ_02741 Purine nucleoside phosphorylase 1
MKKFIEESAQFLKERGFEAPEIGIILGTGLGQFVDKVEIISSVSYNHIPNFPTATVEFHT
GKLIYGTLGGKKVIVMQGRFHIYEGYTLRDVSYPVRVMNELGIKKLLISNAAGAINLNFK
KGEIMLIEDHINLQGGSPLAFKGVEQLGSRFTDMSEPYDVSMRNILKDIAKTEEITLHEG
VYASVVGPQLETRAEYRFLKIIGSDTVGMSTVPEVIVANHLDLPVAAVSVITDECDPENL
APVDIQDIMAAAGKAEPDMVKLFTQLIEKL
>KECLDBNJ_02742 hypothetical protein
MGLLSKKDTDSEKDFETEFHFPTSDKALLIFTRNPELGKVKTRLASGVGDAAALEIYKFL
LQHTVNITQNLSVDKQVYYSEKIRASDYWDKNTFTKKLQHGDDLGARMQKAFSGAFASGY
KKAIIIGSDMYDLSQKDLEEAFAALDEHDFVVGPAEDGGYYLLGMTFLKPELFSNKTWGT
ETVLKDTLADLSSESVKLLETRNDVDYYEDIKGIEAFKPFLPEHLK
>KECLDBNJ_02743 Thiosulfate sulfurtransferase GlpE
MKFHLLLALLLPLFGFCQKKSIDKLLETYNTRSIPYISVQELKMNLEAYTILDTRKREEF
EVSHLPSAIWVGERPQNAFLDSISNKKKPIVVYCTVGIRSEDFGEKLERKTGKTAYNLYG
GIFAWKDAGFKIVNAKGKSTQKVHTFSKNWEDYLSTGIAVH
>KECLDBNJ_02744 Aldose 1-epimerase
MITIKPFDTTQDGRPVLSVKLKNSSGMEAHFITYGAILQRLIVPDAGGFTDVVLGYNDLH
SYEEDTFFMGQLVGRSANRIANATVSLDGKKVALSANEGTNHLHGGFEGFGKKIWEVAEL
EDEVIFSYLSKDGEEGYPGNLETKMFVKLTEENALEMRLEATTDKETIVNLTRHEYFNLN
PSSGKSIAKHQLLINGEGILPKTEQNVPDGSVKPVENTPFDLRELRFLEQPLAQLEGGFD
HNYVLEKYSKEVPAAVLAAPSGSPKMELYCTQPGIQFYSANGIEKIENKTVMIQGPSPAL
CLEPQFFPDTPNHPNFPSTVLKPGEQYKHTITYKFL
>KECLDBNJ_02745 Glycerol kinase
METSYIIAFDQGTTSTRAILFDEHGKVVAISQKELKQYYPQSGWVEHDPEMIFNDQKEVF
EAVVQKAKVPLEAIKGIGITNQRETTVVWDKKTGKPVYNAICWLDKRTEAICEGLRERGL
SRYILKNTGLVIDSYFSATKIKWILDNVEGAREKAEAGDLLFGTVDSWLIFKFTGKHRTD
HTNACRTMLYNIKDMAWDQELLEELTIPKKMLPKVQPSSSDFGRITYQDAEFPIYGVAGD
QQAALFGQGGYKSGMAKNTYGTGCFMLLNTGKKPSFSKNGLITTLCCTLEDKKPKYALEG
SVFVGGASIQWLRDQVGIIENAEETNAICQSIPPLEDLFFVPAFNGLGAPYWDGNAKGSI
QGLTFSTGRKELVKATVEALAYQVTDLIKAMEEDSGKQIKTLKVDGGACANDYLMQFQAD
LLDAQVDRPEMLEVTAWGAALLAGIKVGIWTQKDIATLRSADQVFEPEMDVRTRNHKQES
WELAVMRTRSGYAETIEKEKEPLRFSVRDRKRYIKKAKKKKFDLVIIGGGVTGAGIALDA
ATRGMSVCLIEKNDFASGTSNKSTKLVHGGLRYLKQMEIGLVKESGTERAIVHKLAPHLV
VPEKMLLPLIEGGQYGKFLTSVGLKVYDLLANVDDEDKRRMLTKEETLEREPILDESTLL
GGGFYAEYRTDDARLTIELMKKAAGFGAICLNYCEMDDFVYNYKGKITAVNCKDHNTGKT
FEVEGRTFVSATGPWVDKLRKKDESMNNKHLHLTKGVHLVFPKEKLPVHQSLYFDVPDGR
MIFAIPRGRVTYVGTTDTNYSGSLDRVVATKADIKYLLDAVNGTFPDINLTEEDIESSWA
GLRPLIHEDEKDPSELSRKDETFISKSGLISIAGGKLTGYRKMAQRVNETVSKRLKEKFG
KTYDESRTQHIALTSHALRNTQEVEDYQNYLEQELEFMQIDNAAFKAWYLVSTYGKQTDI
IKNKINYFRDADVNDRLVRAELWYSVNYEMTNSLADFFVRRTGRLYFNIETVTQYRQQAV
QDFINYLDWDEERVAFENKKLDELLYDATHFYESEILS
>KECLDBNJ_02746 Ribonucleotide monophosphatase NagD
MDKGFLIDMDGVIYSGNDLIPGADTFIKTLQDRGIPFLFMTNNSQRSPIDVVNKLRPMGI
HIKEENVYTSAMATAWFLGFTKPNGTAYVLGEGGLLSSLHENGYSLVTQDPDYVVVGEGR
NFTLEMANNAVDMILGGAKLIATNLDPSPKKIGWSNLGIKAIVKMIEEATGRKAFSVGKP
SPVMMRAARKKLGLTTDQTIVIGDTMDTDILGSIQMGYKTILTLSGVSKQEEIGTYAFGP
DMVIDSLKDFNIDEALEKLSVENNVAEF
>KECLDBNJ_02747 UDP-glucose 4-epimerase
MKILVTGGLGFIGSHTVVELQNAGYEVVIIDDLSNASEDVLDGIEAITGKRPEFEKLDLR
DRNAVSAFFKKYADVSGAIHFAASKAVGESVHKPLLYYENNLSSLVYLLKELTGKASANF
IFSSSCTVYGQAEELPITESAPVKPAESPYGNTKQIGEEIIRDTAKVYENFKAIALRYFN
PIGAHESVEIGELPLGVPQNLVPFITQTAAGLREELSVFGNDYPTEDGTCVRDYIHVVDL
AKAHVKALTRLVESENKSNYEVFNLGTGTGSSVLEVINTFEEVSGVQLPYKIVDRREGDV
VAAYADTEHANNELGWKSELTLADALDSAWKWEKKVRGIK
>KECLDBNJ_02748 HTH-type transcriptional regulator DegA
MSTKTTLKGIAEHLNLSISTVSKALADSPEISEATKLLVKTAARQLKYRPNAMARGLKSS
RTNTLGVVIPNIMHNFFAKVIVGMEEEATKNGYSLVTCISNESLEKEKQSLNMLSDVSVD
AIIISLTSETQESNEIEHLNDVLHYDIPLVMFDRANTDVACDSVVINDFSGAFEATSYLY
KTGCKNVALLSTLSNTSVGNKRLAGYQAAVSKEAGAVPKVLYTKLATLEQDLGTFLDKNE
IDALITTDESSAIYAMNTIRTKGLEVPNDVSVIGFTDGTLARNYFPSVTTVKQQAEIMGK
KAIEIALKNINAKEKEAPKQEVIETELVIRNSTRKL
>KECLDBNJ_02749 Galactose-1-phosphate uridylyltransferase
MVDFNDNSHRRYNILTGEWILVSPHRTKRPWQGKEEDIVVEERPSYDPNCYLCPGNERAG
GHINENYTEPWSFVNDFAALKNDVPQAKFKSGLLKAESESGICKVVCFSPDHSLTLPVMD
VENIDKVIALWQREYRELGKKSDINHVQIFENKGATMGCSNPHPHGQIWAQRTIPQEVAK
KNKHLREYWNDNGVSLLAEYLKEELALQERIIVETEYFVALVPYWAVWPYEVMILPKKQH
RTILTLSEAERLDYAKIIKAVTIKYDNLFKISFPYSSGIHQAPTDGQDWDCWHFHMSFYP
PLLRSATVKKFMVGYEMFATPQRDITAEMAAKTLRNLADTHYTKN
>KECLDBNJ_02750 Galactokinase
MEQQITHSQSPEHIAQLGAFKAEVVINSPGRVNLIGEHTDYNNGFVMPTAIDKTIQFYLK
KNGTPSQARITSLNYDSHFSFDVATYDPNGAEWTRYIVGVVEEIKKLGHSLKGFDCMMYS
NLPMGAGISSSAALECGLAKGINELFDLGLTDLEIIKLSQMAEHNYVGTKCGVMDQFASV
MSKENHVIQLDCQSLEYQLLPFAIEPYKLLLLNTNVSHSLSTSEYNVRRAECEAGVALLQ
KWYPEIITLRDVTLEQLQKHKADFDPVVYKRCEYVLEENQRVALAAKALKAEDLKTFGTL
MYGSHEGLQHKYQVSCKELDFLTDFSKNYDAVLGCRMMGGGFGGCTINLIHEDHIDAYVE
AAKKAYHKQFNIKLSTFTAMPANGGERIH
>KECLDBNJ_02751 putative symporter YidK
MALISFLAFTILVAVISWLAVRKSDESTSDGYFLGGRSLTAGVIAGSLLLTNLSTEQIVG
LNGSAYKDGLSVMAWETLAALSIVVTAIFLLPRYLKGGITTVPQFLAERFDTTTKTITSG
LFLTGYVVVLLPVILYSGSVAISGMFDVPTLLGVSDTTALVICIWGIGIIGSIYAVFGGL
KAVAVSDSINAVGLIIGGVMIPVFGLMAIGDGSVLEGLSTLVDANPERFDSTGEPGQEVP
FATIFTGMMLVQLFYWGTNQQIIQRGLGAKSLAEGQKGLLLAAFLKILGPIILVLPGMIA
YYYFEGELASSDLAYPELVRAVLPKPLMGFFAAVLFGAILSSFNSVLNSSVTLFGIDIYK
QHINKEASESVVVKYGKIFGVCLALAAMFIAPLIANAGSLFSYLQEINGIYSIPIFTIIV
VGYFTKRVPAIAAKIGIVSGSILYIISQFVMKPYFGEENYPHYLHVMAILFVTNIIIMLL
IGKVVPRKEPFVLEYTKKVSIEPYKYVNQVGIVICLIVVGIYIYFAK
>KECLDBNJ_02752 Acyl-CoA dehydrogenase
MDFSLSEEHLMIRDAAREFAQNELLPGVIERDEQQHFPKELIKKMGEMGFLGMMAPTEFG
GGGMDTISYVLVMEELSKIDASASVIVSVNNSLVNYGLANYGSQAQKEKYLSKLTTGEKL
GAFCLSEPEAGSDATSQKTTAIDKGDHYILNGTKNWITNGGSADYYLVIAQTDKEKKHRG
INAFIVEKGWEGFEVGPKEQKLGIRGSDTHSLIFNDVKVPKENRIGEDGFGFKFAMKTLS
GGRIGIAAQALGIAAGAYELARDYSKVRKAFGTEICNHQAIAFKLADMNVEIEAARHLVM
KAAWDKDQGNNYDISSAMAKLYASKVAMDVTVEAVQVHGGNGFVKEYHVERLMRDAKITQ
IYEGTSEIQKIVISRGLLS
>KECLDBNJ_02753 Anhydro-N-acetylmuramic acid kinase
MNSTTYLMLGVMSGTSLDGVDLAYVRFTKTKHWQYELLSCETIPYETEWVIRLQNAVDLP
QSALVSLDQEYTAYLATLIQDFRARNPLSHIDAIASHGHTILHQPAQGTTYQIGNRPELA
RLCNNLVVCDFRVEDVALGGQGAPLVPIGDQLLFHKYDACLNIGGFANLSFQKGEARIAF
DTCPANIVLNQLTRKLGLPFDKDGLIAKSGKIDTAVLDQLNALPFYSQTGPKSLGLEWVK
AEIFPILNASDVAVEDLIATFTQHIAVQLAKTFVQLPATKNGILVTGGGAFNKHLIAITQ
NLVQHKLIVPEASLIEFKEALIFAFMGVLRLRNTNNVLKCVTGASKDHCAGLLYSP
>KECLDBNJ_02754 NAD-specific glutamate dehydrogenase
MKDLLKRYENKEPEIVFHWNDPETEAEGWTVINSLRGGAAGGGTRMRVGLDRNEVLSLAK
TMEVKFTVSGPAIGGAKSGINFDPSDPRKKGVLERWYAAVSPLLKSYYGTGGDLNVDEIH
EVIPITEESGVWHPQEGVFNGHFKPTEADKINRIGQLRQGVIKVLENSVYSPDVSRKYTV
ADMITGYGVAEAARHFYEIYGGNLEGKRAVIQGFGNVGSAAAYYLAQQGAKIVGIIDAAG
GLINEEGFSFEEIKDLFLNKKGNTLVAENLIPFEEVNKRIWEIKTEIFAPCAASRLVTKA
QIDTMIDAGLEVISCGANVPFADKEIFFGPIMEYTDAKVSVIPDFISNCGMARVFAYFME
RRVQMTDEAIFNDTSLTIKNAIQNTFNHNSSKQNLSETAFELALQQLV
>KECLDBNJ_02755 Na(+)/H(+) antiporter NhaB
MLKYFLGSSPRWFKMAMIAFLIFNVISYYVLGPMVTAWLFIGEFIFTLAMALKCYPLQSG
GILALEALILGLTSPEAAYEEVDQNLEVVLLLVFMVAGIYFMKPMLMYIFSKVFTKIKSK
VVLSMLFVFLAAVLSAFLDALTVTAVLISVAVGFYGVYHKIHSMESADYDADKVPDREAL
SGETLEQFRGFLRSLIMHGVVGTALGGVCTLVGEPQNLLIGEKMGWEFIEFFERMAPITI
PVLVCGLLTTFLLEKTKLFGFGDKLPAVARTIIENYTAEVDEKRTPKESFGLWIQGISAI
LLILSLALHLAPVGFIGLFLIVVQTAFMGITDEHSLGKAFEEALPFTALLVVFFVVVAMI
HDQHLFTPIIEYVLEMDPASQPSMFYLANGILSMISDNVFVATVYINEVQVAFDAGNITR
EQFNHLAVAINTGTNLPSVATPNGQAAFLFLLTSSLAPLINLSYGRMVKMALPYTIVLGG
VGLLGVYMFL
>KECLDBNJ_02756 hypothetical protein
MLTLLLQEGAETLPSLAAEEEPVEKTLSLFDLLMSGGLPGQIIILVLFVLLFVAIYIYFE
RLFAIKAASGMDSNFMNQIKDNVANGKIEAAKVLCAQQNSPVSRLTAKGISRIGSPLEDI
NTAIENSGRLEVYRLEKNVSVLATIAGAAPMIGFLGTVIGMVLAFHQLATSSGQAEMGNL
AEGIYTAMTTTVAGLIVGIIAYIGYNHLVVRTDKVVHQMEATAVDFLDMLNEPV
>KECLDBNJ_02757 hypothetical protein
MNLRGRNKVSPEFSMSSMTDIVFLLLVFFLLTSPAITPDALDLILPKAKGKTSNQQNLSV
SITKDLDIYVNKERVLPNNLESFINSELSGVEDPTIILRAEEGVPIEEAVSVMDIANRNK
YKIVLAVRPN
>KECLDBNJ_02758 hypothetical protein
MSFLDTKHKRKSFTLTSIIYVLFLILLFFAGLTYLDPPPESGIAINFGTSDVGSGTIQPQ
AAVESAPRNTTPEPPQVEKSTEVKEEVVTQETEEAPVIKEEPKKEIKKPVEQQPKKTETK
PVEAKKPDPKPDKSTTDALSSILNGPKSSGTERGGEGNDNQAGDKGDPNGDPNASSYYGN
GKGLDGDGNYQLGGRKALSKPKRVQDCNEAGIVVVSIEVDRNGNVIKATPGVRGTTNNSR
CLLDPAKAAALATKFNPDTDAPSRQIGKIVYKFSLSE
>KECLDBNJ_02759 Folylpolyglutamate synthase
MNYQQTLQYMFERLPMFQRQGASAFKKDLGNITKLCDYLNNPQNTFKSIHVGGTNGKGST
SHMLASVLQEAGYKVGLHTSPHLKDFRERIRVNGEMAEENFVVEFVEAHKAFIEAHQLSF
FELTVGMAFEYFKIQQVDVAIIEVGLGGRLDSTNIITPELSVITNIGLDHTAFLGDTLKA
IAGEKAGIIKPNIPVVIGERQEETTEVFETAAKKNHAPIVFASDNQFPDLESELKGSYQQ
KNKATVQQAVHVLNQKNDFQIPEAALITGIKNVIRNTGLVGRWQIIQESNPKIVCDTGHN
KEGLTYVMRQLKEEQYRQLHIVLGVVSDKDLNSVLPLFPKDAAYYFSKPDVPRGLSEEDL
QQKALHFGLRGKKFEKISQALNAAKKASDPEDLIFVGGSTFVVAEII
>KECLDBNJ_02761 Beta-lactamase
MIVRKPLVIGTLIVLIAVFALTRPQFHSQTVHKQPAAEFLNPLILKEQQEKARVFKMRKA
ALQTAIDAYFKKAIEDRLIIGAGVSIVTGDSIILKSGYGKRNVYKSDTVNDQTVFRLGSL
SKGFTGILAGIEVKEGNLSWEDKLIDAVPAFGLKDKANAQTITLSNVLSHTTGVPYHCYT
NLVEDGLKLQTIADRFKVINTYTKPGLIYSYQNAMFALSGEMMHAATGQTLQALLQNKLF
TPLHMNTASTDYEAMITTNNYAFPHKSTWKGWRRLPVNKKYFNAVAAGGVNASADDMGKW
MRFLLGHNETILDAEGLAAVFKPEIEIPDAHKYYQRWKGHLRSSYAYGWRVHEFVDAETG
NASTMIHHGGSVSDFRNEIAIFPGEDLGICVLFNSQTSLASSVIPELHELVKNVMNTPVE
GLELGKLASAY
>KECLDBNJ_02762 Glucose 1-dehydrogenase
MQKPNERLKNQTAIVTGSSTGIGAAVALALGRDGANVVVNYHSSEEEAQEVADQINKESL
CGEAIIVQCDVSKEEEVQAMFKRTIEKFGTVDILVANSGLQKDAALHEMTLKDWQTVIDV
NLTGQFLCAREAIREFMRRGMREDVSKALGKIIHMSSVHQVIPWAGHANYAASKGALKML
MESICQEYAPLKIRCNSIAPGAIKTDINKDAWETESALQELYKVIPYKRIGVPEDVGDTA
AWLASDESDYINGTTLFVDGGMTCYPGFTTNG
>KECLDBNJ_02763 hypothetical protein
MGKKNTVEQKRLDAHYAGQEDWLHWGPYLSERQWGTVREDYSPQGDAWGYFPHDHARSRV
YRWGEDGLAGFTDRYCNVCFGLALWNGNDSILKERLFGLTGPEGNHGEDVKELYYYLENT
PTHSYMKHLYKYPQAKFPYGDLVRENQKRNRKEAEFELIDTGVFKNDAYFDVVTEYAKAG
PDDICIKISVTNRNTKKAELHVLPQLWIRNFWSFRDMPFKPSITKNEGDKHSVHVKHPYT
GDYNFYFEKPDQLLFTENETNDERLYLQPNDHPYKKDFFHTAVINKNFRLAKKKEEGTKF
APYYKRKLKGGETVVFKVRLTTETLTEAFSSDFDALFTQRYEECVDFYEGVNQIENTEAK
GIQRQAFAGLLWSKQYYNYEVEQWIKGDPKVSTPPESRKSGRNSNWKTLRNHDIHLMPDK
WEYPWYAAWDSAFHCITMAYVDPEFAKKQLLLFTKEWYMAPNGQIPAYEWNFSDVNPPTQ
AFAALQIFKIERDTVGKQDIDFLKRIFNKLSLNFTWWVNQEDRRQNNVFQGGFLGLDNIG
VFDRSSGIPGNAHLEQVDGTSWMALYCLNMLEISIKIAFEDPSYEEMATKFFGHFIFIAE
ALNKLNEDFEGTWDEEEGFFYDKLVFEDGTFQPIKVRSIVGIMSLIAVLHISKETLDRLP
NFKYSVNWFRKYRQANLKYQVIQEFSEDSDLLLALVPKERVEIMLKAVFDQNEFLSDHGL
RSLSKIHEEIYKIDINGTNYEIKYEPAESESSMFGGNSNWRGPVWMPFNYLFVTAIKEFR
DYYGKDLEVEYPTGSGKILGLNEIRNDLMKRLLSLFQTDEEGSRPVNAQHDQLYKDVNFK
DLVMFYEYFHGDTGRGIGASHQTGWTALIANMINEIY
>KECLDBNJ_02764 hypothetical protein
MAKDVFKKSFILFSILFTMHALNAQDFKFTKDHDALLVKDLEKSAQFYSTILGLPEIYNA
GLGPKFRWFALDNKVQIHLIESEDDSFTPHKGVHLALNVDDLDGFMTFLKQKNIPFENWP
GEPGITNTRPDGVRQIYLRDPDGYWIEINTNTL
>KECLDBNJ_02765 Na(+)/H(+) antiporter NhaP
MDFYLITAILVGLAAAFGYINVRFLKLPNTIGLMLITLLFTLAVLALSAVDDTLLEAEKE
IISNIDFEKVLLDGMLSFLLFAGALHTNFEQLRLQRWPVMVFATVGVLTSTFLVGGALYY
VLMLLGFDISFIYCLLFGALISPTDPIAVLGILKQAGAPKKLETKIVGESLFNDGVGVVV
FLTLYKIAGSTEAVTTTDILELFGLEVLGGIALGLALGWVAYKLMKSIDDYDIEVIITLA
AVMVGTVIAQKLHMSAPLAMVTAGLVVGNDTVRKTTMSKQTETYVDKFWELIDILLNTIL
FVLIGMEMLVLTFDTSALLAGCIAIPVVLLCRYISLLLPINFFEKHLNFVPRTDVIMTWG
GLRGGISIALALSLTQEMHRDLFLVITYVIVVFSIIVQGLSVGAVIKRLGVSETANAAEP
SGH
>KECLDBNJ_02766 hypothetical protein
MVLYAFAIFLVIIALLPLTQGTHWIIRGWDFIRVQTSVLQIIVLGLLLWLEYPEASWQYV
VLISLAITLVFQLYVVFPYTSFFPRQSKKPKNTANLNKISLLSSNVLQTNREYHKLIEQV
HLHKPDLLLVMETDKQWEEGLSEIEQDYPNVVRVPLDNFYGMHLYSKYELSETQVNYLVE
KDVPSIFTKVHHGGSTPLELICVHPAPPSPTENETSEERDAELLIVGKAVRILEDNHPII
VCGDLNDVVWSRVSKLFAKVTGLIDPRIGRGLFPTFHADYWYLRFPIDHLFHSTNVTVDK
MMRLPHIGSDHYPMFFSFWLENGKPISPPEVEKEIEEEVEERIEEGLERAE
>KECLDBNJ_02767 ABC transporter ATP-binding protein NatA
MSINVETITKNYGSQKALDGLSFSVNKGEVTGFLGPNGAGKSTMMKILTTYLKPTSGEAT
VNTYSTEKQPLAVRKSVGYLAENNPLYPEMYIREYLKLHAELNKISTSRIDEVIALTGLQ
PEISKKIKQLSKGYKQRVGLAAALIHDPEVLILDEPTTGLDPNQLREIRALIRSIGKTKT
VLLSTHIMQEVEAVCDRVIIINKGKIVADKRLDELKSGSDQIIVVEFDYRVELEFFQQLD
RVTHVANPVGFVYEITFNTQQDKRAVLFDFAHDNGLKILQLNKKNTSLEHLFQQLTN
>KECLDBNJ_02768 P-protein
MKHKVAIQGIKGSFHHKVAQDFFSEDVEVIDCNSFQDLVNRLIKGDATDAVMAIENSIAG
SIIPNYALLDHHNLNIEGERYLAISQNLMVMPGQKLDDIHEVWSHPMALLQCKEFFKDKE
HIRLVEDDDTAGAAKRIADGNLKGIGAIAGTTAASIYGLEVIAHDIQTIKDNSTRFFILN
TNGRTEADVPDKASVKFLTDHKRGSLAAVLNVMSDCRLNLTKIQSLPVIETPWKYSFFVD
VTFEDYADFEKAKKLLDIMAQEFKILGEYKNRKS
>KECLDBNJ_02769 LL-diaminopimelate aminotransferase
MIIASANRLNQTSEYYFSRKLKEVRALAAAGKPIINMGVGSPDLPPPPHVIKALTSSLVD
APAHQYQSYKGLPQLTEAMADFYQKRYAVTLNPEDEILPLMGSKEGIMHISMAFLNPGDE
VLIPNPGYPTYTSVTRLVEAEPIYYNLDASNNWMPDYSALEKRDLSKVKLMWVNYPHMPT
GAKATTADFEKLVAFAKANKILLVNDNPYSFILNENPQSILSVAGAKEVAIELNSLSKSF
NMSGWRVGMLLGAVDYVSTVLTVKSNMDSGMFYGIQKGAAAVLTEGEAWFSGLNEIYEKR
REQVWKLADLLGCTYDKNAAGMFVWAKLPEGTGDAEAFIDDILINKSVFITPGSIFGSQG
AGYIRFSLCVTEDKIKEAIGRF
>KECLDBNJ_02770 Prephenate dehydrogenase
MEDFKNIFVLGIGLIGGSLARDLKRVLPGSTIYGVDSNDDHLDEAVGLGVIDHSARFEAI
NQADLVILAIPVDQANLFLPPVLDAIAPNALVMDVGSTKGSVCDAVQDHPKRDQFLAAHP
IAGTEFSGPSAAIENLYKNKTMILCEVEKTREDLLAKAMQIFEALPMQIRYMNPHSHDKH
IAYVSHLSHISSFMLGKTVIEKEKNEKDIFDMAGSGFASTVRLAKSNPATWTPIFKENKA
NVLESLTEYINNLTHFKNVLEAENYEEVFNEMHNTNHIKSILKGLS
>KECLDBNJ_02771 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENKKELRNWLDAFNLDHPLVIAGPCSAETEEQVLKIAHELKDTDATVFRAGIWKPRTRP
GMFEGVGALGLKWLQKAKEETGMLTTTEVANPNHVELALKHDVDILWIGARTTVSPFNIQ
EIAEALKGTDKTVLIKNPVNPDLALWLGAVERFYTQDVKNLGVIHRGFSTYEKTRYRNNP
EWQVAVDLQNQFPDLPLILDPSHIAGRRDIIFDLCQTGLDLNYDGIMVETHYDPDNAWSD
AKQQITPATLVQIMKDLKIRKEEGTAAEFNNKLNTLRTQIDVVDHQLIESLGKRMKIADA
IGELKTENNVAILQSKRWNEILGAMILEGEKHNLSEEFILRVFKAIHQESINHQKKISRM
EEA
>KECLDBNJ_02772 hypothetical protein
MKFKTTLLLFFGLLSIPLCAQVMEYQTVTVIESIIPNGIGRSRMISTEAERDYKEFTSER
SEEDNSRNKADRGDIRVKNFEETKLLNFFNLGGIRFQNIAANDAVVTSKINAMAEEGWEL
AFVNSGVESYGGKDDENGIYVTRYIFKRPKQG
>KECLDBNJ_02773 Small ribosomal subunit biogenesis GTPase RsgA
MKGIVYKSTGSWYSVKDDSGNFYDCRIKGRFRIQGIKSTNPVAVGDRVVFELEETGDAVT
GVIKAIEDRDNYIIRKSVNLSKQTHIIAANIDRCFLIITLNNPPTFTAFIDRFLVTCEAY
GIEAVLLFNKVDTLSAEEFGEVKYLAEMYREIGYTCIGISAKTGKNVDQVKALMTGTTSM
FSGHSGVGKSTLVNAIEPALDLKTKAISDQHMQGQHTTTFAEMFDLSFDARIIDTPGIKG
FGVVDIEKEELGDYFPEFFALKEHCKFNNCLHLEEPKCAVKEALERDELHWSRYESYKQI
IEGDEENYRRNIYDQNP
>KECLDBNJ_02774 D-aminoacyl-tRNA deacylase
MRVVVQRVSEASVTIENVIKSKIGIGFVVLLGITSEDTEEDIEWLTSKICGLRVFGDAEG
LMNESILDKNGEILLISQFTLFASTRKGNRPSFIKAAKPDQAIPLYEKFIGELSKKLQRQ
VQTGEFGADMKVALVNDGPVTISIDSKNKE
>KECLDBNJ_02775 hypothetical protein
MAKKLLLLLFVTSSVAFSQDLKLSALTVNPELSEGADSVFRNEEITLDLSREGKLKTLIS
RVVTVYNKAGLGDVAAYVGYDNNTKVNSIEAYIYDLSGKEREHFKERDFKDVSAVDGGTL
YADSRVLYLDYTPTTYPFTVHFISETTSETTAFLRPWMPLSRYKSGTEFSKFTVIYPPEQ
TLHVKETHLDGYAIEKEELADRTVWTAKDLAPVTWEYSAPDLDQRVPRVKCFFDTFYLSG
VPGIAKTWKDFGRWMYTDLVKDTQDLDQATITEAKALVAGLETDEEKARAIYQYVQDKVR
YISVQVEIGGWKPMNASDVHRLGYGDCKALSNYTQSLLKAVGIKSYYTVLYGKSDKESLD
TDVVAMQGNHAILGVQLGDEIQFLECTSQETPFGYMGSFTDDREVLLLTEDGGKLARTTK
YEQDENRVALEAAFKFDASGGLEGTITRASSGIFYANRMSLARLDQKDLSDYYYKAFDAI
NGLSVSNIQLNNDRMNVVYTESLDARATNYGSKVGANFLLRLNAFALGRDAIPPKYAHRK
SELIILRGTTQEDKIAITLPEGYEVGALPEDVVIEEQFGSYHATFRREGTQLYYTRTLKF
NEGNYPVAQYENYRDFYKTVVRNDSQKVLIQKI
>KECLDBNJ_02776 hypothetical protein
MRKITWFAFLLVTSCGVAQDFRFGKVTVEELQEEVHSKDADADAAILYREQFSHIDYFEN
DGLMLTTEVYERIKIYNTDGFDWGTQQIPLYTGGSKNESVGKIKGVTYTLNGDKIEESKL
RNDGIFDEEKNKFYDVKKFTMPNLQPGCVIEFQYEVVSPYLSTIDEIRLQEEIPVNKADV
SFYTPEWLVYQLHRKGIFPLDIEQTSKAATINYRVRQGVSNGGSVGFAQRSSVGSGVQMR
KIDYQKKGYKVLAQDIPAMREEAYSSNIDNYRAALSFELSFTQYPGEPLETITSSWEAVS
KTIYDSENFGGQLKSVRFFDDDIDELLAGANDPVEKLARIYEFVKQKMVWNKYIGIYADE
GVKEAYKSGVGNSADINLMLVSMLRYAGLDANPVILSTRDNGIPVFPTRNGFNDVIAGAK
IGEHTFLMDATNKMGMPDLLDEELLNWNGRVIREDGSSEWVNLYPSKHATESTIISSEIT
EDLVAVGTLQSRYTGNYGLTYRKNLGSRTEEEQLKAFEQMHSGVDIADLELKNALEVSNP
LEVAYNFEMLNGVEEVGGKLYVSPLLHVTTTENPFKSEVRAHPVDFKFPWKDRYIISIKI
PEGYTVESLPESALYHMTDKMASYVYRVSASEDKINISTEMAFNSSIIAPDYYQDLKKFY
ETIVTKQNEKIVLTKI
>KECLDBNJ_02777 hypothetical protein
MRYKLLMITMVVLMGAVHCAQAQKIKLDKVTKDELELKVYAEDSTAAAIYLDKVRETYFD
YKTSSGFLIINEFKERIKILSKEGLDYATKKILNYKNDSDKELVDDIEGVTYNLVDGKIE
EIELKKDGIFENERSEHWDETSITMPAVQVGSIVEWSYTTISPFYKIDDLILQEDLPIVE
YYAKIRTPGMFTFRRLKKGYFDITPKESIVDGGVNFENAYGQSNYASYKELVAEYTQNDV
PALKEEVFLINPDNYRRSIVYELISTEFTEGNKKEYATTWEEVAKTIFKQREFGGQMSPS
LSLKKVAARMVADHKTQAEKIEAALAYVKSKIKWNGNYGKYTDDGIDDALKRGSGDVAEI
NLLLTVLLRECGVQANPVLIGTKQHGIPSFPTLEGYNYVVVGVRDGLKTILLDATDKFSA
PNILPTRVYNWYGRMVNKEGVSQEIDLYETISPQKDRYVMADLNEDGSINGVLKQRYKSL
EAFELRHKVDEESLETYTQERAVDLGVDEVTNLKLEGIEELSAPITESLEFKINQGVDQI
PGQIYLNPLLFFTMGDNPFKSDVRISPVEFNYPFFHNTNVTLKLPEGYEVQQLPEPIKIA
LPGELGSFVYSITHMGQTLQVMTKFNLTGTFVPYDYYQSLKEFFNRRVAKETEKVILQKS
I
>KECLDBNJ_02778 hypothetical protein
MKIDDAQKAVDEWINNHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKNKDL
GEELADVLFVVLCLANQTGIDLQDAFDKKLDLKTKRDHDRHHNNKKLQ
>KECLDBNJ_02779 3-phosphoshikimate 1-carboxyvinyltransferase
MKLKLHQKEPHLDGDIAITGSKSESNRLLLLQALFGNFKIKNLSNSHDSQVMQKALASKE
KEVDIHHAGTAMRFLTAYFAAFEGRETILTGSSRMQERPIGLLVDALRELGADITYQNNE
GYAPLLIKGKKLTKSTVSLAANVSSQYISALMMVGASLPGGIEINLIGQITSVPYIEMTR
SLLTQLGIESSFEGQQIKIKPAGAINVSEMVVESDWSSASYYYSLAALCDTAKLKISSYK
KDSLQGDSVLAELYQKLGVKTTFEGHAVLLEKVDQPKPKRVEFDLANSPDIAQTIAVTCY
GLGIACDLYGLHTLKIKETDRLEALKAELTKLGAHISVTDKSLHLEGSTNFQSDVTIKTY
QDHRMAMAFAPFGLRASILFEDAEVVNKSYPDFWEDLHTLGFKINEV
>KECLDBNJ_02780 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MGMKLSHFNFDLPKELLAEYPAENRDEARLMVLNRKTQTIEHKLFKDLIDYFEPNDVMVL
NNTKVFPARLYGNKEKTGARIEVFLLRELNSETRLWDVLVDPARKIRIGNKLYFGDDESL
VAEVIDNTTSRGRTLRFLYDGSYQEFRNKLTELGETPLPKYIKRDVEPEDAERYQTIFAK
NEGAVAAPTAGLHFSKHLLKRLEIKGLNFAEVTLHVGLGTFSPVEVEDLSKHKMDSEEAY
IDSSATTTINKAIGENRKVCAVGTTVMRALESSVSSNKTLNEFSGWTNKFIFPPYDFSIA
NCMITNFHTPKSTLMMMVSAFAGHDFMKEAYEQAVKEKYKFYSYGDAMLII
>KECLDBNJ_02781 Dual-specificity RNA methyltransferase RlmN
MKNTQKDIRALSREELRDFFVSQGEKAFRGNQVYEWLWVKGAHSFDDMTNISKETRAFLD
EHFVINHIKVDQMQRSSDGTIKNAVKLHDNLTVESVLIPTASRTTACVSSQVGCSLNCKF
CATARLKRMRNLNPDEIFDQVVAIDQQSRLYHNRPLSNIVFMGMGEPLMNYKNVVKSIEK
ITDPEGLGMSPKRITVSTSGVPKIIKKMADDEVKFNLAVSLHSALDDVRTDIMPFNEQMP
LQELKEALQYWYVKTKKRITYEYVVWRGINDQDKDIEALIDFCLAVPSKVNLIEYNPIDD
GQFQQADPLAIDRYVAKLEDRGITVTVRRSRGKDIDAACGQLANKNG
>KECLDBNJ_02782 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MKVVEQIKQPIAHEMELFEQKFSLSMKSKVPLLNRITHYIVNRKGKQMRPMFVFLVAKML
GDERLNDRTYRGASVIELIHTATLVHDDVVDDSYRRRGFFSLNALWKNKIAVLVGDFLLS
KGLLLSIDNEDFDLLQIISVAVREMSEGELLQIEKARDLDITEEVYFEIIRQKTATLIAA
CCAMGACAIHASKKDVEAMRKFGELIGLAFQIKDDLFDYGSQKIGKPTGIDIKEQKMTLP
LIYAVNNSDKKQSKWLINSVKNHNKDKKRVNEVITYVKESGGLDYAVAKMKALQQEALKI
LDKYPESKYKEALVLMVNYVIERKK
>KECLDBNJ_02783 ECF RNA polymerase sigma factor SigW
MKVITFFNSEKQLIKKAAQGNREAQRKLYDTHAPKMLGVCRRYLNDVMQAEEAMCNGFLK
VFKNLDRFRDEGSFEGWVRRIMVNESISYLRKEQKITFTDYEQQADDTTYNPVDSELDAE
EIQFLIDRLPEGYRAVFVMYAVEGYKHQEIAKMLDISESTSKSQLFKARKLLQQKLNELN
TYQYGTDKV
>KECLDBNJ_02784 hypothetical protein
MAPIKFEDNIRERLEHREIKPSAEAWQKLEASLDQEAKPAKSKKSYGWVLIAASFIGILI
LAGRYVFQDEMDKNPVNQVVETPAEMQNEQKNEPTETFQQKQQEIVVQEETSVAVHEEHQ
IAEPPKKRKEKPVIQKYEEAVAVTDSQKASADEKLDQTTQSKIDAEVNDLISKVQEQQNS
GVAYSDAEIDQLLRDAQRDIISEKMFDRERNTISAEALLYEVEEELDPSFRDRIFEALKD
GFMKAREAIVSRNN
>KECLDBNJ_02785 hypothetical protein
MRFLLLLLITLSSVLPQKTFAQETEKEETIATLNAKKEEVVQKEKEALKIEVLAINKRFE
NGELTEEEATILKKEAAKKHARNIEDKLAILESKIDLLERNETDLDDDSIFGIFIGNDKV
TLGSGDKEEVVYDRRTTSDIVLGIGFNNAIIDGQSLNDSPYKIGGSRFFELGLAWKTRVF
DNTNFLRLKYGFSFQFNGLKIDDNQYLVEQGDQTVLETFPLDLDKSKFRMDHLVFPVHFE
IGPSTKKVHDDYFRYSTHNQFKLGLGGYAGFNLLTIQKLKYEENGEDRKDKFKQNFNTNN
FIYGVSGYIAFGDTALYVKYDLNTIFKNNPVEQRNFSVGLRFDMD
>KECLDBNJ_02786 DNA primase
MISKTTIDAVFETARVEEVIGDFVQLKKSGSNFKGLSPFSDERTPSFMVSPVKQIWKDFS
SGKGGNAVAFLMEHEHFTYPEAIKYLAKKYNIEVEETEQTDEQKEQANERESMYVVSEFA
RDYFHKTLLNSEQGKAIGLSYFKERGFTEETIEKFQLGYSPDVWDAFTSEAIRKGYKLEF
LEKTGLTIVKEEKQFDRFKGRVMFPIHSLSGRVLGFGGRILTNEKKAAKYLNSPESEIYH
KSKVLYGIYYAKQAIAKEDNCYLVEGYTDVIQLHQLGIENVVSSSGTALTPEQIRLINRL
TPNITVLFDGDAAGQRASLRGIDLILEQGMNVKVCSFPEGEDPDSFSKSHTLTEVEDFLK
KNAKDFIQYKASLLVKEAQGDPIKKAGLVRDMVESIAKIPDVIKREIYVQECARIMDIKE
DVLFNTLAQIRNKGKKDAVQTTEKRPAEGEMIPLKNEEKVKFERQYELEQNIIKLLITFA
NEPVQFVDLVYDEDKDGKLIEREEKRELIIYEKIYLDLQEDEVEFANDDFKAIYPLLIEH
LTREEGDIKLDQLGEVLPASQMEKISSIAFEPEKHTLHAWDRHEIYVKTLKENSGLETVQ
TLLNLRHFLIQRKMAEFGEQLKTGELPENAQEFLEDYKDYKTLEVLIAKKRNLVIMPFMR
>KECLDBNJ_02787 Transcriptional activator protein ExaE
MITITIADHHPIIVDGLTHILKNTIHEIIDVVSDGKDLIASLEEEVPDLVIMEIDMPNLQ
GLTAIKELRKLFPGIKIMVYSTHPEGMYALSAIKAGAMGYIGKTADTATVLKAVIQVARG
GIYLNNNLVEMLSNTDPSHNSTLAYRYKKLSTRETEVLNMLSSGKRNKDIAESLDINEKT
VSTYKTRLLKKLDAGSLAELIQQARLLQTSDL
>KECLDBNJ_02788 NH(3)-dependent NAD(+) synthetase
MQTEKVIDHIVNWLKTYATNANIQGFVVGISGGIDSATTSSLCAKTGLRVLCVEMPIHQP
PSHVTRAQEHIAQLKKRFANVSDVRVDLTETFETFKTALPAAETDTNPGLELSLANTRAR
LRMSTLYYFAGLHGYLVAGTGNKVEDFGVGFYTKYGDGGVDLSPIADLMKSEVYALAKEL
GVPESIQVAKPTDGLWGDDRSDEDQIGATYDELEWAMLQDEQGKSSEDFEGRQKQVFSIY
KGFNNANKHKMEPIPVCTIPEDLK
>KECLDBNJ_02789 hypothetical protein
MVNLLKNEMFQQVRIALSMGFRFFLGLTVFLMVGCKNDVKIPEEISQIPIALEVDRFDQK
FAKVDASELPELIAAYPYLFPEQYDEQFWRDKIQDTIQLELNSEVAQSFPDFNEETQELD
NLFKHIKYYYPKTPLPKVVTITSDVAYRTPVILTDSLLIIGLDNYLGEDHHFYKGIQRFY
TQNFRKEQIDVDVADAFVRTLVRKQGSRRFLDEMIYHGKRLYMMEQLLTLEAKNEIIGYT
PEQLDWAEANEVDIWTYFVENELLFDTDSKLLSRFINPAPFSKFYLEFDNESPPRLGRYI
GWQMVKAYMQRNTIPLQMLPGKSSDEIFKQANYKPRK
>KECLDBNJ_02790 hypothetical protein
MKTEIKLSVELDENRVPEKISWNAPDGGVSHEPAKALMLSLWDHKKQEAARIDLWTKDMP
VDEMKVFFHQTLVSMANTFKRATDDDKMSATMMDFCDYFAEKLELKK
>KECLDBNJ_02791 hypothetical protein
MITLLFVYNARSGTLNALLDGVHKIVSPSTYSCKLCRLTHGAFQEREMWKAFRQSTALNM
EFYHRDEFLQNCTAERNDQWEFPVILSKTETGLNVFLSKEELETLNTEAALIQAIKAKLK
TL
>KECLDBNJ_02792 putative GTP-binding protein EngB
MHIKSAEFLVSNSNVAKCPKNKMPEYAFIGRSNVGKSSLINMLTDRKNLAKTSGRPGKTQ
LINHFVINQTWYLVDLPGYGYARVSKKVKKEFQKFITQYFEEREQLVSAFVLIDCRHEPQ
PIDREFMQYLGEKQIPFSIIFTKADKLKPKALERNIEHYKQELLAGAWAEMPNYFISSAT
NSTGKDEILDYINAINEQLKES
>KECLDBNJ_02793 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MSIFVAKPLADLLIMKHQLKTEGKFTYLEVGEGTPIVILHGLMGGLSNFDAVTDHFSQNG
YKVVIPELPLYSMPLIKTGVKTFAKYLNDFIAMKGFKEVILLGNSLGGHIALYHTKLYPE
VMKALVITGSSGLYESAMGESYPKRGDYEYIKKKAEDVFYDPAVATKEIVDEVYETVNDR
NKLIKTLAIAKSAIRHNMAQDLPHMNTSTCIIWGRNDNVTPPEVAEDFDKLLPDSDLYWI
DKCGHAAMMEHPKEFNEILSRWLKERNF
>KECLDBNJ_02794 Transcriptional regulator MraZ
MMPSALKKQLAKELQEGFVVKRSVFNSCLELWPMSEWEVMMKKLNGLNRFVKKNVDFIRR
FTAGVKLVEADASGRLLIPKDLIAFASITKDIVLTSGGNIIEIWDAVGYEEAVSNDDGDF
AALAEEVMGDQNDIPDGLS
>KECLDBNJ_02795 Ribosomal RNA small subunit methyltransferase H
MDYHNPVLLKETVDGLAIKPDGVYVDVTFGGGGHSREILKRLGADGKLFAFDQDKDALEN
AIDDPRFTLINENFRFAKRFLRFYGAAQVDGILGDFGVSSHQFDVAERGFSTRFDAKLDM
RMNQGDKLSAYHVVNEYAEEDLSRVLLQYGELRSAPKLARTLVSVRKDQPIETTEDLKQA
LQSYLPKGREHKLLAQIYQAIRIEVNQELEVLKEFLQQTEEMLKPGGRLSLISYHSLEDR
LVKRYMRNGLFEGEPEKDIFGNFSVPFKKVGGLIVPSKEEIKQNNRARSAKLRVAEKL
>KECLDBNJ_02796 hypothetical protein
MKEGIYHILKGKFLFSDDAVKNWRMIIFLSVLAIVMIGSSHRADKKVHLISQLNAEVKEL
HSEFVDTRLEARRLKMETVVTRQVAEQGLAPSLTPPKKIKVTKTP
>KECLDBNJ_02797 Stage V sporulation protein D
MYLVAGGMFLFALFVAFKLCDIQLAEGDKYKELAEARTERMFTIPANRGNLYAGDGSLLA
TSVPKYDIRFDALAPKQTDFEENIQGLSKGLAEQLGKPQSYYIDLLRKARVNKNRYLLLA
RNLGYSKYLAIKKLPLFNKGPYKGGIITEQRTVREHPLDKIAERTIGYDRLTEYGRYSEA
GLEGAFGPYLRGKEGRRLKQRIAKGQWKPIGDDNIVEPQDGYDVISTIDVNIQDIAHHAL
LASLEKFEADHGCVVVMETKTGEIKAISNLGRTEDGDGYYEDRNYAVYESAEPGSTFKLM
AMVAALEDRVIDTSDVVDTENGRVRFYNRTVYDSHWGGYGKISAARAFELSSNTAFAKII
NEGYKDDPKRFLKRLYNMGLNDKLGLEIKGEGSPKFPYPGDANWYGTTLPWMAFGYGVSL
TPLQTLTFYNAIANDGEMVKPRFIKEVKKWDASIEKFEKEVINPAICSQSTIDKAQEMMK
NVVERGTGKDIYSKNFSMSGKTGTCQTEYWKEEGKYIASFAGYFPAENPEYSCIVVIHKP
NKKIGYYGGVVAAPVFRKIAQKVYSDTPLVDEVKLADANTSSVEKDFENYYQQAQKAAET
IPNVRGMSGMDAVSLLENLGLQVEFSGSGKVKSQSLKAGQKLSKNQKIILQLS
>KECLDBNJ_02798 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MILLKDILYKVTLESVTGNPNVPVNAIHFDSRKVGLNDVFVAISGTQSDGHDFIKKAEEQ
GAIAIICERMPEVFVNGITYVQTSDTAQALAVMASNYYENPSENLKLVGITGTNGKTTIA
TLLHQLFTKAGFKAGLLSTVKVLVGDEEFPATHTTPDSLTINKYLAMMNDAGVEYCFMEV
SSHGIHQKRTEGLHFEGGIFTNLSHDHLDYHKTFAEYRDVKKSFFDHLPKTAFALSNIDD
KNGQVMLQNTQAKKVTYALKSFADYRAQILENQFTGLLLKVNDQEVWVKLIGSFNAYNVL
AIYAAAELLGLSQLEALQYLSELTSVSGRFQYMISAKKITAIVDYAHTPDALKNVLETIN
DIRTKNEELITVVGCGGDRDRTKRPKMGKIAAALSTKVVFTSDNPRSEDPDAIIEEIEKG
VEPVDYKKTVAITSRKQAIKAACQMAEENDIILIAGKGHETYQEVKGERTDFDDFKIVKE
LLTELNK
>KECLDBNJ_02799 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFEYLERAYNFPGASLFGFITFRAAIAIIMSLAISTIWGKRIILYLQKKQLGESIR
DLGLEGQVEKAGTPTMGGLIIILATLIPVFLLAKLENIYVILLIVTTLWMGAIGFMDDFL
KIRKKNKEGLQGKFKIFGQVGLGIIVGATIFFHPGVTVKDEIANKPAQQEELVDSSTTEF
SSEEKALTTTIPFVKNNEIDYSILVSWLGEDYVKYAWLLFIPIVIFIVTAVSNGANLTDG
IDGLAAGSSAIIVLTLGIFAWVSGNIIFSDYLDVMYIPRSGEMVIFITAFVGALVGFLWY
NTYPAQIFMGDTGSLTIGGIIAVIAIAIRKELLIPLLCGIFFMETLSVMLQVSWFKYTKK
KTGEGRRIFLMSPLHHHYQKKGLHESKIVTRFWIIGILLAIITIVTLKVR
>KECLDBNJ_02800 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKRLVILGGGESGIGTAILGKKEGFEVFVSDFGKIKPKYLDVLKNIEIEWEDGGHTEAKI
LNADLVMKSPGIPDKAPLIKKLVEAGISVISEIEFAARYTKATLVGITGSNGKTTTTMLM
AHLLKQAGLKSVAAGNIGDSFAKWVALDDQDFYALEISSFQLDGIVDFAPHIAILTNITP
DHLDRYEYKFENYIKSKFRIAENQTEKDYLIYDADDPVITDWLAKHPVRSQCIPFSISKQ
QKKGAYYAQEEINILIDDTTMTMSTKNLTIKGAHNTKNAMAAATAARLLSIRKATIRESL
EGFQGVEHRLEQVLKINHVSYINDSKATNVNATFYALDSISAPTVWIVGGVDKGNDYKDL
FPLVNEKVKAIICLGVDNAKLMQTFSGMVENIIETQSITEAVKIAYKLSDKGDNVLLSPA
CASFDLFENYEDRGRQFKEAVRNL
>KECLDBNJ_02801 putative peptidoglycan glycosyltransferase FtsW
MSRTKNIFSTLKGDRAIWAITAFLALFSFLPVFSASSNLAYLYGNGETLPFLVRHFMHLV
LGFAIIYGVHKVPAHYFKGLSIIGIPIVIILLLITMAQGTTIDGANASRWIKVPFVGITF
QTSTLASVVLMIYIARYLSKIKDEQITFKESILPLWVPVALVLGLILPANFSTTAIIFAM
VLTLVFMGGYPFKYLAIIVATGLLALTMFVLAAKAFPGVFPNRVDTWMSRIDSFADDEDS
EGDYQIEKAKIAIATGGLTGLGPGKSVQKNFLPQSSSDFIYAIIVEEFGLVGGLMLLLMY
LLLLFRILVVAHKADTVFGKLAVMGVGLPIVFQALINMAVAVELFPVTGQTLPLVSSGGT
SIWMTCLAIGIILSVSAKRDEVRAKEEDEMNPLDVLSEAM
>KECLDBNJ_02802 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKNYKFILSGGGTGGHIYPAIAIADALKAKYPQAEFLFVGSQDRMEMEKVPKAGYEIKGL
WIAGLQRKLTWSNLMFPFKLISSLFKSAGIIRKFKPDVVIGTGGFASGPLLEMATRYNVP
ALIQEQNSYAGITNKLLAKKVQKICVAYDEMQRFFPQDKIVKTGNPVRQDLLAIDSLREQ
GMAKFNLKKNKKTLLVLGGSLGARAINKMLDRELQFILDQEVQIIWQSGQLYYEEYKKHN
AVEDVQVLPYIDTMNLAYAAADIIISRAGAGSVSELMLVGKPVIFIPSPNVAEDHQTKNA
EAIVSKNAAILLKEKEAEQQFKPVFKTLVHDEAKQQLLGDNIKKIALPQATEHIVNEVEK
LLKQ
>KECLDBNJ_02803 UDP-N-acetylmuramate--L-alanine ligase
MKTLDHISHIYFIGIGGIGMSALARYFHAAGKEVAGYDKTPSQITRSLEELGIRISYQDT
LEAIPAEFKVLDKTLVVYTPAVPKAHTAYQFYLTEGFQIKKRAEVLGWLTQEKFCFAVAG
THGKTTTSAMLGHLMAFCELPMTAFLGGIAENYQSNLIQQGEEIVVVEADEFDRSFMQLF
PNIAAITSMDADHLDIYGDAEALQKSFRDFAAQVKEDGVLFVKNGLPLDGITVGVEDHSA
YAALNVKIENGAYHFDLKHPDGLIEDLVLNLPGRHNLSNATTALAMALHYGCPADKLAKA
LFAFKGVNRRFTYRIKKENEVLIDDYAHHPAEINAVHSAVREMYPNKRVLAVFQPHLFSR
TRDFMEEFAASLAQFDELLLLDIYPAREEPIEGVTSEKLLELIPLTRKEVISKAQLEEKL
QASKATIKVMMGAGDIGEEILKLTKTLAV
>KECLDBNJ_02804 Cell division protein FtsQ
MKINWFYIRMLVLVVLTLGLVAFTHKRNANRKVKEVQINFEAGANLFVTAESVDKLLIQN
GKPIEGQYKEILDLKDLEDKLDAHAMIADADVYMTLDGVVGATVKQRKPLARVQTQTPFY
IDEEGKTMPLSSNYSARVPLVTGVSQEQVKEVYPLLKYIQEDKVLATQVVGISRFKNGDY
SLTLRVLDYDVVIGKIEQLSSKFSNYKAFYQKAIKDNSLEVYKSVDLRFKGQVVGTKK
>KECLDBNJ_02805 Cell division protein FtsA
MEHKDIAVGLDIGTTKIVAMIGRYNEYHKLEILGIGKSKSLGVHRGVVNNITQTIQSIQQ
AVQEAESVSGMKIEDVVVGIAGQHIRSLQHSDYITRADADQVIGPKDIDMLCNQVHKLVM
LPGEEIIHVLPQEYKVDGQAEITQPIGMYGGRLEANFHVVVGQVSSIRNIGRCVKSAGLN
LDKITLEPLASANAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITE
DIKEGCSIIEKQAELLKIKFGSAWPGENKDNEIVSIPGLRGREPKEITLKNLSKIIHARV
VEIVEQVYLEIKNYGHEEQKKKLIAGIVLTGGGSQLKHLKQLVEYITGMDTRIGYPNEHL
AGDSDSETTSPLYATAVGLVMNSLEHQRNIQDDEPQDTAVVEEEPVIEPLLEDDPAEQEE
EKPAAAKKPRKSIFDTWAEKFKDFLDNAE
>KECLDBNJ_02806 Cell division protein FtsZ
MSNTDFENISFDLPKNQSNVIKVIGVGGGGSNAINHMFSQGIKGVDFVVCNTDAQALENS
PVPIKIQLGVSLTEGLGAGANPEVGEKAAIESSEDVKQMLGTNTKMVFITAGMGGGTGTG
AAPVIAKMSKEMDVLTVGIVTIPFQFEGKMRNEQAQLGVEKLRSHVDSLIVINNNKLREV
YGNLGFKAGFSKADEVLATASRGIAEVITHHYTQNIDLRDAKTVLSNSGTAIMGSANASG
ASRAQDAIRKALDSPLLNDNKITGAKNVLLLIVSGTEEITIDEIGEINDHIQDEAGHSAN
IIMGVGEEESLGDAISVTIIATGFNVEQQNDIVNTETKKIIHTLEDEQRAQHDLTPKNTG
GTLNFDTPAPKKEAPAPEKKPIVHTLDDTDDPMDLMVNKPKKETPKPKMDLIPTTELIRN
LQVVYEEVLDHSEPEITFEEEEEELEFKIVSVEEPTYKPQADLFNQEEEEQFTLSFDLPL
NEKASPTQEEFIAEDEEEEVVYNLDDDINDIEVNNPVEIVSVTEVNENGEKRYSLDDYME
MEDHLNSAQPTQQKRAEPQKKQEEEIAFERKTVAPVEKEEVKEEDGDPMNAPISQLLTER
AAERRRMMKEFNYKFHNNQSRIDEIEKQPAYKRMGVNLDSNPSAKSSISRTSLSTDENDE
MQLRRNNSFLHDNVD
>KECLDBNJ_02807 hypothetical protein
MSLQTEVMTAMKAAMKAKDQNALASLRAIKSAILTAQTESGAGDELSEDQEIKMLQKLVK
QRKDSAAIYQEQGREEMAQEELAQAKVIEQFLPEQLSQEEIEQVVAAIIEKTGASGMQDM
GKVMGLASQELAGKADGKTISTIVKSKLA
>KECLDBNJ_02809 Tyrosine recombinase XerD
MRTSKTFSIQFWADTRKNKNGEVLIYARITMDQKRLSISLKRNVPLELWDSQNKRVLGNS
VMAKQLNQYLDLAKSQLYQSYMELKAADKVLTAQMIKDYFMGEDKSTKTLVQLIDYHREK
IKGTLAKGTIRNFRITESYVLKFLKSNKLEDIFLSRLDYKFICDFETFLVQYYPKGHPRA
MSHNTVMKHIQRLRKMIRLAYHLEWLDKDPFRRWKTTFEKTDREFLSEHELSNLATYEFP
LERLERVRDLFLFSCYTGISYVDLNKLTPNNIWKGEDDKKWIVTNRQKTNTRVKVPLMPT
ALRLIEKYREHPLTEVSGTLFPPITNERANLYLKEIAEACGLTKNLTFHMARHTFATTVT
LSNGMPIETVSKLLGHTKIATTQIYARVLDKKVEEDMNKLQEVLQSKTTSSNKAAGRLKI
IR
>KECLDBNJ_02810 hypothetical protein
MEEFYLKKITKEVFEKAQNKSASHSNYALSKEVEATTTLSYRTVERAFDKYINGRGKGNK
PIANTIEEFCRYLGYRDYAEYVENNKAKELVQEEIGLRENEEIDDSSVKVKALSNQKRWY
SISIFGTFALTLIIIVYFIAKNRASEPSASIKCMTWTGSEFEEIACGSGAYSTYGTAIEP
YEKKRFENFRRVDVDITTQFFSEQNQKPLFWYYKNDQGEIEYYTSAGLHPVNGETLKAIT
EYIIEKYVPIHQNKPSSFVQDTK
>KECLDBNJ_02811 hypothetical protein
MKKIIIALCIVAFNGVLASCSADAYEERLITNTQATEGDDEKVTPPPPPPPPSEGDE
>KECLDBNJ_02812 hypothetical protein
MLYSRFFLIICFLAIGCTSRTDTSLDFVLDTDDFDSISYYDLKAQKKEYSLQQRNEFATK
AFIKVRHKTVDLRFGRLLYQKNYLHLLLGEYDSLLHYDKLINNNNLLDDPHILAMHQYLM
GYYFETIVQQPDSAFNHYTKSQFYYQQASDSSGVAKALLNMGGIQKEQNDFFGSKETLTE
ALKFTIKNKDQQTYFSILDRLAQDHRKLKNLQEAAALYQIILKESPLQDLAAYQNNLATI
YIDQKKFTDAITLLEVISGDDLQHSNTLTARVLDNLAYAKWSMGTSVPPENFLLALEIRK
DINDLKGVLASYTHLGEFYMERQPNRAMVYFDSVIDISRKLNIPRAEQEALKFKMQLAPQ
NITYKNRYITLQDSLSASELKVKTQFAKYKYDDKLKQESILRLEKEKATKELEASRERTA
KWAFFIGVLGLFILLVLGYYLYKQRVRRLRTQNRADRVEASYKTEAVLSQRLHDDFGAGL
HHVMLLVQSKSEPEKILNELDKLYQQSRDFSREINAVDTGVNYKEALYTMLDQIKPENTR
LLISGSKEITWQVLSNVTKITLYKVLRELFINMAKHSQATIVTLNFKKNSEGIEIRYSDN
GVGVSQNEKIIKNGLLNTEKRIEAIGGNDYF
>KECLDBNJ_02813 hypothetical protein
MFKKVLIAEDFQGDNKSIVDTLKAKLRIPEVQEEFYCDKAFNRLKVAHINQEAYDVLITD
LSFKKDHTHQNIVSGYELIEVSRKLQPDIKIIVNSMEENPVQIKTLFDSYKINAYVCKGR
QSLDELVKAMELVRDGAFYISPQIDLNLGKNLFELDELDLVILKNLANGLSKKQIRVKLK
KMDLRPNSESAIDKRVSKLFDEFGAKNSTELVAKLIREGLI
>KECLDBNJ_02814 hypothetical protein
MIRYQNRNRDSGVAFYELLSNGIVVHFTTGAIYEYTYATAGKTSIDQMKKLAESGSGLNS
YINQNVKYKYSRKIR
>KECLDBNJ_02815 hypothetical protein
MGNTIGHILISYDINRSHTEVKRKLEEKGYLDHFKYHGASKTYYLPNTTLWHTKMSSSQA
LEDLKSVCQMYSVVLEKAVAVKASEFIAI
>KECLDBNJ_02816 hypothetical protein
MILLMSFFEIQAQSAPQDTLVETPCCEEGRGCTGSSYCTACKNCSGCKHCAKNGGTCGVC
RRVRTTPVRSVSSKTTPVSAKFKKGMRLHVSSPVLNLREAPSASSKILGKLKVDQEVEVM
EVLDSWCKVKVLSSQNTGYVYRDYLK
>KECLDBNJ_02817 hypothetical protein
MEYKVIPFIASIDRSKENTKQVAEQLEALIKNQTADGWNYERLESVSSYVQPTQGCFSFG
GEQGYSTAHQMVVFSRDF
>KECLDBNJ_02818 Putative membrane protein insertion efficiency factor
MRVFLILLIKFYWVLIPKAKRRRCLFKKSCSHYVFDITKDEGFFEGLKALNFRYKNCRPG
YYILKEEQLLISASGKSFDNHHIKEEIF
>KECLDBNJ_02819 hypothetical protein
MGYRKGYYRKDGTYVQGHYISKTSSKQKVKSKKGCFLLMLALVSILGIEACNPESDCPTR
KCSDYNSQAQAQQEFNENPSCLENLDSDNDGIPCENLPKN
>KECLDBNJ_02820 hypothetical protein
MISTELKSHFLRLYQMAFSDDNFDVLEMKMLYHFAEERGVSRAELDAILVNPSHNSTVPD
STEEKISYLYDLALMIWADGKVDPDELVTLKKYCLKFGFLDENIPELTSFLLENAGKKLP
KQQLMNLIQE
>KECLDBNJ_02821 hypothetical protein
MSSLKSIFTVKKNEKIPDEKPQVEDVKQVKLTFFESGYGSSKQAEGNHRVFRTCLEEVYM
DYKGKCRENEQLQKELKAPYLDEKGRQETELKKRKTALGLLEETVSAIEHKIRSLKNDMV
EVKRNPEVYGLEVDKRPKAQFYIGLFVLLPITLYLLVFYISASYSAFFKNFDSDKLGEAI
FDAEAFSKAIADGWLEGVFVATIPFAFMGLGYLIHMFQKQKGIMSFVKIGMLFTITFIFD
AILAYLIEQKLYDFYKTPDSPPFDLTIAFSSVEFWGIIFAGFIVYIIWGLVFDFIMKEYE
NFDMIKSFIRSKQEEIKNEELELNKAKEKLPPIKEEISGIEGKILDLQRTIDGFVFSNKH
YLTYHAEYVKGWFLAIADNFDGRKRQEELYRSCEEQEKLHLVKYNIDNEDYEGRLYKLIN
>KECLDBNJ_02822 hypothetical protein
MRIKIIANLILLSFLIVACKSEPKEAHKAITESNEPVDRLSPERPDLNVSILLDLSDRIN
PDKYPDEAMQFYERDLGYINSIANAFEIHLRNKRSIKINDQIQLYIDPEPADSKLNKKLA
DLKLKFTRDNATKDKILTVTEKYDSIPRLIYEASILDDAYVGSDVWRFFKNKINDFCIEE
DHRNILVVLTDGYIYHKNTVLKENGLTSYLTPQTIRGFKLNTSNWEENIEAKNYGFIPAN
KNLNTLEVLVLGINPDPKNPYEEDVIFKYWEDWFAKMGIETYELKQALLPSDMNAIIQEF
IWDE
>KECLDBNJ_02823 Deoxyribonuclease
MKKYILLVLLFCSFASFSQQKELILASWNIQDFGKTKNTEELEQIAEILRDTDIIAIQEV
VAGYGGAQAVAKLSDILNRKGAKWDYVISDPTNSSKYVTERYAFIWKTSNIKIKNRGKLI
AALDSKVDREPFTINFYLDSKVLQVINFHSRPHDNNPQAEIKAISEYIVNAKTGSLIFAG
DFNTIVQDPVFSTLKSNGFVPALVEQKTTLKRSCTGLDYLNHAIDNVFYSKDLTYIDSGV
LDFVMSCDQLDKARKLSDHLPVYIKFSLY
>KECLDBNJ_02824 CRISPR-associated endoribonuclease Cas2
MWVLVFFDLPTETRTERKVAARFRKNLLDDGFAMFQFSIYMRFCASRENASVHIKRTKNN
LPKKGKVCVMQITDKQFGMMELFHGQKEVEPEQPSQQLELF
>KECLDBNJ_02825 CRISPR-associated endonuclease Cas1
MIKRTLFFGNPAYLNTRNEQLVVTFPEEDKKEVTIPIEDLGYVVLEDPQITITNGLMMKL
VQNKTAIITCDKQHLPCSLIQPLVGHSEQTERMRHQLNASLPLKKNLWQQTVSAKIYNQA
LHLESRGKNAKKLKRWSTDVKSGDTGNLEAVAAAHYFQNLFSEVFGFSRNQKGIAPNNLL
NYGYAILRAVVARALVSSGMIPSVGIFHRNKYNAFCLADDIMEPYRIYVDALVYEIVETG
CNIEELSKTLKAELLRIPAMDVYIDGKWSPLMNAVSRTTSSLYDCFLGTNRKILYPEYTV
NRSLE
>KECLDBNJ_02826 CRISPR-associated endonuclease Cas9
MYAHNIAHQENLLKQKDTFIHLFLKDILFYHRPLKSQTGLVSRCSFEKRVYVDSLTGDKH
EVKIKGMPKSHPLFQEFRIWQLAHNLRIQKREAEENGKLKINLDVTNQFIRNKSDLAKFF
NFLYNKKDINQKQLVAYFIRDKKEQSLYRWNFTDDNKIKLDCNQTRPALLSKLSKEDKRK
FDEQFELKLWHIIYSVTDKSEYDTAIGRFGESNSLSEETTEKLKRAPMLKKEYATYSEKA
VKKLLGLMRCGCHWSEVSIHPSSIQIIDKLLTGEFDERIENQVREKAIKLDKIEHFQGLP
LWLASYIVYGKHSEVDATQWKSSKDLAEYINTFKQHSLRNPIVEQVLLESLRVTLDIWEY
YAEKFGLQFEEYIDEKTGKKVKSYDRLFSKIHIEIGRELKNPKKVREKMTNSNNKNKDTN
QRIRKLLFELKNVKEVENVIPNSRTHFDKLKIFEQTVLSNYSEKELKAEKLDSKLTVEKF
IKKNQPTFSEILKYKLWLEQKYISPYTGKIIPLTQLFTSKYEIEHVIPQSKFLDNSFNNK
IICETEVNTLKDNRTAYTFIQEFQEAEVPLSGGGSVSILKKETYEKLVKENYDGRKKENL
LRETMPQKMSERQMNDMRYISKAALKIYSNIVREEGERESTVKNVLPVAGKVTAKLRREW
GLNQVWSGLVEERFKRLNRLICGEENENNGLFGTWVDDGGYFRTEVPLEIREDFDIKRID
HRHHALDALIIASLTSNHVNYINNEHTKSDLKRYDLGLTLRDTKQIEKTHPLTEKKTKHT
VLGNYKKPWETFTQDAKSALQEIVISFKQNLRAINKAQNYNWRYKDNAGKVVYTKNGVPK
KQWIEQVSSKTDKTSNNKTNWAIRKPLHEETVYGILENGEYKGDLVKREPLNISFDEKKI
ETVIDPVVRSILLRHIKQDKFKGQIDEKGNIFKPEEVAFSAKGIKDLNENILTLNNGVFH
HPIKKARLRFPKGKKFSIKKWEDKEGNLLRETKFVKSATGTNLYFCIYEKEGKRKYYVPP
FEEILEIQKLEQDLPLEQKKNVPEQHPDFHDFKLKFYLQPNDLVYIPVKNDEDMGFENLG
RQQLENIYLFKDGSGTTANFIPMFSADVIYNISNKENREKFADAYNLDKGELIKNEYGLG
SPQLKNQNSVDGIQVKSVCWKLQTDRLGNITKVLK
>KECLDBNJ_02827 CRISPR-associated endonuclease Cas9
MKRILGLDLGTNSIGWALIEILEDGTKRIIKLGSRIIPMSKEVLGNFEKGVTKSQTAERT
DDRGVRRLYARSRTRRERLLRILNILDYLPDNFSNQIDFDEKKGQFKKGSEPLIAYSYKV
DENGNRIFNFMDSYEEMEKEFRMRYPNLPKLNKKGKPYRLPYDWTIYYLRKKGLTQKISN
QELAWILLNFNQKRGYYQERDEKEVEIDENKKVELIVLKAEQFKITDQKVDDKPLYEIIF
DNGWIYDNTTTKPEIWEGVDIEFIVTSTINKDGSIKRTFKKVDSEKDWEAIKRKTEQDLR
KSQKGADKTFVGKYIYETLLENPKQKIRGELIRTIDRDFYFDELEVILRTQLKFREEQWG
IKICTKERFRNCTHTTLPIKRIC
>KECLDBNJ_02828 hypothetical protein
MPKRFSRINFHTETVERFKKYAIVNDANYTETLEAILDFFEQNSINPFEPFDDSKQRLET
LINKRMDGVEAILRRIETEQTKPTKELLDRLFNQQEEKQPKFVERKFR
>KECLDBNJ_02829 hypothetical protein
MGKETIKLTRKIQLQVNAPTKVEKKEVYDTLYRWQNRSFRAANLIISHLYIQERVKEFFY
LSEGIRYKLADEKKAEDGMLNRSKMNCTYRVVSDRFKGEIPTNILANLNNTIINNFRNHL
SEYSKGERALANFKRNIAFPFGPVAIHGLSYNEAQKAFCFRLFSIPLKTYLGKDHTDKRK
LLEQLVAGKIKLCTSRIQLKKQKIYWLATFEFEKEIHNLKTEVIAEASLSLEYPITVKSG
KATLRIGNREEFLYRRLALQAAQKRAQSGAAYCRPGKGFKRKTKAVEKFYELEKNYVSNR
LHVYSRKLIDFCIKQQAGTLILLNQEAKIEAAQQERFVLRNWNYYELTKKIEYKAKKAGI
ELLID
>KECLDBNJ_02830 hypothetical protein
MKRFQLDTYYNAFKKGCPHAFEAIYTQYYHSVYWMGRSILKDVYAVENILQDTFLILWEK
RDRIQSPEHLNAFVHFVMKSECIYQYNKPRNAFQRNLSRLDYLENYQDYLGGYNEDEEAA
HLQRQEADQKALDQIQRVLPLLSSERKLLVELCLKYGFQYKAIAQAMGTSTAKTSIEVKG
AIKDIKNIITNGSTPEAKTTPIRELKAQANMTRKQKKVLQLRTEKQYSFAAISKELSLSI
QEVHQQFMAAYKLLQHKQNQQ
>KECLDBNJ_02831 hypothetical protein
MNINFLISKAISEWIKDAKSNRDFGLNHDIDEKIVRRILDEKEYRIPVETLKRICDARQI
KLSDFFSKIGE
>KECLDBNJ_02832 hypothetical protein
MGTWGTAIKSNDTSADIYAEFFDLYNDGKEPTEIKKKLISDNPNGENDFWFALALALWET
KSLSTDILEKVREIIENESDLKIWRELDASESDIKKRKVVLDKFLAKLESEKAKPIARKR
KKNKQPIFETGTCLVFKLANGNYGSAIVLSSDLETGYGYNLIVTTRLNQSTKPTLEDVEK
SEVLINNFGDWQKSTAWSWYLPDNYKNNIYEPIGKFEIQKKYNAKNSEIVFGYTSNWDFV
SSSILKQMDFEKTNGKTKTFPTKRLIKSKKIKWWQIR
>KECLDBNJ_02833 hypothetical protein
MNRAIIYIFLILSFGCKAQEKETGFVWNIENEKIHNENRNDSTKWSSKNWKADTDNIKVS
GKPMINGVFPVPDYDLTDSTFNGLGYSGSWQGIDLKDKKIIYHSLYVNKNAVNQKFIDDK
PNEVFFTIAVLTDSIDLKRYSHTDVSITSRNHPHYVGQGFVKTKGNEIDFISFLTADRND
YAIVNMRLFDLRIGRIILIAPQKDGTLCSLQLDAPIMSSEEMDDHIESLMTNNKEVIKFF
TKSENI
>KECLDBNJ_02834 Antitoxin HigA
MLPDLDKIKGVHPGAVLKRALKKRGITGSDLARTIDEHKQTISAILNRRRAVNAKLSIKL
GEVFSVEADYFMLLQASYDVQQQVAANYGRIPNLNHFRKALFWDTQLERIDWDKNKRAVI
QRVLERGNGKEIQELLSFYGRQTVKKIAQSIKKSYLPSFEENLKNYNLIE
>KECLDBNJ_02835 hypothetical protein
MELQLNTVSELLWNTLQKLMEIQELHSFRLVGGTSLSLQRGHRESIDIDLFSDAPYGSID
FEKIESILRVTFPYFSSSSELVGIGKSYFIGNTEDDLVKLDLFYTDPFVFPLIMEQKVRF
ASVQEIAAMKLEVVGQGGRKKDFWDIHELLESYTLNELIGFYLKRYPYNLSTEELMNKIV
DFSLAEDDFTPNCYRGKIWELIKLDLEELVER
>KECLDBNJ_02836 hypothetical protein
MSALFKKYIPLPFEGGVAVLLLRVALSLFLFFGHGMGKILKLTSNEPVQFLDPIGIGQEL
SLVLATTAETLGALFILLGLFTRVATIPVLFTLGVACFIVHGSRGFSGMETLLLYLLGFI
VILLMGPGKYALDARM
>KECLDBNJ_02837 hypothetical protein
MNPNKEWSRRNFLKTTSAAGTFAVMNPFSAFAQKTYDIDPKVAAIVAQSFAIDTHNHMDV
PFDGAEFDAQAVPLSNELHKSGFKAISMTFCVDRPKLNYEGEAFKRFITTLDKHDQILRA
NGIKRVLNSRDLLHAKKASKPVVIQSVEGGHFLEGKLERLEFAYNRGLRHLGLLHDAQSA
YPLGDIYTNPSQFGGLTPLGIEVVTACEKSGILVDLAHCSDEAINDALEKMSKPAIISHT
GLNTQLGNDQRMAKMMMPRLISKQQAKIVAEAGGVIGVRTHLVETPTEMAQHIAALCDIV
GTRHVSIGTDSRMAVQKGGNARGLTNQFWHTSAQGFFYTLVDAMLKIGFTKEEILNIGGG
N
>KECLDBNJ_02838 Xylose operon regulatory protein
MRLYSTYPDLNKEFYHFDLDTFPQSDYLEFKEVAFKNQDYTVDSTIHFNKDIVIIHNKRN
CKKDLIEQVNVEGSFVLIAYLISGELEINQPAFRYLLDNDKLRIVFAQQTNNQVITPANC
TTESILIYLRSSYLINLLKHEEWKDNNSIYTLINNDIGLTSVRANDVQVTHSIQKTILGI
IQSTASSRIPKHLVGIKLRELLLRVYQNDSLLYDDENAAAHTGIQARITKALNYIEHHYL
DTPTIQQVSRHVMLNEMQLKKEFKSTYGKTIRAYIIELKMKRAFELLKTNTIAETASILG
YQSISYFTSTFKKYYKVLPSKIKNTK
>KECLDBNJ_02839 Vitamin B12 transporter BtuB
MFLSLLVCNTLGYSQERYSISGKLSDQAGAPLTDAYIYLEHTQIYTMTNQAGEFKLSAPV
GTYQLVCSLMGYEKKTISIELHNDLNVAYKLGPDREMQLDEVQIKGKSVIEKVRESAYNV
VAVDAQAMTNTTADLSNALEQASGVKVRRSGGLGSRASISLNGFTGRRVKLFMDGVPMEG
FGDAFQLNNIPVSIADRIEVYKGVVPIEFGTDAMGGVINIVTNQRSNTFVDASYAFGSFN
THRASVSTGFTSKNGFSVLVNGFLNYSDNNYKVHLDKMLDVNTGTYVAGDYEVERFHDTY
QNKTVMAKAGFVKKWWADRFFVGLTVGELEADVQNAYTMEIVYGARTRASKTLLPSLEYY
KRNFLTKNLTARVTANYNHNANKSIDTVARLYNWYGDYATTRTGGESGTNTLSEFKDNNV
SATANLSYDINKKHSIKLNDVITGYERKLSSDVPLDQLTSATDTMRRASRKNVIGLSYGY
RPSKKWNVNFFGKHYYQYVVGPVDTVTVGNNSQYEEQERSFQTSGYGLAATYFFNNAIQL
KASAERAYNLPSAQQLFGDEVLNTANTSLKAENSSNFNLGVSSNSRFKNDDVLYVDVNGY
YRLTKDFIQRVQSARYGTVGNVNFGRVRNIGADAEVRYYHKNKVMVGGTLTYMDLRNREQ
IRDASSSVASSTYNNRMPNIPYFFGNADAAYYVHDIFGKNNVLSLNYNFNYVGEFYLLWE
SQGSSSTKATLPEQVYHDFSVNLSLAKGTYNITLEALNFTDARLYDNFSLQKPGRAFNVK
FRYYWNRRK
>KECLDBNJ_02840 hypothetical protein
MNINFKTSTLGLFLAGALLTACSNDDSSTEEPTEQEVNLEAKYFIAAENDNGTYFLTEES
LNSGTTTTTGNGIEDPNSYTHYSYNGNEAVMGLWYRQGNPAIGVMYGLDASGTLTEIGAG
FQMTNGYSSVGPFENYIVATRGGITFDDGSVGQNFYFIDLDNDATVSSKQLTTLDLVGNG
LECNLVGVVDAGDGSFLSAVEVQDGDVDMCYIVKLDADATVLNILEDDRIGQALGQWRSA
RYSLIANDDEGNTYVFGNPNGGTLKGGALKIPQGSTSFDSSYYFNIQDQADGYAFRKVYH
VTGKYFLLEFYNEYEPGNGTAATQYGIVNVETQSFSWITGLPSTDNINDVGWPYASDDVV
YIPITTADASPTVYVVDPVTASATAGIVVESATAIGGLAKLEYEPETTN
>KECLDBNJ_02841 Phosphocholine transferase AnkX
MKQRITFLFIVLGILGSSFAQSTVLATNTFWESNPDLNSVKAEVKKGFDFANMGISDDPI
MLAIRNEADLNIITYLLEQPDVDIDKLVFEGRHYLHIAANDGNDQLVDYLLENGSDIDFL
DANGHTAFTFAGFQGHLTKDMIDVFIKHGIDLNKKYPEKNGANILLISIPYDKDLTITDY
LVSKGVSINSVDDDGNTAFNHAAKIGSVPMMKTLLERGVTYTDEALLIASQGTYRSANDI
EVYYYLVNDLGISPTLTSEEGQNVLHAIAKKNDQDEVINYFLSKGVDVNQQDEDGNTPFL
NAAGGRSFKAVELMFPYLAEGAVNATNAQGKTALMLTAGSNAPEAVSFLIENGAEVALKD
KRGNDAGFYLIDSYRAPRRGRGPTTESNAQNPVEAKLKTLLAAGYAINTLQEANTSLLHL
AAEKNELTLVKPLVDNGIDLNVVNGNGNTALHIAAMKAENEKILALLVKAGADMSIETQF
GETAYDLAGENEAISGKAEKLSFLK
>KECLDBNJ_02842 hypothetical protein
MKRILCCLVAVLVLGATQGWRSKSDEQLKLKCLIQLTNYSGEGAYMAASLIDQNGTYEQT
LYVMGQDEKWYNELVSWFSFFEKKKEAVDAISGATIAGGERTICVLEIPKEKLDKGYKLR
FETSVESQKYYENDVEVALTSSTIKGNYEGTGYIRYVRLIPN
>KECLDBNJ_02843 hypothetical protein
MLLRVLITLQNTTNESFLNQVNQFEDVLPLYLQIKKPDHFRDQAYFQDN
>KECLDBNJ_02844 hypothetical protein
MNFLKLINYMKPILLVSAGLILSTFSAQAQSKKDLDRQAIKDMCGCYEVTFKYAETFSPD
GNYEKHDDYTASALEWGQLVEDAENKISIQHLLVIQDTMVIKHWRQDWTFEDQDLFFYDA
NNTWDIVKKDASDVKGQWAQKVYQVDDSPRYSGSATWVHVDGKKVWQNTTPAPLPRREYT
KRRDYNIMERNNQVAITDYGWLHEQDNKKVLHAEDADDRIIAEEKGYNIYEQVADERCAA
AQAWWKENEALWAKVRKEWDAVFASNDRLKLKDKVDGQRLYSVMFALEPDATSADIKKVI
TDFIE
>KECLDBNJ_02845 Colicin I receptor
MILNSKCILCFIVGVLGVYHVQAQTSVPVEKQTDSLEEVLITATRTQRQLSSLPLPAQII
SKETIAQSGSVRLSDILAEQTGLITVPDYGGGEGIQIQGLDSQYILILIDGVPLVGRSAG
TLDLYRITVGNIKQIEVVKGASSSLYGSDALGGVINIITESPQKPFQSAINYRGGSLNSH
DLSLNTGVKEERLALSLFANRYSSDGYDLDESTSLQTVEPFTNYTAQVKGKYDFSEATSL
LLSSRFYAQNQEYKASEILSGESDITEWNGQVLFSQQFTDKITSTLELYGTNYHTESYLQ
DEEGAENSRSFYDQTLLRPELRTVYALNDKHNFIGGIGYTYESLERTDFSQDPVFKAPYV
YVQYDTHLLNNLNIIAGARYDMHNVYRSQLSPKLAARYKVDNSLAFKASVGSGFKAPAFR
QLYFDFTNATVGYTVLGYEAVPTAIAEMQARGELANIIVPVSEFDDSLKPETSVNINLGV
DYKFSKLLTTSLNLFRNNLNNLIDTRIIATKTNGQSVFSYVNVNESFTQGLEFSYTYNPF
KNISFSGGYQLLFAKDKEAVEAFEAGTVYGRTSANASAFVLDKKDYFGLYNRSRHTANFK
VFYNLPQYKADVNMRATYRSKYGLSDTNGNGYLDNYDTFVDGYAIVDFAVNKVLYKNITL
GAGIDNLLNFTDTQNVTNIPGRLYFAKLNLTL
>KECLDBNJ_02846 hypothetical protein
MNTFKTLAAIALILGFVSCSNDDDATPLLEVETETVANLHAPQSGGQGQPVSGAFTKFDF
ETGAETTSETDWDVAFRGTTIIVNGGESQGTTDEPERTGDAAVYIADGTMSTVTDVDASL
FTQDSASGFAIATGSGNGWYNYTGAPSHLINPIPGKILVFRTTAGLYAKVEIISYYENAP
AEPDAFSDATPYYTFNYVYQPNAGVTTF
>KECLDBNJ_02847 Regulatory protein PchR
MKIQSILNEDDLLYEENLSKLSEGELLEKSIETQPKHTASAKASLKLSRDFCIIDTRFDF
KKPTVDKFSISGDFIMISCVVRGESVRQNLEKDRNLELGQVHFSYSKKINERVRMPQSKT
RYICLLISRTKYLDLLKNESWVARDPFYNAIKTSKRIPLGTYSFPLGFQMNQIISEILEC
KWEHHIQLEFIQLKIKELLLHVFNISVENPSKEEANLSEHSKEKIEKAKAYLTVNYKNPP
TIKKLSRIVLINEVHLKSGFKKLYGTTIKKFVIDLRMQKAYSLLKSKSVNEIAESTGYKS
VPHFIATFKKYYGQTPKQVLVQQNP
>KECLDBNJ_02848 Vitamin B12 transporter BtuB
MADANGDYRLRIAPGTYELTVSLMGYLDQTQNITLSAAETKTLNIQLEEDPEMTLDDVLV
KGRSAIRDVQESSYNVVALDAEPLHNTTLDVSQALERVSGVRVRRTGGVGSDYNVMLNGF
TGRHVKFFIDGIPMEGFSSAFQLNNIPINLAKRIEVYKGVVPITFGSDALGGAINIVTEN
GKQNFVDASYSFGSFNTHKSFVNAAYTADSGFTARLTAFQNYSDNDYKVTTEIVDLETSQ
FTGDVREVRRFHDMYRNYTVMAKVGVVNTSYADELLLGFTYGDEYDEQQHPAYMKIAFGQ
RYGTSETLMPTLSYRKRNLFTENLNVSLTANYNFGESSNIDDSYRRYNWLGEFIETDAPG
EFNYAKTYFRNRNGSANANVTYTLAEKHAFTVNNVLNLFSRKSRNEVEPSAADAYPSETI
KNILGVGYKYQPTDDLSISSFYKYYYNKVNQYADPTGSGEFENLGASTEDHGYGLAASYF
LLENLQLKSSYEKAYRLPTGRELFGAGNDFELGNPDLKPESSDNFNFGVNYNWLIAKNHQ
FNIDASFIYRDIKDFIRQVPNPTNGVMQPGNEASVKNRGVDLEMRYNYASLFSLGGSFTY
QNLRNKLKYRAGRDVVSTIYNDRIPNMPYLYGNADLTFYFSKLWQEQDRMNVSYNLLYIH
EFDYSYESYGGIKVPTQIAHDLAVNYSLKNGKYNISLECRNILNEDLYDNFSLQKPGRSF
AVKLRYFLDKFN
>KECLDBNJ_02849 hypothetical protein
MKFNFKQTNRFSLAVLALMSLAACSDDDTVVDDGGETPVETGAQYLIASTDSENSYLNTT
SDISQGSVSPLGGTATQVIGTPSWYFYNDIAAYSFVYNQGDPGTTQSFALNSAGEVEARN
EINLNVSIQSRGIVDNLMYVQYSSRNYEEPVSTFYTINGDTQVVSGPYTIDTEALAGNGE
YAYVTDVAQWGDYVLLGFRPIKAGSDNGDSAFNSDFNDHTYVGVFNKALELQTVIEDEGR
TGAVAGQSRSQGETGVEPVENGDVYVFSSAIDAEGEVPSGVLKINNGTLAFDQDYFFDIT
AASGGYAVYRSFYVGENTFVLQMFTEPGSGTASSSATRNKFAVVNVVDQTFEWVTGIPEG
ITSIGAPYIDEDNNEVAFPIETNLYPTIFIVNADTATMSEGIEVVAEGISAIGKLTPQE
>KECLDBNJ_02850 hypothetical protein
MYNSKIVLFLLGFFTYALGYSQHHAETNKQQIFSTSLKQERELWIKLPFNYDPAEAYDVM
IVLDAEKYFELTNVLVDNRMRYGKLNPAILVGIPNPNMEERSRNLTFSRSTVDQKGEATT
RYTSENSGKAEAFAAFLNEEVLSFLSQEFRVKQFGIIGHSFGGYFALYNSTLEDKISEYI
LIDPSLWYNNGEALQQIETHIERLKERDGIHFYLAHEDGIKNNSTKMASLARIFDKHDIA
YTNFVYRNENHGSVILPALVDILRDKGKNIQRTPRHKIKK
>KECLDBNJ_02851 Phosphocholine transferase AnkX
MKSAQHIFGALMLFVGLTLSAQESNQLLSRDFWSNNPSLADVKASVAAGNDPSEPNGSNF
DPVVLAITNDAPVEIVDYLFEQDGNSVNKLTHDGRTYIFWAAYRGNYPLVKKFADAGAQM
DLVDDHGYSVLNFAANAGVTDTQIFDYLIAKGSDPKTEKNHNGANALLLNLPSQKDFKMV
EYFESKGLSLQDTDDEGNNAFVYAARAGNVELMNKLVKKGIDPKVINKEGGNAILAAAQG
TRRGSSPLSVFKYLEGLGIDPNVTTTSGTNPLHILAGRNKDMDIFSYFLAQGVDPTAVDG
EGNTPLMYASMRNDLEVVKLFEAKTEDINHTNEEGASALSMAVAGNSPEVISYLLAEGAD
ASIVDDKGNTLMTYLVDAYNPRSAADFDAKMALLQKEGVDFSATQKNQENMLLLAVKKNS
LPLTKKALALDIDVNQADADGSTPLQIAALRADDTAILELLVANGADTTVTTDFGESVLD
LANENEILTSSKARLDFLK
>KECLDBNJ_02852 hypothetical protein
MRLKTLILGLFCFTLFSFVKNDSAETTFKCLIQITNYSGEGAYVVVSLINPQGEYEKTLL
VQGDDEEWYPDLTGWWEQQKVKNENIDGIAGATVGAGGRGIGSFKIAQDKLDSGYKLRFE
TAVEDQKYYQDDLMIPLDQASLNGKFAGKGYIRYVRLMASN
>KECLDBNJ_02853 Bifunctional cytochrome P450/NADPH--P450 reductase
MILSIWRYSHLVLAVSSFLFILLAALTGIVLAFEPIDHAALNYSEGQKDLPVTQLIDTLK
STYDEVLSVEIDEAGFVKASVLSMDGDSGDFYINPLSGKKVGEIEKQAEVFQFATSLHRS
LFLKSTGRFFVGLASFLLFLISITGLILIIKRQQGIKAFFNRIIKDNFYSYYHIYLGRLL
LLPIIIITLTGVYLSLQRFEILPDIVLSHDVDYAVITADPQRPLAEFPALQNITLRDVRY
IEFPFSPDVEDPYKISLTDKEILVNQVTGEIISEVPYPFVNMMSHYSTVLHTGRGSVLWS
IVLAAACISILFFIYSGFKMTFMRRKGRINNKFKEAQCEIVILVGSETGSTMSFAGLFYN
ELLNKGKKVFLTQMDKYQKFPKMEHLVIFTSTYGDGEPPANATKFMSQLQKNNQSQDFNY
SVVGFGSLAYPSYCKFAFDVDDALKASSGAQELLGVYTINNKSWEAFDQWVDQWGERLGL
ALDVPRDNAVTKPRKKPKKFKVIAKTQAQDSADDTFLVTLQSEKSLKFKSGDLLAIYPEK
DAHERLYSIGKNLKGELLLSVKRHEFGLCSNFLNDLSVGCTLDAVRVKNPEFHLKSSQKA
IMIATGTGIAPFLGMFADNHKKKERILYWGARNEASFELYKPQIDTAVDQGQLSKFIPAY
SRVGSDKIYVQHLIASDHLRFANALKDGVVLMICGSISMQKEVIAALQEICQTYELKPLS
YYQNRDQVKMDCY
>KECLDBNJ_02854 hypothetical protein
MRPSPQRVVKLEWLTVILLIVNFFATYSFELETFRLTRMISLAVLVLYFLFHKRVKGLLL
VMAFAFFMSREVGYQFFESLWGTEWYMASAMLGYLFLFLDRLPFIKYGFSIWIIVLALIL
IAATLTILVTLGELARPNLNSHAELIFFYGYGIALIFLILAAFYYNHVLNSTRSLLYTFM
VFGFMMSDIAACLAYYNKVTSLYYVDRGFFILSMAMLTHFGLNLHGAKRERKDLKMLR
>KECLDBNJ_02855 hypothetical protein
MSNSRVHHSIVRQDLQLNKLLYYALLLAALNFLAISFLPTIPMRSVRLLTTVFFLTYYSF
FIVGRNTYVLAILLLLLVRDVFYVFYWQGNAAYYFFLFSILSYGVLLLKQWRRLAKIEFI
IPSLLVGLLLAMAFIYLITCLKDIIAPGLESTGVLWIFYVFGSFIVVTLLSALYYYYRVG
SRRSICFGFLVFNLMVTDVAFTVAYYTASYNMYYLERLTYISALVLLLHYGLNTKLLNRE
LQNS
>KECLDBNJ_02856 Peptide chain release factor 1
MLERLNFIKQRFDEVSDLIIQPDIISDQKRYVELNKEYKDLRALMDERENYIKHTQRIEE
AEEIIADGSDPEMTEMAKLQLEEAKEAMPALEEKIRFMLVPKDPEDAKNAVMEIRAGTGG
DEASIFAGDLYRMYMKYCESKGWRTSTIDYSEGTSGGYKEIQVEVTGEDVYGTLRFEAGV
HRVQRVPQTETQGRVHTSAATVMVFPEAEEFDVEIDPKDVRIDYFCSSGPGGQSVNTTYS
AVRLTHEPTGLVAQCQDQKSQHKNKEKAFKVLRSRLYDLELAKKQEEDAAKRGSMVTSGD
RSAKIRTYNYPQGRVTDHRINLTLYDLANIIDGDIQKIIDELQLVSNTEKLAEGGDQI
>KECLDBNJ_02857 Orotidine 5'-phosphate decarboxylase
MNINTLVEQIKKKQSVLCVGLDTDLDKIPKHLLKEEDPIFAFNKAIIDATHSFTVAYKPN
TAFYEAYGLKGWESLEKTINYLNEKHPDIFTIADAKRGDIGNTSSRYAKAFFEDLGFDSV
TTAPYMGKDSIEPFLAFEEKFTIMLALTSNPGAFDFQTQTIEGTELYKKVIATSTTWEHS
ERLMYVVGATKAEYLAEIRNIIPNAFLLVPGVGAQGGSMDEVFKYGMNSNAGLLINSSRG
IIYASTSEDFAQAAATEAERLQKQMASHLAKLS
>KECLDBNJ_02858 Vitamin B12-binding protein
MVDQLGREINLKNTPKRIVCLVPSLTELLVDLGLSDQLCGVTKFCVHPENLKDQKTVVGG
TKSIHIDRIKALKPDFILCNKEENTQEIVAACEQIAPVYVSDINDFDAFYTLVSNLGVLL
NCQPKAKALNSAVKNRFAQFRKGVAAAPTRNVLYLIWRNPLMAAGRATFINILLEACKFN
NVIIEQDSRYPEVDLELLKKADFVLLASEPFPFSEKHKAEFESELEAQILCVDGEYFSWY
GSRLLKAFDYFERLLLEMH
>KECLDBNJ_02859 SusD-like protein
MNNLYKFSILMFIAVFTFSCDDNLEIDPEQSIDGSQALNSEQNIAALLLGVYEEAGQGVS
FGGDIQIMADLLGASDQISWFGTFLAPRQLIQKSLLVDNTFVRDTWFNNYETINQTNLII
DNLDVITSSDAYRAQIEGEAKFLRAMSYFELVRLWGLPYEAGTTNSQPGVPLRLIGYEDY
SQPLPAERASVEEIYAQVLSDLEDAYTNLPASNDIFADRYAAQALRARVYLQMQNYAAAR
DAANDVIENSGASLTGSFADAFNNDADSSEDLFDFQVTNQTGNSDLITFYASQDNGGRGG
DIVLNPAYFALFPDADDERANFTYIGDYGDNLTGKYTNQFANIAIFRLAEMYLIRAEGNI
MENTAVGQTPAEDVNLLRLRAGAETVSAPLTQEDILLERQLELAFEGFLLHDLKRTQNDV
DGLPYNDPSLVLPIPQNEMDTNDLIGDNNPGYGS
>KECLDBNJ_02860 TonB-dependent receptor SusC
MKNRKLLFSFSILMMLTCYFSFAQSKTVSGTVTDDQGLPLPGVNITIQGTTTGTQTDFDG
NYSISAAEGETLVFSYLGFQNQQVIITATSTYNVTMAASTDELDEVLVVGYGTQSKRTLT
DNIVKLSAEDIDEVPVSNFQSALVGKAAGVQITQTNGKVEGGLNIRVRGATSISAGTQPL
YVLDGIPLYNANESNNGAPTNPLLSISPNEIESIEILKDASSAAIYGSRGANGVVIITTK
TGKEGKAEFSVNLSHGLSEPTNTRDWLSSAQYIELFTEAAINAVGTSFADEASAIEYIEG
TFDFLAAGTDWRNGAVDTDWQDLAFQNGYVSDADFSMSGGNAKTSYFFSGSLNETRGIIR
GNELRRFNGRTNITHKFSDRFNIGMNLSYSRSDIDRIANDNAFVTPLQAIAQPHISPAYN
EDGTPNANTIYPNFLLQEENAFYNTIIRRVNGRTFGDYEILDGLKINGNFAYDLYYQTED
NFTGRNAPFQSTNGEVFASSVNAENYIVSGFLSYDKQLGDLHTLGLVAGTELNETTRRYE
SVTANQFPSDDFQTVDGGADIVAGSGNRSANAFFSLFARATYDYANKYLLKASIRRDGSS
RFGANERYGVFPAFSAGWVISEESFLQDSQTLSYLKLRGSWGKTGNADIGNFPSRYLFGA
ISYNQRPGISLSQPGNPDLTWETTTQTDFGIEFGFLNGRISGEVDYYHKNTDGLLFNVPL
IPSSGASSISSNIGELENKGFEFVLNADIIQTEGFQWSTSFNAAYNKNEILSLPNNNNDI
VSGQNIQRVGEPVNAFYMYEYAGVDPDNGDGLYYINSTNEDGSLNRETTNNPNEANRVVV
GNPFPEWYGGITNTINFMNVDLSFTFQGEFGSAIYNGGGRFQSASADYFDNQTLDQYTDR
WQQPGDITDVPQARLFGGNGTAQSTRYLDENDFIRLRNATLGYTIPDEVIERYGFTKIRV
YVTGVNLLTITDYEGYDPEARSDAGGVGQAFYSVPPARTFSVGLNVKF
>KECLDBNJ_02861 Sulfofructose kinase
MANPLKIVVAGPIPRDTISTYENDIIMRYGCVTHPVIALAKLLDAEGVVVPVSNMHKKDE
AGITAEFAPFKNIDLSGINTKEDSGTVILLDFKDQNNREEKQLACMNPIRPKHIKKHLDA
AVFVFVPITDFEISLSTLKHIKKHSDATIVFDAHGATTAMDVKGHRHRKFWVDRDEWLPY
IDVLKMNLEESQCMSFANEYEHEIPSIYDENATEHLDDLAKHVLKKGVSYFYVTMDSRGC
ILYSLQDNQLKKDWIASVKVDKVVDTTGCGDSFAGGLAYGFAKYDDPIKAGQFANILGAR
RTQGKNWDVFKTAEETENIRLQNYGE
>KECLDBNJ_02862 hypothetical protein
MKKLVALLSILILSSCAELQSVVDNLPNQTGIDNATIASGLRQALDFGIEKQVTKLTQKD
GFYGNSLVKILLPEELQKVDQTLRNVGLSSLADEGLKVLNRAAEDAVSEATPIFVDAVKG
ITFADAKTILLGADDSATTYLQNKTSTQLYDKFNPVIKSSFRKVGADQIWSNLITKYNAL
PLTNDVNPDLTDYVTQEALKGVYTMIAVEEKEIRTDFSARTTTLLKKVFALQD
>KECLDBNJ_02863 Formyltetrahydrofolate deformylase
MQKITLLINCPDRKGIVTTITQFILERQGNIVYLDQHVDRQEGIFFMRVESEFDQEEFSI
ADFEMQFIAQFVDDYQLTYQLFDAYYKPRLALFVSKYDHCLYDLLGRYASGELPVEIPLI
ISNHPDLEIVAKRFEIPFKHIAVTKATKAAAEAEQIAAIKEHQIDLIVLARYMQIISDEF
VAQFKNKIINIHHSFLPAFIGAKPYHAAFERGVKIIGATSHYVTADLDEGPIIEQEIVRV
SHVHSVQDFILKGRDLEKIVLARAIKAHVEHKVLVFGNKTVIFS
>KECLDBNJ_02864 Fused isobutyryl-CoA mutase
MNQIQPYIPKHKVRIVTAASLFDGHDAAINIMRRIIQATGVEVIHLGHDRSVEEVVNTAI
QEDVQAIAMTSYQGGHTEYFKYMYDLLQEKGAGHIKIFGGGGGVILPEEIEELMDYGITR
IYAPDDGREMGLQGMINDLVEKADFAPSAEALPQTEKIQNALQEKNVNVLARLISMAENN
HDVFLEKFKEAEAISSVPVLGITGTGGAGKSSLVDELVRRFLNDFPDKNLGIISVDPSKR
KTGGALLGDRIRMNAINSPRVYMRSLATRQSNLALSKHVQEAVDVLKAAQYDLIILETSG
IGQSDTEILEHSDVSLYVMTPEFGAATQLEKIDMLDFADLVSINKFDKRGAQDALRDVKK
QYMRNHQLWEVDQKDLPVYGTIASQFNAPGMNKLYSEIIKTLNAKTEANFESTFSATDEL
SEKIFVIPPARTRYLSEIAENNRGYDDTAATQAEVAQKLYGIFKTLDTVTGELPELDKTG
LILDDAAEDQDLAKLLLTEFDKVKMNLDPYNWEVILGWQDKVNRYKDPVYTFKVRDKEIK
IETHSESLSHSQIPKVALPKYQAWGDILKWVLQENVPGEFPYTAGLYPFKRTGEDPTRMF
AGEGGPERTNRRFHYVSMGLPAKRLSTAFDSVTLYGNDPDHRPDIYGKIGNAGVSICCLD
DAKKLYSGFDLANPMTSVSMTINGPAPMLLGFFMNAAVDQACEKYITENNLEDEVEQTIQ
SIYKENRLDRPVYNGELPEGNNGLGLMLLGVTGDQVLPADVYSKIKEETIKQVRGTVQAD
ILKEDQAQNTCIFSTEFALRLMGDVQEYFIENQVRNFYSVSISGYHIAEAGANPITQLAF
TLANGFTYVEYYLSRGMDINKFGPNLSFFFSNGIDPEYAVIGRVARRIWSKALKHKYGAN
PRAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNAYDEAITTPTEES
VRRAMAIQLIINKELGLAKNENPIQGAFIIEELTDLVEEAVLTEFDRLTERGGVLGAMET
MYQRSKIQEESLYYETLKHNGDFPIIGVNTFLSSKGSPTVKPAEVIRATEAEKQAQINTL
TKLHKAYEDQAENALRKVQEAAIKNDNIFEQLMEATKICSLGQITEALFEVGGQYRRNM
>KECLDBNJ_02865 hypothetical protein
MPSEDDFNSQNDYQDSELFKKATEILKLANRIAEIAASYEIDSKDKNEQEILRSQALFIR
EDASIIPSKIAGAYHCDLYDIKMEKATIIRKCARDLATHMTGLEMFGFKETEYLNLLRNE
IEDFRILFAEWVKTFDPWNYMIDRWGLFNPPGINYNDPDPDDDLPFDPDDLDFED
>KECLDBNJ_02866 hypothetical protein
MTYIPRNTHLYNQAIEILRLSRSVSNYLVYDLAHLKKDGSEDPYVYFTGDIVRQSDSLAP
EILKAENMAFQDDRLKQAASIERLTSSLYRTCERLERAESNGKDFVRILRREIRKFRKLQ
HKWMMTL
>KECLDBNJ_02867 HTH-type transcriptional regulator LrpC
MNIDSVNWKILQLLQRNARMSVSAIGREIGITSPAVAERIRKMEDAGILIGYKAEISHIE
SGHQLKAIITLRAFMGRLKPFLEKVHDFSEVLNCYRITGNENIFMEVVLFDQFHLEEFID
KLITYGETKTHIVLSTVIENAPIRTRKEDRKKKSE
>KECLDBNJ_02868 hypothetical protein
MKHFFRQLGPGLLFAGAAIGVSHLVQSTRAGADYGFGLVWALVLIHVIKYPFFQFGPRYA
AATGQSLLDGYKRLGKAVLILYFCINLLTIFTIQTAVTIVTAGIATYIFDVNWDITIWSL
IITAICAVILLIGRYNLLDRLMKVIVITLTISTLAAAFMAGSQTSEAVSLTQILPKDSVG
IAFLIAFMGWMPAPLDISIWHSLWSLEKAKSGAITPKSAVFDFNIGFLGTIIVGTCFVAL
GTFIMFHSGSSFSSSGVAFAKQLIDMYTGSLGNWAFYLIGIAALTTMFSTTLTTLDASPR
SMAKTLDLITDKKIKHSYFIWIVILILGTVGILFFLTNEMGTLVQIATILSFLTAPFFAI
SNVLVMNSSAVPKEHRPSKLLNYFSWFAIVLLILFSLWYLSTLF
>KECLDBNJ_02869 ECF RNA polymerase sigma factor SigW
MEVNQDIVNHKITQAKSGSQSAFNYLLNTYWNMVYRFQLERTQDDFKAEEITIQTFAKAF
NQLESYDSTYKFSTWLITISKNLHIDLLRKENSRQRHFSKDEKVNKVADDNPTAEDALIT
EQSLSELKGHIKKLKPHYQEMINLRYFQEMSYKEMAQTLNEPMSNVKVKLLRARRLLSDL
IEKEH
>KECLDBNJ_02870 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MLIPKLLEQDFSVFEILVVNDHSTDESLELLREFDQKHHNFKFLNLTEQTGKKAGITAAV
SLAQYDRLVFTDADCIPASKHWLRSMHSAFMPNAEIVLGYGAYLKLKNSFLNKLIRFETL
LTALQYFAYALHKNTYMGVGRNLAYTKTLFTTSGGFEAHKHVKPGDDDLFVNQNATPTNV
ALCINPKAFTISQPKTTWKSWFIQKRRHVGIAHLYQAKHQVQLALFYCSQVLFFLFFLGA
ALTATAHFYIILCLFVVRELYVWGIYATTAKKLQERDLIPFILLLEPFLVSLQMLIFISN
SLVKPRRWK
>KECLDBNJ_02871 hypothetical protein
MKLLLITLLLLGLAFAGIAIKIWAKKDGKFAGTCASQNPYLNKSGEACGMCGKMPDEIGD
CSTSKAS
>KECLDBNJ_02872 Immunogenic protein MPB70
MKFNKLIIALAVSTGVLVSCNDGKKNEEEIRLEEQEMQTAEADKAAKEAEEAEMKAQQMK
EEARANSIASKAMAAEELDTLVLALKAAGLSEMLMAEGEYTVFAPTDYAFSQLKKGTLED
LTKAENKEQLVSVLQYHVISGIMRSEDLGKAIDAGNGKAKIQTVKGEELTIMRDGDQIVI
RDGKGKKAQIVLGNIEASNGVVHEVNKVLMSK
>KECLDBNJ_02873 UDP-N-acetylenolpyruvoylglucosamine reductase
MQITHNASLKPYNTFGISAKAKAFISVTDIAMLKEALHLEAYPEKFILGGGSNMLLKSDV
NALVIHVALKGIKTVKETADNIWLEVACGENWHEFVMYCVNHGYGGVENMALIPGNVGTA
PVQNIGAYGVELKDHFYSCTAIHRTTLEQKTFSLKDCCFGYRDSVFKNELKDQYVITSVT
FQLDKNKHQLHTGYGAIQQVLNEKEISDPSIKDIAQAVIAIRSSKLPDPKKLGNSGSFFK
NPVVPKTIFETIQQKYPEMPFYPVSEAEVKIPAGWLIEQAGFKGKRFGDAGVHKNQALVL
VNYGNASGDEIWDLALRIQKEVHQQFGIEIQPEVNIIE
>KECLDBNJ_02874 Aspartate aminotransferase
MPQLSQKGQLMPQSPIRKLVPFAEAAEARGVQIHQLNIGQPDIQTPQPALNAVKEANIEV
LSYSHSAGFLSYRQKLAAYYGKQGIEMDANDIIITTGGSEALLFAMGSITDPGDEVIIPE
PFYANYNGFATASGVTVKPVISSFESGFALPPIAEFEKQITAKTKAIIICNPGNPTGYLY
SKDELDQLSELVKKHDLFLIADEVYREFAYDGLQHNSVLNQREIDEHTIMIDSVSKRFSM
CGARIGCIVSRNKELMATAMKFAQARLSPPTLAQIASEAALDTPQSYFDEVISEYVDRRD
TLVAGLEAIPGVRVAKPKGAFYCIAELPVKNSDDFAQWLLESFEVNKKTVMVAPAAGFYS
TPGEGLNQVRIAYVLKKEDLIEAVELLKEALSQYKD
>KECLDBNJ_02875 hypothetical protein
MRYVYLIPVLFIYMINFEGFPQGAFLLPDGKNHIKIKADVVNNLMIIPVQVNGVELSFLL
DTGVRSTILFDAEADYPLKLNNKSTVWLRGSGDGEPSKAIKSTQNIINIGASAAINQTVY
YIPDSAQNFSPRLGFPVHGIIGYALLKDLCVELNYQRGFIKLYDPEYFRSKKFRSFTALN
FELKEGKPYLNIGLNQNEKDFRAKLLLDSGSGDALWLFHNTHEDIAVSENAFKDHLGLGL
NGEVTGYRSRINRLSLGDYELDKVNVAYPDDQSLTYLNGMNFRNGSIGASVLRRFTVYLD
YGKKKLFLRKNRYFDEPFRYNRSGLVVEHTGFELVADIDYGIAKSRTITTADGSTRSVFL
ETNVVQFPQLRLKPNFEIAAIREDSPGADAGLVVGDKLLKINGRDVRKLELSDITKHFFK
DEGAVLRLRIERNGVEFNRRLKLKKLLVDE
>KECLDBNJ_02876 hypothetical protein
MILAVGLMTLGLQAQDKKAAITFETDVIDYGDVAHGGDGTREFKFTNTGDAPLVISKAYS
TCGCTVPSPPKDPIAPGDTGVIKVKYDTNRSPGPIRKTITVYTNASAEPYTLKIKGTLLP
ATN
>KECLDBNJ_02877 Valine--tRNA ligase
MALASKYSSKDVEQKWYDYWMEHNYFHSEPNEKEPYTIVIPPPNVTGILHMGHMLNNTIQ
DVLIRRARLKGFNACWVPGTDHASIATEAKVVAKLKAEGVNKSELTREEFLKHAWEWTDK
YGGTILEQLKKLGASCDWERLRFTMDDTMSASVIQSFVDLYNKGLIYRGHRMVNWDPEAQ
TTLSDEEVIHEERQGFLYYLNYKLAGSDETLTIATTRPETIFGDTAICINPYDERFTHLK
GKKAIVPIANREVPIIEDEYVDLEFGTGCLKVTPAHDENDKMLGDKHQLEVIDIFNDDAS
LNEHGLHYKGKDRFVVREEIVAELKAAGVLVKTEKHTNKVGTSERTKAVIEPKLSDQWFL
KMKELAAPAIKAVLDTDEVNLFPKKFENTYRHWMENIRDWNISRQLWWGQQIPAYYYGNG
REDFVVAKSREEALEAAKVKTGNAQLTDADLRQDEDALDTWFSSWLWPMSVFDGVANPDN
TDFKYYYPTNDLVTGPDILFFWVARMIMAGYEYTGEKPFTNVYLTGLVRDAERRKMSKSL
GNSPDAMKLIDDYGADGVRVGLLLSASAGNDLLFDEDLCQQGKGFINKIWNAFRLIKGWE
VDDTIPQPESSKKGLAWYNERFKQATVEIEDHFSKYRISDALMATYKLVWDDFCSWLLEI
VKPEYGKPIDKVTFDAVIEALENNLRILHPFTPFASEEIWQNIADRTPEEALIINEWPKI
TEPDEAILADFDLAAQTITGVRAIRKEKNISFKDELELFVLNTEGFSDSFDTVITKLCNL
SKIESTDASVDGALSFRVKANEYFIPLTGAIDVEAELAKINEELKYTKGFLKSVSGKLSN
ERFVNNAPEKVVAIERQKQADAEAKIEALQKRLAALS
>KECLDBNJ_02878 hypothetical protein
MTKEELDKAFQAAYEKASATTVALPQDIQLLLYAYYKQGNHKSKLIPLENIKENDLRSAF
KYNALIQIKGLSATEAKKEYIKLVAQHIP
>KECLDBNJ_02879 Phosphatidylserine decarboxylase proenzyme
MFHKEGYTIIIVTLLVVAIGFVSTQTWVSPVWLQYVCYAALVIFLILILQFFRNPSRKAA
GNIEEIVSPVDGKVVVIEEVFEKEYFNEKRLQVSIFMSPLNVHVTRYPAGGKVVYSKYHP
GKYLVAWHPKASEENERTTVVVRSTSFGDVLYRQIAGALAKRIVNYAKEGDEVFQGEDSG
FIKFGSRVDVFLPLDTPIAVTLNQKVKGAQSVIATLK
>KECLDBNJ_02880 Phosphatidate cytidylyltransferase
MRELSVRALSGFLYVIILLFSIFYSEKWYILLFLLFGIITLREFLRLIGFQFWYTYLILI
GFILFFSYYKLSKPATLVLLGLTVGTGLYLMKNLFSEKIRKYNKLQKLHITVFYIIASFV
FLTLLPTHGDDFSPYTVAGLFVLIWTNDTFAYIVGKSFGRHKLFPSISPKKTIEGFFGGL
VFACIASYFIHKFTHSLNFNIWLSLAVVMSTLGTFGDLIESKLKREAGVKDSGTLMPGHG
GLYDRLDSILFASPFIYLVLIVFEYVS
>KECLDBNJ_02881 hypothetical protein
MSIFNKLFKQKSSSSSESPSNKGPERGKYMPDITAPADERFTKHFILNGGKFLYCIDMDE
VHESFDNILLENDWYEQEAYCMDDKLQKLFDGYNLEFGHNKESSFFLSTCENLIADDGSL
LVSSNQIKEKKLKELPQNFVIFATTSQIVNNIGEGLRGIKKKNTGQIPTNITTIKNFEPK
EGTKDFMSYGSSAKNLYLLLLEDL
>KECLDBNJ_02882 ATP-dependent zinc metalloprotease FtsH
MAEKSKKPTPNKPKFSAWWIYTAIILVFFAINYFSNSSDYGSPKEILQDQLTNFITDGDV
KRIDISTTPGKKVAYIYLTDDAKNKDKHTKPANDGMNFLNSTGGADYEYRYGTLENFEKT
LKELKVEKDFQIKYLPTDNDWAGQLFTMLLPIVIIIGIWIFIMRRMSSGGAGGAGGQIFN
IGKSKAKLFDEKTDVKTSFKDVAGLEGAKEEVQEIVDFLKSPDKYTNLGGKIPKGALLVG
PPGTGKTLLAKAVAGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPAIIFIDE
IDAIGRARGKANFSGSNDERENTLNQLLTEMDGFGTNTNVIVLAATNRADVLDTALMRAG
RFDRQIYVDLPDVRERKEIFEVHLRPLKKVADELDTEFMAKQTPGFSGADIANVCNEAAL
IAARQGKAAVGRQDFLDAVDRIVGGLEKKNKIITPEEKRAIAFHEAGHATVSWMLEHAAP
LVKVTIVPRGRSLGAAWYLPEERLIVRPEQMLDEMCAAMGGRAAEKVTFDKISTGALSDL
EKVTKQARMMVTTYGLNDKIGNLTYYDSSGQNEYNFNKPYSEKTAELIDKEISKIIEEQY
QRAIKILEDNKDKLHELAEVLLDKEVIFKDNLEKIFGKRPFEKTQEAEVKDTPVSES
>KECLDBNJ_02883 Ribosomal silencing factor RsfS
MAKKEVSTDQLITTILEGIEEVKGQNIDLLDLREIENMVCDYFIVCNGTSNTQVAAIVNS
IQKTVSKKLKDKPWHVEGMQNAEWVLMDYVNVVVHVFQKHIREYYDIESLWGDAKVTSIE
SNY
>KECLDBNJ_02884 Bifunctional ligase/repressor BirA
MKIVKLNATTSTNSYLRSYTKELNPDTDVLVWTVEQRSGRGQRGAFWEAQPGKNLTFSVF
KRIEALSLDRSFYITMATSLAVFEVLEQLGLQQLSVKWPNDILAGRSKICGILIESVIRK
DLTAVIIGIGLNVNQVQFSRAPRATSIALETGRYFDLEEILDLLIQKFYTFVARIVSGDF
EALKAEYEQKLFRRDKASTFEDPSGNRFTGIIKEVSKTGKLIVQLEDELYKAFDLKELKL
LY
>KECLDBNJ_02885 hypothetical protein
MHIESPKKTIDKSPETIYNFLNDVNNYKKLMPDSISKFEILNEKRFLFALKGMPDIVLEL
KNSVPYNKVVLGAASDKLPFTLTANIKELTENSSEASFEFEGEFNAMMSMMIKGPITKFI
QTLAENLQTI
>KECLDBNJ_02886 Orotate phosphoribosyltransferase
MILKKETAKKTAELLLQINAIKLQPQNPFTWASGWKSPIYCDNRITLSYPPIRNYLRENI
ANQIELLYGKPDVIAGVATGAIGIGMLVADFLNLPFVYIRPEAKKHGRQNQIEGKLEPGQ
SVVVVEDLISTGKSSLMAVDALKAAEANVKGMLAIFTYGFDISKSNFEQYGIDLHTLSDY
DHLLEQALDTQYISEKEKLTLQTWRLSPNTWQAAPIK
>KECLDBNJ_02887 Diadenosine hexaphosphate hydrolase
MYKVFVNDVPIILSTEKYIGENYTSIPIKRAKIKSIIKQVNRGQLTHINLYHAKGKKLLK
FLKKKLPVVVAGGGMVFNDHSEILFIKRNGKWDLPKGKLEKKETIEECAVREVSEETGCQ
DLVLGDLITVTYHVFKRNGKFKLKETYWYKMTTSYSGPLEPQPSEGIKKVRWKNFEKSQK
ALTMSYENIKLLFPKEYLISNPKDRVA
>KECLDBNJ_02888 hypothetical protein
MKASLLSLLFLLTIACAEKPKPEDFDLVTPFEKGDGNQTPIYDEVMAYYEDLDAAYVSIK
TYKIGRTDSGEPLTLVTYNTNRTFDSEFADAKEVTRILINNGIHPGESDGIDATMMMMRD
LANGTIETPENVWIGAIAVYNIGGALNRNTGTRANQNGPEEYGFRGNAQNYDLNRDFVKA
DTYNARAFAEIYHMVNPDVLIDNHVSNGADYQYVLTHLFTQHNKLGDELGDYLHTELQPQ
LEQDLAAKDWPITPYVNVFNQVPEIGFSQFMDYPRYSTGYSTLWNTFGMMVETHMLKPYK
DRVTGTYELMKSMIKITEKDGAKMQALRKAKDSLYRSGALTGQAYTLQFEIDSSRTSTLN
FLGYEGEQKTSTVTGMSRLKYDRNKPFEKEVTYYNYMKPASDVTIPAAYIIPQGWRHVIE
RLKENEIDFERFQKDSMLTAEVYHIADYKTRNQVYEGHYLHYNTEVETSTQEIKIRKGDY
WVKTNQSGLRYIMEMLEPSGVDSFFNWNYFDTILQQKEHFSPYVWEDRAQELLDADPELK
EAFDTKKQEDARFAQNWYAQLEWIYEHSDNYEKAYLRYPIFRITN
>KECLDBNJ_02889 hypothetical protein
MFEHTHPYPPFNLEHATKLIVGTLPPPRFTTGDLLPEDVDFCYGSKNGMLWPILDQIFDL
GLVYENTAHAIEQRSHFLKSRNIGVCDIVAAAKREKVDASDLGMQEVELRDLIGYLERFP
QIHTLIFTGGASKNGPEYFFRKQLKEHHVKLNVISSEVPRIHQFQMGERSIKTVSLTAPS
GAANRAIGSMKSYKEQKLKDPQFSTFDFRIQQYRPFF
>KECLDBNJ_02890 hypothetical protein
MARTPSNMLPLGTQAPFFTLPNPLTNKHVTLTDVAGERGTVVMFICNHCPFVKHVNDEVV
RIANDYRVLGFGFVAISSNDVENYPEDSPWLMRETARKYNFSFPYLYDETQQTAKDYDAA
CTPDFYLFDAELKLIYRGQLDDSRPGNGIPVNGRDLREALDNVFNNRQQNELQKPSLGCG
IKWKQDANPS
>KECLDBNJ_02891 hypothetical protein
MKNTYSSLSVAIEELQKKGYDTDFNLVDEGIESKAHKKTWKAGQIEVEEAFRFEGMTNPG
DNSVLYVINTDSGEKGLLVDAYGAYSGQISQEMIQKLKIEHNE
>KECLDBNJ_02892 putative chaperone CsaA
MNNDLKWSEFERVDMRVGTILSVSDFPEARKPAFQLNIDFGDVIGIRKTSAQITKRYQRQ
ELVGKQVIAVVNFPKKQIANFMSECLLLGAVEGEEVTVLNPDLPVPNGLRIG
>KECLDBNJ_02893 hypothetical protein
MTPRVEATDAAKKIIDQLREEHGELMFHQSGGCCDGSSSMCFPKGDLMINETDVYLGTIH
DCEFYMSKDQFEYWKHTQLTVDITSGRGSSFSLEIPLGIRFVIKSRMYTEEEAKNLSPTR
SGEP
>KECLDBNJ_02894 Long-chain-aldehyde dehydrogenase
MSDVQTASANVVEKPKFKDQYENFIGGKWTSPVKGQYFDNVSPVDGANFTRIPRSTSEDI
EKAIDAAWEAAPKWNNSAAAYRSNLLLKIADVMEQNLEALARAETWDNGKAIRETMAADL
PLAVDHFRYFAGVIRAEEGSVSELDSNTVCINVTEPLGVVGQIIPWNFPILMATWKLAPA
LAAGNCVVLKPAEQTPVGILILMELIEDILPAGVLNIVNGFGAEAGKPLASSPRINKIAF
TGETTTGQLIMQYASKNITPVTLELGGKSPNVFFESVMDADDEFFDKCLEGATLFALNQG
EVCTCPSRLLVQESIFDDFVERVVERTKAIKLGHPLSPDTMMGAQASNDQYEKILNYINI
GKEEGAEVLCGGDAAYNEGLEGGYYIQPTILKGNNKMRVFQEEIFGPVLCVTSFKDEADA
IEIANDTLYGLGAGVWTRDTHQAYQISRAIKAGRVWVNNYHNYPAHAPFGGYKKSGIGRE
NHKMMLAHYRHTKNMLISYDKKSMGFF
>KECLDBNJ_02895 Arabinose operon regulatory protein
MHLPDTFYKNRKLENLVENQTSFTLNNAAMHVFETHQQAERVLLQFDKPVLASMLHGKKI
MHLRDHNSFDFLPGESLILPADELMCIDFPDAEHRNPTRCLAMAISEDKIKNVVTLMNEN
IGKADGQEWSLMDYNFHFTNDAGIFQILQRLLFLFTENHPSKDFFVDNMLQELIVRILQT
NNRKIYTDKALKLSNDNRLAFIIQYIREHLHESLSVETLSKKACMSESNFYRVFKNELGI
SPVDFINTERIKLAVSLLQDPNKKIKNVYLECGFESRSYFNRVFKRMNQISPGAFQAKAA
QH
>KECLDBNJ_02896 hypothetical protein
MHPNEQLITDFYLAFKNHDPQGMTTCYAKNIIFEDPAFGKIQGKRAFAMWYMLIERGGDA
LQIDFSEVQANDYNGSAKWTATYTYGPQKRKVVNHVVGTFSFQNGKIVQHTDHFDLWRWS
QQALGFKGYLLGWTKFMKLKIQQNTSKALSSYLHKMKSFDVAF
>KECLDBNJ_02897 hypothetical protein
MKSKILFIISVLFGLLFINSGLNKFFNYMPLPEDMSPEMLELFNAFTTIGWLMPLIAIVE
IIAGILVMFKPTRALGAIMLFPILVGILLLHLLNEPSGLLMAIVFFALDIWFLFESRNKL
KPLFNK
>KECLDBNJ_02898 Catalase-peroxidase
MENKNGKDHGTDGKVWDVNESSKCPFLSGEMNHVTGQGTTNRDWWPNQLNLNILKQNSSL
VDPMDEDFDYGEAFKSLDLAAVKQDLHDLMTDSQDWWPADYGHYGPFFIRMAWHAAGTYR
IHDGRGGAGSGQQRFAPLNSWPDNANLDKARLLLWPIKKKYGNKLSWADLLILAGNCAHE
SMGLKMFGFAGGREDVWEPEEVYWGAETEWLGNKERYEGGELEKALGAAHMGLIYVNPEG
HNANPDPVESAHFIRETFGRMAMNDYETVALIAGGHTFGKTHGAADPEEHVDAEPAAAGM
EAMGTGWKNNYGSGKGADTITSGLEGAWTDTPTQWSNKYFENLFGYEWELTKSPAGAHQW
KPKDNAGAGTVPDAHRPDVKHAPFMLTTDLSLRFDPEYEKISRHFMENPEEFADAYSRAW
FKLTHRDMGPKERYLGPEVPQEELIWQDPIPAVDHELVSDADVAHLKKNILESGHSISEL
VSVAWASASTFRGSDKRGGANGARIRFAPQRTWEVNNPEQLDAVLKTLEGIQKSFNDSQS
GNKKVSLADLIVLAGSAAVEKAAQDAGHNINVPFTPGRADALEEKTDASAFDALEPVADG
FRNYMKDRFAIKAEEFLVDRAQLLTLTPPEMTVLVGGLRVLNTNFDGSDYGVFTDKPQTL
TNDFFVNLLDMNTTWKAVSEEDELFEGSDRNTGEKKWTGTRVDLIFGSNSELRALAEAYA
LEDSGERFVKHFVKTWVKVMNLDRYDLQ
>KECLDBNJ_02899 D-lactate dehydrogenase
MKVAFFSTKKYDQEFFESINTDFNHQLTFFETALNAHTASLAKDFDAVCVFVNDDLNAET
INKLADAGVKIIALRCAGFNNVDLKATEAQNIPVVRVPAYSPQAVAEHAVALILTLNRKT
HKAYNRVRENNFSLEKLTGFNLYGKTVGVIGTGIIGQCFAKIMLGFGCKVLAYDIKPNAE
LKESGVTYVDLDKLLKEADIISLHCPLNEHTHHLMNAEAFEKMKESAMLINTGRGALIDT
TAVVEALKSEKLGYLGIDVYEQESGLFFNDLSETVNKDDDFLRLMSFPNVLITGHQGFFT
VEALEQIAHVTLKNLTDFEQGKELENKVST
>KECLDBNJ_02900 hypothetical protein
MKATTIDQVIEQLDAIILTEKQNNSSLAFFPILYNRVTKRIKAGIEAEEFYDNARMEQLD
VIFANRYIEAYQHYKAGNPPTESWFNAFKISEALVMQHLLLGINAHINLDLGIAAAETTG
AHALADFEQDFNKINEVLAAMVADVKAAIGKVSPLFKLLELVGKGKEDKLVSFSINIARD
GAWLFANQYAAAVEKEEAIADRDQVIAALAVQLVNPKSKLLQVVAKVVRFFEVKDVQSVA
AILER
>KECLDBNJ_02901 hypothetical protein
MNTTEATTVSQYIAEFPEPVQEKMKLIRSLIKKAAPEATEGISYHMPAYKLNKKPLVYFG
GFVNHIGFYATPVTHEHFKDQLSGYKNGKGSVQFPHSEPLPEQLILAMIQFKVSELSKSL
KL
>KECLDBNJ_02902 Chloramphenicol acetyltransferase 2
MIEEIALETYTRKEQFNFFKDFEEPFFGITTTVDLTRAYAYCKANALPIFAYYLHAANTA
VNAIPNFKQRIHKNKIIAYDRIDVSTTIARPNHTFGFSMIKHAADFNLFKTNFSAEKERV
QNTTQLMPDGMTDQVVHYSALPWFTFSAVSHARKFSINDSCPKITFGKIQQEAGQVTLPV
SVHAHHALVDGYHVGLLMEAMQNTLDRQ
>KECLDBNJ_02903 cAMP-activated global transcriptional regulator CRP
MFQEASNFLDFVEELYAQDTAGVSLIEFNAKEMLMHQGSAAQHVFILKSGLCKIGLEEEN
GKEYILAFLSTGEILGELELIRDEPRLCSVQALNKVEAYKLTKACFLNLLNTDLKLNRLI
INAYAERITNTSKKASFQKLYTTENGLQRILKLQETEKIEISKADLSAYLGISVRSLNRL
LKQRENS
>KECLDBNJ_02904 UvrABC system protein A
MAKEGYVVVQGARQNNLKNVSVEIPRDALVVFTGISGSGKSSLAFGTLYAEAQRRYLESV
SPYARRLFNQMPIPEVDAIDGLPPAVALQQQRSSGSTRSTVGSVTTLSNLLRMLYSRAGN
YPEGQELLYADAFSTNTPEGACPECHGLGKVYSVTEKSLVPDDSLTIRERAIAAWPKAWQ
GKNLRDILVTLGYDVDIPWKELPQEEKDWILFTEETPTVPVFRDRSPQEVQQALKNNEQP
SYKGTYTSAKNYILQTYANSPSASMKKRVSEYMVGSTCPTCYGKRLRPESLSVTFAGYDI
AEIAQLPLKKLLEIFKPYSEGSAAALKKLAKTNQEKVLVTQRIAEDFVSRIEVLLDLGLG
YLALDRNTPTLSPGEHQRLRLATQVRSNLFGVVYVLDEPSAGLHPADTAALLRTLAMLKD
GGNSIFVVEHELDVVRQADWIVDVGPDAGEGGGRILYSGPPEGLKDCATSKTRAHLFNEN
PFQKPSRKQPQHWLKLEGITRNNLNQLDAAFPIGALTSVTGVSGSGKSSLVSQALVELMK
IHLGNPTSEENEESDELLQQETEQPPSGSITAGSEHLKRMVLVNQKPIGRTPRSNLATYT
GLFDTVRKLFAKTDLAKSRKYKAGRFSFNVGKGRCPNCEGEGAVMVELLFLPSVYAPCPV
CEGTRYNAETLEVTYNDKNIAEVLNMTVTEATDFFKAEARVHQLLQLLEDVGLGYLRLGQ
PATELSGGEAQRIKLAKELQRQNNGKTLYVLDEPTTGLHPTDVEKLQLQLNHLVEAGNTV
VLVEHDMQVIAASDWVIDMGPGAGDEGGNIVVAGTPEEVAVSSTSKTAPYLKEVLNS
>KECLDBNJ_02905 Isonitrile hydratase
MLKILSILSIALLLTSCNTQSKKTEVATQENTTSTDTLTKHLKPFNTELPTIGLLMYNGV
LQSEVVATSDVFAKPTEAGEQLFNVITIAETTNPITTEEGLHLVPDYTVENCPKLTALFV
PSAYDMYAQVHNEALVNFIKQKNEETQYTVSNCAGAQLIGASGIAKGHKIVTYIGGGTQL
QKDYPELLVQNDSLVTFAEDGKFLSSNGNLASYISALELLEKMTDAHHREFVESYLYLDR
LQNWER
>KECLDBNJ_02906 Ferri-bacillibactin esterase BesA
MKASLVLLLFCSFSLLGQKLPERLSETDFTIGKTISIQSKILKGERVLNVYLPQHYSADS
TKTYPVIYLLDGSKDEDFIHIAGIVQFGSFSWINMLPETIVVGIANVDRKRDFTYPSQNS
LDQEEFTTSGKSAHFIQFLEEELQPFIAANFKTSEEKTLIGQSLGGLLATEILFKKPELF
DKYIIVSPSLWWDDEKLLNAPTPSFTSSKSIYIAGGKEGEVMERTAKTLYNRLNQQQDEK
TRVFYEFLEDKDHGDALHIAVYHAFEKIFGSQKNTQ
>KECLDBNJ_02907 hypothetical protein
MRIILIAVLMLVLGCTKTSTPPSSFKSLAAKSSSIAGKTAYLASPFVTAGNRIYMVGHQD
GSFPDLGWHIKGEMGGIWDHPIKLMDGFDLAVLHENDTLTLNNADRFVNYPFTNMHEFAW
AEKNLNIQRWQFVPDDTEGLIIQLAFENTGEAKKVQLDFTGISDLRPTWLGDRTGMIDSK
DQAVFDEQNKLWKVKDQNNPWYVLFGSSVKPTATAQTSTQDATTQSSLSHTLQLPAASTT
VFTYYIAGSYQSEAAALATYKKMQARSTDLFQAKKERYEQLASHSKLSIPDKSIAQAFEW
LKYNSDWLVRRVPEVGTGISAGIPDYPWWFGVDSEYALKGLMAIGQTKTVYSSIRLLDSL
SEATNGNGRIVHEVSTNGAVFNPGNINETPQFASLIWEVYRWNGDRKFLETYYPSIKKGM
QWLLSEKDTDQNLFPDGYGMMEIHGLDSEMIDVASYTQHALVDAAKIAEVLKDTATAENY
KAKAAVLKEQINTQFWSEAFNSYADFIGTDAQALHLIEDAIVRADTLEKPWAVTELKETR
DYIKNNPSAAARPFVLYHNWVVNTPMEMGIAPPEKAKKALKTAEQFVNPFGVFVTGIDRD
DSAGSDEGSFKGSSSFSYTGAVMTLPTSVQAIAENNYGNPDAALDYIKRMTRSFSFAFPG
SMYEVSPDYGMISQAWNIYGFAIPIVQQFFGIAPDAANHTITIKPQMPKDWNDVALEHVK
IGDNAVSVFYTKTNNQIKLRVTQTQSDWTLKLILPKELDGKSFRSSSSSSQVTTDENNFI
LSGKGELELILEEE
>KECLDBNJ_02908 hypothetical protein
MKHIFLIIILSSFWACNYKKDNAVSKIKNPNPEKVIQKKLSGKEVVAELEKLGYFNLTNE
SESDTVKTDFQKAYTDLNFFQGPMRGETLNFMDNRYHWVDCEELFEIGGLTEYLNQVKPT
FDKLGLELKFANEKSEQDQNSWKHTIELNGIEYTAFDGQFSDLDWGIAYVNFIEMLNAEL
RRQNSDEQFYPINCGNDGMFVLLTPKQLDFVNRNYPIDNEHPTTMSNWKSRNGI
>KECLDBNJ_02909 hypothetical protein
MNFSTLIIFLLLIKSFSLSAQEKLEIGQHIYKDKLTFISLNANNEFEYLKYYNWSPLTIE
EKRKAEKNENPTRGTIGYVSGAKGKGNYELKDGKLILKFSEFKKYMDNKTDFNAETITMV
FIISEFIK
>KECLDBNJ_02910 Protein TolB
MLLTLMGCQSKNYDLAYVTDRDNTLDICITSSENKEIINLTNSDITEYNLTWSKDGTEIF
YTSYEKTGRKVKSVNVLDKSIKVIINDSIIQSVNDVSKDNERMIISSSEHHKKGELYLYD
IETNSKIRITNNEFYEAGAKFSPDEKTVVVSIQTKVSDSINYSGTAEIFEIKLSDLSLNR
LTDLEGFNALPEYSPNGELITFHHCDNGKCDIMMMEFDGLNLVNLTNGKDDNRWPRWSPD
GKWISFTKTIDNNSDIYFISKDGKRVKPIITTEFRDEIAIFKPN
>KECLDBNJ_02911 hypothetical protein
MPRIELRTEIKADKEIVFDLSRSIDLHKISTEHTNETAIAGKISGLIALNESVTWRAKHF
GIYQRLTSKITEFDRPNYFADEMVSGAFSKFKHEHHFTDLNGGTLMIDYFDYKSPIGILG
KIADKIFLVKYMTDLLTERNRIVKEFAESDKWKRILTV
>KECLDBNJ_02912 hypothetical protein
MKKEETYPRSFSHIGITVPNIKEAVKFYSEVMGWYTIMEPSKVKKERETAIGQMCIDVFG
EGWEEFEIAHMSTSDGIGIELFSFPNGKKEAPEFNPFNTGLFHFCVQDPHIENLIEKIVS
SGGKQRMPIREYYPNDKPYKMCYVEDPFGIVFEIYTHSYELTYSSGAYEE
>KECLDBNJ_02913 putative HTH-type transcriptional regulator YtcD
MNKIYCPLNYTMKLIGTKWKPLVLFHLLEGPVRSGKLQNKVPHISNKMFTQTVRELEKDN
LITRKVYPVVPPKVEYELTEKGKSLESILKSLDSWGKEMSAFS
>KECLDBNJ_02914 Metallothiol transferase FosB
MTFTFNHLALSVKDVNESIQFYQKVLQLEEIENTASNSKTRWLSLNQGKQLHLIPRPNSE
IKIDKAVHFALSTPDLENAISNLENLKIEFSDWKDIPNKVYVRKDGIKQIYFQDPNGYWI
ELNDDV
>KECLDBNJ_02915 hypothetical protein
MGKTLSILILILISSCEKSDYETIDYEAFEITVPKNWSEYEINGIDSYVSGLITDKGDTL
IFDLGWYSPDLTKNPEVLVFEQSEYEEFSDKQKKQLKKVKHLVIEDFLTAEYDAKDYLKY
EFQTDSIDCFVAKFIKPKNKGFGASGIYIDSLKGGGPNSNKTRLSFYGNNLSDSTQMEFF
RALKTIKLTKYCE
>KECLDBNJ_02916 hypothetical protein
MTFPLLNITPECWTYENLIDCVIFDEFIYTDKDSVFMELYKDKLFCDCNGKIFKAVKKAE
LTEKWRNWLKFIPNIWKREIIFQPTGENWTVEELRNYLLNRVSELKTNEQTEKWKTQLKK
AKNHSELIYG
>KECLDBNJ_02917 Tyrosine recombinase XerD
MYFSSMKPIIKLLNLRHRNVNHIGLQFAYHDGLKAVIKYELQAQWSQTHRLWYVLDTPKN
LKRIYSVLAALCTIDTSGYEARQASNKETQPLTAMQRSVLNGYYRYLQGKRYSQSTIKTY
TFFVSEFVKFQYKIAFEDYTNRQVELFIEQVFIERKYSISSQRQFISALKLFTTYFPHTQ
ISALRLTRPKKSKKLPEVISQEQFLSLVQAAKNLKHRTIICVLYGSGLRISELLNLELKD
LDPDRNQLFIRNAKGRKDRYAQLSAYLKPLLFNYLNTYKPQRYFIEGPNGKAYSASSVRK
FLVVYAQKAGIAQRITPHILRHSYATHLLEQGVGIRHIQELLGHSKPETTMIYTHVTQKD
LSAIKSPLDSVIAKFKLDKQEQKFLLSRKL
>KECLDBNJ_02918 hypothetical protein
MGKQYLINGHSMLKERIKSIENLVVSGTIFILEY
>KECLDBNJ_02919 hypothetical protein
MGLMIDTNKGMLTGLVGSVVFVKGKNGEAIVRSRPMRNTAKPTPKKQQSCDRFAVVGAFI
KPMYPFLKGSFTDWLEKRTARDAVRSYTLKNAVKLEQGKPVIDYPKFLISTGKQRVYNPI
LQQREKTELLLEWQPDSTQAFAHSDDLLSVVGYAPQTSEYVFFEACATRAAAQLQLELPE
ALAAAPVHFWVTFSTPTGDSYAYSTYLGLL
>KECLDBNJ_02920 hypothetical protein
MENQVNLKGAERAATHTSRMSKERIENAVKQLNEISESDYEKVLGLANVCKPFRSVLHKT
PDDYGMTQWEDVFLHGIDGVPLDGWYIPAKGGESNKLVIFNHALPMCRSGFQGHFGLPFS
GYDNVEIDFVIQMKHLTDAGYNVLAYDIRNHGRSGTSNNGVSGIGQLEWRDCAGVKTYVD
NHPRLSKMKVALYSQCMGGNSQYEAISRRPELFENVTCMVSPMVVSMRAIYEAFSELQGV
SQYLDLVDFELMKMGGWLMDEMTPHTAAPDVKMPVFMIQVKDDAWTKNPEDGQKTFDLLG
SREKEIHWIENTPLRFKDGYNYFGRHPEKVLAFLDKYMS
>KECLDBNJ_02921 Regulatory protein SoxS
MSQKFNIPDFAKYLNITDSKDDDLLMILYDDKSKIPLKSEPVVIDFYLLALKLDFDNTVD
YGQTDFDHTESLLYFDAPNNHIAWDLDKPMTGYNLLISADFFDTYAKRYSFMHYNDHEAL
FVKDDEKQILLDLFTKAYTEYQSTQFSKAIVTSYANLILTYIEKYYKRQFDTRSLLYNQV
VTDFRKNLEHFFSSGDTIKELPSVGYFAQRSNLSSNYFGDVIKHFTGESAQSHIQHYVIQ
LAKLKLRETSLPISQIAYSLGYDYPTYFSRFFKKEVGVTPSVYRNQ
>KECLDBNJ_02922 hypothetical protein
MLYAIGITVMLGFLAVLLSWWLHLLFVGILICFILITLLAPFVDVPRMVKAGKLTYHSVF
LLAEAPKDGVLILHGGTLFDYVYVLDFKQSGKARTAFILQHYLEGLLHLIATYEQQETPL
KLRWTSYIVNQSTAARLGFKPQPKDGLQQLILAFNYGNLLVSNSLAKGKLSFPKLSATQT
YEAALDDLIARKAYIKQLLKRVQ
>KECLDBNJ_02923 tRNA pseudouridine synthase C
MMSLTETHTVPPQENPLRLQEYGVGIFKAAATKSALKKLLKKGYIKINGAPASTGTWIKG
GEVLTLEIPQQHKNQKKLRLALDVLYEDEFLAVVHKPAGILVSGNSFKTLARALPQNLNE
SSLADACTPQPAHRLDYATTGAVLVGKTRESIRQLNQLFENKAISKTYYAVTIGVMPTSG
TINTPVDDKESVSTYTVEVSVASPRFKQLNLVRLEPQTGRRHQLRKHLAGIGHPILGDRD
YCPKELLLQGKGMYLHAHKLRFTHPATQKYLEIADPIPQKFLKLFP
>KECLDBNJ_02924 D-alanyl-D-alanine-carboxypeptidase/endopeptidase AmpH
MKYLYITLLFSFCLGTTFAQDAKKDYTEALQLVEVWLDAQKDFDQLPGLSAIVVEDQDVL
WSGAVGLANVADKVSTQPSTLCSICSISKLFTSVAIMKLYDEGKLRLDDRISDLLPQYNL
KQQYAASGPITVRSLLTHSSGLPREADAPYWTAPEFDFPTTEEVDAGLKNQETLYPASTY
FQYSNLGLTLLGEIVAEVSGMPYETYVAENILKPLGLADTRTELPEALYGSELAFGYNAL
DRSGNRDKLNFFQANGIMPAAGFSSNVTDLGKFASWQLRLRDTTTTEVLKPSTLKLMQQV
HFTDPNWKTTWGLGFVVYKGSNGNTWVGHGGSCPGYRTALQIDLKRKLAFSVMINASATN
PGKYINGINGIISKVKETEKTDESEQPIDLSEYTGYYNTKPWWSELYIGTWGDKLVTLNL
PADDPAEAMTMYKHISGDTFRKIREDKELGETLTFERDAAGKIVRYKQHGNYSVKFDPHA
K
>KECLDBNJ_02925 hypothetical protein
MKTYKTGLLALALGALVSCKTTTTTSTASKAPEAPEAPEAPAKPATPQQPEMLTGETERM
ELQTGTFGSWFNPRYAEYDIDKDVVMQLKPLLEDVDVTVFMGTWCSDSKRETPRFYKILD
AAGKTQDVELITVDRSKTTPEGLEEGKDIKRVPTLIFSKNGTELGRIVEYPIESLEKDML
KILQNKPYKHAYAD
>KECLDBNJ_02926 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MILDGWGFAPNKDVSAVDLAETPFIDSLYTKYPHAQLLTHGGNVGLPDGQMGNSEVGHMN
LGAGRIVYQDFAKINKALKEDKLREQKELKDAFAYAKENKKPIHLLGLVSDGGVHAHIDH
VKGLIKAANEVGVEEVYVHAFTDGRDVDPQSGAGFIEDLDGYAKENGAKLASITGRYFAM
DRDTRWERVKKAYDAAVKGIGTKTTDPVAAIKQSYADGTTDEFLEPLVITKNDAPVATIN
ECDVVLFFNYRTDRGRELTRMLSQEDFPEQDTKKLDLYYVTMTNYDQTFENIHIIFDKDN
LTNTIGEVVSKAGKKQIRIAETEKYPHVTFFFSGGREKEFEGETRLIAKSPDVATYDLKP
EMSAYEVRDKITAELKKEEVDFVCLNFANPDMVGHTGVIEAAIAACEAVDSCAKDVIETG
LEHGYSTIVIADHGNCETMKNEDGSPNTAHTTNPVPIIVVDNDIKSVKDGILGNVSPTIL
AMMGVDKPEEMDQESLVS
>KECLDBNJ_02927 Beta-barrel assembly-enhancing protease
MKLGGRALKLFLGVAIVAFGVIRYCGSQEENPYTGRTQAISLSTEEEIAIGLQNAPIMAE
QHGGLYPDQRLQNQIDAVGKKLVDNTIAQETPYQYEFHLLSDPNTVNAFALPGGQIFITY
ALYKRLSSEDQLAGILGHEIGHVVGRHSAERIAESELANTVATGAQVGADAGMLASQLGQ
TILLKNGRGDELESDDLGVKFMIEAGYDPEALIEVMQILKEASGGQRVPEFQSSHPDPDN
RIEKIRAAIDKYRA
>KECLDBNJ_02928 D-alanyl-D-alanine carboxypeptidase
MKRRRFIQTTALATAALSSFPNWALTQETLSTDQLIGKGNPELIEKNGYRLRPAVSAAFD
NMAAAAQQDGIGIQVVSSYRDYAHQNRIWERKFKSYTANGMSDLDAIKKIIEYSTIPGTS
RHHWATDLDIIQSGTGVTSNVLDPDKFHGTGPFCELKAWLDQHAESFGFYEVYTNNYGRK
GFNYEPWHFSYAPLSVGYLQQYKKLDVAEILQQEHLLGSEAFTSAFINQYRTENILDINP
ALLS
>KECLDBNJ_02929 hypothetical protein
MQGVLKTNPFTIHEITSAETYAVRHPVLRAGRPLETCAMPGDDAEDTFHLGLFDEDKLIG
VVTFMNATKPQFKGKQYQLRGMAVLDGYQGKGLGNLLVAAGEARLKAAGYKLLWCNARIK
ALNFYTRKGFKIEGEPFEIEPIGTHYLLYKNLE
>KECLDBNJ_02930 hypothetical protein
MDYTIQHRENDKRGMFWIEGEHGKISELTYTVQDENTIIVDHTETKMEHEHQGYASKLLD
HTVAWARSKNIKIEPLCPFAEVKFDEKPEYADVRA
>KECLDBNJ_02931 Aminoalkylphosphonate N-acetyltransferase
MSKITVTRLYKEDINTFLPLVQELMEHTVEENLLKVRFTEMFEHRYQCRGIYIEGELAGV
FGLWFAVRHYAGKTCEVDHVYIKPEFRNRGLGKQVFQWIYDYARAEGCETSELNTYVHNF
PSHKFYMNENYVIKGYHFLKKL
>KECLDBNJ_02932 Peptidase E
MKNLILASTSTVHGGSYLDYLKPQLSEHFKAAKRIIFIPYARPGGISHELYTAKAQEFFK
QLNIEVVGLHQFKDPAEALKKAEGVFTGGGNTFLLVKQLYEYKVLEVLRDRLYENMPYLG
TSAGTNIAGVSMQTTNDMPIVYPPSFKTLGAVPFNINPHYLDPVEGSTHMGETRETRIKE
FHQFNALPVVGLREGSWIEVKKRVYTLRGPHSARIFEADKAPYELPTDSEITVN
>KECLDBNJ_02933 TonB-dependent receptor SusC
MKLVTTLLLCLSIGFSLQAQVARVMIDGQIIVPAGDDVAGIVVYNKTAQRGTITSEEGTF
DIAVARNDEVVIQSVQFAPITVVVDQGVVSSKQMNVTLRETVNVLDEIIVTPYDLTGDIV
ADVNRVRTVDPVPFDGSDIRIEDSQYDKNSPADNIAIDDQRWRYGLNFVNIFKAIFQKSD
GEEEEAAEDELAEMYSNTFFQNNLDIKKEHIGLYMDYVAANGLTKEMLEQGNELALIQFL
IDKREDFKKELAASK
>KECLDBNJ_02934 hypothetical protein
MKTFLPLAFLFCSMIGFAQNSKSITTTPERVAQEVSQQSDQTNEEKIKNTADKTTAMQHT
YSAPNCSRGFYATPIKQQSKKAILPEQKRALDSLKHSPYLAYATRGF
>KECLDBNJ_02935 hypothetical protein
MNNNIPFPSNSLGSILGGAAHFKVQLCILSFFVCTFCIQAQEVQMLEGRVINDSIEHEYL
HILNLTLQKGTITTQSGNFTIPVRQNDTLYISALQFKHQEIVITPQIFERRYIEIKLETE
VTELEDVNISDTDLSGRLGDDMNLPKLEKPFDPAAAGLPVYTGPVRTQEERRLYTATHSA
GGIIPVDAVINAISGRTAYLKRIVKLSNMELKVQEARNLVSDSTYIYRLRIGPRYIDDFV
HYVYMDQQEHLAIASSNNPLALMEMLLEQAPLYIRSKEQEGVAVQSDLEN
>KECLDBNJ_02936 hypothetical protein
MHFKRRIFTGLMRKTILLLLVALPLLGAAAHKYYFSVTQADYDAKDHALKMVTRVFYDDL
QKVFQERYDKSIKVDASYDQKKLDGYIERYFNQKFIVKINGKERRLNYIGHKDEMDYVVC
FIEVTDVQNPKSISIENTLLMDLFQDQKNVVHLNTGTTKKSFLLTRDNDKAVLNFSE
>KECLDBNJ_02937 hypothetical protein
MKQLKHTFFAVLLLVGATAVAQEEQAPKEKQAGHTNTNKFRQLYNEFATPNQYRTASGAP
GPAYYQNEADYEMKITLNDENQTISGYETITYQNNSPDQLEYLWVQLDQNIRKKDSPARE
RNGSGMSPVAQPAGIVSEYMQEPFDGGFNISEVTQDGKPLKYMINYTMMRVEMPEPLASG
DSFEFSIRWNYNIPEHTVDRARSGYESFPDGNKNYVIAQFFPRMCVYNDVEGWQNYQFWG
SGEFALPFGDYDVEITVPADHLLDGTGNLVNRKDVYSKEEYKRWEQATKSYDKPVIIRTQ
AEAENIEKGHSTKTKTWKLQAENVRDFAFTSSRKYIMDAQAVKFPKGDVMAISIYPKEGN
PLWEEYSTKAVVQTLESYSRMTFDYPYPKAISVHGKNQGMEYPMICWNYGRPNEDGSYSD
RTKFGMISVIIHEVGHNFFPMIVNSDERQWGWMDEGINTFVQYVAEQDFGENYPEAIAPN
AKYPSRRGAPSAITGYMGGNQDFIAPIMSNPENVYQLGNNAYGKPATALNILRETVMGRE
LFDYSFKTYAQRWMFKHPTPEDFFRTMEDASAIDLDWYWRGWFYTTENVDMGVEEVKSYY
LTDKPTQAGKALMERYGVDPAGRDLVYVVEEDGEDYDPAMKSKSSLENAPNLQEFLMDNF
SAAERAKLKAPKHFYAIKFNKPGGIPMPIIVEYSYADGTKEKVTYPVQVWRMNDAEVTKV
LATDKELTGVLLDPDLETADVDVSNNSWPKQAQESEFDSFKEGAED
>KECLDBNJ_02938 Sec-independent protein translocase protein TatA
MSIPLFISGGEIAFVIFIVIMVFGADKVPDIARGLGKGMRTLKNATEDIKSEITKSADKQ
GINTDIAKDMKKEIDDAKKNIEEITGSVKRKF
>KECLDBNJ_02939 Putative O-methyltransferase/MSMEI_4947
MHFISEDLDDYAVAHSEKEPELLRKLTRETYQKVVQPRMLSGHYQGRILSMIAKLANPKV
ILEVGTYTGYSALCLAEGLQPDGILHTIDVNEELVDLQKKYFDASAYAKNIKQHLGPALD
IIPKIEEDFDLIFMDADKPNYPAYFDLIIDRLRPGGLLLSDNVLWSGKVVEPLNPKDTST
KALLEYNRLLAEDDRLETVLLTIRDGLTISRKRQE
>KECLDBNJ_02940 Kynurenine 3-monooxygenase
MKTQEQEHILIIGAGLCGSLLALRMAQRGYKVTLMEKRPDLRKEIVDSGRSINLAFSDRG
MKGLRLAGLEDKVLPLCIPMNGRMIHNAEGQLFMSPYSGRNEYINSISREDLNIMLLDEC
DKMPAIKMQFNQKCTGVNIETAQATFEDHKTGETITYQADVVMGADGVGSALRKSMLEHR
KFLFSYGQDFLTHGYKELSFPPKADGEFLVEKNALHIWPRGKDMMIALPNLDGSFTVTLF
LSWEEGKDSFDSLNTDEAVLDYFKREYPDALALMPDLLTEFKENPTSPLGTIKCSPWHAY
GKVLLLGDAAHGIVPFYGQGMNSAFEDIYVLDQYLDQYAGDWKTVFKAYQEERKEDTDAI
ADLAVDNFHEMKAHTARPIFQEKRKLEIAFEEAFPTEYFSKYALVTFREDLRYSEAMRRG
RVQDKAILNLIYDGKFTKDMSLRTKLDLMKQETRKMLHDEEVLEGLESED
>KECLDBNJ_02941 Kynureninase
MSEQSSTHYKNTLAFAKQADADDTLARFRDEFNFPKDEAGNNLIYLCGNSLGLQPKKAKE
YVAQELSNWAELAVEGHFKAKIPWTTYHEVMTKSMADIVGAKPGEVVLMNTLSTNLHLMM
VSFYRPTAKRYKILIESDAFPSDSYAVKSQIKEKGYNPDDALLLWQPREGEHLNRFKDLE
ALMAEHGEEIALVMIGNSNYYTGQKYPIKEITQLGHRYGCKVGFDLAHGVGNIDADLHDN
GPDFAVWCTYKYLNSGPGAIGGCFVHERHADDKDIPRFTGWWGHKMDSRFNMRVDFDPIP
GAEGWQLSNPPILSMAPIRASLELFAEAGFQNIRAKSKKLTGYLEFLINELDDDRIALLT
PKNAEERGCQLSIQVKNADRSMHDGFMQAGIICDWREPDVIRVAPAPLYNSFEDVYEMTQ
RLKELLATL
>KECLDBNJ_02942 Inner membrane protein YbjJ
MNSLRLVFSNLRYFTPVFLFATLNILYGTWAIYIPKITAKLQLSEGELGFAVFFMALGTL
CTIPFVPRFIKNIGLGKAVLFAVIGFCVLIIQPFLASTYVLLCASLFGVGIFSGLLDVTI
NTLVTEIERRDEVHFMSVSHGFFSLGGMLGAGLGSLLMPYIALPKWHIAGVSALLILINL
LLCKHYFSIKAAAHEETSSFKLKNLRPLVGLALIGFLVMAAEGAIVDWSALYMEQVTLAS
AALAGLGYTIFNGTMAIGRFFGDAISASYGSRLIIIVGSFIAAIGFGIILSGSTIYALLG
FGAVGLGLSIVVPELFRYSGNLKGIRAEEGISFIAGTGFVGLLLGPVFLGFLAETFSLKG
SFSALLCFTALAGLIAVRLKRN
>KECLDBNJ_02943 hypothetical protein
MKKILFLTGLSLSLFACKNESQETTAQPPVVNTEELAEKDRTPEEEIAYKIAEANGLKNW
KSVTEVQFTFNVDRGDSHFERAWKWNPQTMDVTMRSDKDTVSFNRKEVDSLSMDADKGFI
NDAYWLLAPMHLVWDEGTTLTVQDTATAPMSQQKLSKITLTYNGEKGGYTPGDAYDFFYD
DEFMVREWIYRRGNVSEYSMVTTWEDYKDYKGIKIAADHKAPEDAVHLYFTDIAVKTEE
>KECLDBNJ_02944 Quercetin 2,3-dioxygenase
MKKILHRSETRGDANHGWLHSKHTFSFANYYDPQRMNFGVLRVLNDDKVSGGMGFGTHPH
QNMEIISIPLSGDLEHQDSMGNTTVIKEGDIQVMSAGTGVQHSEYNKNKDEEVRFLQIWV
IPHTQNVEPRYDQITLKKEDRKNKLQQVLSPNKEDAGVWIHQDAWFNMVDLDADKAVTYD
FNLVSNGLYLFVLEGSVEVADEKLERRDGLGIFETQSITLKASEQASVLLMEVPLRV
>KECLDBNJ_02945 hypothetical protein
METPIKLELVGQKGELFALKYPGLQIPIHVNQELLEKFKASDEYVVIEHQSPPEYTNELW
ASSDTKSQINT
>KECLDBNJ_02946 Bicyclomycin resistance protein
MTKRFTTSSRNLIILILGTLIAIGPFSIDMYLPGFGNVADDFGVDISKVGLTLTSYLIGI
ALGQLAYGPLMDRFGRRRPLIGGLILFTVTALLCAFSWNLNILIAARFFMALGGCAGMVA
SKAIVRDLFEKKQVADVLSTLMLIMGVAPIIAPTVGGIVIGAFDWEAVFYILAVFAILML
LLITFVLPESAAPNRSTSLRPKNIILEYLSILRNREFFIFAITRGFTMGCLLSYVSSAPF
IFIEFFELSEQQFGWVFGSNALGLILGSQINRLALKRFSLLQITVTTCVALSILTACGLG
ISFLNLINFWVVYPFLFMMLFLIGFQNPNVTALSLDPFTKQAGSASALIGSIGMIFGSVA
SILVAQLVTESVKPLLYILFGSALCSLALVLYYLNRRKTYALQTS
>KECLDBNJ_02947 hypothetical protein
MNSKKALPLILILLFVTLPVLAQEKSYDFGLYLGGVNYYGEVGKKKAIAPNRAFFGLIGK
MNFNEKLSARATLTYMTLYADDRNAGDEYRANGRGQSLFYSFENSHIELTAGIEYTPFSF
FNNSRNPIDFYVFGGIGAAYGDELYYPLSAGFEDVAAEKYGTSTRLVVPFGAGLKTFVGS
KFMLGLELAPRYTTSDNFDGSHPDEPRLEPNQLPNFANNDWYTYIGITLTYRIGKGSDAY
CDCTL
>KECLDBNJ_02948 putative HTH-type transcriptional regulator YybR
MEKADAKMITFRGNEYPCCASLTMGIIGGKWKTVILFHLINKKLRYNELRKSMPTVTERT
LSLQLKALEEDGLIKRKVYTSKPPLKVEYSLTDFGKTLIPLIQSIADWGDFVIEEYAK
>KECLDBNJ_02949 Oxygen-insensitive NAD(P)H nitroreductase
MNLKETLDWRYTTKEFDPNKTISESDMRQVKNLLRMSPSSVNLQPWHFIIAESKEGKERI
ATGTQGFFHFNEPKIVNASAVILFCSKIDADDKYYQHIADTDDKSGRFPNEDIKNGFLGA
VKTFAGIHKYDLKDLNHWMEKQVYLNIGSFLLGVAALGIDATPMEGIDVKALDEEFGLRE
KGYTSLVAVSIGYRAESDFNATEKTPKSRLPESEIITVI
>KECLDBNJ_02950 hypothetical protein
MIQSNFYLILFVGLIFSCDNPKSEEKTTENTISEIIKNPTNKVGLSSDILWEKMNPARGD
QSPLAGTIWGDRKAEVSTGYIGKFIDGFSSPAHIHNVTYRAIVMKGLIHNDDPKAENMWM
PVGSFWTQPAGEPHITSAKGEETMAYIEIDNGPYLVKPTNESFDNGERPVNIDASNMVWL
DNTQTNWISGDNQSKISFLWKNAEDICGVLVKLPEHFRGKIYSRGTIFYGVIIGGNVDYK
MPDTDSVINLDAGSYFESTGNSVHDISTPEDTLIYIRSSDKIKIE
>KECLDBNJ_02951 putative ABC transporter ATP-binding protein
MARRLDSINDSKKTNVRASFQALRFIPRFFKEIGQVSPLLFTLNLLSRLINAFAPVVILW
VGKLIIDEIIAQVAATSPDYTTLWNYVLIEFGVTIIADIINRVIAITDGLLGDQYNIVSS
EKMIRKTSKIDMVHLEDSEFYDKLERARQQTQGRVGLMSLALGQLQSLISIATLIAGLIY
FQPLLIILLALSIIPLFINEIRFSGQQYSLSRSWTTERRELDYLRYIGANDKTAKEIKLF
GLTDFIANRFKTLSQQYYQINKKLTVKRSIYSAIFNVLGVVCYYAAYLVIIKSVLEGTIT
VGELTFLSASFNRLRNTLQSFFTSFTRITQSALYLKDYFDFIDLEIPDEHKNALPLPKVV
REGFEIQDVHFSYPGSEHQVLKGVSFQLKAGEKMAFVGQNGAGKTTLIKLLLRFYEPTQG
AILLDGVNINRYNKAEYQQMFGVIFQDFFRYEFTLRENIAVGDIGSVTDDNRIQEAARLS
LANEVIEGLSLGYDTQLGKRFKDGQELSGGQWQKVALARAYMKDAQVMVLDEPISALDAR
AEYEVFERFIALTEGKTSIIISHRFSTVRMADRILVLKDGKILELGTHDQLMQTPSLYAE
LFELQAQGYK
>KECLDBNJ_02952 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MWNLEGKTALITGGTKGIGRATVLEFAKLGAKVIFTARDGAAVTAFQQELGEMGYIASGM
QGDVTSEDDQDKLTDFVFQRSGSLDILVNNAGMNIRKEAIMYEVEEYEQVINTNLIAPFE
LTRKFFALLKRSGKASVINVASVAALQDVKSGAPYAMAKAGILQQTRSLASEWADKNIRV
NAISPWYTETPLVKPIIDQKERYAKIVERTPLNRFAQPEEIASAIAFLAMDKASYITGQN
ITADGGLSANAL
>KECLDBNJ_02953 Glyoxal reductase
MSITTVNKEITNLQGTWELSNGVRMPYFGLGVWKAEDGKEVINAVKWALAAGYRHIDTAK
AYDNEEGVGKAIKESGIPREDIFLTSKLWNSDQGYEATLEAFEKTLSRLDTDYLDLYLIH
WPVEGKYKDTWRALEKLYKDGKIKAIGVSNFLEHHLKDLMQDAEIKPMVDQLEFHPWLVQ
KDLQKFCKENGIQYEAWSPLMQGKAFKNETLKQLGEKYSKSPAHIVLRWDLQNGVITIPK
STSKDHIESNAAIFDFELTEEDMQTINALDKHERIGPDPDNFDF
>KECLDBNJ_02954 hypothetical protein
MKRIFLFLFLAGVMGTTLQSCRESTGDKIEDAADDIGDAAEDAVD
>KECLDBNJ_02955 hypothetical protein
MRDIIWLIVVILIIGWLVGYFGFAESVGSLIHILLVLAVIAILYRLATGRRL
>KECLDBNJ_02956 (6-4) photolyase
MAKTLRLILGDQLNQKHSWYDQVDDDVLYFMAEMRQETDYVTHHIQKILGFFSAMRNFSQ
WLEDRGHSVIYYKLDHPDNTQDLTKNLNQLFKAHHIDRFEYQLPDEYRLDEQLKNFCNDI
SLQTQAVDTEHFLTSRTDLADFFEGKKTLTMEYFYRHMRKKYNIMMVNDKDPEGGKWNFD
HSNRKKWKGEPEIPPERGFRTDLSEIHKMVKDAGIKTIGSVDAENFNWPTSRPDALSVLN
YFCSNLLKHFGDYQDAMDPDQAYLFHSRLSFAMNSKMLHPLEVIEKVISHWREHKEEIDI
SQVEGFVRQILGWREYMRGIYWMKMPGYRRSNKLDNQNELPEFYWTAKTKMNCLHHAIKQ
SLEHAYAHHIQRLMITGNYALLTQTHPDEVDAWYLGIYIDALEWVEITNTRGMSQFADGG
IVATKPYVSSGSYINKMSNYCSSCHYSVSKKTGEKACPFNSLYWNFLLEKKEHFENNQRM
NMMMGMLEKKDPDELEQLVKRAQEIIKNPQNF
>KECLDBNJ_02957 Cryptochrome DASH
MSNTAVNAADEIKILMNLVWFRNDLRTLDNISLQQACSNDAGVVAVYCFDPRHFKMGPFG
FKKTERFRAQFLIETIQELHEDLRKLNITLLVYLEKPEDVIPKLAAKYKASQIYYQKEWT
AEEVEVQHNVKEACEASVTFTANYDQFLIHPEDLPYDSFEAIPNVFTHWRKTCEKSLHIR
KCVEPQQQPKTNLIDEPTEIPSLSDLGLEDFKIDNRTAFPFNGGTQQASQRIQQYFWESK
KLQVYKKTRNGLVGTDYSSKLSAWLANGSVSARIIYWEIKKFERDEAKNDSTYWLFFELM
WRDFFKYISLKYGNSIFKIGGILNKDYDWHSNKAAQKEWITGNTKYDFVNANMKEIAATG
WMSNRGRQNVASFWAKELQQDWRVGAAYFESMLIDYDVHSNYGNWMYNSGVGNDPRDRKF
NIQSQAERYDSSGKYQRLWLEPSLFE
>KECLDBNJ_02958 hypothetical protein
MRHYTAEQIADMPSRYRAHFINSCTGFKSANLLGSISEDGVSNVAIFSSVTHLGSNPPLL
GFVLRPTSVERNTYDNLKKSGVFTVNHVNQNFIKEAHKTSAKYAGNVSEFDKTLLNEEYL
DDFKAPYVKQSRIKLGCEFENEYFIKENNCHFIIGAIKHIYVDREIQAEDGWLNLERAQT
VCIDGLDGYALPQILNRFTYAQPDQAVKSITDLGS
>KECLDBNJ_02959 N-ethylmaleimide reductase
MKTDQPLLQSFKLGATTLKNRVVMAPMTRSRADNPENAPTDMHVEYYTQRASAGLIITEG
SQVSPQAVGYIHTPGIHSAAQVAGWKKVVDAVHAEDGKIFIQLWHVGRMSHPDFHNGDKP
LAPSAVNPNAKAFTSEGFKDTVEPKAMTLEEIQQTQEDFVTAAKNAMEAGFDGVEIHSSN
GYLFHQFFNKNSNVRTDNYGGSIENKARFFFETLDKVKAVMPENKIGVRFNPSLNGVFGI
DATEETIPTFDYIVERLNNYDLAYLHLSEPFTDVSDIDFLETEIAKHYRPKYHGNLMINA
NFDQESGNAVIKEGNADLVAYGKLYISNPDLVERFAIKAPTAEWDQDTFYTQGEKGYTDY
PKYNLQAQEA
>KECLDBNJ_02960 hypothetical protein
MKTLTNTSLVLFALTASAQNDFSKYKWRNRIVVFSTTSLETESFVNHWQHMKNSTKKIED
RNILLFVLAKGRLYDKDLKVVSGFQVGPLRQKYQIPNTYEGITLIGKDGGVKFQKTFPLD
VKIIFETIDQMPMRKSEMRENIDD
>KECLDBNJ_02961 Peptide methionine sulfoxide reductase MsrA
MRFITSYIVLITLCLSCKNTTSLESDQKMAKLPPVQTQPVEGYERAYFASGCFWCVEVIF
ESIKGVKEAVSGYSGGFEEHPTYKEVSYGKTNHAEAVEVFYNPDTVSYRNLVIAFFGSHD
PRHCIAKVLIAANSIDL
>KECLDBNJ_02962 hypothetical protein
MQSFYQTKTPILLSIYNMAKKTEATVEEKLRALYDLQLIHSRVDTIRNVRGELPLEVEDL
EDEVAGLNTRLDKLGGELSLIDDQIKAKKILIEDAKAAIKKYTEQQKNVRNNREYNSLSK
EIEFQELEIQLAEKNIREFRAQIEQKNEVIDSTKERLDERKKHLKHKKDELDEILAETEK
EEQALLEKGESYEEQIDERLVKAYKRIRSNVRNGLAVVAIERGASGGSFFTIPPQVQVEI
AGRKKIITDEHSGRILVDEELAKEESEKMEAIFAKL
>KECLDBNJ_02963 GTP cyclohydrolase 1 type 2 
MTIKDVAQTLEEFAPLANAEDFDNVGLLLGNYQTQITGILVTLDTLEQTVDEAIAKNCNL
IISFHPIIFSGLKKITGKNYVERVVLKAIQNDIAIYAIHTALDNMPHGVSKGMCDALNLE
QRKILIPKKGAIKKLTTYVPKNEVITVREALFKAGAGNIGNYEECSFSTKGKGTFKGNEH
SNPSVGNRGELHIEKEVQLNITFEARLQSPILSALFAAHSYEEVAYEITTLDNANQNIGM
GMIGELPEALEELDFLNQVKKAFQAEGIRYSALRGQPVKKVAVLGGSGSFAIDAAKAAGA
DALITADLKYHQFYEAEGQIVLADIGHYESEQYTKNILTDFLTKKFTNFAVVLSDENTNP
IKYL
>KECLDBNJ_02964 Tetraacyldisaccharide 4'-kinase
MKDLRKILWPFSVPYDGVTRVRNYLFEKGIFEQKSYDFPVIGIGNLSVGGTGKTPMTEYV
LHLLKEEYHLATLSRGYGRSTKGFLPVTPEDHASEVGDEPLQFAIKFEQVAVAVCEDRQT
GIAKLMQQTPKPEVVVLDDVFQHRKVQPGYLIMLTAYNDLFYKDLVLPAGNLRESRQGAS
RAHCIVVTKCPSSLGEREMQAIQMKIGAYSNASVYFSSIGYGEIQGNPAFTDYSTLRNKK
ITVVTGIAKPEPFFDFLKGKNLNFEALRFKDHHNFTPKELQALDQHEVILTTEKDYMRLN
GKLHKATLLYVPIEMQFLKETERFNNDLLNFVKQHVPKE
>KECLDBNJ_02965 Signal transduction histidine-protein kinase BarA
MLIDRKLLVVLFTLISVVCFGQQSSRSENVQNIQIDSLLLGGIYAMEQADFESAIVNIKK
AEALSIKSLNQSGEAISNQLLSKIYFERGDPKLATPLILNAIKLHQELLELDNLGQDYLI
YSQILSKTGNYERALPFLENAALIFESTRDEDSRVQLATTYLYEGNILQELKNNEEALLK
YQQAEAILNKTKGKHSYLLCRAFLQQGRMNFLLNQLDTALSYANKAHELSLNNNYPQLEV
DGLNLLSTIYSARQEFEEAFSYLSLYNQKRSSYFGENNSTAKNVAIRNALLANINADDYD
PAKRVQANKITTVLIIALFTILCLLALSLYKNNNLRAKANELLQAKNAELMIAKENAEKA
SVVKAQFLSTITHELRTPMYAVTGLTHLLLSENPTEEQKKHLDSLKFSGEYLLSLINNIL
DLNKLEADKVEVEQATFNLRKRVDDVLFALERSAQEKGNKLNLEYDEEIPDQIIGDPLMI
SQILINLIGNGNKFTRDGDIFIRIKQLSSNESQTYLHFEVEDTGEGISKKKQKDIFQNFT
QGSVQINRKFGGTGLGLSIVKRLLTLQKSKIELESTLGKGSKFFFDIKYGLAKSKTNETE
ERVYEIDYEALKGKKLLVVEDNKINQMITRKILEKNEMMCEVADNGEIAIEKVRFENFDL
VLMDIHMPGISGIEATQKIREFNKDLPILALTAVTIEENIDDFYLAGFNDIIPKPYKVEE
FFFKIHNALKRKNVIL
>KECLDBNJ_02966 Glyceraldehyde-3-phosphate dehydrogenase
MRTIKIGINGFGRIGRRLFRLLHEHPQIEVVAINDKANGATLAHLLKYDSIHGIFPPEIS
YQDAALYVDQQVVQLYQESDPGRIPWKNHDLDLIVEATGKFKTEEALLPHLEAGAPKVIL
SVPPADDHIKTIVLGVNDTLLDGSERIISNASCTTNNAAPMIKVVNDLCGIKQAYITTVH
SYTTDQSLHDQPHADLRRARAAGQSIVPTTTGAAKALTKIFPDLSEVIGGCGIRVPVPNG
SLTDLTLNVARETTIEEINAAFEHAASHELKGILEFTNVPLVSIDIVGNTHSVIVDAQMT
SVIGNLVKLIGWYDNETGYSSRLIDLILKIS
>KECLDBNJ_02967 Lipoyl synthase
MNTETLAAPVHKPKPKWLRVKLPTGKKYTELRSLVDKYDLHTICTSGSCPNMGECWSEGT
ATFMILGNVCTRSCGFCGVKTGRPDTLDWEEPEKVARSIKLMKIKHAVITSVDRDDLKDM
GSIMWAETVKAIRRMNPDTTLETLIPDFQGNERNIDRIVEVAPEVVSHNMETVKRLTREV
RIQAQYERSLGVLKYLKEQGIRRTKSGIMLGLGETEDEVIQSLKDLREADVDVVTIGQYL
QPSKKHLAVKQFITPDQFKKYETIGLEMGFRHVESSALVRSSYKAQKHLN
>KECLDBNJ_02968 hypothetical protein
MKRFTLPFLIIAIVTGIYGFGGFDLWATEAARILFLISADLFVVSLFAKFLFKKNPKPIA
QQVKS
>KECLDBNJ_02969 hypothetical protein
MRNLSLALLLLISVYGLKAQEQVLHRGAVTETVTANDSISIPYSIYLPPTYDVNNPSNAL
FIFDSEGEGTKATRLFVSALQGENYIIVANNKPLPQALDSLDANAKMGLHIMQDVFRKVS
LDMNNVYLAGHKSGAKVASALSYIVRGKANLLLIDDVYFANRFADQAQENLAIGVVGEAS
PNYYQMEDYFYMMKAYNNDNTLYFVEETKTWPSAALMGTLINRLYHLNNERLNKKLSDTV
WQRQYQTDLNTIKQLTLADEYVNAYELATDLKGEYRGNVDLDPLRDLQRGLRRSDAYKQE
KRYMRSDDIEEGLLLDDISYFLDEDLALGSFSNLGYWDERIQQFRAAAQNSAKPKEQKVA
KRMLGYIDYVVTDFLTLNRVALFDQRIFANVLRTLLDPENDKAYLDIISLAAIDGDDNTA
YFYLEELLKQGYDDYEALYSIPKTELLRIKPTYNELVESYLGKSKF
>KECLDBNJ_02970 Tetracycline resistance protein, class B
MKRIFTSYLNTFKGLSKEIWWLALITLVNRAGAMVIPFLSLYLRDDLGFSLSRVGWVMTC
FGFGSLFGSWLGGILSDKLGYYKTILLSLIATGIGFLGLQFITSFWAVCIGFFALITVAD
MSRPAFFVALSAYSKPENKTRSLTLIRLAINLGFSAGPALGGIIIASIGYFGLFLADGIT
CILAGLLLIQTLNPKKAKETDQEKMIENPLAPHKDRLYVIFLIALALFGVVFVQYFSTVP
VYYKEVRLLTESQIGLLLGMNGLMIFLFEMPLIAFMEAKNWNHISNVIGGLVLTGLSFGF
FYFSGWNGVLILGMAVATLGEMIAFPFGNAFALRRAKLGRQGAYMGLYSMSFSLAHIFGH
NSGMQLVDRLGYKSTWAIMAAITVVALLLLIYVKRNKDFSKI
>KECLDBNJ_02971 hypothetical protein
MKILKYLFFLLLIVFIAGAIYFATKDGTYEIEESKIIDAPVSVVFDKVNEYKTWETWGPW
KQEDPTMVFNYPEKTSGEGASYSWNGEEVDGAMRTTSVIEDQRIEQDITFITPGGERDAN
VFWQFEEVEEGTKVTWGIRGEHTLMDKAYFTLGGYDFDGEMRTMYDKGLTALDQLINADM
KVYSIDVSGITQYSGGFYMYATTATSIEHIDEKVMELIPQVKSFMEGNNITILGKPLTIY
NSKDPVNNSAIISSGIPTTSRIVVPEDSAILCGFLPAYTVIKTRLTGNTSNLDEAWKKTE
AYMQEYNYVAAPESSKFEFYIVGPEDTPNPAEWVTELYLPVQVEELPSGSL
>KECLDBNJ_02972 hypothetical protein
MFTTGQWVFAALFFIAFVFFVSRSYRKDRKLHKKEYRGSFWILIGFIVFVALLFLIKLTL
NK
>KECLDBNJ_02973 hypothetical protein
MKKRLAAVHEFHSTFGLGIEEAPKADLGEAKNLLRFNLMKEENEEYLDAANNNDLTEVAD
ALGDMLYILCGTILEHGMQHKIEEVFDEIQRSNMSKLGADGKPVYREDGKVLKGPAYFKP
NIKKILDN
>KECLDBNJ_02974 Energy-dependent translational throttle protein EttA
MSAINYVSVESIAKAFGERVLFKDLSFGINEGQKIGLVAKNGTGKTSMLDILAGAENPDS
GQVVYRKGIKISFLPQEPDLDPNLSVEQTIFDSDNEILNVISAYEHALQNMEDTEAYQKA
FDQMEAHQAWDFETQYKQILFQLKLDDLDRKVEKLSGGQKKRLALANMLLSKPDLLILDE
PTNHLDLEMIEWLEQFFAKENFTLFMVTHDRYFLERVCNEIIELDEGKLYSYKGNYAYYL
EKRDARITNEEVETGKAKQLFKKELEWMRRQPKARTTKSKSRIDDFAEIKERAHKRRNDH
EVQLELNMERLGSKIVELHKVSKSFKDRVILDKFDYNFQRADRIGIIGKNGTGKSTFLNI
LTGKMPPDGGKIVIGETIQFGYYTQKGIEIKHGQKVIDVIKEFGDYIPLKKGRQISAGQL
LERFLFDRKKQYDFVEKLSGGERKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLESFL
LDYPGCLIVVSHDRYFMDKIVDHLFVFRGQGVVEDFPGNYSDFRAYDSGPAVIQEEDPQP
KVEKETNKDNWKTAGSALSYNEQKEYNRLERDIAKLEKEKEKKEAEFLNPDLSGDEINQA
SVELQQIQDKIDEFTERWFDLSAKMEG
>KECLDBNJ_02975 Protein-L-isoaspartate O-methyltransferase
MWYIIKAYSQFLRKATNQHGVHSPFVYTFVTKCLYRKTPEEAKKQLKAYRNSLRQSNEVI
EVTDFGAGSRVFKSNRRAVKDIAKYAGARFSRMKLLYRVVTYFKPKAILELGTSVGLASV
SLALPKTGKVTSLEGCPQTATVAQRHLKSAEISNVEVVVGDFKQTLPQVISEKFDLIYFD
GNHSKEATLKYFEQLLPTAHNDSVWIFDDIYWSPEMTQAWELIKQHPRVSVTVDCFWLGF
VFFRTEQVEEHFKIRI
>KECLDBNJ_02976 putative ABC transporter ATP-binding protein YknY
MSSLIDITDIRRDFPLGNEIVHVLKGIDLQIDKGEYVAIMGPSGSGKSTLMNLLGCLDTP
TSGTYILNNRDVSAMTDDELAEVRNKEIGFVFQTFNLLPRTTALDNVALPMVYAGYSKPE
RHKRAEEVLQDVGLADRMDHKPNQLSGGQRQRVAVGRALVNKPSIILADEPTGNLDSKTS
VEIMSLFDAIHAAGNTVILVTHEEDIAEHAHRVIRLRDGLIESDVRRSVEV
>KECLDBNJ_02977 hypothetical protein
MIALALLVKGIDQYRLTTRNQTVVVKVVDCYKQTSHRSRYFLKFKYDNQIYTKRIKGVQF
QNLKKVDSLKLLTNRERNEFIFVDEIKRDNGFVYSFIFFVAGVLIIRYGYNLRRNNE
>KECLDBNJ_02978 hypothetical protein
MKAVVSPAKSLDFESKLPTTRSSQPQFLEEAETLNKKLERKTKDEISDLMSISDKLADLN
YQRYKEFSTPFTKENARPAVYAFDGDVYTGLDAYTIPTEKLDKLEDTLRILSGLYGVLKP
FDLMQAYRLEMGTKLKSGRNDDLYEFWDDKITEALNAELKEDELFLNLASNEYFKSVKPE
KLKVPVITPVFKDYKNGKLKIISFYAKKARGSMVRYIIDKDVQTIDQLKGFDYGGYGFSE
QYSDLDKNELVFVR
>KECLDBNJ_02979 30S ribosomal protein Thx
MGKGDQKTKRGKIHRGTYGKLRPRKKKSSATTADVPTKQTATKTKEADKATSDKSLADKK
P
>KECLDBNJ_02980 putative peptidyl-prolyl cis-trans isomerase
MQEGIYAKFHTPKGEILVKLEHEKTPGTVGNFVALAEGNLENSAKKQGNPYYDGLKFHRV
IPDFMIQGGCPQGTGTGNPGYQFDDEFDSSLKHDAPGKLSMANAGPGTNGSQFFITHTAT
PWLDGKHTVFGSVVEGQDVVDAIAQGDIMDKVEIIRQGAEAEGFNAVEAFRTFEGAREKR
IAEEREKRKAELDKLSEGFKETESGLRYQIIQKGDGKKAEKGKMVSVHYKGQLADGTVFD
SSYKRNQPLDFQVGVGQVISGWDEGIGLLQVGDKARFVIPSDLGYGSRGAGGVIPPDAIL
VFDVELMDVK
>KECLDBNJ_02981 putative branched-chain-amino-acid aminotransferase
MTDTLKVTKIAESKINQVDFSNLAFGTVFTDHMFVCEYKNGKWQTPEILPYGPLQMDPSA
KVFHYGQAVFEGMKAYKDDKGDVYMFRPEENFNRINKSGERLAMPAFEKDYFFDGLNTLL
NLDKDWIKPGEGNSLYIRPFVIATENGVSASPSSEYKFVIICAPAQAYYSGEVRVLFADH
YSRSADGGVGFAKAAGNYAAQFYPTELAKAKGYNQVVWTDANTHEYLEEAGTMNVFFRVN
DTLLTAPTNDRILDGITRKSLIELAKSQGINVEVRPVKVAEIVEAAENGSLKEMFGAGTA
AVISPISGFTHKEKAFDLPTMEDAYATKLKKQLTELQANRSEDPFGWRYEVPAIEV
>KECLDBNJ_02982 hypothetical protein
MKKYLVFAFLGIGLISCKEGASNQEDVAVAEAVATSELAVYGDDFKNETTLSAFELGDIY
NNLKPGDTINVTFEGPVEDVCQKKGCWMQVDVGATDPVFIKFKDYGFFVPKDIKDKKVVV
HGQAFVSETSVEELQHYAKDGGKSEEEIAAITMPKKTLGFTATGVKINQ
>KECLDBNJ_02983 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MERKIVKTGDGSTTIQFTEWNEQYHSMHGAVQEAKHVFLKMGFDFWKELHPETTLLHILE
IGFGTGLNALLTLIHAEKIQQNIHYEGVEAYPVLAEEIAQLNYLEAAQAETYASVFEKMH
QTSWEQTETITEAFQLKKRKQRFETITDVDQHDLIYFDAFGARVQPELWGESIFEKMYTA
LKTGGVLVTYAAKGSVRRAMQAVGFTVERLPGPPGKREMLRAVKG
>KECLDBNJ_02984 hypothetical protein
MKHFITLILLLAFGSETSAQAVRKYSNEFLNIGVDAAALAMANAVTANTNDVNSGYWNPA
GLVNLEDNQLSLMHASYFANIALYDYAAFAKPLDDRTALEVSLIRFGVDDILNTTQLIDA
DGNIDYNRISLFSTADYAFTVSFAREMPVQGLNIGANAKIIRRIIGDFASSWGFGIDLGI
QYQTEDWYFGAMARDITTSVNSWAIDEEQFATISDAVEGQNQELPETLEVTIPKLQLGVA
RNWLINYDYSIKAEIDLMMRFAQTNDLISSSAISATPAAGVEFGYTGIVFIRAGVGNFQE
ITQLDGSNRIGFQPNIGVGFQYKGIHIDYALTDIGDQSAAIYSNIFSLKLDWELFR
>KECLDBNJ_02985 hypothetical protein
MNIKSYIPNAFTMANLFCGMLGVFFAATGHLDYAAYAVVAGVFFDFFDGFFARMFKVEGE
LGLQLDSLADVVTSGVVPGMVMFQMLHKLEHWNTGERWVEAGLSWESLSLLPFLGFAITL
ASAFRLAKFNIDTRQTTSFIGLPTPANALLILSLPLIVQFQDYAIAETLITNTWFLLALT
ALSCYMLNAEIPLFALKFKSWGLAENKIRYGFLLLAIILLFWLTFAAIPLIIIAYVLISI
ATRNT
>KECLDBNJ_02986 RNA pyrophosphohydrolase
MNISENLLNQIKQVKSLAEAGLVYNKENYDAERYEELRELALQMMSILSDKPVDQLHDFF
LPEGDYPTAKVDVRGLILNAQDEILLVKETVDDKWTLPGGWADVGLTPTENVLKEIAEET
GFKAEVKRLLAVLDKRNYPHPPQPHYVYKLCYLCEIVEGDFDPNFDIGGVNWFSLEALPE
LSEDRILEEQLVKLVAIAKGDAAVFSD
>KECLDBNJ_02987 Lipopolysaccharide export system ATP-binding protein LptB
MKLRAENLMKSYKGRKVVKSITVEVAQGEIVGLLGPNGAGKTTSFYMIVGLVKPNGGTIY
LDNKDITKYPMYKRAQNGIGYLAQEASVFRKLSIEENILSVLQMTKMSKKEQLAKMEELI
DEFSLGHIRKNRGDLLSGGERRRTEIARALATNPNFILLDEPFAGVDPVAVEDIQRIVAQ
LKQKNIGILITDHNVQETLAITDHTYLMFEGNILKHGVPEELAADEMVRKVYLGQNFELR
KKKLFQ
>KECLDBNJ_02988 hypothetical protein
MSEKTLNQVEEFNAYRAKMNDKILADKNKIINRIFNLDTNAFAPGALDVKTKELLGLVAS
TVLRCDDCVRYHLESCFKEGVTKEQVMETLSIGTLIGGTIVIPHLRRAYEYWEVLEENAS
K
>KECLDBNJ_02989 Sec-independent protein translocase protein TatCy
MAKNKNANPDEMSFLDHLEELRWHLIRATLAIVIVGVVAFVFKDFIFDAIIFAPANADFI
SYDLLCQLAQMVGSDKGCVNEMNFTIQNRTMGGQFNAAIWTSIIVGIVVAFPYVIYEFWK
FISPGLYEKERKNSRGFIVISSLLFFMGVLFGYYIIAPLSINFLANFTVGDMVDNEFDID
SYIGLVRASALAAGLIFELPIIIYFFTKIGLVTPQFLRKYRKYALIIVLVVSAVITPPDI
STQVIVSIPILILYEASILISAFVTRQEARELKRAQQRAAKKQ
>KECLDBNJ_02990 Arabinose 5-phosphate isomerase KdsD
MNTYEQILDSAKRTIAMELEAVANLHTLIDQDFAKAVSCIYNAKGRVIISGVGKSAIIAQ
KIVATLNSTGTPSVFMHAADAIHGDLGTIQKDDVVICLSNSGNTAEIKVLIPLIKNQENT
VIAMTSNKDSFLAKQADALILAYAEKEACPHNLAPTTSTTVQLVMGDALALALLDLRGFS
KEDFAKYHPGGALGKRMYLRVNELVALHDKPEVTPDTPIKKVIVEISHKRLGVTAVTEGS
KIVGIITDGDIRRMLETNEVLTGLTAASIMSKNPKRITTDALATEALELLESNSITQLLA
VDSANNYAGVVHLHDLIKEGIL
>KECLDBNJ_02991 ATP-dependent DNA helicase RecQ
MSSEEIDLYASLKKYFGFSQFKGLQEDVIKSIIEGKHTFVIMPTGGGKSLCYQLPALIKD
GTAIVVSPLIALMKNQVDALRGISKENGIAHVLNSSLNKGEVKQVKEDITNGVTKLLYVA
PESLTKEENVEFLRSQKISFVAIDEAHCISEWGHDFRPEYRNLRQIIKRIGDDIPIIAVT
ATATPKVQEDIMKNLGMSGANAFKASFNRPNLYYEIRPKTKNVDADIIRFVKQNQGKSGI
IYCLSRKRVEELAQVLQVNGISAVPYHAGLDAKSRVKHQDMFLMEDVDVVVATIAFGMGI
DKPDVRFVIHHDIPKSIESYYQETGRAGRDGGEGHCLAYYSYKDIEKLEKFMSGKPVAEQ
EIGHALLQEVVAYAETSMSRRKFILHYFGEEFDNETGEGGDLDDNVRNPKKKHEAQDDVV
KLLEVVDKTGAIYKGKELVFTLVGKSNAIISSHKTDTDAYFGCGKDKESSYWKALLRQVL
VAGYLRKDIETYGVIKLTPKGTDFIKNPESFMMTEDHAYDESADAVAVASGAKAGGGTDP
KLVAMLKDLRKKVGKRKGVPPYIVFQDPSLEDMAIKYPTSIEELANVFGVGEGKAKKYGR
EFIELIAAYVEENDILKPDDLVVKSTGSNSGLKLYIIQNVDRKLPLDDIASAKGLEMPEF
VKEMEAIVYSGTKLNINYWIEDILDEDQQEELHEYFLEAETDKIEAALDEFDGDYDEDEL
RLYRIKFISEVAN
>KECLDBNJ_02992 hypothetical protein
MLLLAFFTTLGSCIPTKKLTYLQETQTAQDSIIQVNLQQQPYRVQINDVLSIRVKALDQE
LVALFNPQTNGEEGNNLGEGYYYDGFAVDRHGAIRLPTLGEVQVLGYTTEEIREIIEKKL
LDDYFTAEANIFVTVKLAGIKYTIGGEVGSPGVKVELVEQLSLLDAIVNSGDISEYGDRT
DVLIIRQYPGGKKIHHIDMTKIDALNSPYYFIQPNDVILVNPLPQKSLGVGTTGLQSLTT
VVSILTLATTTILLFARL
>KECLDBNJ_02993 Putative tyrosine-protein kinase in cps region
MEDEFEIKDLQNFFDFRGFLLKILAWWPLFVVCIGIAYYIAHYKNVRRQTVYRMSNMITV
KDDQNPFFTSNTSLTFNWGGTTDKVQTAIILLRSRSHNETVVEALQYYVDYLQQGEYHLE
DIYGATPFLVDVNTARPQLLGKQIKIVFTSDSTYTLSIDFNGGSAPAQNYDTKEMLNLPL
PAAKISKQYTLGDPIDLPYFNFKLNPSGLPPVLGKEYLIRFNAFDGTVGRYRGIGIDQTP
SGSSILTLSLTGNNKARLVDYLNASVRILAETQLERKNLFATKTIQFIDSSLAVKSVEMK
NVQEELDKFRDENSSIGIGSSEESLIAKITELDAQKQNLEQRLQYYQDLENYLRTREDYG
TDIPAPSITGIGEGSVTQSVSSIIELAEERRRLAYTAKPNNPAFKDLDRRIDAIKAVLFE
NMASSQQIIRGQLREVRNEIAATEGQMRKLPQEQQQLFGIQRRYNLTEGAYGVFLDKRSQ
AGIVKAANVSDIVIIDEAKDTGGGAIGPNTEVSYVMAVVGGTVVPLAIVFLLFFFDTKIG
NPNEIKRLSSIPVLGAIGKSSSKSNLVVIEDPRSAIAEAFRGLRSSLQFIYRKQQIEGAK
TVRITSSVSGEGKTFCSINLASVFALSQRKTVLVGLDLRKPKIFGDFNLPNDTGVVNYLI
GENTLDEIVQPTKIPHLDVILAGAVPPNPSELLMSEQMDTLMEELKKEYDYIILDTPPVG
LVSDALELDEYVDATLYVIRQHYTKKGMLRLINDKYKKKEISNISFVLNYFSAKSKLGYG
YGYGYEYGYGYGKYGEAYRHQQRAGVLTILKRKAKKVARWINEQLEH
>KECLDBNJ_02994 Teichoic acid translocation permease protein TagG
MKEQDDWLYEINAKQSLLAIDFKEIWRYKDLLLLFVRRDIVSAYKQTILGPLWYVIQPLF
TGVIFTLVFNNIASIQTGGAPPFLFNLAGITMWSYFAQCLNNTSNTFASNAGLFSKVYFP
RIITPLSQAISALFKLSIQLLIFACFYLYFVLKGYALQPDVTLWLFPVVLGILAVLGLGL
GMLISSLTTKYRDFRILIGFATTLLMYVSAVMYPIAEVQNSETLSEYTWVVELNPIAILI
EAFRYMTLQEGIFNWGLLGYCALLSLMVFFVGLVVFNRTGRNFIDTI
>KECLDBNJ_02995 Teichoic acids export ATP-binding protein TagH
MSIILKAENISKQYRLGTVGTGTLRDDFKRNWAKLRGKEDPFLKVGAVNDRSQKSTEDYV
WALRDINFEVKQGEVLGIIGKNGAGKSTLLKILSRVTAPTTGVIKSRGRIASLLEVGTGF
HHELTGRENIYLNGAILGMTRAEINTKLDEIIHFSGCERYIDTPTKRYSSGMTVRLAFAV
AAHLEPEILVVDEVLAVGDAEFQKKAIGKMQDISQGEGRTVLFVSHNMASVRSLCIRGLL
LENGTSIYEGDIDSTVGHYLDKNKTKTSKSFVSPLVFSEDQIVRIKSFKILSKIQTGSEF
DYEFVLESRYSNTVELAIGFVTSQNERVYQIFSGNSCEPFNLIDGEQIIRGSIKQLPLTA
GSYTLNLWAGSGKIQYVFHKDALQVEVSLGSFKETKIVAHRNYALVGDAKWEYHD
>KECLDBNJ_02996 hypothetical protein
MIEHKYRTHNREPFFEIARSIIPANGLVLDVGGGDGSFARFCGLSNLFILEGNPESAEKL
KAAFSNAVYGRLPKLPFEDRFFDVIHMSHVIEHLQPQEVYDTLVEFDRCCKPGGALVISA
PLLWEGFYNDLSHVKPYTPHIFKKYLCDYQENNFTRPKISNTYKVERLVYRYKVKNENAI
FQPSKNKFYNKLKSLFQRFYFSTFQFYEKSGYTIVLRKKAD
>KECLDBNJ_02997 hypothetical protein
MAVLKSLIKIEGTLDDLTFYKGKNGYLIRTKGGISKNRIKNDPAFVRTRENGNEFGLAAT
AGKVLRRALLELIRNAKDGTLTSRLMRQMSLIKNQDTTSPRGLRNPAVGLTTPEGKVLLQ
NFDFNENAILAQVLRADYTVNTTTGEISIPDFIPGTQLVAPPGATHVTLQSAFLNLDFTT
EVRDLQLSDPVNLPINLTPDNVTLAPAVVTGTGITMMLLQLSFFQEMNGVQYHLNNGAFN
TLNIVHVV
>KECLDBNJ_02998 hypothetical protein
MLMARICIYPQDVAMITGKGIRYGRQVIQDIKVQQGKSRHQLVTIEELCLYLDLPYHQVY
AMINPRKPVPHQP
>KECLDBNJ_02999 putative glycosyltransferase EpsJ
MHDQPLVSIIIPTYNRAHLIGETLDSVLAQTYTNWEGIVVDDGSTDATDKVLAEYVAKDS
RFQYHHRPKERPKGANACRNYGFELSRGEFVNWFDDDDIMLKHFLQTKISHIDQKEVLHI
CGGYQGTKDLKDLSVFQCKSESLYKDYVLWNIQIFTPSVLFRRSFLENKNLFNTELHKAQ
EAEFLSRIFFTLPRRYYSITQEPLFIYRQHEHSKSQINRLEYNKKFKYSEAFFAVANISR
AKRIRDVDLIEYFGNFLINACFRALEKSDKKTYYYIKWNIFFLLQPYSTKKAIEFFGTVE
LLDIYFKSSYRLEKRWRQFNWKSLVS
>KECLDBNJ_03000 putative glycosyltransferase EpsJ
MDVSIIIPLFNKEDFVVETLKSIEDQTFMDWECIIVDDGSTDNSLGKVKDYIQDKERFRL
YNRPHIRMKGASTCRNVGLEMAKGKYIQFLDADDLISSEKLKRQVDLLNYKDGFTISTCR
WGRLSSGETIIYENLSSYINCNSVPDFLSSLIKDHGYFPLHAYLIPKILIDRAGQWNEHL
GLNDDGEFMARVLCYTQRIIFSSHSLALYRTHSGNNLSSSSDLNSLKKAMYSWQLIDNQL
AIAFGQRQHFYIEWNLKSFYREVKQNNPEYLKDLEPFFENVIVKSSKFSTVKRRLRKRLK
SFLSFAR
>KECLDBNJ_03001 Putative glycosyltransferase EpsF
MHYGSLGGAERQGLGLAKFLTEEYQCEVSLLLTFSDELQPDFKQFATACHIRHIFHTHAP
YLVCWKELSYRNLKRLVWSFKYIWGYRKILEPYGFDYIFPFLNFPSKVAFYLYKVLPTVK
FTFWHQLGLDVFKPDELFEKYASRAVPAVIANSQTGLELYKKHYELDVEKSYILPQYLTM
EYLHFDKKEIRKKFNIPQDALVFGMIAHYREDKKHELILEAFKKVSENFEDVFLVFTGNR
ESSGYTRIKYDALEKSIREEGLDSKVRLLSQESIEEVLSSLDVGLLISEIEGMPNAVMEY
MLYGLPVIASDHPGCKYLLKESPYLISNSRELLIGKMLELLNSPSERELQGLKNREHINS
FTRESYVRDLSIIIKRHL
>KECLDBNJ_03002 putative glycosyltransferase EpsJ
MPTYNGQAYIDEAIASILNQTFEDFELIVVDDCSTDHTPSLLESFRLQDSRIKIITNKQN
LKLPASLNVGHRLAQGEYLTWTSDDNILYSNFLERLVTVLETSSEDVVYSDFNVINDQSK
HIRVYKVSPVSLLPFENGIGASFLYRKEVFQKFNYNEDLHGIEDYDFWVRAAQVFSFRYI
DEILYNYRIHRASLTSKIFRDTKAQRNFDRGLKIVLDNFHSMSPNTRKMLFQFQRPDNWN
WSFYFKVRKKAEEELKTWAIHQGEAYNTLVENYLSRLRFLFVNCSKPNYQSKLILVKPEI
LSKRFSRYTSLKILKRMFMNILKSRINFNCN
>KECLDBNJ_03003 Chondroitin synthase
MISIVITYFNSSEFINRALYYAHLQKVVEKEIIVVDDGSDNNNKKILSQYADLIDLLITQ
KNKGQAAARNAGISKATGDFILNWDVDDYFEAEFSSEALKILEEKSNIKLVSSYALRTSN
EISGELIKPLGGNYQNFLFENAALGSAMFRKLDWENAGGYDEKIKVGYEDWDFYLRLLYP
KGEAFIIPEQLFTYHRHPESTTSLILRERSALIKRKYIYKKNETIYQQHYPELIDDVFYR
LEREEQERYKNLERIEYKIGYYILNPLRKLKKHFTYFRKGLTSKVVVK
>KECLDBNJ_03004 Alpha-(1,3)-fucosyltransferase FucT
MKPILKIQFSDFWPGFILEENYIYRLLNKNYKLEISDNPDVLIYSCFGNEFLKFKCLRIF
FTSENRSTNFLETDYSISFEFKKTKRHYRLPYFAVRILESNLLTQLKIPELEESLRLYNA
REFCAMVVSNPRSQERIDFYKKLDAFRSVASGGKYLNTTGAPVPNKIDFIQNYRFVLSYE
NERHPGYLTEKIFDAFLAKTIPIYWGDPLVNTVFNAKRFIDRSNFKSDEECINEILRINA
DPEQYAKILSEPVFVKPLPNYLDENKFLGFLNEAIENRGNSYLVAKSYKGRLAFLRRRLT
RIKAQLIKRIRLY
>KECLDBNJ_03005 Putative glycosyltransferase EpsE
MLPVYNAKAFIAESIQSILDQTEPDFELLIVDDCSTDGSIEIIDSFKDPRIIFHKKKRNS
GYTESLNWAIDQAKGEYIARMDADDVSLPNRFEKQLKFLMFNPDISICGTDAFVRGGNLI
FNYPQTPKAIFTNLLMGNSLIHPSIFGRSEIFKKFKYDRSKEPAEDYDLFTRLVIENKRL
ANIPEKLLIYRLHSEQTSEVRKIKQIQSAKRSMLQLFKYFNYDQDLYPDSLVSNAIWPER
VFLRPELIQAIKWYASLNSLKKNLDIDHSYLNFVLKRKRYNLLKFCLKHGNSRDYGYNFY
VWAQLFRLSPKMFVKGLLN
>KECLDBNJ_03006 Alpha-(1,3)-fucosyltransferase FucT
MKSPISIYFVDFWPGFQPDDNFLYKALKQKHSIILNEEKPDILFFSVFGKKHLKYLRSCR
VFFSGENRPLNEESFDYSISWHLKTKNNHYHLPMFKVHIAERDYLRKRIYTSLDKSSLRD
IWRSKTKFCCMVVSNPKCIVRNNFYKELSQFENIDSGGRLYNNIGGEVRDKETFIKDYKF
VISFENSDASGYTTEKIIEPLMDYSFPVYWGNRLITSEINENKILHYDEKRNSISDIYAM
MKKIEGDEDFALELLAEKPFLKNPDIFAIESDFILFLDKIVENHHKKKNLLKVIEPHFKF
LAHHIQKHAGKGFKKFSRLR
>KECLDBNJ_03007 GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase
MRYPKVTILLATFNRSHLILETLESIANQTYTHFECLITDDNSTDDTEVVVNNFIKTDSR
FYYFKKPKKNPQGLSATRNFGLDLAQERNAEYIQFFDDDDIMHPQKLELQIQPFYENPDL
DLTVCMYRKFHELETIEFDLNKADNQDCEIVSKNILKSFYLNQFNLNSLGPLWKSRSLAN
YRFDESLFYAEEREFYLRIFLLETISYVPVKKILFWYRKHPKAITSNLYSNPKIKADSEK
LFQDGYLKLILKQRKPPFYILKSYVQIAIKNGRNDYIKQIQNHLAEPRNFLIPNRLALLI
YSKLFQLVKV
>KECLDBNJ_03008 hypothetical protein
MNSLAIVIPYFKLKFFQHTLESLSRQTNMSFVVYIGNDGSPESPDRIISEYKKRMLINYS
SFKDNLGSTSLVKHWHRCIEMINDEKYLMILGDDDVLDPECIEEFYKVINLIEKQNIKVL
RYATRIIDVSGKPISNEHYCVQYESSLKFFIKKLSGKARSSLSEYIFLSKQVKSSLIDFP
LAWYADDLLYLKASDFGTIYTINESKVGVRASPFNISGDNLLNKKKNVASNLFFHHLLTK
YKDRFSDKEINLLINRLEKSVINNKTNLKLFSNLYQVYFKYGEFRRLVPFFKNAFKSIRF
>KECLDBNJ_03009 hypothetical protein
MRNGVNPEKLKNEKLPVFLHRVIVPVFIPNLEDEYYLNHLEVFEKFLGQLIRTLNLQTTA
ITLINNNSCDEIAGVIEKYRPAIDKLVWYAENKGKVFPVLQEARSAAEAFITITDADVLF
YEGWEQAVFKVFASCPKAGVVAPLPSPALAFYENTAVFSDQYLTCGIAYKKLMSDVEAEL
YLAGMGNDSLLNRENRKYSWKERQYVLKNANALIGCGHFVATYRSELFEAKKNQPLIKFK
NGLEREFIDSLSDEKGYYRLSTVETYAYHMANNLDEHSRSFILEKENKVSEDLIQRAGYS
TRSLLPWKLRKLVFRIIKRLFKL
>KECLDBNJ_03010 hypothetical protein
MVQNSSKNLLVVTDSINPEDSSGSKANVAFIKSLIGNGYKVCVIHYTQVELQIKGAECVL
AKERRANLTYVLGGIQRTVQRNLGVNWSVFLENRFGFSFTFFNDSKSIVKTLERFRITDF
DLIISLSKGESFRPHHAILQLPLWHLKWLAYIHDPYPFQNYPKPYTFVPKGAIQKDHFFN
KVATHCKFAGFPSRLLADHMAGFYPEFKEKSVVIPHQYDNVISGVSLPSFFKDAAFNIVH
TGNLIGGRSPEGLLKGFQLFLESQEEARQESYLYLVGPSSNYRELMSLYKHAPQFIFHPG
VSYAESLALQQAASVNLIVEASDTDFSPFLPAKMAHCVMVDKPILALSPKKSEVRRLLGE
DYVCQSEADDSEQIAGILSGLYLKWKNTKAESWRLNRTDLQDYFSSAYLNKQIQNILNAS
A
>KECLDBNJ_03011 Putative glycosyltransferase EpsE
MPLLDSQDVSIIITTYNRKRELVFTLNTLREVIADDGIYIWDDASTDHTFEYISSEYPEI
NIFQNTVNKGLIANRNQLMQAAPTEYVLSLDDDAHFLNPEALEKAMSFMQENFNCAVLSF
RLFWGLQKPANQKTTEKTYQVGNFLGGAHLMRKSAWDNFIKSYPEWYHFYGEEDYAAMKL
FRAKQVIFYFPKVLVHHRVSLKNRKKSAEETSLRTQWALQAAWSNYLIFYPKQKAWLKIM
YSIKEQLRLKFLKGDFNILISIFFAGSELLKNRKYRKIVDSRFTKEELECYSNLPASPIY
WNYS
>KECLDBNJ_03012 N-acylneuraminate cytidylyltransferase
MNSYLILIPARAGSQRFPGKNMRQLGDKPLVGHSIAYALKNDLSDIVVTSNDAAVLNFAA
QNKIQVIERPDSLAGNEEPVITALQHAVNQLQKKYEAVILLQPTNPLRPEGLLKEAIAVF
EREDCDSLMTVSRNEHKLGTIFNNQFIPYNYEMGQRSQDLEPLYYENGLLYIFKTALLNQ
GKLLGEQNYSLIVDHPFAEIDIDTEADFKKAEFFLNVYKS
>KECLDBNJ_03013 8-demethyl-8-alpha-L-rhamnosyl tetracenomycin-C 2'-O-methyltransferase
MVINRIKKRIPKTLRKRFKRILIKPLALWYRKDLVALATLFETDKHGFHNYMPVYHNHFS
HYRKQKINLLEIGVGGFEDPEKGGHSLRMWKVYFRKANIYAIDIVDKSSIQEKRIKIFKG
SQADPDFLKQTINSIGSIDLVIDDGSHLNEHVIKSFKILFPLLNSGGIYVIEDTQTAYWS
SLGGGHPSDHALQTSMNYFKYLIDGLNYKEFKWDYEPTYMDKNIDSIHFYHNLIFIYKK
>KECLDBNJ_03014 hypothetical protein
MPQTLGISVVIRNKNQSQALEFLLKNLTSRYFDQINEIIVLDNCSTDTSRAISEKHRVRF
EVIKEFSYGGSANRAAEVANFPIVVMFSAHAYPVSHDFFTSIRLEFQKNQNLAGVRCIHN
PNDYVNYIENISSKQDPNKSGLIFCGSAFSKRVWEKHQFKSDITTFEDKEWSVRVLKAGY
DIVLAPAIFCYDIKRTKKQEFFRYKNELIGAYQLWHKDISLKYAVKSFLGSCLKIFSNLF
SDLYYALKKLFIHLKFLTKRPDKF
>KECLDBNJ_03015 N,N'-diacetyllegionaminic acid synthase
MNPYIQIENRKIGPDYPPLVIAEIGINHEGSLQVAKELVDAAHRAGAEVVKHQTHIVEDE
MSGAAKKVIPGNATVSIYEIMKRCALDEADEIALKKYVEEKGMFFISTPFSRAAANRLQA
MHVSAYKIGSGECNNYPLLKHIAGFGKPVILSTGMNTLESVSKAVQIFKDAGTPLALLHT
TNLYPTPTHLVRLGAMTQLHQAFPDVPFGLSDHTLNNNACLGAVALGASILERHFTDHMQ
RTGPDIVCSMDEEACAELIRSSKEIWLMRGGEKAPTKEEQVTIDFAFATVCTIAPIKEGE
VFTEANIWVKRPGTGEILAEQFEDILGKKAARAIAEDAQLKFSDIQ
>KECLDBNJ_03016 hypothetical protein
MSSIKQFLNTAYQRVIDYYFNLRLQCNQQLILKNKSNGIFAVEVFSKMGFGANFIWLLEI
LEYCDSAGLKPFVIFRNPSKRIGSKSFSEFVKFKNDSQKPFFLHYAVMRSFKELGLNTAW
NYNSALTLERANYLLNKYLKIDAEVTEFVHKYSAIEFKANRIIGVHFRGTDKIAEAPAVS
YEQVKKVLLSEFEKESQNIQFFLASDDHTFIDYMTLEFEENQILCRTINRSKNGKPIHIT
AKNHREVNREALIDCLILAKCDKLIKTASILSGCSVVFNPNLEVEMLNEPYPNYRFFPEK
LFLK
>KECLDBNJ_03017 UDP-N-acetylglucosamine 2-epimerase
MKKIAFLTGTRADFGKLKSLIRAVHDSTDFAYGIFATGMHLLEQYGLTVIEIEKAGFQNI
ERFPNHTSEATMDLTLAKTIEGFSAFVKTVEPDLIIVHGDRVEALAGAIVGSLNNILVGH
IEGGELSGTVDELIRHSVSKLSHIHFVSHETAATRLVQMGELESSIFNIGSADLDVLFSE
TLPNLETVKTYYNIPFESYAVVLFHSVTTAHQETATHAFDFVAALLEDDQNYVVIYPNND
RGSSAILKAYRQFQEHPQFRLFPSLRFEYFITLLKNATFLVGNSSAGIHEAPYLGIPTVN
VGRRQENRDLQTDSIIHVDNAKAAILKGIASAKALKVKPKGTKSTITAASGFLEALRTES
FWQIDHQKQFRDL
>KECLDBNJ_03018 hypothetical protein
MKVYNVYILRCRDKTYYTGITSDLWERVEQYQSGKYNNSYTSSRRPIELVYYCEFTEPEL
AIEFEKRIKKWSQAKKEALINGEFEKLPNLAKKRFK
>KECLDBNJ_03019 hypothetical protein
MTLASQKTLGIVITDGVGFRNFVLSTFLTKAARSFEKVVIFSGLPSTAYPDLDAAFFTIV
ELPVFTETKKNWFWRKLKEVAHLQKHKSNPGIADNYEMNKAKSWSAHGLLVRFVYAVSSI
FHSEKNILRYEKFHERSFAGDAIVTKYGEILKEHEPDILFFTHQRPPFIATLVFWAKKLK
IPTASFIFSWDNLASKGRMASTFDYFLVWSDLMKRELLRFYPYTNPQAVSIVGTPQFEPY
VLPEFDMPKTNFLEAFDLNADEKIMCYSCADATIGPNDPLVIATLAEGIRSGAIDSCQLL
VRTSPAEDEQRFAETKTKYPEIKWNHPKWELTREGHPEPWSQRVPTREDLSMLKAILKFC
DLNVNMLSTMSLDFMLFEKPVVNTAFGNGANGLYNDQRFLQYEHYDNVVKSGAVKIAKNA
EELYTAVNAYLRNPNLDLENRRKLIDMQVGKPLNETTQACVQALKNTL
>KECLDBNJ_03020 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MSTKRLAVVCNYVLRADRIGGMDRFFVAYDKAAKAKGYEVDWFFPDVLDKTFYEGVTLFS
AEGNSSVEAFFLNYLQENEKTYTALVTHFTELCTPFYKKAKQAGRIKNLIAIDHNPRPLN
GFPLKKQLKNRLKGYLHHKAIDRFIGVSSYTARHIVKDLGKVVARKTGVIYNGIDTSVFK
KRENHDLNQEGKVQFVVVSHLRESKGLQDLIDALALLKPDLQNKLHITIYGEGPLEEGLK
QQAKDKGVDQLLTFKGSSSEIPQLLADYQYLIQPTYMECFSLSILESLSANVPVITTTVG
GNPEIIKEDKNGFLVQPKDKRALAAIIEEVVLGDRKITEDTSVLIEKEYTLDRMVAEHIN
LLD
>KECLDBNJ_03021 Alpha-maltose-1-phosphate synthase
MHIAFLTPEYPHPYLNRSGGLGTSIKNLASSLVEAGERVTVFVYSQAEDREFEDQGVQIH
SIAKRKYTFAGWYLHSKFLQRYINKIILLDGINVLEAPDWTGITALMHFKCPLVIRCNGS
DGYFCHLDSRKQKPKNRWFEMQALKNADHILAASAFTAKLTKAIFGLKNEIQVIPNSIDT
ELFKPVQIPEVSNRILYYGSVIRKKGVLELAEICNLVFKENASARLILAGNDVKDVFTGR
STQELFMEVVKSKFHNQIEFKGLLPYKAVQEEIAKASVVVLPSFAEALPMTWIEAMAMEK
ALVTSNIGWANEVMIDGETGYAVDPKDHQAYSDAILQLLDSETLRKRMGINARKRVSEKF
ATQVVVKQNLEFYKSLV
>KECLDBNJ_03022 hypothetical protein
MILLIHNNKHPVEILKDGQPLDMYIQKQAVSAACFLLAEKFPKEFFVWVHQDLKGNLNID
FFKAHSNTIEMLSYAANKSLVISEEMGYVDQSVFFRIQPNVKYPTWLMSGSAGYISCKAL
NHFRSFLPMYANFDLFLCVLAKVGMPKGLRAYSEPRLIKKPDYSGISFSKNTNATYSAIG
ALLGKKWLLIFELQRLMYSRKMNPIQLAKTYLTKSLSYSEIPNLEIDDANQNEAESRLSF
DIVIPTLGRKEVLKQTLEDLAVQSLLPKCVIIIEQNSNSDSVSELDYLYTVSWPFEIKHT
FTHQTGACNARNLALDQVEADWVFLADDDLRIPNDFLQSANSFIQNEKPQAFTVSCLQQG
EVEQEDTVIQWPSFGSGCSFVKASALKSIRFDMALEHGFGEDADFGMQLRKSGVDILYNP
FLKLLHLKAPVGGFRKSVDKPWQSENLSPKPAPTVLASILKHATPSQIKGYKTLLFLKFY
RLQKNKNPFSYFLHMQKRWKVSLFWAEKLSNTK
>KECLDBNJ_03023 hypothetical protein
MMFSLIVCTYQRAEALNRLLASVAIQTTYPDEILIIDGSKDLETQQSISSQTIRNLKYFK
VEEKDRGLTLQRNFGIEKLNPKSGIVCFLDDDVILEPDYFEAVLEAFDSDIDIVGVGGVA
TNENLWKPSSRKHSTDKVYVFEGFERSESQRFYLRNKLGLQSPDLPGVMPDFSHGRTYGY
PLTGKNYEVDLLIGMSMNFRRKVIEDEKFSLYFDGYGLYEDAEYCLRALKYGKNVMCTAA
RLEHLHDPSGRPDLYKYGKMVIRNGWYVWRVKYPNPNIKARIKWNATALLLTLIRLSNVL
TTSNKMGALRETIGRTVGWWSLFFNKPKLQ
>KECLDBNJ_03024 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKFAVITHIEHFEKEGDFYSYGPYVREMNLWFKGVDEVRVVGTFSSKNPGSIDLPYKATR
LQLIKVPSFDITSIAQAGRALLVLPVIIKKIYQEMSGVDHIHLRCPGNIGLLGAIVQLFF
PKKKKTAKYAGNWDPKSKQPWSYNLQKWILSNSFLTKNMQVLVYGAWPNQSKNIKPFFTA
TYTEADNNALPLRKYDLPLRFLFVGGLVPGKRPLYTLALVNELISKGFPAELHFYGDGPQ
KELLLDFITEHHLEKSVFLHGNQSAATVAEAYKKSHFLILPSKSEGWPKAVAEAMWWGVI
PIATPISCVPWMLDHGNRGILIKAKLESDAAQLEAFLKDKTGLKDMAQKASAWSRNYTLD
LFEAELKKLL
>KECLDBNJ_03025 O-antigen biosynthesis glycosyltransferase WbnH
MRILQLIDSLAIGGAERMAVNYANALYDRVEVSALCSTRQEGLLRELIKPEVPYLYLARK
RRLDVAAVFRLKRFIKQHQIKIIHAHGSSYFIAALVKLMTPGLKLIWHDHYGNSEYLEDR
NTGYLKLFSTLFDAVFSVNKKLAIWAKRTLKVEKTFYIKNFIAEALPYDTTENFRGVRGK
RLVCVANLRPQKNHHLLIDAFEKLLETDPEYTLHLFGEAPDTLYAKSILQRLKEHPFKSS
VFYHGLYLKMSAVLPHFDAGVLSSNSEGLPLALLEYGQAGLAVITTDVGQCKQVLDDAGI
CVPPEDNEAFASALLHLEENPLKTQQKPKIFQNKVQEHYGAPSILTEVLSIYAQII
>KECLDBNJ_03026 hypothetical protein
MQLIGLHVAIGFAIYLFRFLGLFYFLGSMVFFILWIFQSGNKQNQALLAAAYMTAGEVFF
RMTGGSLIPWEAGKYSVICFILIGLFFSGTSRKSAPYWLYLLLLIPGVLYAAETLNFDTN
VRKAVIFNLSGPFCLGISALYCYDRKISKQQFHHLIWALLMPVIALGVYLLFYTPDTREV
LNGTNSNFALSGGYGPNQVATALGIGMFALVVQLFVNSKNKLIFFINLGLLMFLTYRGII
TFSRGGIFTAALISLAFIVMYFQGVSSKKRNAISFYLVILGSAIAITWLISSVRTMGLID
LRYANKDAAGRIKEDLTTGRQELVTSELTFFMNNPVMGIGVGKTKEYREEKLDILAASHN
EISRLLSEHGVFGLIALLILLAAPLFYRIGNRKNYLFYSFYGFWFLTINHSSMRVAAPAF
LYALALLNVMHEPKNTVPRQQISQ
>KECLDBNJ_03027 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MSQRILYLGNKLANKGFTPTGIDTLGPRLEAEGFLLRYASDKRNKVLRLLAMLWAVFKSR
NWADYVLIDTYSTQSFWFAYCSGRLCSLLGLNYIPILHGGNLPERLKTSPKASEILFRNA
YINVAPSAYLMDCFSKNGFLKVTNIPNTIDLSLYHFKQRKTIQPKLLWVRSFAEIYNPLL
AVRLFHFLHLKYPAAELCMVGPDKDGSLELCKAEAERLGITVRFTGKLSREAWCTLAAYY
DLFINTTHFDNTPVSLLEAMALGLPVISTNVGGISKLITDDQNGLLVAANDETAFVSAIE
RLLHHPELVERLTTRAYQTVQTFNWEEVKQQWHKLLS
>KECLDBNJ_03028 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MKDQTAPLMSWIPNIHFEISERKILLRILDLVAITLTLVLVYSLFQFDYLKIRYSRWGWV
FVLWLYYTVFAAIFELYDLQKAASFQTTLKNILLTVSTTVLFFILTPFVTPVLPENRLQI
LLFFASMVVGLLVWRFAYISLISAPRFNKRILVVGNSFDINLIAENLHKADPNYRVIGFV
NTDEMQAKDFDRRLKAIEVANLIKSIKRYSVSEIVVASAAQGVGVELYNKLLVLLERGFP
IREYTQVYEEITHRVPVQHVERDFYKYFPFSRSNKNRFYLFISRLFNVIFALCVMFVSLF
IIPLVFIGNLMGNRGPLFYTQERVGLNGKPFHILKLRTMIINAEAEGAQWASRADRRITP
FGKILRNLRIDEIPQCVNILKGEMSLIGPRPERPVFVQELSEKIPFYQIRHTVKPGLTGW
AQVRGRYAESIDDTLEKLQYDLFYIKHRNLFLDLNILLKTISTVLYYRGQ
>KECLDBNJ_03029 Apolipoprotein N-acyltransferase
MKNLLLACATGLLLALAWPTYGFPLLLFFGFVPLLFATRNLNTSDVKRPRLKLFGLSYLA
FFIFNIITTWWLYNSTGFGMWFAVLANSLLMTLVWMLYSRISKRFSISLSLTFLGALWML
FEFMHLNWEFAWPWLNLGNAFATYTGLIQWYEYTGTFGGTLWVWLVNALIFKGILAYAER
KNRRILSVKLAIVAAVILIPIGISQLILLNYTETENPVEVVLLQPNIDPYTEKYNTTNER
IADLLFEEASKTLTSSTDYLIAPETVLAEGAGVDLRSFAFSAERQKAQQFLEDYPNLNYL
AGIQFYRVYNDKAATLPTSNYVGKDRIGNPIWADFFNSAFLLNQQDSIQIYHKSKLVVGV
ENFPYQNVLKPLLGDIMLDLGGTVSMKTTQDNRVAFTGSNDTKVGPVICYESVYGAFVTD
YVKEGAEFLAIITNDAWWGDTQGHKQHLNYARLRAIETRRSIARSANTGISAFINQKGEL
IKELGYGLRGSLKGTLNANKTLTFYVRFGDYLARLAFIPVLLLLILSFFIKRRVTQV
>KECLDBNJ_03030 Epimerase family protein
MRILITGATGLIGQALTKQLLRANHEVHYLTTSPDKIETKPNYKGFLWNTAKGQLDVACL
KGVRTIVHLAGASIAERWTEDYKKTILESRTQTAQLLFDTLKSNEHEVKHFVSASAIGAY
PSSRTQLYTEAFETYNPGFLGTVVEAWEASADQFKSLGLKVSKVRVGVVLAENGGALEKL
IQPINYYVGSPLGDGKQWQSWIHLDDLAGIFKTVIINAYEGIYNAVVPAPVTNETLIKEA
ATVLNKPLFMPKVPAFMLKLILGEMAAIVLESQKVSSQKIEHKGYIFKFTQLNKALKDLL
ED
>KECLDBNJ_03031 Protein YceI
MSPIYFIVYLRAIFNVSAIFDLSINTKKVFIMKTKFLSLFAMAALFTAVVSCKNENKNET
EAAEAEAAVEATAEATKYMVDKEASEIKWLGEKPTGTHDGVVGLESGVVRVEGEQISGSF
LIDMTSITVQDLEGDQKASLEDHLKGTVEGKEGDFFNVQKFPTAAFEITGVTEGEDGKKM
MSGNLTLKETKKNIEFPVTYEVSGNTMTLKSEPFTIDRTDWNVNYGSKSVFDNLGDKFIN
DDIELEFTIVANQQM
>KECLDBNJ_03032 Protein GrpE
MSSENKEEILHENEENNAQDVQDATQEAQNEPAAAEDIATDEDELAKYKADLEKEKDKFL
RLFAEFENYKRRTSKERVELFKTAGQEVMQAMLPVLDDFDRAMVEIEKAKDKNLQKGVEL
ISNKLRETLKTKGLKQMEVQAGDAFDADVHEAITQIPAPQEDLKGKIVDVVEKGYELGER
IIRYPKVVVGQ
>KECLDBNJ_03033 Chaperone protein DnaJ
MKEDYYDILGISKNATAAEIKKAYRKKAIKYHPDKNPGDSEAEDMFKKAAEAYEVLGDEN
KRARYDQYGHQAFEGGGFGGGGGMNMDDIFSQFGDIFGSAFGGGGGFGGFGGGFGGQRRT
KGSNLRIRVKLTLEEIANGAEKKIKVKRKKQASGTTYKTCSTCNGTGQVTRVTNTILGRM
QTASPCTACGGSGQMIDSKPSDADAQGMRTEEETVSIKIPAGVVDGMQLKVTGKGNEAPG
NNGIAGDLLVVIEEAEHETLSREGDNLHYDLYISIPEAVLGTSKEIDTVTGKVRIKIEEG
AQSGKILRLRGKGIPSINGYGKGDLLVHVNVWTPKNLKKEQREFFENMLDDEHFSPQPQQ
EDKSFFEKVKDMFS
>KECLDBNJ_03034 ABC transporter ATP-binding protein NatA
MPHPDSYQDDTKLKFVRNECLMGLPRGSLLQTSMTDLLVADHIHKKYGKYTALNDLSIQV
PKGSVFGLLGPNGAGKTTLIRIINQITMPDTGKVYLDGEALDQKHIINIGYMPEERGLYK
SMKVGEQVIYLARLKGLTKAEAKERSKYWFERLGMTDWWNKKIQELSKGQAQKVQFIVTV
LHQPKLLIFDEPFSGFDPINATLIKDEILKLRDDGATILFSTHRMESVEQMCDHIALMHK
SNKVLDGRLSDIKRAYRTNTFEVGIQTADDSVQSLEVLKKNVLESAHDDWQLQPASFKTI
NEHDLKLQVKIPEGLSPNDLLGFLANKGTINHFVEVVPTANDIFIQTINAN
>KECLDBNJ_03035 hypothetical protein
MGSLALIIKREYKARVSNRSFIIMTFLSPLIVVGMIMLITYLTQLNQAGKQTIVVVDESG
LFYKDFESTAEIDYLDLSPQGLDTAKDLVEEQNYFGLLYIPENVKKNTSGVRFYGNEAPG
ISTIESIEEQIETKLTNEKLLDRGVDLDLIDASETLVSITIEDFSGERTSKISNWIKAGF
GGGAGYLLMMFIIIYGNMVMRSVIEEKTNRIIEVIISSVKPFKLMMGKIMGTTLAGITQF
MIWLLIGGGLLTFLTLFLGLDANTPNAAMGGMATTDLDKIELILLDVLNLPLLKLACFFL
IYFIGGYFLYSSIYAAIGAAVDSETDTQQFMLPIIMPLMLAIYVGFFAVIENPDGSIATI
FSMIPLTSPIVMLMRIPFGVPWWQLALSVGILIATFIFTVWFGSKIYRVGILMYGKKPTY
KEILKWIKY
>KECLDBNJ_03036 Mechanosensitive channel MscK
MIQEEVKETVKEGAEKVKDVIEENVWGTIQDFLNLGIHFKTGNTPIDFTVGHLLLVILAF
IVATAALRLIRSFITRNMDLENELKFKSIFKFIRYIVYVIVVVITLSASGIDVTVLLTAS
AALFVGLGLALQDLFTDIIGGIFIMVDKSLSVGDVIEIDGKVGRVFEIKLRTTRALTRDD
KVIIIPNHHFINEIVFNYTQNHKTTRETVKVGVAYGSDTQLVRKILLDCAGKQNGVLKNP
KPTVLFEEFGDSSLNFGVFFFINDSFSDPRIKSEIRFRIDEEFRKNNITIPFPQRDVHFY
PTENQ
>KECLDBNJ_03037 hypothetical protein
MTKYILVPVMLVAMFTMRSQTTDIARVEYMHIPFSNSNNSVGRFRALLQVPIPLDKELNN
ILVAGFEYRNTHIDIKDAVPDGFNVQDVSTLHRISAYAGYVWRFKEHWVFGVKAGARINS
NIAGTLVPDDWIYTASIYAINDMKKNSPTKPYRWIFGLDYSSTPGRNFPLPLVNYYREFH
PNWTYTLGVPKTNVRHYLNDSHKDALQAFVSLDNFFANIQNNMIIDGRTAENISMTIIMG
GLGYEHYFTEHLLYYAYATHSISNDFRLRNNDRDDIYTINSDNTFYFRTGVKFKF
>KECLDBNJ_03038 Transcriptional regulatory protein ZraR
MSKILIIEDEAAIRRVLTKILTEENKAYQVEEAEDGLAGMEKIKDQDYDLVLCDIKMPKM
DGVEVLEATKKIKPEIPMVMISGHGDLDTAVNTMRLGAFDYISKPPDLNRLLNTVRNALD
RKNLVVENTRLKKKVSKQYEMIGESEPIAKIKDIIEKVAPTEARVLITGPNGTGKELVAH
WLHEKSDRAKGPMVEVNCAAIPSELIESELFGHVKGAFTSANKDRAGKFEAANGGTIFLD
EIGDMSLSAQAKVLRALQESRVSRVGSDKDIKVDVRVLAATNKDLKKEIADGKFREDLYH
RLAVILIPVPPLNDRRDDIPLLVNHFANKVAGEQGTAVKNFTGKAVEKLQEYDWTGNIRE
LRNVVERLIILGGSEVSEEDVQLFASK
>KECLDBNJ_03039 hypothetical protein
MKASDYQITAPIKLADLKTHEDFGKTKELEQELDEVSKKIAAIQNAMYAHGKYAALICIQ
GMDTAGKDSLIREVFKNFNARGVVVHSFKTPTSLELGHDYLWRHYIALPARGKVGVFNRT
HYENVLVTRVHPEYILNENIPGVNDVSDIDEAFWEKRFEQINNFEKHIADNGTIIFKFFL
HLSKEEQKHRLLRRLNKPNKNWKFSAGDLKERALWDEYQQCYEDAINKTSKFHAPWYIIP
ADDKPTARLILANILLEKLSSYKDIEEPELDEKTKSNIDAYRKQLESE
>KECLDBNJ_03040 Bacterial leucyl aminopeptidase
MLFAGFHLVSAQTTKDSLQLRNFYDLSLLDGNSYEWLDELSNDIGARLSGSAGAEKAVQW
AKKELESIGLDKVWLQPVMVPKWERGAPEKAHIKGPDGSIDVPVCALGGSIATTADGVTA
EVVEVQGIEDLAKFGEAQLKGKIVFYNRPMQADLIQTFSAYGGCVDQRYSGAREAAKYGA
VGVIVRSMNLRMDDLPHTGSMSYGDLPNDKRIPAAAISTNGAALLSKLLKKDKNTQFYLK
MNCKNYEEDVPSFNVIGEITGSEKPNEFMVVGGHLDSWDLGDGSHDDGAGVVQSMEVLRL
MKAANYKPKHSIRVVLFMNEENGLRGGTEYAKVAKQEGEKHVFALESDAGGFTPRGFSFD
ADKANFEQVQNWIPLFKPYLIHFFELGGSGADVGPLKEEGTVLAGLRPDSQRYFDHHHAS
NDTFDAVNKRELELGAATMTSLVYLFDNHGVIPPITNEKPLKD
>KECLDBNJ_03041 hypothetical protein
MAILGSLIKGIIDISDKVIPESNPLDEQQEVLKSLLKKAKNTQFGSFYSFEAILESENPA
KTFAEEVPFFDYNSLNEEWWSKLHDGESDVTWPGIPHYFALSSGTTGKSSKRIPVTDEMV
DAIRMAGIKQVGALAHFDLEPDFFEKEIMMLGSSTNLQERDGHEEGEISGISASNIPFWF
RGYYKPGEDIAKIDDWDERVQHIAEKAEEWDIGALSGIPSWIELMLEKVIEHHNLNNIHE
IWPNLQVYTSGGVAFQPYEKSFNALLGKPIIVIDTYLASEGFIAFQARPETDAMKLVTDN
GIYFEFVPMNPDYINQDGSIVQDAPVVGLADVEEDQDYILIISTVSGAWRYLIGDTIAFT
NKERAEIKITGRTKFFLNTVGSQLSVNKMEAAVQELEEQFDIKIPEFTIAAKRNPEDDEF
YHYWYLGTETSVSNEELADALDKSLQEANKNYGVARSKALKGVFVNTVSPEIFYEWSGAN
KKKGGQVKMEKVMNEEKFAEWEAFVKEHA
>KECLDBNJ_03042 hypothetical protein
MHNDPELTHKEIPDVLAQEIKVALSYYPELAETPIAFRFKKDIKKSTMQAQPAFSSLLNP
RAKRKYFVFISKKIQIETESFKITDIPSDVLIGWIGHELGHIMDYKNRSSLGLIWFGLKY
LYFPKFIREAERAADTFAVSHGMGKYILVTKDFILNHAHISAKYKARIKRLYLSPEEIML
LINENKNLEEELEV
>KECLDBNJ_03043 Multidrug resistance protein NorM
MLSIYTKEFRQNLKIAYPVMLGQLGHILVALADNLMVGRLGAAQLAAVSLGNSLIFIALS
LGIGFSFAITPLVAEADGAGDTQTGRNYFHHGIVMCALNGILLFVLLLLAKPILYYLDQP
VEVVELAIPYMDIVAFSLIPLMVFQAFKQFADGLSNTRYAMYATLVSNVVNVLFNFLLIY
GFWIFPRLELVGAAYGTLISRFFMLWMLYYILSRKKKFQPYFVWTRRKAFQLPIFKKLFD
LGFPTAMQMLFEVSLFTSCIFLSGILGTNAQAANQIALNLAAMTFMIAVGLGVTATIRVG
NQKGKADFENMRRIAFSLFLQVFLIEAVFAVGFILLKDILPTFYIDNVEVIALAAQLLIV
AALFQLSDGLQVVILGALRGLQDVNIPTFICFIAYWLIGFPVAWYFGQEDQMASQGIWYG
LLAGLSASAVLLYIRFIYLSRKLIHQVSEGKTTAG
>KECLDBNJ_03044 Pentapeptide repeat protein MfpA
MNELLTDQIFENHNFAENPLVADFEDCVFKSCVFAKANLSKLTFTNCTFENCDWSAAKLV
QTAFQECEFSSCKMLGIAFEACNTFLFQIYCAQCTLDFSSFYQVDLSSSQFSQCQLKEAD
FTEANLSGVFLDECNLAGATFDQTNLEKTDFSSAVHYELNPDENKIRGAIFSKEGLAGLL
SSYHIKIV
>KECLDBNJ_03045 hypothetical protein
MNPESLIELAYYKMPFGKYQDRYLVEIPEYYFTWFKQKGFPEGKLGFMMQQMHEIKINGL
EELIFKIKRQYPAPQPKRKP
>KECLDBNJ_03046 CTP synthase
MADTKYIFVTGGVSSSLGKGIIAASLAKLLQARGYSVTIQKLDPYINVDPGTLNPYEHGE
CYVTDDGAETDLDLGHYERFLNVNTSQANNVTTGRIYQSVIEKERRGEFLGKTVQVVPHI
TNEIKERIKHLGNTGDYDIVITEIGGTVGDIESLPYIESVRQLKWELGDENALVIHLTLV
PYLSAAGELKTKPTQHSVKTLMESGIKADILVCRTEHELSDDLREKLALFCNVRKEAVIQ
SIDASTIYDVPNLMLEEGLDTITLQKLSLSQENEPELIRWNEFLRRHKNPKAEVTIGLIG
KYVELQDSYKSILEAFIHAGAENEVKVRVEPIHSEFISQDVIQNKISKLDGLLVAPGFGE
RGIEGKIKAVQYAREHKIPFLGICLGMQMAVIEFSRNVAGLKDANSTEMQKDTSAPVISL
MEDQKDLKHMGGTMRLGAWDCKLAAGSIVADVYDAEMITERHRHRYEFNDSYRETLEKAG
LKITGTNPKTGLVEIIEMEDHPWFVGVQYHPEYKSTVANPHPLFVAYVQAAVKYSQSKSS
DNVAHN
>KECLDBNJ_03047 Membrane protein insertase YidC
MIMEEKKFDKQSMIGFLLIGAILLFMLWQNQPSDEELAAQKAQEEQVEAHEAAAEKASQT
DAVVESTTPQNDSLALERYKATLGSFAYSATLPSATDDVTELENDVLALKVSNKGGFITE
ARLKNFKSYDSVPVYLIKDGNSRFNLTFSTTDNRTLNSENLYFEPSLSKEGENQVLSMKL
KVSDSEYLEYRYTLKPDDYMMGFGIKTVGLQNVVNTSQPINLDWQLKGYRHAKSITYENR
YTRLTYEYEEGDHDKLSQTGDDDAIETNVDWFNFRQHFFSSILLTDQPFDEVRFSSKNLV
EDEEVDTVYTKQYAANMQLKPVNGELNYAMDFYYGPTDYQILNNYDRDIDEAMPLGWGIF
GVINKYLIIPFFNFLIAYFPAGIAIILLTISIKLLLSPVQYKQYLSQGKMKVLRPEINEI
NEKYADNPMKKQQETMKLYSKAGASPLSGCIPGLLQIPVFYALFTFFPSAFALRHKSFLW
ADDLSSYDKIADLPFHIPFYGDHVSLFPILASIAIFIYMTMTTGQSMQQAQQPGMPNMKF
LMYLSPIMMLFFFNNYASGLSLYYFISNLITIGIMLVIKNFILDEDKIHAKIATAKAKPK
KKSKFSQKFSEMMEQAEKQQRNK
>KECLDBNJ_03048 Immunogenic protein MPB70
MKKLTTKIHLILFTALLAGFTSCSDDDDAGMITEESETIADFVASEEDYSSLAEALDRTG
LTATLDAEGTYTVFAPNNAAFEAYLDGTAVADVPVEDLTQILLNHVLAVEARASSLATGY
VNNLATYADTDANLSMYINVDSDVVTINGGSELEGGANVTATDFEFSNGIVHTVDAVITL
PTVATFAVADPTFTQLETALTADASFSFVNTLTSAGTFTVFAPTNDAFADLLAELEISGF
GDLDTSVLAAALSLHVVNGANVRAEDLTTGTVTTLGGAIEVDASNATLTDANGRVSTIVV
TDVQASNGVVHAIDTVLLPGL
>KECLDBNJ_03049 tRNA-specific 2-thiouridylase MnmA
MKTVVVGLSGGVDSSVSAYLLKEAGYNVIGLFMKNWHDDSVTISDECPWLDDSNDAMLVA
EKLGIPFQTVDLSEQYKERIVDYMFREYEMGRTPNPDVLCNREIKFDVFMKIALELGADF
VATGHYCQRGETEIDGKSVCQLLAGADANKDQSYFLCQLSQEQLSKTLFPIGHLQKSEVR
KIAKEQDLVTAEKKDSQGLCFIGKVRLPDFLQQQLKPKEGVIVEISAARAQEKIEDLHES
SAADVAVEDVTVLAKKPKYSLTDGKIVGKHQGAHYFTKGQRKGLAVGGTPEPLFVIDTDV
EENIIYTGQGKEHPGLLRKALFVQESEVHYIREDLKLAEGEVRATKARIRYRQPLENAWL
HKVENGLFVSFENPQAAISEGQFVAWYDGAECLGSGVIS
>KECLDBNJ_03050 Nitronate monooxygenase
MNIITALFDIEYPLIQAGMVWNSGWELASAVSNAGGLGLLGAGSMYPEVLREHIQKCKAA
TTKPFGVNVPLLYPDIDKLMQIIIEEGVQIVFTSAGNPKTWTSHLKEHGIKVVHVVSSVK
FALKAQEAGVDAVVAEGFEAGGHNGREETTTFALIPMVKEELDIPLIAAGGIATGKGMLA
AMILGADGVQIGSRFVATPEASSHQAFKDLVVEAKEGATELTLKELAPVRLLKNKFYTDV
KQLYETTPTKEQLSALLGRGRAKKGMFEGDLEEGELEIGQIAGLIHEIKPAAAVVDEIIS
EFQATKLPEL
>KECLDBNJ_03051 hypothetical protein
MKRLLIYTGTAIFSLAILACNTQTTKKDLAENKPAETELTKPQPPAEEVVPEGYEVYKSP
SLMEGWKLSFLHPERASVEGSGTQMIIRYTGEDNSFYGGLTDGFIVSMTMSNDEALEQKI
ENNTPEKMGEYEVYSYRALNSIGSAQVDHYLIQLNASGDSQPVYADFSMAVKGDSDAEYK
AMIQEIFESMTWSQETV
>KECLDBNJ_03052 HTH-type transcriptional activator RhaR
MKRYTQFNRLIVDDFTTDVWQHPLHNHNHYEVIFIRSGSGIHHLNNSLVPYEPGHLYLLG
PEDEHEFIIEKTTNFVYFKFTKLYFDTFDGENPAVWNQHIDKLLSKKWSRKRNLLRNKED
VSIVDDLFKLIVTEYERNALLSKKLVNHHFKAILLVLNRNGPNCDKKQQRRADSDITEAL
LEYIELNIYDPKSVSQKQIAQHFHYSPNYIGILFKKNIGASLKKYIQDYRFNLLKQRLKH
GHLSTKQLSLDFGFTDESHLHKFVKTQSGKSLLQLKKQILPERA
>KECLDBNJ_03053 hypothetical protein
MTKKQAAYTLARLPIGFSFLGHGFIRIPKLTAFAQGMTNSFAETYLPVELVKPFALILPF
VELLLGIALIIGFKAKETAAVSIVLVCVLIFGSSFQENWSAVAIQLFYGLYLAILFLFSE
HNQGVLSKSN
>KECLDBNJ_03054 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MDLQLKGKSALVTGSTAGIGKAIAKGLAQEGAHVIINGRKAKDIAEVIKDLKKETGNEEI
TGIVADFAKKEHIDHLLEEIPDVDILVNNVGIFNQVDFENITDDEWFEMFEVNVMSGVRL
ARHYFPKMLKKNEGRIIFISSESALNIPTEMVHYGFSKTAQLAISRGLARLSKGTNVTVN
SVLPGPTMSRANANDLEETAKEQDTSVEKVVEAFFEERRPTSLIQRFAETEEVANMVVYV
ASPLSAATNGAALRVDGGVANYIV
>KECLDBNJ_03055 2,4-dinitroanisole O-demethylase subunit alpha
MRNTITVAIAILFGVLVRAQEMKTIKVENNLYMVGDRTYSCFYVTDDQVVVIDPLDARHA
EATMKAINKVTDLPVKTVFYSHNHWDHISGAQIFKAEGATIISHEKAAETITPNPDVLMP
DQTWTGSDTIYSFGNKHIELFFYGRNHGDGMTVFRFPEHNIVFTIDLVVPDRVLYAYLPD
ADPKNWVASLKEIQQLDFDTLLMSHVRAVGTRKDLTLMQNYFDDLYAAVETELDNGTNLF
KIPNKVELPKYKHWKNYEEWLPMNVWRILMEKSIGQ
>KECLDBNJ_03056 General stress protein 69
MAAYERVAHSYGKINRTIIRKLKAMKKIQIGTTDLHVAPINLGGNVFGWTLDEKQSFEIL
DAFVDQGFNFIDTADMYSYWVDGKDGGQSETILGKWMKSRGNRDQIIMATKVGGETGTHP
VDTSKKHILEAVDKSLKRLQTDYIDLYYTHFDDEKTPVEETLEAYDEIIKAGKVRHIAAS
NISPERLEASFAASEKNNLPKYQALQPHYNLVEREGYESNYAPLAEKYNFTVFPYWSLAA
GFLTGKYRSEDDLNKSVRGDSVKKYLDKKGLEVLKALDQVSEKHNTSQATVSLAWLMAQP
HIGAPIASATSEKQLKTIFEAPKLKLDSEDLAVLNTASK
>KECLDBNJ_03057 hypothetical protein
MKLKLRLHPFFILSFLALGSTFMVSCDSDDTLPVEPEEATVAQLQSFSVKPGKNRVFVEG
TVPANANIAEIRIYWNEQSDSKTIAVSSSSEAQQISTYIENLDEKFYAFEVQTVTAAGDG
SILLKGGSEVYGDNYSNLLFNRPVNANVLEESSLTIEFGEMDLSTGVIGTQLNYETTEGS
QEELFIPVSKNDLKITDFKAGTSYSYRSVFVPSPVAVDTFYTDNASYMPIEFPKLVNAAV
PFAASSISGRWGILEDWTTTDPVLIHNGHGGWDEWNNNIFNIESGWGAPAITNGKVYQSV
MTGPGEFALEVSVRDSNHSESDEGGAYFVIAKGTTLPDVADVTTSAEVLAYERIHTTANS
GTPEVYSIPYTIEEATTITIGQVTTQWGQTPGRFCNIFSFEIVPGN
>KECLDBNJ_03058 hypothetical protein
MIPEVFLGTLFIFLLVVVLTRIFGLKSFSKMTGFDFVITVAIGNIIGMSINSSKPAILLG
AFILLALFALNYAVTLLRFKSKKAEDLIDNDPLLLMENGQILEENMKASKVTQAELQSKL
REANVIRLSQVKAVILETTGEISVLHSNDQSITIEDYIMGDVIRQK
>KECLDBNJ_03059 Oligo-1,6-glucosidase
MKKLLLFSLLLSVIISCNENKKTSNTSTEPEQSIDKKWWKEAIVYQIYPRSFQDTDGDGV
GDLQGIINRLDYVKDLGVTAVWLNPIYSSPNDDNGYDVSDYRNIMSDFGTMEDFDTMLSE
MHARDIKLVMDIVVNHSSDEHPWFKESRSSRDNPYRDYYHWWPAEKGEPPYRYSLFDAEG
NAWKYDEKTDAYYLHYFSQKQPDLNWENPKVRQEVYDIMTYWAEKGVDGFRLDAFQFAAK
DTTFPEFPKGFEKNFIQYYAMQDGLHDYLKEMNEQVFSKYDVMSVAEGAGRTLEEAHELV
DADRNEINMAYAFDGVDIPKAEGYKLSTFKETFSKWDSAFADKGWISIFLSNHDQARMVS
RYANDSLPYRAPSAKMLNTFILSMRGTPYCYFGDELGMTNNPKLQNIEDYQDIAAINGYK
KAKSQGEDMETFIQNLRFGSRDHGRTPMQWDASEHAGFTSGNPWLPINPNYVDVNTEAEL
ADKNSVLNHFKKMTALRRGSDVLIYGDYALLLPEHPHVHAYTRSLGDEQFLVILNFSKEK
VSVILEELGNFSELKINNYSNLNKKANELQLEPYQAVILAKS
>KECLDBNJ_03060 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MTPVKAWVSAARIRTLPLSVSGIIVGSSMAYNSGFFRWDICILALLATLGFQILSNFAND
YGDGVKGTDNHERIGPARAMQSGLLTAKQLKNGMVFTASVTLLISIALIYTAFGSERFLE
SVLFFVLGLLAILAAVKYTVGKSAYGYMGLGDLFVFIFFGLVAVAGSYYLYAAQLDAVVF
LPALTVGFLSIAVLNLNNMRDRLSDARAKKNTLAVFLGPKKSKFYHYFLIVGALVASLLF
FHFTNTYLWSVIACVVFIPLGKHLAYVAQNESPALLDPELKKVALATFFFSVLFTLGFLF
>KECLDBNJ_03061 hypothetical protein
MKITYYGQNCFGLETKEATILTDPFITGNELAKDKIDIADLNPDYIFLTHAHQDHTLDAE
TIAKQADAIIVSNFEIANHYGEKGIETHPMNHGGSWKFPFGKVKYVNAIHTSSFPDGSYG
GQPGGFVFSIDDKTIYMAGDTALTMDMKLIGMEFDLDLAILPIGDNFTMGIKDAVLASDF
IECNNIIGCHYDTFGYIEIDHEGAKKAFDAVEKQLTLLEIGSSYEL
>KECLDBNJ_03062 L-Ala-D/L-Glu epimerase
MTASYKKFILNFKRPSGTSRGVMNVKETWFLKIEELDKVGFGECGILRGLSIDDRPDYED
TLKWVCDNIHLGEETLYERLTDFPSIQFGVEMAFRSFHAKNPFELFPSAFTQGNEGIAIN
GLIWMGSPEFMQDQITEKLSAGFDCIKMKIGAIDFDAEIELLQGIRDRFPKEKITLRVDA
NGAFAPAEALQKLERLAALDLHSIEQPIKQQQEDAMAQLCATTPLPIALDEELIGVFGYA
KQKELLQKIKPQYIILKPSLVGGFRGCDTWIQLAEEQGIGWWITSALESNIGLNAIAQYT
YTKSTSIPQGLGTGALYTNNVSSPLEIKHGELWYMPENRWSFQF
>KECLDBNJ_03063 hypothetical protein
MFIVQAFKALHEFWRYLVGSVLIIAASTIGQIPFTLAILGKLWMDNQGSPEELGNAMGSL
DQATLMGVLDKNLTLFLLLLSFVFALGGVFLAVKYLHKQKMKDIITTRKKFDWGRVWFAF
IMITIYTIGTTLLSYYIAPEEFEVTFDLIPFLILCVVAILFVPIQTSVEEFVFRGYLMQG
FGVLAKNRWFPLVMTSFIFGGLHYFNPEIGAMGDIVMVFYFGTGLLLGIMTLMDEGMELA
LGFHAANNLISALLVTADWTAFQTYSIFKDISDPTAGIVDVLPVFIIYPIFLGILAYKYK
WTGWKEKLFGLVKKPKETQLEDNLVPD
>KECLDBNJ_03064 2-succinylbenzoate--CoA ligase
MSKYPVHPEFQLNGMSLKAASLREFAQEIQKTGELYEQELGEFILDWLNDKDYVLVNTSG
STGAPKSIKLLKKHMVNSAKATGKRFDLEAGATALHCLPTRFIAGKMMLVRAVILGWKLD
VVPPKSNPLDQVLKRYDFSAMTPFQLDNSIARMHLLAKLIVGGGPFSQTLKELVQDCPTK
IYETYGMTETITHIAVRRVNSKKNREGEPPFKTLSKVTVSKDERGCLVIKAPRVATDPIV
TNDLVDLISYKKFHWLGRIDNVINSGGIKLYPESIEKKLAHQIDVPFIIGAEEDAVLGEK
LILVIECDSFDASRLNFEVLGKYETPKRIYCTPKFIRTNNGKVKRGATLKSLTAAEEI
>KECLDBNJ_03065 hypothetical protein
MRYLFIIAITLFSMQSIYAQYGYGRGYGGYGGYGRSRMGSMMGASQTPQGPTEEPPTAAE
IAEERLPDYVAEFELDPFQTEVLRTYLEDYFNKVMGLQKDETKDAETMRKDFERMQNEFK
ADLKSILTEEEVEKLIAMDFSNSAVRKRKKNRDN
>KECLDBNJ_03066 hypothetical protein
MRKILLLLVCLFFLNIPFSYSQILPERDRAVLVDKILSERFKRVLPDVMSRSDIDMWVLI
TREYNEDPVVRTMLPATWLNARRRTMLVFYWDEDRFKLEKLAVARYNIGDNITSAWDKEK
EPDQWKALMELITKYNPQKIGLNYSDNYGIADGISKTDYELFMNTLPENYKNKVVSAEDL
AVGWIETRTALEMQLFEELVGITHDIIREAFSSKVITPGKTTTEDVVWFLRQKVTDMGLE
TWFHPTVDLQRDSEPLESHITAFTNHSEGQVIQPGDLLHCDFGITYLGLNTDCQQHAYVL
KDGETQAPEFLREAFKKGNQLQDILTGNFATGKSGNAILKESLEEAKQAGLQPSIYTHPL
GLYGHSAGPTIGMWDAQEGVPGSGDYPLYENTTYAIELNTTVTLPQWDKDIRIMLEEDGF
WGANGFKYINQRQEALLLLK
>KECLDBNJ_03067 Inner membrane transport protein YdhP
MFKKSLIALAIGGFGIGMTEFVMMGILPDVAKDLNITIPQAGHFISAYALGVVIGAPILV
GIAGNYSPKKILFSLMIAFTVFNSLSVFASSYGLMLISRLLSGLPHGAFFGVGAVVASRL
VAKEKAASAVAMMFSGLTVANIIGIPLGTYVGHNISWRYTFMIVVVIGLITVLAIRFWLP
KIEKSEPIPIKQALKIFKRTELWLILGITAIGTGGFFAWYSYITPLLTEVSGFDNDMVIF
ILMLAGLGMTCGNVLGGKLADTFSPIKATAILLSAMTLCLITISLIAPIQWAMLLMVFVT
GAFAFSTAPSIQMLMIKSAKESEMLASSVNQAAFNIANAVGAYLGGLPIAAGYGYTAPEL
VGACLAFGGILLSISVMLLRKKRAKLTAQEA
>KECLDBNJ_03068 putative propionyl-CoA carboxylase beta chain 5
MDIKFNKNEDHNKLLVSDLKRRFAKVQLGGGEKRIAKHHEKGKLTARERIDFLLDDAEKA
IEIAAFAGEGMYAEHGGCPSGGVVVKMGHISGKQCIVVANDATVKAGAWFPITGKKNLRA
QEISIENRLPIIYLVDSAGVYLPMQDEIFPDKEHFGRIFRNNAVMSSMGITQISAVMGSC
VAGGAYLPIMSDEAMIVDKTASIFLAGSYLVKAAIGETIDNETLGGATTHCEISGVTDYK
ATDDRDALTRIKNIMGKIGDFEKAGFNRIDAAKPKEDPQDIYGILPAKRSDQYDMTEIIK
RLVDNSEFEEYKEGYGQTLITAYARIDGWAVGIVANQRKIVKTKKGEMQFGGVIYSDSAD
KATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFTIVVG
NSYGAGNYAMCGKAYDPRLIAAWPSAELAVMSGNSAAKVLLQIETASLKKQGKEITPEVE
KELYDKIKARYDEQVSPYYAASRIWTDAIIDPLDTRKWISTGIEAANHAPIEKKFNLGVI
QV
>KECLDBNJ_03069 hypothetical protein
MMNKNTVLGWATFIMIVVGLGLIAMGAFKYSEVAGWGFASVGIGFFAIAWVFNALKGRV
>KECLDBNJ_03070 hypothetical protein
MEEALLKEQLLKHLKGGEAFTPVSELLDKISFKKSGKRPLGLPYSFYEVFYHMVYAQKDI
LDFCIAEEYNTPSWPKDYWPGSNTAATKEEWQALQQQFYTDQEALREFIDTTDLSLLDTP
KHGKEQTIVRELALVLEHNAYHTGQLAIILRLLGLL
>KECLDBNJ_03071 Energy-dependent translational throttle protein EttA
MSDDKKIIFSMTGVSKTFPGANTPVLKNIYLSFFYGAKIGILGLNGSGKSTLLKIIAGID
KNYQGDVTSDKEFSVGYLEQEPQLDDEKTVLEVVKEGAADTVAILDEYNQINDQFGLEEV
YSDPDKMEKLMNRQAVLQDEIDARGAWELDNKLEVAMDALRTPPADQKIGVLSGGERRRV
ALCRLLLQEPDVLLLDEPTNHLDAESVHWLEHHLAQYKGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSKRMAQEQKQASKRQKTLERELEWVRMAPKGRQAKQKARL
SNYDKLLSQDQKQTDEKLEIYIPNGPRLGTNVIDAKGVSKAFGEKLLYEDLNFVLPQAGI
VGVIGPNGAGKTTIFKMIMGETEPDKGAFTVGETAKIAYVDQSHSNIDPEKTIWENFSDK
QELIMMGGRQVNSRAYLSRFNFSGSEQNKKVSMLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVVISHDRWFLDRICTHILAFEGDSQVYFFEGGFSDYE
ENKKKRLGGDLMPKRIKYKKLVR
>KECLDBNJ_03072 hypothetical protein
MSLKDLKVTAFDADDTLWVNETFFRDAEVAFAKHLSAYGDEDEIVQKLLDTEIKNLDTYG
YGIKGFTLSMLETAHRLMGDQMQADTIDFILNKGKEMLAEPVELLPHIEEVLEQLAKKYK
LVVATKGDLLDQERKLIKSGLIDYFHHVEIVSDKKETQYKKLVKHLDIAPHEFLMIGNSL
KSDVIPVLAMGGYAFHIPFHTTWSHEQIDDEINHSKFKALKSAYELLDLL
>KECLDBNJ_03073 hypothetical protein
MKEEHKRAAILFAVLAAFAIIICFFQPSFGKGLLFGLGIAVLIYILRSFLPRRQ
>KECLDBNJ_03074 hypothetical protein
MENENKNTGIKIVTGILAVLLVVAGAFAIKLYNQEKNTKAELTEEKELVLNDLKQMVTKY
DAVIEENNLKDTELNQARDRIQVLIDSVQQMDASISVLRRYRDEVYKLKKEREFLFAQND
SLKGMNKMLAMRVDSTSYELEVSKMKRDSLAMVKEELAEKVALGASLAANKLVGTGVIVR
NSGKLVENDNARRVDRIRACYTVPQNRIADAGDKQLYVQVLDPQNNILGENKTVKLDSVT
SVTYSAISKFYYEKTALDICENIAPKGGEFAKGLYKINIFDGGRMIATTNLVLD
>KECLDBNJ_03075 hypothetical protein
MTLHKITPYFTLLFTFLILSCSSGSDSDNTPTDPTQANKQALGSSARDFLSAEEFTSMNV
EIAYVDGFKPSETTLNNLRSFFTERLNKPDGVTFTETVVPATSVGSLNRDEYVAIENDNR
TVFNEGDALGVWVFFADQNSESDEGNSRILGTAYRNTSCIIFGTTLREFSRGITGPSLTQ
LETITTEHEFGHLFGLVNLGTEMVRDHEDETADDDGGETPNKHCDQEDCLMYFQTVADAT
STAMNNLPTFGEFCLEDLRANGGK
>KECLDBNJ_03076 hypothetical protein
MAEKDSQNPDIFGQALLDFYNENYTEDITVISSLTEDDEIPVPYLFRSYEEMPLVEQEAL
ELAQGKTLDIGACAGSHSLYLQDKGIDVLALDISEGAIEVCKNRGVKNTVVSDVLDYDEN
GYDTLLLMMNGTGIFQTLKNTEGYLSHLRSLLKPGGQILVDSSDIAFMYEEEDGSYWRDA
SRDYYGEVTFKIQYKEQTSLAFDWLYLDYKTLKTEAKKAGFTCEKICDGPHYDFLARLIK
TTS
>KECLDBNJ_03077 hypothetical protein
MDEFIEQLPNLAKDKHKETAAYFKKLKRKPPKDLDYQMQELHDEEFERTDCLTCANCCKT
TGPLFTDRDISRIAKHFRMKDAQFIDTYLRIDEDNDYVLQEVPCTFLGADNYCMIYDVRP
KACAEFPHTDRKKFQQITNITLKNVAICPAAYNIVEQMKERIKLK
>KECLDBNJ_03078 hypothetical protein
MKNIIKILFLVSTATGFSQQIDADKSAFAHTFSIVARDTETGEMAVAVQSHWFSVGSLVS
WGKSGVGVVATQSFVNPSYGPKGLALMQEGMSAEAALEQLIGEDEGKAYRQVAFLDVNGN
ASAYTGEKCVVYASQITGDNFSVQANMMLTDQTVPAMAEAFEKYSELPLAERMVEVLKAA
QAAGGDIRGKQSAALIVVGPELVENPWEEYKINLRVDDHQNPIEELDRLLKVARAYEYMN
RGDLAVEAGDMPEALQQYSTAETMFPDNLEMKFWKAVAMANDGQLEEAKPIFKVIFEQDE
NWREMIGRLVKPGLLTVSASEVAEIQKL
>KECLDBNJ_03079 Bacterial leucyl aminopeptidase
MKKTFYLCLLGASLSTGLFAQTQEETVEAIVKEATENSQLKLLAHQLLDVVGPRLVGSPE
MKHAHDWAVETYADWGIDAENQQWGVWKGWDRGITHIDLVSPRRVSLEGMQLAWSPATKS
KGVEAEVIVLPEAKDSVSFKNMLSQVAGKFVLVSMPQPTGRPDDNWEEWATPESFEKMKK
DRDALNDAWNARIKATGYSSRELPKILEEAGAVGVITSNWSRGFGVNKVFSAYTEEIPMV
DIALEDYGLLYRLADYGDKPVIKVVAESEELGEQPTFNTIAQIKGSEKPEEYVILSAHFD
SWDGGQGATDNGTGTLVMMEAMRILKQVYPNPKRTILVGHWGSEEQGLNGSRSFVKDHPE
IVAGVQAVFNQDNGTGRVANISGNGFLNAYDYLGRWLNAVPDEVASIETHFPGAPGRGGS
DYASFVAAGAPAFNLSSLSWNYWNYTWHTNRDTYDKIVWDDVQNNAILTAVLAYMASEDD
EKTSREQIVLPVNKRTGEQMTWPEPRDGNRRGGLDD
>KECLDBNJ_03080 Esterase EstB
MKKSFSLRWLCICAILVHIQFFAQENLLPKVQPEAAGMSSSRLAYLDTMALEALAEKQVP
GMVALVARNGKLVYHKAFGAANAQGEALDSNSIFRIASQTKAITSTAVMILWERGKFQLD
DPISKYIPEFKDAQVLDSLLPDGSYTTHPAVRPITIRHLLTHTSGIGYGQIDGDPRFKKI
YDAAGVTDLFTTEKITIEESVKKLAKLPLHHNPGDNFTYSEGLDVLGYFIEIISGKPLDE
FFRTEIFEPLAMHNTYFYLPKEKQDLLVAVQTKKDGRWIDFPTTFYDPDYPKKGKMTFFS
GGAGLSSMPVDYAQFLQMYLNKGTFNGNRILSRTTVDFILSNQIGEIWKGNGSHHGLAFS
VVDDLGAAKGGKGSAGTFEWGGYFNTQYFADPEEQLIGIIMKQTQKVGGDETGWKFRNIV
LSAIAD
>KECLDBNJ_03081 hypothetical protein
MKSIIILVCAFFFSAPFYGQRLYGTITDAKTQEPIEGVNVFIKSIKKGVTSKNDGIFYFE
QAHGLEQQDTILFNMVGYHTLKLTLAQYETQNKQVRLVEEKFINSKPVKGSNRVITLGKA
NSSIK
>KECLDBNJ_03082 hypothetical protein
MAFRLFKSTFFLVFVISISCGNTPGTKNQSLPSPESQNDALAKTKTPEPAPIVLGANRTE
VYLPLLKDKKVAVVGNPSSLILKTSSSSEKVYTHLVDSLVAHEINIVKVFSPEHGFRGTA
DAGEAVKDGKDPKTGLPVISLYGNNKKPKPEQLAGVDVIVFDIQDVGVRFYTYIATLHYV
MQAAAEASIPVIVLDRPNPNGSYVDGPIMEAAHTSFLGMHAGVPLVHGMTIGEYAQMMNQ
EGWLQTAHPAKLTVVAMQNYTHNLTYSLPVRPSPNLPNDQSIMLYPSLGLCEGTTLNAGR
GTEMQFQVIGSPFLPQEQYTFSYTPQPNFGSKNPKFKGETCNGLDLRMLPKLQKVDLHFI
IDAYRNYEKKAEFFNTKNFTAHAGTAQLQQQIESGATMQEIRVSWQDGLEAFKVLRQKYV
LYP
>KECLDBNJ_03083 Lipoprotein-releasing system transmembrane protein LolE
MNFEYFTAKRIIGAKKYKSTASTPIIKIAIIAIILGVVMMMITIATGVGLQQKIKEKVSA
FNGDIIISQFDGNNSDITLNPIPKNQNFYPDFDAVPEVTHVQVTATKAGVIRTATDFEGI
IVKGVGDDYRWDYMQDFLIEGHVPDYTENLNTEILVSRYQANRLGFKNGDKVIVFFLKED
GGFLNRRFDIVGIYDSGFQEFDESFIFADIRHVQKLNNWEADQVGAFEVFVSDFDRLNEI
GTAIYENTDSFLNTMTITQKYYSIFEWLSLFDFNIALIIVVMIIVAGINMIVALLVLILE
RTPMVGILKALGANNWSIRKIFMYNALYLVGVGLFWGNVIGLGLLLLQHYFGLITLNPET
YYVSEAPVYIDWYYIVLLNVGTFLLCALMLLIPSYVVTRISPVKTIKFE
>KECLDBNJ_03084 hypothetical protein
METAIRTAIYIHAFFGGIGLLSGTLSLVTKKGGKVHIQSGKWFVIGMLVSSGLSLPIACM
PGHHNPFLFLIGVFTIYMVLVGKRVLRFKRKTAQVSKLDWGITITMTLLSVLMILCGILN
SFGNNVLFIFFGIISLMLCFQDFRFWRKPRRSKTGWLAQHIGKITGAYIASVTAFLVGGM
KMQGLMVWILPSVIGNTFIIYYIIKVRGGFKKRKKVTS
>KECLDBNJ_03085 Putative cystathionine beta-synthase
MQYAENILETIGETPLVKMNKLTADLPCLVLAKYETFNPGNSTKDRMALKMVEDAEAQGL
IKPGGTIIEGTSGNTGMGLALAAIVKGYTMVCVISDKQSKEKIDILKAVGCEVVVCPTDV
DPDDPESYYSTSKRLAKETPNSWYVNQYDNPSNAQAHFESTGPEIWDQTDGKVTHFICGV
GTGGTISGVGNFLKSKNPDIKIWGVDTYGSVFKKYHETGIFDENEIYPYITEGIGEDILP
ENVDFKIIDGFTKVTDKDAAVYTRRLAREEGFFLGNSAGAAVKGLLHLKDKFTKDDVVVI
LFHDHGSRYINKMYNDEWMREKGFLE
>KECLDBNJ_03086 hypothetical protein
MKNSMLTLALATSMIFASCVDRKTNDNGEVELEEKNQQVTPEDMFQTSGQEGETSPEDLA
EINSAKKVINDYFDALERGETNEAYEVLSQSNSERTTPSEFAEKHANVETATVSYTTDPQ
VVKGANGTDVKLPFRYTILTKDGNTMSYNGSAMIVKSSEEDADYKIQGMTMTREES
>KECLDBNJ_03087 hypothetical protein
MKEAFLHYLWQFRKFEGATSTGLPLSDEQRSIQVIHPGSYNELAGPDFFNAQIRIGDQLW
AGNVEVHLKSSDWYLHRHERDQAYSNVILHVVWEDDCEVFDAANLPIPTLVLSDKVSPQM
LQSYKALLEAKSYRFINCEQNFAEVDTGLFEHWIERLYFDRLERKVSHVLGKLESVTGDW
EAVLFMTLARNFGTVINADAFEELAQIIPFSIVRKLGQQPGQLEAALLGQAQMLADDPIE
QQPKLWKKDYLYIKHKFELSEGIRYPMQFFKLRPPNFPGIRISQLAQLYEQHQDLFSKCM
AAQTRSELQKLLKVSTSTYWETHYTFGKPHKPRIKKLSDAFIDVLIINSIIPLKFAYAQA
KGLDVQEQLLDLMRSIPLEKNSVVSTFEKLKTFERDALHSQALLQLKREYCDLNQCLKCE
IGNYLISN
>KECLDBNJ_03088 hypothetical protein
MKFIYAIRHFFERNGFYVSSRLADRLGIRAKNVRLFFIYLSFATAGLGFAVYLVLAFWLK
LKDLVYTKRTSVFDL
>KECLDBNJ_03089 Voltage-gated potassium channel Kch
MLMLGVFGFRFLAEYTWTDAVYMTMITISTVGFGEVQPLNDSAKIFTVILILVSVIVLGY
AISIITEYILSRSNFELIKQRSVQKKIDSLNNHVIVVGFGRNGKQAAQKLTTYGRPFVVI
ERDEEIVNKFHSDQILFVTGNANEDEVLVQAGVKRASTLISALPDDSDNLFVVLSARQIN
PDLKIISRASEETTYQKLKFAGADNVIMPDKIGGDHMASLVVVPDLVEFLDNLQVATEGR
VNVQQVTFEAVCPDLKTRSIRDIDLRNKTGCSIIGYKSADGDYIINPEASLKLERGCILI
VIGRPEQIENLHREFAI
>KECLDBNJ_03090 Amino-acid carrier protein AlsT
MKHKLSLLVFLFTSLIGSAQESAPIGIDDQIDQAFAPVSTFFSNVVFFTIFDIPFVLILL
VFSALFFTVYFGFPNFRYFWRAIQTVRGKYEDIENHGAKVLYGEDGIANGVDLNKVDIEE
HIEALDDDLAVDGDIVDTIRDESSAGEVSHFQALATAVSGTVGNGNIAGVALAIALGGPG
ATFWMIICGLLGMSSKFVECTLGVQYRDVGEDGTVYGGPMFYLTKGLKEKGFATLGKIAA
VVFAIFCIGGSFGGGNAAQSNQATIVIKELFNLESTGAGFWIGVVIAILVGVIIIGGIKR
IAQVTEKVVPFMAVMYLVACIYIIGLNFSLIDDAIALIVEEAFNPTAFGVGSVIGVLLVG
FKRAAFSNEAGAGSASIAHSAVRTKYSASEGLVALLEPFIDTVVICTMTALVIIIFNFGG
FFEYGGDGSGAVIIDGLSYEGAGITSKAFAEYIPFSNIFLTVAVVLFAVSTMISWSYYGI
QAWKFLFGRGKVADMVYKLLFLTFIVIGAAANMRSIWDFSDAMIFAMIFPNMVGLFFLFP
VVKKQLNRYLDAIKLKREALK
>KECLDBNJ_03091 Amino-acid carrier protein AlsT
MKKIMFSICCLMFPIMTFAQESMSVGESINAAFEKYTTPIVETIMYPVVIAGKELPIVIL
ILLLGALFFTLYFKGVNLRYFKDSIKTAWGKYDDLDHYVPAEEEIVVEDGKVKDTVKLTG
EVQGEVTHFQALTASLSATVGLGNIAGVAVAIAIGGPGATVWMIIAGLLGMASKFVECTL
GVKYREVDENGKTYGGPMYYLSKGLNEMKMKGLGKVLAVFFAIMCIGASFGGGNMFQSNQ
ASSQLIQMTGWDNPNAGLYLGIIMAVIIGLVIIGGIKRIGSFTEKVVPFMAIIYVLAGFI
IIAINIDMVGFALGQIWDGAMNPNAAFGGVVGVMIVGFQRAAFSNEAGVGSAAIAHSAVK
TRYPASEGLTASLGPFVDTVIICTMTAIVIIITNAKHNLFTYGNLDAASNVMLNETNEPI
NGVDLTSVAFDSAIPYFSIVLTIAVVLFAISTAISWSYYGLQSWKFLFGKGKVTDIVYKV
LFLVFVIVGASSSLGAVIAFSDAMIFAMVFPNIIGLVLLSPKVRRELQAYLNAIKIGRMD
AVIDKDSKSTKKAS
>KECLDBNJ_03092 hypothetical protein
MKLKSHFFLDSRQRSGILLLVLILMLSWGAYFFKNSFQQKENVSVIELVNYEQQLDSLVQ
LKEELNKPEIYPFNPNFITDYKGYTLGMNTEEVDKLLRFREKNNWINSAEDFQRVTGVSD
SLLALISPYFKFPEWVTQPATKKRRYSTSVKPNPTKDLNTVDFKALMALENMNEAIAKRI
LSYRRKLGGFLEDNQLYDVYGIKASQVRSIKEVYTVLSKPEIVMIDVNKANASDLSTVPF
VTFDIARDIIDYRTLHGAITNLDDLLKIDGITAYKLERIKLYLSTNQN
>KECLDBNJ_03093 Caffeyl-CoA reductase-Etf complex subunit CarC
MNNVYFSEEHKLFRESLRDFLQKEVVPHIEKWEKTGEIERFIWTKMGEMGYFGLASPEEY
GGLDLDIFYTVIFLEELQRINSGGFAAAMWAHAYLAMTHLKAEGDSFIKEKYLAPSITGE
KIGCLCITEPFGGSDVAGMRSTAVLEGDHYILNGSKTFITNGVYSDYLVVAAKTSPDKGN
KGLSIFVIDRDAEGVSATKLDKLGWRASDTGEIAFNDVKVPVANLMGEEDKGFTYIMQHF
ALERLIMGVNAHARAEFALEYAMQYMSERTAFGKTIDRFQALRHSVAEMASEIEMVKAFN
YSIAHNLNTGDYVVKEASMSKLLSTKIADEVIYKCLQMLGGYGYMEDYPLARMFRDSRLG
PIGGGTSEILKEIIAKMVIDKKEYKPATK
>KECLDBNJ_03094 30S ribosomal protein S21
MLIIPVKDGENIDRALKRFKRKFDRTGTMRKLRDRQAFTKPSVERRREIQKASYIQGLRD
QENI
>KECLDBNJ_03095 Tyrosine recombinase XerC
MYLNAFIDYLELERKYSAHTVLAYQKDLEAFFRFVKELYEVEDPKMINYTFVRSWIAQLT
EAGVSHRSINRKISSLKAFYKFLLKTGNITHSPLAQHKSLKMKKEIQVPFSEAEVDTVLK
ALQASEEFSDLRDLAIVSLFYATGMRRSELINLKISDVDFSAHNIKVLGKRNKERIIPLI
FWVEEGLKKYLEARENYGVDKNNPFLLLTNKGDKLYETFVYRIINDYFSKVSQKTKTSPH
MLRHTFATHLLNNGADLNAVKELLGHASLASTQVYTHTSIAELGRVYKNAHPRNFKKQ
>KECLDBNJ_03096 hypothetical protein
MKVNVQTPHFVADQKLINFIQKKMDKLEKFYDHIIYADVFLKLENTSDRQNKIVEILLSV
PGNELIVKKQAKSFEEGADNCAHSLERLLMRRKQKIRASA
>KECLDBNJ_03101 Elongation factor Tu
MAKATFDRSKPHLNIGTIGHVDHGKTTLTAAITTVLANAGLSELRSFDSIDNAPEEKERG
ITINTSHVEYATANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFMNKVDMVDDEELLELVEMEVRDLLSFYEYDGDNGPVVQGSALGALN
GEQKWVDKVMELMEAVDNWIELPARDVDKPFLMPIEDVFSITGRGTVATGRIETGVANTG
DPVEIIGMGAEKLTSTITGVEMFRKILDRGEAGDNVGILLRGIEKTQISRGMVITKPGSV
TPHTKFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGNISLPDGVEMVMPGDNLTI
TVELINSIAMNVGLRFAIREGGRTVGAGQVTEILE
>KECLDBNJ_03103 Protein translocase subunit SecE
MAGLINYLQESYNELKNHVTWTPLSEAQRLTVVVVVFTIVFSLAIWGVDTVFSRAIKAYF
NLVGA
>KECLDBNJ_03104 Transcription termination/antitermination protein NusG
MAIANNTKDWYVVRAVSGQENKVKGYIEQEISRFNLEDYIEQVLVPTEKVVQIRNGKKIN
KERVYFPGYIMIHANLGGEVTHMIKSINGVIGFLGETKGGDPVPLRTSEVNRMLGKVDEL
AVKTDNVAIPFVLGETVKVIDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSYMQ
VEKV
>KECLDBNJ_03105 50S ribosomal protein L11
MAKEVSKVVKLQVKGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKAGKVLPVVITV
YGDKSFDFVVKTPPAAIQLMEAAKIKGGSGEPNRKKVASVTWDQIRAISEDKMPDLNAFT
VESAMRMVAGTARSMGITVKGQAPF
>KECLDBNJ_03106 50S ribosomal protein L1
MAKVTKKQKEARAKVDSGSTYTLAEASALIKEVSKVNFDPSVDLAVRLNVDPRKANQMVR
GVVTLPHGTGKDVKVLALVTPDKEAEAKEAGADFVGLDEYLEKIKGGWTDVDVIVTMPSV
MGKLGPLGRVLGPRGLMPNPKTGTVTMDIAKAVSDVKAGKIDFKVDKTGIVHAAIGKASF
DAEKIAANARELITTLVKLKPTAAKGVYIKSIFMSSTMSPSVEVDSKRFAEQ
>KECLDBNJ_03107 50S ribosomal protein L10
MTREEKSQVIEDLTAQLADSANIYLADISGLNADTTSKLRRACFKANVKLAVVKNTLLAK
AMESSEKDFGELPEVLKGNTSIMLSETGNAPAKVIKEFRKKSEKPLLKGAFIEEAIYIGD
DQLDALVDIKSREELIGEIVGLLQSPAKNVISALKSGGSTIAGLVKTLQEREG
>KECLDBNJ_03108 50S ribosomal protein L7/L12
MADLKDFAEQLVNLTVKEVNELATILKDEYGIEPAAAAVAVAGPAAGGDDAGEEQTEFDV
ILKAAGGSKLAVVKLVKELTGAGLKDAKELVDNAPSPIKEGIAKDEAEAIKSQLEEAGAE
VELK
>KECLDBNJ_03109 DNA-directed RNA polymerase subunit beta
MQAKQAERLNFSSVKNRPEYPDFLDIQIKSFQDFFQLETKSEERGNEGLYNTFLENFPIT
DTRNNFVLEFLDYFVDPPRYSIQECIERGLTYSVPLKARLKLYCTDEEHEDFETIVQDVY
LGTIPYMTPSGTFCINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEF
ATDINSVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEVKVSKTGLKKYLGRKL
AARVLNTWHEDFVDEDTGEVVSIERNEIVLDRDTVLEKEHVDEILDAGAKTILLHKEDNQ
LADYAIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYNLGEV
GRYRMNKKLGLDIGMDKQVLTKQDIITIVKYLIELINSKAEIDDIDHLSNRRVRTVGEQL
STQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLAVYAK
VNNMGFIETPYRTVTDGKIDLETKPKYLSAEEEEGMLIAQANNPMDDSGKIEEERVIARM
EGDFPVVEPNTVHYADVSPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLRADSP
IVGTGLERQVASDSRVLINAEGDGEVEYVDANEITIKYDRTDDERMVSFDGDSKTYQLIK
FRKTNQSTSINLKPIVRRGDRVKKGQVLCQGYATEAGELALGRNMKVAFMPWKGYNFEDA
IVISEKVVRDDIFTSIHVDEYSLDVRDTKLGNEELTNDIPNVSEEATKDLDENGMIRIGA
EVKPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLRGVVIDKKLFA
RAIKDKRKRAKDKEDIAALEAEYDQKFDDLKAILVDKLFQLVNGKTAQGVKNDLGEEVLP
KGKKFTLKMLNAVEDYTHLNQGTWTTDDATNVLIADLLHNYRIKENDLQGNLRREKFTIS
VGDELPAGIIKLAKVYVAKKRKLKVGDKMAGRHGNKGIVARIVRQEDMPFLEDGTPVDIV
LNPLGVPSRMNIGQIYETVLGWAGQKLGRKYATPIFDGATLDQINELTDEAGIPRFGHTY
LYDGGTGDRFDQPATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQRFG
EMEVWALEAYGASATLREILTVKSDDVIGRAKTYESIVKGEPMPEPGLPESFNVLMHELK
GLGLDIRLEE
>KECLDBNJ_03110 DNA-directed RNA polymerase subunit beta'
MARDNDKNAVKRFDQISIGLASPEAILAESRGEVLKPETINYRTHKPERDGLFCERIFGP
VKDYECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPVAHIWYFRSLPNKI
GYLLGLPSKKLDMIIYYERYVVIQPGIAKNEEGEELKKMDFLTEEEYLNVLESIPQENMY
LEDSDPNKFIAKMGAECLVDLLRRIDLNELSYDLRHKANNETSKQRKTEALKRLQVVESL
RDANKNRENLPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLM
EIKAPEVILRNEKRMLQEAVDSLFDNTRKSSAVKTDSNRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPELKLYECGLPKDMAAELYKPFVIRKLIERGIVKTVKSAKKIIDK
KEPVVWDILENVLKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFNADFDG
DQMAVHLPLGPEAILEAQMLMLASNNILNPANGAPITVPSQDMVLGLYYMTKARKSTPEH
PILGEGITFYSAEEVVIAHNQKRVNINANIKIRTKDFNENGELVYQIIDTTVGRVLFNES
VPEECGYINEVLTKKSLRDVIARILKLTSVPRTAEFLDSIKTLGYTFAFRGGLSFSLGDI
IIPAEKYEMIEEANTQVDGIMSSYNMGLITNSERYNQVIDVWTSTNASLTELSMKRIRED
QQGFNSVFMMLDSGARGSKEQIRQLTGMRGLMAKPKKSNDGGGAIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIVNSEDCGTLRGVEVSALKKNE
EIVETLEARIIGRIALNDVVNPLNSEVIVEAGAEITEELGAEISKAPIESVEVRSPLTCE
ASKGICAKCYGRNLATNKMVQMGEAVGVVAAQSIGEPGTQLTLRTFHVGGIAGNISEENK
VVSKFDGRLEIEDLKTVEGEAPDGSTSQIVISRTSEAKIVDAKTGILLSTNNIPYGSQLF
MKDGDKVAKGDTICTWDPFNGVIISEFAGKIKYENIEQGVTYQVETDEQTGFQEKVISES
RNKRMIPTLHIMGKKDEVIRSYNLPVGAHLMVDDDEKIKIGKILVKIPRKSAKAGDITGG
LPRVTELFEARNPSNPAVVSEIDGVVSFGKIKRGNREIIVESKLGEVKKYLVKLSNQILV
QENDFVRAGMPLSDGSVTPEDILAIKGPSAVQQYLVNEVQEVYRLQGVKINDKHFEVVVR
QMMRKVRIQDPGDTIFLENQLVHKDDFITENDAIFGMKVIEDAGDSETLKAGQIISPREL
RDENSILRREDKNLATARDVVAATATPVLQGITRASLQTKSFISAASFQETTKVLNEAAV
SGKVDTLEGLKENVIVGHRIPAGTGLRRYDKIIVGSKQELEELNAAREEVNFN
>KECLDBNJ_03111 hypothetical protein
MTEDEKNKNGQLNIELDENVAQGQYSNLAIINHSVSEFVVDFINIMPGTPKSKVKSRIIL
TPQHAKRLAKALQENVKRFEKAHGEIKDYEKQPIPLNFGPTGQA
>KECLDBNJ_03112 Peptide chain release factor 3
MSIKKEIARRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEIE
RQRGISVATSVLAFEYNGTKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQT
EKLVQVCRMRKIPMIVFVNKLDREGKDAFELLDEIEQKLDLNVTPLSFPIGMGYDFKGIY
NIWEKNVNLFSGDSRKNIEETIEIEDISSTELDKLIGSESAETLREELELVTGVYPDFDQ
QAYSKAEQQPVFFGSALNNFGVRELLDCFISIAPPPRPKESEERIVKPEEKDFTGFVFKI
HANMDPKHRDRLAFVKIVSGVFERNTPYLHVRNGKKLKFSSPNAFFAERKEIVDISYPGD
IVGLHDTGNFKIGDTLTQGEEIHYKGIPAFSPEHFRYINNADPMKSKQLEKGIDQLMDEG
VAQLFTLELNGRKVIGTVGALQYEVIQYRLEHEYGAKCTYEPLSVHKACWVEPKDPKSEE
FKEFLRVKQRFMAKDKRGQLVFLADSPFTLQMTQQKYPNVKLHFVSEFK
>KECLDBNJ_03113 hypothetical protein
MINNTLLNFLFSYPRLIITITMLTLFTNGVIAQSSVSLTYSRDLDHSLSETIQYYTIDVS
NINSSKTTYELTAALVDCNDGSLADKEVQFELNSEAGAVINSITVDAASKATFTLKTTKI
DLDTTSWSCVEIQLIPKGGLRSQGGSVVIKQLNPGNSNSK
>KECLDBNJ_03114 hypothetical protein
MPDANALPDGTYDVMATATDAAGNSSSDATTDELTIDTTAPTVPTVDLLTTNDNTPTITG
TADSADDLTVMLNGITYTEGDGNLTDNGDHTWTLVVPDANALPDGTYDVMATATDAAGNS
SSDATLDELTIDSTGPGIPTVNSQTTADVTPTITGTADSSESLTVSVNSVTYVEGDGNLV
DNGDDTWTLTIPDGNEIEEGTYDVMAQSSDGVGNTSVDATIDELVINIGIPSGDDNQVFC
STDPVTLQDIVLDQSNIVWYDQQTGGVQLDPTTPLADGVTYYAALVVDGVEGNGRFGVTV
MLTQPTTASIEASQANACLGTEIIYTTQSGMSNYMWTITSGGSITSGGGLDDNFVAVIWD
IPGNNTVSVTYDTTLSCIVETSADLEVIAEACSDLSISKSVNLMNPAIGEQVTYLIEVTN
TGETDITNIQVSEALPSGLEFDSFTAPIGNYNPLTGVWTIPSLAANSSTTLTVVATVLST
GDYRNVAEIITSTPIDSNTGNNTSEVEIDPDCLMVFNEFSPNGDGMNDLFTVRCIEKYPN
NTVNVYNRVGQLVFTASGYLNTWNGDSNVANSINKSSGLPAGTYYYAIELGEGERTLTGW
IYIAR
>KECLDBNJ_03115 hypothetical protein
MTKIVTTLIKLMIVACSAAGIYGQQAPNYTQYMYNTMTVNPAYAGSSDALNITANYKAQF
TGIDGAPETINLGLETPVTYNVGLGLNITRDALGPSEDLNIDGNFSYAIQLAERTYLSFG
LKAGFRVLNVDFRKGVFDNPNDPSFMNNINNQFLGVLGAGTYLYSDQWYLGLSTPNFFSQ
EYYDEEDDFVNTEQLHVYLIGGYIFDISQNTKFKPAALFDYVEGAPIRANLSANFLFLER
FTIGAGYSMDAAVSALAGFQVTNNIFIGYAYDYNTSDFNQYNEGSHEILIKFSLARRRGA
TFSPRFF
>KECLDBNJ_03116 Outer membrane lipoprotein Omp16
MRTIYILLLFISVNTFAQSNLKKANELYDRHIYIEAAPAFEKYMASAKKENVTPDIYMKM
GDVYYNLKDYYKAKEYYEIWYKKVGPNQDNSQGFQYYDTLRYLKEYDKASQVVELYLKEK
GTPEMLNAYYEEKSRFEELIKGDTLYTIKNLELNSQYADFGGAISEGTFVFTSARNKEAN
KIYERDNTPYLAIYKADMNGPESFSNIGLFNKELETPYHDATVSFSPNSKYIYFASSAQD
NNRKIFTGDKRNYFNIYRVDLTAKKIKKELLPFNGETYSSGHPFVTEDGTKLFFASDMPG
GYGRADIYVCDIYEDGTYSKPRNLGPLINSIVDDYFPFYKDNTLYFSSEGHVGFGGLDVY
KTNFQDGIFGAVINLGPNINSNADDFAYVAGLEPDSGYFSSDRAGGKGGDDIYSFKYNVK
ECLQTITGTVYDLETKEILSGAKVTAYINGDQVHQEVITDEKGSYTMMLNCETTYTLEAT
KAGYGEDALDFSTDLIPGHLMDMVDFRLKDLSEIFVTDGDVEKIRIDPIYFEYYRYNIND
VAAIQLKRVIEVMDSYPEMIIKIESHTDQRGTDYFNKTLSSNRANSTKDWLIENGIDPSR
IESAIGYGESRPIHICDEDGKTCTELEYSENRRSEFIVVSR
>KECLDBNJ_03117 Sodium-dependent dicarboxylate transporter SdcS
MKFNKFIFLVLGPVLFLILQQLDAPTGMSQPAYDILCVTIWMALWWVTEVVPIAVTALLP
IVLFPLTGAVDISTTTASYGHKYVFLYMGGFILAIAIEKWNLHKRIALHIIKIIGTNVKN
IILGFMVATAFLSMWISNTATSVMMLPIGMSIVSQLKDNPNTIADENMIFGKALMLGIAY
SASIGGVATLIGTPPNLVFAGYIEEVYAIDISFFQWFKFGFPISLILLVISWWYLTNIAY
SFKQKDFPGGKAEINRLLKELGPMQREEKTVLVVFTTTAICWITRSFFLENWFPGIDDTI
IAIAAGILLFTLNASGKGKRILHWEEAVNIPWGIILLFGGGMALASGFEVTGLAKWFGLQ
MTLLDALPLLLIILLVIFSVNFITELTSNLATTAMLLPILAPIALELDLNPYMLLVATTV
AASCAFMLPVATPPNAVVFGSGYLKIPDMVKAGFWMNIVSIILLTLFVYFMLPVVWDFDP
YGFSKKFVTEGISG
>KECLDBNJ_03118 Ribulose-phosphate 3-epimerase
MTPKYLAPSILAADFANLERDIKMVNASDADWLHVDVMDGVFVPNISFGMPVVQAITQHA
KKVIDVHLMIVDPDRYIKTFAALGSTNLTVHYEACTHLHRTLQAIKAEGMKAGVALNPHT
PVHLLKDVITDIDQVIIMSVNPGFGGQSFIENTYRKVRELKEIILTHNANTLIEIDGGVT
DHNAKQLIESGADVLVAGSFIFKAENPTETIKTIKELIS
>KECLDBNJ_03119 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKTYAFLEQANERPPSPEEIAKELDMTVNEVKESLKNAGRHV
SMDAPLIEGEDSNLYDVLRSGESPNPDRELLSESLSTEIERALETLTPREADVVRLYFGL
GHQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>KECLDBNJ_03120 Sensory/regulatory protein RpfC
MSSFIDRLLNHRATRITKSDSTEDPIKNFFNYLISLGTPGPRLKLLESKIENFEFPEDAY
LAEICVVNFYLDLEFYLINHDARYINTEEKLRLQIKKQFPKIANSNAFLPLYTSGKNQEI
SLAQLFLITILKKFKDEDPELNTTISWLNSLEKAYHAEPSSDLVQQINSFRRIKDDAYKI
NKEFGEIFGQDFVDSAFSGTKEEFFSYYEKLNAVVAINDVMPQLFTSLLNESANKDYFKP
PIEPLPPQEPPLPKQKPSAHSAQTTHVDVLENLLDGYLLFDNSGAIKGMNTLSTRIFGLE
KEQLKQTSVYKLFPEAISTKLHKDIQNLYKQQPLALIGNRVELDIKNTQGELMPYEVTFT
NNYSEPVDTFSLFIRNITERKDTLKAKMNAERTAEAKTTFLSNMSHEIRTPLNVILGLSE
ILIKKGFDDKQLLKKNLEGISFSAKNLLSIVNDILDFSKIEAGKLTLQSSDFNLAEVVSN
LSNAFEVKAREKGLKLNTEIDPSIPDIVIGDQYRLNQIITNLLGNAIKFTKRGVIQLDLK
LVEETAESVKIKFTVKDTGIGIPAEQLNKIFDSFYQVDEPEHAKINGTGLGLSITKELIN
LQGGKLSAESLVGEGSTFYFDLSFEKSKRKKLQDLEKPVDGKPKHLKGLTVLVAEDNKMN
QFYIRQLLQGLEVQADIAENGEEAVAIYTNAPKKYDLILMDMHMPVMNGLDAIAAIRRSE
QDQLNKVPIVACSADVFPEARKNAIKAGIDFYLTKPLKEEALKEVLYWLISDNSSSERSV
EQKQQHPKPPEPQKAQPEMAPSCIDLNQLFAIFDNDKDFVIALLEVFITETPEDFNSLRN
CVEREYYARASTLAHKMKSSFMNLGMTEHGHHLQQIETHLKNADKIEEAKTHLKAFEMLY
NKALVDVNLQLIGLKEV
>KECLDBNJ_03121 Gamma-glutamyl phosphate reductase
MQLLNSDIKNKVLDSMMNIIESRKSEILEANKKDLEAFNRDDQALYDRLVVNDAKISGMI
QAIKEVRDQEDPVSQEISNTTLDSGLKIINKTAPFGTIMIIYESRPDVTIEAAVLAFKAN
NKILLKGGKEAHHSNVVLVDCWKQALRENDLDESWITMLQMNREETQAFLKNPDQPLDLI
VPRGGERLIGFVKEHAKCAVLVSGRGNNFLYVHPKADWAKTIEVIINAKTDKISGCNALD
KVLVDKNIADYEAKIKELDQILKAKGVEVLADEASKEVLSDNTVIPNEDTWYEEFLAMKI
VLGAVDSMEEAMEKINTYSGGHSSAIMTTDKEAATTFMENIDTAAVYHNASTRFTDGGQM
GVGAELAISTDKLHHRGPLGLKQLVTNKYYVFGDGHVRV
>KECLDBNJ_03122 Glutamate 5-kinase
MSTKRVVIKVGTNVMTNRNNRIVGPVLHELVRQIAELYEKGYQPVLVSSGSAIAGKEVLG
ECNYEDASTRRQIFSSVGQPRMMRHYYTLFNSFGMHCAQLLATKRDFAPGKHRENMINCY
EGLLSEGIIPIANEDDAVSLTMSMFTDNDELASLVAELINADALILLTDTDGLYTGHPDD
DESEKLTEVHPEQKVEQYVQENNKAEGEGRGGMKSKLKIAKETARKDITCFIANGKKPNV
IVDLLEGKEIGTKFQA
>KECLDBNJ_03123 Pyrroline-5-carboxylate reductase
MKVLVLGAGNMGLTYAEGMANSPFLNKRKLMIFDVSPQKTEALSTMAQFDAYDSIEECVP
QADVIFIAVKPYHSQSLFDSIKPYINQDQLFVSLMAGVTINTIQEGLGVKKVIRTMPNLP
AKVGKGVTSFTESKEVSRVELLTVRSLLDTTGESIHVETEQFIDASTGISGSGPAYVFYF
MQSMLEAALKMGFSPNDSKVLVSQTFEGAVKLFNESDLTPEKWMDRVASKGGTTRAALDS
MEDNNVKELIKEAAYAAFDRATELGKEK
>KECLDBNJ_03124 Polyribonucleotide nucleotidyltransferase
MIPKTFKEVIDLGDGREISIETGKLAKQAHGSVVVQSGKCMLLCTVVSNYKQSDVDFLPL
TVDYREKFAAAGRYPGGFFKREARPSDGEVLTMRLVDRVLRPLFPKDYHAETQVMIQLMS
HDEDVMPDAMAGLAASAAIQLSDFPFECAISEVRVGRVNGEFIINPSRTQLAESDIDMVI
GASADSVMMVEGEMDEISEEEMTEAIKAAHEAIKVQCEAQIRLAEAFGKKPTREYEPEVE
DAELEKKVYDLTYDKVYEVAKAGSSKHERSTAFDAIKEEVKGTFSEEDLEAFGDLISKYF
YKAEKAAVRDLTLNEGLRLDGRKTTEIRPIWCETDYLPSVHGSSIFTRGETQALATVTLG
TSREANQIDMPSYEGEETFYLHYNFPPFSTGEARPIRGTSRREVGHGNLAQRALKGMIPA
DCPYTVRVVSEILESNGSSSMATVCAGTMAIMDAGVKLKKPVSGIAMGLITDVESGKYAV
LSDILGDEDHLGDMDFKVTGTADGITACQMDIKVKGLSYEILVKALHQARDGRLHILNHL
TDTISEPRGDVKDYAPKMVTTRIANEYIGALIGPGGKVIQELQKETGTTIVINEDPVTEE
GIVEILGTGTEGINAVLAKIDSITFKPKVGESYKVKVIKMLDFGAVVEYLAAPGNEVLLH
VSELAWERTENVSDVVNMGDEFEVKYFGIDSRTRKEKVSRKALLPKPEGYKERAPRNNDN
KDRGSRDNRGRDNRNKDRKRD
>KECLDBNJ_03125 30S ribosomal protein S15
MYLTQEKKDEIFSQYGKDKNDTGSAEGQIALFTHRINHLTEHLKRNRKDFNTERSLVKLV
GKRRALLDYLTKKDINRYRAIVKELGLRK
>KECLDBNJ_03126 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAWFKRKEKGIQTATENKKDVPKGLWYKSPTGKIIDADELAKNFYVSPEDDYHVRIGSNE
YFSILFDEGKYKELDKNLTSKDPLGFEDTKKYVDRLKDAEAKTGLKDAVRTAVGKSMGKD
LVVAAMDFKFIGGSMGSVVGEKIARAADYSLKHNVPLVIISKSGGARMMEAALSLMQLAK
TSAKLAQLAEAKIPYISLCTDPTTGGTTASFAMLGDINISEPGALIGFAGPRVVRDTTGQ
ELPEDFQTAEFLKEHGFLDFISHRKELKKNINLYIDLILNQPVRN
>KECLDBNJ_03127 Fructose-bisphosphate aldolase class 2
MSHSIKPGVATGKEVQAIFKHAKENGYALPAVNVIGSNTINGVLETAAKLNAPVILQFSN
GGAQFNAGKGYANDNQQAAVAGAIAGAKHVHELAKRYGATVILHTDHCAKKLLPWIDGLL
DASEEYYKEHGHSLFSSHMIDLSEEPIEENIELCKKYLERMSKMEMTLEIELGITGGEED
GVDNSDVDVSKLYTQPEEVAYAYEELSKVSDQFTIAAAFGNVHGVYKPGNVKLTPKILKN
SQEYISEKYGVGENHIDFVFHGGSGSTVEEIREGISYGVIKMNIDTDLQWAFTEGIRKYF
DANADYLQTQIGNPTGEDSPNKKFYDPRVWLRKGEESFVARLEKAFEDLNNVNTL
>KECLDBNJ_03128 Outer membrane protein assembly factor BamA
MCIFEVIFIKKPLQKLSAKIGLFIILLLVLAACDAVKRVPQGKYLLSENEIVVNGEVNEA
YNINNIPYLQPNTKVPLLGTPVRLYIYNWARPNLDTILQHKLNDNDQRTLKFWSGVLSRK
QLDKYIKFKLGFNDVLKDFGEEPAIITENLTKRSADRLTEYYNSKGWFNAETTYEIEKDS
ANKRAKVIYSVNTQRPYIIDSLKTFIKSAAADSIYQAHKNESFIKKDAQYELLDINAETS
RITELMRNNGLFHFDQEFISFVGDSVNTNHRVNLEMNIRNREIRGRDSVYELPLKVHKIS
KVKVTTDYGYALRNDTYSDSLVRDDHYLYAYDKLRYKSKRLIDAIFIEPGETYSDEARNQ
TLIRLSQLGTFRYPDLRFSEDPDDPEGTDLIANILLTPLPKFNLRADFDISTSNIQRFGI
AGGGSLRIRNVLGGMETLQISGRASIGDSRTAAGSNSPELFDITEIGADVSLTIPRIFFP
IRTNFIAPEMSPSTSFTTGIGIQQNIGLDKQNVTGGINYKWTPSENLNYRFDLFDIQYVR
NLNISNYFNVYENSYDELNTIALGYPTQVLPYLNEDGNLDIPDGALDFINAVQNRNIAVT
TTEFNDVVNIEERRQRLTEDNLILASSFTYYKNTRDNLFDDEFTSFRAKLEVAGNTLSAI
SNLIGLEENENGSSRVLGVTFSQYVKTELDFIKHWDFGNDNILAVRAYGGIAIPYGNSNS
IPFIRSFFGGGSNDNRAWQAYRLGPGSTDSPNDFNEANMKLAFNAEQRFTFLGDLKGAIF
ADVGNIWNALDNIEDPQATFTGLKSLEDIAVGTGFGLRYDFSFFVLRFDIGFKTYDPALP
NGERWFKNTNFSNAVYNVGINYPF
>KECLDBNJ_03129 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MVSKSQIKLITSLSQKKYRQQHGLFVVEGIKGIQEFLDSHYTLHSLYALKGYFEAQNAIE
IAEAALKKISFLKTPQKALAVFEIPKLSSEKEAGFQLVLDDVRDPGNLGTLIRLCDWYGI
KTLVCSQQTVDCFNPKVVQATMGSLTRVKVHYTNLDTYLSGQTLPVYGAFMDGENVYRAS
MLEDAILVLGNEANGISSAVSEKIQHKICIPQFGTSTTESLNVAIAGAILVSEFKRG
>KECLDBNJ_03130 putative trans-aconitate 2-methyltransferase
MWEADLYREKHGFVFNYGKDLISMLNPQEGERILDLGCGTGELTAAIAESGAQLVGIDAS
QEMIDAAQSKFDGIEFITARGESFIDKKPYDAIFSNATLHWILNPEAAISAMYSNLKTGG
RLLLEMGGAGNIETIITALSAVLKEKGYIKQSRTINWYFPKLGTYCYFLEKSGFQVTFAH
LYERPTKLKDPETGIIDWLNMFAKHYFTDIPDAEADAIRKEVQEQVHQALFRDGHYYADY
KRLRICAIK
>KECLDBNJ_03131 hypothetical protein
MQKKLVLVFFLIWAGSQIQAQFLTRERILNDENFDKKSWSWGYYFGINRYDFNFDYKEDR
PDIYVEQNYGFNVGLLGNKRINEYLDLRFEPGLVYNARTLFYLDIPGDENDRIRELNSTY
IHFPLLLKFSTKRLNNFKPFVVGGFSYSHNLSSNEKNPDDNSSGQFRMTNNTFYYEVGFG
IDLYLPYFKFSPSIRGVFALSDELVRDEDPNSLYTSNIEVMQSRGIFLNFTFQ
>KECLDBNJ_03132 Demethylmenaquinone methyltransferase
MSGNVNPYKNSDRSKREQVEQMFDTISKEYDGLNRVISFGIDVKWRKKVVNMVAATQPKR
ILDVATGTGDLAINLAKTDAEKIIGLDISAGMLQVGKDKIASKNLSTTIEMVQGDSENLP
FEDNYFDAITVAFGIRNFETLEKGLSEILRVLKPGGIFVILETSVPTKFPFKQGYGLYTK
TLLPLIGRVFSKDRDAYAYLSESASVFPYGEKLNNILRKTGFTHVEDHPQTMGVATIYSA
SK
>KECLDBNJ_03133 Trk system potassium uptake protein TrkA
MQGFAHKVTAKGVGFLSMFEPNSNCLTPRVAGCLLKIAMKIVIAGAGEVGFHLAKLLSFE
SQDITLIDVDKDSISYADTHLDIRTIRGDSTSIAVLKEARIDTTDLIIAVTASETTNITV
CVLAKQMGAKRTIARISNTEFIENQEVAGFKKFGIDELISPESLAASEIELLLNQSAFND
SYEFENGALTMVGTSLSRTASFVGKSVKEAARIFPTLHFMPIAIQREGTQYTLIPRGDTI
FKEGDQVYFMTVKEGVEELYKLTGKMKQEIRNVMILGGSKIGYKTARDLCSHNFKVKLVE
KDNDKAYDLAENLPKTLVINGDGRNVELLEEENIYDMDAFIAVTGNSETNIMSCLVAKSK
SVKKTIALVENMDYFQLSHSIGIDTLINKKLLAANNIFRYIRKGDVVAMTKLNNMNAELL
EFSAKPNSKVIGKRIRDLDFPRSATIGGIVRDGKGIIPLGENRIEVGDRIVVCCLLRSIN
KVERMFI
>KECLDBNJ_03134 Trk system potassium uptake protein TrkH
MGVLLLFNGAFMLVSAIVGYFYDAVSVAVGIISAGLLTVFLGMIFMFFTRDHKKEIQKRE
GYIVVTFGWIFMSLSGCLPYLFTGSIPSFTNAFFETISGYTTTGASILNDIEAIPNGVLF
WRSTTHWIGGMGIIVLAIAILPLLGIGGMQLFAAEAPGPNADKLHPRITDTAKRLWLIYF
GYTVAETILLQIAGMSFLDAVNHAMSTLSTGGFSTKNASVAYWNDNPAVQYIIILFMFLA
GTNFVLSYFAFKGKLRNVWKDEEFKLYSAFTVGFTLLVVLIIIFRADVSVSSIDHPMVLG
EYESAIRHGLFQVISVITTTGFVSADFTMWAPFATIIFFGLMFLGGSAGSTSGGIKVVRH
LMIVRNGVLEFKRTLHPNAILPVRHNGKAVKKEIVFNILAFFILYLLAWIIGACGLASMG
LDFPTALGGSASSLGNVGPAFGILSPVNNFDALPVLGKWWCAFLMLIGRLELFTVLILLT
PFFWRNR
>KECLDBNJ_03135 Thioredoxin reductase
MKNYDLIIIGGGPIGLACGIAATKANLNYIILEKGVLVNSLYNFPEQMTFFSTSNLLEIG
DVPFVAHNDKPTRKEALEYYRRVYDSWKLNVQLYTPVESMTQSEGGYVLQTPKGAYNTSA
VIVSTGFYDTARRLNVPGEELAKVRHFYDSPHPYVNQKILVVGAANSACDVALETYYKGA
EVTMAIRSNEIYPKTKYWIKPNIENRIKEGSIKAYFESTVEEIKPHSVILNTPDGTVELE
NDFVLAMIGYTPDFNLFERLGIPVDEENHKKPIHNEETLETPLPNVYVAGVINSGLKTSK
LFIENTRVHADMIIKDLKKKLAVTSE
>KECLDBNJ_03136 Immunogenic protein MPB70
MKTRNLFSTMLVALMMVATTQVFAQETKMVGGAAMFPTKNIVENAVNSKDHTTLVAAVKA
AGLVETLQGEGPFTVLAPTNAAFEKLPEGTVANLLKPENKKALQGVLTYHVIAGKNSAAA
IIQDIKDGGGTAEWTTVNGQKLWGMLDGDMVQIKDQAGNVATVTIADVNQSNGVIHVIDT
VLLPEM
>KECLDBNJ_03137 Aspartate aminotransferase
METLTNQLSDRINNLAASATLAMAAKARELRAEGKDIIGLSLGEPDFNTPDFIKDAAIQA
VNDNYNSYTPVDGYVELKDAIINKFKRDNKLTYDRSQIVVSTGAKQSLYNVAQVCLNPGD
EVLLPCPYWVSYSDIVKLAEGVPVEIETSLDTDFKMTPEQLEAAITPKTKMLWYSSPCNP
SGSIYSEAELRALADVLQKHPQIVVVSDEIYEHINYVGGHASMAQFEDMYDRVVTVNGVA
KAFAMTGWRIGYIGAPSYIARACNKIQGQVTSGANCIAQRAVITALEAPVSKIQYMVDEF
KERRKLILGLFNNIEGFECNEPEGAFYVFPNISHYFGKTLNGTTINNASEFALYILEQAN
VATVTGEAFGNPNCIRISYAASQDQIKEALARIKKAVS
>KECLDBNJ_03138 NADPH-dependent stearoyl-CoA 9-desaturase
MEDTKTIKFSRVDSAKFFRTLNKRVNAYFKDNNVERTGNWKLYVKTIVMFSLFLTPYFLL
LSIDMPGWAQLLLTIVMGVGMAGVGMNVMHDGNHGSFSKKKWVNKVMGSSIYILAGNVYN
WQVQHNVLHHTYTNIHGHDEDLEAGRILRFSKHAKWYKHHRFQHYYSIFLYGLLTFNWAL
TTDFLQMKRYLKRKLSYGEFPNPKLEWTKLVITKLIYLSIWIILPLLILDIAWWKVLLGF
FVMHYTAGVILSVVFQLAHVIDEADMPLPDQTGTMKNTWAIHQLFTTVNFSTKNKIVNWF
TGGLNHQVEHHIFPHISHIHYTKISKIVKETAQEFNLPYNEYKTTRKAVIAHFRYLKEMG
MRPALQTA
>KECLDBNJ_03139 Ribosomal RNA small subunit methyltransferase G
MELIKHYFSDLDENQLIQFGKLNELYQDWNLKINVVSRKDIDEIYLRHVLHSLGIAKVQA
FKPGAQILDVGTGGGFPGIPLAILFPETQFHLVDSIGKKIKVVEEVAAGLNLKNVKITND
RVENISGEYDFIVSRAVAQMETFVRWIKGRIAKKSEHQLKNGILYLKGGDLTEELQLYKS
AKIYDLSDYFKEDFFETKKVVHLPLKYKG
>KECLDBNJ_03140 hypothetical protein
MTTEDNKMYVLKVKYSVIDVSKKKSKRRITRKKEKLYLVRDPESIDDKLKELEDTLLEID
QEQRTTLLNRAKDFLRSFGTRCNRTYLNMLRT
>KECLDBNJ_03141 1-pyrroline-5-carboxylate dehydrogenase
MSKGFFEVPVAINEPVKSYAPGTPEREEVLKAYKNLYNSTIDVPLYINGEKIETSNTRTM
SPPHDHKHALGKYSLAEKKHVEDAISTALEARKKWAKMPWEQRAAIFLKAAELIQGPYRY
KINAATMLAQSKNIFQAEIDSACELIDFLRFNVQYMSEIYSEQPESSAAAWNRVEHRPLE
GFIYSVTPFNFTAIAGNLPAAPALMGNTVVWKPSDSQVYSAQVIMEVFEEAGVPAGVINM
VMGDPEMITDTVLASPDFAGIHFTGSTHVFKDIWAKIGANIHTYKTYPRIVGETGGKDFI
LAHPTANPKQVATAISRGAFEFQGQKCSAASRVYVAKSIWSEVKEFLLEDIKSFKMGSPE
DMSNFITAVIHEGSFDKLAKYIDQAKEDSEAEIIAGGNYDKSTGYFVEPTVIVTTDPKYT
TMTTELFGPVVSIYVYEDADWAKTLELVDDCDYALTGAVLSGDRYAIVEATDALQNAAGN
FYINDKPTGAVVGQQPFGGARASGTNDKAGSVLNLLRWVSPRLIKETFVTPEDYRYPFLG
E
>KECLDBNJ_03142 Protein ApaG
MVEQVTKGIRVSVDTYFEGSFTKEGMLFYAFGYKVSITNNSEDTVQLLSRSWDIYDALNI
QEKVVGEGVIGQKPVLKPGETHTYSSGCLLRSPFGAMNGYYTMINFTNSAQFQVSIPTFK
LSATHLLN
>KECLDBNJ_03143 hypothetical protein
MGKQLEQTSRKSLRYRGNECLNCGHPLEISDRYCSYCGQLNSTKKLSLQDYFGEFIISIV
NYDSRFRYTVKDLLFKPGVITRNFTSGKRMRYANPFRFFLSVSIIYFLLSGFLDFIQIAD
AESEENPSLQNIFNFQDDDDQAEIPLDSINYYKTLALNTKDKDSLEQLPLIYRRESSLDT
LNFVSRTAFKLKMFHIFSLQTKVENPYQALDSLEYSKSKLNVWLYDREKGLKRIQENPVA
FGQYLAKKIPVFLFFLAPLFACFFLLLYYKSESVRFHKNKLRATSRKKLQSLFKTPYIGG
FCLYCLASLRSVFVVRRSYNYMEHVIFIFHIFTFLFLVLLLLLVPEFLMGSSLLSGLFIS
FVAPFYFYKALRNFYQESRLRTLMKFFILNIVFLMLGILTGSVFFFLTAALY
>KECLDBNJ_03144 hypothetical protein
MKTFSTLFLLLAICSLFGQVATEVPAPPYIKSVQFYGNTAQSQLPVIRLGDPLNLSFDDI
IGDEADYYYTITHHNYDWTTSVLAKTEYLKGVDDVRIMNYTNSVSTLQLYTHYELQIPNQ
YSTAILKSGNYLLSIFNNDDELIFSRKFMIYDPQVTVGVEVLRTRNLEFIEEKQVVNFNV
DSGENILINPDETVKPLIIQNNDLKRSVGNIPPQYSIGNLLQYRYDDETSFYAGNEFFDY
DNKDIRAATNRVQYIELLKLYHNYLYGNNTRKDGVYTYNPDLNGNFQINTIQGDQPKVNA
EYAWIHFSLDHPQRPEGEEIHLYGNFNNFVIEDATKLQFNPENQRYELPILLKQGYYNYR
YVVVKDGKMLKYNPVDGDFWQTENVYDVLVYYRAPGSRYDELIGRGNALSTSISNVRRD
>KECLDBNJ_03145 Na(+)-translocating NADH-quinone reductase subunit A
MSKDIKIKKGLDIKLVGEAEKTLAEAPKSRTYVIKPSDFHLVTPKMLFKEGASLKAGEPL
FFAKKDESIKFVSPVSGTLTEIKRGAKRVITHLVIEADGKDTTVEFPTLDVATANAEAIK
ARMLESGLWPFIKQRPYDIIASTKTTPDAIFISGHNSAPLAPDYNFSLKGKEAYIQAAIT
ALSKLTSGKIYLGVAKAADSVFANISEVEMHTVSGPHPSGNVGTQINKIAPINKGETVWT
IAPENLAIIGELFLTGKFNPERVISVAGSGVKAPKYYRTKIGAEVSTFAYSAGVEGDNVR
MISGNVLTGAQVAADGHLGYYHNEFTVIPEGDDYELFGWNKPVFNKISSSRALTFSWLFP
NKKYDLDTNTNGEHRAFVVTGNYEEVFPLDIYPLQLLKACMVQDLDAMEALGMYEVAPED
FALTEFVCVSKQPHQAIIRKGLDLMHAEIG
>KECLDBNJ_03146 Na(+)-translocating NADH-quinone reductase subunit B
MGLKEKLHGIKEDFKGKKMAPAFNALHTFLYTPNETTHNGSHIRAVDDLKRTMNTVIMAL
VPVLIWGIFNAGYQHYAAVDAANGVIREASLFGNFFTWDNFTMGAITVLPLVIVSYAVGL
AVEFVFAVIKGHEVEEGYLVTGMLVPLIVPVDIPLWMLAVAVIFGVVIGKEVFGGTGMNI
LNPALTIRAFLFFAYPTWMSGDKVWVHGAKEAVGTPDAISGETILGSYAQNSSVVYDFTD
KFFGFIPGSVGETSTFLILLGGLFLMFTKIASWRIILSAIVGAAAMGLIFNGVVDAGWIT
ESSKFYGLMSTPYWEHLIIGGIAFGIVYMATDPVSGAQTNTGKYWYGFLIGFISIMIRVF
NPAYPEGVFLAILLMNVFAPTIDHYVVQANVKKRMKRLKLKTA
>KECLDBNJ_03147 Na(+)-translocating NADH-quinone reductase subunit C
MANTDKNSYTIIFAIVMVLVVGALLAFTASSLKPTITENERFEKQQNILYAMGINENVEG
SVNFIPTAEVEAEFSKYIKQQLVIQNGEVKQDSAAYLIDLKGELSKDMSERKLPLFVGEK
EGKDYYIIPLYGKGLWDAIWGFVALDADYVVQGVFFDHKGETPGLGANIKERYFMDDFTG
EEIMNGTQYEGITVAKGNNDPLNDRKDDGKVDAIAGATITGNGVTAMINSTVKLYIPYLK
DIKL
>KECLDBNJ_03148 Na(+)-translocating NADH-quinone reductase subunit D
MALLSKKDRGLIMDPLADNNPITIQVLGICSALAITAQLKASIVMAVSVLFVLSVGNVVI
SLMRNIIPSKIRIIVQLVVVAALVIIVDQVLKAFAYELSKTLSVFVGLIITNCIIMGRFE
AFALGNGPYRSFLDGIGNAAGYGAILIIVGFSRELLGSGTLLGFKVLGDPIEKTGLYAIG
YENNGFMLLSPMALIVVGIIIWVQRSRNKTLIEEN
>KECLDBNJ_03149 Na(+)-translocating NADH-quinone reductase subunit E
MEHVELFFKSIFIDNMVFATFLGMCSYLAVSKKVSTAVGLGAAVIFVLAVTVPMNWLLDQ
YVLRPGALTWLGPEYAEYDLSFLSFILFIATIATMVQLVEIVVEKFAPALYTSLGIFLPL
IAVNCAILGGSLFMQSRDIQTLGLAFNYGLASGIGWFLAILAIAAIREKIRYSNVPAPLR
GLGITFIITGLMAIGFMSFGGMLTGGEEKTETTDEVAKVEVQSQDTVEEEESLAEVSQEI
NNK
>KECLDBNJ_03150 Na(+)-translocating NADH-quinone reductase subunit F
MFLAASTGGVIAATVVAFLVLTLVLVGLLLFAKEKLSPSGPVKITINGEKEIEVDSGSSL
LSTLGGKKVFLPSACGGGGTCIQCECHVLSGGGEALPTETPHFTRKELAAGARLACQVKV
KQDMDITIPEEVFGIKKWEATVVRNYNVASFIKEFVVEIPEDMDYKAGGYIQIEIPETTV
KFEDIDITAHPEEHETPDKFKEEWDKFKLWPLVMKNTETVERAYSMASYPAEGREIMLNV
RIATPPFDRAKGGWMDVNPGVASSYIFSRKKGDKVTISGPYGEFFINESEAEMLYVGGGA
GMAPMRSHLYHLFKTLKTGRKVTYWYGGRSKRELFYLQHFYELEKEFDNFKFYLVLSEPL
EEDNWKVKEDIDSPGDGFVGFVHNAVIEQYLSKHDEPEEIELYFCGPPLMNKAVQKMGED
FGIPDENIRFDDFGG
>KECLDBNJ_03151 hypothetical protein
MAELLNKQELHNLAMNIVGKDLEAQGFEFLGVNSELKRNPQFVALRDKKLHFVIVRAVSY
PENANAYDEGFMSEMKLHADKFNAKTFYAGVGLGSAEDYGKPVEKGDSYTVIYNGLQEIE
>KECLDBNJ_03152 FAD:protein FMN transferase
MKYLLGLVLGLIAISCDTDPKLVVLSGQALGTGYQVQFYADERFEVSQKFDSTIAAINKS
MSTYQPDSDISKINAGNTTVVVDAMFKEVLALSRKVYQATNGYYDPTVGILVNAYGFGPG
KPLKQLDSTTLDSLKAYVGLDKIKISEEGKIIKDDKSVYLDFNSIAKGYCIDRIGAMLEE
NGVEHYLIELGGELLAHGKNLSKDQAWRVGIENINAPVTDRDYTEAVSLENKGMAGSGNY
RKFRVDSVTGQRYVHTVNPLTGLAEKSDVLSSTVIAKTCAEADAYATAFMALGFERSKQV
LEQADAIDAYLLYTQSEGDSVQVYMSTKFQEYLIPAN
>KECLDBNJ_03153 hypothetical protein
MQKSYFILFVLLAFNNWIYSQANDCTNAIILCGNTPVGVEPNGIGFDEFSLPGNFVPPCY
SFNTATVWFEINIDQAGTLGFDIVPGNGTDDYDFAVYGPVTDCANLGRSIRCSSTNPQNA
GVSANTGLNATETDVTEGPGGNGNGYLQELTVNAGERYYLLVDRAIGAGGFSINLNVTAT
FPETPDYNTVQDIEVCDVVGNNDGFYDFNLASQASSITSGHPDSQVSFHASLGDANLDQN
PLPNTYTNTTANRQTIYARISSRTGPCSSIETFDLIVNRDPVYINPNQLYICNVTTVENY
DLAALNDQITGSDLDLNITYYSSSIDAFTNRGAITNINVPFSGIEIFFNIRNTATGCIIT
DSFRLDYEYGPILSQPDPLIYCRDDNTTLTYDLSDIESEALNGLDPDDFDTYFYESTANR
ANDVDRLPISWDASANSRTLYFRTINSATGCYTDGSFDILVVDSPDYAFEEIQYLCIDDP
NPFTLQIDAGFTRYEWSTGQSGATLNSITVNQPGTYSVTAFNSYGCSTTKTTQVLASERA
TIVDVEVVGLNYPQNEAIINVTGQGAYEFSLDNGGYTSNNSFTGLSRGYHTITVRDLNGC
GSVQSQAFLILDYPRYFTPNGDGYHDTWELIGLNEYPGAYVRIYDRYGKLLKELSAQDAR
WDGTYLDKILKPDDYWFELVLPEGARVTGHFSLIN
>KECLDBNJ_03154 Demethylrebeccamycin-D-glucose O-methyltransferase
MISSLFKRVLNSVPRPLLIRLSYIARPFLAFSLRGNTYQDPIDGKTFKKFLPYGYENQRE
NVLSPSTLSLERHRLLWLYLKEETDFFKAKKKVLHFAPEQAFYKRFKQMQNLDYTTTDLN
SPLADVKADICDLPFSENTYDIIFCNHVLEHIPDDTKAMQELYRVLKPGGMAILQIPQDL
SRAKTFADDSITDPKERAKVFGQYDHVRIYGRDYFDKLRSIGFEVKEIDLTAKMPVETVD
KYRLAPGELLPVCFK
>KECLDBNJ_03155 hypothetical protein
MQLETWIDYREDNWEEGYKIGLSNYGQVRSYNKNPNGNIIKGGHINGYVTVNIKLANGKR
RNFYLHKLLAKAFLKAGENEKAVLHLNHDKTDNRVTNLKWATHKERYAHQKTSPLDIKRR
TSGERHYTKLSYAEAKVLKKKLLDPNRRTRLKVLAKQFGVSEMQLHRIKTGENWGDLQV
>KECLDBNJ_03156 Methionine aminopeptidase 1
MIIVKTREEIELMRESALIVSKTLGALAAEVKPGVTTLELDKIAETCIRDHGAIPGFLGL
YDFPNSLCMSPNEQVVHGIPNNKPLENGDIISIDCGALKNGFYGDHAYTFEVGEVAPETK
KLLKVTKESLYKGIEQFKFGNRVGDVGYAIQKYCEDHGYGIVRELVGHGLGAKMHEDPEM
PNYGRRGRGKKFIEGMVVAIEPMVNRGTHRIKQHRDGWTITTRDGEPSAHFEHDVALVDG
KPELLSTFKYIYDALGITSDEEDAFRAQPITN
>KECLDBNJ_03157 hypothetical protein
MRKAIIILAFLCCVSGLQAQVDSLQVLSFSEYISLVKQNHPVAKQANLILETGDAKLLKA
RGGFDPKVEVDFDQKVFKETEYYDLLNATFKIPTWYGIDLKAQFEENEGYYLNPQKTVPE
NGLYTAGISASLGQGLWINERMATLKQAKVYQQQARADLDLAVNAILHDAAVAYFDWLQA
YKKVLLYERSLENTIVRFRGIKQSALLGDIPLIDTTEAKISVQSRALSLKEVELEYVQKK
LELANYLWLGNNIPVELQDDVFPQDDLAFVIDETLDITGFDLADFQINEHPKMRSLAYKV
EGLEIEKRLKANKLLPVIDVNYNFISSEPENLDSFYTQNYKAGLHFKMPLFLRKERGDLE
LAKLKLQDTELDLTNLRLQLQNKIKAVNTELFTLQEQNAMAEELVTNYATMLNAEERKYQ
VGESSIFLINSRELKLIDSQLKQIELTYKLYKAKAKLFKTIANNPDNI
>KECLDBNJ_03158 Colicin V secretion protein CvaA
MLNISQDKINEKVDISGYKASKKVLEKKHYAYFNRFLKVFTVILIVVLFLPWTQTISGIG
YVTTLTPEQRPQTIQSPIPGRVEKWYVREGESVKKGDTILFITEVKNEYFDPNLVERTDQ
QVRAKASSVESYKNKVNALGNQIEALRSERILKLKQADNKRIQAQLKIKSDSIDFEATKT
NLRIAERQYERTLALQQEGLKAVTDVEEKRLKLQEAQAKIISQENKLLASRNELLNAQIE
LNRLEATYADKISKAQSDQATALSTQLDTEAAVSKLENTRTNYEIRNNLYYVRAPQDGFI
NKAIIGGIGETFKEGQQLVSIMPTNYDIAVETYVKPIDLPLIHDGEKVRIQFDGWPSIVF
SGWPYNSFGTFGGKVVAVERFISPNGKYRVLLAPDPDEQPWPEALRIGAGANTLALLEDV
PIWYELWRKLNGFPPNYYTPTTATPNKDSAKK
>KECLDBNJ_03159 Alpha-hemolysin translocation ATP-binding protein HlyB
MDSKTLTPWQRFVRLLKLEKKDFLQILYYAIFAGLVSLSLPLGIQAIVNLIQGAQITTSW
IILVVLVTLGVAFVGALQLMQIRILENVQQKIFTRASFEFTYRFPKIKMSELKDYYPPEL
ANRFFDILTIQKSLYKLVLDFPAALVQIVFGLVLLSFYHPFFIFYGILLILLIYLVFKFT
GNTGLQTSLTESKYKYKIAHWIQEIARALVSFKLSGRSSLALDKNDALVSDYVDARESHF
KILRIQFIQMIAFKVLVTAGLLLIGGFLVLNQTMNIGQFVAAEIIIVLIINSVEKLILGL
ENFYDLLTALEKVGQVVDKKLEDQELSKPFDNADNLNLELRNVSYVDKADEVIILDKVSL
EINPGEHVLINGPNGAGKSTLLKIIAGILEPTSGEFFINNKSVKGIQLNHYRALLGQSFP
EETPFEGTILDNITFGDKTVPQENIDWAIEKMGLSDFVKDQPKGLDTLIKPEGQRLSKTI
ADKIVMARSIVRKPKVLILKEPLTKFSAEEKERIVNFLFDKSNSWAIIVASKDEAWRNCC
ERTLWLDGGKLSTSN
>KECLDBNJ_03160 hypothetical protein
MDELLRNLKIIINDNVYLKDPESSLLGRRIVKHGILLINELGFDNFTFKKLGDCIESNES
SIYRYFENKHKFLIYLTNWYWGWKEYQLAFATANIHDPKEKLEQAIEILTREVEEDHSFN
HINEVALNKIVINEYSKSYLTKEVDDENKEGYFVIYKRLSTRLKEMIADVNEGYPYPASL
ASTILAGSLHQHFLKDHFTSLTDCGKKTSPSQYFIHLTSNLLNS
>KECLDBNJ_03161 DEAD-box ATP-dependent RNA helicase CshA
MAQNFKSLGLNKNLIKGLNELGIVKPTQIQEEAIPLLLEGNAHLVGQAQTGTGKTAAYGL
PILERINANQKSIQALILCPTRELSQQVAKQLFKFTKYTEKIFTEAVYGGEKIDIQIKNL
SRPTHIVVATPGRLIDLLNRKAIDLSQVHTVVLDEADEMLSMGFKQQLDEILSALRNVEN
KWLFSATMPHGIKQIVNQHMAEDAYRIQISRDVVNKNIEHKFLQCEEVDKLPILLDFLRS
KKGERGIIFCKTKAATAKLAKQLIAKNVAAEALQGDMLQKERDKVMRAFKNESLRLLVAT
DIAARGIDVQDLTFVIHYQMPDQEEYYTHRSGRTARAGKEGLSLALVTSKELRTLRNYEK
SLGIGFSEVKAR
>KECLDBNJ_03162 Thioredoxin-like protein
MKTSFGNLTDSETPVLIDFFATWCGPCQTLAPILEDVKKDLGEKVKIVKVDVDKNQTLAQ
KFQVRGVPTLMLFKNGEQVWRQSGVLTRADIKKVIESY
>KECLDBNJ_03163 putative sugar epimerase YhfK
METSKENVLVAGANGTTGKLIVSYLDQSQYYNPVAMVRKQEQQKQFKIQGIDTVLGDLEK
DLSKAVKGIDKVIFTAGSGGDTGPEKTIDVDQEGAKRLIDASKDVEVKKFIMLSSINADN
PESSESLKHYLEAKRKADNYLKNSGLNYTIVRPGTLKNEEGTRKIEAALDVEHGEVTRDD
VAYTLVHVLNDDVAQNAVFEMVEGEQRIEDAIKEF
>KECLDBNJ_03164 hypothetical protein
MNRYTSICFVVFTLTLFSCVESIPKNLEVESQSKEQIFDKGTRTSKEKFVGDVYMNLLVP
EDSIYTTKSGSVTFEAGSRTNWHYHPSGQILMVTEGTGYHQIEGQAKETIVKGDVIKVPK
NVKHWHGASADEAMTHIFVIPNTEMGASVWFEPVSDAEFTE
>KECLDBNJ_03168 Shikimate kinase
MKIYLIGYMGSGKSTLGKILAQEQEMNFIDFDHFLEEKEGKSIAKIFEERGEIYFRKKES
EYLNELLQGYDNTIISLGGGTPCYGDAMERIKAAEGTSVYINVGVAELTQRLWSQRDHRP
VLKHQDTPEKLEEFIRKHLFERSYYYNQAAVKLMVKGEPVGELVAQLQQKLF
>KECLDBNJ_03169 Bifunctional protein PyrR
MMKIEVQTILDHEDIKNKIRRIAYQIYESNVDEKEIILAGIALNGYVIAERLKAILEEVS
ALQCTLCKVTMNKTAPQGTVETSLNASEYKDKSLVLIDDVLNSGTTLIYGVKHFLDVPLK
QFKTAVLVNRNHKKYPVKADFKGISLSTSLNERVKVRFKPGKDSAILE
>KECLDBNJ_03170 Thiopurine S-methyltransferase
MKTDLNKNYWEHRYQNDQTGWDAGQVTQPLKEYTDQITNKDLKILVPGAGYGHEVLHLAH
LGFENVTVVDFSVSALRNLKARLPENCNYQLIEGDFFDHNGTYDLILEQTFFCALEPDLR
PSYVQHCFDLLAEKGKIAGVLFNFELTEKGPPFGGSLTEYQNLFTPYFEFRTLEACYNSI
KPRQGNELFFIFEKSTTAK
>KECLDBNJ_03171 Heat shock protein 15
MRVDKYLWCVRYFKTRSIATNACKKGQVKINDVAVKPSREVFPSDTIQVRKNQINYVIEV
LDHPPSRVGAKLVGLYCVDKTPAENLEKLDLLKYSQDYYRKKGTGRPTKKDRRDLDDFYE
NDDFFED
>KECLDBNJ_03172 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MMTMVRKVFVAVMGLLFFVSCKKDDDGTTEIEVRDRGEVQVESSANLRAYLDTHFYNYEE
FETPAADFDFKIRFDTISGANADKTPLSSQVITRQYTFEDTDYELYILKAREGAGVQPTF
ADSTFVNYQGSVVGGDRFDASVTPVWFDLTQVVFGFANGVSELKAGTQFTQNADGTYSFG
DDYGIGAVFIPSGLGYFNSSGTGFSAYSDLVFTFDLYRAVEDSDNDNDGVPNWKEDINGN
HYVNELGDDTDGDNVPDYLDTDDDGDGTSTRDELDFDEDGNTIYIDSNNDGLDDYLDPDI
G
>KECLDBNJ_03173 hypothetical protein
MKRAFLGILFLAVSFAHAQSDPGFGIKAGLNYGGTGDISDSAENAYQDPSSDIGYHVGVF
GRTGEKLFLRPELVYTKLNSTYEDDDFSMQKLDLPVLVGLEVIGPLQVFAGPAFQYILDT
EYDGITLGDVKNDFTVGLNVGAAIALGKLGVDLRYERGFGDNEAEFLDSNGIITSGSRID
TRPDQLILSVSLNL
>KECLDBNJ_03174 1-deoxy-D-xylulose-5-phosphate synthase
MKKFTNSGNIDTRSGFGAGMDELGKTHEDVVALCADLTGSLKLNDFAKNHPERFFQTGIA
EANMIGMAAGMTIGGKIPYATSFANFATGRVYDQIRQSVAYSGKNVKICASHAGLTLGED
GATHQILEDLGLMKMLPGMTVINPCDFNQTKAATIAIADHDGPVYLRFGRPSVPNFTEAD
GKFEIGKALHLVEGSDVTILATGHLVWHALEAAEALEEKGISAEVINIHTIKPLDDEAIL
NSIKKTRCVVTCEEHNYLGGLGESVSGLLAKNDPVYQEFVATNDTFGESGTPAQLMEKYG
LNTKSIVEAVNRVLAKK
>KECLDBNJ_03175 Transketolase
MPNTKQLEDFVSQVRRDIVRQVHQVSSGHPGGSLGCTEFFVALYQEVMKRKEGFDMDGKD
EDLFFLSNGHISPVFYSVLARSGYFPVEELNTFRKIDSRLQGHPTTHEGLPGIRIASGSL
GQGMSVALGAAQTKKLNGDDSLVYSLHGDGELQEGQNWEAILYAAGNKVDNLIATIDLNG
QQIDGSTDDVLNMGSVRAKFEAFGWDVLDVEKGNDIEAIIAGLNEAKSRTGKGKPVCILL
HTIMGHGVDFMMNGHAWHGKAPNDEQLEKALAQNPETLGDY
>KECLDBNJ_03176 Queuine tRNA-ribosyltransferase
MLFNLVTKDAASKARAGAITTDHGTIETPIFMPVGTVATVKGVHQRELEQDINPDIILGN
TYHLYLRPQTEILEKAGGLHKFMNWDRNILTDSGGYQVYSLSANRKIKEEGVKFKSHIDG
SFHMFTPERVMEIQRSIGADIIMAFDECTPYPCDYNYAKRSMHMTHRWLDRCINHLAKTP
VKYGYDQAFFPIVQGSTYKDLRKQSAEYIANSGAVGNAIGGLSVGEPAEEMYAMTEVVTE
ILPEDKPRYLMGVGTPINILENIALGIDMFDCVMPTRNGRNGTLFTQHGTINIKNKKWEA
DFSALDPDGTTWVDTAYSKAYVRHLFSVNEILGRQIGTIHNLGFYMWLVREARKHIIAGD
FYSWKEKMVKQMDKRL
>KECLDBNJ_03177 Lipopolysaccharide export system permease protein LptG
MKILDWYILKRYLGTFIGMLLLFIPIGITVNLAEKIDKMLANEVPFVEVAIYYLNFTIYF
ANLLFPLFLFLSVIWFTSKLANNTEVIAFLSSGVSFYRFLRPYLIGATLVCIGAYILGTY
LAPNASRGFNEFTYEYLKNGKAARETRNVYRQINDHDYIYVSRFTPSSKMGQNFTLEHFE
DNTLQYKIQARSIVYRPEDTLYRLNGYKKRIVGKEGDILISKPKLDTLFSFDLEDLTPLE
YIAETLTTPRLREFIDKERARGSSAINRYEVVLYKRYSLPVSAYILTIIAVAVSSMKRRG
GMGINLALGISLAFIFIFFDKVFGTISEQSDFSPMVAVWLPNVLFGILAVYLLNRAKR
>KECLDBNJ_03178 hypothetical protein
MQNDSLKSYLHFHVIVFIWGFTAVLGALISIGATALVWYRMLIASLVIFVYIKIKGISLK
AKGKTVLELAGVGVLIALHWLTFFGAVKIANVSITLAMMSTGAFFTSILEPIFYKRKLIW
YELVFGLLVIGGLYLIFEVETRYTEAIIVALISALLAALFTLFNGKYAKKHDSVMISFYE
LLTGALFITVFLAVTNRFDASFFQVQQTDWIYLIILATVCTAYAFIASVKVMKHLTPYTI
MLTTNMEPVYGIILAFLILGDAEQMNTGFYFGAILILLTVILNGILKNARRRKAARALNT
IKTN
>KECLDBNJ_03179 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLEFEQPIKELEEQLQKCSLIGQESDVDVTNTCKQIEKKLIDTKKEIYKNLTPWQRVQ
LSRHPNRPYTLDYIKALCGDTFLELHGDRNVKDDKAMIGGLGKIGDQSFMLIGQQKGFNT
KTRQYRNFGMANPEGYRKALRLMKSAEKFNLPVVCFIDTPGAYPGLEAEERGQGEAIARN
ILEMTRLKVPIIVVIIGEGASGGALGIGVGDKVLMLENTWYSVISPESCSSILWRSWEFK
EQAADALKLTAKDMKKQKLIDEIVKEPLGGAHSDREATFTTIKEEILKAFKEFKNLSPKD
LVEKRMDKYSNMGVFKG
>KECLDBNJ_03180 Replicative DNA helicase
MENLKTKPNFINPKKDVISLERGKLPPQAIDLEQVVLGAMMIDKKGVDEIIDILSPEVFY
KDAHQHIYDAVRALFENGEPIDLLTVSQQLKQMGKLDQAGGDYYLIQLTQKVSSSAHIEY
HARIILQKYIQRSLIKISNEIIEEAYDETTDVFDLLDNAESKLYEVTQGNIKRSSETAQS
LVIQAKKKIEEISNKEGLSGIPSGFDRLDKLTSGWQASDLIIVAARPGMGKTALTLSMAR
NIAVGQNIPVAFFSLEMASVQLITRLISSETGLSSEKLRTGKLEKHEWEQLNVKVKSLEK
APLFIDDTPSLSIFDLRAKARRLASQHGIKMIIIDYLQLMTAGGSQKGGNREQEISMISR
NLKALAKELMVPVIALSQLSRAVETRGGSKRPLLSDLRESGAIEQDADIVSFIYRPEYYK
IDEWDDEERSPTEGQAEFIIAKHRNGGLENIRLKFLGHLGKFDNLDDFSTPYQFESAMNQ
NAAANDDTFTPDSFPTPDQAFGSSMNDGGFDRNGEDEVPF
>KECLDBNJ_03181 hypothetical protein
MDAESQKEHLKAYGITYWTLAQQQKVKWLLNYRGGAFLLPDTEELQKECKIRGVSFEVLS
DAKTESILSEIESPSQNMEAIVLEKAPKIAVYTPDSSVPWDDAVTMVLEYAEIPYDKIYD
REVLADELVLYDWLHLHHEDFTGQYGKFYGSYRATSWYIEEKKQAEALATELGYDKVSKA
KLAVATKISDYVIGGGFMFAMCSATDSFDIALSATGVDICEPMFDGDASEANYQSKINFE
RTFAFTDFTLVKNPQQYEFSSIDTTPFRRVPADTDYFSLKSFSAKWDPVPTMLCQNHTAL
VKGFMGQTTAYNPKEIKANVLVMGENKANGEARYIHGVKGKGFFTFYGGHDPEDYQHRVG
DPKTELKLHPTSPGYRLILNNILFPAAKKKKQKT
>KECLDBNJ_03182 hypothetical protein
MKRTVLLLCCLCLLAGLQRKSARMPWRSGHTLRWSDFQALPDEHSGFSASANTGISHRYT
ISKAGVLDPSKSIIKANFYPKLSWYKPELIDEFTLKHEQTHFDISEVHARMFRKAVAEFR
FTRNSKAEIQKIYKKIESSRRNMQQQFDAETEHSVNREAERRWEFNVEALLRKYRHWAD
>KECLDBNJ_03183 hypothetical protein
MIREGSTVQWKWGNGTAKGEVKESYAKEITKTIDGSEITRKGEQGNKALLIKQEDGSTVL
KLESEVEKA
>KECLDBNJ_03184 Threonylcarbamoyl-AMP synthase
MAEFIKLYDENPSEREIKRIVEVLKNDGVIIYPTDTVYGLGCDITSNRALERVAQLRGVK
LAKANFSFICEDLSNLSDYVRQIDTPTFKLLKRALPGPYTFILPGNNNLPTVFKKKKTVG
IRVPDNNIARAIVKHLGNPIISTSIYDEDDVIEYTTDPELILEKWDKLVDVVVDGGYGGN
IPSTVIDLTSGEAVLIREGKGDLTI
>KECLDBNJ_03185 Outer membrane porin F
MVSASALVLLSSCVSQKKYAALEAKQKETQDMLNTATVKLNACLAQSETMKEQITDLRSA
NNNLINTQGNLTTLSAKGAENLEKSLEQMKEKDLQIKAFRDAMNRKDSVTLALVTSLKGA
IGNLNDEDIEINVEKGVVYVSISDKLLFNSGRWDVTNRAKEVLGKVATVVKNKPDIEFMV
EGHTDSKPISTSVIEDNWDLSVKRATSVVRILQEEFGVPPERMVAAGRSYYVPLASNDTA
EGRARNRRTRIVVLPKLDQFYKMIEEGMPKN
>KECLDBNJ_03186 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKTAIVILNWNGKKLLEEFLPSVIKHSAHLATIYVADNASTDASVAFVQAEFPQVKIIQN
ASNGGYAKGYNDALQYLDEELLILMNSDIKTTSGWLETMIKAFETDSNLGAAQPKLLDLK
KKTHFEYAGAAGGFLDSLGYPFCRGRIFDTCEEDTGQYNDSLEIFWATGACLAVRKSVFW
QAGALDEDFFAHQEEIDLCWRIKNLGYSIQYIGESVVYHLGGATLEQMNPKKTFLNFRNN
LMLLLKNVAGFKVYPILFARMCLDGIAAFKFLTEGKPKHFTAVLKAHFNFYAQIPKLLNK
RARTSGNQPYAKVKSIVWEYFIRKNMHYTDIF
>KECLDBNJ_03187 hypothetical protein
MITFETMQELNFPPYAFRLKSSENKPLIFDPIRKKFVVLTPEEWVRQHVVKHLLAAYKYP
LSLINVEKELKINNTSKRYDGVVFNPDGSIFLIIECKAPKVKITQETFDQIARYNLAVKA
EYLMVTNGLNHYYCQMDYEAKKYVFLRDIPVYSL
>KECLDBNJ_03188 hypothetical protein
MVEEVTRIVKDIKKGNLRPIYFLMGEEPYYIDQLADYIADNVLTEEEKGFNQMVLYGRDV
SLDDVLSQAKRFPMMAERQVVIVKEAQDMSREILAQPDKSKNKLEAYAENPQPTTVLVFC
YKYKKLDKRKRVYKEIAKSGLIFESKKLYENQVGDWIRRVMSGKGYTVEPKAAHMLVEFL
GTDLSKINNELEKLRLILPEGSTITPLAVEENIGISKDFNNFELQRAIGEKDVVKAHRII
NYFSQNPKDNPMVVTIALLFSFFQNLLIYHGLPSKDKSTVAKALKVNPYFVGQYVDAARN
YPMKKVSHIVNLLRTADVKSKGVGAYNLSQGDLLKELLVQIMS
>KECLDBNJ_03189 Ribosomal RNA small subunit methyltransferase E
MQLFYHPEIAAEAKEATFPKDESKHIIKVLRKRTGDVLDITNGAGNFFKAEIIVASPSNC
TVKILEVTSEQPLPYHLHLAVAPTKLNDRFELFLEKATEIGISEISPIICDHSERKVIKE
ERYERIIQSAMKQSLKAHIPKLNEAQFFSDFLEAAKHFNGDRFIAHCEETNRFSLKQKLQ
PKRDVLILIGPEGDFSPSEIEQAIQAGFSPVMLGESRLRTETAAIVATHSVAFVNEV
>KECLDBNJ_03190 tRNA N6-adenosine threonylcarbamoyltransferase
MSKNNTYILAIESSCDDTAAAVLHNDKTLANVVAGQAVHEQYGGVVPELASRAHQQNIVP
VVHEALRKANVKKEDLNAIAFTSGPGLMGSLLVGTSFAKSLAMGLDIPLIDVNHMQAHIL
AHFIEEEGYDKPEFPFLAMTISGGHTQIVRVDSYFDMTVIGQTLDDAVGEAFDKSAKILG
LPYPGGPLIDKYAQLGNPKAYKFTKPKVGDLDFSFSGLKTAVLYFYQKEVAADPDFVEKN
RNDICASIQHTIINILMDKIKKAVKQTGIKQVAIGGGVSANSGIRKALKDAEQKYGWKTF
VPKFEYTTDNAAMIGIVGYLKYLEENLAETGYTDTKVMAQSRLKI
>KECLDBNJ_03191 hypothetical protein
MLLIIFSIPAVQTSVAKKVTKALNDTYGTAISINKIQLKYNGNALIKEVYIADHHQDTLI
YAQTVETSLLSIRSLIENEMPLGDIYLGAAKLYVKKYQGEENDNLYVFSQKFNTGKTGGT
PFKLSASEVEIEDMHFKFIDEDLDTPEVINYHNLYIRAEDFDLDDVTITTQIKDLRFDAD
RDYHLRGLEADFKYNPDEIILKEMVLSTEHSVIRGDVYLDTRNDAFQDFNNLVKIDIDFD
ESKISTTDLQAFYAEFGAGEDILLSGKLQGTLNDFTVTDFDLTGLSNSRILGNVRFEQLL
GDNSTFRINGDYRQLKTTYLDLTSLLPNILGNNLPPELVRLGTVDLTGTLNVSENTVYVK
SNIQTDLGFLETDIDLRNTQNIQNASYVGMLRGEQFNMGRLLKVPELKNITFNVRVNGSG
VEAETLDTRVEGVISSATYNNYTYRGITVAGNLQNPNFDGRLTVRDPNANFTFDGLIDVS
EEIHTYDFTADIARIDLGKLNFLRDSSAVLKGKVVMDMRGTNIDDTGGVIAFSEASFENA
NDLYEFQDFVITSGFRRGIRTITMNSPDIISGQVSGVFKIGDVKALFQNAIGSLYTNYEP
QTVTENQFMDFNIQIYSKIVEVLVPDVELEPDTFVRGSVVADDSDFKLTFRSPRIKAFGV
MAEAINVRVDNKNPLFNAYVEADSIGSGVYGVSDFNLINVTLKDTLFIRSEFKGGPDKQD
NFDLSFYHTINEENNSVVGFKRSSLRFKNNEWFLNEQDNKNNKIVFDNNFLDWDLKELTL
SHDKERISLKGQVKDSTYKDIQTNFENVRLSHITPYIDSLDMRGLVNGNLDVLQKEGVYL
PNSSVNIANFTINDILMGDLDLSIEGNESLTNYQVNTRLNNDDVEVLSALGTIDVGQENP
SIDLDVQLRKLNMKAFSPLGGEVISKIRGLASGRATVTGDYRNPDVDGELLLREAGLAIP
YLNTDYDFRGTARITLDDQEFRFGSVALVDTKYKTTGTLTGSISHQYFRDWEMDLDVNTD
RLVVLDTEPDDFALYYGTAFISGEASLTGPTDELVIDVTATTQEGTVFKIPLSDTESFGD
NSNIYFLSPEEKQARLDGEEVVIEEIKGLELNFDLEVTRDAEVEIVVDEVNGSTLKGRGA
GYLLIQINTNGKFNMFGDFTPYSGTYNFRYSGVVQKQFNILPEGKISWDGNPTEALLDIS
AVYNTQANPSILLENPSINRKIPVNVIINLDGELIQPEITFDFEFPNTSSIVTSELAYRL
DNRATRELQAFSLVTQGSFFSQSGIDAQSAAYGNLIETASGIFNDLLSDEDGKFNVGLDY
VQADNRPDLQTSGRFGFTLSTQISKKVLINGKVGVPVGGISEQAVVGDVEVNFLLNEDGS
LRATIFNRQTDIQFVARNNEGYTQGAGLSYSVDFNTFKELIQKIFKGKAREVEEEIKVIQ
PDSEIPYNGFDQ
>KECLDBNJ_03192 ATP-dependent 6-phosphofructokinase 1
MAQKIRKIGVLTSGGDSPGMNAAVRAVVRTCAYHKIDCVGIYRGYEGLIDGDFEPMDARS
VRDIINRGGTMLKSARSDRFRTPEGRKIAYDNLVENKIDGLVLIGGDGTFTGGLIFNREY
NFPVMGIPGTIDNDISGTDKTLGYDTALNTAVEAIDKIRDTASSHNRLFFVEVMGRDVGH
IALNAGVGAGAEEILIPEENLGLDRLLESLLRSKASGKTSSIVVVAEGDKTGKNVFELKD
YVDENLDGYDVRVAVLGHMQRGGSPSCYDRVLASRMGVKAVESLLEGESNYMVGIQHEKM
ELYPIEKAIKGKSHINKELVRVSEIMTT
>KECLDBNJ_03193 Glyceraldehyde-3-phosphate dehydrogenase A
MGNLKLGINGFGRIGRIVFRATVKRDNVDVVAINDLLDVEHLAYLLKYDSVHGNFDGTVE
VKDGNLVVDGKTVRITAERDPKNLKWDEVGADVVAECTGIFTSMETADYHIQAGAKKVVI
SAPSKDVPMFVMGVNHKDVTADNKIVSNASCTTNCLAPLAKVLNDAYGIEEALMTTVHAT
TATQMTVDGPSKKDWRGGRSALANIIPASTGAAVAVTKVIPELKGKLTGMAFRVPTPDVS
VVDLTVKLSKDTSYEDIKKTFKAASEGEMAGVLGYTEEAVVSQDFVSDPRTSIFDAGAGI
ELNSKFFKIVSWYDNEFGYSNKLVDLAEYVNSL
>KECLDBNJ_03194 hypothetical protein
MILLVDSGSTKTDWIALNAEGTEIFQTQTFGLNPQVLSAEILTERIINNYELYKHRHDVT
HVHFYGAGCGTQKPKELIQGVFEDFFDKAQEIDIKEDTYAALYATTRKDEAGIVCIIGTG
SNCSLYDGENIEQKVTSLGYILMDDGSGNYFGRQLLRDFHFNKIPKELAYEFAKQFDLTA
ESIKNHLYKMPNPNTYLAQFARFVITNKDHEYCRKLIRKGFKLFIEHQILQFENAKEIPV
HFVGSIAFYLQAELKELLQEYDLKIGKVLKRPIEGLVAYHKNYMMV
>KECLDBNJ_03195 2-iminobutanoate/2-iminopropanoate deaminase
MKKIISTTNAPAPIGPYNQAVFAGDTLFVSGQIPLDPKTGELVSGDIAAETKMVMQNLEA
ILTEAGLTFENVVKSSIFLSDMNSFAQVNEVYGTFFKEETAPARETVEVANLPKFVNVEI
SVIAIK
>KECLDBNJ_03196 hypothetical protein
MKIALTFTKIVLIPLQTKILSVLLVLGLSLSYYGSLQAQELPVNTLKTIPADTTESNNRL
IPKGNLLVETPDESAQDSTAQDSIVAPREALTDIVKYTATDYSRFDRRANKLYLYNEAQV
AYTDITITAGQIIVDNNTNTVFAKGITDSTGYTQPPVFVQGPNTVEPDSIKYNFKTEKAL
IYGSRTQQQEFYIKNEVSKRVNDSVVFMKNVRFTTSENEEDPEYYFYARKVKFVPNKKIV
TGLVNMFVYDVPIPLGVPFSYFPMEKETSVSGFIMPSPGENNERGYFLQNGGYYFALNDY
MDLTLTGDYYTNGSYALRAASAYRKRYKFSGNVNIRFERLLSSERGLPDFSETNTYNIQW
SHSQDSKSNPNSRFSASVNLGSSNYFQQSTNIDNTASRLTNTLSSSVSYSKTFQTVPQVN
LALTARHSQNTQTQAINMTLPSVNLNVDRIYPFAPKAGSKKGIFQNINFNYSMSGENRFE
TTDSLFFTPQMFRDAELGVRHSIPVTTNFKLFKHFSVSASTNLQESWVFETIDQRFDPTT
REIVLDTVNGFDRFNTYNFSTSVGTTVYGQANFGDDKKIQAIRHTMKPSVSFNYNPAFDQ
YYETFLAPELDDPNGDLTREVTYSRFEGGFYGAPSNFSSSGISFSVNNTVEAKVRDRDST
AIEPKKIDLISNLAISTNYNFLADSLKLSPVSVRGTIPIIQSKLSVNFNMTLDPYALNNN
NRRIDKLNIANGGSLFRLTNASANFGYSFSSKSFGKENDDLEDENTQTARNGGRRDNLLG
EDSRQLQNKFNDTEGADEDPDKEQELYNYTIPWNLRVNYNVNYGNAARQNMITSHAINFS
GDVELGEKWFVGASSGIDLTTGKFTPTQLRFARDLESFNMTFAWTPFGTYASWNFFIGIK
SSVLSDLKYEQRRTPDQQL
>KECLDBNJ_03197 N-acetylmuramoyl-L-alanine amidase AmiA
MRTITTYILVFLLAVTGQNIFANKKPADTKKFVVVIDAGHGGKDPGKNAKGNLLEKNIAL
KIALLVGEELQKHSDIEVVYTRKTDVFVELAERGAIANRANADLFVSIHCNAHNSQALGA
ETYVLGLHRNKTNFEVAKAENEVIYLEDNYEEKYAQYNLNSPESLIGLTLMQEEFLDQSI
QLASYVQDNFRVKLHRKDRSVKQAGFVVLHQTVMPSILIETGFITNDEEGRYLNSSNGQK
EIAHAIAEAVGKYKDNVSTNDFLGITKVVPAVEVKDVIVDDAIFKVQIAASSRSLDTKPY
NFKGLRGIQKNKEGKLYKYYYGDTSNYTEIERKLQEAKSKGYKTAYIVAFKNGIKQNANE
FINKS
>KECLDBNJ_03198 hypothetical protein
MNISREVKTGLLAVIAIALLIFGYSFLKGNNLLNNDRTYYAIYDNVEGLSQGSNVTINGL
VVGKVLSIDFADSRGDLLVTFNVQNDFQFSKNSKAQIYGGGLIGGKNLSIVPDYERGDVA
ESGDTLQGTIDEGIFELVNERLTPLQAKVEEVINSTDSVLVGVSDVLDKKTRKNLRETIE
QISQTAANFNQASNSLNKLLADNDQKLTRTFTNLDEMSANFNKVSDSLSKVDVNALVMRM
ESVLADFESISSKIENGEGTLGQFINDDKMYNNLERATKQMEELMQDIKLNPKRYVHFSV
FGKNPGPYEEPKDSLR
>KECLDBNJ_03199 Lactate utilization protein B
MQYLPNILFVIALAAGVGFFVFNIKKLIRNIKLGRDEDRTDNKAQRFKNMAKIALGQYKM
VVRPVSGIIHVLVYLGFIIINLEVLEIIIDGIFGTHRIFSFLGGFYDFLIAVFEIFALLV
LVGVIIFWIRRNILHIKRFLNREMKGWPKLDANLILYFEVVLMLLFLTMNAADLTLQTKG
AEHYASAEGIVGAFPVSQFIAPFFENLSIPTLIVIERAAWWIHILGILVFLNYLYYSKHL
HILLAFPNTYFARLKPQGQFDNLEAVTNEVKLMMDPEADPYAMPEEGAEDEVPAKFGASE
ATDLSWAQLLNAYTCTECGRCTSECPANQTGKKLSPRRIMMATRDRIEDIGKNIDANKGT
FKEDGKQLLDDYISREELWACTTCNACVEACPVGINPLSIIMDMRQYLVMEQSAAPTDLN
NAMTNIENNAAPWPFNQMDRANWISEN
>KECLDBNJ_03200 hypothetical protein
MKKEEVDKMLSDKLQDGEHVSPVLPEGVKNYLIDIDGTITEDVPNEEPERMATCKPFPDA
LATLNKWYDEGHIICFFTSRTEEHREVTENWLNEHGFNYHSLLMGKPRGGNYHWIDNHLV
RATRYKGKFTDLVEKDVTIEVFKD
>KECLDBNJ_03201 Lactate utilization protein A
MAEAIKVPTMAEYMAQGKSPEVLFWVGCAGSFDDRAKKITKAFVKLLAKAGVDFAVLGTE
ESCTGDPAKRAGNEFLFQMQAVTNIEVLNAYDVKKIVTACPHCFNTIANEYPGLGGNYEV
LHHTQFLKTLIKEERLTVEGGKFKGKRITFHDPCYLARANRIYEAPRELLEKLEVELVEM
KRCKTKGFCCGAGGAQMFKEPEPGTKDVNIARTEEALETKSEVIAAACPFCNTMMTDGVK
NKEKEDAVAVMDIAEMIASAEDL
>KECLDBNJ_03202 hypothetical protein
MLTPFSELSDTSRLWIYQSDRKFTEEELPLLQQYLSAFLEKWTAHGAALNAGFEIKYDRF
IIIGLDQTQSSASGCSIDAQVHFIQELEKEFSVTLLDKMNVTYIQNDRLHFKPLADFKKM
AKDGAVGKKTIVFNNLVNTKEEYLDQWEVPAIESWHSRFF
>KECLDBNJ_03203 Beta-hexosaminidase
MLRDRFILGVVLLLTISCFSQTRNPLIAKDLTEQQAWVDSIYDGMTLKEKIGQLFMVDVF
SRDPKSVTDAVKTLIKKHHIGGLIFSKGGPVRQAKLTNEYQALSKVPLMVAMDAEWGLAM
RLDSTYAFPWNMTLGAIKDDKLVEQVGRQIGLHSKRMGVHINFAPDVDINVNPENPIIGN
RSFGEDRDNVTDKSVAFLRGMQGVGVLGSAKHFPGHGDTNQDSHKTLPTIPFSRKRLDSI
EMYPYKKVIDAGIASIMVAHLNVPALDNRAGYPTSLSSKVVTGILKDSLGYQGLIFTDAL
NMKGASNYDEPGEIDLAAFNAGNDILLMSENVAKAIAKIEEAYTKGTITEKRLARSVKKI
LFAKFKVGLNNYEPIAMQNLYQDLNSPEDEVVYRKAMANALTVLKNNQAILPVKNIEDKK
IAYVELGDDSGAPFYIALQKYAKVTKIEGASASDYVTKLTDFNYVIIGFHRSNDNPWKSY
KFTAREVGIIEAIAAAKPTVLDVFVRPYALFDLKNTTNLEGVVMSYQNSTIAQDLSAQLI
FGAIEAKGKLPVSVGTDFKINTSYETGTLRRLKYGIPEEEGMDSQKLNSIEGLMKEGLTD
VMFPGAQVLVARHGKVIYEKAFGYHTYTKKQPVQLDDVYDLASMTKILATLPLLMKRYDE
GKLTLEDKLGTLLPVLQGTNKQSITVKEVLSHYGRLKPWIPFYRATFDDSGALSKAYYRT
RPEENFDLKVAEDLYLRNDYPDTIVKIIADSDLLSRRVYKYSDLSYFLFKKYLEDSEGDD
LNGLTQKYYYRSLGANKMGYKPLDRLAKKDIVPSENDNYWRMQQVQGYVHDMGAAMEDNI
GGHAGLFSNANDVAKMMQMYLQNGYYGGKRYFSKETMDAFNTCYYCSNGVRRGVGFDKPQ
LGTAGPTCGCVSDNSFGHSGFTGTLTWADPKTEIIYVFLSNRTFPTADNRKLISSSLRTR
IQEVIENAVIP
>KECLDBNJ_03204 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGIALSKRGHEVHFITYKQPVRLDLLNEKIFFHEVNVPEY
PLFHFQPYELALSSKLVTIIKAYHIDVLHVHYAIPHAYAGYMAKKMLQQEGITIPMVTTL
HGTDITLVGNHPFYKPAVTFSINKSDVVTSVSQSLKDDTNRLFDIKRKIKVIPNFIDLST
VKNTFTDCQRGLMASENERIITHISNMREVKCIPDVIKTFYHIQKEIPSKLIMVGEGPER
APAETLAEELGIATKVIFLGNSNEIDKVLCFSDLFLLPSKAESFGLAALEAMAHGVPVIS
SNAGGLSEVNINGVSGFMSAVGAVEEMAQNALRILSADADLARFKQQAREQAANFAIEKI
VPMYEEVYEKAIQKNEPKKTSVS
>KECLDBNJ_03205 hypothetical protein
MKKLLIAFVVIAGFSFSAQAQDIAPNALGLRLGDSDGFGAEISYQRALGGNNRLELDLGL
RDGDNYDGFKLAGLYQWVWNIDGGFNWYAGVGGGLASYGYDDNRYDDDTFVFAAGDIGIE
YDFDIPLVLSLDFRPEIGFGDGNDYYDNDDLDFDIALGIRYQF
>KECLDBNJ_03206 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MITHLTEALTELKESLDGDLFFDDLHKTLYATDASVYRQIPAGVAFPKSEQDIQQLILFA
EKNKIGLIPRTAGTSLAGQCVGDGLVVDVSKYFTEIIWLDVQNKTVTVQPGVIRDELNRY
LEPHGLFFAPNTSTSNRCMIGGMVGNNSSGTTSIQYGVTRDKVLQLKTILSDASTVRFQE
ISAKAFHKKRKLNTLEGKLYSRIYNQLNNAKAQEEIRSKFPKPEIHRRNTGYALDALLDN
SVFNKESEQLFNMCKLLSGSEGTLAFTTEITLQLDELPPKHGVMVAAHFESITACLEAVV
PAMQHKLYACEMMDKVILDCTLNNREQQKNRFFIEGDPAAILMLEVRANTLDDARKQALE
LIATIDNSGLSYAYPTLEGSQINQALELRKAGLGLLGNIVGDRKAVACIEDTAVALEDLA
PYINEFSALMADFKQDAVYYAHAGAGELHLRPILDLKKADDVELFRKITTAVANLVKKYQ
GSMSGEHGDGLVRGEFVELMIGSANYERLKQIKTLFDPHNIFNPGKLVNANPMDENLRYT
PDREEPEIDTLFNFDDSQGILRAAEQCNGTGDCRKLPAAGGTMCPSYRATRDEKDSTRGR
ANALREFLTKSERKNSFNHKELKEVFDLCLSCKACASECPSNVDVAALKAEFEYQYKKEN
GSSLRTRAFAFNAYLNKVGAVLPGVTNRLYKAKLSGRFIRKTLEVAPERSLPPVSKRTLR
ARFKKLKAFNPKQSIKTVYLFADEFTNYLDAQIGEDAVILLQRLNYEVRIVAHAESGRSF
ISKGFLKEARKAAQKNITIFKDLIDEEHPLIGIEPSAILGFRDEYLRLAKDVEEAKALAK
NTFTIEEFLSAEIKAERIKATSFTTEAKKLKIHGHCHQKSLSGIEHTFSVLNLPVNYTPT
IIPSGCCGMAGSFGYEKEHYALSMQIGEQTLFPAVRKASEDTLIAAPGTSCRHQIKDGTQ
RQAQHPVTILKNALV
>KECLDBNJ_03207 hypothetical protein
MTQLQLNNLNVSIDKGQLSSFKKDDYEYIHQVGSPGWGKSDDEMFPIIGPTDEANFKVKT
PKGEAILDQHGLLRELTYTLTSSTTTTAVFEKQYTAGTKIKNSKFPKKSTEEWLSWPYDF
VFKKQFSLSENGLTIDFVISGEPEMPFMLGYHPAFKLRTEKPTVTHPNKEISLAEIMAVG
SRAFQVPDCTEITLNDEKSITLKSEGFGNFMLWTEVTNMVCVEPVSFYPYAVAQENLNEG
FQTLPEEGVTFSVLLEI
>KECLDBNJ_03208 hypothetical protein
MKAATVTQLKKELKHKDEDELLNICLRLSKFKKENKELLTYLLFESDYEPGYVTLIKENI
DEQFEALNTRNYYWMKKSIRKILRETKKYIRYSGNKETEVQLLLYFCEKMQAVRPAIRNN
NTLRNLYLRQLEYIHKKIGALHEDLHLDYYNALEKLN
>KECLDBNJ_03209 Peroxiredoxin OsmC
MKFSRKASANWKGQIKAGMGTISTESKVLDASKYGFATRFEDGKGTNPEELIGAAHAGCF
TMQLTAFLGEEGYTAEDLKTDANVTFEDGAITKIDLTLVGKVPECDAETFKKIATKAKEN
CPVSKLLNAEISLDASLEE
>KECLDBNJ_03210 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MSPLVLYILPAVIAFLTSFMVGRLLCTQKLARYFIDDIGGKKLHQRAVPASGGIALIIGV
VLPIVLFDQIIINSAYFYFMMGAIGMFLLGLVDDLKPLGWLLKLLFQIAIITAVVVLGDL
RLESVLLEHSFFRLPYALSVLISVVMITFLTNAFNFIDGVDGLATAVALVFILGLLYFQT
PFSGVFLMCLAAALFGFRQLNREPAALFMGDSGSLFIGFCCACLGIFFLEADLNINNTQL
DSFQQRLPVLLALFWFPIADTIRVLILRLSRKQSLFKRDKLHSYSSLLRLGHSHSRIVTL
VVILTLLNVFGAWYLEPLLGVSLFLVVQVAFSIVLHFYLNSLIKKFTYQKESSNG
>KECLDBNJ_03211 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MDEPKKIALALPSIEATAVDYLAEVVNQNWVTSGGPTGTKFEKQLQEFLQTEREVVALNS
GTAALHLALKLAGVQRDDFVLCQTMSFVASANPIDYLGAIPVFIDSEKSTYNLAPEYVKE
AIKWCLKQNKKPAALVAVHSFGIPCQVKEIARLCKDYEIPLIEDAAEALGSKYKNQPCGL
FGDYGMLSFNGNKIITTGGGGALICKDTQEAEEARHLSRQAKSTAIGFEHDAVGFNYAMP
GLNAALGLSQLQTLTERIQKKRELYQFYQECFAEIEEIEVLSVQNEEYYANYWLTVIRFT
GSNSTKNPEQFQAFLAKKGIESRFPWKPLHLQEIYDEQHYFGAQNAETLWKTGLCLPSGC
GLIKEDLNRIQQAINAYFSA
>KECLDBNJ_03212 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MEISELKNQTILITGAAGSIGRELVLGLAQYEPQQLILVDISELGMHSLLQEMAIHFPKV
KLTYYLESICDATFIAALFERHLIDLVFHAAAYKHVSLMEVNVCAAVKTNIKGAKLLIDT
SCKHNISRFIFISTDKAVEPVSIMGMTKKVVEEYLLFKKTENITTQLSILRLCNVYDSSG
SVVPVFKERIKQNLPLEIKGNDVQRAYIHKDQLLPMVLAILDSEHSDGVFIPKHFSVQTV
AQIANHWVQELLGSSLSEYPVVNKALPEYEKEKELLHLKSDTVHSMDNDVLLRIAPSTTQ
IDIEMLTQSIKAAEAFKDAEARVLLQKLAIA
>KECLDBNJ_03213 Tyrosine-protein phosphatase YwqE
MFSIFSSKKFLAAKLGEFTDIHNHILPGIDDGAKTPEDSLQLLTQFKEMGITNLICTPHT
MSDYYPNTPETILDAEATLKTFLKENGHSEFSIRSSSEYMMDSGLVDLLENKQILPLKDN
YVLVEMSYLQPPVNLREILFKVGNSGFVPVLAHPERYAFYHAKYDTYNELKNICKFQLNA
LSISGYYGPGIAKIALKLLSEGMYDFIGTDTHHMRHVENLKKVKFAGKYEQDLDRIISNT
NANFS
>KECLDBNJ_03214 hypothetical protein
MLFWLCFIFTSTAQELPPVLNFTPEQYNAENQNWDITQGEDKLIYVANNSGLLEYDGAKW
RLYPTSNKTIMRSVATQGDLIYTGAYMEFGYWERGSNGLLQYTSLSDKLDEPLIEDEQFW
NIILVDNLILFQSLDRIYSYNTETSNFQIIDSESAIVRSFLVGKSVYFQQEGLGLYQLQN
GQPVLIADALPFSDYLLVALYSKDNTLMVVTQKHGIFQLKPNGEMSSWNYEAQDAIANET
VYAALQLSDQTLLLGTISNGLYHLDASGKIKYQIDQVSGLSNNTVLSLWEDQEAHVWLGL
DNGISVVNSNSAFRVYTDYDGSLGAVYAAKKHKGYLYLGTNQGLFYKKDAAASEEYQLIP
DTKGQVWRLNILGDALICGHHEGTFRVEENRVIPIANIAGTWDVHQLNDTLAIQGNYSGL
YILERKETGWQLRNKLEGFDISSRYFAFSGPQELYVSHEYKGVFKLNIDDSFRTITESRL
LKQLPKGAKSSIFKYNNEVLYAYEEGIFRLNKSAKVFEKDSLLSRTFLESGGYSSGKLTY
DTGNNRLWAFNEQEVLYFEPGILADQLKVRRIALPAKTRKDIPGFENITYLDANTYLLGN
ATGYIVLDTEKLSDEKYSIKLRTMKNGSREGELVTLDQTTTEAFHYKQNTFAFDFSVAEY
EKFRAVVYQYRLKGLYEEWTNWSTSATASFENLPPGTYTFEARARIGDQLSENTLHYSFT
VARPWYLSVVAIIIYGVLLVLIFIGIQVVNRKFYKRQKERLIEINQRKLEVATYENERRI
MKLENEKLQQDVESKNRELAASTMSIVKKNELLNAIKKELDSDTQENELKSVIKIIDKNL
NPKKDWEFFREAFNNADKDFLKKIKEQHPKLTPNDLKLCAYLRLNLSSKEIAPLLNISVR
SVEIKRYRLRKKMELEHEESLVEYILSI
>KECLDBNJ_03215 TonB-dependent receptor SusC
MKSFLSLILFGLLTSGLFSQTGTEVRVTGTVTDMSGMPLPGVNVIVKGSSSGTSTDFDGL
FSLDVPSSSILVFSYLGFQTQEIAVNGAADLNVQLVEDTSALDEVVVVGYGTQKKKEITG
AVSVVGSETIEEQNPVRVEQALQGRVAGVNISSNSGSPGSASTISIRGISTNGDNRPLIL
VDGAVIEDLSVINPNDIESINVLKDATAGIYGVRAANGVILITTKGGRKNSDLRVDVDTY
VGLQETTRKLPVLNATEYGVIINEAYAAGNQALPFPNLAVLGQGTNWQDEVFRQALLSDI
NATVYGGGEKSAYSVGAGYLDQDGIVGGGAVNFNRFTGRGSYDYDILENLKFSSTAIYTH
SNRKTLSENALGSVLFNAVNMAPTFSVRDANGDFTIANGLGNEVINPIAQIANTFNTNEV
DKLTGTVGLSYNFWNHFTAESRYQFNYSEVRGRSYLPAGLNFGDGKVFNNLGVNQYFVND
SFFRDYTFDNFLTYQNTFADDHNLTVLLGMSAFKTSGEFYNFTGRDVPGTAFGEATLDGA
GEVIDARDISGPAEFDQRLLSYFTRVQYNYKERYLLSAVLRRDGSSNFGPENKFGYFPSA
SIGWVASDEPFFGSSDLLNFLKLRASYGILGNDRIGAFGYVSTLNAEGTYVFDDELVNGV
AAGQLSNPEIKWERQKTFDVGFDARLFNNRIDLTMDYFKRRTDDLLLVPQVSGILGVYAP
GAGAPIVNAGSVENQGLEFSVSYDQPIGDDAGFNLSYNFTTLKNEVLEVGNESGFIPGGS
FGFGQEPPARMEAGFPIGYFYGLQTNGIFQSQAEVDAHATQTDATLGDLRYVDQNGDGVI
NGDDRVNIGDPIPDVTMGLNLGFNYKNFDFTAYAFASIGNDIVRSYDRNQNLTNKTNYVL
DRWTGPGSTNSYPRVTVGPNSNLLFSDFYVEDGSYVRLQNVQLGYSLGNEVLDQLGIRKL
RFYLAVTNAFTLTEYKGYDPSASSGAPIGGGIDQGFYPVPRTYTAGMNFKF
>KECLDBNJ_03216 SusD-like protein
MKKYNIQRAFLSLLAAVLMVACGDDFVEVDPINENSEDFFNTEEDYQEALVGAYDLLQAT
YLNVMVGEIASDNTLAGGESATDTPGIQEIDNMTHTPVNQQLRDIWGWMFAGVNRANYIL
EFQDKIDFSGKDQIIAQARFLRAYYYFELVKWFGDVPLAVDQRLLFGDQFNVDRTPKAEV
YAQIEQDLIFAAETLPATQAEEGRITSGAARALLGKAYLYQDKFTEAASALDQVIAGPYD
LVDDYSTIFELEGENNIESVFEVQYTDKEGAGFGCLQCSEGNVAVGFNGIRNYSGPLFDS
GFSFNVPVQEAYDAFEPGDMRRDIAILNIEEFAAANGATYNEGYEHTGFYNRKYIARKGD
ANLGDANLTNPNNYRSIRFADVLLMAAEAHNRKANANDALAREYLNRVRRRAFGDTDHDI
AASGATLTDFILEERRLELVGEGHRFFDLVRTGRAAQNIPGFTANKNELFPIPTIEIQLA
GNRWEQNQGY
>KECLDBNJ_03217 hypothetical protein
MKILRLLIAFLAVAQIFTACEDDVITNYALQEISAPTGVTANFAITQDDTGMVTITPVGE
GASTFTIDFGVEGETPITINAGESTTYTYAEGEYLVRITATGATGLTSEFNQMIKVSFTA
PENLDFETTVSGLTAVVTPSADNATMFDVYFGASDEEEAVTVMAGSAAEFTYEEPGDYRV
RVVAKGASVNTIELTKTVTITGAVDPMALPITFDDPTVNYAFGTFNGAAFEVVTNPDLSG
ANTTESNVGGITNSGAQYEGGAFTLGTPVDFSGANKTITLKFWSDVEVPVLLKFEGGLNG
ERQNEITKTHSGSGWETLSFDFATEAVKSYIDGSQGVGEPFVPTGQYATMVIFVDGPGTT
AGTFYIDDVEQTGGATEPMMAAPTPEAAEADVLSIFSDSYTDPTSVNYFPNWGQSTTYEQ
VDLAGNAAIKYGNANYQGIDLGDEYDASGYEFVHIDVWSADYASIPFFIIDTSGERPVNL
EVTAGEWTSIDIPLSAFTDQEISVTNVFQFKFDVQPDNGGTFYIDNLYFYNQAAAAPENP
EAAAPAPTFDAANVLSIFSDSYTDPASVNYYPNWGQSTTYEQVDLGGDAAIKYGNANYQG
IDLGGEYDASGYEFVHIDVWSADYASIPFFIIDTSGERSVNLEVTTGEWTSIDIPLSAFT
DQGISITNVFQFKFDVQPDNGGTFYIDNVYFHN
>KECLDBNJ_03218 Beta-glucanase
MLLFLAVGCQDDDNTLEQILVPQNLEVTMDVTEDGSGNVTFTATADNAVTYRFAFPDGTT
AVAPSGVYTKRFTKSGLNTYQITVMAYGQGGVNSSKLVEVTVESDFSDPEAIELLTGGGS
KTWYWAASEPNHLGVGPNNDDATQNYFWAYFSFTEPFALANIPAATCAYDDEFIFSTTTG
EDLTYEYDNNGASFFNRSYASVVNGQSPDDSCYEFDTSGERAVSLAPSESVVAAERKRGT
TMTLTNDGFIGYYIGTNEYEILSLTENRMLLRAIQGNDQGLAWYIILTAEKPVQGSGPQA
EEDDFPNLVWSDEFDTDGAPDPANWTYDLGNGQAGWGNNELQYYTDRSDNVVVEDGVLKI
TAQRESYMGFDFTSARLKSEGLQEFTFGRYEIRAKLPEGVGTWPAIWMLGADYMTNPWPG
TGEIDIMEHVGRNQNEVLSTLHFPGNSGANAISEATTVETVSSEFHVYAAEWTETQIRFY
VDDELYHIFQNDETKPFNKDFFMILNVAMGGNLGGDVDASFSQSAMEVDYVRVYQRD
>KECLDBNJ_03219 Beta-glucosidase BoGH3B
MYASTSAINLKEKTMKQFKIVLIAVFAPLFASEAQTKGINDLDPVVEHKIDSILELMTVK
EKVGQMVQYNGSFDVTGAPSDIDSKTKLQKLKNGEVGSMLNVLTAEATREAQQVVMENSR
LKIPLLFGYDVIHGYKTMFPVPLGESASWDLDAMELSASIAAKETAAAGVHWTFAPMIDV
SRDARWGRIMEGAGEDPYLNAVIGVARIKGFQGSDLADVATIAACAKHFAGYGFAEAGRD
YNTVNVGTSELQNAILMPFKAAAEAGVATFMNSFNEIDGVPSTASTYLQRDILKGVWDYK
GFMVSDWGSIAELIPHGYAEDKMQAGELAVVAGSDMDMEGRVYEEALEPLVNENTIDEAL
LDDAVRRILRVKFHLGLFEDPYKYSDAQREQEVLLAEAHLEAARDIARKSIVLLKNENSV
LPLSKALESITVIGPLADDKDSPLGNWRAQADKNSAVSVLEGIQNAVGKEVQINYAKGAD
LGMGERSFLMPLEINDTDTSGFAKAIEAAKKSEVVVMVLGEDAFQTGEGRSQTGIQLRGV
QQELLDEVVKVNPNVVLVLMNGRPLDISKPNEEVSAIVETWFLGSQAGNAIADVLFGAYN
PSGKLPISFPRNVGQEPLYYNQKNTGRPASDMVTYSGYQDSSREALFPFGFGLSYTTFEY
GAISLSASEFSGEEKLEVTIELTNTGAVAGKETVQLYLRDLVASRTRPVKELRDFKQVSL
KPGETKKVTFEISAKTLEFYTANNTWEAESGSFKVMLGSNSRDLKEASFQYKK
>KECLDBNJ_03220 Beta-glucanase
MKKVLVVIAIISFGVHAQERELMWSDEFNGDALDLTSWNFELGDGCPNLCGWGNNERQVY
TKENHRLENGKLIITAKKEGDLYTSTRITSQGKHEFQYGRMEARAKVAVGQGIWPAFWML
GSDIKEVGWPACGEIDILEYVGREEDMVYTTLHVPAGHGDSAFSKKTKFEDIEEGYHVYA
AEWSPEQIEFFVDDQSVFVYSPEDKTKAVWPFDQPFYFIINLAIGGNFGGPEVDDSIFPQ
EYAIDYVRVYQLEP
>KECLDBNJ_03221 Putative thiazole biosynthetic enzyme
MSTLTSITIRPELLENREYILQQALGKTKIKAVSVIDWRIRKRSIDARNKPIKLQLQIEI
WQQGEQREPLNRFVPKEVSNAPKIAIIGAGPAGLYAALRAIEAGLRPIVFERGKDVRERR
RDLAKINKDQLVNPESNYCFGEGGAGTYSDGKLYTRSKKRGNVLKGLEWLVHFGADEDIL
VDAHPHIGTNKLPKVISAMREAIIAAGGEVHFNAKLTDIHIENKILKGIVINEEKQYTFD
EVVLATGHSARDIFYLMHEKGVKIEAKPFALGVRAEHQQEVINYIQYHGETDNPYLPPAA
YSLVEQVDGMGVYSFCMCPGGIIAPCATQQEEVVTNGWSPSKRNNPYANSGIVVSVAPKD
LPNYAPDDPFVSLNFQKEVERACWIAGGKTQQVPAQRMTDFVNGRLSNDFPKTSYQPGIV
SADLNKVLPKLIANRLKKAFVLFNKKMPGYLSKEAVLHAPESRTSSPVSIPRNLKTLEHI
EVKGLYPCGEGAGYAGGIMSAAIDGINCVDAIAKKYQLV
>KECLDBNJ_03222 hypothetical protein
MKRNILAGFALSLMITVSSCRESAEATTDESMQETSMEEVTPEAPVLEEAPVEAPAEVVV
DSAAVTTPEAE
>KECLDBNJ_03223 hypothetical protein
MNLVYQGNNSLVDSAVRRATQVINSSFFQKHLLEHLNNDDAQLTQQLLHHINTSTHENLI
IHTYWNVLKRDKITLTTNPDTLRINLAHFRKSRGLILEQIVRNYTLLEFKKLKANFTENA
SRDEILASRISSLANVYA
>KECLDBNJ_03224 Polygalacturonase
MKLLKSTLLVTLLISLFSCKNQKETKTSAENFLIIDTLNVTAPFGNYNIQTPDFKNAPQF
LITDFGAEQADQDKTSKAIATAIDSAHARNGGTVVIPKGEWLTSKIHFKSHVNLHLEEGA
TLLFSENPQDYLPAVLSTWEGMECYNYSPLIYAYDCENVAITGKGKLKAKMDTWKVWFAR
PSGHMQNLKQLYEMASKDVPVEERQMVNDSANFRPQFIQFNRCKKVLLEGISIENSPFWV
IHPYLSSDVVIRNVNVYAHGHNNDGVDPEMSQNVLIEDCVFDQGDDAIAVKAGRNQDAWR
LNTPVKNVVVRNCLVKNGHQLLAIGSELSGGVENIYMENCEVEPNAKLNHLLFIKTNERR
GGYVKNIYMENIKAGRIDMGVLGIETDVLYQWRDLVPTYERRLTQIEQIHMKNIKAKNVD
FVSRILGEAELPVRDIQLTTIQVDSIRDTETTHQNVENFKRTE
>KECLDBNJ_03225 Metalloprotease TldD
MKRRNFVQLAGLGAGALMVPSAMMGNNIAAEALLEPGLDIATKKSLADVALNTARSLGAS
YADARIGRYLNQYVFTREDKVQNVVNTESFGIGVRVIANGTWGFASTNDVTDAGIKKATQ
QAVSIAKANSKIQTEPVTLAPVEAHGEVSWKTPIVKDFREVPVSEKVELLLDANAAAMNA
GANFVNSALFMVNEQKYFASTDGSYIDQDIHRIWPTFGVTAIDREAGKFKSRDALSAPMG
MGYEYMDGLESEKLKSPAGFNLYRNSYDIIEDATTAAKQAKEMLTAESVMPGKYDLVLEP
NHLGLTIHESVGHPLELDRVLGYEANYAGTSFATLDKWKAGDFKYGSDIVNIVADKTQPH
SLGAVGYDDEGVKTKKWDLIRNGTLVNYEAIRDQVSILGQNESHGCCYAQSWNDVQFQRM
PNVSLEPGKEPYSVEEMIKDVEKGIYIAGRGSYSIDQQRYNFQFGGTVFYEIKDGKIVGM
LNDVAYQSNTQEFWNSCAKICDEKDYRLFGSFFDGKGQPSQVSAVSHGSSTARFNGANVI
NTGRSV
>KECLDBNJ_03226 Metalloprotease PmbA
MAIYTEEEARAILEKAMSFSKADACVMNLGGSESGNIRYARNTVSTAGHQSNQSLAVESS
FGKKSGTATIDEFDDESLEKVVRRSEELAQLSPENPEYMEPLGPQTYDKSITYVEATANV
TPEYRAEVAANSIKPAAVQDVTAAGFLDDGAGFSAMLNSNGLFAYNKSTNVDFTVTMRTN
DGTGSGWVTRDYNDITKFDAEEASAIAIDKAVMSREARAIEPGRYTVILEPAAASDLLGR
FRGAFNARTADEGRSFMSKEGGGTKLGEKIVDERVNIWSDPLHPDVPASTWSGDGLPRKK
TQWIENGVVKNLAYDRYWASQQGVEPVPFAANMIMEGGDTSFDEMIKSTKRGILVTRFWY
IRSVDPQTLLFTGLTRDGTFYIENGQIKYPVKNFRFNESPIIMLNNLEALGKQVRVNGNL
LPYMKVRDFTFTSLSDAV
>KECLDBNJ_03227 hypothetical protein
MNTEFFFTRLQYESGDWDVDQRMPSNLLNSLVEYTTLKISTTENIISLSSDAIFECPFCY
ISGHKLVQFTPKERENFEKYVRNGGFVFADDCNHDIDGLFAKSFERQMEDIFGPDELKKI
PNDHELYSSFFEFEDGPPATSQELNGWGDDLVHEYLKAIEINGRIGVLYSNKDYGCEWDY
DFRNKRFYRIDNTRFGVNIVMYALTS
>KECLDBNJ_03228 hypothetical protein
MDNNLVKIEQEVNSLTAKIKQLKQEIGKIIIGQEETVEQLLITFLAGGHALLEGVPGLAK
TLMIRTLAQAIDLKFKRIQFTPDLMPSDIIGTEILEEDQTTGKKFFEFNKGPIFSNIILA
DEINRTPPKTQAALLEAMQEFEVTYSGKTYALDRPFFILATQNPIEQSGTFPLPEAQQDR
FLLYIRIGYPTEAEETTILKATTSSKKAKVESVLSGEEIIRLQQLVREVPISDELISKVS
KIIRATRPETTSDEYVKQWVSWGAGPRAGQAMILTAKARALSQGRLSVTPDDLKFVAFPV
LRHRVIVNFKAEAANITTDTVTQKLLETIL
>KECLDBNJ_03229 hypothetical protein
MQTNYQELLKPEILHEVSGLSLIARVVVDGYLQGLNRSKSLGSGMEFSQYRGYEPGDDLR
LLDWKMLARSGRYYIKQSEIESQVSVKFILDASNSMAHKEGELTKMDYARVLTASLAYLA
HQQGDEVGLFALSENHMTTIYPKASIQHFNRLLQELLTVETTGTWPMSAISNERLHERGR
KELIFFITDMYEHSDELSAFIKALKTSRNEVAVLQIMGQDEVNFDYKGTVTFEDLETGSK
LKISAKEAKKHYLENLQNKLKQTEELLLSQGISHQVFTMGEPLGETLNLFLKKRINLV
>KECLDBNJ_03230 hypothetical protein
MFFANPMYLWALLGLAVPVAIHLWSKDEGRTIKVGSIANLRESENAQTRTLQLNEWLLLL
LRLLVIALLVVILAEPFVKTTTKNQDLVYLVEPELLKIDTFKTSIDSLAESKTVKLFLED
FPEYNAADSVKTVAANYWQLAQDFEMLKADSLVVFSQSLVRGFKGKRPEITENVNWVTID
SIQTVEGIVALTQLQDSVEVLEVKSTKEQLRFKKSVREAAAVQNLETDLEIEFLDTLQVY
AFAEDSLQTNLKFLKTGFEALSTYLKRPITVTEITQNETQQEGILIWISLSDTPEFTGTL
LKYQPDAFDSDLIAQNGTHFSLTLNLTRKNVVEQHLAEQLLPLLNLYPELEKAVQKYDRR
VLADAFATPLRTAKDQELNHASSIPLTHWFWLALLIALIVERLLSRIRKQ
>KECLDBNJ_03231 hypothetical protein
MSNTGKHSVLKFKQRWQSQLWLLVLLLALLPAMLLFILTKGIVISLLLFVVLATVGFLLY
KPLALGISKVIAYIDARIQHSEYSAGLVFQPTEELSSLGQIQRYRTEQKLANELKALKTP
IDFKHFGFLLFGVLVGTLILGVLLNTNDSLFDEEAIQPENEMVIRAVDSAEAKIIPPKII
QQSVTVRYPGYTGIAARTSEKMDIKALEGSQITWILTFDQPVDSVFMESQSAQYEMKTNA
KTYQRTQQLTTSGFYSFRFVDTLGNAYVSDLHSIETLVDAPPQVDILNLDQFTSFEPGDE
KNIAFDTQIIDDYGISAAYIVATVSRGSGESVKFREEQIAFNSAITKGSKQQSLSQQLNL
DQLKMEPGDELYFYVHAQDLKTPKPNVARSETYFAVIKDTTEYEYVEAGGMGVDLLPDYF
RSQRQLIIDTKKLLKDKPNLSTKEFNSTSNELAFDQKSLRLKYGEFMGDEAEGGLAAQTE
DPGMLSDDDADPLAEYSHRHDSSNEHNLVEVEHEHEGEEAEEEDPLEKYVHNHSDPEEST
LFAKSLKQKLREALNIMWDAELHLRMFEPEKSLPYQNEALKLIQEIKNSSRIYVHRIGFD
PPPIKEDKRLTGELKEVSSTTKQEDMEQAARFDAIQKTISRIEELIAFQVKPNSEDQQLF
EDAGNELAALAIEQPGNYLETLQQLNWISQTLDADVEALKELQNGLLKALPVEEAKPNTQ
NAKFSKLDAVLVKNLDADE
>KECLDBNJ_03232 hypothetical protein
MSELTFVHSAYWISGLIAAVILLAIFVVKEWPRKSRNFVLRLAAGFVAILALLTIALKPA
HLTSVDGKQGVLLTSGYQEAQLDSLRETNPELKELMYQDHIDRDELDSISQLFILGSGVK
PYDFWQLEGKTVKLLKTEIPNGINQLSYSKTLTEGEELNITAYYSKPKPGNQIVLQAPGN
LGLDSIQFKAAADTVFSLQAKVKAPGDFVYNLVEKDSFGRVLNNEALPVHISPEKQLSVV
MLSAFPSFEFKYLKNYLAELNHQVLVRSQLTQNRFKYEYFNQERKPFNALSTSGLNHLDL
LILDAGAWQSLSQNEQNSIKDAITQEGLGVFLMASEELFYGSQPLIDFKFTRTAQTEVEL
QDGTVVSTFGYYLNPATNFNATLKSGNQILAGQRFIGFGSVSTTVLSNTYALQLKGNQER
YKSLWSEILKSVLKPESGEVFWEERDQILTPNEPYTIEFRTAVSEFILTDTDGNSIPVIQ
DPDIPELWSATFYPEDTGWFTLRFSAGDTISEYAYYVFTEADWKARAAQGLTKANQDFFR
KGDAEVEELQVKRPINPIYFFVLFVLAMGYLWLEPKLRS
>KECLDBNJ_03233 hypothetical protein
MKTLLSIFSIITLSLSTAVIPVNDDPSTQQLTFDGYEGGYYFFSDEAYQAVVLESDSELV
MDLKNNDAVGEQFEVAYEPKAQTETSSSQGTIESIKKIK
>KECLDBNJ_03234 Putative NAD(P)H nitroreductase YfkO
MSLLDDLKWRYAAKSMNGAEVPQEKLDYILEAARLAPSSSGLQPYKVFVITNKELLEKIK
NVAWNQSQVTDCSHLLVFAAWDGYTNERVSAVFNYTMDQRGLPHETMDDYKQNIMSLYEP
LGKEWQADHASKQSYISFAMAIAAAAEQKVDATPMEGFVPAEVDKLLELEGSGYKSTLLL
TLGYRDADNDWLVNMKKVRTPKEDFITEIK
>KECLDBNJ_03235 putative HTH-type transcriptional regulator YtcD
MCEDELNCNEKIRAIHDTMDVLSGKWKVSIIACLCYQGMRFSELLREVEGISGRMLSREL
KDLEMNKLIERTVVDTKPVSVFYKITDYGASLKELTDVIAEWGIKHRALITEDFKKVTL
>KECLDBNJ_03236 hypothetical protein
MKEIESTLQNKGIRPTAMRMLIYKFMAEKNSAQGLSDLELAFTKADRTTVYRTLKTFEEK
GVVHQIDDGTGVLKYALCEPGCRCDIERDLHLHFHCNACDKTICLTEHKIPHINLPDGFI
AEDANLVVKGICDSCSTY
>KECLDBNJ_03237 Zinc-transporting ATPase
MHGFFSELSIMKEHTHTSEHHVEEGCCAKHSTSGTSEHHHHGTLAFKTYAPGLFSFLMLA
SGMLLDHFEASFFKGTWRLIWYIIAYIPVGVPVLQDSWESIKKGSVFTEFLLMSIATLGA
FILGEYPEGVTVMLFYAVGELFQHAAVDKAKNNIKALLDVRPNEAMVFREGKFVPTAPED
VKIGERVQVRKGEKVPLDGTLLSAKASLNTAALTGESKPDSVKQGETVYAGSINLDGVIE
LETTAIFTESSIARILELVQNATTRKSKTELFIRKFAKVYTPIVAFLALALTFLPYFFVA
DYVFKEWLYRALIFLVISCPCALVISIPLGYFGGLGAASRNGILFKGASFLDAITKVKFV
VTDKTGTLTQGVFRIKTIATENGWSEAEFMTYVKALEAQSTHPIAKAIQEYQVESSSVEA
REVQEHSGKGLQALINGKTVLAGNATLLKSHNIEIPKSLEDIVETLVLVAIDGDFAGYIV
VADELKPDAKTAIQKLKEAGVQQIVMLSGDKDTITQKVAKSLGITWANGGLLPEDKLREV
EQLQAQGSTKVAFIGDGINDAPVLATADVGIAMGGLGSDVAIETADVIIQTDEPSKVAQA
MRIGKATRKIVWQNIALAFGVKAAVLILGAGGLATMWEAVFADVGVAFLAILNAIRLQHM
KWD
>KECLDBNJ_03238 hypothetical protein
MIKTLYLIAFLLFGLNCNAQEIDADLLAIKAKMDAVNTFSAKLQLDLDAPFINMPTKRAE
MEYQRGKDLKFSSDDFVILPKRGLDFTLSELFEHPFITVDRGMQTLDGNQVKVLNVIPTG
DDSDMALATLFLDTEQQRIAASEITTKKNGTYKLKMQYDQALTILPNYVEVAFAIEKLKI
PLNFMGSDTKIDRKTMRNMDTKTGVLKLKITDYQIDLQP
>KECLDBNJ_03239 hypothetical protein
MIPLLKAELFKLFRESKTWYAVAAVLLIEFIILIAAYFQGATILELLLDNLRQSFYFEGT
LLNGNLLLYIILNSLWFNLPLILMIVSSALITEEYKNGTLKTLMLQAVSKRKLMLAKYLT
SAIFTLLMLLLLMTSTFLLAYGIFGSGDLVVYLGTLNFFPAEEAFKRILMAFASGTLSML
FFTTVSVTLGILLKEPAKTWIASAFFLILSSLLLKADFGLGSMERFFFAKLTNSWQRFFD
YELQLQEILIDNIALTIYTFLVALGGMYLFTKQDVG
>KECLDBNJ_03240 ABC transporter ATP-binding protein NatA
MLNAIKLSKSYKSGKVLDAVSISLEPGKISGLLGRNGAGKTTLFKILCGLITPDDGAVQQ
DSKKAKPIGAVIEEPGLYTYLNAYENLKLFAQIQAAPADRTSLENYLTQVGLPLDRKDPV
RNFSMGMKQRLGIAIALLNAPDILILDEPFSGLDPTGVASLIQLIKTLAQQNIAILVSSH
LMAELQKSCDYLYVIDQGKIVNEGPTQTLLNALISVYTLTGTAIEKAQSLQPYVLHAETN
TVTINCEHIPVSVVLRSTLEEGFEVHSCVPNISLEQLIIPLNA
>KECLDBNJ_03241 hypothetical protein
MHFSDLPKQPSTFVSYWNVGKLLYGALFLFILETVFYYTKFVEAYTEKTILIIAFWLWCL
MFSFIHIFLVTMDVWSRFQNYKRIKDHLFQHGFTPKIAEHYKGSKCQRMALYAAAKELGM
QTEIEQHYAQAGIKWYHFIPQFMIQDPLFPFKKYFWSRTFLEKYYEPKFEFRNAQKITTE
C
>KECLDBNJ_03242 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MKKLQLLPVFIFLLLNSLSRAQEMIPESYINPLDIDYTYMVYNSSKNISYRSGADPAVIE
FRGEYYMFVTRSFGYWHSTDLVNWEFIKPKQWFFEGSNAPTAFNYKDSLVYFAGDPAGYG
SILYTDNPKEGLWNPVASISNNIQDSELFIDDDGKTYLYWGSSNVHPIRVKMLNKNDRML
ETGVTKDLINLDEEAHGWERFGENNFHPTLKEGYMEGASMTKHNGKYYLQYAAPGTQFNV
YGDGVYVGETPLGPFEYMPNNPMSFKPGGFTNGAGHGITVKQTNGQYWHFATMALASNSH
WERRLCMFPTYFDEDGLMYSNTSYGDYPRHAPSHPTKAGEHNGWMLLSYKGKVTVSSSQL
QITKSTITDGDFEVTEIPQKTNANGSILSEVLTDENPKSFWVAEANDAQQWVSIEMNKPG
NIYALQLNFHDHESGIYTRVEGLKHRFIIEASEDGKTWETVIDRSKSYKDTPNAYLVLNQ
PVKAQYIRYKNIKVPGNNLALSEIRVFGKGFGKKPTKVKAFKVARQPDRRDAQLTWDVIK
NAQGYNIRWGIAPDKLYQSWLVYNDHELFMRCLDRDQTYYFSIEAFNENGISEKTEVMKV
D
>KECLDBNJ_03243 tRNA modification GTPase MnmE
MQIQDTIAALATAPGAGAIAVIRVSGTQALSIVSDLFQAKSKKKLIEQDSHTLHLGNIID
GSRIIDEVLVSIFKGKRSYTGEPTVEISCHGSSYIQQEILQLLFRNGCRAAKAGEFTLRA
FINGKMDLSQAEAVADLIASDNAGAHQIAMQQMRGGFSNEIAQLRQELLNFASLIELELD
FAEEDVEFANREEFQQLISKITRVLKRLIDSFATGNVIKNGIPVAIVGEPNVGKSTLLNA
LLNEERAIVSDIAGTTRDTIEDEISIGGIGFRFIDTAGIRETADVIEGLGIKKTFEKIAQ
AQVVLYLINSEKFKDQAELFTVEIQKIRNRFPDKPLVLVANKIDHLTEAEQESINNQLAK
LVSEGNKSAVLLISAKTGTGVEALKEQLLQFVNTGALRNNETLVTNSRHYDALLKALEEI
EKVQLGIDAGLSGDLLAIDIREALYHFGEITGQVTNDELLGNIFANFCIGK
>KECLDBNJ_03244 hypothetical protein
MKRTLLFLAVSFVVGVSAQANERLQGQTRTANTASKLQLEPVVFIERGVEFLVYPDGTLD
FNLPPASISLNGRRVNQIYYNPNSVYGSNQAYRKGYIQYNRNGQVAQIGNLNIDYHRNGS
VEKIGDIALTYKKGRLAKIGNLKMHYDRSGRIYKQTGTISKAYKVHGVRSQTVYSTRSRR
S
>KECLDBNJ_03245 UvrABC system protein A
MIVDVSKANPKENIIIKGAKLHNLKNINTIIPRNKLVVITGLSGSGKSSLAFDTLYAEGQ
RRYVESLSSYARQFLGRLNKPKVDYIKGIAPAIAIEQKVNSTNPRSTVGTSTEIYDYLKL
LFARIGKTYSPISGDEVKKDTVTDVVDYVKQFDERSKLLLLAPFLVEEGRKIEEKLNILQ
QQGYARIKVNDTVVRIDEAGSIKKTDKLFLVVDRIIKKDDEDFYNRLADAVQTAFYEGKG
EAFIEDLDTGKQRHFSNSFELDGMSFLEPNVHLFSFNNPYGACPTCEGYGDVIGIDEDLA
VPNTALSVYENAVFPWRGDSMSYYRDQLVNNAYKFDFPIHKPYFELSDAQKELLWNGNQY
FEGIHQFFEFLESKAYKIQNRVMLSRYRGKTRCKTCGGKRLRKEANYVKIGGTTITDLVG
LPLNKVADFFKNLQLSEHDSKIAKRLLTEIESRLEFLSKVGLNYLTLNRKSNTLSGGESQ
RINLATSLGSSLVGSMYILDEPSIGLHPKDTERLIEVLKNLRDLGNTVIVVEHDEDIMKA
ADEIIDIGPEAGTFGGDVVAVGTYDEILKSESLTAKYLNGDLEIKVPEKRRESKYYVEVK
GARENNLKNIDVRFPLGMFVAVTGVSGSGKSTLVKKLLYPALLKETGGYGEKMGQMTGIE
GKFDNINHIEFVDQNPIGRSSRSNPVTYIKAYDDIRSLFAGQKLSKIRNFQTKHFSFNVD
GGRCENCKGEGEVTIEMQFMADVHLECEVCKGKRFKKEVLEVTFEDKNIDDILNMTIDDA
IAFFKEHKQDKITRKLKPLQDVGLGYVTLGQSSSTLSGGEAQRIKLASFLVKGTSKEKNL
FIFDEPTTGLHFHDIQKLLTSFQALIKKGHSILVVEHNLDLIKCADHVIDLGLEGGENGG
YLIASGTPEEVAKNKKSYTAPYLKDKL
>KECLDBNJ_03246 ECF RNA polymerase sigma-E factor
MEEMLTTDATLVSSYIKGDESALSILISRHQQRVYSFIYSKVYDRDVTEDIFQDTFIKVI
RTLKRGGYNEEGKFLPWVMRISHNLVIDHFRKNKRMPKFDNTGDFNIFSVLGDPDLNAEK
RIIKDQVEEDVRKLIDELPEDQRDVLVMRIYKDMSFKEIAERTDVSINTALGRMRYALIN
LRKVIEKNNIVLTN
>KECLDBNJ_03247 hypothetical protein
MENIYSKKACALDNNLKPTQETVDRILNYSKALSVMNTKFGKFENLLN
>KECLDBNJ_03248 hypothetical protein
MSRTLLFFFLMMCANLSIGQALSHLDGTVNISLEDETIDATYTLSNLPVDTQTLSFRLNE
FIKVKSISLNGERIASSKVPQNCTDCLIYTVLVGCEVVITPQSTLTIVTEGKFKNFDSEG
GAKRYKGQLVYSNGVLRATNSDKWYPEIVNKSSNISDYMDPFNYTYSITANCEDCDKIYI
GKGQPQPSGTEFTNAQAEGDLVLLAGNLEYQTGKYANYINVPQEAIPALEAKFAKTRGFL
EELTQVSPNDKVVYAQVSSPVYGNESTYNTIINTGAQVDVKKIDDAIEEGDAYFYMASAF
KPESQLDRMLLQSLAKYVKLRYLKKYSVDQYNNLNSFLEGNTSNSGLASERRELSALLIS
PEQFKILENEIGEAEMNAFISNVFQNLRVGKRSMQAFTDSFNQIQLANKSERFAQLEKNL
QTQFELRSTIPDAREVITEY
>KECLDBNJ_03249 hypothetical protein
METDSPNQIAVFSYGTLQDPEVQKELYNRVLEGQPDRLSGYILERINLLDSSFNYIAYPI
AKPTGNPQDSVEGVVFYLSEHELKFTDTYESEAYERVLIKLDSGIEAIVYQTPIR
>KECLDBNJ_03250 hypothetical protein
MNYKYLLLSLFFAYTSIFGQAPELTAVGDQVYCPLTSIPIATDFELNNPGGTVIDALYIQ
ISSGYEQGNDFLEFPNLNPNITQSFNAADGKLTLRFSSTITNAEIIEAVEAVTFRSDDAS
VSGKKEFSISIGQANYLPSSDHYYEYVPANLITWQDARIAAENRTYYGLQGYLATITTLD
EAVLCGEQTQGAGWIGGTDEAVEGVWEWVTGPEGLAGGLEFWRGGPGGSTTTFAYWNPGE
PNNTNGGEDYAHITAPGVGIEGSWNDLRTTGETNPLFQAKGYIVEYGGMPGDPVLKIAAA
TQIRIPVTSATGDSRCGPGVVTLDATTNAGELHWYDSQSGGNILFTGTQFTPNLTSSQTF
YVAAEPAGCTSGKRRAVQAEILPEVAAPNQITFSNCDEDGTPDGFVDFNLQQIIPYLTAD
PAVHVTFYSTRFDADTNSGSNVLTTPYNNASGNTIYAYIFNSAGCSAVSEVQLQVSTTTF
PTGFLYNLTSCDTDAQQDGFMDFDLNEASSAMLNVFPSGANLEVSYFRSEQDALLAQNEI
NTASFYRNEVAYNQIVYVRVEDQDSGGCYGVGPHLELQVEALPIFDVVNEGKFCSNASSF
TLETENAQGVYNYSWYDASNTRISTSAQVTVTTPGIYTVTATTAYGCISEPKQIEVIASE
AALLELENIEVIQENGSNSIHIADLSLLGIGDYEFALGDPIGPYQTDPTFDDVAIGLQTL
YVRDQNGCGISSIEIPVLGFPKYFTPNNDGYHDTWGAQGVVSNEFSAIQILIFNRFGKLL
KTLYDFNSSWDGSTRGSNLPADDYWYKVLLTKTDGSIVNYQGHVTLKR
>KECLDBNJ_03251 hypothetical protein
MKNLLKCSLLSAFVGFGLLLLHSCRTDFEPSLSTGNLEFSRDTIFLDTVFSNIGSSTYSF
KVYNRSNELISIPQVRLAQGENSQYRLNIDGIPGKTFENVELPAKDSIYVFVETTVNASQ
QDEDQFLYTDQILFDSGVYEQRVALVTLIQDAIFLFPERNAQGIKETLTLGTDEDGNAIT
IEGFILEEDQLVWTNQKPYVIYGYAGVADEQTLRIEAGARIHFHENSGIILSNGARLEAD
GSLSQDPDRLEGEIILEGDRLEPEFSAVPGQWGTLWFTPGSTARMQHVTIKNNAIGILAE
GHSNTNTPDHYLKNVQIYNTASVGLYGVNASILGENLVIGNSGISNFWARQGGSYEFVHS
TFANYWNQSFRNTPSVQLANFLETEDELLIADLTKAQFTNSIIYGNATRELGLEAVDAAT
FQYNFSNSLVRFEDPFDDFTANPLYQFANETLYTDILLNEDPNFENTSLNNYKIIAPSAA
RALGNESGAIQVPTDLLGIAREEHIDSGAYQATDNEN
>KECLDBNJ_03252 hypothetical protein
MRIYNLLAVFILSLTLLACGNGKDLSKSFKLTLNKAENSLKNGDQVSISLKSKGEIPIDS
VIYKLDGAVLGTKTDLSALEIAFDVTKLGAKNLSAQVYAEGKQATLNSKLTFLASETPTL
YTYEIVNTYPHDKSSYTQGLEFHDNILYESVGEYGESGLLKTELETGKILERKDLEKKYF
AEGLTVINNQLVQLTWRENVGFVYDLNSFEKTDTFNYGKSKEGWGLCNDGQVIYKSDGTE
KIWLLDPQTFAEQEYIQVVDSKKLRSKYNELEWVDGKIYANSYQFDSISIINPTSGAIEG
VVDLRPLKKEISSITDADNEVLNGIAYNAATKQLYVTGKHWDKLFEIRLIKK
>KECLDBNJ_03253 Cyclopentanol dehydrogenase
MSQVVLITGASSGIGKSIAEFLVTKGFIVYGTSRNPKNELVNGVHFLALDVTQGETVKAA
VAAVLAKESRIDVLINNAGKGITGPLEEIPEEELKSIFETNYFGPLKVIKAVLPAMREQR
SGLIINVTSIAGYMGLPYRSAYSATKGALGLTTEALRMELKEFNIKLTNVAPGDFATNIA
SGRYHAPLKETSPYKENYGKSLALMDEHVDHGEDPQKMGKAVYAIITEKEPKVHYKVGAF
MQKISVFLKGVLPSKIYERLLLNHYKL
>KECLDBNJ_03254 Transaldolase
MKFFIDTANLDQIKEAQELGVLDGVTTNPSLMAKEGITGRENILKHYVDICNLVDGDVSA
EVIATDIDGMIKEGEELAALHEQIVVKIPMIKDGIKALKYFSDKGIKTNCTLVFSVGQAL
LAAKAGATYVSPFLGRLDDISTDGLQLISDIRLVYDNYAFETQILAASVRHTMHVIDCAK
LGSDVMTGPLSSIEGLLKHPLTDIGLEKFLADYKKGNS
>KECLDBNJ_03255 hypothetical protein
MSVKLLLATFLSLSLLGCSEQTHKAKSGTYLGGEIVNPTSNFVLLRKNDRLIDSIKLDQN
NRFLYKIENPQEGLYQIFHNEGQIIFIEPNDSLMLRVNTYEFDETLTFSGFGAPRNNLLV
ELFLLNEHENELMLQDEIYQQDPETFSKSIALLKAEREKILQDFLKKNEADAYFEKIAET
VVNYDFYARKEVYPMSHFGVDRVAFLESLPQSFFDYRKDADFNDASLLELYSYQRFLINY
FNQAAFKDYYKQEAYDPLSFTHNLHKLRLIDSQIENDSVESFLLTRTIRDYLANSNDKKG
GQTLYDMYMERIASKDDKVIIQELYESNKNIETGKRIPNEKLVNFDNDTLSFERIINKPT
FIFFWSSSRKSHAIRAQKLASSLQQKYPEYSYLAINVNDSYDNWQNTVSRYNFDSAKQYY
FKDSFDELAEDLALNSLLKTFIVDRNGIIINAHANIFSSNFEQELLEALNQ
>KECLDBNJ_03256 putative ABC transporter ATP-binding protein YbiT
MLSVSNLSVQFGKRVLFDEVNVSFTQGNCYGIIGANGAGKSTFLKIISGKEDPTSGHVHL
EPGKRMSVLEQDHYAYDEHTVLETVLMGNKPLFKIKTEIDALYADYSDENAERIGELQVE
FEEMNGWNADSDAAALLSNLGITEDLHYSLVKDLDGKQKVRVLLAQALFGNPDVLIMDEP
TNDLDYETINWLENFLANYDNCVIVVSHDRHFLDAVCTHISDIDFGKISHFSGNYTFWYE
SSQLAARQRAQQNKKAEEKKKELEEFIRRFSANVAKSKQATSRKKMIDKLNVNEIKPSSR
RYPAIIFEREREAGDQILNVEKLASSIDGEVLFKNVNLNLAKGDKVVVYSKDSRATTAFY
EILNGKQNALEGKYEWGVTTNQSYLPVDNQEFFDNELTLVDWLRQYAKTEQEREEVYLRG
FLGKMIFSGEEALKTSNVLSGGEKVRCMLSRMMMQRANVLMFDEPTNHLDLESITAINNS
LKNFKGTILLTTSDHEFAQTVGNRIVELTPKGAIDRYLTFDEYMNDPKIKEQREQMYAVE
A
>KECLDBNJ_03257 hypothetical protein
MIKDSKYERVYTGSEINVNHLKSQLEGAGISSVVRNDHESAIRAGFGSDYDRGVLLFVEK
DNLLRAKHIIEKSTSEPKFTDAELEEQATQSRLKEQTTERKGERPLIQKEEKPKRSFFNL
ALNAGLLIYSLWRLYPLTQGEDLPTYRILLSSFIAVFCGYTLVRHFIKK
>KECLDBNJ_03258 hypothetical protein
MLLKRTNIHEKLLREQRLNTNAGESKIINWVNQFLKNTPANNAPILDKLKQQNGDTTATA
FVFDKLDTERIFHEKSIKRICVDYRLRFLDTHFFKGTYPQEALDEIKHLEEAHETSLSNF
KIMAPSKMFVLSKTDDPLLFAPMGNGYYYLIHKWGNDLHPLRKLLMWPFKTFETLVFTIM
LSSILATVLVPDGLFAPEQSLSQDAMVFFFMFKSIAAVVIYYGFALGKNFNTAIWKCQYD
KAQ
>KECLDBNJ_03259 Phenylalanine--tRNA ligase beta subunit
MQISYNWLKQFINIDWEAEKTGNLLTDLGLEVEGIEAFQSVKGGLKGIVVGHVLTCVKHP
NADRLKLTTVDLGDGEPVQIVCGAPNVDAGQKVPVATVGTTLYDDKGEPWKIKKGKIRGE
VSNGMICAEDELGLGESHDGIMILEEDLKPGTPLAKIFEVEDDYVFEIGLTPNRADAMSH
MGTARDLRAGLIQSGVHPEFITPSTSSFRIDNRTQKISVQVLNNEKAPRYCGITLSGLTV
KESPAWIQNRLKAIGLTPKNNIVDITNYVLHELGQPLHAFDLAKIAGKQINVKTVAAGTK
FTTLDGIERELHEEDLMICDAEKPMCIAGVFGGEHSGVTEETTSIFLESAYFDPVSIRKT
AKRHALNTDASFRFERGIDPNITEYALIRAVLLIQECAGGEVTSDVVDFYPKKIEDHQVV
LNFDRAEKLIGEAIPKETIKSILSSLDIKINNITESGIGMTIPAYRNDVTREVDVIEEIL
RVYGYNKIQFKSKLNASVSKSSRFADHKIQQVTGTLLASLGFNEILNNSLTSPVYASLND
AFKEDYNVTMLNPLSTDLSVMRQSLLFSGLEVVAFNSNRRQPDLKLFEFGKSYHNFPGGR
EEYKHLTLLLSGKQNAENWFQQQQNTTFFDLKGSVEAVLSRLGIAQWKVKPVKDAQFSEG
LEYTVQKKQVVSFGLVSKAIRKHFDIEQEVLFADFNWDTILDLVQQNSIKFVPIPKNPAV
RRDFALLLDQEVTFDQIYQEAFMVEKKLLQNVALFDVYEGENLPEGKKSYAVSFTLQDEH
KTLTDKEIDKIMNKLQQRFEKSLNAELR
>KECLDBNJ_03260 ATP-dependent DNA helicase RecG
MSSKLQTPIDYLKGVGPNRANLLRSELGIHTYQDLLNLFPNRYIDKTQYYTVSQLQPTSA
DVQIIGKVTHIKTAGEGRSKRLVATFIDQTGAMELVWFKGLKWIRESLKINVPYVAFGKV
QRFGSSYSIAHPDLELLEEHKKGLRIAMQPVYPSTEKLSNKGITNRVMNGLMQTLFQEVH
KSIEESLSESIRNTLKLISRREAYLNIHFPQQQEKLAKAQFRLKFEELFFIQLQLLVKNQ
LHKQKIKGYAFEEIGDYFTTFYNKHLPFKLTGAQKRVVKEIRNDLGKPAQMNRLLQGDVG
SGKTIVALMTMLIALDNNFQACLMAPTEILAIQHFQGISELCEKLNIKIALLTGSSKTKE
RREIHESLEDGSLNILIGTHALLEDKVKFKNLGLAVIDEQHRFGVAQRSKLWHKNELPPH
ILIMTATPIPRTLAMSVYGDLDVSVIDELPPGRKAIKTVHRYDNNRLKVFGFIRDEIKKG
RQIYVVYPLIQESEALDYKDLMDGYESIAREFPMPDYQISIVHGQMKPADKDYEMNRFVN
GETQIMVATTVIEVGVNVPNASVMIIESAERFGLSQLHQLRGRVGRGADQSYCILMTGHK
LSEDSKTRLQTMTQTNDGFEIAEVDLKLRGPGDIMGTQQSGVLNLKIADIVKDNGVMKIA
RNYASALLKEDPQLAQPENLPIRKTYAQVMKFKNIWNYIS
>KECLDBNJ_03261 hypothetical protein
MLKREPFFLILLLVIAAALQLLFFGASGFSVEKTTAINIDDTYYVVSVLYIFPGIFCLLL
FSGNGLKLLIQKKSEIATVLFFIIASGVLLVFSTQFLSALHEMQSADEATTMLIKILNSI
RLFVALLAGITLVFIGKKIYKRLSNS
>KECLDBNJ_03262 Aminopeptidase N
MRLIFSLIAAFLISTTYAQQTETVDFERIYALLDFDFAKSSVTGKMEIKFTMKANADFVY
LDAKNIAKYEALLNSKIVPTHTDEGRIIFTQSFEKGKTYNLMLNYTAQPNKALYFVNNGG
FQQIWTQGQGKYTSNWLPSIDDMNDKIEFDLSIVAYPGQEVIANGVLKEKEEVEDKFIWH
YEMSEPMSSYLVAVVLGDYRKQSRRSDSGVPIDLYYYPEDSLKVMTTYKYSDDIFDFLEE
EIGVPYPWPVYKQVPVKDFLYAGMENTTATIFSDAYMVDRSGFTDRNYVNVNAHELAHQW
FGDYVTETSGTHHWLQEGFATYYALLAEAEVLGDEVYAWKLFQSAMQLKAMTDKGNGESL
LNPKASSLTFYEKGAWALHMLRKQIGDEAFKTAVKNYLNAHKFSNVETEDFLAEARAASG
QDLQAFEQNWLQAADFRYEEAIATLQDFPVIQRYKRTVDLRKLSYGQKSQKLFDLLALPD
KYSGPEAIYQLADVSPAAAGRIYERAFYTNNPWVRQAIAQTVTKVPAAMKTNYERLLNDD
SYITRELAFMNLWTSFPSERHKYLDKMKGVQGFSNHNVEILWLALAISTLDYEEAYIRDH
FFRLTRYTGNRYSFETREQAFTKLYQLQLFEPKSLKNLVEACFHHNWRFAQTCRQILDEV
VKNADYRRELKKLDISDEKEKQLLAEKLT
>KECLDBNJ_03263 hypothetical protein
MRALVISGGGSKGAYAGGVAQHLIEEQGHKYDLFLGTSTGSLLISQLANNNIKRAYEVYT
QVNQNTIFNVNPFNIKKRGDREYVSINYWNTVWQFIRRKRTFGESKNLLKNIKKNLSKTE
FEQIKKQTADVVVTVSNLTKNTVEYKSIRNWDYEDFCEWIWISCNYIPFMSLVKKNGFEY
ADGGFGCIVPIREAIRRGATEVDAIILESENMEYNKVLGNNPFSLMVNLFGFLMDQVEYH
DVIVGKLAAINKDVPLNLYYTPSKLTENSLIFNKKLMTNWWQQGWDYAAAKAKQAQENKL
RELPETE
>KECLDBNJ_03264 hypothetical protein
MKLFCTLLLAALLFISGCDASSKATDEESCTETNIAYVSEVTGDSRVAAGDELELSVSFP
VNNGCGQFNAFTETEDGNVITIEVEAIYDTCSMCTMDIPTRTAPYTFQAETEGSYTLKFK
SSETEFITKTITVN
>KECLDBNJ_03265 K(+)/H(+) antiporter NhaP
MNLTIENIVFIGSVLLLISIIVGKTSYKFGVPTLILFLGIGMIAGSDGIGGIQFDNPQIA
QFIGIVSLNFILFSGGLDTQWSSVKPILREGLALSTAGVLLTAVSLGCFVYYVTDFTIYE
SMLLGSIVSSTDAAAVFSILRSKSLALKTNLRPTLELESGSNDPMAYVLTIAFLTLVINQ
DQGLISVIPMLLKQMVIGGIAGFLFGKFSKLIINKIELGFEGLYPVLVIALMFITFSATE
FIGGNGFLAIYICAVYLGNQDLIHKQTILKMFDGLAWLMQIVLFLTLGLLVFPTQVIPYI
GIGLMISLFLIFVARPVGVFISLAFFKMKMRRRFYISWVGLRGAVPIVFATYPLLAGIDK
ANMIFNIVFFISLTSVLIQGTTLSVVAKWLKVGLPEESKAQRNMNHLISEIPKTAMREIK
ISPHCKAADTKIIDLGFPKNAIIAMIKRNDKFLTPKGSTVINAGDTLVVLSEDEEGLDDV
IKCVN
>KECLDBNJ_03266 hypothetical protein
MRYLLSLITIVFLLVGCDEQKKESSSINPINWEKRRATITNQDSLKPAKTYLGIYSEIYS
TSEHLTHDLTVTVSLRNTSETAAVYLTKGAYYDTTGKLIHTYFDFPIVLKPLETVEIIIE
EGDKTGGTGGNFIFNWLDDASVTDPLFEGIMISTRGTQGLSFTTEGKRIE
>KECLDBNJ_03267 hypothetical protein
MNDILDILIPVLPAVVVGLLAYYFFDGFLKNEENRRRFILHKEAQTEALPIRLQAYERLT
LFLERISPLQLLIRVKPTGEDKKAYVDLLAATIEQEFEHNLTQQVYVSNECWAAIKSAKN
TLIQQLRKTLADTQLQSAQDIREYILTNFDESQNPTSLALDYLKAEVQELFG
>KECLDBNJ_03268 Glutamate synthase [NADPH] large chain
MNDFFTFLAQIPWWAWILIVLVIIGIRDVFFNKKHIITHNFPIVGHIRYMLESIGPELRQ
YIVANNREELPFNRIERGWIYASAKNQNNYEGFGTDQNIYEANYIFINNAMMGFKVPPEH
PNAKNPYFLPCAKVMGAYNKRRKPYRPASAINVSAMSFGSLSARAIESLNRGCKLAHAYH
NCGEGGLSPYHKKGADIVYQIGTGYFGVRDEHGNFSLEKMVALVEANPEIKAIEVKLSQG
AKPGKGGVLPASKITQEISEIRHVPMGKDVISPATHTAFDGVEGLIEFVEQIAEATGLPV
GIKAAIGKLQDWEKLAQLMVKTNKGPDFIQVDGGEGGTGAAPPSFADHVSLPWVYAFSDL
YKIFKKHHLTDRIVFIGSGKLGLPAKGAMAFAMGADVINVAREAMLSIGCIQAKACHNNT
CPSGVATQNKWLQSGINIEDKAVRTNFYFKNFRKELLEITHACGYEHPCQLTTEDVDLTL
GDKNLSQTLAACFTYHKVEVPFEGMSSLLNCQYLGGHYDRETVKSEKSGQKQFEDVRY
>KECLDBNJ_03269 hypothetical protein
MKRVPLLLCFLLLNILGCKQAEPLSLTQLQNPVGSENIAYQWGFLALEATAHDTEWFNPR
PTVTSRFLGLIFTATFDAWSRYDAAATPVYLKNVDRTPAKEHNLRSKEIAISYAAYRAMC
EYYPKDQPMFAEFMNTLGLDPKDESTDASTPVGIGNLAAKAVIEARTGDGANQYGEETGS
DGITYFDYTGYKPVNSDTIMVDPNRWQPKYFTDNNGKKYAPGCLTPYWDKVKPIGLKSGD
QFRPGPPPLIGSEELKTQVDEVVMLQANLSDADKALVEFMRDGPKSVQQAGHWLNFAQFV
SRRDQHTLDQDIKMYFYNQMVAMDAFIASWDSKMFYDFARPYALVHEYYSGKTITAWGGK
DIGMIEMDGSQWRPYSPDNFLCPPFPSYTSGHSTISGGCAEALKLWTGSDTFGAEATLVA
GALTEPKHLGDTITLKFPTFTKAGEMAGISRVMGGYHIQADNIAGLELGRNVAHEDYAFY
LKHVGK
>KECLDBNJ_03270 putative hydrolase YxeP
MKQLNTLFFFALGLSAFAQSANPDLIAAAEAIEPKVINWRHDIHEHPELSNREFETAAKV
AKHLESLGIEVQTEVAKTGVVGILKGDHPGKVVALRADMDALPVTERNDLPFKSEVTTTF
MGAETGVMHACGHDTHVAILMGTAEVLAQNKDKIHGTVKFIFQPAEEGAPPGEEGGAALM
IKEGVLKSPDVDAIFGLHINSATPVGTIAYKPGGTMAAVERFVVNIKGKQTHGSQPWGGV
DPIYIASKIVDGFQSIISRESNLLVEPAVITVGKITAGVRFNIIPESAELIGTVRTLDPD
MRELIIRRMTEMSEGLAKAYGGSATIEFQSNTAITYNDLELTEQMLPTLQGVAGTENVKL
VKATTGGEDFSYFQEEVPGFFFFLGGMTPGNTEAYPHHTPDFQIDDDGMLLGVKTMSQLV
VDYLSAS
>KECLDBNJ_03271 hypothetical protein
MKLKRFVFGLFSLLISIYAEAQKKVEGPLIHGYGETFAVPQPDLAVDTEADYKVVFDIAN
APEDPAKLNPYFNTVARFLNMHAHAGIEKSKLQPVLVVHGSAAFGLLKNKFYKEQFGVDN
PNLELLNTLHKLKIPVILCGQTAGARDISVEKRWGKTQLALSAMTALIQYQNMDYALISF
>KECLDBNJ_03272 hypothetical protein
MKTNYLFLFIFCSLLFISCTEDGALSESEDSFTEDGLASSEPGGESSGVGDGDGSQDNSG
IVTAGEWNDLTNWSFWQNLLNQEEADAFTSDWQFNTTNRFSFKVTDASNLPAVDIPISVK
QGNNIVWEARTDNQGTAELWIDLKNNAQKTADASAYSFYINNTPITSSVHAFSQGVNTIK
LNVSVPVQSKVDLAFIVDATGSMGDEMDFLKDDLKQVIQNVKSNDGNLQISTGTVFYRDT
GDAYVVKESAFTTNLESTLSFISDQEAEGGGDFPEAVHTALKTGVDQLQWSTSAKSRIAF
LLLDAPPHNESQIKDDMHTSIQKAAKKGIKIIPIVASGINKETEFLMRNFSITTNGTYVF
ITNDSGVGNDHLEPTVGEYEVEYLKDLMVRLITKYTE
>KECLDBNJ_03273 ATP-dependent DNA helicase PcrA
MEALLAGLNEAQRAPVLQKEGAMMVIAGAGSGKTRVLTMRIAHLMQQGVDAFNILSLTFT
NKAAREMKTRIGTIVGNSEAKNLWMGTFHSVFAKILRIEGHHLGFPPNFTIYDSQDSQRL
ISTIIKEMGLDKDIYKYKQVHSRISSFKNSLITVKAYFQNPELMEADAMAKKPRLGEIYK
EYVDRCFKAGAMDFDDLLLRTNELLARFPEVLAKYQKRFQYILVDEYQDTNHSQYLIVKA
LADRYQNICVVGDDSQSIYAFRGANINNILNFQRDYDDVKVYRLEQNYRSTKNIVEAANS
VIEHNQTKLDKVVWTANDSGPKIVVHRSLTDGEEGRYVASNIFETKMNQQLKHSDFAILY
RTNAQSRAMEDALRKREIPYRIFGGLSFYQRKEIKDVLAYLRILVNPNDEEALKRIINYP
ARGIGATTLDRLTIASKQYNRSIFEVMENIQHLDININNSTKNKLYNFVNMIHSFKIMSE
NQDAFAVAETVARKTGLLQELKKDGTPEGIARIENIEELLNGMRDFVEGQKEIADATGSL
TEFLEDVALATDMDKEVDDIDRVSLMTIHLAKGLEFPYVYIVGMEEDLFPSGMSMNTRSE
LEEERRLFYVALTRAEKQAYLTYTESRYRWGKLIDAEPSRFIEEIDEQYLDIQTPMDTYR
YKPMIDSDIFGEPDKSKLRLKKPVSGTPPTMGKPSEEQLRKLRKLRPQAASAPQTDELNG
KLQKGMHVEHSRFGRGQVLNLEGAGQDQKAEIQFQTGGIKKLLLRFAKLKILD
>KECLDBNJ_03274 UDP-2,3-diacylglucosamine hydrolase
MKRKVELVILSDVHLGTYGAHAKELVSYLQSIKPKTLVLNGDIIDIWQFRKRYFPKSHLQ
VIKKIISLAAKGAKVYYITGNHDEKLRKFSPVEFGNISILDKLVLNLDGKKAWIFHGDVF
DASIQHTKWIAKLGGWGYDFLIILNSFINWCLVSLGRPKYSLSKKIKNSVKKAVSFISDF
EETAAELAIENKFDYVICGHIHQPQMRKVETPQGDCLYLNSGDWIENLTALEYDKGIWSL
MEYEKQNLPETQEDESVNTEIDPVALLASIKTF
>KECLDBNJ_03275 Chorismate synthase
MAGNTFGKLFTLTTFGESHGEAIGGIIDGCPAGIEIDLDLVYRDMERRKPGQSKIVTQRK
EPDSVNFFSGIFEGKTTGTPIGFNIVNTNQKSHDYSHIKDTYRPSHADYTYDQKYGVRDY
RGGGRSSARETASRVAAGAIAKQFLKDIKINAFVDSVGEIHMTTPYQELDFDKIESNIVR
CPDEAFAEKMIDKIKEIRKAGDTIGGTVMCVIQNVPVGLGEPVFDKLHAELGKAMLSINA
VKGFEYGSGFHGASMLGSEHNDLFNADGSTKTNLSGGIQGGISNGMDIYFRVAFKPVATI
MQNQPTIDKEGNATEMQGKGRHDPCVVPRAVPIVEAMAALVLADYMLLNKGSKI
>KECLDBNJ_03276 Proton/glutamate-aspartate symporter
MKKIALHWKIIIGLVLGIIWALISSQLGWSQFTIDWIAPFGKIFINLLKLIAVPLVLFSI
ISGVANLGDPASLGRMGGKTLLAYLVTTVLAVGMGLFLVNLIGPGKLVDEQSRIDNRISY
EIWAAEEGYVIKDGINYLQDPEFMDRAREISDLTKSDLKDASMNDKMQAADATKDAGPLQ
PLVDIVPDNFFSSLADNGLMLQVIFFGLFFGISMLFIDQKKVAPVTKAVDGIMEVFLKMV
DFTMQAAPFFVFALLAGVVSQMAGNDIGKVVEIFKGLSWYSLTVFGGLGLMIFVIYPLIF
KIFVRKVSYFGFFRAMGPAQTLAFSTSSSAATLPVTMECVEDNLGVDKKVTSFVLPIGAT
VNMDGTCLYQAVAVVFLAQLHMIDLTIGQQLTIVLTATLASIGSAAVPSAGLVMLIIVLE
SVGLNPAWIGIIFPVDRILDMCRTVVNVTGDATVSSVIAKGEGMFNYNPNKEPDAAFDID
EKQ
>KECLDBNJ_03277 hypothetical protein
MKTFLLLLLFGNYFLYAQVGIGTTSPSESSMLEINSEASDGSFKGMMPPRVTIAQRDLIN
PTDADTGLMVFVNDPDASIYGLQVYNGTFWENIYLLQSSIQPTEVSFTITETSQSESDVA
IDLEFNITNPSTTNGLTLTVAASSYADLAETTAQVITIPPNTQVFNATEVFTLVDDTEVE
GNEQILFSITNASGGSGAPTIGANSIFDLTVVDNDVNLWINEIHYDNLGGDVEERVEIAG
SAGIDLTGYSIYHYNGSGGTIISTENILGIIVEISSGIGVKNIDFTSLQNGPDALALVDP
SGNVIQFLSYEDEVIATEGPAAGMTSILLSISEEPAVTIGLSMQLTGAGNQYTDFTWTLA
PDTIDAINSGQTFN
>KECLDBNJ_03278 (S)-2-haloacid dehalogenase 4A
MTQPRLLIFDVNETLLDLKPLARRINAVLSDEHAFELWFSTLLHYSLVETVSGKHQDFSK
IAKATFEMTAAKYKKVLAEEEIDSILGLITQLPAHSDVAKALAKLKNKYTLVALTNGNSQ
VAKEQLNFAEIAPLFDRIFSVDEAEAFKPNAKPYQFVLSEMQVDPENAMLVAAHGWDITG
AQRAGLQTSFIAREGKFKYPLAEQPTYDCTDLNELVERLT
>KECLDBNJ_03279 TonB-dependent receptor SusC
MKKYYAIAFIALLCSNFLSASEKPLIAQNSKIEKVTVFLQGATIERSASVQLKTGVNELV
FDNLSPDIIENSIQLRGLKNASILSIAFNLDYLDKKNVSAEYESLETRLDELLFERNAIQ
STIEGYERELKLLSENQRINSDNTDLSLEKIKQISTYYRQRSTEIQNTIYKQKRALQDLE
RDINDHRQQMNNLEDSRKEMRGEITVKLQAESASYLNMELSYNIENAGWFPFYDIRANNT
IDPIELSYKASVYQQSGIDWDDVNLVLSTGDPNTNNLKPDLQPKYLNFVNRNYKPSSAVS
RNNFKHNPTVRSVSGIVTDDSGAPLPGVNIAQTGSTNGTTSDFDGKYRIAINNSGGNELR
YSYVGFETQSIPVYASMMNVRLEANQEVLEEVAIVGYETTDVSRALAGKAAGINIRGSNS
VAPASYNENVQAKEESLTNTRFEIKKRYTIVSNSDITTIEIDAFNLPANYQHYAAPELNE
NVFLTATVTDWERYDLLQGEANIYFEGSYAGKTAISPLATTDSLEISLGIDPNIIVKREK
KDNFKSKSLLGGTRVVTNAYEISVRNSKSSTINLLLEDRIPVSQNKEIKISDQETADADY
DEQTGILKWKLELAPKASATKNFSYEVRYPKDRYINL
>KECLDBNJ_03280 hypothetical protein
MKGKIILFDGVCNLCNGAINFIIKHDPKGIFKFASLQEETGQKLLAQHNIDPQETDSIVL
IDDDKVSVKSSAALRIAKNLNQGYPLLFGFMIIPTFIRNGVYDFIAANRYKWFGKKESCM
LPTPELRSRFLD
>KECLDBNJ_03281 hypothetical protein
MNRGLAKSLLFLGALLLVLNILFTASFTDIGFILSVTANLLLILAMIQVLYFNKQR
>KECLDBNJ_03282 Endonuclease MutS2
MIKIHPKTLSDLEFHTVCAQLSALCITDIGKVKALKLAPQRNYRKTLFVLDQTQEYINAD
THETPIPNHGFDALDHELKMLGIEDTVLEVGSFRKIGSLSETVNTHLRYFRKFQETFLVL
HQTVRDTEYTTALTDEINTIVDRYGEIKDDASPVLLQTRRAINEVKGKINSSFASALSRY
ASYGYLDEIRESIVDNVRVLAVSAMHRRKVKGSILGNSKTGSIVYIQPEATQSHQRELNN
LLYDEQEEVKRILKALTDFVRPFSPLLKEYQKLLSTIDVIAAKAKYAKKLDAVLPKITKD
RELEIKEAYHPLLLLNNRKRGEKTYPQDIKLDADNRIIVISGPNAGGKSITLKTVGLLQV
MLQSGLLIPVHEYSRFCLFDKILTDIGDNQSIENHLSTYSYRLKNMNYFLRKCDDKTLFL
IDEFGTGSDPELGGALAETFLEVFYERNSYGIITTHYANLKMMANETEAITNANMLFDSR
TLEPLYKLYVGEAGSSFTFEVAQKNGIPYSLINRSKKKVERGKIRFDKSIANLQKERSKL
AKTTTSLKTKEQEAAKQQQELNKTNARIQEKLESYQELYDSNQRLIYLGQKLDDLSEKFF
SNKNKKLLLDELYKVVQIENSKRQRQNAKQKRAQKAKERRIQQEAEKKVEVIRQKKKEEK
QKEIQVEKAKPKVSLQVGDQVRLPDGRAVGSIDKIEKGKATVDYGMFTTQVDVDTLEFVK
RPKAK
>KECLDBNJ_03283 Uracil-DNA glycosylase
MNVDIHPSWKALLAEEFDKPYFKDLVDFVKTEYTQHTCYPKGKDIFKAFDLCSFDDLKVV
IIGQDPYHGPGQAHGLCFSVPNGVAPPPSLINIYKELETDLSISAPANGNLERWAEQGVL
LLNATLTVRAHQAGSHQGKGWEQFTDRVIELISEQKENVVFLLWGGFAKKKAAKLNKQKH
HILTSGHPSPLSANRGYWFGNQHFSKTNALLQQQGLVPIQW
>KECLDBNJ_03284 hypothetical protein
MVTFLIILGALLIINVLLFKFSVAGGPVAEKPRKHVTPKQKDLRQPLAFNKAS
>KECLDBNJ_03285 hypothetical protein
MTTIRIGGVPEHFNLPIHLCIEEGLFAEKGIHVEWVEFPGGTGAMNAALRNDEIDLAIIL
TEGIIKDIANGNPSKIIQNYVSSPLRWGVHVASKSDFYTIADLEDKRPAISRYGSGSHVM
AYVQANELGWDTSKIECVVVNNIDTAVEALAQKDADYFMWEHFTTKPLVDKGIFRRVGDF
PTPWSSFVIAATDKAIEDQSEILRIVLEVINAKTSVFKGLSRIETQLAERYQQNLEDIKK
WLSITSWSQNQLENSERDLVLKYLKKLDMVDKTSDSQQYLKKI
>KECLDBNJ_03286 Polyphosphate kinase
MENDLADNLIHRDLNWLSFNARVLQEAQDKENNPLYERMKFLAIYSSNLDEYFRVRVSQL
RQMKRVEKSIRKKLALKPNRTVKQILAIVKEQQEAFGKIYNDEILPELAKNNIVLVPSEQ
YTNIQAQLANIWFIAHIKNNLETKVIDPSKEKEIFLENQSLYLCVTFSDSKNIGFVKIPT
QTNDRFVDLGKVEGTYHITFLDDIIRYEIHNIFNSETIDGVYEIKLSRDAELYIDDELGG
ILAERIYKSLEQRQEGQPTRLLYDAAMPKPVAKRLRKLLNLGKIDMMPGGRYHNFNDFFK
FPDPTNNPELHYENKAFIKHRTLEKVPDFFKAIAEKDQLVHFPFMSFNYVERFVEQAAAD
DAVTHIKISLYRVADESVLTSALLKAIKNGKKVTIFIEAKARFDEENNITWGRKFEEQGA
RVIYSYPRIKVHSKILMIIREEQDKPVRYAYIGTGNFNGETSKIYCDHGLFTAHKKITKE
LGRVFRVLEGELIIPRNKHLLISPFTTRRTFEKLIHNEIEAAQAGKKAQITAKMNSLEDP
DMIQLLYKASQAGVQIRLIVRGFTCLIPGVKGLSENIYMTSIVDRYLEHGRIYLFYNGGD
EQMYMGSADWMTRNLDRRIEVLTPIYDKDLFAELKDILVLQLADNVKARIQDEAESNVYV
KQKSGDKRIRSQYEIYDYLKLKNH
>KECLDBNJ_03287 Purine nucleoside phosphorylase DeoD-type
MTLAPSEFILNEDGSIYHLHLLPHQIAQTIITVGDPDRVDTVTQHFDSIECSVQKREFKT
TTGVYQGKRITVISTGIGTDNIDIVLNELDALVNIDFKTQMLKPEHTALQIIRLGTSGSI
QKDIPVDAVLLSEKALGFDALLHFYQSKTVRDQHLEQAFVAHTKWNPEKSIPYAVSASAS
LLNHFKTKAHYTGITATNVGFYGPQGRQLRLKTEDSALNNKLETFKHKGERITNLEMETS
GIYGLSTLLGHQALSVNAILANRATGVFSKNPANTVNQMIIAALDRIALL
>KECLDBNJ_03288 hypothetical protein
MHITNGDSLTDRLNTLDLDGDLVIWREMLCEGPTVEKVGSPEFIAARKKFFKETYKISEA
DYEQKFVSQLNKLNAINSYDEVILWFEFDLFCHINMLAAISYLIQHKSTMPIYIVCSGWV
KGQSQLKGLSELTDEQLFMHYDKKIRLAPEDLKIAHHIWQLYCDEKPIELKAEIKKSSNF
KYLSSCIRAHIERFPNKNTGLNTLETNILKLIDLHDITSKQQLCGFVLNYQGYYGYGDMQ
ISRMIKALKPFFRMHEGKLVLSTKGKNVLEGSENYYDIVKDQSTYGGTHKYSFLYNPASH
ELLKYS
>KECLDBNJ_03289 hypothetical protein
MDLQDQLKNLFPDHEPEPDQHEEDPNDLGIWMQEDPLLCKYEKRKGKPITIIEGYTGADS
DFKILSKELKKMLGVGGSFKKEQIIIQGDYRDKIMTFLKDKGFKVKRVGG
>KECLDBNJ_03290 hypothetical protein
MNNIPSVNLADFLSEDPAKKQKFVDEIGKAYEEIGFVSLKNHFLDDALVDALYSEVKSFF
DLPEATKQKYEIDGLGGQRGYISFGKEHAKGKKEGDLKEFWHFGQEPDADANLIEEYPEN
VEVKELENFNKTGMEAYKMLEKTGIYVLRALALYIGLDEFYFDKWARNGNSILRPIHYPP
ITEEPKGAVRAGAHGDINLITLLMGASAGGLQVLRNDGEWIDAIPNEDELVINVGDMLER
HTNNKLRSTIHRVTNPPKEQWDTPRYSIPFFMHPRSEMPLNCLEECIDDAHPKAYPDITA
GEFLHQRLVEIGLIKK
>KECLDBNJ_03291 2-oxoisovalerate dehydrogenase subunit beta
MNIEENLQRALQSYDLNSETLLKLYEHVLRPRRIEEKMLILLRQGKISKWFSGIGQEAIA
VGLTLALHSDEYILPMHRNLGVFTSREIPLDRLFSQWQGKSNGFTKGRDRSFHFGTQDYK
IVGMISHLGPQLGVADGIALAHKLSNEAKVTAVFTGEGGTSEGDFHEALNVASVWDLPVL
FCIENNGYGLSTPTSEQYRCEHLADRAKGYGMESHIIDGNNILEVYTKLSTIAQSVRERS
RPVLIEFKTFRMRGHEEASGVKYVPETLLGTWALRDPVTNFESYLIEKGLLTEALKHEIE
DKIHQEIEQALQKVATEPAVSADLHTELNDVFAPVEFTQIKPGEATQQVRFIDAIQVGLR
QSLERFANLVLMGQDVAAYGGVFKITEGFVEQFGSERIRNTPICESAIVETAMGLAINGY
KAIVEMQFADFVSSGFNPIVNYLAKSYYRWGQPADVVIRMPCGAGVGAGPFHSQTNEAWF
THTAGLKVVYPAFPYDAKGLLAAAIEDQNPVLFFEHKALYRTITQEIPEDYYTLPLGKAS
VVQEGSKITLITYGAPVHWVIEVLNDHKDWSVELIDLRSLIPLDYNTIKASVAKTGKVLL
VTEDVNFGSITADISAYIAEECFTYLDAPIKRLSSLDTPVPFAQLLENQYLAKRKLAEAI
KALLAY
>KECLDBNJ_03292 hypothetical protein
MLKFYRNQKDGNYSLTHFNSAKLNTINSKKSTVASLYFWTITNQ
>KECLDBNJ_03293 hypothetical protein
MLKWTVIFIIIAIVAAIFGFGGIASGAESIAKILFFIFIVLFLISLLSRLFR
>KECLDBNJ_03294 hypothetical protein
MKRIITVLLLSVFLVSCGSSDQVVKQSRKTLKGYWNLDNINYNNAPGVYDVTLFGDASSE
CMVGSTWRFIPNNNFGNYEITDGSCALGKRYFVWSIPAQESATSYDILLKPTDEKMKSTM
NNAGFRLNINYLSDNELTFTQTVQVDGKPFTIVMNFSKISE
>KECLDBNJ_03295 putative lipoprotein YiaD
MKNILKNVSVFAIAITMLTGCEATRNANNQQKGTVIGAAGGAILGAVIGNNVGKKGDGGE
LGAVIGGVVGGAAGNVIGKKMDKQAQRIEEEIPGAEVERVDDGIVVNFDENSGVYFATNK
YDINSASQETLNGLARVMQEYPQTNVLVVGHTDSTGSADYNMTLSKNRAQAVTNYLVTQG
IASGRFTTQWYGEEQPKYTNDTAEGRSKNRRVTLAIVPNQEMVNEAKQEAGEN
>KECLDBNJ_03296 Menaquinone reductase
MKKSFNIAIIGAGLAGLTAAIHLRKSGFDVLLFEKEHFPKHKVCGEYLSNEILPYWNYLG
VDPLQWGAVAIDHLALSAVNGNSLDIKLPLGGFGISRYELDHHLLEYALSLGCTLIPQTV
EDIHFAENTFSVSTKDQQEFKAHLVIGAFGKRSNLDFKLDRNFTNSKNNWLAVKAHYAGE
IRSDQVSLHNFKGGYCGISRVENHKINVCYLTRTEAFKPFKNIEEFQQKVLCENPHLRKF
FSQAESLLDQPLSISQIAFQSKPSVENHMLMCGDSAGLIHPLCGNGMAMAVISAKLASEC
ICEYVNQDWSRSELEQHYEQLWKRTFTNRLRAGNLLQRALQNDSLTSTGIQVLKHLPKVT
QKLIQTTHGKPLKI
>KECLDBNJ_03297 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MDDPHVDEATLKAALAEVTRVNKYLGGQQVTLEGLRYFFDRFPQKSYTILDVGCGDGAML
RSIANFARKRSIAVKLIGIDINPKSIALAQKRSQDFPEVSFQVQDVFKLNETHLEIDIIT
STLTMHHFTDTEILKFLAQFLKLANLGIVINDLQRSTIAYRLFQAYSRVFMRSAMARHDG
LISIERAFTKNELLSFTSKLGVQSFNIKWRWAFRYLWILENQK
>KECLDBNJ_03298 Alpha-pyrone synthesis polyketide synthase-like Pks11
MALGVQIFMDIRKSKVAIAGVAKAVPQYSRETQEILPLVTQWMAGQQERFQRKVKKIFTN
AGVDKRYSIMAPDEVFTATSFEHKNNIYKREVIQLGEDALRSALEKTGWEPQSLDYIITV
SCTGIMIPSLDAYLINRLKLRQDITRLPVTEMGCAAGISGMLYANDFLKANPGKRAAVIA
VESPTATFQLDDFSMANIVSAAIFGDGAACVLLSSEEKALGPKIIDTEMYHFYDAEQMMG
FDLTNNGLKMILDKSVPETIAAHFPQIINPFLAKNDISISEVNNLVFHPGGKKIVQTVES
LFGASGKNIDDTKEVLRLYGNMSSVTVLYVLERFLNRKIPAEDYGLMLSFGPGFSAQRIL
LQW
>KECLDBNJ_03299 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MVNTFEFNTEETANSWALILGGSSGLGFASAKKLAAKGLHLCIVHRTRRSKLEEFNPTIE
ALRETGIQIESFNLDALNPATIDKVKDFFTKQNASVKVLLHSIAKGNLKPIYAEDASVAK
LSGKDFILTAEAMAVSLYDWASAFANVGLFEENGKILTFTSEGSTKPLPNYAAVSAAKAA
LEAIIRSLAFELAPLKITANCIQAGVTNTESLQLIPGSDQIIAQALERNPQKRLTTPEDV
ANVVYLLTKPEANWINGAVIPVDGGEHLR
>KECLDBNJ_03300 L-allo-threonine aldolase
MKIDLRSDTITKPTPGMLDAMMHAEVGDDVYKEDPSVNKLEAHIAELFGMDSALYFPTGS
MTNQAAIKIHTQPGEQLIADKYAHVYNYEGGGVSFNSGVSCKLVDGHRGMITADQVEEHI
NPPDFYHSPLTSLVCLENTTNKGGGACYDFREILKIRKICDDHGLGFHLDGARLWNALVV
TDESPRDYGAAFDTISVCLSKGLGAPMGSVLVGKQKFMDKAMRVRKVLGGGMRQVGFAAA
AGLYGIEHHWQRMADDHKRAQELSIALNQHTEVAHVEPVETNILIFNLRADADELQFIER
LKAEDIHISALGKGKLRIVTHYDYTEAMHQHFLAFLKQG
>KECLDBNJ_03301 hypothetical protein
MALKVAISHKTKYKYDKRISLSPHIFRLRPAPHSRTPIEAYSLKIKPENHFFNWQQDPFG
NYLARVVFPEKTDELSIDVEIIADLKTINPFDFFVEDSVEEFPFKYKDSLKKELLPYLEI
TDDGPLLKKFLKTIDVSEQLTIYFLIGLNRHINEYLNYTVRMEPGVQSCEETLEKKLGSC
RDFAWLLVQSLRHLGLAARFVSGYLVQLKSDEKSLDGPSGPEEDFTDLHAWAEVYIPGAG
WIGLDSTSGLLAGEGHIPLACTPSFESAAPVVGFSDPAETEFEFDNSVTRIFESPRVTKP
YTEAQWNAIYELGFEVERELQAGDVRLTMGGEPTFVSIDDMESEQWNTAADGPEKRKLSE
GLSKRLLHKFGQGGMFHHAQGKWYPGEPIPRWSIGLHWRKDGIPIWKDESLMASFNEEYD
LPEGITKTFLQELALNLGIRLEYITPAYEDVFYFMWEEGRLPVDVDPLKGDDVATSVRNR
LNKVLEQGLDKKIGHVMPLANIQGKWVTSPWRFRRNHLFLIPGNSPVGLRLPLNSLIEEP
DVPTQPIADPDLFDKRQPFGPYGEALEKRKAAEKPKKKNGKVDYNADKQEKNPFARTAIC
AEVRDKKLYLFLPPLDNAETFIDLMASVEAAAKKLNVPVLIEGYEPPRDNRLEVLKVTPD
PGVIEVNVHPAKNWDELTKNTLTLYEEAKKSRLGTEKFMLDGKHTGTGGGNHVTLGGVTP
ADSPLLRRPDLLRSLLTFWQHHPGLSYLFSGGFIGSTSQAPRVDEGRQENLYELEIAFNQ
IPEDEDVPFWLTDRLFRHLLTDITGNTHRAEFCIDKLYSPDSSSGRLGILELRAFDMPPH
AQMSLMQMLLVRTLVSWFWNEPYKHKLTRWGTQLHDKFLMEHYVREDIKDIVAQLNAAGY
PFKLDWFDPFFEFRFPLYGLVDIKDMKVELRAAIEPWNVLGEAMTGGGTSRYVDSSLERV
QIKVSNFNDERYVLTCNGVKVQLSNTGVKGEYVAGVRYKAWQPWSALHPTIPVDTPLVFD
IVDLWNQRSIGGCTYFVSHPGGRNYETYPINSLEAESRRINRFWDIGHTQGTLVYTEKEP
DTKLAGRTLKSTSSDKTFNFKEIPVNPEFPHLLDLRKK
>KECLDBNJ_03302 hypothetical protein
MTVATNAWFTKYFTDYTYDEMFTPDLSVKEDWQELLENFKRIGIDGLTQRQNDINWLLEE
NGVTYNVYNDPNGLNRPWNLNVVPLILQAKEWQKIEKGLKQRAHLLDLVLKDVYGERKLI
KEGIVPHEVIYGHRGFLRQCDKIQYKIDKHLLLYAADLARGTDGRMWVVNDRSQAPSGMG
YALENRSTANRVLSDIFAEMNIKRLSEFFKEFNELLLEASPDKVENPNIVILTPGSHNET
YFEHAYLASFLGYPLVQGNDLVVRDGFLFMKSLKGLKKVHVVLRRVDDVFTDPLELREDS
HLGVAGLLDVVRRQNVAVVNPIGSGVLENPGLIPFMPAICKYFLKEDLQLPQIASWWCGQ
EKEKDYVLKNLANLVIKPIDRTNREHIHFGSQMTEEELATLRKEILKKPYHFVAQERISF
STAPNYSKGTFEPRNMVARTFTIAGKNGYNVMPGGLVRVAPERGKLRVSNQRGGTSKDFW
IIGDLKSEETANYSWNRKSAVSASGLDDLPSLTAENLYWAGRYVGRTLVNARFLRMVLKQ
MNTPEISSNQQTCSVKMNILYKAVTQMTGTYPGFMEKNKEGVYAIDNPLKEMMAVVLDRN
KIGSLANSMMMFSNSYYSIRNLWSSDMWRVFENIQKLWRNLENEKEITVNKMIKTLNQLI
TRLIAFMGLIEESIMVEQGLLLYFIGLQLEQSMLTITKCRSLLVIKQSGQTEYEVLESLL
SSHESLNIYRYSYRSYIRVEPVISLLLMDLKYPRSLTFQLGRLQKDISRLPHSQKSDALM
HYEKYVFEAFSKLRLANSDQLATVKENDGNIRKDLDKLLEELSDLLFSTSQTISNTYFNH
TYKQSQLVDQNFPL
>KECLDBNJ_03303 Protein-glutamine gamma-glutamyltransferase
MLYSVTHTTKYDYDAPVSYCHNIAVLKPRRSLGQELLEYKMSIAPEADEVSERVDFFGNF
ITRFSIQKEHKQLKVTTKSKLRREYEQYKTEFRSDRCTKVSLEQAKENLLKTDLEILDAK
QFVLDSIFINKTGEAVEKYARESFKPNRSVFEAAEELMQRIYTDFKFVSGFTSVSTPIDV
VMQERKGVCQDFAQIAIACIRAIGLPARYISGYIETLPPPGQEKLIGADASHAWFSIFIP
GFGWVDFDPTNNQIPGDQHLVVGWGRDYYDVPPLKGVVYGSGKSRLSVEVDIARVV
>KECLDBNJ_03304 hypothetical protein
MLNLVRTDSKNPDFLKMVKELDQTLKVTDGDDHAFYNQFNALDRIKNVIVAYDSGIPVAC
GAFREYGPRSVEIKRMYTKPLYRKRGYASAILEALENWAIEIGYNKCVLETGIFQPPAIA
LYKKRQYDVIPNYGQYSGVGGSMCFLKYLAAS
>KECLDBNJ_03305 Acetyl esterase
MKNALLIVLVCILWSCTNEEVPATIDVATDLPAQTLSNTSYGPGNQQIYDLYLPEARSRN
KTKVLVLIHGGGWIDGDKRDMQAYIPFLQENFPEHAILNMNYTLANPPETTAFPQQFEEI
GLALTEISQNVETLQVRAEFILIGVSAGAHLALYYDSVYDENDQVKGVCSIVGPTNLDDE
FYQNHPEYSVAIPQLIDANAYPEADTLAQAVSPAYQVSTATSPTLMFYGNDDPLVPITNA
TFMQERLEEFSVVNSLTIYNGGHGNWSNEDQLDLQSKLENFINIYLEVSE
>KECLDBNJ_03306 hypothetical protein
MKATLQISEKNFTGSQDAISRCLNRIMEVRVLEINLKKNIIAVDYAKPSVYERIKNELNC
LGLSVGEYKPIK
>KECLDBNJ_03307 hypothetical protein
MSLLGRILGNASEIPAEELSTKYERLLTDSEQVELGFKLLRDVFIFTTKRLILIDVQGVT
GSKVEYKSLPYKNISRFSLETAGTFDLDAELKIWISSENVPSVSKKFTKQIDVYAIQRYL
AAKVL
>KECLDBNJ_03308 Xylose isomerase
MSTYFKNIDPIKFEGKESDNPLAFKYYDENKVVAGKTLKEHMRFAMAYWHTLNNKGGDPF
GAPTETFSWDANPDPVIRAKDKMDAAFEFMTKLGLPYYCFHDVDLVDEAPSLGEFEKRIA
AVVDYAKTKQQESGIKLLWGTSNLFSNPRYMNGAATNPNFDVVAYAGAQLKIAIDATLAL
GGENYVFWGGREGYMSLLNTDMKRELDHLAQFLTIARDYARKQGFKGNFLIEPKPMEPTK
HQYDFDAATSLGFINKYGLQDDFKLNLEVNHATLASHTFEHELQVAVDAGMLGSIDANRG
DYQNGWDTDQFPIDVYEATQAMLVILEGGGIQGGGINFDAKVRRNSTDLEDKFIAHIAGM
DTFARGLIAADHVLQHTSYKELRKNRYASFDQGNGAKFESGALSLEALSTLGHQTGEPKP
YSGKQELFEQLIANAF
>KECLDBNJ_03309 Xylulose kinase
MYFLGIDLGSSSIKLAVLDANTGKSVGSCTVPDHEMIIKAPQSGWAEQDPQLWWEYTCTG
VKKLKDHGVDISLIKAIGISYQMHGLVLTDKDLNILRPSIIWCDSRAAPIGEKYYQEKGA
TFFQDRVLQSPGNFTAAKLKWVQQHEPELFDQVAHMMLPGDYLAAKFSGIAQTSKSGLSE
AALWDFKKNALAEEVLDALDLPRAVIPEVVANFSHQATIAPHIAERLGFSKDVAITYRAG
DQPNNALALNVNQPGEIATTAGTSAVIYSVTDQDAFDTENRINTFLHVNNTEAQKRNGVL
LCINGSGILYQWLRKILSTGKDKFLSYDFLNAQAAQAGPGSAGLNFYPFGNGVERIFNNK
KSFSGLQNLDFNRHGATHMVRAACEGIVYAMNYGFEVMQHIGAGGHSVKATKANLFLSPV
FRDIFVNTTQTTLALYKTNGAEGAARGAAHGYGFYTSLDDAAHGLELLSTQEPQPELKQQ
YTDLYQTWKNNIQIIA
>KECLDBNJ_03310 hypothetical protein
MAKQYEATILDSITIDCVIFGFNQGALEVLLVKHADGISKDKWGLPGGWIFTDESTDAAA
NRLLLELTGIKDVYLEQLRAFSEPDRFPVSRVITVGYYALIKKQDWTGLKPGATASEVAW
FKVSEVETLIYDHRHILGVGLRRLRRRIKQEPIGFNLLPEKFTLLQLMHLYEEILGYEMD
KPNFRRKILRMNLLTALDEKQKDVSHRAATLYKFNPETYQKLLEKGFNFEF
>KECLDBNJ_03311 Outer membrane protein OprM
MKKIIDIHTIKRKPNIKRYLIASCILLILLILGSCKVGQQYERPQFDDVSEEFYVKDSIF
NDSLAEAAITRDSLMMSHIPWREFIEDSTLIALIDTALVNNIDLQKAMRNMDIGMEYLAQ
SKANFLPSVNATPAGFRREYYSENYNNYGSNRARRNHGETPPTSLYTERLEYTSALQADW
EIDIWGKLRWQKEAARADFMKSQEFKKAVQTELIAEVASTYYNLIMLKSQVEVAEKNYAL
NDSTYNIVKLQYDAGETTSLALQQTKSQQLKAQSLIPQLERQYTVQENKLNRLLGRSPRA
IELTANFDDIQFQEKYKTGVPIELVKNRPDVAMAEYELIAQNARTGVAEALKYPSLSIGA
GLGLNSFELENFFDPVSSAFALLNGSIFQPIFNNRKLKTNYRVALTEREIAQLEFKDNLI
GAVEDVSNSLTRINKLTQEYKIAQERIEVTQKGLKDAALLFRGGFANYLEVITAQSDALE
SELNEINTKKQILIANIELYRSLGGGWQ
>KECLDBNJ_03312 Efflux pump membrane transporter BepE
MFKKIIKKPVFTLVITIVLVLAGAASITSLPVERFPEIAPPSVSVAVYYPGGNAETVAKS
VLLPIEEALNGTENMTYANSTATNSGRGRVTIYFKPGTNPDQAAVDIQNRISVITEKIPP
EVTEAGISVTKRMKGSIMTINIFSRDSTYDETFLNAYTRINIRRELKRVEGLAEASILRQ
RDYAMRIWLNPQKMASYNLTPREVYNQVKDQNFEAAPGKFGENSDELFEIVMKYDGRFSE
IEEYENLVIKTNKDGAQLRLKDVARIEFGASNYTSENRLDGKPSVTIDIVQMNGANAKTI
DERIREILEEQKKLFPEGIDYEITYSVRDQIDESMSQVMHTLVEAFILVFIVVFIFLQDF
RATIITAISIPVSLLGTFFFLNIIGASMNVLSMLSLVLAIGIVVDDAIVVMEAIHEKMTH
HGLSARKAVSAAMDEITGAIISITVVIAAVFLPVAFLSGPVGVFYQEFAYTIIFAVLISA
INALTLTPVLTKIFFGKKKRNKKKRGMAKTVSELRQVRKVKVAKRKGLRKFDSGFDKFTG
KYLNVVRWFLNHKWIGVGSLVLIIVATVLLSRITPSAFIPTEDDNFLIFSMKMPEGSSLH
RTNAALRKADSILQRDPAVKGVNTVSGFNVVDNANSPSSGLGYVQLKHAAERGEIQEIQE
VIKHLLSELDQIPETDFNMYPRPTIQGFGNFDGVQFMLQDRADGDLGEFGQIVNEFINTL
SNQKEVDNAFTSFNPNFPQYRLKIDYEKAKALGVSVKDMMFTVQSYFGRVQPGDFNRFSR
QYGVYMQADIPYRESPESFNSIFVKNDKGEMVPVNTIVRLEQAYGPEVVNRYNLYNAAKI
NVTPAKGYSTGDVMKKIEELTSEKLPASLSYEWTSMSLEEKNSGGDTIIVFIIIILLVYF
ILASQYESFLLPLAVMLSLPVGIFGVFAAINLAGLDNNIYVQIGIIMLIGLLAKNAILIV
EFVAQKRRAGLSAFDAVLEASALRIRPIIMTSLAFTVGLVPLMFAEGSSAQGNHSVSIGT
AGGMVGGIVLGIFVIPVMAYIFQMLHDKYNLERYGDKEIEE
>KECLDBNJ_03313 Multidrug efflux pump subunit AcrA
MNYLNNPNTKFAVLLALCLTIFASCREEEVEDEGLPLPVISLQETSAAKNFEYIGSIEGV
ESVEIRPQVDGILEEIYVDEGEFVEKGQPLFKINSQPYMEDYKNAMANVNLEKAKLEKAQ
SDVERLQPLIDNEVISEVRMKSVKADYQVALSSLQQAQAQAANMRINLDFTTIKAPVNGF
MGRIPKSIGNVVKKTDSEPLTNLSNVNDIYVYFSMSESDYLYFERAKNDTLSKKNKVNDQ
VKLVLADGSIYEHGGKIDANSGQIDRSTGSITLRAKFNNPDTLLRSGNTGKILMEEIYQS
AILVPQSATTFIQDKKFVFILDENNIAQRREIITKGRSGDNYIVDSKSLSPKDRIVVSGL
DKLASGIKVKPLQRGQLTSSL
>KECLDBNJ_03314 hypothetical protein
MKTTSRTLLSFFTFLLVLVGCENTQKKELAAKFDKLEMQHDSLEQVHAEFKTVHSEMTQK
HQEFTTALEEMELQDSTILEDVAKHEAILKKHEATIEGHDAMIAAHEELKAGFEEKSEAE
MEAQLEEMMDNHQQLMSEHEEMESEHKMMMDEHQAILPKVDTTTTAEM
>KECLDBNJ_03315 Colicin I receptor
MKHLHLWLLLLCCGAAFAQNTFVATLKNSETQEPLYGVSVSIKTLNKGAISNAEGLVRIE
NIPNGTYLLELRYVGFETQNITRTFPLSAEENNQTFYLHHAEEQMEEVVIQSTRSSRTFQ
DIPTRLEFIAGEELAEKGNMKPGDIRMLLNESTGIQTQQTSATSYNSSIRIQGLDGKYTQ
LLRDGLPLYSGYSGGLSLMQIAPLDLKQVEVIKGASSTLYGGGAIAGLVNLISKTPEDEP
ELSFMANGTSALGLDLSGFYSQKYGQTGATVFASYNLGTPYDPADNGLTAIPKFERFTLN
PKFYLYLNEKTNLNVGFNYVNEDRLGGAMDYVKGDSETGYFERNKTDRLSTQILGSHQLS
DNTALTVKNSISFFEREIDIPSYTFAGRQTSSFSEINIATSLTKTEWVAGANLWTENFKQ
QQGDPAQDLSFTNYTAGVFAQNIWDIREQWTLETGLRTDYQSDYGVFVLPRLSLMFEPTN
LLTFRIGGGMGYKTPTVFTEDVERLQFRSVQPINIDETDAERSIGFNLDGNYKWSITNEL
NLSTNVLLFYTRIDDPLVLNRTSGALYEFVQPGGHICSQGIEANMRWKYKDFKLFVGYTL
ADVNQHYNGASEQYPLVSQHRLNNVLMYEKHDNFWIGLEGYYYSPQKLNDGTTGQSYWIL
GVMTEKKLGEKFSVFLNFENFLDTRQSRFDTIYTGTLNDPNFRDIYAPVDGFVINGGFKL
KL
>KECLDBNJ_03316 hypothetical protein
MKILVILFALLTFSLSTVTCCVGNITGVEYHQDDEDDCEDGPCDEPCSPFFNCGTCTGFS
VQEFENLDFQQEQIPTQKIVSISYLRAGEFHDSSFRPPRA
>KECLDBNJ_03317 Alkaline phosphatase 4
MNRRHFFRNTTLGALGTSLLTPFDSLQAAEHALSFKNKKAKNIIMLVSDGMSTGTLNMAD
LHLRRHTGKSSNWMQLYSDNKVTRALMDTASASSIVTDSAAAASSWGGGVRVPNGALNVS
QNGEQHLPLWQKFKKAGKKAGTVTTVPATHATPAGFCVNSKSRNAMEDIAEMYLEHQFDV
VMGGAQKYFSAEARKDKKDVFAAFENAGYQVFKNRKEMLNAKRRKPILGVFGNDALPYSI
DRENEETLKKETPSLAEMTQTAIDAMKDHKQGFTLLVEGGKVDWAAHGNDIAGLIFDQIA
FDEAIKTAIDFAEKDKETLVIITTDHGNANPGVIYGGDANDHFDSIQNYKHSNEWILNGF
NPDTTLSQIKERINYANGIGITDEEAQTIVRYYDDLVAEDGLYNPRHLPFGVLADIQKRY
NSVGWISMQHSADYVELAMYGPGSELLQPFVKNTDLHYLMLKAAEVENVF
>KECLDBNJ_03318 hypothetical protein
MKSKQPQSNPVRHWLKTNFQFRGKPRSIKAFGGANKICLGLFLLVSFFGYSQKNIIWQDL
AQVNFEEKYFETYGEYFLYPHFEDSLKAMEGKQVTITGFFLNIDPENDIYILSKSPMASC
FFCGAAGPETAIELQFDNPSKYRTDDVVTVTGVLNLNADDINHFNYILTDCTVKRAK
>KECLDBNJ_03319 hypothetical protein
MNIWKISLSNIFHKPLYALLSVLSLSISIGLLLGIQQLDASIKYQFENSLGDVDMVLGAK
GSPLQLVLASVLHMDNPTGNISLAEAEKITKNPLIKKAVPISYGDNYQGFRILGSNEEFA
GLYEAELAEGREPSKSMEVTLGSTVAEETDLKIGDTFMSSHGLTENTVEVHNHPLTVVGI
YKPTYKVIDKLIVTRLESIWDVHEHGENHHEEDEQQAGDEHHDEVEPQEEHNEEAHVSTA
PHQEEGHHHEESDKEITAMLVSFRNVMGMLTMPRRINKETNMQAALPNYELERLFNFTGV
GVRAVSWIAYIILAISCVTIFISLFKMVRERAFDLALMRTYGASNFQLLRIVAYEGFLLV
FVSLLVGVLLSQVGLHFAFSAFKSGYNQDILLKLPYTQMVKTVLLILVMVGIAILLAILP
ILKMNVSKILSNEK
>KECLDBNJ_03320 putative ABC transporter ATP-binding protein
MIQTHNLSFQHAPTLETLRFPDLLLEREENLLILGKSGIGKTTLLHLLAGLLQPKTGTVN
LDNIALHSLSAKKRDRFVGQHIGVVFQKNYAIRSLDVMQNLEARLFFAGLKSKRERLHDL
LEQLNLAAHKNKKIHQLSEGQLQRLGIALAVVHQPQVILADEPTSSLDDENCEVVMQLLL
EQAEQQNANLVVITHDARVKPLFQNQIIL
>KECLDBNJ_03321 hypothetical protein
MKIKFVSLFTLLAVLAISCKDKPKETETETEVEVVEETAETPITIEKLEGSPAYAEASIK
ITKPTAETVKAAEGGIDFAFDVQNYELGAQTDSDLTGNLANSDKGQHIHFIVDNDPYSAH
YEPTFKKELEDGTHYLVAFLSRSYHESVKNPNAFIAKKVVVGAESVDAPEVDLSEPTLIY
SRPKGEYTGDVTENLLLDFYLLNTTLSEGGNYVKATINGEEFKLTEWVPYIVKGLPKGEA
TVKLELLDKDGQVLPGAFNTVERTVTLK
>KECLDBNJ_03322 hypothetical protein
MARLLLYFLLTPHLFCTSCNNPAKQDNVSIINEKRIVDTFKKALNTVSLDHFYITLDSVT
FAQLKGSDFINSQYANLDQGIPDFTPINANSTSAYLRGKRQYIEILGPQNAFNEPVGKSG
IGFALSEKKGFSLSNAPELHETGTKFLKAADTVSFNIDNTAAVWYKAFYTYGMATNLSTW
YAYYNPEFLGHLHHEEISEYTSEAFLKTAYHPNKLFNEITGIEMHCNLADHFRIARELQL
LGCTLAGKNNNDLLYVVDGIKLSIRLDETLDKSKITTIAATLNAPDHRTITFKNLTIKNT
GYQTVWSLN
>KECLDBNJ_03323 hypothetical protein
MHKTVKHRISLVLLALFISMKMLGLHVLAHDGDQEHFVHCKLCEHAVVGDHYNPALLSDN
TAFQVLTPQAPATTQIVDRYAFTFCDNFIANPLFSRPPPAQA
>KECLDBNJ_03324 Thioredoxin reductase
MKIQFKTTYEVIIIGGSYSGLSAAMALGRSLRSVLIIDGGNPCNKQTPHSHNFITHDGEK
PHVIAQKAKEQVLNYDTVHFLEDFALSGKKAENGFEISTKSGKTFKARKLIFATGIKDVM
PDIEGFSACWGITAIHCPYCHGYEFKSDKTAIMANGEHAFHIASLVNNLTDDLTILTQGT
PDFDENQRAKLKKHDINIIETPVTKFEHQDGSLEKVILEDGTSLTLKAVYAGLPFEQHSD
IPQQLGCSLTETGHLKVDLFQKTEVPGIYACGDNTSRMRSVAYAVSTGNIVGAMVNNELT
QEDF
>KECLDBNJ_03325 Putative metal chaperone YciC
MKKLPVTVLSGFLGAGKTTLLNHILHNKQGLKVAVIVNDMSEVNIDAQLVENENTLSRTE
EKLVEMSNGCICCTLREDLIIEVKKLAKAQKFDYLLIESTGISEPIPVAQTFSFESEDGS
IDLSTFSYVDTMVTVVDAFNFLKDFSSPQYLVDRNLTDIDGDNRTIVNLLTDQVEFANVI
LLNKVDLVTEAELRNLYDILHKLNPEAHIIPTKNSEIDLREVINTGLFDFEKAEASAGWI
RELENEHTPETEEYGIGSFVFRSKKPFHPERFLAFVQHQFPSTIIRSKGLFWLASRPDQA
IIWSSAGGSLKTDPAGVWWASMSFAERISYASFVNNQALIESEWDTNFGDRKIELVFIGQ
HLEVDRIKQQLEACLLADDELTQWKTGNLDAIDNWPIPKYQNL
>KECLDBNJ_03326 hypothetical protein
MKEKYFDMIGVYAAFLCLIHCVLAPVLFLLPLGFSHNPIIDISFLTIGIFPVIKVMRSAA
PLYIKVLLSISWVAVLVAVLLESVFHKESILIFFGAGGLITGHLINYSNHKH
>KECLDBNJ_03327 GTP cyclohydrolase 1
MKYTDLDLLEDIGDSHYSDNVDTPLRPDAFVKSDEEKIEAIQKHFKKIMEELGLDITDDS
LSGTPYRVAKMYVKELFYGLNPANKPKLSTFNNKYGYRKMLVEQNISIDSACEHHFLPIT
GFAHVGYIPEEKVIGLSKINRLVNYYAHRPQVQERLCLQILKDLQETLNTQSVIVMINAE
HLCVSSRGIKDKTSSTITVEYGGAFENTEIRNEFLACLNPIE
>KECLDBNJ_03328 Ferric uptake regulation protein
MAIVRKTKSVHTLLEVMKQAGEALSVVDLVNRLDQEMNKTTVYRILDRLEDEGLLHSFQG
KDGLKWYAQCQDCSTEHHTDMHPHFQCVQCGKTTCLPLEVTIPKVPNVKIQSASLLLTGL
CEECLT
>KECLDBNJ_03329 hypothetical protein
MKKEKLIFGTLGLLGLLFTACDSNDDGTSPENPEAGVESKYIITATPTAAGSEGVADYIL
TTDAINEGSISTAGNGIEQDGTYRYYITTNNKFFSMLYGQGNPGAVTSYELNAEGSLEKL
SDFQSETVQAFAAVDDEILLIKISRNADSPIASWYRFDTNTLQFVAEGQINTQELADKES
GELAFFTWITQVGDKVYLPYFTMKGCCSDSFGTIYPNEANIAVYSYPEMEYETTIHDERT
SFIGRYFVNGLSVDENGDAYAFSSSVATTNGELSSTLPSAVTRIPSGSTQFDDYYFNIEE
ASGGLYVTDQVYVGNGKFVGIMASERTSAYASGNQYAIIDVYNQTVTPVSGTPNPETVVL
TSSKSNYVSDNKSTVSVGITTETGSWIYNIDVASATATQGKEVVGGTITAISKLDVVE
>KECLDBNJ_03330 TonB-dependent receptor SusC
MSKQLRNLVIAFTLVLIGVAGNAQNVITGKILDQNQEPIPGATVLIKNTTTGTLTADNGS
YQLKSSQKGRFTLEASFMGFKTFSKAIELTGSTQLTLNITLEEATNALDEVTVTGKSVVQ
QVRDKAFNVSVVDTKKLSNTTLDLGHALDKVSGVRVRENGGVGSQMNFSINGFRGRQIKF
FLDGIPMENFGSAFQLNNIPVNLADRIEVYKGVVPIGLGADALGGAVNIVTNSYTQNHLE
ASYSYGSFNTHRSTVNAIYVSDSGFTAQVNAFQNYSDNTYKVDVDVADINTGEYYPNQEV
ERFNDQYHNETAIINVGVANKSYADQLLLGVTLGKSYQEIQTGARLVSVFGGWHSRANIV
MPSLKYKKDDFIIKKLNARISANYNLGSEQNIDTLNRRYNWLGQFKEYDGAGGERSYSLY
KYRNNNGIATASFNYKIDDHQTIALSNTFNTFNRKGEDEANPDNDRYDEPRKTMKNVLGL
GYTYEQENWNASVFMKNFFQQNEFTASYNPTGNYGDVAYYNTINTFNHIGYGTALTYFLH
KNLQFKASFEKTYRLPAANELFGDVINLQGNTDLKPEYSYNYNLGTSYWLTFKQNLINFN
LNTFYRDASDFIRPELNQNQTMQVMGNLASVTNAGIESEIRYQHGKSFAAGLSVTYQELR
NDTRFVGDQTVESIVYRDRIPNMPYLYGNADANYTFFNVLRKDDNFNIGYNLLYVHEFYL
YWPSQGSEKLVIPEQLAHDVTLTYTLNKKLQFTLECRNITDRNLYDNFSLQKPGRAFFGK
IKYTIL
>KECLDBNJ_03331 Erythromycin 3''-O-methyltransferase
METYKKWSTQDLIELSNQLGCPSGPQGIAVARRMQESNKEMVINAFTALDVQHNNNILEL
GPGNGWHLSHVLKNRKHLTYTGLDISTLMIEEAKKYNSTFAKQQALEFKAYNGKLLDFSE
AEFDKIIAVNTLYFWQEPTKIISQLYKLLKKGGALVLGYAERKFMEQLPFTQHGFELYDS
VELLSLLEKCGFSNFQLKVHTDSVLSKMGTAVERDYTILKVTK
>KECLDBNJ_03332 hypothetical protein
MGQRLYNVFFHTHTISGIVISALLYVIFFTGSISFLRDEINAWERNEPIKSAYFSTIDFD
QALNELSTDKPLYGRDLMFNHRYFERRLGATMTKSKDTTIQDAPQRGRRGNFFYMDMDTF
KKEDYTSNYSLGEFFYRLHFFAQLNFFSRSGYYLSGFVAFFFLFAVITGVIVHWKKIIPS
FYVFRPKGKWKNIWTDAHVALGMIGLPYQFMFALTGCFLIIGYMVMFPPVQSFIYGDDVQ
AFTKDIQYEENPTYEFTYQPLETVPSINDFVARTLNKWPDIKLTALDVINYGDQSMHVKI
YGAPDFDQKLLGTGHITYRVQDGQVVNTKDPYGKISYAEGSLNLLRRLHYGDFGGYGMKL
IYLLLGFITCFVILSGVLIWLVARDKKHVAPAKRIFNKWLVHIYMAACLSLYPVTAATFT
AIKVFGTDLGDTRQIFMYHVFFYSWLGLSLVLIALRNNYLINKICLILGSILALSVPVAN
GLVTGNWPWVSWSSGFSQIFVVDLFWILMSLSSIAVVFKLKNKDTSKASTVKRSPA
>KECLDBNJ_03333 hypothetical protein
MPANKKHLTRSPWQRLAKLIAGFVGGYCITQLLFMLILKFAAPTETLITLQYAGFAVWVT
LFLVVYLVENGYKILALYALLCAVLYSLINLI
>KECLDBNJ_03334 hypothetical protein
MLSLSILLTALGFYCCYSTSKRAILPKGNPVVLWASSNTKTSKYLGLFLLTLGLILCVIN
LGLGSGSFSFLVILMTIASIQVLIGPLFITNSKQLAVVFVLALILELFL
>KECLDBNJ_03335 hypothetical protein
MSYMSLIYKNPYGSVFTISDAPNPKCNYQLVIDSMGIFMSKKDIYSLLNIVRSYFQPCYC
ENCQGKLPDKLYLPDTNSELCLMVDPLLLADFEELFVGATFHIEMQETLKNHEIDS
>KECLDBNJ_03336 Regulatory protein PchR
MIHTRAGEIRSRVEEVARSIVLTSRNEIEQAGARFALERINAAHLESTATLQENDLDLKI
TDAFLEEFAITRVQLTTDKTVSLQWPQQDEASVKIVLLLKGKIVLSVANNLVALQPDHLN
MIYQRTDALSLIHETGATDFVVLTLSENFIKTLIPQTEHDVFDKDTRLKIFFESGFKKSA
VMSDLINHILDYKCPKYLKRIHLQSKITELFFQLLLVYSKKQATVTQMPVHIEKQMYEAR
QQIIENIRNPYTLKTLARTIGTNEYELKRNFKQTFGMTVFGYINEVRMQRAQKYLKSSHL
SIALIADKIGYKNPQHFSTAFKKSTGVTPSAYRDKLN
>KECLDBNJ_03338 hypothetical protein
MEEKVKFEIEFPIQASPSLLYQYMSSPSGMSEWFADNVNSRGEYYTFIWNGSEEKAKLLG
KKSDERIKFRWMDDVEDENLYFFELRIVVDEITKDVSLIVTDFAEEDEIDEGKMFWENQI
SELKHIIGSN
>KECLDBNJ_03339 D-alanine aminotransferase
MINFNGTLTETPQFSAHNRGMLYGDAVFETIRYSGGKLFFWEDHYFRLMASMRILRMEIP
MGFTLEDLQDELLKVVEAENLKDQAASLRLTVTRNEGGKYLPEDNNVSFYIFAKELKDPF
FTLTEDHYEVELYKDHYVNADLLSTLKTANKIIHVTGSIFAKENDYANCLLLNTNKSVVE
ALNGNLFLVKGSTIKTPPLEEGCLRGIIRKQLIEIIAKLDEFTIEEAAISPFELQKADEL
FITNAIVGIQPISKYRKKTYTNTVAKNLLGKLNAKARLG
>KECLDBNJ_03340 hypothetical protein
MTTNKPQKGKLLIAEPAIIGDVSFNRSVVLLANHNEEGSVGFILNKPLTFTLNELIPEIK
GDAMQIYNGGPVEQDNLYFLHKVPNLIPESIEISNGIYWGGDFDTVVDLIASNKISTDEI
RFFLGYSGWDCNQLDSELDANAWIVTDNTYDKEIINKCFPELWKEKMLELGGEYLLWSNA
PENPSNN
>KECLDBNJ_03341 DNA-binding protein HU-beta
MNKSDLIDAMAEDAGITKAAAKKALESFLGNIEKSLKGGDRVSLVGFGSWSVSKRAAREG
RNPQTGKTIQIAAKNVVKFKAGSDLSDAVN
>KECLDBNJ_03342 hypothetical protein
MSVKLLFIVLTNLDGYFVHASNSAGNHGLC
>KECLDBNJ_03343 Methionyl-tRNA formyltransferase
MRDLRIIFMGTPDFAVAGLENLVENNYTIVGVITAPDRPAGRGQKIQQSAIKKYALSQDL
KVLQPTNLKSEAFLEELKSLNANLHIVVAFRMLPEVVWQMPEYGTFNLHASLLPDYRGAA
PINWAIIKGEKETGVTTFFIDEKIDTGAIILQEKVAISEAENAGELHDRLMHLGSEVILK
TVKLIAEGPVETVAQPKQEQLHTAYKLNRENTRINWDQPSKQVYNHIRGLSPYPVAWTLF
TNGDAQEHQLKVYKATLASVEESNELGNPSVGKIKVNHDKLYVSAEDGWVRLDEVQLSGK
KRMPVKDLLNGFSIQSEAKTL
>KECLDBNJ_03344 ATP-dependent DNA helicase RecQ
MMTTPQEALQKFWGYASFRSKQLEIITSVLNGKDTFALLPTGGGKSLCYQIPAVIKEGIT
LVISPLLSLMKDQVVQLEKRGIKALHIPGGIKYQELDVLLDNCIFGNYKLLYLSPERLQN
ELVLARLKQMNINLLAIDEAHCISQWGHDFRPAYRNIQAFREQFQEIPCIALTATATAAV
QQDIITQLALKEVTTFRDSFKRKNLANKVLYEESKQQRIVQLFKQHPGSGIVYVRSRKSA
QYFAQFLNEYGISAHFYHGGLGNGERQERFAAWSQNKTQVMVATSAFGMGIDKADVQTVI
HVELPESLESYFQEAGRAGRNGQQATSVILFNNSDKDRLTNQFLKVLPSVSFVKKVYKKL
NSYFQISYGEGEHETFRFDFTEFCKTYDFNTLLTYNALQLLDRNSVLLLSQEFYRRATLQ
FSVSAINLTYYLIRNPGIDSIVKSLLRTYSGIYDNAITIDHALIAKKAGVPLVKIHQTLL
QLHKDDVAVYEHSHADTAITFLVQREDDLVINRISKAITAQNTRKVDQVKSMLRYIETPV
CRSKQLLAYFEEHQQEACGICDICQKKLKTKAPRALEDQILHYLNQGACSSKTLLEVLKI
KREEDLLSSLKLLLMQKKIKITPSNLYQRI
>KECLDBNJ_03345 hypothetical protein
MSIFTANYERPKAFILTAKRIVLIGGPSTGKTTLLNALKEKGYPCLDEVSREVIKAAQQE
GIEQLFLTEPLLFSDKLLERRIQQYLDAGALDAEYVFIDRGIPDVSAYMDFIGQEYPDRF
TKANSTYRYDKIFLLPLWRDIHVTDKERYESFEEAVKIQDELLKTYRSCGYTPIEVPKVP
VEDRLDFILKHMTL
>KECLDBNJ_03346 hypothetical protein
MSTDKNSEEFYKKLKGRLEETTQWPSAYLYKFIVPSDNQKIAQIEEIFDNMGAVINTKES
SKGTYTSVSINVRMQDPDAVIAKYKEVASVEGVISL
>KECLDBNJ_03347 hypothetical protein
MIDQLEYNTEREKLIIPEYGRHLQKMVNQAVEEEDEKKRNIIARSIIAVMGNLQPHLRDV
PDFQHKLWDQLFIMSDFKLDVVSPYDKPSKEKLEEHPDPLDYPQNHPKYRFYGNNIKRMI
DVAVQWEKGQKREALEFTIANHMKKCFLNWNKDTVDDEVIFKHLFELSDGQINLAKKDED
LKEAQKLMRNKKSGKSYRKKSGRGKKRY
>KECLDBNJ_03348 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MGTFQIEGGHQLKGSIQPQGAKNEALQILCAVLLTPEKVVIDNIPDIVDVNKLITILSNL
GVKIQKLGKGKYSFKSDALHLEYLESEQFKKEGGGLRGSIMIVGPLLARFGKGYIPRPGG
DKIGRRRLDTHFEGMIKLGAKFRYNKEERFYGVEAPEGLRGTFMLLDEASVTGTANIVMA
AVMAEGETTIYNAACEPYLQQLCKMLNKMGAKISGIGSNMLKIEGVKALNGCEHSILPDM
IEIGSWIGLAAMTKSEITIKNVSWNDLGLIPATFRKLGITVEKRGDDIFIPAHTEGYEIE
TFIDGSFMTISDAPWPGFTPDLLSIVLVVATQAKGEVLIHQKMFESRLFFVDKLIDMGAK
IILCDPHRATVIGHDFKSTLKATTMSSPDIRAGISLLIAALSAKGTSTIHNIEQIDRGYE
NIDERLRAIGAKIIRTA
>KECLDBNJ_03349 Putative 5'(3')-deoxyribonucleotidase
MTIFVDMDEVIADTYQAHIDLYNNKYNATLKKEDCLGHEVWQMVPEPHQGYVRNHANERG
FFIDLKVMKDSQEVMRELHDKHDLYIASAAMQFKTSLEEKADWLDKHFPFIPWQNRILCG
HKHVLRGDVLIDDRSYNLAAFEGRGIQFTSPHNVNTNGFDRADTWQDIADLLL
>KECLDBNJ_03350 hypothetical protein
MWKFYRDITRFAALFALVCIPIGSLTSATVLFGILGTPVGLLMFHYFQKEEFYGYYNLGY
TKLKLIGTTWLVNLALTPVLLLLSFIILKLVRLGAIAS
>KECLDBNJ_03351 Lipopolysaccharide export system ATP-binding protein LptB
MALLQVNNISKSFGKKQILESADFQLATGEILGVFGRNGSGKSTLLTILFGTQTAKTGTI
KINETQHSVRKHFWNKNPIVANELIGYLPQFSFLSQSSKVWDLIPRYFEGAAQDLIFRAP
RMSKIANRKVNELSLGERRYLEVLIVGNLKHPFLLLDEPFSMVEPLFKGLIHEFLSSLKS
KKGILLTDHYYQDVWQLADRNLVLKDGKLKTVNALEDLVNAGYLRSM
>KECLDBNJ_03352 putative methyltransferase
MKDNFSNHAQDYAKFRPTYPKAVFEFLYELIPEKLNAWDVATGNGQVAVELATNFQNVLA
TDLSAQQLAEAPQLKNIAYRVQTSETAFDYDAKFDLITVAQAIHWFDFDKFYANVKAHLA
PQGILAVIGYSVFETSGKLNEVIQHFYKNITDKYWDPERRYLDEHYQTIPFPFQEITVPK
FEMEVRWTKVQFLNYLNTWSAVKHYEKANGQNPLELIKADVEANWGNAVIRKFSFPLLFR
LGMNT
>KECLDBNJ_03353 hypothetical protein
MKKLVLLLALGAMILSSASCSSYRTSRNANNSAPGQVKKVYGAQSAKAFAPGQQKKKNKN
KKN
>KECLDBNJ_03354 Deoxyribodipyrimidine photo-lyase
MSTVSIFWFRRDLRLDDNVGFLEALKGSHPVLPIFIFDKEILNELPKDDARVTFIYETLQ
KMRNELQEDHGSSLALFYGKPETVWKQLIKDYDIDTIYTNHDYEPYALERDEHIKKLLNK
EDINFKTYKDQVIFEKDEVVKGDGDPYVVYTPYKNKWQEIFDEDEHLKIHYTSQHLKNLI
QNSRLPNLDLSDMGFKKSSIEIPEYDVTPTLIQNYEDTRNFPAQDGTSHLGPHLRFGTVS
VRKMVKKAIAEKNTVFWSELIWREFFMQILYHYPKTVNNAFRSKYDRIEWRNNKKEFEKW
KKGETGYLLVDAGMRQLNTTGYMHNRVRMLVASFLCKHLLIDWRWGEAYFAEKLLDYEQS
SNVGNWQWAAGSGVDAAPYFRIFNPMTQVDKFDKDKKYIKEFVPEFDTEEYPEKMVNHKE
ARERCLKTYKAAVS
>KECLDBNJ_03355 2-(S)-hydroxypropyl-CoM dehydrogenase
MKKNILLIGGSHGIGKSIIETLDSDYTIYVASRTEEDLPENVTHIKYDVTQDTLETETLP
DVLDGFVYCPGSINLKPFKMLSEETFNEDLQLNFMGLIKSLKAIEDRLKKSDQASLVFFS
TVAVKMGMPFHTSVAAAKGAIEGFAKALAAEYAPQYRVNVIAPSLTDTPLASRLLGNEKK
KEKMDERHPLKRVGTPQDIAKVAAFLLSEESSWVTGQILGIDGGMSTLNIH
>KECLDBNJ_03356 hypothetical protein
MKIYTLHTKQNLPISLEKAWSFLSDPKNLKVITPDYMGFEILSGADRPMFPGQIIQYNVT
PIAGINTKWVTEITHVKHLEYFVDEQRFGPYSLWHHKHFLKEIPGGVEMEDIVDYKVPAG
ILGQLVRPVLVKPKLQEIFEYREQKLTELFGTYTKPKGNLEGISREDILN
>KECLDBNJ_03357 hypothetical protein
MKKIILSCFLALSALTQAQIQTPAASAHATLTQTVGLTEVTVDYSRPNRRGREIVGNLVP
YGKIWRTGANATTKFTVDKPVRIADKELAAGTYSVYTVPGEDMWEVVFYTDHSNPLITEF
EDSKIALRTMVEPIEMPMNMETFTIVIDDVMADSAVMSFLWDNTIVPVKFSVNTDAEVMA
NIEQALQGPSAGDYYNAAVYYLNSGKDIQQAKTWMDEAMAKTETPRFWQLRQQSLILAKA
GDKKGAIEAAKASLAGAKAAGNADYVKMNTDSLKEWGGM
>KECLDBNJ_03358 1,5-anhydro-D-fructose reductase
MKIIRWGILGLGKIANSFATDLQQVEGSVLYAVASRSQEKADHFGAEYNATQCYNSYEQL
VKDPNVDAVYIATPHVRHHQDTLLCLQHKKAVLCEKPFAMNRKQVEEMITTAQANNTLLM
EALWTRFMPHYKFVQQELESGRYGTVKTLAADFCFEAEFNPEGRLFNKALGGGSLLDIGI
YPIFCALALFGKPDHIEAKAKIGKTGVDEETEMTFKYNSGISAFLSSSILKKTPTTATLV
CEKGMLILNSRFHQTDKVTTILEGTKIEHDFAYTGKGYYFEIEHFAELLRQEKKESPLMS
YAFSRLLISTLDEVRELINLQYA
>KECLDBNJ_03359 Sodium/glucose cotransporter
MQTIDWIVLVVTLAFIVLYGVYRTRGRRNVQDYIRGGNESKWWSVGLSVMATQASAITFL
STPGQAYNDGLGFVQFYFGLPIAIIIICIFFIPIYYKLNVYTAYEYLESRFDLRVRSLAS
ALFLLSRGLAAGITIFAPSIILSAVLGWDLNTLNIIIGLLVVIYTISGGTKAVTVTQKQQ
MGIIFSGMFVAFFLIISYLPEDINFNNALEIAGASGKLNVLDFSFDFENRYTFWSGILGG
TFLMLSYFGTDQSQVQRYLSGKSLREMQLGMIFNGLLKVPMQFFILLVGVMVFVFYQFNP
TPLNFNPAATKAVHGTPFEKEYNGLQVKLNELRSDKSELSHLLATDPQAEVTAQTGSTVS
AKAALANINNEENKLRDQGRMLIGLADKNVETNDKDYVFIHFILNNLPRGLIGLLLAVIL
SAAMSSTASELNALAATTTVDFYRRNLKEDRDEAHFVDAAKWFTLSWGILAILIACTANL
FDNLIQLVNIIGSLFYGTILGIFMSAFFIKKIKSRAVFIGAIVTQFIVFALFGLDKFEII
RLPYLWLNVVGCASVIAWSLLIQSTSKTGTTAA
>KECLDBNJ_03360 hypothetical protein
MMQPKKEGWSKYYTLVLVMNAVYIVLFFLLMNYYTA
>KECLDBNJ_03361 Mycothiol S-conjugate amidase
MRFLFVFLCCISLQLQAQKPKKPTSSEIFEQIKSLNFLGTALYLAAHPDDENTAMISYLA
NEVHARTGYLSLTRGDGGQNLIGPEIRELLGVIRTQELLAARRTDGGEQRFTRANDFGYS
KNPEETLTFWEQDEVLKDVVWAIRNFQPDIIINRFDHRSPGSTHGHHTLSAMLSVAAFDK
VGDPNVFPEQLELTNTWQPKRLFFNTSWWFYGSREKFEAADKSNLVSVDVGSYYPAYGLS
NTEISALSRSQHKSQGFGNTGTRGEQVEYLELLKGDLPANGNLFEGIDTSWNRVQGGAAI
GVILMNVQKNYDFQNPSASLPQLIKAYDLITKLEDSYWRTLKTKQITEVIKACAGLYLEA
ATHTQTAIAQQNIVVSIEAINRSPFPIRLEQISLLPEEKEFKTAIDLDQNETFKTDLNIN
TGNAALTTAYWLTEEGSVGMYNVDDQKLIGLPETPRKFKAVFQLTMNDVSIPVTTELVYK
YNDRVDGEVYEPFEIVPKASVAVKDPVIIFADAQPKIIQTDVTAFIDNLEASVALNVPAD
WKVSAPQKIQISQKGETKSLSFTVTPPKNASEGELQPELTINGERITDKVVKIDYDHIPL
QTLVLPSQNKLVRLDIAKKGSYIGYIAGAGDVIPESLRQIGYQVAEIAPVEITAENLKNF
DAVVMGVRAYNVVEELQYKQRILLNYVENGGTMVVQYNTARGFSFENLGPYPLHLSSDRV
TDEFADVTILDPDAEILNYPNKITDKDFEGWVQERGLYFPDTYDEAYKPVLSIHDKNEDP
SEGSLLISKYGKGHYIYTGLSFFRELPAGVSGAYRLFANMLSVGKNNEKIKQ
>KECLDBNJ_03362 Septum formation protein Maf
MLQPLLRNKKLILASQSPRRQELLRSLEVPFEIRLKPIDESYPDGMQPAQIAEYIAKKKA
EAFSAQLTADEILITGDTLVFKNNKALGKPKDAIEAKEMLQLLSGTHHEVISSVCVTTAQ
QQLVAHDSAKVYFRAFTAAEIAHYIETYKPFDKAGAYGIQEWIGHIALQKLEGSYNTVMG
LPTQKLYDLLQELLAA
>KECLDBNJ_03363 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MTFFKFIRYKNLLLIALTQILVHYGFLKALDLPTALSDLNFFILSLATLFIAAAGYIIND
IQDVAIDRINKPNKTFIPAPFSQNSAFNYYLVLNISGVGLGFLLSYRMGFGNFATLFVLI
SALLYVYANFLKRVLLLCNLIVSVIVASAIGIVMVFDVIPVLQGNEQQLVNPLSVLKDYA
VFALMLNFLREIIKDIEDANGDYAAGIQSLPILLGLERTAKLSAYIAVTYIFTVLGYIYV
YLQANVWISLYLVIAVVIPLVFFCIKARYAEKHKHYSFLSKLLKLIMLLGILSLGVLTLT
LKY
>KECLDBNJ_03364 hypothetical protein
MTTLIKLFISGFAALMLTSCNFNLQMGQIEGNGNVVTQDLNLTQDFTRVHSSNGWDVVLE
KGNSYKVVAEVDDNLLEYLDVHYEGSTLRIESTDNSNIGNASSRLIHVTYVQPLEAIKAS
SASNITAAEVLTGDKINLDVSSAATVKLGLDIRDVEADASSAGTLSLNGQAQRLDFDASS
AATINAKDLKAEFCNAEASSAGSIRTYVSKEITTNASSGGDIDYWGEPQQVAVNESSGGS
VSKK
>KECLDBNJ_03365 hypothetical protein
MNKTVNINLAGLFFHVDEHAYAKLQRYLDAIKRSFTDAQGREEIIQDIEARIAELFNERV
KNERQVIGITEVDEVINIMGQPEDYRIDEELFEDEPVHNTYSSTKSSSKKLYRDTDTSWI
GGVCTGLGHYLQIDAVWIRIALVLLTIFSWGGFILIYAAFWIFVPEARTTAEKLEMRGKP
VNIDNIQRKVKEGFDTVADSVKNVDYVKYGNKARKGANSLAGTLGKIIMFILKVFVKFIG
ILLVLIGGSTLIGLFVGLFSAGTLDFLDGSIADYVDMVNTSGAPLWLLSLLTFFAVGIPF
FMLFYLGLRILVNTLKRIPVVAKLTMLGVWFVAIMALAVLGVRQGMATAVEGESVVSEVL
PIKAGDTLSVKMITQNQYGAYKYHNDSWKIRTDSEGSKVLYNRDVNLSVQKSDSPEAKLM
IRKSAQGNSYDAAQDRAANIVYHFEMDGNTLLLDNYFISGIKNKYRSQEVDLILAIPEGT
VLFTDKNIESYHRNRYSDLLNYEHVGYHTLMNDAELTCLDCPEKPIEEFEELEEIEESQW
KADEAEQDTLTTGTVYEYKSEAKPKKDGVAVRPEVQNDTVLKVLDTIN
>KECLDBNJ_03366 hypothetical protein
MKIENTKAQMRKGVLEYCILSILKDEDAYVAEILDTLKDAKLLVVEGTIYPLLTRLKNAG
LLSYRWEESTSGPPRKYYGLTETGKLFLNELSSTWDDLQKAVQLVTTQKSKNNE
>KECLDBNJ_03367 hypothetical protein
MENSITTGQKNTATFIHLSVFTQFIFPLGNFIAPLLIWAALKRDSIFVDNHGRRALNFQM
STLVYAIGIVIISIPFIIYQIVNIVDTQGYFDLETQFDHFVLPNAAASGLIITALVFGLL
LLALFVVTLFSVISAAVSASNGEDYKYPLTINFLKPRSVSPVDSASDSSTEVS
>KECLDBNJ_03368 hypothetical protein
MALTPSKFNSFIMFKLPSAWLCGVRVKEISETTCKTSVKHKWINQNPFNSMFWAVQGMAA
ELSTGAMVINQIKESGKKISMLVANNKASFTKKATGKIIFTCNDGHKIADAIEKTIATGE
GQTFWMQSIGMNEDGVVVSTFDFEWTVKVKS
>KECLDBNJ_03369 hypothetical protein
MTAHEIDYQIYGEEMQYVEIELDPQEGVIAEAGTFMMMEDGIRMETIFGDGSKNDSGLLN
KIFGAGKRLLTGESMFMTVFYNDIVGKKKVSFASPYPGKIIPIDLTKNGGRFICQKDAFL
CAAKGVSIGIEFSRKLGRGLFGGEGFIMQKLEGDGMAFVHAGGTTYKKELGLGEKLKVDT
GCIIGFDHTVNYDIEFVGGIKNTIFGGEGVFFATLTGPGTVYIQSLPFSRLAKRVWAAAP
QMGGKDKGEGSILGGLGDLLDGDNRF
>KECLDBNJ_03370 hypothetical protein
MFEYTKTILKKVSFDSVLFCKELQKAAKRLLPYEIEELKEWIEDLVKTNPDLNQCMIYLN
A
>KECLDBNJ_03371 Hydrogen peroxide-inducible genes activator
MTITQLKYVLAVAENQNFTKAAEKTFVTQPTLSMQIQKLEDELDILIFDRSKKPIELTDI
GSKIVTQARNIVNEANRISDIVDQQKGFIGGEFKLGVIPTVMPTLLPMFLRNFINRYPKV
KLKIEELPTDTIVERLAEGHLDAAIAATPLQLEDIKERPLYYEPFVAYVPANHALHNIEK
LTTADLDLNDMLLLEDGHCFRDGVVNLCKTNRNYEEETFSLESGSFETLVRLANEGLGMT
LLPYLHTLDIKDEEKKYLHHFKEPAPAREVSLLYHKSELKMQIIEALRATIAGVVKGAIT
FQNVQIISPLPQTQGAFRK
>KECLDBNJ_03372 hypothetical protein
MKTTVVLLMTFISLISYSQETSSITVTINNVPNDKGVVGYGLYSKDNFMVAAPVKAAESN
ITNSKTTVTFEDVPLGTYAILCYHDSNGNGKMDFETNGMPTEAYGGSNNVMTMGPPRWED
CKFELTEKPVELEIRF
>KECLDBNJ_03374 hypothetical protein
MVMAVVVLLTTMSFTVDMHYCGDTLVDFSFIQDVQTCGMEKAEPAKSCSNSMISKKSCCS
DEQLIIEGQDDLKQDFIQLTFEQQIFVASFAYSYISLFERTESKEISFSDHSSPFIRRDL
QVLHQTFLI
>KECLDBNJ_03375 Cation efflux system protein CusA
MLNKSIKFLIENKLVAVILLALFVGWGIVNAPFNWETSILPTDPVAVDAIPDIGENQQIV
FTKWQGRSPQDIEDQITYPLTTSLLGIPGVKTIRSSSMFGFSSIYIIFEEDVEFYWSRSR
ILEKLNSLPANLLPDGVNPALGPDATGLGQIFWYTLEGRDKDGNVTGGWDLQELRSIQDY
YVKYGLSSASGVSEVASIGGYVQEYQVDVDPEKMRQYNIGLTDIVKAVKESNQDIGAQTL
EINQAEYLVRGLGYVKSVSDIENAVVTSENFTSIRIKDIANVHLGPQTRRGILDKEGAEV
VGGVVVARYGANPLEVINNVKDQIAELSSGLPTKTLADGRTSQVTIVPFYDRTQLIQETL
HTLNEALTLEILITILVIIVMVFNLRASILISGLLPVAVLMVFITMKLFNVDANIVALSG
IAIAIGTMVDVGVILAENMIRHLEDEKLRFRESGIEYTTNEIIYNATAEVSGAILTAVLT
TIISFLPVFTMIGAEGKLFRPLAFTKTMALSASLVIALFLIPPFAAFLFRKTNIRQRSKL
FLNGLLIALGITALVFGYWLGLILIAFGCSGLFFSLKAKKEYNHTIAGYRLNINQNVVNI
IISCIAIVVLLAEYWRPLGFDRSILMNLIFVAIICFGLLGVFTVFRRYYDSILRWALQNR
YLFLLIPTTVLILGVVIMRNTGKEFMPALNEGSFLLMPTSLPHAGVEENKRVLQQLDMAV
ASIPEIETVVGKAGRTESALDPAPLSMYENVIQYKSEYMRNENGERQRYRVNDDGLFVLK
GDKFIINPNNEIDDDANYEASQLKTSATRNDLIEDSDGEYYRNWRPEISSPDDIWNEIVK
VTKFPGVTSAPKLQPIETRLVMLQTGMRAPMGIKVKGPDLKTIENFGLQLEDILKQAEGV
KEQAVFADRIVGKPYLLIDIKRDQLARYGISIMDVQEVLQVAVGGMPLTQTVEGRERYGV
RVRYPRELRANPEDLKSIYVPVSTGSPVPLGELVDIRYEQGPQVIKSEDTFLIGYVLFDK
LDGFAEVDVVENAQALIQQKIDNGDLVVPQGISYRFTGTYENQLRAEKTLSVVVPLCLLV
IFLILYFQFRSVSTSLMVFTAIAVAFAGGFIMIWLYGQDWFFNFSFFGENLRDLFNMKTI
NLSVAVWVGFIALFGIATDDGVVMATYLDQSFKSNEPDSKKGIRLATLEAAGKRIRPCLM
TTVTTVLALLPVLTSTGKGSDIMIPMAIPIFGGMIIDVTSYFLLPVLYSWKKEYQLKRAN
K
>KECLDBNJ_03376 hypothetical protein
MKNIKIIICLLFVSAFAKAQQLQSYIDEAENNNPEIQAFELRYNIAEEKVNEANWLPNTE
VSAGYFVSEPETRVGAQRARIGVKQMLPWFGTISARENYATSMAEAEYVEITIAKRKLAL
SVAQSYYRLYETRAKQKVLDENIQLLKTYERLALTSVEVGKASAVDVLRLQIRQNELQQQ
KEVLEEEFNSEQTTFNNLLNRDENSTVEIVATMEIPEDDPTYGTDALSLNPELLKYDKLY
ESIAQSELLNQRESLPMIGFGVDYLPVTERSDVNFSDNGKDVLMPMVSVSIPIFNNRYKS
ISRQNELRQQEIETQKSQRLNVLESAFAKAISQRNQARIKFNTQTMNLKQAKDAEQILIK
NYETGTIDFNDVLDIQELQLKFQMNQIESVQMYYVQQSIINYLIQ
>KECLDBNJ_03377 HTH-type transcriptional activator RhaR
MVKDFYIKNMVCDRCIKVLRDELHKAKISLLDIELGRLRLDMNEKEQLSILTEILKRNGF
ALIASTEDKLTEQVKIELIKLLKVIPLEIDGKLSDFLADKLQKDYSKISKVFSIIEGITI
EKYFIKLKIEKVKELIQTPDYNFTEISQLLDYSNVNHLSKQFKSETGMSLSDYKDGHKNF
RNPLDKII
>KECLDBNJ_03378 Copper resistance protein A
MKMLRIITLLLFSSTVFAQVGTNGQDRKEEGRPVKEYNLTIEENEMTLAGVTAKGMTING
SIPGPVLEFNEGDLAIINVTNKMDEETSVHWHGLILPNFYDGVPYLTTPPIKPGTTFQYR
IPINQSGTYWYHSHTMLQEQSGVYGSIVIQPKEKTLDYDKDLVVVLSDWTNEDPMNVLRN
LKRGNEWYQVKKGTAVPLSRVIKEGALGAQFKFWRDRMEGADIADIYYPAFLSNGKSLAE
YPEFKPGEKVRLRFINASASTYYWVDFGGGNPLLVASDGVDVQPVSKSRFLFGIAETYDV
IVTIPEGTLEVTATAQDGSGHTSIQLGNGTLYPAKRIDRPDKVAMMKQMAKMDMKMGAPA
MVGNKKKNTPEVLMQKYGMKMNMKDGEMKMGMNDKMSMKDGKMNDQMDMKMDDAMGMKMD
SMAMNHKGDSDKMKDHMQHDMSKMQKDSSSFDYETRKTYFNYDFLKAKENTTYKDDLPVN
DILLNLTGNMQRYVWSLNGVPLSETDKINIKGGEVTRITLNNLTMMHHPMHLHGHYFRVI
NENGERSPLKHTVNVPPMQKVVIEFYNEEYGDWFFHCHVLYHMMGGMARVFSYDTPRDER
MKDYPVQKLINETDHYYSWGLLRAGSNFNELFLMSSNIRNGFGLRAEFDYDKNLEAEVNY
DRYLNDWLRLYVGVNTETEIPNSFDEFNTVGLVGVKYFTPYRFYVDVSMDHQLRPRIRLD
REILIFPRIFLEGEYEYRADFGWVNDIGNSSYESETQWLVGLSYILSRNFSIQANYNNRY
GWGGGLLARF
>KECLDBNJ_03379 hypothetical protein
MKTTIAAFALIAFIGCKEKQTVEINTPEEVKTAKENTADVADQGFIDGMTGKVWHNYLEI
KMALAKSDESQAKSISKDMAASFGEERMEMKQLAHQMADAQDIEEVRELFAQFTEKAGPM
FEDALSEGTIYKKYCPMAFNNEGAYWYAAVKEITNPYFGEKMLKCGSVKKTINK
>KECLDBNJ_03380 hypothetical protein
MKMMKQNVMIAGLALVLLSATACKDGNKNEPAAPMSNEMHQESMDDMMDDKPMNEDDEMA
MNNGQDAKAEAILTDYFKLKDALVADDNAKAKELGASLATTLGKLDISEYTDTQQSDLKD
IVEDAVEHAEHISESDIAHQREHFKVLSKDVTDMVAITGTENTVYQQFCPMYDGGSAWLS
TSKDVKNPYYGSKMLTCGKVQKEIN
>KECLDBNJ_03381 hypothetical protein
MKIVKIIAGIFLVALVLIQFIPVDYNQNDTVPQTDFMVVHKVPEAIQKKIQVSCYDCHSN
NTQYPWYNRVQPVAWFLEDHIKEGKAELNFNEWDSLSSRRKTSKLRSIIKQIESGEMPLD
SYTLIHRDAKFSKEETEEIINWVTQLKDSL
>KECLDBNJ_03382 hypothetical protein
MKKIKMSIAAMLLLTVSFAYAQEKDKMDHSNMKMDHSKMMDTKTDAKAEVILNDYFNLKD
ALVADDTKKAAQLGTTLVASLKAFDSSHYTKEQQSELADIIEDATEHAEHIAESAIDHQR
EHFKTLSKDITDMVAITGTKNTLYQQFCPMYDGGTAWLSTKEEVRNPYYGSQMLKCGKVQ
REIN
>KECLDBNJ_03383 hypothetical protein
MKVLKIIAWIALIAFVVIQFFPMDYNQSETLPQTDFMLVNKVPATVEKSLQVSCYDCHSN
YTKYPWYNKVQPVAWFLEDHIKEGKAELNFNEWDTYSDRRKNSKLRSIIKQIENGQMPLD
SYTLIHRDAILSKEEKEAVLNYMKTLKDDLE
>KECLDBNJ_03384 hypothetical protein
MKTIKIFSIILVIAFSGSFTNVFALNEKRNDSDKIELSTNITSIAQSDDVKADFDAFPNL
HPMVVHFPIVLLIIAVLLQLIQLCTLNRTMDWVILLMVGAGFIGAYVASTLVHPHTAELT
EIAQRILDQHDKYAEWTLWSSALAAILKIVSLFWVKLKRGFEIAVFLVMAFSAYSVSEAG
HYGSQLVYIEGVGPQGKYIEIENEESQGESNEHSH
>KECLDBNJ_03385 Glutamate synthase [NADPH] large chain
MRRGFIVTSIILILALAAIIILYPLLWWLALILLPILVLGLIDYFQKSNNIRRTYPLLGR
ITNLLEKQRHVVQETVLLNRTEGKPFNWIQKEIVYKRAEDAVKNQPFGTQIPYDEVGREW
FTHSTYPAKEIKDDFRVTIGSSKCSKPYSASILNLAGMSYGSISKNATLAFNGGAKIAGF
AQNTGEGGFTPYHQEYGADVIFQFGTGYFGCRTEEGDFDPKKFAEIASNEVVKMIEIKVS
QGAKPGFGAILPAKKNTEEIAKYRDVEKGTEILSPPHHAAFSNDSEMIAFIQELRKLSGG
KPIGIKMCIGQKDEFERMVRTFAEKKNYPDFIAIDGAEGGSGAAHMESLHWAGLPIIEAI
HFANGILKKYGLRDEIKVMAAGKIISAFDIYRMLALGADTCYSARGMMFALGCVQSLKCN
LDTCPTGITTMEPSRVASLVVEDKKTKVANYHKNTIEAFKELLKSMGIENRRSIDKKYII
RRINENDTKTYDEIFIDNK
>KECLDBNJ_03386 hypothetical protein
MDKEKDIETTRAFYGQLFNSSRYVLLVLLIASVIELFALPTLEGSYAIIILLALTLLKIG
FIIALSFNQLMKIIGQSHLLSHVLVLFGYLIVLIVFSFAIDYTALQFVDAIHFKMNNSIG
NDGLSVFFDLSYFSLITFSSVGYGDIVPISLPAKTLVVLEVALRFFVLVFGIANVNRIRV
NK
>KECLDBNJ_03387 hypothetical protein
MKTIKLTTVVMLLIIATSPLFGQDANTEKEAVLTVMKTYKGALQNLTTDGTFELFTENSE
VFESGGVEGTYSHYIEHHLGPELGHFEKFEFTDYEINVKVDVPYAFTTETYIYTIVLNPD
DKGNNRTIKKKGVATSILEKIDGKWKITKMHSSSRNVK
>KECLDBNJ_03388 Putative permease
MTDFLKQWGEAAYTTTGFFWMALWAFILGYIISSMIQIFVTEKKMQKTMGENEGKSVLLG
TFFGFISSSCSFSALAGTKSIFKKGASFVSSIAFLLASTNLVIELGIIISIFLGWQFVVG
EYVGGILLIGISWILIRLINPKKLIEKARKNLENEDDDEMDGSKDWKKQIKNEDSWARVA
KKYKMEWQMVWKDVTVGFTVAGITAAFVPDSFFQTLFINSGQGNTDFTFLEILEHIVVGP
VAAFLTFIGSMGNIPLAALLFGKGVSFAGVMAFIFSDLVVFPVLRINAKYYGWKMSLFIT
FLLFTALIGTALALHYGFDLLNMLPDSSQVKIQDSEFFKIDYTFFLNVAFLIISAYLVYL
GFFKKKDVEHSMSEMAPKSPLLEKILKYAAFICYIWLAGGLIVKFLVN
>KECLDBNJ_03389 hypothetical protein
MKTFDTLSQTMTHLQEQGYTYDFNLCSGHIECNALKLKLHPEDFDVDEMHRYEGMSSTDD
NSVLYAISSKNGIKGLLVDAYGVYAENISEAMRKKLR
>KECLDBNJ_03390 Silver exporting P-type ATPase
MKHTYHIHGMTCKGCQNHVEKTLSNIEGVTSASVNLEKAEATIEMESHIPIETFQKVLND
DGDTYSIHKPGEHHHKDDSASAKAKKPQPKGKGTGTFYCPMHCEGDKTYDKPGDCPVCGM
DLVEEQNLTATTSEQWTCPMHPEVVKDGPGDCPICGMDLVPMEPDLSAEEKTYKKLLKKF
WIAVSFTLPIFFIAMSEMLSNNPLESILEIKYWNWIQFVLSLPVVFYATWMFFERAYRSI
VTWNLNMFTLIGIGTGVAWVFSVFGMLFPQLFPQDFLTESGTVFVYFEATTVILTLVLLG
QVLEARAHSKTNSAVKELLKLAPNKAIKVVDGNEEEVSIDQIEKGDILRVKPGDKIPVDG
KITEGETTVDESMISGEPIPVNKSVDDKVSSGTINGNQSFLMEAEKVGSDTLLSQIIKMV
NDASRSRAPIQKLADTVSGYFVPIVIFIAVITFIVWAIWGPEPAYVYGFVNAIAVLIIAC
PCALGLATPMSVMVGVGKGAQNGVLIKNAEALEKMDKVDTLIVDKTGTITEGKPTVEKVG
SFDDKQFSESEILHFIASLNSSSEHPLAEATVKYGKQQNVELSKTENFSAITGKGVEGTV
DGKKLDLGNDRMMEYAKATISSAMEDEAQSFQKQGKTVSYLAIDGKVSGYVVIGDKIKKT
SAKAIKELQDKGIAVIMLTGDNHDTAQAVASELNLADFKASMLPENKLQEVEKLQNEGKV
VAMAGDGINDAPALAKSNVGIAMGTGTDVAIESAMITLVKGDLHGIVKAKNLSHMVMRNI
KENLFFAFIYNTLGVPIAAGVLFPFFGLLLSPMIAALAMSFSSVSVITNALRLRTKKIDS
>KECLDBNJ_03391 hypothetical protein
MVNRKTAKWIRKAHRYLGIFLGIQFLMWTISGMYFSWTDIDEIHGDHFKKEIPEQTAFSG
LVGSSQLNIQEPIKSLELLEIADAPYYWINETVLYNALTGTKKDELTEQEAIKVSERYML
ADLEFDQIRRIESVGDHHEYRGRPLPAYEISYKTDENLKAYVAIENGAFQTVRHRDWRWF
DFLWMTHTMDYQGRDNFNTIVLRAFSLLGLITVLSGFILWYISSPTLRKLIKNNRK
>KECLDBNJ_03392 hypothetical protein
MENSMENKKKNQYTKFVGMLATSFVAMYITMYLNTYEWDHVWFSLTRFYMVCLGIAAMAI
IMFVAMRGMYKNKKKNIAIVLGSIVLFVSALTLVREQKSTVGDVLWMKAMIPHHSIAILT
SKRADIKDPEAKKLAEEIIEAQLREIAQMKKIIYRLENEKEE
>KECLDBNJ_03393 Cobalt-zinc-cadmium resistance protein CzcB
MKKNINYISIAVIAGLLAGYLIFGNSGTEQNAVKDLSDMSDTHDHSGESENQMWTCSMHP
QIMQPEPGDCPICGMDLIPAESGADGLAMNEIKMTENAMALANIQTTIVGNGSMSEDDGM
ISLSGKIDTNEENNAVQASYFDGRIERLNVNYEGQKVNLGQTLATIYAPNLVAAQQELLT
TASLKESQPELYKAVRNKLKNWKLSDNQIDAIESSGNVRDNFPVYATVSGTVSEVMAREG
DYVKQGQPILKVSNLNSVWAEFDAYENQISDLKVGQKIKVVTNAYANKEFDATVSFIDPI
LNNATRTVTVRATLKNTDDLFKPGMFVTGKLKGEMMMTNEVITVPASAVMWTGERSLVYI
KTNPNEPVFEMREVTIGNRNGENYAVTEGLQNGDEIVTNGTFTVDAAAQLQGKNSMMNQE
KKEDAMMPMSEMNMEFSENFQKQFKKALKPYLQMKDALVASDANQVSAFAKATSTALKSA
DIKSLGSMEQSHIKKSIEMLDAIAENDILENQRDHFVILNENMVPIAMSVNGTDAMLYVQ
KCPMANNNKGAVWLSAEKDIRNPYYGDAMLTCGSVIEEIK
>KECLDBNJ_03394 Chromosome-partitioning protein Spo0J
MTTKASTTKKRSRAKSTATKEVNGKKSPVLQIQNLPLGKIKTDPEQPRKTFKKDALQQLS
ESIEEHGVLQPITVRQLNGHYVIVMGERRYRASKLVGKKTIPCIVRTYENNDVLEVQIIE
NLQRQDLEPTEEAEAIAYLSEKYAPTEIAKRLGRTDNFIRQRLKLAGLIEGFKHFVRNGE
MTISLGVGVALFAPEEQQMMLETMGKDFNAHQINRMIKDQTYDLEKASFDVTDKKLVPKA
GSCVECPFNAANQGNLFGEGKMVCTKSACFETKKNKIVLELD
>KECLDBNJ_03395 hypothetical protein
MNLIEKAKKQNILLIPEIRQYWADDENNQLIISQLEKSGLKVYLLDDVEIIENPIKPTIE
AIRKEYQHYDYSEDELKAEFKEAIENYEEELKNYNSASDNGFVNGIVFHPDTYQHKTVFV
KIIEKSKHKSSEYSAPLANRKMADCTPEEQIIKINEREIRKKQIENNKHFEEVVEMIRET
KYIATKKTLSTDEMVAFSISLFENNVDYMSQQKYFSKFLGDTSKMTKVEMVENFKKKFKK
EVFHKLIRYMITKQVHFGESNHLNNLTNISFYNAMQGYYKSKIASIEKEYTEKREKREAR
LKERIAVLEKKVKELNK
>KECLDBNJ_03396 hypothetical protein
MKRVSEKSKISPQEAEIHYQSSKENYNIEGAESHLAYYREKHPIYYAVLLQNV
>KECLDBNJ_03397 hypothetical protein
MYLQNLQQDEIFVPSEMKSLKSLTQMESRRGLENAIISNGKIVNVVSNSYGHIPNQLFFK
KAEEMLTDAQLNFHKRTINKNDRSFITDFIIDDKSQFSVKNKEDLILPMLRFKNSYDGSE
KTSGNFGFYRKVCSNGLHVSQAEIEFSIKHSKNNTHLIMPRLNNLFDKFLDNEFYTITKK
FDKMKEFKIIDTKEFVRAILDRTKLFRYECSDKNNDPSKKSREVLEILNYEALLLDEQPN
LWLGYNAFNSVLHNVLKKSFCQQERLDKKLFDEVYALA
>KECLDBNJ_03398 hypothetical protein
MKIKTMNTLKTIALAAVCIAFTSCSSDDDNTPTPDPIEAELVSNLFAPQTGGQGQPVGGE
FAKFDFETGMQTTSDTDWDIAFRGTTIAVNGGTVTGTDDEPARNGDAGATIATGTFASVT
TAEGLTFDQDADGSFAIPTGSDNGWYNYNPMVNVVTPIPGKVLVFRTRDGRYAKVEILSY
YKDNPSQPDPQTDESRYYTFNYVYNPNEGETSFE
>KECLDBNJ_03399 Colicin I receptor
MRLTFCFILFTFCYQTSIGQNEQKTVRDSLKVEKLEEVILTATRTERQLSSLPLPVTLIS
KKKILQSGTIRLDEILNEQTGIITVTDESGFEGVQIQGIASDYILILIDGVPLVGRSAGN
FDLSRLTVGNIKQIEVVKGPSSSLYGSEALGGVINIITEKPKSEELHGNASYRFGSFTQQ
DINVDIKQRYKKLRYVFFANRFSSEGYDLNPDVDGQTVNPFENYTVNGRIYYDFNDKLSL
FTSARFYDQVQDAGFTFNDVAFEGDSKEREWNAHARIDQKWNDRLDTSYELYYTNYTANE
RLADPISEDVLSDSDFDQKLFRPEIRGNYAFADAGTLTAGFGFQYDELDRTFFDETVSFN
SQYAYAQYDFNPVERLNVIAGARFDNHSEYSNQFSPKLAMRYKLTNAISVKGSVGYGFKA
PDFRQLYFDFTNSAVGYTVLGYNVALDKLRELREQGQILDVVVSEDDLNNPLEAESSVGY
NVGLTFKEGKWNSELNFFRNDIKNLIDTRIIARKTNGQNVFSYVNFDEIYTTGFEINTGY
KITNALNLSAGYQLLYAYDKKKQQEVEDGQVFARDPATNQTVAVTQSDNFGLVNRSRHNA
NFKVFYDIASAKANINLRLLYRSKYAQFDTNGNGLIDTYDTSFIDGYVTTNIAASKTFYD
DFTLQVGANNLLDYTDNNIPTLPGIQGYVKLNYQF
>KECLDBNJ_03400 hypothetical protein
MKTPAYIVLALLFSINAISQPSKKQEDREAIKKMCGCYEVTFNFAETFNYSNDSLYKPSK
TKVDKGLEWAQLVTDEDDKIQIQHLLQVGNPADPHIVKHWRQDWLFENTDLYTYNADNEW
TFKRMPASEVEGQWTQKVYQVDDSPRYEGSATWVHVDGKSYWENTTPAPLARREYTTRSD
YNLLMRGNRQEITDYGWLHDQDNSKIIREDGKEDVLLAKEKGYNTYKKVDDSRCAAAEKW
WQENEEKWAKVRAKWDEVYGRNKDLVLEEKVDNKVLYKYLFDEGYEEVAKIDEVIESFVK
RP
>KECLDBNJ_03401 Phosphocholine transferase AnkX
MKHLTIIWLFLALLLSVGQVSAQENIFLDRSFWKGNPDLETVKQKIVEGNDATALNQFAF
DATIYAMLEKADDDILKYLLSLEGNPIDKNTHDSRIYLHWAAYAGLTDIVEHLLNEGSSV
TKLDSHGYTPLAFAVNAGQTNPELFEAFEKYGINLLEEKNDSGANLLLLAAPSLSNEAEL
DYFLEKGFELGSKDDIGNGIFNYTAKKGNAEFLDLLIKKGVDYKSLNAAGGNAFLFAVQG
GRVYSNPLSVYEYLRDLGIEPNVVTKEGYTPLHRLAYSNTDPAIFEFFLAAGADVNQKDA
DGNTPFLNAVYRNELAMVKLLSKDVKDFNIANNNGETALMLAVQRNSPEVVKFLLDKGGN
AFAKAENGNTVAYYLLESFDSGNPSTFIDKLKLLQDKDVQFNTTQAEGNTLLHLAAKAND
LELLKRIAAFDIDIDAKNDEGLTALHVAAMKAADDKMMKYLISKGADTKVKTDFEETVYD
LAIENEMLQKQNTSLNFLK
>KECLDBNJ_03402 hypothetical protein
MKNLFKIIPAIALAGFLLTAFTTSNSKAVKCLIQMTNYTGEGAYVVVSLLTPEGEYEETL
YVQGKDSEWYSEIPEWWKFYGKYRPDIDAISGATISGGERTVTVLQIPEDKIDKGYSLRF
ETSVEDQEYYADDIQFELTTENLKAKKEGKGFIRYVRMLPN
>KECLDBNJ_03403 Ferredoxin--NAD(P)(+) reductase (naphthalene dioxygenase ferredoxin-specific)
MTLSIWRYSHLILAVASSLFLLIAAITGCILAVEPISHQAKGYAVQDLDQVSLTTTIDAL
KSSYDEVFSLEVESSGFVKASVLTSEIETLDIYVDPKTGAQLGVVKERPFIYSFATNLHR
SLFLKSIGRFFVGLISLLLLLIAITGLLLLAKRQGGFKRLFSKVQKDYFELRYHVILSRW
FFVPIVILAFTGVYLSAEKFELLPDASIAHQEIESSNETQNFESLKDIPFFKQTTLNEVR
KVEFPFSEDPEDYFHIALKDKEVRINQQSGQLISIAEYPFVQLVSRLSWVLHTGEGSVLW
SIVLLLASVSILFFMYSGFAMTLKRRKKVITTAAMPDKDDCEFVILVGSETGTTYDFARR
FYDSLTTAGKKVFLTELNEYSAFAKVKYIIILTATYGEGEPPTNARKFTTLFPNIKQPNK
IQYAVVGFGSLEYPDYCKFAIQTDALLQSDSNFQPLLPLYKINNATAADFKNWVKQFSER
LGIPLSFEVPKTKKSKNKKFAFEVMERTELNTDDTFLIRLKAKRDIKFTSGDLLTIFPEE
TEVARQYSIAKMDDEVLLSVKKHPYGKGSSYLFNLNTGDTIKAVIDANTHFHFPKKTSSA
VLIANGTGIAPFLGMMKANNNTKINLFWGGRTHNSADIYDAVLNRLPSRYQNGIVHKCYS
REEQRQYVQDLIIDKKEIVLDTIDNNGTIMICGSLAMQHDILDVLESLLNGHNIIRLDEL
QHNGQLRMDCY
>KECLDBNJ_03404 Single-stranded DNA-binding protein
MSTIRNHVQLIGNVGQEPTVTNLESGKKVARFSLATNEYYKDSKGEKQTDTNWHTVVAWG
KTAEIVEKYVEKGKEVGITGKLKTRTYTTDDGNQRYVTEVVADEILLLGSKNDK
>KECLDBNJ_03405 hypothetical protein
MKAQVNEIKISYKGGLKSSMWKKIGNSKDAAELLFEDWDKDTIGIQETFKVVLLNNSNKV
KGVYQLSQGGITSTLIDIRLLFAVILKSLSVAIILTHNHPSGKLEPSDADKKLTNKIKKA
SKLFDITILDHLIFAPDGDYYSFSDNGIL
>KECLDBNJ_03406 hypothetical protein
MVYLNFTDLSEEAQNRLLETSKEDVKRKFGDSIRKYVKENYGCFETMIEEEALRNLYSYT
YVFNI
>KECLDBNJ_03407 hypothetical protein
MDSFITIRFKRKTAKRFQEFSKMHFKTHTEAMENILDFFLYNEISPREKLGPTGRTIEAK
LLKRINAVIAIMRDVEKTQTKPTVAMLQSLFVMEEPNKKPLIVEKKYAEEKKEVRLPAGE
AGFRERRNIKNEL
>KECLDBNJ_03408 hypothetical protein
MYITITPQKMGGNFSKSSADFVGYLEKENQGLEQQDMEHFFNQYGDEISAEEVIKEIDGN
TAKLEKHEPRFYSITVSPSKYELQKLQNSSEDLKKYTRELMKDYVASFNREIKGRPVNID
DIKYYAKIEHQRTFKGTDFQVKENQPYATKILQLKTEIRNIQEGRAEGNIKRMKKEIAKL
ERQAPYQQNGKRIVQGMRKDGNQSHIHIIVSRKDASNRFSLSPGSKYKASDVKLNGEIVK
RGFDRDTFFEKAEKTFDKTFGYKRNFAETYKARKDFVKNPNLYFAALMKLPANEKALAFK
MIAKTGLPIVPNIPVSQTQIALRILKRLRRGAEIAIKSSSIGI
>KECLDBNJ_03409 hypothetical protein
MQLDNLITILSIIGLASCIFCAVFRISRYAFIVNFLVLGAMVFYLNEENRLILISLYLAC
PLILINIGMYVFLHKTDKPLNGDSKYQVSFAITKGNFKLDNIKRGASIIGSAGSGKTESV
VYGFLKHFRKEGFCGIIHDYKNFELTEMAYPLFKDSDIPFKVISFDKIIHRVNPIAPRYL
ENEESVNEVSRVLIENLLEQRESGTTGTTKFFNDAAEGLIGGLIWKLKTTYPQFCTLPHL
IAIYQYLDTDSLIQFLETNTTSRAMADAFISGKDSDRQTAGVKSTLANALKRISTQRIFM
ALSADEVPLNINNEKNPAVISIVNNPKFETSYSPVIATIIHTITKQMSVRSSKPSFLLME
EAPTIRLLNMHRIPATLRSYDIATIYVMQDKIQNDMMYGDKASKAILSNLSYQFFGKVND
PDTAKYYERFFEIIKDPTKSISRGHNLDFDTRITTGEKEIPKIRAEVFFRLKQGEFITYA
DGKDKKVQFKLSKINRQLPEVAKQYSSADMNANFERVYDEVRSIFS
>KECLDBNJ_03410 hypothetical protein
MKNTIRVERAKLEISQQELAEKVEVSRQTIHSIERGKKTPSVELAIRMARYFKIPVEELF
IIE
>KECLDBNJ_03411 hypothetical protein
MVVSSGVALLLTNAYQLFNIILMFGAGTGLIFILRWFWWRINAWSEISAMFSSGIISILF
NFTSLGVVLFGTAEADGILPNWSTYPVVVLLTSIVWLAVTFLTRPEKDKTLFDFYKQTQP
GGPGWEKIIIKARAQGAALVMTNQKWSVPAGILATLVGCVTIYGALFSTGYWIYGYYTQA
SILTLLTLIATIALVKLWQRIKTRVF
>KECLDBNJ_03412 Arabinoxylan arabinofuranohydrolase
MINFKRLAFKLFFLYFLFACKDETTKLKNSFNLPQTNISNPIVDGYYADPSIIIENGKFY
IYATKDPWGKDDLAFLESSDFKSWKLKKINWPTKEDCTSPTSNGSMVWAPSVVKAKNGNY
YMYVSVGSEVWAGVATSPGGPWKNAMDDNTPLITQDLFPDYHMIDAEAFIDDDGQAYLYW
GSGLNWMNGRCFVVKLKKDMITFDGEIMDVTPENYFEAPAMIKRNGIYYLMYSDGKVIED
TYKVRYAIGDNPFGPFKEAETSPILSTASDSITYSPGHHTVFSKGGQNYILYHRHSANSP
QSTGLLRELCVDSLNFTKDGLIKNVKPSGIASF
>KECLDBNJ_03413 L-fucose mutarotase
MNSTTYCYACDLKDDEKLIADYKKYHKAVWPEIIKSIKDSGILKMQIYHCYNRLFMITEV
SESFDLERKQKMDKENPIIQEWEQLMWKYQQALPKANPDEKWILMDCIFKI
>KECLDBNJ_03414 L-fucose-proton symporter
MKNQSKVPVVAKSVLLPFILITSLFALWGFANDITNPMVSAFKKVLELDNFQASLVQLAF
YGGYFTMALPAAIFVNRYSYKKGVLVGLGLYAVGALLFYPAAAYEEFGFFLSALYILTFG
LAFLETTANPYILSMGAEKTATQRLNLAQAFNPMGALLGLIVAQKFILASLQSDDLLPDG
TTVYSTLSEEAKAVVRTADLAVIRDPYVLLGIVVIGFLVVISLVNMPQNAHQESKVKIGG
SIKRLFKSRKFTGGVIAQAFYVGAQIMCWTYLYQYAESFGIENTKAVNYGIAALVVFLIG
RWVGTALLKYVDSGKLLLFFAIGAALATLITIIVPGMTGLIALVSISFFMSIMFPTIYGI
ALEGQGEDAKFGAAFLVMAIVGGALMPTLQGLILDLGGAGYTDISILGVPEVNFSFILPF
ICFMIIGIYGRDVYRKYNLNY
>KECLDBNJ_03415 Dihydroanticapsin 7-dehydrogenase
MNLNLKDKIVVVTGSAGMPGSIGHSIVFALAEEGAIPVLLDRNARGFEYEAQLREQGLDS
TFYQTDLSDAQQIKNSIEQLSAKYGRIDAIINNVGVNDGVSLEGSLDDFMYSLKLNLVSF
YATVKYALPLLKASKGNILNVGSKVAITGQGGTSGYAAAKGGVLGLTREWAVDLIKYGIR
SNALIIAESYTPAYENWIETLDNGAEKLQAIRNTIPLENRMTSTQEIADTVLFTISEKSS
HTTGQFLFVDGGYVHLDRALLPAK
>KECLDBNJ_03416 hypothetical protein
MIIDTHQHFWQYNPVKHSWIDDEMAAIRRDFMPQDLQPVYEEHDITGCIAVQADQTLEEN
TFLLNLASDYDFIKGVIGWVDFQSDAVQKDLNYYAEMPLMKGYRHVLQSEADNSFLLRKS
FLNGISKLKNTGAVYEILVFSHQLPAVLEFVKLFPEQQFVIDHIAKPYIKAGYIDAWALL
MKAIGSYENVSCKISGMVTEADYKIWKPIDLMPYMNVVLEAFGPNRIVYGSDWPVCLVAG
SYAQVLSVAQAFSGQLSKDEQELFFYKNAQRIYTL
>KECLDBNJ_03417 L-galactonate-5-dehydrogenase
MNYIVCEEPGTFLLKEQDIPKPKAGESLLRIRKIGICGTDIHAFGGTQPYFNYPRVLGHE
IAAEYVEGSAVGFNTGDAVSFIPYFSCGSCVACRNGLTNCCTSIKVFGVHIDGGMAEYVV
VPDGYLLHGEGLDFDELALVEPLAIAAHGVRRAGVREGETVLVMGAGPIGIGLIKFAQQA
GAQVIALDVNEHRLDFCKDELGVWQTLNPMNADVMERLAEITNGDMPTVIIDATGNRNVM
NSAFQYLAHGGRYVLVGLQKGELSFSHPEFHKRESTLMSSRNATREDFQYVIESIKSGTI
NPKKYITHRIAFKDLPSGFEDLLAPENNVIKALVEIND
>KECLDBNJ_03418 hypothetical protein
MKRRNALKLGAAAAAGLYLNPMLARANFFNPEQKGPFKPNWDSLSKYQVPEWFRDAKFGM
WAHWGPQCEPESGDWYARGMYQEGTWQYKSHIENYGHPSKFGFKDVIHMWKADQWNPQEL
VDLYKNAGAKYFMAMANHHDNMDLWDSTYQPNWNSVKMGPKKDIIAGWEQAARKAGLPFA
LSVHAAHAWSWYEPSQRADKNGPLAGVPYDGNLTIEDGKGTWWEGIDPQELYAQNHPLSE
DSYDNGKIHSQWNWGNGVTPPSEQYCDKFYNRTIELIDKFNPDLLYFDDTALPLWPVSNV
GLEIAAYMYNKSLDKKGNPQAVITGKILDEEQRKALVWDIEKGQSNEIEPLPWQTDTCIG
SWHYDKGIYRDKRYKSAKQVIHSLIDVVSKNGNLMLNIPVKGDGSIDELERAIVEEIGEW
MRLNGKSIYGTRPWKIFGEGPQQESAAALTAQGFNEGKGKPYSSSDFRFVTKGDRLYATV
MSWPENGKVLINALRSDSPYLNKSIKKVKLVSTGKKLKFKQNAEGLEVYFPQEKPAASYA
NPLEIKY
>KECLDBNJ_03419 hypothetical protein
MKTFQNISIKLCFVLALGYGVVSCEYDNFDEPQTTIQGRIVDASGNLVPTQQPNGTRIRL
YDQAYENVQPIALWGMPDGTYEYTRIFSGSYKVIADGPFFPIDTLLTNIQDVENLDIEVV
PFLSLSNISAEENGSDVEVTYSISRTQVVGKINKLAVFVNTTPFVDSNNFINTNAESDVS
GMSDDELLNNVQQKVISGLEPGEKYYIRAAARAANSGNYYNYSEMIELEL
>KECLDBNJ_03420 SusD-like protein
MKNFKIKMISCLVLLGIFHSCDDDFLDRQPLNIISESDVWNSLTGVEAYLVTLYNNMQTE
DFNYNGIIDYQGYLPFVTDICLRAKTWGTVSNVSIMPSNAYGWWGYGQVRQANLFLENID
DASISQDQKVILRGEARFIRAFYYFSMVKRYGGVPIIEDAQQFTGDNLAELQVSRNKEQE
VYDWIASELDLAIADLPATRGSDDKFRATKWAAYALKSRAMLYAASSARYAGVQLNGLIG
IPSSEAERYYTAAKNASKAIMDSEQYTLFDESDDKAQNFYDLFMGDGTNSEMIFVKAFKA
PDKTHSFDFFNTPHSFRIDWGSGYNPTVDLVQDYEYIDGSEGTLRVNDANGNPIKYQNPA
DLFEGKDPRFFATVLYPFAPYQGGIVEVRAGIIDNGQTITAGNLTDLYGQGSEAVTIMGK
DGPSANSDPTKTGFYLHKFINDSQQVPDGRSETPWPIFRYAEVLLNYAEATVELGENGLA
LDAINRIRTRAGIASLENVDRDKIRHERKVELAFENHRFWDLRRWRNGTEILNNTQPLAL
NPYLIWEDKTYIFSIDNAPRQPRTWTEQMYWEAIPGNEISTNPNMIQNPLY
>KECLDBNJ_03421 TonB-dependent receptor SusC
MNKKQTRAGLGGDRMRLKIKSAVLVFSCFSGLIAQAGIEDNPFAESAIPWVNDSYVVKND
THTVFGKEQQEITGTVTDQDGNPVIGVNVVVKGTSTGTVTDFDGNFAIKAATDQILVFSF
VGFKSQEVPIDGRTNLQVVLEGDVSQLDDVVLIGYTERKESNVTSAVATIKADEISRAPV
SNLSQSFAGRLPGVVSTQRSGEPGYDGAGVSIRGFGNALVIVDGVPQNYTQLDPNEVASI
TILKDAAAAVYGVRAANGVILVETKKGKYGKPVFKYDAYVGVQTPTRYPELTSAADFVLL
NDEGEINQGRSPVYGREVYEQYRNGELPSYDWYDLTIRQYSPQTQHTISAQGGTEDIDYY
MSVGMFNQEGMWRTKDNNYERYNFRSKVTGRFSDNFSATMNLSGRIENRNTPGLSAANIM
WGILRAHPTSGPYANDNPEYYNETNVPFFQPVALSNSDVSGYNRDNFNNFTGILSLDYKV
KQIEGLSLKGMYSYLREFARVKNWSPEFDLYNYNAETDAYNVGYTGGSPTRLTETFRQNT
ETLAQFSMNYKRTFGDKHTFEGLALFEQRESYGDDFNASREYSLDAVQYLFAGLDANKNN
NGGAYEFASRGLVGRAYYDYDDKYILELVFRYDGSSRFPQGSQWGFFPAVTAGWRISDEG
FFKNTIDFVNNLKLRGSWGKVGDDQGANYQFVTGFTYPSGNYIYGNNVVPGLVERGIPNP
NLTWYESTTTNLGLDAALLNSKLTLQFDYFYRQRDGLLATRFLSLPGTFGASLPQENLNS
DSDRGFELVVGTNQSLGDFQFDVNANVTYTRSKYGYQERAPFTSSENEWRQKAEGRWKNI
WWGYEAIGQFQSQEEIDNWAVVQDGQGNRSLRPGDIKYLDYNGDGIIDGGDNKPIGRGTT
PEIMFGTNINVSYKNFDFSVLFQGAANFNFYFTDEFQSPIFNNANSLATFMDRWRREDPY
DLTSEWIPGKYPATIPSGSPNNKYNSSFWLQNANYLRLKNIQLGYTLPKGVCETLGITNA
RVYINGLNVYTWDKLKYANVDPETPGGNGLFYPQQRVWNTGVNVTF
>KECLDBNJ_03422 Transposon Tn10 TetD protein
MLHTHSYSLLNADYVQLNARWNYKNVISPYYRLYYIDDGAGEVSNLSKKLVLKPGYLYLI
PSFTLCNLKCDTYLSQYFIQFFEETPDGISQFKDNRDLMELKASDTDVHLIKRLIKINPG
RGINRSDNPKVYEKETYYKEYRDLNRNMRISVQFESQGIILLLLSRFLESTRFKQEELNK
IPSTVLDAINYIQINLGSALTVADLSDYVNQNKDYFSRIFLEHTGSRPLAYIHKKRIERA
QYLIVTTNKTLLDIAFETGFNTLPHFSKIFKKQVQITPAAYRKQNLQIT
>KECLDBNJ_03423 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MKLIKLDRQSHEDCSFTINNTRDRHFLKIWHYHPELELVLILESTGTRFIGDSIAKFTPG
ELVLLGPNLPHMWLNDPIYFKEENEEFQARAIAIHFKQDFLGADFFTRPEMRILARLLQA
AQRGLVFKNIPPEVPEQLKNLKHLEPFERSLSLLQLLKELAMLDYHPLTGAGYLSEAYNT
GAGNFDKVYEYLYKNFRESISLEDVAALIPMNPSAFSRLFSKFHKKSLMRYLNEIRIGYA
CRLLMEPHERVSEIGFASGYNSLSNFNRQFKKVTGKTPKEYAEIHSKMP
>KECLDBNJ_03424 L-fuconate dehydratase
MKTEVIITGYEVVDVRFPTSQFLDGSDAMNPDPDYSAAYVILKTSQEGLEGHGLTFTIGR
GNELCVAAIDSIMPLILNKSLASFTANMGAFWKMITGDSQLRWLGPEKGVIHLATGAVVN
AVWDLYAKAEEKPLWKLLADMSAEELVSCVDFTYITDAITPAEAIAMLRKLEGTKQQRID
KLLQKGYPAYTTSAGWLGYSDEKMRKLCREAKAEGFKHMKIKVGKDLKDDMRRAQIIREE
IGDDLKLMMDANQKWDVTEAIANMAELKKFSPWWIEEPTSPDDVLGHAAITKAVAPIKVA
TGEHCQNRVIFKQLMQAGAIEICQIDSCRLAGVNEVLAVLLMAAKFEIPVCPHAGGVGLC
EYVQHLSMIDYIAISGSLENRIIEYVDHLHEHFFDPVVIKNGAYMPPKLPGYSITMKPDS
LKDYEFPKGTIWQEIAQKN
>KECLDBNJ_03425 Dihydroanticapsin 7-dehydrogenase
MKPFQLTHKTALVTGGASGIGRAIAETFAKNGARVVILDFNETQAKEVVEAFKAEGLELQ
YIICDVSKAEEIQQIVDDIASQNKIDILVNNAGVAHVGNIENTTEADLDRIYSINIKGVY
NCVKAVIKHMKGNNGVIINMASIASSVGISDRFAYSMSKGAVLTMTYSIAKDYVDQGIRC
NSISPARVHTPFVDGFIAKNYPDNQKEMFEKLSKTQPLGRMGKPAEIAHLALYLASDEAS
FITGTDFPIDGGFIKLNG
>KECLDBNJ_03426 Ureidoglycolate lyase
MKLIRFGAAGKEKPGVQLDSGKRIDVSAFGEDYTEAFFENDGLNRLQSWLSSEQDNCPEV
SAETRLGAPLVRPSKIVCIGLNYVSHAKETGMEVPKEPILFFKATSAIVGPNDDVIIPKG
SEKTDWEVELAVVIGKKASYVSEAEALDYVAGYTLHNDYSERAFQIERAGQWVKGKSCDT
FAPLGPFIATKDEIKDPNKLNLWLKLNGEQLQNSNTSDFVFNVQQVVSYISQFMTLLPGD
IISTGTPFGVGMGFNPPRYLKPGDVVELGIEGLGTSKQKATEYKN
>KECLDBNJ_03427 hypothetical protein
MDTPASNTLKNLISESYIFILLCILTLESNSKQRAQSIKFGFSTLIDIAIYFTSFCIQWP
FV
>KECLDBNJ_03428 hypothetical protein
MTWVREQEEFYKAQIKLNMLQAMDTVESITIPKASSDGYAGVEYFKEFN
>KECLDBNJ_03429 hypothetical protein
MLLNQLPPGTQNPDDNFPVDFKDPFEVIVFVILPMLIIIGYILWKRKRKKRKD
>KECLDBNJ_03430 hypothetical protein
MGIKRGPKHIAKLTGQPDRRQHDNKGTPGNTPCLKPHKHKKGD
>KECLDBNJ_03431 hypothetical protein
MFCTAFYQYLTVRYADEFAVDPNYCIAVDISRAKDLSYTEILKSGTSEILLNTITDLNEL
L
>KECLDBNJ_03432 hypothetical protein
MFVSLFFSKKKGSEHSCSAFRSFLGELEVFFEVVGYGGELHMYASLFCMLP
>KECLDBNJ_03433 Spermidine/spermine N(1)-acetyltransferase
MQQITVRKITTANIIELQNIGKLTFAETFSSENSETNMKEYLENGFSTEKLTEELTDQNS
EFYFAELDGKTIGYLKVNVGQSQTEIKDHNALEIERIYVLKEFHGKKVGQILYNKAIELA
KDKNVEFVWLGVWEQNPRAIRFYEKNGFVAFDKHVFKLGNDEQADIMMKLKME
>KECLDBNJ_03434 hypothetical protein
MYISISPQKQGGNYPKSSGGFVAYLEKENEEDINMQKEFFFNQDEEHITPEQVVQAIDQN
TAKLKAKEPKFYSITLSPSQRELGQLQNSSKDLKAYTRAVMKDYVTCFNRELDGRPIAIK
DILYFAKVEHQRTYKGTDIQVRENQPYATKILKLHSEIRKIRQGSAQGRIEDLAREVARL
EQQAPHQQNGKRIIQGMPKAGNQSHIHIIVSRKDASNTISLSPGSKYKASQTN
>KECLDBNJ_03435 hypothetical protein
MDKGYEKERFVNLSIKESVARDFRVFSKKLSSSQSMALREMLDFFQVNELSPNERLGPSG
RTMEANLKKRINAVIAIIRDIEKTQTKPTNAMLQSLFELEPQKEKPLIVEKKYAQDSKQP
RFREKQKED
>KECLDBNJ_03436 hypothetical protein
METRINEISLSYRPKRKAEHWPQISSSSLAAHVIYQNWDQNTIAVYESFKIVLLNNSNKV
KGIYQISAGGITGTLVDLRLLFAVALKSLSVALILAHNHPSGTLRPSEADKQLTRKIKAG
GDFLDIKILDHIIINPTGDYYSFADEGIL
>KECLDBNJ_03437 hypothetical protein
MSAQSKQLIEQLQGFCGSATCYQIPMLRTKYTEGIKYLTEQAQCHWLVTDTAVMCKSLKN
KSNFIVILFKRNPKSVQERTHKEAKITYADGNGTILLEQEYEYTDFPLDELRLFFVDDML
MLPNEY
>KECLDBNJ_03438 Single-stranded DNA-binding protein
MSTLRNQVQLIGNVGQEPTLTTLESGKKVVRFSLATNEFYKNAKGEKTQDTQWHTIVAWG
KTAELIENYAPKGKELALTGKLKSRSYTDTAGLKRYVTEVEASEIVLLGSKSE
>KECLDBNJ_03440 hypothetical protein
MNTDWKEEEFWNALSHGLGIMLGFLGIGLLLYYDTSKSNYSTLSILFYGCSIVMLYSAST
LYHLISHTSWKHILRKIDHISIYFLIAGTYTPVALIALESSTGWLIFWTVWGIALVGTVL
KIFFTGRFEVLSLLLYLLMGWLIVFDWNNLLAVSSDTGINLLMLGGAFYTVGIVFYAVRK
IPFNHLIWHFFVLAGSICHFLFILIDVI
>KECLDBNJ_03441 hypothetical protein
MFSKEESKKIREDFWIFFGKRYPRKWLLYDTKVKEINLKFSFDKTKAMVSFDIETHDTVF
REYYFEKFESLKNLLKTEVSEDILFEKEYIRSSGKIISRIYVEKLNVNIHNKKHWPEVFE
FFHDNMEKFELFWWEYQDFITA
>KECLDBNJ_03442 hypothetical protein
MIFILPIAAVVLGFLIALWFKPKVNAAIKLLLAFSGAFLLSITIFEFLPELYASGSKHVG
LFIMAGLLFQILLEFLSRGAEHGHLHVDADSSKLPWLLFLSLAVHSVLEGFPLYKNADLV
LGISIHKIPIAIIISSFLLASKINTYKTLLFLIVFALMTPLGSYVSTFEFWTTEVTNYIN
AAVVGVLLHVSTTILFESSKNHQFNATKFGVILLGIALAYLL
>KECLDBNJ_03443 Ribosomal RNA large subunit methyltransferase L
MAENFKMLAKTLFGFEDLLARELRELGAGDIEIGTRSVSFSGDTGFMYKANLCCRTAIKI
LKPLRSFVVKDENALYAAVKSIDWSQYMRVNDTFVINATLSGEQFTHSLFVAQKAKDAVV
DQFREATGERPDVDLKFPDLSIDIHIRHNRCTISLDSSGVSLHQRGYRLNTNVAPINEVL
AAGCLMLSGWKGHSDFLDPMCGSGTMLIEAAMIACNIPPNLNRKQFGFENWHDWDPDLFD
IIEASALKKIRDFHFTIQGYDKDPSVIEKAKENIKNAELSEFISIKEADFFKTEKERERH
LQMVFNPPYGERIPVEMETFYKNIGDTLKQNYKDTEAWFITSNLESLKHVGLRTSRKIKL
YNGSLESRLVKYDIYAGSKKAKYQNND
>KECLDBNJ_03444 Dipeptidyl-peptidase 6
MNYGICPLSIVPMRLEPADAAEMINQVLYGEHFKVLEIRKKWSRIRLAHDKYEGWIDNKQ
YKEITAEDYDDAEKRTPILASDLLQMATSSDEHVLSIPLGAQLANLALTGDHYEGNSVAE
KKEKATFINTALLYLKSPYLWGGRTPFGLDCSGFTQMVYRLNGHALFRDASQQATQGEPL
SFIEESEPGDLAFFDNDEGAIVHVGIMLQDNYIIHCHGEVRIDRIDHTGIYNAERRTHTH
KLRVIKRII
>KECLDBNJ_03445 putative acetyl-CoA acyltransferase
MKKDIVIVSAVRTPIGSFLGSLSSLTAVDLGVAAIKGALTKINLDPSLVDEVFMGNVVQA
GVGQAPARQAALGAGIPKNVPCTTVNKVCASGMKAVMFAAQSIALGDNDIVVAGGMESMS
QIPHYVHMRNGQKFGPTTLIDGMQKDGLVDAYDGNAMGVCADACATKYNFSREDQDAFAI
ESYKRSAAAWESGKFADEVIPVEVPQRRGEPVVVSEDEEFKNVRMEKISSLRPAFSKDGT
VTAANASTINDGAGAVILMTREKAEELNLDILCSIKGYADAATDPEWFTTAPSKALPKAL
AKAGVGQGEIEYFEFNEAFSVVGLANMKILGLSTDKVNVNGGAVSLGHPLGCSGVRILIT
LINVLKQNNAKLGAAAICNGGGGASAMVISR
>KECLDBNJ_03446 Cyclic-di-AMP phosphodiesterase PgpH
MSSILNRFYKNQGALYKVLLCIASTILIVYLFPKSGKFQFDFQQNKPWQYDNLYAPVDFA
ILKSEDQLEQERAEAENSIIPYFNYDQDIANEAKAAYENQFSSVFTDSIFRDRQIELKKF
GSQILEDIYKYGVISDLAAFQEGRKIYLRRGNEIEETSIENLNTTDEISALINRRLVNGP
YVQAVNRFKELFYDVVQPNVTYDEKLTNKELNAELSKIAPTKGVVNKGSRIVAKGEIVEQ
STYQILKSLQAEYESQSWTASKYNWVVFGYVLLVSVALTMLLLFIKTYREHVFENNTMVT
FIFFNIILMVLFTTLIVKYDANYVYVVPLCILPLVIKAFFDSRLGLFTHVITLLLLGFIV
PNTSEYMFLQVIAGIVTILTVSELYKRANLFISVGQITFMYIIGYFAFHIIHEGTIDNLQ
WETFSLFIITGLATLFVQPLIYAYEKIFGLVSDLSLLELTDTNSKLLKNLANKAPGTFHH
SLNVANLAEAAANEIGANAMLTRVGALYHDIGKMLNPTDFTENQSTGINTHEDLSPKESA
RIIIDHVINGIEVARKNNLPDRVIDFIRTHHGTSTVYYFYKKAQEQDEDVNIDDFRYPGP
LPFSKETAILMMADSVEAASKSLKSPTSVLIDSFVEKIINKQMEENQFLNATITFKEIQI
IKKVLKSKLNNIYHLRIEYPE
>KECLDBNJ_03449 Tyrosine recombinase XerD
MITSHTLNVHFWLKKSSVRKDGTFPIYARISIGSASRVDLSTKQNVLEQNWCDKSSRVGK
RIKDARRINDELDAIYSEVKKAYKELRNEGVPISAKAVKLRCTGKDRPVSTIRDLIQYHT
ENDLKKLAPGTAKNYAATEKYILRFVKSEYKCDDIYLSQIDYTFIVKFEDYLRDCKTLKK
AQPLNNNGRMKHLERLKKFTTLALKHRWIKSNPFALYQLKYEDFDCPFLEENELKTISSI
TLTDDSLSIVRDVFVFSCYTGLCYIEVKNLKTGDIVNGIDKEDWIMVRRQKSKTPVKLPL
LEQAKRILEKYQEVSQDVHTNKLLPVFSDQKINKYLKEIAKLCKIEKNLTFHVARHTFAT
TVTLLNDVPIETVSKMLGHTKLSTTQKYARVVEQKISKDMSSLRSKLKQTNRTSTKSKTY
KDNGHLRIV
>KECLDBNJ_03450 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MSHNHKSQKFGLVFSLSIILNTLYVIVEFFYGMRVDSSALIADAWHNASDVFSLILAWIA
YKLTLIPANNRFTYGYQKTTILVSFLNGAIIIIAAFFIAWEAIQKLNSANEIPGELIIYV
SIIGLFINTGTALLFWNSQKNDLNMREAFLHMAADAGVTLAVLCGGLSIKFLDLEWIDPL
LSILIVIVIIYSSWGLLKESLYLLIDAVPKHLDLEKIKFEVLNFDGVLAVKSIHIWALST
TQTTASMILQVNPGTSDVSVKEISGRLTEKFKLQKTTIELQYED
>KECLDBNJ_03451 hypothetical protein
MNSSEHILLNSKLRPTAMRILIFSFLRKHRQALTITDIESEFQKVSRSTVLRTIKTFEKK
GLIHAIIDDSKYLKYALNDPNQPEHQNHLHLNCLSCNHTYCMYNYTLPQISIPPRYHVKT
TQILVKGICDICQIK
>KECLDBNJ_03452 Cobalt-zinc-cadmium resistance protein CzcB
MNFNIKPIFYVALVIFSLSSCKEGKTDQSGHEKHNETAPADNGDQPQKANAGLERKKLHL
SQQKFEAMELKVDSLPTKSLTALVEANGQLEVPPQNEAAITAIIGANVTSIKVIEGNKVS
KGSVLGYLSHPDLVKLQTDYTSAYNKMIFLEKEYNRQKRLYEAEVASGRKYQETESEYNS
VKGLFKGLESQLQLFHLNLNQLRSGKFYNQIPIVSPIDGYVEQVNIKVGQFVQQQTEMFE
IVNTDHIHADLMVFEKDVSKVKEGQTVAITIESLPESDLSAKIYSVGKTFEQQPKALHVH
AEIENRDSNLLPGMYLTAKIATSQDNVTALPEEAVITENGEDYIFTAKKVTENEEEVWAL
SPLKVQTGQSDTGWIEIKLLQPLEERQMVVWNKAYYLISEMNKGETEHGH
>KECLDBNJ_03453 Cobalt-zinc-cadmium resistance protein CzcA
MINKIIAFSIRNKLIVGLFILFLIGVGLYSMSTINLGAQPDITNNQVQIITQSPNLATED
IEQFVTYPVELAMANLPGVNEIRSVSRFGLSVVTIVFKEDMGTYLPRQLVGEKLNEVKSE
IPEQFGSPEMGPITTGLGEIYQYTLKAEEGYEDKYSPTELRTIQDWIVKRQLALTEGVVE
VNAFGGKIKQYEIAIDPAKLNAMNVTMTEVFDALQENNVNTGGAYIEKNKMANFIRGEGL
VRSLDDVRQIVIKNENGLPILVKDVAEKVHFGNQVRYGAFTQDGHEAVGGMVLMLRGDNP
NSVVNTVRDRIREVQKSLPQGLKIVPFLDRSALIGRTTATIEKNLIEGALIVIFVLVLLL
GSFRGGLVTASLIPLSLLFAFILMKALGVWANLMSLGAIDFGIIVDGAVIIVEGTVHEIE
KRIKAGKQQFDQPQMDEVVYDASSTVMNSAFFGQVIILIVFTPILFLTGIEGKMFRPMAF
TFGFAVLGAIILCLTYVPVITSLMMRPAIKNRNWFHNVEDKISGFSNGMMNRINKGYRPI
VLKSLNHRIIVLVIAVILLLGAGFTFSKMGGEFIPSIDEGDIAMQALLRPGSSLSESIET
SKKIENIVLDNFPEVETMVARIGVADIPTDPMPMDIADTYIILEKNKDHWTSADTKEELI
KKIKEKLSIVPGVNFVFSQPVELRFNELLTGVREDVAIKLYGEDLDVLSQKAAKMAAIIK
TVPGAGDVNLEATSGLPQMTVRFSRRKVAQYGLNIQKLNQYVSTAFAGGTAGVIFEGEKR
FDMVVRLDEKHRKDIDNLKNLLIDLPGGNQIPIKEVADISYQPGPMQISRDNTSRRIYVG
VNVRGRDVESMVNDIQTKMDAQLDLPPGYHIEYGGAFENLQRAKDRLTIVVPIALALIFL
LLYFALGSFSQSIMIYMAVPLAAIGGIFAIAVRGMPFSISAGVGFIVLFGVAVLNGLVLI
SRLNSLKKEGVMDIQERILIGTQERIRPIFLTALAAIMGFFPMALSHGAGASVQRPLATV
VIGGLITATLLTLIVVPVLYSFVEKSGNKNYGKPGKAAINPGLIAIILGLGSMGIPASAS
AQTQDRPQQSAPEQDILKVAQGFYTISLRDAVEKAQANYPKMKAAQLEIENQEVRKKTVW
DLGTTQIFTGGEELPDSRNGDEGIYTIVGVQQQNIDVFSIGAKNKLQNEKIELSETALDL
TSLQIEREVSKAWGDAYTSKRKYQLYVELDSIFRDFEQAARLRYETEASSKLEYLAATNQ
ARQVSLQKMQAYRDYLGNLQKLNLWLVSDTPYTVADTSVDEMNTPILQRKDSIKSHPMLD
YYEHQIGVAYAKRNLSTKAFFPKFNAQYGRQKIAGQKGFFSFQVGISIPLFFGPDLGYAQ
SAKIQTQIAQQNFKAKKLQFNSKYQDLQQEYLKWQESWKYYEQEALLLAKEQRDGAVFAY
KEGGISYTSFLQTVRDAIGIQSKSWDALNNYLRSKYELEFFLNSAKQ
